PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Rasmussen, RS; Schaarup, AMH; Overgaard, K				Rasmussen, Rune Skovgaard; Schaarup, Anne Marie Heltoft; Overgaard, Karsten			Therapist-Assisted Rehabilitation of Visual Function and Hemianopia after Brain Injury: Intervention Study on the Effect of the Neuro Vision Technology Rehabilitation Program	JMIR RESEARCH PROTOCOLS			English	Article						stroke; vision; rehabilitation; brain injury	POSTSTROKE FATIGUE; STROKE PATIENTS; SENSITIVITY; INVENTORY; VALIDITY; INDEX	Background: Serious and often lasting vision impairments affect 30% to 35% of people following stroke. Vision may be considered the most important sense in humans, and even smaller permanent injuries can drastically reduce quality of life. Restoration of visual field impairments occur only to a small extent during the first month after brain damage, and therefore the time window for spontaneous improvements is limited. One month after brain injury causing visual impairment, patients usually will experience chronically impaired vision and the need for compensatory vision rehabilitation is substantial. Objective: The purpose of this study is to investigate whether rehabilitation with Neuro Vision Technology will result in a significant and lasting improvement in functional capacity in persons with chronic visual impairments after brain injury. Improving eyesight is expected to increase both physical and mental functioning, thus improving the quality of life. Methods: This is a prospective open label trial in which participants with chronic visual field impairments are examined before and after the intervention. Participants typically suffer from stroke or traumatic brain injury and will be recruited from hospitals and The Institute for the Blind and Partially Sighted. Treatment is based on Neuro Vision Technology, which is a supervised training course, where participants are trained in compensatory techniques using specially designed equipment. Through the Neuro Vision Technology procedure, the vision problems of each individual are carefully investigated, and personal data is used to organize individual training sessions. Cognitive face-to-face assessments and self-assessed questionnaires about both life and vision quality are also applied before and after the training. Results: Funding was provided in June 2017. Results are expected to be available in 2020. Sample size is calculated to 23 participants. Due to age, difficulty in transport, and the time-consuming intervention, up to 25% dropouts are expected; thus, we aim to include at least 29 participants. Conclusions: This investigation will evaluate the effects of Neuro Vision Technology therapy on compensatory vision rehabilitation. Additionally, quality of life and cognitive improvements associated to increased quality of life will be explored.	[Rasmussen, Rune Skovgaard; Overgaard, Karsten] Univ Hosp Copenhagen, Dept Neurol N108, Herlev Hosp, Herlev Ringvej 75, DK-2730 Herlev, Denmark; [Schaarup, Anne Marie Heltoft] Inst Blind & Partially Sighted IBOS, Hellerup, Denmark		Rasmussen, RS (corresponding author), Univ Hosp Copenhagen, Dept Neurol N108, Herlev Hosp, Herlev Ringvej 75, DK-2730 Herlev, Denmark.	rsr@sund.ku.dk		Rasmussen, Rune/0000-0002-5630-122X	Helsefonden; Jaschafonden; Fondation Juchum; Soren og Helene Hempels Legat; Handelsgartner Ove William Buhl Olesen og aegtefaelle fru Edith Buhl Olesens Mindelegat; Tommerhandler Fogs Fond; Marie og Borge Kroghs Fond; Else and Aage Gronbeck-Olsens Legat	We would like to thank Dorthe Marie Degn for her invaluable help raising funds for this study. Funding has been provided by Helsefonden, Jaschafonden, Fondation Juchum, Soren og Helene Hempels Legat, Handelsgartner Ove William Buhl Olesen og aegtefaelle fru Edith Buhl Olesens Mindelegat, Tommerhandler Fogs Fond, Marie og Borge Kroghs Fond and Else and Aage Gronbeck-Olsens Legat. No source of funding had any involvement in the study apart from provided funding.	Bech P, 2001, J AFFECT DISORDERS, V66, P159, DOI 10.1016/S0165-0327(00)00309-8; Cassidy TP, 1999, AGE AGEING, V28, P257, DOI 10.1093/ageing/28.3.257; Christensen D, 2008, CEREBROVASC DIS, V26, P134, DOI 10.1159/000139660; Feigin VL, 2017, CIRC RES, V120, P439, DOI 10.1161/CIRCRESAHA.116.308413; George S, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-87; HARTMANMAEIR A, 1995, AM J OCCUP THER, V49, P507, DOI 10.5014/ajot.49.6.507; Hayes A, 2012, NEUROREHABILITATION, V31, P19, DOI 10.3233/NRE-2012-0771; Jones SA, 2006, AGE AGEING, V35, P560, DOI 10.1093/ageing/afl074; Lerdal A, 2011, INT J NURS STUD, V48, P1258, DOI 10.1016/j.ijnurstu.2011.02.019; Loring D W, 1990, Arch Clin Neuropsychol, V5, P1, DOI 10.1016/0887-6177(90)90002-7; Mangione CM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1050, DOI 10.1001/archopht.119.7.1050; McInnes JK., 2000, VIS IMPAIR RES, V2, P129, DOI DOI 10.1076/VIMR.2.3.129.4422; Moster S, 2014, J NEUROL SCI, V343, P105, DOI 10.1016/j.jns.2014.05.047; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Poulsen MB, 2015, STROKE, V46, P3470, DOI 10.1161/STROKEAHA.115.010860; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; Sorensen MS, 2011, DAN MED BULL, V58	19	1	1	1	2	JMIR PUBLICATIONS, INC	TORONTO	59 WINNERS CIRCLE, TORONTO, ON M4L 3Y7, CANADA	1929-0748			JMIR RES PROTOC	JMIR RES. Protoc.	FEB	2018	7	2							e65	10.2196/resprot.8334			8	Health Care Sciences & Services; Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	GG7ZB	WOS:000432916000020	29487042	Green Published, gold			2022-02-06	
J	Saherwala, AA; Bader, MK; Stutzman, SE; Figueroa, SA; Ghajar, J; Gorman, AR; Minhajuddin, A; Olson, DM				Saherwala, Ali A.; Bader, Mary Kay; Stutzman, Sonja E.; Figueroa, Stephen A.; Ghajar, Jamshid; Gorman, April R.; Minhajuddin, Abu; Olson, DaiWai M.			Increasing Adherence to Brain Trauma Foundation Guidelines for Hospital Care of Patients With Traumatic Brain Injury	CRITICAL CARE NURSE			English	Article							HEAD-INJURY; MANAGEMENT; OUTCOMES; PROPHYLAXIS; PRESSURE; TRIAL	BACKGROUND The Brain Trauma Foundation has developed treatment guidelines for the care of patients with acute traumatic brain injury. The Adam Williams Initiative is a program established to provide education and resources to encourage hospitals across the United States to incorporate the guidelines into practice. OBJECTIVE To explore the relationship in hospitals between participation in the Adam Williams Initiative and adherence to the Brain Trauma Foundation guidelines for patients with acute traumatic brain injury. METHOD Hospitals that participated in the Adam Williams Initiative entered data into an online tracking system of patients with traumatic brain injury for at least 2 years after the initial site training. Data included baseline hospital records and daily records on hospital care of patients with traumatic brain injury, including blood pressure, intracranial pressure, cerebral perfusion pressure, oxygenation, and other data relevant to the 15 key metrics in the Brain Trauma Foundation guidelines. RESULTS The 16 hospitals funded by the Adam Williams Initiative had good overall adherence to the 15 key metrics of the recommendations detailed in the Brain Trauma Foundation guidelines. Variability in results was primarily due to data collection methods and analysis. CONCLUSIONS The Adam Williams Initiative helps promote adherence to the Brain Trauma Foundation guidelines for hospital care of patients with traumatic brain injury by providing a platform for developing and standardizing best practices. Participation in the initiative is associated with high adherence to clinical guidelines, a situation that may subsequently improve care and outcomes for patients with traumatic brain injury.	[Saherwala, Ali A.; Stutzman, Sonja E.; Figueroa, Stephen A.; Olson, DaiWai M.] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Bader, Mary Kay] Mission Hosp, Surg Trauma Neuro Intens Care Unit, Mission Viejo, CA USA; [Figueroa, Stephen A.] Univ Texas Southwestern Med Ctr Dallas, Dept Neurosurg, Dallas, TX 75390 USA; [Ghajar, Jamshid] Stanford Univ, Sch Med, Neurosurg, Palo Alto, CA 94304 USA; [Ghajar, Jamshid] Stanford Univ, Sch Med, Stanford Concuss & Brain Performance Ctr, Palo Alto, CA 94304 USA; [Ghajar, Jamshid] Brain Trauma Fdn, Palo Alto, CA USA; [Gorman, April R.] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA; [Minhajuddin, Abu] Univ Texas Southwestern Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA		Olson, DM (corresponding author), UT Southwestren Med Ctr, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	daiwai.olson@utsouthwestern.edu	Saherwala, Ali/K-1660-2019; Olson, DaiWai/I-5932-2019	Olson, DaiWai/0000-0002-9280-078X; Figueroa, Stephen/0000-0002-6363-8496; Saherwala, Ali/0000-0002-8947-416X	Adam Williams Institute	The Adam Williams Institute has partnered with and received products from Aspect Medical Systems, NeurOptics, KCI, Medivance Inc, and Integra Neurosciences. Parts of the writing and data analysis of this project were supported by the Adam Williams Institute.	Abdel-Aziz H, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0814-z; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Bader MK, 2014, CRIT CARE NURSE, V34, P39, DOI 10.4037/ccn2014112; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cheater F, 1997, CLIN EFFECTIVENESS N, V1, P4, DOI DOI 10.1016/S1361-9004(97)80022-2; Chen AY, 2011, EMERG THEMES EPIDEMI, V8, DOI 10.1186/1742-7622-8-4; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Crossley S, 2014, CRIT CARE, V18, DOI 10.1186/cc13835; Edwards P, 2005, LANCET, V365, P1957; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Fox JL, 2010, CAN J EMERG MED, V12, P355; Francke AL, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-38; Fu TS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145469; Garbin P A, 1991, J Qual Assur, V13, P28; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; Gupta D, 2016, WORLD NEUROSURG, V89, P169, DOI 10.1016/j.wneu.2015.12.097; Hesdorffer DC, 2002, J TRAUMA, V52, P1202, DOI 10.1097/00005373-200206000-00031; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Kannan N, 2018, PEDIATR EMERG CARE, V34, P325, DOI 10.1097/PEC.0000000000000803; Perkins GD, 2003, CRIT CARE, V7, pR67, DOI 10.1186/cc2339; Phelan HA, 2012, J TRAUMA ACUTE CARE, V73, P1434, DOI 10.1097/TA.0b013e31825ac49e; Phelan HA, 2012, J NEUROTRAUM, V29, P1821, DOI 10.1089/neu.2012.2459; Roberts I, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000033.pub2; Robertson CS, 2001, ANESTHESIOLOGY, V95, P1513, DOI 10.1097/00000542-200112000-00034; Tinetti ME, 2004, NEW ENGL J MED, V351, P2870, DOI 10.1056/NEJMsb042458; Van de Louw A, 2001, INTENS CARE MED, V27, P1606; Veatch R. M., 2015, CASE STUDIES BIOMEDI; Zafar SN, 2011, J TRAUMA, V71, P1179, DOI 10.1097/TA.0b013e3182140d38	32	1	1	0	1	AMER ASSOC CRITICAL CARE NURSES	ALISO VIEJO	101 COLUMBIA, ALISO VIEJO, CA 92656 USA	0279-5442	1940-8250		CRIT CARE NURSE	Crit. Care Nurse	FEB	2018	38	1					E11	E20		10.4037/ccn2018691			10	Critical Care Medicine; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Nursing	FY6NX	WOS:000426966400002	29437084	Bronze			2022-02-06	
J	Segev, S; Shorer, M; Peleg, TP; Apter, A; Fennig, S; Rassovsky, Y				Segev, Shira; Shorer, Maayan; Peleg, Tammy Pilowsky; Apter, Alan; Fennig, Silvana; Rassovsky, Yuri			Gender Differences in Neurocognitive Performance Among Children With Posttraumatic Stress Disorder and Mild Traumatic Brain Injury	JOURNAL OF TRAUMATIC STRESS			English	Article							SEX-DIFFERENCES; SYMPTOMS; ADOLESCENTS; AGE; CONCUSSION; VETERANS	Posttraumatic stress disorder (PTSD) and mild traumatic brain injury (mTBI) are frequent sequelae after motor vehicle accidents (MVAs). These two pathologies often have overlapping neurocognitive deficits across several domains, such as attention, memory, and executive functions. The present study was an effort to examine the contribution of gender to these overlapping symptoms. To this end, psychodiagnostic and neuropsychological data were collected on 61 children and adolescents 3 months following MVA. All participants were diagnosed with PTSD, and about half (n = 33) also received a diagnosis of mTBI. Analyses of variance revealed significant interactions between gender and mTBI (<mml:msubsup>p2</mml:msubsup>=.15), such thatgirls with mTBIs preformed significantly worse than noninjured girls on measures of executive functions (Cohen's d = 3.88) and sustained attention (Cohen's d = 3.24). Boys, on the other hand, did not differ significantly on any of those measures, irrespective of TBI injury status. Similarly, comparisons to the normative population revealed that, whereas boys showed impaired neurocognitive performances regardless of TBI status, impaired performances in girls were limited to those cases in which the girls were comorbid for PTSD and mTBI. It appears then that whereas PTSD alone might explain boys' reduced neurocognitive performance, among girls the comorbidity of PTSD and mTBI is required to account for performance deficits.	[Segev, Shira; Rassovsky, Yuri] Bar Ilan Univ, Dept Psychol, IL-52900 Ramat Gan, Israel; [Segev, Shira; Shorer, Maayan; Apter, Alan; Fennig, Silvana] Schneider Childrens Med Ctr Israel, Dept Psychol Med, PTSD Unit, Petah Tiqwa, Israel; [Rassovsky, Yuri] Bar Ilan Univ, Leslie & Susan Gonda Goldschmied Multidisciplinar, Ramat Gan, Israel; [Rassovsky, Yuri] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Peleg, Tammy Pilowsky] Schneider Childrens Med Ctr Israel, Neuropsychol Unit, Petah Tiqwa, Israel; [Peleg, Tammy Pilowsky] Hebrew Univ Jerusalem, Dept Psychol, Jerusalem, Israel		Rassovsky, Y (corresponding author), Bar Ilan Univ, Dept Psychol, IL-52900 Ramat Gan, Israel.	yurir@biu.ac.il		Rassovsky, Yuri/0000-0002-6362-9944	Israel Insurance Association	This study was carried out as part of a PhD dissertation by Shira Segev at Bar Ilan University, Ramat Gan, Israel. This study was supported in part by a grant from the Israel Insurance Association.	American Congress of Rehabilitation Medicine (ACRM), 1993, DEF MILD TRAUM BRAIN; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Beers SR, 2002, AM J PSYCHIAT, V159, P483, DOI 10.1176/appi.ajp.159.3.483; Blinman TA, 2009, J PEDIATR SURG, V44, P1223, DOI 10.1016/j.jpedsurg.2009.02.027; Brenner LA, 2009, MIL MED, V174, P347, DOI 10.7205/MILMED-D-01-5808; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Catale C, 2009, J CLIN EXP NEUROPSYC, V31, P331, DOI 10.1080/13803390802134616; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; Conners C.K., 2004, CONNERS CONTINUOUS P; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Davidson L., 2005, THESIS; Davis DP, 2006, J NEUROTRAUM, V23, P140, DOI 10.1089/neu.2006.23.140; Delis DC., 2001, DELIS KAPLAN EXECUTI; FARACE E, 2000, NEUROSURGICAL FOCUS, V0008, P00001, DOI [DOI 10.3171/F0C.2000.8.1.152, DOI 10.3171/foc.2000.8.1.152]; Foa EB, 2001, J CLIN CHILD PSYCHOL, V30, P376, DOI 10.1207/S15374424JCCP3003_9; Gordon SN, 2011, CLIN NEUROPSYCHOL, V25, P337, DOI 10.1080/13854046.2010.550634; Jamshidian M, 1999, J EDUC BEHAV STAT, V24, P21, DOI 10.2307/1165260; Kaplan E, 2004, WECHSLER INTELLIGENC; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Morrison Wynne E, 2004, Pediatr Crit Care Med, V5, P145, DOI 10.1097/01.PCC.0000112373.71645.2A; Perry Bruce D., 1999, Current Opinion in Pediatrics, V11, P310, DOI 10.1097/00008480-199908000-00008; Pineau H, 2014, BEHAV SCI-BASEL, V4, P471, DOI 10.3390/bs4040471; PsychTech LLC, 2010, WECHSLER INTELLIGENC; Sbordone RJ, 2010, PSYCHOL INJ LAW, V3, P63, DOI 10.1007/s12207-010-9066-z; Scherwath A, 2011, BRAIN INJURY, V25, P401, DOI 10.3109/02699052.2011.557351; Scott JC, 2015, PSYCHOL BULL, V141, P105, DOI 10.1037/a0038039; Segev S, 2016, NEUROPSYCHOLOGY, V30, P800, DOI 10.1037/neu0000299; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Turley MR, 2012, CAN J SCH PSYCHOL, V27, P166, DOI 10.1177/0829573512440420; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004	38	1	2	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-9867	1573-6598		J TRAUMA STRESS	J. Trauma Stress	FEB	2018	31	1					64	70		10.1002/jts.22250			7	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	FY4JV	WOS:000426789700007	29388703				2022-02-06	
J	Vollmer, BL; Kirkwood, MW; Comstock, RD; Currie, D; Grubenhoff, JA				Vollmer, Brandi L.; Kirkwood, Michael W.; Comstock, R. Dawn; Currie, Dustin; Grubenhoff, Joseph A.			Assessing the Clinical Utility of the Question, "Is Your Child/Are You Back to Normal?" in Pediatric Concussion Symptom Resolution	CLINICAL PEDIATRICS			English	Article						concussion; mild traumatic brain injury; emergency department; postconcussive syndrome; children	TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; EMERGENCY-DEPARTMENT; GENDER-DIFFERENCES; CHILDREN; ADOLESCENTS; AGREEMENT; AGE	This study investigates the relationship between the general question, Is your child/are you back to normal? and a validated postconcussive symptom scale when assessing symptom resolution following concussion. Children with acute concussion were enrolled during an emergency department visit. Sensitivity and specificity analyses compared the true/false question, My child is/I am back to normal at 3 days postinjury with the Concussion Symptom Inventory (CSI; gold standard). A total of 201 participants were enrolled in the study with complete data. The true/false questions of My child is/I am back to normal had sensitivities of 78.4% and 59.3% and specificities of 75.0% and 86.4% for caregiver and child responses, respectively, when compared with their corresponding CSI. This study demonstrates that asking a parent or child if the child is back to normal has poor sensitivity and modest specificity in determining if a child's symptoms have resolved within 3 days of sustaining a concussion relative to a standardized symptom scale.	[Vollmer, Brandi L.; Comstock, R. Dawn; Currie, Dustin] Colorado Sch Publ Hlth, Aurora, CO USA; [Vollmer, Brandi L.; Kirkwood, Michael W.; Comstock, R. Dawn; Grubenhoff, Joseph A.] Univ Colorado, Sch Med, Aurora, CO USA; [Kirkwood, Michael W.; Grubenhoff, Joseph A.] Childrens Hosp Colorado, Aurora, CO USA		Vollmer, BL (corresponding author), Univ Colorado, Dept Neurol, Sch Med, Acad Off 1 Bldg,Room 5512,12631 East 17th Ave, Aurora, CO 80045 USA.	Brandi.vollmer@ucdenver.edu	Grubenhoff, Joseph A/H-9994-2019	Grubenhoff, Joseph A/0000-0001-5072-4064; Vollmer, Brandi/0000-0002-0593-9012	Thrasher Research Fund Early Career Award; NIH/NCATS Colorado CTSI GrantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR000154]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Funding for the conduct of this study was provided by a Thrasher Research Fund Early Career Award to Dr Grubenhoff. Use of REDCap Database was supported by NIH/NCATS Colorado CTSI Grant UL1 TR000154. Contents are the authors' sole responsibility and do not necessarily represent official NIH or Thrasher Research Fund views.	Asemota AO, 2013, J NEUROTRAUM, V30, P67, DOI 10.1089/neu.2012.2605; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Bazarian JJ, 2009, BRAIN INJURY, V19, P85; Centers for Disease Control and Prevention, RAT TBI REL EM DEP V; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; EISER C, 1995, J ADOLESCENCE, V18, P307, DOI 10.1006/jado.1995.1021; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Faul M, 2010, TRAUMATIC BRAIN INJU; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Grubenhoff JA, 2016, J PEDIATR-US, V174, P27, DOI 10.1016/j.jpeds.2016.03.027; Grubenhoff JA, 2010, PEDIATRICS, V126, P688, DOI 10.1542/peds.2009-2804; Hajek CA, 2011, CHILD NEUROPSYCHOL, V17, P17, DOI 10.1080/09297049.2010.495058; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Kirkwood MW, 2014, PEDIATRICS, V133, P643, DOI 10.1542/peds.2013-3195; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; National Center for Injury Prevention and Control C. f. d. C. a. i. P., 2003, REP C MILD TRAUM BRA; Pleacher MD, 2006, BRIT J SPORT MED, V40, DOI 10.1136/bjsm.2005.019067; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Romero-Acosta K, 2013, J MENT HEALTH, V22, P33, DOI 10.3109/09638237.2012.734655; Zemek R, 2014, PAED CHILD HEALT-CAN, V19, P474, DOI 10.1093/pch/19.9.475	21	1	1	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0009-9228	1938-2707		CLIN PEDIATR	Clin. Pediatr.	FEB	2018	57	2					146	151		10.1177/0009922817693300			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	FR3GL	WOS:000418954000003	28198194				2022-02-06	
J	Walthall, JDH; Burgess, A; Weinstein, E; Miramonti, C; Arkins, T; Wiehe, S				Walthall, Jennifer D. H.; Burgess, Aaron; Weinstein, Elizabeth; Miramonti, Charles; Arkins, Thomas; Wiehe, Sarah			Descriptive Correlates of Urban Pediatric Violent Injury Using Emergency Medical Service Patient-Level Data	PEDIATRIC EMERGENCY CARE			English	Article						youth violence; emergency medical services; injury prevention; geospatial analysis	DEATH REPORTING SYSTEM; TRAUMATIC BRAIN-INJURY; INFORMATION-SYSTEMS; PEDESTRIAN INJURY; UNITED-STATES; PREVENTION; SURVEILLANCE; CHILDREN; EPIDEMIOLOGY; PATTERNS	Objective This study aimed to describe spatiotemporal correlates of pediatric violent injury in an urban community. Methods We performed a retrospective cohort study using patient-level data (2009-2011) from a novel emergency medical service computerized entry system for violent injury resulting in an ambulance dispatch among children aged 0 to 16 years. Assault location and patient residence location were cleaned and geocoded at a success rate of 98%. Distances from the assault location to both home and nearest school were calculated. Time and day of injury were used to evaluate temporal trends. Data from the event points were analyzed to locate injury hotspots. Results Seventy-six percent of events occurred within 2 blocks of the patient's home. Clusters of violent injury correlated with areas with high adult crime and areas with multiple schools. More than half of the events occurred between 3:00 pm and 11:00 pm. During these peak hours, Sundays had significantly fewer events. Conclusions Pediatric violent injuries occurred in identifiable geographic and temporal patterns. This has implications for injury prevention programming to prioritize highest-risk areas.	[Walthall, Jennifer D. H.; Weinstein, Elizabeth; Miramonti, Charles] Indiana Univ, Sch Med, Dept Emergency Med, Indianapolis, IN USA; [Walthall, Jennifer D. H.; Weinstein, Elizabeth; Wiehe, Sarah] Indiana Univ, Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Burgess, Aaron] Maponics LLC, IUPUI Dept Geog, Indianapolis, IN USA; [Miramonti, Charles; Arkins, Thomas] Indianapolis IEMS, Dept Publ Safety, Indianapolis, IN USA; [Wiehe, Sarah] Child Hlth Serv Res, Indianapolis, IN USA		Walthall, JDH (corresponding author), 705 Riley Hosp Dr,Suite 3064, Indianapolis, IN 46202 USA.	jdhewlet@iu.edu	Wiehe, Sarah/ABH-4578-2020	Wiehe, Sarah/0000-0002-8148-0848			Bell N, 2010, INT J ENV RES PUB HE, V7, P1002, DOI 10.3390/ijerph7031002; Bernard Stephanie J., 2007, Morbidity and Mortality Weekly Report, V56, P1; Colantonio A, 2011, EMERG THEMES EPIDEMI, V8, DOI 10.1186/1742-7622-8-7; Cusimano M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008669; Edelman LS, 2007, J NURS SCHOLARSHIP, V39, P306, DOI 10.1111/j.1547-5069.2007.00185.x; Gilchrist Julie, 2012, Morbidity and Mortality Weekly Report, V61, P270; Kallan MJ, 2008, PEDIATRICS, V121, pE1342, DOI 10.1542/peds.2007-1512; Karch Debra L., 2012, Morbidity and Mortality Weekly Report, V61, P1; Lynch CA, 2011, ACAD EMERG MED, V18, P972, DOI 10.1111/j.1553-2712.2011.01153.x; Mecredy G, 2012, INJURY PREV, V18, P81, DOI 10.1136/injuryprev-2011-040011; Monuteaux MC, 2012, ACAD EMERG MED, V19, P535, DOI 10.1111/j.1553-2712.2012.01341.x; Parks SE, 2014, MMWR SURVEILL SUMM, V63, P1; Schuurman N, 2008, CAN J SURG, V51, P389; Schuurman N, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-233; Senger C, 2011, J PEDIATR SURG, V46, P927, DOI 10.1016/j.jpedsurg.2011.02.032; Shepherd JP, 2000, BRIT MED J, V321, P1481, DOI 10.1136/bmj.321.7275.1481; Soobader MJ, 2001, AM J PUBLIC HEALTH, V91, P632, DOI 10.2105/AJPH.91.4.632; Statter M, 2011, J TRAUMA, V71, pS511, DOI 10.1097/TA.0b013e31823a4b70; Warden C, 2010, PREHOSP EMERG CARE, V14, P137, DOI 10.3109/10903120903538682; Weiner EJ, 2009, J TRAUMA, V66, pS10, DOI 10.1097/TA.0b013e3181937bc8; Wirtz SJ, 2001, AM J PUBLIC HEALTH, V91, P468	21	1	1	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	FEB	2018	34	2					69	75		10.1097/PEC.0000000000000807			7	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Emergency Medicine; Pediatrics	FW1YM	WOS:000425096500008	27755329				2022-02-06	
J	Kamiutsuri, K; Tominaga, N; Kobayashi, S				Kamiutsuri, Kei; Tominaga, Naoki; Kobayashi, Shunji			Preoperative elevated FDP may predict severe intraoperative hypotension after dural opening during decompressive craniectomy of traumatic brain injury	JA CLINICAL REPORTS			English	Article						Decompressive craniectomy; Coagulation disorder; Fibrinogen degradation product (FDP); Intraoperative hypotension; Dural opening	RISK-FACTORS; COAGULOPATHY; CRANIOTOMY; SURGERY	Purpose: Coagulation disorder and intraoperative hypotension are representative complications of traumatic brain injury which cause worse perioperative outcome. The aim of this study was to survey the relation of coagulation disorder and intraoperative hypotension (IH) during decompressive craniectomy. Method: Patients who underwent emergency decompressive craniectomy due to traumatic brain injury were retrospectively surveyed. The relation between preoperative coagulation date and intraoperative hypotension (systolic blood pressure < 60 mmHg after dural opening) was analyzed. Results: Of 41 patients screened, 12 patients (27.9%) developed IH. Fibrinogen degradation products (314 vs 64. 4 mu g/mL; p = 0.01) were significantly higher in the IH group. In contrast, fibrinogen (181 vs 239 mg/dL; p = 0.01) was significantly lower in the IH group. Reduction rate of sBRP before and after dural opening (%) was higher in IH group than in non-IH group (49.1 vs 27.6%: p = 0.001). Conclusions: Preoperative elevated FDP may predict IH after dural opening during traumatic decompressive craniectomy.	[Kamiutsuri, Kei; Kobayashi, Shunji] Rinku Gen Med Ctr, Dept Anesthesiol, Izumisano, Japan; [Tominaga, Naoki] Shin Komonji Hosp, Dept Cardiovasc Internal Med, Kitakyushu, Fukuoka, Japan		Kamiutsuri, K (corresponding author), Rinku Gen Med Ctr, Dept Anesthesiol, Izumisano, Japan.	k-kamiutsuri@rgmc.izumisano.osaka.jp		Kamiutsuri, Kei/0000-0001-6058-1255			BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bijker JB, 2007, ANESTHESIOLOGY, V107, P213, DOI 10.1097/01.anes.0000270724.40897.8e; Cap AP, 2011, J TRAUMA, V71, pS78, DOI 10.1097/TA.0b013e3182218cd8; Carlucci MTO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090125; Chhabra Gaurav, 2013, J Emerg Trauma Shock, V6, P180, DOI 10.4103/0974-2700.115332; Di Battista AP, 2016, SHOCK, V46, P96, DOI 10.1097/SHK.0000000000000642; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Fei AH, 2015, SCI REP-UK, V5, DOI 10.1038/srep09391; Grindlinger GA, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3251-9; Juratli TA, 2014, J NEUROTRAUM, V31, P1521, DOI 10.1089/neu.2013.3241; Kawaguchi M, 1996, J NEUROSURG ANESTH, V8, P117, DOI 10.1097/00008506-199604000-00003; Kinoshita K, 2004, RESUSCITATION, V60, P151, DOI 10.1016/j.resuscitation.2003.07.005; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Kolias AG, 2016, BRIT J NEUROSURG, V30, P246, DOI 10.3109/02688697.2016.1159655; Lemcke J, 2014, BLOOD COAGUL FIBRIN, V25, P353, DOI 10.1097/MBC.0000000000000042; Miller P, 2006, ANESTH ANALG, V103, P869, DOI 10.1213/01.ane.0000237327.12205.dc; Sharma D, 2012, J NEUROSURG ANESTH, V24, P178, DOI 10.1097/ANA.0b013e318254fb70; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Suehiro E, 2014, CLIN NEUROL NEUROSUR, V127, P97, DOI 10.1016/j.clineuro.2014.10.007; Wang K, 2013, NEUROL RES, V35, P642, DOI 10.1179/1743132813Y.0000000187; Wilson MH, 2014, INT J CLIN PRACT, V68, P5, DOI 10.1111/ijcp.12246	21	1	1	1	2	SPRINGEROPEN	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	2363-9024			JA CLIN REP	JA CLIN. REP	JAN 16	2018	4								8	10.1186/s40981-018-0146-5			6	Anesthesiology	Emerging Sources Citation Index (ESCI)	Anesthesiology	FS8IY	WOS:000422655600001	29457118	Green Published, gold			2022-02-06	
J	Abdel-Salam, OME; Galal, AF; Hassanane, MM; Salem, LM; Nada, SA; Morsy, FA				Abdel-Salam, Omar M. E.; Galal, Asmaa F.; Hassanane, Mahrousa M.; Salem, Lamiaa M.; Nada, Somaia A.; Morsy, Fatma A.			Grape Seed Extract Alone or Combined with Atropine in Treatment of Malathion Induced Neuro- and Genotoxicity	JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY			English	Article						Comet Assay; DNA Fragmentation; Chromosomal Aberrations; Grape Seed Extract; Malathion; Oxidative Stress	INDUCED OXIDATIVE STRESS; TRAUMATIC BRAIN-INJURY; PARAOXONASE 1 PON1; DNA-DAMAGE; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; LIPID-PEROXIDATION; MICRONUCLEUS ASSAY; NITRIC-OXIDE; IN-VIVO	The aim of this study was to investigate the effect of treatment with grape seed extract (GSE) on the neurotoxic and genotoxic effects of acute malathion exposure. Rats received malathion (150 mg/kg by i.p. injection) for two successive days alone or combined with GSE at doses of 150 or 300 mg/kg, orally or with GSE at 300 mg/kg and atropine at a dose of 2 mg/kg, i.p. Malondialdehyde (MDA), reduced glutathione (GSH), nitric oxide, paraoxonase (PON1) were determined in cortex, striatum, and rest of brain tissue (subcortex). Interleukin-1 beta (IL-1 beta), and butyrylcholinesterase (BChE) activities were determined in brain regions. Cytogenetic analyses for chromosomal aberrations in somatic and germ cells, micronucleus test, Comet assay, DNA fragmentation of liver cells and histopathological examination of brain and liver sections were also performed. Malathion resulted in an increase in MDA, nitric oxide; a decrease in GSH and PON1 activity in different brain regions. IL-1 beta increased, while BChE activity decreased in brain after the administration of malathion. The insecticide also caused marked structural and numerical chromosomal aberrations and increased liver DNA fragmentation. The Comet assay showed a significant increase in DNA damage of peripheral blood lymphocytes. These effects of malathion were alleviated with the administration of GSE alone or combined with atropine. Addition of atropine to treatment with GSE was associated with significant decrease in MDA, BChE and chromosomal aberrations compared with GSE only treatment. Our data indicate that GSE protects against malathion neurotoxic and genotoxic effects, most likely through reducing brain oxidative stress and inflammatory response.	[Abdel-Salam, Omar M. E.; Galal, Asmaa F.] Natl Res Ctr, Dept Toxicol & Narcot, Tahrir St, Cairo 12311, Egypt; [Hassanane, Mahrousa M.; Salem, Lamiaa M.] Natl Res Ctr, Dept Cell Biol, Tahrir St, Cairo 12311, Egypt; [Nada, Somaia A.] Natl Res Ctr, Dept Pharmacol, Tahrir St, Cairo 12311, Egypt; [Morsy, Fatma A.] Natl Res Ctr, Dept Pathol, Tahrir St, Cairo 12311, Egypt		Abdel-Salam, OME (corresponding author), Natl Res Ctr, Dept Toxicol & Narcot, Tahrir St, Cairo 12311, Egypt.		Abdel-Salam, Omar M.E./L-1296-2017	Abdel-Salam, Omar M.E./0000-0002-4450-1582			Bagchi D, 1998, GEN PHARMACOL, V30, P771, DOI 10.1016/S0306-3623(97)00332-7; Bagchi D, 2000, TOXICOLOGY, V148, P187, DOI 10.1016/S0300-483X(00)00210-9; Bains JS, 1997, BRAIN RES REV, V25, P335, DOI 10.1016/S0165-0173(97)00045-3; Belin AC, 2012, NEUROSCI LETT, V522, P30, DOI 10.1016/j.neulet.2012.06.007; Blasiak J, 2004, MUTAT RES-FUND MOL M, V554, P297, DOI 10.1016/j.mrfmmm.2004.05.011; Boje KMK, 2004, FRONT BIOSCI-LANDMRK, V9, P763, DOI 10.2741/1268; Boskovic M, 2011, CURR NEUROPHARMACOL, V9, P301, DOI 10.2174/157015911795596595; BREWEN GJ, 1978, CHEM MUTAGENS, V5, P127; Brocardo PS, 2005, TOXICOLOGY, V207, P283, DOI 10.1016/j.tox.2004.09.012; CHATONNET A, 1989, BIOCHEM J, V260, P625, DOI 10.1042/bj2600625; Cnubben NHP, 2001, ENVIRON TOXICOL PHAR, V10, P141, DOI 10.1016/S1382-6689(01)00077-1; Cokugras AN, 2003, TURK J BIOCHEM, V28, P54, DOI DOI 10.1016/J.CBI.2005.10.013; Costa LG, 1999, CHEM-BIOL INTERACT, V119, P429, DOI 10.1016/S0009-2797(99)00055-1; Costa LG, 2013, TOXICOLOGY, V307, P115, DOI 10.1016/j.tox.2012.07.011; Cui QJ, 2014, NEUROCHEM RES, V39, P1254, DOI 10.1007/s11064-014-1306-2; Delgado EHB, 2006, NEUROCHEM RES, V31, P1021, DOI 10.1007/s11064-006-9111-1; Diamond ML, 2014, EPILEPSIA, V55, P1109, DOI 10.1111/epi.12628; DULOUT FN, 1983, MUTAT RES, V122, P163, DOI 10.1016/0165-7992(83)90055-6; Duysen EG, 2007, TOXICOLOGY, V233, P60, DOI 10.1016/j.tox.2006.11.069; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fortunato JJ, 2006, NEUROCHEM RES, V31, P671, DOI 10.1007/s11064-006-9065-3; Furlong CE, 2000, NEUROTOXICOLOGY, V21, P581; Garaj-Vrhovac V, 2002, J APPL TOXICOL, V22, P249, DOI 10.1002/jat.855; Garcia SJ., 2006, TOXICOLOGY ORGANOPHO, P145, DOI 10.1016/B978-012088523-7/50012-0; Geula C, 2004, DRUG TODAY, V40, P711, DOI 10.1358/dot.2004.40.8.850473; Gibb RK, 1997, GYNECOL ONCOL, V65, P13, DOI 10.1006/gyno.1997.4637; Girard E, 2007, LIFE SCI, V80, P2380, DOI 10.1016/j.lfs.2007.03.011; Guendez R, 2005, FOOD CHEM, V89, P1, DOI 10.1016/j.foodchem.2004.02.010; GUTTERIDGE JMC, 1995, CLIN CHEM, V41, P1819; Halliwell B, 2001, DRUG AGING, V18, P685, DOI 10.2165/00002512-200118090-00004; HALLIWELL B, 1989, FREE RADICALS BIOL M, P22; Hancock DB, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-6; Hassan H.M., 2013, GLOB J PHARM, V7, P241; HAYWOOD PT, 2000, CURR ANAESTH CRIT CA, V11, P331; HEDDLE JA, 1973, MUTAT RES, V18, P187, DOI 10.1016/0027-5107(73)90035-3; HIGASHINO K, 1972, CLIN CHIM ACTA, V41, P313, DOI 10.1016/0009-8981(72)90526-8; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Hwang IK, 2004, LIFE SCI, V75, P1989, DOI 10.1016/j.lfs.2004.05.013; Jansen KL, 2009, TOXICOL APPL PHARM, V236, P142, DOI 10.1016/j.taap.2009.02.001; John S, 2001, J NUTR BIOCHEM, V12, P500, DOI 10.1016/S0955-2863(01)00160-7; Jokanovic M, 2010, ENVIRON TOXICOL PHAR, V29, P195, DOI 10.1016/j.etap.2010.01.006; Jokanovic M, 2009, TOXICOL LETT, V190, P107, DOI 10.1016/j.toxlet.2009.07.025; Krishna G, 2000, MUTAT RES-FUND MOL M, V455, P155, DOI 10.1016/S0027-5107(00)00117-2; Liu CM, 2014, FOOD CHEM TOXICOL, V72, P295, DOI 10.1016/j.fct.2014.07.033; Lu T, 2002, BBA-MOL CELL RES, V1590, P16, DOI 10.1016/S0167-4889(02)00193-3; Manthripragada AD, 2010, EPIDEMIOLOGY, V21, P87, DOI 10.1097/EDE.0b013e3181c15ec6; Maroni M, 2000, TOXICOLOGY, V143, P1; McGeer PL, 2002, J NEUROVIROL, V8, P529, DOI 10.1080/13550280290100969; Mileson BE, 1998, TOXICOL SCI, V41, P8; MILLER R C, 1973, Environmental Health Perspectives, V6, P167, DOI 10.2307/3428073; Minami M, 2006, J PHARMACOL SCI, V100, P461, DOI 10.1254/jphs.CRJ06005X; MONCADA S, 1991, PHARMACOL REV, V43, P109; Moncada S, 2006, J NEUROCHEM, V97, P1676, DOI 10.1111/j.1471-4159.2006.03988.x; Moore PD, 2011, MUTAT RES-GEN TOX EN, V725, P78, DOI 10.1016/j.mrgentox.2011.07.007; Moore PD, 2010, ENVIRON TOXICOL, V25, P221, DOI 10.1002/tox.20492; MOSHAGE H, 1995, CLIN CHEM, V41, P892; Pezzoli G, 2013, NEUROLOGY, V80, P2035, DOI 10.1212/WNL.0b013e318294b3c8; PRESTON KL, 1987, J PHARMACOL EXP THER, V243, P1002; QUAN N, 1994, J NEUROIMMUNOL, V49, P125, DOI 10.1016/0165-5728(94)90188-0; Reus GZ, 2008, J AGR FOOD CHEM, V56, P7560, DOI 10.1021/jf800910q; RUIZLARREA MB, 1994, STEROIDS, V59, P383; Saito M, 1998, J AGR FOOD CHEM, V46, P1460, DOI 10.1021/jf9709156; SALVADORI DMF, 1988, MUTAT RES, V204, P283, DOI 10.1016/0165-1218(88)90101-2; Sayre LM, 2008, CHEM RES TOXICOL, V21, P172, DOI 10.1021/tx700210j; SCHMID W, 1975, MUTAT RES, V31, P9, DOI 10.1016/0165-1161(75)90058-8; Schulz JB, 2000, EUR J BIOCHEM, V267, P4904, DOI 10.1046/j.1432-1327.2000.01595.x; Silman I, 2005, CURR OPIN PHARMACOL, V5, P293, DOI 10.1016/j.coph.2005.01.014; SINGH NP, 1994, INT J RADIAT BIOL, V66, P23, DOI 10.1080/09553009414550911; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Strathearn KE, 2014, BRAIN RES, V1555, P60, DOI 10.1016/j.brainres.2014.01.047; TAYLOR P, 1991, J BIOL CHEM, V266, P4025; TitenkoHolland N, 1997, MUTAT RES-GEN TOX EN, V388, P85, DOI 10.1016/S1383-5718(96)00140-4; Trevisan R, 2008, BASIC CLIN PHARMACOL, V102, P365, DOI 10.1111/j.1742-7843.2007.00182.x; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; VANBAO T, 1974, HUMANGENETIK, V24, P33; WALTER Z, 1980, HUM GENET, V53, P375, DOI 10.1007/BF00287059; Wang J, 2008, J NEUROSCI, V28, P6388, DOI 10.1523/JNEUROSCI.0364-08.2008; Wang NN, 2010, TOXICOL LETT, V196, P125, DOI 10.1016/j.toxlet.2010.04.008; Watson AD, 1995, J CLIN INVEST, V96, P2882, DOI 10.1172/JCI118359; Windham GC, 1998, AM J IND MED, V33, P164, DOI 10.1002/(SICI)1097-0274(199802)33:2&lt;164::AID-AJIM8&gt;3.0.CO;2-Y; Zintzaras E, 2004, J HUM GENET, V49, P474, DOI 10.1007/s10038-004-0176-x	81	1	1	0	7	AMER SCIENTIFIC PUBLISHERS	VALENCIA	26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA	1533-4880	1533-4899		J NANOSCI NANOTECHNO	J. Nanosci. Nanotechnol.	JAN	2018	18	1					564	575		10.1166/jnn.2018.13943			12	Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	FP3VT	WOS:000417546800080	29768882				2022-02-06	
J	Abiko, K; Shiga, T; Katoh, C; Hirata, K; Kuge, Y; Kobayashi, K; Ikeda, S; Ikoma, K				Abiko, Kagari; Shiga, Tohru; Katoh, Chietsugu; Hirata, Kenji; Kuge, Yuji; Kobayashi, Kentaro; Ikeda, Satoshi; Ikoma, Katsunori			Relationship between intelligence quotient (IQ) and cerebral metabolic rate of oxygen in patients with neurobehavioural disability after traumatic brain injury	BRAIN INJURY			English	Article						traumatic brain injury; cerebral metabolism; intelligence quotient	POSITRON-EMISSION-TOMOGRAPHY; WORKING-MEMORY; PREFRONTAL CORTEX; DEFAULT-MODE; FDG-PET; GLUCOSE-METABOLISM; COGNITIVE CONTROL; BROCAS REGION; RESTING-STATE; NETWORK	Objective: Cerebral metabolism may play a significant role in neurobehavioural disability following traumatic brain injury (TBI). In this study, we examined the relationship between intelligence quotient (IQ) and the cerebral metabolic rate of oxygen (CMRO2) in the lateral prefrontal cortex, which was measured by O-15-labelled gas positron emission tomography (PET), in patients with TBI. Materials and methods: The subjects were 12 patients (eight males and four females) who suffered from neurobehavioural disability following TBI. Their mean age was 33.3 years. The cause of injury was traffic accidents in all patients and the mean period after injury was 44.8 months. These patients underwent O-15-labelled gas PET and tests using either the Wechsler Adult Intelligence Scale-Revised (WAIS-R) or the Wechsler Intelligence Scale for Children-Revised (WISC-R). Pearson's correlation between CMRO2 and total IQ (TIQ) was calculated. Results: A statistically significant correlation was observed between TIQ and CMRO2 in the right Brodmann areas (BAs) 44 and 45. The lower the WAIS score, the higher the CMRO2 in both areas. Conclusion: Neurological function negatively correlated with the metabolism of oxygen. It was possible that changes in brain networks increased the neuronal activity in the undamaged areas and that the increased activity compensated for the function decline.	[Abiko, Kagari; Ikeda, Satoshi; Ikoma, Katsunori] Hokkaido Univ Hosp, Dept Rehabil Med, Sapporo, Hokkaido, Japan; [Shiga, Tohru; Katoh, Chietsugu; Hirata, Kenji; Kobayashi, Kentaro] Hokkaido Univ, Sch Med, Dept Nucl Med, Sapporo, Hokkaido, Japan; [Kuge, Yuji] Hokkaido Univ, Dept Tracer Kinet, Sapporo, Hokkaido, Japan; [Abiko, Kagari] Sapporo Azabu Neurosurg Hosp, Dept Rehabil Med, Sapporo, Hokkaido, Japan		Abiko, K (corresponding author), Hokkaido Univ Hosp, Dept Rehabil Med, Kita Ku, North 14th,West 5th, Sapporo, Hokkaido 0608648, Japan.	kagali@huhp.hokudai.ac.jp					Amunts K, 1999, J COMP NEUROL, V412, P319, DOI 10.1002/(SICI)1096-9861(19990920)412:2<319::AID-CNE10>3.0.CO;2-7; Berlucchi G, 2011, NEUROPSYCHOL REHABIL, V21, P560, DOI 10.1080/09602011.2011.573255; Buckner RL, 2007, NEUROIMAGE, V37, P1091, DOI 10.1016/j.neuroimage.2007.01.010; Celsis P, 1999, NEUROIMAGE, V9, P135, DOI 10.1006/nimg.1998.0389; Duncan J, 2000, SCIENCE, V289, P457, DOI 10.1126/science.289.5478.457; FALZI G, 1982, ARCH NEUROL-CHICAGO, V39, P239, DOI 10.1001/archneur.1982.00510160045009; Fink GR, 2006, ROLE BROCAS AREA LAN; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; Gray JR, 2003, NAT NEUROSCI, V6, P316, DOI 10.1038/nn1014; Grodzinsky Y, 2008, TRENDS COGN SCI, V12, P474, DOI 10.1016/j.tics.2008.09.001; Gross H, 1996, J NEUROPSYCH CLIN N, V8, P324; Hori Y, 2013, J NUCL MED, V54, P207; HUMAYUN MS, 1989, NUCL MED COMMUN, V10, P335, DOI 10.1097/00006231-198905000-00004; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Iverson GL, 2004, APPL NEUROPSYCHOL, V11, P85, DOI 10.1207/s15324826an1102_3; Kasahara M, 2011, BRAIN INJURY, V25, P1170, DOI 10.3109/02699052.2011.608210; Kato T, 2007, J NEUROTRAUM, V24, P919, DOI 10.1089/neu.2006.0203; Keller SS, 2009, BRAIN LANG, V109, P29, DOI 10.1016/j.bandl.2008.11.005; Kim YH, 2009, NEUROREHAB NEURAL RE, V23, P468, DOI 10.1177/1545968308328728; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Krieger-Redwood K, 2015, NEUROPSYCHOLOGIA, V76, P92, DOI 10.1016/j.neuropsychologia.2015.02.030; Kuroda S, 2004, J NUCL MED, V45, P943; LARRABEE GJ, 1986, INT J NEUROSCI, V29, P141, DOI 10.3109/00207458608985644; Levine B, 2002, J NEUROL NEUROSUR PS, V73, P173, DOI 10.1136/jnnp.73.2.173; Li N, 2014, J NEUROTRAUM, V31, P395, DOI 10.1089/neu.2013.3059; MATARAZZO JD, 1984, J CLIN NEUROPSYCHOL, V6, P351, DOI 10.1080/01688638408401227; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; Minamoto T, 2015, CORTEX, V71, P277, DOI 10.1016/j.cortex.2015.07.025; Munoz-Cespedes JM, 2005, NEUROPSYCHOL REV, V15, P169, DOI 10.1007/s11065-005-9178-5; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.080523; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Provenzano FA, 2010, NUCL MED COMMUN, V31, P952, DOI 10.1097/MNM.0b013e32833e37c4; Pugh KR, 1996, NEUROIMAGE, V4, P159, DOI 10.1006/nimg.1996.0067; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ranganath C, 2003, NEUROPSYCHOLOGIA, V41, P378, DOI 10.1016/S0028-3932(02)00169-0; Rasmussen IA, 2008, J NEUROTRAUM, V25, P1057, DOI 10.1089/neu.2008.0520; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shiga T, 2006, EUR J NUCL MED MOL I, V33, P817, DOI 10.1007/s00259-005-0033-y; Skranes J, 2013, CORTEX, V49, P2264, DOI 10.1016/j.cortex.2013.06.001; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Sugiura L, 2011, CEREB CORTEX, V21, P2374, DOI 10.1093/cercor/bhr023; Sun XW, 2005, NEUROIMAGE, V26, P36, DOI 10.1016/j.neuroimage.2005.01.022; Tanji J, 2008, PHYSIOL REV, V88, P37, DOI 10.1152/physrev.00014.2007; Turner GR, 2008, NEUROLOGY, V71, P812, DOI 10.1212/01.wnl.0000325640.18235.1c; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; van Veluw SJ, 2012, BRAIN STRUCT FUNCT, V217, P797, DOI 10.1007/s00429-012-0381-x; Venkatesan UM, 2015, J NEUROTRAUM, V32, P252, DOI 10.1089/neu.2013.3318; Zhang J, 2010, J NEUROTRAUM, V27, P35, DOI 10.1089/neu.2009.1049; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	52	1	1	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	11					1367	1372		10.1080/02699052.2018.1496478			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GZ6GX	WOS:000449534000008	30010427				2022-02-06	
B	Aebi, M; Steinhausen, HC	DeLisi, M	Vazsonyi, AT; Flannery, DJ		Aebi, Marcel; Steinhausen, Hans-Christoph	DeLisi, M		Violent Juvenile Offenders: A Psychiatric and Mental Health Perspective	CAMBRIDGE HANDBOOK OF VIOLENT BEHAVIOR AND AGGRESSION, 2ND EDITION	Cambridge Handbooks in Psychology		English	Article; Book Chapter							OPPOSITIONAL DEFIANT DISORDER; CALLOUS-UNEMOTIONAL TRAITS; TRAUMATIC BRAIN-INJURY; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; COGNITIVE-BEHAVIOR THERAPY; CRIMINAL-JUSTICE SYSTEM; LIFE-COURSE-PERSISTENT; AGGRESSIVE-BEHAVIOR; ANTISOCIAL-BEHAVIOR		[Aebi, Marcel] Univ Zurich, Zurich, Switzerland; [Steinhausen, Hans-Christoph] Univ Basel, Basel, Switzerland		Aebi, M (corresponding author), Univ Zurich, Zurich, Switzerland.						Aebi M., 2016, EUROPEAN PSYCHIAT; Aebi M, 2016, J CHILD PSYCHOL PSYC, V57, P729, DOI 10.1111/jcpp.12473; Aebi M, 2014, EUR CHILD ADOLES PSY, V23, P283, DOI 10.1007/s00787-013-0458-y; Aebi M, 2013, J CHILD PSYCHOL PSYC, V54, P941, DOI 10.1111/jcpp.12039; Allwood MA, 2008, J COMMUNITY PSYCHOL, V36, P989, DOI 10.1002/jcop.20277; Allwood MA, 2011, J CLIN CHILD ADOLESC, V40, P659, DOI 10.1080/15374416.2011.597081; American Psychiatric Association, 2013, DIAGN STAT MAN MENT; Arseneault L, 2000, ARCH GEN PSYCHIAT, V57, P979, DOI 10.1001/archpsyc.57.10.979; Avenevoli S, 2015, J AM ACAD CHILD PSY, V54, P37, DOI 10.1016/j.jaac.2014.10.010; BAER PE, 1987, J BEHAV MED, V10, P449, DOI 10.1007/BF00846144; Bauermeister JJ, 2007, J ABNORM CHILD PSYCH, V35, P883, DOI 10.1007/s10802-007-9141-4; Benedek E. P., 2010, PRINCIPLES PRACTICE; Brodie MJ, 2016, PHARMACOL REV, V68, P563, DOI 10.1124/pr.115.012021; Brook JS, 2011, AM J ADDICTION, V20, P509, DOI 10.1111/j.1521-0391.2011.00179.x; Bubier JL, 2009, CLIN PSYCHOL REV, V29, P658, DOI 10.1016/j.cpr.2009.08.005; Bukstein O. G., 2006, CLIN HDB CHILD ADOLE; Burke JD, 2014, J CHILD PSYCHOL PSYC, V55, P264, DOI 10.1111/jcpp.12150; Burke JD, 2012, J CHILD PSYCHOL PSYC, V53, P1176, DOI 10.1111/j.1469-7610.2012.02598.x; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Christopher PP, 2012, PSYCHIAT SERV, V63, P33, DOI 10.1176/appi.ps.201100174; Cipriani A, 2016, LANCET, V388, P881, DOI 10.1016/S0140-6736(16)30385-3; Cole WR, 2008, BRAIN INJURY, V22, P932, DOI 10.1080/02699050802454808; Colins O, 2010, CAN J PSYCHIAT, V55, P255, DOI 10.1177/070674371005500409; Colins O, 2009, DRUG ALCOHOL DEPEN, V100, P39, DOI 10.1016/j.drugalcdep.2008.08.013; Colins OF, 2013, J NERV MENT DIS, V201, P478, DOI 10.1097/NMD.0b013e3182948068; Copeland WE, 2007, AM J PSYCHIAT, V164, P1668, DOI 10.1176/appi.ajp.2007.06122026; Copeland WE, 2014, AM J PSYCHIAT, V171, P668, DOI 10.1176/appi.ajp.2014.13091213; Copeland WE, 2013, AM J PSYCHIAT, V170, P173, DOI 10.1176/appi.ajp.2012.12010132; Dadds MR, 2014, J CHILD PSYCHOL PSYC, V55, P771, DOI 10.1111/jcpp.12155; Daley D, 2014, J AM ACAD CHILD PSY, V53, P835, DOI 10.1016/j.jaac.2014.05.013; Davies S, 2003, DEV MED CHILD NEUROL, V45, P292, DOI 10.1017/S0012162203000550; DODGE KA, 1990, SCIENCE, V250, P1678, DOI 10.1126/science.2270481; Dooley JJ, 2008, BRAIN INJURY, V22, P836, DOI 10.1080/02699050802425444; Dutton DG, 2013, AGGRESS VIOLENT BEH, V18, P310, DOI 10.1016/j.avb.2012.12.002; Elia J, 2009, PSYCHIAT RES, V170, P192, DOI 10.1016/j.psychres.2008.10.008; Elkington KS, 2015, J AM ACAD CHILD PSY, V54, P302, DOI 10.1016/j.jaac.2015.01.002; Eschmann S, 2011, J SUBST USE, V16, P295, DOI 10.3109/14659890903531253; Faraone SV, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.20; Fast DK, 2009, DEV DISABIL RES REV, V15, P250, DOI 10.1002/ddrr.66; Fazel S, 2015, LANCET PSYCHIAT, V2, P224, DOI 10.1016/S2215-0366(14)00128-X; Fazel S, 2014, LANCET, V384, P1206, DOI 10.1016/S0140-6736(14)60379-2; Fazel S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001150; Fazel S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000120; Ford JD, 2010, J ADOLESCENT HEALTH, V46, P545, DOI 10.1016/j.jadohealth.2009.11.212; Franklin ME, 2015, PSYCHIAT RES, V227, P78, DOI 10.1016/j.psychres.2015.02.009; Freitag CM, 2012, J NEURAL TRANSM, V119, P81, DOI 10.1007/s00702-011-0659-9; Frick PJ, 2014, PSYCHOL BULL, V140, P1, DOI 10.1037/a0033076; Ghanizadeh A, 2009, J CHILD NEUROL, V24, P679, DOI 10.1177/0883073808331086; Gorman DA, 2015, CAN J PSYCHIAT, V60, P62, DOI 10.1177/070674371506000204; Granic I, 2006, PSYCHOL REV, V113, P101, DOI 10.1037/0033-295X.113.1.101; Hamshere ML, 2013, AM J PSYCHIAT, V170, P909, DOI 10.1176/appi.ajp.2013.12081129; Hecker T, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00080; Henggeler SW, 2016, FAM PROCESS, V55, P514, DOI 10.1111/famp.12232; Hodgins S, 2009, ACTA PSYCHIAT SCAND, V119, P484, DOI 10.1111/j.1600-0447.2008.01327.x; Hoeve M, 2014, ADM POLICY MENT HLTH, V41, P379, DOI 10.1007/s10488-013-0472-x; James AC, 2015, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004690.pub4, 10.1002/14651858.CD004690.pub3]; Jensen CM, 2015, ADHD-ATTEND DEFICIT, V7, P27, DOI 10.1007/s12402-014-0142-1; Jensen PS, 1997, J AM ACAD CHILD PSY, V36, P1065, DOI 10.1097/00004583-199708000-00014; Jones C, 2012, SCHIZOPHRENIA BULL, V38, P908, DOI 10.1093/schbul/sbs090; Kadesjo B, 2001, J CHILD PSYCHOL PSYC, V42, P487, DOI 10.1111/1469-7610.00742; KANDEL DB, 1982, J AM ACAD CHILD PSY, V21, P328, DOI 10.1016/S0002-7138(09)60936-5; Kazdin AE, 1997, J AM ACAD CHILD PSY, V36, P1349, DOI 10.1097/00004583-199710000-00016; Kelleher I, 2012, PSYCHOL MED, V42, P1857, DOI 10.1017/S0033291711002960; Kerig PK, 2012, J TRAUMA STRESS, V25, P272, DOI 10.1002/jts.21700; Kilpatrick DG, 2003, J CONSULT CLIN PSYCH, V71, P692, DOI 10.1037/0022-006X.71.4.692; Kolko DJ, 2010, J ABNORM PSYCHOL, V119, P713, DOI 10.1037/a0020910; Konner M, 2015, NEW ENGL J MED, V372, P784, DOI 10.1056/NEJMc1415936; Kowatch RA, 2005, J AM ACAD CHILD PSY, V44, P213, DOI 10.1097/00004583-200503000-00006; Kraut AA, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-11; Larson K, 2011, PEDIATRICS, V127, P462, DOI 10.1542/peds.2010-0165; Leibenluft E, 2011, AM J PSYCHIAT, V168, P129, DOI 10.1176/appi.ajp.2010.10050766; Leigh BC, 1999, ADDICTION, V94, P371, DOI 10.1046/j.1360-0443.1999.9433717.x; Levy F, 2005, J AM ACAD CHILD PSY, V44, P368, DOI 10.1097/01.chi.0000153232.64968.c1; Maas CD, 2010, VIOLENCE VICTIMS, V25, P131, DOI 10.1891/0886-6708.25.2.131; Martin SE, 2001, AM J ADDICTION, V10, P136, DOI 10.1080/105504901750227796; Maughan B, 2004, J CHILD PSYCHOL PSYC, V45, P609, DOI 10.1111/j.1469-7610.2004.00250.x; Maxfield MG, 1996, ARCH PEDIAT ADOL MED, V150, P390, DOI 10.1001/archpedi.1996.02170290056009; Merikangas K. R., 2014, RES PRACTICE CHILD A; Miklowitz DJ, 2014, AM J PSYCHIAT, V171, P658, DOI 10.1176/appi.ajp.2014.13081130; Moffitt TE, 2002, DEV PSYCHOPATHOL, V14, P179, DOI 10.1017/S0954579402001104; MOFFITT TE, 1993, PSYCHOL REV, V100, P674, DOI 10.1037/0033-295X.100.4.674; Mohr-Jensen C, 2016, CLIN PSYCHOL REV, V48, P32, DOI 10.1016/j.cpr.2016.05.002; Moore E, 2014, J HEAD TRAUMA REHAB, V29, P239, DOI 10.1097/HTR.0b013e31828f9876; NolenHoeksema S, 2009, HANDBOOK OF DEPRESSION IN ADOLESCENTS, P1; Ollendick T. H., 2006, CLIN HDB CHILD ADOLE; Peng XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079476; Plattner B, 2012, PSYCHIAT RES, V198, P285, DOI 10.1016/j.psychres.2012.02.006; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Popova S, 2016, LANCET, V387, P978, DOI 10.1016/S0140-6736(15)01345-8; Quanbeck CD, 2005, PSYCHIAT SERV, V56, P847, DOI 10.1176/appi.ps.56.7.847; Roland E, 2002, AGGRESSIVE BEHAV, V28, P198, DOI 10.1002/ab.90022; Ruchkin V, 2007, J ABNORM CHILD PSYCH, V35, P578, DOI 10.1007/s10802-007-9114-7; Schofield PW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132558; Silverman WK, 2008, J CLIN CHILD ADOLESC, V37, P105, DOI 10.1080/15374410701817907; Slifer KJ, 2009, DEV DISABIL RES REV, V15, P144, DOI 10.1002/ddrr.60; Smeets KC, 2015, EUR CHILD ADOLES PSY, V24, P255, DOI 10.1007/s00787-014-0592-1; Smith P, 2013, CURR OPIN PSYCHIATR, V26, P66, DOI 10.1097/YCO.0b013e32835b2c01; Sourander A, 2006, J AM ACAD CHILD PSY, V45, P578, DOI 10.1097/01.chi0000205699.58626.b5; SPOHR HL, 1993, LANCET, V341, P907, DOI 10.1016/0140-6736(93)91207-3; Steiner Hans, 2011, Child Adolesc Psychiatry Ment Health, V5, P21, DOI 10.1186/1753-2000-5-21; Steinhausen H.-C., 2006, CLIN HDB CHILD ADOLE; Steinhausen Hans-Christoph, 2007, Child Adolesc Psychiatry Ment Health, V1, P12, DOI 10.1186/1753-2000-1-12; Steinhausen HC, 2003, J CHILD PSYCHOL PSYC, V44, P677, DOI 10.1111/1469-7610.00154; STEINHAUSEN HC, 1993, J AM ACAD CHILD PSY, V32, P990, DOI 10.1097/00004583-199309000-00016; Stouthamer-Loeber M, 2004, DEV PSYCHOPATHOL, V16, P897, DOI 10.1017/S0954579404040064; Streissguth AP., 1996, UNDERSTANDING OCCURR; Swendsen J, 2012, ARCH GEN PSYCHIAT, V69, P390, DOI 10.1001/archgenpsychiatry.2011.1503; Swenson CC, 2010, J FAM PSYCHOL, V24, P497, DOI 10.1037/a0020324; Teplin LA, 2002, ARCH GEN PSYCHIAT, V59, P1133, DOI 10.1001/archpsyc.59.12.1133; Tremblay R. E., 2012, ENCY EARLY CHILD DEV; van der Stouwe T, 2014, CLIN PSYCHOL REV, V34, P468, DOI 10.1016/j.cpr.2014.06.006; Viding E, 2012, AM J PSYCHIAT, V169, P1109, DOI 10.1176/appi.ajp.2012.12020191; Vreugdenhil C, 2004, SCHIZOPHRENIA BULL, V30, P73, DOI 10.1093/oxfordjournals.schbul.a007069; WEISS B, 1994, J ABNORM CHILD PSYCH, V22, P389, DOI 10.1007/BF02168081; Wichstrom L, 2012, J CHILD PSYCHOL PSYC, V53, P695, DOI 10.1111/j.1469-7610.2011.02514.x; Wilson HW, 2009, J CHILD PSYCHOL PSYC, V50, P769, DOI 10.1111/j.1469-7610.2008.01974.x; World Health Organization, 1992, INT CLASS DIS REL HL; Young S, 2011, WORLD J BIOL PSYCHIA, V12, P124, DOI 10.3109/15622975.2011.600319	118	1	1	0	0	CAMBRIDGE UNIV PRESS	CAMBRIDGE	THE PITT BUILDING, TRUMPINGTON ST, CAMBRIDGE CB2 1RP, CAMBS, ENGLAND			978-1-316-63221-5; 978-1-107-18043-7	CAMB HANDB PSYCHOL			2018							278	300			10.1017/ 9781316847992		23	Criminology & Penology; Psychology, Multidisciplinary	Book Citation Index – Social Sciences & Humanities (BKCI-SSH)	Criminology & Penology; Psychology	BO7HX	WOS:000524491500017					2022-02-06	
J	Afshari, J; Haghpanahi, M; Kalantarinejad, R; Rouboa, A				Afshari, Javad; Haghpanahi, Mohammad; Kalantarinejad, Reza; Rouboa, Abel			Biomechanical investigation of astronaut's seat geometry to reduce neck and head injuries while landing impact	INTERNATIONAL JOURNAL OF CRASHWORTHINESS			English	Article						Traumatic brain injury; neck injury; optimal design of spacecraft seat; finite element model; landing impact	TRAUMATIC BRAIN-INJURIES; HUMAN RESPONSE; ACCELERATION; ORIENTATIONS; MODELS	The present study aims at designing a seat position to preserve the safety of occupants under acceleration and impact loads of landing conditions. So, using astronaut multi-body dynamics, initially, the astronaut's dynamic response to sustained loads while landing impact is at work was determined. Next, by applying the sustained loads to the three-dimensional finite element model of the head, the dynamic response of the head to sustained loads was determined. Subsequently, the probability of occupants' being injured was assessed by changing the seat angles and using the neck-injury index and the head-tissue injury criteria. Furthermore, sensitivity analysis was carried out in order to evaluate the sensitivity of injuries to changed seat angles. Results indicate that changing the trunk angles leads to changes up to 12% and 108% in the probability of injuries to the head and neck, respectively. Moreover, changing the angles of head and neck leads to changes up to 10% and 192% in the probability of injuries to the head and neck, respectively. Results also indicate that the probability of injuries to the head and neck can be reduced up to 0.17 and 0.23, respectively, if the astronaut is seated in an optimal landing position.	[Afshari, Javad; Haghpanahi, Mohammad] Iran Univ Sci & Technol, Sch Mech Engn, Tehran, Iran; [Kalantarinejad, Reza] Minist Sci Res & Technol Iran, Aerosp Res Inst, Tehran, Iran; [Rouboa, Abel] Univ Tras Os Montes & Alto Douro, CIENER INEGI Polo UTAD, Vila Real, Portugal; [Rouboa, Abel] Univ Penn, MEAM Dept, Philadelphia, PA 19104 USA		Haghpanahi, M (corresponding author), Iran Univ Sci & Technol, Sch Mech Engn, Tehran, Iran.	mhaghpanahi@iust.ac.ir		Rouboa, Abel/0000-0003-2652-8789			BROWN WK, 1966, AEROSPACE MED, V37, P394; Chamouard F., 1986, AAAM Q J, V8, P11; Cheng Z, 1997, Space Med Med Eng (Beijing), V10, P340; Deck C, 2008, INT J CRASHWORTHINES, V13, P667, DOI 10.1080/13588260802411523; Deck C., 2007, P IRCOBI INT RES COU; Do S, 2012, ACTA ASTRONAUT, V81, P239, DOI 10.1016/j.actaastro.2012.06.022; Doorly MC, 2007, INVESTIGATIONS HEAD; Du H.L, 2004, CHINA J CLIN REHAB, V8, P1474; Gadd C. W., 1966, P 10 STAPP CAR CRASH; Ghaffari M., 2012, 2012 19th Iranian Conference of Biomedical Engineering (ICBME 2012). Proceedings, P7, DOI 10.1109/ICBME.2012.6519651; Ghaffari M., 2014, J MODERN ENG, V14, P54; Gohmert D.M., 2014, SAFER SPACE SAFER WO, V699; Haland Y., 1996, P IRCOBI C, P123; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Homma T, 1996, RELIAB ENG SYST SAFE, V52, P1, DOI 10.1016/0951-8320(96)00002-6; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Jr E.W., 1963, HUMAN RESPONSE SEVER; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Kumar K.V., 1992, ISSUES HUMAN ACCELER; Lawrence C, 2007, NASATM2007214669; Liu BK, 2008, AEROSP SCI TECHNOL, V12, P331, DOI 10.1016/j.ast.2007.08.004; Liu BK, 2009, INT J CRASHWORTHINES, V14, P585, DOI 10.1080/13588260902896441; Liu X, 2013, AEROSP SCI TECHNOL, V29, P321, DOI 10.1016/j.ast.2013.04.003; Liu Xin, 2012, Journal of Mechanical Engineering, V48, P168, DOI 10.3901/JME.2012.21.168; Newman J., 1986, INT IRCOBI C BIOM IM, V14, P121; Otte D., 1999, P INT RES COUNC BIOM, V27; Post A, 2015, NEUROSURGERY, V76, P81, DOI 10.1227/NEU.0000000000000554; Saboori P, 2011, IMECE 2011, V2, P89; Shuaeib FM, 2002, J MATER PROCESS TECH, V123, P406, DOI 10.1016/S0924-0136(02)00048-1; Sobol I.M., 1993, MATH COMPUT MODEL, V1, P407; Trosseille X., 1992, DEV FEM HUMAN HEAD A; Wang Y.L., 1996, SPACE MED MED ENG CH, V9, P60; Wang Y.L., 1994, SPACE MED MED ENG CH, V7, P157; Ward CC., 1977, INTRACRANIAL PRESSUR; WEIS EB, 1963, AEROSPACE MED, V34, P1122; Zanoosi AAP, 2015, ACTA ASTRONAUT, V115, P58, DOI 10.1016/j.actaastro.2015.04.016; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhou C., 1997, P INT C BIOM IMP IRC	39	1	1	3	11	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1358-8265	1754-2111		INT J CRASHWORTHINES	Int. J. Crashworthiness		2018	23	4					355	365		10.1080/13588265.2017.1328724			11	Engineering, Manufacturing; Engineering, Mechanical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	GU4KB	WOS:000445251500001					2022-02-06	
J	Afzal, A; Rehman, L; Ali, M; Buzdar, S; Bokhari, I; Sheikh, M				Afzal, Ali; Rehman, Lal; Ali, Muhammad; Buzdar, Shakeel; Bokhari, Iram; Sheikh, Munwar			Prevalence of hyponatremia in traumatic brain injury and its association with severity and outcome	TRACE ELEMENTS AND ELECTROLYTES			English	Article						hyponatremia; traumatic brain injury (TBI); serum osmolarity	IN-HOSPITAL MORTALITY; INTENSIVE-CARE-UNIT; NEUROSURGICAL PATIENTS; INDEPENDENT PREDICTOR; RISK-FACTORS; PATHOPHYSIOLOGY; HEMORRHAGE; DIAGNOSIS; ETIOLOGY; THERAPY	Objective: To determine the prevalence of hyponatremia and its association with severity and outcome in traumatic brain injury. Study design: Descriptive. Place and duration of study: Department of Neurosurgery, Jinnah Postgraduate Medical Center, Karachi. Duration of study was from July 08, 2015 to January 07, 2017. Materials and methods: Data was collected retrospectively for all traumatic brain injury patients admitted during the study period. Demographics, mechanism of injuries, associated injuries, operative procedures, morbidity, and mortality were analyzed on a predesigned questionnaire. Severity of traumatic brain injury (TBI) by calculating Glasgow Coma Scale (CGS) was noted along with etiology and duration of head injury. All patients were investigated by CT brain, and the presence of hyponatremia was noted by measuring serum electrolytes on a 12 hourly basis till discharge or mortality. Results: Out of 300 patients with TBI, 216 (72%) were male and 84 (28%) were female with a mean age of 28.5 +/- 8.6 years. The mean GCS on admission was 8.5 +/- 2.6 ranging from 05 - 15 with 46 (15.3%) patients having mild, 158 (52.7%) having moderate, and 96 (32%) patients having severe head injury. The mode of injury was road traffic accidents in 168 (56%) patients followed by fall in 52 (16.7%). The time since injury ranged from 1 to 72 hours with a mean of 28.6 +/- 10.8 hours. A total of 156 (52%) patients developed hyponatremia, with the mean serum sodium level of 129.6 +/- 8.4 mEq/L ranging from 119 to 142 mEq/L. Hyponatremia developed early (< 5 days) in 124 (80%) of the affected 156 patients and late (> 5 days) in the remaining 32 (20%) patients. Most patients developed hyponatremia after 72 hours, and moderate head injury (GCS 9 - 12) was found to be associated with more severe hyponatremia. The serum osmolarity varied from 253 to 303 mOsm/L with a mean of 273 mOsm/L. Moderate hyponatremia was associated with higher short term mortality with an overall mortality rate at 7% (p-value < 0.024). Conclusion: Hyponatremia is common in neurosurgical patients and can manifest with increased frequency in any grade of TBI with increased morbidity and mortality. Early recognition and prompt treatment remains the mainstay of management in the complex setting of brain injury.	[Afzal, Ali; Rehman, Lal; Ali, Muhammad; Buzdar, Shakeel; Bokhari, Iram; Sheikh, Munwar] Jinnah Postgrad Med Ctr, Dept Neurosurg, Rafiqui Shaheed Rd, Karachi, Pakistan		Afzal, A (corresponding author), Jinnah Postgrad Med Ctr, Dept Neurosurg, Rafiqui Shaheed Rd, Karachi, Pakistan.	dokterali@gmail.com	Afzal, Ali/Q-9205-2019				Amin A, 2012, J HOSP MED, V7, P634, DOI 10.1002/jhm.1973; ARIEFF AI, 1976, MEDICINE, V55, P121, DOI 10.1097/00005792-197603000-00002; BARCLAY L, MEDSCAPE MED NEWS; Bennani SL, 2003, REV MED INTERNE, V24, P224, DOI 10.1016/S0248-8663(02)00811-1; Brimioulle S, 2008, INTENS CARE MED, V34, P125, DOI 10.1007/s00134-007-0905-7; Chitsazian Z, 2013, ARCH TRAUMA RES, V2, P91, DOI 10.5812/atr.9877; Clayton JA, 2006, QJM-INT J MED, V99, P505, DOI 10.1093/qjmed/hcl071; Friedman B, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.06.001; Gill G, 2006, CLIN ENDOCRINOL, V65, P246, DOI 10.1111/j.1365-2265.2006.02583.x; GULLANS SR, 1993, ANNU REV MED, V44, P289, DOI 10.1146/annurev.med.44.1.289; Hoorn EJ, 2006, NEPHROL DIAL TRANSPL, V21, P70, DOI 10.1093/ndt/gfi082; Kao L, 2009, PITUITARY, V12, P347, DOI 10.1007/s11102-009-0188-9; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kirkman MA, 2013, NEUROCRIT CARE, V18, P406, DOI 10.1007/s12028-012-9805-y; Kuramatsu JB, 2014, STROKE, V45, P1285, DOI 10.1161/STROKEAHA.113.004136; Lohani S, 2011, WORLD NEUROSURG, V76, P355, DOI 10.1016/j.wneu.2011.03.042; Mohan S, 2013, AM J MED, V126, P1127, DOI 10.1016/j.amjmed.2013.07.021; Moro N, 2007, SURG NEUROL, V68, P387, DOI 10.1016/j.surneu.2006.11.052; Padhi R, 2014, INDIAN J CRIT CARE M, V18, P83, DOI 10.4103/0972-5229.126077; Rahman M, 2009, NEUROSURGERY, V65, P925, DOI 10.1227/01.NEU.0000358954.62182.B3; Schrier RW, 2010, NAT REV NEPHROL, V6, P185, DOI 10.1038/nrneph.2010.21; Sherlock M, 2006, CLIN ENDOCRINOL, V64, P250, DOI 10.1111/j.1365-2265.2006.02432.x; Sherlock M, 2009, POSTGRAD MED J, V85, P171, DOI 10.1136/pgmj.2008.072819; Spasovski G, 2014, EUR J ENDOCRINOL, V170, pG1, DOI 10.1530/EJE-13-1020; Sturdik I, 2014, EUR J INTERN MED, V25, P379, DOI 10.1016/j.ejim.2014.02.002; Tzoulis P, 2014, CLIN ENDOCRINOL, V81, P401, DOI 10.1111/cen.12429; Upadhyay A, 2006, AM J MED, V119, pS30, DOI 10.1016/j.amjmed.2006.05.005; Verbalis JG, 1998, SEMIN NEPHROL, V18, P3; Verbalis JG, 2013, AM J MED, V126, pS5, DOI 10.1016/j.amjmed.2013.07.006; Waikar SS, 2009, AM J MED, V122, P857, DOI 10.1016/j.amjmed.2009.01.027; Yumoto T, 2015, ACTA MED OKAYAMA, V69, P213; Zilberberg MD, 2008, CURR MED RES OPIN, V24, P1601, DOI 10.1185/03007990802081675	32	1	1	0	5	DUSTRI-VERLAG DR KARL FEISTLE	DEISENHOFEN-MUENCHEN	BAHNHOFSTRASSE 9 POSTFACH 49, D-82032 DEISENHOFEN-MUENCHEN, GERMANY	0946-2104			TRACE ELEM ELECTROLY	Trace Elem. Electrolytes		2018	35	2					61	66		10.5414/TEX01504			6	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	GB5MW	WOS:000429110000002					2022-02-06	
J	AlSulaim, HA; Haring, RS; Asemota, AO; Smart, BJ; Canner, JK; Ejaz, A; Efron, DT; Velopulos, CG; Haut, ER; Schneider, EB				AlSulaim, Hatim A.; Haring, R. Sterling; Asemota, Anthony O.; Smart, Blair J.; Canner, Joseph K.; Ejaz, Aslam; Efron, David T.; Velopulos, Catherine G.; Haut, Elliott R.; Schneider, Eric B.			Conscious status is associated with the likelihood of trauma centre care and mortality in patients with moderate-to-severe traumatic brain injury	BRAIN INJURY			English	Article						TBI; conscious; trauma centre; mortality	OLDER-ADULTS; SCORE; IDENTIFICATION; VALIDATION; PREDICTION; ACCESS; SCALE	Objective: To assess the relationship between The International Classification of Diseases, Ninth Revision, Clinical Modification-derived conscious status and mortality rates in trauma centres (TC) vs. non-trauma centres (NTC).Methods: Patients in the 2006-2011 Nationwide Emergency Department Sample meeting, The Centers for Disease Control and Prevention criteria for traumatic brain injury (TBI), with head/neck Abbreviated Injury Scale (AIS) scores 3 were included. Loss of consciousness (LOC) was computed for each patient. Primary outcomes included treatment at a level I/II TC vs. NTC and in-hospital mortality. We compared logistic regression models controlling for patient demographics, injury characteristics, and AIS score with identical models that also included LOC.Results: Of 66,636 patients with isolated TBI identified, 15,761 (23.6%) had missing LOC status. Among the remaining 50,875 patients, 59.0% were male, 54.0% were 65years old, 56.7% were treated in TCs, and 27.3% had extended LOC. Patients with extended LOC were more likely to be treated in TCs vs. those with no/brief LOC (71.1% vs. 51.4%, p<0.001). Among patients aged <65, TC treatment was associated with increased odds of mortality [Adjusted Odds Ratio (AOR) 1.79]; accounting for LOC substantially mitigated this relationship [AOR 1.27]. Similar findings were observed among older patients, with reduced effect size.Conclusion: Extended LOC was associated with TC treatment and mortality. Accounting for patient LOC reduced the differential odds of mortality comparing TCs vs. NTCs by 60%. Research assessing TBI outcomes using administrative data should include measures of consciousness.	[AlSulaim, Hatim A.; Haring, R. Sterling; Asemota, Anthony O.; Smart, Blair J.; Canner, Joseph K.; Ejaz, Aslam; Efron, David T.; Velopulos, Catherine G.; Haut, Elliott R.; Schneider, Eric B.] Johns Hopkins Sch Med, Dept Surg, Johns Hopkins Surg Ctr Outcomes Res, Baltimore, MD USA; [Haring, R. Sterling; Haut, Elliott R.; Schneider, Eric B.] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Schneider, Eric B.] Univ Virginia, Sch Med, Dept Surg, Charlottesville, VA 22908 USA; [Velopulos, Catherine G.] Univ Colorado Hosp, Dept Surg, Aurora, CO USA; [AlSulaim, Hatim A.] Qassim Univ, Dept Surg, Unaizah Coll Med, Buraydah, Saudi Arabia		Schneider, EB (corresponding author), Sch Med, Dept Surg, 1300 Jefferson Pk Ave,Suite 4621A, Charlottesville, VA 22908 USA.	eschnei1@jhmi.edu	Haut, Elliott R./J-3948-2019	Ejaz, Aslam/0000-0002-1387-2604; Haring, R. Sterling/0000-0002-5417-3914; Haut, Elliott/0000-0001-7075-771X			Alamgir H, 2006, OCCUP ENVIRON MED, V63, P290, DOI 10.1136/oem.2005.026047; [Anonymous], 2018, ICD ICD 9 CM INT CLA; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clark DE, 2010, ICDPIC STATA MODULE; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2001, DOI 10.1089/neu.2013.3047; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; DuBose JJ, 2008, ARCH SURG-CHICAGO, V143, P1213, DOI 10.1001/archsurg.143.12.1213; Faul M, 2010, TRAUMATIC BRAIN INJU; Faul M, 2016, PREHOSP EMERG CARE, V20, P594, DOI 10.3109/10903127.2016.1149651; Ferreros I, 2012, REV NEUROLOGIA, V54, P719, DOI 10.33588/rn.5412.2011701; Glance LG, 2009, ANN SURG, V249, P1032, DOI 10.1097/SLA.0b013e3181a38f28; Haider AH, 2012, J TRAUMA ACUTE CARE, V72, P1695, DOI 10.1097/TA.0b013e318256a010; Haut ER, 2012, JAMA-J AM MED ASSOC, V307, P2589, DOI 10.1001/jama.2012.6626; Healthcare Cost and Utilization Project, 2014, OV NAT EM DEP SAMPL; KNAUS WA, 1981, CRIT CARE MED, V9, P591, DOI 10.1097/00003246-198108000-00008; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Powell JM, 2016, AM J OCCUP THER, V70, DOI 10.5014/ajot.2016.020909; Raum MR, 2009, CRIT CARE MED, V37, P1972, DOI 10.1097/CCM.0b013e31819fe96a; Ryb GE, 2011, J TRAUMA, V71, P742, DOI 10.1097/TA.0b013e31822ba010; Sharma S, 2014, J AM COLL SURGEONS, V218, P51, DOI 10.1016/j.jamcollsurg.2013.10.005; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Wang K, 2016, FRONT BIOSCI-LANDMRK, V21, P890; Wasserman EB, 2015, PREHOSP EMERG CARE, V19, P202, DOI 10.3109/10903127.2014.959225; Weeks SR, 2016, INJURY, V47, P125, DOI 10.1016/j.injury.2015.07.004; Willenbring BD, 2016, PREHOSP EMERG CARE, V20, P1, DOI 10.3109/10903127.2015.1056896	28	1	1	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	6					784	793		10.1080/02699052.2018.1451658			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GE9BZ	WOS:000431526200013	29561720				2022-02-06	
J	Austin, HM; Balendra, N; Langenderfer, JE; Ustinova, KI				Austin, H. M.; Balendra, N.; Langenderfer, J. E.; Ustinova, K. I.			Decomposition of leg movements during overground walking in individuals with traumatic brain injury	BRAIN INJURY			English	Article						Gait; coordination; dual-task walking	CEREBELLAR-ATAXIA; GAIT; COORDINATION; ABNORMALITIES; LOCOMOTION; FALLS; ARM	Objective: Walking requires precise coordination of bilateral lower extremity motions at all joints. This ability can be affected by traumatic brain injury (TBI). The study investigated inter-joint coordination of lower extremities during overground walking after TBI.Methods: Ten individuals with post-injury ataxia, postural stability and gait abnormalities, as well as 10 sex- and age-matched control subjects were involved in the study. Participants walked at self-selected speed in three experimental conditions: normal walking without any additional task; walking with a narrow base of support, and walking while holding a cup full of water. Inter-joint coordination was analysed as the percentage of gait cycle during which the leg movement was decomposed with 0% indicating simultaneous motion of the two joints (i.e. hip-knee, knee-ankle, and hip-ankle) through the entire gait cycle or 100% indicating motion of only one joint. Decomposition was calculated for each pair of joints and for the left and right leg separately.Results: Participants with TBI showed greater decomposition indices and poorer inter-joint coordination respectively than control individuals for all joint pairs (p<0.01). Walking with the narrower base of support or with a cup, increased movement decomposition in the TBI group, but not in the control group.Conclusion: The results revealed post-injury gait impairment that manifests as decomposition of multi-joint motions of the lower extremities during overground walking.	[Austin, H. M.; Balendra, N.; Ustinova, K. I.] Cent Michigan Univ, Dept Phys Therapy, Mt Pleasant, MI 48859 USA; [Langenderfer, J. E.] Cent Michigan Univ, Sch Engn & Technol, Mt Pleasant, MI 48859 USA		Ustinova, KI (corresponding author), Cent Michigan Univ, Doctoral Program Phys Therapy, Mt Pleasant, MI 48858 USA.	ustin1k@cmich.edu	Ustinova, Ksenia I/M-8250-2016	Ustinova, Ksenia I/0000-0002-1531-7591			[Anonymous], 2009, MANAGEMENT CONCUSSIO; Bastian AJ, 1996, J NEUROPHYSIOL, V76, P492, DOI 10.1152/jn.1996.76.1.492; Bastian AJ, 1998, ANN NEUROL, V44, P601, DOI 10.1002/ana.410440405; BERG K, 1989, Physiotherapy Canada, V41, P304; Bernstein AN, 1967, THE COORDINATION AND; Bickerstaff RE, 1989, NEUROLOGICAL EXAMINA; Chiu SL, 2013, GAIT POSTURE, V38, P717, DOI 10.1016/j.gaitpost.2013.03.010; Cossette I, 2016, BRAIN INJURY, V30, P1648, DOI 10.1080/02699052.2016.1200143; CRENNA P, 1994, MOTOR DEV CHILDREN, P103; Dimitrova D, 2004, J NEUROPHYSIOL, V91, P489, DOI 10.1152/jn.00094.2003; Donker SF, 2001, J MOTOR BEHAV, V33, P86, DOI 10.1080/00222890109601905; Duncan WP, 1987, STROKE REHABILITATIO; Earhart GM, 2001, J NEUROPHYSIOL, V85, P759, DOI 10.1152/jn.2001.85.2.759; Fritz NE, 2015, J NEUROL PHYS THER, V39, P142, DOI 10.1097/NPT.0000000000000090; Goodkin H, 1993, CANADIAN J NEUROLO S, V20, pS3; Harding AE, 1990, NEUROLOGY CLIN PRACT; KLOCKGETHER T, 1990, J NEUROL NEUROSUR PS, V53, P297, DOI 10.1136/jnnp.53.4.297; Levin MF, 1996, BRAIN, V119, P281, DOI 10.1093/brain/119.1.281; Mark H, 1993, CANADIAN J NEUROLO S, V20, pS3; McFadyen BJ, 2003, J HEAD TRAUMA REHAB, V18, P512, DOI 10.1097/00001199-200311000-00005; McKechnie D, 2015, DISABIL REHABIL, V37, P2291, DOI 10.3109/09638288.2014.1002578; Medley A, 2006, BRAIN INJURY, V20, P1403, DOI 10.1080/02699050601082057; Middleton A, 2015, J AGING PHYS ACTIV, V23, P314, DOI 10.1123/japa.2013-0236; Morton SM, 2003, J NEUROPHYSIOL, V89, P1844, DOI 10.1152/jn.00787.2002; Palliyath S, 1998, MOVEMENT DISORD, V13, P958, DOI 10.1002/mds.870130616; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Patla EA, 1991, ADAPTABILITY HUMAN G, P3; PERRY J, 1995, STROKE, V26, P982, DOI 10.1161/01.STR.26.6.982; Potts MB, 2009, CEREBELLUM, V8, P211, DOI 10.1007/s12311-009-0114-8; Shumway-Cook A, 2012, MOTOR CONTROL TRANSL; Shumway-Cook A, 1990, J HEAD TRAUMA REHAB, V5, P51, DOI DOI 10.1097/00001199-199012000-00007; Soto-Ares G, 2001, CHILD NERV SYST, V17, P263, DOI 10.1007/s003810000411; Stoffregen TA, 2007, J MOTOR BEHAV, V39, P126, DOI 10.3200/JMBR.39.2.126-138; Tester NJ, 2012, GAIT POSTURE, V36, P49, DOI 10.1016/j.gaitpost.2012.01.004; Topka H, 1998, EXP BRAIN RES, V119, P483, DOI 10.1007/s002210050364; USTINOVA KI, 2003, HUM PHYSL, V29, P642, DOI DOI 10.1023/A:1025832420924; Ustinova KI, 2014, J NEUROL PHYS THER, V38, P125, DOI 10.1097/NPT.0000000000000035; Vallee M, 2006, ARCH PHYS MED REHAB, V87, P806, DOI 10.1016/j.apmr.2006.02.031; VanderHill MS, 2014, GAIT POSTURE, V40, P652, DOI 10.1016/j.gaitpost.2014.07.015; WATERS RL, 1988, J ORTHOPAED RES, V6, P215, DOI 10.1002/jor.1100060208; Williams G, 2013, BRAIN INJURY, V27, P434, DOI 10.3109/02699052.2012.750754; Williams G, 2009, ARCH PHYS MED REHAB, V90, P587, DOI 10.1016/j.apmr.2008.10.013; Wrisley DM, 2004, PHYS THER, V84, P906, DOI 10.1093/ptj/84.10.906	43	1	1	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	6					739	746		10.1080/02699052.2018.1444203			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GE9BZ	WOS:000431526200007	29494269				2022-02-06	
J	Avanali, R; Bhadran, B; Panchal, S; Kumar, PK; Abhishek, V; Gulhane, K; Harison, G				Avanali, Raghunath; Bhadran, Biju; Panchal, Sunil; Kumar, Krishna P.; Abhishek, V; Gulhane, Kshitij; Harison, G.			Antero posterior elongation of midbrain in traumatic brain injury-significant sign yet a mistaken entity	BRITISH JOURNAL OF NEUROSURGERY			English	Article						Midbrain elongation; basal cisterns; traumatic intra cerebral hematoma	COMPUTED-TOMOGRAPHY; PROGNOSTIC-FACTORS; HERNIATION; MANAGEMENT; DIAGNOSIS; MODERATE; MRI	Background: Antero posterior elongation of the midbrain is observed occasionally in severe traumatic brain injury and generally implies a bad outcome. The objective of the study was to document midbrain elongation and identify the implications of this finding. Methods: This prospective study included 100 patients with traumatic intracranial haematoma of more than 20 cc in volume. Key measurements were taken in the midbrain and pontine regions and the status of perimesencephalic basal cisterns was noted. All the predictors were analyzed for the outcome. Results: In twenty-nine patients the distorted midbrain appeared to be elongated in the antero posterior direction on visual inspection of CT head images. However, on statistical analysis, it was made out that there is no demonstrable anteroposterior lengthening of the midbrain. The factors influencing the appearance and outcome were discussed. Conclusions: Although not a true sign, the finding of the elongated appearance of the midbrain in traumatic brain injury still holds significance as a predictor of mortality. Hence, this finding should alert neuro-surgeons or intensivists to expedite the administration of suitable interventions in a salvageable patient.	[Avanali, Raghunath; Bhadran, Biju; Panchal, Sunil; Kumar, Krishna P.; Abhishek, V; Gulhane, Kshitij; Harison, G.] Govt Med Coll, Dept Neurosurg, Alappuzha, Kerala, India		Avanali, R (corresponding author), Govt TD Med Coll, Neurosurg, Alappuzha 688005, Kerala, India.	raghunimhans@yahoo.co.in					Altmeyer W, 2016, MAGN RESON IMAGING C, V24, P305, DOI 10.1016/j.mric.2015.11.011; Barthelemy EJ, 2016, WORLD NEUROSURG, V88, P411, DOI 10.1016/j.wneu.2015.12.044; Broder JS, 2010, PSYCHIAT CLIN N AM, V33, P821, DOI 10.1016/j.psc.2010.08.006; Fedi M, 2008, J NEURO-OPHTHALMOL, V28, P289, DOI 10.1097/WNO.0b013e31818eb48d; FISHER CM, 1995, CAN J NEUROL SCI, V22, P83, DOI 10.1017/S0317167100040142; Frattalone AR, 2013, NEUROSURG CLIN N AM, V24, P309, DOI 10.1016/j.nec.2013.03.006; Gean AD, 2010, NEUROIMAG CLIN N AM, V20, P527, DOI 10.1016/j.nic.2010.08.001; Hilario A, 2012, AM J NEURORADIOL, V33, P1925, DOI 10.3174/ajnr.A3092; Hussain SI, 2008, J NEUROL SCI, V268, P190, DOI 10.1016/j.jns.2007.11.008; Jacobs B, 2010, J NEUROTRAUM, V27, P331, DOI 10.1089/neu.2009.1105; JENNETT B, 1975, LANCET, V1, P480; Kim HJ, 2012, J KOREAN NEUROSURG S, V51, P24, DOI 10.3340/jkns.2012.51.1.24; Kim JJ, 2011, NEUROTHERAPEUTICS, V8, P39, DOI 10.1007/s13311-010-0003-3; Kubal WS, 2012, RADIOL CLIN N AM, V50, P15, DOI 10.1016/j.rcl.2011.08.010; LAINE FJ, 1995, AM J ROENTGENOL, V165, P967, DOI 10.2214/ajr.165.4.7677003; OSBORN AG, 1977, RADIOLOGY, V123, P93, DOI 10.1148/123.1.93; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; Tomlinson B E, 1970, J Clin Pathol Suppl (R Coll Pathol), V4, P154; Woischneck D, 2015, CLIN RADIOL, V70, P278, DOI 10.1016/j.crad.2014.11.010	19	1	1	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.		2018	32	2					129	135		10.1080/02688697.2018.1432748			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GQ1IE	WOS:000441381700004	29383966				2022-02-06	
J	Bahuleyan, B; Patel, VT; Usurumarthi, P; Madhavan, GK; Thomas, SG				Bahuleyan, Biji; Patel, Vineetkumar Thakorbhai; Usurumarthi, Prashanth; Madhavan, Girish Kuranjiyoor; Thomas, Santhosh George			Posttraumatic Intralaminar Hematoma Developing between Cranial Dural Layers: A Case Report	PEDIATRIC NEUROSURGERY			English	Article						Trauma; Hematoma; Dura mater; Dural layers	EPIDURAL HEMATOMA; MANAGEMENT	We present a case of post-traumatic hematoma developing between the 2 layers of the cranial dura in a 2-year-old child following head injury. This child presented with history of fall from a height in altered sensorium with paucity of movements on the left side. Computerized tomography scan of the brain showed a right parietal linear fracture with an underlying hyperdense biconvex hematoma. Emergency evacuation of the hematoma was done. On elevation of the scalp flap, a fibrous membrane was seen protruding between the fracture lines. Following craniotomy, the hematoma was identified between the 2 layers of the dura and the fibrous membrane that protruded between the fracture lines was identified as the endosteal layer of dura. The hematoma was evacuated after opening the outer endosteal layer. After evacuation of the hematoma, the endosteal and meningeal layers could be identified separately and the point where these 2 layers split to enclose the hematoma was identified at the outer border of the hematoma. The child had no neurological sequel at the time of discharge. (C) 2017 S. Karger AG, Basel	[Bahuleyan, Biji; Patel, Vineetkumar Thakorbhai; Usurumarthi, Prashanth; Madhavan, Girish Kuranjiyoor; Thomas, Santhosh George] Kerala Inst Med Sci, Dept Neurosurg, Thiruvananthapuram, Kerala, India		Bahuleyan, B (corresponding author), Kerala Inst Med Sci, Anayara PO,Post Box 1, Thiruvananthapuram 695029, Kerala, India.	drbijib@yahoo.com					Chung CK, 1999, J NEUROL NEUROSUR PS, V66, P248, DOI 10.1136/jnnp.66.2.248; HAINES DE, 1991, ANAT RECORD, V230, P3, DOI 10.1002/ar.1092300103; Maugeri R, 2015, AM J CASE REP, V16, P811, DOI 10.12659/AJCR.895231; Paiva WS, 2010, ARQ NEURO-PSIQUIAT, V68, P888, DOI 10.1590/S0004-282X2010000600011; Pascual JM, 2012, SCHMIDEK SWEET OPERA, P1513	5	1	1	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291	1423-0305		PEDIATR NEUROSURG	Pediatr. Neurosurg.		2018	53	1					55	58		10.1159/000480663			4	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	FQ4DA	WOS:000418306600009	29080894				2022-02-06	
J	Bai, ZF; Song, DY; Deng, H; Li-Tsang, CWP				Bai, Zhongfei; Song, Danyang; Deng, Huan; Li-Tsang, Cecilia W. P.			Predictors for return to work after physical injury in China: A one-year review	WORK-A JOURNAL OF PREVENTION ASSESSMENT & REHABILITATION			English	Article						Tendency; workers with physical injuries; disability; vocational rehabilitation; severity of disability	LOW-BACK-PAIN; TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; PROGNOSTIC-FACTORS; OCCUPATIONAL INJURY; MENTAL-DISORDERS; SICK LEAVE; BURDEN; ABSENCE; MULTICENTER	BACKGROUND: Several studies have explored the factors influencing patients' return to work (RTW) status. However, only few studies have tried to explore the predictors for RTW in subpopulations in terms of different levels of disability, particularly in the Chinese population. OBJECTIVE: This study describes the trends in patient's RTW and explores the predictors associated with RTW for patients with work-related injury in Mainland China. METHODS: A total of 457 patients with different types of injury were followed up for one year. Patients were stratified into three groups according to the grade of disability as follows: mild, moderate, and severe. Variables affecting RTW were then compared between the three groups, and multiple logistic regression was performed to identify the predictors for RTW. RESULTS: The RTW rates during the study period were significantly different among the three groups. RTW tended to increase rapidly during the early stage, but the increase plateaued during the later stage. For the mild disability group, educational level, expectation to RTW, and other types of injury (e.g., spinal cord injury, traumatic brain injury, and burn) were significant predictors for RTW. White-collar work and better employer satisfaction were positive predictors for RTW for the moderate group. Meanwhile, no significant predictor for RTW was determined for the severe disability group. CONCLUSIONS: RTW tended to increase rapidly during the early stage, but the increase plateaued during the later stage. The predictors for RTW also varied among the patients with different levels of disability. These predictors may help vocational rehabilitation service providers provide more accurate intervention.	[Bai, Zhongfei; Song, Danyang; Deng, Huan; Li-Tsang, Cecilia W. P.] Hong Kong Polytech Univ, Dept Rehabil Sci, Kowloon, Hong Kong, Peoples R China; [Bai, Zhongfei] Shanghai Yangzhi Rehabil Hosp, Shanghai Sunshine Rehabil Ctr, Dept Occupat Therapy, Shanghai, Peoples R China		Li-Tsang, CWP (corresponding author), Hong Kong Polytech Univ, Dept Rehabil Sci, Kowloon, Hong Kong, Peoples R China.	cecilia.li@polyu.edu.hk		Bai, Zhongfei/0000-0001-9800-7080			Cancelliere C, 2016, CHIROPR MAN THER, V24, DOI 10.1186/s12998-016-0113-z; Casey PP, 2014, WORK, V48, P11, DOI 10.3233/WOR-131608; Chang VC, 2014, OCCUP ENVIRON MED, V71, P695, DOI 10.1136/oemed-2014-102097; Cornelius LR, 2011, J OCCUP REHABIL, V21, P259, DOI 10.1007/s10926-010-9261-5; Driscoll T, 2012, INJURY PREV, V18, pA228, DOI 10.1136/injuryprev-2012-040590w.12; Dunstan DA, 2013, WORK, V46, P25, DOI 10.3233/WOR-2012-1481; Durand MJ, 2014, WORK, V48, P579, DOI 10.3233/WOR-141914; Ferdiana A, 2014, J REHABIL MED, V46, P984, DOI 10.2340/16501977-1873; Henschke N, 2008, BMJ, V337; Henschke N, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a171; Iles RA, 2008, OCCUP ENVIRON MED, V65, P507, DOI 10.1136/oem.2007.036046; Jensen OK, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-140; Jorgensen K, 2013, SCAND J PUBLIC HEALT, V41, P18, DOI 10.1177/1403494812468518; Kang SK, 2011, SAF HEALTH WORK, V2, P52, DOI 10.5491/SHAW.2011.2.1.52; Kendrick D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-584; Leigh J, 1999, EPIDEMIOLOGY, V10, P626, DOI 10.1097/00001648-199909000-00032; Leigh JP, 2011, MILBANK Q, V89, P728, DOI 10.1111/j.1468-0009.2011.00648.x; MACKENZIE EJ, 1987, AM J PUBLIC HEALTH, V77, P329, DOI 10.2105/AJPH.77.3.329; MacKenzie EJ, 1998, AM J PUBLIC HEALTH, V88, P1630, DOI 10.2105/AJPH.88.11.1630; Odgaard L, 2017, J HEAD TRAUMA REHAB, V32, pE57, DOI 10.1097/HTR.0000000000000239; Opsteegh L, 2009, J OCCUP REHABIL, V19, P245, DOI 10.1007/s10926-009-9181-4; Ozegovic D, 2010, SPINE, V35, pE708, DOI 10.1097/BRS.0b013e3181d12432; Piha K, 2013, EUR J PUBLIC HEALTH, V23, P693, DOI 10.1093/eurpub/cks162; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Santana VS, 2013, IND HEALTH, V51, P463, DOI 10.2486/indhealth.2013-0020; Shi QY, 2014, J HAND THER, V27, P55, DOI 10.1016/j.jht.2013.10.001; Steenstra IA, 2005, OCCUP ENVIRON MED, V62, P851, DOI 10.1136/oem.2004.015842; Steenstra IA, 2005, J OCCUP REHABIL, V15, P591, DOI 10.1007/s10926-005-8037-9; Takala J, 2014, J OCCUP ENVIRON HYG, V11, P326, DOI 10.1080/15459624.2013.863131; Verkerk K, 2012, PHYS THER REHABIL J, V92, P1093, DOI 10.2522/ptj.20110388; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Wilbanks SR, 2015, DISABIL REHABIL, V37, P739, DOI 10.3109/09638288.2014.938177	32	1	1	1	4	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1051-9815	1875-9270		WORK	Work		2018	60	2					319	327		10.3233/WOR-182735			9	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	GL1ST	WOS:000436889900014	29865101				2022-02-06	
J	Bell, KR; Bushnik, T; Dams-O'Connor, K; Goldin, Y; Hoffman, JM; Lequerica, AH; Nakase-Richardson, R; Zumsteg, JM				Bell, Kathleen R.; Bushnik, Tamara; Dams-O'Connor, Kristen; Goldin, Yelena; Hoffman, Jeanne M.; Lequerica, Anthony H.; Nakase-Richardson, Risa; Zumsteg, Jennifer M.			Sleep after TBI: How the TBI Model Systems have advanced the field	NEUROREHABILITATION			English	Article						Sleep disorders; sleep dysfunction; traumatic brain injury; traumatic brain injury model systems	TRAUMATIC BRAIN-INJURY; FATIGUE; MODULE; APNEA; CONSEQUENCES; DEPRIVATION; DISTURBANCE; PREVALENCE; SCALE; RAT	BACKGROUND: Identification and management of comorbidities in TBI has become an increasing focus for optimizing TBI outcomes. Recent meta-analyses highlight sleep disturbance and sleep disorders following TBI (Mathias & Alvaro, 2012). Improving the recognition and treatment of sleep disorders in TBI should be a central focus of rehabilitation. The Traumatic Brain Injury Model System (TBIMS) has created an infrastructure allowing multi-center investigations into sleep dysfunction in those who have had a moderate to severe TBI and received inpatient rehabilitation. OBJECTIVE: This paper will describe the 1) infrastructure used to advance sleep dysfunction/disorders research following TBI, 2) preliminary findings from these studies, and 3) repository of data which can be accessed for secondary analyses by investigators outside of the TBIMS infrastructure. METHODS: Two internal mechanisms allow investigators at TBIMS sites to collaborate on projects of shared interest: Research Modules and Special Interest Groups (SIG). RESULTS: To date, five studies have resulted from the TBIMS collaborative process focusing on insomnia, circadian disruption, and sleep apnea. CONCLUSIONS: Future directions for the SIG include continued development of available knowledge and understanding of the multidimensional factors that contribute to TBI-related sleep disturbance, optimal assessment tools, effectiveness of available treatments, and treatment compliance in this population.	[Bell, Kathleen R.] Univ Texas Southwestern, Dept Phys Med & Rehabil, Dallas, TX USA; [Bushnik, Tamara] NYU Langone Hlth, Rusk Rehabil, 240 East 38th St,17-48, New York, NY 10016 USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Goldin, Yelena] JFK Johnson Rehabil Inst, Edison, NJ USA; [Goldin, Yelena] Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ USA; [Hoffman, Jeanne M.; Zumsteg, Jennifer M.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Lequerica, Anthony H.] Kessler Fdn, E Hanover, NJ USA; [Lequerica, Anthony H.] Rutgers New Jersey Med Sch, Newark, NJ USA; [Nakase-Richardson, Risa] James A Haley Vet Hosp, Def & Vet Brain Injury Ctr, MHBS, Tampa, FL USA; [Nakase-Richardson, Risa] Univ S Florida, Div Pulm & Sleep Med, Morsani Coll Med, Tampa, FL USA		Bushnik, T (corresponding author), NYU Langone Hlth, Rusk Rehabil, 240 East 38th St,17-48, New York, NY 10016 USA.	tamara.bushnik@nyulangone.org		Zumsteg, Jennifer/0000-0002-0678-0103; Bell, Kathleen/0000-0002-0928-2046; Bushnik, Tamara/0000-0003-3328-257X	VHA Central Office VA TBI Model System Program of Research from General Dynamics Health Solutions from the Defense and Veterans Brain Injury Center within the Defense Health Agency [W91YTZ-13-C-0015]; Patient Centered Outcomes Research Institute (PCORI Project)Patient-Centered Outcomes Research Institute - PCORI [CER-1511-33005]; U.S. Department of Veterans Affairs Health Services Research and Development COIN grantUS Department of Veterans Affairs [1 I50 HX001233-01]	The Polytrauma Rehabilitation Center Traumatic Brain Injury (TBI) Model System collaboration is an Interagency Collaboration between the Department of Veterans Affairs and the Department of Health and Human Services (National Institute on Disability, Independent Living, and Rehabilitation Research). This research is sponsored by VHA Central Office VA TBI Model System Program of Research, Subcontract from General Dynamics Health Solutions (W91YTZ-13-C-0015, PI: Nakase-Richardson) from the Defense and Veterans Brain Injury Center within the Defense Health Agency, contract with the Patient Centered Outcomes Research Institute (PCORI Project CER-1511-33005, PI: Nakase-Richardson), U.S. Department of Veterans Affairs Health Services Research and Development COIN grant (1 I50 HX001233-01; CINDRR).	Balk EM, 2012, FUTURE RES NEEDS DIA; Cantor JB, 2012, J HEAD TRAUMA REHAB, V27, pE1, DOI 10.1097/HTR.0b013e318270f91e; Dahdah M. N, 2018, BRAIN INJURY PROFESS, V14, P12; Dash MB, 2009, J NEUROSCI, V29, P580, DOI 10.1523/JNEUROSCI.5486-08.2009; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; Holcomb EM, 2016, J HEAD TRAUMA REHAB, V31, P82, DOI 10.1097/HTR.0000000000000230; Lequerica A, 2014, NEUROREHABILITATION, V35, P485, DOI 10.3233/NRE-141141; Lequerica A, 2012, J HEAD TRAUMA REHAB, V27, pE28, DOI 10.1097/HTR.0b013e31826fe574; Lequerica AH, 2017, NEUROPSYCHOL REHABIL, V27, P1019, DOI 10.1080/09602011.2016.1231120; Longordo F, 2009, EUR J NEUROSCI, V29, P1810, DOI 10.1111/j.1460-9568.2009.06719.x; Makley MJ, 2008, NEUROREHAB NEURAL RE, V22, P341, DOI 10.1177/1545968308315598; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McDermott CM, 2003, J NEUROSCI, V23, P9687; Monden K. R, 2018, BRAIN INJURY PROFESS, V14, P20; Nakase-Richardson R, 2018, BRAIN INJURY PROFESS, V14, P7; Nakase-Richardson Schwartz DJ, 2018, BRAIN INJURY PROFESS, V14, P8; Nallu S, 2018, BRAIN INJURY PROFESS, V14, P22; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; PCORI, 2016, R151133005 PCORI; PCORI, 2018, COMP SLEEP APN ASS S; Rutherford GW, 2009, J HEAD TRAUMA REHAB, V24, P421, DOI 10.1097/HTR.0b013e3181c13439; TBIMS NDSC, 2018, COMP SLEEP APN ASS S; Trzepacz PT, 2001, J NEUROPSYCH CLIN N, V13, P229, DOI 10.1176/appi.neuropsych.13.2.229; Walker MP, 2009, ANN NY ACAD SCI, V1156, P168, DOI 10.1111/j.1749-6632.2009.04416.x; Webster JB, 2001, ARCH PHYS MED REHAB, V82, P316, DOI 10.1053/apmr.2001.20840; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Zeitzer J. M, 2018, BRAIN INJURY PROFESS, V14, P16; Zunzunegui C, 2011, SLEEP, V34, P1261, DOI 10.5665/SLEEP.1252	28	1	1	2	5	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2018	43	3					287	296		10.3233/NRE-182538			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HA8FK	WOS:000450524200005	30347631				2022-02-06	
B	Benbadis, SR; LaFrance, WC		LaFrance, WC; Schachter, SC		Benbadis, Selim R.; LaFrance, W. Curt, Jr.			Clinical Features and the Role of Video-EEG Monitoring	GATES AND ROWAN'S NONEPILEPTIC SEIZURES, 4TH EDITION			English	Article; Book Chapter							PSYCHOGENIC NONEPILEPTIC SEIZURES; TRAUMATIC BRAIN-INJURY; ICTAL EYE CLOSURE; EPILEPTIC SEIZURES; CHRONIC PAIN; DIAGNOSIS; INDUCTION; PSEUDOSEIZURES; MISDIAGNOSIS; SUGGESTION		[Benbadis, Selim R.] Univ S Florida, Dept Neurol, Tampa, FL 33620 USA; [Benbadis, Selim R.] Tampa Gen Hosp, Tampa, FL 33606 USA; [LaFrance, W. Curt, Jr.] Rhode Isl Hosp, Dept Neurol, Providence, RI USA; [LaFrance, W. Curt, Jr.] Rhode Isl Hosp, Dept Psychiat, Providence, RI USA; [LaFrance, W. Curt, Jr.] Brown Med Sch, Providence, RI USA		Benbadis, SR (corresponding author), Univ S Florida, Dept Neurol, Tampa, FL 33620 USA.; Benbadis, SR (corresponding author), Tampa Gen Hosp, Tampa, FL 33606 USA.						American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; AMINOFF MJ, 1988, NEUROLOGY, V38, P558, DOI 10.1212/WNL.38.4.558; Asadi-Pooya AA, 2014, EPILEPSY BEHAV, V31, P304, DOI 10.1016/j.yebeh.2013.10.019; Azar NJ, 2008, EPILEPSIA, V49, P132, DOI 10.1111/j.1528-1167.2007.01215.x; Bayly J, 2013, EPILEPSIA, V54, P1402, DOI 10.1111/epi.12207; BAZIL CW, 1994, EPILEPSIA, V35, P768, DOI 10.1111/j.1528-1157.1994.tb02509.x; Behrouz R, 2006, EPILEPSY BEHAV, V8, P649, DOI 10.1016/j.yebeh.2006.02.003; Benbadis SR, 2009, NEUROLOGY, V73, P843, DOI 10.1212/WNL.0b013e3181b78425; Benbadis SR, 2008, EUR NEUROL, V59, P267, DOI 10.1159/000115641; Benbadis SR, 2007, EPILEPSY BEHAV, V11, P257, DOI 10.1016/j.yebeh.2007.05.013; Benbadis SR, 2006, NEUROLOGY, V67, P904, DOI 10.1212/01.wnl.0000221738.82505.bf; Benbadis SR, 2006, EPILEPSY BEHAV, V9, P106, DOI 10.1016/j.yebeh.2006.02.011; Benbadis SR, 2013, NEUROLOGY, V80, pS47, DOI 10.1212/WNL.0b013e3182797539; Benbadis SR, 2010, EPILEPSIA, V51, P2338, DOI 10.1111/j.1528-1167.2010.02683.x; Benbadis SR, 2009, EPILEPSY BEHAV, V15, P106, DOI 10.1016/j.yebeh.2009.02.002; Benbadis SR, 1999, EUR NEUROL, V41, P114, DOI 10.1159/000008015; Benbadis SR, 2005, EPILEPSY BEHAV, V6, P264, DOI 10.1016/j.yebeh.2004.12.007; Benbadis SR, 2004, EPILEPSIA, V45, P1150, DOI 10.1111/j.0013-9580.2004.14504.x; Benbadis SR, 2004, NEUROLOGY, V63, P1728, DOI 10.1212/01.WNL.0000143273.18099.50; Benbadis SR, 1996, NEUROLOGY, V47, P63, DOI 10.1212/WNL.47.1.63; BENBADIS SR, 1995, ARCH INTERN MED, V155, P2346, DOI 10.1001/archinte.155.21.2346; Benbadis SR, 2003, J CLIN NEUROPHYSIOL, V20, P42, DOI 10.1097/00004691-200302000-00005; Benbadis SR, 2001, NEUROLOGY, V57, P915, DOI 10.1212/WNL.57.5.915; Benbadis SR, 2000, NEUROLOGY, V55, P1780, DOI 10.1212/WNL.55.12.1780; Benbadis SR, 2000, NEUROLOGY, V55, P1904, DOI 10.1212/WNL.55.12.1904; Benbadis SR, 2007, CONTINUUM MINNEAP MI, V13, P48; Beniczky S, 2014, EPILEPSIA, V55, P1128, DOI 10.1111/epi.12669; BERGEN D, 1993, ARCH NEUROL-CHICAGO, V50, P1059, DOI 10.1001/archneur.1993.00540100054014; Bhatia M, 1997, ACTA NEUROL SCAND, V95, P363, DOI 10.1111/j.1600-0404.1997.tb00226.x; Brigo F, 2012, EPILEPSY BEHAV, V25, P251, DOI 10.1016/j.yebeh.2012.06.020; Brigo F, 2012, SEIZURE-EUR J EPILEP, V21, P568, DOI 10.1016/j.seizure.2012.06.005; Burneo JG, 2003, NEUROLOGY, V61, P714, DOI 10.1212/WNL.61.5.714-a; Carton S, 2003, SEIZURE-EUR J EPILEP, V12, P287, DOI 10.1016/S1059-1311(02)00290-X; Chabolla DR, 2006, EPILEPSY BEHAV, V9, P307, DOI 10.1016/j.yebeh.2006.06.009; Chen DK, 2008, EPILEPSY BEHAV, V13, P115, DOI 10.1016/j.yebeh.2008.02.018; Chen DK, 2010, EPILEPSY BEHAV, V17, P188, DOI 10.1016/j.yebeh.2009.11.012; Chung SS, 2006, NEUROLOGY, V66, P1730, DOI 10.1212/01.wnl.0000218160.31537.87; COHEN LM, 1992, INT J PSYCHIAT MED, V22, P131, DOI 10.2190/NEHN-8QJN-1BGY-24NB; COHEN RJ, 1982, ANN NEUROL, V11, P391, DOI 10.1002/ana.410110413; Cragar DE, 2006, CLIN NEUROPSYCHOL, V20, P552, DOI 10.1080/13854040590947380; Davies KG, 2000, EPILEPSY BEHAV, V1, P436, DOI 10.1006/ebeh.2000.0124; Davis BJ, 2004, EUR NEUROL, V51, P153, DOI 10.1159/000077287; De Timary P, 2002, SEIZURE-EUR J EPILEP, V11, P193, DOI 10.1053/seiz.2001.0617; Derry CP, 2006, ARCH NEUROL-CHICAGO, V63, P705, DOI 10.1001/archneur.63.5.705; DESAI BT, 1982, ARCH NEUROL-CHICAGO, V39, P202, DOI 10.1001/archneur.1982.00510160008002; DEVINSKY O, 1989, NEUROLOGY, V39, P527; Dhiman V, 2013, EPILEPSY BEHAV, V27, P427, DOI 10.1016/j.yebeh.2013.03.005; Direk N, 2012, EPILEPSY BEHAV, V23, P138, DOI 10.1016/j.yebeh.2011.11.013; Driver-Dunckley E, 2011, PSYCHOSOMATICS, V52, P337, DOI 10.1016/j.psym.2011.01.008; Duncan R, 2004, J NEUROL NEUROSUR PS, V75, P1009, DOI 10.1136/jnnp.2003.022632; Duncan R, 2006, NEUROLOGY, V66, P1644, DOI 10.1212/01.wnl.0000223320.94812.7a; Dworetzky BA, 2010, EPILEPSY BEHAV, V19, P65, DOI 10.1016/j.yebeh.2010.06.052; Elzawahry H, 2010, EPILEPSY BEHAV, V18, P306, DOI 10.1016/j.yebeh.2010.04.041; Fahn S, 1988, Adv Neurol, V50, P431; Frucht MM, 2000, EPILEPSIA, V41, P1534; Gardella E, 2006, EPILEPTIC DISORD, V8, P267; Gardella E, 2006, EPILEPSIA, V47, P59, DOI 10.1111/j.1528-1167.2006.00879.x; GATES JR, 1985, ARCH NEUROL-CHICAGO, V42, P1183, DOI 10.1001/archneur.1985.04060110065017; Gazzola DM, 2012, EPILEPSY BEHAV, V25, P662, DOI 10.1016/j.yebeh.2012.10.008; Geyer JD, 1999, NEUROLOGY, V52, P743, DOI 10.1212/WNL.52.4.743; Glosser G, 1999, EPILEPSIA, V40, P1750, DOI 10.1111/j.1528-1157.1999.tb01593.x; Goya G, 2014, EPILEPSY RES, V108, P1120, DOI 10.1016/j.eplepsyres.2014.02.015; GUBERMAN A, 1982, CAN J PSYCHIAT, V27, P401, DOI 10.1177/070674378202700508; GULICK TA, 1982, NEUROLOGY, V32, P24, DOI 10.1212/WNL.32.1.24; Hill SW, 2011, EPILEPSY BEHAV, V22, P505, DOI 10.1016/j.yebeh.2011.08.001; HOEFNAGELS WAJ, 1991, J NEUROL, V238, P39, DOI 10.1007/BF00319709; Hudak AM, 2004, J HEAD TRAUMA REHAB, V19, P290, DOI 10.1097/00001199-200407000-00003; HUNTER J, 1949, ELECTROEN CLIN NEURO, V1, P113, DOI 10.1016/0013-4694(49)90014-0; Iranzo A, 2005, NEUROLOGY, V65, P247, DOI 10.1212/01.wnl.0000168864.97813.e0; Labate A, 2012, EPILEPSIA, V53, P377, DOI 10.1111/j.1528-1167.2011.03347.x; LaFrance WC, 2008, J AM ACAD PSYCHIATRY, V36, P227; LaFrance WC, 2008, CURR OPIN NEUROL, V21, P195, DOI 10.1097/WCO.0b013e3282f7008f; LaFrance WC, 2013, EPILEPSIA, V54, P2005, DOI 10.1111/epi.12356; LaFrance WC, 2013, EPILEPSIA, V54, P718, DOI 10.1111/epi.12053; LaFrance WC, 2006, EPILEPSY BEHAV, V8, P451, DOI 10.1016/j.yebeh.2006.02.004; Lambert C, 1944, BRIT MED J, V1944, P70; LANCMAN ME, 1994, ANN NEUROL, V35, P359, DOI 10.1002/ana.410350319; Leeman BA, 2009, EPILEPSY BEHAV, V15, P110, DOI 10.1016/j.yebeh.2009.01.013; LEMPERT T, 1994, ANN NEUROL, V36, P233, DOI 10.1002/ana.410360217; LESSER RP, 1983, NEUROLOGY, V33, P502, DOI 10.1212/WNL.33.4.502; LUTHER JS, 1982, ANN NEUROL, V12, P458, DOI 10.1002/ana.410120508; Martin RC, 1998, SEIZURE-EUR J EPILEP, V7, P385, DOI 10.1016/S1059-1311(05)80007-X; McGonigal A, 2002, J NEUROL NEUROSUR PS, V72, P549; MEIERKORD H, 1991, NEUROLOGY, V41, P1643, DOI 10.1212/WNL.41.10.1643; MONTAGNA P, 1988, ELECTROEN CLIN NEURO, V70, P172, DOI 10.1016/0013-4694(88)90116-2; Ney GC, 1998, ARCH NEUROL-CHICAGO, V55, P726, DOI 10.1001/archneur.55.5.726; Nowack WJ, 1997, CLIN ELECTROENCEPHAL, V28, P225, DOI 10.1177/155005949702800407; O'Sullivan SS, 2007, EPILEPSY BEHAV, V11, P77, DOI 10.1016/j.yebeh.2007.04.003; PEGUERO E, 1995, EPILEPSIA, V36, P586, DOI 10.1111/j.1528-1157.1995.tb02572.x; Penin H, 1968, UMSSCH WISSENSCH TEC, V7, P211; Perrin MW, 2010, EPILEPSY BEHAV, V19, P32, DOI 10.1016/j.yebeh.2010.06.006; Posner JB, 2007, PLUM POSNERS DIAGNOS, V4th, P297; RAMSAY RE, 1993, NON-EPILEPTIC SEIZURES, P47; Reuber M, 2003, EPILEPSY BEHAV, V4, P205, DOI 10.1016/S1525-5050(03)00104-5; Reuber M, 2003, ANN NEUROL, V53, P305, DOI 10.1002/ana.3000; Reuber M, 2002, ACTA NEUROCHIR, V144, P901, DOI 10.1007/s00701-002-0993-7; Reuber M, 2002, NEUROLOGY, V58, P493, DOI 10.1212/WNL.58.3.493; Reuber M, 2011, EPILEPSIA, V52, P2028, DOI 10.1111/j.1528-1167.2011.03162.x; Ribai P, 2006, J NEUROL, V253, P328, DOI 10.1007/s00415-005-0991-9; Riley TL, 1980, AM J EEG TECHNOL, V20, P89; Rosemergy I, 2013, EPILEPSY BEHAV, V27, P81, DOI 10.1016/j.yebeh.2012.12.024; Salinsky M, 2015, J HEAD TRAUMA REHAB, V30, pE65, DOI 10.1097/HTR.0000000000000057; Salinsky M, 2011, NEUROLOGY, V77, P945, DOI 10.1212/WNL.0b013e31822cfc46; Sandstrom SA, 2006, NEUROLOGY, V67, P544, DOI 10.1212/01.wnl.0000234968.40364.31; Schachter SC, 1996, J EPILEPSY, V9, P249, DOI 10.1016/S0896-6974(96)00042-4; Scheepers B, 1998, SEIZURE-EUR J EPILEP, V7, P403, DOI 10.1016/S1059-1311(05)80010-X; Selkirk M, 2008, EPILEPSIA, V49, P1446, DOI 10.1111/j.1528-1167.2008.01611.x; Sen A, 2007, EPILEPSY RES, V77, P62, DOI 10.1016/j.eplepsyres.2007.07.009; Seneviratne U, 2012, EPILEPSIA, V53, pe63, DOI 10.1111/j.1528-1167.2011.03382.x; Sheldon R, 2002, J AM COLL CARDIOL, V40, P142, DOI 10.1016/S0735-1097(02)01940-X; Sheldon RS, 1998, CAN J CARDIOL, V14, P811; SLATER JD, 1995, EPILEPSIA, V36, P580, DOI 10.1111/j.1528-1157.1995.tb02571.x; Smith D, 1999, QJM-INT J MED, V92, P15, DOI 10.1093/qjmed/92.1.15; SPERLING MR, 1990, ANN NEUROL, V28, P320, DOI 10.1002/ana.410280304; Stagno SJ, 1996, J EPILEPSY, V9, P153, DOI 10.1016/0896-6974(96)00002-3; Stephenson J, 2004, EPILEPTIC DISORD, V6, P15; Stone J, 2011, J PSYCHOSOM RES, V71, P369, DOI 10.1016/j.jpsychores.2011.07.005; SUMNER JW, 1952, NEUROLOGY, V2, P395, DOI 10.1212/WNL.2.9-10.395; Syed TU, 2009, NEUROLOGY, V72, P1646, DOI 10.1212/WNL.0b013e3181a55ef7; Syed TU, 2008, EPILEPSIA, V49, P898, DOI 10.1111/j.1528-1167.2007.01456.x; Syed TU, 2011, ANN NEUROL, V69, P997, DOI 10.1002/ana.22345; TEMKIN NR, 1984, EPILEPSIA, V25, P450, DOI 10.1111/j.1528-1157.1984.tb03442.x; TERADA K, 1995, J NEUROL NEUROSUR PS, V58, P745, DOI 10.1136/jnnp.58.6.745; THACKER K, 1993, ANN NEUROL, V33, P414, DOI 10.1002/ana.410330417; Tinuper P, 2004, EPILEPTIC DISORD, V6, P27; Trimble MR, 2001, CONT APPROACHES STUD, P143; van der Kruijs SJM, 2014, J PSYCHIATR RES, V54, P126, DOI 10.1016/j.jpsychires.2014.03.010; Varela HL, 2007, J CLIN NEUROPHYSIOL, V24, P390, DOI 10.1097/WNP.0b013e31812f6c11; Vossler DG, 2004, NEUROLOGY, V63, P516, DOI 10.1212/01.WNL.0000133208.57562.CB; WALCZAK TS, 1994, NEUROLOGY, V44, P394, DOI 10.1212/WNL.44.3_Part_1.394; Wennberg R, 2000, CAN J NEUROL SCI, V27, P131; Wennberg R, 2001, NEUROLOGY, V56, P133, DOI 10.1212/WNL.56.1.133-a; Willert C, 2004, ACTA NEUROL SCAND, V109, P318, DOI 10.1046/j.1600-0404.2003.00232.x; Woollacott IOC, 2010, EPILEPSY BEHAV, V17, P228, DOI 10.1016/j.yebeh.2009.12.002; Zaidi A, 2000, J AM COLL CARDIOL, V36, P181, DOI 10.1016/S0735-1097(00)00700-2	135	1	1	0	0	CAMBRIDGE UNIV PRESS	CAMBRIDGE	THE PITT BUILDING, TRUMPINGTON ST, CAMBRIDGE CB2 1RP, CAMBS, ENGLAND			978-1-316-27545-0; 978-1-316-61397-9				2018							44	57			10.1017/9781316275450		14	Clinical Neurology; Psychiatry	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Psychiatry	BQ5QF	WOS:000606976000005					2022-02-06	
J	Blankenship, AP; Canto, AI				Blankenship, A. Paige; Canto, Angela I.			Traumatic Brain Injuries and Special Education Services in the Schools	EXCEPTIONALITY			English	Article							WORKING-MEMORY; CHILDREN; STUDENTS; REHABILITATION; TBI; CONSEQUENCES; ADOLESCENTS; DEFICITS; REENTRY; THEMES	The purpose of this study is to replicate a study conducted by Hux, Marquardt, Skinner, and Bond (1999) in which the researchers explored the frequency of traumatic brain injuries (TBI) in the special education population as compared to the frequency of TBI among students in general education. Hux and colleagues (1999) found that roughly one-quarter of their sample received evaluations for special education services at some point, and that almost half their sample had sustained at least one TBI. Similarly, the current study explored the frequency of TBI in both general education and special education groups in a kindergarten through twelfth grade school. Results indicated that the sample in the current study reported a lower incidence rate of TBI than the general population as well as that in the 1999 study by Hux and colleagues. Additionally, only one student in the current sample (5% of TBI group) reported a history of TBI along with receiving special education services. Discrepancies between the current study and the Hux and colleagues (1999) study are explored, and possible reasons for the discrepancies are discussed.	[Blankenship, A. Paige; Canto, Angela I.] Florida State Univ, Tallahassee, FL 32306 USA		Blankenship, AP (corresponding author), Florida State Univ, Dept Educ Psychol & Learning Syst, 1114 W Call St, Tallahassee, FL 32304 USA.	apb11@my.fsu.edu					Anderson V, 2009, DEV NEUROREHABIL, V12, P253, DOI 10.3109/17518420903086899; Arroyos-Jurado E, 2000, J SCHOOL PSYCHOL, V38, P571, DOI 10.1016/S0022-4405(00)00053-4; Arroyos-Jurado E., 2006, EXCEPTIONALITY, V14, P125, DOI [10.1207/s15327035ex1403_2, DOI 10.1207/S15327035EX1403_2]; Bigler ED, 2012, NEUROSCI LETT, V509, P1, DOI 10.1016/j.neulet.2011.12.009; Canto A. I., 2011, COMMUNIQUE, V40, P35; Canto A. I., 2011, COMMUNIQUE, V40, P1; Canto AI, 2014, EDUC PSYCHOL PRACT, V30, P88, DOI 10.1080/02667363.2014.883498; Centers for Disease Control and Prevention (CDC), 2014, TRAUM BRAIN INJ US F; Centers for Disease Control and Prevention (CDC), 2014, RAT TBI REL EM DEP V; Chesire D. J., 2011, COMMUNIQUE, V40, P8; Chesire DJ, 2011, J APPL SCH PSYCHOL, V27, P60, DOI 10.1080/15377903.2011.540513; Clark E, 1999, SCHOOL PSYCHOL REV, V28, P242; Clark E, 1996, J LEARN DISABIL, V29, P549, DOI 10.1177/002221949602900509; DAmato RC, 1996, J LEARN DISABIL, V29, P670, DOI 10.1177/002221949602900611; Donders J, 1997, Pediatr Rehabil, V1, P179; FARMER JE, 1995, SCHOOL PSYCHOL REV, V24, P230; Farmer JE, 1996, J LEARN DISABIL-US, V29, P532, DOI 10.1177/002221949602900508; Faul M, 2010, TRAUMATIC BRAIN INJU; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Florida State University Schools, 2014, OV STUD DEM; Ginstfeldt T, 2010, BRAIN INJURY, V24, P1123, DOI 10.3109/02699052.2010.506853; Glang A, 2010, J HEAD TRAUMA REHAB, V25, P426, DOI 10.1097/HTR.0b013e3181fb8f45; Glang A, 2008, NEUROREHABILITATION, V23, P477; Greenspan AI, 2000, BRAIN INJURY, V14, P417; Hunter SJ, 2012, EXECUTIVE FUNCTION AND DYSFUNCTION: IDENTIFICATION, ASSESSMENT AND TREATMENT, P1, DOI 10.1017/CBO9780511977954; Hux D, 1998, BRAIN INJURY, V12, P667; Hux K, 1999, BRAIN INJURY, V13, P447; Jantz P., 2014, WORKING TRAUMATIC BR; Jantz PB, 2007, SUPPORT LEARN, V22, P84, DOI 10.1111/j.1467-9604.2007.00452.x; Kinsella G J, 1997, J Int Neuropsychol Soc, V3, P608; Kinsella GJ, 1998, NEUROPSYCHOL REHABIL, V8, P351, DOI 10.1080/713755576; Leon County School District, 2014, 2014 2015 APPR BUDG; Mandalis A, 2001, BRAIN COGNITION, V47, P210; Mandalis A, 2007, DEV NEUROPSYCHOL, V32, P683, DOI 10.1080/87565640701376045; Martelli M. F., 2002, J CONTROVERSIAL MED, V9, P1; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P125, DOI 10.1016/S0003-9993(96)90156-2; Max J. E., 2012, PSYCHIAT TIMES, V29, P17; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Ornstein TJ, 2009, J CHILD PSYCHOL PSYC, V50, P506, DOI 10.1111/j.1469-7610.2008.01997.x; Rivara FP, 2012, AM J PUBLIC HEALTH, V102, P2074, DOI 10.2105/AJPH.2012.300696; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; Savage Ronald C, 2005, Pediatr Rehabil, V8, P92; Schutz LE, 2010, INT J SPEC EDUC, V25, P55; Semrud-Clikeman M, 2010, APPL NEUROPSYCHOL, V17, P116, DOI 10.1080/09084281003708985; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Ylvisaker M, 2001, J HEAD TRAUMA REHAB, V16, P76, DOI 10.1097/00001199-200102000-00009	47	1	1	0	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0936-2835	1532-7035		EXCEPTIONALITY	Exceptionality		2018	26	4					218	229		10.1080/09362835.2016.1238379			12	Education, Special	Social Science Citation Index (SSCI)	Education & Educational Research	GU1DR	WOS:000444996200002					2022-02-06	
S	Santos, JB; Hernandez, AG; Gallardo, AMR; Espana, LEA	Santos, JB; Hernandez, AG; Gallardo, AMR; Espana, LEA			Bonilla Santos, Jasmin; Gonzalez Hernandez, Alfredis; Rios Gallardo, Angela Magnolia; Arroyo Espana, Laura Evelyn	Santos, JB; Hernandez, AG; Gallardo, AMR; Espana, LEA		Clinical Fundamentals and Methods for Formulating Neurocognitive Assessment and Rehabilitation Protocols	NEUROCIENCIA COGNITIVA: EVALUACION E INTERVENCION EN DANO CEREBRAL POR TRAUMA CRANEOENCEFALICO	Investigacion en Psicologia		Spanish	Article; Book Chapter						neuropsychological assessment; Neuropsi; recovida rehabilitation program; Mayo-Portland assessment protocol		The purpose of this chapter is to describe a methodological proposal as a tool for the assessment and intervention of tbi-derived cognitive deficits, since patient care is complex and must be approached in a multidisciplinary manner. Neurosurgeons, neuropsychologists, rehabilitators, internists, specialized nurses, caregivers, etc. should be involved, neuropsychological assessment being essential as a diagnostic tool in the study of the cognitive, functional and behavioral situation of those who have suffered a tbi. Neuropsychological tests such as Neuropsi Attention and Memory are fundamental tools for the design of the patient's cognitive profile, because they allow to assess various cognitive processes and executive functions. Emotional and behavioral changes should also be considered in assessment and rehabilitation, as indicators of the patient's process of integrating in and adapting to the new conditions of the social and physical environment; as a result, the Mayo-Portland adaptability inventory (mpai-4) was implemented. Finally, emphasis is placed on the need to adapt rehabilitation protocols to the assessed dimensions, focusing on cognitive processes, functional-behavioral, and affective-family areas.	[Bonilla Santos, Jasmin] Univ Cooperat Colombia, Psicosaberes Res Grp, Neiva, Colombia; [Gonzalez Hernandez, Alfredis] Univ Surcolombiana, Neiva, Colombia; [Gonzalez Hernandez, Alfredis] Colciencias Category Dneuropsy Grp, Neiva, Colombia; [Rios Gallardo, Angela Magnolia] Univ Surcolombiana, Res & Social Outreach, Neiva, Colombia; [Rios Gallardo, Angela Magnolia] Colciencias Category Dneuropsy Res Grp, Neiva, Colombia		Santos, JB (corresponding author), Univ Cooperat Colombia, Psicosaberes Res Grp, Neiva, Colombia.						Munoz-Cespedes JM, 2004, REV NEUROLOGIA, V38, P852, DOI 10.33588/rn.3809.2003446; Ostrosky-Solis F., 2003, NEUROPSI ATENCION ME	2	1	1	0	0	UNIV COOPERATIVE COLOMBIA	MEDELLIN	COLOMBIA 41-70, MEDELLIN, ANTIOQUIA 00000, COLOMBIA	2500-6401		978-958-760-080-3; 978-958-760-079-7	INVESTIG PSICOL			2018							69	78			10.16925/9789587600803		10	Psychology, Experimental; Rehabilitation	Book Citation Index – Social Sciences & Humanities (BKCI-SSH)	Psychology; Rehabilitation	BQ1RA	WOS:000577080900003					2022-02-06	
J	Brodie, F; Bever, G; Hwang, DG				Brodie, Frank; Bever, Gregory; Hwang, David G.			Performance of Bio-Occlusive Dressing as Barrier Protection from Presurgical Chlorhexidine Skin Preparation	CURRENT EYE RESEARCH			English	Article						Chlorhexidine; toxic keratitis; surgical scrub; Tegaderm; bio-occlusive dressing	GENERAL-ANESTHESIA; NONOCULAR SURGERY; PREVENTION; ANTISEPSIS; KERATITIS; IODINE	Purpose/Aim of the study: Chlorhexdine has been shown to provide excellent and cost-effective presurgical antisepsis. However, standard presurgical concentrations of chlorhexidine (2-4%) are known to cause ocular injury, even in cases in which a bio-occlusive dressing (Tegaderm) was applied beforehand to the closed eye.Materials and Methods: Three experiments were conducted to assess the barrier performance of Tegaderm to chlorhexidine skin prep in vitro and on non-ocular skin. The experiments used water as a control group.Results: In the first in vitro experiment, the chlorhexidine group showed penetration at the edges of the Tegaderm at 5minutes while the water (control) group never penetrated the Tegaderm. A subsequent experiment testing the central permeability of the tegaderm showed it to be impermeable to both chlorhexidine and water after 90minutes. In the in vivo experiment, the chlorhexidine group showed penetration at 10minutes, while the water (control) group never penetrated the Tegaderm.Conclusions: These data suggest Tegaderm is permeable at the edges to chlorhexidine but not water. Based on this, along with reports of ocular injury from chlorhexidine skin preparation of the head despite prior application of Tegaderm over the eyes, we advise against using bio-occlusive adhesive dressing to protect the ocular surface from chlorhexidine exposure. We suggest an alternative presurgical antiseptic agent such as povidone-iodine be employed whenever possible.	[Brodie, Frank; Bever, Gregory; Hwang, David G.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA USA		Hwang, DG (corresponding author), Univ Calif San Francisco, Dept Ophthalmol, Cornea Serv, 10 Koret Way, San Francisco, CA 94143 USA.	david.hwang@ucsf.edu					ANDERSON DA, 1995, J ORAL MAXIL SURG, V53, P321, DOI 10.1016/0278-2391(95)90232-5; BATRA YK, 1977, ANESTH ANALG, V56, P363; Bever GJ, 2016, WORLD NEUROSURG, V96, DOI 10.1016/j.wneu.2016.09.035; Darouiche RO, 2010, NEW ENGL J MED, V362, P18, DOI 10.1056/NEJMoa0810988; GREEN K, 1980, ARCH OPHTHALMOL-CHIC, V98, P1273; Grixti A, 2013, OCUL SURF, V11, P109, DOI 10.1016/j.jtos.2012.10.003; HAMED LM, 1987, AM J OPHTHALMOL, V104, P50, DOI 10.1016/0002-9394(87)90292-3; Lavery HJ, 2010, EUR UROL SUPPL, V9, P257, DOI 10.1016/S1569-9056(10)60783-X; Lee I, 2010, INFECT CONT HOSP EP, V31, P1219, DOI 10.1086/657134; Macksey LF, 2011, SURG PROCEDURES ANES, P944; MACRAE SM, 1984, AM J OPHTHALMOL, V97, P221, DOI 10.1016/S0002-9394(14)76094-5; Malafa MM, 2016, PLAST RECONSTR SURG, V137, p790E, DOI 10.1097/PRS.0000000000002108; Roth S, 1996, ANESTHESIOLOGY, V85, P1020, DOI 10.1097/00000542-199611000-00009; Steinsapir KD, 2017, DERMATOL SURG, V43, P1, DOI 10.1097/DSS.0000000000000822	14	1	1	1	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0271-3683	1460-2202		CURR EYE RES	Curr. Eye Res.		2018	43	5					576	579		10.1080/02713683.2017.1408128			4	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	GC9BP	WOS:000430092800002	29190159				2022-02-06	
J	Cattran, C; Oddy, M; Ramos, SD; Goodson, A; Wood, R				Cattran, Charlotte; Oddy, Michael; Ramos, Sara da Silva; Goodson, Anna; Wood, Rodger			The development of a measure of social cognition following acquired brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Measurement; questionnaire; outcome prediction; post-injury personality	ECOLOGICAL VALIDITY; INFERENCE TEST; HEAD-INJURY; PERCEPTION; AWARENESS; SELF; PERSONALITY; IMPAIRMENT; OUTCOMES; LESIONS	Deficits in social cognition following acquired brain injury (ABI) have been found to be both prevalent and disabling. Despite this, relatively little attention has been given to identifying the characteristics of such deficits in a systematic way. We describe the development of self and informant versions of a new questionnaire designed to measure the changes in social cognition that may occur following ABI, the Brain Injury Rehabilitation Trust (BIRT) Social Cognition Questionnaire (BSCQ). Seventy-two participants (Mean age =36 years, SD=12), with different forms of ABI (76% traumatic brain injury, 8% cerebrovascular accident, 15% other) and who were on average 20 months post-injury (SD=16), took part in the study. The measure demonstrates excellent psychometric properties, including high test-retest (.94) and split-half (.92) reliability, high internal consistency (Cronbach's alpha=.92), and good concurrent validity. The questionnaire measures characteristics that are distinguishable from measures of cognitive ability. There was moderate overlap between self-report and informant versions of the questionnaire (r=.50), but the informant version had the strongest predictive value of outcome, measured with the Mayo-Portland Adaptability Inventory III, one year later. The potential uses of the measure in relation to theory and practice are discussed. The results suggest that the BSCQ is a useful screening tool for those with ABI.	[Cattran, Charlotte] Royal Cornwall Hosp, Act Assistance Brain Injury Serv, Knowledge Spa, Truro, Cornwall, England; [Oddy, Michael; Ramos, Sara da Silva; Goodson, Anna] Brain Injury Rehabil Trust, Five Oaks Rd, Horsham RH13 0TP, W Sussex, England; [Cattran, Charlotte; Oddy, Michael; Wood, Rodger] Swansea Univ, Dept Psychol, Swansea, W Glam, Wales		Ramos, SD (corresponding author), Brain Injury Rehabil Trust, Five Oaks Rd, Horsham RH13 0TP, W Sussex, England.	sara.dasilvaramos@thedtgroup.org					Andresen EM, 2000, ARCH PHYS MED REHAB, V81, pS15, DOI 10.1053/apmr.2000.20619; Baddeley AD, 1994, DOORS PEOPLE TEST VI; Bechara A, 2002, BRAIN, V125, P1673, DOI 10.1093/brain/awf169; Ben-Yishay Y, 2000, REHABIL PSYCHOL, V45, P112, DOI 10.1037/0090-5550.45.2.112; Bramham J, 2009, J NEUROPSYCHOL, V3, P125, DOI 10.1348/174866408X293994; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess P.W., 1997, HAYLING BRIXTON TEST; Cattran CJ, 2011, BRAIN INJURY, V25, P1035, DOI 10.3109/02699052.2011.607787; Channon S, 2000, NEUROPSYCHOLOGIA, V38, P1006, DOI 10.1016/S0028-3932(99)00154-2; Cicerone KD, 1997, ARCH CLIN NEUROPSYCH, V12, P173, DOI 10.1016/S0887-6177(96)00022-4; Ekman P., 1976, PICTURES FACIAL AFFE; Fiske S.T., 2013, SOCIAL COGNITION BRA; Hamsher K., 1989, MULTILINGUAL APHASIA; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P333, DOI 10.1097/00001199-200507000-00005; Holm S, 2009, NEUROPSYCHOL REHABIL, V19, P444, DOI 10.1080/09602010802296402; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; Kendall E, 1996, NEUROPSYCHOL REHABIL, V6, P101, DOI 10.1080/713755502; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; Malec J. F., 1994, J HEAD TRAUMA REHAB, V9, P1, DOI [10. 1097/ 00001199- 199412000- 00003, DOI 10.1097/00001199-199412000-00003]; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2004, NEUROPSYCHOL REHABIL, V14, P285, DOI 10.1080/09602010343000237; McDonald S., 2002, AWARENESS SOCIAL INF; McDonald S, 2006, DISABIL REHABIL, V28, P1529, DOI 10.1080/09638280600646185; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; McDonald S, 2012, AUST PSYCHOL, V47, P39, DOI 10.1111/j.1742-9544.2011.00054.x; Ready RE, 2001, CLIN NEUROPSYCHOL, V15, P314, DOI 10.1076/clin.15.3.314.10269; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rey A., 1964, EXAMEN CLIN PSYCHOL; Rust J, 1999, MODERN PSYCHOMETRICS, V2nd; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Tate RL, 1999, CORTEX, V35, P39, DOI 10.1016/S0010-9452(08)70784-6; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; Uddin LQ, 2007, TRENDS COGN SCI, V11, P153, DOI 10.1016/j.tics.2007.01.001; Wall Sarah E, 2011, Clin Child Psychol Psychiatry, V16, P301, DOI 10.1177/1359104511401187; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P113, DOI 10.1080/13803390902806543; Young A., 2002, FACIAL EXPRESSIONS E	38	1	1	0	8	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2018	28	4					633	648		10.1080/09602011.2016.1202121			16	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	GA4CA	WOS:000428276000009	27398837				2022-02-06	
S	Charek, DB; Collins, M; Kontos, A		Hainline, B; Stern, RA		Charek, Daniel B.; Collins, Michael; Kontos, Anthony			Office-based concussion evaluation, diagnosis, and management: adult	SPORTS NEUROLOGY	Handbook of Clinical Neurology		English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; COGNITIVE-BEHAVIORAL THERAPY; MOTOR SCREENING VOMS; KING-DEVICK TEST; HIGH-SCHOOL; NEUROCOGNITIVE PERFORMANCE; VESTIBULAR REHABILITATION; POSTTRAUMATIC MIGRAINE; POSTURAL STABILITY	Concussion is a major public health concern, with an estimated 1.6-3.8 million sport-related concussions occurring annually in the United States. Although the majority of injured athletes recover within 7-21 days, 20-30% of athletes experience protracted recovery spanning more than a month, suggesting as many as 320,000-760,000 athletes may experience prolonged symptoms. This highlights the need for efficacious clinical interventions to facilitate recovery. While concussion was historically conceptualized as a homogeneous injury, a more nuanced understanding has recently emerged and led to a refined approach of categorizing concussions into clinical trajectories or symptom profiles. These categorizations correspond with targeted rehabilitation strategies focused on specific symptom clusters and deficits. Multidisciplinary teams, with collaborating neuropsychologists, neurologists, neurosurgeons, sports medicine physicians, athletic trainers, and physical therapists, are valuable to concussion management due to the heterogeneous nature of the injury. This chapter will provide an overview of a multimodal, clinical profile-based approach to assessment and targeted treatment of athletes with sport-related concussion. We describe a profile-based model for conceptualizing the injury, review relevant modifying factors, discuss components of a comprehensive assessment, and examine targeted treatment approaches.	[Charek, Daniel B.; Collins, Michael; Kontos, Anthony] Univ Pittsburgh, Dept Orthopaed Surg, UPMC Sports Med Concuss Program, 3200 S Water St, Pittsburgh, PA 15203 USA		Collins, M (corresponding author), Univ Pittsburgh, Dept Orthopaed Surg, UPMC Sports Med Concuss Program, 3200 S Water St, Pittsburgh, PA 15203 USA.	Collinsmw@upmc.edu					Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; Alsalaheen B, 2016, SPORTS MED, V46, P1487, DOI 10.1007/s40279-016-0532-y; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Austin MW, 2014, NEUROSCI RES, V87, P8, DOI 10.1016/j.neures.2014.06.007; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Baker JG, 2012, REHABILITATION RES P, P2012; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bell KR, 1999, J HEAD TRAUMA REHAB, V14, P34, DOI 10.1097/00001199-199902000-00006; Bressel E, 2007, J ATHL TRAINING, V42, P42; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brown NJ, 2014, PEDIATRICS PEDS, P2013; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Choe MC, 2016, J CHILD NEUROL, V31, P76, DOI 10.1177/0883073814568152; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Ciuffreda Kenneth J, 2008, Optometry, V79, P18, DOI 10.1016/j.optm.2007.10.004; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Cotman CW, 2002, EXERC SPORT SCI REV, V30, P75, DOI 10.1097/00003677-200204000-00006; Covassin T, 2008, J ATHL TRAINING, V43, P119, DOI 10.4085/1062-6050-43.2.119; Covassin T, 2014, J ATHL TRAINING, V49, P462, DOI 10.4085/1062-6059-49.2.03; Covassin T, 2013, AM J SPORT MED, V41, P2890, DOI 10.1177/0363546513509962; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P167, DOI 10.1136/jnnp.73.2.167; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Dunn AL, 2005, AM J PREV MED, V28, P1, DOI 10.1016/j.amepre.2004.09.003; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Gallaway M, 2017, OPTOMETRY VISION SCI, V94, P68, DOI 10.1097/OPX.0000000000000935; Gibson S, 2013, BRAIN INJURY, V27, P839, DOI 10.3109/02699052.2013.775494; Giza CC, 2005, BEHAV BRAIN RES, V157, P11, DOI 10.1016/j.bbr.2004.06.003; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Goldberg J.M., 2012, VESTIBULAR SYSTEM 6; Gottshall K, 2011, NEUROREHABILITATION, V29, P167, DOI 10.3233/NRE-2011-0691; Gottshall KR, 2010, J NEUROL PHYS THER, V34, P94, DOI 10.1097/NPT.0b013e3181dead12; Green W, 2010, J REHABIL RES DEV, V47, P183, DOI 10.1682/JRRD.2009.04.0041; Griesbach GS, 2004, BRAIN RES, V1016, P154, DOI 10.1016/j.brainres.2004.04.079; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Hillier Susan L, 2011, Clin Otolaryngol, V36, P248, DOI 10.1111/j.1749-4486.2011.02309.x; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kacperski J, 2016, SEMIN PEDIATR NEUROL, V23, P27, DOI 10.1016/j.spen.2015.08.005; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; King D, 2015, J NEUROL SCI, V357, P75, DOI 10.1016/j.jns.2015.06.069; King LA, 2017, ANN BIOMED ENG, V45, P2135, DOI 10.1007/s10439-017-1856-y; Kinnaman KA, 2013, ACTA PAEDIATR, V102, pE424, DOI 10.1111/apa.12315; Kontos AP, 2017, J ATHL TRAINING, V52, P256, DOI 10.4085/1062-6050-51.11.05; Kontos AP, 2016, AM J SPORT MED, V44, P1400, DOI 10.1177/0363546516632754; Kontos AP, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0571-y; Kontos AP, 2016, BRIT J SPORT MED, V50, P139, DOI 10.1136/bjsports-2015-095564; Kontos AP, 2014, J INT NEUROPSYCH SOC, V20, P324, DOI 10.1017/S1355617713001471; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Leddy JJ, 2018, CLIN J SPORT MED, V28, P13, DOI 10.1097/JSM.0000000000000431; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Leddy JJ, 2013, J HEAD TRAUMA REHAB, V28, P241, DOI 10.1097/HTR.0b013e31826da964; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lee YM, 2013, J NEUROSURG-PEDIATR, V12, P537, DOI 10.3171/2013.7.PEDS12572; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Manuel JC, 2002, J ADOLESCENT HEALTH, V31, P391, DOI 10.1016/S1054-139X(02)00400-7; Mathiasen R, 2018, J NEUROTRAUM, V35, P691, DOI 10.1089/neu.2017.5072; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, J SCI MED SPORT, V16, P178, DOI 10.1016/j.jsams.2013.02.009; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Meehan WP, 2011, CLIN SPORT MED, V30, P115, DOI 10.1016/j.csm.2010.08.003; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; Milde-Busch A, 2010, HEADACHE, V50, P1104, DOI 10.1111/j.1526-4610.2010.01706.x; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Murray DA, 2017, BRIT J SPORT MED, V51, P442, DOI 10.1136/bjsports-2016-096081; Naguib MB, 2012, J LARYNGOL OTOL, V126, P26, DOI 10.1017/S002221511100291X; Nguyen S, 2017, ARCH PHYS MED REHAB, V98, P1508, DOI 10.1016/j.apmr.2017.02.031; Oluellet MC, 2007, ARCH PHYS MED REHAB, V88, P1581, DOI 10.1016/j.apmr.2007.09.006; Pavlou M, 2013, NEUROREHAB NEURAL RE, V27, P208, DOI 10.1177/1545968312461715; Pavlou M, 2010, J NEUROL PHYS THER, V34, P105, DOI 10.1097/NPT.0b013e3181dde6bf; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Petraglia AL, 2012, NEUROSURGERY, V70, P1520, DOI 10.1227/NEU.0b013e31824cebe8; Piao CS, 2013, NEUROBIOL DIS, V54, P252, DOI 10.1016/j.nbd.2012.12.017; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Randolph C, 2009, ARCH CLIN NEUROPSYCH; Reddy CC, 2013, J HEAD TRAUMA REHAB, V28, P260, DOI 10.1097/HTR.0b013e318257fbc6; RELANDER M, 1972, BMJ-BRIT MED J, V4, P777, DOI 10.1136/bmj.4.5843.777; Reynolds Erin, 2014, Neurosurgery, V75 Suppl 4, pS71, DOI 10.1227/NEU.0000000000000471; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Ritter KG, 2017, J SPORT REHABIL, P1; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Scheiman M, 2003, OPTOMETRY VISION SCI, V80, P214, DOI 10.1097/00006324-200303000-00011; Scheiman M, 2011, COCHRANE DB SYST REV, V3; Scheiman M, 2011, OPTOMETRY VISION SCI, V88, P1343, DOI 10.1097/OPX.0b013e31822f4d7c; Schnadower D, 2007, CURR OPIN PEDIATR, V19, P258, DOI 10.1097/MOP.0b013e3281084e85; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Silberstein Stephen D, 2002, Curr Pain Headache Rep, V6, P240, DOI 10.1007/s11916-002-0041-6; Strohle A, 2009, J NEURAL TRANSM, V116, P777, DOI 10.1007/s00702-008-0092-x; Subotic A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183092; Sufrinko A, 2018, J HEAD TRAUMA REHAB, V33, P7, DOI 10.1097/HTR.0000000000000315; Sufrinko AM, 2017, J PEDIATR-US, V185, P167, DOI 10.1016/j.jpeds.2017.02.072; Sufrinko AM, 2017, CLIN J SPORT MED, DOI [10.1097/JS.0000000000000528, DOI 10.1097/JS.0000000000000528]; Thiagarajan P, 2014, BRAIN INJURY, V28, P930, DOI 10.3109/02699052.2014.888761; Thiagarajan P, 2014, NEUROREHABILITATION, V34, P129, DOI 10.3233/NRE-131025; Thomas DG, 2015, PEDIATRICS PEDS, P2014; Trauer JM, 2015, ANN INTERN MED, V163, P191, DOI 10.7326/M14-2841; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Vancampfort D, 2014, PSYCHIAT RES, V219, P361, DOI 10.1016/j.psychres.2014.05.016; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; Webbe FM, 2015, BRAIN INJURY, V29, P129, DOI 10.3109/02699052.2014.937746; Williams RM, 2014, SPORTS HEALTH, V6, P434, DOI 10.1177/1941738114545612; Womble Melissa N, 2016, Am J Orthop (Belle Mead NJ), V45, P352; Wu JQ, 2015, JAMA INTERN MED, V175, P1461, DOI 10.1001/jamainternmed.2015.3006; Zuckerman SL, 2014, J NEUROSURG-PEDIATR, V13, P72, DOI 10.3171/2013.9.PEDS13257	144	1	1	0	0	ELSEVIER	AMSTERDAM	Radarweg 29, PO Box 211, AMSTERDAM, NETHERLANDS	0072-9752		978-0-44-463955-4; 978-0-444-63954-7	HAND CLINIC			2018	158						91	105		10.1016/B978-0-444-63954-7.00010-0			15	Clinical Neurology; Sport Sciences	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Sport Sciences	BP1MW	WOS:000540371100012	30482379				2022-02-06	
J	Chen, MY; Ye, XH; Gao, F; Qiu, MJ				Chen, Meiyuan; Ye, Xianghua; Gao, Feng; Qiu, Minjian			Intracranial pial arteriovenous fistulas: two case reports	INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE			English	Article						Intracranial pial arteriovenous fistula (pAVF); digital subtraction angiography (DSA); endovascular treatment	OSLER-WEBER DISEASE; HEREDITARY HEMORRHAGIC TELANGIECTASIA; VASCULAR MALFORMATIONS; ENDOVASCULAR TREATMENT; VENOUS DRAINAGE; BRAIN; OCCLUSION; RESECTION; CHILDREN; VARICES	Objective: Pial arteriovenous fistulas (pAVFs) are rare neurovascular lesions of the brain. They are characterized by arteriovenous malformation but with absent intervening nidus of vessels, and thus are easily misdiagnosed or never diagnosed. Misdiagnosis and inadequate treatment can lead to recurrent fistulas and cerebral hemorrhage. Methods: We report two cases diagnosed as pAVFs. We also performed a brief review concerning the development, etiology, pathology, manifestation, diagnosis, and treatment of pAVFs. Results: Case 1, a 44-year-old male, who had suffered from paroxysmal left limbs disability for one year that had aggravated in the last two months. Digital subtraction angiography (DSA) showed a pAVF in the left temporal lobe fed by a branch of the left middle cerebral artery (MCA), and in the late arterial phase, no nidus or dural arteriovenous fistulas were detected (Figure 1E, 1F). The author considered his pAVF was related to transient venous hypertension secondary to mild trauma or recanalization of asymptomic phlebothrombosis. Moreover, there were no recurrent symptoms after the timely endovascular treatment. In Case 2, a 52-year-old male patient was presented with a 3-day history of headache. DSA showed the right MCA was pushed, a dilated vessel image in right occipitoparietal lobe presented previously, draining via the right sigmoid sinus and the right jugular vein, but no nidus was found (Figure 2B, 2C). And the author considered this pAVF was related to used brain concussion. This patient recovered completely after endovascular treatment. Both cases had been taking Nimotop for 1 month after discharge, and no recurrent cerebral hemorrhage occurred during a follow up of 1 year. Conclusions: More attention should be dedicated to cerebral hemorrhage cases with unknown causes, which may well be pAVFs. Endovascular treatment is the first choice for pAVFs, and DSA findings and their interpretation by an experienced radiologist are essential for the correct and timely diagnosis.	[Chen, Meiyuan] Hangzhou Normal Univ, Affiliated Hosp, Dept Neurol, Hangzhou 310000, Zhejiang, Peoples R China; [Chen, Meiyuan; Ye, Xianghua; Gao, Feng; Qiu, Minjian] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Neurol, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China		Qiu, MJ (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Neurol, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China.	3196011@zju.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471168]; Science Technology Department of Zhejiang Province [2017C33050]	This work was supported by grants from National Natural Science Foundation of China (No.81471168) to Feng Gao and the Science Technology Department of Zhejiang Province (No.2017C33050) to Minjian Qiu.	ALBERT P, 1990, ACTA NEUROCHIR, V103, P30, DOI 10.1007/BF01420189; ALMEIDA GM, 1990, CHILD NERV SYST, V6, P216, DOI 10.1007/BF01850976; AOKI N, 1991, NEUROSURGERY, V28, P619, DOI 10.1227/00006123-199104000-00027; BARNWELL SL, 1990, NEUROSURGERY, V26, P122, DOI 10.1227/00006123-199001000-00017; Bendok BR, 1999, NEUROSURGERY, V44, P888, DOI 10.1097/00006123-199904000-00124; CARRILLO R, 1984, J NEUROSURG, V60, P1085, DOI 10.3171/jns.1984.60.5.1085; Coubes P, 1996, CHILD NERV SYST, V12, P785; GARCIAMONACO R, 1991, CHILD NERV SYST, V7, P48, DOI 10.1007/BF00263834; GARCIAMONACO R, 1995, NEURORADIOLOGY, V37, P60, DOI 10.1007/BF00588522; GILLER CA, 1994, NEUROSURGERY, V35, P778, DOI 10.1227/00006123-199410000-00033; HALBACH VV, 1989, AM J NEURORADIOL, V10, P747; Hoh BL, 2001, NEUROSURGERY, V49, P1351, DOI 10.1097/00006123-200112000-00011; KADER A, 1994, NEUROSURGERY, V34, P801, DOI 10.1227/00006123-199405000-00003; KIKUCHI K, 1994, SURG NEUROL, V41, P374, DOI 10.1016/0090-3019(94)90030-2; LASJAUNIAS P, 1986, NEUROSURG REV, V9, P253, DOI 10.1007/BF01743632; Lv X, 2009, AM J NEURORADIOL, V30, P851, DOI 10.3174/ajnr.A1436; Lv XL, 2010, WORLD NEUROSURG, V73, P385, DOI 10.1016/j.wneu.2010.01.023; Matsubara S, 2000, AM J NEURORADIOL, V21, P1016; Meyer FB, 1997, J NEUROSURG, V87, P934, DOI 10.3171/jns.1997.87.6.0934; MIYASAKA Y, 1992, J NEUROSURG, V76, P239, DOI 10.3171/jns.1992.76.2.0239; Nelson K, 1992, NEUROIMAG CLIN N AM, V2, P307; OYESIKU NM, 1988, DEV MED CHILD NEUROL, V30, P245; Phatouros CC, 1999, STROKE, V30, P2487, DOI 10.1161/01.STR.30.11.2487; SANTOSH C, 1991, NEURORADIOLOGY, V33, P65, DOI 10.1007/BF00593338; SMITH MD, 1990, AM J NEURORADIOL, V11, P1199; SPETZLER RF, 1992, J NEUROSURG, V76, P918, DOI 10.3171/jns.1992.76.6.0918; Talamonti G, 1997, J Neurosurg Sci, V41, P337; VINUELA F, 1987, J NEUROSURG, V66, P198, DOI 10.3171/jns.1987.66.2.0198; Yang WH, 2011, BRIT J NEUROSURG, V25, P580, DOI 10.3109/02688697.2011.566382	29	1	1	2	6	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	1940-5901			INT J CLIN EXP MED	Int. J. Clin. Exp. Med.		2018	11	5					5269	5274					6	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	GI0AJ	WOS:000434031300121					2022-02-06	
J	Chester, V; Alexander, RT				Chester, Verity; Alexander, Regi T.			Head banging as a form of self-harm among inpatients within forensic mental health and intellectual disability services	JOURNAL OF FORENSIC PSYCHIATRY & PSYCHOLOGY			English	Article						Traumatic brain injury; forensic psychiatry; learning disabilities; self harm; self injury	POSITIVE BEHAVIORAL SUPPORT; PEOPLE; INJURY; UNIT	Introduction: Head banging' is a common form of self-harm, linked to numerous negative outcomes including significant brain damage. However, little research has investigated head banging behaviour and its correlates in clinical populations. Method: Head banging episodes were identified from the incident records (n=5417) of two inpatient forensic services (one intellectual disability and one mental health), using relevant search terms. Rates were compared between individual patients, by gender, diagnosis and level of security. Incident accounts were analysed qualitatively using thematic analysis. Results: Head banging incidents occurred approximately every 3 days in each service, with 229 incidents recorded in 1 year. Individual patient rates varied widely, ranging from 1 to 38 incidents within 1 year. Women, and patients in higher levels of therapeutic security, were significantly more likely to engage in head banging. Qualitative incident reports indicated that head banging was associated with mental distress, anger and psychotic experiences. Discussion: Head banging occurs frequently in forensic services, and has documented associations with traumatic brain injury in affected individuals, thus negatively impacting progress through the care pathway and treatment outcomes. Further research should investigate short- and long-term management strategies and treatment approaches, in order to minimise harm.	[Chester, Verity; Alexander, Regi T.] St Johns House, Palgrave, England		Chester, V (corresponding author), St Johns House, Palgrave, England.	veritychester@priorygroup.com	Alexander, Regi/X-5286-2019; Chester, Verity/B-7847-2013	Alexander, Regi/0000-0002-3554-2948; Chester, Verity/0000-0003-0710-6177			Alexander RT, 2011, ADV MENT HEALTH INTE, V5, P22, DOI 10.5042/amhid.2011.0013; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Brown J, 2009, J APPL RES INTELLECT, V22, P503, DOI 10.1111/j.1468-3148.2009.00504.x; Chester V., 2017, PSYCHOL CRIME LAW; Daniels JE, 2007, HARVARD REV PSYCHIAT, V15, P70, DOI 10.1080/10673220701307588; Department of Health, 2014, POS PROACT CAR RED N; Duperouzel H, 2010, J APPL RES INTELLECT, V23, P606, DOI 10.1111/j.1468-3148.2010.00559.x; Fee V. E., 1992, SELF INJURIOUS BEHAV, P3, DOI DOI 10.1007/978-1-4613-9130-2; Fielding L., 1976, REPORT STATEWIDE SEL; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Graham R., 2014, SPORTS RELATED CONCU; Health and Social Care Information Centre, 2015, LEARN DIS CENS REP; Hillbrand M, 1996, PSYCHIAT QUART, V67, P33, DOI 10.1007/BF02244273; HOF PR, 1991, ACTA NEUROPATHOL, V82, P321, DOI 10.1007/BF00308819; Kahng S, 2002, AM J MENT RETARD, V107, P212, DOI 10.1352/0895-8017(2002)107<0212:BTOSIT>2.0.CO;2; KING BH, 1993, AM J MENT RETARD, V98, P93; Klonsky ED, 2007, CLIN PSYCHOL REV, V27, P226, DOI 10.1016/j.cpr.2006.08.002; LaVigna GW, 2012, J INTELLECT DEV DIS, V37, P185, DOI 10.3109/13668250.2012.696597; MADEN T, 1996, WOMEN PRISONS PSYCHI; McClean B, 2007, J INTELLECT DISABILI, V11, P281, DOI 10.1177/1744629507080791; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MIRON NB, 1971, B SUICIDOLOGY, V8, P64; Morrissey C., 2017, HEALTH SERV DELIVERY, V5, DOI [10.3310/hsdr05030, DOI 10.3310/HSDR05030]; Morrissey C, 2017, BJPSYCH OPEN, V3, P41, DOI 10.1192/bjpo.bp.116.003616; NHS Health Research Authority, 2013, DEF RES; SALCIDO R, 1992, Brain Injury, V6, P293, DOI 10.3109/02699059209029671; Sarkar, 2011, ADV PSYCHIAT TREATME, V17, P435, DOI [10.1192/apt.bp.110.008045, DOI 10.1192/APT.BP.110.008045]; Sarkar J, 2011, J FORENSIC PSYCHI PS, V22, P845, DOI 10.1080/14789949.2011.622407; Stein D. J., 2001, SELF INJURIOUS BEHAV; Vollm B., 2017, NIHR J LIB, DOI [10.3310/HSDR05110, DOI 10.3310/HSDR05110]; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; [No title captured]	33	1	1	2	8	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1478-9949	1478-9957		J FORENSIC PSYCHI PS	J. Forensic Psychiatry Psychol.		2018	29	4					557	573		10.1080/14789949.2018.1425472			17	Criminology & Penology; Psychiatry	Social Science Citation Index (SSCI)	Criminology & Penology; Psychiatry	GL7GN	WOS:000437365700004					2022-02-06	
J	Creed, JA; Son, J; Farjat, AE; Swisher, CB				Creed, Jennifer A.; Son, Jake; Farjat, Alfredo E.; Swisher, Christa B.			Early withdrawal of non-anesthetic antiepileptic drugs after successful termination of nonconvulsive seizures and nonconvulsive status epilepticus	SEIZURE-EUROPEAN JOURNAL OF EPILEPSY			English	Article						Nonconvulsive seizure (NCS); Nonconvulsive status epilepticus (NCSE); Continuous critical care EEG (CCEEG); Antiepileptic drug (AED) withdraw	INTENSIVE-CARE-UNIT; REFRACTORY STATUS EPILEPTICUS; CONVULSIVE STATUS EPILEPTICUS; TRAUMATIC BRAIN-INJURY; EPILEPSY SURGERY; DOUBLE-BLIND; METAANALYSIS; MORTALITY; MONOTHERAPY; MANAGEMENT	Purpose: Multiple antiepileptic drugs (AEDs) are often necessary to treat nonconvulsive seizures (NCS) and nonconvulsive status epilepticus (NCSE). AED polypharmacy places patients at risk for adverse side effects and drug-drug interactions. Identifying the likelihood of seizure relapse when weaning non anesthetic AEDs may provide guidance in the critical care unit. Method: Ninety-nine adult patients with successful treatment of electrographic-proven NCS or NCSE on continuous critical care EEG (CCEEG) monitoring were identified retrospectively. Patients were determined to undergo an AED wean if the number of non-anesthetic AEDs was reduced at the time of discharge compared to the number of non-anesthetic AEDs at primary seizure cessation. Primary outcome was recurrent seizures either clinically or by CCEEG during hospitalization. Secondary outcome measures included hospital length of stay and discharge disposition. Results: The rate of recurrent seizures in the wean group was not statistically different when compared to the group that did not undergo an AED wean (17% vs. 13%, respectively; p = 0.77). The wean group had a median value of 4 (IQR: 3-4) non-anesthetic AEDs at the time of primary seizure cessation compared with 3 (IQR: 2-3) in the non-wean group (p < 0.0001). However, both groups had similar values of AEDs at discharge (median of 2 (IQR: 2-3) vs. 3 (IQR: 2-3) for wean and non-wean groups respectively; p = 0.40). Discharge disposition (favorable, acceptable, or unfavorable) was similar between groups (p = 0.32). Conclusions: Early weaning of non-anesthetic AEDs does not increase the risk of recurrent seizures in patients treated for NCS or NCSE during their hospitalization. (C) 2017 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.	[Creed, Jennifer A.; Swisher, Christa B.] Duke Univ, Med Ctr, Dept Neurol, Durham, NC 27708 USA; [Son, Jake] Duke Univ, Sch Engn, Durham, NC USA; [Farjat, Alfredo E.] Duke Univ, Dept Biostat & Bioinformat, Sch Med, Durham, NC USA		Creed, JA (corresponding author), Duke Univ, Med Ctr, Dept Neurol, Durham, NC 27708 USA.			Swisher, Christa/0000-0001-7753-7023; Son, Jake/0000-0001-6780-9902			Abou-Khalil BW, 2016, ANTIEPILEPTIC DRUGS, V22, P132; [Anonymous], 2016, R LANG ENV STAT COMP; Berg AT, 2007, EPILEPSY BEHAV, V10, P219, DOI 10.1016/j.yebeh.2006.12.001; Bhullar IS, 2014, J TRAUMA ACUTE CARE, V76, P54, DOI 10.1097/TA.0b013e3182aafd15; Boshuisen K, 2012, LANCET NEUROL, V11, P784, DOI 10.1016/S1474-4422(12)70165-5; Brophy GM, 2012, NEUROCRIT CARE, V17, P3, DOI 10.1007/s12028-012-9695-z; CALLAGHAN N, 1988, NEW ENGL J MED, V318, P942, DOI 10.1056/NEJM198804143181502; CHADWICK D, 1991, LANCET, V337, P1175; Claassen J, 2001, NEUROLOGY, V57, P1036, DOI 10.1212/WNL.57.6.1036; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; De Marchis GM, 2016, NEUROLOGY, V86, P253, DOI 10.1212/WNL.0000000000002281; DeLorenzo RJ, 1998, EPILEPSIA, V39, P833, DOI 10.1111/j.1528-1157.1998.tb01177.x; Hessen E, 2007, J INT NEUROPSYCH SOC, V13, P393, DOI 10.1017/S13556177070555; Hirsch LJ, 2013, J CLIN NEUROPHYSIOL, V30, P1, DOI 10.1097/WNP.0b013e3182784729; Hixson JD, 2010, CURR TREAT OPTION NE, V12, P434, DOI 10.1007/s11940-010-0083-8; Holtkamp M, 2005, J NEUROL NEUROSUR PS, V76, P534, DOI 10.1136/jnnp.2004.041947; JORDAN KG, 1995, NEUROL CLIN, V13, P579, DOI 10.1016/S0733-8619(18)30035-5; Kaplan PW, 2007, EPILEPSIA, V48, P39, DOI 10.1111/j.1528-1167.2007.01345.x; Kerling F, 2009, EPILEPSY BEHAV, V15, P476, DOI 10.1016/j.yebeh.2009.05.016; Kim YD, 2005, EPILEPSIA, V46, P251, DOI 10.1111/j.0013-9580.2005.28004.x; Laccheo I, 2015, NEUROCRIT CARE, V22, P202, DOI 10.1007/s12028-014-0070-0; Ladino LD, 2014, EPILEPSY RES, V108, P765, DOI 10.1016/j.eplepsyres.2014.01.024; Lossius MI, 2008, EPILEPSIA, V49, P455, DOI 10.1111/j.1528-1167.2007.01323.x; Lowenstein DH, 1998, NEW ENGL J MED, V338, P970, DOI 10.1056/NEJM199804023381407; Mayer SA, 2002, ARCH NEUROL-CHICAGO, V59, P205, DOI 10.1001/archneur.59.2.205; Menon R, 2012, NEUROLOGY, V79, P770, DOI 10.1212/WNL.0b013e3182644f7d; Pandian JD, 2004, ARCH NEUROL-CHICAGO, V61, P1090, DOI 10.1001/archneur.61.7.1090; Park KI, 2010, ANN NEUROL, V67, P230, DOI 10.1002/ana.21884; PRIVITERA M, 1994, EPILEPSY RES, V18, P155, DOI 10.1016/0920-1211(94)90008-6; Rosemergy I, 2012, INTERN MED J, V42, P1023, DOI 10.1111/j.1445-5994.2012.02818.x; Schiller Y, 2000, NEUROLOGY, V54, P346, DOI 10.1212/WNL.54.2.346; Shih JJ, 2009, NEUROLOGIST, V15, P122, DOI 10.1097/NRL.0b013e3181901ad3; Shneker BF, 2003, NEUROLOGY, V61, P1066, DOI 10.1212/01.WNL.0000082653.40257.0B; Specchio LM, 2004, CNS DRUGS, V18, P201, DOI 10.2165/00023210-200418040-00001; Specchio LM, 2002, J NEUROL NEUROSUR PS, V72, P22, DOI 10.1136/jnnp.72.1.22; Swisher CB, 2015, J CLIN NEUROPHYSIOL, V32, P147, DOI 10.1097/WNP.0000000000000157; Swisher CB, 2013, EPILEPSY BEHAV, V26, P203, DOI 10.1016/j.yebeh.2012.11.053; TOWNE AR, 1994, EPILEPSIA, V35, P27, DOI 10.1111/j.1528-1157.1994.tb02908.x; Towne AR, 2000, NEUROLOGY, V54, P340, DOI 10.1212/WNL.54.2.340; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Yasiry Z, 2014, SEIZURE-EUR J EPILEP, V23, P167, DOI 10.1016/j.seizure.2013.12.007; Young GB, 1996, NEUROLOGY, V47, P83; Zaccara G, 2008, SEIZURE-EUR J EPILEP, V17, P405, DOI 10.1016/j.seizure.2007.12.003	43	1	1	0	2	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	1059-1311	1532-2688		SEIZURE-EUR J EPILEP	Seizure	JAN	2018	54						45	50		10.1016/j.seizure.2017.12.001			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FV8RI	WOS:000424854100008	29248799	Bronze, Green Published			2022-02-06	
J	Crisp, R				Crisp, Ross			Rogers and Goldstein redux: the actualizing person responding to trauma and loss	PERSON-CENTERED AND EXPERIENTIAL PSYCHOTHERAPIES			English	Article						Person-centered psychotherapy; Actualization; Kurt Goldstein; traumatic brain injury	INTERPRETATIVE PHENOMENOLOGICAL ANALYSIS; ACQUIRED BRAIN-INJURY; EXISTENTIAL ONTOLOGY; MERLEAU-PONTY; PSYCHOTHERAPY; SELF; EXPERIENCE; PEOPLE; GROWTH; EXPLORATION	Carl Rogers' concept of actualization is discussed in relation to neuropsychiatrist Kurt Goldstein's concept of self-actualization, both of which explain the inherent capacity of the human organism for growth through adversity. It is argued that Rogers' organismic perspective is compatible with the existential-ontological elements of Goldstein's holistic, biological conception of the human organism. There is, however, a fundamental difference in their concepts of actualization and their metaphors of self-healing that reflects their dissimilar clinical milieus and philosophico-existential perspectives. Rogers' metaphor of self-healing calls up the client's organismic experiencing in a therapeutic relationship whereas Goldstein's refers to the patient and pathology that is an indication of lawful variations of the normal self-regulating process. Their concepts of actualization are considered in relation to six existential-ontological dimensions of human experience delineated by Hersch. It is argued that they provide a more indepth understanding of an individual's experience than the dominant biomedical models of disease. This process is illustrated by drawing on the self-reported experiences of persons with traumatic brain injury concerning the extent of their recovery and post-traumatic growth. Considered together, the legacies of Goldstein and Rogers span biology and phenomenology, existential philosophy and humanistic psychology.	[Crisp, Ross] Australian Psychol Soc, Melbourne, Vic, Australia; [Crisp, Ross] World Assoc Person Ctr & Experiential Psychothera, Melbourne, Vic, Australia		Crisp, R (corresponding author), Australian Psychol Soc, Melbourne, Vic, Australia.; Crisp, R (corresponding author), World Assoc Person Ctr & Experiential Psychothera, Melbourne, Vic, Australia.	ross.crispsy@gmail.com	Crisp, Ross/Q-1838-2019	Crisp, Ross/0000-0003-3684-4021			ANGYAL A, 1951, J PERS, V20, P131, DOI 10.1111/j.1467-6494.1951.tb01517.x; Bohart A. C., 2013, HDB PERSON CTR PSYCH; Bohart AC, 2017, PERS-CENTERED EXP PS, V16, P14, DOI 10.1080/14779757.2017.1298051; Brodley B. T., 2011, PRACTICING CLIENT CT, P153; Carrick L., 2013, HDB PERSON CENTRED T, P359; Coetzer R, 2007, J HEAD TRAUMA REHAB, V22, P39, DOI 10.1097/00001199-200701000-00005; Corsi L., 2012, INT BODY PSYCHOTHERA, V11, P57; Craig E, 2015, PHILOS PSYCHIATR PSY, V22, P79, DOI 10.1353/ppp.2015.0027; Crisp R., 1993, DISABIL HANDICAP SOC, V8, P393, DOI DOI 10.1080/02674649366780371; Frankel M, 2010, PERS-CENTERED EXP PS, V9, P69, DOI 10.1080/14779757.2010.9688505; Gendlin E. T., 2006, BEFINDLICHKEIT HEIDE; Goldstein K, 1995, ORGANISM HOLISTIC AP; Grace JJ, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01162; Hawley CA, 2008, BRAIN INJURY, V22, P427, DOI 10.1080/02699050802064607; Heidegger Martin, 1962, BEING TIME, P437; Hersch EL, 2015, PHILOS PSYCHIATR PSY, V22, P107, DOI 10.1353/ppp.2015.0022; Howes H, 2005, PSYCHOL HEALTH, V20, P129, DOI 10.1080/0887044042000272903; Joseph S, 2005, REV GEN PSYCHOL, V9, P262, DOI 10.1037/1089-2680.9.3.262; Joseph S, 2015, PERS-CENTERED EXP PS, V14, P178, DOI 10.1080/14779757.2015.1043392; Judd D, 2005, BRAIN INJURY, V19, P437, DOI 10.1080/02699050400010994; Jumisko Eija, 2005, J Neurosci Nurs, V37, P42; Kriz J, 2007, PERS-CENTERED EXP PS, V6, P30, DOI 10.1080/14779757.2007.9688426; Lawson S, 2008, THER RECREAT J, V42, P236; Lennon A, 2014, BRAIN INJURY, V28, P27, DOI 10.3109/02699052.2013.848378; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Madison G, 2010, PERS-CENTERED EXP PS, V9, P189, DOI 10.1080/14779757.2010.9689066; Martin R, 2015, DISABIL REHABIL, V37, P1234, DOI 10.3109/09638288.2014.961653; Merleau-Ponty M., 2012, PHENOMENOLOGY PERCEP; Moreira V, 2012, PERS-CENTERED EXP PS, V11, P48, DOI 10.1080/14779757.2012.656410; Morley J., 1995, HUMANISTIC PSYCHOL, V23, P358, DOI DOI 10.1080/08873267.1995.9986836; Muenchberger H, 2008, BRAIN INJURY, V22, P979, DOI 10.1080/02699050802530532; Nochi M, 2000, SOC SCI MED, V51, P1795, DOI 10.1016/S0277-9536(00)00111-8; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; Noppeney U, 2001, J Hist Neurosci, V10, P67; O'Callaghan C, 2006, NEUROPSYCHOL REHABIL, V16, P579, DOI 10.1080/09602010500368834; Padilla R, 2003, AM J OCCUP THER, V57, P413, DOI 10.5014/ajot.57.4.413; Patterson FL, 2009, J MENT HLTH COUNS, V31, P149; Prigatano GP, 2013, NEUROREHABILITATION, V32, P751, DOI 10.3233/NRE-130899; Prigatano GP, 2003, INT REV PSYCHIATR, V15, P371, DOI 10.1080/09540260310001606755; Quinn A, 2008, J HUMANIST PSYCHOL, V48, P458, DOI 10.1177/0022167808316247; Rogers, 1961, BECOMING PERSON; Rogers C.R., 1959, PSYCHOL STUDY SCI, P184; Rogers CR., 1951, CLIENT CENTERED THER; Sacks O., 1995, ORGANISM HOLISTIC AP, P7; Sartre Jean-Paul, 1992, BEING NOTHINGNESS PH; Schmid PF, 2013, PALGRAVE MACMILLAN, P66; Snijder A, 2013, PERS-CENTERED EXP PS, V12, P100, DOI 10.1080/14779757.2013.804648; Spielhofer H, 2003, PERSON CTRED EXPERIE, V2, P75; Tedeschi RG, 2004, PSYCHOL INQ, V15, P1, DOI 10.1207/s15327965pli1501_01; Tratter AMD, 2015, PHILOS PSYCHIATR PSY, V22, P133, DOI 10.1353/ppp.2015.0017; TUDOR K, 2006, PERSON CTR THERAPY C; Verhoeff B, 2016, HIST PHIL LIFE SCI, V38, P117, DOI 10.1007/s40656-016-0099-9; Warner MS, 2009, PERS-CENTERED EXP PS, V8, P109, DOI 10.1080/14779757.2009.9688484; Whitehead P. M., 2017, HUMANISTIC PSYCHOL, V45, P71, DOI DOI 10.1037/hum0000047; Whitehead PM, 2015, PROG BIOPHYS MOL BIO, V119, P502, DOI 10.1016/j.pbiomolbio.2015.07.003	55	1	1	0	8	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1477-9757	1752-9182		PERS-CENTERED EXP PS	Pers.-Centered Exp. Psychother.		2018	17	1					70	85		10.1080/14779757.2018.1431563			16	Psychology, Clinical	Emerging Sources Citation Index (ESCI)	Psychology	GP8YH	WOS:000441201700005					2022-02-06	
S	D'Ascanio, S; Alosco, ML; Stern, RA		Hainline, B; Stern, RA		D'Ascanio, Steven; Alosco, Michael L.; Stern, Robert A.			Chronic traumatic encephalopathy: clinical presentation and in vivo diagnosis	SPORTS NEUROLOGY	Handbook of Clinical Neurology		English	Article; Book Chapter							PROFESSIONAL FOOTBALL PLAYERS; LIFE COGNITIVE IMPAIRMENT; HIGH-SCHOOL FOOTBALL; RETIRED NFL PLAYERS; ALZHEIMERS-DISEASE; LEAGUE PLAYERS; 1ST EXPOSURE; RECURRENT CONCUSSION; DEPRESSIVE SYMPTOMS; HEAD IMPACTS	Exposure to repetitive head impacts from contact sport participation (e.g., American football, boxing, soccer) is associated with the neurodegenerative disorder known as chronic traumatic encephalopathy (CTE). The neuropathology of CTE is becoming well defined, and diagnostic criteria have been developed and are being refined. The critical next step in this emerging field is the diagnosis of CTE during life. The objective of this chapter is to describe what is currently known about the clinical presentation and in vivo diagnosis of CTE. This chapter reviews studies in which clinical manifestation of CTE was examined through retrospective telephone interviews with informants of individuals whose brains were donated and were diagnosed with CTE through neuropathologic examination. In vivo research examining the long-term neurobehavioral consequences of repetitive head impacts is also reviewed, followed by a comparison of the existing provisional clinical diagnostic criteria for CTE, as well as preliminary research on possible fluid and neuroimaging biomarkers. An illustrative case study of CTE is presented, and the chapter concludes with a discussion of gaps in knowledge and future directions.	[Stern, Robert A.] Boston Univ, Alzheimers Dis Ctr, 72 E Concord St,Suite B7800, Boston, MA 02118 USA; [Stern, Robert A.] Boston Univ, Sch Med, Dept Neurol, CTE Ctr, 72 E Concord St,Suite B7800, Boston, MA 02118 USA		Stern, RA (corresponding author), Boston Univ, Alzheimers Dis Ctr, 72 E Concord St,Suite B7800, Boston, MA 02118 USA.; Stern, RA (corresponding author), Boston Univ, Sch Med, Dept Neurol, CTE Ctr, 72 E Concord St,Suite B7800, Boston, MA 02118 USA.; Stern, RA (corresponding author), Boston Univ, Sch Med, Dept Neurosurg, 72 E Concord St,Suite B7800, Boston, MA 02118 USA.; Stern, RA (corresponding author), Boston Univ, Sch Med, Dept Anat & Neurobiol, 72 E Concord St,Suite B7800, Boston, MA 02118 USA.	bobstern@bu.edu	, Bob/ABA-8507-2020		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS102399] Funding Source: NIH RePORTER		Adler CM, 2018, CLIN J SPORT MED, V28, P100, DOI 10.1097/JSM.0000000000000391; Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Alosco Michael L, 2018, Alzheimers Dement (Amst), V10, P56, DOI 10.1016/j.dadm.2017.10.003; Alosco ML, 2017, BRAIN INJURY, V31, P1116, DOI 10.1080/02699052.2017.1294709; Alosco Michael L, 2017, Alzheimers Dement (Amst), V7, P33, DOI 10.1016/j.dadm.2016.11.003; Alosco ML, 2017, J NEUROTRAUM, V34, P772, DOI 10.1089/neu.2016.4536; Alosco ML, 2017, J NEUROPSYCH CLIN N, V29, P6, DOI 10.1176/appi.neuropsych.16030043; Amen DG, 2016, J ALZHEIMERS DIS, V53, P237, DOI 10.3233/JAD-160207; Asken BM, 2017, JAMA NEUROL, V74, P1255, DOI 10.1001/jamaneurol.2017.2396; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Banks SJ, 2014, J NEUROPSYCH CLIN N, V26, P44, DOI 10.1176/appi.neuropsych.12070185; Banks SJ, 2014, ARCH CLIN NEUROPSYCH, V29, P54, DOI 10.1093/arclin/act079; BARBER R, 1995, J NEUROL NEUROSUR PS, V59, P61, DOI 10.1136/jnnp.59.1.61; Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; Baugh CM, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0306-5; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Bowman KM, 1940, INJURIES SKULL BRAIN, P309; Casson IR, 2014, SPORTS HEALTH, V6, P384, DOI 10.1177/1941738114540270; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; Cherry JJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185079; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Coughlin JM, 2017, JAMA NEUROL, V74, P67, DOI 10.1001/jamaneurol.2016.3764; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; CRITCHLEY M, 1957, BMJ-BRIT MED J, V1, P357, DOI 10.1136/bmj.1.5015.357; Critchley M, 1964, BLACK HOLE OTHER ESS; Critchley M, 1949, PUNCH DUNK SYNDROMES; DAVIS PB, 1991, ARCH NEUROL-CHICAGO, V48, P613, DOI 10.1001/archneur.1991.00530180069019; Deep-Soboslay A, 2005, BIOL PSYCHIAT, V57, P96, DOI 10.1016/j.biopsych.2004.10.016; Deshpande SK, 2017, JAMA NEUROL, V74, P909, DOI 10.1001/jamaneurol.2017.1317; Dickstein DL, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.175; Didehbani N, 2013, ARCH CLIN NEUROPSYCH, V28, P418, DOI 10.1093/arclin/act028; Esopenko C, 2017, J NEUROL NEUROSUR PS, V88, P512, DOI 10.1136/jnnp-2016-315260; Ford JH, 2013, J NEUROTRAUM, V30, P1683, DOI 10.1089/neu.2012.2535; Gardner A, 2014, BRIT J SPORT MED, V48, P84, DOI 10.1136/bjsports-2013-092646; Gardner Raquel C, 2015, Neurol Clin Pract, V5, P285; Gardner RC, 2016, J NEUROTRAUM, V33, P157, DOI 10.1089/neu.2014.3805; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Goswami R, 2016, BRAIN STRUCT FUNCT, V221, P1911, DOI 10.1007/s00429-015-1012-0; GRAHMANN H, 1957, Psychiatr Neurol (Basel), V134, P261; GROSS AG, 1958, J NEUROSURG, V15, P548, DOI 10.3171/jns.1958.15.5.0548; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hampshire A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02972; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; HOF PR, 1991, ACTA NEUROPATHOL, V82, P321, DOI 10.1007/BF00308819; Houck Z, 2018, J INT NEUROPSYCH SOC, V24, P1, DOI 10.1017/S1355617717000716; Iverson GL, 2014, BRIT J SPORT MED, V48, P162, DOI 10.1136/bjsports-2013-092935; JOHNSON J, 1969, BRIT J PSYCHIAT, V115, P45, DOI 10.1192/bjp.115.518.45; Jokl E, 1950, BMJ-BRIT MED J, V2, P1291; Jokl E, 1933, MUNCH MED WOCHENSCHR, V80, P560; Jokl E.F., 1941, MED ASPECT BOXING; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Koerte IK, 2016, J NEUROTRAUM, V33, P346, DOI 10.1089/neu.2015.3880; Levitch CF, 2018, J INT NEUROPSYCH SOC, V24, P147, DOI 10.1017/S1355617717000790; Lin AP, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0094-5; Ling HL, 2017, ACTA NEUROPATHOL, V133, P337, DOI 10.1007/s00401-017-1680-3; Mahar I, 2017, NEUROSCI BIOBEHAV R, V83, P622, DOI 10.1016/j.neubiorev.2017.08.023; Martland H., 1928, JAMA-J AM MED ASSOC, V91, P1103, DOI DOI 10.1001/JAMA.1928.02700150029009; MAWDSLEY C, 1963, LANCET, V2, P795; McCrory P, 2013, BRIT J SPORT MED, V47, P327, DOI 10.1136/bjsports-2013-092248; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Millspaugh JA, 1937, US NAVAL MED B, V35, P297; Mitsis EM, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.91; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Montenigro PH, 2015, BRAIN PATHOL, V25, P304, DOI 10.1111/bpa.12250; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Multani N, 2016, J NEUROL, V263, P1332, DOI 10.1007/s00415-016-8141-0; Noy S, 2016, J NEUROPATH EXP NEUR, V75, P1145, DOI 10.1093/jnen/nlw092; Olsson B, 2016, LANCET NEUROL, V15, P673, DOI [10.1016/s1474-4422(16)00070-3, 10.1016/S1474-4422(16)00070-3]; Omalu B, 2018, NEUROSURGERY, V82, P237, DOI 10.1093/neuros/nyx536; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Parker HL, 1934, J NEUROL PSYCHOPATHO, V15, P20; Randolph C, 2013, J INT NEUROPSYCH SOC, V19, P873, DOI 10.1017/S1355617713000805; Ravina A, 1937, PRESSE MED, V45, P1362; Reams N, 2016, JAMA NEUROL, V73, P743, DOI 10.1001/jamaneurol.2015.5015; ROBERTS GW, 1990, LANCET, V335, P918, DOI 10.1016/0140-6736(90)90520-F; Schultz V, 2018, J NEUROTRAUM, V35, P278, DOI 10.1089/neu.2017.5145; SERCL M., 1962, WORLD NEUROL, V3, P351; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; Solomon GS, 2016, AM J SPORT MED, V44, P1106, DOI 10.1177/0363546515626164; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; Stern RA, 2016, J ALZHEIMERS DIS, V51, P1099, DOI 10.3233/JAD-151028; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Strain JF, 2017, J NEUROTRAUM, V34, P372, DOI 10.1089/neu.2016.4446; Strain JF, 2015, JAMA NEUROL, V72, P773, DOI 10.1001/jamaneurol.2015.0206; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Tarazi A, 2018, J NEUROTRAUM, V35, P1003, DOI 10.1089/neu.2017.5290; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; Victoroff J, 2013, NEUROREHABILITATION, V32, P211, DOI 10.3233/NRE-130839; Williams DJ, 1996, PATHOLOGY, V28, P102, DOI 10.1080/00313029600169653; Wortzel HS, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/424280; Wright MJ, 2016, J CLIN EXP NEUROPSYC, V38, P561, DOI 10.1080/13803395.2016.1139057	104	1	1	1	1	ELSEVIER	AMSTERDAM	Radarweg 29, PO Box 211, AMSTERDAM, NETHERLANDS	0072-9752		978-0-44-463955-4; 978-0-444-63954-7	HAND CLINIC			2018	158						281	296		10.1016/B978-0-444-63954-7.00027-6			16	Clinical Neurology; Sport Sciences	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Sport Sciences	BP1MW	WOS:000540371100029	30482356				2022-02-06	
J	Das, JM; Sapkota, R; Shrestha, B				Das, Joe M.; Sapkota, Rashmi; Shrestha, Binjura			Pediatric dural venous sinus thrombosis following closed head injury: an easily overlooked diagnosis with devastating consequences	ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY			English	Article						Child; closed head injuries; cranial venous sinus thrombosis; decompressive craniectomy; early post-traumatic seizures	PATIENT; TRAUMA; CHILD	Dural venous sinus thrombosis (DVST) is an uncommon finding after traumatic brain injury. The diagnosis can often be initially missed, particularly if not associated with an overlying fracture. Pediatric DVST following closed head injury and without an overlying fracture is very rare, with only 20 cases reported in the literature to date. Here we present the case of a 19-month-old boy who presented with a history of trivial fall and an episode of fever. On presentation, the pediatric Glasgow Coma Scale (pGCS) score was E3V4M6, and initial brain computed tomography (CT) was normal. He was initially conservatively managed. However, subsequent CT, taken following an episode of seizure, revealed right tentorial subarachnoid hemorrhage and falx hematoma. Conservative management was continued till he started developing recurrent seizures with a decrease in pGCS scores. Repeat CT revealed sinus thrombosis that involved the posterior aspect of the superior sagittal sinus with a massive brain edema. The coagulation profile was normal, and no fracture overlying the sinus was observed. Although he underwent emergency bifrontal decompressive craniotomy, he did not recover. This study emphasizes on the importance of not missing the diagnosis of sinus thrombosis and the devastating consequences that can occur if it is overlooked.	[Das, Joe M.; Sapkota, Rashmi; Shrestha, Binjura] Teaching Hosp, Coll Med Sci, Dept Neurosurg, POB 23, Bharatpur 10, Chitwan, Nepal		Das, JM (corresponding author), Teaching Hosp, Coll Med Sci, Dept Neurosurg, POB 23, Bharatpur 10, Chitwan, Nepal.	drjoemdas@gmail.com	Das, Joe M/E-6549-2014; Das, Joe M/J-2562-2019	Das, Joe M/0000-0002-6373-1500; Das, Joe M/0000-0002-6373-1500; Sapkota, Rashmi/0000-0001-6391-7869			Beer-Furlan A, 2013, CHILD NERV SYST, V29, P1231, DOI 10.1007/s00381-013-2184-7; Campbell J.P, 2009, IEEE INT REL PHYS S, P382; Dobbs TD, 2012, J CLIN NEUROSCI, V19, P1058, DOI 10.1016/j.jocn.2012.01.002; Khursheed N, 2013, ULUS TRAVMA ACIL CER, V19, P69, DOI 10.5505/tjtes.2013.79745; Muthukumar N, 2005, CHILD NERV SYST, V21, P86, DOI 10.1007/s00381-004-0926-2; Ochagavia AR, 1996, LANCET, V347, P1564, DOI 10.1016/S0140-6736(96)90721-7; RAO KCVG, 1981, RADIOLOGY, V140, P391, DOI 10.1148/radiology.140.2.7255715; Reith W., 2016, DIAGNOSTIC INTERVENT, P131; Wilcher J, 2016, PEDIATR EMERG CARE, V32, P872, DOI 10.1097/PEC.0000000000000344; Yuen HW, 2005, ANN ACAD MED SINGAP, V34, P639	10	1	1	0	0	TURKISH ASSOC TRAUMA EMERGENCY SURGERY	ISTANBUL	KOPRULU MEHMET PASA SOC, DENIZ ABDAL MAH, DADASOGLU AP, 25-1 SEHREMINI, ISTANBUL, 00000, TURKEY	1306-696X			ULUS TRAVMA ACIL CER	Ulus. Travma Acil Cerrahi Derg.	JAN	2018	24	1					74	77	PMID 29350373	10.5505/tjtes.2017.22823			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	GA3OA	WOS:000428237600015	29350373	Bronze			2022-02-06	
B	Diagana, M; Dumas, M		Preux, PM; Dumas, M		Diagana, Mouhamadou; Dumas, Michel			Other Diseases: Traumatic Brain Injuries, Tumors, and Multiple Sclerosis	NEUROEPIDEMIOLOGY IN TROPICAL HEALTH			English	Article; Book Chapter							RISK-FACTORS; VITAMIN-D; EPIDEMIOLOGY; PREVALENCE; CELLS; BIRTH; CONSORTIUM; RADIATION; EXPOSURE; AGE		[Diagana, Mouhamadou] Fac Med Nouakchott, Nouakchott, Mauritania; [Diagana, Mouhamadou; Dumas, Michel] Univ Limoges, Limoges, France; [Diagana, Mouhamadou; Dumas, Michel] INSERM, UMR NET 1094, Limoges, France		Diagana, M (corresponding author), Fac Med Nouakchott, Nouakchott, Mauritania.; Diagana, M (corresponding author), Univ Limoges, Limoges, France.; Diagana, M (corresponding author), INSERM, UMR NET 1094, Limoges, France.						Adeloye A, 1989, NEUROSURURGERY AFRIC; Aguemon AR, 2005, ANN FR ANESTH, P36; Andrews N B, 2003, West Afr J Med, V22, P167; Ascherio A, 2013, EXPERT REV NEUROTHER, V13, P3, DOI 10.1586/14737175.2013.865866; Ascherio A, 2010, LANCET NEUROL, V9, P599, DOI 10.1016/S1474-4422(10)70086-7; Bardrinarayan M, 2010, INDIAN J COMMUNITY M, V35, P115, DOI DOI 10.4103/0970-0218.62568; BARLOW J S, 1960, Trans Am Neurol Assoc, V85, P189; BARLOW JOHN S., 1960, ACTA PSYCHIATR ET NEUROL SCAND SUPPL, V35, P108, DOI 10.1111/j.1600-0447.1960.tb08673.x; Bartosik-Psujek H, 2010, MULT SCLER, V16, P1513, DOI 10.1177/1352458510379611; Belbasis L, 2015, LANCET NEUROL, V14, P263, DOI 10.1016/S1474-4422(14)70267-4; Beretich BD, 2009, MULT SCLER J, V15, P891, DOI 10.1177/1352458509105579; Broalet E, 2007, AFR J NEUROL SCI, V26, P27; Cabre P, 2005, BRAIN, V128, P2899, DOI 10.1093/brain/awh624; Cabre P, 2009, J NEUROL SCI, V286, P58, DOI 10.1016/j.jns.2009.04.039; ClementLacroix P, 1996, BRIT J DERMATOL, V134, P77, DOI 10.1046/j.1365-2133.1996.d01-732.x; Committee of Brain Tumor Registry of Japan, 2003, NEUROL MED-CHIR, V43, P1, DOI [10.2176/nmc.43.S1, DOI 10.2176/NMC.43.S1]; Coo H, 2004, NEUROEPIDEMIOLOGY, V23, P1, DOI 10.1159/000073969; Correale J, 2007, ANN NEUROL, V61, P97, DOI 10.1002/ana.21067; Dalmay F, 2010, MULT SCLER J, V16, P899, DOI 10.1177/1352458510366856; DEAN G, 1971, BMJ-BRIT MED J, V3, P725, DOI 10.1136/bmj.3.5777.725; DEAN G, 1967, BRIT MED J, V2, P724, DOI 10.1136/bmj.2.5554.724; Diakite Ak, 2005, Mali Med, V20, P17; Dumas M, 2000, MED HYPOTHESES, V55, P517, DOI 10.1054/mehy.2000.1109; Eyanga VC, 2008, CAHIER SANTE, V18, P39; Fekih Hassen A, 2012, TUNIS MED, V90, P25; Fleming J, 2007, ANN NEUROL, V61, P85, DOI 10.1002/ana.21092; Furio L, 2005, J INVEST DERMATOL, V125, P1032, DOI 10.1111/j.0022-202X.2005.23904.x; Gu J, 2009, NEUROTHERAPEUTICS, V6, P427, DOI 10.1016/j.nurt.2009.05.001; Harder T, 2008, AM J EPIDEMIOL, V168, P366, DOI 10.1093/aje/kwn144; Ibebuike K, 2014, AFR HEALTH SCI, V14, DOI 10.4314/ahs.v14i4.24; Idowu OE, 2008, AFR HEALTH SCI, V8, P1; Johnson KJ, 2014, CANCER EPIDEM BIOMAR, V23, P2716, DOI 10.1158/1055-9965.EPI-14-0207; Karkouri M, 2010, CHILD NERV SYST, V26, P1021, DOI 10.1007/s00381-010-1097-y; Katchy KC, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-58; Konan K, 2006, REV INT SC MED, V8, P44; Krishnamachari B, 2015, ANN EPIDEMIOL, V25, P270, DOI 10.1016/j.annepidem.2014.12.007; LEIBOWITZ U, 1966, J NEUROL NEUROSUR PS, V29, P60, DOI 10.1136/jnnp.29.1.60; Leray E, 2016, REV NEUROL-FRANCE, V172, P3, DOI 10.1016/j.neurol.2015.10.006; LEVY LF, 1975, INT SURG, V60, P286; Little RB, 2013, CANCER CAUSE CONTROL, V24, P1025, DOI 10.1007/s10552-013-0178-0; LOVASTE M G, 1986, Neuroepidemiology, V5, P220, DOI 10.1159/000110831; Malmer B, 2007, CANCER EPIDEM BIOMAR, V16, P1730, DOI 10.1158/1055-9965.EPI-07-0081; McDowell TY, 2010, NEUROEPIDEMIOLOGY, V34, P238, DOI 10.1159/000297749; Mostert S, 2012, ARCH DIS CHILD, V97, P508, DOI 10.1136/archdischild-2011-300829; Munger KL, 2006, JAMA-J AM MED ASSOC, V296, P2832, DOI 10.1001/jama.296.23.2832; Ngulde SI, 2015, CUREUS, V7, DOI 10.7759/cureus.372; Okamoto H, 2005, J NEUROSURG, V102, P294, DOI 10.3171/ped.2005.102.3.0294; Pouchieu C, 2016, REV NEUROL-FRANCE, V172, P46, DOI 10.1016/j.neurol.2015.10.007; Preston-Martin S, 2005, SAMJ S AFR MED J, V95, P776; Sanou J, 2012, REV AFR ANESTH MED U, V17, p7P; Sanoussi S, 2009, J SURG TECH CASE REP, V21, P13; Sawcer S, 2014, LANCET NEUROL, V13, P700, DOI 10.1016/S1474-4422(14)70041-9; Shekhar Chandra, 2015, J Emerg Trauma Shock, V8, P131, DOI 10.4103/0974-2700.160700; Simpson S, 2011, J NEUROL NEUROSUR PS, V82, P1132, DOI 10.1136/jnnp.2011.240432; Talons L, 2014, KIS MED, V5, P51; Taylor BV, 2016, MULT SCLER, V17, P1171; Willer CJ, 2005, BMJ-BRIT MED J, V330, P120, DOI 10.1136/bmj.38301.686030.63; Wong TT, 2015, CANCER, V15, P2156; Zhao HY, 2014, TUMOR BIOL, V35, P3875, DOI 10.1007/s13277-013-1514-4	59	1	1	0	1	ACADEMIC PRESS LTD-ELSEVIER SCIENCE LTD	LONDON	125 LONDON WALL, LONDON EC2Y 5AS, ENGLAND			978-0-12-804625-8; 978-0-12-804607-4				2018							297	303		10.1016/B978-0-12-804607-4.00021-6			7	Public, Environmental & Occupational Health; Neurosciences; Tropical Medicine	Book Citation Index – Science (BKCI-S)	Public, Environmental & Occupational Health; Neurosciences & Neurology; Tropical Medicine	BJ4AD	WOS:000424737900023					2022-02-06	
J	Dismuke-Greer, CE; Gebregziabher, M; Ritchwood, T; Pugh, MJ; Walker, RJ; Uchendu, US; Egede, LE				Dismuke-Greer, Clara E.; Gebregziabher, Mulugeta; Ritchwood, Tiarney; Pugh, Mary Jo; Walker, Rebekah J.; Uchendu, Uche S.; Egede, Leonard E.			Geographic Disparities in Mortality Risk Within a Racially Diverse Sample of US Veterans with Traumatic Brain Injury	HEALTH EQUITY			English	Article						traumatic brain injury; veteran; mortality; geographic; disparities; racial; ethnic	ACUTE MYOCARDIAL-INFARCTION; QUALITY-OF-CARE; UNITED-STATES; IMPACT	Purpose: Traumatic brain injury (TBI) is a signature injury among the U.S. veterans. Hispanic U.S. veterans diagnosed with TBI have been found to have higher risk-adjusted mortality. This study examined the adjusted association of geographic location with all-cause mortality in 114,593 veterans diagnosed with TBI between January 1, 2000 and December 31, 2010, and followed through December 31, 2014. Methods: National Veterans Health Administration (VHA) databases containing administrative data including International Classification of Diseases, 9th Revision (ICD-9) codes, sociodemographic characteristics, and survival were linked. TBI was identified based on ICD-9 codes. Cox proportional hazards regression methods were used to examine the association of time from first TBI ICD-9 code to death with geographic location, after adjustment for TBI severity, race/ethnicity, other sociodemographic characteristics, military factors, and Elixhauser comorbidities. Results: Relative to urban mainland veterans with a median survival of 76.4 months, veterans living in the U.S. territories had a median survival of 69.1 months, whereas rural mainland veterans had a median survival of 77.1 months, and highly rural mainland veterans had a mean survival of 77.6 months. The final model adjusted for race/ethnicity, TBI severity, sociodemographic, military, and comorbidity covariates showed that residing in the U.S. territories was associated with a higher risk of death (hazard ratios=1.24; 95% confidence interval 1.15-1.34) relative to residing on the U.S. mainland. The race/ethnicity disparity previously found for the U.S. veterans diagnosed with TBI seems to be accounted for by living in the U.S. territories. Conclusion: The study shows that among veterans with TBI, mortality rates were higher in those who reside in the U.S. territories, even after adjustment. Previous documented higher mortality among Hispanic veterans seems to be explained by residing in the U.S. territories. The VA has a mission of ensuring equitable treatment of all veterans, and should investigate targeted policies and interventions to improve the survival of the U.S. territory veterans diagnosed with TBI.	[Dismuke-Greer, Clara E.; Gebregziabher, Mulugeta] Ralph H Johnson Vet Affairs Med Ctr, Hlth Equ & Rural Outreach Innovat Ctr, Charleston, SC USA; [Dismuke-Greer, Clara E.] Med Univ South Carolina, Dept Med, Div Internal Med, Charleston, SC 29425 USA; [Gebregziabher, Mulugeta; Ritchwood, Tiarney] Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA; [Pugh, Mary Jo] Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT USA; [Pugh, Mary Jo] VA Salt Lake City Hlth Care Syst, IDEAS Ctr Innovat, Salt Lake City, UT USA; [Walker, Rebekah J.; Egede, Leonard E.] Med Coll Wisconsin, Dept Med, Div Gen Internal Med, Milwaukee, WI 53226 USA; [Walker, Rebekah J.; Egede, Leonard E.] Med Coll Wisconsin, Ctr Adv Populat Sci CAPS, Milwaukee, WI 53226 USA; [Uchendu, Uche S.] US Dept Vet Affairs, Hlth Equ, Washington, DC USA; [Uchendu, Uche S.] Hlth Management Associates, Washington, DC USA		Dismuke-Greer, CE (corresponding author), Ralph H Johnson Dept Vet Affairs Med Ctr, Hlth Equ & Rural Outreach Innovat Ctr, 109 Bee St, Charleston, SC 29401 USA.	clara.dismuke@va.gov			U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC); U.S. Department of Veterans Affairs Chronic Effects of Neurotrauma ConsortiumUS Department of Veterans Affairs [W81XWH-13-2-0095]; Health Equity and Rural Outreach Innovation Center at the Ralph H. Johnson VAMedical Center, Department of Veterans Affairs [HX001229]	This material is based upon work supported by the U.S. Army Medical Research and Materiel Command and from the U.S. Department of Veterans Affairs Chronic Effects of Neurotrauma Consortium under Award No. W81XWH-13-2-0095. The U.S. ArmyMedical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office. Any opinions, findings, conclusions or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the views of the U.S. Government, or the U.S. Department of Veterans Affairs, and no official endorsement should be inferred. This study was also supported by the Health Equity and Rural Outreach Innovation Center at the Ralph H. Johnson VAMedical Center, Department of Veterans Affairs Award HX001229. The authors report no conflicts of interest. The views, opinions, and/or findings contained in this article are those of the authors and should not be construed as an official Veterans Affairs or Department of Defense position, policy or decision, unless so designated by other official documentation.	Abrams TE, 2011, ANN INTERN MED, V155, P80, DOI 10.7326/0003-4819-155-2-201107190-00003; Abrams TE, 2010, J RURAL HEALTH, V26, P310, DOI 10.1111/j.1748-0361.2010.00318.x; Baldwin LM, 2004, J RURAL HEALTH, V20, P99, DOI 10.1111/j.1748-0361.2004.tb00015.x; Belanger HG, 2016, J REHABIL RES DEV, V53, P767, DOI 10.1682/JRRD.2015.09.0187; Bouldin ED, 2015, J RURAL HEALTH, V31, P410, DOI 10.1111/jrh.12115; Centers for Disease Control and Prevention (CDC), 2016, TRAUM BRAIN INJ BAS; Dismuke CE, 2016, GLOB J HLTH SCI, V8, P260; Dismuke Clara E, 2015, Glob J Health Sci, V7, P156, DOI 10.5539/gjhs.v7n6p156; Dismuke CE, 2015, AM J PUBLIC HEALTH, V105, P1696, DOI 10.2105/AJPH.2014.302545; Egede LE, 2012, AM J PUBLIC HEALTH, V102, pS266, DOI 10.2105/AJPH.2011.300176; Evans CT, 2013, PM&R, V5, P210, DOI 10.1016/j.pmrj.2012.12.004; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Gutierrez N, 2011, ARCH INTERN MED, V171, P1579, DOI 10.1001/archinternmed.2011.305; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Hu JH, 2013, J NEUROTRAUM, V30, P1755, DOI 10.1089/neu.2013.2857; Lund BC, 2013, J RURAL HEALTH, V29, P172, DOI 10.1111/j.1748-0361.2012.00428.x; MacKenzie TA, 2010, J RURAL HEALTH, V26, P318, DOI 10.1111/j.1748-0361.2010.00300.x; Morgan M, 2012, PSYCHIAT SERV, V63, P182, DOI 10.1176/appi.ps.201000531; Nunez-Smith M, 2011, ARCH INTERN MED, V171, P1528, DOI 10.1001/archinternmed.2011.284; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; The CDC NI H DoD and VA Leadership Panel, 2013, REP C TRAUM BRAIN IN; TRAUMATIC BRAIN INJURY (TBI), 2016, DOD STAND SURV CAS D	23	1	1	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA		2473-1242		HEALTH EQUITY	Health Equity		2018	2	1					304	312		10.1089/heq.2018.0047			9	Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Public, Environmental & Occupational Health	VJ6UP	WOS:000617436500042	30374469	gold, Green Published			2022-02-06	
J	Fabri, TL; Stewart, ML; Stevens, SA				Fabri, Tracy L.; Stewart, Mary L.; Stevens, Sara A.			Informing pediatric rehabilitation: Language-based neuropsychological profile following traumatic brain injury and stroke secondary to arteriovenous malformation	JOURNAL OF PEDIATRIC REHABILITATION MEDICINE			English	Article						Acquired brain injury; traumatic brain injury; arteriovenous malformation; left-laterality; language neuropsychological outcome; rehabilitation	HEAD-INJURY; CHILDREN; CHILDHOOD; ADOLESCENTS; TERM; TBI; PREDICTORS; SERVICES; DEFICITS; LESION	PURPOSE: To describe language-based neuropsychological outcomes following brain injury in two pediatric populations commonly treated in rehabilitation settings, namely severe traumatic brain injury (sTBI) and stroke secondary to arteriovenous malformation (AVM). METHODS: Investigated were children between the ages of 6 and 16 who were admitted to a brain injury rehabilitation program in a pediatric rehabilitation hospital and who were diagnosed with a left-sided sTBI (n = 16; mean age = 13.2) or a left-hemispheric stroke secondary to AVM (n = 16, mean age = 10.7). Groups were compared on demographic information, as well as general cognitive and language-based neuropsychological measures, controlling for age. RESULTS: Children in the AVM group presented with greater deficits, at trend levels, relative to the sTBI group on measures of working memory, verbal fluency, and an aphasia screening tool. CONCLUSIONS: This study represents an initial step in understanding the language-based neuropsychological outcomes of children diagnosed with sTBI compared to those with stroke secondary to AVM, which will help inform the rehabilitation process. With this knowledge, clinicians, families, and educators will be better equipped to provide informed individual rehabilitation programs, recommendations, and education for children and adolescents with brain injuries.	[Fabri, Tracy L.; Stewart, Mary L.; Stevens, Sara A.] Holland Bloorview Kids Rehabil Hosp, Brain Injury Rehabil Team, Toronto, ON, Canada; [Stevens, Sara A.] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada		Stevens, SA (corresponding author), Holland Bloorview Kids Rehabil Hosp, 150 Kilgour Rd, Toronto, ON, Canada.	sstevens@hollandbloorview.ca	Fabri, Tracy/AAR-8791-2021				Allman C, 2013, CHILD NEUROPSYCHOL, V19, P97, DOI 10.1080/09297049.2011.639756; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; [Anonymous], 2016, CANADIAN STROKE BEST; Babikian T, 2006, J MAGN RESON IMAGING, V24, P801, DOI 10.1002/jmri.20696; Catroppa C, 2004, BRAIN LANG, V88, P68, DOI 10.1016/S0093-934X(03)00159-7; Cohen MJ, 1991, CHILDRENS MEMORY SCA; Crowe LM, 2014, J HEAD TRAUMA REHAB, V29, P217, DOI 10.1097/HTR.0b013e31829babfd; Delis DC, 2004, J INT NEUROPSYCH SOC, V10, P301, DOI 10.1017/S1355617704102191; Delis DC., 2001, DELIS KAPLAN EXECUTI; Delis DC., 1994, CALIFORNIA VERBAL LE; Dettmer J, 2014, J HEAD TRAUMA REHAB, V29, P224, DOI 10.1097/HTR.0b013e3182a1cd68; Dikel TN, 2001, NEUROCASE, V7, P503; Donders J, 2004, J INT NEUROPSYCH SOC, V10, P482, DOI 10.1017/S1355617704104025; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Ewing-Cobbs Linda, 2002, Semin Pediatr Neurol, V9, P209, DOI 10.1053/spen.2002.35502; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Fuentes A, 2016, CHILD NEUROPSYCHOL, V22, P1, DOI 10.1080/09297049.2014.969694; Glang A, 2008, NEUROREHABILITATION, V23, P477; Hoffman N, 2000, ARCH CLIN NEUROPSYCH, V15, P47, DOI 10.1016/S0887-6177(98)00156-5; Horton Jr AM, 1997, NEUROPSYCHOLOGY HDB, V2, P73; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; Jordan LC, 2007, PEDIATR NEUROL, V36, P73, DOI 10.1016/j.pediatrneurol.2006.09.017; Kirton A, 2015, LANCET NEUROL, V14, P92, DOI 10.1016/S1474-4422(14)70227-3; Kitchen L, 2012, STROKE, V43, P1602, DOI 10.1161/STROKEAHA.111.639583; Levin HS, 2000, J CLIN EXP NEUROPSYC, V22, P1, DOI 10.1076/1380-3395(200002)22:1;1-8;FT001; Lindsay S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124679; Lo WD, 2011, J CHILD NEUROL, V26, P1174, DOI 10.1177/0883073811408424; Max J, 1999, J INT NEUROPSYCHOLOG, V5; Miller LJ, 2003, REHABIL PSYCHOL, V48, P237, DOI 10.1037/0090-5550.48.4.237; O'Keeffe F, 2014, CHILD NEUROPSYCHOL, V20, P557, DOI 10.1080/09297049.2013.832740; Prasad MR, 2002, PEDIATR NEUROSURG, V36, P64, DOI 10.1159/000048355; Ryan NP, 2016, INT J DEV NEUROSCI, V49, P23, DOI 10.1016/j.ijdevneu.2015.12.004; Shunk AW., 2006, APPL NEUROPSYCHOLOGY, V13, P275, DOI [DOI 10.1207/S15324826AN1304_9, DOI 10.1207/S15324826AN1304_]; TEASDALE G, 1974, LANCET, V2, P81; Verger K, 2000, BRAIN INJURY, V14, P495; Wechsler D, 2003, WECHSLER INTELLIGENC; Wheeler SM, 2011, J CLIN ENDOCR METAB, V96, pE1427, DOI 10.1210/jc.2011-0119; Whigham KB, 2007, COGN BEHAV NEUROL, V20, P244, DOI 10.1097/WNN.0b013e31815e6224; Wolfson, 1993, HALSTEAD REITAN NEUR; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514	40	1	1	0	1	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1874-5393	1875-8894		J PEDIATR REHAB MED	J. Pediatr. Rehab. Med.		2018	11	1					15	21		10.3233/PRM-160429			7	Pediatrics	Emerging Sources Citation Index (ESCI)	Pediatrics	GS5FA	WOS:000443681400003	29630561				2022-02-06	
J	Faraji, AH; Ochalski, PG; Ozpinar, A; Blatt, JE; Pollack, IF				Faraji, Amir H.; Ochalski, Pawel G.; Ozpinar, Alp; Blatt, Jason E.; Pollack, Ian F.			Isolated Traumatic Diastasis of the Clival Synchondroses without Clival Fracture	PEDIATRIC NEUROSURGERY			English	Article						Brain injury; Craniocervical junction; Head trauma; Skull base; Skull fracture; Traumatic brain injury	SPHENO-OCCIPITAL SYNCHONDROSIS; CENTRAL SKULL BASE; HEAD-INJURY; CT; FEATURES; PATIENT; FISSURE; CLOSURE	Traumatic clival fractures in the pediatric population are associated with high mortality rates. In our previously reported series, a subset of clival fractures were associated with traumatic diastasis of the surrounding clival synchondroses. Herein, we describe a pediatric case of an isolated traumatic The first case reports of pediatric clival fractures in the diastasis of the clival synchondroses without clival fracture with significant injury to neurovascular structures. To our knowledge this is the first report to describe this entity. Careful radiological attention should be made towards the clival synchondroses in crushing head injuries to best tailor screening for cerebrovascular injury even in the absence of clival fractures. (C) 2018 S. Karger AG, Basel	[Faraji, Amir H.; Ozpinar, Alp; Pollack, Ian F.] Univ Pittsburgh, Dept Neurol Surg, Med Ctr, Pittsburgh, PA 15260 USA; [Faraji, Amir H.; Ozpinar, Alp; Pollack, Ian F.] UPMC, Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA; [Ochalski, Pawel G.] WellSpan Neurosurg, York, PA USA; [Blatt, Jason E.] Univ Florida, Dept Neurol Surg, Gainesville, FL USA		Faraji, AH (corresponding author), UPMC, Presbyterian Hosp, 200 Lothrop St,Suite B-400, Pittsburgh, PA 15213 USA.	farajia@upmc.edu		Faraji, Amir/0000-0002-4329-5422			Adem C, 1999, J RADIOL, V80, P863; Balboni AL, 2005, ANAT REC PART A, V282A, P38, DOI 10.1002/ar.a.20149; Biffl WL, 1999, AM J SURG, V178, P517, DOI 10.1016/S0002-9610(99)00245-7; Carter DA, 1998, J TRAUMA, V44, P230, DOI 10.1097/00005373-199801000-00039; CORRADINO G, 1990, NEUROSURGERY, V27, P592, DOI 10.1227/00006123-199010000-00015; Feiz-Erfan I, 2007, J NEUROSURG, V107, P364, DOI 10.3171/JNS-07/08/0364; Hoyte D A, 1975, Birth Defects Orig Artic Ser, V11, P255; IRWIN GL, 1960, RADIOLOGY, V75, P450, DOI 10.1148/75.3.450; JOSLYN JN, 1988, RADIOLOGY, V166, P817, DOI 10.1148/radiology.166.3.3340778; LAINE FJ, 1990, RADIOGRAPHICS, V10, P591, DOI 10.1148/radiographics.10.4.2198631; MADELINE LA, 1995, RADIOLOGY, V196, P747, DOI 10.1148/radiology.196.3.7644639; Menku A, 2004, NEUROSURG REV, V27, P194, DOI 10.1007/s10143-004-0320-2; Ochalski PG, 2011, J NEUROSURG-PEDIATR, V7, P261, DOI 10.3171/2010.12.PEDS10190; Ochalski PG, 2009, NEUROSURGERY, V65, P1063, DOI 10.1227/01.NEU.0000360154.18604.28; Okamoto K, 1996, AM J NEURORADIOL, V17, P117; Resnick DK, 1997, NEUROSURGERY, V40, P1177, DOI 10.1097/00006123-199706000-00012; SANDERS BB, 1973, J NEUROSURG, V39, P610, DOI 10.3171/jns.1973.39.5.0610; Takeshi M, 2006, J TRAUMA, V60, P1245, DOI 10.1097/01.ta.0000196932.11384.ac; Tortosa JG, 2004, J NEUROSURG, V100, P645, DOI 10.3171/jns.2004.100.4.0645; WACKENHEIM A, 1985, NEURORADIOLOGY, V27, P226, DOI 10.1007/BF00344493; WEST OC, 1993, RADIOLOGY, V188, P329, DOI 10.1148/radiology.188.2.8327674	21	1	1	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291	1423-0305		PEDIATR NEUROSURG	Pediatr. Neurosurg.		2018	53	4					270	274		10.1159/000488058			5	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	GK2ME	WOS:000435963700009	29672322				2022-02-06	
J	Fayemi, PO; Muchenje, V				Fayemi, P. O.; Muchenje, V.			Expression of ovine ubiquitin C-terminal hydroxylase 1, pH and colour of variety meats from head-stunned Dohne Merino sheep	SOUTH AFRICAN JOURNAL OF ANIMAL SCIENCE			English	Article						Biomarker; edible offal; halal slaughter; ovine species; stunning	TRAUMATIC BRAIN-INJURY; AIR RELATIVE-HUMIDITY; SLAUGHTER TRAITS; ANIMAL-WELFARE; HYDROLASE L1; QUALITY; UCH-L1; EXPOSURE; FAT	Ubiquitin C-terminal hydroxylase (UCH-L1) has been identified in few transcriptome studies as a biomarker coding for trauma and perception of pain in non-meat species. For the first time, real-time polymerase chain reaction (qPCR) assay was used to quantitate the expression of ovine ubiquitin C-terminal hydroxylase 1 (ovUCH-L1 mRNA) from head-stunned Dohne Merino ewes and lambs presented for slaughter at a high-throughput abattoir. The correlation between ambient environment and quality of variety meats from those ovine species was also determined. The level of ovUCH-L1 mRNA expression found in lambs was high, based on the outcome of qPCR quantification. The effect of head stunning shows that ewes exhibited higher capacity to impede electric insults than lambs. Except for the trachea and heart, ambient conditions had a negative correlation with pH of most variety meats. Similarly, a negative correlation was observed between total colour difference (Delta E*) for fillet and dew point. Saturation index of a few variety meats showed a moderate relationship with ambient temperature. Industrially, the results on ambient conditions are important for post-mortem control of pH, colour, and preservation of other physiochemical properties of variety meats. Findings from qPCR quantification indicated that ovUCH-L1 is a novel candidate marker for pain detection in head-stunned ovine species.	[Fayemi, P. O.; Muchenje, V.] Univ Ft Hare, Fac Sci & Agr, Dept Livestock & Pasture Sci, Private Mail Bag X1314, ZA-5700 Alice, Eastern Cape Pr, South Africa		Fayemi, PO (corresponding author), Univ Ft Hare, Fac Sci & Agr, Dept Livestock & Pasture Sci, Private Mail Bag X1314, ZA-5700 Alice, Eastern Cape Pr, South Africa.	pfayemi@ufh.ac.za			Govan Mbeki Research and Development Centre (GMRDC); Red Meat Research and Development (RMRD-SA); National Research Foundation (NRF) of South AfricaNational Research Foundation - South Africa [T079, THRIP T113]	The authors are grateful to Govan Mbeki Research and Development Centre (GMRDC), Red Meat Research and Development (RMRD-SA) and National Research Foundation (NRF) of South Africa (Projects T079 and THRIP T113) for funding this study.	Abdullah AY, 2010, J APPL POULTRY RES, V19, P46, DOI 10.3382/japr.2009-00079; Arnaoutakis GJ, 2011, J THORAC CARDIOV SUR, V142, P902, DOI 10.1016/j.jtcvs.2011.06.027; Arnau J, 2012, LWT-FOOD SCI TECHNOL, V47, P133, DOI 10.1016/j.lwt.2011.12.023; Arnau J, 2001, MEAT SCI, V58, P65, DOI 10.1016/S0309-1740(00)00132-7; Bishop P, 2016, BIOCHEM J, V473, P2453, DOI 10.1042/BCJ20160082; Blyth BJ, 2011, J NEUROTRAUM, V28, P2453, DOI 10.1089/neu.2010.1653; Chulayo AY, 2013, S AFR J ANIM SCI, V43, pS64, DOI 10.4314/sajas.v43i5.12; Cloete JJE, 2012, MEAT SCI, V91, P318, DOI 10.1016/j.meatsci.2012.02.010; Cloete JJE, 2004, S AFR J ANIM SCI, V34, P189; Commission International de L'Eclairage, 1976, COLORIMETRY; Damon M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033763; Das C, 2006, P NATL ACAD SCI USA, V103, P4675, DOI 10.1073/pnas.0510403103; Day INM, 2010, PROG NEUROBIOL, V90, P327, DOI 10.1016/j.pneurobio.2009.10.020; Farouk MM, 2000, MEAT SCI, V56, P139, DOI 10.1016/S0309-1740(00)00031-0; Farouk MM, 2013, MEAT SCI, V95, P805, DOI 10.1016/j.meatsci.2013.04.028; Fayemi PO, 2013, TROP ANIM HEALTH PRO, V45, P1597, DOI 10.1007/s11250-013-0404-5; Food and Agricultural Organisation (FAO), 1991, MAN MEAT COLD STOR O, P92; Gottschalk A., 2001, FAMILY PHY, V63; Grandin T., 2010, IMPROVING ANIMAL WEL; Gregory N. G., 2007, ANIMAL WELFARE MEAT; Kamenski C., 2006, VARIETY MEATS VITAL; Kenneth M., 1999, UNDERSTANDING WHAT H, P1; Lambooij E., 2012, MEAT SCI, V87, P2160; MACDOUGALL DB, 1982, FOOD CHEM, V9, P75, DOI 10.1016/0308-8146(82)90070-X; McKeegan DEF, 2006, APPL ANIM BEHAV SCI, V99, P271, DOI 10.1016/j.applanim.2005.11.002; McNeil I., 1987, CARCASS CHILLING; Nakyinsige K, 2013, MEAT SCI, V95, P352, DOI 10.1016/j.meatsci.2013.04.006; Nowak B, 2007, MEAT SCI, V75, P290, DOI 10.1016/j.meatsci.2006.07.014; Orr KS, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-79; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Prinz S., 2010, ANIM WELF J, V15, P7; Saricoban C., 2010, World Applied Sciences Journal, V9, P14; Setsuie R, 2007, NEUROCHEM INT, V51, P105, DOI 10.1016/j.neuint.2007.05.007; Varga A, 2006, J VIROL METHODS, V132, P146, DOI 10.1016/j.jviromet.2005.10.004; Velarde A, 2002, ANIM WELFARE, V11, P333; Vogel KD, 2011, J ANIM SCI, V89, P1412, DOI 10.2527/jas.2010-2920; Weaver AL, 2009, MEAT SCI, V81, P51, DOI 10.1016/j.meatsci.2008.06.020; Wilhelm J, 2003, CHEMBIOCHEM, V4, P1120, DOI 10.1002/cbic.200300662; Wilson CL, 2015, J HEPATOL, V63, P1421, DOI 10.1016/j.jhep.2015.07.034; Young OA, 1999, MEAT SCI, V52, P47, DOI 10.1016/S0309-1740(98)00147-8	40	1	1	0	3	SOUTH AFRICAN JOURNAL OF ANIMAL SCIENCES	HATFIELD	C/O ESTIE KOSTER, PO BOX 13884, HATFIELD 0028, SOUTH AFRICA	0375-1589			S AFR J ANIM SCI	South Afr. J. Anim. Sci.		2018	48	1					88	97		10.4314/sajas.v48i1.11			10	Agriculture, Dairy & Animal Science	Science Citation Index Expanded (SCI-EXPANDED)	Agriculture	FW3PK	WOS:000425220500011		gold			2022-02-06	
S	Festing, MFW		Srivastava, AK; Cox, CS		Festing, Michael F. W.			The Principles of Experimental Design and the Determination of Sample Size When Using Animal Models of Traumatic Brain Injury	PRE-CLINICAL AND CLINICAL METHODS IN BRAIN TRAUMA RESEARCH	Neuromethods		English	Article; Book Chapter						Traumatic brain injury; Preclinical; Experimental design; Sample size; Statistical analysis		There is a crisis in preclinical research involving laboratory animals. Too many experiments, in all disciplines, have been found to give results which turn out to be irreproducible. And, unfortunately, the results of clinical trials of potential treatments of traumatic brain injury (TBI), suggested by extensive animal research, have so far been disappointing. Faulty experimental design could be one of several possible causes. This chapter briefly covers the basic principles of experimental design, with emphasis on completely randomized, randomized block (cohort), and factorial designs. The determination of sample size is discussed together with some aspects of the statistical analysis and presentation of the results. The Standardized Effect Size (Cohen's d) is introduced as a description of the magnitude of a response.	[Festing, Michael F. W.] Univ Leicester, Med Res Toxicol Unit, Leicester, Leics, England		Festing, MFW (corresponding author), Univ Leicester, Med Res Toxicol Unit, Leicester, Leics, England.						Bebarta V, 2003, ACAD EMERG MED, V10, P684, DOI 10.1197/aemj.10.6.684; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Cohen J., 2013, STAT POWER ANAL BEHA; Cumming G, 2012, UNDERSTANDING NEW ST, P2012; Ellis PD, 2010, ESSENTIAL GUIDE TO EFFECT SIZES: STATISTICAL POWER, META-ANALYSIS AND THE INTERPRETATION OF RESEARCH RESULTS, P1; FESTING M, 1972, NATURE, V238, P351, DOI 10.1038/238351a0; Festing M., 2016, DESIGN ANIMAL EXPT; Festing MFW, 2016, METHODS MOL BIOL, V1438, P1, DOI 10.1007/978-1-4939-3661-8_1; Festing MFW, 2014, TOXICOL PATHOL, V42, P1238, DOI 10.1177/0192623313517771; Fisher R. A., 1960, DESIGN EXPT; Freedman LP, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002165; Hill AB, 1967, PRINCIPLES MED STAT; Jin HB, 2016, MED SCI MONITOR, V22, P678, DOI 10.12659/MSM.897201; Kilkenny C, 2010, LAB ANIM-UK, V44, P377, DOI 10.1258/la.2010.0010021; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]; Lin YP, 2015, NEURAL REGEN RES, V10, P1088, DOI 10.4103/1673-5374.160100; Mead R, 1988, DESIGN EXPT; Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1; Reid N., 2000, THEORY DESIGN EXPT; Russell W. M. S., 1959, PRINCIPLES HUMANE EX; SCHWARTZ WJ, 1990, J NEUROSCI, V10, P3685; Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Teng SX, 2015, BRAIN BEHAV IMMUN, V45, P145, DOI 10.1016/j.bbi.2014.11.006; Zhang CC, 2015, MOL MED REP, V12, P7351, DOI 10.3892/mmr.2015.4372	26	1	1	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	0893-2336	1940-6045	978-1-4939-8564-7; 978-1-4939-8563-0	NEUROMETHODS	Neuromethods		2018	139						201	225		10.1007/978-1-4939-8564-7_13	10.1007/978-1-4939-8564-7		25	Cell Biology; Neurosciences	Book Citation Index – Science (BKCI-S)	Cell Biology; Neurosciences & Neurology	BL5CO	WOS:000451267100015					2022-02-06	
J	Fotakopoulos, G; Makris, D; Tsianaka, E; Kotlia, P; Karakitsios, P; Gatos, C; Tzannis, A; Fountas, K				Fotakopoulos, George; Makris, Demosthenes; Tsianaka, Eleni; Kotlia, Polikceni; Karakitsios, Paulos; Gatos, Charalabos; Tzannis, Alkiviadis; Fountas, Kostas			The value of the identification of predisposing factors for post-traumatic amnesia in management of mild traumatic brain injury	BRAIN INJURY			English	Article						Post-traumatic amnesia; mild traumatic brain injury; management of traumatic brain injury	MINOR HEAD-INJURY; WESTMEAD PTA SCALE; COGNITIVE IMPAIRMENT; RECOVERY; CONCUSSION; SYMPTOMS; AGE; CONSCIOUSNESS; INFORMATION; PREDICTION	Object: To identify the risk factors for post-traumatic amnesia (PTA) and to document the incidence of PTA after mild traumatic brain injuries.Methods: This was a prospective study, affecting mild TBI (mTBI) (Glasgow Coma Scale 14-15) cases attending to the Emergency Department between January 2009 and April 2012 (40months duration). Patients were divided into two groups (Group A: without PTA, and Group B: with PTA, and they were assessed according to the risk factors.Results: A total of 1762 patients (males: 1002, 56.8%) were meeting study inclusion criteria [Group A: n=1678 (83.8%), Group B: n=84 (4.2%)]. Age, CT findings: (traumatic focal HCs in the frontal and temporal lobes or more diffuse punctate HCs, and skull base fractures), anticoagulation therapy and seizures were independent factors of PTA. There was no statistically significant correlation between PTA and sex, convexity fractures, stroke event, mechanism of mTBI (fall +/or beating), hypertension, coronary heart disease, chronic smokers and diabetes (p>0.005).Conclusion: CT findings: (traumatic focal HCs in the frontal and temporal lobes or more diffuse punctate HCs and skull base fractures), age, seizures and anticoagulation/antiplatelet therapy, were independent factors of PTA and could be used as predictive factors after mTBI.	[Fotakopoulos, George; Tsianaka, Eleni; Gatos, Charalabos; Tzannis, Alkiviadis; Fountas, Kostas] Univ Hosp Thessaly, Univ Hosp Larissa, Dept Neurosurg, Thessaly, Greece; [Makris, Demosthenes; Kotlia, Polikceni] Univ Hosp Larissa, Dept Head Crit Care, Larisa, Greece; [Karakitsios, Paulos] Publ Hlth Syst Palamas, Dept Gen Med, Palamas, Greece		Fotakopoulos, G (corresponding author), Univ Hosp Thessaly, Univ Hosp Larissa, Dept Neurosurg, Thessaly, Greece.	gfotakop@yahoo.gr	MAKRIS, DEMOSTHENES/J-5953-2015	MAKRIS, DEMOSTHENES/0000-0003-1951-6421; fotakopoulos, george/0000-0002-2491-2886			Ahmed S, 2000, BRAIN INJURY, V14, P765; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; American Psychiatric Association, 1994, AM PSYCHIAT ASS DIAG; Arciniegas DB, 2010, PSYCHIAT ANN, V40, P540, DOI 10.3928/00485713-20101022-05; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Cappa KA, 2011, HEALTH PSYCHOL, V30, P542, DOI 10.1037/a0025220; Centers for Disease Control and Prevention, 2014, C TRAUM BRAIN INJ US; Charidimou A, 2016, NEUROLOGY, V86, P505, DOI 10.1212/WNL.0000000000002362; Chermann JF, 2014, ASIAN J SPORTS MED, V5; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; De Simoni S, 2016, BRAIN, V139, P3137, DOI 10.1093/brain/aww241; Dufouil C, 2005, CIRCULATION, V112, P1644, DOI 10.1161/CIRCULATIONAHA.104.501163; Faux S, 2011, BRAIN INJURY, V25, P14, DOI 10.3109/02699052.2010.531686; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Silva SCFE, 2012, REV ESC ENFERM USP, V46, P30, DOI 10.1590/S0080-62342012000700005; Ganti L, 2016, MILITARY MED RES, V3, DOI 10.1186/s40779-016-0091-4; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hayter C, 2016, APPL NEUROPSYCH-ADUL, V4, P1; Jagust W, 2005, ARCH NEUROL-CHICAGO, V62, P1545, DOI 10.1001/archneur.62.10.1545; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kerr J, 2007, EMERG MED J, V24, P330, DOI 10.1136/emj.2006.044230; Konigs M, 2012, J NEUROL NEUROSUR PS, V83, P1048, DOI 10.1136/jnnp-2012-302635; Kornbluth J, 2011, NEUROCRIT CARE, V14, P134, DOI 10.1007/s12028-010-9409-3; Kume T, 2017, TURK PSIKIYATR DERG, V28, P198, DOI 10.5080/u22644; Laloux P, 2004, ACTA NEUROL BELG, V104, P13; Lorberboym M, 2002, AM J EMERG MED, V20, P310, DOI 10.1053/ajem.2002.34201; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Marr A., 2004, CENTRAL NERVOUS SYST; Meares S, 2011, BRAIN INJURY, V25, P1198, DOI 10.3109/02699052.2011.608213; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Metting Z, 2010, J NEUROTRAUM, V27, P2183, DOI 10.1089/neu.2010.1395; Mok VCT, 2009, J NEUROL, V256, P750, DOI 10.1007/s00415-009-5008-7; Okroglic S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053455; Peachey T, 2011, EMERG MED J, V28, P707, DOI 10.1136/emj.2010.093872; Ponsford J, 2004, BRAIN INJURY, V18, P603, DOI 10.1080/02699050310001646152; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Potapov A A, 2016, Zh Vopr Neirokhir Im N N Burdenko, V80, P93, DOI 10.17116/neiro201680293-101; RUSSELL WR, 1946, BRAIN, V69, P280, DOI 10.1093/brain/69.4.280; Sachdev PS, 2015, HARVARD REV PSYCHIAT, V23, P320, DOI 10.1097/HRP.0000000000000090; Sharp David J, 1800, Pract Neurol, V15, P172, DOI 10.1136/practneurol-2015-001087; Shores EA, 2008, J NEUROL NEUROSUR PS, V79, P1100, DOI 10.1136/jnnp.2007.132571; Shores EA, 2006, J INT NEUROPSYCHOL S; Smits M, 2007, J NEUROL NEUROSUR PS, V78, P1359, DOI 10.1136/jnnp.2007.117143; Stein SC, 2001, J TRAUMA, V50, P759, DOI 10.1097/00005373-200104000-00032; Stewart R, 1999, DIABETIC MED, V16, P93, DOI 10.1046/j.1464-5491.1999.00027.x; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Swainson R, 2001, DEMENT GERIATR COGN, V12, P265, DOI 10.1159/000051269; Tate RL, 2005, POSTTRAUMATIC AMNESI; TEASDALE G, 1974, LANCET, V2, P81; Terwilliger VK, 2016, J NEUROTRAUM, V33, P761, DOI 10.1089/neu.2015.4082; van der Naalt J, 2001, J CLIN EXP NEUROPSYC, V23, P837, DOI 10.1076/jcen.23.6.837.1018; Wade D, 2014, ALCOHOL CLIN EXP RES, V38, P294, DOI 10.1111/acer.12247; Warden DL, 2005, J NEUROTRAUM, V22, P1178	56	1	1	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	5					563	568		10.1080/02699052.2018.1432075			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FY7WL	WOS:000427074200006	29400569				2022-02-06	
J	Gaines, KD; Soper, HV				Gaines, K. Drorit; Soper, Henry V.			Neuropsychological assessment of executive functions following pediatric traumatic brain injury	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						Concussion; development; executive; neuropsychology; pediatric	MILD; TRAIL; NETWORKS; CIRCUITS; DISORDER; CHILDREN; OUTCOMES; LESIONS	Assessment of executive functions in the adult is best captured at the stage where full maturation of brain development occurs. Assessment of executive functions of children, however, is considerably more complicated. First, assessment of executive functioning in children represents a snapshot of these developing functions at a particular time linked stage, which may have implications for further development. Second, neuropsychological measures available to assess executive functions in children are limited in number and scope and may not be sensitive to the gradual developmental changes. The present article provides an overview of the salient neurodevelopmental stages of executive functioning and discusses the utilization of recently developed neuropsychological measures to assess these stages. Comments on clinical implications of these findings regarding Traumatic Brain Injury will be provided.	[Gaines, K. Drorit] Vet Affairs Greater Los Angeles Nucl Med, Los Angeles, CA USA; [Gaines, K. Drorit] Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90024 USA; [Soper, Henry V.] Fielding Grad Univ, Clin Psychol, Santa Barbara, CA USA		Gaines, KD (corresponding author), 8383 Wilshire Blvd,St 800, Beverly Hills, CA 90211 USA.	drdgaines@gmail.com					ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Axelrod Bradley N, 1992, Clin Neuropsychol, V6, P143, DOI 10.1080/13854049208401851; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Baron I. S., 2004, PRESS; Baron IS, 2012, CHILD NEUROPSYCHOL, V18, P586, DOI 10.1080/09297049.2011.631906; Bazarian JJ, 2006, ACAD EMERG MED, V13, P199, DOI 10.1197/j.aem.2005.07.031; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; BENTON AL, 1968, NEUROPSYCHOLOGIA, V6, P53, DOI 10.1016/0028-3932(68)90038-9; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Bolter J. F., 1985, NEUROPSYCHOLOGY INDI, P41; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Cole MW, 2013, NAT NEUROSCI, V16, P1348, DOI 10.1038/nn.3470; Cromwell HC, 2011, NEUROSCI BIOBEHAV R, V35, P2026, DOI 10.1016/j.neubiorev.2011.02.008; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; ESTES WK, 1974, AM PSYCHOL, V29, P740, DOI 10.1037/h0037458; Fletcher-Janzen E., 1989, HDB CLIN CHILD NEURO, P17, DOI 10.1007/978-1-4899-6807-4_2; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Goldman P. S., 1973, PLASTICITY AND RECOV, P149; Granacher Jr R. P., 2008, TRAUMATIC BRAIN INJU; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; Hamsher K, 1989, AJA; Hartikainen K., 2003, DETECTION CHANGE EVE, P99, DOI DOI 10.1007/978-1-4615-0294-4; Hartlage L. C., 1986, SPRINGER, P441; Hartlage L. C., 1975, PEDIAT PSYCHOL, V3, P23; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Heaton R.K., 1981, WISCONSIN CARD SORTI; Heaton RK, 1991, COMPREHENSIVE NORMS; Horton AM, 1987, NEUROPSYCHOLOGY, V1, P39, DOI 10.1037//0894-4105.1.2.39; Horton Jr A. M., 1986, CHILD NEUROPSYCHOL, VII, P299; Horton  Jr A. M., 1994, BEHAVIORAL INTERVENT; HYND GW, 1988, PEDIATRIC NEUROPSYCH; HYND GW, 1981, NEUROPSYCHOLOGICAL A; Khundrakpam BS, 2013, CEREB CORTEX, V23, P2072, DOI 10.1093/cercor/bhs187; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Knight RT, 2003, IS CL CO NE, P259; Konigs M, 2015, PEDIATRICS, V136, P534, DOI 10.1542/peds.2015-0437; Korkman M., 2007, NEPSY II; Koziol L. F., 2014, THE MYTH OF EXECUTIV; Koziol LF, 2013, APPL NEUROPSYCH-CHIL, V2, P141, DOI 10.1080/21622965.2013.748390; Koziol LF, 2012, CEREBELLUM, V11, P505, DOI 10.1007/s12311-011-0321-y; Koziol LF, 2010, CEREBELLUM, V9, P499, DOI 10.1007/s12311-010-0192-7; Krasnegor N.A., 1996, ATTENTION MEMORY EXE; Lezak M. D., 2004, PRESS; Lezak M. D., 1995, PRESS; Luria A.R., 1966, HIGHER CORTICAL FUNC; Luria A.R., 1980, HIGHER CORTICAL FUNC, V2d; Luria A. R, 1973, BASIC BOOKS; Luria A. R., 1963, MACMILLAN; Luria A. R., 1969, ENGLAND; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Margulies S. S., 2010, PEDIATRIC TRAUMATIC; Mars R. B., 2011, MIT PRESS; Max JE, 2000, J INT NEUROPSYCH SOC, V6, P279, DOI 10.1017/S1355617700633039; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Menon V, 2013, TRENDS COGN SCI, V17, P627, DOI 10.1016/j.tics.2013.09.015; Mesulam M. M., 2000, PRESS, pxviii; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; Meyers J. E., 1995, INC; MILNER B, 1963, ARCHIVES OF NEUROLOG; Mitrushina M., 1999, PRESS; Munson S, 2006, PEDIATRICS, V117, P1372, DOI 10.1542/peds.2005-0826; Njiokiktjien C., 2010, BRAIN LESION LOCALIZ, P157; Patay Z, 2014, CEREBELLUM, V13, P580, DOI 10.1007/s12311-014-0575-2; PERECMAN E, 1987, FRONTAL LOBES REVISI, P1; Picton TW, 2007, CEREB CORTEX, V17, P826, DOI 10.1093/cercor/bhk031; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Reitan R., 1993, PRESS; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Reitan R. M., 1992, NEUROPSYCHOLOGICAL E; Reitan R.M., 1974, CLIN NEUROPSYCHOLOGY; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Reitan RM, 2004, ARCH CLIN NEUROPSYCH, V19, P281, DOI 10.1016/S0887-6177(03)00042-8; Reynolds C, 1989, PROFESSIONAL MANUAL; Reynolds C. R, 2006, TEST OF VERBAL CONCE; Reynolds C. R., 2003, COMPREHENSIVE TRAIL; Reynolds C. R, 2008, SPRINGER, P69; Reynolds C. R., 1981, NEUROPSYCHOLOGICAL A, P87; Romine CB, 2005, APPL NEUROPSYCHOL, V12, P190, DOI 10.1207/s15324826an1204_2; ROSEN W G, 1980, Journal of Clinical Neuropsychology, V2, P135, DOI 10.1080/01688638008403788; Roth R. M, 2008, SPRINGER, P217; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Shaheen S, 2013, APPL NEUROPSYCH-CHIL, V2, P116, DOI 10.1080/21622965.2013.792668; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Soper H. V, 2008, NEUROPSYCHOLOGY HDB, P681; Spreen O, 1995, INC; STORANDT M, 1984, ARCH NEUROL-CHICAGO, V41, P497, DOI 10.1001/archneur.1984.04050170043013; Stuss DT, 2001, PSYCHOL ASSESSMENT, V13, P230, DOI 10.1037//1040-3590.13.2.230; TEUBER H, 1962, Dev Med Child Neurol, V4, P3; UDDIN LQ, 2010, FRONT SYST NEUROSCI, V4; Unsworth N, 2009, J INDIVID DIFFER, V30, P194, DOI 10.1027/1614-0001.30.4.194; Wedding D., 2008, SPRINGER, P3; Wiley CA, 2016, J NEUROTRAUM, V33, P1866, DOI 10.1089/neu.2015.4272; Yeates K. O., 2010, PEDIATRIC TRAUMATIC; Yeates Keith Owen, 2005, Pediatr Rehabil, V8, P5; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003; Zaytseva Y, 2015, PHILOS ETHICS HUM ME, V10, DOI 10.1186/s13010-015-0026-9; Zillmer E, 2001, PRINCIPLES OF NEUROP; [No title captured]	102	1	1	0	6	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child		2018	7	1					31	43		10.1080/21622965.2016.1229406			13	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	GE0RZ	WOS:000430924700004	27676192				2022-02-06	
J	Gelernter, R; Weiser, G; Kozer, E				Gelernter, Renana; Weiser, Giora; Kozer, Eran			Computed tomography findings in young children with minor head injury presenting to the emergency department greater than 24 h post injury	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Emergency department; Pediatrics; Traumatic brain injury; Computer tomography	RADIATION-EXPOSURE; RETROSPECTIVE COHORT; PEDIATRIC CT; CANCER; RISK	Background: Large studies which developed decision rules for the use of Computed tomography (CT) in children with minor head trauma excluded children with late presentation (more than 24 h). Objective: To assess the prevalence of significant traumatic brain injury (TBI) on CT in infants with head trauma presenting to the emergency department (ED) more than 24 h from the injury. Methods: A retrospective chart review of infants less than 24 months old referred for head CT because of traumatic brain injury from January 2004 to December 2014 in Assaf-Harofeh medical center was conducted. We used the PECARN definitions of TBI on CT to define significant CT findings. Results: 344 cases were analyzed, 68 with late presentation. There was no significant difference in the age between children with late and early presentation (mean 11.4 (SD 5.6) month vs 10. 5 (SD 7.0) month, P = 0.27). There was no significant difference between the groups in the incidence of significant TBI (22% vs 19%, p = 0.61). Any TBI on CT (e.g. fracture) was found in 43 (63%) patients with late presentation compared with 116 (42%) patients with early presentation (p = 0.002, OR 2.37, 95% CI 1.37-4.1). Conclusion: A similar rate of CT-identified traumatic brain injury was detected in both groups. There was no significant difference in the incidence of significant TBI on CT between the groups. Young children presenting to the ED more than 24 hours after the injury may have abnormal findings on CT. (c) 2017 Elsevier Ltd. All rights reserved.	[Gelernter, Renana; Kozer, Eran] Assaf Harofeh Med Ctr, Pediat Emergency Unit, Beer Yaagov, Israel; [Weiser, Giora] Shaare Zedek Med Ctr, Pediat Emergency Unit, Jerusalem, Israel; [Kozer, Eran] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel		Gelernter, R (corresponding author), Assaf Harofeh Med Ctr, Pediat Emergency Unit, Beer Yaagov, Israel.	grenana@gmail.co.il					Barrow A, 2012, EMERG MED J, V29, P983, DOI 10.1136/emermed-2011-200523; Borczuk P, 1997, ACAD EMERG MED, V4, P410; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2002, PEDIATR RADIOL, V32, P228, DOI 10.1007/s00247-002-0671-1; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Centers for Disease Control and Prevention, TRAUMATIC BRAIN INJU; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Hamilton M, 2010, PEDIATRICS, V126, pE33, DOI 10.1542/peds.2009-0692; Hemphill RR, 1999, ACAD EMERG MED, V6, P957, DOI 10.1111/j.1553-2712.1999.tb01248.x; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Kuppermann N, 2008, PEDIATR RADIOL, V38, pS670, DOI 10.1007/s00247-008-0996-5; Mandera M, 2000, CHILD NERV SYST, V16, P156, DOI 10.1007/s003810050484; Marincowitz C, 2016, EMERG MED J, V33, P538, DOI 10.1136/emermed-2015-205370; Marincowitz C, 2015, SYST REV-LONDON, V4, DOI 10.1186/s13643-015-0154-8; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Schunk JE, 1996, PEDIATR EMERG CARE, V12, P160, DOI 10.1097/00006565-199606000-00004; Sellin JN, 2017, CHILDS NERV SYST; VOSS M, 1995, BRIT MED J, V311, P1395, DOI 10.1136/bmj.311.7017.1395	20	1	1	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JAN	2018	49	1					82	85		10.1016/j.injury.2017.09.012			4	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	FS9VT	WOS:000422767800013	28923560				2022-02-06	
J	Geurten, M; Majerus, S; Lejeune, C; Catale, C				Geurten, Marie; Majerus, Steve; Lejeune, Caroline; Catale, Corinne			Questionnaire of Memory (Q-MEM): A new measure of everyday memory functioning in school-age children	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						Children; memory; psychometric properties	TRAUMATIC BRAIN-INJURY; INVENTORY CHEXI; ADHD; VALIDITY	We present a new measure of everyday memory, the Questionnaire of Memory (Q-MEM), which is specifically adapted for the ecological assessment of memory disorders in school-age children and constructed with four sections tapping effortful/intentional learning, automatic/procedural learning, prospective memory/organization, and working memory. Confirmatory Factor Analyses supported the Q-MEM's four-factor structure in 700 five-to twelve-year-old children. The analyses also revealed a good internal reliability and a good test-retest fidelity. Finally, comparisons between Q-MEM profiles of children with learning disabilities and typically developing children revealed significant differences. Therefore, the Q-MEM is a promising measure for identifying memory problems in children.	[Geurten, Marie] Univ Liege, Psychol & Neurosci Cognit Unit, Liege, Belgium; [Geurten, Marie; Majerus, Steve] Univ Aix Marseille, Dept Psychol, Marseille, France; [Lejeune, Caroline; Catale, Corinne] Univ Liege, Psychol & Speech Therapy Consultat Ctr CPLU, Liege, Belgium		Geurten, M (corresponding author), Univ Liege, Neuropsychol Unit, Dept Psychol, Trifac Pl Orateurs 1, B-4000 Liege, Belgium.	mgeurten@ulg.ac.be		Majerus, Steve/0000-0002-8206-8097; Geurten, Marie/0000-0003-3743-5246	National Fund for Scientific Research (NFSR); Marie Sklodowska-Curie; regional, national and international programmes	This work was supported by a Grant from the National Fund for Scientific Research (NFSR) to S. Majerus and by a Grant from the Marie Sklodowska-Curie Co-funding of regional, national and international programmes to M. Geurten.	Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Alloway T.P., 2008, WORKING MEMORY RATIN; Alloway TP, 2009, LEARN INDIVID DIFFER, V19, P242, DOI 10.1016/j.lindif.2008.10.003; Alloway TP, 2009, CHILD PSYCHIAT HUM D, V40, P353, DOI 10.1007/s10578-009-0131-3; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Catale C, 2014, EUR REV APPL PSYCHOL, V64, P221, DOI 10.1016/j.erap.2014.07.001; Catale C, 2015, J ATTEN DISORD, V19, P489, DOI 10.1177/1087054712470971; CONNERS CK, 1970, CHILD DEV, V41, P667, DOI 10.2307/1127215; Conners CK, 1998, J ABNORM CHILD PSYCH, V26, P279, DOI 10.1023/A:1022606501530; Cowan N., 1995, ATTENTION MEMORY INT; Drysdale K, 2004, CHILD NEUROPSYCHOL, V10, P67, DOI 10.1080/09297040490911087; Geurten M, 2016, CLIN NEUROPSYCHOL, V30, P558, DOI 10.1080/13854046.2016.1178331; Gioia G. A., 2003, BEHAV RATING INVENTO; Gonzalez LM, 2008, J INT NEUROPSYCH SOC, V14, P337, DOI 10.1017/S135561770808020X; Hedges R, 2015, APPL NEUROPSYCH-CHIL, V4, P285, DOI 10.1080/21622965.2014.925806; HERRMANN DJ, 1982, PSYCHOL BULL, V92, P434, DOI 10.1037/0033-2909.92.2.434; Joreskog KG., 2006, LISREL 8 80 WINDOWS; Kadesjo B, 2004, EUR CHILD ADOLES PSY, V13, P3, DOI 10.1007/s00787-004-3002-2; Kerns KA, 2001, CHILD NEUROPSYCHOL, V7, P162, DOI 10.1076/chin.7.3.162.8744; Kliegel M, 2007, COGNITIVE DEV, V22, P33, DOI 10.1016/j.cogdev.2006.08.003; Kline R. B., 2005, PRINCIPLES PRACTICES; Levick WR, 2010, BRAIN IMPAIR, V11, P144, DOI 10.1375/brim.11.2.144; Skowronek J. S., 2008, LEARN DISABIL RES PR, V23, P25, DOI [10.1111/j.1540-5826.2007.00260.x, DOI 10.1111/J.1540-5826.2007.00260.X]; Thorell LB, 2008, DEV NEUROPSYCHOL, V33, P536, DOI 10.1080/87565640802101516; Thorell LB, 2010, J CLIN EXP NEUROPSYC, V32, P38, DOI 10.1080/13803390902806527; Tulving Endel, 1995, P839; Vriezen E. R., 1996, J INT NEUROPSYCH SOC, V2, P40; Ward H, 2002, J CLIN EXP NEUROPSYC, V24, P458, DOI 10.1076/jcen.24.4.458.1032; Ward H, 2007, CHILD NEUROPSYCHOL, V13, P219, DOI 10.1080/09297040600910003; Wechsler D, 2005, WECHSLER INTELLIGENC	30	1	1	0	6	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child		2018	7	1					44	51		10.1080/21622965.2016.1239201			8	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	GE0RZ	WOS:000430924700005	27726446				2022-02-06	
J	Greene, D; Sample, PL; Johns, N; Palmer, M				Greene, David; Sample, Pat L.; Johns, Nicole; Palmer, Maureen			Readiness to recognize: A qualitative case study of educational identification of TBI	NEUROREHABILITATION			English	Article						Educational identification; traumatic brain injury (TBI); special education	TRAUMATIC BRAIN-INJURY; ADOLESCENTS; STUDENTS; CHILDREN	BACKGROUND: The educational identification (ED-ID) of students with traumatic brain injury (TBI) has been legislated in numerous states, and TBI has become its own special education category. Questions abound as to whether these changes will lead to more readily identifying these students to provide appropriate special education supports. OBJECTIVE: Elucidate one state's response to legislative changes around ED-ID of TBI. METHODS: This is a phenomenological case study of nine school districts in one state. Researchers conducted focus groups as well as individual interviews with various special education staff. On-going analysis of the focus group and interview data occurred, until themes were finalized. RESULTS: Reactions of staff comprised two opposing viewpoints: those supporting and carrying out ED-ID ("Toward ED-ID") and those describing processes and attitudes that stand in the way ("Barriers"). Themes that were supportive of ED-ID include Credible History, Personnel, Targeted Intervention, Effective Communication, and Education. Themes aligned with the barrier viewpoint include Concussion Protocols, Medical Nature, Misidentification, Stigma, and Communication Breakdown. CONCLUSION: While many districts reported success with ED-ID for TBI, responses to the ED-ID legislation and TBI category were mixed, with enough barriers identified to cause concern over whether the legislative and policy changes have been overall beneficial.	[Greene, David; Sample, Pat L.; Johns, Nicole; Palmer, Maureen] Colorado State Univ, Dept Occupat Therapy, Ft Collins, CO 80523 USA		Greene, D (corresponding author), Colorado State Univ, Dept Occupat Therapy, Ft Collins, CO 80523 USA.	david.greene@colostate.edu			Colorado Traumatic Brain Injury Trust Fund Research Program	This work was funded by the Colorado Traumatic Brain Injury Trust Fund Research Program. For information, please point your browser to: http://tbicolorado.org/.	Blosser JL, 1991, J HEAD TRAUMA REHAB, V6, P73; Creswell J. W., 2016, QUAL INQ; Creswell JW, 2007, COUNS PSYCHOL, V35, P236, DOI 10.1177/0011000006287390; DePompei R, 1998, NEUROREHABILITATION, V11, P85, DOI 10.1016/S1053-8135(98)00013-4; DePompei R, 2008, J HEAD TRAUMA REHAB, V23, P191, DOI 10.1097/01.HTR.0000327251.16010.3b; Dettmer J, 2014, J HEAD TRAUMA REHAB, V29, P224, DOI 10.1097/HTR.0b013e3182a1cd68; Glang A, 2015, EXCEPTIONALITY, V23, P211, DOI 10.1080/09362835.2014.986612; Glang A, 2010, J HEAD TRAUMA REHAB, V25, P426, DOI 10.1097/HTR.0b013e3181fb8f45; Guttormsen E., 2014, THESIS; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Mathias K., 2015, THESIS; McCaleb K. N., 2006, PHYS DISABILITIES ED, V25, P61; Savin- Baden M., 2013, QUALITATIVE RES ESSE, P226; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Turkstra LS, 2008, NEUROREHABILITATION, V23, P501; U. S. Department of Education Individuals with Disabilities Education Act (IDEA) Data Center, 2014, TREND DAT TABL B3A B; US Department of Education National Center for Education Statistics, 2016, 2016014 NCES US DEP; Ylvisaker M, 1991, J HEAD TRAUMA REHAB, V6, P10, DOI DOI 10.1097/00001199-199103000-00006	19	1	1	0	0	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2018	42	3					277	288		10.3233/NRE-172382			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GE2RW	WOS:000431063300004	29660963				2022-02-06	
J	Gu, ZX; Jiang, Y; Zhou, M; Gu, M; Song, XY; Sha, L				Gu, Zuxing; Jiang, Yu; Zhou, Min; Gu, Ming; Song, Xiaoyu; Sha, Lui			A Cyber-Physical System Framework for Early Detection of Paroxysmal Diseases	IEEE ACCESS			English	Article						Cyber-physical system; early detection; knowledge model; paroxysmal disease	TRAUMATIC BRAIN-INJURY; SYMPATHETIC HYPERACTIVITY; AUTONOMIC INSTABILITY; MANAGEMENT; DYSAUTONOMIA; DIAGNOSIS; CONSENSUS	Paroxysmal diseases of inpatients are globally recognized as one of the top challenges in medicine. Poor clinical outcomes are primarily caused by delayed recognition, especially due to diverse clinical diagnostic criteria with complex manifestations, irregular episodes, and already overloaded clinical activities. With the proliferation of measuring devices and increased computational capabilities, cyber-physical characterization plays an increasingly important role in many domains to provide enabling technologies. This paper presents a cyber-physical system (CPS) framework to assist physicians in making earlier diagnoses of paroxysmal sympathetic hyperactivity based on existing medical knowledge. We propose a configurable diagnostic knowledge model to characterize clinical criteria to reduce domain knowledge deficiency between physicians and computer scientists. We present a component-based medical CPS framework to employ the knowledge models and integrate medical devices. Our approach aims to relieve medical staff from the heavy burden of clinical activities and to provide timely decision support. We evaluate our approach on 128 realworld clinical cases. Compared with the state-of-the-art approach, the results demonstrate that we enable early detection in 11.02% more patients and detect the condition 16.57 hours earlier on average.	[Gu, Zuxing; Jiang, Yu; Zhou, Min; Gu, Ming] Tsinghua Univ, Sch Software, Beijing 100084, Peoples R China; [Song, Xiaoyu] Portland State Univ, Dept Elect & Comp Engn, Portland, OR 97207 USA; [Sha, Lui] Univ Illinois, Dept Comp Sci, Champaign, IL 61820 USA		Gu, ZX (corresponding author), Tsinghua Univ, Sch Software, Beijing 100084, Peoples R China.	guzx14@mails.tsinghua.edu.cn			NSFCNational Natural Science Foundation of China (NSFC) [61527812]; National Science and Technology Major Project [2016ZX01038101]	This work was supported in part by the NSFC Program under Grant 61527812 and in part by the National Science and Technology Major Project under Grant 2016ZX01038101.	Akcil EF, 2015, TURK J ANAESTHESIOL, V43, P297, DOI 10.5152/TJAR.2015.82957; Baguley IJ, 2007, BRAIN INJURY, V21, P1175, DOI 10.1080/02699050701687375; Baguley IJ, 2007, J NEUROL NEUROSUR PS, V78, P539, DOI 10.1136/jnnp.2006.096388; Baguley IJ, 2014, J NEUROTRAUM, V31, P1515, DOI 10.1089/neu.2013.3301; Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; Benson M, 2000, J CLIN MONIT COMPUT, V16, P211, DOI 10.1023/A:1009977917319; Blackman JA, 2004, ARCH NEUROL-CHICAGO, V61, P321, DOI 10.1001/archneur.61.3.321; Caldwell SB, 2014, BRAIN INJURY, V28, P370, DOI 10.3109/02699052.2013.865265; Deepika A, 2015, AUTON NEUROSCI-BASIC, V193, P149, DOI 10.1016/j.autneu.2015.08.003; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Fernandez-Ortega JF, 2012, J NEUROTRAUM, V29, P1364, DOI 10.1089/neu.2011.2033; Goddeau RP, 2007, NEUROCRIT CARE, V7, P217, DOI 10.1007/s12028-007-0066-0; Godo S, 2017, TOHOKU J EXP MED, V243, P11, DOI 10.1620/tjem.243.11; Gu Y, 2015, SIGNAL PROCESS, V106, P294, DOI 10.1016/j.sigpro.2014.08.011; Gu ZX, 2016, IEEE INT C BIOINFORM, P818, DOI 10.1109/BIBM.2016.7822630; Haque SA, 2014, INT J DISTRIB SENS N, DOI 10.1155/2014/217415; Hopcroft J.E., 2001, INTRO AUTOMATA THEOR; Hughes JD, 2014, NEUROCRIT CARE, V20, P454, DOI 10.1007/s12028-013-9877-3; Jiang Y, 2016, 2016 IEEE/ACM 38TH INTERNATIONAL CONFERENCE ON SOFTWARE ENGINEERING COMPANION (ICSE-C), P112, DOI 10.1145/2889160.2889233; Larach MG, 2010, ANESTH ANALG, V110, P498, DOI 10.1213/ANE.0b013e3181c6b9b2; Lee, 2015, P ACM IEEE 6 INT C C, P110; Lee I, 2010, DES AUT CON, P743, DOI 10.1145/1837274.1837463; Lee S, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-1898-x; Levy ER, 2011, J PALLIAT MED, V14, P1355, DOI 10.1089/jpm.2010.0444; Li H, 2017, IEEE ACCESS, V5, P2665, DOI 10.1109/ACCESS.2017.2669438; Lv LQ, 2011, ARCH PHYS MED REHAB, V92, P1515, DOI 10.1016/j.apmr.2011.01.014; Nazif TM, 2012, EUROPACE, V14, P1188, DOI 10.1093/europace/eus014; Pahlavan K, 2015, IEEE ACCESS, V3, P2730, DOI 10.1109/ACCESS.2015.2508003; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; Shumway R. H, 2011, TIME SERIES ANAL ITS, P319; Sood SK, 2018, FUTURE GENER COMP SY, V88, P764, DOI 10.1016/j.future.2018.01.008; Tretmans Jan, 2008, Formal Methods and Testing. An Outcome of the FORTEST Network. Revised Selected Papers, P1, DOI 10.1007/978-3-540-78917-8_1; Umbriaco F, 2013, ADV EMERG NURS J, V35, P303, DOI 10.1097/TME.0b013e3182aa05a0; Voros A.N.S., 2015, CYBERPHYSICAL SYSTEM, P87; Voros N S, 2015, CYBERPHYSICAL SYSTEM; Zheng GL, 2015, IEEE ACCESS, V3, P825, DOI 10.1109/ACCESS.2015.2445336	37	1	1	0	3	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2169-3536			IEEE ACCESS	IEEE Access		2018	6						34834	34845		10.1109/ACCESS.2018.2850039			12	Computer Science, Information Systems; Engineering, Electrical & Electronic; Telecommunications	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Telecommunications	GN6RX	WOS:000439223300018		gold			2022-02-06	
J	Guthrie, R				Guthrie, Robert			Physical activity following acute concussion and persistent postconcussive symptoms in children and adolescents	PHYSICIAN AND SPORTSMEDICINE			English	Article						Post-concussion symptoms; brain concussion; post-concussion syndrome; cerebral concussion	CONSENSUS STATEMENT; SPORT; REST; EXERCISE	The management of concussion in pediatric patients has always been guided by treatment guidelines that have been drawn from consensus statements rather than clinical research projects. Grool and colleagues conducted a clinical research project on an early return to physical activity and its effect on post-concussion symptoms. The study enrolled 3063 pediatric patients, age 5.0 to 17.99 years of age who presented to one of nine Pediatric Emergency Research Centers in Canada. 2413 patients completed the primary outcome for exposure. A total of 1677 patients (69.5%) instituted some level of early physical activity, including light aerobic exercise (n = 795 or 32.9%), sport-specific exercise (n = 214 or 8.9%), non-contact drills (n = 143 or 5.9%), full-contact practice (n = 106 or 4.4%), or full competition (n = 419 or 17.4%), while 736 (30.5%) instituted no physical activity. Patients were evaluated by a web-based survey or a telephone-based survey at days 7 and 28 after their initial visit, and their symptoms were evaluated by using the Post Concussive Symptom Inventory (PCSI). Early return to physical activity was associated with a lower risk of Persistent Post-Concussive Syndrome (PPCS) than in patients reporting no physical activity at 28 days (24.6% vs. 43.5%, Absolute risk difference, (ARD), 18.9% (95% CI 14.7-23.0%). Among the sub-group of patients who were symptomatic at day 28 (n = 803), PPCS was more present in the patients that reported no physical activity, (n = 584: PPCS 52.9%), than those with light aerobic activity (n = 494 [46.4%; ARD, 6.5%; 95% CI 5.7-12.5%], moderate activity [n = 176 (38.6%; ARD, 14.3%; 95% CI 5.9%-22.2%], or full contact activity [n = 133 (36.1%; ARD, 16.8%; 95% CI 7.5%-25.5%]. Therefore, in patients aged 5 to 18 years with acute concussion, a return to physical activity within 7 days of acute injury was associated with less symptoms at 28 days than in patients who had a period of prolonged rest rather than an early return to physical activity.	[Guthrie, Robert] Ohio State Univ, Emergency Med, Dublin, OH USA		Guthrie, R (corresponding author), Ohio State Univ, Dublin, OH 43017 USA.	robertguthriemd@gmail.com					Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Buckley TA, 2016, J HEAD TRAUMA REHAB, V31, P233, DOI 10.1097/HTR.0000000000000165; Chrisman SPD, 2016, JAMA-J AM MED ASSOC, V316, P2491, DOI 10.1001/jama.2016.17562; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Gibson S, 2013, BRAIN INJURY, V27, P839, DOI 10.3109/02699052.2013.775494; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; McCrory P, 2017, BRIT J SPORT MED, V51, P1557, DOI 10.1136/bjsports-2017-098065; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Steinberg N, 2013, J HEAD TRAUMA REHAB, V28, P250; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966	17	1	1	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.		2018	46	4					416	419		10.1080/00913847.2018.1516479			4	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	HC7ZK	WOS:000452020500003	30142294				2022-02-06	
J	Han, F; Yan, N; Huo, JL; Chen, XY; Fei, Z; Li, X				Han, Feng; Yan, Nan; Huo, Junli; Chen, Xiaoyan; Fei, Zhou; Li, Xia			Asiatic acid attenuates traumatic brain injury via upregulating Nrf2 and HO-1 expression	INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE			English	Article						Asiatic acid; traumatic brain injury; Nrf2; HO-1	OXIDATIVE STRESS; HEME OXYGENASE-1; CEREBRAL-ISCHEMIA; UNITED-STATES; PATHWAY; RATS; INDUCTION	The neuroprotective role of asiatic acid (AA) against cerebral ischemia has been previously reported. However, whether AA attenuates traumatic brain injury (TBI) has not been investigated. The current study aims to evaluate the effect of AA and its underlying mechanisms. We first established TBI model in SD rats. Neurological score, brain water content, and cell apoptosis were evaluated. Oxidative stress was detected by assessing the levels of malondialdehyde (MDA), 4-hydroxy-2-nonenal (4-HNE), and 8-hydroxy-2-deoxyguanosine (8-OHdG) in the brain tissue of rats 24 h after brain injury. Finally, we evaluated the expression of Nrf2 and HO-1 using Western blot and Real-time quantitative PCR. Our results suggest that AA improved neurological dysfunction, decreased brain edema and neuronal apoptosis. In addition, AA attenuated oxidative stress after TBI. Notably, AA up-regulated the expression levels of Nrf2 and HO-1. In summary, our study suggests that AA confers neuroprotection against TBI via reducing oxidative stress and enhancing Nrf2 and HO-1 expression.	[Han, Feng; Huo, Junli; Chen, Xiaoyan; Fei, Zhou; Li, Xia] Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, 127 Changle West Rd, Xian 710032, Shaanxi, Peoples R China; [Yan, Nan] Fourth Mil Med Univ, Xijing Hosp, Dept Clin Lab, Xian, Shaanxi, Peoples R China		Fei, Z; Li, X (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, 127 Changle West Rd, Xian 710032, Shaanxi, Peoples R China.	fzh2016fmmu@sina.com; 59931-9033@qq.com					Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; Bruschetta Giuseppe, 2017, Front Neurosci, V11, P6, DOI 10.3389/fnins.2017.00006; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Cuadrado A, 2008, CURR PHARM DESIGN, V14, P429, DOI 10.2174/138161208783597407; Gao YY, 2017, AM J TRANSL RES, V9, P887; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Hashim P, 2011, MOLECULES, V16, P1310, DOI 10.3390/molecules16021310; Jiang W, 2016, LIFE SCI, V157, P45, DOI 10.1016/j.lfs.2016.05.004; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Lee KY, 2012, STROKE, V43, P1632, DOI 10.1161/STROKEAHA.111.639427; Li XK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160026; Li ZL, 2016, INFLAMMATION, V39, P1642, DOI 10.1007/s10753-016-0398-z; Ma ZG, 2016, INT J BIOL SCI, V12, P861, DOI 10.7150/ijbs.14213; O'Connell KM, 2013, BIOL RES NURS, V15, P253, DOI 10.1177/1099800411431823; Reichard JF, 2007, NUCLEIC ACIDS RES, V35, P7074, DOI 10.1093/nar/gkm638; Shen XF, 2013, INT J MOL SCI, V14, P21598, DOI 10.3390/ijms141121598; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Wang BD, 2016, BRAIN RES, V1643, P70, DOI 10.1016/j.brainres.2016.04.048; Witherell HL, 1998, CANCER EPIDEM BIOMAR, V7, P91; Yang YQ, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00580	23	1	1	0	2	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	1940-5901			INT J CLIN EXP MED	Int. J. Clin. Exp. Med.		2018	11	1					360	366					7	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	FU3WS	WOS:000423783500042					2022-02-06	
J	Hirsch, S; Belanger, HG; Levin, H; Eggleston, BS; Wilde, EA; McDonald, SD; Brearly, TW; Tate, DF				Hirsch, Shawn; Belanger, Heather G.; Levin, Harvey; Eggleston, Barry S.; Wilde, Elisabeth A.; McDonald, Scott D.; Brearly, Timothy W.; Tate, David F.			Exploring the factor structure of a battery of neuropsychological assessments among the CENC cohort	BRAIN INJURY			English	Article						Exploratory factor analysis; Neuropsychology; Traumatic brain injury; Cognition	TRAUMATIC BRAIN-INJURY; NIH TOOLBOX; PREFRONTAL CORTEX; COGNITIVE CONTROL; VALIDITY; METAANALYSIS; CONCUSSION; MEMORY	Objective: The goal of the Chronic Effects of Neurotrauma Consortium (CENC) study is to explore the effects of concussions among Service Members and Veterans. A factor model was fit to selected neuropsychological measures to identify potentially useful relationships between assessments collected on CENC-enrolled participants.Method: 492 post-9/11 participants with combat exposure were enrolled across four VA study sites. Participants completed assessments including concussion history, neurocognitive functioning, and self-report questionnaires. Exploratory factor analyses (EFA) using four different methods with varimax and promax rotations were used to analyse the cognitive variables. Final model selection was based on factor loadings towards simple structure.Results: The scree plot suggested the number of factors to be extracted was between 4 and 5. EFA produced a 5-factor MINRES model with promax rotation that resulted in a factor loading with variables loading on only one factor with a predefined threshold (0.40). Variables loaded on five cognition domains: list learning, working memory/executive skills, cognitive control, fluency, and memory.Conclusion: These results provide reasonable evidence that data collected from the CENC neuropsychological battery can be reduced to five clinically useful factors. This will enable us to use the factors for further study of the impact of concussion on neurodegeneration.	[Hirsch, Shawn; Eggleston, Barry S.] RTI Int, Res Triangle Pk, NC USA; [Belanger, Heather G.] James Haley VA Med Ctr, Tampa, FL USA; [Belanger, Heather G.] Univ S Florida, Tampa, FL USA; [Levin, Harvey; Wilde, Elisabeth A.] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Levin, Harvey; Wilde, Elisabeth A.] Baylor Coll Med, Houston, TX 77030 USA; [Wilde, Elisabeth A.] Univ Utah, Salt Lake City, UT USA; [McDonald, Scott D.] Hunter Holmes McGuire VA Med Ctr, Richmond, VA USA; [Brearly, Timothy W.] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA; [Brearly, Timothy W.] WG Bill Hefner VA Med Ctr, Salisbury, NC USA; [Tate, David F.] Univ Missouri, Missouri Inst Mental Hlth, St Louis, MO 63121 USA		Hirsch, S (corresponding author), RTI Int, 3040 East Cornwallis Rd, Res Triangle Pk, NC 27709 USA.	shirsch@rti.org	Brearly, Timothy/T-1739-2019; Tate, David F/I-3963-2013	Brearly, Timothy/0000-0002-6320-0654; Tate, David F/0000-0003-0213-1920; Hirsch, Shawn/0000-0001-6280-9559; Eggleston, Barry/0000-0003-0472-9707	Defense and Veterans Brain Injury Center, US Army Medical Research and Material Command (USAMRMC)	This material is based upon work supported with resources and the use of facilities at: Hunter Holmes McGuire Veterans Affairs Medical Center (VAMC) in Richmond, VA; James A. Haley Veterans Hospital (VH), Tampa, FL; Audie L. Murphy Memorial VH, San Antonio, TX; and Michael E. DeBakey VA Medical Center, Houston, TX and is based upon work supported in part by the Defense and Veterans Brain Injury Center, US Army Medical Research and Material Command (USAMRMC).	Alwin, 2008, HDB COGNITIVE AGING, P506, DOI [10.4135/9781412976589.n30, DOI 10.4135/9781412976589N30]; Barlas F. M., 2013, DEP DEFENSE HLTH REL; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Benedict R., 1997, BRIEF VISUOSPATIAL M; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; CATTELL RB, 1961, PSYCHOL BULL, V58, P160, DOI 10.1037/h0045221; Cole WR, 2018, ARCH CLIN NEUROPSYCH, V33, P102, DOI 10.1093/arclin/acx036; Cooper DB, 2018, J HEAD TRAUMA REHAB, V33, P81, DOI 10.1097/HTR.0000000000000375; CORRIGAN JD, 1987, J CLIN PSYCHOL, V43, P402, DOI 10.1002/1097-4679(198707)43:4<402::AID-JCLP2270430411>3.0.CO;2-E; Delis D.C., 1987, CVLT CALIFORNIA VERB; Delis DC., 2001, DELIS KAPLAN EXECUTI; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Gershon R., 2012, NIH TOOLBOX SCORING; Gershon RC, 2013, NEUROLOGY, V80, pS2, DOI 10.1212/WNL.0b013e3182872e5f; Harding IH, 2016, CEREB CORTEX, V26, P557, DOI 10.1093/cercor/bhu208; HENDRICKSON AE, 1964, BRIT J STATIST PSYCH, V17, P65, DOI 10.1111/j.2044-8317.1964.tb00244.x; Hicks R, 2013, J NEUROTRAUM, V30, P1852, DOI 10.1089/neu.2013.2938; Hodes RJ, 2013, NEUROLOGY, V80, pS1, DOI 10.1212/WNL.0b013e3182872e90; Horn J, 1965, RATIONALE TEST NUMBE; Howe L, 2009, CLIN NEUROPSYCHOL, V23, P329, DOI 10.1080/13854040801945060; Kuhn M., 2013, APPL PREDICTIVE MODE, V26; Lovstad M, 2012, BRAIN COGNITION, V80, P237, DOI 10.1016/j.bandc.2012.07.008; Mac Donald CL, 2017, JAMA NEUROL, V74, P821, DOI 10.1001/jamaneurol.2017.0143; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mungas D, 2014, J INT NEUROPSYCH SOC, V20, P579, DOI 10.1017/S1355617714000307; Raiche G., 2010, R Package Version, V2, P3; Rencher A. C., 1995, METHODS MULTIVARIATE; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Ross SA, 2013, APPL NEUROPSYCH-ADUL, V20, P120, DOI 10.1080/09084282.2012.690798; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Schwartz ES, 2016, J INT NEUROPSYCH SOC, V22, P851, DOI 10.1017/S1355617716000746; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Walker WC, 2016, BRAIN INJURY, V30, P1469, DOI 10.1080/02699052.2016.1219061; Wechsler D., 2008, WECHSLER ADULT INTEL; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded; Wilson RS, 2010, ARCH NEUROL-CHICAGO, V67, P855, DOI 10.1001/archneurol.2010.129	38	1	1	2	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	10			SI		1226	1235		10.1080/02699052.2018.1492738			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GS6YO	WOS:000443846200009	29985676				2022-02-06	
J	Johnson, CD; Williams, VJ; Heebner, NR; Wohleber, MF; Simonson, AJ; Rafferty, DM; Reinert, A; Sell, TC				Johnson, Caleb D.; Williams, Valerie J.; Heebner, Nicholas R.; Wohleber, Meleesa F.; Simonson, Andrew J.; Rafferty, Deirdre M.; Reinert, Andrew; Sell, Timothy C.			Relationship of performance on the sensory organization test to landing characteristics	JOURNAL OF SPORTS SCIENCES			English	Article						Postural stability; stop-jump; landing mechanics; sensory organization test; SOT	FUNCTIONAL JOINT STABILITY; CRUCIATE LIGAMENT INJURY; POSTURAL STABILITY; BIOMECHANICAL MEASURES; SENSORIMOTOR SYSTEM; ANKLE INSTABILITY; DROP JUMP; CONCUSSION; HEALTHY; PROPRIOCEPTION	Jump landing tasks have been used to assess landing characteristics and require significant sensorimotor feedback to maintain functional joint stability (FJS) throughout the task. Postural stability (PS) also requires significant sensorimotor feedback and control and would seemingly involve similar sensory feedback pathways. However, previous literature clarifying the relationship between these two processes, maintaining FJS and PS, is limited. 80 Special Tactics Operators. PS was assessed using the Sensory Organization Test (SOT). SOT variables included: Composite, Somatosensory, Visual, Vestibular, and Preference scores. Landing characteristics were assessed using motion analysis during a double-legged (DLSJ) and single-legged (SLSJ) stop jump task. Pearson's correlation coefficients were calculated to assess the relationship between SOT scores and landing characteristics (alpha < .05). For the DLSJ, significant correlations were found between: Composite and peak posterior ground reaction forces (-.257), Vestibular and peak knee abduction moment (-.237), and Preference and initial contact hip flexion (-.297), peak hip flexion (-.249). For the SLSJ, significant correlations were found between: Somatosensory and peak vertical ground reaction forces (-.246); Preference and initial contact hip flexion (-.295), peak hip flexion (-.262). The results indicate that the SOT may not be a sensitive enough tool to assess sensorimotor control in a healthy, athletic population.	[Johnson, Caleb D.; Williams, Valerie J.; Wohleber, Meleesa F.; Simonson, Andrew J.; Rafferty, Deirdre M.] Univ Pittsburgh, Neuromuscular Res Lab, Pittsburgh, PA USA; [Heebner, Nicholas R.] Univ Kentucky, Sports Sci Res Inst, Lexington, KY USA; [Reinert, Andrew] Air Force Special Operat Command, Off Command Surg, Hurlburt Field, FL USA; [Sell, Timothy C.] Duke Univ, Michael W Krzyzewski Human Performance Lab, Durham, NC USA		Johnson, CD (corresponding author), 3860 S Water St, Pittsburgh, PA 15213 USA.	cdj20@pitt.edu			711 HPW/RH [FA8650-12-2-6271]	This work was supported by the 711 HPW/RH [FA8650-12-2-6271].	Akbari Asghar, 2015, Glob J Health Sci, V8, P68, DOI 10.5539/gjhs.v8n4p68; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Chu YC, 2012, MIL MED, V177, P41, DOI 10.7205/MILMED-D-11-00134; Clark S, 2008, J ORTHOP SPORT PHYS, V38, P262, DOI 10.2519/jospt.2008.2406; Cohen J., 2013, STAT POWER ANAL BEHA; DAVIS RB, 1991, HUM MOVEMENT SCI, V10, P575, DOI 10.1016/0167-9457(91)90046-Z; Dickin DC, 2007, CLIN J SPORT MED, V17, P109, DOI 10.1097/JSM.0b013e31803bf647; Fransz DP, 2014, J BIOMECH, V47, P3248, DOI 10.1016/j.jbiomech.2014.06.019; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Heebner NR, 2015, GAIT POSTURE, V41, P535, DOI 10.1016/j.gaitpost.2014.12.009; Herman DC, 2017, SPORTS MED, V47, P1003, DOI 10.1007/s40279-016-0607-9; Hertel J, 2008, CLIN SPORT MED, V27, P353, DOI 10.1016/j.csm.2008.03.006; Hewett TE, 2005, AM J SPORT MED, V33, P492, DOI 10.1177/0363546504269591; Hirsch MA, 2003, ARCH PHYS MED REHAB, V84, P1109, DOI 10.1016/S0003-9993(03)00046-7; Horita T, 2002, EUR J APPL PHYSIOL, V88, P76, DOI 10.1007/s00421-002-0673-6; KADABA MP, 1990, J ORTHOP RES, V8, P383, DOI 10.1002/jor.1100080310; Lee AJY, 2008, CLIN BIOMECH, V23, P1065, DOI 10.1016/j.clinbiomech.2008.04.013; Lepers R, 1997, EUR J APPL PHYSIOL, V76, P55, DOI 10.1007/s004210050212; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Oberlander KD, 2012, J BIOMECH, V45, P1387, DOI 10.1016/j.jbiomech.2012.02.029; Patel AV, 2007, J ATHL TRAINING, V42, P66; Paterno MV, 2010, AM J SPORT MED, V38, P1968, DOI 10.1177/0363546510376053; Riemann BL, 2002, J ATHL TRAINING, V37, P71; Riemann BL, 2002, J ATHL TRAINING, V37, P80; Sell TC, 2012, PHYS THER SPORT, V13, P80, DOI 10.1016/j.ptsp.2011.06.006; Shumway-Cook A, 2001, MOTOR CONTROL THEORY, V2; Walden M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3042; WOLTRING HJ, 1986, ADV ENG SOFTW WORKST, V8, P104, DOI 10.1016/0141-1195(86)90098-7; Wrisley DM, 2007, ARCH PHYS MED REHAB, V88, P1049, DOI 10.1016/j.apmr.2007.05.003	29	1	1	0	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0264-0414	1466-447X		J SPORT SCI	J. Sports Sci.		2018	36	10					1155	1161		10.1080/02640414.2017.1363402			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	GB4RT	WOS:000429049100010	28777695				2022-02-06	
B	Johnson, LSM		Johnson, LSM; Rommelfanger, KS		Johnson, L. Syd M.			CHRONIC TRAUMATIC ENCEPHALOPATHY Ethical, Legal, and Social Implications	ROUTLEDGE HANDBOOK OF NEUROETHICS	Routledge Handbooks in Applied Ethics		English	Article; Book Chapter							BRAIN-INJURY; CONCUSSION; SPORT; LEAGUE; STATEMENT; ASSOCIATION; MANAGEMENT; REST		[Johnson, L. Syd M.] Michigan Technol Univ, Dept Humanities, Philosophy & Bioeth, Houghton, MI 49931 USA; [Johnson, L. Syd M.] Michigan Technol Univ, Dept Kinesiol & Integrat Physiol, Houghton, MI 49931 USA; [Johnson, L. Syd M.] Dalhousie Univ, Novel Tech Eth, Neuroeth, Halifax, NS, Canada		Johnson, LSM (corresponding author), Michigan Technol Univ, Dept Humanities, Philosophy & Bioeth, Houghton, MI 49931 USA.; Johnson, LSM (corresponding author), Michigan Technol Univ, Dept Kinesiol & Integrat Physiol, Houghton, MI 49931 USA.						Anderson AJ, 2000, PEDIATRICS, V105, P657, DOI 10.1542/peds.105.3.640; [Anonymous], 2016, BBC; Bailes Julian E, 2015, Neurosurgery, V62 Suppl 1, P15, DOI 10.1227/NEU.0000000000000811; Barr J., 2011, PAINKILLER USE TODAY; Barr J., 2011, ESPN; Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; Bauer RM, 2012, CLIN NEUROPSYCHOL, V26, P177, DOI 10.1080/13854046.2012.663001; Belson K, 2015, NY TIMES; Belson K., 2017, NY TIMES; Bey T, 2009, WEST J EMERG MED, V10, P6; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Boston University CTE Center, 18 YEAR OLD HIGH SCH; Branch J, 2011, NY TIMES; Breslow J., 2014, PBS FRONTLINE; Breslow Jason M., 2015, FRONTLINE; Breslow Jason M, 2014, FRONTLINE; Broglio SP, 2016, J ATHL TRAINING, V51, P511, DOI 10.4085/1062-6050-51.7.04; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brower MC, 2001, J NEUROL NEUROSUR PS, V71, P720, DOI 10.1136/jnnp.71.6.720; Carpenter L., 2015, GUARDIAN; Carter B., 2013, BBC NEWS; Chin LS, 2011, US NEUROL, V7, P33; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Cottler LB, 2011, DRUG ALCOHOL DEPEN, V116, P188, DOI 10.1016/j.drugalcdep.2010.12.003; Critchley M., 1949, HOMMAGE CLOVIS VINCE, P131; Cusimano MD., 2011, OPEN MED-WARSAW, V5, P57; Dawber Thomas R., 1980, FRAMINGHAM STUDY EPI; Dessy A, 2014, CLIN NEUROL NEUROSUR, V122, P59, DOI 10.1016/j.clineuro.2014.04.003; Erdal K, 2012, ARCH CLIN NEUROPSYCH, V27, P473, DOI 10.1093/arclin/acs050; Fainaru Steve, 2012, ESPN; Gandy S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004274; Gardner A, 2014, BRIT J SPORT MED, V48, P84, DOI 10.1136/bjsports-2013-092646; Goodman Brenda, 2007, NY TIMES; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hirsley M., 1999, CHICAGO TRIBUNE; Johnson L. S. M., 2013, BIOETHICS FORUM; Johnson L.S.M., 2016, PHILOSOPHER; Johnson LSM, 2015, NEUROETHICS-NETH, V8, P15, DOI 10.1007/s12152-014-9213-4; Johnson LSM, 2015, NEUROETHICS-NETH, V8, P1, DOI 10.1007/s12152-015-9233-8; Johnson LSM, 2012, J SCHOOL HEALTH, V82, P180, DOI 10.1111/j.1746-1561.2011.00684.x; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Klein J. Z., 2011, NY TIMES; Leal W, 2015, J CRIM JUST, V43, P397, DOI 10.1016/j.jcrimjus.2015.08.001; Maroon JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117338; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McCrory P, 2001, CLIN J SPORT MED, V11, P144, DOI 10.1097/00042752-200107000-00004; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Mendez MF, 2010, J AM ACAD PSYCHIATRY, V38, P318; Millspaugh JA, 1937, US NAVAL MED B, V35, P297; Morris B., 2014, FIVETHIRTYEIGHT; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Myer GD, 2014, J ORTHOP SPORT PHYS, V44, P164, DOI 10.2519/jospt.2014.5298; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Reimer A., 2016, SB NATION; Roth M., 2013, PITTSBURGH POST GAZA; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Schwarz A, 2010, NY TIMES; Schwarz A., 2016, NY TIMES; Sfera A., 2014, FRONT PSYCHIATRY, V5, P1; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; U. S. Soccer, 2015, US SOCC PROV ADD INF; Warsh JM, 2009, CLIN J SPORT MED, V19, P134, DOI 10.1097/JSM.0b013e3181987783; Wortzel HS, 2013, J AM ACAD PSYCHIATRY, V41, P274	70	1	1	0	0	ROUTLEDGE	ABINGDON	2 PARK SQ, MILTON PARK, ABINGDON OX14 4RN, OXFORD, ENGLAND			978-1-315-70865-2; 978-1-138-89829-5	ROUT HBK APPL ETHICS			2018							225	240					16	Ethics; Health Policy & Services; Medical Ethics; Neurosciences; Philosophy	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Social Sciences - Other Topics; Health Care Sciences & Services; Medical Ethics; Neurosciences & Neurology; Philosophy	BM3LM	WOS:000462274100016					2022-02-06	
J	Jonker, F; Jonker, C; Bronzwaer, L; Scherder, E				Jonker, Frank; Jonker, Cees; Bronzwaer, Laura; Scherder, Erik			A right amygdalohippocampectomy: A diagnostic challenge	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Amygdalahippocampectomy; Psychiatry; Behavioral symptoms; Cognition; Affective TOM	TEMPORAL-LOBE EPILEPSY; STEREOTACTIC RADIOFREQUENCY AMYGDALOHIPPOCAMPECTOMY; TRAUMATIC BRAIN-INJURY; SELECTIVE AMYGDALOHIPPOCAMPECTOMY; SOCIAL COGNITION; FRONTAL-LOBE; NEUROPSYCHOLOGICAL OUTCOMES; EMOTION RECOGNITION; VOLUME REDUCTION; DECISION-MAKING	Objective: Amygdalohippocampectomy (AHE) is the resective surgery for medically intractable mesial temporal lobe epilepsy. To date no study has investigated a wide range of neuropsychiatric symptoms in right AHE outpatients. Patients and methods: Three patients with right AHE participated in this study. The control group are patients with cognitive complaints with no history of epilepsy or neurological impairment and no structural abnormalities on the MRI/CT. We expected no difference in verbal memory compared to the controls. Concerning affective Theory of Mind (ToM) we expect a difference between controls and AHE patients. In terms of behavior it is expected that coping and behavioral questionnaires do not significantly differ between AHE and controls, but that proxies of AHE patients do report more behavioral/psychiatric symptoms. Results: No significant difference was found between groups concerning the cognitive functions. For affective ToM we did find a significant difference (p = 0.044). A significant difference for the use of more reassuring thoughts (p = 0.006) and a trend for less passive reactions on the coping questionnaire, suggesting an 'active coping style'. Overall, AHE patients report fewer problems the self- reported questionnaires. Proxies of the AHE patients reported a trend for more behavioral disinhibition compared to proxy ratings of the control group. Conclusion: Right AHE patients underestimate their behavioral and emotional changes due to self-awareness deficits. Ratings of significant others are of immense importance for the detection of psychiatric and behavioral problems. Lesions in the amygdala- orbitofrontal cortex connection disrupt the emotional network, which might explain our results.	[Jonker, Frank; Bronzwaer, Laura] GGZ Altrecht, Ctr Neuropsychiat, Vesalius, Woerden, Netherlands; [Jonker, Frank; Scherder, Erik] Vrije Univ, Fac Behav & Movement Sci, Sect Clin Neuropsychol, Amsterdam, Netherlands; [Jonker, Cees] Vrije Univ, Med Ctr, Inst Hlth & Care Res EMGO, Amsterdam, Netherlands		Jonker, F (corresponding author), Altrecht Neuropsychiat, Vesalius Polanerbaan 2, NL-3447 GN Woerden, Netherlands.	f.a.jonker@vu.nl		Jonker, Frank/0000-0002-6786-5573			Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Ammerlaan EJG, 2008, ACTA NEUROBIOL EXP, V68, P214; Bach LJ, 2006, NEUROPSYCHOL REHABIL, V16, P397, DOI 10.1080/09602010500412830; Barry D, 2008, BRAIN COGNITION, V66, P243, DOI 10.1016/j.bandc.2007.09.001; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; Benson N, 2010, PSYCHOL ASSESSMENT, V22, P121, DOI 10.1037/a0017767; Bonilha L, 2005, BRAZ J MED BIOL RES, V38, P409, DOI 10.1590/S0100-879X2005000300012; Bush G, 1999, BIOL PSYCHIAT, V45, P1542, DOI 10.1016/S0006-3223(99)00083-9; Butman J, 2007, ACTAS ESP PSIQUIATRI, V35, P8; Cleary RA, 2013, EPILEPSY BEHAV, V26, P322, DOI 10.1016/j.yebeh.2012.09.038; Clusmann H, 2002, J NEUROSURG, V97, P1131, DOI 10.3171/jns.2002.97.5.1131; CORRIGAN JD, 1987, J CLIN PSYCHOL, V43, P402, DOI 10.1002/1097-4679(198707)43:4<402::AID-JCLP2270430411>3.0.CO;2-E; Costafreda SG, 2008, BRAIN RES REV, V58, P57, DOI 10.1016/j.brainresrev.2007.10.012; Cusi AM, 2012, J PSYCHIATR NEUROSCI, V37, P154, DOI 10.1503/jpn.100179; Devinsky O, 2005, NEUROLOGY, V65, P1744, DOI 10.1212/01.wnl.0000187114.71524.c3; Dolan RJ, 2007, PHILOS T R SOC B, V362, P787, DOI 10.1098/rstb.2007.2088; ESLINGER PJ, 1993, NEUROPSYCHOLOGIA, V31, P17, DOI 10.1016/0028-3932(93)90077-D; Giovagnoli AR, 1996, ITAL J NEUROL SCI, V17, P305, DOI 10.1007/BF01997792; Glascher J, 2003, J NEUROSCI, V23, P10274; Gleissner U, 2002, EPILEPSIA, V43, P87, DOI 10.1046/j.1528-1157.2002.24101.x; Glosser G, 2000, J NEUROL NEUROSUR PS, V68, P53, DOI 10.1136/jnnp.68.1.53; Gregorio G. Wolters, 2015, BR J CLIN PSYCHOL, V54; Hegde S., 2016, NEUROCASE, V1-6; Hill SW, 2012, SEIZURE-EUR J EPILEP, V21, P353, DOI 10.1016/j.seizure.2012.03.002; KATZ A, 1989, EPILEPSIA, V30, P763, DOI 10.1111/j.1528-1157.1989.tb05336.x; Lutz MT, 2004, EPILEPSIA, V45, P809, DOI 10.1111/j.0013-9580.2004.54003.x; Malikova H, 2015, NEUROPSYCH DIS TREAT, V11, P2927, DOI 10.2147/NDT.S95497; Malikova H, 2014, STEREOT FUNCT NEUROS, V92, P372, DOI 10.1159/000366003; Malikova H, 2012, EPILEPSY RES, V102, P34, DOI 10.1016/j.eplepsyres.2012.04.017; Malikova H, 2010, STEREOT FUNCT NEUROS, V88, P42, DOI 10.1159/000268741; Mansouri Alireza, 2014, Epilepsy Res Treat, V2014, P306382, DOI 10.1155/2014/306382; Mattsson P, 2005, SEIZURE-EUR J EPILEP, V14, P40, DOI 10.1016/j.seizure.2004.02.009; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Morgan B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038116; Morino M, 2006, EPILEPSY BEHAV, V9, P95, DOI 10.1016/j.yebeh.2006.04.017; Nyhus E, 2009, BRAIN COGNITION, V71, P437, DOI 10.1016/j.bandc.2009.03.005; Oishi K, 2015, ANN NEUROL, V77, P68, DOI 10.1002/ana.24300; Ozmen M, 2004, EPILEPSY BEHAV, V5, P133, DOI 10.1016/j.yebeh.2003.10.009; Paparrigopoulos T, 2008, EPILEPSY RES, V81, P30, DOI 10.1016/j.eplepsyres.2008.04.011; Peng BW, 2014, EPILEPSY RES, V108, P1839, DOI 10.1016/j.eplepsyres.2014.09.007; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Pintor L, 2007, SEIZURE-EUR J EPILEP, V16, P218, DOI 10.1016/j.seizure.2006.12.004; Richard-Mornas A, 2014, NEUROCASE, V20, P666, DOI 10.1080/13554794.2013.826695; Shamay-Tsoory SG, 2007, NEUROPSYCHOLOGIA, V45, P3054, DOI 10.1016/j.neuropsychologia.2007.05.021; Shamay-Tsoory SG, 2011, NEUROSCIENTIST, V17, P18, DOI 10.1177/1073858410379268; Shaw P, 2007, NEUROPSYCHOLOGIA, V45, P2783, DOI 10.1016/j.neuropsychologia.2007.04.020; Spencer D., 2012, EPILEPSY RES TREAT, P1; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Spreen O, 1998, COMPENDIUM NEUROLOGI, V2; Stone VE, 2003, NEUROPSYCHOLOGIA, V41, P209, DOI 10.1016/S0028-3932(02)00151-3; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Suriadi MM, 2015, EPILEPSY BEHAV, V42, P14, DOI 10.1016/j.yebeh.2014.10.025; Van der Elst W, 2005, J INT NEUROPSYCH SOC, V11, P290, DOI 10.1017/S1355617705050344; von Rhein B, 2012, J NEUROL NEUROSUR PS, V83, P887, DOI 10.1136/jnnp-2011-302025; Watson C, 1997, ARCH NEUROL-CHICAGO, V54, P1521, DOI 10.1001/archneur.1997.00550240071015; Wendling AS, 2015, EPILEPSY RES, V111, P26, DOI 10.1016/j.eplepsyres.2015.01.002	58	1	1	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	JAN	2018	164						57	63		10.1016/j.clineuro.2017.11.010			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	FV6YE	WOS:000424727200013	29175724				2022-02-06	
B	Joyal, CC; Morais, HB		Proulx, J; Beauregard, E; Carter, AJ; Mokros, A; Darjee, R; James, J		Joyal, Christian C.; Morais, Hugo B.			Neuropsychological and neurological assessments of sexual homicide offenders Their current and potential functions in the prosecution, detention, therapeutic progression, and release of individual cases	ROUTLEDGE INTERNATIONAL HANDBOOK OF SEXUAL HOMICIDE STUDIES	Routledge International Handbooks		English	Article; Book Chapter							OBSESSIVE-COMPULSIVE DISORDER; TRAUMATIC BRAIN-INJURY; PERSONALITY-DISORDER; EXECUTIVE FUNCTION; THETA/BETA RATIO; ABNORMALITIES; PROFILES; PAIN; EEG; PSYCHOPATHY		[Joyal, Christian C.] Univ Quebec Trois Rivieres, Sexol Program, Dept Psychol, Trois Rivieres, PQ, Canada; [Joyal, Christian C.] Philippe Pinel Inst Montreal, Montreal, PQ, Canada; [Morais, Hugo B.] Jefferson Comprehens Care Syst Inc, Little Rock, AR USA		Joyal, CC (corresponding author), Univ Quebec Trois Rivieres, Sexol Program, Dept Psychol, Trois Rivieres, PQ, Canada.; Joyal, CC (corresponding author), Philippe Pinel Inst Montreal, Montreal, PQ, Canada.						American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Arns M, 2014, BIOL PSYCHOL, V95, P108, DOI 10.1016/j.biopsycho.2013.11.013; Arns M, 2013, J ATTEN DISORD, V17, P374, DOI 10.1177/1087054712460087; Barratt ES, 2003, BEHAV SCI LAW, V21, P619, DOI 10.1002/bsl.555; Bartels R. M., 2017, WILEY HDB THEORIES A, V1, P187; Beauregard E, 2002, INT J OFFENDER THER, V46, P386, DOI 10.1177/0306624X02464002; Beauregard E, 2007, INT J OFFENDER THER, V51, P420, DOI 10.1177/0306624X06294432; Bedard MJ, 2009, ARCH CLIN NEUROPSYCH, V24, P585, DOI 10.1093/arclin/acp052; Beech A, 2005, J INTERPERS VIOLENCE, V20, P1366, DOI 10.1177/0886260505278712; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Benning SD, 2003, PSYCHOL ASSESSMENT, V15, P340, DOI 10.1037/1040-3590.15.3.340; Blair RJR, 2007, TRENDS COGN SCI, V11, P387, DOI 10.1016/j.tics.2007.07.003; Blair RJR, 2001, J NEUROL NEUROSUR PS, V71, P727, DOI 10.1136/jnnp.71.6.727; Blair RJR, 2004, BRAIN COGNITION, V55, P198, DOI 10.1016/s0278-2626(03)00276-8; Briken P, 2006, J FORENSIC SCI, V51, P683, DOI 10.1111/j.1556-4029.2006.00105.x; Briken P, 2005, J FORENSIC SCI, V50, P1204; BRITTAIN RP, 1970, MED SCI LAW, V10, P198, DOI 10.1177/002580247001000402; Burgess A. W., 1986, J INTERPERS VIOLENCE, V1, P251, DOI [10.1177/088626086001003001, DOI 10.1177/088626086001003001]; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Calzada-Reyes A, 2013, J FORENSIC LEG MED, V20, P19, DOI 10.1016/j.jflm.2012.04.027; Calzada-Reyes A, 2012, J FORENSIC LEG MED, V19, P29, DOI 10.1016/j.jflm.2011.10.002; Carter AJ, 2010, PSYCHOL CRIME LAW, V16, P25, DOI 10.1080/10683160802621933; Cavazza M., 2014, OPEN ACCESS I, V41, P42; Chabot RJ, 1996, BIOL PSYCHIAT, V40, P951, DOI 10.1016/0006-3223(95)00576-5; Chamberlain SR, 2005, NEUROSCI BIOBEHAV R, V29, P399, DOI 10.1016/j.neubiorev.2004.11.006; Chan HC, 2015, CRIM BEHAV MENT HEAL, V25, P66, DOI 10.1002/cbm.1925; Cheng Y, 2008, NEUROIMAGE, V40, P1833, DOI 10.1016/j.neuroimage.2008.01.064; Cheng YW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002113; Cooke D. J., 2001, VIOLENCE PSYCHOPATHY, P123; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Decety J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00489; Decety J, 2013, JAMA PSYCHIAT, V70, P638, DOI 10.1001/jamapsychiatry.2013.27; DENNEY RL, 2008, CLIN NEUROPSYCHOLOGY; Dietz P E, 1990, Bull Am Acad Psychiatry Law, V18, P163; Douglas, 1988, SEXUAL HOMICIDE PATT; DOUGLAS JE, 1992, POCKET GUIDE CRIME C; Fabian JM, 2012, AGGRESS VIOLENT BEH, V17, P1, DOI 10.1016/j.avb.2011.07.002; Fan Y, 2011, PSYCHOL MED, V41, P1641, DOI 10.1017/S003329171000228X; Frohman EM, 2002, ARCH NEUROL-CHICAGO, V59, P1006, DOI 10.1001/archneur.59.6.1006; Glaser D, 2000, J CHILD PSYCHOL PSYC, V41, P97, DOI 10.1111/1469-7610.00551; GRATZER T, 1995, J FORENSIC SCI, V40, P450; Gregory S, 2012, ARCH GEN PSYCHIAT, V69, P962, DOI 10.1001/archgenpsychiatry.2012.222; GUSTAFSON SB, 1995, EUR J PERSONALITY, V9, P147, DOI 10.1002/per.2410090302; Hanlon RE, 2013, CRIM JUSTICE BEHAV, V40, P933, DOI 10.1177/0093854813479779; Harenski CL, 2012, ARCH GEN PSYCHIAT, V69, P283, DOI 10.1001/archgenpsychiatry.2011.1566; Harlow MC, 2007, J AM ACAD PSYCHIAT L, V35, P536; Hazelwood R.R., 1980, FBI LAW ENFORC B, V49, P1, DOI 10.4324/9781315196756; Hazelwood R. R., 2009, PRACTICAL ASPECTS RA, P55; Hazelwood RR, 2000, AGGRESS VIOLENT BEH, V5, P267, DOI 10.1016/S1359-1789(99)00002-6; Healey J, 2016, SEX ABUSE-J RES TR, V28, P512, DOI 10.1177/1079063214547583; Henry M, 2012, J NEUROSCI METH, V210, P125, DOI 10.1016/j.jneumeth.2012.07.025; Hill A, 2006, J PERS DISORD, V20, P671, DOI 10.1521/pedi.2006.20.6.671; HOLMES RM, 1989, PROFILING VIOLENT CR; Horn NR, 2003, NEUROPSYCHOLOGIA, V41, P1959, DOI 10.1016/S0028-3932(03)00077-0; Hucker S, 1988, ANN SEX RES, V1, P33, DOI DOI 10.1177/107906328800100104; Huyser C, 2011, J CHILD PSYCHOL PSYC, V52, P1251, DOI 10.1111/j.1469-7610.2011.02439.x; Jauk E, 2016, PERS INDIV DIFFER, V101, P486, DOI 10.1016/j.paid.2016.05.171; Joyal C. C., 2016, 35 ANN C ASS TREATM; Joyal C. C., 2015, 34 ANN C ASS TREATM; Joyal CC, 2015, J SEX MED, V12, P328, DOI 10.1111/jsm.12734; Kessler RC, 2006, ARCH GEN PSYCHIAT, V63, P669, DOI 10.1001/archpsyc.63.6.669; Kimonis ER, 2013, CHILD MALTREATMENT, V18, P108, DOI 10.1177/1077559513483002; Kirenskaya-Berus A. V., 2003, HUMAN PHYSL, V29, P278, DOI [10.1023/A:1023982119972, DOI 10.1023/A:1023982119972]; Krack P, 2010, TRENDS NEUROSCI, V33, P474, DOI 10.1016/j.tins.2010.07.002; Krikorian R, 2004, BRAIN COGNITION, V54, P257, DOI 10.1016/j.bandc.2004.02.038; Langevin R, 2006, BRAIN COGNITION, V60, P206; Langevin R, 1998, J INTERPERS VIOLENCE, V13, P315, DOI 10.1177/088626098013003001; Langevin R., 1988, ANN SEX RES, V1, P263, DOI [DOI 10.1177/107906328800100206, 10.1007/BF00852801, DOI 10.1007/BF00852801]; Lansbergen MM, 2011, PROG NEURO-PSYCHOPH, V35, P47, DOI 10.1016/j.pnpbp.2010.08.004; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Lochner C, 2002, DEPRESS ANXIETY, V15, P66, DOI 10.1002/da.10028; LYNAM D, 1993, J ABNORM PSYCHOL, V102, P187, DOI 10.1037/0021-843X.102.2.187; MACCULLOCH MJ, 1983, BRIT J PSYCHIAT, V143, P20, DOI 10.1192/bjp.143.1.20; Maltby N, 2005, NEUROIMAGE, V24, P495, DOI 10.1016/j.neuroimage.2004.08.041; Maniglio R, 2010, AGGRESS VIOLENT BEH, V15, P294, DOI 10.1016/j.avb.2010.02.001; Matsuo K, 2009, HUM BRAIN MAPP, V30, P1188, DOI 10.1002/hbm.20588; McEllistrem JE, 2004, AGGRESS VIOLENT BEH, V10, P1, DOI 10.1016/j.avb.2003.06.002; Meloy JR, 2000, AGGRESS VIOLENT BEH, V5, P1, DOI 10.1016/S1359-1789(99)00006-3; Menzies L, 2008, NEUROSCI BIOBEHAV R, V32, P525, DOI 10.1016/j.neubiorev.2007.09.005; Minzenberg MJ, 2009, ARCH GEN PSYCHIAT, V66, P811, DOI 10.1001/archgenpsychiatry.2009.91; MOFFITT TE, 1993, DEV PSYCHOPATHOL, V5, P135, DOI 10.1017/S0954579400004302; Monastra VJ, 2001, NEUROPSYCHOLOGY, V15, P136, DOI 10.1037//0894-4105.15.1.136; Moore A, 2012, BEHAV BRAIN RES, V226, P309, DOI 10.1016/j.bbr.2011.07.048; Moulier V, 2006, NEUROIMAGE, V33, P689, DOI 10.1016/j.neuroimage.2006.06.037; Mouras H, 2008, NEUROIMAGE, V42, P1142, DOI 10.1016/j.neuroimage.2008.05.051; Neveu S. -M., P INT SOC PRES RES; Nolin P, 2007, CHILD ABUSE NEGLECT, V31, P631, DOI 10.1016/j.chiabu.2006.12.009; Ogilvie JM, 2011, CRIMINOLOGY, V49, P1063, DOI 10.1111/j.1745-9125.2011.00252.x; Olley A, 2007, J AFFECT DISORDERS, V104, P15, DOI 10.1016/j.jad.2007.02.023; Parada M, 2016, J SEX MED, V13, P1508, DOI 10.1016/j.jsxm.2016.08.008; Paulhus DL, 2002, J RES PERS, V36, P556, DOI 10.1016/S0092-6566(02)00505-6; Peng WW, 2015, BIOL PSYCHOL, V109, P141, DOI 10.1016/j.biopsycho.2015.05.004; Ponseti J, 2012, ARCH GEN PSYCHIAT, V69, P187, DOI 10.1001/archgenpsychiatry.2011.130; Prause N, 2014, PSYCHOPHYSIOLOGY, V51, P226, DOI 10.1111/psyp.12173; PRENTKY RA, 1989, AM J PSYCHIAT, V146, P887; Priyadharshini S., 2017, INT J MED RES PHARM, V4, P46; Quinsey VL, 2003, ANN NY ACAD SCI, V989, P105; RESSLER RK, 1986, J INTERPESONAL VIOLE, V1, P288, DOI DOI 10.1177/088626086001003003; Ritter K, 2011, PSYCHIAT RES, V187, P241, DOI 10.1016/j.psychres.2010.09.013; Ronningstam E., 2016, CURR BEHAV NEUROSCI, V3, P34, DOI [10.1007/s40473-016-0060-y, DOI 10.1007/S40473-016-0060-Y]; Ruocco AC, 2007, J NEUROPSYCH CLIN N, V19, P27, DOI 10.1176/appi.neuropsych.19.1.27; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Salnaitis CL, 2011, APPL NEUROPSYCHOL, V18, P37, DOI 10.1080/09084282.2010.523381; Schiepek G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071863; Schiffer B, 2011, J SEX MED, V8, P1975, DOI 10.1111/j.1743-6109.2010.02140.x; Schlesinger LB, 2007, AGGRESS VIOLENT BEH, V12, P242, DOI 10.1016/j.avb.2006.09.007; Schmidtke K, 1998, BIOL PSYCHIAT, V43, P666, DOI 10.1016/S0006-3223(97)00355-7; Schoenleber M, 2011, PERSONAL DISORD, V2, P113, DOI 10.1037/a0021870; Schulze L, 2013, J PSYCHIATR RES, V47, P1363, DOI 10.1016/j.jpsychires.2013.05.017; Simpson G, 1999, J HEAD TRAUMA REHAB, V14, P567, DOI 10.1097/00001199-199912000-00005; Simpson GK, 2013, J HEAD TRAUMA REHAB, V28, P202, DOI 10.1097/HTR.0b013e31828dc5ae; Stein DJ, 2000, CNS SPECTRUMS, V5, P37; Stoleru S, 2012, NEUROSCI BIOBEHAV R, V36, P1481, DOI 10.1016/j.neubiorev.2012.03.006; Stone MH, 2001, J PERS DISORD, V15, P1, DOI 10.1521/pedi.15.1.1.18646; Tot S, 2002, CAN J PSYCHIAT, V47, P538; van den Heuvel OA, 2005, ARCH GEN PSYCHIAT, V62, P922, DOI 10.1001/archpsyc.62.8.922; Volavka J, 2002, NEUROBIOLOGY VIOLENC; WHITE JL, 1994, J ABNORM PSYCHOL, V103, P192, DOI 10.1037/0021-843X.103.2.192; Woodruff CC, 2011, BRAIN RES, V1405, P69, DOI 10.1016/j.brainres.2011.05.046; Woodworth M, 2013, INT J LAW PSYCHIAT, V36, P144, DOI 10.1016/j.ijlp.2013.01.007	120	1	1	0	0	ROUTLEDGE	ABINGDON	2 PARK SQ, MILTON PARK, ABINGDON OX14 4RN, OXFORD, ENGLAND			978-1-315-21228-9; 978-0-415-79148-9	ROUT INT HANDB			2018							402	418					17	Criminology & Penology	Book Citation Index – Social Sciences & Humanities (BKCI-SSH)	Criminology & Penology	BN2OO	WOS:000477051800027					2022-02-06	
J	Kaski, D; Buttell, J; Greenwood, R				Kaski, Diego; Buttell, Joseph; Greenwood, Richard			Targeted rehabilitation reduces visual dependency and improves balance in severe traumatic brain injury: a case study	DISABILITY AND REHABILITATION			English	Article						Visual dependency; BPPV; rehabilitation; traumatic brain injury; gait; balance	GAIT ABNORMALITIES; POSTURAL CONTROL; DISORDERS; DIZZINESS; DEFICITS; VERTIGO	Purpose: To further understand the mechanisms underlying gait impairment following traumatic brain injury. Case report: A 58-year-old man presented with marked unsteadiness and motion sensitivity following a severe traumatic brain injury. He underwent a 6-week inpatient rehabilitation program focused on re-weighting and subsequently re-integrating ascending interoceptive information, by gradual reduction of maladaptive visual fixation techniques. We report clinical neurological outcomes and measures of functional outcome, as well as an objective assessment of visual dependency (the rod and disk test) at baseline and after the rehabilitation. Results: Clinically, the patient had gait unsteadiness exacerbated by visual motion. A significant reduction in visual dependency occurred with tailored multi-disciplinary rehabilitation via gradual removal of visual fixation strategies that the patient had developed to maintain balance (t-test; p < 0.01), as well as clinical improvements in gait, balance, and functional outcome. Conclusions: We highlight the importance of visual dependency in the generation of maladaptive gait strategies following brain injury. Our data suggest assessing and treating visual dependency to be an important component of gait rehabilitation after traumatic brain injury.	[Kaski, Diego; Greenwood, Richard] UCL, Inst Neurol, London WC1N 3BG, England; [Buttell, Joseph; Greenwood, Richard] Homerton Univ Hosp, Reg Neurol Rehabil Unit, London, England		Kaski, D (corresponding author), UCL, Inst Neurol, London WC1N 3BG, England.	d.kaski@ucl.ac.uk		Kaski, Diego/0000-0002-0591-646X			Baik JS, 2007, MOVEMENT DISORD, V22, P395, DOI 10.1002/mds.21283; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Buster TW, 2016, BRAIN INJURY, V30, P1249, DOI 10.1080/02699052.2016.1183822; Cousins S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105426; Fife TD, 2013, SEMIN NEUROL, V33, P238, DOI 10.1055/s-0033-1354599; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; Guerraz M, 2001, BRAIN, V124, P1646, DOI 10.1093/brain/124.8.1646; Honaker JA, 2014, OTOL NEUROTOL, V35, P1111, DOI 10.1097/MAO.0000000000000432; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; Massion Jean, 1994, Current Opinion in Neurobiology, V4, P877, DOI 10.1016/0959-4388(94)90137-6; Merello M, 2012, FUNCT NEUROL, V27, P217; Williams G, 2009, ARCH PHYS MED REHAB, V90, P587, DOI 10.1016/j.apmr.2008.10.013	12	1	1	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2018	40	7					856	858		10.1080/09638288.2016.1276976			3	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	FY5XU	WOS:000426912400016	28112541	Green Submitted			2022-02-06	
J	Khan, K; Saeed, S; Ramcharan, A; Gray, S				Khan, Khuram; Saeed, Saqib; Ramcharan, Alexius; Gray, Sanjiv			A case series of closed head trauma with pituitary stalk disruption resulting in hypopituitarism	INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS			English	Article						Pituitary disorders; Endocrinology; Neurological injury; Neurology; Traumatic brain injury; Hypopituitarism	BRAIN-INJURY; ACUTE-PHASE; RISK	INTRODUCTION: Traumatic brain injury (TBI) is one of the main causes of morbidity and mortality in young trauma patients with resultant multi-organ effects. Hypopituitarism following TBI can be debilitating and life threatening. TBI which causes hypopituitarism may be characterized by a single head injury, such as from a motor vehicle accident, or by chronic repetitive head trauma, as seen in combative supports including boxing, kick-boxing, and football. In the majority of cases, a diagnosis of hypopituitarism can be entirely missed resulting in severe neuro-endocrine dysfunction. We present a case series of two patients diagnosed with hypopituitarism after TBI and treated appropriately with favorable outcome. CASE PRESENTATIONS: The first case is a 34 year-old male, who presented to the emergency department with blunt head trauma after a motor vehicle accident while riding his bicycle. He suffered from severe cranio-facial injuries, resulting in multifocal hemorrhagic contusions, epidural hematoma, and extensive cranio-facial fractures involving the sinuses. The patient developed persistent hypotension with a blood pressure as low as 60/40 mmHg on hospital day three. The second case is a 56 year-old male with a history of schizophrenia, who suffered traumatic brain injury after he was hit by a train. The patient sustained multiple facial fractures, pneumocephalus and C2/7 transverse processes fractures. He also had persistent hypotension, unresponsive to standard treatment. Investigation revealed a deficiency of anterior pituitary hormones resulting from pituitary axis disruption. DISCUSSION: Hypopituitarism is becoming an increasingly recognized complication following TBI, ranging from total to isolated deficiencies. Traumatic Brain Injury is a major public health problem and is one of the leading causes of disability. Understanding and recognizing pituitary dysfunction after TBI can lead to better outcomes and improved quality of life. CONCLUSION: Patients with major head injury and, in particular, those with fractures of the base of the skull, must be closely monitored for signs and symptoms of endocrine dysfunction. Appropriate dynamic pituitary-function screening should be performed. (C) 2018 The Author(s). Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd.	[Khan, Khuram; Saeed, Saqib; Ramcharan, Alexius; Gray, Sanjiv] Columbia Univ, Med Ctr, Harlem Hosp, Dept Surg, New York, NY 10027 USA		Khan, K (corresponding author), Columbia Univ, Med Ctr, Harlem Hosp, Dept Surg, New York, NY 10027 USA.	khank1@nychhc.org		Ramcharan, Alexius/0000-0002-4890-7360			Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Agha RA, 2016, INT J SURG, V36, P319, DOI 10.1016/j.ijsu.2016.10.025; Agrawal A, 2012, INDIAN J NEUROTRAUM, V9, P123, DOI 10.1016/j.ijnt.2012.11.005; Bavisetty S, 2008, NEUROSURGERY, V62, P1080, DOI 10.1227/01.neu.0000325870.60129.6a; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; Bondanelli M, 2007, J NEUROTRAUM, V24, P1687, DOI 10.1089/neu.2007.0343; Cryan E., 1918, DTSCH MED WOCHENSCHR, V44, P1261; Giordano Giulio, 2005, Pituitary, V8, P227, DOI 10.1007/s11102-006-6045-1; Giuliano S, 2017, ENDOCRINE, V58, P115, DOI 10.1007/s12020-016-1183-3; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Powner DJ, 2006, NEUROCRIT CARE, V5, P61, DOI 10.1385/NCC:5:1:61; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476	12	1	2	0	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2210-2612			INT J SURG CASE REP	Int. J. Surg. Case Rep.		2018	43						69	71		10.1016/j.ijscr.2018.01.014			3	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	GC6NM	WOS:000429908700016	29477026	Green Published, gold			2022-02-06	
J	Kidd, DE				Kidd, Douglas E.			Neurodivergence Enminded/Embodied: Living with Severe Traumatic Brain Injury	WORD AND TEXT-A JOURNAL OF LITERARY STUDIES AND LINGUISTICS			English	Article						traumatic brain injury; acquired disability; identity		This article positions my experiences as a severe traumatic brain injury (TBI) survivor relative to other TBI survivors and in context of persons with disabilities (PWDs) living in the United States and the world. This autoethnographical account (by autoethnography I understand a method or form of social research that serves the purpose of exploring personal experiences of the researcher) examines the life of a neurodivergent individual whose brain functions in ways that deviate significantly from social norms. I explore profound changes to my identity and the resultant social disconnection I encounter since acquiring a severe TBI more than a decade ago. The profound alterations to my identity affect my ability to process, and then adjust, to the demands of my surroundings As I decode, decipher and process the world, at times my brain damage triggers and/or produces episodes of temporal dissonance. As these shifts in timing occur, they have tremendous impact on my emotional stability. Despite these outward difficulties, I celebrate my altered awareness of time and new identity as a disabled person. Connecting relevant critical trauma studies scholarship to the themes addressed here, the article examines how moving through trauma, coma and amnesia to a new life with cognitive, emotional, psychological, and physical impairments importantly enriches expression of my humanity. I will demonstrate the salient aspects of my new life - emotional sensitivity and volatility - may on the surface seem detrimental and undesirable; however, these qualities greatly enhance my identification with and empathy for others, which in turn drive my artistic, social, cultural and political expression, along with my quest for community.	[Kidd, Douglas E.] Univ Toledo, Liberal Studies Concentrat Disabil Studies, Toledo, OH 43606 USA		Kidd, DE (corresponding author), Univ Toledo, Liberal Studies Concentrat Disabil Studies, Toledo, OH 43606 USA.	dkidd@rockets.utoledo.edu					Eiesland Nancy L., 1994, DISABLED GOD LIBERAT; Faul M, 2010, TRAUMATIC BRAIN INJU; Garland-Thomson R, 2006, J VIS CULT, V5, P173, DOI 10.1177/1470412906066907; Goffman E., 1963, STIGMA NOTES MANAGEM; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Johnson Renee, 2005, STATE INJURY INDICAT; Kidd D, 2017, BARRIERS AND BELONGING: PERSONAL NARRATIVES OF DISABILITY, P87; Kidd Douglas, 2016, REV DISABILITY STUDI, V11, P1; Kidd Douglas, 2015, SCAR ANTHOLOGY, P83; Kidd Douglas E, 2013, Narrat Inq Bioeth, V3, P199, DOI 10.1353/nib.2013.0065; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Stiles J, 2010, NEUROPSYCHOL REV, V20, P327, DOI 10.1007/s11065-010-9148-4; Whitacre Troy, 2018, SLEEP ISSUES NEUROMU, P117; Wicks A., 2016, CRITICAL TRAUMA STUD, P135	16	1	1	1	5	UNIV PETROL-GAZE PLOIESTI	PLOIESTI	BD BUCURESTI 39, PLOIESTI, 100680, ROMANIA	2069-9271	2247-9163		WORD TEXT	Word Text		2018	8						48	60					13	Literary Theory & Criticism	Emerging Sources Citation Index (ESCI)	Literature	HH2WN	WOS:000455580600003					2022-02-06	
J	Kobayashi, Y				Kobayashi, Yasutaka			A Case of Traumatic Brain Injury Presenting with Musical Hallucinations	CASE REPORTS IN NEUROLOGY			English	Article						Musical hallucinations; Traumatic brain injury; Attention disorder	AUDITORY HALLUCINATIONS; PHENOMENOLOGY; PREVALENCE	A 67-year-old woman was hospitalized for rehabilitation from the after effects of a traumatic brain injury. In addition to memory impairment, attention disorder, and executive dysfunction, she experienced musical hallucinations. Brain magnetic resonance imaging revealed cerebral contusion in the bilateral temporal lobes and the left frontal lobe. Case reports of musical hallucinations caused by traumatic brain injury are extremely rare. (C) 2017 The Author(s) Published by S. Karger AG, Basel	[Kobayashi, Yasutaka] Fukui Gen Hosp, Dept Rehabil Med, 58-16-1 Egami Cho, Fukui, Fukui 9108561, Japan		Kobayashi, Y (corresponding author), Fukui Gen Hosp, Dept Rehabil Med, 58-16-1 Egami Cho, Fukui, Fukui 9108561, Japan.	yasutaka_k@mri.biglobe.ne.jp		Kobayashi, Yasutaka/0000-0002-6305-2444			[Anonymous], 2008, CLIN ASS ATT; BERRIOS GE, 1990, BRIT J PSYCHIAT, V156, P188, DOI 10.1192/bjp.156.2.188; Cole MG, 2002, INT J GERIATR PSYCH, V17, P444, DOI 10.1002/gps.618; Evers Stefan, 2006, Curr Psychiatry Rep, V8, P205, DOI 10.1007/s11920-006-0024-0; Fujita K, 2007, JAPANESE VERSION WEC; Fukunishi I, 1998, PSYCHOSOMATICS, V39, P175, DOI 10.1016/S0033-3182(98)71368-4; Golden EC, 2015, BRAIN, V138, P3793, DOI 10.1093/brain/awv286; Griffiths TD, 2000, BRAIN, V123, P2065, DOI 10.1093/brain/123.10.2065; Hori H, 2001, PSYCHOPATHOLOGY, V34, P164, DOI 10.1159/000049301; Sugishita M, 2007, JAPANESE VERSION WEC; Teunisse RJ, 1996, LANCET, V347, P794, DOI 10.1016/S0140-6736(96)90869-7; Watamori T, 2002, JAPANESE VERSION RIV	12	1	1	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1662-680X			CASE REP NEUROL	Case Rep. Neurol.		2018	10	1					7	11		10.1159/000481451			5	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	GI9NG	WOS:000434851200002	29515418	Green Published, gold			2022-02-06	
J	Kruppa, C; Dudda, M; Schildhauer, TA; Seybold, D				Kruppa, Christiane; Dudda, Marcel; Schildhauer, Thomas A.; Seybold, Dominik			Arthroscopic Treatment of a Posterior Labral Interposition after a Pediatric Hip Dislocation-A Case Report	EUROPEAN JOURNAL OF PEDIATRIC SURGERY REPORTS			English	Article						hip dislocation; arthroscopy; loose body; labral tear	CHILDREN; ADOLESCENTS; FRACTURE; RISK; MRI	We report the case of a 13-year-old boy, who suffered a posterior hip dislocation from playing soccer. Closed reduction was performed urgently. Because of a nonconcentric hip after closed reduction, further imaging was done. An intra-articular bony fragment was identified. Arthroscopic treatment was performed. Through an anterior portal we were able to locate the intra-articular bony fragment, which was located within the region of the fovea. After lifting of the caudal enfolded labral complex, we were able to remove the fragment. Evidence of a grade 3 cartilage defect was present at the femoral head. We were able to reduce the enfolded posterior labral complex, which was stable afterwards without the necessity of additional suture fixations. The concentric hip reduction was confirmed on an anteroposterior view of the hip postoperatively. The patient was instructed to toe tip weight-bearing for 6 weeks with limited range of motion to 60 degrees of hip flexion. Eight weeks after surgery, he was free of pain and discomforts. From our experience, the arthroscopic intervention after pediatric hip dislocation associated with intra-articular bony fragments or posterior labral complex injuries, represents to be a preferred minimally invasive method in contrast to open surgical procedures.	[Kruppa, Christiane; Schildhauer, Thomas A.; Seybold, Dominik] Ruhr Univ, BG Univ Hosp Bergmannsheil, Dept Gen & Trauma Surg, Bochum, Germany; [Dudda, Marcel] Univ Klinikum Essen, Dept Orthopaed & Traumatol, Essen, Nordrhein Westf, Germany		Kruppa, C (corresponding author), BG Univ Hosp Bergmannsheil, Dept Gen & Trauma Surg, Burkle de la Camp Pl 1, D-44789 Bochum, Germany.	Christiane.Kruppa@ruhr-uni-bochum.de		Schildhauer, Thomas/0000-0002-3232-9869	DFG Open Access Publication Funds of the Ruhr-Universitat Bochum	We acknowledge support by the DFG Open Access Publication Funds of the Ruhr-Universitat Bochum.	Alaia MJ, 2014, BULL HOSP JT DIS, V72, P154; Blanchard C, 2016, J PEDIATR ORTHOPED, V36, P602, DOI 10.1097/BPO.0000000000000507; Chun KA, 2004, SKELETAL RADIOL, V33, P728, DOI 10.1007/s00256-004-0800-z; Ganz R, 2001, J BONE JOINT SURG BR, V83B, P1119, DOI 10.1302/0301-620X.83B8.11964; Hwang Jung-Mo, 2016, Hip Pelvis, V28, P164, DOI 10.5371/hp.2016.28.3.164; Ilizaliturri VM, 2011, AM J SPORT MED, V39, p50S, DOI 10.1177/0363546511411642; Jayakumar P, 2012, J BONE JOINT SURG BR, V94B, P290, DOI 10.1302/0301-620X.94B3.26957; Kashiwagi N, 2001, ARTHROSCOPY, V17, P67, DOI 10.1053/jars.2001.8024; Kocher MS, 2005, J PEDIATR ORTHOPED, V25, P680, DOI 10.1097/01.bpo.0000161836.59194.90; Mayer SW, 2015, PEDIATR RADIOL, V45, P1355, DOI 10.1007/s00247-015-3317-9; Morris AC, 2017, J PEDIATR ORTHOPED, V37, P435, DOI 10.1097/BPO.0000000000000670; Nepple Jeffrey J, 2011, Iowa Orthop J, V31, P187; Ong C, 2013, CLIN ORTHOP RELAT R, V471, P1277, DOI 10.1007/s11999-012-2627-6; OUTERBRIDGE RE, 1961, J BONE JOINT SURG BR, V43, P752; Philippon MJ, 2013, J PEDIATR ORTHOPED, V33, pS126, DOI 10.1097/BPO.0b013e318274f834; Philippon MJ, 2009, ARTHROSCOPY, V25, P169, DOI 10.1016/j.arthro.2008.09.013; Podeszwa DA, 2015, J PEDIATR ORTHOPED, V35, P435, DOI 10.1097/BPO.0000000000000316; Roy DR, 2016, J HIP PRESERV SURG, V3, P97, DOI 10.1093/jhps/hnv070; Roy DR, 2009, J CHILD ORTHOP, V3, P89, DOI 10.1007/s11832-008-0143-8; Rubel IF, 2002, PEDIATR RADIOL, V32, P435, DOI 10.1007/s00247-001-0634-y; Wylie JD, 2015, J HIP PRESERV SURG, V2, P303, DOI 10.1093/jhps/hnv036	21	1	1	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	2194-7619	2194-7627		EUR J PEDIATR SURG R	Eur. J. Pediatr. Surg. Rep.	JAN	2018	6	1					e43	e47		10.1055/s-0038-1661408			5	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	GN0IR	WOS:000438647300001	30013888	gold, Green Published, Green Submitted			2022-02-06	
B	Kumar, A; Cox, CS		Atala, A; Cetrulo, KJ; Taghizadeh, RR; Murphy, SV; Cetrulo, CL		Kumar, Akshita; Cox, Charles S., Jr.			Human Umbilical Cord as Treatment for Traumatic Brain Injury in Children	PERINATAL STEM CELLS: RESEARCH AND THERAPY			English	Article; Book Chapter							MESENCHYMAL STEM-CELLS; TRANSPLANTATION; THERAPY		[Kumar, Akshita; Cox, Charles S., Jr.] Univ Texas Houston, McGovern Med Sch, Houston, TX 77004 USA		Kumar, A (corresponding author), Univ Texas Houston, McGovern Med Sch, Houston, TX 77004 USA.			Kumar, Akshita/0000-0002-4021-4092			Ali H, 2012, STEM CELL REV REP, V8, P210, DOI 10.1007/s12015-011-9287-x; Araki T, 2017, NEUROL MED-CHIR, V57, P82, DOI 10.2176/nmc.ra.2016-0191; Bedi SS, 2013, J TRAUMA ACUTE CARE, V75, P410, DOI 10.1097/TA.0b013e31829617c6; Carrade DD, 2011, CYTOTHERAPY, V13, P1180, DOI 10.3109/14653249.2011.602338; CDC, 2017, TRAUM BRAIN INJ CONC; Centers for Disease Control and Prevention, 2016, RAT TBI REL ER VIS A; Chen Jieli, 2006, NeuroRx, V3, P466, DOI 10.1016/j.nurx.2006.07.007; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Collins Christy L, 2014, Inj Epidemiol, V1, P13; Cox CS, 2017, STEM CELLS, V35, P1065, DOI 10.1002/stem.2538; Dalous J, 2012, PEDIATR RES, V71, P482, DOI 10.1038/pr.2011.67; Guan J, 2013, BIOMATERIALS, V34, P5937, DOI 10.1016/j.biomaterials.2013.04.047; Hankinson TC, 2016, WORLD NEUROSURG, V92, P540, DOI 10.1016/j.wneu.2016.06.012; Hsieh JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072604; Jackson ML, 2017, J SURG RES, V214, P38, DOI 10.1016/j.jss.2017.02.078; Kannan Nithya, 2014, Int J Crit Illn Inj Sci, V4, P131, DOI 10.4103/2229-5151.134152; Meier C, 2006, PEDIATR RES, V59, P244, DOI 10.1203/01.pdr.0000197309.08852.f5; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Secco M, 2008, STEM CELLS, V26, P146, DOI 10.1634/stemcells.2007-0381; Stevenson CB, 2014, OPERATIVE PEDIAT SUR; Wang S, 2013, BRAIN RES, V1532, P76, DOI 10.1016/j.brainres.2013.08.001; Wang YW, 2012, STEM CELLS DEV, V21, P1401, DOI 10.1089/scd.2011.0441; Weiss ML, 2006, STEM CELLS, V24, P781, DOI 10.1634/stemcells.2005-0330; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Yang CC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003336	25	1	1	0	1	ACADEMIC PRESS LTD-ELSEVIER SCIENCE LTD	LONDON	125 LONDON WALL, LONDON EC2Y 5AS, ENGLAND			978-0-12-812063-7; 978-0-12-812015-6				2018							249	255		10.1016/B978-0-12-812015-6.00018-2	10.1016/C2016-0-00794-5		7	Cell & Tissue Engineering; Medicine, Research & Experimental	Book Citation Index – Science (BKCI-S)	Cell Biology; Research & Experimental Medicine	BP0PO	WOS:000535857000019					2022-02-06	
J	Lah, S; David, P; Donohue, H; Epps, A; Tate, R; Brookes, N				Lah, Suncica; David, Pamela; Donohue, Hayley; Epps, Adrienne; Tate, Robyn; Brookes, Naomi			PTA scale for children aged 4 to 7 years: Selecting developmentally valid and reliable items	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						Children; memory; orientation; posttraumatic amnesia	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC AMNESIA; YOUNG-CHILDREN; HEAD-INJURY; MEMORY; ORIENTATION; DURATION	The aim of this study was to select developmentally valid and reliable items for inclusion in criterion-referenced (pass > 90%) posttraumatic amnesia (PTA) scale for children aged 4 to 7 years in a prospective cohort study. Fifty-two typically developing children (26 male/26 female) aged 4 to 7 years were administered a set of 10 items (5 orientation, 5 memory) over 3-4 days. The total score obtained on the set of 10 items had poor developmental validity and test-retest reliability. Nevertheless, individual item analysis identified five items (three orientation and two memory items) that were consistently passed by >90% of the children on each day of testing. For these five items the total scores did not differ significantly either between age groups or between days of testing. Test-retest was extremely high (close to 1). The five items had excellent developmental validity and test-retest reliability. This study identified 5 (3 orientation and 2 memory) items that met our selection criterion and form a new PTA scale, the Sydney PTA scale (SYPTAS), for children aged 4 to 7 years.	[Lah, Suncica; David, Pamela; Donohue, Hayley] Univ Sydney, Sch Psychol, Sydney, NSW, Australia; [Lah, Suncica; Donohue, Hayley] Australian Res Council Ctr Excellence Cognit & It, Sydney, NSW, Australia; [Epps, Adrienne; Brookes, Naomi] Sydney Childrens Hosp, Brain Injury Rehabil Program, Randwick, NSW, Australia; [Tate, Robyn] NHMRC Ctr Res Excellence Traumat Brain Injury Reh, Sydney, NSW, Australia; [Tate, Robyn] Univ Sydney, Sydney Med Sch, Rehabil Studies Unit, Northern Clin Sch, Sydney, NSW, Australia		Lah, S (corresponding author), Univ Sydney, Sch Psychol A18, Sydney, NSW 2008, Australia.	suncica.lah@sydney.edu.au		Lah, Suncica/0000-0003-2282-4812			Akobeng AK, 2007, ACTA PAEDIATR, V96, P338, DOI 10.1111/j.1651-2227.2006.00180.x; Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; de Haan M, 2006, TRENDS NEUROSCI, V29, P374, DOI 10.1016/j.tins.2006.05.008; EWINGCOBBS L, 1990, NEUROSURGERY, V27, P683, DOI 10.1227/00006123-199011000-00003; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Fernando K., 2002, BRAIN IMPAIR, V3, P34, DOI [10.1375/brim.3.1.34, DOI 10.1375/BRIM.3.1.34]; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Javouhey E, 2006, EUR J PEDIATR, V165, P519, DOI 10.1007/s00431-006-0118-z; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MAROSSZEKY NEV, 1993, CLIN NEUROPSYCHOL, V7, P85, DOI 10.1080/13854049308401890; Pink B., 2011, SOCIOECONOMIC INDEX; Rocca A, 2008, BRAIN IMPAIR, V9, P14, DOI 10.1375/brim.9.1.14; RUIJS MBM, 1992, DEV MED CHILD NEUROL, V34, P885; Sattler J. M., 2004, ASSESSMENT CHILDREN; SCHECTER DAVID E., 1955, JOUR NERV AND MENTAL DIS, V121, P301, DOI 10.1097/00005053-195504000-00001; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Snow P, 2013, TRAUMATIC BRAIN INJU, P34; Tate RL, 2001, J HEAD TRAUMA REHAB, V16, P525, DOI 10.1097/00001199-200112000-00002; Taylor HG, 2008, J INT NEUROPSYCH SOC, V14, P734, DOI 10.1017/S1355617708081150; Wechsler D., 2002, WECHSLER PRESCHOOL P; Wechsler D, 2005, WECHSLER INTELLIGENC; Wheeler MA, 1997, PSYCHOL BULL, V121, P331, DOI 10.1037/0033-2909.121.3.331; Willoughby KA, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00053	23	1	1	0	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child		2018	7	3					257	267		10.1080/21622965.2017.1306443			11	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	GR5KM	WOS:000442669800008	28388214				2022-02-06	
J	Lindsey, A; Marquardt, TP; Harris, JL				Lindsey, Andre; Marquardt, Thomas P.; Harris, Joyce L.			Semantic and phonological retrieval in traumatic brain injury	APHASIOLOGY			English	Article						Traumatic brain injury; retrieval; semantic; phonological; memory	CLOSED-HEAD INJURY; FUZZY-TRACE THEORY; FALSE-MEMORY; OLDER ADULTS; COGNITIVE IMPAIRMENT; SEX-DIFFERENCES; DEFICITS; RECALL; YOUNG; ASSOCIATIONS	Background: Identifying associations or links between encoded stimuli can influence whether those stimuli are successfully retrieved at a later time. Aims: The purpose of this study was to investigate the influence of semantic and phonological lexical targets on recall in individuals with mild to moderate traumatic brain injury (TBI) and to identify if individuals with TBI form associations when recalling related information. Methods & Procedures: Forty-seven individuals, 14 with TBI, completed the Deese-Roediger-McDermott (DRM) word retrieval paradigm in which six digitally recorded word lists were presented auditorily. Three of the lists contained semantically related words and three contained phonologically related words. Outcomes & Results: Non-brain-injured (NBI) participants recalled significantly more phonological and semantic stimuli than participants with TBI. Phonologically related stimuli resulted in increased intrusions for both TBI and NBI participants. For participants with TBI, age and time post injury were not significantly correlated with performance on the DRM paradigm, though the number of semantically related items recalled was moderately correlated with performance on standardised assessments. Though TBI participants recalled fewer words, they appeared to utilise recall strategies in a manner similar to NBI peers with intrusion data suggesting that both groups were forming associations between words. Conclusions: Individuals with mild to moderate TBI successfully identify associations between encoded stimuli and used those associations when recalling target information.	[Lindsey, Andre; Marquardt, Thomas P.; Harris, Joyce L.] Univ Texas Austin, Dept Commun Sci & Disorders, Austin, TX 78712 USA; [Lindsey, Andre] Univ Connecticut, Dept Speech Language & Hearing Sci, Storrs, CT 06269 USA		Lindsey, A (corresponding author), Univ Texas Austin, Dept Commun Sci & Disorders, Austin, TX 78712 USA.; Lindsey, A (corresponding author), Univ Connecticut, Dept Speech Language & Hearing Sci, Storrs, CT 06269 USA.	andre.lindsey@uconn.edu		Lindsey, Andre/0000-0002-2489-0808	American Speech-Language Hearing Association Students Preparing for Academic-Research Careers award	This study was funded by support from the American Speech-Language Hearing Association Students Preparing for Academic-Research Careers award.	Adamovich B. B., 1992, SCALES COGNITIVE ABI; Andreano JM, 2009, LEARN MEMORY, V16, P248, DOI 10.1101/lm.918309; BRAINERD CJ, 1990, DEV REV, V10, P3, DOI 10.1016/0273-2297(90)90003-M; Brainerd CJ, 2002, CHILD DEV, V73, P1363, DOI 10.1111/1467-8624.00477; Brainerd CJ, 2002, CURR DIR PSYCHOL SCI, V11, P164, DOI 10.1111/1467-8721.00192; Brainerd CJ, 2002, J MEM LANG, V46, P120, DOI 10.1006/jmla.2001.2796; BURKE DM, 1991, J MEM LANG, V30, P542, DOI 10.1016/0749-596X(91)90026-G; Busch RM, 2005, J CLIN EXP NEUROPSYC, V27, P1022, DOI 10.1080/13803390490919263; Casarin Fabíola Schwengber, 2014, Dement. neuropsychol., V8, P266, DOI 10.1590/S1980-57642014DN83000011; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Coelho CA, 2005, BRAIN INJURY, V19, P1139, DOI 10.1080/02699050500110678; Coelho C, 2013, AM J SPEECH-LANG PAT, V22, pS438, DOI 10.1044/1058-0360(2013/12-0076); Curtiss G, 2001, J INT NEUROPSYCH SOC, V7, P574, DOI 10.1017/S1355617701755051; Delis D.C., 2000, CALIFORNIA VERBAL LE; Dewhurst SA, 2004, PSYCHOL SCI, V15, P782, DOI 10.1111/j.0956-7976.2004.00756.x; Dimoska-Di Marco A, 2011, J CLIN EXP NEUROPSYC, V33, P471, DOI 10.1080/13803395.2010.533158; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Hampstead BM, 2012, NEUROPSYCHOLOGY, V26, P385, DOI 10.1037/a0027545; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P284, DOI 10.1037/0894-4105.18.2.284; James LE, 2000, J EXP PSYCHOL LEARN, V26, P1378, DOI 10.1037//0278-7393.26.6.1378; Kimura D, 2003, PSYCHOL REP, V93, P263, DOI 10.2466/PR0.93.5.263-264; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; Lukatela G, 1996, PERCEPT PSYCHOPHYS, V58, P823, DOI 10.3758/BF03205486; Mcwilliams J, 2008, BRAIN INJURY, V22, P243, DOI 10.1080/02699050801935252; Payne JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033079; Paz-Alonso PM, 2013, SCHIZOPHR RES, V147, P320, DOI 10.1016/j.schres.2013.04.007; Perri R, 2000, CORTEX, V36, P213, DOI 10.1016/S0010-9452(08)70525-2; Ries M, 2006, NEUROPSYCHOLOGIA, V44, P2233, DOI 10.1016/j.neuropsychologia.2006.05.021; ROEDIGER HL, 1995, J EXP PSYCHOL LEARN, V21, P803, DOI 10.1037/0278-7393.21.4.803; Roediger HL, 2001, PSYCHON B REV, V8, P385, DOI 10.3758/BF03196177; Slewa-Younan S, 2004, ARCH PHYS MED REHAB, V85, P376, DOI 10.1016/j.apmr.2003.05.007; Sohlberg M., 2001, COGNITIVE REHABILITA; Sohlberg M.M., 2011, OPTIMIZING COGNITIVE; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; Watson JM, 2001, NEUROPSYCHOLOGY, V15, P254, DOI 10.1037//0894-4105.15.2.254; Wiegner S, 1999, J CLIN EXP NEUROPSYC, V21, P159, DOI 10.1076/jcen.21.2.159.925	38	1	1	1	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0268-7038	1464-5041		APHASIOLOGY	Aphasiology		2018	32	2					233	246		10.1080/02687038.2017.1338660			14	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	FY9PQ	WOS:000427199100006					2022-02-06	
J	Liu, J; Hu, XM; Li, XJ; Zhao, H				Liu, Jie; Hu, Xue-Ming; Li, Xiao-Jian; Zhao, Hui			Traumatic stress affects alcohol-drinking behavior through cocaine- and amphetamine-regulated transcript 55-102 in the paraventricular nucleus in rats	MOLECULAR MEDICINE REPORTS			English	Article						alcohol drinking behavior; cocaine- and amphetamine-regulated transcript 55-102; traumatic stress; hypothalamus-pituitary-adrenal axis	CONTEXT-INDUCED REINSTATEMENT; PITUITARY-ADRENAL AXIS; VENTRAL TEGMENTAL AREA; CART PEPTIDES; DRUG-DEPENDENCE; MESSENGER-RNA; BRAIN-INJURY; REWARD; CONSUMPTION; SEEKING	Cumulative evidence has suggested an association between stress and alcohol self-administration; however, less is known about the role of traumatic stress in alcohol drinking behavior. It has been reported that cocaine- and amphetamine-regulated transcript (CART) 55-102 may be involved in mediating stress responses and regulating reward and reinforcement. The aim of the present study was to evaluate the role of CART 55-102 in alcohol drinking behavior of rats in the presence or absence of traumatic stress. Alcohol drinking behavior was examined using the two-bottle choice drinking paradigm (one bottle contained 10% alcohol and the other contained filtered water), which was initiated 1, 3 and 7 days post-trauma (T1, T3 and T7), for 14 days in rats; the control group was initiated from T0. The results indicated that exposure to trauma significantly increased alcohol consumption and preference, particularly drinking from T3. Immunohistochemistry revealed that the lowest level of CART 55-102 immunoreactivity within the paraventricular nucleus (PVN) was exhibited in the T3 group. Additionally, an intra-PVN injection of CART 55-102 attenuated alcohol-drinking behavior in a dose-dependent manner, in the T3 group. Furthermore, the significant increase in circulating adrenocorticotrophic hormone (ACTH) and corticosterone (CORT) concentrations in the T3 group were inhibited by CART 55-102 administration to the PVN, in particular CORT levels were significantly decreased. Positive correlations between alcohol preference and ACTH and CORT levels were also observed. These results indicated that CART 55-102 in the PVN serves an inhibitory role in traumatic stress-induced alcohol drinking behavior, possibly through disturbing hypothalamus-pituitary-adrenal axis hyperactivity.	[Liu, Jie; Hu, Xue-Ming; Li, Xiao-Jian; Zhao, Hui] Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, Dept Integrat Med & Neurobiol, 138 Yixueyuan Rd, Shanghai 200032, Peoples R China		Zhao, H (corresponding author), Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, Dept Integrat Med & Neurobiol, 138 Yixueyuan Rd, Shanghai 200032, Peoples R China.	mayzhao1122@yahoo.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471370, 81573712]	The present study was supported by grants from the National Natural Science Foundation of China (grant nos. 81471370 and 81573712). The authors would like to thank Dr. Qiu-Qin Han (School of Basic Medical Sciences, Fudan University, Shanghai, China) for her help in revising the manuscript.	Adams RS, 2013, SUBST USE MISUSE, V48, P821, DOI 10.3109/10826084.2013.797995; Anthenelli R, 2012, ALCOHOL RES-CURR REV, V34, P381; Bakhtazad A, 2016, PEPTIDES, V84, P1, DOI 10.1016/j.peptides.2016.06.010; Balkan B, 2006, NEUROPEPTIDES, V40, P185, DOI 10.1016/j.npep.2006.02.001; Becker HC, 2011, PSYCHOPHARMACOLOGY, V218, P131, DOI 10.1007/s00213-011-2443-9; Beckwith SW, 2016, ALCOHOL CLIN EXP RES, V40, P1100, DOI 10.1111/acer.13044; Blednov YA, 2011, BRAIN BEHAV IMMUN, V25, pS92, DOI 10.1016/j.bbi.2011.01.008; Blednov YA, 2012, ADDICT BIOL, V17, P108, DOI 10.1111/j.1369-1600.2010.00284.x; Chen YW, 2014, ALCOHOL, V48, P657, DOI 10.1016/j.alcohol.2014.08.005; Cook CJ, 2004, PHYSIOL BEHAV, V82, P751, DOI 10.1016/j.physbeh.2004.06.013; Dandekar MP, 2008, BRAIN RES, V1240, P119, DOI 10.1016/j.brainres.2008.09.023; Deroche V, 1997, J PHARMACOL EXP THER, V281, P1401; Dimopoulou I, 2008, HORM-INT J ENDOCRINO, V7, P237, DOI 10.14310/horm.2002.1203; DOUGLASS J, 1995, J NEUROSCI, V15, P2471; FAHLKE C, 1995, PSYCHOPHARMACOLOGY, V117, P216, DOI 10.1007/BF02245190; Federico A, 2015, EUR REV MED PHARMACO, V19, P1922; Feng XM, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-225; Galesi FL, 2016, EUR J PHARMACOL, V788, P84, DOI 10.1016/j.ejphar.2016.06.020; Herman JP, 2003, FRONT NEUROENDOCRIN, V24, P151, DOI 10.1016/j.yfrne.2003.07.001; Janet C, 2010, GUIDE CARE USE LAB A; Jaworski JN, 2003, LIFE SCI, V73, P741, DOI 10.1016/S0024-3205(03)00394-1; Kimmel HL, 2000, J PHARMACOL EXP THER, V294, P784; King BJ, 2010, BEHAV NEUROSCI, V124, P423, DOI 10.1037/a0019540; Koob G, 2007, AM J PSYCHIAT, V164, P1149, DOI 10.1176/appi.ajp.2007.05030503; Koob GF, 2004, NEUROSCI BIOBEHAV R, V27, P739, DOI 10.1016/j.neubiorev.2003.11.007; Koob GF, 2001, NEUROPSYCHOPHARMACOL, V24, P97, DOI 10.1016/S0893-133X(00)00195-0; Koylu EO, 1997, J NEUROENDOCRINOL, V9, P823, DOI 10.1046/j.1365-2826.1997.00651.x; Koylu EO, 2006, PEPTIDES, V27, P1956, DOI 10.1016/j.peptides.2006.03.032; Kristensen P, 1998, NATURE, V393, P72, DOI 10.1038/29993; Kuhar MJ, 1999, SYNAPSE, V33, P163, DOI 10.1002/(SICI)1098-2396(19990901)33:3<163::AID-SYN1>3.0.CO;2-T; Linthorst ACE, 2008, PHARMACOL BIOCHEM BE, V90, P163, DOI 10.1016/j.pbb.2007.09.019; Marco EM, 2017, PHARMACOL BIOCHEM BE, V152, P68, DOI 10.1016/j.pbb.2016.11.005; Millan EZ, 2012, BEHAV NEUROSCI, V126, P690, DOI 10.1037/a0029953; Mou Huilin XZXL, 2016, DRUG METABOL TOXICOL, V5; Ostroumov A, 2016, NEURON, V92, P493, DOI 10.1016/j.neuron.2016.09.029; Rogge G, 2008, NAT REV NEUROSCI, V9, P747, DOI 10.1038/nrn2493; Sharma A, 2014, PSYCHONEUROENDOCRINO, V50, P194, DOI 10.1016/j.psyneuen.2014.08.019; Smith SM, 2004, ENDOCRINOLOGY, V145, P5202, DOI 10.1210/en.2004-0708; Sperling RE, 2010, PSYCHOPHARMACOLOGY, V210, P199, DOI 10.1007/s00213-010-1844-5; Stanley SA, 2004, AM J PHYSIOL-ENDOC M, V287, pE583, DOI 10.1152/ajpendo.00576.2003; Stanley SA, 2001, BRAIN RES, V893, P186, DOI 10.1016/S0006-8993(00)03312-6; Sun CM, 2015, INT J CLIN EXP MED, V8, P15738; Ursano RJ, 2009, BRAIN RES, V1293, P2, DOI 10.1016/j.brainres.2009.03.030; Wan YJ, 2010, CRIT CARE MED, V38, P2190, DOI 10.1097/CCM.0b013e3181f17bcb; Weil ZM, 2016, J NEUROTRAUM, V33, P895, DOI 10.1089/neu.2015.3953; Xiao S, 2009, BRAIN RES, V1255, P162, DOI 10.1016/j.brainres.2008.12.007; Zhao H, 2002, NEUROSCIENCE, V114, P1019, DOI 10.1016/S0306-4522(02)00233-6	47	1	1	2	6	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	JAN	2018	17	1					1157	1165		10.3892/mmr.2017.7989			9	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	FT8WG	WOS:000423433300148	29115641	Bronze			2022-02-06	
J	Maiman, D; Pintar, F; Malik, W; Yoganandan, N				Maiman, Dennis; Pintar, Frank; Malik, Waqar; Yoganandan, Narayan			AIS scores in spine and spinal cord trauma: Epidemiological considerations	TRAFFIC INJURY PREVENTION			English	Article						AIS; spine injury; spinal cord injury; demographics	LONG-TERM OUTCOMES; ODONTOID FRACTURES; CONSECUTIVE SERIES; ELDERLY-PATIENTS; DUAL DIAGNOSIS; BRAIN-INJURY; MANAGEMENT; COMPLICATIONS; MORTALITY; SURGERY	Background: The Abbreviated Injury Scale (AIS) is an internationally accepted coding system created by the Association for the Advancement of Automotive Medicine, utilized to code traumatic injuries as a function of severity, the latter often defined as mortality risk. Periodic reassessment of that risk is prudent, in light of advances in health care and relationship of nonanatomic factors to death.Objective: The objective of this study was to reevaluate the risk of death associated with spine fractures with and without neurologic deficit, age factors associated with it, and the impact of hospital coding on the accuracy of these efforts.Methods: Medical records and imaging of patients treated at a level 1 trauma center from 2014 through 2016 with discharge International Classification of Diseases, 10th revision (ICD-10) diagnoses of spinal trauma and spinal cord injury (SCI) were reviewed. Data were collected on demographics, complications, neurologic status, and outcomes.Results: Three hundred seventy patients met the criteria for inclusion in this effort. Errors in ICD-10 discharge codes were seen in 45% of the cases, both false positive and negative. One hundred thirty-four patients, with a mean age of 45, were admitted with neurologic deficit. There were 8 SCI-related deaths; 2 were postoperative out of 110 undergoing surgical treatment. All deaths in this group were in patients with upper level SCI, with a mean age of 68. Ten patients had spontaneous neurologic improvement within 24h. One hundred nineteen patients without deficit had AIS 2 scored fractures; there was one postoperative death out of 47 patients undergoing surgical treatment. One hundred seventeen patients without deficit suffered AIS 3 fractures; 66 underwent surgery without any deaths. There was one nonoperative death. Age and high quadriplegia were the only factors associated with mortality.Conclusions: Mortality risk in patients with deficit was associated more with age at injury than extent of anatomic injury. Spine trauma without neurologic deficit is benign in younger populations and AIS scores could be age adjusted. Mortality risk is higher in high cervical injuries with neurologic deficit and in the elderly. An incidental finding is that demographic studies based solely on discharge ICD coding may contain errors and should be considered critically.	[Maiman, Dennis; Pintar, Frank; Malik, Waqar; Yoganandan, Narayan] Med Coll Wisconsin, Dept Neurosurg, 9200 West Wisconsin Ave, Milwaukee, WI 53226 USA; [Pintar, Frank] Med Coll Wisconsin, Dept Biomed Engn, Milwaukee, WI 53226 USA		Maiman, D (corresponding author), Med Coll Wisconsin, Dept Neurosurg, 9200 West Wisconsin Ave, Milwaukee, WI 53226 USA.	dmaiman@mcw.edu					Agresti A., 2013, CATEGORICAL DATA ANA, V3; Association for the Advancement of Automotive Medicine, 2005, ABBR INJ SCAL; Association for the Advancement of Automotive Medicine, 1994, INJ IMPL SCAL; Association for the Advancement of Automotive Medicine, 2015, ABBR INJ SCAL; Chapman J, 2013, SPINE, V38, P1098, DOI 10.1097/BRS.0b013e318286f0cf; Di Battista AP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0500-3; Drazin D, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/3623875; Fredo HL, 2016, BMC SURG, V16, DOI 10.1186/s12893-016-0172-z; Furlan JC, 2009, J NEUROTRAUM, V26, P1707, DOI [10.1089/neu.2009.0888, 10.1089/neu.2009-0888]; Greene KA, 1997, SPINE, V22, P1843, DOI 10.1097/00007632-199708150-00009; He B, 2016, SPINE J, V16, P547, DOI 10.1016/j.spinee.2015.11.065; Kaminski L, 2017, J NEUROTRAUM, V34, P2027, DOI 10.1089/neu.2016.4955; Kushner DS, 2014, PHYS MED REH CLIN N, V25, P681, DOI 10.1016/j.pmr.2014.04.005; Lenehan B, 2012, SPINE, V37, P321, DOI 10.1097/BRS.0b013e31822e5ff8; Macciocchi S, 2008, ARCH PHYS MED REHAB, V89, P1350, DOI 10.1016/j.apmr.2007.11.055; MAIMAN DJ, 1982, NEUROSURGERY, V11, P471, DOI 10.1097/00006123-198212000-00022; Meldon SW, 1995, J TRAUMA, V39, P1110, DOI 10.1097/00005373-199512000-00017; Miller Christopher P, 2015, Am J Orthop (Belle Mead NJ), V44, pE173; Miller Matthew L, 2008, Ann Adv Automot Med, V52, P101; Oliver M, 2012, INJURY, V43, P1296, DOI 10.1016/j.injury.2012.04.021; Pirouzmand F, 2010, J NEUROSURG-SPINE, V12, P131, DOI 10.3171/2009.9.SPINE0943; Rizvi SAM, 2012, J TRAUMA ACUTE CARE, V72, P682, DOI 10.1097/TA.0b013e318236b675; Ryang YM, 2016, WORLD NEUROSURG, V87, P381, DOI 10.1016/j.wneu.2015.12.026; Schoenfeld AJ, 2011, SPINE, V36, P879, DOI 10.1097/BRS.0b013e3181e8e77c; Selvarajah S, 2014, J NEUROTRAUM, V31, P228, DOI 10.1089/neu.2013.3098; Soliman HM, 2016, TRAFFIC INJ PREV, V17, P11, DOI 10.1080/15389588.2016.1198870; Sommer JL, 2004, BRAIN INJURY, V18, P1297, DOI 10.1080/02699050410001672288; Stein DM, 2010, NEUROCRIT CARE, V13, P29, DOI 10.1007/s12028-010-9359-9; Stricsek G, 2017, NEUROSURG CLIN N AM, V28, P147, DOI 10.1016/j.nec.2016.08.007; Tee JW, 2013, GLOB SPINE J, V3, P75, DOI 10.1055/s-0033-1337124; The World Health Organization, 2010, INT CLASS DIS; Thesleff T, 2016, SPINE J, V16, P918, DOI 10.1016/j.spinee.2015.11.054; Wang TY, 2016, SPINE, V41, P438, DOI 10.1097/BRS.0000000000001249	33	1	1	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-9588	1538-957X		TRAFFIC INJ PREV	Traffic Inj. Prev.		2018	19			1			S169	S173		10.1080/15389588.2017.1410144			5	Public, Environmental & Occupational Health; Transportation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Transportation	GA9TD	WOS:000428682800026	29584506				2022-02-06	
B	McCulloh, C; Zhou, Y; Besner, GE		Atala, A; Cetrulo, KJ; Taghizadeh, RR; Murphy, SV; Cetrulo, CL		McCulloh, Christopher; Zhou, Yu; Besner, Gail E.			Transplantation of Amniotic Fluid-Derived Neural Stem Cells	PERINATAL STEM CELLS: RESEARCH AND THERAPY			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; SPINAL-CORD; NECROTIZING ENTEROCOLITIS; SCHWANN-CELLS; HIRSCHSPRUNGS-DISEASE; FUNCTIONAL RECOVERY; GROWTH-FACTOR; EXOSOMAL RNA; RAT MODEL; DIFFERENTIATION		[McCulloh, Christopher; Zhou, Yu; Besner, Gail E.] Nationwide Childrens Hosp, Columbus, OH 43205 USA		McCulloh, C (corresponding author), Nationwide Childrens Hosp, Columbus, OH 43205 USA.						Ahmed AI, 2016, J ROY ARMY MED CORPS, V162, P98, DOI 10.1136/jramc-2015-000475; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI 10.1161/CIR.0000000000000485; Bethell G, 2016, J PEDIATR SURG, V51, P1581, DOI 10.1016/j.jpedsurg.2016.06.006; Biocell Center Corporation, 2010, PRES AMN FLUID STEM; Bliss T, 2007, STROKE, V38, P817, DOI 10.1161/01.STR.0000247888.25985.62; BRUNDIN P, 1986, EXP BRAIN RES, V65, P235; Centers for Disease Control, 2017, PREV SEV TBI; Chang DJ, 2013, CELL TRANSPLANT, V22, P1427, DOI 10.3727/096368912X657314; Chen XH, 2003, J NEUROTRAUM, V20, P623, DOI 10.1089/089771503322144545; Cheng LS, 2016, PEDIAT RES NOVEMBER, V2017, P1; Cipriani S, 2007, CELL BIOL INT, V31, P845, DOI 10.1016/j.cellbi.2007.01.037; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; COUSINEAU J, 1982, PRENATAL DIAG, V2, P241, DOI 10.1002/pd.1970020402; Cunningham FG, 2010, WILLIAMS OBSTET, P1239; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; Duess JW, 2014, PEDIATR SURG INT, V30, P791, DOI 10.1007/s00383-014-3540-8; Eaton S, 2013, EXPERT OPIN BIOL TH, V13, P1683, DOI 10.1517/14712598.2013.849690; Edgar JR, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0268-z; Eldh M, 2012, MOL IMMUNOL, V50, P278, DOI 10.1016/j.molimm.2012.02.001; Fattahi F, 2016, NATURE, V531, P105, DOI 10.1038/nature16951; Fauza D, 2004, BEST PRACT RES CL OB, V18, P877, DOI 10.1016/j.bpobgyn.2004.07.001; Fei XT, 2013, CELL BIOCHEM BIOPHYS, V67, P689, DOI 10.1007/s12013-013-9558-z; Fitzgibbons SC, 2009, J PEDIATR SURG, V44, P1072, DOI 10.1016/j.jpedsurg.2009.02.013; Fitzsimons CP, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-25; Galindo LT, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/564089; Gardiner C, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.19671; Gazalah H, 2016, METHODS MOL BIOL, V1462, P689, DOI 10.1007/978-1-4939-3816-2_38; Gholizadeh-Ghalehaziz S, 2015, INT J STEM CELLS, V8, P115, DOI 10.15283/ijsc.2015.8.2.115; GOSDEN CM, 1983, BRIT MED BULL, V39, P348, DOI 10.1093/oxfordjournals.bmb.a071847; Harting MT, 2009, J SURG RES, V153, P188, DOI 10.1016/j.jss.2008.03.037; Hartmann K, 2013, AM J STEM CELLS, V2, P108; Hatada I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003189; Hill CE, 2007, EUR J NEUROSCI, V26, P1433, DOI 10.1111/j.1460-9568.2007.05771.x; HOEHN H, 1982, METHOD CELL BIOL, V26, P11; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; Hotta R, 2016, NEUROGASTROENT MOTIL, V28, P498, DOI 10.1111/nmo.12744; Juliandi B, 2010, DEV GROWTH DIFFER, V52, P493, DOI 10.1111/j.1440-169X.2010.01175.x; Kanno H, 2015, REV NEUROSCIENCE, V26, P121, DOI 10.1515/revneuro-2014-0068; Kefalopoulou Z, 2014, JAMA NEUROL, V71, P83, DOI 10.1001/jamaneurol.2013.4749; Kim EY, 2014, HUM CELL, V27, P51, DOI 10.1007/s13577-013-0080-9; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Lasser C, 2012, EXPERT OPIN BIOL TH, V12, pS189, DOI 10.1517/14712598.2012.680018; Lau P, 2008, J NEUROSCI, V28, P11720, DOI 10.1523/JNEUROSCI.1932-08.2008; LINDVALL O, 1988, LANCET, V2, P1483; Liu SJ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-66; Lunyak VV, 2005, CELL, V121, P499, DOI 10.1016/j.cell.2005.05.003; Ma HY, 2011, MOL MED REP, V4, P849, DOI 10.3892/mmr.2011.510; Maguire CT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053372; Marsh SE, 2017, NEUROCHEM INT, P1; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; Mathieu P, 2010, J NEUROCHEM, V112, P1368, DOI 10.1111/j.1471-4159.2009.06548.x; McCulloh CJ, 2017, J SURG RES, V214, P278, DOI 10.1016/j.jss.2017.03.026; McCulloh CJ, 2017, J PEDIATR SURG, V52, P999, DOI 10.1016/j.jpedsurg.2017.03.028; McGovern Institute for Brain Research at MIT, 2014, BRAIN DIS NUMB; Molina-Holgado E, 2010, J NEUROCHEM     0706, P114; Mun-Fun H, 2015, RES VET SCI, V102, P89, DOI 10.1016/j.rvsc.2015.07.010; Nakashima K., 2016, NEUROEPIGENETICS, V5, P1, DOI [10.1016/j.nepig.2016.01.001, DOI 10.1016/J.NEPIG.2016.01.001]; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Nori S, 2015, STEM CELL REP, V4, P360, DOI 10.1016/j.stemcr.2015.01.006; Orciani M, 2011, J BIOL REG HOMEOS AG, V25, P115; Ostergard D R, 1970, Obstet Gynecol Surv, V25, P297, DOI 10.1097/00006254-197004000-00001; Pappa KI, 2009, REGEN MED, V4, P423, DOI 10.2217/RME.09.12; Pierce J, 2016, CELL TISSUE BANK, V17, P413, DOI 10.1007/s10561-016-9572-7; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prusa Andrea-Romana, 2002, Med Sci Monit, V8, pRA253; Qin MD, 2016, INT J BIOL SCI, V12, P558, DOI 10.7150/ijbs.11051; Rager TM, 2016, J PEDIATR SURG, V51, P942, DOI 10.1016/j.jpedsurg.2016.02.061; Rehni AK, 2007, BEHAV BRAIN RES, V183, P95, DOI 10.1016/j.bbr.2007.05.028; Roubelakis MG, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/107836; Roubelakis MG, 2011, J CELL MOL MED, V15, P1896, DOI 10.1111/j.1582-4934.2010.01180.x; Schmidt W, 1992, Adv Anat Embryol Cell Biol, V127, P1; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Shamberger R., 2012, PEDIAT SURG, P1265, DOI 10.1016/B978-0-323-07255-7.00101-X; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Shear DA, 2011, RESTOR NEUROL NEUROS, V29, P215, DOI 10.3233/RNN-2011-0593; Shi ZS, 2010, STROKE, V41, P1185, DOI 10.1161/STROKEAHA.109.568451; Shimozaki K, 2005, J NEUROCHEM, V93, P432, DOI 10.1111/j.1471-4159.2005.03031.x; Singh RP, 2009, CELL TRANSPLANT, V18, P1197, DOI 10.3727/096368909X12483162197204; Tajiri N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043779; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Underwood Mark A, 2005, J Perinatol, V25, P341, DOI 10.1038/sj.jp.7211290; Wang HB, 2012, ARCH MED SCI, V8, P563, DOI 10.5114/aoms.2012.29412; Wang JM, 2011, BIOMATERIALS, V32, P7454, DOI 10.1016/j.biomaterials.2011.06.036; Wang KH, 2015, BIOTECHNOL APPL BIOC, V62, P591, DOI 10.1002/bab.1315; Wei J, 2015, PEDIATR RES, V78, P29, DOI 10.1038/pr.2015.63; Xiong Y, 2017, NEURAL REGEN RES, V12, P19, DOI 10.4103/1673-5374.198966; Yan ZJ, 2013, NEUROCHEM RES, V38, P1022, DOI 10.1007/s11064-013-1012-5; Yang JX, 2012, J AM COLL SURGEONS, V215, P534, DOI 10.1016/j.jamcollsurg.2012.05.037; Young HE, 2001, ANAT RECORD, V263, P350, DOI 10.1002/ar.1112; Yuan T, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt224; Zani A, 2014, EUR J PEDIATR SURG, V24, P57, DOI 10.1055/s-0033-1350059; Zani A, 2014, GUT, V63, P300, DOI 10.1136/gutjnl-2012-303735; Zhang J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/727542; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579; Zhou Y, 2016, J PEDIATR SURG, V51, P87, DOI 10.1016/j.jpedsurg.2015.10.016; Zhou Y, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt387	99	1	1	0	0	ACADEMIC PRESS LTD-ELSEVIER SCIENCE LTD	LONDON	125 LONDON WALL, LONDON EC2Y 5AS, ENGLAND			978-0-12-812063-7; 978-0-12-812015-6				2018							39	51		10.1016/B978-0-12-812015-6.00003-0	10.1016/C2016-0-00794-5		13	Cell & Tissue Engineering; Medicine, Research & Experimental	Book Citation Index – Science (BKCI-S)	Cell Biology; Research & Experimental Medicine	BP0PO	WOS:000535857000004					2022-02-06	
J	Moss, D				Moss, Donald			I hurt so: hypnotic interventions and palliative care for traumatic brain injury	ANNALS OF PALLIATIVE MEDICINE			English	Article						Traumatic brain injury (TBI); post-traumatic stress disorder; hypnosis; palliative care; spirituality	AUDIOVISUAL STIMULATION; REHABILITATION; INSOMNIA; EFFICACY	This article presents a case study in which self-hypnosis, hypnosis-assisted psychotherapy, and palliative care strategies were provided within a multi-modal integrative treatment program for a 38-year-old woman with traumatic brain injury (TBI) secondary to motor vehicle accident. Self-hypnosis was helpful in anxiety reduction and pain management. Hypnosis-assisted psychotherapy was beneficial in de-sensitizing many post-traumatic memories, and in managing post-concussion pain, including neuropathic pain and post-traumatic migraine headaches. A variety of palliative care techniques and spiritual interventions were applied to enhance sleep, moderate cognitive deficits, and enhance quality of life.	[Moss, Donald] Saybrook Univ, Coll Integrat Med & Hlth Sci, 475 14th St,9th Floor, Oakland, CA 94612 USA		Moss, D (corresponding author), Saybrook Univ, Coll Integrat Med & Hlth Sci, 475 14th St,9th Floor, Oakland, CA 94612 USA.	dmoss@saybrook.edu	Moss, Donald/AAT-8302-2020	Moss, Donald/0000-0001-7436-7313			Ayers M. E., 1999, INTRO QUANTITATIVE E, P203; Beck A T, 1974, Mod Probl Pharmacopsychiatry, V7, P151; Centers for Disease Control and Prevention, 2001, RAT TBI REL EM DEP V; Centers for Disease Control and Prevention National Center for Injury Prevention and Control Division of Unintentional Injury Prevention, C TRAUM BRAIN INJ US; Crasilneck HB, 1985, CLIN HYPNOSIS PRINCI, P486; Family Caregiver Alliance, INC PREV MAJ CAUS BR; FYDRICH T, 1992, J ANXIETY DISORD, V6, P55, DOI 10.1016/0887-6185(92)90026-4; McGrady A, 2013, PATHWAYS ILLNESS PAT, P282; Tang HY, 2014, APPL PSYCHOPHYS BIOF, V39, P219, DOI 10.1007/s10484-014-9263-8; Tang HY, 2016, APPL PSYCHOPHYS BIOF, V41, P39, DOI 10.1007/s10484-015-9308-7; TELLEGEN A, 1974, J ABNORM PSYCHOL, V83, P268, DOI 10.1037/h0036681; Thornton KE, 2008, APPL PSYCHOPHYS BIOF, V33, P101, DOI 10.1007/s10484-008-9056-z; VANDIXHOORN J, 1985, J PSYCHOSOM RES, V29, P199, DOI 10.1016/0022-3999(85)90042-X; Vanhaudenhuyse A, 2015, ACTA NEUROL BELG, V115, P771, DOI 10.1007/s13760-015-0459-3; World Health Organization, NEUR DIS PUBL HLTH C; Yapko MD, 2012, TRANCEWORK INTRO PRA, P664; [No title captured]	17	1	1	0	3	AME PUBL CO	SHATIN	FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG 00000, PEOPLES R CHINA	2224-5820	2224-5839		ANN PALLIAT MED	Ann. Pallliat. Med.	JAN	2018	7	1					151	158		10.21037/apm.2017.08.16			8	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services	FT8ZR	WOS:000423442200012	29156905	hybrid			2022-02-06	
J	Nagele, DA; McCart, M; Hooper, SR				Nagele, Drew A.; McCart, Melissa; Hooper, Stephen R.			A call for implementing preferred practices for brain injury screening in youth to improve transition	NEUROREHABILITATION			English	Article						Traumatic brain injury; acquired brain injury; brain injury screening; transition	EARLY IDENTIFICATION; CHILDREN	BACKGROUND: It is vital to engage in systematic screening to identify and serve children who may have sustained an acquired brain injury (ABI) - either traumatic or non-traumatic, so they can be successfully transitioned between environments and life stages. This is particularly important for children and adolescents given the impact an ABI can have on learning and social functioning over the course of the neurodevelopmental process. A pattern of repeated, undiagnosed mild brain injuries may lead to mood or behavior disorders, learning problems. Despite increasing awareness of brain injury as a public health issue, there has not been implementation of systematic screening practices in schools or other public health settings similar to other conditions (e.g., vision disorders, Autism Spectrum Disorders). OBJECTIVES: What is needed to address this lack of systematic screening for ABI is a rationale for systematic screening for ABI in children and adolescents, including examining successful models of screening for other disorders and conditions. METHODS: A review was conducted of available ABI screening methods, including a description of the available screening tools for pediatric ABI, along with supporting research findings. RESULTS: A comparison was made of these pediatric ABI screening tools, looking at the purpose of the tool, the populations and settings in which the tool can be used, the time and cost for administering the tool, the evidence basis in the literature supporting the tool, and the types of outcomes that can be attained from using the tool. CONCLUSION: Recommendations are made for procedures for systematically implementing ABI screening in pediatric settings including schools, primary care providers, mental health, and juvenile justice systems to improve the access to brain injury services and affording more successful transition of adolescents into the adult roles.	[Nagele, Drew A.] Beechwood NeuroRehab, 469 E Maple Ave, Langhorne, PA 19047 USA; [Nagele, Drew A.] Philadelphia Coll Osteopath Med, Philadelphia, PA USA; [McCart, Melissa] Univ Oregon, Ctr Brain Injury Res & Training, Eugene, OR 97403 USA; [Hooper, Stephen R.] Univ N Carolina, Sch Med, Dept Allied Hlth Sci, Chapel Hill, NC USA		Nagele, DA (corresponding author), Beechwood NeuroRehab, 469 E Maple Ave, Langhorne, PA 19047 USA.	dnagele@woods.org	McCart, Melissa/AAN-1506-2020; Hooper, Stephen/X-8171-2019		National Institute on Disability and Rehabilitation Research [H133G140059]	Dr. McCart's participation in this project was completed with funding from the National Institute on Disability and Rehabilitation Research, grant #H133G140059.	ACOG Committee on Practice Bulletins, 2007, Obstet Gynecol, V109, P217; Cantor JB, 2004, ARCH PHYS MED REHAB, V85, pS54, DOI 10.1016/j.apmr.2003.08.113; Cantor JB, 2006, J HEAD TRAUMA REHAB, V21, P424, DOI 10.1097/00001199-200609000-00039; Colorado State University Occupational Therapy Department, 2014, LIF OUTC BRAIN INJ R; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2012, BRAIN INJURY, V26, P139, DOI 10.3109/02699052.2011.648705; Dams-O'Connor K, 2014, J HEAD TRAUMA REHAB, V29, P479, DOI 10.1097/HTR.0000000000000099; deFur S., 2010, EXCEPTIONALITY, DOI [10.1207/S15327035EX110206, DOI 10.1207/S15327035EX110206]; Dettmer J, 2014, J HEAD TRAUMA REHAB, V29, P224, DOI 10.1097/HTR.0b013e3182a1cd68; Dreyer B, 2016, AAP STATEMENT US PRE; Duby JC, 2006, PEDIATRICS, V118, P405, DOI 10.1542/peds.2006-1231; Dunst C. J., 2004, TRACELINES, V1, P1; Faul M, 2010, TRAUMATIC BRAIN INJU; Gioia GA, 2012, PEDIATR ANN, V41, P198, DOI 10.3928/00904481-20120426-10; Glascoe FP, 2005, MENT RETARD DEV D R, V11, P173, DOI 10.1002/mrdd.20068; Haarbauer-Krupa J, 2017, J HEAD TRAUMA REHAB, V32, P367, DOI 10.1097/HTR.0000000000000287; Hux K, 2009, BRAIN INJURY, V23, P8, DOI 10.1080/02699050802590353; Insel T., 2013, NEW UNDERSTANDING ME; Johnson CP, 2007, PEDIATRICS, V120, P1183, DOI 10.1542/peds.2007-2361; Kaba F, 2014, J ADOLESCENT HEALTH, V54, P615, DOI 10.1016/j.jadohealth.2013.12.013; Levitt JM, 2007, J SCHOOL PSYCHOL, V45, P163, DOI 10.1016/j.jsp.2006.11.005; Michigan Department of Community Health, 2004, ADDR MICH PUBL SERV; Minkovitz C., 2006, OSKIS PEDIAT PRINCIP, P95; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Nagele D., 2018, BRAIN INJURY O UNPUB; Nagele D. A., 2018, UNDER IDENTIFI UNPUB; Nebraska Department of Health and Human Services, 2016, SCH HLTH SCREEN SCRE; Neubert D. A., 2003, EXCEPTIONALITY, V11, P63, DOI 10. 1207/S15327035EX1102_02; Oregon Department of Education, 2017, SCH HLTH SCREEN; Pennsylvania Department of Health, 2009, MAND SCH HLTH SERV; Picard M., 1991, HELPS TBI SCREENING; Squires J., 2009, AGES STAGES QUESTION, V3; Texas Health and Human Services, 2017, TEX GUID SCH HLTH PR; The Ohio Valley Center for Brain Injury Prevention and Reha- bilitation, 2013, OH STAT U TBI ID MET; US Department of Education National Center for Education Statistics, 2016, 2016014 NCES US DEP; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zwaigenbaum L, 2015, PEDIATRICS, V136, pS1, DOI 10.1542/peds.2014-3667B	37	1	1	1	2	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2018	42	3					289	298		10.3233/NRE-172386			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GE2RW	WOS:000431063300005	29660967				2022-02-06	
J	Nakadate, H; Zhang, YL; Han, L; Aomura, S; Matsui, Y				Nakadate, Hiromichi; Zhang, Yuelin; Han, Lu; Aomura, Shigeru; Matsui, Yasuhiro			Finite element head model simulation of the case suspected of diffuse axonal injury in the traffic accident	INTERNATIONAL JOURNAL OF CRASHWORTHINESS			English	Article						Traumatic brain injury; neurological injury; reconstruction analysis; finite element head model; intracranial pressure; intracerebral von Mises stress	TRAUMATIC BRAIN-INJURY; CERVICAL-SPINE; STRUCTURAL-PROPERTIES; FE MODEL; RECONSTRUCTIONS; VALIDATION; PREDICTION; EXTENSION; STRENGTHS; FLEXION	A traumatic brain injury case that diffuses axonal injury was suspected in the physician's diagnosis was simulated using finite element head model based on medical information such as MRI and CT. First, the head model matched the subject's head dimensions and material properties of the skull from the subject's age. Next, the site of the subject's head collision was estimated from the contusion, and collision velocity was estimated from the presence or absence of skull fractures and from the presence or absence of intracranial microhaemorrhage. Finally, we predicted the region of onset and severity of the neurological injury from intracerebral von Mises stress, and the analytical result showed the possibility of mild and partly moderate neurological injury. Furthermore, we assessed the effect of each parameter on the severity of the neurological injury and ascertained that collision velocity is the factor with the greatest effect on von Mises stress.	[Nakadate, Hiromichi; Han, Lu; Aomura, Shigeru] Tokyo Metropolitan Univ, Grad Sch Syst Design, Hino, Tokyo, Japan; [Zhang, Yuelin] Aoyama Gakuin Univ, Coll Sci & Engn, Sagamihara, Kanagawa, Japan; [Matsui, Yasuhiro] Natl Traff Safety & Environm Lab, Chofu, Tokyo, Japan		Nakadate, H (corresponding author), Tokyo Metropolitan Univ, Grad Sch Syst Design, Hino, Tokyo, Japan.	nakadate@tmu.ac.jp			Japan Society for the Promotion of ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [25289064]	Grant-in-Aid for Scientific Research (Scientific Research B) from the Japan Society for the Promotion of Research [grant number 25289064].	Al-Bsharat AS, 1999, P 43 STAPP CAR CRASH; Azouvi P, 2000, CURR OPIN NEUROL, V13, P665, DOI 10.1097/00019052-200012000-00009; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Chatelin S, 2011, J MECH BEHAV BIOMED, V4, P1905, DOI 10.1016/j.jmbbm.2011.06.007; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Fahlstedt M, 2015, J BIOMECH, V48, P1331, DOI 10.1016/j.jbiomech.2015.02.057; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Gennarelli TA, 1998, NEUROSCIENTIST, V4, P202, DOI 10.1177/107385849800400316; Giordano C, 2014, J BIOMECH, V47, P1052, DOI 10.1016/j.jbiomech.2013.12.036; Giordano Chiara, 2014, Stapp Car Crash J, V58, P29; Gourin CG, 1996, J TRAUMA, V41, P129, DOI 10.1097/00005373-199607000-00021; Irwin AL, 1997, P 41 STAPP CAR CRASH; Karami G, 2009, J MECH BEHAV BIOMED, V2, P243, DOI 10.1016/j.jmbbm.2008.08.003; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; MAXWELL WL, 1993, ACTA NEUROPATHOL, V86, P136, DOI 10.1007/BF00334880; MCCALDEN RW, 1993, J BONE JOINT SURG AM, V75A, P1193, DOI 10.2106/00004623-199308000-00009; Nahum AM, 1977, P 21 STAPP CAR CRASH; Nightingale RW, 2007, J BIOMECH, V40, P535, DOI 10.1016/j.jbiomech.2006.02.015; Nightingale RW, 2002, J BIOMECH, V35, P725, DOI 10.1016/S0021-9290(02)00037-4; O'Riordain K, 2003, CLIN BIOMECH, V18, P590, DOI 10.1016/S0268-0033(03)00111-6; Panjabi MM, 2001, SPINE, V26, P2692, DOI 10.1097/00007632-200112150-00012; Roth S., 2008, COMPUTER METHODS PRO, V93, P32; Roth S, 2008, COMPUT METH PROG BIO, V90, P262, DOI 10.1016/j.cmpb.2008.01.007; Roth S, 2010, COMPUT METH PROG BIO, V99, P25, DOI 10.1016/j.cmpb.2009.10.004; Sahoo D, 2014, J MECH BEHAV BIOMED, V33, P24, DOI 10.1016/j.jmbbm.2013.08.022; Servadei F, 2007, CURR OPIN CRIT CARE, V13, P163, DOI 10.1097/MCC.0b013e32807f2a94; Shreiber D. I., 1997, P 41 STAPP CAR CRASH; Stemper Brian D, 2004, Annu Proc Assoc Adv Automot Med, V48, P149; Wang KKW, 2006, CURR OPIN NEUROL, V19, P514, DOI 10.1097/WCO.0b013e3280102b10; Willinger R, 2003, INT J CRASHWORTHINES, V8, P605, DOI 10.1533/ijcr.2003.0264; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Yuelin Zhang, 2011, Journal of Biomechanical Science and Engineering, V6, P191, DOI 10.1299/jbse.6.191	34	1	1	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1358-8265	1754-2111		INT J CRASHWORTHINES	Int. J. Crashworthiness		2018	23	2					182	192		10.1080/13588265.2017.1316901			11	Engineering, Manufacturing; Engineering, Mechanical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	FX5EZ	WOS:000426102200008					2022-02-06	
J	Nasri, A; Kacem, I; Sidhom, Y; Ben Djebara, M; Gargouri, A; Gouider, R				Nasri, Amina; Kacem, Imen; Sidhom, Youssef; Ben Djebara, Mouna; Gargouri, Amina; Gouider, Riadh			Isolated spinal cord compression syndrome revealing delayed extensive superficial siderosis of the central nervous system secondary to cervical root avulsion	JOURNAL OF SPINAL CORD MEDICINE			English	Article						Superficial Siderosis; Spastic paraplegia; Spinal cord compression; Myelopathy; Pseudomeningocoele	BRACHIAL-PLEXUS INJURY; HEMOSIDEROSIS	Context: Cervical root avulsion secondary to traumatic plexus injury is a rare etiology of superficial siderosis (SS) of the central nervous system (CNS). We describe the case of an isolated progressive compressive myelopathy revealing this complication and discuss the pathogenesis of such a presentation, its clinical and imaging peculiarities with a literature review. Findings: We report on the case of a 48-year-old man with history of left brachial plexus injury at the age of 2 years. Since the age of 38 years, he had presented with a progressive paraplegia, bladder and erectile dysfunction, neuropathic pain and sensory level. The diagnosis was made by spinal cord and brain magnetic resonance follow-up imaging revealing hypointensity T2-weighted gradient echo linear dark rim around the entire neuraxis and cervical dural pseudomeningoceles. These MRI findings were suggestive of extensive hemosiderin deposition consolidating the diagnosis of SS of CNS. Conclusion/Clinical relevance: Our case report illustrates diagnosis difficulties in unusual or paucisymptomatic presentations of SS. A history of brachial plexus trauma with nerve root avulsion should prompt gradient-echo T2-weighted imaging to bring out such a complication. Superficial siderosis of the CNS should be included in the panel of differential diagnosis of the parethospastic syndromes and compressive myelopathy.	[Nasri, Amina; Kacem, Imen; Sidhom, Youssef; Ben Djebara, Mouna; Gargouri, Amina; Gouider, Riadh] Razi Hosp, Dept Neurol, Tunis 2015, Tunisia; [Nasri, Amina; Kacem, Imen; Sidhom, Youssef; Ben Djebara, Mouna; Gargouri, Amina; Gouider, Riadh] Univ Tunis El Manar, Fac Med, Tunis, Tunisia		Gouider, R (corresponding author), Razi Hosp, Dept Neurol, Tunis 2015, Tunisia.	riadh.gouider@gnet.tn	Gouider, Riadh/AAX-2634-2020	Gouider, Riadh/0000-0001-9615-3797; BEN DJEBARA, Mouna/0000-0002-5647-2598			Aoyama T, 2009, SPINAL CORD, V47, P826, DOI 10.1038/sc.2009.35; Aquilina K, 2005, ACTA NEUROCHIR, V147, P291, DOI 10.1007/s00701-004-0460-8; BONITO V, 1994, J NEUROSURG, V80, P931, DOI 10.3171/jns.1994.80.5.0931; Burk K, 2001, J NEUROL, V248, P1005, DOI 10.1007/s004150170060; Carod-Artal FJ, 2001, REV NEUROLOGIA, V33, P548, DOI 10.33588/rn.3306.2001176; Cohen-Gadol Aaron A, 2004, Neurosurg Focus, V16, pE10; Decramer T, 2016, CLIN NEUROL NEUROSUR, V143, P104, DOI 10.1016/j.clineuro.2015.11.020; Ellika Shehanaz, 2012, Indian J Radiol Imaging, V22, P108, DOI 10.4103/0971-3026.101083; Gonella MC, 2010, CLIN NEUROL NEUROSUR, V112, P82, DOI 10.1016/j.clineuro.2009.09.005; Hamill RC., 1908, J NERV MENT DIS, V35, P594, DOI [10.1097/00005053-190809000-00027, DOI 10.1097/00005053-190809000-00027]; KOEPPEN AH, 1992, J NEUROL SCI, V112, P38, DOI 10.1016/0022-510X(92)90129-9; Kole MK, 2004, J NEUROSURG, V100, P718, DOI 10.3171/jns.2004.100.4.0718; Kumar N, 2007, ARCH NEUROL-CHICAGO, V64, P491, DOI 10.1001/archneur.64.4.491; Le Rhun E, 2008, REV NEUROL-FRANCE, V164, P264, DOI 10.1016/j.neurol.2007.08.010; Leveque M, 2009, NEUROCHIRURGIE, V55, P315, DOI 10.1016/j.neuchi.2008.02.066; Lummel N, 2015, J NEUROL, V262, P1455, DOI 10.1007/s00415-015-7736-1; McCarron MO, 2003, J NEUROL NEUROSUR PS, V74, P1326, DOI 10.1136/jnnp.74.9.1326; Nunes J, 2011, NEURORADIOL J, V24, P249, DOI 10.1177/197140091102400213; Saft C, 2014, THER ADV NEUROL DISO, V7, P276, DOI 10.1177/1756285614548189; Sinha P, 2017, INT J CASE REP IMAGE, V8, P11; Tari-Capone F, 2013, NEUROL SCI, V34, P1861, DOI 10.1007/s10072-013-1336-6; Ting Simon Kang Seng, 2011, Acta Neurol Taiwan, V20, P257; Yamawaki Takemori, 2013, Brain Nerve, V65, P843	23	1	1	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1079-0268	2045-7723		J SPINAL CORD MED	J. Spinal Cord. Med.		2018	41	4					490	495		10.1080/10790268.2017.1329053			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GJ8MJ	WOS:000435643600014	28580859	Green Published			2022-02-06	
J	Nunez-Patino, RA; Zorrilla-Vaca, A; Rivera-Lara, L				Nunez-Patino, Rafael A.; Zorrilla-Vaca, Andres; Rivera-Lara, Lucia			Comparison of intensive versus conventional insulin therapy in traumatic brain injury: a meta-analysis of randomized controlled trials	BRAIN INJURY			English	Article						Traumatic brain injury; insulin therapy; outcomes	TIGHT GLYCEMIC CONTROL; ENTERAL NUTRITION; UNITED-STATES; HYPERGLYCEMIA; MORTALITY; IMPACT; GUIDELINES; MANAGEMENT	Objective: To compare intensive insulin therapy (IIT) and conventional insulin therapy (CIT) on clinical outcomes of patients with traumatic brain injury (TBI).Methods: MEDLINE, EMBASE, Google Scholar, ISI Web of Science, and Cochrane Library were systematically searched for randomized controlled trials (RCTs) comparing IIT to CIT in patients with TBI. Study-level characteristics, intensive care unit (ICU) events, and long-term functional outcomes were extracted from the articles. Meta-analysis was performed with random-effect models.Results: Seven RCTs comprising 1070 patients were included. Although IIT was associated with better neurologic outcome (GOS > 3) (RR=0.87, 95% CI=0.78-0.97; P=0.01; I-2=0%), sensitivity analysis revealed that one study influenced this overall estimate (RR=0.90, 95% CI=0.80-1.01, P=0.07; I-2=0%). IIT was strongly associated with higher risk of hypoglycaemia (RR=5.79, 95% CI=3.27-10.26, P<0.01; I-2=38%). IIT and CIT did not differ in terms of early or late mortality (RR=0.96, 95% CI=0.79-1.17, P=0.7; I-2=0%), infection rate (RR=0.82, 95% CI=0.59-1.14, P=0.23; I-2=68%), or ICU length of stay (SMD= -0.14, 95% CI=-0.35 to 0.07, P=0.18; I-2=45%0.)Conclusions: IIT did not improve long-term neurologic outcome, mortality, or infection rate and was associated with increased risk of hypoglycaemia. Additional well-designed RCTs with defined TBI subgroups should be performed to generate more powerful conclusions.	[Nunez-Patino, Rafael A.] Pontificia Univ Javeriana, Fac Hlth Sci, Sch Med, Cl 18 118-250, Cali, Colombia; [Zorrilla-Vaca, Andres; Rivera-Lara, Lucia] Johns Hopkins Univ Hosp, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21287 USA; [Zorrilla-Vaca, Andres] Univ Valle, Hosp Univ Valle, Fac Hlth, Cali, Colombia; [Rivera-Lara, Lucia] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA		Nunez-Patino, RA (corresponding author), Pontificia Univ Javeriana, Fac Hlth Sci, Sch Med, Cl 18 118-250, Cali, Colombia.	ranunez@javerianacali.edu.co	Vaca, Andres Zorrilla/I-9274-2014; Rivera-Lara, Lucia/AAX-8233-2020	Vaca, Andres Zorrilla/0000-0001-8140-8486; Rivera-Lara, Lucia/0000-0002-9053-2283; Nunez-Patino, Rafael A./0000-0003-2915-5420			Arabi YM, 2008, CRIT CARE MED, V36, P3190, DOI 10.1097/CCM.0b013e31818f21aa; BERO L, 1995, JAMA-J AM MED ASSOC, V274, P1935, DOI 10.1001/jama.274.24.1935; Bilotta F, 2008, NEUROCRIT CARE, V9, P159, DOI 10.1007/s12028-008-9084-9; Bilotta Federico, 2007, J Neurosurg Anesthesiol, V19, P156, DOI 10.1097/ANA.0b013e3180338e69; Butler SO, 2005, PHARMACOTHERAPY, V25, P963, DOI 10.1592/phco.2005.25.7.963; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chourdakis M, 2012, JPEN-PARENTER ENTER, V36, P108, DOI 10.1177/0148607110397878; Cinotti R, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0498-9; Cochran A, 2003, J TRAUMA, V55, P1035, DOI 10.1097/01.TA.0000031175.96507.48; Coester A, 2010, J TRAUMA, V68, P904, DOI 10.1097/TA.0b013e3181c9afc2; Cryer PE, 2007, J CLIN INVEST, V117, P868, DOI 10.1172/JCI31669; de Azevedo JRA, 2007, ARQ NEURO-PSIQUIAT, V65, P733, DOI 10.1590/S0004-282X2007000500001; DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Finfer S, 2015, INTENS CARE MED, V41, P1037, DOI 10.1007/s00134-015-3757-6; Godoy DA, 2010, NEUROCRIT CARE, V13, P425, DOI 10.1007/s12028-010-9404-8; Green DM, 2010, NEUROCRIT CARE, V13, P299, DOI 10.1007/s12028-010-9417-3; Jacobi J, 2012, CRIT CARE MED, V40, P3251, DOI 10.1097/CCM.0b013e3182653269; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Kramer AH, 2012, CRIT CARE, V16, DOI 10.1186/cc11812; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; Liu-DeRyke X, 2009, NEUROCRIT CARE, V11, P151, DOI 10.1007/s12028-009-9228-6; McClave SA, 2009, JPEN-PARENTER ENTER, V33, P277, DOI 10.1177/0148607109335234; Meier R, 2008, CRIT CARE, V12, DOI 10.1186/cc6974; Moghissi ES, 2009, DIABETES CARE, V32, P1119, DOI 10.2337/dc09-9029; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b2535, 10.1371/journal.pmed.1000217, 10.1016/j.ijsu.2010.02.007]; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Mowery NT, 2009, J TRAUMA, V66, P145, DOI 10.1097/TA.0b013e3181938c5e; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; Perner A, 2003, INTENS CARE MED, V29, P642, DOI 10.1007/s00134-002-1628-4; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tomlinson DR, 2008, NAT REV NEUROSCI, V9, P36, DOI 10.1038/nrn2294; Van den Berghe G, 2005, NEUROLOGY, V64, P1348, DOI 10.1212/01.WNL.0000158442.08857.FC; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vespa P, 2012, CRIT CARE MED, V40, P1923, DOI 10.1097/CCM.0b013e31824e0fcc; Wang Y, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006458; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yang M, 2009, INT J NURS STUD, V46, P753, DOI 10.1016/j.ijnurstu.2009.01.004; Yendamuri S, 2003, J TRAUMA, V55, P33, DOI 10.1097/01.TA.0000074434.39928.72; Zafar SN, 2011, J NEUROTRAUM, V28, P1307, DOI 10.1089/neu.2010.1724	45	1	1	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	6					693	703		10.1080/02699052.2018.1457181			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GE9BZ	WOS:000431526200002	29580096				2022-02-06	
S	Osier, N; Dixon, CE		Srivastava, AK; Cox, CS		Osier, Nicole; Dixon, C. Edward			Controlled Cortical Impact for Modeling Traumatic Brain Injury in Animals	PRE-CLINICAL AND CLINICAL METHODS IN BRAIN TRAUMA RESEARCH	Neuromethods		English	Article; Book Chapter						Traumatic brain injury (TBI); Experimental brain trauma; Controlled cortical impact (CCI); Preclinical research; Animal models; Cortical contusion		Controlled cortical impact (CCI) is one of the most common experimental models of traumatic brain injury (TBI). The original CCI device used a pneumatic piston to induce TBI in ferrets; CCI has since been adapted for use in other species of test animals and electromagnetically driven devices are now commercially available. Whether a pneumatic or electromagnetic device is used, the reproducible injury parameters can be adjusted to achieve a desired injury severity in a given species of test animal. The three main goals of this chapter are to: (1) give an overview of the CCI model, including its historical development, key features, and device options; (2) provide a detailed protocol including materials and methods; and (3) discuss considerations relevant to execution, troubleshooting, and dissemination.	[Osier, Nicole] Univ Texas Austin, Sch Nursing, Holist Adult Hlth Div, Austin, TX 78712 USA; [Osier, Nicole] Univ Texas Austin, Dell Med Sch, Dept Neurol, Austin, TX 78712 USA; [Dixon, C. Edward] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [Dixon, C. Edward] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Dixon, C. Edward] VA Pittsburgh Healthcare Syst, Pittsburgh, PA USA		Osier, N (corresponding author), Univ Texas Austin, Sch Nursing, Holist Adult Hlth Div, Austin, TX 78712 USA.; Osier, N (corresponding author), Univ Texas Austin, Dell Med Sch, Dept Neurol, Austin, TX 78712 USA.		Osier, Nico/Q-7913-2017	Osier, Nico/0000-0002-2903-6774			Adelson PD, 2013, CHILD NERV SYST, V29, P43, DOI 10.1007/s00381-012-1932-4; Bondi CO, 2014, J NEUROTRAUM, V31, P873, DOI 10.1089/neu.2014.3328; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Cheng JP, 2012, J NEUROTRAUM, V29, P2684, DOI 10.1089/neu.2012.2560; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Dapul HR, 2013, J NEUROTRAUM, V30, P382, DOI 10.1089/neu.2012.2536; Dennis AM, 2009, J NEUROTRAUM, V26, P889, DOI 10.1089/neu.2008.0512; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dong TT, 2015, J CEREBR BLOOD F MET, V35, P1435, DOI 10.1038/jcbfm.2015.87; Donovan V, 2014, J CEREBR BLOOD F MET, V34, P715, DOI 10.1038/jcbfm.2014.6; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Eslami M, 2016, NEUROL RES, V38, P269, DOI 10.1179/1743132815Y.0000000086; Febinger HY, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0386-5; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Fritz HG, 2005, J NEUROTRAUM, V22, P807, DOI 10.1089/neu.2005.22.807; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GOVONS SR, 1972, EXP NEUROL, V34, P121, DOI 10.1016/0014-4886(72)90193-8; Griesbach GS, 2008, NEUROSCIENCE, V154, P530, DOI 10.1016/j.neuroscience.2008.04.003; Hawryluk GWJ, 2016, J NEUROSURG, V125, P1217, DOI 10.3171/2015.7.JNS15809; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; Hemerka JN, 2012, J NEUROTRAUM, V29, P2192, DOI 10.1089/neu.2011.2303; Hill JL, 2016, J NEUROCHEM, V139, P106, DOI 10.1111/jnc.13726; Hutchinson EB, 2016, SHOCK, V46, P167, DOI 10.1097/SHK.0000000000000659; Jamnia N, 2017, J NEUROTRAUM, V34, P1351, DOI 10.1089/neu.2016.4517; Jin G, 2012, SHOCK, V38, P49, DOI 10.1097/SHK.0b013e3182574778; Kilbaugh TJ, 2011, J NEUROTRAUM, V28, P763, DOI 10.1089/neu.2010.1635; Kim YH, 2018, J NEUROSCI RES, V96, P501, DOI 10.1002/jnr.24099; King C, 2010, J NEUROTRAUM, V27, P1895, DOI 10.1089/neu.2009.1178; Klemenhagen KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074510; Ko J, 2016, SCI REP-UK, V6, DOI 10.1038/srep31215; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kramer S P, 1896, Ann Surg, V23, P163, DOI 10.1097/00000658-189601000-00031; Lee JH, 2014, J NEUROTRAUM, V31, P1417, DOI 10.1089/neu.2013.3251; LIGHTHALL J W, 1990, Journal of Neurotrauma, V7, P65, DOI 10.1089/neu.1990.7.65; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; LINDGREN STEN, 1965, BIOPHYSIK, V2, P320; Manley GT, 2006, J NEUROTRAUM, V23, P128, DOI 10.1089/neu.2006.23.128; MCDONALD JW, 1989, EXP NEUROL, V106, P289, DOI 10.1016/0014-4886(89)90162-3; McPherson RW, 1994, NEUROBIOLOGY CENTRAL, P12; MEANEY DF, 1994, J NEUROTRAUM, V11, P599, DOI 10.1089/neu.1994.11.599; Mirzayan MJ, 2012, EXP TOXICOL PATHOL, V64, P133, DOI 10.1016/j.etp.2010.07.007; Mirzayan MJ, 2008, NEUROL RES, V30, P476, DOI 10.1179/174313208X276916; Monaco CM, 2013, EXP NEUROL, V247, P410, DOI 10.1016/j.expneurol.2013.01.007; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; NILSSON B, 1977, J NEUROSURG, V47, P241, DOI 10.3171/jns.1977.47.2.0241; OMMAYA A K, 1971, International Journal of Neuroscience, V1, P371, DOI 10.3109/00207457109146986; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; Osier ND, 2017, NEUROSCI LETT, V650, P18, DOI 10.1016/j.neulet.2017.03.053; Pareja JCM, 2016, METHODS MOL BIOL, V1462, P345, DOI 10.1007/978-1-4939-3816-2_19; PARKINSON D, 1978, NEUROSURGERY, V3, P176, DOI 10.1227/00006123-197809000-00008; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Pleasant JM, 2011, J NEUROTRAUM, V28, P2245, DOI 10.1089/neu.2010.1499; RIGOR, IMPR QUAL NINDS SUPP; RINDER L, 1968, ACTA NEUROPATHOL, V11, P183; Sandhir R, 2010, NEUROCHEM INT, V56, P188, DOI 10.1016/j.neuint.2009.10.002; Schwerin SC, 2017, J NEUROSCI METH, V285, P82, DOI 10.1016/j.jneumeth.2017.05.010; Shein SL, 2014, J NEUROTRAUM, V31, P1386, DOI 10.1089/neu.2013.2985; Shin SS, 2013, J NEUROTRAUM, V30, P259, DOI 10.1089/neu.2012.2462; Shin SS, 2012, J NEUROTRAUM, V29, P843, DOI 10.1089/neu.2011.1966; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Sindelar B, 2017, J NEUROTRAUM, V34, P1703, DOI 10.1089/neu.2016.4648; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Smith DH, 2015, J NEUROTRAUM, V32, P1725, DOI 10.1089/neu.2014.3861; Song SJ, 2016, J NEUROSCI RES, V94, P409, DOI 10.1002/jnr.23714; Songarj P, 2015, NEUROSCI LETT, V584, P253, DOI 10.1016/j.neulet.2014.10.037; Statler KD, 2006, BRAIN RES, V1076, P216, DOI 10.1016/j.brainres.2005.12.106; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; Thompson SN, 2006, EXP NEUROL, V201, P253, DOI 10.1016/j.expneurol.2006.04.013; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Whalen MJ, 1999, J CEREBR BLOOD F MET, V19, P835, DOI 10.1097/00004647-199908000-00002; Woertgen C, 2001, J NEUROTRAUM, V18, P569, DOI 10.1089/089771501300227378; Xiong LL, 2017, MOL NEUROBIOL	74	1	1	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	0893-2336	1940-6045	978-1-4939-8564-7; 978-1-4939-8563-0	NEUROMETHODS	Neuromethods		2018	139						81	95		10.1007/978-1-4939-8564-7_5	10.1007/978-1-4939-8564-7		15	Cell Biology; Neurosciences	Book Citation Index – Science (BKCI-S)	Cell Biology; Neurosciences & Neurology	BL5CO	WOS:000451267100007					2022-02-06	
J	Pan, S; Li, C; Qu, J; Qu, Y; Xia, P; Qi, ZP; Yang, YD				Pan, Su; Li, Chen; Qu, Ji; Qu, Yang; Xia, Peng; Qi, Zhiping; Yang, Yudan			Geniposide protects against spinal cord injury in rats through attenuating the regulation of inflammatory response and the Bcl2/Bax pathway	INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE			English	Article						Geniposide; spinal cord injury; inflammatory response; neuronal apoptosis; Bcl2/Bax	GARDENIA-JASMINOIDES; OXIDATIVE STRESS; CELLS; REGENERATION; EXTRACT	Spinal cord injury (SCI) causes loss of neurological function, depending upon the severity of injury, which may lead to paralysis. However, there is still no effective pharmacotherapy for SCI treatment so far. Geniposide (GEN), a traditional Chinese medicine, which is reported to possess a wide range of health benefits. A previous study shows that GEN displays various anti-inflammatory and anti-apoptosis properties in oxygen and glucose deprivation-induced brain microvascular injury. However, it is unclear whether GEN could protect against traumatic spinal cord injury, and the underlying molecular mechanisms associated with this process still remain unknown. In the present study, the Basso, Beattie, Bresnahan scores, and the water content of the spinal cord were used to analyze the therapeutic effects of GEN on neurological function in the SCI rats. The serum levels of nuclear factor-kappa B p65 unit, interleukin (IL)-4, IL-6 and IL-10 were detected using commercial kits. The expression levels of Bcl-2, Bax, Caspase-3, Caspase-6 and Caspase-7 were measured via western blot analysis. The results demonstrated that the neurological function and the water content of the spinal cord in these SCI rats began to ameliorate after GEN treatment. Meanwhile, GEN was found to have inhibitory effects on inflammatory response, compared with the SCI group. In addition, GEN significantly reduced the protein expression of Bax, Caspase-3, Caspase-6 and Caspase-7 and promoted the protein expression of Bcl-2 in the SCI rat model, which indicated that the protective effect of GEN might be associated to anti-apoptosis activation. In summary, GEN protected against spinal cord injury in rats through attenuating inflammatory response and the regulation of Bcl-2 and Bax pathway.	[Yang, Yudan] Jilin Univ, China Japan Union Hosp, Sci Res Ctr, Changchun, Jilin, Peoples R China; [Pan, Su; Li, Chen; Qu, Ji; Qu, Yang; Xia, Peng; Qi, Zhiping] Jilin Univ, Hosp 2, Dept Orthoped, Changchun, Jilin, Peoples R China		Yang, YD (corresponding author), Jilin Univ, China Japan Union Hosp, Dept Cent Lab, Changchun 130033, Jilin, Peoples R China.	yangyudan@jlu.edu.cn			Jilin Province Science and Technology Development Plan [20180414060GH]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81301289]	This project was supported by the Jilin Province Science and Technology Development Plan (Grant no. 20180414060GH) and the National Natural Science Foundation of China (Grant no. 81301289).	Alexander JK, 2009, PROG BRAIN RES, V175, P125, DOI 10.1016/S0079-6123(09)17508-8; Bareyre FM, 2003, TRENDS NEUROSCI, V26, P555, DOI 10.1016/j.tins.2003.08.004; Basso DM, 1996, J NEUROTRAUM, V13, P343, DOI 10.1089/neu.1996.13.343; Bastien D, 2014, EXP NEUROL, V258, P62, DOI 10.1016/j.expneurol.2014.04.006; Bethea JR, 1998, J NEUROSCI, V18, P3251; Cizkova D, 2006, CELL MOL NEUROBIOL, V26, P1167, DOI 10.1007/s10571-006-9093-1; Cui BZ, 2014, EXP THER MED, V7, P1233, DOI 10.3892/etm.2014.1608; Hu JG, 2016, EXP NEUROL, V277, P190, DOI 10.1016/j.expneurol.2016.01.002; Jiang ZS, 2015, MOL MED REP, V12, P5349, DOI 10.3892/mmr.2015.4045; Koo HJ, 2006, J ETHNOPHARMACOL, V103, P496, DOI 10.1016/j.jep.2005.08.011; Liao JW, 2014, MOL MED REP, V10, P1225, DOI 10.3892/mmr.2014.2352; Liu H, 2013, J ASIAN NAT PROD RES, V15, P94, DOI 10.1080/10286020.2012.723203; Liu YF, 2014, MOL CLIN ONCOL, V2, P411, DOI 10.3892/mco.2014.248; Luo Y, 2015, MOL MED REP, V12, P7132, DOI 10.3892/mmr.2015.4274; Meng XQ, 2015, INT J CLIN EXP PATHO, V8, P12207; Miller LE, 2016, MED DEVICES-EVID RES, V9, DOI 10.2147/MDER.S103102; Mohammadi E, 2013, J SPINAL CORD MED, V36, P66, DOI 10.1179/2045772312Y.0000000032; Nakajima H, 2010, SPINE, V35, P497, DOI 10.1097/BRS.0b013e3181b8e89b; Neefkes-Zonneveld CR, 2015, ARCH PHYS MED REHAB, V96, P30, DOI 10.1016/j.apmr.2014.07.006; Ni H, 2005, J SPINAL CORD MED, V38, P199; Ravikumar R, 2005, J NEUROTRAUM, V22, P240, DOI 10.1089/neu.2005.22.240; Sa CL, 2012, J ETHNOPHARMACOL, V142, P136, DOI 10.1016/j.jep.2012.04.027; Shacka JJ, 2005, CNS NEUROL DISORD-DR, V4, P25, DOI 10.2174/1568007053005127; Xiao Lei, 2011, Zhongguo Zhen Jiu, V31, P400; Zhang HY, 2013, PHARM BIOL, V51, P221, DOI 10.3109/13880209.2012.717088; Zhang P, 2013, BRAIN RES BULL, V97, P8, DOI 10.1016/j.brainresbull.2013.05.005	26	1	1	0	3	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	1940-5901			INT J CLIN EXP MED	Int. J. Clin. Exp. Med.		2018	11	4					3644	+					8	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	GE6JV	WOS:000431333500075					2022-02-06	
S	Paquin, H; Taylor, A; Meehan, WP		Hainline, B; Stern, RA		Paquin, Hugo; Taylor, Alex; Meehan, William P., III			Office-based concussion evaluation, diagnosis, and management: pediatric	SPORTS NEUROLOGY	Handbook of Clinical Neurology		English	Article; Book Chapter							SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; PERSISTENT POSTCONCUSSIVE SYMPTOMS; MINOR HEAD-INJURY; HIGH-SCHOOL; NEUROCOGNITIVE PERFORMANCE; NEUROPSYCHOLOGICAL CONSULTATION; ACTIVITY LEVEL; CHILDREN; RECOVERY	More children and adolescents are participating in competitive sports than ever before, causing an overall increase in sport-related injuries. Concussion is a common injury in the pediatric population and its prevalence has increased with increased visibility and awareness. This chapter will discuss the clinical presentation, evaluation, and management of concussions sustained by pediatric athletes, while addressing the distinctive factors that pertain to this population. Management of concussion should be tailored to patients' symptoms and should focus on an early and gradual return to both cognitive and noncontact low-risk physical activity. A multidisciplinary approach is often helpful in addressing more specific symptoms, which fall into the somatic, cognitive, vestibular, emotional, and sleep domains. A prolonged recovery is defined by symptoms lasting more than 4 weeks. Individualized return-to-play decisions should focus on the safety of the young athlete.	[Paquin, Hugo] CHU Ste Justine, Div Pediat Emergency Med, 3175 Chemin Cote St Catherine, Montreal, PQ H3T 1C5, Canada; [Taylor, Alex] Boston Childrens Hosp, Div Neurol & Psychiat, Boston, MA USA; [Meehan, William P., III] Boston Childrens Hosp, Div Sports Med, Boston, MA USA		Paquin, H (corresponding author), CHU Ste Justine, Div Pediat Emergency Med, 3175 Chemin Cote St Catherine, Montreal, PQ H3T 1C5, Canada.	hpaquin@icloud.com			National Football League Players Association; National Hockey League Alumni Association	Dr. Meehan receives royalties from ABC-Clio Publishing for the sale of his book, Kids, Sports, and Concussion: A Guide for Coaches and Parents, and royalties from Wolters Kluwer (UpToDate author). Dr. Meehan's research is funded, in part, by a grant from the National Football League Players Association and by philanthropic support from the National Hockey League Alumni Association.	Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Arbogast KB, 2013, CLIN PEDIATR, V52, P397, DOI 10.1177/0009922813478160; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Barr WB, 2001, J ATHL TRAINING, V36, P297; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bernard CO, 2016, J INT NEUROPSYCH SOC, V22, P793, DOI 10.1017/S1355617716000709; Blume HK, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0516-x; Borsting EJ, 2003, OPTOMETRY VISION SCI, V80, P832, DOI 10.1097/00006324-200312000-00014; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Brooks BL, 2016, CHILD NEUROPSYCHOL, V22, P1001, DOI 10.1080/09297049.2015.1075491; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; CDC, 2016, HEADS; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Condo M, 2009, J HEADACHE PAIN, V10, P361, DOI 10.1007/s10194-009-0142-2; Connery AK, 2016, CLIN NEUROPSYCHOL, V30, P579, DOI 10.1080/13854046.2016.1177596; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; DeMatteo C, 2015, CLIN PEDIATR, V54, P783, DOI 10.1177/0009922814567305; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Dubrovsky AS, 2014, HEADACHE, V54, P878, DOI 10.1111/head.12334; Eccleston C, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003968.pub3; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Garcia-Rodriguez JA, 2014, CAN FAM PHYSICIAN, V60, P523; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gioia GA, 2015, BRAIN INJURY, V29, P195, DOI 10.3109/02699052.2014.965210; Gioia GA, 2012, PEDIATR ANN, V41, P198, DOI 10.3928/00904481-20120426-10; Gottshall K, 2003, LARYNGOSCOPE, V113, P1746, DOI 10.1097/00005537-200310000-00016; Grady MF, 2010, CURR PROB PEDIATR AD, V40, P154, DOI 10.1016/j.cppeds.2010.06.002; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Grubenhoff JA, 2016, J PEDIATR-US, V174, P27, DOI 10.1016/j.jpeds.2016.03.027; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Hanson E, 2014, CLIN PEDIATR, V53, P1221, DOI 10.1177/0009922813518429; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Howell DR, 2016, ACTA PAEDIATR, V105, pE426, DOI 10.1111/apa.13486; Howell DR, 2016, AM J SPORT MED, V44, P1040, DOI 10.1177/0363546515625045; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P745, DOI 10.1007/978-0-387-76978-3_24; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Kirkwood MW, 2016, J PEDIATR-US, V169, P244, DOI 10.1016/j.jpeds.2015.10.014; Kirkwood MW, 2014, PEDIATRICS, V133, P643, DOI 10.1542/peds.2013-3195; Kirkwood MW, 2010, CLIN NEUROPSYCHOL, V24, P860, DOI 10.1080/13854040903527287; Kirkwood MW, 2009, ACTA PAEDIATR, V98, P1409, DOI 10.1111/j.1651-2227.2009.01448.x; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Kutcher JS, 2010, CURR SPORT MED REP, V9, P16, DOI 10.1249/JSR.0b013e3181caa89d; Leddy JJ, 2013, J HEAD TRAUMA REHAB, V28, P241, DOI 10.1097/HTR.0b013e31826da964; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Mannix R, 2013, NEUROSURGERY, V73, P129, DOI 10.1227/01.neu.0000429846.14579.41; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; Master CL, 2012, PEDIATR ANN, V41, pE180, DOI 10.3928/00904481-20120827-09; McClain R, 2015, PRIMARY CARE, V42, P77, DOI 10.1016/j.pop.2014.09.005; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2013, BRIT J SPORT MED, V47, P272, DOI 10.1136/bjsports-2013-092145; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; Moran B, 2015, SOUTH MED J, V108, P553, DOI 10.14423/SMJ.0000000000000340; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; Nestoriuc Y, 2008, J CONSULT CLIN PSYCH, V76, P379, DOI 10.1037/0022-006X.76.3.379; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Pardini D., 2004, BR J SPORTS MED, V38, P661; Phillips S, 2015, PRIMARY CARE, V42, P243, DOI 10.1016/j.pop.2015.01.010; Pinchefsky E, 2015, PEDIATR NEUROL, V52, P270, DOI 10.1016/j.pediatrneurol.2014.10.015; Pinchefsky E, 2015, PEDIATR NEUROL, V52, P263, DOI 10.1016/j.pediatrneurol.2014.10.013; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Randolph C, 2005, J ATHL TRAINING, V40, P139; Randolph C, 2011, CURR SPORT MED REP, V10, P21, DOI 10.1249/JSR.0b013e318207831d; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Schneider DK, 2017, BRIT J SPORT MED, V51, P1473, DOI 10.1136/bjsports-2015-095645; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Tan CO, 2014, NEUROLOGY, V83, P1665, DOI 10.1212/WNL.0000000000000944; Taylor AM, 2015, J PEDIATR-US, V167, P738, DOI 10.1016/j.jpeds.2015.05.036; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Thomas DJ, 2018, CLIN J SPORT MED, V28, P56, DOI 10.1097/JSM.0000000000000413; Wang F, 2003, HEADACHE, V43, P601, DOI 10.1046/j.1526-4610.2003.03102.x; Wilson Maria-Carmen B, 2006, Curr Pain Headache Rep, V10, P387, DOI 10.1007/s11916-006-0065-4; Wing R, 2013, EMERG MED CLIN N AM, V31, P653, DOI 10.1016/j.emc.2013.05.007; Yeates KO, 2012, INT J DEV NEUROSCI, V30, P231, DOI 10.1016/j.ijdevneu.2011.05.008; Zemek R, 2014, GUIDELINES DIAGNOSIN; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	96	1	1	0	0	ELSEVIER	AMSTERDAM	Radarweg 29, PO Box 211, AMSTERDAM, NETHERLANDS	0072-9752		978-0-44-463955-4; 978-0-444-63954-7	HAND CLINIC			2018	158						107	117		10.1016/B978-0-444-63954-7.00011-2			11	Clinical Neurology; Sport Sciences	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Sport Sciences	BP1MW	WOS:000540371100013	30482337				2022-02-06	
J	Pinhasi-Vittorio, L				Pinhasi-Vittorio, Limor			Writing, sharing, and healing: the interplay of literacy in the healing journey of the recovering from substance abuse	JOURNAL OF POETRY THERAPY			English	Article						Addiction; healing; literacy; trauma; writing	BRAIN-INJURY; WOMEN; PERCEPTION; LANGUAGE	This paper explores the role of literacy in the lives of women who are recovering from substance abuse. It discusses the work and products of a one-year literacy workshop in which participants were immersed in reading, writing and sharing of different writings and works of arts. The work with the women converged around their poetry, prose and free writing during their literacy workshop and journaling. Conversations about their writing revealed four themes: (1) finding one's voice, (2) shifting self-perceptions, (3) writing as an outlet for expression and for sharing traumatic events, and (4) talking about addiction. The overarching concept of these four themes is literacy as a healing tool. This paper discusses the role of writing as a tool for healing from traumatic events and dealing with addiction.	[Pinhasi-Vittorio, Limor] Lehman Coll, Dept Counseling Leadership Literacy & Special Edu, Carmen Hall Room B-20,250 Bedford Pk Blvd West, Bronx, NY 10468 USA		Pinhasi-Vittorio, L (corresponding author), Lehman Coll, Dept Counseling Leadership Literacy & Special Edu, Carmen Hall Room B-20,250 Bedford Pk Blvd West, Bronx, NY 10468 USA.	limor.pinhasi-vittorio@lehman.cuny.edu					Anderson C., 2000, WRITING HEALING INFO; Angelou M., 1978, PHENOMENAL WOMEN; [Anonymous], 2010, PICKING FENCES; Ashley OS, 2003, AM J DRUG ALCOHOL AB, V29, P19, DOI 10.1081/ADA-120018838; Baldwin C., 2005, STORYCATCHER MAKING; Barton D., 2000, SITUATED LITERACIES; Barton D., 2007, LITERACY INTRO ECOLO; Ben-Yosef E., 2016, QUALITATIVE REPORT, V21, P489; Ben-Yosef E., 2008, PERSPECTIVES NEW YOR, V7, P3; Brady T. M., 2005, WOMEN SUBSTANCE ABUS; Brice-Heath S., 2008, LANGUAGE LITERACY NC; Charmaz, 1991, GOOD DAYS BAD DAYS S; Cohen JB, 2007, J PSYCHOACTIVE DRUGS, P347; CookGumperz J, 2006, STUD INTERACT SOCIO, V25, P1, DOI 10.2277/ 0521525675; Covington SS, 2008, J PSYCHOACTIVE DRUGS, P377; Desalvo L., 2000, WRITING WAY HEALING; Frank, 1995, WOUNDED STORYTELLER; Freire P., 2000, PEDAGOGY OPPRESSED; Freire P., 1987, LITERACY READING WOR; Gee J. P, 2010, NEW LITERACIES MULTI, P165; Gilbert KR, 2002, DEATH STUD, V26, P223, DOI 10.1080/07481180211274; Glesne C., 2015, BECOMING QUALITATIVE; Hunter KM., 1991, DOCTORS STORIES; Kleinman Arthur, 1988, ILLNESS NARRATIVES S; Kress Gunther, 2005, WRITING RETHINKING P; Laub, 1992, TESTIMONY CRISES WIT; Luria A.R, 1968, MIND MNEMONIST LITTL; Luria A. R, 1982, LANGUAGE COGNITION; Luria AR., 1972, MAN SHATTERED WORLD; MacCurdy, 2000, WRITING HEALING INFO, P158; Madigan, 2011, NARRATIVE THERAPY; McKerracher A., 2014, CANADIAN REV ART ED, V41, P117; Nye C. H., 1999, PSYCHOANALYTIC SOCIA, V6, P5; Nye E. F., 1997, QUALITATIVE INQUIRY, V3, P439; Parry A., 1994, STORY REVISIONS NARR; Pennebaker J. W., 2014, EXPRESSIVE WRITINGS; Pennebaker J.W., 2004, WRITING HEAL GUIDED; Pennebaker J. W., 1995, EMOTION DISCLOSURE H, P93; Pennebaker JW, 1997, PSYCHOL SCI, V8, P162, DOI 10.1111/j.1467-9280.1997.tb00403.x; Piercy M., BARBIE DOLL; Pinhasi-Vittorio L., 2008, RADICAL TEACHER, V83, P30, DOI DOI 10.1353/RDT.0.0022; Pinhasi-Vittorio L, 2008, TOP STROKE REHABIL, V15, P288, DOI 10.1310/tsr1503-288; Pinhasi-Vittorio L, 2007, TOP STROKE REHABIL, V14, P115, DOI 10.1310/tsr1401-115; Pinhasi-Vittorio L, 2009, THEORY ACTION, V2, P19, DOI 10.3798/tia.1937-0237.09002; Pinhasi-Vittorio L, 2011, THEORY ACTION, V4, P122, DOI 10.3798/tia.1937-0237.11025; Pinhasi-Vittorio L, 2013, J LANG LIT EDUC, V9, P54; RAY KW, 1999, WONDROUS WORDS WRITE; Sacks O., 1998, MAN WHO MISTOOK HIS; Shapiro J, 2002, FAM MED, V34, P96; Street B. V., 2002, LITERACY DEV ETHNOGR; Terr L. C., 2003, FOCUS, V1, P322, DOI DOI 10.1176/FOC.1.3.322; TERR LC, 1991, AM J PSYCHIAT, V148, P10; [No title captured]	53	1	1	1	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0889-3675	1567-2344		J POETRY THER	J. Poetry Ther.		2018	31	4					209	223		10.1080/08893675.2018.1504668			15	Psychology, Multidisciplinary	Emerging Sources Citation Index (ESCI)	Psychology	HJ2TE	WOS:000457022000002					2022-02-06	
S	Putukian, M; Schepart, Z		Hainline, B; Stern, RA		Putukian, Margot; Schepart, Zachary			Sideline assessment of concussion	SPORTS NEUROLOGY	Handbook of Clinical Neurology		English	Article; Book Chapter							SYSTEMATIC VIDEO ANALYSIS; HOCKEY LEAGUE NHL; SPORT; RELIABILITY; SPECIFICITY; SENSITIVITY; RECOVERY; VALIDITY; SCAT3	The recognition and sideline evaluation of possible sport-related concussion are difficult tasks for a physician and other clinicians. Sideline assessment tools have continued to evolve over the years, but objective biomarkers of concussion do not currently exist. Sideline video review programs may aid in the recognition of possible concussion as additional information for the sideline athletic medicine staff. Additional investigational assessments include visual oculomotor processing, reaction time, and rapid eye movements and attention. As the presentation of concussion is variable and symptoms may evolve over time, it is important that athletes with possible concussion are followed with serial assessments. If the diagnosis is unclear, it is advised to err on the side of caution and not allow the athlete to return to competition on the day of the injury. This chapter will review the current issues regarding the sideline assessment of concussion.	[Putukian, Margot; Schepart, Zachary] Princeton Univ, Univ Hlth Serv, Athlet Med, Princeton, NJ 08544 USA		Putukian, M (corresponding author), Princeton Univ, Athlet Med, Princeton, NJ 08544 USA.	putukian@princeton.edu					Azad AM, 2016, BMJ OPEN SPORT EXERC, V2, p1 6; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Davis GA, 2017, BRIT J SPORT MED, V51, P859, DOI 10.1136/bjsports-2017-097492; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P870, DOI 10.1136/bjsports-2017-097508; Eckner JT, 2014, BRIT J SPORT MED, V48, P112, DOI 10.1136/bjsports-2012-091579; Gardner AJ, 2015, BRAIN INJURY, V29, P1182, DOI 10.3109/02699052.2015.1034179; Howitt Scott, 2016, J Can Chiropr Assoc, V60, P322; Hutchison MG, 2015, BRIT J SPORT MED, V49, P552, DOI 10.1136/bjsports-2013-092235; Hutchison MG, 2015, BRIT J SPORT MED, V49, P547, DOI 10.1136/bjsports-2013-092234; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Leong Danielle F, 2015, J Optom, V8, P131, DOI 10.1016/j.optom.2014.12.005; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; Makdissi M, 2016, J SCI MED SPORT, V19, P859, DOI 10.1016/j.jsams.2016.02.015; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Patricios J, 2017, BRIT J SPORT MED, V51, P888, DOI 10.1136/bjsports-2016-097441; Putukian M, 2017, J ATHL TRAINING, V52, P236, DOI 10.4085/1062-6050-52.1.08; Putukian M, 2015, CLIN J SPORT MED, V25, P36, DOI 10.1097/JSM.0000000000000102; Shehata N, 2009, BRIT J SPORT MED, V43, P730, DOI 10.1136/bjsm.2009.059832; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Wilkins JC, 2004, J ATHL TRAINING, V39, P156	29	1	1	0	0	ELSEVIER	AMSTERDAM	Radarweg 29, PO Box 211, AMSTERDAM, NETHERLANDS	0072-9752		978-0-44-463955-4; 978-0-444-63954-7	HAND CLINIC			2018	158						75	80		10.1016/B978-0-444-63954-7.00008-2			6	Clinical Neurology; Sport Sciences	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Sport Sciences	BP1MW	WOS:000540371100010	30482377				2022-02-06	
J	Quang, CY; Rosal, LM; Blair, SG; Simmons, JD; Rusyniak, WG; Brevard, SB				Quang, Celia Y.; Rosal, Lindy M.; Blair, Scott G.; Simmons, Jon D.; Rusyniak, W. George; Brevard, Sidney B.			Craniofacial Impalement Injury: Projectile Fragment to the Head	ARCHIVES OF TRAUMA RESEARCH			English	Article						Brain injuries; cranial trauma; craniocerebral trauma; head injuries; head trauma; missile; missile injuries; penetrating	TRAUMATIC BRAIN-INJURY; LONG-TERM DISABILITY; UNITED-STATES	Circular saws and angle grinders are two of the most dangerous pieces of electrical equipment on a worksite. Besides the danger that any high-powered, sharp piece of equipment possesses, these pieces use circular saw blades that can splinter into projectile fragments. A 60-year-old male was cutting a steel pipe with a circular saw when a fragment of the 12-inch blade flew off, impaling him in the upper face just to the right of the midline. He was wearing eyeglasses, the bridge of which was driven into his skull on impact of the fragment. He was brought to the trauma center where he underwent imaging of his face and head. This revealed that the blade and his glasses had penetrated 1.2 cm into the right frontal lobe of the brain, resulting in facial fractures and intraparenchymal hemorrhage. He underwent bifrontal craniotomy, removal of the blade and his glasses, evacuation of hematoma, and dural reconstruction. Postoperatively, he was awake with a Glasgow Coma Scale of 15 and no neurologic deficits. The complex nature of craniofacial injuries makes a multidisciplinary approach to these patients essential. Prompt diagnosis and treatment by the appropriate specialists are vital to optimize patient outcomes.	[Quang, Celia Y.; Blair, Scott G.; Simmons, Jon D.; Brevard, Sidney B.] Univ S Alabama, Div Acute Care Surg & Burns, Dept Surg, Mobile, AL USA; [Rusyniak, W. George] Univ S Alabama, Div Neurosurg, Dept Surg, Mobile, AL USA; [Rosal, Lindy M.] Wright State Univ, Dept Surg, Dayton, OH 45435 USA		Blair, SG (corresponding author), Univ S Alabama, Div Acute Care Surg & Burns, 2451 Fillingim St,Suite 10-1, Mobile, AL 36688 USA.	sblair@health.southalabama.edu					Adekoya N., 2002, SURVEILLANCE TRAUMAT, P1; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Eppley BL, 2002, J CRANIOFAC SURG, V13, P35, DOI 10.1097/00001665-200201000-00006; Faul M, 2010, TRAUMATIC BRAIN INJU, P1; LANGLOIS JA, 2003, TRAUMATIC BRAIN INJU, P1; Le TH, 2009, MT SINAI J MED, V76, P145, DOI 10.1002/msj.20102; Rusyniak WG, 1993, BRAIN SURG COMPLICAT, V2, P1335; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	9	1	1	0	0	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	2251-953X	2251-9599		ARCH TRAUMA RES	Arch. Trauma Res.	JAN-MAR	2018	7	1					30	32		10.4103/atr.atr_25_18			3	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	GU9WE	WOS:000445705400007		gold			2022-02-06	
S	Qubty, D; Glazer, S; Schreiber, S; Rubovitch, V; Pick, CG		Ennaceur, A; Silva, MAD		Qubty, Doaa; Glazer, Sandra; Schreiber, Shaul; Rubovitch, Vardit; Pick, Chaim G.			Mild Traumatic Brain Injuries and Object Recognition	HANDBOOK OF OBJECT NOVELTY RECOGNITION	Handbook of Behavioral Neuroscience		English	Article; Book Chapter							IMPROVES NEUROLOGICAL RECOVERY; ONE-TRIAL TEST; COGNITIVE DEFICITS; MICROGLIAL ACTIVATION; RODENT MODELS; MOUSE MODEL; MEMORY; RATS; MICE; IMPAIRMENTS		[Qubty, Doaa; Glazer, Sandra; Rubovitch, Vardit; Pick, Chaim G.] Tel Aviv Univ, Sackler Sch Med, Dept Anat & Anthropol, Tel Aviv, Israel; [Glazer, Sandra] Miami Univ, Dept Psychol, Oxford, OH 45056 USA; [Schreiber, Shaul] Tel Aviv Sourasky Med Ctr, Dept Psychiat, Tel Aviv, Israel; [Schreiber, Shaul; Pick, Chaim G.] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Pick, Chaim G.] Tel Aviv Univ, Dr Miriam & Sheldon G Adelson Chair, Tel Aviv, Israel; [Pick, Chaim G.] Tel Aviv Univ, Sackler Fac Med, Ctr Biol Addict Dis, Tel Aviv, Israel		Pick, CG (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Anat & Anthropol, Tel Aviv, Israel.; Pick, CG (corresponding author), Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel.; Pick, CG (corresponding author), Tel Aviv Univ, Dr Miriam & Sheldon G Adelson Chair, Tel Aviv, Israel.; Pick, CG (corresponding author), Tel Aviv Univ, Sackler Fac Med, Ctr Biol Addict Dis, Tel Aviv, Israel.		Schreiber, Shaul/E-5821-2010	Schreiber, Shaul/0000-0002-2189-0693			Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Baalman KL, 2013, J NEUROTRAUM, V30, P741, DOI 10.1089/neu.2012.2478; Bolouri H., 2015, BRAIN NEUROTRAUMA MO; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; CHOI DW, 1987, J NEUROSCI, V7, P357; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Desai AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085237; Deselms H, 2016, J NEUROSCI METH, V272, P69, DOI 10.1016/j.jneumeth.2016.02.002; DeWitt DS, 2013, J NEUROTRAUM, V30, P688, DOI 10.1089/neu.2012.2349; Doulames VM, 2015, FRONT BEHAV NEUROSCI, V9, DOI [10.3389/fnbeh.2015.00369, 10.3389/fnbeh.2015.00275]; Eakin K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090617; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; ENNACEUR A, 1989, BEHAV BRAIN RES, V33, P197, DOI 10.1016/S0166-4328(89)80051-8; Ennaceur A, 2010, BEHAV BRAIN RES, V215, P244, DOI 10.1016/j.bbr.2009.12.036; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Gold EM, 2013, REGEN MED, V8, P483, DOI 10.2217/rme.13.41; Greig NH, 2014, ALZHEIMERS DEMENT, V10, pS62, DOI 10.1016/j.jalz.2013.12.011; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; Harrison JL, 2015, BRAIN BEHAV IMMUN, V47, P131, DOI 10.1016/j.bbi.2015.01.001; Heim LR, 2017, J NEUROTRAUM, V34, P2518, DOI 10.1089/neu.2016.4909; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Israelsson C, 2009, J NEUROTRAUM, V26, P1307, DOI [10.1089/neu.2008.0676, 10.1089/neu.2008-0676]; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; LINDGREN STEN, 1965, BIOPHYSIK, V2, P320; Luo T, 2013, ANESTHESIOLOGY, V119, P1370, DOI 10.1097/ALN.0000000000000020; Mangels JA, 2002, NEUROPSYCHOLOGIA, V40, P2369, DOI 10.1016/S0028-3932(02)00084-2; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McAllister T., 2001, J NEUROPSYCHIATRY CL, V13, P141; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Munyon C, 2014, BRAIN RES, V1582, P220, DOI 10.1016/j.brainres.2014.07.036; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Osier N. D., 2015, BRAIN NEUROTRAUMA MO; Ouyang W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171976; Rachmany L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03792-9; Rachmany L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079837; Rachmany L, 2013, AGE, V35, P1621, DOI 10.1007/s11357-012-9464-0; Rowe RK, 2014, SLEEP, V37, P743, DOI 10.5665/sleep.3582; Rubovitch V, 2017, SCI REP-UK, V7, DOI 10.1038/srep41269; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Saykally JN, 2012, NEUROSCIENCE, V223, P305, DOI 10.1016/j.neuroscience.2012.07.070; Spain A, 2010, J NEUROTRAUM, V27, P1429, DOI 10.1089/neu.2010.1288; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P1, DOI 10.1176/appi.neuropsych.18.1.1; Tashlykov V, 2009, J MOL NEUROSCI, V37, P16, DOI 10.1007/s12031-008-9094-2; Tashlykov V, 2007, BRAIN RES, V1130, P197, DOI 10.1016/j.brainres.2006.10.032; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Watanabe J, 2013, NEUROBIOL DIS, V59, P86, DOI 10.1016/j.nbd.2013.06.017; Xie K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064907; Yang SH, 2013, J SURG RES, V184, P981, DOI 10.1016/j.jss.2013.03.075; Zhao ZR, 2015, J NEUROTRAUM, V32, P1347, DOI 10.1089/neu.2014.3739; Zhao ZR, 2013, J CEREBR BLOOD F MET, V33, P1897, DOI 10.1038/jcbfm.2013.144; Zhao ZR, 2012, J NEUROTRAUM, V29, P2475, DOI 10.1089/neu.2012.2511; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	59	1	1	0	0	ELSEVIER ACADEMIC PRESS INC	SAN DIEGO	525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA	1569-7339		978-0-12-812012-5	HBK BEHAV NEUROSCI			2018	27						331	339		10.1016/B978-0-12-812012-5.00022-7			9	Behavioral Sciences; Neurosciences	Book Citation Index – Science (BKCI-S)	Behavioral Sciences; Neurosciences & Neurology	BN0OY	WOS:000473297700023					2022-02-06	
S	Renaud, B; Denoroy, L; Collin-Chavagnac, D; Mertens, P; Parrot, S		Parrot, S; Denoroy, L		Renaud, Bernard; Denoroy, Luc; Collin-Chavagnac, Delphine; Mertens, Patrick; Parrot, Sandrine			Clinical CNS Microdialysis of Glutamate with a Special Methodological Focus on Human Spinal Cord	BIOCHEMICAL APPROACHES FOR GLUTAMATERGIC NEUROTRANSMISSION	Neuromethods		English	Article; Book Chapter						Glutamate; Central nervous system; Spinal cord; Brain; Microdialysis; Human; Patient	TRAUMATIC BRAIN-INJURY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; EXTRACELLULAR AMINO-ACIDS; IN-VIVO MICRODIALYSIS; CEREBRAL ENERGY-METABOLISM; INTRACEREBRAL MICRODIALYSIS; BEDSIDE MICRODIALYSIS; DORSAL-HORN; CAPILLARY-ELECTROPHORESIS; MCA INFARCTION	Glutamate has a paramount role in central nervous system since it is the main excitatory neurotransmitter in both the brain and the spinal cord. In clinical studies, the monitoring of glutamate has revealed tight links between the variations of its interstitial concentration and those of other metabolic biomarkers and partial pressure in oxygen within tissue. The use of microdialysis has allowed to monitor glutamate over several days in patients with brain injury, epilepsy, or Parkinson's disease. We describe here a neurochemical method carried out in the spinal cord of patients suffering from chronic pain compared to patients suffering from spasticity, with a stress on peculiarities on such a monitoring. We provide also a detailed discussion on the significant usefulness of microdialysis and its technical and methodological limits in the specific field of clinical research.	[Renaud, Bernard] Univ Lyon 1, Lyon Neurosci Res Ctr, INSERM, U1028,CNRS,UMR5292, Lyon, France; [Denoroy, Luc; Parrot, Sandrine] Univ Lyon 1, Lyon Neurosci Res Ctr, INSERM, U1028,CNRS,UMR5292,NeuroDialyT Unit, Lyon, France; [Collin-Chavagnac, Delphine] Hosp Civils Lyon, Grp Hosp Sud, Ctr Biol & Pathol Sud, Lab Biochim & Biol Mol, Pierre Benite, France; [Mertens, Patrick] Lyon 1 Univ, Hosp Civils Lyon, INSERM 1028, Dept Neurosurg,Dept Anat, Lyon, France		Renaud, B (corresponding author), Univ Lyon 1, Lyon Neurosci Res Ctr, INSERM, U1028,CNRS,UMR5292, Lyon, France.						Agren-Wilsson A, 2003, J NEUROL NEUROSUR PS, V74, P217, DOI 10.1136/jnnp.74.2.217; Alves OL, 2003, ANN NY ACAD SCI, V993, P25, DOI 10.1111/j.1749-6632.2003.tb07508.x; Alves OL, 2003, ANN NY ACAD SCI, V993, P48; Baker DA, 2007, HBK BEHAV NEUROSCI, V16, P33, DOI 10.1016/S1569-7339(06)16003-8; Belli A, 2008, ACTA NEUROCHIR, V150, P461, DOI 10.1007/s00701-008-1580-3; Berg A, 2006, INTENS CARE MED, V32, P1741, DOI 10.1007/s00134-006-0375-3; Berger C, 2008, NEUROCRIT CARE, V9, P352, DOI 10.1007/s12028-008-9093-8; Berger C, 2005, STROKE, V36, pE4, DOI 10.1161/01.STR.0000151328.70519.e9; Berger C, 2002, STROKE, V33, P519, DOI 10.1161/hs0102.100878; Bert L, 2002, NEUROPHARMACOLOGY, V43, P825, DOI 10.1016/S0028-3908(02)00170-3; Bianchi L, 2004, NEUROCHEM RES, V29, P325, DOI 10.1023/B:NERE.0000010462.72557.6d; Buchanan RJ, 2015, NEUROSCI LETT, V589, P73, DOI 10.1016/j.neulet.2015.01.028; Buchanan RJ, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00081; BULLOCK R, 1995, STROKE, V26, P2187, DOI 10.1161/01.STR.26.11.2187; CARLSON H, 1992, NEUROSCI LETT, V140, P30, DOI 10.1016/0304-3940(92)90674-V; Cavus I, 2005, ANN NEUROL, V57, P226, DOI 10.1002/ana.20380; Cavus I, 2008, EPILEPSIA, V49, P1358, DOI 10.1111/j.1528-1167.2008.01603.x; Cavus I, 2016, EPILEPSIA, V57, P288, DOI 10.1111/epi.13269; Chamoun R, 2010, J NEUROSURG, V113, P564, DOI 10.3171/2009.12.JNS09689; Chavagnac D, 2002, THESIS U CLAUDE BERN; Chen KC, 2006, J THEOR BIOL, V238, P863, DOI 10.1016/j.jtbi.2005.06.035; Chen SL, 2016, J NEUROCHEM, V139, P700, DOI 10.1111/jnc.13854; Dohmen C, 2003, STROKE, V34, P2152, DOI 10.1161/01.STR.0000083624.74929.32; Engstrom ER, 2005, NEUROSCI LETT, V384, P7, DOI [10.1016/j.neurlet.2005.04.030, 10.1016/j.neulet.2005.04.030]; Hillman J, 2006, ACTA NEUROCHIR, V148, P319, DOI 10.1007/s00701-005-0670-8; Hillman J, 2005, NEUROSURGERY, V56, P1264, DOI 10.1227/01.NEU.0000159711.93592.8D; Hlatky R, 2004, J NEUROTRAUM, V21, P894, DOI 10.1089/0897715041526195; Ho CL, 2008, J CLIN NEUROSCI, V15, P428, DOI 10.1016/j.jocn.2006.08.011; Hutchinson PJ, 2005, PHYSIOL MEAS, V26, P423, DOI 10.1088/0967-3334/26/4/008; KANTHAN R, 1995, J NEUROL NEUROSUR PS, V59, P326, DOI 10.1136/jnnp.59.3.326; Kanthan R, 1996, NEUROSCI LETT, V209, P207, DOI 10.1016/0304-3940(96)12642-2; KANTHAN R, 1995, STROKE, V26, P870, DOI 10.1161/01.STR.26.5.870; Kett-White R, 2002, NEUROSURGERY, V50, P1213, DOI 10.1097/00006123-200206000-00008; Kilpatrick M, 2010, J NEUROSCI METH, V190, P106, DOI 10.1016/j.jneumeth.2010.04.013; LINDEFORS N, 1989, J PHARMACOL METHOD, V22, P141, DOI 10.1016/0160-5402(89)90011-9; Lorrain DS, 2002, NEUROSCI LETT, V327, P198, DOI 10.1016/S0304-3940(02)00393-2; Marion DW, 2002, CRIT CARE MED, V30, P2619, DOI 10.1097/00003246-200212000-00001; Mathieu L, 2003, MONITORING MOL NEURO, P225; Mazzeo AT, 2008, ACTA NEUROCHIR, V150, P1019, DOI 10.1007/s00701-008-0021-7; Meierhans R, 2010, CRIT CARE, V14, DOI 10.1186/cc8869; Mellergard P, 2012, J NEUROTRAUM, V29, P112, DOI 10.1089/neu.2010.1732; Mendelowitsch A, 1998, ACTA NEUROCHIR, V140, P349, DOI 10.1007/s007010050108; Mendelowitsch A, 1998, J NEUROL NEUROSUR PS, V64, P611, DOI 10.1136/jnnp.64.5.611; Mertens P, 2000, NEUROREPORT, V11, P1795, DOI 10.1097/00001756-200006050-00040; Mertens P, 2001, J NEUROSURG, V94, P165, DOI 10.3171/spi.2001.94.1.0165; Miller CM, 2007, NEUROCRIT CARE, V6, P22, DOI 10.1385/NCC:6:1:22; Nilsson OG, 1999, NEUROSURGERY, V45, P1176, DOI 10.1097/00006123-199911000-00032; Nilsson OG, 2006, NEUROSURGERY, V59, P521, DOI 10.1227/01.NEU.0000227521.58701.E5; Parrot S, 2004, J NEUROSCI METH, V140, P29, DOI 10.1016/j.jneumeth.2004.03.025; Parrot S, 2004, ELECTROPHORESIS, V25, P1511, DOI 10.1002/elps.200305852; Parrot S, 2000, THESIS U CLAUDE BERN, P1; Petersen KL, 2014, PAIN, V155, P929, DOI 10.1016/j.pain.2014.01.019; Phang I, 2016, ANN NEUROL, V80, P522, DOI 10.1002/ana.24750; Quintard H, 2015, NEUROCRIT CARE, V22, P243, DOI 10.1007/s12028-014-0062-0; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Reinstrup P, 2011, NEUROCRIT CARE, V14, P441, DOI 10.1007/s12028-010-9486-3; Richards DA, 2003, PHARMACOL RES, V48, P101, DOI 10.1016/S1043-6618(03)00081-1; RONNEENGSTROM E, 1992, J CEREBR BLOOD F MET, V12, P873, DOI 10.1038/jcbfm.1992.119; Sakowitz OW, 2013, STROKE, V44, P220, DOI 10.1161/STROKEAHA.112.672352; Samuelsson C, 2007, J CEREBR BLOOD F MET, V27, P1309, DOI 10.1038/sj.jcbfm.9600433; Samuelsson C, 2009, J NEUROSURG, V111, P910, DOI 10.3171/2008.8.JNS0889; Sarrafzadeh A, 2005, J NEURORADIOLOGY, V32, P348, DOI 10.1016/S0150-9861(05)83168-2; Sarrafzadeh A, 2003, STROKE, V34, P1382, DOI 10.1161/01.STR.0000074036.97859.02; Sarrafzadeh AS, 2004, STROKE, V35, P638, DOI 10.1161/01.STR.0000116101.66624.F1; Sarrafzadeh AS, 2003, BRIT J NEUROSURG, V17, P340, DOI 10.1080/02688690310001601234; Sarrafzadeh AS, 2002, CRIT CARE MED, V30, P1062, DOI 10.1097/00003246-200205000-00018; Saveland H, 1996, NEUROSURGERY, V38, P12, DOI 10.1097/00006123-199601000-00004; Schley M, 2007, EUR J PAIN, V11, P299, DOI 10.1016/j.ejpain.2006.03.003; Schneweis S, 2001, STROKE, V32, P1863, DOI 10.1161/01.STR.32.8.1863; SINDOU M, 1994, STEREOT FUNCT NEUROS, V62, P164, DOI 10.1159/000098613; SINDOU M, 1974, J COMP NEUROL, V153, P15, DOI 10.1002/cne.901530103; Sindou M, 2014, NEUROSURGERY SPASTIC; SKILLING SR, 1988, J NEUROCHEM, V51, P127, DOI 10.1111/j.1471-4159.1988.tb04845.x; Stahl N, 2001, ACTA ANAESTH SCAND, V45, P977, DOI 10.1034/j.1399-6576.2001.450810.x; Stefani A, 2005, ANN NEUROL, V57, P448, DOI 10.1002/ana.20402; Tholance Y, 2015, ACS CHEM NEUROSCI, V6, P1902, DOI 10.1021/acschemneuro.5b00299; Thomas PM, 2005, SURG NEUROL, V63, P70, DOI 10.1016/j.surneu.2004.02.031; Thomas PM, 2004, ACTA NEUROCHIR, V146, P143, DOI 10.1007/s00701-003-0189-9; Thomas PM, 2003, EPILEPSY RES, V54, P73, DOI 10.1016/S0920-1211(03)00035-4; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Tolias CM, 2002, CHILD NERV SYST, V18, P368, DOI 10.1007/s00381-002-0623-y; Truini A, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0009-2; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Wibom C, 2010, J PROTEOME RES, V9, P2909, DOI 10.1021/pr901088r; Wilson CL, 1996, EPILEPSY RES, V26, P245, DOI 10.1016/S0920-1211(96)00057-5; Woitzik J, 2014, STROKE, V45, P1183, DOI 10.1161/STROKEAHA.113.004475; Xu W, 2002, ACTA NEUROCHIR, V144, P679, DOI 10.1007/s00701-002-0946-1; Zhou QQ, 2011, J PAIN, V12, P297, DOI 10.1016/j.jpain.2010.09.002	89	1	1	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	0893-2336	1940-6045	978-1-4939-7228-9; 978-1-4939-7227-2	NEUROMETHODS	Neuromethods		2018	130						523	558		10.1007/978-1-4939-7228-9_17	10.1007/978-1-4939-7228-9		36	Cell Biology; Neurosciences	Book Citation Index – Science (BKCI-S)	Cell Biology; Neurosciences & Neurology	BK0DH	WOS:000430336300019					2022-02-06	
S	Rhea, CK; Kuznetsov, NA; Wright, WG; Haran, FJ; Ross, SE; Duckworth, JL		Srivastava, AK; Cox, CS		Rhea, Christopher K.; Kuznetsov, Nikita A.; Wright, W. Geoffrey; Haran, F. Jay; Ross, Scott E.; Duckworth, Josh L.			Assessments for Quantifying Neuromotor Functioning After Repetitive Blast Exposure	PRE-CLINICAL AND CLINICAL METHODS IN BRAIN TRAUMA RESEARCH	Neuromethods		English	Article; Book Chapter						Neuromotor; Balance; Postural control; Gait; Concussion; Sub-concussion; mTBI; Blast exposure	TRAUMATIC BRAIN-INJURY; LOW-LEVEL BLAST; CONTROL FOLLOWING CONCUSSION; BTRACKS BALANCE PLATE; MILD HEAD-INJURY; POSTURAL-CONTROL; VIRTUAL-REALITY; NEUROCOGNITIVE PERFORMANCE; CEREBRAL CONCUSSION; LOCOMOTOR DEFICITS	Blast exposure may result in associated head trauma throughout the Traumatic Brain Injury (TBI) spectrum-ranging from weapon fire resulting in sub-concussive exposure and a mechanotransductive physiologic response to improvised explosive device (IED) detonation resulting in moderate and severe TBI associated with tissue-level disruption. Head trauma-regardless of severity-can result in changes to neurological functioning, which may alter neuromotor performance. Thus, measurement of neuromotor performance has been commonly used as a way to assess and track changes in functioning after head trauma. A number of subjective assessments have been developed over the years to help clinicians and researchers measure changes in neuromotor performance. In recent years, technological advances have led to more portable and cost-effective tools to objectively measure neuromotor performance, reducing the human error associated with subjective assessment. This chapter reviews relevant subjective and objective neuromotor assessments commonly used with populations who have head trauma.	[Rhea, Christopher K.] Univ N Carolina, Dept Kinesiol, Greensboro, NC 27412 USA; [Kuznetsov, Nikita A.] Louisiana State Univ, Baton Rouge, LA 70803 USA; [Wright, W. Geoffrey] Temple Univ, Philadelphia, PA 19122 USA; [Haran, F. Jay; Duckworth, Josh L.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Haran, F. Jay; Ross, Scott E.] Univ N Carolina, Greensboro, NC USA		Rhea, CK (corresponding author), Univ N Carolina, Dept Kinesiol, Greensboro, NC 27412 USA.						Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Adam O, 2015, NEUROLOGY, V85, P219, DOI 10.1212/WNL.0000000000001758; Alberts JL, 2015, J ATHL TRAINING, V50, P578, DOI 10.4085/1062-6050-50.2.01; Alberts JL, 2016, BRIDGE LINKING ENG S, V46, P23; Alsalaheen BA, 2016, CLIN J SPORT MED, V26, P46, DOI 10.1097/JSM.0000000000000185; Amick R.Z., 2015, J MOB TECHNOL MED, V4, P40, DOI [10.7309/jmtm.4.2.6, DOI 10.7309/JMTM.4.2.6]; Baker CS, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12252; BALOH RW, 1994, J AM GERIATR SOC, V42, P405, DOI 10.1111/j.1532-5415.1994.tb07489.x; Bandak F, 2014, HDB CLIN NEUROL, V127, P89; Bartlett HL, 2014, GAIT POSTURE, V39, P224, DOI 10.1016/j.gaitpost.2013.07.010; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Bazarian JJ, 2016, BRIDGE LINKING ENG S, V46, P26; BELAIR J, 1995, CHAOS, V5, P1, DOI 10.1063/1.166069; Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Benedict SE, 2017, INT J ATHL THER TRAI, V22, P23, DOI 10.1123/ijatt.2016-0086; BERG K, 1989, Physiotherapy Canada, V41, P304; BERG KO, 1992, CAN J PUBLIC HEALTH, V83, pS7; Blum L, 2008, PHYS THER, V88, P559, DOI 10.2522/ptj.20070205; Boissy P, 2017, TELEMED E-HEALTH, V23, P503, DOI 10.1089/tmj.2016.0205; Boulos Maged N Kamel, 2014, Online J Public Health Inform, V5, P229, DOI 10.5210/ojphi.v5i3.4814; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Broglio SP, 2012, EXERC SPORT SCI REV, V40, P138, DOI 10.1097/JES.0b013e3182524273; Brown CN, 2007, J ATHL TRAINING, V42, P367; Brown HJ, 2013, J EXERC MOV SPORT, V45, P4; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P61, DOI 10.1016/j.jshs.2016.01.007; Burghart M., 2017, CURRENT RES CONCUSSI, V4, pE1, DOI DOI 10.1055/S-0036-1597914; Cantin JF, 2007, BRAIN INJURY, V21, P327, DOI 10.1080/02699050701209972; Carr W, 2015, J HEAD TRAUMA REHAB, V30, P47, DOI 10.1097/HTR.0000000000000064; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Catena RD, 2007, GAIT POSTURE, V25, P406, DOI 10.1016/j.gaitpost.2006.05.006; Catena RD, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-8; Catena RD, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-25; Catena RD, 2009, EXP BRAIN RES, V194, P67, DOI 10.1007/s00221-008-1669-1; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chang JO, 2014, CLIN J SPORT MED, V24, P256, DOI 10.1097/JSM.0000000000000016; Chiu SL, 2013, GAIT POSTURE, V38, P717, DOI 10.1016/j.gaitpost.2013.03.010; Chou LS, 2004, GAIT POSTURE, V20, P245, DOI 10.1016/j.gaitpost.2003.09.007; Clark RA, 2010, GAIT POSTURE, V31, P307, DOI 10.1016/j.gaitpost.2009.11.012; COHEN H, 1993, PHYS THER, V73, P346, DOI 10.1093/ptj/73.6.346; Cohen HS, 2014, LARYNGOSCOPE, V124, P545, DOI 10.1002/lary.24314; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Covassin T, 2003, J ATHL TRAINING, V38, P238; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Denis A. M., 2007, INTENS CARE MED, P1011; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Duckworth Josh L, 2013, Pathophysiology, V20, P23, DOI 10.1016/j.pathophys.2012.03.001; Feld JA, 2001, NEUROREHAB NEURAL RE, V15, P239, DOI 10.1177/154596830101500312; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Fino PC, 2016, GAIT POSTURE, V50, P69, DOI 10.1016/j.gaitpost.2016.08.026; Fino PC, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0177-y; Fino PC, 2016, J BIOMECH, V49, P1983, DOI 10.1016/j.jbiomech.2016.05.004; Fox ZG, 2008, J ATHL TRAINING, V43, P456, DOI 10.4085/1062-6050-43.5.456; Fralick M, 2016, CAN MED ASSOC J, V188, P497, DOI 10.1503/cmaj.150790; Gao JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016749; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Glass L, 1979, Ann N Y Acad Sci, V316, P214, DOI 10.1111/j.1749-6632.1979.tb29471.x; Goble DJ, 2016, INT J SPORTS PHYS TH, V11, P149; GOLDBERGER AL, 1990, SCI AM, V262, P43; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; HAALAND KY, 1994, J CLIN EXP NEUROPSYC, V16, P448, DOI 10.1080/01688639408402655; Hanninen T, 2016, J SCI MED SPORT, V19, P636, DOI 10.1016/j.jsams.2015.08.005; Haran FJ, 2013, INT J SPORTS MED, V34, P350, DOI 10.1055/s-0032-1304647; Hausdorff JM, 2007, HUM MOVEMENT SCI, V26, P555, DOI 10.1016/j.humov.2007.05.003; HAUSDORFF JM, 1995, J APPL PHYSIOL, V78, P349, DOI 10.1152/jappl.1995.78.1.349; Hays K, 2015, ARCH PHYS MED REHAB, V96, pe44; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Howe JA, 2006, CLIN REHABIL, V20, P885, DOI 10.1177/0269215506072183; Howell D, 2015, J BIOMECH, V48, P3364, DOI 10.1016/j.jbiomech.2015.06.014; Hunt TN, 2009, CLIN J SPORT MED, V19, P471, DOI 10.1097/JSM.0b013e3181c12c7b; Iacono D, 2017, PHYS MED REH CLIN N, V28, P301, DOI 10.1016/j.pmr.2016.12.007; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; Kerrigan DCC, 1999, J HEAD TRAUMA REHAB, V14, P136, DOI 10.1097/00001199-199904000-00004; Kovacs SK, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00047; Kuznetsov NA, 2018, PHYSIOL MEAS, V39, DOI 10.1088/1361-6579/aaa3c2; Lange RT, 2012, J INT NEUROPSYCH SOC, V18, P595, DOI 10.1017/S1355617712000239; Langton, 2010, WOMEN LAW ENFORCEMEN; Lee BC, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-10; LEHMANN JF, 1990, ARCH PHYS MED REHAB, V71, P955; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; MACKEY MC, 1977, SCIENCE, V197, P287, DOI 10.1126/science.267326; MACKEY MC, 1987, ANN NY ACAD SCI, V504, P16, DOI 10.1111/j.1749-6632.1987.tb48723.x; Manley GT, 2017, J NEUROTRAUM, V34, P2721, DOI 10.1089/neu.2016.4729; Mayagoitia RE, 2002, GAIT POSTURE, V16, P55, DOI 10.1016/S0966-6362(01)00199-0; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McFadyen BJ, 2003, J HEAD TRAUMA REHAB, V18, P512, DOI 10.1097/00001199-200311000-00005; McFadyen BJ, 2009, ARCH PHYS MED REHAB, V90, P1596, DOI 10.1016/j.apmr.2009.03.010; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mendez MF, 2013, NEUROREHABILITATION, V32, P397, DOI 10.3233/NRE-130861; Moon Y, 2016, HUM MOVEMENT SCI, V47, P197, DOI 10.1016/j.humov.2016.03.010; Mourcou Q, 2015, SENSORS-BASEL, V15, P23168, DOI 10.3390/s150923168; Mourcou Q, 2015, LECT NOTES COMPUT SC, V9102, P141, DOI 10.1007/978-3-319-19312-0_12; Muir Brad, 2014, J Can Chiropr Assoc, V58, P361; Myer GD, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00074; Needham CE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00072; Norris ES, 2017, J REHABIL SCI RES, V3, P77; O'Connor SM, 2016, J BIOMECH, V49, P4142, DOI 10.1016/j.jbiomech.2016.10.020; O'Sullivan M, 2009, AGE AGEING, V38, P308, DOI 10.1093/ageing/afp009; Ochi F, 1999, J HEAD TRAUMA REHAB, V14, P105, DOI 10.1097/00001199-199904000-00002; Omkar S, 2009, INDIAN J PHYSIOTHER, V3, P44; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Patterson J.A., 2014, INT J ATHL THER TRAI, V19, P4, DOI [10.1123/ijatt.2013-0094, DOI 10.1123/IJATT.2013-0094]; Patterson JA, 2014, INT J SPORTS PHYS TH, V9, P135; Perry J, 1999, J HEAD TRAUMA REHAB, V14, P116, DOI 10.1097/00001199-199904000-00003; Pickett TC, 2007, J REHABIL RES DEV, V44, P983, DOI 10.1682/JRRD.2007.01.0001; Pietrzak E, 2014, GAMES HEALTH J, V3, P202, DOI 10.1089/g4h.2014.0013; Poole VN, 2015, DEV NEUROPSYCHOL, V40, P12, DOI 10.1080/87565641.2014.984810; Powers KC, 2014, GAIT POSTURE, V39, P611, DOI 10.1016/j.gaitpost.2013.05.026; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Rabago CA, 2011, J NEUROL PHYS THER, V35, P185, DOI 10.1097/NPT.0b013e318235d7e6; Ragnarsd?ttir M., 1996, PHYSIOTHERAPY, V82, P368, DOI 10.1016/S0031-9406(05)66484-X; Reed-Jones RJ, 2014, SEMIN SPEECH LANG, V35, P186, DOI 10.1055/s-0034-1384680; Rhea CK, 2017, MIL MED, V182, P147, DOI 10.7205/MILMED-D-16-00140; Rhea CK, 2017, INT SOC POSTURE GAIT; Rhea CK, 2014, GAIT BIOMETRICS BASI; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Rochefort C, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117695507; Roeing KL, 2017, ARCH GERONTOL GERIAT, V73, P222, DOI 10.1016/j.archger.2017.08.002; Morales CR, 2017, PEERJ, V5, DOI 10.7717/peerj.2820; Rothweiler B, 1998, ARCH PHYS MED REHAB, V79, P881, DOI 10.1016/S0003-9993(98)90082-X; Saether R, 2013, DEV MED CHILD NEUROL, V55, P988, DOI 10.1111/dmcn.12162; Shah Nirtal, 2016, JMIR Rehabil Assist Technol, V3, pe4, DOI 10.2196/rehab.4511; Shively SB, 2012, J HEAD TRAUMA REHAB, V27, P234, DOI 10.1097/HTR.0b013e318250e9dd; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Shumway-Cook A., 1995, MOTOR CONTROL THEORY; Smith Douglas H, 2016, Bridge (Wash D C), V46, P79; Snell FI, 2010, J PSYCHOSOC NURS MEN, V48, P22, DOI [10.3928/02793695-20100107-01, 10.3928/02793695-20100108-02]; Soangra Rahul, 2013, Biomed Sci Instrum, V49, P180; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Sowell ER, 2007, CEREB CORTEX, V17, P1550, DOI 10.1093/cercor/bhl066; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; Stone JR, 2013, J NEUROTRAUM, V30, pA120; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Talavage TM., 2016, BRIDGE LINKING ENG S, V46, P91; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; Turner RC, 2012, J NEUROSURG, V117, P1110, DOI 10.3171/2012.8.JNS12358; Tyson SF, 2009, CLIN REHABIL, V23, P824, DOI 10.1177/0269215509335018; Ustinova KI, 2014, BRAIN INJURY, V28, P486, DOI 10.3109/02699052.2014.888593; Vaillancourt DE, 2002, NEUROBIOL AGING, V23, P1, DOI 10.1016/S0197-4580(01)00247-0; van Emmerik REA, 2016, J SPORT HEALTH SCI, V5, P3, DOI 10.1016/j.jshs.2016.01.013; Vohralik SL, 2015, AM J PHYS MED REHAB, V94, P325, DOI 10.1097/PHM.0000000000000221; Walker WC, 2016, BRAIN INJURY, V30, P1469, DOI 10.1080/02699052.2016.1219061; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; WEST BJ, 1987, AM SCI, V75, P354; Williams G, 2010, J HEAD TRAUMA REHAB, V25, P366, DOI 10.1097/HTR.0b013e3181cd3600; Wiri S, 2017, 30 INT S SHOCK WAV, V2, P1367; WOBER C, 1993, ARCH PHYS MED REHAB, V74, P1151; Wright WG, 2017, DISABIL REHABIL, V39, P1564, DOI 10.1080/09638288.2016.1226432; WRISLEY DM, 2004, FUNCT GAIT ASSESS PH, V84, P906; Wunderle K, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000006; Young L, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00089; Youssef AR, 2017, EXPERT REV MED DEVIC, V14, P481, DOI 10.1080/17434440.2017.1325319	169	1	1	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	0893-2336	1940-6045	978-1-4939-8564-7; 978-1-4939-8563-0	NEUROMETHODS	Neuromethods		2018	139						283	305		10.1007/978-1-4939-8564-7_18	10.1007/978-1-4939-8564-7		23	Cell Biology; Neurosciences	Book Citation Index – Science (BKCI-S)	Cell Biology; Neurosciences & Neurology	BL5CO	WOS:000451267100020					2022-02-06	
S	Robinson, MA; Jaber, SM; Piotrowski, SL; Gomez, TH		Srivastava, AK; Cox, CS		Robinson, Mary A.; Jaber, Samer M.; Piotrowski, Stacey L.; Gomez, Thomas H.			Pre-Procedural Considerations and Post-Procedural Care for Animal Models with Experimental Traumatic Brain Injury	PRE-CLINICAL AND CLINICAL METHODS IN BRAIN TRAUMA RESEARCH	Neuromethods		English	Article; Book Chapter						Animal welfare; Animal use protocol; Traumatic brain injury; Experimental models; Support; Assessments	FACIAL EXPRESSIONS; HEALTH-STATUS; BLOOD-FLOW; ANESTHESIA; IMPACT; PAIN; HYPOGLYCEMIA; ATIPAMEZOLE; KETAMINE; SWINE	In vivo models of traumatic brain injury (TBI) are powerful means of examining the progression and sequelae after neurologic injury at the cellular and molecular level. Drafting the animal use protocol, acquiring animals, and preparing the animals for the procedure must be considered in advance of the start of the actual study. The provision of supportive care in the post-procedure period cannot be overlooked as a critical component of experimental success. This chapter introduces these topics to the researcher studying TBI in animal models.	[Robinson, Mary A.; Piotrowski, Stacey L.; Gomez, Thomas H.] Univ Texas Hlth Sci Ctr Houston, Ctr Lab Anim Med & Care, Houston, TX 77030 USA; [Jaber, Samer M.] Univ Massachusetts, Sch Med, Dept Anim Med, Worcester, MA USA; [Jaber, Samer M.] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA		Robinson, MA (corresponding author), Univ Texas Hlth Sci Ctr Houston, Ctr Lab Anim Med & Care, Houston, TX 77030 USA.						Alderson P, 1997, BRIT MED J, V314, P1855, DOI 10.1136/bmj.314.7098.1855; [Anonymous], 2016, JAVMA-J AM VET MED A, V249, P755, DOI 10.2460/javma.249.7.755; Baker NJ, 2011, J AM ASSOC LAB ANIM, V50, P916; Berkner J, 2016, METHODS MOL BIOL, V1462, P11, DOI 10.1007/978-1-4939-3816-2_2; Berry ML, 2007, MOUSE BIOMEDICAL RES, V1, P53, DOI [10.1016/b978012369454-6/500169, DOI 10.1016/B978012369454-6/500169]; Brady RD, 2016, SCI REP-UK, V6, DOI 10.1038/srep34491; Brown MJ., 2015, LAB ANIMAL MED, V3, P1653, DOI [10.1016/B978-0-12-409527-4.00039-0, DOI 10.1016/B978-0-12-409527-4.00039-0, DOI 10.1016/B9780-12409527-4.000390]; Browne KD, 2006, EXP NEUROL, V201, P301, DOI 10.1016/j.expneurol.2006.04.008; Bruins B, 2013, ANESTH ANALG, V116, P838, DOI 10.1213/ANE.0b013e3182860fe7; Capdevila S, 2007, LAB ANIM-UK, V41, P255, DOI 10.1258/002367707780378096; Caro AC, 2013, J AM ASSOC LAB ANIM, V52, P577; Chang YS, 1999, BRAIN RES, V844, P135, DOI 10.1016/S0006-8993(99)01940-X; Cheng JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115765; Clevenger AC, 2015, J NEUROTRAUM, V32, P120, DOI 10.1089/neu.2014.3570; Conour LA, 2006, ILAR J, V47, P283, DOI 10.1093/ilar.47.4.283; Crumrine R Christian, 2011, Exp Transl Stroke Med, V3, P10, DOI 10.1186/2040-7378-3-10; Cullen DK, 2016, METHODS MOL BIOL, V1462, P289, DOI 10.1007/978-1-4939-3816-2_17; Davies JA, 2015, JAVMA-J AM VET MED A, V246, P327, DOI 10.2460/javma.246.3.327; Di GQ, 2013, NOISE HEALTH, V15, P217, DOI 10.4103/1463-1741.113506; Done S., 1995, In Practice, V17, P318; Duke JL, 2001, CONTEMP TOP LAB ANIM, V40, P17; Febinger HY, 2014, J AM ASSOC LAB ANIM, V53, P29; Friess SH, 2012, LAB ANIM-UK, V46, P164, DOI 10.1258/la.2011.011084; Friess SH, 2007, EXP NEUROL, V204, P234, DOI 10.1016/j.expneurol.2006.10.010; Gelberg HB, 2010, VET PATHOL, V47, P576, DOI 10.1177/0300985810367894; Glass TF, 1999, J NEUROTRAUM, V16, P771, DOI 10.1089/neu.1999.16.771; GOODWIN RFW, 1957, J PHYSIOL-LONDON, V136, P208, DOI 10.1113/jphysiol.1957.sp005753; Hall ANB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159442; Hellewell SC, 2016, METHODS MOL BIOL, V1462, P253, DOI 10.1007/978-1-4939-3816-2_15; Henninger N, 2016, BRAIN, V139, P1094, DOI 10.1093/brain/aww001; Hickman DL, 2010, J AM ASSOC LAB ANIM, V49, P155; Hoogstraten-Miller Shelley L, 2008, Curr Protoc Immunol, VChapter 1, DOI 10.1002/0471142735.im0112s82; Horn CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060537; HOUPT TR, 1995, PHYSIOL BEHAV, V57, P49, DOI 10.1016/0031-9384(94)00208-M; Institue of Laboratory Animal Research, 2003, GUID CAR US MANN NEU; Institute for Laboratory Animal Research, 2011, GUID CAR US LAB AN; ISHITAKE T, 1990, Kurume Medical Journal, V37, P235; Izer JM, 2014, J AM ASSOC LAB ANIM, V53, P675; Jaber SM, 2014, J AM ASSOC LAB ANIM, V53, P684; Janssen CF, 2017, J AM ASSOC LAB ANIM, V56, P142; Kamnaksh A, 2011, J NEUROTRAUM, V28, P2145, DOI 10.1089/neu.2011.1983; Kanitz E, 2009, PHYSIOL BEHAV, V98, P176, DOI 10.1016/j.physbeh.2009.05.007; Kao CH, 1998, AM J GASTROENTEROL, V93, P1108; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Langford DJ, 2010, NAT METHODS, V7, P447, DOI [10.1038/NMETH.1455, 10.1038/nmeth.1455]; Leitgeb J, 2013, ARCH ORTHOP TRAUM SU, V133, P659, DOI 10.1007/s00402-013-1710-0; Magden E. R., 2015, LAB ANIMAL MED, P771, DOI DOI 10.1016/B978-012-4095274.000171; Margulies SS, 2015, BRAIN PATHOL, V25, P289, DOI 10.1111/bpa.12247; Mayer CL, 2013, HEADACHE, V53, P1523, DOI 10.1111/head.12173; Mayer J, 2007, LAB ANIMAL, V36, P43, DOI 10.1038/laban0607-43; McDonald SJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0555-1; Mishra RK, 2017, J NEUROSCI RURAL PRA, V8, P64, DOI 10.4103/0976-3147.193538; MORTON DB, 1985, VET REC, V116, P431, DOI 10.1136/vr.116.16.431; NILSSON P, 1994, BRAIN RES, V637, P227, DOI 10.1016/0006-8993(94)91237-8; Office of Laboratory Animal Welfare, 2015, PUBL HLTH SERV POL H; Office of Laboratory Animal Welfare, 2002, I AN CAR US GUID; Osier N, 2016, METHODS MOL BIOL, V1462, P177, DOI 10.1007/978-1-4939-3816-2_11; Peterson K, 2008, J NEUROTRAUM, V25, P62, DOI 10.1089/neu.2007.0424; Prins ML, 2008, J CEREBR BLOOD F MET, V28, P1, DOI 10.1038/sj.jcbfm.9600543; Prins ML, 2014, J LIPID RES, V55, P2450, DOI 10.1194/jlr.R046706; Prins ML, 2009, J NEUROTRAUM, V26, P1083, DOI 10.1089/neu.2008-0769; Rowe RK, 2013, LAB ANIMAL, V42, P286, DOI 10.1038/laban.257; Saha JK, 2005, EXP BIOL MED, V230, P777, DOI 10.1177/153537020523001012; Sande A, 2010, J VET EMERG CRIT CAR, V20, P177, DOI 10.1111/j.1476-4431.2010.00527.x; Smith AJ, 2018, LAB ANIM-UK, V52, P135, DOI 10.1177/0023677217724823; Smith AC, 2006, ILAR J, V47, P358, DOI 10.1093/ilar.47.4.358; Sotocinal SG, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-55; Stasiak KL, 2003, CONTEMP TOP LAB ANIM, V42, P13; Sullivan S, 2013, J NEUROTRAUM, V30, P1770, DOI 10.1089/neu.2013.2913; SWIATEK KR, 1968, AM J PHYSIOL, V214, P400, DOI 10.1152/ajplegacy.1968.214.2.400; Swindle MM, 2016, SWINE IN THE LABORATORY: SURGERY, ANESTHESIA, IMAGING, AND EXPERIMENTAL TECHNIQUES, 3RD EDITION, P39; Syring RS, 2001, J AM VET MED ASSOC, V218, P1124, DOI 10.2460/javma.2001.218.1124; Tanaka Tadashi, 2005, J Anesth, V19, P277, DOI 10.1007/s00540-005-0341-1; Taylor SJ, 1999, CRIT CARE MED, V27, P2525, DOI 10.1097/00003246-199911000-00033; Thau-Zuchman O, 2012, J NEUROTRAUM, V29, P375, DOI 10.1089/neu.2010.1673; Thelin EP, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00023; Thompson HJ, 2003, NEUROBIOL DIS, V12, P163, DOI 10.1016/S0969-9961(02)00030-X; Toth LA, 2015, J AM ASSOC LAB ANIM, V54, P708; Tsitsilonis S, 2015, INJURY, V46, P661, DOI 10.1016/j.injury.2015.01.044; Tzamkiozis T, 2010, INHAL TOXICOL, V22, P59, DOI 10.3109/08958378.2010.519408; Ullman-Cullere MH, 1999, LAB ANIM SCI, V49, P319; Viscardi AV, 2017, FRONT VET SCI, V4, DOI 10.3389/fvets.2017.00051; White H, 2017, J NEUROL NEUROSCI, V8, P188, DOI [10.21767/21716625.1000188, DOI 10.21767/2171-6625.1000188, 10.21767/2171-6625.1000188]; White H, 2011, CRIT CARE, V15, DOI 10.1186/cc10020; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; YAGER JY, 1992, PEDIATR RES, V31, P138, DOI 10.1203/00006450-199202000-00009	86	1	1	1	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	0893-2336	1940-6045	978-1-4939-8564-7; 978-1-4939-8563-0	NEUROMETHODS	Neuromethods		2018	139						155	172		10.1007/978-1-4939-8564-7_10	10.1007/978-1-4939-8564-7		18	Cell Biology; Neurosciences	Book Citation Index – Science (BKCI-S)	Cell Biology; Neurosciences & Neurology	BL5CO	WOS:000451267100012					2022-02-06	
S	Rowe, RK; Griffiths, D; Lifshitz, J		Srivastava, AK; Cox, CS		Rowe, Rachel K.; Griffiths, Daniel; Lifshitz, Jonathan			Fluid Percussion Model of Traumatic Brain Injury	PRE-CLINICAL AND CLINICAL METHODS IN BRAIN TRAUMA RESEARCH	Neuromethods		English	Article; Book Chapter						Fluid percussion; Rat; Mouse; Brain injury; Concussion; Trauma; Diffuse; Focal; Righting reflex; Fencing response		Research models of traumatic brain injury (TBI) hold significant validity towards the human condition, with each model replicating a subset of clinical features and symptoms. After 30 years of characterization and implementation, fluid percussion injury (FPI) is firmly recognized as a clinically relevant model of TBI and the hallmarks of TBI in man can be faithfully reproduced. Variations in the surgical procedure provide the ability to induce focal, diffuse, or mixed focal and diffuse brain injury in various laboratory species. Being fully scalable, fluid percussion can induce mild, moderate, or severe brain injury in subjects of either sex, at any age. This chapter outlines the procedures for FPI in adult male rats and mice. With these procedures, it becomes possible to generate brain-injured laboratory animals for studies of injury-induced pathophysiology and behavioral deficits, for which rational therapeutic interventions can be evaluated.	[Rowe, Rachel K.; Griffiths, Daniel; Lifshitz, Jonathan] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ 85016 USA; [Rowe, Rachel K.; Griffiths, Daniel; Lifshitz, Jonathan] Univ Arizona, Coll Med, Dept Child Hlth, Phoenix, AZ 85004 USA; [Rowe, Rachel K.; Lifshitz, Jonathan] Phoenix Vet Affairs Healthcare Syst, Phoenix, AZ 85012 USA		Rowe, RK (corresponding author), Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ 85016 USA.; Rowe, RK (corresponding author), Univ Arizona, Coll Med, Dept Child Hlth, Phoenix, AZ 85004 USA.; Rowe, RK (corresponding author), Phoenix Vet Affairs Healthcare Syst, Phoenix, AZ 85012 USA.						Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Floyd CL, 2002, J NEUROTRAUM, V19, P303, DOI 10.1089/089771502753594873; Iwamoto Y, 1997, NEUROSURGERY, V40, P163, DOI 10.1097/00006123-199701000-00036; Lifshitz J, 2016, BRAIN INJURY, V30, P1293, DOI 10.1080/02699052.2016.1193628; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Rowe RK, 2013, LAB ANIMAL, V42, P286, DOI 10.1038/laban.257; THIBAULT LE, 1992, J NEUROTRAUM, V9, P311, DOI 10.1089/neu.1992.9.311; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Vink R, 2001, J NEUROTRAUM, V18, P839, DOI 10.1089/089771501316919201; Yamamoto T, 1988, J NEUROTRAUM, V5, P69, DOI 10.1089/neu.1988.5.69	12	1	1	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	0893-2336	1940-6045	978-1-4939-8564-7; 978-1-4939-8563-0	NEUROMETHODS	Neuromethods		2018	139						97	110		10.1007/978-1-4939-8564-7_6	10.1007/978-1-4939-8564-7		14	Cell Biology; Neurosciences	Book Citation Index – Science (BKCI-S)	Cell Biology; Neurosciences & Neurology	BL5CO	WOS:000451267100008					2022-02-06	
J	Saleh, S; Swanson, KI; Bragg, T				Saleh, Sara; Swanson, Kyle I.; Bragg, Taryn			Successful surgical repair and recovery in a 2-week-old infant after birth-related cervical fracture dislocation	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						cervical trauma; spine; neonate; pediatric neurosurgery	SPINAL-CORD-INJURY; PEDIATRIC-PATIENTS; CHILDREN; MANAGEMENT; ADOLESCENTS; SURGEON; TRAUMA; HEAD	Cervical spine injuries are the most common spine injuries in the pediatric population. The authors present the youngest known patient who underwent cervical spine fusion to repair birth trauma-induced cervical fracture dislocation, resulting in spondyloptosis and spinal cord injury. A 2-week-old boy was found to have spondyloptosis and spinal cord injury after concerns arose from reduced movement of the extremities. The patient's birth was complicated by undiagnosed abdominal dystocia, which led to cervical distraction injury. At 15 days of age, the boy underwent successful C-5 corpectomy, with anterior C4-6 and posterior C2-7 arthrodesis, using an autologous rib graft for a C-5 fracture dislocation. MRI performed 2 weeks postoperatively revealed significant improvement in the alignment of the spinal canal. The patient was discharged from the hospital in a custom Minerva brace and underwent close follow-up in addition to occupational therapy and physical therapy. At the latest follow-up 4.5 years later, the patient was able to walk and ride a tricycle by himself. The authors describe the patient's surgery and the challenges faced in achieving successful repair and cervical spine stabilization in such a young patient. The authors suggest that significant neurological recovery after spinal cord injury in infants is possible with appropriate, timely, and interdisciplinary management.	[Saleh, Sara; Swanson, Kyle I.; Bragg, Taryn] Univ Wisconsin, Dept Neurol Surg, Sch Med & Publ Hlth, 600 Highland Ave,Box 8660, Madison, WI 53792 USA; [Swanson, Kyle I.] Phoenix Childrens Hosp, Barrow Neurol Inst, Dept Neurosurg, Phoenix, AZ USA; [Bragg, Taryn] Phoenix Childrens Hosp, Barrow Neurol Inst, Div Neurosurg, Phoenix, AZ USA		Saleh, S (corresponding author), Univ Wisconsin, Dept Neurol Surg, Sch Med & Publ Hlth, 600 Highland Ave,Box 8660, Madison, WI 53792 USA.	ssaleh@wisc.edu	Kehoe, Clare/ABC-7984-2020	Saleh, Sara/0000-0002-2127-8701; Swanson, Kyle/0000-0003-2639-7010			Babu RA, 2016, PEDIATR NEUROSURG, V51, P1, DOI 10.1159/000439540; Caird MS, 2005, J PEDIATR ORTHOPED, V25, P484, DOI 10.1097/01.bpo.0000158006.61294.ff; Campbell J M, 1968, Aust N Z J Obstet Gynaecol, V8, P22, DOI 10.1111/j.1479-828X.1968.tb00676.x; Caulfield Philip., 2012, NEW YORK DAILY NEWS; Cirak B, 2004, J PEDIATR SURG, V39, P607, DOI 10.1016/j.jpedsurg.2003.12.011; Easter JS, 2011, J EMERG MED, V41, P252, DOI 10.1016/j.jemermed.2010.03.018; Eleraky MA, 2000, J NEUROSURG, V92, P12, DOI 10.3171/spi.2000.92.1.0012; FARLEY FA, 1992, J SPINAL DISORD, V5, P410, DOI 10.1097/00002517-199212000-00005; Ghatan S, 2002, NEUROSURG CLIN N AM, V13, P227, DOI 10.1016/S1042-3680(01)00002-X; Gressot LV, 2014, J NEUROSURG-PEDIATR, V13, P196, DOI 10.3171/2013.11.PEDS13422; Ha SY, 2015, CHILD NERV SYST, V31, P341, DOI 10.1007/s00381-014-2527-z; Hall D E, 1999, Pediatr Rev, V20, P13; Holland CM, 2016, J NEUROSURG-PEDIATR, V17, P353, DOI 10.3171/2015.3.PEDS13568; Jain A, 2015, J CHILD ORTHOP, V9, P171, DOI 10.1007/s11832-015-0657-9; Klimo P, 2007, NEUROSURG CLIN N AM, V18, P599, DOI 10.1016/j.nec.2007.09.004; Kokoska ER, 2001, J PEDIATR SURG, V36, P100, DOI 10.1053/jpsu.2001.20022; NITECKI S, 1994, J PEDIATR SURG, V29, P1409, DOI 10.1016/0022-3468(94)90131-7; Oluigbo CO, 2008, CHILD NERV SYST, V24, P87, DOI 10.1007/s00381-007-0412-8; Pajewski TN, 2007, EUR SPINE J, V16, pS115, DOI 10.1007/s00586-007-0419-6; Platzer P, 2007, J TRAUMA, V62, P389, DOI 10.1097/01.ta.0000221802.83549.46; Sribnick EA, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.02.008; Tekes A, 2011, MAGN RESON IMAGING C, V19, P777, DOI 10.1016/j.mric.2011.08.004; Thirumala PD, 2014, SPINE J, V14, P1572, DOI 10.1016/j.spinee.2013.09.035; Ul Haq I, 2012, BMJ CASE REP, V2012, P2	24	1	1	1	4	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	JAN	2018	21	1					16	20		10.3171/2017.7.PEDS17105			5	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	FR2PI	WOS:000418908800005	29053055	Bronze			2022-02-06	
J	Samudra, NP; Park, SM; Gray, SE; Sebai, MA; Olson, DM				Samudra, Niyatee P.; Park, Soo M.; Gray, Sara E.; Sebai, Mohammed A.; Olson, DaiWai M.			Inconsistency in Reporting Variables Related to Intracranial Pressure Measurement in Scientific Literature	JOURNAL OF NURSING MEASUREMENT			English	Article						intracranial pressure; reproducibility; internal validity; measurement; research design	TRAUMATIC BRAIN-INJURY; MANAGEMENT; MORTALITY	Purpose: To assess whether the collection and communication of intracranial pressure (ICP) values were standardized and reproducible. Methods: Integrative review of clinical trials (n = 357) reporting ICP as a variable. Results: Only 24.1% of studies reported adequate data required for replication. Of the 357 reports, 342 provided information about the design, 274 discussed sampling strategy, 294 identified the ICP device type, 312 provided a unit of measure, 121 provided anatomical localization for measuring ICP, and 83 provided information about patient positioning. Conclusions: The majority of literature evaluated did not provide enough data for replication of results. Measuring and reporting ICP in the scientific literature is not standardized. A uniform standard would strengthen the quality of the evidence in neurocritical care and neurosurgical literature and better establish clinical guidelines for ICP management in neurologically injured patients.	[Samudra, Niyatee P.; Gray, Sara E.; Olson, DaiWai M.] Univ Texas Southwestern Med Ctr, Dallas, TX 75235 USA; [Park, Soo M.] Texas Womans Univ, Denton, TX 76204 USA; [Sebai, Mohammed A.] Alfaisal Univ, Riyadh, Saudi Arabia		Olson, DM (corresponding author), Univ Texas Southwestern Med Ctr, Dept Neurol & Neurotherapeut, 5959 Harry Hines Blvd, Dallas, TX 75235 USA.	DaiWai.Olson@UTSouthwestern.edu	Olson, DaiWai/I-5932-2019	Olson, DaiWai/0000-0002-9280-078X			Biersteker HAR, 2012, CRIT CARE MED, V40, P1914, DOI 10.1097/CCM.0b013e3182474bde; Cardim D., 2016, NEUROCRIT CARE, V80, DOI [10.1227/NEU.0000000000001432, DOI 10.1227/NEU.0000000000001432]; Cardim D, 2016, J NEUROTRAUM, V33, P792, DOI 10.1089/neu.2015.4134; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Chung DY, 2017, NEUROCRIT CARE, V26, P356, DOI 10.1007/s12028-016-0352-9; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Dawes AJ, 2015, J TRAUMA ACUTE CARE, V78, P492, DOI 10.1097/TA.0000000000000559; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Glimaker M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091976; Karvellas CJ, 2014, CRIT CARE MED, V42, P1157, DOI 10.1097/CCM.0000000000000144; Kawoos U, 2015, INT J MOL SCI, V16, P28979, DOI 10.3390/ijms161226146; Kim MO, 2015, J HYPERTENS, V33, P1233, DOI 10.1097/HJH.0000000000000539; McNutt M, 2014, SCIENCE, V346, P679, DOI 10.1126/science.aaa1724; O'Phelan K, 2016, CEREBRAL HERNIATION; Olson DM, 2014, NEUROCRIT CARE, V20, P15, DOI 10.1007/s12028-013-9847-9; Rangel-Castillo L, 2008, NEUROL CLIN, V26, P521, DOI 10.1016/j.ncl.2008.02.003; Stocchetti N, 2014, ACTA NEUROCHIR, V156, P1615, DOI 10.1007/s00701-014-2127-4; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255; Yuan Q, 2015, J NEUROSURG, V122, P574, DOI 10.3171/2014.10.JNS1460; Zacchetti L, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1137-9; Zeng JS, 2014, BMC ANESTHESIOL, V14, DOI 10.1186/1471-2253-14-19	23	1	1	0	1	SPRINGER PUBLISHING CO	NEW YORK	11 WEST 42ND STREET, NEW YORK, NY 10036 USA	1061-3749	1945-7049		J NURS MEAS	J. Nurs. Meas.		2018	26	3					415	424		10.1891/1061-3749.26.3.415			10	Nursing	Emerging Sources Citation Index (ESCI)	Nursing	HF8GL	WOS:000454479000002	30593569				2022-02-06	
S	San Lucas, A; Redell, J; Dash, P; Liu, Y		Srivastava, AK; Cox, CS		San Lucas, Anthony; Redell, John; Dash, Pramod; Liu, Yin			Computer-Assisted Approaches to Identify Functional Gene Networks Involved in Traumatic Brain Injury	PRE-CLINICAL AND CLINICAL METHODS IN BRAIN TRAUMA RESEARCH	Neuromethods		English	Article; Book Chapter						Gene networks; TBI subtype classification; Biomarkers; Protein interactions; Gene expression profiles; Greedy search algorithm	DATABASE; PATHWAYS; ONTOLOGY; MODEL	Traumatic brain injury (TBI), a leading cause of death and disability in industrialized countries, is a result of an external force damaging brain tissue, accompanied with delayed pathogenic events which aggravate the injury. Molecular responses to TBI have not been well characterized, leaving molecular classification of TBI cases difficult. TBI subtype classification is an important step towards the development and selective application of novel treatments. To improve TBI classification, we have performed a network-based computational analysis on gene expression profiles from entire rat genome to identify functional gene subnetworks. The gene expression profiles are obtained from two experimental models of injury in rats: the controlled cortical impact (CCI; a focal brain injury) and fluid percussion injury (FPI; a diffuse brain injury). We demonstrate that the analysis of gene subnetworks is more suitable to classify the heterogeneous responses to different TBI models, compared to conventional analysis using an individual gene list. We therefore believe that effectively incorporating gene expression profiles into protein interaction information can improve the identification of functional subnetworks involved in TBI. The systems approach could lead to a better understanding of the underlying complexities of the molecular responses after TBI and the identified subnetworks could have important prognostic functions for patients who sustain mild TBIs.	[San Lucas, Anthony] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Redell, John; Dash, Pramod; Liu, Yin] Univ Texas Hlth Sci Ctr Houston, Dept Neurobiol & Anat, Houston, TX 77030 USA; [Dash, Pramod; Liu, Yin] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX USA		San Lucas, A (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA.			Dash, Pramod/0000-0001-6746-1002			Agarwala R, 2017, NUCLEIC ACIDS RES, V45, pD12, DOI [10.1093/nar/gks1189, 10.1093/nar/gky1069, 10.1093/nar/gkw1071, 10.1093/nar/gkx1095]; Albert-Weissenberger Christiane, 2010, Exp Transl Stroke Med, V2, P16, DOI 10.1186/2040-7378-2-16; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Carey VJ, 2005, BIOINFORMATICS, V21, P135, DOI 10.1093/bioinformatics/bth458; Chatr-aryamontri A, 2015, NUCLEIC ACIDS RES, V43, pD470, DOI 10.1093/nar/gku1204; Dong J, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-24; Fortney K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r13; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goel R, 2012, MOL BIOSYST, V8, P453, DOI 10.1039/c1mb05340j; Grandhi R, 2014, J NEUROSURG SCI, V58, P249; Huntley RP, 2015, NUCLEIC ACIDS RES, V43, pD1057, DOI 10.1093/nar/gku1113; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Mychasiuk R, 2014, J NEUROTRAUM, V31, P749, DOI 10.1089/neu.2013.3132; Redell JB, 2013, J NEUROTRAUM, V30, P752, DOI 10.1089/neu.2012.2437; SAKIA RM, 1992, J ROY STAT SOC D-STA, V41, P169, DOI 10.2307/2348250; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Savarraj JPJ, 2017, NEUROLOGY, V88, P1535, DOI 10.1212/WNL.0000000000003842; Wang ZX, 2015, BIOINFORMATICS, V31, P3529, DOI 10.1093/bioinformatics/btv392; Wang ZX, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-153; Yu Z, 2010, J NEUROPHYSIOL, V103, P499, DOI 10.1152/jn.00775.2009; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhu YN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S21	23	1	1	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	0893-2336	1940-6045	978-1-4939-8564-7; 978-1-4939-8563-0	NEUROMETHODS	Neuromethods		2018	139						349	360		10.1007/978-1-4939-8564-7_21	10.1007/978-1-4939-8564-7		12	Cell Biology; Neurosciences	Book Citation Index – Science (BKCI-S)	Cell Biology; Neurosciences & Neurology	BL5CO	WOS:000451267100023					2022-02-06	
J	Schmitt, KU; Muser, MH; Thueler, H; Bruegger, O				Schmitt, Kai-Uwe; Muser, Markus H.; Thueler, Hansjuerg; Bruegger, Othmar			Crash-test dummy and pendulum impact tests of ice hockey boards: greater displacement does not reduce impact	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							INJURY SURVEILLANCE SYSTEM; OLYMPIC WINTER GAMES; DESCRIPTIVE EPIDEMIOLOGY; MENS; CHAMPIONSHIPS; BIOMECHANICS; CONCUSSION; MECHANISMS; AMERICAN; PLAYERS	Background One injury mechanism in ice hockey is impact with the boards. We investigated whether more flexible hockey boards would provide less biomechanical loading on impact than did existing (reference) boards. Methods We conducted impact tests with a dynamic pendulum (mass 60 kg) and with crash test dummies (ES-2 dummy, 4.76 m/s impact speed). Outcomes were biomechanical loading experienced by a player in terms of head acceleration, impact force to the shoulder, spine, abdomen and pelvis as well as compression of the thorax. Results The more flexible board designs featured substantial displacement at impact. Some so-called flexible boards were displaced four times more than the reference board. The new boards possessed less stiffness and up to 90 kg less effective mass, reducing the portion of the board mass a player experienced on impact, compared with boards with a conventional design. Flexible boards resulted in a similar or reduced loading for all body regions, apart from the shoulder. The displacement of a board system did not correlate directly with the biomechanical loading. Conclusions Flexible board systems can reduce the loading of a player on impact. However, we found no correlation between the displacement and the biomechanical loading; accordingly, displacement alone was insufficient to characterise the overall loading of a player and thus the risk of injury associated with board impact. Ideally, the performance of boards is assessed on the basis of parameters that show a good correlation to injury risk.	[Schmitt, Kai-Uwe; Muser, Markus H.] AGU Zurich, Zurich, Switzerland; [Thueler, Hansjuerg; Bruegger, Othmar] Bfu Swiss Council Accid Prevent, Bern, Switzerland		Schmitt, KU (corresponding author), AGU Zurich, Working Grp Accid Mech, Winkelriedstr 27, CH-8006 Zurich, Switzerland.	schmitt@agu.ch		Schmitt, Kai-Uwe/0000-0003-3439-9323	Swiss Council for Accident Prevention (bfu); Swiss Ice Hockey Federation	This study was funded by the Swiss Council for Accident Prevention (bfu) and the Swiss Ice Hockey Federation.	Agel J, 2007, J ATHL TRAINING, V42, P241; Agel J, 2007, J ATHL TRAINING, V42, P249; Agel J, 2010, CAN J SURG, V53, P319; Benson Brian W, 2005, Med Sport Sci, V49, P86, DOI 10.1159/000085393; Darling SR, 2011, BRIT J SPORT MED, V45, P492, DOI 10.1136/bjsm.2009.063693; Duprey S., 2007, Computer Methods in Biomechanics and Biomedical Engineering, V10, P361, DOI 10.1080/10255840701463986; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Flik K, 2005, AM J SPORT MED, V33, P183, DOI 10.1177/0363546504267349; MacCormick L, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967113518181; Mihalik JP, 2012, ANN BIOMED ENG, V40, P141, DOI 10.1007/s10439-011-0405-3; Poutiainen P, 2014, EUR J SPORT SCI, V14, P11, DOI 10.1080/17461391.2012.725106; Schmitt KU, 2014, VDI-BUCH, P1, DOI 10.1007/978-3-642-54281-7; Tuominen M, 2017, BRIT J SPORT MED, V51, P244, DOI 10.1136/bjsports-2016-097119; Tuominen M, 2017, BRIT J SPORT MED, V51, P36, DOI 10.1136/bjsports-2016-095992; Tuominen M, 2016, BRIT J SPORT MED, V50, P1406, DOI 10.1136/bjsports-2015-094647; Tuominen M, 2015, BRIT J SPORT MED, V49, P30, DOI 10.1136/bjsports-2014-093688; Usman J, 2011, J SCI MED SPORT, V14, P547, DOI 10.1016/j.jsams.2011.05.006; Wennberg R, 2004, CAN J NEUROL SCI, V31, P373, DOI 10.1017/S0317167100003474; Wilcox BJ, 2015, J BIOMECH, V48, P2201, DOI 10.1016/j.jbiomech.2015.04.005; Wilcox BJ, 2014, J ATHL TRAINING, V49, P514, DOI 10.4085/1062-6050-49.3.19; Wilcox BJ, 2014, J BIOMECH, V47, P109, DOI 10.1016/j.jbiomech.2013.10.004	21	1	1	1	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	JAN	2018	52	1								10.1136/bjsports-2017-097735			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	FR5UC	WOS:000419130700009	29084724	Green Published, Green Submitted, hybrid			2022-02-06	
S	Scott, D; Saatman, KE		Srivastava, AK; Cox, CS		Scott, Danielle; Saatman, Kathryn E.			Cognitive and Motor Function Assessments in Rodent Models of Traumatic Brain Injury	PRE-CLINICAL AND CLINICAL METHODS IN BRAIN TRAUMA RESEARCH	Neuromethods		English	Article; Book Chapter						Traumatic brain injury; Novel object recognition; Beam walking; Rotarod	ROTAROD TEST; BEHAVIORAL DEFICITS; RECOGNITION; RECOVERY; OBJECT; RATS; IMPAIRMENTS; TASK; MICE; SENSITIVITY	Cognitive and motor dysfunction is common in people who have experienced a traumatic brain injury (TBI). These deficits can include memory loss, learning impairment, dizziness, difficulty with balance, and loss of fine motor control and coordination. Cognitive function and vestibulomotor tasks have been widely used in clinically relevant rodent models of experimental TBI to study the relationship of neurobehavioral dysfunction to injury severity, secondary injury mechanisms, or putative therapeutic interventions. Here we describe paradigms for the novel object recognition task, a test of memory, and beam walking and rotarod tasks, tests of coordinated motor function. Key advantages and disadvantages are presented, and potential problems and adaptations of these behavioral tests are discussed.	[Scott, Danielle; Saatman, Kathryn E.] Univ Kentucky, Dept Physiol, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40506 USA		Scott, D (corresponding author), Univ Kentucky, Dept Physiol, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40506 USA.						Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Bales JW, 2012, ANIMAL MODELS ACUTE, VII, P385, DOI DOI 10.1007/978-1-61779-782-8_33; Bales JW, 2012, ANIMAL MODELS ACUTE, VII, P377, DOI [10.1007/9781-61779782-8_34, DOI 10.1007/9781-61779782-8_34]; Byard RW, 2017, J FORENSIC SCI, V63, P151, DOI [10.1111/15564029.13509, DOI 10.1111/15564029.13509]; Cai L, 2012, NEUROSCI LETT, V506, P261, DOI 10.1016/j.neulet.2011.11.019; Cohen SJ, 2015, BEHAV BRAIN RES, V285, P105, DOI 10.1016/j.bbr.2014.08.002; Dachir S, 2014, BRAIN RES, V1555, P78, DOI 10.1016/j.brainres.2014.01.044; Desai A, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0714-4; DUNHAM NW, 1957, J AM PHARM ASSOC, V46, P208, DOI 10.1002/jps.3030460322; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gao YY, 2016, J SURG RES, V206, P67, DOI 10.1016/j.jss.2016.07.014; Goulart BK, 2010, NEUROSCIENCE, V167, P969, DOI 10.1016/j.neuroscience.2010.03.032; Grayson B, 2015, BEHAV BRAIN RES, V285, P176, DOI 10.1016/j.bbr.2014.10.025; Hall ANB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159442; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Haus DL, 2016, EXP NEUROL, V281, P1, DOI 10.1016/j.expneurol.2016.04.008; Im SH, 2010, NEUROSCIENCE, V169, P259, DOI 10.1016/j.neuroscience.2010.04.038; Lagraoui Mouna, 2012, Front Neurol, V3, P155, DOI 10.3389/fneur.2012.00155; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Lee YA, 2016, PHYSIOL BEHAV, V165, P146, DOI 10.1016/j.physbeh.2016.07.014; Lindner MD, 1998, J NEUROTRAUM, V15, P199, DOI 10.1089/neu.1998.15.199; Luong TN, 2011, JOVE-J VIS EXP, DOI 10.3791/2376; Madathil S. K., 2015, BRAIN NEUROTRAUMA MO; Madathil SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067204; Mannix R, 2014, J NEUROSURG, V121, P1342, DOI 10.3171/2014.7.JNS14272; Monville C, 2006, J NEUROSCI METH, V158, P219, DOI 10.1016/j.jneumeth.2006.06.001; Muradashvili N, 2015, METAB BRAIN DIS, V30, P411, DOI 10.1007/s11011-014-9550-3; O'Connor CA, 2007, EXP NEUROL, V205, P145, DOI 10.1016/j.expneurol.2007.01.034; Ouyang W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171976; Perez-Garcia G, 2016, SCI REP-UK, V6, DOI 10.1038/srep21275; Pleasant JM, 2011, J NEUROTRAUM, V28, P2245, DOI 10.1089/neu.2010.1499; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Rachmany L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079837; Rozas G, 1997, BRAIN RES PROTOC, V2, P75, DOI 10.1016/S1385-299X(97)00034-2; Rubovitch V, 2017, SCI REP-UK, V7, DOI 10.1038/srep41269; Rustay NR, 2003, BEHAV BRAIN RES, V141, P237, DOI 10.1016/S0166-4328(02)00376-5; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Schoch KM, 2012, EXP NEUROL, V236, P371, DOI 10.1016/j.expneurol.2012.04.022; Shiotsuki H, 2010, J NEUROSCI METH, V189, P180, DOI 10.1016/j.jneumeth.2010.03.026; Silvers JM, 2007, J NEUROSCI METH, V166, P99, DOI 10.1016/j.jneumeth.2007.06.032; Simon-O'Brien E, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0687-3; Srodulski S, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-30; Stanley JL, 2005, J PSYCHOPHARMACOL, V19, P221, DOI 10.1177/0269881105051524; Statler KD, 2006, BRAIN RES, V1076, P216, DOI 10.1016/j.brainres.2005.12.106; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Yan EB, 2013, NEUROSCIENCE, V248, P17, DOI 10.1016/j.neuroscience.2013.05.045; Yang SH, 2013, J SURG RES, V184, P981, DOI 10.1016/j.jss.2013.03.075; Yu W, 2016, J NEUROSCI, V36, P11084, DOI 10.1523/JNEUROSCI.2273-16.2016; Yu YW, 2016, J NEUROTRAUM, V33, P2044, DOI 10.1089/neu.2015.4229	51	1	1	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	0893-2336	1940-6045	978-1-4939-8564-7; 978-1-4939-8563-0	NEUROMETHODS	Neuromethods		2018	139						139	154		10.1007/978-1-4939-8564-7_9	10.1007/978-1-4939-8564-7		16	Cell Biology; Neurosciences	Book Citation Index – Science (BKCI-S)	Cell Biology; Neurosciences & Neurology	BL5CO	WOS:000451267100011					2022-02-06	
B	Shah, SO; Kim, BS; Govind, B; Jallo, J		Loftus, CM		Shah, Syed Omar; Kim, Bong-Soo; Govind, Bhuvanesh; Jallo, Jack			Intracranial Pressure Monitoring and Management of Raised Intracranial Pressure	NEUROSURGICAL EMERGENCIES, 3RD EDITION			English	Article; Book Chapter						external ventricular device; increased intracranial pressure; intracranial pressure management; multimodality monitoring	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; SEVERE HEAD-INJURY; HYPERTONIC SALINE 7.5-PERCENT; ARTERY TERRITORY INFARCTION; AMINO-ACID RELEASE; MODERATE HYPOTHERMIA; DECOMPRESSIVE CRANIECTOMY; THERAPEUTIC HYPOTHERMIA; CEREBROSPINAL-FLUID	During the last few decades, our understanding of increased intracranial pressure has improved. We now have advanced neuroimaging along with multimodality monitoring techniques that allows us to effectively manage raised intracranial pressures. With the development of dedicated neuroscience intensive care units, management of these patients has continually improved. Treatment with protocol-driven therapy has increased favorable outcomes when compared with historical controls. In this chapter, we will explain the indications and contraindication for intracranial pressure monitoring. The bulk of this chapter, however, will be dedicated to the actual medical and surgical management of patients with raised intracranial pressures.	[Shah, Syed Omar] Thomas Jefferson Univ, Jefferson Hosp Neurosci, Div Crit Care & Neurotrauma, Neurol & Neurol Surg,Dept Neurol Surg, Philadelphia, PA 19107 USA; [Kim, Bong-Soo] Temple Univ, Lewis Katz Sch Med, Dept Neurosurg, Philadelphia, PA 19122 USA; [Govind, Bhuvanesh] Thomas Jefferson Univ, Dept Neurol Surg, Philadelphia, PA 19107 USA; [Jallo, Jack] Johns Hopkins All Childrens Hosp, Pediat Neurosurg, St Petersburg, FL USA; [Jallo, Jack] Johns Hopkins All Childrens Hosp, Neurosurg, St Petersburg, FL USA		Shah, SO (corresponding author), Thomas Jefferson Univ, Jefferson Hosp Neurosci, Div Crit Care & Neurotrauma, Neurol & Neurol Surg,Dept Neurol Surg, Philadelphia, PA 19107 USA.						Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Adamides AA, 2006, ANZ J SURG, V76, P163, DOI 10.1111/j.1445-2197.2006.03674.x; AVEZAAT CJJ, 1979, J NEUROL NEUROSUR PS, V42, P687, DOI 10.1136/jnnp.42.8.687; Bacher A, 1998, CRIT CARE MED, V26, P108, DOI 10.1097/00003246-199801000-00024; BARR J, 1995, INT ANESTHESIOL CLIN, V33, P131, DOI 10.1097/00004311-199500000-00008; BATJER HH, 1990, ARCH NEUROL-CHICAGO, V47, P1103, DOI 10.1001/archneur.1990.00530100071015; BATTISTELLA FD, 1991, J TRAUMA, V31, P182, DOI 10.1097/00005373-199131020-00005; Bauer RB, 1973, STROKE, V4, P547, DOI 10.1161/01.STR.4.4.547; BERGER S, 1995, NEUROSURGERY, V37, P98, DOI 10.1227/00006123-199507000-00015; Biswas AK, 2002, CRIT CARE MED, V30, P2742, DOI 10.1097/00003246-200212000-00020; BOLDT J, 1991, BRIT J ANAESTH, V67, P595, DOI 10.1093/bja/67.5.595; BOURGOUIN PM, 1995, AM J NEURORADIOL, V16, P1495; Brain Trauma Foundation American Association of Neurological Surgeons Congress of Neurological Surgeons Joint Section on Neurotrauma and Critical Care, 2003, C NEUR SURG JOINT SE; Brown JIM, 1998, J NEUROTRAUM, V15, P253, DOI 10.1089/neu.1998.15.253; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Bullock RM, 2000, J NEUROTRAUM, V17, P449; BURKE AM, 1981, J NEUROSURG, V55, P550, DOI 10.3171/jns.1981.55.4.0550; Calfee DP, 2000, SEMIN NEUROL, V20, P353, DOI 10.1055/s-2000-9397; Cardin V, 1999, J NEUROSCI RES, V56, P659; CHOI DW, 1995, TRENDS NEUROSCI, V18, P58; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; Coimbra R, 1997, J TRAUMA, V42, P602, DOI 10.1097/00005373-199704000-00004; Cold G E, 1990, Acta Neurochir Suppl (Wien), V49, P1; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; Cormio M, 1999, J NEUROTRAUM, V16, P927, DOI 10.1089/neu.1999.16.927; Corso CO, 1999, J TRAUMA, V46, P417, DOI 10.1097/00005373-199903000-00011; Cruz J, 2004, J NEUROSURG, V100, P376, DOI 10.3171/jns.2004.100.3.0376; Davis, 1999, Curr Treat Options Neurol, V1, P157, DOI 10.1007/s11940-999-0015-7; De Cosmo G, 2005, CURR DRUG TARGETS, V6, P741; DEARDEN NM, 1986, J NEUROSURG, V64, P81, DOI 10.3171/jns.1986.64.1.0081; DEMOPOULOS HB, 1980, ACTA PHYSIOL SCAND, P91; DICKMAN CA, 1991, NEUROSURGERY, V28, P467, DOI 10.1227/00006123-199103000-00026; Dziedzic T, 2003, CLIN NEUROL NEUROSUR, V105, P87, DOI 10.1016/S0303-8467(02)00106-3; EBERHARDT KEW, 1992, INFECTION, V20, P12, DOI 10.1007/BF01704886; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; FEIG PU, 1977, NEW ENGL J MED, V297, P1444, DOI 10.1056/NEJM197712292972608; FRENCH L A, 1964, Clin Neurosurg, V10, P212; FRESHMAN SP, 1993, J TRAUMA, V35, P344, DOI 10.1097/00005373-199309000-00003; Gemma M, 1996, J NEUROSURG ANESTH, V8, P137, DOI 10.1097/00008506-199604000-00007; GILLER CA, 1993, NEUROSURGERY, V32, P737, DOI 10.1227/00006123-199305000-00006; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; GO KG, 1991, CEREBRAL PATHOPHYSIO; Gondim FDA, 2005, J NEUROSURG, V103, P444; Grady MS, 2006, J NEUROSURG, V104, P467, DOI 10.3171/jns.2006.104.4.467; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; GREENWOOD J, 1988, J CEREBR BLOOD F MET, V8, P9, DOI 10.1038/jcbfm.1988.2; GROSS D, 1988, J TRAUMA, V28, P751, DOI 10.1097/00005373-198806000-00005; Gupta R, 2004, STROKE, V35, P539, DOI 10.1161/01.STR.0000109772.64650.18; Hacke W, 1996, ARCH NEUROL-CHICAGO, V53, P309, DOI 10.1001/archneur.1996.00550040037012; Hadani M, 1997, J NEUROTRAUM, V14, P629, DOI 10.1089/neu.1997.14.629; Hartl R, 1997, J TRAUMA, V42, pS41, DOI 10.1097/00005373-199705001-00008; Henderson WR, 2003, INTENS CARE MED, V29, P1637, DOI 10.1007/s00134-003-1848-2; HESS JR, 1992, J TRAUMA, V32, P40, DOI 10.1097/00005373-199201000-00009; Holcroft J W, 1989, Prog Clin Biol Res, V299, P331; HSIANG JK, 1994, CRIT CARE MED, V22, P1471, DOI 10.1097/00003246-199409000-00019; HUANG PP, 1995, ANN SURG, V221, P543, DOI 10.1097/00000658-199505000-00012; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; JOURDAN C, 1993, NEUROCHIRURGIE, V39, P304; KASSELL NF, 1980, NEUROSURGERY, V7, P598, DOI 10.1227/00006123-198012000-00011; Kempski O, 1997, J TRAUMA, V42, pS38, DOI 10.1097/00005373-199705001-00007; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; KOBASHI M, 1993, NEUROSCI LETT, V158, P47, DOI 10.1016/0304-3940(93)90609-O; KONTOS HA, 1977, STROKE, V8, P358, DOI 10.1161/01.STR.8.3.358; Koura SS, 1998, ACT NEUR S, V71, P244; Krieger DW, 2004, STROKE, V35, P1482, DOI 10.1161/01.STR.0000126118.44249.5c; Lang E W, 1994, Neurosurg Clin N Am, V5, P573; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; LIEN YHH, 1991, J CLIN INVEST, V88, P303, DOI 10.1172/JCI115292; LUNDBERG N, 1959, Acta Psychiatr Scand Suppl, V34, P1; LYETH BG, 1993, J NEUROTRAUM, V10, P57, DOI 10.1089/neu.1993.10.57; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; Markgraf CG, 2001, J NEUROSURG, V95, P979, DOI 10.3171/jns.2001.95.6.0979; Marmarou A, 2005, ACT NEUR S, V95, P277; MARSHALL LF, 1978, J NEUROSURG, V48, P169, DOI 10.3171/jns.1978.48.2.0169; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; MARTIN NA, 1995, J NEUROTRAUM, V12, P897, DOI 10.1089/neu.1995.12.897; Mathisen GE, 1997, CLIN INFECT DIS, V25, P763, DOI 10.1086/515541; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Mendelow AD, 2005, LANCET, V365, P387; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; MUIZELAAR JP, 1988, J NEUROSURG, V69, P923, DOI 10.3171/jns.1988.69.6.0923; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; Nilsson P, 1996, J CEREBR BLOOD F MET, V16, P262, DOI 10.1097/00004647-199603000-00011; Nonaka M, 1998, J NEUROL SCI, V157, P25, DOI 10.1016/S0022-510X(98)00062-8; Obrist WD, 1996, XENON TECHNIQUES CBF, p471C; OCHIAI C, 1982, STROKE, V13, P788, DOI 10.1161/01.STR.13.6.788; Oestern HJ, 2011, THORACIC ABDOMINAL V; OGATA H, 1993, CIRC SHOCK, V41, P113; OLDFIELD BJ, 1994, NEUROSCIENCE, V60, P255, DOI 10.1016/0306-4522(94)90219-4; Olson JE, 1997, ACAD EMERG MED, V4, P662, DOI 10.1111/j.1553-2712.1997.tb03757.x; Paczynski RP, 1997, CRIT CARE CLIN, V13, P105, DOI 10.1016/S0749-0704(05)70298-0; Perez-Perez AJ, 2002, AM J NEPHROL, V22, P573, DOI 10.1159/000065279; Peterson B, 2000, CRIT CARE MED, V28, P1136, DOI 10.1097/00003246-200004000-00037; Pfenninger J, 2001, CRIT CARE MED, V29, P1489, DOI 10.1097/00003246-200107000-00039; PIATT JH, 1984, NEUROSURGERY, V15, P427, DOI 10.1227/00006123-198409000-00023; PICKARD JD, 1993, J NEUROL NEUROSUR PS, V56, P845, DOI 10.1136/jnnp.56.8.845; PIPER IR, 1990, J NEUROSURG, V73, P871, DOI 10.3171/jns.1990.73.6.0871; Polderman KH, 2001, J NEUROSURG, V94, P697, DOI 10.3171/jns.2001.94.5.0697; Poli de Figueiredo L F, 1995, Cardiovasc Surg, V3, P679; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; POUNGVARIN N, 1987, NEW ENGL J MED, V316, P1229, DOI 10.1056/NEJM198705143162001; Procaccio F, 2000, J Neurosurg Sci, V44, P11; Qureshi AI, 1998, CRIT CARE MED, V26, P440, DOI 10.1097/00003246-199803000-00011; Qureshi AI, 1998, J NEUROSURG ANESTH, V10, P188, DOI 10.1097/00008506-199807000-00010; RABINOVICI R, 1992, SURG GYNECOL OBSTET, V175, P341; Rabinstein AA, 2002, NEUROLOGY, V58, P1367, DOI 10.1212/WNL.58.9.1367; Raichle ME, 1972, STROKE, V3, P566, DOI 10.1161/01.STR.3.5.566; RAMIRES JAF, 1992, CIRC SHOCK, V37, P220; Ratanalert S, 2004, SURG NEUROL, V61, P429, DOI 10.1016/S0090-3019(03)00579-2; REA GL, 1983, NEUROSURGERY, V12, P401, DOI 10.1227/00006123-198304000-00005; REED RL, 1992, J TRAUMA, V33, P465, DOI 10.1097/00005373-199209000-00022; REED RL, 1991, J TRAUMA, V31, P8, DOI 10.1097/00005373-199101000-00002; REIVICH M, 1964, AM J PHYSIOL, V206, P25, DOI 10.1152/ajplegacy.1964.206.1.25; RESNICK DK, 1994, NEUROSURGERY, V34, P252, DOI 10.1227/00006123-199402000-00007; Resnick DK, 1997, J TRAUMA, V42, P1108, DOI 10.1097/00005373-199706000-00021; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; ROHRER MJ, 1992, CRIT CARE MED, V20, P1402, DOI 10.1097/00003246-199210000-00007; ROPPER AH, 1986, NEW ENGL J MED, V314, P953, DOI 10.1056/NEJM198604103141504; ROSOMOFF HL, 1954, AM J PHYSIOL, V179, P85, DOI 10.1152/ajplegacy.1954.179.1.85; SATO M, 1991, ACTA NEUROCHIR, V110, P174, DOI 10.1007/BF01400687; SCHALEN W, 1992, ACTA ANAESTH SCAND, V36, P369, DOI 10.1111/j.1399-6576.1992.tb03483.x; Schatzmann C, 1998, ACT NEUR S, V71, P31; SCHMALL LM, 1990, EQUINE VET J, V22, P273, DOI 10.1111/j.2042-3306.1990.tb04266.x; Schroder ML, 1998, ACT NEUR S, V71, P127; Schrot RJ, 2002, LANCET, V359, P1633, DOI 10.1016/S0140-6736(02)08545-8; Schulz-Stubner S, 2005, CRIT CARE MED, V33, P2723, DOI 10.1097/01.CCM.0000187093.71107.A8; Schwab S, 1997, NEUROLOGY, V48, P1608, DOI 10.1212/WNL.48.6.1608; Schwab S, 1998, STROKE, V29, P2461, DOI 10.1161/01.STR.29.12.2461; Schwab S, 2001, STROKE, V32, P2033, DOI 10.1161/hs0901.095394; Schwarz S, 1998, STROKE, V29, P1550, DOI 10.1161/01.STR.29.8.1550; SHAFER SL, 1993, J CLIN ANESTH, V5, pS14; Sheikh AA, 1996, CRIT CARE MED, V24, P1226, DOI 10.1097/00003246-199607000-00027; SHENKIN HA, 1962, J NEUROSURG, V19, P897, DOI 10.3171/jns.1962.19.10.0897; Shiozaki T, 1998, J NEUROSURG, V89, P206, DOI 10.3171/jns.1998.89.2.0206; Shiozaki T, 2001, J NEUROSURG, V94, P50, DOI 10.3171/jns.2001.94.1.0050; SMITH DS, 1980, ANESTHESIOLOGY, V53, P186, DOI 10.1097/00000542-198009000-00002; Smith SL, 1996, J NEUROTRAUM, V13, P1, DOI 10.1089/neu.1996.13.1; SPIERS JP, 1993, CIRC SHOCK, V40, P29; Stefini R, 1999, NEUROSURGERY, V45, P626, DOI 10.1097/00006123-199909000-00038; STERNS RH, 1986, NEW ENGL J MED, V314, P1535, DOI 10.1056/NEJM198606123142402; Stiefel MF, 2004, J NEUROSURG, V101, P241, DOI 10.3171/jns.2004.101.2.0241; Stocchetti N, 1993, J NEUROTRAUMA S, V10, P187; Stover JF, 1999, J NEUROTRAUM, V16, P135, DOI 10.1089/neu.1999.16.135; Suarez JI, 1998, CRIT CARE MED, V26, P1118, DOI 10.1097/00003246-199806000-00038; Taneda M, 1996, J NEUROSURG, V84, P762, DOI 10.3171/jns.1996.84.5.0762; Tollofsrud S, 1998, ACTA ANAESTH SCAND, V42, P145, DOI 10.1111/j.1399-6576.1998.tb05100.x; TRACHTMAN H, 1993, J AM SOC NEPHROL, V3, P1913; VALERI CR, 1987, ANN SURG, V205, P175, DOI 10.1097/00000658-198702000-00012; vanHengel P, 1997, NETH J MED, V50, P21, DOI 10.1016/S0300-2977(96)00060-5; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; VIDEEN JS, 1995, J CLIN INVEST, V95, P788, DOI 10.1172/JCI117728; Vincent JL, 2005, CRIT CARE MED, V33, P1392, DOI 10.1097/01.CCM.0000166890.93559.2D; WALD ER, 1995, PEDIATRICS, V95, P21; WALSH JC, 1991, J SURG RES, V50, P284, DOI 10.1016/0022-4804(91)90192-O; WARD JD, 1985, J NEUROSURG, V62, P383, DOI 10.3171/jns.1985.62.3.0383; WINER JW, 1991, NEUROSURGERY, V29, P739, DOI 10.1227/00006123-199111000-00016; Winter CD, 2005, J CLIN NEUROSCI, V12, P619, DOI 10.1016/j.jocn.2005.02.002; Yoo DS, 1999, J NEUROSURG, V91, P953, DOI 10.3171/jns.1999.91.6.0953; YOSHIHARA M, 1995, J NEUROSURG, V82, P386, DOI 10.3171/jns.1995.82.3.0386; ZORNOW MH, 1989, J TRAUMA, V29, P484, DOI 10.1097/00005373-198904000-00011	164	1	1	1	1	GEORG THIEME VERLAG	STUTTGART 30	RUDIGERSTR 14, W-7000 STUTTGART 30, GERMANY			978-1-62623-343-0; 978-1-62623-333-1				2018							9	23					15	Critical Care Medicine; Emergency Medicine; Clinical Neurology; Surgery	Book Citation Index – Science (BKCI-S)	General & Internal Medicine; Emergency Medicine; Neurosciences & Neurology; Surgery	BP9GX	WOS:000569351700004					2022-02-06	
J	Shaklai, S; Peretz Fish, R; Simantov, M; Groswasser, Z				Shaklai, Sharon; Peretz Fish, Relly; Simantov, M.; Groswasser, Z.			Prognostic factors in childhood-acquired brain injury	BRAIN INJURY			English	Article						Long-term function; severe traumatic brain injury (tbi); anoxic brain injury (AnBI)	PERSISTENT VEGETATIVE STATE; DROWNED CHILDREN; HEAD-INJURY; REHABILITATION; ADOLESCENTS; RECOVERY; MULTICENTER; MODERATE; RETURN; WORK	Background: A long-term follow-up study comparing children after anoxic brain injury (AnBI) with those after traumatic brain injury (TBI) was conducted, and prognostic factors were mapped.Methods: A prospective historical study following long-term functional outcome after childhood brain injury was conducted in two phases. The first phase included patients suffering from moderate-severe TBI. The second phase assessed children after AnBI, and the results were compared. Functional outcome was recorded and factors influencing prognosis were outlined.Results: On admission vegetative state (VS) was twice as prevalent in the AnBI subgroup. Approximately 90% of children with TBI and 60% of patients with AnBI gained independency in activities of daily living (ADL) and mobility. Long-term positive outcome, i.e., return to school and open-market employment, were higher in patients with TBI when compared with AnBI (61% and 48.1%, respectively). Significant outcome-predicting factors were VS at admission to rehabilitation, length of loss of consciousness (LOC) up to 11days and functional independence measure (FIM) score at admission and discharge. Aetiology was not found to be a predicting factor.Conclusions: Duration of unconsciousness is the main long-term negative prognostic outcome factor. Anoxic brain damage, associated with longer periods of unconsciousness also heralds a less favourable outcome.	[Shaklai, Sharon; Peretz Fish, Relly; Groswasser, Z.] Loewenstein Hosp & Rehabil Ctr, Dept Pediat Rehabil, 278 Ahuza St,POB 3, Raanana, Israel; [Shaklai, Sharon; Groswasser, Z.] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Simantov, M.] Israel Natl Ctr Trauma & Emergency Med, Gartner Inst, Tel Hashomer, Israel		Shaklai, S (corresponding author), Loewenstein Hosp & Rehabil Ctr, Dept Pediat Rehabil, 278 Ahuza St,POB 3, Raanana, Israel.	sharons5@clalit.org.il					Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Avesani R, 2013, EUR J PHYS REHAB MED, V49, P611; Chang W C, 1997, J Outcome Meas, V1, P192; Chang WC, 1997, CONCURRENT VALIDITY, V1, P259; COSTEFF H, 1990, J NEUROSURG, V73, P684, DOI 10.3171/jns.1990.73.5.0684; Cullen NK, 2011, BRAIN INJURY, V25, P35, DOI 10.3109/02699052.2010.531691; Cullen NK, 2009, PM&R, V1, P1069, DOI 10.1016/j.pmrj.2009.09.013; Cullen NK, 2008, BRAIN INJURY, V22, P1013, DOI 10.1080/02699050802530581; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Eilander HJ, 2007, BRAIN INJURY, V21, P53, DOI 10.1080/02699050601151795; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Farmer JE, 1996, J LEARN DISABIL-US, V29, P532, DOI 10.1177/002221949602900508; Fertl VK, 2000, COURSE POSTACUTE INP, V47, P231; Fitzgerald A, 2012, STUDY 93 CASES BRAIN, V24, P1311; Fragala MA, 2002, BRAIN INJURY, V16, P149, DOI 10.1080/02699050110103328; Grauwmeijer E, 2012, ARCH PHYS MED REHAB, V93, P993, DOI 10.1016/j.apmr.2012.01.018; GROSWASSER Z, 1989, ARCH PHYS MED REHAB, V70, P186; Heindl UT, 1996, NEUROPEDIATRICS, V27, P94, DOI 10.1055/s-2007-973756; Jensen MP, 2005, ARCH PHYS MED REHAB, V86, P116, DOI 10.1016/j.apmr.2004.01.040; Kinsella G J, 1997, J Int Neuropsychol Soc, V3, P608; Koskiniemi M, 2005, ARCH PEDIAT ADOLESC, V149, P249; KRIEL RL, 1994, PEDIATR NEUROL, V10, P207, DOI 10.1016/0887-8994(94)90024-8; KRUUS S, 1979, ACTA PAEDIATR SCAND, V68, P315, DOI 10.1111/j.1651-2227.1979.tb05013.x; LEVIN HS, 1991, ARCH NEUROL-CHICAGO, V48, P580, DOI 10.1001/archneur.1991.00530180032013; Nybo T, 1999, BRAIN INJURY, V13, P759; PEARN J, 1977, LANCET, V1, P7; Petrella RJ, 2002, AM J PHYS MED REHAB, V81, P639, DOI 10.1097/00002060-200209000-00001; Schmidt JG, 1997, J NEUROL REHABIL, V11, P189; Shaklai S, 2014, BRAIN INJURY, V28, P915, DOI 10.3109/02699052.2013.862739; Smania N, 2013, J HEAD TRAUMA REHAB, V28, P131, DOI 10.1097/HTR.0b013e31823c0127; Suominen PK, 1997, RESUSCITATION, V35, P111, DOI 10.1016/S0300-9572(97)00036-1; TOMPKINS CA, 1990, BRAIN COGNITION, V13, P86, DOI 10.1016/0278-2626(90)90042-M; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Weschsler D, 1991, WESCHLER INTELLIGENC; Wright J, 2000, THE FIM TM	39	1	1	2	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	5					533	539		10.1080/02699052.2018.1431843			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FY7WL	WOS:000427074200001	29381392				2022-02-06	
J	Shrestha, P; Ansari, SR; Ghimire, RK; Gongal, DN; Devkota, UP				Shrestha, Pratyush; Ansari, Safiur Rahman; Ghimire, Ram Kumar; Gongal, Dinesh Nath; Devkota, Upendra Psd			Transcranial doppler ultrasonography cerebral blood flow dynamics study of neurosurgical patients in peri-agonal period with fixed dilated or non-reacting pupils	BRITISH JOURNAL OF NEUROSURGERY			English	Article						Dilated pupils; nonreacting pupils; peri-agonal; pulsatility index; transcranial doppler	TRAUMATIC BRAIN-INJURY; PULSATILITY INDEX; INTRACRANIAL-PRESSURE; DEATH; DIAGNOSIS; RELIABILITY; VELOCITY	Introduction: Fixed dilated and unreactive pupils are a harbinger of imminent death in neurosurgical patients, signifying that the brainstem is not functioning. Transcranial Doppler (TCD) ultrasonography is a noninvasive, bedside method of determining the flow velocities in the basal cerebral arteries, used extensively in various neurosurgical conditions. Aims and Objectives: To study the cerebral blood flow dynamics of neurosurgical patients in peri-agonal period with fixed dilated or non reacting pupils using TCD. Materials and Methods: Repeated TCD studies were done in patients with fixed dilated or unreactive pupils in a tertiary care, neurosurgical hospital over a year, recording the various waveforms and indices as Pulsatility Index (PI), Resistivity Index, Peak systolic flow velocity (PSV), End diastolic flow velocity (EDV), Mean cerebral blood flow velocity (MCBFV) of their middle cerebral artery in their peri-agonal period. The subsequent change in the indices as the patients died or improved was analyzed. Results: A total of 104 TCD studies were done on 57 patients. Mean initial PI and MCBFV in the patients that died were 1.52 +/- 0.76 and 28.55 +/- 14.92 cm/sec respectively; and in the patients that showed neurosurgical recovery was 1.11 +/- 0.28 and 36.52 +/- 8.56 cm/sec respectively. Four out of 57 patients showed neurosurgical recovery and all of them had an initial PI less than 1.4 and they showed decrement in PI and increment in MCBFV on subsequent TCD study. The specificity and positive predictive value of the TCD waveform in predicting death was 100%, however, it had low sensitivity (47.17%) and negative predictive value (12.5%). Conclusion: The various indices and waveforms of TCD can be useful in assessing the cerebral blood flow dynamics in patients with various traumatic and non-traumatic ailments in the peri-agonal period; and hence help in their management as well as in the confirmation of brainstem death.	[Shrestha, Pratyush; Gongal, Dinesh Nath; Devkota, Upendra Psd] Natl Inst Neurol & Allied Sci, Dept Neurosurg, Kathmandu, Nepal; [Ansari, Safiur Rahman] Natl Inst Neurol & Allied Sci, Dept Epidemiol & Biostat, Kathmandu, Nepal; [Ghimire, Ram Kumar] Natl Inst Neurol & Allied Sci, Dept Radiodiag, Kathmandu, Nepal		Shrestha, P (corresponding author), Natl Inst Neurol & Allied Sci, Kathmandu, Nepal.	pratyush_shrestha@yahoo.com		Shrestha, Pratyush/0000-0003-0469-2131			AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Bellner J, 2004, SURG NEUROL, V62, P45, DOI 10.1016/j.surneu.2003.12.007; Bouzat P, 2011, NEUROSURGERY, V68, P1603, DOI 10.1227/NEU.0b013e31820cd43e; DAVALOS A, 1993, MED CLIN-BARCELONA, V100, P249; Dosemeci L, 2004, TRANSPLANTATION, V77, P71, DOI 10.1097/01.TP.0000092305.00155.72; FERI M, 1994, CRIT CARE MED, V22, P1120, DOI 10.1097/00003246-199407000-00012; Gura M, 2011, TURK NEUROSURG, V21, P210, DOI 10.5137/1019-5149.JTN.3574-10.1; Hadani M, 1999, INTENS CARE MED, V25, P822, DOI 10.1007/s001340050958; Holman E, 1925, J AMER MED ASSOC, V84, P1329, DOI 10.1001/jama.1925.02660440015006; Kawakami M, 2010, CLIN IMAG, V34, P327, DOI 10.1016/j.clinimag.2009.09.006; Koehler PJ, 2015, J NEUROSURG, V122, P453, DOI 10.3171/2014.10.JNS14148; Leyden E, 1866, ARCH PATHOL ANAT, V37, P519, DOI [10.1007/BF01935598, DOI 10.1007/BF01935598]; Maercker A, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13751; Moeller JJ, 2007, CURR NEUROL NEUROSCI, V7, P417, DOI 10.1007/s11910-007-0064-9; PAOLIN A, 1995, INTENS CARE MED, V21, P657, DOI 10.1007/BF01711544; PETTY GW, 1990, NEUROLOGY, V40, P300, DOI 10.1212/WNL.40.2.300; POWERS AD, 1989, NEUROSURGERY, V24, P884, DOI 10.1227/00006123-198906000-00015; Purkayastha S, 2012, SEMIN NEUROL, V32, P411, DOI 10.1055/s-0032-1331812; Rasulo EA, 2008, EUR J ANAESTH, V25, P167, DOI 10.1017/S0265021507003341; ROPPER AH, 1987, NEUROLOGY, V37, P1733, DOI 10.1212/WNL.37.11.1733; Splavski B, 2006, BRIT J NEUROSURG, V20, P386, DOI 10.1080/02688690601048104; Tan H, 2001, Chin J Traumatol, V4, P156; Tazarourte K, 2011, ACTA ANAESTH SCAND, V55, P422, DOI 10.1111/j.1399-6576.2010.02372.x; White H, 2006, INTENS CARE MED, V32, P981, DOI 10.1007/s00134-006-0173-y; ZURYNSKI Y, 1991, Neurological Research, V13, P248; Zweifel C, 2012, NEUROSURGERY, V71, P853, DOI 10.1227/NEU.0b013e3182675b42	26	1	1	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.		2018	32	2					182	187		10.1080/02688697.2018.1467374			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GQ1IE	WOS:000441381700012	29693475				2022-02-06	
J	Sioka, C; Konstanti, E; Papadopoulos, A; Ragos, V; Papadimitropoulos, K; Koulouras, V; Fotopoulos, A				Sioka, Chrissa; Konstanti, Eleonora; Papadopoulos, Athanasios; Ragos, Vasilios; Papadimitropoulos, Konstantinos; Koulouras, Vasilios; Fotopoulos, Andreas			Heterotopic ossification in patients previously hospitalized in an intensive care unit	NUCLEAR MEDICINE REVIEW			English	Article						heterotopic ossification; bone scan; intensive care unit; head injury management	TRAUMATIC BRAIN-INJURY; SPINAL-CORD INJURY; BONE; EXPERIENCE	BACKGROUND: Heterotopic ossification (HO) is a potential complication in patients hospitalized in an intensive care unit (ICU). In this study we examined the association of HO diagnosed with three-phase bone scan (3pBS) in association with various parameters in patients previously hospitalized in ICU. MATERIAL AND METHODS: We retrieved patient records of the last 12 years subjected to 3pBS and diagnosed with HO from the Department of Nuclear Medicine (2004 up to 2016) and searched for a name match from ICU records. RESULTS: We found 61 patients that had a positive 3pBS for HO of whom 17 patients were hospitalized in the ICU. Among the 17 patients, twelve fulfilled the study criteria and were included in the study. The mean age was 38 years and 92% were males. HO was unilateral in 7 and bilateral in 5 patients. Patients with unilateral HO had up to 2 joints with HO, while those with bilateral had up to 4 joints. HO was most frequently observed in lower limbs, with hip being the most common joint affected. In the upper limbs, HO occurred predominantly in bilateral joints with elbow being the most frequently involved joint. Patients with longer duration of ICU stay had more joints affected. CONCLUSION: HO is a potential complication in patients with ICU hospitalization. Since 3pBS is an imaging method for early detection of HO, patients hospitalized in ICU should be screened with 3pBS for appropriate management.	[Sioka, Chrissa; Papadimitropoulos, Konstantinos; Fotopoulos, Andreas] Univ Hosp Ioannina, Dept Nucl Med, Ioannina, Greece; [Konstanti, Eleonora; Koulouras, Vasilios] Univ Hosp Ioannina, Dept Intens Care Unit, Ioannina, Greece; [Papadopoulos, Athanasios] Univ Hosp Ioannina, Dept Med Phys, Ioannina, Greece; [Ragos, Vasilios] Univ Hosp Ioannina, Dept Head & Neck Surg, Ioannina, Greece		Fotopoulos, A (corresponding author), Univ Hosp Ioannina, Dept Nucl Med, Ioannina, Greece.	professor.fotopoulos@yahoo.com	Sioka, Chrissa/J-3381-2019	Sioka, Chrissa/0000-0002-2184-4945			Atkinson GJ, 2010, AM J PHYS MED REHAB, V89, P245, DOI 10.1097/PHM.0b013e3181c5657c; Banovac K, 1997, SPINAL CORD, V35, P158, DOI 10.1038/sj.sc.3100380; BRESSLER EL, 1987, AM J ROENTGENOL, V148, P931, DOI 10.2214/ajr.148.5.931; Chen HC, 2009, BURNS, V35, P857, DOI 10.1016/j.burns.2008.03.002; dell'Erba L, 2003, J ENDOCRINOL INVEST, V26, P88, DOI 10.1007/BF03345129; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; Geismar SL, 1997, PEDIATR EMERG CARE, V13, P386, DOI 10.1097/00006565-199712000-00007; Guerrier G, 2015, AUST NZ J PUBL HEAL, V39, P188, DOI 10.1111/1753-6405.12362; Hunt JL, 2006, J BURN CARE RES, V27, P535, DOI 10.1097/01.BCR.0000226023.58438.14; JENSEN LL, 1987, AM J PHYS MED REHAB, V66, P351; Johns JS, 1999, J HEAD TRAUMA REHAB, V14, P269, DOI 10.1097/00001199-199906000-00007; Kesikburun S, 2011, BRAIN INJURY, V25, P127, DOI 10.3109/02699052.2010.536198; KIM SW, 1992, PARAPLEGIA, V30, P803, DOI 10.1038/sc.1992.155; Kocaaga Z, 2007, J REHABIL MED, V39, P500, DOI 10.2340/16501977-0086; Mavrogenis AF, 2011, ORTHOPEDICS, V34, DOI 10.3928/01477447-20110124-08; ORZEL JA, 1985, J NUCL MED, V26, P125; Paul S M, 1993, NeuroRehabilitation, V3, P66, DOI 10.3233/NRE-1993-3308	17	1	1	0	0	VIA MEDICA	GDANSK	UL SWIETOKRZYSKA 73, 80-180 GDANSK, POLAND	1506-9680	1644-4345		NUCL MED REV	Nucl. Med. Rev.		2018	21	2					100	103		10.5603/NMR.2018.0027			4	Radiology, Nuclear Medicine & Medical Imaging	Emerging Sources Citation Index (ESCI)	Radiology, Nuclear Medicine & Medical Imaging	GP3AZ	WOS:000440711600007	30070350	gold, Green Submitted			2022-02-06	
J	Song, IK; Choi, S; Lee, S; Kim, EH; Lee, JH; Kim, HS; Kim, JT				Song, In-Kyung; Choi, Soolyoen; Lee, Seohee; Kim, Eun-Hee; Lee, Ji-Hyun; Kim, Hee-Soo; Kim, Jin-Tae			Risk Factors for Intraoperative Hypocapnia in Pediatric Neurosurgical Patients: A Retrospective Cohort Study	PEDIATRIC NEUROSURGERY			English	Article						Anesthesia; Hypocapnia; Pediatric neurosurgery; Risk factors	TRAUMATIC BRAIN-INJURY; ACID-BASE-BALANCE; METABOLIC-ACIDOSIS; CARBONIC-ANHYDRASE; SUBARACHNOID HEMORRHAGE; HEAD-INJURY; HYPERVENTILATION; TOPIRAMATE; ASSOCIATION; VENTILATION	Background: Hypocapnia has been associated with an increased risk and adverse outcomes in the injured brain. This study aimed to identify risk factors of intraoperative hypocapnia in pediatric neurosurgical patients when tidal volumes and respiratory rates were determined based on their weight and age, respectively. Methods: Electronic medical records of pediatric patients (<= 18 years) who underwent neurosurgery from December 2014 to January 2016 were retrospectively reviewed. Minute ventilation was fixed according to each patient's weight and age. Hypocapnia was defined as arterial partial pressure of carbon dioxide < 35 mm Hg from intraoperative arterial blood gas analysis. Patients were divided into hypocapnia and nonhypocapnia groups. Risk factors for intraoperative hypocapnia were found using univariable and multivariable logistic regression analyses. Results: Of the 333 pediatric patients analyzed, 101 (30%) and 232 (70%) were included in the hypocapnia and nonhypocapnia groups, respectively. There was no difference in the minute ventilation between the two groups. The hypocapnia group had more patients taking valproate (8.9 vs. 2.2%; p = 0.008; OR, 4.441; 95% CI, 1.449-13.61) and carbonic anhydrase inhibitors (7.9 vs. 2.2%; p = 0.018; OR, 3.905; 95% CI, 1.245-12.25). An operation for hydrocephalus was more commonly performed in the hypocapnia group (26.7 vs. 15.9%; p = 0.017; OR, 1.923; 95% CI, 1.094-3.379). In the multivariable regression analysis, valproate (OR, 3.939; 95% CI, 1.250-12.41; p = 0.019), carbonic anhydrase inhibitor (OR, 3.345; 95% CI, 1.029-10.88; p = 0.045), and operation for hydrocephalus (OR, 1.838; 95% CI, 1.032-3.272; p = 0.039) were independent risk factors for intraoperative hypocapnia. Conclusions: Pediatric patients taking valproate and carbonic anhydrase inhibitors and who were scheduled for surgery of hydrocephalus were at risk of developing intraoperative hypocapnia during neurosurgery, a finding warning the surgeon that a conventional ventilatory strategy would endanger these patients. (C) 2018 S. Karger AG, Basel	[Song, In-Kyung] Asan Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea; [Choi, Soolyoen] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Lee, Seohee; Kim, Eun-Hee; Lee, Ji-Hyun; Kim, Hee-Soo; Kim, Jin-Tae] Seoul Natl Univ Hosp, Dept Anesthesiol & Pain Med, 101 Daehak Ro, Seoul 03080, South Korea		Kim, JT (corresponding author), Seoul Natl Univ Hosp, Dept Anesthesiol & Pain Med, 101 Daehak Ro, Seoul 03080, South Korea.	jintae73@gmail.com	Kim, Hee Soo/J-5453-2012; KIM, JIN TAE/D-5734-2012; Kim, Jin-Tae/T-7983-2019	KIM, JIN TAE/0000-0002-3738-0081; Kim, Jin-Tae/0000-0002-3738-0081			Akca O, 2006, CURR OPIN ANESTHESIO, V19, P19; Buunk G, 1997, STROKE, V28, P1569, DOI 10.1161/01.STR.28.8.1569; Caulfield EV, 2009, J TRAUMA, V66, P1577, DOI 10.1097/TA.0b013e3181a3931d; Coles JP, 2007, CRIT CARE MED, V35, P568, DOI 10.1097/01.CCM.0000254066.37187.88; Curley G, 2010, CRIT CARE MED, V38, P1348, DOI 10.1097/CCM.0b013e3181d8cf2b; Curry R, 2008, PEDIATR CRIT CARE ME, V9, P141, DOI 10.1097/PCC.0B013e318166870e; Davis PJ, 2010, SMITHS ANESTHESIA IN, P71; Davison AS, 2011, CLIN CHEM, V57, P1233, DOI 10.1373/clinchem.2010.151225; EDWARDS R, 1977, ANESTH ANALG, V56, P786; Gennari F. J., 2005, ACID BASE DISORDERS; Gregory George A., 2012, GREGORYS PEDIAT ANES; IDRIS AH, 1994, CRIT CARE MED, V22, P1827; Imberti R, 2002, J NEUROSURG, V96, P97, DOI 10.3171/jns.2002.96.1.0097; Inoue T, 2000, EPILEPSIA, V41, P1642; Ko CH, 2001, DEV MED CHILD NEUROL, V43, P701, DOI 10.1017/S0012162201001268; KRAPF R, 1991, NEW ENGL J MED, V324, P1394, DOI 10.1056/NEJM199105163242003; Laffey JG, 2002, NEW ENGL J MED, V347, P43, DOI 10.1056/NEJMra012457; Laskey AL, 2000, PEDIATR NEUROL, V22, P305, DOI 10.1016/S0887-8994(99)00143-5; Lindskog S, 1997, PHARMACOL THERAPEUT, V74, P1, DOI 10.1016/S0163-7258(96)00198-2; Maranhao MV, 2011, REV BRAS ANESTESIOL, V61, P124; Mittal V, 2009, CASE REP MED, V2009, DOI 10.1155/2009/802121; Moon HS, 2011, KOREAN J ANESTHESIOL, V61, P519, DOI 10.4097/kjae.2011.61.6.519; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Maranhao MVM, 2011, REV BRAS ANESTESIOL, V61, P232, DOI [10.1590/S0034-70942011000200013, 10.1016/S0034-7094(11)70028-9]; Neumann JO, 2008, INTENS CARE MED, V34, P1676, DOI 10.1007/s00134-008-1123-7; Oi S, 2010, NEUROL MED-CHIR, V50, P859, DOI 10.2176/nmc.50.859; Pappas A, 2011, J PEDIATR-US, V158, P752, DOI 10.1016/j.jpeds.2010.10.019; Philippi H, 2002, EPILEPSIA, V43, P744, DOI 10.1046/j.1528-1157.2002.37201.x; RANDALL HT, 1976, SURG CLIN N AM, V56, P1019; RICHE H, 1994, ACTA NEUROCHIR, V127, P240, DOI 10.1007/BF01808774; SIESJO BK, 1972, KIDNEY INT, V1, P360, DOI 10.1038/ki.1972.47; Sivagnanam M, 2012, HYDROCEPHALUS OVERVI; Solaiman O, 2013, J NEUROSURG ANESTH, V25, P254, DOI 10.1097/ANA.0b013e3182806465; SWENSON ER, 1984, ANN NY ACAD SCI, V429, P547, DOI 10.1111/j.1749-6632.1984.tb12386.x; Swenson ER, 1998, EUR RESPIR J, V12, P1242, DOI 10.1183/09031936.98.12061242; Takeoka M, 2001, EPILEPSIA, V42, P387, DOI 10.1046/j.1528-1157.2001.04500.x; Tebb Z, 2006, SOUTH MED J, V99, P375, DOI 10.1097/01.smj.0000209220.40105.0c; Williamson CA, 2015, NEUROCRIT CARE, V23, P330, DOI 10.1007/s12028-015-0138-5; Wilner A, 1999, EPILEPSIA, V40, P792, DOI 10.1111/j.1528-1157.1999.tb00781.x	39	1	1	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291	1423-0305		PEDIATR NEUROSURG	Pediatr. Neurosurg.		2018	53	2					121	127		10.1159/000486203			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	FZ0QS	WOS:000427276800008	29342464				2022-02-06	
J	Sorinola, A; Buki, A; Sandor, J; Czeiter, E				Sorinola, Abayomi; Buki, Andras; Sandor, Janos; Czeiter, Endre			Effectiveness of Traumatic Brain Injury Management Guideline Introduction in Hungary	TURKISH NEUROSURGERY			English	Article						Case fatality ratio; Guideline; Guideline introduction; Hungary; Traumatic brain injury	SEVERE HEAD-INJURY; EPIDEMIOLOGY	AIM: To describe the impact of the Traumatic Brain Injury management guideline introduction in Hungary. MATERIAL and METHODS: Hospital discharge records (HDR) including age, gender, codes of interventions applied, ICD codes of diagnosed disorders of patients admitted between 01/01/2004 and 31/12/2010 with the diagnosis of intracranial injury (S06 by ICD10) from every inpatient institution in Hungary were collected from the database of National Health Insurance Fund (NHIF). The Case Fatality Ratios (CFR) for one week, one month and six months were calculated for the periods before and after the guideline introduction. The change of CFRs was applied as indicators for change of clinical quality elicited by the guideline. RESULTS: The centers together at one week, one month and six months had pre-guideline introduction CFRs of 23.4%, 37.7% and 47.5% and post-guideline introduction CFRs of 22.1%, 39.1%, and 50.0% respectively. The secondary institutions together at one week, one month and six months had pre-guideline introduction CFRs of 21.5%, 34.8% and 46.3% and post-guideline introduction CFRs of 21.9%, 37.0%, and 48.9% respectively. None of the CFRs showed significant change. CONCLUSION: The effectiveness of TBI management guideline adaptation in Hungary is poor. Without supportive financing and external auditing system, guideline introduction alone cannot achieve standard clinical practice and a reduction in CFR.	[Sorinola, Abayomi; Buki, Andras; Czeiter, Endre] Univ Pecs, Dept Neurosurg, Pecs, Hungary; [Buki, Andras] Univ Pecs, Janos Szentagothai Res Ctr, Pecs, Hungary; [Buki, Andras; Czeiter, Endre] Hungarian Acad Sci, Pecs, Hungary; [Buki, Andras; Czeiter, Endre] Univ Pecs, MTA PTE Clin Neurosci MR Res Grp, Pecs, Hungary; [Sandor, Janos] Univ Debrecen, Dept Prevent Med Biostat & Epidemiol, Debrecen, Hungary		Sorinola, A (corresponding author), Univ Pecs, Dept Neurosurg, Pecs, Hungary.	sorinola_abayomi@hotmail.com	Czeiter, Endre/B-1404-2009	Czeiter, Endre/0000-0002-9578-6944	European UnionEuropean Commission [602150]; Hungarian Brain Research Program [KTIA_13_NAP-A-II/8]	This work was supported by the European Union 7th Framework Program for Research and Technical Development in the context of CENTER-TBI (Grant Number 602150) and by the Hungarian Brain Research Program (grants Number KTIA_13_NAP-A-II/8).	Brain Trauma Foundation, 2007, GUID MAN SEV TRAUM B; Centers for Disease Control and Prevention, 2016, INJ PREV CONTR TRAUM; Cnossen MC, 2016, J NEUROTRAUM; Csepregi Gyula, 2007, Orvosi Hetilap, V148, P771, DOI 10.1556/OH.2007.27879; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Grinkeviciute DE, 2008, MEDICINA-LITHUANIA, V44, P119, DOI 10.3390/medicina44020015; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Keris V, 2007, WORLD J SURG, V31, P1352, DOI 10.1007/s00268-007-9002-x; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mahad DH, 2015, LANCET NEUROL, V14, P183, DOI 10.1016/S1474-4422(14)70256-X; Mauritz W, 2014, WIEN KLIN WOCHENSCHR, V126, P42, DOI 10.1007/s00508-013-0456-6; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Scottish Intercollegiate Guidelines Network (SIGN), 2013, BRAIN INJ REH AD NAT; Shivaji T, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-2; Steudel WI, 2005, ACTA NEUROCHIR, V147, P231, DOI 10.1007/s00701-004-0441-y; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y	18	1	1	0	0	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.		2018	28	3					410	415		10.5137/1019-5149.JTN.19396-16.1			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GJ3WT	WOS:000435231900011	28585669	Bronze			2022-02-06	
J	Swallow, JS; Joseph, JR; Willsey, K; Almeida, AA; Lorincz, MT; Park, P; Szerlip, NJ; Broglio, SP				Swallow, Jennylee S.; Joseph, Jacob R.; Willsey, Kylene; Almeida, Andrea A.; Lorincz, Matthew T.; Park, Paul; Szerlip, Nicholas J.; Broglio, Steven P.			Online postconcussion return-to-play instructions	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						concussion; mild traumatic brain injury; guidelines; online resources; return to play; trauma	ACUTE CONCUSSION; SPORTS; IMPACT; INFORMATION; STATEMENT; ASSOCIATION; SYMPTOMS; INTERNET; CHILDREN; ACCESS	OBJECTIVE The authors of recent concussion guidelines have sought to form a consensus on injury management, but it is unclear if they have been effective in conveying this information to the public. Many parents and athletes obtain medical recommendations via the Internet. This review is aimed at evaluating consistency between online resources and published guideline statements in postconcussion return-to-play (RTP) decisions. METHODS Five websites were selected through a Google search for RTP after concussion, including a federal government institution (Centers for Disease Control and Prevention) website, a national high school association (National Federation of State High School Associations) website, a popular nationally recognized medical website for patients (WebMD), a popular parent-driven website for parents of children who participate in sports (MomsTeam), and the website of a private concussion clinic (Sports Concussion Institute), along with a university hospital website (University of Michigan Medicine). Eight specific items from the Zurich Sport Concussion Consensus Statement 2012 were used as the gold standard for RTP recommendations. Three independent reviewers graded each website for each of the 8 recommendations (A = states guideline recommendations appropriately; B = mentions guideline recommendation; C = does not mention guideline recommendation; F = makes inappropriate recommendation). RESULTS A grade of A was assigned for 45.8% of the recommendations, B for 25.0%, C for 25.0%, and F for 4.2%. All the websites were assigned an A grade for the recommendation of no RTP on the day of injury. Only 1 website (WebMD) mentioned medication usage in conjunction with the Zurich statement, and only 2 websites (Sports Concussion Institute and University of Michigan Medicine) mentioned appropriate management of persistent symptoms. None of these websites commented correctly on all 8 guideline recommendations. CONCLUSIONS Online resources are inconsistent in relaying guideline recommendations for RTP and provide a potential source of confusion in the management of concussion for athletes and their parents, which can result in inappropriate RTP decisions.	[Swallow, Jennylee S.; Broglio, Steven P.] Univ Michigan, Sch Kinesiol, NeuroTrauma Res Lab, Ann Arbor, MI 48109 USA; [Joseph, Jacob R.; Park, Paul; Szerlip, Nicholas J.] Univ Michigan, Dept Neurosurg, 1500 East Med Ctr Dr,Rm 3552 TC, Ann Arbor, MI 48109 USA; [Willsey, Kylene] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Almeida, Andrea A.; Lorincz, Matthew T.] Univ Michigan, Dept Neurol, NeuroSport, Ann Arbor, MI 48109 USA		Joseph, JR (corresponding author), Univ Michigan, Dept Neurosurg, 1500 East Med Ctr Dr,Rm 3552 TC, Ann Arbor, MI 48109 USA.	jojacob@med.umich.edu	Lorincz, Matthew Thomas/P-7785-2019				Ahmed OH, 2012, BRIT J SPORT MED, V46, P675, DOI 10.1136/bjsm.2010.081620; Amante DJ, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4126; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Berg GM, 2014, JAAPA-J AM ACAD PHYS, V27, DOI 10.1097/01.JAA.0000442712.05009.b1; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Del Vicario M, 2016, P NATL ACAD SCI USA, V113, P554, DOI 10.1073/pnas.1517441113; Diaz JA, 2002, J GEN INTERN MED, V17, P180, DOI 10.1046/j.1525-1497.2002.10603.x; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Fendrich H, 2015, ASS PRESS       0128; Flaherty MR, 2016, J PEDIATR-US, V178, P268, DOI 10.1016/j.jpeds.2016.08.025; Flores G, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0331-y; Fox Susannah, 2011, HLTH TOPICS 80 INTER; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li H., 2017, CLIN J SPORT MED, P1; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McLendon LA, 2016, PEDIATR NEUROL, V62, P9, DOI 10.1016/j.pediatrneurol.2016.03.009; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Powell J, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1600; Straus LB, GRADUAL RETURN PLAY; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; West TA, 2014, J NEUROTRAUM, V31, P159, DOI 10.1089/neu.2013.3031; Zuckerman SL, 2017, J NEUROSURG-PEDIATR, V19, P652, DOI 10.3171/2017.1.PEDS16611	28	1	1	0	8	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	JAN	2018	21	1					44	48		10.3171/2017.7.PEDS17180			5	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	FR2PI	WOS:000418908800010	29125444	Bronze			2022-02-06	
J	Tshimangani, T; Pongo, J; Mabiala, JB; Yotebieng, M; O'Brien, NF				Tshimangani, Taty; Pongo, Jean; Mabiala, Joseph Bodi; Yotebieng, Marcel; O'Brien, Nicole F.			Pediatric Acute Severe Neurologic Illness and Injury in an Urban and a Rural Hospital in the Democratic Republic of the Congo	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							PLASMODIUM-FALCIPARUM; BACTERIAL-MENINGITIS; AFRICAN CHILDREN; MALARIA	Empirical knowledge suggests that acute neurologic disorders are common in sub-Saharan Africa, but studies examining the true burden of these diseases in children are scarce. We performed this prospective, observational study to evaluate the prevalence, clinical characteristics, treatment approaches, and outcomes of children suffering acute neurologic illness or injury (ANI) in an urban and rural site in the Democratic Republic of the Congo. Over 12 months, 471 out of 6,563 children admitted met diagnostic criteria for ANI, giving a hospital-based prevalence of 72/1,000 admissions. Two hundred and seventy-two children had clinical findings consistent with central nervous system infection but lacked complete diagnostic evaluation for definitive classification. Another 151 children were confirmed to have cerebral malaria (N = 109, 23% of admissions), bacterial meningitis (N = 38, 8% of admissions), tuberculous meningitis (N = 3, 0.6% of admissions), or herpes encephalitis (N= 1, 0.21% of admissions). Febrile convulsions, traumatic brain injury, and epilepsy contributed less significantly to overall hospital prevalence of ANI (3.19/1,000, 1.37/1,000, and 1.06/1,000, respectively). Overall mortality for the cohort was 21% (97/471). Neurologic sequelae were seen in another 31% of participants, with only 45% completing the study with a normal neurologic examination. This type of data is imperative to help plan effective strategies for illness and injury prevention and control, and to allow optimal use of limited resources in terms of provision of acute care and rehabilitation for these children.	[Tshimangani, Taty] Clin Univ Kinshasa, Hop Pediat Kalembe Lembe, Kinshasa, DEM REP CONGO; [Pongo, Jean] Univ Sci & Technol Lodja, Dept Pediat, Lodja, DEM REP CONGO; [Mabiala, Joseph Bodi] Clin Univ Kinshasa, Dept Pediat, Kinshasa, DEM REP CONGO; [Yotebieng, Marcel] Ohio State Univ, Coll Publ Hlth, Columbus, OH 43210 USA; [O'Brien, Nicole F.] Nationwide Childrens Hosp, Dept Pediat, 700 Childrens Dr,FOB 2134, Columbus, OH 43205 USA; [O'Brien, Nicole F.] Ohio State Univ, Columbus, OH 43210 USA		O'Brien, NF (corresponding author), Nationwide Childrens Hosp, Dept Pediat, 700 Childrens Dr,FOB 2134, Columbus, OH 43205 USA.	tshimangataty@yahoo.fr; jeanpongo01@gmail.com; bodi@yahoo.fr; yotebieng.2@osu.edu; nicole.obrien@nationwidechildrens.org	Yotebieng, Marcel/L-2083-2013	Yotebieng, Marcel/0000-0003-2110-2631			Agueda S, 2013, BRAZ J INFECT DIS, V17, P401, DOI 10.1016/j.bjid.2012.12.002; Bang A. T., 2005, J PERINATOL S, V25, P62; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Beare NAV, 2006, AM J TROP MED HYG, V75, P790, DOI 10.4269/ajtmh.2006.75.790; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Birbeck GL, 2001, TROP DOCT, V31, P82, DOI 10.1177/004947550103100209; Bower JH, 2005, NEUROLOGY, V64, P412, DOI 10.1212/01.WNL.0000150894.53961.E2; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; Edmond K, 2010, LANCET INFECT DIS, V10, P317, DOI 10.1016/S1473-3099(10)70048-7; Harding SP, 2006, TROP DOCT, V36, P1, DOI 10.1258/004947506776315781; Iloeje S O, 1997, West Afr J Med, V16, P80; Lewallen S, 1999, T ROY SOC TROP MED H, V93, P619, DOI 10.1016/S0035-9203(99)90071-8; Lewallen S, 2000, ARCH OPHTHALMOL-CHIC, V118, P924; Novelli VP, 1999, CARE CRITICALLY ILL, P281; Ofovwe GE, 2005, J NATL MED ASSOC, V97, P488; Phillips V, 2015, HEALTH AFFAIR, V34, P1196, DOI 10.1377/hlthaff.2015.0095; Saez-Llorens XM, 2008, LONG PRINCIPLES PRAC; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Sylvia WA, 2008, AFR J NEUROL SCI, V27, P19; Ulimwengu J., 2009, 2009 ANN M JUL 26 28; Urdea Mickey, 2006, Nature, V444 Suppl 1, P73, DOI 10.1038/nature05448; Yansouni CP, 2013, LANCET INFECT DIS, V13, P546, DOI 10.1016/S1473-3099(13)70004-5; Yihenew G, 2014, INTERDISCIP PERSPECT, V6, P1	23	1	1	0	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.		2018	98	5					1534	1540		10.4269/ajtmh.17-0784			7	Public, Environmental & Occupational Health; Tropical Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Tropical Medicine	GG9RD	WOS:000433037800051	29512478	Green Published			2022-02-06	
J	Tsushima, WT; Ahn, HJ; Siu, AM; Fukuyama, T; Murata, NM				Tsushima, William T.; Ahn, Hyeong Jun; Siu, Andrea M.; Fukuyama, Tama; Murata, Nathan M.			Computerized neuropsychololical test performance of youth football players at different positions: A comparison of high and low contact players	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						Contact frequency; football; neuropsyhological; positions	HIGH-SCHOOL FOOTBALL; HEAD IMPACT EXPOSURES; STATES HIGH-SCHOOL; DIVISION-I; CONCUSSION; EPIDEMIOLOGY; SPORTS; FREQUENCY; INJURY	The aim of this study was to examine the effects of head impact frequency on the neuropsychological test results of football players who participate in different positions on the team. Based on the biomechanical measures of head impact frequency reported in high school football, a High Contact group (n = 480) consisting of offensive and defensive linemen was compared with a Low Contact group (n = 640) comprised of receivers and defensive backs. The results revealed that the High Contact group obtained poorer performances on the Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) on three Composite scores (Verbal Memory, Visual Motor Speed, Impulse Control) and the Total Symptom score compared to the Low Contact group. The present study is the first, to date, to report differences in the neuropsychological test performances of athletes who participate in high and low contact football positions. The findings raise tentative concerns that youth football players exposed to repetitive head trauma, including subconcussive impacts, may be at risk for lowered neuropsychological functioning and increased symptoms.	[Tsushima, William T.] Straub Med Ctr, Psychiat & Psychol Dept, 888 South King St, Honolulu, HI 96813 USA; [Ahn, Hyeong Jun] Univ Hawaii, John A Burns Sch Med, Off Biostat & Quantitat Hlth Sci, Honolulu, HI 96822 USA; [Siu, Andrea M.] Hawaii Pacific Hlth, Res Inst, Honolulu, HI USA; [Fukuyama, Tama] Scripps Coll, Dept Human Biol, Claremont, CA 91711 USA; [Murata, Nathan M.] Univ Hawaii Manoa, Dept Kinesiol & Rehabil Sci, Honolulu, HI 96822 USA		Tsushima, WT (corresponding author), Straub Med Ctr, Psychiat & Psychol Dept, 888 South King St, Honolulu, HI 96813 USA.	wtsushima@straub.net			NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20 GM103466] Funding Source: Medline; NIMHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD) [U54 MD007601, U54 MD007584] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM103466] Funding Source: NIH RePORTER; National Institute on Minority Health and Health DisparitiesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD) [U54MD007601, U54MD007584] Funding Source: NIH RePORTER		Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; BUCKLEY WE, 1988, AM J SPORT MED, V16, P51, DOI 10.1177/036354658801600109; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Cournoyer J, 2014, J ATHL TRAINING, V49, P654, DOI 10.4085/1062-6050-49.3.34; Crisco JJ, 2012, J APPL BIOMECH, V28, P174, DOI 10.1123/jab.28.2.174; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Dick R, 2007, J ATHL TRAINING, V42, P221; Fainaru-Wada Mark, 2013, LEAGUE DENIAL NFL CO; Funk JR, 2012, ANN BIOMED ENG, V40, P79, DOI 10.1007/s10439-011-0400-8; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Jinguji TM, 2011, PHYS MED REH CLIN N, V22, P565, DOI 10.1016/j.pmr.2011.08.001; Kerr ZY, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116664500; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115603979; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lovell M. R., 2006, SPORTS NEUROPSYCHOLO, P193; Lovell M. R., 2012, CLIN INTERPRETATION; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Noble JM, 2013, NEUROPSYCHOL REV, V23, P273, DOI 10.1007/s11065-013-9239-0; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; SAS Institute Inc, 2011, BAS SAS 9 3 PROC GUI; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P236, DOI 10.1093/arclin/act009; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Stephens R, 2010, J NEUROPSYCH CLIN N, V22, P295, DOI 10.1176/appi.neuropsych.22.3.295; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Talavage TM, 2013, J NEUROTRAUM, V30, P1; Tsushima WT, 2016, APPL NEUROPSYCH-CHIL, V5, P149, DOI 10.1080/21622965.2015.1052813; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832	37	1	1	1	9	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child		2018	7	3					217	223		10.1080/21622965.2017.1290530			7	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	GR5KM	WOS:000442669800004	28631970	Green Accepted			2022-02-06	
J	van Ee, E; Murris, S; Kool, D				van Ee, Elisa; Murris, Sophia; Kool, Daniel			We Used to Live on Our Own Little Islands: A Qualitative Evaluation of Multifamily Therapy with Veterans	JOURNAL OF AGGRESSION MALTREATMENT & TRAUMA			English	Article						Anger; conflict; family relationships; family therapy; mental health; PTSD; qualitative research; veterans	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; MALE VIETNAM VETERANS; FAMILY; PTSD; PARTNERS; SOLDIERS; INTERVENTIONS; ADJUSTMENT; SYMPTOMS	Research has shown a consistent negative association between increased symptoms of posttraumatic stress disorder (PTSD) in veterans and successful functioning in family relationships. Despite compelling reasons to involve family members in the treatment of veterans, there is still a significant shortage of evidence-based programs. Multifamily therapy (MFT) is a combination of psychodynamic group therapy with systemic therapy and aims to elicit behavioral changes through the restructuring of interactional patterns in families. The purpose of this study is to qualitatively explore the efficacy of MFT in a convenience sample of Dutch veterans (nine) and their family members (23) who participated in an MFT program. Four basic themes were identified in the transcripts of the semi-structured interviews: 1. stronger family bond and reduced conflict, 2. understanding PTSD and its effect on the family, 3. working with other families, and 4. suggestions for improvement of MFT. In this study, participants described angry outbursts, interpersonal withdrawals, and emotional numbing as characteristic of their daily familial experiences. After MFT, the anger outbursts and fights diminished in most cases. MFT results in more fulfilling relationships within veteran families. MFT does not decrease symptomatology but is capable of enhancing the mental health of the veteran and their family members.	[van Ee, Elisa; Murris, Sophia; Kool, Daniel] Reinier van Arkel, Psychotraumactr Zuid Nederland, Shertogenbosch, Netherlands; [van Ee, Elisa] Radboud Univ Nijmegen, Behav Sci Inst, Nijmegen, Netherlands		van Ee, E (corresponding author), Psychotraumactr Zuid Nederland, Bethaniestr 10, NL-5211 LJ Den Bosch, Netherlands.	e.van.ee@reiniervanarkel.nl			Bond van Nederlandse Militaire Oorlogs-en dienstslachtoffers	This study was supported by a grant from the 'Bond van Nederlandse Militaire Oorlogs-en dienstslachtoffers' to Elisa van Ee, Principal Investigator.	Asen E., 2010, MULTIFAMILY THERAPY; Asen E, 2012, J FAM THER, V34, P347, DOI 10.1111/j.1467-6427.2011.00552.x; Batten SV, 2009, PSYCHOL SERV, V6, P184, DOI 10.1037/a0015392; Berz J. B., 2008, J PSYCHOL TRAUMA, V7, P37, DOI [10.1080/19322880802125969, DOI 10.1080/19322880802125969]; Boeije H., 2010, ANAL QUALITATIVE RES; Dirkzwager AJE, 2005, J FAM PSYCHOL, V19, P217, DOI 10.1037/0893-3200.19.2.217; Falloon IRH, 2002, FAMILY INTERVENTIONS IN MENTAL ILLNESS: INTERNATIONAL PERSPECTIVES, P3; Fischer EP, 2013, PROF PSYCHOL-RES PR, V44, P127, DOI 10.1037/a0032024; Galovski T, 2004, AGGRESS VIOLENT BEH, V9, P477, DOI 10.1016/S1359-1789(03)00045-4; Gewirtz AH, 2014, ADV CHILD DEV BEHAV, V46, P89, DOI 10.1016/B978-0-12-800285-8.00004-2; Gewirtz AH, 2010, J CONSULT CLIN PSYCH, V78, P599, DOI 10.1037/a0020571; Haagen JFG, 2015, CLIN PSYCHOL REV, V40, P184, DOI 10.1016/j.cpr.2015.06.008; Harkness LL, 1991, NATL CTR PTSD CLIN N, V2, P12; JORDAN BK, 1992, J CONSULT CLIN PSYCH, V60, P916, DOI 10.1037/0022-006X.60.6.916; Khaylis A, 2011, MIL MED, V176, P126, DOI 10.7205/MILMED-D-10-00094; Lauterbach D, 2007, J TRAUMA STRESS, V20, P161, DOI 10.1002/jts.20194; Lemmens G, 2008, HDB SYSTEEMTHERAPIE, P463; Makin-Byrd K, 2011, PROF PSYCHOL-RES PR, V42, P47, DOI 10.1037/a0022292; MALONEY LJ, 1988, SMITH COLL STUD SOC, V58, P122, DOI 10.1080/00377318809516639; Manguno-Mire G, 2007, J NERV MENT DIS, V195, P144, DOI 10.1097/01.nmd.0000254755.53549.69; OSHEA MD, 1985, FAM PROCESS, V24, P555, DOI 10.1111/j.1545-5300.1985.00555.x; Perlick DA, 2013, PSYCHIAT SERV, V64, P534, DOI 10.1176/appi.ps.001622012; Ruscio AM, 2002, J TRAUMA STRESS, V15, P351, DOI 10.1023/A:1020125006371; Samper RE, 2004, J TRAUMA STRESS, V17, P311, DOI 10.1023/B:JOTS.0000038479.30903.ed; Straits-Troster K, 2013, PSYCHIAT SERV, V64, P541, DOI 10.1176/appi.ps.001632012; Surgeon General Mental health, 1999, HLTH CONSMOK 50 YE; WHO, 2001, WORLD HLTH REPORT 20	27	1	1	0	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1092-6771	1545-083X		J AGGRESS MALTREAT T	J. Aggress. Maltreatment Trauma		2018	27	6					689	702		10.1080/10926771.2018.1473904			14	Psychology, Clinical; Criminology & Penology; Family Studies; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Criminology & Penology; Family Studies; Psychiatry	GM8BI	WOS:000438429600007					2022-02-06	
J	Webster, J; Kim, JH; Hawley, C; Barbir, L; Barton, S; Young, C				Webster, Joseph; Kim, Jeong Han; Hawley, Carolyn; Barbir, Lara; Barton, Sharon; Young, Cynthia			Development, implementation, and outcomes of a residential vocational rehabilitation program for injured Service members and Veterans	JOURNAL OF VOCATIONAL REHABILITATION			English	Article						Vocational rehabilitation; Veterans; VA; community reintegration	POSTTRAUMATIC-STRESS-DISORDER; OCCUPATIONAL PERFORMANCE-MEASURE; TEST-RETEST RELIABILITY; TRAUMATIC BRAIN-INJURY; DYNAMIC GAIT INDEX; COMMUNITY REINTEGRATION; PSYCHOMETRIC PROPERTIES; PTSD CHECKLIST; SELF-EFFICACY; WALKING SPEED	BACKGROUND: The Service member Transitional Advanced Rehabilitation Program (STAR) is a novel model designed to promote interdisciplinary collaboration while delivering comprehensive physical, psychosocial and vocational rehabilitation services. The STAR program was established as a pilot program in 2011 and is now approved for permanent continuation. It is housed in the Polytrauma Transitional Rehabilitation Center at Hunter Holmes McGuire VA Medical Center in Richmond, Virginia. OBJECTIVE: The present study introduces the development, implementation, participant characteristics and five-year program outcomes of the STAR program. METHODS: A paired sample t-test was employed to compare pre and posttest functioning in the following areas: physical, mental and emotional, vocational, and community integration. Mixed analysis of variance was further employed to determine the impact of demographic variables such as age, gender, race/ethnicity and marriage status on recovery. RESULTS: Statistically significant improvements in physical, mental and emotional, and vocational functioning was found in participants after completion of the STAR program. Regarding demographic variables, only marital status appeared to impact PTSD recovery. CONCLUSIONS: The STAR program's vocational rehabilitation and community reintegration services, as well as efforts to improve physical and psychological functioning, have demonstrated positive outcomes. Overall, the development and implementation of the program has been highly successful.	[Webster, Joseph; Barton, Sharon; Young, Cynthia] Hunter Holmes McGuire VA Med Ctr, Transit Adv Rehabil Program STAR Program, Richmond, VA USA; [Kim, Jeong Han; Hawley, Carolyn] Virginia Commonwealth Univ, Dept Rehabil Counseling, Richmond, VA USA; [Barbir, Lara] Radford Univ, Dept Counseling Psychol, Radford, VA 24141 USA		Webster, J (corresponding author), Hunter Holmes McGuire VA Med Ctr, Transit Adv Rehabil Program, Richmond, VA 23224 USA.	joseph.webster@va.gov					Barlow J, 2002, BRIT J GUID COUNS, V30, P37, DOI 10.1080/030698880220106500; Barrett DH, 2002, PSYCHOSOMATICS, V43, P195, DOI 10.1176/appi.psy.43.3.195; Barskova T, 2009, DISABIL REHABIL, V31, P1709, DOI 10.1080/09638280902738441; Batten SV, 2009, PSYCHOL SERV, V6, P184, DOI 10.1037/a0015392; Beck A. T., 1996, MANUAL BECK DEPRESSI, VII; BERG K, 1995, SCAND J REHABIL MED, V27, P27; BERG K, 1989, Physiotherapy Canada, V41, P304; Berglind H, 2002, DISABIL REHABIL, V24, P719, DOI 10.1080/09638280210124301; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bodiam C., 1999, BRIT J OCCUP THER, V62, P123, DOI [10.1177/030802269906200310, DOI 10.1177/030802269906200310]; Bohannon RW, 1997, AGE AGEING, V26, P15, DOI 10.1093/ageing/26.1.15; Bowden MG, 2007, J REHABIL RES DEV, V44, P355, DOI 10.1682/JRRD.2006.03.0033; Bradley R, 2005, AM J PSYCHIAT, V162, P214, DOI 10.1176/appi.ajp.162.2.214; Brusse KJ, 2005, PHYS THER, V85, P134, DOI 10.1093/ptj/85.2.134; Burke HS, 2009, J REHABIL, V75, P5; Burns AS, 2011, NEUROREHAB NEURAL RE, V25, P149, DOI 10.1177/1545968310376756; Carpenter L, 2001, Can J Occup Ther, V68, P16; Chard KM, 2010, J TRAUMA STRESS, V23, P25, DOI 10.1002/jts.20500; Collen F M, 1990, Int Disabil Stud, V12, P6; Connelly DM, 2009, PHYSIOTH CAN, V61, P78, DOI 10.3138/physio.61.2.78; Conybeare D, 2012, J CLIN PSYCHOL, V68, P699, DOI 10.1002/jclp.21845; Cup EHC, 2003, CLIN REHABIL, V17, P402, DOI 10.1191/0269215503cr635oa; Dedding C, 2004, CLIN REHABIL, V18, P660, DOI 10.1191/0269215504cr746oa; Edward J. Q. L., 2006, J OCCUPATIONAL REHAB, V16, P529, DOI [10.1007/s10926-006-9034-3, DOI 10.1007/S10926-006-9034-3]; Flansbjer UB, 2005, J REHABIL MED, V37, P75, DOI 10.1080/16501970410017215; Ford JD, 1997, J CONSULT CLIN PSYCH, V65, P547; Gaiter S. L., 2015, THESIS; Gustafson DH, 2013, ADDICTION, V108, P1145, DOI 10.1111/add.12117; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Hawley ST, 2017, BREAST CANCER RES TR, V161, P557, DOI 10.1007/s10549-016-4082-7; Helgeson VS, 2006, J CONSULT CLIN PSYCH, V74, P797, DOI 10.1037/0022-006X.74.5.797; Hergenrather KC, 2008, J REHABIL, V74, P34; Herman T, 2009, GAIT POSTURE, V29, P237, DOI 10.1016/j.gaitpost.2008.08.013; Hollman John H, 2008, J Geriatr Phys Ther, V31, P53; IOM, 2012, TREATM POSTTR STRESS; Jang Y, 2004, ARCH PHYS MED REHAB, V85, P1890, DOI 10.1016/j.apmr.2004.02.032; Jonsdottir J, 2007, ARCH PHYS MED REHAB, V88, P1410, DOI 10.1016/j.apmr.2007.08.109; Kerns RD, 2003, J REHABIL RES DEV, V40, P371, DOI 10.1682/JRRD.2003.09.0371; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; KUYKEN W, 1994, INT J MENT HEALTH, V23, P24, DOI 10.1080/00207411.1994.11449286; Lam T, 2008, SPINAL CORD, V46, P246, DOI 10.1038/sj.sc.3102134; Liptak J. J., 2009, JOB SEARCH KNOWLEDGE; Livneh H, 2016, J OCCUP REHABIL, V26, P13, DOI 10.1007/s10926-015-9601-6; Lorig KR, 2003, ANN BEHAV MED, V26, P1, DOI 10.1207/S15324796ABM2601_01; MacKenzie Ellen J, 2006, J Am Acad Orthop Surg, V14, pS205; Maguen S, 2010, J TRAUMA STRESS, V23, P86, DOI 10.1002/jts.20434; Monson CM, 2008, PSYCHOL ASSESSMENT, V20, P131, DOI 10.1037/1040-3590.20.2.131; Nelligan JA, 2008, J CLIN PSYCHIAT, V69, P810, DOI 10.4088/JCP.v69n0514; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; Paltamaa J, 2007, ARCH PHYS MED REHAB, V88, P1649, DOI 10.1016/j.apmr.2007.07.032; Pollock N, 1998, CANADIAN OCCUPATIONA; Prudential, 2012, VET EMPL CHALL PERC; Reiso H, 2003, SPINE, V28, P1468, DOI 10.1097/00007632-200307010-00020; Resnik L, 2011, J REHABIL RES DEV, V48, P89, DOI 10.1682/JRRD.2010.04.0070; Resnik L, 2009, J REHABIL RES DEV, V46, P469, DOI 10.1682/JRRD.2008.07.0082; Robert L. W., 2016, CLIN GUIDE PSYCHIAT; Ruggiero KJ, 2003, J TRAUMA STRESS, V16, P495, DOI 10.1023/A:1025714729117; Sampere M, 2012, J OCCUP REHABIL, V22, P15, DOI 10.1007/s10926-011-9313-5; Sampson MJ, 2003, INT J GERIATR PSYCH, V18, P23, DOI 10.1002/gps.763; Sayer NA, 2009, J REHABIL RES DEV, V46, P703, DOI 10.1682/JRRD.2009.01.0008; Schottenbauer MA, 2008, PSYCHIATRY, V71, P134, DOI 10.1521/psyc.2008.71.2.134; Schultz IZ, 2004, PAIN, V107, P77, DOI 10.1016/j.pain.2003.09.019; Shumway-Cook A, 2001, MOTOR CONTROL THEORY, V2; ShumwayCook A, 1997, PHYS THER, V77, P46, DOI 10.1093/ptj/77.1.46; Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00; Steffen T, 2008, PHYS THER, V88, P733, DOI 10.2522/ptj.20070214; Sutker PB, 2002, J PSYCHOPATHOL BEHAV, V24, P25, DOI 10.1023/A:1014049123935; Tsai J, 2015, PSYCHOL MED, V45, P165, DOI 10.1017/S0033291714001202; Van Loo MA, 2004, BRAIN INJURY, V18, P1041, DOI 10.1080/02699050410001672314; Watson MJ, 2002, PHYSIOTHERAPY, V88, P386, DOI [10.1016/S0031-9406(05)61264-3, DOI 10.1016/S0031-9406(05)61264-3, 10.1016/S0031_9406(05)61264_3]	70	1	1	1	5	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1052-2263	1878-6316		J VOCAT REHABIL	J. Vocat. Rehabil.		2018	48	1					111	126		10.3233/JVR-170919			16	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	FX7FX	WOS:000426253900009					2022-02-06	
J	Xue, PY; Zhang, XY; Bai, J; Wang, Z				Xue, Peiyun; Zhang, Xueying; Bai, Jing; Wang, ZizhongJohn			Acoustic and kinematic analyses of Mandarin vowels in speakers with hearing impairment	CLINICAL LINGUISTICS & PHONETICS			English	Article						Hearing impairment; acoustic analysis; kinematic analysis; formants; electromagnetic articulography	TRAUMATIC BRAIN-INJURY; ELECTROMAGNETIC ARTICULOGRAPHY; COCHLEAR IMPLANT; SPEECH-INTELLIGIBILITY; SPEAKING RATE; CHILDREN; TONGUE; MOVEMENTS; SPACE; VOICE	The central aim of this experiment was to compare acoustic parameters, formant frequencies and vowel space area (VSA), in adolescents with hearing-impaired (HI) and their normal-hearing (NH) peers; for kinematic parameters, the movements of vocal organs, especially the lips, jaw and tongue, during vowel production were analysed. The participants were 12 adolescents with different degrees of hearing impairment. The control group consisted of 12 age-matched NH adolescents. All participants were native Chinese speakers who were asked to produce the Mandarin vowels /a/, /i/ and /u/, with subsequent acoustic and kinematic analysis. There was significant difference between the two groups. Additionally, the HI group produced more exaggerated mouth and less tongue movements in all vowels, compared to their NH peers. Results were discussed regarding possible relationship between acoustic data, articulatory movements and degree of hearing loss to provide an integrative assessment of acoustic and kinematic characteristics of individuals with hearing loss.	[Xue, Peiyun; Zhang, Xueying; Bai, Jing; Wang, ZizhongJohn] Taiyuan Univ Technol, Coll Informat Engn, Taiyuan, Peoples R China; [Wang, ZizhongJohn] Virginia Wesleyan Coll, Dept Math & Comp Sci, Norfolk, VA USA		Zhang, XY (corresponding author), Taiyuan Univ Technol, Coll Informat Engn, Taiyuan, Peoples R China.	tyzhangxy@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [61371193]; Scientific and Technological Research Projects of Shanxi Province of China [20120313013-6]	This study was supported by the National Natural Science Foundation of China [Grant Number 61371193] and the Scientific and Technological Research Projects of Shanxi Province of China [Grant Number 20120313013-6].	Bartle CJ, 2006, BRAIN INJURY, V20, P529, DOI 10.1080/02699050500487613; Baudonck N, 2011, FOLIA PHONIATR LOGO, V63, P154, DOI 10.1159/000318879; Bradlow AR, 1996, SPEECH COMMUN, V20, P255, DOI 10.1016/S0167-6393(96)00063-5; Chuang HF, 2012, INT J SPEECH-LANG PA, V14, P119, DOI 10.3109/17549507.2011.639391; Ferguson SH, 2002, J ACOUST SOC AM, V112, P259, DOI 10.1121/1.1482078; Goozee JV, 2000, BRAIN INJURY, V14, P153, DOI 10.1080/026990500120817; Gugsch C, 2008, J OROFAC ORTHOP, V69, P257, DOI 10.1007/s00056-008-0702-0; HAMMARBERG B, 1980, ACTA OTO-LARYNGOL, V90, P441, DOI 10.3109/00016488009131746; Hocevar-Boltezar I, 2008, WIEN KLIN WOCHENSCHR, V120, P228, DOI 10.1007/s00508-008-0944-2; Horga D, 2006, CLIN LINGUIST PHONET, V20, P211, DOI 10.1080/02699200400027015; Iskarous K, 2010, J ACOUST SOC AM, V127, P3717, DOI 10.1121/1.3409485; Jafari N, 2016, J VOICE, V30, DOI 10.1016/j.jvoice.2015.10.006; Kant AR, 2012, CLIN EXP OTORHINOLAR, V5, pS14, DOI 10.3342/ceo.2012.5.S1.S14; Kroos C, 2012, J PHONETICS, V40, P453, DOI 10.1016/j.wocn.2012.03.002; Kuruvilla M, 2007, BRAIN INJURY, V21, P601, DOI 10.1080/02699050701427525; Ladefoged P., 2001, COURSE PHONETICS, V4th ed.; Lee SH, 2015, AM J SPEECH-LANG PAT, V24, P739, DOI 10.1044/2015_AJSLP-14-0063; Leung MT, 2011, J ACOUST SOC AM, V129, P316, DOI 10.1121/1.3514529; Liker M, 2007, CLIN LINGUIST PHONET, V21, P1, DOI 10.1080/02699200400026991; LINDBLOM B, 1970, J ACOUST SOC AM, V48, P120, DOI 10.1121/1.1974958; LINDBLOM B, 1990, NATO ADV SCI I D-BEH, V55, P403; Mahmoudi Z, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-3; Milenkovic PH, 2010, J ACOUST SOC AM, V127, P1002, DOI 10.1121/1.3277214; MONSEN RB, 1976, J SPEECH HEAR RES, V19, P279, DOI 10.1044/jshr.1902.279; Neufeld C, 2014, J ACOUST SOC AM, V135, P352, DOI 10.1121/1.4836515; Nicolaidis K, 2016, INT J SPEECH-LANG PA, V18, P378, DOI 10.3109/17549507.2015.1101155; Ozbi M., 2008, INVESTIGATIONES LING, V16, P150; Parkinson A J, 1996, J Am Acad Audiol, V7, P305; Poissant SF, 2006, INT J PEDIATR OTORHI, V70, P1195, DOI 10.1016/j.ijporl.2005.12.008; Riely RR, 2003, J APPL PHYSIOL, V94, P2119, DOI 10.1152/japplphysiol.00502.2002; ROBBINS J, 1987, J SPEECH HEAR DISORD, V52, P271, DOI 10.1044/jshd.5203.271; Sapir S, 2010, J SPEECH LANG HEAR R, V53, P114, DOI 10.1044/1092-4388(2009/08-0184); Shosted R, 2012, J ACOUST SOC AM, V131, P455, DOI 10.1121/1.3665998; Slis A, 2013, J ACOUST SOC AM, V134, P4496, DOI 10.1121/1.4828834; TURNER GS, 1995, J SPEECH HEAR RES, V38, P1001, DOI 10.1044/jshr.3805.1001; Verhoeven J, 2016, J COMMUN DISORD, V59, P24, DOI 10.1016/j.jcomdis.2015.10.007; Watchorn C., 2005, J FLUID MECH, V533, P1; Weismer G, 2001, FOLIA PHONIATR LOGO, V53, P1, DOI 10.1159/000052649; Wieland EA, 2015, J SPEECH LANG HEAR R, V58, P254, DOI 10.1044/2015_JSLHR-S-13-0250; Yunusova Y, 2009, J SPEECH LANG HEAR R, V52, P547, DOI 10.1044/1092-4388(2008/07-0218)	40	1	1	0	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9206	1464-5076		CLIN LINGUIST PHONET	Clin. Linguist. Phon.		2018	32	7					622	639		10.1080/02699206.2017.1416492			18	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	GJ8UE	WOS:000435666100005	29265931				2022-02-06	
J	Yildirim, T; Okutan, O; Akpinar, E; Yilmaz, A; Isik, HS				Yildirim, T.; Okutan, O.; Akpinar, E.; Yilmaz, A.; Isik, H. S.			Neuroprotective effects of high-dose human albumin against traumatic spinal cord injury in rats	BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY			English	Article						human albumin; spinal cord injury; rats	ACUTE ISCHEMIC STROKE; ALIAS PILOT TRIAL; MULTIPLE-SCLEROSIS; INTERFERON-BETA; THERAPY; MECHANISMS; BRAIN; RESPONSES; ERYTHROPOIETIN; ESCALATION	BACKGROUND AND OBJECTIVES: Human serum albumin (HA) is a unique multifunctional protein with neuroprotective properties. We aimed to delineate the mechanisms of HA-induced neuroprotection, supresses inflammatory response and lipid peroxidation after spinal cord injury (SCI). METHODS AND STUDY DESIGN: Adult female Wistar rats weighing 210-250 g were used for the study. The rats were randomly and blindly allocated into five groups. The one-way analysis of variance (ANOVA) for parametric data and Shapiro-Wilk test was used for evaluating the normal distribution of the variables. Kruskal-Wallis for nonparametric data was used to compare groups. Electron and light microscopies were used to demonstrate ultrastructural changes in spinal cord. RESULTS: The HA group was significantly different from all the other groups (p < 0.05). Both MPSS and HA treatments decreased the MPO significantly. HA treatment decreased the lipid peroxidation. HA treatment prevented the worsening of clinical results. In the HA treatment group, the ultrastructure was protected significantly. The neuronal bodies and axonal structures were normal except for some limited edematous spaces. CONCLUSIONS: HA improves early clinical results, protects spinal cord ultrastructure, and decreases MPO and LPO levels after spinal cord contusion injury	[Yildirim, T.; Okutan, O.; Akpinar, E.; Yilmaz, A.; Isik, H. S.] Ordu Univ, Sch Med, Neurosurg, TR-52200 Ordu, Turkey; [Okutan, O.; Akpinar, E.] KTO Karatay Univ, Sch Med, Neurosurg Dept, Konya, Turkey		Yildirim, T (corresponding author), Ordu Univ, Sch Med, Neurosurg, TR-52200 Ordu, Turkey.	mdtimur@hotmail.com					Adogwa O, 2014, SPINE, V39, P1513, DOI 10.1097/BRS.0000000000000450; Allen AR., 1911, JAMA-J AM MED ASSOC, V57, P878, DOI DOI 10.1001/JAMA.1911.04260090100008; ANDERSON DK, 1993, ANN EMERG MED, V22, P987, DOI 10.1016/S0196-0644(05)82739-8; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Belayev L, 1999, BRAIN RES, V845, P107, DOI 10.1016/S0006-8993(99)01952-6; Belayev L, 2002, STROKE, V33, P1077, DOI 10.1161/hs0402.105555; Belayev L, 2001, STROKE, V32, P553, DOI 10.1161/01.STR.32.2.553; Bhuiyan M U, 2016, Mymensingh Med J, V25, P277; Bohl DD, 2016, SPINE, V41, P1693, DOI 10.1097/BRS.0000000000001591; Buemi M, 2000, EUR J PHARMACOL, V392, P31, DOI 10.1016/S0014-2999(00)00081-9; Carlson SL, 1998, EXP NEUROL, V151, P77, DOI 10.1006/exnr.1998.6785; Chen XB, 2014, J SPINAL CORD MED, V37, P72, DOI 10.1179/2045772313Y.0000000131; Dumont RJ, 2001, CLIN NEUROPHARMACOL, V24, P254, DOI 10.1097/00002826-200109000-00002; EMERSON TE, 1989, CRIT CARE MED, V17, P690, DOI 10.1097/00003246-198907000-00020; Ginsberg MD, 2006, STROKE, V37, P2100, DOI 10.1161/01.STR.0000231388.72646.05; Gok B, 2007, SPINE, V32, P873, DOI 10.1097/01.brs.0000259841.40358.8f; Gok HB, 2007, J CLIN NEUROSCI, V14, P138, DOI 10.1016/j.jocn.2006.10.016; Goussev S, 2003, J NEUROSURG, V99, P188, DOI 10.3171/spi.2003.99.2.0188; HALLIWELL B, 1990, ARCH BIOCHEM BIOPHYS, V280, P1, DOI 10.1016/0003-9861(90)90510-6; HALLIWELL B, 1988, BIOCHEM PHARMACOL, V37, P569, DOI 10.1016/0006-2952(88)90126-8; Hamada Y, 1996, J NEUROCHEM, V32, P192; Hauben E, 2003, TRENDS PHARMACOL SCI, V24, P7, DOI 10.1016/S0165-6147(02)00013-5; Jin GX, 2014, SPINE J, V14, P1902, DOI 10.1016/j.spinee.2013.10.049; Kallmann BA, 2000, BRAIN, V123, P687, DOI 10.1093/brain/123.4.687; Kaptanoglu E, 2005, J NEUROSURG-SPINE, V3, P53, DOI 10.3171/spi.2005.3.1.0053; Kaptanoglu E, 2004, NEUROSURG REV, V27, P113, DOI 10.1007/s10143-003-0300-y; Limone P, 2002, ACTA NEUROL SCAND, V105, P372, DOI 10.1034/j.1600-0404.2002.01155.x; Liu ZG, 2001, J NEUROIMMUNOL, V112, P153, DOI 10.1016/S0165-5728(00)00403-3; MEANS ED, 1983, J NEUROPATH EXP NEUR, V42, P707, DOI 10.1097/00005072-198311000-00009; Palesch YY, 2006, STROKE, V37, P2107, DOI 10.1161/01.STR.0000231389.34701.b5; Pan JZ, 2002, J NEUROSCI RES, V68, P315, DOI 10.1002/jnr.10215; Profyris C, 2004, NEUROBIOL DIS, V15, P415, DOI 10.1016/j.nbd.2003.11.015; Schnell L, 1999, EUR J NEUROSCI, V11, P3648, DOI 10.1046/j.1460-9568.1999.00792.x; SUZUKI M, 1994, ACTA NEUROCHIR, P434; Taoka Y, 1997, NEUROSCIENCE, V79, P1177, DOI 10.1016/S0306-4522(97)00011-0; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; TOMITA H, 1994, ACTA NEUROCHIR, P547; Yang LQ, 2004, SPINE, V29, P966, DOI 10.1097/00007632-200405010-00004; Yong VW, 1998, NEUROLOGY, V51, P682	39	1	1	0	2	COMENIUS UNIV	BRATISLAVA I	SCH MEDICINE, SPITALSKA 24, BRATISLAVA I, SK-813 72, SLOVAKIA	0006-9248	1336-0345		BRATISL MED J	Bratisl. Med. J.		2018	119	2					86	91		10.4149/BLL_2018_016			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW3CI	WOS:000425183100004	29455542	gold			2022-02-06	
J	Zotov, PB; Lyubov, EB; Ponomareva, TG; Skryabin, EG; Bragin, AV; Ananeva, OV				Zotov, P. B.; Lyubov, E. B.; Ponomareva, T. G.; Skryabin, E. G.; Bragin, A., V; Ananeva, O., V			SOMATIC PATHOLOGY AMONG SUICIDE RISK FACTORS. REPORT II	SUICIDOLOGY			Russian	Article						suicide; suicidal attempt; suicidal behavior; suicide risk; risk factors; prevention; somatic diseases; somatic pathology	SYSTEMIC-LUPUS-ERYTHEMATOSUS; TRAUMATIC BRAIN-INJURY; ILL CANCER-PATIENTS; MAJOR DEPRESSION; ASSISTED SUICIDE; MENTAL-DISORDERS; PRIMARY-CARE; CHRONIC PAIN; IDEATION; POPULATION	Report II presents a review of the literature on suicidal behavior (SB) of patients with certain somatic diseases. It was shown that co-morbidly ill patients with SB were more socially maladjusted. Somatic suffering makes the patient more vulnerable to micro-social conflicts, often associated with a sense of burden, loneliness and pain, reducing the threshold of fear of death. In cancer, the risk of suicide is 2-4 times higher compared to the general population. In Western Europe and the United States, 0.2-0.5% of deaths of cancer patients are caused by suicide. At the same time, up to 50% of suicides occur when diagnosed with a localized and potentially curable disease. Among the victims of suicides in Russia, there are <= 0.5% cancer patients with male female ratio of 4:1 and mean age of 67 years. At the same time, it is possible that only <1/3 of suicides are actually registered. The risk of suicide is higher for white male husbands, who suffer worse pain and functional limitations. The level of suicide mortality increases with the age of diagnosis - higher in the older (55-65 years), the highest - at the age of >= 80 years. Personality disorders are recorded in 50% of suicidal cancer patients. In 20% of patients receiving palliative care, SB (including suicidal attempts) were detected before the diagnosis of cancer. The risk of suicide with depressive cancer patients is not 2-4 times higher, but 25 times higher. The prevalence of clinical depression among cancer patients is 5-40%. The "critical period" of suicide for men (more often) and women is the first 1-2 years after the diagnosis. The first year accounts for 40% of suicides. The risk factors among these patients are: chronic and poorly controlled pain, metastasis, treatment failure, limitation of self-care. The risk group also includes people who refuse treatment. 20% of patients report suicidal thoughts and hopelessness. The majority of patients thinking about death will not commit suicide, but 50-60% of those who committed suicide shared their suicidal thoughts (plans) with their relatives and medical staff. Almost half (45%) of oncologists are confronted with SB of cancer patients, which indicates its prevalence, but only in isolated cases there is an active survey of patients for this topic. The majority (62%) of oncologists believe that active identification of suicidal ideation may provoke suicide of patients. Among the ways of suicide, self-hanging and poisoning dominate, including an overdose of analgesics and sedatives; it usually happens at home and is planned. More than <1/4> patients think about euthanasia. Lung disease. The risk of SB increases in COPD (men), pneumonia. With bronchial asthma there is a fourfold increase in the risk of suicide attempts. Cardiovascular diseases. Patients with chronic heart failure have the highest association with psychiatric diseases. Persons with implantation of a cardiostimulator, often young and middle-aged, have the highest suicide mortality rates. When making a suicidal attempt by self-poisoning in 12.6-13.5% hypotensive and anti-arrhythmic drugs are used (general population). Gastrointestinal diseases. After gastrectomy for peptic ulcer, suicide was registered in 13.7%, but half of the victims suffered from alcoholism. With gastrointestinal bleeding, the risk of suicide increases 3.4-4.5 times, which is also associated with alcohol problems of the contingent. The risk of SB is significant in case of kidney diseases and renal failure. The risk of depression and SB increases as the level of glomerular filtration decreases and persists even after its correction. The risk of suicide increases in the period of the first 3 months of the start of dialysis therapy and grows 25 times in the course of long-term treatment (relative to the general population). Kidney transplantation does not reduce the risk of suicide, possibly due to lifelong treatment and the fear of organ rejection. The share of suicide-related deaths in type I diabetes mellitus can be 7.7%, in type II - 1.3%. AIDS / HIV, especially those associated with the use of surfactants, mental disorders, and social distress, increase the risk of SB by 24-36 times. The risk of suicide in stroke is increased in women and men <60 years 13 and 3-6 times respectively, >60 years - 1.5-2 times. The average time interval between hospitalization and suicide is 1.9 +/- 1.8 years. Spinal cord injuries make up almost fivefold growth of SB. Among deceased patients with spinal cord injury, 4.2% of deaths are related to suicide attempts. Epilepsy (especially temporal) accounts for a fivefold increase in the risk of suicide and 25-fold with resistance to therapy; increased by almost an order of magnitude with concomitant mental disorder, 16 times higher at the onset of the disease before 18 years of age. Suicide may account for 10% of deaths of these patients. Suicides in hospitals. The average age of somatic patients, victims of suicide in a multidisciplinary hospital is 54 while in a psychiatric one it is 41. Somatically, patients are often fall down from a height during hospitalization from 2 days to several months (30 days on average). In somatic hospitals 1/4 suicide victims suffer from the main cause of SB - depression. Only 15% were consulted by a psychiatrist before the tragedy. Conclusion: All illnesses are associated with distress, pain, impairment of functioning, but severe diseases are particularly hard for patients. Apparently, it is essential to find the balance of risk factors and anti-suicidal factors (for example, the internal pattern of the disease determines the rejection of treatment and the hope of healing). Anti-suicidal factors should be identified and strengthened; variable risk factors should be monitored and leveled. The main anti-suicidal factor is adequate therapy. The primary care staff is the key "watchman" in preventing SB. One of the few scientifically proven effective elements of an anti-crisis program is training in identifying depression and SB. The postvention measures (after the patient's SB) are also important in regards to close victims, other patients (bystanders), and professionals. SB prevention means empathy for the sufferer and his family, attention to their immediate and changing needs.	[Zotov, P. B.; Skryabin, E. G.; Bragin, A., V; Ananeva, O., V] Tyumen State Med Univ, Tyumen, Russia; [Lyubov, E. B.] Natl Med Res Ctr Psychiat & Narcol, Moscow Inst Psychiat, Moscow, Russia; [Ponomareva, T. G.] Psychiat Hosp 13, Moscow, Russia		Zotov, PB (corresponding author), Tyumen State Med Univ, Tyumen, Russia.	note72@yandex.ru; lyubov.evgeny@mail.ru; pb13@zdray.mos.ru; skryabineg@mail.ru	Zotov, Pavel/U-2807-2017	Zotov, Pavel/0000-0002-1826-486X			Abbey J. G., I3337626 ETD COLL FO; Ahmedani BK, 2014, J GEN INTERN MED, V29, P870, DOI 10.1007/s11606-014-2767-3; Ahn MH, 2015, PSYCHO-ONCOLOGY, V24, P601, DOI 10.1002/pon.3705; Akechi T, 2010, PSYCHO-ONCOLOGY, V19, P384, DOI 10.1002/pon.1587; Ambrumova A.G., 1980, DIAGNOSTIKA SUICIDAL; Ambrumova A. G, 1979, AKTUALNYE VOPROSY SO, P149; Anguiano L, 2012, CANCER NURS, V35, pE14, DOI 10.1097/NCC.0b013e31822fc76c; Bindler L, 2009, Rev Med Suisse, V5, P646; Bjorkenstam C, 2005, SCAND J PUBLIC HEALT, V33, P208, DOI 10.1080/14034940410019226; Bleyer A, 2009, SEMIN ONCOL, V36, P194, DOI 10.1053/j.seminoncol.2009.03.003; Bolton JM, 2015, PSYCHOL MED, V45, P495, DOI 10.1017/S0033291714001639; Bolund C., 1985, J PSYCHOSOC ONCOL, V3, P17; Boyarkina S. I., 2004, THESIS; Breitbart W., 2011, DEPRESSION CANC, P125; Campbell G, 2015, AUST NZ J PSYCHIAT, V49, P803, DOI 10.1177/0004867415569795; Carrieri MP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171645; Charlier P, 2012, MED HYPOTHESES, V79, P264, DOI 10.1016/j.mehy.2012.05.005; CHATTONREITH J, 1990, REV EPIDEMIOL SANTE, V38, P125; Chi CC, 2017, AM J CLIN DERMATOL, V18, P621, DOI 10.1007/s40257-017-0281-1; Chochinov HM, 1998, PSYCHOSOMATICS, V39, P366, DOI 10.1016/S0033-3182(98)71325-8; Chung JH, 2016, ANN GEN PSYCHIATR, V15, DOI 10.1186/s12991-016-0122-2; Chung KH, 2010, SUICIDE LIFE-THREAT, V40, P107, DOI 10.1521/suli.2010.40.2.107; Clarke DM, 2002, AUST NZ J PSYCHIAT, V36, P733, DOI 10.1046/j.1440-1614.2002.01086.x; Costantini A, 2014, J PSYCHOSOC ONCOL, V32, P383, DOI 10.1080/07347332.2014.917136; Coughlin S. S., 2013, J DEPRESS ANXIETY, V19; Crocetti E, 2012, EPIDEMIOL PREV, V36, P83; Dormer NRC, 2008, MED J AUSTRALIA, V188, P140, DOI 10.5694/j.1326-5377.2008.tb01555.x; Druss B, 2000, ARCH INTERN MED, V160, P1522, DOI 10.1001/archinte.160.10.1522; Egeberg A, 2016, BRIT J DERMATOL, V175, P493, DOI 10.1111/bjd.14633; Emanuel EJ, 1996, LANCET, V347, P1805, DOI 10.1016/S0140-6736(96)91621-9; Fang CK, 2014, SUPPORT CARE CANCER, V22, P3165, DOI 10.1007/s00520-014-2290-4; Fang F, 2008, BRAIN, V131, P2729, DOI 10.1093/brain/awn161; Farberow N. L., 1971, SUICIDE LIFE-THREAT, V1, P184; Filiberti A, 2002, TUMORI J, V88, P193, DOI 10.1177/030089160208800303; Fishbain DA, 2015, PAIN MED, V16, P1057, DOI 10.1111/pme.12686; Fonda JR, 2017, AM J EPIDEMIOL, V186, P220, DOI 10.1093/aje/kwx044; Fuller-Thomson E, 2016, RHEUMATOL INT, V36, P1237, DOI 10.1007/s00296-016-3498-z; GANZINI L, 1994, AM J PSYCHIAT, V151, P1631; Gomez-Peralta TG, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15061198; Guidance on Cancer Services, 2004, CANCER MED; HARRIS EC, 1994, MEDICINE, V73, P281, DOI 10.1097/00005792-199411000-00001; Hem E, 2004, J CLIN ONCOL, V22, P4209, DOI 10.1200/jco.2004.02.052; Hong JP, 2018, J PSYCHIATR RES, V96, P135, DOI 10.1016/j.jpsychires.2017.10.005; Inhestern L, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3347-9; Innamorati M, 2014, AM J GERIAT PSYCHIAT, V22, P1158, DOI 10.1016/j.jagp.2013.03.003; Inoue K, 2017, PSYCHIAT RES, V250, P155, DOI 10.1016/j.psychres.2017.01.076; Jhee JH, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008476; Johnson TV, 2012, PSYCHO-ONCOLOGY, V21, P351, DOI 10.1002/pon.1905; Jones JE, 2003, EPILEPSY BEHAV, V4, pS31, DOI 10.1016/j.yebeh.2003.08.019; Kang CR, 2016, AIDS CARE, V28, P306, DOI 10.1080/09540121.2015.1093593; Kasimova L.N., 2011, SUICIDOLOGY, V1, P54; Kelly B, 2003, PSYCHOL MED, V33, P75, DOI 10.1017/S0033291702006827; Kerkhof A., 1994, FINDINGS MULTICENTRE; Kiffel J, 2015, FRONT PUBLIC HEALTH, V3, DOI 10.3389/fpubh.2015.00028; Kniga M. Y., 2017, SCI FORUM SIBERIA, V3, P69; KNOP J, 1981, ACTA PSYCHIAT SCAND, V63, P346, DOI 10.1111/j.1600-0447.1981.tb00683.x; KOVACS M, 1975, SUICIDE, V5, P98; KRASNOV VN, 1999, SOCIALNAJA KLINICHES, V9, P5; [Кутлубаев Мансур Амирович Kutlubaev Mansur Amirovich], 2016, [Неврологический журнал, Nevrologicheskii zhurnal], V21, P124, DOI 10.18821/1560-9545-2016-21-3-124-130; Le Strat Y, 2015, LIVER INT, V35, P1910, DOI 10.1111/liv.12612; Leung YW, 2013, PSYCHO-ONCOLOGY, V22, P2537, DOI 10.1002/pon.3319; Lewis DS, 2014, J NEUROSCI NURS, V46, P241, DOI 10.1097/JNN.0000000000000062; Lin HC, 2009, PSYCHO-ONCOLOGY, V18, P1038, DOI 10.1002/pon.1483; Lindner R, 2014, Z GERONTOL GERIATR, V47, P502, DOI 10.1007/s00391-013-0563-z; Liu CH, 2017, NEPHROL DIAL TRANSPL, V32, P1524, DOI 10.1093/ndt/gfw244; Lyubov EB, 2017, SUICIDOLOGY, V8, P3; Lyubov EB, 2015, SUICIDOLOGY, V6, P3; Lyubov EB, 2015, SUICIDOLOGY, V6, P18; Lyubov E. B., 2012, SUICIDOLOGY, P20; Malinowska K, 2018, POL J SURG, V90, P23, DOI 10.5604/01.3001.0011.7490; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; McCorkle Ruth, 2006, Health Care Women Int, V27, P45, DOI 10.1080/07399330500377507; McGinty EE, 2012, PSYCHIAT SERV, V63, P714, DOI 10.1176/appi.ps.201100169; McGuire N. K., 2011, INPATIENT SUICIDE GE; Meyer HAM, 2003, PALLIATIVE MED, V17, P604, DOI 10.1191/0269216303pm813oa; Meyer-Rochow VB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141583; Miccinesi G, 2004, EUR J CANCER, V40, P1053, DOI 10.1016/j.ejca.2003.12.022; Miller M, 2008, J CLIN ONCOL, V26, P4720, DOI 10.1200/JCO.2007.14.3990; MILLER RJ, 1994, SEMIN ONCOL, V21, P787; Minagawa H, 1996, CANCER, V78, P1131, DOI 10.1002/(SICI)1097-0142(19960901)78:5<1131::AID-CNCR26>3.3.CO;2-J; Minino AM, 2010, DEATHS PRELIMINARY D; Misono S, 2008, J CLIN ONCOL, V26, P4731, DOI 10.1200/JCO.2007.13.8941; Mok CC, 2014, RHEUMATOLOGY, V53, P714, DOI 10.1093/rheumatology/ket404; Mystakidou K, 2006, PSYCHO-ONCOLOGY, V15, P355, DOI 10.1002/pon.972; Nakash O, 2014, PSYCHO-ONCOLOGY, V23, P40, DOI 10.1002/pon.3372; National Institute for Clinical Excellence, 2004, GUIDANCE CANC SERVIC; Nelson CJ, 2009, ONCOLOGIST, V14, P891, DOI 10.1634/theoncologist.2009-0059; Ng CWM, 2017, SINGAP MED J, V58, P72, DOI 10.11622/smedj.2017006; Nishida Tomomi, 2008, Palliat Support Care, V6, P183, DOI 10.1017/S1478951508000278; Nissim R, 2009, SOC SCI MED, V69, P165, DOI 10.1016/j.socscimed.2009.04.021; Peltzer K, 2013, INDIAN J MED RES, V138, P194; Perini G, 2014, SOC PSYCH PSYCH EPID, V49, P693, DOI 10.1007/s00127-013-0765-0; Pompili M, 2012, J PSYCHOSOM RES, V73, P411, DOI 10.1016/j.jpsychores.2012.09.011; Prilensky A.B., 2016, SCI FORUM SIBERIA, V2, P95; RAMIREZ AJ, 1995, BRIT J CANCER, V71, P1263, DOI 10.1038/bjc.1995.244; Rasic DT, 2008, PSYCHO-ONCOL, V17, P660, DOI 10.1002/pon.1292; Recklitis CJ, 2010, J CLIN ONCOL, V28, P655, DOI 10.1200/JCO.2009.22.8635; Roberts SE, 2018, PSYCHOL MED, V48, P578, DOI 10.1017/S0033291717001787; Robson A, 2010, PSYCHO-ONCOLOGY, V19, P1250, DOI 10.1002/pon.1717; Savic G, 2018, SPINAL CORD, V56, P2, DOI 10.1038/sc.2017.98; Schneider KL, 2008, J PSYCHOSOC ONCOL, V26, P49, DOI 10.1300/J077v26n02_04; Semple CJ, 2004, CANCER NURS, V27, P434; Shneidtnan E, 1985, DEFINITION SUICIDE; Shrum J M, 2014, BMJ Case Rep, V2014, DOI 10.1136/bcr-2014-204589; Singh S, 2017, J AM ACAD DERMATOL, V77, P425, DOI 10.1016/j.jaad.2017.05.019; Stanley IH, 2017, J PSYCHIATR RES, V84, P161, DOI 10.1016/j.jpsychires.2016.10.004; Starinec N. G., 2013, MEZHDUNARODNYJ NEVRO, V6, P60; Strada E. A., 2009, PRIM PSYCHIAT, V16, P49; Suarez-Almazor ME, 2002, J CLIN ONCOL, V20, P2134, DOI 10.1200/JCO.2002.08.025; Tang KT, 2015, PSYCHOSOMATICS, V56, P190, DOI 10.1016/j.psym.2014.05.020; Tang NKY, 2006, PSYCHOL MED, V36, P575, DOI 10.1017/S0033291705006859; Teasdale TW, 2001, J EPIDEMIOL COMMUN H, V55, P863, DOI 10.1136/jech.55.12.863; Terentyeva Z. M., 2007, THESIS; Titova Y. A., 2014, THESIS; Trevino KM, 2014, PSYCHO-ONCOLOGY, V23, P936, DOI 10.1002/pon.3505; Urban D, 2013, CHEST, V144, P1245, DOI 10.1378/chest.12-2986; van der Lee ML, 2005, J CLIN ONCOL, V23, P6607, DOI 10.1200/JCO.2005.14.308; Van Orden KA, 2010, PSYCHOL REV, V117, P575, DOI 10.1037/a0018697; VISKUM K, 1975, ACTA PSYCHIAT SCAND, V51, P221, DOI 10.1111/j.1600-0447.1975.tb11088.x; Vojceh V. F, 2007, PSIHOSOMATICHESKIE R, P149; Vyssoki B, 2015, J AFFECT DISORDERS, V175, P287, DOI 10.1016/j.jad.2015.01.028; Walker J, 2008, J CLIN ONCOL, V26, P4725, DOI 10.1200/JCO.2007.11.8844; Wang B, 2017, EUR J ENDOCRINOL, V177, pR169, DOI 10.1530/EJE-16-0952; Wassermann D., 2009, SUICIDOLOGY SUICIDE, P293; World Health Organization, PREV SUIC GLOB IMP; Wu JJ, 2017, J EUR ACAD DERMATOL, V31, P1168, DOI 10.1111/jdv.14175; Wu VCC, 2018, J AFFECT DISORDERS, V238, P187, DOI 10.1016/j.jad.2018.05.046; Yamauchi T, 2016, DIABETES METAB, V42, P184, DOI 10.1016/j.diabet.2015.11.008; Yamauchi T, 2014, PSYCHOSOM MED, V76, P452, DOI 10.1097/PSY.0000000000000079; Yousaf U, 2005, BRIT J CANCER, V92, P995, DOI 10.1038/sj.bjc.6602424; Zhang L., 2017, BMC PSYCHIATRY, V14, P17; Zotov P. B, 2017, SIBERIAN J PSYCHIAT, V2, P110; Zotov P. B, 2018, ACAD J W SIBERIA, V14, P76; Zotov P. B., 2011, SUICIDOLOGY, V2, P18; Zotov P. B, 2013, ACAD J W SIBERIA, V9, P70; Zotov P.B., 2005, THESIS; Zotov P. B, 2001, PALLIATIVE CARE REHA, V2-3, P20; Zykov V.V., 2013, TYUMEN MED J, V15, P5	138	1	1	1	10	TYUMEN STATE MEDICAL ACAD	BELGOROD	RM 1, ST PODEBY 69A, BELGOROD, 00000, RUSSIA	2224-1264			SUICIDOLOGY	Suicidology		2018	9	4					85	108		10.32878/suiciderus.18-09-04(33)-85-108			24	Psychology, Multidisciplinary	Emerging Sources Citation Index (ESCI)	Psychology	HJ5HG	WOS:000457208800008		gold			2022-02-06	
J	Zwemer, E; Bernson-Leung, M; Rea, C; Patel, AA; Guerriero, R; Urion, DK; Toomey, SL				Zwemer, Eric; Bernson-Leung, Miya; Rea, Corinna; Patel, Archana A.; Guerriero, Rejean; Urion, David K.; Toomey, Sara L.			Education on the Brain: A Partnership Between a Pediatric Primary Care Center and Neurology Residency	CLINICAL PEDIATRICS			English	Article						medical education; pediatric neurology; resident training; innovation	MEDICAL-EDUCATION	The national shortage of pediatric neurologists is worsening, yet referral rates by pediatricians are high. Suboptimal training of pediatric residents in care of patients with neurologic disease may be a contributing factor. We formed a partnership between the Boston Children's Primary Care at Longwood clinic and Child Neurology Residency Training Program. The educational intervention included lectures, observed neurologic examinations, in-person and virtual triage, and an electronic medical record-based consult system. Residents in other primary care clinics served as the comparison group. Intervention-group residents reported significantly improved confidence in diagnosis of chronic/recurrent headache, attention deficit hyperactivity disorder (ADHD), and developmental delay; initial management of ADHD and developmental delay; and secondary management of ADHD, developmental delay, and concussion/traumatic brain injury. Comparison-group residents reported significantly improved confidence only in diagnosis of developmental delay. Our multipronged intervention is a promising approach to improving pediatric resident training in pediatric neurology and may be generalizable to subspecialty collaborations for other residency programs.	[Zwemer, Eric] Univ N Carolina, Sch Med, Dept Pediat, Chapel Hill, NC USA; [Bernson-Leung, Miya; Patel, Archana A.; Urion, David K.] Boston Childrens Hosp, Dept Neurol, Boston, MA USA; [Bernson-Leung, Miya; Rea, Corinna; Patel, Archana A.; Urion, David K.; Toomey, Sara L.] Harvard Med Sch, Boston, MA USA; [Rea, Corinna; Toomey, Sara L.] Boston Childrens Hosp, Dept Med, Boston, MA USA; [Guerriero, Rejean] St Louis Childrens Hosp, Dept Neurol, St Louis, MO 63178 USA; [Guerriero, Rejean] Washington Univ, Sch Med, St Louis, MO USA		Zwemer, E (corresponding author), Univ N Carolina, Childrens Hosp, Dept Pediat, Div Gen Pediat & Adolescent Med, 101 Manning Dr, Chapel Hill, NC 27514 USA.	eric_zwemer@med.unc.edu		Guerriero, Rejean/0000-0001-7788-6661; Patel, Archana A/0000-0002-1159-0128; Bernson-Leung, Miya/0000-0002-7766-2323	HMS Center for Primary Care's Academic Innovations Collaborative (AIC); Boston Children's Hospital	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the HMS Center for Primary Care's Academic Innovations Collaborative (AIC) and Boston Children's Hospital.	Agarwal RL, 2014, CLIN PEDIATR, V53, P682, DOI 10.1177/0009922814528280; Bale JF, 2009, J PEDIATR-US, V154, P602, DOI 10.1016/j.jpeds.2008.10.021; Dall TM, 2013, NEUROLOGY, V81, P470, DOI 10.1212/WNL.0b013e318294b1cf; Grant E, 2007, ACAD MED, V82, P304, DOI 10.1097/ACM.0b013e31803080c8; Maria B. L., 2009, CURRENT MANAGEMENT C; MARIA BL, 1993, J CHILD NEUROL, V8, P73, DOI 10.1177/088307389300800110; Mehta NB, 2013, ACAD MED, V88, P1418, DOI 10.1097/ACM.0b013e3182a36a07; Shaw T, 2011, J CONTIN EDUC HEALTH, V31, P103, DOI 10.1002/chp.20113; Turchi Renee M, 2009, Pediatrics, V124 Suppl 4, pS428, DOI 10.1542/peds.2009-1255O; Vernacchio L, 2012, HEALTH SERV RES, V47, P1755, DOI 10.1111/j.1475-6773.2012.01391.x; Werner RM, 2005, J PEDIATR-US, V146, P20, DOI 10.1016/j.jpeds.2004.08.061	11	1	1	0	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0009-9228	1938-2707		CLIN PEDIATR	Clin. Pediatr.	JAN	2018	57	1					46	51		10.1177/0009922817691819			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	FO4NN	WOS:000416821600010	28952326				2022-02-06	
J	Zwick, M; Carney, N; Nettleton, R				Zwick, Martin; Carney, Nancy; Nettleton, Rosemary			Exploratory reconstructability analysis of accident TBI data	INTERNATIONAL JOURNAL OF GENERAL SYSTEMS			English	Article						Reconstructability analysis; machine learning; OCCAM; information theory; traumatic brain injury; health care analytics	TRAUMATIC BRAIN-INJURY	This paper describes the use of reconstructability analysis to perform a secondary study of traumatic brain injury data from automobile accidents. Neutral searches were done and their results displayed with a hypergraph. Directed searches, using both variable-based and state-based models, were applied to predict performance on two cognitive tests and one neurological test. Very simple state-based models gave large uncertainty reductions for all three DVs and sizeable improvements in percent correct for the two cognitive test DVs which were equally sampled. Conditional probability distributions for these models are easily visualized with simple decision trees. Confounding variables and counter-intuitive findings are also reported.	[Zwick, Martin] Portland State Univ, Syst Sci Program, Portland, OR 97207 USA; [Carney, Nancy] Oregon Hlth & Sci Univ, Sch Med, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA; [Nettleton, Rosemary] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA		Zwick, M (corresponding author), Portland State Univ, Syst Sci Program, Portland, OR 97207 USA.	zwick@pdx.edu			US Army Contracting Command, Aberdeen Proving Ground, Natick Contracting Division [W911 QY-14-C-0086]	This work was supported by the US Army Contracting Command, Aberdeen Proving Ground, Natick Contracting Division [contract number W911 QY-14-C-0086] awarded to Stanford University, with a subcontract award to the Brain Trauma Foundation, and a second-tier subcontract awarded to Portland State University.	Ashby W. R., 1964, GENERAL SYSTEMS YB, V9, P99; Johnson M., 2000, P WORLD C SYST SCI I; Johnson Michael W., 2005, THESIS; JONES B, 1985, INT J GEN SYST, V11, P133, DOI 10.1080/03081078508934905; Klir G., 1985, ARCHITECTURE SYSTEMS, DOI [10.1007/978-1-4757-1168-4, DOI 10.1007/978-1-4757-1168-4]; KLIR GJ, 1986, SYST RES, V3, P267, DOI 10.1002/sres.3850030410; Krippendorff K., 1986, QUANTITATIVE APPL SO, V62; National Center for Injury Prevention and Control Division of Unintentional Injury Prevention Epidemiology and Rehabilitation, 2015, CTR DIS CONTR PREV R; Preece M. H. W., 2012, THESIS; Preece MHW, 2013, BRAIN INJURY, V27, P83, DOI 10.3109/02699052.2012.722260; Preece MHW, 2011, J NEUROL NEUROSUR PS, V82, P447, DOI 10.1136/jnnp.2010.215228; Preece MHW, 2010, NEUROPSYCHOLOGY, V24, P493, DOI 10.1037/a0018903; Samadani U., 2016, NEUROSURGEON, V5; Willett K, 2004, KYBERNETES, V33, P997, DOI 10.1108/03684920410534047; Zwick M, 2004, KYBERNETES, V33, P877, DOI 10.1108/03684920410533958; Zwick M, 2004, KYBERNETES, V33, P1041, DOI 10.1108/03684920410534092; Zwick M, 2011, ANN HUM GENET, V75, P157, DOI 10.1111/j.1469-1809.2010.00628.x	17	1	1	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0308-1079	1563-5104		INT J GEN SYST	Int. J. Gen. Syst.		2018	47	2					174	191		10.1080/03081079.2017.1412435			18	Computer Science, Theory & Methods; Ergonomics	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering	FU4UT	WOS:000423848800005		Green Submitted			2022-02-06	
J	Arbour, C; Gosselin, N; Levert, MJ; Gauvin-Lepage, J; Michallet, B; Lefebvre, H				Arbour, Caroline; Gosselin, Nadia; Levert, Marie-Josee; Gauvin-Lepage, Jerome; Michallet, Bernard; Lefebvre, Helene			Does age matter? A mixed methods study examining determinants of good recovery and resilience in young and middle-aged adults following moderate-to-severe traumatic brain injury	JOURNAL OF ADVANCED NURSING			English	Article						age; nursing; recovery; resilience; traumatic brain injury	PSYCHOSOCIAL ADJUSTMENT; POSTTRAUMATIC AMNESIA; IMPACT; SCALE; RISK; MULTICENTER; EXPERIENCE; MORTALITY; OUTCOMES; STRESS	Aim: To examine whether age contributes to functional recovery and resilience after moderate-to-severe traumatic brain injury. Background: The ability to recover may change across the lifespan, but the influence of age on brain injury outcome is understudied. Design: Mixed methods study. Methods: All adults of working age (18-64 years) discharged from a level I trauma centre between 2010-2013 after sustaining a moderate-to-severe traumatic brain injury were considered. Functional recovery was assessed during a telephone interview with the Glasgow Outcome Scale-Extended 12-36 months postinjury. A subgroup completed the Connor-Davidson Resilience Scale and a face-to-face interview about resilience. Results: Ninety-seven young (mean age: 27 years; 75% male) and 47 middle-aged brain trauma survivors (mean age: 53 years; 75% male) completed the telephone interview. Eight young and five middle-aged adults were also assessed for resilience. Overall, young participants experienced more severe head injuries. Yet, they achieved slightly higher levels of functional recovery compared with middle-aged ones as per the Glasgow Outcome Scale-Extended. Controlling for CT scan findings and posttraumatic amnesia duration, age was not found to be associated to functional recovery in adults of working age. Although both groups showed similar levels of resilience, young participants discussed the challenges related to "having more time on their hands" and "being a changed person", two elements perceived positively by middle-aged ones. Conclusion: While age does not appear to interfere with functional recovery in adults of working age, younger brain trauma survivors could benefit from nursing interventions to strengthen their resilience process related to re-employment orientation and identity.	[Arbour, Caroline; Levert, Marie-Josee; Gauvin-Lepage, Jerome; Lefebvre, Helene] Univ Montreal, Fac Nursing, Montreal, PQ, Canada; [Gosselin, Nadia] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Michallet, Bernard] Univ Quebec Trois Rivieres, Dept Speech & Language Therapy, Trois Rivieres, PQ, Canada		Arbour, C (corresponding author), Univ Montreal, Fac Nursing, Montreal, PQ, Canada.	caroline.arbour@umontreal.ca	Gauvin-Lepage, Jerome/AAD-6699-2020		Canadian Institute of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Fonds de la Recherche du Quebec-Sante (FRQ-S); Quebec Rehabilitation Research Network postdoctoral fellowship	This study was supported by the Canadian Institute of Health Research (CIHR; Operating grant to Nadia Gosselin and a postdoctoral fellowship to C. ARBOUR) and by the Fonds de la Recherche du Quebec-Sante (FRQ-S; Salary award to N. GOSSELIN). This study was also supported by a Quebec Rehabilitation Research Network postdoctoral fellowship awarded to C. ARBOUR. For the remaining authors, no sources of funding were declared.	Aburn G, 2016, J ADV NURS, V72, P980, DOI 10.1111/jan.12888; American Psychological Association, 2014, ROAD RES; Arbour C, 2016, CRIT CARE MED, V44, pE1186, DOI 10.1097/CCM.0000000000001960; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Beck C T, 1993, West J Nurs Res, V15, P263, DOI 10.1177/019394599301500212; Charmaz K., 2014, BROKERAGE CLOSURE IN; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Cooney Adeline, 2011, Nurse Res, V18, P17; Creswell J.W., 2003, HDB MIXED METHODS SO, P209; Crump C, 2016, DIABETOLOGIA, V59, P728, DOI 10.1007/s00125-015-3846-7; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; Diehl M, 2010, DEV PSYCHOL, V46, P1132, DOI 10.1037/a0019937; El-Matbouly M, 2013, SCI WORLD J, DOI 10.1155/2013/354920; Faul M, 2010, TRAUMATIC BRAIN INJU; Felten B S, 2000, Clin Nurs Res, V9, P102; Folkman S., 1984, STRESS; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Hardy SE, 2004, J AM GERIATR SOC, V52, P257, DOI 10.1111/j.1532-5415.2004.52065.x; Hinck S, 2004, QUAL HEALTH RES, V14, P779, DOI 10.1177/1049732304265774; Holland JN, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/902802; Mena JH, 2011, J TRAUMA, V71, P1185, DOI 10.1097/TA.0b013e31823321f8; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Klonoff P., 2014, PSYCHOTHERAPY BRAIN; Kreutzer JS, 2016, ARCH PHYS MED REHAB, V97, P708, DOI 10.1016/j.apmr.2015.12.003; Lamond AJ, 2008, J PSYCHIATR RES, V43, P148, DOI 10.1016/j.jpsychires.2008.03.007; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; Lee HS, 2008, J IMMIGR MINOR HEALT, V10, P415, DOI 10.1007/s10903-007-9104-4; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Livingston DH, 2005, J TRAUMA, V59, P1298, DOI 10.1097/01.ta.0000196002.03681.18; MacLeod S, 2016, GERIATR NURS, V37, P266, DOI 10.1016/j.gerinurse.2016.02.014; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89; Mehta M, 2008, INT J GERIATR PSYCH, V23, P238, DOI 10.1002/gps.1868; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Montross LP, 2006, AM J GERIAT PSYCHIAT, V14, P43, DOI 10.1097/01.JGP.0000192489.43179.31; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Nygren B, 2005, AGING MENT HEALTH, V9, P354, DOI 10.1080/1360500114415; Nygren B, 2007, QUAL HEALTH RES, V17, P1060, DOI 10.1177/1049732307306922; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Raj R, 2014, CRIT CARE, V18, DOI 10.1186/cc13814; Roy DE, 2012, J ADV NURS, V68, P181, DOI 10.1111/j.1365-2648.2011.05830.x; Schulz-Heik RJ, 2016, BRAIN INJURY, V30, P271, DOI 10.3109/02699052.2015.1113567; Smith TW, 2006, ANNU REV CLIN PSYCHO, V2, P435, DOI 10.1146/annurev.clinpsy.2.022305.095257; Tabachnick BG, 2007, USING MULTIVARIATES, V5th; Tate RL, 1999, PSYCHOL MED, V29, P713, DOI 10.1017/S0033291799008466; TEASDALE G, 1974, LANCET, V2, P81; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Toukhsati SR, 2017, EUR J CARDIOVASC NUR, V16, P64, DOI 10.1177/1474515116640412; Tuckett Anthony G, 2004, Nurse Res, V12, P47; Walker WC, 2010, J NEUROL NEUROSUR PS, V81, P87, DOI 10.1136/jnnp.2008.161570; Wells M., 2010, ONLINE J RURAL NURSI, V10, P45, DOI [10.14574/ojrnhc.v10i2.55, DOI 10.14574/OJRNHC.V10I2.55]; Willemse-Van Son AHP, 2009, J REHABIL MED, V41, P521, DOI 10.2340/16501977-0377; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540; Zador Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158762; Zafonte RD, 1997, ARCH PHYS MED REHAB, V78, P1103, DOI 10.1016/S0003-9993(97)90135-0	56	1	2	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0309-2402	1365-2648		J ADV NURS	J. Adv. Nurs.	DEC	2017	73	12					3133	3143		10.1111/jan.13376			11	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	FQ4YO	WOS:000418365200034	28677245	Green Submitted			2022-02-06	
J	Boop, FA				Boop, Frederick A.			THE 2017 AANS PRESIDENTIAL ADDRESS A world of innovation	JOURNAL OF NEUROSURGERY			English	Article						neurosurgery; presidential address; AANS	TRAUMATIC BRAIN-INJURY; HISTORICAL VIGNETTE; TRIAL; OUTCOMES	The 2016 scientific meeting of the American Association of Neurological Surgeons (AANS) focused on the theme "A World of Innovation." In his presidential address, 2016 AANS President Frederick Boop compared the historical development of the specialty of neurological surgery with that of the development of global communications. In the early years, general surgeons training in the United States would spend post-residency time abroad learning from surgical masters in Europe and other places. Since Harvey Cushing's day, neurosurgeons from around the world continue to travel abroad, with many now coming to America for training at centers of excellence. Current clinical practice is defined by multi-national, multi-center clinical trials, and the AANS subsidiary NeuroPoint Alliance has positioned itself to serve as an international center for the oversight of such trials. The Neurosurgery Research & Education Foundation and the Journal of Neurosurgery Publishing Group have made it possible for a neurosurgeon anywhere with Internet access to learn relevant surgical anatomy, learn new neurosurgical procedures, and watch masters in the field perform operations via high-definition surgical videos at no cost via learning platforms such as the Rhoton Collection, the Neurosurgical Atlas, and Neurosurgical Focus video supplements. At the same time, patients are now traveling abroad to seek medical specialty care. Although the globalization of health care poses certain threats, it also presents neurosurgeons with a world of opportunities.	[Boop, Frederick A.] Univ Tennessee, Hlth Sci Ctr, Dept Neurosurg, Memphis, TN 38163 USA; [Boop, Frederick A.] Semmes Murphey Neurol & Spine Inst, 6325 Humphreys Blvd, Memphis, TN 38120 USA		Boop, FA (corresponding author), Semmes Murphey Neurol & Spine Inst, 6325 Humphreys Blvd, Memphis, TN 38120 USA.	frederickboop@gmail.com					Benabid AL, 2009, LANCET NEUROL, V8, P67, DOI 10.1016/S1474-4422(08)70291-6; Bliss M., 2005, HARVEY CUSHING LIFE; Bucy PC, 1985, NEUROSURGICAL GIANTS; Burgess M, 2016, WIRED; Burns B, ATLANTIC CABLE; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; CUSHING H, 1931, NEW ENGL J MED, V204, P1235; Daly M, 2011, HEALTHCARE FINANCE; Debonne Y, 1993, MODERN MARVELS TRANS; Fehlings MG, 2015, SPINE, V40, P1322, DOI 10.1097/BRS.0000000000000988; Fritzell P, 2001, SPINE, V26, P2521, DOI 10.1097/00007632-200112010-00002; GREENBLATT SH, 1991, J NEUROSURG, V75, P808, DOI 10.3171/jns.1991.75.5.0808; Horowitz Michael D, 2007, MedGenMed, V9, P33; Ito J., 2016, WHIPLASH SURVIVE OUR; Kimmell KT, 2013, J NEUROSURG, V119, P789, DOI 10.3171/2013.4.JNS121520; Kolata G, 2017, NY TIMES, pA17; Lenke LG, 2016, SPINE, V41, P204, DOI 10.1097/BRS.0000000000001338; Mathews MS, 2008, J NEUROSURG, V108, P608, DOI 10.3171/JNS/2008/108/3/0608; Molyneux AJ, 2005, LANCET, V366, P809, DOI 10.1016/S0140-6736(05)67214-5; National Resident Matching Program, 2017, NAT RES MATCH PROGR; Oppenheim H, 1909, DEUT MED WOCHENSCHR, V35, P697, DOI 10.1055/s-0029-1201407; Quest D, HIST SOC NEUROLOGICA; Segouin C, 2005, INT J QUAL HEALTH C, V17, P277, DOI 10.1093/intqhc/mzi059; Shanafelt TD, 2015, MAYO CLIN PROC, V90, P1600, DOI 10.1016/j.mayocp.2015.08.023; SMITH FP, 1962, J NEUROSURG, V19, P609, DOI 10.3171/jns.1962.19.7.0609; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Walker AE, 1951, HIST NEUROLOGICAL SU; Wang Y, 2013, TIME; Zaidi HA, 2017, NEUROSURGERY, V80, P146, DOI 10.1093/neuros/nyw009	30	1	1	0	8	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	DEC	2017	127	6					1203	1212		10.3171/2017.7.JNS171329			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FO5KM	WOS:000416895700001	29191125	hybrid			2022-02-06	
J	Dadkhah, B; Faramarzi, AS; Amri, P; Mohammadi, MA				Dadkhah, Behrouz; Faramarzi, Asieh Shabani; Amri, Parviz; Mohammadi, Mohammad Ali			Comparison of Changes in Arterial Blood Oxygen Saturation and Occurrence of Cardiac Dysrhythmia in Patients with Head Trauma undergoing Open and Closed Suction	JOURNAL OF RESEARCH IN MEDICAL AND DENTAL SCIENCE			English	Article						Head Trauma; Open Suctioning; Closed Suctioning; Arterial Blood Oxygen Saturation; Cardiac Dysrhythmia		Endotracheal suctioning is one of the most important care that done continuously in patient with Brain injuries. Type of suctioning affected on the hemodynamic status of patients, this study was performed with the aim of comparing changes in Arterial Blood Oxygen Saturation and Occurrence of Cardiac Dysrhythmia in head trauma patients with open and closed suction. In this cross-over clinical trial study, 88 patients who under mechanical ventilator were enrolled randomly divided into two groups. Closed and open suctioning each done for each patient and changes on Arterial Blood Oxygen Saturation and Occurrence of Cardiac Dysrhythmia at intervals before, during. Immediately, five, ten and fifteen minutes by using paired t-test, ANOVA with repeated data and Fisher's exact test were performed by software SPSS version 22. 88 patients with ranging from 15 to 45were enrolled. 68% of patients were male. The most cause of head injury was car accident (75%) that the most frequent CT scan findings associated with intraventricular hemorrhage (22%). The occurrence of Cardiac Dysrhythmia and changes on Arterial Blood Oxygen Saturation was more in open method of endotracheal suctioning. There were significant relationships between Arterial Blood Oxygen Saturation and occurrence of Cardiac Dysrhythmia in Multiple time intervals with type of suctioning.(p<0.001). According to the findings, to reduce Arterial Blood Oxygen Saturation and incidence of Cardiac Dysrhythmia due to endotracheal suctioning, the use of closed suction in the intensive care unit is recommended.	[Dadkhah, Behrouz; Mohammadi, Mohammad Ali] Ardabil Univ Med Sci, Sch Nursing, Dept Nursing, Educ Nursing, Ardebil, Iran; [Faramarzi, Asieh Shabani] Ardabil Univ Med Sci, Dept Nursing, Student Res Comm, Ardebil, Iran; [Amri, Parviz] Babol Univ Med Sci, Sch Med, Dept Anesthesiol, Mazandaran, Iran		Faramarzi, AS (corresponding author), Ardabil Univ Med Sci, Dept Nursing, Student Res Comm, Ardebil, Iran.	asiehshabanifaramarzi@gmail.com	Dadkhah, Behrouz/P-1169-2017	Dadkhah, Behrouz/0000-0001-5925-2905			AF Wahlberg A., 2012, DRIVER BEHAV ACCIDEN; Afshari A, 2014, NURS MIDWIFERY STUD, V3, DOI 10.17795/nmsjournal14097; Akgul S, 2002, J CLIN NURS, V11, P826, DOI 10.1046/j.1365-2702.2002.00655.x; Alipour N, 2015, J EVIDENCE CARE, V3; [Anonymous], 2002, TRAUMA NURSING; Asgari M, 2004, INTENSIVE NURSING CA; Chulay M, 2010, AACN ESSENTIAL CRITI; Crisp L, 2005, FUNDAMENTALS NURSING; Davaei M, 2009, EMERGENCY SURG UROLO; Etemadifar s, 2008, IRAN J NURSING, V21, P31; jedi F Rangraz, 2001, KASHAN U MED SCI J, V6, P88; Jongerden IP, 2012, J CRIT CARE, V27, P647, DOI 10.1016/j.jcrc.2012.02.016; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; Lee Eun-Sook, 2004, Taehan Kanho Hakhoe Chi, V34, P1315; McQuillan KA, 2008, TRAUMA NURSING RESUS; Merri A, 2012, BOOK CRITICAL CARE T, V3, P161; Miller R.D., 2011, BASICS OF ANESTHESIA; Mofrad MN, 2013, INTENSIVE CARE ICU; Nazmieh H, 2010, J RAFSANJAN U MED SC, V9; Ozen D, 2014, EFFECTS OPEN CLOSE S; Rafiei MR, 2013, J ESFAHAN MED SCH, V26; Saxena S, 2006, WORLD PSYCHIATRY, V5, P179; Seyed Mazhari M, 2010, J CRITICAL CARE NURS, V2, P133; Sharma BR, 2005, INJURY, V36, P579, DOI 10.1016/j.injury.2004.09.009; Soleimani H, 2001, J KERMANSHAH U MED S, V4, P65; Stackhouse RA, 2007, BASICS OF ANESTHESIA, P231; Zolfaghari M., 2008, HAYAT, V14, P13	27	1	1	0	2	AMBER PUBLICATION	GUJARAT	402, PARIJAT APT, WALKESHWARI NAGAR, JAMNAGAR, GUJARAT, 361 008, INDIA	2347-2545	2347-2367		J RES MED DENT SCI	J. Res. Med. Dent. Sci.	DEC	2017	5	6					89	94		10.24896/jrmds.20175616			6	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	FS0HZ	WOS:000419456000016					2022-02-06	
J	Fan, E; Skippen, PW; Sargent, MA; Cochrane, DD; Chanoine, JP				Fan, Eileen; Skippen, Peter W.; Sargent, Michael A.; Cochrane, David D.; Chanoine, Jean-Pierre			Central adrenal insufficiency following traumatic brain injury: a missed diagnosis in the critically injured	CHILDS NERVOUS SYSTEM			English	Article						Hypopituitarism; Central adrenal insufficiency; Hydrocortisone; Pediatrics; Brain injury; Adrenal cortex function tests	DYSFUNCTION	High-dose steroid administration is no longer recommended in the treatment of acute traumatic brain injury (TBI) as it failed to prove beneficial in improving patients' outcome. However, a masked benefit of steroid administration in TBI management was that it provided corticosteroid replacement therapy in patients with TBI-related central adrenal insufficiency. We report the case of a 12-year-old boy who suffered a severe TBI from a motor vehicle accident that resulted in complete deficiency of anterior pituitary function. Central adrenal insufficiency was not ruled out by a near normal response to a low-dose ACTH test performed on D11. Consideration should be given to the empirical treatment of TBI pediatric patients with stress doses of corticosteroids if injury to the hypothalamus or pituitary gland is possible until a formal assessment of the hypothalamic-pituitary-adrenal axis can be made.	[Fan, Eileen; Chanoine, Jean-Pierre] British Columbia Childrens Hosp, Endocrinol & Diabet Unit, 4480 Oak St, Vancouver, BC V6H 3V4, Canada; [Fan, Eileen; Skippen, Peter W.; Sargent, Michael A.; Cochrane, David D.; Chanoine, Jean-Pierre] Univ British Columbia, 4480 Oak St, Vancouver, BC V6H 3V4, Canada; [Skippen, Peter W.] British Columbia Childrens Hosp, Pediat Intens Care Unit, 4480 Oak St, Vancouver, BC V6H 3V4, Canada; [Sargent, Michael A.] British Columbia Childrens Hosp, Dept Radiol, 4480 Oak St, Vancouver, BC V6H 3V4, Canada; [Cochrane, David D.] British Columbia Childrens Hosp, Div Neurosurg, 4480 Oak St, Vancouver, BC V6H 3V4, Canada		Cochrane, DD (corresponding author), Univ British Columbia, 4480 Oak St, Vancouver, BC V6H 3V4, Canada.; Cochrane, DD (corresponding author), British Columbia Childrens Hosp, Div Neurosurg, 4480 Oak St, Vancouver, BC V6H 3V4, Canada.	jchanoine@cw.bc.ca	Chanoine, Jean-Pierre/K-5026-2019	Chanoine, Jean-Pierre/0000-0002-5167-2064; Cochrane, Douglas/0000-0002-4907-4583			Brain Trauma Foundation, 2016, GUID MAN SEV TRAUM B; Dupuis C, 2010, INTENS CARE MED, V36, P1906, DOI 10.1007/s00134-010-2012-4; Fernandez-Rodriguez E, 2015, ENDOCRIN METAB CLIN, V44, P151, DOI 10.1016/j.ecl.2014.10.012; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Mirzaie B, 2013, ARCH MED SCI, V9, P68, DOI 10.5114/aoms.2012.30833; MOUNTJOY KG, 1994, MOL CELL ENDOCRINOL, V99, pR17, DOI 10.1016/0303-7207(94)90160-0; Ospina NS, 2016, J CLIN ENDOCR METAB, V101, P427, DOI 10.1210/jc.2015-1700; Reifschneider K, 2015, J CLIN MED, V4, P1536, DOI 10.3390/jcm4081536; Richmond E, 2014, ENDOCRINE, V45, P3, DOI 10.1007/s12020-013-0049-1; Tanriverdi F, 2015, ENDOCR REV, V36, P305, DOI 10.1210/er.2014-1065; Ulutabanca H, 2014, CHILD NERV SYST, V30, P1021, DOI 10.1007/s00381-013-2334-y	11	1	1	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	DEC	2017	33	12					2205	2207		10.1007/s00381-017-3536-5			3	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	FL3ST	WOS:000414144400025	28721596				2022-02-06	
J	Fatahiyah, MS; Hanapiah, FA				Fatahiyah, Siti M.; Hanapiah, F. A.			Merging the Research on Halal Concept Using Humanoids for Patient with Brain-Impairment: Its Maqasid and Principles	PERTANIKA JOURNAL OF SOCIAL SCIENCE AND HUMANITIES			English	Article						Brain-impaired; humanoid robots; Islamic perspective; rehabilitation; spiritual		There is a marked increase in survival rates of traumatic brain injury (TBI) survivors in Malaysia as a result of improved acute health care management. Humanoid robots have been proposed as a therapy option to improving TBI management. Hence, the purpose of this paper is to provide insights on the use of humanoids for augmenting therapy in a brain-impaired individual, particularly the permissibility (halal) of using Maqasid principles as a therapy option for TBI. Spirituality and religious interventions will be the main focus of the paper. Data was collected using in-depth interviews with the rehabilitation physicians and therapists as well as via library search, and literature review. Since using humanoid is a new area in rehabilitation, literature on this is scarce, particularly those that are Islamic-based or Islamic oriented. The study also examines the provision of new theories of embodied spirituality relative to humanoids and their perspectives including their impacts on society, ethics, and theological implications of their basic assumptions.	[Fatahiyah, Siti M.] Univ Teknol MARA UiTM, Acad Contemporary Islamic Studies ACIS, Shah Alam 40450, Selangor, Malaysia; [Hanapiah, F. A.] Univ Teknol MARA UiTM, Fac Med, Sungai Buloh 47000, Selangor, Malaysia		Fatahiyah, MS (corresponding author), Univ Teknol MARA UiTM, Acad Contemporary Islamic Studies ACIS, Shah Alam 40450, Selangor, Malaysia.	sitif006@salam.uitm.edu.my; fazah@salam.uitm.edu.my	Hanapiah, Fazah/AAW-8811-2021	Hanapiah, Fazah/0000-0003-3409-7210	Niche Research Grant Scheme of Epigenetics Humanoid Intervention Incorporating Religious Attribute for Brain Impairment [600-RMI/NRGS 5/3 (11/2013).]	The authors acknowledge with gratitude University Teknologi Mara, Malaysia and the Niche Research Grant Scheme of Epigenetics Humanoid Intervention Incorporating Religious Attribute for Brain Impairment (600-RMI/NRGS 5/3 (11/2013). Utmost thanks go to the members of the team for their excellent support to internalise the objectives of this study and to all members of Islamic Councils including the muftis who gave valuable comments and ideas on this research.	Al-Jauziyah Imam Ibn Qayyim, 2010, HEALING MED PROPHET; Al- Suaidan W., 2007, ISU ISU FIQH PERUBAT; Anderson V, 2012, J HEAD TRAUMA REHAB, V27, P199, DOI 10.1097/HTR.0b013e31821a9d2b; [Anonymous], 2012, MIROS ROAD FACTS; Ayad A., 2013, HEALING BODY SOUL; Duquette A, 2006, P 6 INT WORKSH EP RO, P167; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Graves J. M., 2015, AM J PUBLIC HEALTH, V5, P35; Hashim Hafizan, 2013, Applied Mechanics and Materials, V393, P567, DOI 10.4028/www.scientific.net/AMM.393.567; Jamaluddin SF, 2011, NATL TRAUMA DATABASE; Malik NA, 2015, PROCEDIA COMPUT SCI, V76, P388, DOI 10.1016/j.procs.2015.12.315; Malik NA, 2016, INT J ADV ROBOT SYST, V13, DOI 10.5772/64163; Muda A. L., 2000, PERBAHASAN KAEDAHKAE; Nasaruddin RR, 2012, ADV NATURAL APPL SCI, V6, P588; Prince CG, 2007, PEDIATR RES, V61, P383, DOI 10.1203/pdr.0b013e3180459fdd; Raskovic D, 2004, COMPUT J, V47, P495, DOI 10.1093/comjnl/47.4.495; Sadeeqa S., 2013, INT J PUBLIC HLTH SC, V2, P143; Shafie S., 2006, P INT IFSAM 8 WORLD; Shamsuddin S., 2012, 2012 IEEE 8th International Colloquium on Signal Processing & its Applications, P188, DOI 10.1109/CSPA.2012.6194716; Siti Fatahiyah M., 2010, PERUBATAN MENURUT PE; Yakub F, 2014, INT J REHABIL RES, V37, P9, DOI 10.1097/MRR.0000000000000035; Zafonte RD, 2006, J HEAD TRAUMA REHAB, V21, P403, DOI 10.1097/00001199-200609000-00005	22	1	1	1	3	UNIV PUTRA MALAYSIA PRESS	SELANGOR	SERDANG, SELANGOR, 00000, MALAYSIA	0128-7702	2231-8534		PERTANIKA J SOC SCI	Pertanika J. Soc. Sci. Humanit.	DEC	2017	25				SI		209	216					8	Social Sciences, Interdisciplinary	Emerging Sources Citation Index (ESCI)	Social Sciences - Other Topics	VH8NO	WOS:000456096900018					2022-02-06	
J	Fazeli, PL; Casaletto, KB; Woods, SP; Umlauf, A; Scott, JC; Moore, DJ				Fazeli, P. L.; Casaletto, K. B.; Woods, S. P.; Umlauf, A.; Scott, J. C.; Moore, D. J.		HNRP Group	Everyday Multitasking Abilities in Older HIV plus Adults: Neurobehavioral Correlates and the Mediating Role of Metacognition	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						HIV/AIDS; Aging; Everyday functioning; Executive functions	MEMORY-METAMEMORY DISSOCIATIONS; TRAUMATIC BRAIN-INJURY; NEUROCOGNITIVE DISORDERS; COGNITIVE DYSFUNCTION; INFECTED ADULTS; PERFORMANCE; IMPACT; AGE; INDIVIDUALS; AWARENESS	Objective: The prevalence of older adults living with HIV is rising, as is their risk for everyday functioning problems associated with neurocognitive dysfunction. Multitasking, the ability to maintain and carry out subgoals in support of a larger goal, is a multidimensional skill ubiquitous during most real-life tasks and associated with prefrontal networks that are vulnerable in HIV. Understanding factors associated with multitasking will improve characterization of HIV-associated neurocognitive disorders. Metacognition is also associated with frontal systems, is impaired among individuals with HIV, and may contribute to multitasking. Method: Ninety-nine older (>= 50 years) adults with HIV completed: the Everyday Multitasking Test (MT), a performance-based measure during which participants concurrently attempt four everyday tasks (e.g., medication management) within a time limit; a comprehensive neuropsychological battery; measures of metacognition regarding their MT performance (e.g., metacognitive knowledge and online awareness). Results: Better global neuropsychological performance (i.e., average T-score across all domains) was associated with better Everyday MT total scores (rho = 0.34; p < .001), as was global metacognition (rho = 0.37, p < .01). Bootstrapping mediation analysis revealed global metacognition was a significant partial mediator between neurocognition and Everyday MT (b = 0.09, 95% confidence interval [CI] = 0.01, 0.25). Specifically, metacognitive knowledge (but not online awareness) drove this mediation (b = 0.13, 95% CI = 0.03, 0.27). Conclusions: Consistent with findings among younger persons with HIV, neuropsychological performance is strongly associated with a complex, laboratory-based test of everyday multitasking, and metacognition of task performance was a pathway through which successful multitasking occurred. Interventions aimed at modifying metacognition to improve daily functioning may be warranted among older adults with HIV.	[Fazeli, P. L.] Univ Alabama Birmingham, Sch Nursing, Dept Family Community & Hlth Syst, Birmingham, AL USA; [Woods, S. P.; Umlauf, A.; Moore, D. J.] Univ San Diego, Dept Psychiat, 220 Dickinson St, San Diego, CA 92103 USA; [Casaletto, K. B.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Woods, S. P.] Univ Houston, Dept Psychol, Houston, TX 77004 USA; [Scott, J. C.] Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Scott, J. C.] Philadelphia VA Med Ctr, Mental Illness Res Educ & Clin Ctr VISN4, Philadelphia, PA USA		Moore, DJ (corresponding author), Univ San Diego, Dept Psychiat, 220 Dickinson St, San Diego, CA 92103 USA.	djmoore@ucsd.edu		Scott, J. Cobb/0000-0001-6538-9043; Fazeli, Pariya/0000-0001-6629-0010	California HIV/AIDS Research Program (CHRP) [ID10-SD-057]; University of California San Diego (UCSD) Stein Institute for Research on Aging; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30MH062512, N01 MH22005, HHSN271201000036C, HHSN271201000030C, P50DA026306, U01MH083506, R24MH59745]; NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K99 AG048762/R00 AG048762]; Department of Veterans AffairsUS Department of Veterans Affairs [IK2CX000772]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P01 MH076388]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [P30MH062512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R00AG048762] Funding Source: NIH RePORTER	This work was primarily supported by ID10-SD-057 from California HIV/AIDS Research Program (CHRP) (Determinants of Successful Aging Among Older HIV+ Persons, D.J. Moore, PI) and the University of California San Diego (UCSD) Stein Institute for Research on Aging Faculty Pilot Research Grant, with additional support from the following National Institutes of Health (NIH) grants: P30MH062512 (The HIV Neurobehavioral Research Center [HNRC]); N01 MH22005, HHSN271201000036C, and HHSN271201000030C (The CNS HIV Anti-Retroviral Therapy Effects Research [CHARTER]); P50DA026306 (The Translational Methamphetamine AIDS Research Center [TMARC]); U01MH083506 and R24MH59745 (California NeuroAIDS Tissue Network [CNTN]). Dr. Fazeli is supported by K99 AG048762/R00 AG048762 from NIA (A Novel Neurorehabilitation Approach for Cognitive Aging with HIV, P. Fazeli, PI). Dr. Scott's participation was supported by a Department of Veterans Affairs Career Development Award (IK2CX000772) and NIH grant P01 MH076388.	Alderman N, 2003, J INT NEUROPSYCH SOC, V9, P31, DOI 10.1017/S1355617703910046; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Beck A. T., 1996, MANUAL BECK DEPRESSI, V1; Becker JT, 2009, NEUROLOGY, V73, P1292, DOI 10.1212/WNL.0b013e3181bd10e7; Blackstone K, 2012, CLIN NEUROPSYCHOL, V26, P894, DOI 10.1080/13854046.2012.694479; Blackstone K, 2012, J INT NEUROPSYCH SOC, V18, P79, DOI 10.1017/S135561771100141X; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Casaletto KB, 2016, CLIN NEUROPSYCHOL, V30, P107, DOI 10.1080/13854046.2015.1129437; Casaletto KB, 2014, ARCH CLIN NEUROPSYCH, V29, P818, DOI 10.1093/arclin/acu061; Centers for Disease Control, 2015, 25 CDC; Cherner M, 2007, ARCH CLIN NEUROPSYCH, V22, P343, DOI 10.1016/j.acn.2007.01.009; Chiao S, 2013, AIDS RES HUM RETROV, V29, P949, DOI [10.1089/aid.2012.0229, 10.1089/AID.2012.0229]; Dreher JC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003227; Fernandez-Duque D, 2000, CONSCIOUS COGN, V9, P288, DOI 10.1006/ccog.2000.0447; Foley JM, 2013, AM J ALZHEIMERS DIS, V28, P185, DOI 10.1177/1533317512473192; Hart T, 1998, J HEAD TRAUMA REHAB, V13, P16, DOI 10.1097/00001199-199810000-00004; Hayes, 2018, INTRO MEDIATION MODE; Heaton R. K., 2002, CLIN INTERPRETATION, P181; Heaton R. K., 2004, REVISED COMPREHENSIV; Hinkin CH, 1996, J CLIN EXP NEUROPSYC, V18, P431, DOI 10.1080/01688639608408999; Kliegel M, 2000, MEM COGNITION, V28, P1041, DOI 10.3758/BF03209352; Laloyaux J, 2014, PSYCHIAT RES, V217, P163, DOI 10.1016/j.psychres.2014.03.026; Laloyaux J, 2013, PSYCHIAT RES, V210, P465, DOI 10.1016/j.psychres.2013.06.032; Mahy M, 2014, AIDS, V28, pS453, DOI 10.1097/QAD.0000000000000479; McAlister C, 2013, AGING NEUROPSYCHOL C, V20, P735, DOI 10.1080/13825585.2013.781990; Moore DJ, 2007, J PSYCHIATR RES, V41, P97, DOI 10.1016/j.jpsychires.2005.10.008; Moore RC, 2014, AIDS BEHAV, V18, P1186, DOI 10.1007/s10461-014-0743-x; Morgan EE, 2012, JAIDS-J ACQ IMM DEF, V61, P341, DOI 10.1097/QAI.0b013e31826bfc53; Mugavero MJ, 2007, AM J MED, V120, P370, DOI 10.1016/j.amjmed.2006.05.050; Nasi M, 2017, CLIN EXP IMMUNOL, V187, P44, DOI 10.1111/cei.12814; Ophir E, 2009, P NATL ACAD SCI USA, V106, P15583, DOI 10.1073/pnas.0903620106; Ownsworth T, 2010, NEUROPSYCHOL REHABIL, V20, P59, DOI 10.1080/09602010902949223; Roca M, 2011, NEUROPSYCHOLOGIA, V49, P3525, DOI 10.1016/j.neuropsychologia.2011.09.003; Rourke SB, 1999, J CLIN EXP NEUROPSYC, V21, P757, DOI 10.1076/jcen.21.6.757.852; Sacktor N, 2007, J NEUROVIROL, V13, P203, DOI 10.1080/13550280701258423; Scott JC, 2011, NEUROPSYCHOLOGY, V25, P511, DOI 10.1037/a0022491; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Simone MJ, 2009, UCSF AIDS HLTH PROJE, V24, P1; Stuss DT, 2011, J INT NEUROPSYCH SOC, V17, P759, DOI 10.1017/S1355617711000695; Thames AD, 2011, J CLIN EXP NEUROPSYC, V33, P200, DOI 10.1080/13803395.2010.499357; Thames AD, 2011, CLIN NEUROPSYCHOL, V25, P224, DOI 10.1080/13854046.2010.539577; Toglia J, 2000, NEUROREHABILITATION, V15, P57; United States Senate Special Committee on Aging, 2013, 113 C 1 SESS SEPT 18; Valcour V, 2004, NEUROLOGY, V63, P822, DOI 10.1212/01.WNL.0000134665.58343.8D; Valcour VG, 2005, JAIDS-J ACQ IMM DEF, V38, P31, DOI 10.1097/00126334-200501010-00006; Vance DE, 2011, J ASSOC NURSE AIDS C, V22, P17, DOI 10.1016/j.jana.2010.04.002; VANGORP WG, 1991, J CLIN EXP NEUROPSYC, V13, P812, DOI 10.1080/01688639108401091; Wendelken LA, 2012, J NEUROVIROL, V18, P256, DOI 10.1007/s13365-012-0094-1; WITTCHEN HU, 1994, J PSYCHIAT RES, V28, P57, DOI 10.1016/0022-3956(94)90036-1; Wood E, 2012, COMPUT EDUC, V58, P365, DOI 10.1016/j.compedu.2011.08.029; Woods SP, 2009, NEUROPSYCHOL REV, V19, P152, DOI 10.1007/s11065-009-9102-5	51	1	1	0	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	DEC	2017	32	8					917	928		10.1093/arclin/acx047			12	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	FN7AS	WOS:000416170000001	28575231	Bronze, Green Published			2022-02-06	
J	Hardy, R; Jordan, T; Wolf, A; Johnson, M; Brand, J				Hardy, Richard; Jordan, Torri; Wolf, Allison; Johnson, Matteus; Brand, Jefferson			Concussions and Their Effects on Performance Measures of Major League Soccer Players: A Teaching Tool for Physical Education Teachers	PHYSICAL EDUCATOR-US			English	Article							BRAIN-INJURY; SCHOOL; SPORTS	Concussions are a brain injury that affects the athlete on and off the playing field. The aim of our investigation was to give PE teachers another strategy to use in addition to the recommended approaches set forth by national organizations to convey the message to adolescents regarding the negative effects of concussion. Using the website www. mlssoccer. com, we evaluated the performance measures of MLS players. We compared career performance measures of a control group to the career performance measures of a concussed group, compared career performance measures per position, and compared career performance measures occurring prior to concussion onset to performance measures obtained after concussion occurrence for the concussed group. Of the 2,214 listed players, 288 were eligible for the study. From our sample, 34% sustained a concussion while competing in MLS and 66% were placed in the control group (nonconcussed). In a comparison of the control to the concussed group, total number of shots decreased per season for the concussed group. When the performance measures of both groups were compared by position, midfielders had fewer shots per season, and total shots on goal per season had a trend toward statistical significance. In the comparison of games measures before and after concussion, the total number of seasons and the average games played, total minutes, and shots on goal all decreased per season after concussion occurrence. Concussions negatively affected performance measures of MLS players. PE teachers can use this data to engage with their students about the importance of preventing concussions.	[Hardy, Richard] Douglas Cty Hosp, Res, Alexandria, MN 56308 USA; [Jordan, Torri; Wolf, Allison; Johnson, Matteus] Univ Minnesota, Morris, MN 56267 USA; [Brand, Jefferson] Heartland Orthoped Specialists, Alexandria, MN 56308 USA		Hardy, R (corresponding author), Douglas Cty Hosp, Res, Alexandria, MN 56308 USA.	hardyr@morris.umn.edu					Bramley H, 2012, CLIN PEDIATR, V51, P332, DOI 10.1177/0009922811425233; Centers for Disease Control and Prevention, SAR STOR CONC CAN AF; Centers for Disease Control and Prevention, PHYS ED TEACH AR INV; Centers for Disease Control and Prevention, CONC TRAIN COACH; Fantz A., 2015, CHRIS BORLAND 24 RET; Kohl H. W., 2013, ED STUD BOD TAK PHYS; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; Michigan Action for Healthy Kids, 2005, TIPS TOOLS PROM PHYS; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rink J, 2010, SCHOOLWIDE PHYS ACTI; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Sarmiento K, 2010, J SCHOOL HEALTH, V80, P112, DOI 10.1111/j.1746-1561.2010.00491.x; Schad J., 2015, J MILLER IM READY WA; Theadom A, 2014, J SCI MED SPORT, V17, P591, DOI 10.1016/j.jsams.2014.02.001; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832	17	1	1	0	0	SAGAMORE PUBL LLC	URBANA	1807 N FEDERAL DR, URBANA, IL 61801 USA	2160-1682			PHYS EDUC-US	Phys. Educ.-US	WIN	2017	74	1					150	163		10.18666/TPE-2017-V74-I1-6830			14	Education & Educational Research	Emerging Sources Citation Index (ESCI)	Education & Educational Research	GN2CX	WOS:000438805900008					2022-02-06	
J	Jang, SH; Seo, JP				Jang, Sung Ho; Seo, Jeong Pyo			Delayed degeneration of the left fornical crus with verbal memory impairment in a patient with mild traumatic brain injury: A case report	MEDICINE			English	Article						diffusion tensor tractography; fornical crus; mild traumatic brain injury; verbal memory	DIFFUSION TENSOR TRACTOGRAPHY; INDUCED AXONAL INJURY; BILATERAL INJURY	Rationale:We report on a patient who showed delayed degeneration of the left fornical crus with verbal memory impairment following mild traumatic brain injury (TBI), which was demonstrated by diffusion tensor tractography (DTT).Patient concerns:fter flexion and hyperextension of her head to the opposite side, the patient experienced a dazed feeling for a while at the time of head trauma. The patient's Glasgow Coma Scale score was 15, and mini-mental state examination score was 30.Diagnoses:A 50-year-old right-handed female with 12 years of education suffered from head trauma resulting from a car accident.Interventions:A The patient showed normal memory function at one year after onset: the Memory Assessment Scale (global memory: 124 (95 percentile (%ile)), verbal memory: 111 (77%ile), and visual memory: 132 (98%ile) (A percentile is a measure used in statistics indicating the value below which a given percentage of observations in a group of observations fall). However, the patient began to experience decline of memory function such as forgetfulness at approximately 1.5 years after onset. On the 2-year evaluation, she showed decrement of memory function (global memory: 108 (70%ile), verbal memory: 86 (18%ile), and visual memory: 129 (97%ile).Outcomes:On 1-year DTT, the integrity of the fornix was well preserved between the fornical column and fornical crus. However, on 2-year DTT, a discontinuation was observed in the left fornical crus.Lessons:Delayed degeneration of the left fornical crus was demonstrated in a patient who showed delayed onset of verbal memory impairment following mild TBI.	[Jang, Sung Ho; Seo, Jeong Pyo] Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, 317-1 Daemyungdong, Daegu 705717, South Korea		Seo, JP (corresponding author), Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, 317-1 Daemyungdong, Daegu 705717, South Korea.	raphael0905@hanmail.net			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2016R1A6A3A11933121]	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2016R1A6A3A11933121).	Adnan A, 2013, BRAIN INJURY, V27, P1415, DOI 10.3109/02699052.2013.823659; Aggleton J. P., 1999, BEHAV BRAIN SCI, V22, P444, DOI DOI 10.1017/S0140525X99422034; Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Concha L, 2005, AM J NEURORADIOL, V26, P2267; Hong JH, 2010, J REHABIL MED, V42, P979, DOI 10.2340/16501977-0603; Hong JH, 2010, EUR NEUROL, V63, P252, DOI 10.1159/000277477; Jang SH, 2015, AM J PHYS MED REHABI, V95, pe14; Jang SH, 2016, AM J PHYS MED REHAB, V95, pE75, DOI 10.1097/PHM.0000000000000451; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Lee HD, 2014, BRAIN INJURY, V28, P1485, DOI 10.3109/02699052.2014.930178; Lee HD, 2014, NEURAL REGEN RES, V9, P1313, DOI 10.4103/1673-5374.137579; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Parker GJM, 2005, PHILOS T R SOC B, V360, P893, DOI 10.1098/rstb.2005.1639; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Shiozaki T, 2001, J NEUROTRAUM, V18, P665, DOI 10.1089/089771501750357618; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Sugiyama K, 2007, BRAIN INJURY, V21, P413, DOI 10.1080/02699050701311042; TUCKER DM, 1988, CORTEX, V24, P465, DOI 10.1016/S0010-9452(88)80010-8; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Williams JM., 1991, MAS MEMORY ASSESSMEN; Yeo SS, 2013, J REHABIL MED, V45, P595, DOI 10.2340/16501977-1145	24	1	1	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	DEC	2017	96	51							e9219	10.1097/MD.0000000000009219			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT2QY	WOS:000422992300057	29390470	Green Published, gold			2022-02-06	
J	Ng, ZM; Hong, WJ; Chong, SL; Allen, JC; Loh, LE; Low, DCY; Lee, JH				Ng, Zhi Min; Hong, Wei Jie; Chong, Shu-Ling; Allen, John C., Jr.; Loh, Lik Eng; Low, David Chyi Yeu; Lee, Jan Hau			Correlation of arterial blood gas markers and lactate levels with outcomes in pediatric traumatic brain injury	PROCEEDINGS OF SINGAPORE HEALTHCARE			English	Article						Traumatic brain injury; arterial blood gas; lactate	ADMISSION BASE DEFICIT; HEAD-INJURY; PROGNOSTIC VALUE; MORTALITY; CHILDREN; FLOW; HYPOTHERMIA; PREDICTORS; HYPERVENTILATION; MANAGEMENT	Background: Various physical markers have been used to predict outcome of traumatic brain injury in children. However, the utility of metabolic alterations for prognostication has been poorly described. Thus, we aim to correlate arterial blood gas markers and lactate levels with outcomes in children with moderate to severe traumatic brain injury. Methods: This is a retrospective cohort study that included all patients < 16 years old who presented to the Emergency Department with moderate to severe traumatic brain injury (Glasgow Coma Scale. 13). Serial arterial blood gas results and lactate levels in the first five days of admission to a pediatric intensive care unit (PICU) were reviewed. Primary outcome was in-hospital mortality. Secondary outcomes were 28-day ventilator-free and PICU-free days. A stepwise logistic regression analysis in conjunction with receiver operating characteristic analysis were used to identify variables that were associated with in-hospital mortality. Secondary outcomes were analyzed using multiple linear regression. Results: Among the 43 patients analyzed, more than half of the patients (60%) had severe traumatic brain injury (Glasgow Coma Scale 8). Twenty-seven of the 43 (65%) patients underwent neurosurgical intervention and overall mortality was 9/43 (20.9%). The worst base excess and lactate levels of Day 2 of PICU stay were found to be most predictive for mortality with maximal area-under-curve (95% confidence interval) of 0.967 (0.906, 1.000). Worst lactate level on day 2 of PICU stay was also found to be associated with ventilator-free days and PICU-free days. Conclusion: In children with moderate to severe traumatic brain injury, base excess and lactate on Day 2 of PICU stay were predictors of mortality, duration of mechanical ventilation and length of PICU stay.	[Ng, Zhi Min] KK Womens & Childrens Hosp, Dept Pediat Med, 100 Bukit Timah Rd, Singapore 229899, Singapore; [Hong, Wei Jie] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore; [Chong, Shu-Ling] KK Womens & Childrens Hosp, Dept Emergency Med, Singapore, Singapore; [Chong, Shu-Ling; Loh, Lik Eng; Low, David Chyi Yeu; Lee, Jan Hau] Duke NUS Med Sch, Singapore, Singapore; [Allen, John C., Jr.] Duke NUS Med Sch, Ctr Quantitat Med, Singapore, Singapore; [Loh, Lik Eng; Lee, Jan Hau] KK Womens & Childrens Hosp, Childrens Intens Care Unit, Singapore, Singapore; [Low, David Chyi Yeu] KK Womens & Childrens Hosp, Dept Neurosurg, Singapore, Singapore		Ng, ZM (corresponding author), KK Womens & Childrens Hosp, Dept Pediat Med, 100 Bukit Timah Rd, Singapore 229899, Singapore.	ng.zhi.min@singhealth.com.sg		Lee, Jan Hau/0000-0002-8430-4217			Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; American Association for the Surgery of Trauma, 2003, J Trauma, V54, pS235; Avarello JT, 2007, EMERG MED CLIN N AM, V25, P803, DOI 10.1016/j.emc.2007.06.013; Baxter J, 2016, J TRAUMA ACUTE CARE, V81, P555, DOI 10.1097/TA.0000000000001156; Campbell CGN, 2004, CAN J NEUROL SCI, V31, P213, DOI 10.1017/S0317167100053853; Clausen T, 2005, J NEUROSURG, V103, P597, DOI 10.3171/jns.2005.103.4.0597; Curley G, 2010, CRIT CARE MED, V38, P1348, DOI 10.1097/CCM.0b013e3181d8cf2b; Curry R, 2008, PEDIATR CRIT CARE ME, V9, P141; Davis DP, 2011, PREHOSP EMERG CARE, V15, P184, DOI 10.3109/10903127.2010.545473; Dubendorfer C, 2013, EUR J TRAUMA EMERG S, V39, P25, DOI 10.1007/s00068-012-0212-z; DUNHAM CM, 1991, CRIT CARE MED, V19, P231, DOI 10.1097/00003246-199102000-00020; GEIGER A, 1947, AM J PHYSIOL, V149, P517, DOI 10.1152/ajplegacy.1947.149.3.517; GHAJAR J, 1992, PEDIATR CLIN N AM, V39, P1093; Glasgow JF, 1997, CURR PEDIAT, V7, P187; HARPER AM, 1963, J NEUROL NEUROSUR PS, V26, P341, DOI 10.1136/jnnp.26.4.341; Hindy-Francois C, 2009, J TRAUMA, V67, P1272, DOI 10.1097/TA.0b013e31819db828; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Jung J, 2009, PEDIATR EMERG CARE, V25, P579, DOI 10.1097/PEC.0b013e3181b9b38a; KETY SS, 1948, J CLIN INVEST, V27, P500, DOI 10.1172/JCI101997; Kincaid EH, 1998, J AM COLL SURGEONS, V187, P384, DOI 10.1016/S1072-7515(98)00202-6; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kuo JR, 2004, J CLIN NEUROSCI, V11, P710, DOI 10.1016/j.jocn.2003.10.011; LAMBERTSEN C, 1961, J APPL PHYSIOL, V16, P473, DOI 10.1152/jappl.1961.16.3.473; LEVIN HS, 1995, J NEUROTRAUM, V12, P913, DOI 10.1089/neu.1995.12.913; Lichtveld RA, 2007, EUR J TRAUMA EMERG S, V33, P201, DOI 10.1007/s00068-007-7001-0; Martin MJ, 2006, AM J SURG, V191, P625, DOI 10.1016/j.amjsurg.2006.02.014; McLaughlin MR, 1996, J NEUROSURG, V85, P871, DOI 10.3171/jns.1996.85.5.0871; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Ong LC, 1996, PEDIATR NEUROSURG, V24, P285, DOI 10.1159/000121057; Ouellet JF, 2012, J TRAUMA ACUTE CARE, V72, P1532, DOI 10.1097/TA.0b013e318256dd5a; Protheroe RT, 2011, ANAESTHESIA, V66, P1035, DOI 10.1111/j.1365-2044.2011.06874.x; Rahimi S, 2014, ACTA NEUROCHIR, V156, P187, DOI 10.1007/s00701-013-1929-0; Ramanathan R, 2015, J PEDIATR SURG, V50, P598, DOI 10.1016/j.jpedsurg.2014.08.013; Randolph LC, 2002, J TRAUMA, V53, P838, DOI 10.1097/00005373-200211000-00006; REIVICH M, 1964, AM J PHYSIOL, V206, P25, DOI 10.1152/ajplegacy.1964.206.1.25; Shallwani H, 2015, INT J SURG, V22, P125, DOI 10.1016/j.ijsu.2015.05.054; SIEGEL JH, 1990, ARCH SURG-CHICAGO, V125, P498; Slomovitz BM, 1998, CRIT CARE MED, V26, P1523, DOI 10.1097/00003246-199809000-00019; Soustiel JF, 2006, ACTA NEUROCHIR, V148, P845, DOI 10.1007/s00701-006-0792-7; Unterberg AW, 1997, J TRAUMA, V42, pS32, DOI 10.1097/00005373-199705001-00006; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; VICARIO SJ, 1983, ANN EMERG MED, V12, P145, DOI 10.1016/S0196-0644(83)80554-X; Yendamuri S, 2003, J TRAUMA, V55, P33, DOI 10.1097/01.TA.0000074434.39928.72	46	1	1	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2010-1058	2059-2329		PROC SINGAP HEALTHC	Proc. Singap. Healthc.	DEC	2017	26	4					246	252		10.1177/2010105817704208			7	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	FT7DX	WOS:000423314200008		gold			2022-02-06	
J	Patel, SJ; Trowbridge, CA				Patel, Sheetal J.; Trowbridge, Cynthia A.			Caregivers of youth athletes: Developing a theory-based health communication intervention for concussion education	JOURNAL OF APPLIED BIOBEHAVIORAL RESEARCH			English	Article						community-based interventions; illness; disease prevention; quality of care	SPORTS-RELATED CONCUSSION; FOR-DISEASE-CONTROL; HIGH-SCHOOL; BRAIN-INJURY; FORMATIVE RESEARCH; KNOWLEDGE; CAMPAIGN; PARENTS; HEADS	Sports-related concussions (SRCs) are a public health problem. However, caregivers of youth athletes (CYAs) do not receive targeted education even though they are primary decision makers for youth athletes (YAs) who incur injuries. The purpose of this study was to understand CYA's SRC perceptions via the Health Belief Model (HBM) and Message Source Credibility in order to guide development of CYA SRC health education messages. Key informants (n = 20, e.g., sports personnel, medical practitioners, and researchers) who interact with CYAs and YAs and 30 CYAs (3 males, 27 females) from five different states were interviewed. Questions aimed to identify CYA's understanding of SRC prevention, recognition, treatment, and disposition through the framework of the HBM and message source credibility. CYAs had high-perceived severity of SRCs regardless of sport but mixed views of susceptibility. Despite receiving SRC education, CYAs consistently stated their own lack of understanding and low self-efficacy. The sources and amount of information CYAs receive are barriers to education. Therefore, a health communication intervention from a trusted source that focuses on HBM constructs like perceived susceptibility, education barriers, and cues to action both pre- and post-injury may fill the current educational gap.	[Patel, Sheetal J.] Stanford Univ, Palo Alto, CA 94304 USA; [Trowbridge, Cynthia A.] Univ Texas Arlington, Arlington, TX 76019 USA		Trowbridge, CA (corresponding author), Univ Texas Arlington, Arlington, TX 76019 USA.	ctrowbridge@uta.edu		Trowbridge, Cynthia/0000-0002-1306-9280	University of Texas at Arlington [14669]	The University of Texas at Arlington, Grant/Award Number:; Research Enhancement Program - REP, Grant/Award Number: 14669	Atkin CK, 2001, PUBLIC COMMUNICATION, P125; Bagley AF, 2012, CLIN J SPORT MED, V22, P385, DOI 10.1097/JSM.0b013e3182639bb4; Bonds G. B., 2015, SPORTS J, V11, P2; CDC, 2015, HEADS YOUTH SPORTS P; Chien LY, 2011, INT J GERIATR PSYCH, V26, P1089, DOI 10.1002/gps.2660; Cournoyer J, 2014, J ATHL TRAINING, V49, P654, DOI 10.4085/1062-6050-49.3.34; Creswell JW., 2014, RES DESIGN QUALITATI; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10187; Eichelberger C., 2013, INSURANCE J; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gerberding JLBS, 2003, REP C MILD TRAUM BRA; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Glang A, 2007, J HEAD TRAUMA REHAB, V22, P198, DOI 10.1097/01.HTR.0000271121.42523.3a; Glanz K., 2005, THEORY GLANCE GUIDE, V2nd ed.; Gleadhill S., 2014, J FITNESS RES, V3, P8; Haley E., 2008, J ADVERTISING ED, V12, P25; Harvey H., 2016, LAW ATLAS YOUTH SPOR; Harvey HH, 2013, AM J PUBLIC HEALTH, V103, P1249, DOI 10.2105/AJPH.2012.301107; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Maddock JE, 2008, J HEALTH COMMUN, V13, P208, DOI 10.1080/10810730701807225; Mannings C, 2014, J TRAUMA ACUTE CARE, V77, pS18, DOI 10.1097/TA.0000000000000371; McCracken G., 1988, LONG INTERVIEW; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Mckinlay A, 2011, BRAIN INJURY, V25, P761, DOI 10.3109/02699052.2011.579935; Mrazik M, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2015-094848; Noar SM, 2006, J HEALTH COMMUN, V11, P21, DOI 10.1080/10810730500461059; Nyhan B, 2014, PEDIATRICS, V133, pE835, DOI 10.1542/peds.2013-2365; Okeefe D., 2002, SOURCE FACTORS; Palinkas LA, 2015, ADM POLICY MENT HLTH, V42, P533, DOI 10.1007/s10488-013-0528-y; Provvidenza CF, 2009, BRIT J SPORT MED, V43, pI68, DOI 10.1136/bjsm.2009.058180; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Sarmiento K, 2010, J SCHOOL HEALTH, V80, P112, DOI 10.1111/j.1746-1561.2010.00491.x; Sawyer RJ, 2010, HEALTH PROMOT PRACT, V11, P34, DOI 10.1177/1524839907309377; Shafer A, 2011, J HEALTH COMMUN, V16, P988, DOI 10.1080/10810730.2011.571343; Skinner CS, 2015, HLTH BEHAV HLTH ED T, V5th, P75; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Sullivan SJ, 2009, CLIN J SPORT MED, V19, P228, DOI 10.1097/JSM.0b013e3181a41e43; Tator CH, 2012, J CLIN SPORT PSYCHOL, V6, P293, DOI 10.1123/jcsp.6.3.293; Tomei KL, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12280; Wilson Elizabeth J., 1993, J ACAD MARKET SCI, V21, P101, DOI DOI 10.1007/BF02894421	41	1	1	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1071-2089	1751-9861		J APPL BIOBEHAV RES	J. Appl. Biobehav. Res.	DEC	2017	22	4							e12098	10.1111/jabr.12098			20	Psychology, Clinical	Emerging Sources Citation Index (ESCI)	Psychology	FO9CB	WOS:000417184500017					2022-02-06	
J	Schwizer, P; Demierre, M; Smith, LV				Schwizer, Patrick; Demierre, Marc; Smith, Lloyd V.			An experimental and numerical study of softball to facemask impacts	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART P-JOURNAL OF SPORTS ENGINEERING AND TECHNOLOGY			English	Article						Mild traumatic brain injury; foam; impact; acceleration; finite element model; impact modeling; LS-DYNA; biomechanics; helmet; facemask	PROFESSIONAL FOOTBALL PLAYERS; TRAUMATIC BRAIN-INJURY; RECURRENT CONCUSSION; DEPRESSION; BASEBALL; CATCHERS; RISK	Concussion awareness in sports-related injuries has increased over the past decade. This awareness has resulted in improvement in protective equipment and in our understanding of head injury. While contact sports such as ice hockey and football have been at the forefront of the discussions surrounding concussion, concussion also occurs in non-contact sports like softball and baseball. The aim of this project was to describe facemask response to ball impacts. The study involved one facemask design and two types of foam paddings. A method is presented that allows foam characterization at deformation rates and magnitudes representative of play conditions. The facemask/foam system was placed on a Hybrid III headform and impacted with softballs to measure its response experimentally. A numerical model of the facemask/foam system on a Hybrid III headform showed good agreement with experimental data. Facemask impacts with a stiffer foam showed superior attenuation at high speeds (above 30m/s) while a softer foam attenuated impacts better at low speeds.	[Schwizer, Patrick; Demierre, Marc; Smith, Lloyd V.] Washington State Univ, Sch Mech & Mat Engn, Pullman, WA 99164 USA		Smith, LV (corresponding author), Washington State Univ, Sch Mech & Mat Engn, Pullman, WA 99164 USA.	lvsmith@wsu.edu					ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Beyer JA, 2012, ANN BIOMED ENG, V40, P150, DOI 10.1007/s10439-011-0412-4; BURBANK SD, 2012, J SPORTS ENG TECHNOL, V226, P77; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hutchinson J, 1998, APPL MATH COMPUT, V96, P1, DOI 10.1016/S0096-3003(97)10106-0; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Laudner K.G., 2014, J ATHLETIC ENHANCEME, V3, P1; Murray CJL, 1996, GLOBAL HLTH STAT; National Operating Committee on Standards for Athletic Equipment, 2013, TECHNICAL REPORT; Newman J, 2000, P INT RES C BIOM IMP; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Shain KS, 2010, CLIN J SPORT MED, V20, P422, DOI 10.1097/JSM.0b013e3181f7db25; Society for Automotive Engineers Inc, 1973, TECHNICAL REPORT; STP, STP12291994	18	1	1	0	12	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1754-3371	1754-338X		P I MECH ENG P-J SPO	Proc. Inst. Mech. Eng. Part P-J. Sport. Eng. Technol.	DEC	2017	231	4					336	343		10.1177/1754337117703839			8	Engineering, Mechanical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Engineering; Sport Sciences	FO1VW	WOS:000416557100010					2022-02-06	
J	Vankipuram, S; Sasane, SV; Chandra, A; Ojha, BK; Singh, SK; Srivastava, C; Jaiswal, S; Bajaj, A				Vankipuram, Siddharth; Sasane, Sumeet V.; Chandra, Anil; Ojha, Bal Krishna; Singh, Sunil K.; Srivastava, Chittij; Jaiswal, Somil; Bajaj, Ankur			Four Quadrant Osteoplastic Decompressive Craniotomy versus Conventional Decompressive Craniectomy for Traumatic Brain Injury: A Randomized Controlled Trial	INDIAN JOURNAL OF NEUROTRAUMA			English	Article						four quadrant osteo-plastic decompressive craniotomy; conventional decompressive craniectomy; novel decompression technique; syndrome of trephined; traumatic brain injury; randomized controlled trial	INTRACRANIAL HYPERTENSION; CRANIOPLASTY	Objective Four quadrant osteoplastic decompressive craniotomy (FoQOsD) has been described as a novel technique in the management of patients with traumatic brain injury requiring decompressive surgery. There has not been a randomized controlled trial comparing its outcomes with conventional decompressive craniectomy (DECRA) as yet. Methods A randomized controlled trial of 55 patients was conducted, of whom 29 underwent DECRA and 26 patients underwent FoQOsD. The preoperative baseline demographics, clinical conditions, and radiologic features were similar in both the groups. Clinical outcome was decided by the use of Glasgow coma outcome scale extended (GOS-e) at 3 months. Radiographic outcomes were assessed by measurement of the change in midline shift and brain width expansion (ipsilateral and contra-lateral to hematoma) on the postoperative computed tomographic (CT) scan. Results No significant differences were identified in baseline demographics, clinical condition, Rotterdam CT score, and radiographic characteristics between both the groups. At 3-month follow-up, the mean GOS-e score was comparable in both the groups (3.23 in DECRA group and 3.35 in FoQOsD group, p = 0.856). Mortality analysis at 3 months revealed that nine patients died in the DECRA group and eight died in FoQOsD group. Postoperative imaging characteristics, including Rotterdam score, also did not differ significantly. The percentage reduction in midline shift and percentage brain width expansion on the postoperative CT scan was similar in both the groups (p > 0.05). Conclusion FoQOsD appears to be at least as efficacious as DECRA in providing equivalent clinical outcomes with the added benefit of avoiding a second surgery.	[Vankipuram, Siddharth; Sasane, Sumeet V.; Chandra, Anil; Ojha, Bal Krishna; Singh, Sunil K.; Srivastava, Chittij; Jaiswal, Somil; Bajaj, Ankur] King Georges Med Univ, Dept Neurosurg, Shatabdi Phase 2, Lucknow 226003, Uttar Pradesh, India		Vankipuram, S (corresponding author), King Georges Med Univ, Dept Neurosurg, Shatabdi Phase 2, Lucknow 226003, Uttar Pradesh, India.	neurochandra@gmail.com	Jaiswal, Somil/ABF-7970-2020	Jaiswal, Somil/0000-0001-7879-7521			Ann DH, 2009, J KOREAN NEUROSURG S, V46, P417, DOI 10.3340/jkns.2009.46.4.417; Brain Trauma F, 2008, J NEUROTRAUM, V25, P276; Bullock M, 2011, YOUMANS WINN NEUROLO, P3267; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Erdogan E, 2003, NEUROL INDIA, V51, P479; Flint AC, 2008, J NEUROTRAUM, V25, P503, DOI 10.1089/neu.2007.0442; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Kenning TJ, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0960; Kolias AG, 2016, BRIT J NEUROSURG, V30, P246, DOI 10.3109/02688697.2016.1159655; Kolias AG, 2013, NAT REV NEUROL, V9, P405, DOI 10.1038/nrneurol.2013.106; Kuo JR, 2004, J CLIN NEUROSCI, V11, P486, DOI 10.1016/j.jocn.2003.06.005; Lu J, 2005, ACT NEUR S, V95, P281; Mokri B, 2001, NEUROLOGY, V56, P1746, DOI 10.1212/WNL.56.12.1746; Park J, 2009, J NEUROSURG, V110, P101, DOI 10.3171/2008.4.17540; Peethambaran AK, 2015, NEUROL INDIA, V63, P895, DOI 10.4103/0028-3886.170081; RICHAUD J, 1985, NEUROCHIRURGIE, V31, P183; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965	17	1	1	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0973-0508	2213-3739		INDIAN J NEUROTRAUM	Indian J. Neurotrauma	DEC	2017	14	2-3								10.1055/s-0038-1649329			6	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	GG3BI	WOS:000432566300023					2022-02-06	
J	Yigit, I; Atescelik, M; Yilmaz, M; Goktekin, MC; Gurger, M; Ilhan, N				Yigit, Ihsan; Atescelik, Metin; Yilmaz, Mustafa; Goktekin, Mehmet Cagri; Gurger, Mehtap; Ilhan, Nevin			Investigation of UCH-L1 levels in ischemic stroke, intracranial hemorrhage and metabolic disorder induced impaired consciousness	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Intracranial hemorrhage; Ischemic stroke; Ubiquitin C-terminal hydrolase-L1; Metabolic disorder induced impaired consciousness	C-TERMINAL HYDROLASE-L1; TRAUMATIC BRAIN-INJURY; ALPHA-II-SPECTRIN; PROTEIN; BIOMARKERS	Objective: We aimed to determine the levels of ubiquitin C-terminal hydrolase-L1 (UCH-L1) in patients admitted to the emergency department with impaired consciousness due to metabolic or neurological reasons. Materials - methods: The study included 80 patients with ischemic stroke (IS), 40 patients with intracranial hemorrhage (ICH), 80 patients with metabolic disorder induced impaired consciousness (MDIC) and 40 healthy controls. Results: The levels of UCH-L1 [median (IQR)] were as follows: 5.59 ng/mL (3.90-9.37) in IS, 5.44 ng/ml (4.01-13.98) in ICH, 3.34 ng/ml (2.29-5.88) in MDIC and 3.94 ng/ml (3.31-7.95) in healthy volunteers. Significantly higher levels were detected in IS and ICH than in MDIC and healthy volunteers. In ROC curve analysis, we detected 63.75% sensitivity and 62.5% specificity (AUC = 0.626, p < 0.0199, 95% CI: 0.533-0.713) with a cutoff value of 4.336 ng/ml for IS and 75% sensitivity and 55% specificity (AUC = 0.664, p < 0.0071, 95% CI: 0.549-0.766) with a cut-off value of 4.036 ng/ml for ICH. However, the sensitivity and specificity for MDIC was 36.25% and 77.5%, respectively, with a cut-off value of 3.256 ng/ml (AUC = 0.525, p = 0.6521, 95% CI: 0.432-0.617). UCH-L1 levels were found to increase significantly with increasing time between the onset of symptoms and blood sampling (r = 0.345, p < 0.001). However, no correlation was found between UCH-L1 levels and age (r = 0.014, p = 0.833), GCS (r = -0.115, p = 0.074), mRS (r = 0.063, p = 0.475) and NIHSS (r = 0.056, p = 0.520). Conclusion: In this study, we detected significantly higher levels of UCH-L1 in patients with IS and ICH compared to patients with MDIC and healthy volunteers. (C) 2017 Elsevier Inc. All rights reserved.	[Yigit, Ihsan] Basaksehir State Hosp, Dept Emergency Med, Istanbul, Turkey; [Atescelik, Metin; Yilmaz, Mustafa; Goktekin, Mehmet Cagri; Gurger, Mehtap] Firat Univ, Sch Med, Dept Emergency Med, TR-23200 Elazig, Turkey; [Ilhan, Nevin] Firat Univ, Sch Med, Dept Biochem, Elazig, Turkey		Yilmaz, M (corresponding author), Firat Univ, Sch Med, Dept Emergency Med, TR-23200 Elazig, Turkey.	drmylmz@hotmail.com	Ilhan, Nevin/J-5761-2017; Goktekin, Mehmet Cagri/I-3999-2018; Yilmaz, Mustafa/Q-2794-2015; Atescelik, Metin/V-8844-2018; Gurger, Mehtap/V-8219-2018; Yilmaz, Mustafa/W-5703-2018	Ilhan, Nevin/0000-0002-0208-8929; Goktekin, Mehmet Cagri/0000-0001-7911-8965; Yilmaz, Mustafa/0000-0002-4457-428X; Gurger, Mehtap/0000-0002-5209-2088; 	Firat University Scientific Research UnitFirat University [FUBAP TF.15.01]	This studywas supported by Firat University Scientific Research Unit for Funding (FUBAP TF.15.01).	ANN ES, 1994, ARCH HISTOL CYTOL, V57, P317, DOI 10.1679/aohc.57.317; Berger RP, 2012, J NEUROTRAUM, V29, P162, DOI 10.1089/neu.2011.1989; Chalela JA, 2007, LANCET, V369, P293, DOI 10.1016/S0140-6736(07)60151-2; Chen FJ, 2010, P NATL ACAD SCI USA, V107, P1636, DOI 10.1073/pnas.0911516107; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Hirata K, 1997, J NEUROCYTOL, V26, P799, DOI 10.1023/A:1018570500052; Kanich W, 2002, AM J EMERG MED, V20, P613, DOI 10.1053/ajem.2002.35464; Li YJ, 2013, EPILEPSY RES, V103, P205, DOI 10.1016/j.eplepsyres.2012.08.001; Lin WM, 1997, NEUROREPORT, V8, P2999, DOI 10.1097/00001756-199709290-00002; Liu MC, 2010, EUR J NEUROSCI, V31, P722, DOI 10.1111/j.1460-9568.2010.07097.x; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Pang L, 2014, CLIN BIOCHEM, V47, P72, DOI 10.1016/j.clinbiochem.2013.09.015; Ren C, 2016, SCI REPORTS, P6; Ren CH, 2016, SCI REP-UK, V6, DOI 10.1038/srep24588; Ren CH, 2013, BRAIN RES, V1540, P84, DOI 10.1016/j.brainres.2013.09.051; Setsuie R, 2007, NEUROCHEM INT, V51, P105, DOI 10.1016/j.neuint.2007.05.007; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Wofford JL, 1996, AM J EMERG MED, V14, P649, DOI 10.1016/S0735-6757(96)90080-7	18	1	1	1	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	DEC	2017	35	12					1895	1898		10.1016/j.ajem.2017.06.032			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	FP0YY	WOS:000417337100019	28651886				2022-02-06	
J	Fan, WS; Zhu, L; Chen, JF; Guo, CA; Yan, ZQ				Fan, Wenshuai; Zhu, Liang; Chen, Jifei; Guo, Changan; Yan, Zuoqin			Identifying Patients Who Will Benefit from Single Photon Emission Computerized Tomography and Computerized Tomography After Femoral Neck Fracture	MEDICAL SCIENCE MONITOR			English	Article						Factor Analysis, Statistical; Femoral Neck Fractures; Femyr Head Necrosis; Tomograpriy, Emission-Computed, Single-Photon	AVASCULAR NECROSIS; INTERNAL-FIXATION; HEAD; ARTHROPLASTY; RISK; MRI	Background: Single photon emission computerized tomography and computerized tomography (SPECT/CT) is useful for assessing blood supply within the femoral head after femoral neck fracture, but its use in all femoral neck fracture patients is not feasible. Therefore, the present study aimed to identify the patients for whom SPECT/CT examination will be most beneficial. Material/Methods: Sixty-five patients with a unilateral femoral neck fracture who underwent SPECT/CT examination of the hip and were treated via closed reduction and internal fixation with three screws were enrolled between January 2009 and March 2011. A decision tree model (C 5.0) was used to identify the factors that best reflect blood supply and to build a flowchart for identifying patients who would benefit from SPECT/CT. Results: Fracture type was most strongly associated with the Fracture/Normal (F/N) ratio, which reflects the blood supply to the fractured femoral head. Age and the time interval from injury to examination were also associated with the F/N ratio. SPECT/CT examination is most beneficial for patients with a displaced fracture, especially if they are over 58 years old and the time interval from injury to examination is less than 10 days. Conclusions: Our results indicate that elderly people with a displaced fracture are most likely to benefit from SPECT/CT examination, which can show the blood supply to the femoral head within a relatively short window of time after the injury.	[Fan, Wenshuai; Zhu, Liang; Chen, Jifei; Guo, Changan; Yan, Zuoqin] Fudan Univ, Zhongshan Hosp, Dept Orthoped, Shanghai, Peoples R China		Yan, ZQ (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Orthoped, Shanghai, Peoples R China.	yan1002@hotmail.com	Yan, Zuoqin/AAZ-2059-2020	Yan, Zuoqin/0000-0003-3131-1998	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81371966]; Major Project and Disease of the Shanghai Health System [2014ZYJB0302]	This work was supported by grants from the National Natural Science Foundation of China (No. 81371966) and the Major Project and Disease of the Shanghai Health System, No. 2014ZYJB0302	Amarasekera HW, 2008, J BONE JOINT SURG BR, V90B, P442, DOI 10.1302/0301-620X.90B4.20050; Bachiller FGC, 2002, CLIN ORTHOP RELAT R, P87; Bhandari M, 2005, J BONE JOINT SURG AM, V87A, P2122, DOI 10.2106/JBJS.E.00535; Bhandari M, 2003, J BONE JOINT SURG AM, V85A, P1673, DOI 10.2106/00004623-200309000-00004; Ehlinger M, 2011, ORTHOP TRAUMATOL-SUR, V97, P79, DOI 10.1016/j.otsr.2010.06.014; Han J, 2006, DATA MINING CONCEPTS, P550; Heverhagen JT, 2014, ROFO-FORTSCHR RONTG, V186, P661, DOI 10.1055/s-0033-1356403; Kalhor M, 2012, HIP INT, V22, P307, DOI 10.5301/HIP.2012.9242; Kaushik A, 2010, EUR J RADIOL, V75, P364, DOI 10.1016/j.ejrad.2009.04.045; Konishiike T, 1999, J BONE JOINT SURG BR, V81B, P596, DOI 10.1302/0301-620X.81B4.9013; Lazaro LE, 2015, BONE JOINT J, V97B, P1204, DOI 10.1302/0301-620X.97B9.34704; Loizou CL, 2009, INJURY, V40, P1143, DOI 10.1016/j.injury.2008.11.003; Luk WH, 2010, NUCL MED COMMUN, V31, P958, DOI 10.1097/MNM.0b013e32833e7732; Morimoto M, 2017, J ORTHOP SCI; Nikolopoulos KE, 2003, INJURY, V34, P525, DOI 10.1016/S0020-1383(02)00367-4; Pal, 2005, PRACTICAL MACHINE LE; Shen F, 2011, CHIN J TRAUMATOL, V14, P227, DOI 10.3760/cma.j.issn.1008-1275.2011.04.006; Wang T, 2014, ORTHOPEDICS, V37, pE1117, DOI 10.3928/01477447-20141124-60; Watanabe Y, 2007, J ORTHOP TRAUMA, V21, P456, DOI 10.1097/BOT.0b013e318126bb56; Xiao J, 2012, J ORTHOP TRAUMA, V26, P407, DOI 10.1097/BOT.0b013e318216dd60; Yuan HF, 2015, INT ORTHOP, V39, P1417, DOI 10.1007/s00264-015-2709-7; ZHANG YL, 2016, MEDICINE BALTIMORE, V95	22	1	1	0	2	INT SCIENTIFIC LITERATURE, INC	SMITHTOWN	361 FOREST LANE, SMITHTOWN, NY 11787 USA	1643-3750			MED SCI MONITOR	Med. Sci. Monitor	NOV 28	2017	23						5669	5674		10.12659/MSM.904026			6	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	FN9IK	WOS:000416345400002	29182595	Green Submitted, Green Published			2022-02-06	
J	Hauger, SL; Olafsen, K; Schnakers, C; Andelic, N; Nilsen, KB; Helseth, E; Funderud, I; Andersson, S; Schanke, AK; Lovstad, M				Hauger, Solveig L.; Olafsen, Kjell; Schnakers, Caroline; Andelic, Nada; Nilsen, Kristian Bernhard; Helseth, Eirik; Funderud, Ingrid; Andersson, Stein; Schanke, Anne-Kristine; Lovstad, Marianne			Cognitive Event-Related Potentials during the Sub-Acute Phase of Severe Traumatic Brain Injury and Their Relationship to Outcome	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; cognition; EEG; event-related potentials; prognosis	SOMATOSENSORY-EVOKED POTENTIALS; MINIMALLY CONSCIOUS STATE; VEGETATIVE STATE; IMPAIRED CONSCIOUSNESS; AUDITORY REGULARITIES; PREDICTING OUTCOMES; RETEST RELIABILITY; DIAGNOSTIC UTILITY; PROGNOSTIC VALUE; NATIONAL COHORT	Predicting outcome in the early phase after severe traumatic brain injury (sTBI) is a major clinical challenge, particularly identifying patients with potential for good cognitive outcome. The current single-center prospective study aimed to explore presence and normalization of electroencephalography (EEG)-based event-related potentials (ERPs) in the early phase followings TBI, and their relationship to functional and cognitive outcome 6 months post-injury. Fourteen adult patients (eight males) with sTBI were recruited from the neurointensive care unit (mean age = 38.2 years [standard deviation (SD) = 14.7]; mean lowest Glasgow Coma Scale (GCS) score within first 24 h = 5.4, SD = 1.87). EEG recordings were conducted biweekly at three time-points applying an ERP paradigm encompassing a passive condition involving hearing their own name randomly interspersed between an unfamiliar name (UN), and an active condition with instruction to count their own name. Functional and cognitive outcome 6 months post-injury was measured with Glasgow Outcome Scale-Extended (GOSE) and neuropsychological tests of attention and memory. Ten patients demonstrated a significantly enhanced cognitive P3 in the active counting task compared with passive listening across recordings, and six presented with normalization of P3 in the counting task. Moreover, P3 amplitude to the counting task at the third time-point was positively correlated with both functional outcome (GOSE) and cognition (verbal learning, attentional set-shifting, and switching) 6 months post-injury. ERP can index cognitive capacities in the early phase following sTBI, and the cognitive P3 component in an active design is associated with functional and cognitive outcome, demonstrating that the cognitive P3 may yield valuable information of residual cognition and provide supplementary prognostic information.	[Hauger, Solveig L.; Schanke, Anne-Kristine; Lovstad, Marianne] Sunnaas Rehabil Hosp, Dept Res, N-1450 Nesoddtangen, Norway; [Hauger, Solveig L.; Funderud, Ingrid; Andersson, Stein; Schanke, Anne-Kristine; Lovstad, Marianne] Univ Oslo, Fac Med, CHARM Ctr Habilitat & Rehabil Models & Serv, Dept Psychol, Oslo, Norway; [Andelic, Nada] Univ Oslo, Fac Med, CHARM Ctr Habilitat & Rehabil Models & Serv, Inst Hlth & Soc, Oslo, Norway; [Helseth, Eirik] Univ Oslo, Fac Med, Oslo, Norway; [Olafsen, Kjell] Oslo Univ Hosp, Dept Neurointens Treatment, Oslo, Norway; [Andelic, Nada] Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway; [Nilsen, Kristian Bernhard] Oslo Univ Hosp, Dept Neurol, Oslo, Norway; [Helseth, Eirik] Oslo Univ Hosp, Dept Neurosurg, Oslo, Norway; [Schnakers, Caroline] Univ Calif Los Angeles, Neurosurg Dept, Los Angeles, CA USA; [Schnakers, Caroline] Casa Colina Hosp & Ctr Healthcare, Res Inst, Pomona, CA USA; [Nilsen, Kristian Bernhard] Norwegian Univ Sci & Technol, Dept Neurosci, Trondheim, Norway		Hauger, SL (corresponding author), Sunnaas Rehabil Hosp, Dept Res, N-1450 Nesoddtangen, Norway.	solveig.laegreidhauger@sunnaas.no	Helseth, Eirik/AAH-2466-2020; Laureys, Steven/A-3349-2011	Funderud, Ingrid/0000-0002-4481-7237; Nilsen, Kristian Bernhard/0000-0002-4492-2387; Andelic, Nada/0000-0002-3719-4406	Norwegian Extra Foundation for Health and Rehabilitation through EXTRA funds [2012/2/0084]; Sunnaasstiftelsen	The authors thank all the patients and their families, and the staff of the Department of Intensive Care, OUH, in contributing to this study. This research is supported by the Norwegian Extra Foundation for Health and Rehabilitation through EXTRA funds (Grant 2012/2/0084), and Sunnaasstiftelsen funded NeuroScan equipment.	Andelic N, 2010, DISABIL REHABIL, V32, P1122, DOI 10.3109/09638280903410722; Anke A, 2015, J HEAD TRAUMA REHAB, V30, pE38, DOI 10.1097/HTR.0000000000000080; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Beaumont JG, 2005, NEUROPSYCHOL REHABIL, V15, P184, DOI 10.1080/09602010443000489; Bekinschtein TA, 2009, P NATL ACAD SCI USA, V106, P1672, DOI 10.1073/pnas.0809667106; Benedict, 2001, HOPKINS VERBAL LEARN; Bruno MA, 2012, J NEUROL, V259, P1087, DOI 10.1007/s00415-011-6303-7; Carter BG, 2001, CRIT CARE MED, V29, P178, DOI 10.1097/00003246-200101000-00036; Cassidy SM, 2012, PSYCHOPHYSIOLOGY, V49, P659, DOI 10.1111/j.1469-8986.2011.01349.x; Castano-Leon AM, 2016, J NEUROTRAUM, V33, P1598, DOI 10.1089/neu.2015.4182; Chesnut Randall M., 1997, Emergency Medicine Clinics of North America, V15, P581, DOI 10.1016/S0733-8627(05)70319-9; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Dahm J, 2015, J REHABIL MED, V47, P932, DOI 10.2340/16501977-2016; Daltrozzo J, 2007, CLIN NEUROPHYSIOL, V118, P606, DOI 10.1016/j.clinph.2006.11.019; Delis DC., 2001, DELIS KAPLAN EXECUTI; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Faugeras F, 2012, NEUROPSYCHOLOGIA, V50, P403, DOI 10.1016/j.neuropsychologia.2011.12.015; Giacino JT, 2005, NEUROPSYCHOL REHABIL, V15, P166, DOI 10.1080/09602010443000498; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Hauger SL, 2017, J HEAD TRAUMA REHAB, V32, P185, DOI 10.1097/HTR.0000000000000267; Hauger SL, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/145913; Houlden DA, 2010, CRIT CARE MED, V38, P167, DOI 10.1097/CCM.0b013e3181c031b3; Jacobs B, 2013, NEUROCRIT CARE, V19, P79, DOI 10.1007/s12028-012-9795-9; Jourdan C, 2016, ANN PHYS REHABIL MED, V59, P100, DOI 10.1016/j.rehab.2015.10.009; Kondziella D, 2016, J NEUROL NEUROSUR PS, V87, P485, DOI 10.1136/jnnp-2015-310958; Laureys S, 2007, CONSCIOUS COGN, V16, P722, DOI 10.1016/j.concog.2007.04.004; Lehembre R, 2012, ARCH ITAL BIOL, V150, P122, DOI 10.4449/aib.v150i2.1374; Leonardi M, 2013, BRAIN INJURY, V27, P473, DOI 10.3109/02699052.2012.750758; Lew HL, 2006, J HEAD TRAUMA REHAB, V21, P350, DOI 10.1097/00001199-200607000-00006; Lew HL, 2003, AM J PHYS MED REHAB, V82, P53, DOI [10.1097/00002060-200301000-00009, 10.1097/01.PHM.0000043771.90606.81]; Lovstad M, 2014, J HEAD TRAUMA REHAB, V29, pE31, DOI 10.1097/HTR.0000000000000017; Lovstad M, 2010, J HEAD TRAUMA REHAB, V25, P349, DOI 10.1097/HTR.0b013e3181cec841; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; Mazaux JM, 1998, DISABIL REHABIL, V20, P435, DOI 10.3109/09638289809166108; Noirhomme Q, 2017, NEUROIMAGE, V145, P288, DOI 10.1016/j.neuroimage.2015.12.006; Olivecrona M, 2013, J CLIN NEUROSCI, V20, P996, DOI 10.1016/j.jocn.2012.09.015; Perel P., BMJ, V336, P425; Perrin F, 2006, ARCH NEUROL-CHICAGO, V63, P562, DOI 10.1001/archneur.63.4.562; Perrin F, 1999, CLIN NEUROPHYSIOL, V110, P2153, DOI 10.1016/S1388-2457(99)00177-7; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Robinson LR, 2003, CRIT CARE MED, V31, P960, DOI 10.1097/01.CCM.0000053643.21751.3B; Sandsmark DK, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0654-5; Schnakers C, 2008, NEUROLOGY, V71, P1614, DOI 10.1212/01.wnl.0000334754.15330.69; Schorl M, 2014, CLIN NEUROL NEUROSUR, V123, P25, DOI 10.1016/j.clineuro.2014.05.004; Sherer M, 2005, ARCH PHYS MED REHAB, V86, P896, DOI 10.1016/j.apmr.2004.09.029; Sigurdardottir S, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000039; Silva MA, 2012, AM J PHYS MED REHAB, V91, P890, DOI 10.1097/PHM.0b013e31825a1648; Soberg HL, 2013, J REHABIL MED, V45, P785, DOI 10.2340/16501977-1158; Solbakk AK, 2002, CLIN ELECTROENCEPHAL, V33, P102, DOI 10.1177/155005940203300306; Soltani Maryam, 2000, Critical Reviews in Neurobiology, V14, P199; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; TEASDALE G, 1974, LANCET, V2, P81; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Walhovd KB, 2002, INT J PSYCHOPHYSIOL, V46, P29, DOI 10.1016/S0167-8760(02)00039-9; Wang JT, 2004, CAN J NEUROL SCI, V31, P438, DOI 10.1017/S0317167100003619; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D., 2008, WECHSLER ADULT INTEL; Wijnen VJM, 2007, CLIN NEUROPHYSIOL, V118, P597, DOI 10.1016/j.clinph.2006.11.020; Wijnen VJM, 2014, J CLIN NEUROPHYSIOL, V31, P65, DOI 10.1097/01.wnp.0000436894.17749.0c; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; [No title captured]	67	1	3	0	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2017	34	22					3124	3133		10.1089/neu.2017.5062			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FL9GC	WOS:000414560000008	28594285	Green Submitted			2022-02-06	
J	Thiel, C; Lauber, J; Klingert, W; Klingert, K; Morgalla, MH; Beschorner, R; Peter, A; Grasshoff, C; Konigsrainer, A; Schenk, M; Thiel, K				Thiel, Christian; Lauber, Johannes; Klingert, Wilfried; Klingert, Kathrin; Morgalla, Matthias H.; Beschorner, Rudi; Peter, Andreas; Grasshoff, Christian; Koenigsrainer, Alfred; Schenk, Martin; Thiel, Karolin			Pathophysiological central nervous system changes in a porcine model of acetaminophen-induced acute liver failure	TOXICOLOGY LETTERS			English	Article						Cerebral oxygenation; Acetaminophen intoxication; Acute liver failure; Neuromonitoring; Porcine model	CEREBRAL PERFUSION-PRESSURE; TRAUMATIC BRAIN-INJURY; FULMINANT HEPATIC-FAILURE; INTRACRANIAL-PRESSURE; TISSUE OXYGENATION; INTENSIVE-CARE; HEAD-INJURY; COMPLICATIONS; MANAGEMENT; AUGMENTATION	Background: Critical care management of patients suffering from acute liver failure (ALF) continues to be challenging. Animal models studying the pathophysiological central nervous system alterations during the course of ALF provide an opportunity to improve diagnostic and therapeutic strategies. The aim of this study was to analyse the course of cerebral oxygenation in addition to conventional neuromonitoring during the course of acetaminophen-induced ALF. Methods: ALF was induced by intrajejunal acetaminophen administration in 20 German landrace pigs. All animals underwent invasive hemodynamic and neuromonitoring and were maintained under standardized intensive care support. Neuromonitoring consisted of continuous intraparenchymatous recording of intracranial pressure and brain partial oxygen pressure. Hemodynamic and ventilation parameters were continuously recorded; laboratory parameters were analysed every eight hours. Mean values were compared using the Wilcoxon test. Results: Acute liver failure occurred in all intoxicated animals after 23 +/- 2 h, resulting in death due to ALF after further 15 +/- 2 h. Continuous neuromonitoring was performed in all animals during the whole experiment without observing signs of intracranial haemorrhage. Two hours after manifestation of ALF an increase in brain tissue oxygen (PtiO2) was observed. Brain oxygenation stayed stable until nine hours before death. Intracranial pressure (ICP) remained basically at a plateau level until manifestation of ALF. In the following ten hours a linear and slow increase was observed until five hours before death, followed by a fast and continuous rise in ICP to a final level of 35 +/- 1 mmHg. Cerebral perfusion pressure (CPP) began to decrease 25 h prior to exitus, further decreasing to 18 +/- 2 mmHg at the end of the experiment. A strong negative linear correlation was found between PtiO2 and ICP (R = 0.97). Arterial partial pressure of oxygen (PaO2) below 100 mmHg was associated with lower PtiO2 levels. Changes in arterial partial pressure of carbon dioxide (PaC02) did not influence PtiO2 values. Hemoglobin values below 7 g/dl were associated with lower PtiO2 values. Conclusions: The results of our experiments demonstrate that ICP and PtiO2 measurements indicate impending damage well before serious complications occur and their use should be considered in order to protect endangered brain function in the presence of acetaminophen-induced ALF.	[Thiel, Christian; Lauber, Johannes; Klingert, Wilfried; Koenigsrainer, Alfred; Schenk, Martin; Thiel, Karolin] Tuebingen Univ Hosp, Dept Gen Visceral & Transplant Surg, Hoppe Seyler Str 3, D-72076 Tubingen, Germany; [Morgalla, Matthias H.] Tuebingen Univ Hosp, Dept Neurosurg, Hoppe Seyler Str 3, D-72076 Tubingen, Germany; [Beschorner, Rudi] Tuebingen Univ Hosp, Dept Neuropathol, Calwerstr 3, D-72076 Tubingen, Germany; [Peter, Andreas] Tuebingen Univ Hosp, Dept Internal Med, Div Endocrinol Diabetol Angiol Nephrol Pathobioch, Ottfried Muller Str 10, D-72076 Tubingen, Germany; [Klingert, Kathrin; Grasshoff, Christian] Tuebingen Univ Hosp, Dept Anaesthesiol, Hoppe Seyler Str 3, D-72076 Tubingen, Germany		Thiel, K (corresponding author), Tuebingen Univ Hosp, Dept Gen Visceral & Transplant Surg, Hoppe Seyler Str 3, D-72076 Tubingen, Germany.	Christian.Thiel@med.uni-tuebingen.de; Johannes.Lauber@rbk.de; Wilfried.Klingert@med.uni-tuebingen.de; Kathrin.Klingert@med.uni-tuebingen.de; Matthias.Morgalla@med.uni-tuebingen.de; Rudi.Beschorner@med.uni-tuebingen.de; Andreas.Peter@med.uni-tuebingen.de; Christian.Grasshoff@med.uni-tuebingen.de; Alfred.Koenigsrainer@med.uni-tuebingen.de; Martin.Schenk@med.uni-tuebingen.de; Karolin.Thiel@med.uni-tuebingen.de			TUFF Habilitation Program for Women of the Faculty of Medicine Tubingen, Germany [2341-0-0]	The study was supported by the TUFF Habilitation Program for Women of the Faculty of Medicine Tubingen, Germany, grant no. 2341-0-0.	Aggarwal S, 2005, LIVER TRANSPLANT, V11, P1353, DOI 10.1002/lt.20479; Bernal W, 1999, EUR J GASTROEN HEPAT, V11, P977, DOI 10.1097/00042737-199909000-00005; Bernal W, 2015, J HEPATOL, V62, pS112, DOI 10.1016/j.jhep.2014.12.016; Bernal W, 2013, NEW ENGL J MED, V369, P2525, DOI 10.1056/NEJMra1208937; Bernal W, 2010, LANCET, V376, P190, DOI 10.1016/S0140-6736(10)60274-7; BLEI AT, 1993, LANCET, V341, P157, DOI 10.1016/0140-6736(93)90016-A; De Georgia MA, 2005, NEUROLOGIST, V11, P45, DOI 10.1097/01.nrl.0000149993.99956.09; Detry O, 2006, WORLD J GASTROENTERO, V12, P7405, DOI 10.3748/wjg.v12.i46.7405; Figaji AA, 2008, NEUROSURGERY, V63, P83, DOI 10.1227/01.NEU.0000335074.39728.00; Helbok R, 2014, NEUROCRIT CARE, V21, P85, DOI 10.1007/s12028-014-0040-6; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; Johnston AJ, 2004, INTENS CARE MED, V30, P791, DOI 10.1007/s00134-003-2155-7; Kamat P, 2012, PEDIATR CRIT CARE ME, V13, pE33, DOI 10.1097/PCC.0b013e31820ac08f; Karvellas CJ, 2014, CRIT CARE MED, V42, P1157, DOI 10.1097/CCM.0000000000000144; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; Lang EW, 2007, NEUROSURG REV, V30, P99, DOI 10.1007/s10143-006-0062-4; Lang EW, 2003, CRIT CARE MED, V31, P267, DOI 10.1097/00003246-200301000-00042; Larson AM, 2005, HEPATOLOGY, V42, P1364, DOI 10.1002/hep.20948; Lee WM, 2008, CURR OPIN CRIT CARE, V14, P198, DOI 10.1097/MCC.0b013e3282f6a420; Mulvey JM, 2004, NEUROCRIT CARE, V1, P391, DOI 10.1385/NCC:1:3:391; OGRADY JG, 1993, LANCET, V342, P273; Polson J, 2005, HEPATOLOGY, V41, P1179, DOI 10.1002/hep.20703; Rabinstein AA, 2010, CURR TREAT OPTION NE, V12, P129, DOI 10.1007/s11940-010-0062-0; Reinert M, 2003, ACTA NEUROCHIR, V145, P341, DOI 10.1007/s00701-003-0027-0; Rohlwink UK, 2010, CHILD NERV SYST, V26, P453, DOI 10.1007/s00381-009-1033-1; Rose JC, 2006, CURR OPIN CRIT CARE, V12, P97, DOI 10.1097/01.ccx.0000216574.26686.e9; Smith MJ, 2005, CRIT CARE MED, V33, P1104, DOI 10.1097/01.CCM.0000162685.60609.49; Stravitz RT, 2007, CRIT CARE MED, V35, P2498, DOI 10.1097/01.CCM.0000287592.94554.5F; Thiel C, 2011, EUR SURG RES, V46, P118, DOI 10.1159/000323411; Thiel C, 2010, CRIT CARE, V14, DOI 10.1186/cc9196; Trey C, 1970, Prog Liver Dis, V3, P282; Vaquero J, 2005, LIVER TRANSPLANT, V11, P1581, DOI 10.1002/lt.20625; Zauner A, 1997, NEUROSURGERY, V41, P1082, DOI 10.1097/00006123-199711000-00011	33	1	1	0	6	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0378-4274	1879-3169		TOXICOL LETT	Toxicol. Lett.	NOV 5	2017	281						119	126		10.1016/j.toxlet.2017.09.018			8	Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Toxicology	FL1TW	WOS:000413998300014	28958773				2022-02-06	
J	Adelsky, SJ; Ducharme, S; Wilner, EK; Yudkoff, B; Lejeune, S				Adelsky, Solomon J.; Ducharme, Simon; Wilner, Emily K.; Yudkoff, Benjamin; Lejeune, Simon			Heads Up: The Presentation of Schizoaffective Disorder in an Elite College Soccer Player with Prior Concussion	HARVARD REVIEW OF PSYCHIATRY			English	Article						mood disorders; neuropsychological testing; psychotic disorders; student health services; traumatic brain injuries	TRAUMATIC BRAIN-INJURY; DORSOLATERAL PREFRONTAL CORTEX; BIPOLAR DISORDER; PSYCHOTIC DISORDER; SCHIZOPHRENIA; COGNITION; RISK; ENCEPHALOPATHY; IMPAIRMENTS; DYSFUNCTION		[Adelsky, Solomon J.; Wilner, Emily K.; Yudkoff, Benjamin; Lejeune, Simon] Harvard Med Sch, Boston, MA USA; [Adelsky, Solomon J.; Wilner, Emily K.] Cambridge Hlth Alliance, Cambridge, MA USA; [Adelsky, Solomon J.] Cambridge Hosp, 1493 Cambridge St, Cambridge, MA 02139 USA; [Ducharme, Simon] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Ducharme, Simon] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Ducharme, Simon] Montreal Neurol Inst, Montreal, PQ, Canada; [Ducharme, Simon] McGill Univ, Hlth Ctr, Montreal, PQ, Canada; [Yudkoff, Benjamin] Brigham & Womens Faulkner Hosp, Boston, MA USA; [Lejeune, Simon] MIT, Hlth Serv, Mental Hlth & Counseling, Cambridge, MA 02139 USA		Adelsky, SJ (corresponding author), Cambridge Hosp, 1493 Cambridge St, Cambridge, MA 02139 USA.	sadelsky@cha.harvard.edu					Bilder RM, 2000, AM J PSYCHIAT, V157, P549, DOI 10.1176/appi.ajp.157.4.549; Blanco C, 2008, ARCH GEN PSYCHIAT, V65, P1429, DOI 10.1001/archpsyc.65.12.1429; Callicott JH, 2000, CEREB CORTEX, V10, P1078, DOI 10.1093/cercor/10.11.1078; Carbon M, 2014, CNS SPECTRUMS, V19, P38, DOI 10.1017/S1092852914000601; Cardoso T, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-015-0605-x; David AS, 2005, J NEUROL NEUROSUR PS, V76, pI53, DOI 10.1136/jnnp.2004.060475; Elvevag B, 2000, CRIT REV NEUROBIOL, V14, P1; Franzen MD, 1997, ARCH CLIN NEUROPSYCH, V12, P711, DOI 10.1016/S0887-6177(97)00046-2; Freudenreich O, 2009, EARLY INTERV PSYCHIA, V3, P10, DOI 10.1111/j.1751-7893.2008.00105.x; Fujii D, 2012, J NEUROPSYCH CLIN N, V24, P278, DOI 10.1176/appi.neuropsych.11070176; Fujii DE, 2014, PSYCHIAT CLIN N AM, V37, P113, DOI 10.1016/j.psc.2013.11.006; HAFNER H, 1993, BRIT J PSYCHIAT, V162, P80, DOI 10.1192/bjp.162.1.80; Harvey Philip D, 2012, Dialogues Clin Neurosci, V14, P91; Harvey Philip D, 2011, Innov Clin Neurosci, V8, P14; Hazrati LN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00222; Heinrichs RW, 1998, NEUROPSYCHOLOGY, V12, P426, DOI 10.1037/0894-4105.12.3.426; Hill SK, 2013, AM J PSYCHIAT, V170, P1275, DOI 10.1176/appi.ajp.2013.12101298; Hogarty GE, 2004, ARCH GEN PSYCHIAT, V61, P866, DOI 10.1001/archpsyc.61.9.866; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Lannon P, 2014, DIRECT THREAT CARING; Lecardeur L, 2013, ENCEPHALE, V39, pS64, DOI 10.1016/j.encep.2012.10.011; Lejeune SMW, 2011, J AM COLL HEALTH, V59, P666, DOI 10.1080/07448481.2010.528100; Lewandowski KE, 2013, SCHIZOPHR RES, V148, P34, DOI 10.1016/j.schres.2013.05.012; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; McGorry PD, 2015, J NERV MENT DIS, V203, P310, DOI 10.1097/NMD.0000000000000284; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meilman PW, 2016, J COLL STUD PSYCHOTH, V30, P54, DOI 10.1080/87568225.2016.1105665; Molloy C, 2011, SCHIZOPHRENIA BULL, V37, P1104, DOI 10.1093/schbul/sbr091; Owoso A, 2013, PSYCHOL MED, V43, P2535, DOI 10.1017/S0033291713000536; Ozen LJ, 2011, J INT NEUROPSYCH SOC, V17, P219, DOI 10.1017/S135561771000144X; Pisani AR, 2016, ACAD PSYCHIATR, V40, P623, DOI 10.1007/s40596-015-0434-6; REGIER DA, 1993, ARCH GEN PSYCHIAT, V50, P85; Reichenberg Abraham, 2010, Dialogues Clin Neurosci, V12, P383; Schoenberg MR, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P1, DOI 10.1007/978-0-387-76978-3_1; Scott JG, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P127, DOI 10.1007/978-0-387-76978-3_4; Scott JG, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P219, DOI 10.1007/978-0-387-76978-3_10; SEARLES HF, 1962, J AM PSYCHOANAL ASS, V10, P22, DOI 10.1177/000306516201000102; Seidman LJ, 2002, SCHIZOPHR RES, V53, P31, DOI 10.1016/S0920-9964(01)00162-1; Spitz G, 2013, J NEUROTRAUM, V30, P2038, DOI 10.1089/neu.2013.3021; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Yoon JH, 2008, AM J PSYCHIAT, V165, P1006, DOI 10.1176/appi.ajp.2008.07060945	41	1	1	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1067-3229	1465-7309		HARVARD REV PSYCHIAT	Harv. Rev. Psychiatr.	NOV-DEC	2017	25	6					302	310		10.1097/HRP.0000000000000147			9	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	FN1KY	WOS:000415748500008	29117025				2022-02-06	
J	Bay, E; Garbinski, AM; Maycock, SE				Bay, Esther; Garbinski, Anne Marie; Maycock, Susan E.			Prevention Strategies in Post-TBI Depression in Older Adults A Case Study	PROFESSIONAL CASE MANAGEMENT			English	Article						chronic stress; depression; discharge planning; home care; traumatic brain injury	TRAUMATIC BRAIN-INJURY; PSYCHOSOCIAL INTERVENTIONS; PSYCHIATRIC-ILLNESS; MAJOR DEPRESSION; ALLOSTATIC LOAD; RISK-FACTORS; HEALTH; STRESS; METAANALYSIS; DISORDERS	Purpose: The purpose of this study was to describe a theoretically focused intervention aimed toward chronic stress and depressive symptom management that is coordinated by a case manager and delivered within a home environment by the caregiver. Primary Practice Setting: Home care, community setting. Methods: A case study of an older adult with traumatic brain injury (TBI) secondary to a fall who had significant allostatic load at the time of his injury. "Allostatic load" is a theoretical construct that suggests the brain is experiencing chronic strain on its systems that flexibly respond to stressors. Sustained allostatic load can contribute to chronic conditions and poor outcomes. Findings: Through actions with the family as caregivers, the case manager was able to coordinate a structured home setting and gradual resumption of social activities for this older adult. Focus was on establishing structure, meaningful social interactions, and positive home experiences that maximized the older adult's interests and capacity and mitigated chronic stress. Gradually, the older adult returned to his preinjury capacity and lives independently within the family home. ZImplications for Case Management Practice: The case management process has the potential to mitigate stressors and improve depression management through family-focused care. Although there is limited guidance on prevention of depression, this approach resulted in attainment of safe home care, no hospital readmissions, and return to previous lifestyle for the older adult. This could be useful in the prevention of post-TBI depression.	[Bay, Esther; Maycock, Susan E.] Univ Michigan, Sch Nursing, 400 N Ingalls Bldg, Ann Arbor, MI 48108 USA; [Maycock, Susan E.] Univ MI Hlth Syst, Profess Dev & Educ, Ann Arbor, MI USA		Bay, E (corresponding author), Univ Michigan, Sch Nursing, 400 N Ingalls Bldg, Ann Arbor, MI 48108 USA.	pdq@umich.edu					American Case Management Association, 2013, STAND PRACT SCOP SER; Bellon JA, 2015, PREV MED, V76, pS22, DOI 10.1016/j.ypmed.2014.11.003; Barker-Collo S, 2013, BRAIN INJURY, V27, P1124, DOI 10.3109/02699052.2013.801513; Bay E, 2008, BRAIN INJURY, V22, P233, DOI 10.1080/02699050801953073; Bay Esther, 2004, Res Theory Nurs Pract, V18, P213, DOI 10.1891/rtnp.18.2.213.61278; Bay E, 2009, BIOL RES NURS, V10, P213, DOI 10.1177/1099800408326453; Bay EH, 2014, J NEUROSCI NURS, V46, P142, DOI 10.1097/JNN.0000000000000048; Berthelsen CB, 2015, INT J NURS STUD, V52, P988, DOI 10.1016/j.ijnurstu.2015.01.006; Biester RC, 2016, PROF CASE MANAG, V21, P22, DOI 10.1097/NCM.0000000000000121; Bombardier CH, 2016, J NEUROTRAUM, V33, P2115, DOI 10.1089/neu.2015.4349; Case Management Society of America, 2016, STAND PRACT CAS MAN; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS278, DOI 10.1016/j.apmr.2013.08.295; Centers for Disease Control, 2016, TRAUM BRAIN INJ US F; Centers for Disease Control (CDC) Community Prevention Task Force, 2008, IMPR MENT HLTH ADDR; Cole MG, 2008, AM J GERIAT PSYCHIAT, V16, P435, DOI 10.1097/JGP.0b013e318162f174; Coleman K, 2009, HEALTH AFFAIR, V28, P75, DOI 10.1377/hlthaff.28.1.75; Danese A, 2012, PHYSIOL BEHAV, V106, P29, DOI 10.1016/j.physbeh.2011.08.019; Deb S, 1999, AM J PSYCHIAT, V156, P374; Deb Shoumitro, 2003, Evid Based Ment Health, V6, P59; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Forsman AK, 2011, HEALTH PROMOT INT, V26, pI85, DOI 10.1093/heapro/dar074; Forsman AK, 2011, J AGING HEALTH, V23, P387, DOI 10.1177/0898264310378041; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Gould KR, 2011, J NEUROTRAUM, V28, P1155, DOI 10.1089/neu.2010.1528; Griesbach Grace S, 2015, Handb Clin Neurol, V128, P681, DOI 10.1016/B978-0-444-63521-1.00042-X; Griesbach GS, 2014, J NEUROTRAUM, V31, P674, DOI 10.1089/neu.2013.3151; Guillamondegui OD., 2011, TRAUMATIC BRAIN INJU; Hackett ML, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003689.pub3; Hickam DH, 2013, COMP EFFECTIVENESS R; Institute of Medicine, 2009, PREV MENT EM BEH DIS, V1; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P43; Jorge RE, 2005, J HEAD TRAUMA REHAB, V20, P475, DOI 10.1097/00001199-200511000-00001; Jorge RE, 2007, BIOL PSYCHIAT, V62, P332, DOI 10.1016/j.biopsych.2006.07.024; Juster RP, 2010, NEUROSCI BIOBEHAV R, V35, P2, DOI 10.1016/j.neubiorev.2009.10.002; Karlamangla AS, 2002, J CLIN EPIDEMIOL, V55, P696, DOI 10.1016/S0895-4356(02)00399-2; Krishnamoorthy V, 2015, J TRAUMA NURS, V22, P204, DOI 10.1097/JTN.0000000000000135; Kristman VL, 2016, J HEAD TRAUMA REHAB, V31, pE33, DOI 10.1097/HTR.0000000000000226; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Levin HS, 2005, ARCH GEN PSYCHIAT, V62, P523, DOI 10.1001/archpsyc.62.5.523; McEwen B., 2002, END STRESS WE KNOW I; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Moore RC, 2015, AM J GERIAT PSYCHIAT, V23, P622, DOI 10.1016/j.jagp.2014.08.004; Rao V., 2012, J NEUROPSYCHIATRY CL, V22, P100; Reynolds CF, 2012, ANNU REV PUBL HEALTH, V33, P123, DOI 10.1146/annurev-publhealth-031811-124544; Rockhill CM, 2012, J NEUROTRAUM, V29, P1038, DOI 10.1089/neu.2010.1562; Taylor AN, 2008, J NEUROTRAUM, V25, P311, DOI 10.1089/neu.2007.0486; THURMAN D, 2001, EPIDEMIOLOGY EC HEAD; van Veldhoven LM, 2011, J NEUROL NEUROSUR PS, V82, P782, DOI 10.1136/jnnp.2010.228254; Waldron-Perrine B, 2008, REHABIL PSYCHOL, V53, P426, DOI 10.1037/a0013530; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa	51	1	1	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1932-8087	1932-8095		PROF CASE MANAG	Prof. Case Manag.	NOV-DEC	2017	22	6					284	290		10.1097/NCM.0000000000000224			7	Health Care Sciences & Services	Emerging Sources Citation Index (ESCI)	Health Care Sciences & Services	FV3RK	WOS:000424486200004	29016420				2022-02-06	
J	De Iorio, ML; Nolan, SA; Teague, S				De Iorio, Monica L.; Nolan, Susan A.; Teague, Susan			The Effect of Education Type on Common Misconceptions of Traumatic Brain Injury	REHABILITATION PSYCHOLOGY			English	Article						traumatic brain injury; education; misconception; attribution; factsheet	AGGRESSIVE-BEHAVIOR; WORKING-MEMORY; ASIAN WOMEN; REHABILITATION; ATTRIBUTIONS; PROFESSIONALS; ATTITUDES; CHILDREN; TBI	Purpose: In the current study, we investigated the effects of existing education materials-either a Traumatic Brain Injury (TBI) factsheet or personal stories of people with TBI-on undergraduate students' misconceptions and attributions about the causes of TBI-related behavior. Method: Undergraduate students (N = 164) were recruited through the university participant pool. The participants were randomly assigned to receive either a factsheet about TBI, personal stories of people with TBI, or a control reading. Groups were compared on the number of TBI misconceptions endorsed, scores on an attribution measure, and their willingness to interact with people who have TBIs. Results: Both the TBI factsheet group and the personal stories group endorsed fewer misconceptions, on average, than the control group (p = .02). Additionally, those who read either the personal stories or the factsheet had significantly lower attribution scores, on average, than the control group (p = .001; p = .03). That is, those who read either of the educational materials were more likely to endorse a TBI explanation over an adolescent explanation, compared to those who read a control reading. The groups did not significantly differ on their willingness for social interaction. Implications: Results suggest that, on average, factsheets and personal stories are effective for increasing knowledge about moderate-to-severe TBI as compared to a control group. Personal stories and factsheets may also be useful, on average, for addressing tendencies to discount TBIs as explanations for behavioral change, as compared to a control group.	[De Iorio, Monica L.; Nolan, Susan A.; Teague, Susan] Seton Hall Univ, Dept Psychol, S Orange, NJ 07079 USA		De Iorio, ML (corresponding author), Wayne State Univ, Dept Psychol, 71 W Warren Ave, Detroit, MI 48202 USA.	fv0066@wayne.edu					[Anonymous], 2014, CHRONICLE VISUALIZIN; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Bhugra D, 2004, PSYCHIAT SERV, V55, P827, DOI 10.1176/appi.ps.55.7.827; Conneeley AL, 2012, BRAIN IMPAIR, V13, P72, DOI 10.1017/BrImp.2012.3; de Sousa A, 2012, J CLIN EXP NEUROPSYC, V34, P606, DOI 10.1080/13803395.2012.667067; Farmer JE, 1997, REHABIL PSYCHOL, V42, P273; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fiske S. T., 1991, SOCIAL COGNITION, V2nd; Fraas MR, 2007, DISABIL REHABIL, V29, P1449, DOI 10.1080/09638280601102311; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P331; Greenhalgh T, 2005, BRIT MED J, V330, P628, DOI 10.1136/bmj.330.7492.628; Guilmette TJ, 2004, ARCH CLIN NEUROPSYCH, V19, P183, DOI 10.1016/S0887-6177(03)00025-8; James AIW, 2013, BRAIN INJURY, V27, P1162, DOI 10.3109/02699052.2013.804200; Jones E. E., 1990, INTERPERSONAL PERCEP; KELLEY HH, 1973, AM PSYCHOL, V28, P107, DOI 10.1037/h0034225; Krahn T.M., 2015, HDB NEUROETHICS, P1501, DOI [10.1007/978-94-007-4707-4_126, DOI 10.1007/978-94-007-4707-4_126]; Levin HS, 2002, ANN NEUROL, V52, P82, DOI 10.1002/ana.10252; Lux WE, 2007, J REHABIL RES DEV, V44, P951, DOI 10.1682/JRRD.2007.01.0009; MALLE B. F., 2004, MIND EXPLAINS BEHAV; MCAVOY BR, 1991, BMJ-BRIT MED J, V302, P833, DOI 10.1136/bmj.302.6780.833; McClure J, 2008, BRAIN INJURY, V22, P639, DOI 10.1080/02699050802255585; McClure J, 2006, BRAIN INJURY, V20, P1029, DOI 10.1080/02699050600909870; McClure J, 2011, REHABIL PSYCHOL, V56, P85, DOI 10.1037/a0023354; Novack T., 2002, UNDERSTANDING TBI; Pappadis MR, 2011, J HEAD TRAUMA REHAB, V26, P301, DOI 10.1097/HTR.0b013e3181e7832b; Redpath SJ, 2010, BRAIN INJURY, V24, P802, DOI 10.3109/02699051003709623; Riggio S, 2009, MT SINAI J MED, V76, P163, DOI 10.1002/msj.20097; Ross L., 1991, PERSON SITUATION PER; Slovarp L, 2012, BRAIN INJURY, V26, P48, DOI 10.3109/02699052.2011.635355; Springer JA, 1997, J HEAD TRAUMA REHAB, V12, P41, DOI 10.1097/00001199-199706000-00005; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Turner BJ, 2011, DISABIL REHABIL, V33, P818, DOI 10.3109/09638288.2010.513422; WILLER B, 1993, ARCH CLIN NEUROPSYCH, V8, P461, DOI 10.1016/0887-6177(93)90009-P; WOOD F, 1984, INT J PSYCHIAT MED, V14, P277; Zonfrillo MR, 2014, J PEDIATR-US, V164, P130, DOI 10.1016/j.jpeds.2013.09.022	36	1	1	0	2	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2017	62	4					516	524		10.1037/rep0000131			9	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	FT1CK	WOS:000422871400012	28383947				2022-02-06	
J	Dudley, M; Scott, K; Barker-Collo, S				Dudley, Margaret; Scott, Kelly; Barker-Collo, Suzanne			Is the test of premorbid functioning a valid measure for Maori in New Zealand?	NEW ZEALAND JOURNAL OF PSYCHOLOGY			English	Article							ADULT READING TEST; NEUROPSYCHOLOGICAL TEST-PERFORMANCE; CROSS-CULTURAL NEUROPSYCHOLOGY; TRAUMATIC BRAIN-INJURY; MULTIDIMENSIONAL MODEL; AFRICAN-AMERICANS; WAIS-R; INTELLIGENCE; INDIVIDUALS; ENGAGEMENT	This study examined whether scores on the Test of Premorbid Functioning (TOPF) accurately predicted current performance on the Wechsler Adult Intelligence Scale (Fourth Edition; WAIS-IV) in a sample of 284 neurologically normal Maori (age range 16-90yrs). Participants were recruited from seven areas of New Zealand's (NZ) North and South Islands, as well as from different iwi (tribes) to ensure a representative sample. The hypothesis that the TOPF would not accurately predict current WAIS-IV performance was supported. TOPF scores only accounted for between 32-36% of the variance in WAIS-IV Full Scale Intelligence Quotient (FSIQ) scores as compared to the over 50% typically reported in overseas studies. The TOPF accurately predicted FSIQ categorisation for just over half the sample. These findings suggest that the TOPF is not a valid measure of premorbid functioning for Maori in New Zealand.	[Dudley, Margaret; Scott, Kelly; Barker-Collo, Suzanne] Univ Auckland, Private Bag 92019, Auckland 1142, New Zealand		Dudley, M (corresponding author), Univ Auckland, Private Bag 92019, Auckland 1142, New Zealand.	m.dudley@auckland.ac.nz					ARDILA A, 1995, J CLIN EXP NEUROPSYC, V17, P143, DOI 10.1080/13803399508406589; Arnold B. R., 1994, ASSESSMENT, V1, P239, DOI DOI 10.1177/107319119400100303; Baddeley A., 1992, SPEED CAPACITY LANGU; Barker-Collo S, 2008, NEW ZEAL J PSYCHOL, V37, P53; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Brickman AM, 2006, APPL NEUROPSYCHOL, V13, P91, DOI 10.1207/s15324826an1302_4; CRAWFORD JR, 1989, BRIT J CLIN PSYCHOL, V28, P275, DOI 10.1111/j.2044-8260.1989.tb01377.x; Crawford JR, 2001, PSYCHOL MED, V31, P451, DOI 10.1017/S0033291701003634; CRAWFORD JR, 1989, PERS INDIV DIFFER, V10, P585, DOI 10.1016/0191-8869(89)90043-3; Crowell TA, 2002, ARCH CLIN NEUROPSYCH, V17, P123, DOI 10.1016/S0887-6177(00)00103-7; Dudley M, 2014, NEW ZEAL J PSYCHOL, V43, P14; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Franzen MD, 1997, ARCH CLIN NEUROPSYCH, V12, P711, DOI 10.1016/S0887-6177(97)00046-2; Harwood M, 2010, DISABIL REHABIL, V32, P972, DOI 10.3109/09638281003775378; Holdnack J. A., 2009, ADV CLIN SOLUTIONS W; Houkamau CA, 2010, NEW ZEAL J PSYCHOL, V39, P8; KAUFMAN AS, 1988, J CLIN PSYCHOL, V44, P231, DOI 10.1002/1097-4679(198803)44:2<231::AID-JCLP2270440224>3.0.CO;2-J; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Lichtwark I., 2013, NZ J PSYCHOL, V42, P75; Lichtwark I. T, 2011, THESIS; Manly JJ, 1998, J INT NEUROPSYCH SOC, V4, P291, DOI 10.1017/S1355617798002914; Manly JJ, 1998, NEUROLOGY, V50, P1238, DOI 10.1212/WNL.50.5.1238; Manly JJ, 2002, J INT NEUROPSYCH SOC, V8, P341, DOI 10.1017/S1355617702813157; Matsuoka K, 2006, PSYCHIAT CLIN NEUROS, V60, P332, DOI 10.1111/j.1440-1819.2006.01510.x; McKay W, 2014, PRESS; Nelson H.E., 1991, NATL ADULT READING T, V2nd ed.; OGDEN J, 2001, BRAIN IMPAIR, V2, P1, DOI DOI 10.1375/BRIM.2.1.1; Ogden J. A., 2003, BRAIN IMPAIR, V4, P122, DOI [10.1375/brim.4.2.122.27026, DOI 10.1375/BRIM.4.2.122.27026]; Ogden JA, 1997, NEW ZEAL J PSYCHOL, V26, P2; Razani J, 2007, CLIN NEUROPSYCHOL, V21, P776, DOI 10.1080/13854040701437481; Schrauf RW, 2006, J INT NEUROPSYCH SOC, V12, P391, DOI 10.1017/S1355617706060462; Sibley CG, 2013, CULT DIVERS ETHN MIN, V19, P97, DOI 10.1037/a0031113; Starkey NJ, 2011, NEW ZEAL J PSYCHOL, V40, P129; Statistics New Zealand, 2013, 2013 QUICKSTATS MAOR; Statistics New Zealand, 2013, 2013 QUICKSTATS CULT; STEELE CM, 1995, J PERS SOC PSYCHOL, V69, P797, DOI 10.1037/0022-3514.69.5.797; Strauss E, 2006, COMPENDIUM NEUROLOGI; Veiel HOF, 2001, PSYCHOL ASSESSMENT, V13, P356, DOI 10.1037/1040-3590.13.3.356; Wechsler D., 1997, WAIS 3 ADM SCORING M WAIS 3 ADM SCORING M; Wechsler D., 2011, TEST PREMORBID FUNCT; Wechsler D., 2008, WECHSLER ADULT INTEL	41	1	1	0	0	NEW ZEALAND PSYCHOL SOC	WELLINGTON	BUSINESS MANAGER PO BOX 4092, WELLINGTON, NEW ZEALAND	0112-109X	1179-7924		NEW ZEAL J PSYCHOL	N. Z. J. Psychol.	NOV	2017	46	3					72	79					8	Psychology, Multidisciplinary	Emerging Sources Citation Index (ESCI)	Psychology	GE1AO	WOS:000430949200010					2022-02-06	
J	Jamora, RDG; Shu, LLS; Cenina, ARF; Dioquino, CPC; Canto, PAD				Jamora, Roland Dominic G.; Shu, Leah L. Shiong; Cenina, Alvin Rae F.; Dioquino, Carissa Paz C.; Canto, Patricia Ann D.			Parkinsonism among retired Filipino boxers	BASAL GANGLIA			English	Article						Boxing; CTE; Parkinsonism	CHRONIC TRAUMATIC ENCEPHALOPATHY; PROFESSIONAL BOXERS; PUNCH DRUNK; CONSEQUENCES; CONCUSSION; DISEASE; INJURY; SPORTS	Background and purpose: Repetitive head trauma from boxing has been associated with the development of parkinsonism. This study aimed to determine the frequency of and the risk factors for parkinsonism among retired Filipino boxers. Methods: A total of 21 retired Filipino professional boxers were screened for parkinsonism using the motor part of the Movement Disorder Society - Unified Parkinson's Disease Rating Scale (MDS - UPDRS). Results: Seventeen retired boxers were found to have parkinsonism (80.95%). The factors that significantly increased the risk for parkinsonism among retired Filipino boxers were the number of fights lost (16.47 vs. 7.25, p = 0.0393) and the number of knockouts endured (2.17 vs 1.00, p = 0.0480). Boxers in heavier weight divisions had higher odds of parkinsonism compared to those in lighter weight divisions. However, this was not significant. Conclusion: The frequency of parkinsonism among retired Filipino boxers was 80.95%. The factors that significantly increased the risk for the development of parkinsonism were higher number of fights lost and number of knockouts endured.	[Jamora, Roland Dominic G.; Shu, Leah L. Shiong; Cenina, Alvin Rae F.; Dioquino, Carissa Paz C.; Canto, Patricia Ann D.] Univ Philippines Manila, Philippine Gen Hosp, Coll Med, Dept Neurosci, Manila 1000, Philippines; [Jamora, Roland Dominic G.] St Lukes Med Ctr, Movement Disorder Serv, Inst Neurosci, Quezon City, Philippines; [Jamora, Roland Dominic G.] St Lukes Med Ctr, Neurol Sect, Inst Neurosci, Quezon City, Philippines; [Jamora, Roland Dominic G.] St Lukes Med Ctr, Movement Disorder Serv, Inst Neurosci, Global City, Philippines; [Jamora, Roland Dominic G.] St Lukes Med Ctr, Neurol Sect, Inst Neurosci, Global City, Philippines		Jamora, RDG (corresponding author), Univ Philippines Manila, Philippine Gen Hosp, Coll Med, Dept Neurosci, Manila 1000, Philippines.	rgjamora@up.edu.ph	Jamora, Roland Dominic/AAT-6899-2020; Jamora, Roland Dominic G./AAO-6290-2020	Jamora, Roland Dominic/0000-0001-5317-7369; 			Bernick C, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt177; Canto P.A., 2015, ACTA MED PHILIPP, V49, P52; CASSON IR, 1984, JAMA-J AM MED ASSOC, V251, P2663, DOI 10.1001/jama.251.20.2663; Forstl H, 2010, DTSCH ARZTEBL INT, V107, P835, DOI 10.3238/arztebl.2010.0835; Gartland S, 2001, BRIT J SPORT MED, V35, P308, DOI 10.1136/bjsm.35.5.308; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; JORDAN BD, 1992, RADIOLOGY, V185, P509, DOI 10.1148/radiology.185.2.1410364; Jordan BD, 1996, PHYSICIAN SPORTSMED, V24, P87, DOI 10.3810/psm.1996.05.1358; Lee Lillian V, 2011, Int J Neurosci, V121 Suppl 1, P3, DOI 10.3109/00207454.2010.526728; Ling H, 2015, MOL CELL NEUROSCI, V66, P114, DOI 10.1016/j.mcn.2015.03.012; Lolekha P, 2010, MOVEMENT DISORD, V25, P1895, DOI 10.1002/mds.23210; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Mez J, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0407-7; Montenigro PH, 2015, BRAIN PATHOL, V25, P304, DOI 10.1111/bpa.12250; Parker HL, 1934, J NEUROL PSYCHOPATHO, V15, P20; Rabadi MH, 2001, CLIN J SPORT MED, V11, P194, DOI 10.1097/00042752-200107000-00011; Roberts AH, 1969, BRAIN DAMAGE BOXERS; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Unterharnscheidt F, 1995, Rev Neurol, V23, P1027; Zazryn T, 2007, SPORTS MED, V37, P467, DOI 10.2165/00007256-200737060-00001	20	1	1	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2210-5336	2210-5344		BASAL GANGLIA	Basal Ganglia	NOV	2017	10						1	3		10.1016/j.baga.2017.07.001			3	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	FP1BU	WOS:000417346200001					2022-02-06	
J	Jang, SH; Kwon, YH				Jang, Sung Ho; Kwon, Young Hyeon			Neural reorganization between injured cingula and the brainstem cholinergic nuclei in a patient with cerebral concussion: A case report	MEDICINE			English	Article						cerebral concussion; cingulum; diffusion tensor imaging; head trauma; traumatic axonal injury	DIFFUSION TENSOR TRACTOGRAPHY; AXONAL INJURY; CONNECTION; FATIGUE	Rationale:We report on a patient who showed neural reorganization between injured cingula and the brainstem cholinergic nuclei following cerebral concussion.Patient Concerns:The main concern of the patient is memory impairment.Diagnoses:Cerebral concussion.Outcomes:When she visited our hospital at 2 years after onset, cognitive function was evaluated using 2 scales; the Wechsler Intelligence Scale, and the Seoul neuropsychological screening battery: total IQ 97, verbal immediate recall 5.70 percentile, visual immediate recall 30.75 percentile, verbal delayed recall 3.13 percentile, visual delayed recall 11.00 percentile, verbal recognition <0.01 percentile, and visual recognition 13.70 percentile. Conventional brain magnetic resonance imaging did not show any abnormality. On 2-year diffusion tensor tractography for the cingulum, both anterior cingula were discontinued over the genu of the corpus callosum. One neural fiber bundle originating from the middle portion of the left cingulum descended through the left subcortical white matter, and connected to the left pedunculopontine nucleus (Ch 5) in the midbrain and the left laterodorsal tegmental nucleus (Ch 6) in the upper pons.Lessons:Reorganization of cholinergic innervations between cholinergic nuclei in the basal forebrain and brainstem following injury of the anterior cingulum was demonstrated in a patient with cerebral concussion.	[Jang, Sung Ho; Kwon, Young Hyeon] Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, 317-1 Daemyungdong, Daegu 705717, South Korea		Kwon, YH (corresponding author), Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, 317-1 Daemyungdong, Daegu 705717, South Korea.	kyh7648764@daum.net			National Research Foundation(NRF) of Korea - Korean Government(MSIP) [2015R1A2A2A01004073]	This work was supported by the National Research Foundation(NRF) of Korea Grant funded by the Korean Government(MSIP) (2015R1A2A2A01004073).	American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS, V2nd; Bloch KE, 1999, RESPIRATION, V66, P440, DOI 10.1159/000029408; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Concha L, 2005, AM J NEURORADIOL, V26, P2267; Jang SH, 2017, BRAIN INJURY, V31, P1159, DOI 10.1080/02699052.2017.1288265; Jang SH, 2017, BRAIN INJURY, V31, P416, DOI 10.1080/02699052.2016.1239274; Jang SH, 2016, AM J PHYS MED REHAB, V95, pE18, DOI 10.1097/PHM.0000000000000402; Kang Y.W., 2003, SEOUL NEUROPSYCHOLOG; Lee HD, 2015, NEURAL REGEN RES, V10, P498, DOI 10.4103/1673-5374.153702; Naidich TP, 2009, DUVERNOYS ATLAS HUMA; Nestler EJ, 2001, MOL NEUROPHARMACOLOG; Norrie J, 2010, BRAIN INJURY, V24, P1528, DOI 10.3109/02699052.2010.531687; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; SCHWARTZ JE, 1993, J PSYCHOSOM RES, V37, P753, DOI 10.1016/0022-3999(93)90104-N; Selden NR, 1998, BRAIN, V121, P2249, DOI 10.1093/brain/121.12.2249; Seo JP, 2014, NEURAL REGEN RES, V9, P498, DOI 10.4103/1673-5374.130068; van Huijzen, 2008, HUMAN CENTRAL NERVOU; Wechsler, 1997, WECHSLER ADULT INTEL; Yamada K, 2009, MAGN RESON MED SCI, V8, P165, DOI 10.2463/mrms.8.165; Yeo SS, 2012, NEUROREHABILITATION, V31, P143, DOI 10.3233/NRE-2012-0783; Yoo JS, 2014, BRAIN INJURY, V28, P1257, DOI 10.3109/02699052.2014.901557; 장성호, 2016, [Brain & NeuroRehabilitation, 뇌신경재활], V9, P1	22	1	1	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	NOV	2017	96	45							e8436	10.1097/MD.0000000000008436			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FM5PN	WOS:000415088700025	29137029	Green Published, gold			2022-02-06	
J	Kudo, S; Tanaka, K; Okada, K; Takemura, T				Kudo, Shunsuke; Tanaka, Keiji; Okada, Kunihiko; Takemura, Takahiro			Extracorporeal cardiopulmonary resuscitation for blunt cardiac rupture	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Extracorporeal membrane oxygenation; Extracorporeal cardiopulmonary resuscitation; Thoracic injury; Heart injury; Thoracotomy	TRAUMA	Extracorporeal cardiopulmonary resuscitation (ECPR) followed by operating room sternotomy, rather than re-suscitative thoracotomy, might be life-saving for patients with blunt cardiac rupture and cardiac arrest who do not have multiple severe traumatic injuries.& para;& para;A 49-year-old man was injured in a vehicle crash and transferred to the emergency department. On admission, he was hemodynamically stable, but a plain chest radiograph revealed a widened mediastinum, and echocardiography revealed hemopericardium . A computed tomography scan revealed hemopericardium and mediastinal hematoma, without other severe traumatic injuries. However, the patient's pulse was lost soon after he was transferred to the intensive care unit, and cardiopulmonary resuscitation was initiated. We initiated ECPR using femorofemoral veno-arterial extracorporeal membrane oxygenation (ECMO) with heparin administration, which achieved hemodynamic stability. He was transferred to the operating room for sternotomy and cardiac repair. Right ventricular rupture and pericardial sac laceration were identified intraoperatively, and cardiac repair was performed. After repairing the cardiac rupture, the cardiac output recovered spontaneously, and ECMO was discontinued intraoperatively. The patient recovered fully and was discharged from the hospital on postoperative day 7.& para;& para;In this patient, ECPR rapidly restored brain perfusion and provided enough time to perform operating room sternotomy, allowing for good surgical exposure of the heart. Moreover, open cardiac massage was unnecessary.& para;& para;ECPR with sternotomy and cardiac repair is advisable for patients with blunt cardiac rupture and cardiac arrest who do not have severe multiple traumatic injuries. (C) 2017 Elsevier Inc. All rights reserved.	[Kudo, Shunsuke; Tanaka, Keiji; Okada, Kunihiko] Saku Cent Hosp, Adv Care Ctr, Dept Emergency & Crit Care Med, 3400-28 Nakagno, Saku, Nagano, Japan; [Takemura, Takahiro] Saku Cent Hosp, Adv Care Ctr, Dept Cardiovasc Surg, 3400-28 Nakagno, Saku, Nagano, Japan		Kudo, S (corresponding author), Saku Cent Hosp, Adv Care Ctr, Dept Emergency & Crit Care Med, 3400-28 Nakagno, Saku, Nagano, Japan.	indian_river@hotmail.com	Kudo, Shunsuke/AAN-7575-2020	Kudo, Shunsuke/0000-0002-7174-7174			Bonacchi M, 2013, J THORAC CARDIOV SUR, V145, P1617, DOI 10.1016/j.jtcvs.2012.08.046; Kim Seon Hee, 2012, Korean J Thorac Cardiovasc Surg, V45, P334, DOI 10.5090/kjtcs.2012.45.5.334; Seamon MJ, 2015, J TRAUMA ACUTE CARE, V79, P159, DOI 10.1097/TA.0000000000000648	3	1	1	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	NOV	2017	35	11							1789.e1	10.1016/j.ajem.2017.08.015			2	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	FM6WJ	WOS:000415201700062	28801040				2022-02-06	
J	Lenstra, JJ; Pikstra, ARA; Fock, JM; Metting, Z; van der Naalt, J				Lenstra, J. J.; Pikstra, A. R. A.; Fock, J. M.; Metting, Z.; van der Naalt, J.			Influence of guidelines on management of paediatric mild traumatic brain injury: CT-assessment and admission policy	EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY			English	Article						Mild traumatic brain injury; Paediatric patients; Cranial CT-scan; Hospital admission; Adherence guideline; Risk factors	BLUNT HEAD TRAUMA; COMPUTED-TOMOGRAPHY USE; IDENTIFYING CHILDREN; DECISION RULE; UNITED-STATES; RISK; PREDICTION; RADIATION	Background: The annual number of paediatric injury-related emergency visits and application of computed tomography (CT) has substantially increased, with associated higher risk of malignancies. In 2010, a guideline for CT-assessment based on risk factors for patients with mild traumatic brain injury (mTBI) became effective in all Emergency Departments (ED) in the Netherlands. This study evaluated the influence of this guideline on the frequency of CT-assessments, hospital admissions and factors that are related to guideline adherence. Methods: Retrospective cohort study of paediatric mTBI (<18 years), defined by Glasgow Coma Scale score of 13-15 admitted to the ED of the University Medical Center Groningen from 2008 to 2014. Data before (pre-GL) and after (post-GL) introduction of the guideline were evaluated. Primary outcome parameters were frequency of CT-assessments and hospital admissions after ED. Results: In total 633 patients were enrolled and data from pre-GL (n = 216) and post-GL (n = 315) were compared. Mean age was 7.9 years (SD 5.9), 59% were male. CT-assessments increased from 32% to 46% (p=.001), mostly in children aged 6-18 years. Hospital admissions increased from 38% to 54% (p<.001), mostly in children <6 years. No significant increase in CT-abnormalities is seen. Guideline adherence was 57%, although CT-assessments varied from 44 to 100% depending on presence of specific major risk factors. Conclusions: Introduction of a new guideline on management of paediatric mTBI showed significant increase in CT-assessments and more hospital admissions. In clinical practice, despite increase of guideline adherence the applications of cranial CT-scan varies within age groups and depends on the weighing of risk factors. (C) 2017 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.	[Lenstra, J. J.; Pikstra, A. R. A.; van der Naalt, J.] Univ Groningen, Dept Neurol, Univ Med Ctr Groningen, Hanzepl 1, NL-9713 GZ Groningen, Netherlands; [Fock, J. M.; Metting, Z.] Univ Groningen, Univ Med Ctr Groningen, Dept Child Neurol, Groningen, Netherlands		van der Naalt, J (corresponding author), Univ Groningen, Dept Neurol, Univ Med Ctr Groningen, Hanzepl 1, NL-9713 GZ Groningen, Netherlands.	j.van.der.naalt@umcg.nl		van der Naalt, Joukje/0000-0001-9873-2418			Berdahl CT, 2013, ANN EMERG MED, V62, P486, DOI 10.1016/j.annemergmed.2013.02.018; Blackwell CD, 2007, ANN EMERG MED, V49, P320, DOI 10.1016/j.annemergmed.2006.09.025; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Dayan PS, 2014, ANN EMERG MED, V63, P657, DOI 10.1016/j.annemergmed.2014.01.009; de Gonzalez AB, 2016, BRIT J CANCER, V114, P388, DOI 10.1038/bjc.2015.415; Hageman G., 2010, RICHTLIJN OPVANG PAT; Hall P, 2004, BMJ-BRIT MED J, V328, P19, DOI 10.1136/bmj.328.7430.19; Hawley CA, 2004, J NEUROL NEUROSUR PS, V75, P737, DOI 10.1136/jnnp.2003.020651; Karpas A, 2013, PEDIATR EMERG CARE, V29, P30, DOI 10.1097/PEC.0b013e31827b5090; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Langlois JA., 2004, TRAUMATIC BRAIN INJU; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Marin JR, 2015, J PEDIATR-US, V167, P897, DOI 10.1016/j.jpeds.2015.06.052; Marin JR, 2014, ACAD EMERG MED, V21, P987, DOI 10.1111/acem.12458; McKinlay A, 2009, CHILD CARE HLTH DEV; National Institute for Health and Clinical Excellence, 2007, HEAD INJ TRIAG ASS I, V56; Palchak MJ, 2009, PEDIATR EMERG CARE, V25, P61, DOI 10.1097/PEC.0b013e318196e9c0; Palchak MJ, 2003, ANN EMERG MED, V42, P492, DOI 10.1067/S0196-0644(03)00425-6; Parkin PC, 2009, LANCET, V374, P1127, DOI 10.1016/S0140-6736(09)61634-2; Schonfeld D, 2014, ARCH DIS CHILD, V99, P427, DOI 10.1136/archdischild-2013-305004; Stanley RM, 2014, J PEDIATR-US, V165, P1201, DOI 10.1016/j.jpeds.2014.08.008; van den Brand Crispijn L, 2014, Ned Tijdschr Geneeskd, V158, pA6973; van Pelt ED, 2011, EUR J PAEDIATR NEURO, V15, P519, DOI 10.1016/j.ejpn.2011.05.005; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	25	1	1	0	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1090-3798	1532-2130		EUR J PAEDIATR NEURO	Eur. J. Paediatr. Neurol.	NOV	2017	21	6					816	822		10.1016/j.ejpn.2017.07.019			7	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	FL0FO	WOS:000413887200007	28811137				2022-02-06	
J	Ma, ZW; Jing, LL; Wang, JL; Chen, JQ; Lan, FC				Ma, Zhengwei; Jing, Lele; Wang, Jinlun; Chen, Jiqing; Lan, Fengchong			BIOMECHANICAL ANALYSIS OF OCCUPANT'S BRAIN RESPONSE AND INJURY IN VEHICLE INTERIOR SECOND IMPACT UTILIZING A REFINED HEAD FINITE ELEMENT MODEL	JOURNAL OF MECHANICS IN MEDICINE AND BIOLOGY			English	Article; Proceedings Paper	International Workshop on Biological Mechanics	OCT 17-20, 2017	Guangzhou, PEOPLES R CHINA			Side impact; A/B pillar; brain injury; refined head model; finite element		In vehicle side collisions, traumatic brain injury caused by the impact between occupant's head and the interior parts of A or B pillar is a major reason of death and disability. In order to analyze the biomechanical response and injury mechanism of occupant's brain in side collisions, a refined finite element head model representing the 50th percentile Chinese male was developed. Its improvements of biofidelity comparing to the original head model were illustrated through model simulation against the same post mortem human subjects test. Based on the refined head model, the brain biomechanical responses and injuries in the side impact with interior parts of A pillar and B pillar were analyzed according to FMVSS 201U, and the influences of different impact locations and directions were investigated. The results showed that the brain tissues on impact side sustained positive pressure and those on the opposite side experienced negative pressure. The transmission of pressure wave was easy to cause brain concussion and other diffuse brain injuries. The intracranial pressure distribution exhibited a typical pattern of contrecoup injury. The extreme stress concentration in the junction area of the cerebrum, cerebellum and brain stem could lead to focal injury such as brain contusion and laceration. Moreover, the impact injury of A pillar was more serious than that of B pillar, which was consistent with the traffic injury statistics that the head injury in oblique side collisions was more serious than that of vertical side collisions. Therefore, the interior parts of A pillar should be designed to absorb more energy than those of B pillar under the same conditions. In addition, the severity of brain injury is more sensitive to the variation of the horizontal angle than that of the vertical angle. Both the peak values of the occipital fossa pressure in effect simulations of the horizontal and vertical angles were three to four times of the peak values of the forehead pressure. When the impact horizontal angle was up to 255 degrees, or the vertical angle was up to 45 degrees, the head HIC(d) values would be up to 1320.45 and 1101.06, respectively, which indicated a AIS 3+ injury risk of the head.	[Ma, Zhengwei; Wang, Jinlun] Shenzhen Univ, Coll Mechatron & Control Engn, Shenzhen 518060, Guangdong, Peoples R China; [Ma, Zhengwei; Wang, Jinlun] Shenzhen Technol Univ, Coll Urban Transportat & Logist, Shenzhen 518118, Guangdong, Peoples R China; [Jing, Lele] Shenzhen Hangsheng Elect Co Ltd, R&D Ctr, Shenzhen 518103, Guangdong, Peoples R China; [Chen, Jiqing; Lan, Fengchong] South China Univ Technol, Sch Mech & Automot Engn, Guangzhou 510640, Guangdong, Peoples R China		Wang, JL (corresponding author), Shenzhen Univ, Coll Mechatron & Control Engn, Shenzhen 518060, Guangdong, Peoples R China.; Wang, JL (corresponding author), Shenzhen Technol Univ, Coll Urban Transportat & Logist, Shenzhen 518118, Guangdong, Peoples R China.	wangjl84@szu.edu.cn			Foundation for Distinguished Young Talents in Higher Education of Guangdong Province [2016KQNCX145]; Natural Science Foundation of Guangdong ProvinceNational Natural Science Foundation of Guangdong Province [2015A030313213, 2014A030310270]; Knowledge Innovation Program for Basic Research of Shenzhen City [JCYJ20160520164316902]; Scientific Research Start-up Foundation of Shenzhen University [2016040]	This study is supported by the Foundation for Distinguished Young Talents in Higher Education of Guangdong Province (Grant No. 2016KQNCX145), the Natural Science Foundation of Guangdong Province (Grant No. 2015A030313213 and No. 2014A030310270), the Knowledge Innovation Program for Basic Research of Shenzhen City (Fund No. JCYJ20160520164316902) and the Scientific Research Start-up Foundation of Shenzhen University (Grant No. 2016040). The authors would like to thank the support of these projects.	Al-Bsharat A. S., 1999, STAPP CAR CRASH J, V43, P321; [Anonymous], 1988, 100001988 GBT; [蔡志华 Cai Zhihua], 2012, [汽车工程, Automotive Engineering], V34, P782; Claessens M, 1997, B EXP BIOL MED, V117, P254; Gennarelli TA, 1992, P INT RES COUNC BIOM, P167; Golman AJ, 2014, ACCIDENT ANAL PREV, V64, P1, DOI 10.1016/j.aap.2013.10.026; Hardy W.N., 1997, ASME PUBLICATION AMD, V225, P241; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; Laberge-Nadeau C, 2009, J SAFETY RES, V40, P427, DOI 10.1016/j.jsr.2009.08.005; Nahum A., 1977, 21 STAPP CAR CRASH C, DOI DOI 10.4271/770922; Nahum A.M., 1976, P 20 STAPP CAR CRASH, V20, P785; National Highway Traffic Safety Administration (NHTSA), 1998, TP201U01 NHTSA FMVSS; Post A, 2015, NEUROSURGERY, V76, P81, DOI 10.1227/NEU.0000000000000554; RUAN JS, 1994, J BIOMECH ENG-T ASME, V116, P44, DOI 10.1115/1.2895703; Willinger R, 1999, ANN BIOMED ENG, V27, P403, DOI 10.1114/1.165; Xu Wei, 2008, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V25, P556; YOGANANDAN N, 1995, J NEUROTRAUM, V12, P659, DOI 10.1089/neu.1995.12.659; Zhang B, 2009, P 8 INFATS C, P345; [张建国 Zhang Jianguo], 2007, [应用力学学报, Chinese Journal of Applied Mechanics], V24, P674; Zhang L, 2001, STAPP CAR CRASH J, V45, P375; Zhao Wei, 2011, Chinese Journal of Biomedical Engineering, V30, P110, DOI 10.3969/j.issn.0258-8021.2011.01.019; Zhou C, 1995, P STAPP CAR CRASH J, V39, P121, DOI DOI 10.4271/952714	23	1	1	1	13	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0219-5194	1793-6810		J MECH MED BIOL	J. Mech. Med. Biol.	NOV	2017	17	7							1740018	10.1142/S0219519417400188			24	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biophysics; Engineering	FO3HF	WOS:000416714700020					2022-02-06	
J	Madsen, K; Hesby, S; Poulsen, I; Fuglsang, S; Graff, J; Larsen, KB; Kammersgaard, LP; Law, I; Siebner, HR				Madsen, Karine; Hesby, Sara; Poulsen, Ingrid; Fuglsang, Stefan; Graff, Jesper; Larsen, Karen B.; Kammersgaard, Lars P.; Law, Ian; Siebner, Hartwig R.			Comparison of analytical methods of brain [F-18]FDG-PET after severe traumatic brain injury	JOURNAL OF NEUROSCIENCE METHODS			English	Article						FDG; PET; TBI; Traumatic brain injury; Consciousness; Kinetic modelling; Autoradiographic method; Metabolism	GLUCOSE METABOLIC-RATE; FDG LUMPED CONSTANT; PRACTICAL SCALE; INPUT FUNCTION; HEAD-INJURY; PET; CONSCIOUSNESS; DEOXYGLUCOSE; ISCHEMIA; GLIOMAS	Background: Loss of consciousness has been shown to reduce cerebral metabolic rates of glucose (CMRgIc) measured by brain [F-18]FDG-PET. Measurements of regional metabolic patterns by normalization to global cerebral metabolism or cerebellum may underestimate widespread reductions. New method: The aim of this study was to compare quantification methods of whole brain glucose metabolism, including whole brain [F-18]FDG uptake normalized to uptake in cerebellum, normalized to injected activity, normalized to plasma tracer concentration, and two methods for estimating CMRgIc. Six patients suffering from severe traumatic brain injury (TBI) and ten healthy controls (HC) underwent a 10 min static [F-18]FDG-PET scan and venous blood sampling. Results: Except from normalizing to cerebellum, all quantification methods found significant lower level of whole brain glucose metabolism of 25-33% in TBI patients compared to HC. In accordance these measurements-correlated to level of consciousness. Comparison with existing methods: Our study demonstrates that the analysis method of the [F-18]FDG PET data has a substantial impact on the estimated whole brain cerebral glucose metabolism in patients with severe TBI. Importantly, the SUVR method which is often used in a clinical setting was not able to distinguish patients with severe TBI from HC at the whole-brain level. Conclusion: We recommend supplementing a static [F-18]FDG scan with a single venous blood sample in future studies of patients with severe TBI or reduced level of consciousness. This can be used for simple semi-quantitative uptake values by normalizing brain activity uptake to plasma tracer concentration, or quantitative estimates of CMRgIc. (C) 2017 Elsevier B.V. All rights reserved.	[Madsen, Karine; Fuglsang, Stefan; Graff, Jesper] Copenhagen Univ Hosp Hvidovre, Dept Clin Physiol & Nucl Med, Copenhagen, Denmark; [Madsen, Karine; Law, Ian] Univ Copenhagen, Rigshosp, Dept Clin Physiol Nucl Med & PET, Copenhagen, Denmark; [Hesby, Sara; Siebner, Hartwig R.] Copenhagen Univ Hosp Hvidovre, Ctr Funct & Diagnost Imaging & Res, Danish Res Ctr Magnet Resonance, Copenhagen, Denmark; [Poulsen, Ingrid; Larsen, Karen B.; Kammersgaard, Lars P.] Copenhagen Univ Hosp, Rigshosp, Traumat Brain Injury Unit, RUBRIC Res Unit Brain Injury Rehabil Copenhagen,D, Copenhagen, Denmark		Madsen, K (corresponding author), Univ Hosp Copenhagen, Rigshosp, Dept Clin Physiol Nucl Med & PET, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	karine@nru.dk	Poulsen, ingrid/AAH-2052-2019	Poulsen, ingrid/0000-0002-0342-017X; Law, Ian/0000-0001-9644-7496	Capital region of Denmark (Region H) [R135-A4841]; Lundbeck FoundationLundbeckfonden [R126-2012-12422]; Danish Council for Independent Research, section of Medical Sciences (DFF-FSS) [DFF-1331-00172]; Lundbeck FoundationLundbeckfonden [R186-2015-2138] Funding Source: researchfish; Novo Nordisk FondenNovo Nordisk Foundation [NNF14OC0011413] Funding Source: researchfish	This project has received funding from three different sources, namely the Capital region of Denmark (Region H, grant number R135-A4841), the Lundbeck Foundation (grant number R126-2012-12422), and the Danish Council for Independent Research, section of Medical Sciences (DFF-FSS, grant number DFF-1331-00172).	Annen J, 2016, HUM BRAIN MAPP, V37, P3707, DOI 10.1002/hbm.23269; BROOKS RA, 1982, J NUCL MED, V23, P538; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Graham MM, 2002, J NUCL MED, V43, P1157; Hagen C., 1972, LEVELS COGNITIVE FUN; HAWKINS RA, 1981, J CEREBR BLOOD F MET, V1, P37, DOI 10.1038/jcbfm.1981.5; Huang SC, 2004, MOL IMAGING BIOL, V6, P34, DOI 10.1016/j.mibio.2003.12.002; HUANG SC, 1980, AM J PHYSIOL, V238, pE69, DOI 10.1152/ajpendo.1980.238.1.E69; Huisman MC, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-63; HUTCHINS GD, 1984, J CEREBR BLOOD F MET, V4, P35, DOI 10.1038/jcbfm.1984.5; KUWABARA H, 1991, J NUCL MED, V32, P692; LAMMERTSMA AA, 1987, J CEREBR BLOOD F MET, V7, P161, DOI 10.1038/jcbfm.1987.39; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; REIVICH M, 1985, J CEREBR BLOOD F MET, V5, P179, DOI 10.1038/jcbfm.1985.24; RHODES CG, 1983, ANN NEUROL, V14, P614, DOI 10.1002/ana.410140604; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; Spence AM, 1998, J NUCL MED, V39, P440; Stender J, 2016, CURR BIOL, V26, P1494, DOI 10.1016/j.cub.2016.04.024; Stender J, 2015, J CEREBR BLOOD F MET, V35, P58, DOI 10.1038/jcbfm.2014.169; Stender J, 2014, LANCET, V384, P514, DOI 10.1016/S0140-6736(14)60042-8; TEASDALE G, 1974, LANCET, V2, P81; Wakita K, 2000, J NUCL MED, V41, P1484; WIENHARD K, 1985, J CEREBR BLOOD F MET, V5, P115, DOI 10.1038/jcbfm.1985.15; WILSON PD, 1988, J CEREBR BLOOD F MET, V8, P418, DOI 10.1038/jcbfm.1988.78	24	1	1	1	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	NOV 1	2017	291						176	181		10.1016/j.jneumeth.2017.07.032			6	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	FJ9AP	WOS:000413060100019	28811199				2022-02-06	
J	Oosthuizen, GV; De Wet, J; Bruce, JL; Clarke, DL				Oosthuizen, G. V.; De Wet, J.; Bruce, J. L.; Clarke, D. L.			Rib fracture fixation in a South African public trauma service	SOUTH AFRICAN JOURNAL OF SURGERY			English	Article							FLAIL CHEST; SURGICAL STABILIZATION; MANAGEMENT; METAANALYSIS	Background: Rib fractures and flail chests have traditionally been treated nonoperatively. Current literature suggests that it is not only safe and feasible but also desirable to perform fixation of severe rib fractures. Our unit in the Pietermaritzburg public sector adopted rib fracture fixation in 2014 and in this audit we assess its feasibility in our setting. Methods and Results: We audited our first nine cases of rib fracture fixation performed to date, of which seven were males. The age range was 29 to 67 years. All patients had multiple rib fractures with severe displacement; one had bilateral flail segments and one had severely displaced unilateral single fractures without flail; all others had unilateral flail chests. Time from injury to operation ranged from 3 to 20 days. Of six ventilator dependent patients, all but one were liberated from the ventilator within 3 days after fixation (1-3 days). The remaining patient remained ventilator dependent for 10 days while recovering from traumatic brain injury. This patient aside, all were discharged from ICU within 5 days. Patients with no other significant injuries were discharged from hospital within five to eight days; all being mobile within five days. Procedure-related complications included accidental pleural breach during rib mobilization necessitating intercostal drain placement (2 patients) and superficial wound infection (1 patient). All patients were discharged well. Conclusion: Rib fracture fixation is safe and feasible in our unit and is feasible in the South African public sector.	[Oosthuizen, G. V.; Bruce, J. L.; Clarke, D. L.] Univ KwaZulu Natal, Pietermaritzburg Metropolitan Trauma Serv, Pietermaritzburg, South Africa; [De Wet, J.] Univ KwaZulu Natal, Edendale Hosp, Dept Orthopaed, Pietermaritzburg, South Africa		Oosthuizen, GV (corresponding author), Univ KwaZulu Natal, Pietermaritzburg Metropolitan Trauma Serv, Pietermaritzburg, South Africa.	george.oost@gmail.com	Oosthuizen, George/AAC-5856-2022	Clarke, Damian/0000-0002-8467-1455			BELTRAMI V, 1978, THORAX, V33, P528, DOI 10.1136/thx.33.4.528; Coughlin TA, 2016, BONE JOINT J, V98B, P1119, DOI 10.1302/0301-620X.98B8.37282; Gordy S, 2014, AM J SURG, V207, P659, DOI 10.1016/j.amjsurg.2013.12.012; Granetzny Andreas, 2005, Interact Cardiovasc Thorac Surg, V4, P583, DOI 10.1510/icvts.2005.111807; Gunduz M, 2005, EMERG MED J, V22, P325, DOI 10.1136/emj.2004.019786; Leinicke JA, 2013, ANN SURG, V258, P914, DOI 10.1097/SLA.0b013e3182895bb0; Marasco S, 2015, INJURY, V46, P929, DOI 10.1016/j.injury.2014.12.021; Marasco S, 2015, INJURY, V46, P61, DOI 10.1016/j.injury.2014.06.014; Marasco SF, 2013, J AM COLL SURGEONS, V216, P924, DOI 10.1016/j.jamcollsurg.2012.12.024; Cataneo AJM, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009919.pub2; Mayberry JC, 2009, J TRAUMA, V66, P875, DOI 10.1097/TA.0b013e318190c3d3; Nishiumi Noboru, 2007, Tokai J Exp Clin Med, V32, P126; PARIS F, 1975, THORAX, V30, P521, DOI 10.1136/thx.30.5.521; Pettiford Brian L, 2007, Thorac Surg Clin, V17, P25, DOI 10.1016/j.thorsurg.2007.02.005; Pieracci FM, 2016, J TRAUMA ACUTE CARE, V80, P187, DOI 10.1097/TA.0000000000000925; Pieracci FM, 2015, J TRAUMA ACUTE CARE, V78, P883, DOI 10.1097/TA.0000000000000581; Pulley BR, 2015, J TRAUMA ACUTE CARE, V78, P530, DOI 10.1097/TA.0000000000000563; Sarani B, 2015, INJURY, V46, P2335, DOI 10.1016/j.injury.2015.10.022; Schuurmans J, 2016, EUR J TRAUMA EMERG S; Slobogean GP, 2013, J AM COLL SURGEONS, V216, P302, DOI 10.1016/j.jamcollsurg.2012.10.010; Swart E, 2017, J ORTHOP TRAUMA, V31, P64, DOI 10.1097/BOT.0000000000000750; Tanaka H, 2002, J TRAUMA, V52, P727, DOI 10.1097/00005373-200204000-00020; Vana PG, 2014, AM SURGEON, V80, P527	23	1	1	0	0	SA MEDICAL ASSOC	PRETORIA	BLOCK F CASTLE WALK CORPORATE PARK, NOSSOB STREET, ERASMUSKLOOF EXT3, PRETORIA, 0002, SOUTH AFRICA	0038-2361	2078-5151		S AFR J SURG	South Afr. J. Surg.	NOV	2017	55	4					4	8					5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	FR2GL	WOS:000418885100007	29227049				2022-02-06	
J	Oxford, RG; Chesnut, RM				Oxford, Robert Glenn; Chesnut, Randall Matther			Neurosurgical Considerations in Craniofacial Trauma	FACIAL PLASTIC SURGERY CLINICS OF NORTH AMERICA			English	Article						Craniofacial trauma; Traumatic brain injury (TBI); Critical care of TBI; Medical home for TBI; Medical home for craniofacial trauma	SEVERE HEAD-INJURY; DECOMPRESSIVE CRANIECTOMY; UNITED-STATES; BRAIN-INJURY; PREDICTORS	Spinal and traumatic brain injuries (TBIs) often accompany craniofacial trauma. Neurosurgical considerations can range from initial emergent surgery to conservative management of closed head injuries in patients with craniofacial injuries. This article discusses the most common disorders managed by neurosurgeons in the setting of craniofacial trauma and reviews the usual timing and setting for various treatments that patients with TBI encounter throughout the course of treatment. It also highlights the consequences of TBI on the timing and planning of craniofacial repairs and the importance of multidisciplinary cooperation to provide comprehensive care to survivors of trauma.	[Oxford, Robert Glenn; Chesnut, Randall Matther] Univ Washington, Dept Neurol Surg, Harborview Med Ctr, UW Med, Box 359924,325 Ninth Ave, Seattle, WA 98104 USA		Chesnut, RM (corresponding author), Univ Washington, Dept Neurol Surg, Harborview Med Ctr, UW Med, Box 359924,325 Ninth Ave, Seattle, WA 98104 USA.	chesnutr@neurosurgery.washington.edu					Aarabi B, 2014, J NEUROSURG, V120, P1138, DOI 10.3171/2014.1.JNS131869; [Anonymous], 2001, J TRAUMA, V51, pS34; [Anonymous], 2001, J Trauma, V51, pS3; Chesnut RM, 1997, J TRAUMA, V42, pS4, DOI 10.1097/00005373-199705001-00002; Choi D, 1996, BRIT J NEUROSURG, V10, P571, DOI 10.1080/02688699646880; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dellit TH, 2014, INFECT CONT HOSP EP, V35, P589, DOI 10.1086/675828; Halsted WS, 1904, B JOHNS HOPKINS HOSP, V15, P267; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kalanithi P, 2011, J NEUROSURG, V115, P1013, DOI 10.3171/2011.6.JNS101989; Kellman RM, 2008, CRANIOMAX TRAUM REC, V1, P39, DOI 10.1055/s-0028-1098962; LEMIRE RJ, 1988, JAMA-J AM MED ASSOC, V259, P558, DOI 10.1001/jama.259.4.558; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Moe KS, 2010, NEUROSURGERY, V67, P16, DOI 10.1227/01.NEU.0000373431.08464.43; Morton RP, 2016, J NEUROSURG, V125, P766, DOI 10.3171/2015.8.JNS151390; Peterson EC, 2011, INT J VASC MED, V2011, DOI 10.1155/2011/823525; Peterson EC, 2011, J TRAUMA, V71, P1588, DOI 10.1097/TA.0b013e31822b791d; Pressman JJ, 2001, ATLAS HEAD NECK SURG, V2, P1018; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014	23	1	1	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1064-7406			FACIAL PLAST SURG CL	Facial Plast. Surg. Clin. N. Am.	NOV	2017	25	4					479	+		10.1016/j.fsc.2017.06.002			14	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	FK4WX	WOS:000413498600002	28941502				2022-02-06	
J	Teplan, M; Bajla, I; Rosipal, R; Rusnak, M				Teplan, M.; Bajla, I.; Rosipal, R.; Rusnak, M.			Feature clustering of intracranial pressure time series for alarm function estimation in traumatic brain injury	PHYSIOLOGICAL MEASUREMENT			English	Article						intracranial pressure (ICP) measurement; ICP time-series; ICP feature clustering; Gaussian mixture model; alarm functions	SEVERE HEAD-INJURY; GUIDELINES; MANAGEMENT; HYPERTENSION	Objective: The conventional application of intracranial pressure (ICP) monitoring of traumatic brain injury (TBI) patients consists merely in the acquisition of ICP values in discrete time and their comparison to the established ICP threshold. An exceeding of this threshold triggers a special emergency treatment protocol. This paper addresses the possibility of making use of the rich information latent in the ICP records of known vital and fatal outcomes gathered during real clinical practice of treating TBI patients. Our assumption was that the proposed algorithmic procedure derived from this information could, in addition to ICP monitoring itself, provide a complementary added value. This might help clinicians to make better decisions during a patient's treatment. Approach: We concentrated on studying specific clustering schemes for subsequences of ICP time series. The clusterization problem was formulated for feature vectors which are introduced to represent ICP time subsequences. The ICP transformation to a feature space uses global and local definitions of time subsequences. For clusterization itself, we adopted hierarchical Gaussian mixture models (hGMMs). By using posterior probabilities of the clusters, we introduced three novel alarm functions. We explored two alternative methods of searching for optimum alarm function thresholds (ROC analysis and a novel efficiency measure). Main results: We performed extensive cross-validation experiments on a clinical retrospective data set. The results of the optimization over several hGMMs, various feature space dimensionality and all the types of the novel alarm functions show the potential of the novel alarm functions for supplementing conventional ICP monitoring. Significance: In conclusion, the paper provides a prospective extended ICP monitoring technique for real TBI patients, based on the proposed methodology of ICP subsequence clustering and thresholding of the optimum novel alarm function.	[Teplan, M.; Bajla, I.; Rosipal, R.] Slovak Acad Sci, Inst Measurement Sci, Dept Theoret Methods, Bratislava, Slovakia; [Rusnak, M.] Trnava Univ, Dept Publ Hlth, Trnava, Slovakia		Teplan, M (corresponding author), Slovak Acad Sci, Inst Measurement Sci, Dept Theoret Methods, Bratislava, Slovakia.	michal.teplan@savba.sk	Teplan, Michal/U-3202-2018; Rosipal, Roman/B-8060-2008; Bajla, Ivan/D-6883-2011	Teplan, Michal/0000-0002-9379-0093; 	Slovak Grant Agency for ScienceVedecka grantova agentura MSVVaS SR a SAV (VEGA) [VEGA 2/0138/16, VEGA 2/0011/16];  [MZ 2013/56-SAV-6];  [APVV-0668-12];  [APVV-14-0875]	This work has been supported by the Slovak Grant Agency for Science (projects VEGA 2/0138/16, VEGA 2/0011/16) and by the MZ 2013/56-SAV-6, APVV-0668-12, and APVV-14-0875 grants. We appreciate the helpful assistance of Prof Dr Med. Walter Mauritz, PhD, primarius of the Lorenz Bohler Unfallkrankenhaus Wien, Vienna, Austria, who provided us with an archive data set of ICP records. We appreciate the valuable comments and recommendations of the anonymous reviewers which made it possible to considerably increase the technical quality and readability of the paper. We are grateful to the postdoctoral fellow Dr Radoslav Skoviera who carried out computer experiments aimed at testing Keogh's (Keogh and Lin 2005) claim that 'clustering of time series subsequences is meaningless'.	Arabi YM, 2010, J CRIT CARE, V25, P190, DOI 10.1016/j.jcrc.2009.05.004; Balestreri M, 2004, ACTA NEUROCHIR, V146, P131, DOI 10.1007/s00701-003-0187-y; Bishop CM., 2006, PATTERN RECOGN; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock MR, 1996, J NEUROTRAUM, V13, P643; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chambers IR, 2001, J NEUROSURG, V94, P412, DOI 10.3171/jns.2001.94.3.0412; Chesnut R, 2014, NEUROCRIT CARE, V21, P64, DOI 10.1007/s12028-014-0048-y; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fu TC, 2011, ENG APPL ARTIF INTEL, V24, P164, DOI 10.1016/j.engappai.2010.09.007; Gama J, 2012, PROG ARTIF INTELL, V1, P45, DOI 10.1007/s13748-011-0002-6; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Guiza F, 2015, INTENS CARE MED, V41, P1067, DOI 10.1007/s00134-015-3806-1; Hesdorffer DC, 2002, J TRAUMA, V52, P1202, DOI 10.1097/00005373-200206000-00031; Honda M, 2017, CARE IN PRESS; Indrayan A, 2013, MED BIOSTATISTICS; Jain AK, 2010, PATTERN RECOGN LETT, V31, P651, DOI 10.1016/j.patrec.2009.09.011; Joseph M, 2005, INDIAN J CRIT CARE M, V9, P35, DOI 10.4103/0972-5229.16268; Jun-Yu-Fan R N, 2010, BIOL RES NURS, V11, P317; Keogh E, 2005, KNOWL INF SYST, V8, P154, DOI 10.1007/s10115-004-0172-7; Kuncheva LI, 2013, PROG ARTIF INTELL, V2, P65, DOI 10.1007/s13748-012-0037-3; Lee HJ, 2016, IEEE T BIO-MED ENG, V63, P2169, DOI 10.1109/TBME.2015.2512278; Leeflang MMG, 2008, CLIN CHEM, V54, P729, DOI 10.1373/clinchem.2007.096032; Liu XH, 2012, STAT MED, V31, P2676, DOI 10.1002/sim.4509; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Marmarou A, 1991, J NEUROSURG, V69, P15; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; MingLiu C E, 2002, P 7 INT C SPOK LANG, P1353; Nabney I., 2002, NETLAB ALGORITHMS PA; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; NOVAK D, 2004, CLUST INTR PRESS US, V26, P1; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; TEASDALE G, 1974, LANCET, V2, P81; Vukic M, 1999, ACTA NEUROCHIR, V141, P1203, DOI 10.1007/s007010050419; Zhang X, 2017, PHYSIOL MEAS, V38, P143, DOI 10.1088/1361-6579/aa7256	37	1	1	0	6	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0967-3334	1361-6579		PHYSIOL MEAS	Physiol. Meas.	NOV	2017	38	11					2015	2043		10.1088/1361-6579/aa8a51			29	Biophysics; Engineering, Biomedical; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering; Physiology	FL4DE	WOS:000414176400007	29087961				2022-02-06	
J	Woodard, TJ; Kim, C; Calderon, F; Hill, C				Woodard, Todd J.; Kim, Charles; Calderon, Florencio; Hill, Carolyn			Review of the Diagnosis and Management of Pseudobulbar Affect	US PHARMACIST			English	Article								Pseudobulbar affect (PBA) is a type of affect lability characterized by sudden, frequent, and uncontrollable episodes of crying, and or laughing. The disease states most frequently associated with PBA are Alzheimer's disease, amyotrophic lateral sclerosis, multiple sclerosis, Parkinson's disease, stroke, and traumatic brain injury. Standardized rating scales can be used for PBA as screening instruments or to more objectively measure PBA. The treatments utilized for PBA target serotonin, norepinephrine, and glutamate with goals of reducing severity and episode frequency of PBA.	[Woodard, Todd J.; Kim, Charles] Peach State Hlth Plan, Clin Pharm Serv, Atlanta, GA 30339 USA; [Woodard, Todd J.; Kim, Charles] Philadelphia Coll Osteopath Med, Sch Pharm, Pharm Practice, Suwanee, GA 30024 USA; [Kim, Charles] Mercer Univ, Coll Pharm, Atlanta, GA USA; [Calderon, Florencio] TIESRx, Tampa, FL USA; [Hill, Carolyn] St Anthony Hosp, Behav Hlth Specialty, St Petersburg, FL USA		Woodard, TJ (corresponding author), Peach State Hlth Plan, Clin Pharm Serv, Atlanta, GA 30339 USA.; Woodard, TJ (corresponding author), Philadelphia Coll Osteopath Med, Sch Pharm, Pharm Practice, Suwanee, GA 30024 USA.							0	1	1	0	0	JOBSON PUBLISHING LLC	NEW YORK	100 AVE OF THE AMERICAS, NEW YORK, NY 10013-1678 USA	0148-4818	2331-3501		US PHARM	US Pharm.	NOV	2017	42	11					31	35					5	Pharmacology & Pharmacy	Emerging Sources Citation Index (ESCI)	Pharmacology & Pharmacy	FP1JV	WOS:000417369400005					2022-02-06	
J	Afshari, J; Haghpanahi, M; Kalantarinejad, R				Afshari, Javad; Haghpanahi, Mohammad; Kalantarinejad, Reza			Developing new brain injury criteria for predicting the intracranial response by calculating von Mises stress, coup pressure and contrecoup pressure	JOURNAL OF THE BRAZILIAN SOCIETY OF MECHANICAL SCIENCES AND ENGINEERING			English	Article						Head kinematics; Traumatic brain injury; Computational modeling; Finite element method; Injury criteria; Safety	HEAD IMPACTS; MILD; ACCELERATION; FOOTBALL; CONCUSSIONS; DIRECTION; MODERATE; PLAYERS	Animal and anatomic research has shown that head impact direction is an influential parameter in the risk of traumatic brain injury (TBI). In this field, however, not much research has been done on human subjects. The aim of this study is to assess influences of head impact direction on the intracranial responses. Furthermore, brain injury criteria have been developed to predict the influences of impact direction on probability of head injury and brain responses. For this purpose, 150 head impacts were simulated for three magnitudes and 50 directions of translational impact using finite element head model. Simulations were performed to evaluate pressure and stress responses by brain tissues due to changing the impact direction. Next, statistical analysis was used to develop new head injury criteria. The results indicate that TBI risk in simulations with sagittal and frontal planes are higher than those with transverse plane impacts. Furthermore, it has been shown that impact direction is as important as the impact magnitude and duration to develop head injury index. Moreover, new head injury indices have been proposed for predicting von Mises stress, coup pressure, and contrecoup pressure in the brain which have correlation coefficients 0.86, 0.92 and 0.89 with FEM responses, respectively. However, the results of this study show the influence of impact direction on TBI risk. It also indicates that impact direction and brain responses are necessary for developing head injury index.	[Afshari, Javad; Haghpanahi, Mohammad] Iran Univ Sci & Technol, Sch Mech Engn, Tehran 1684613114, Iran; [Kalantarinejad, Reza] Iranian Minist Sci & Res Technol, Aerosp Res Inst, Tehran, Iran		Haghpanahi, M (corresponding author), Iran Univ Sci & Technol, Sch Mech Engn, Tehran 1684613114, Iran.	j_afshari_m@yahoo.com; mhaghpanahi@iust.ac.ir; rezakalantarinezhad@gmail.com	Haghpanahi, Mohammad/S-8992-2018				Amen DG, 2011, J PSYCHOACTIVE DRUGS, V43, P1, DOI 10.1080/02791072.2011.566489; Atabaki SM, 2007, PEDIATR REV, V28, P215, DOI 10.1542/pir.28-6-215; Bandak F, 2001, P INT TECHN C ENH SA, P7; Bhatoe HS, 1999, ACTA NEUROCHIR, V141, P515, DOI 10.1007/s007010050333; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Deck C, 2008, INT J CRASHWORTHINES, V13, P667, DOI 10.1080/13588260802411523; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Doorly MC, 2007, INVESTIGATIONS HEAD; Duma SM, 2011, EXERC SPORT SCI REV, V39, P2, DOI 10.1097/JES.0b013e318203dfdb; Faul M, 2010, GA NATL CENT INJ PRE; Gadd C., 1966, SAE TECHNICAL PAPER; Gennarelli T.A., 1972, SAE TECHNICAL PAPER; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gennarelli TA., 1987, 872197 SAE; Ghaffari M., 2014, J MODERN ENG, V14, P54; Ghaffari M, 2012, 2012 19TH IRANIAN CONFERENCE OF BIOMEDICAL ENGINEERING (ICBME), P1, DOI 10.1109/IRMMW-THz.2012.6380272; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Huang HM, 1999, J TRAUMA, V47, P538, DOI 10.1097/00005373-199909000-00019; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S, 2003, J NEUROTRAUM, V20, P365, DOI 10.1089/089771503765172327; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Milne G, 2014, INT J CRASHWORTHINES, V19, P323, DOI 10.1080/13588265.2013.859470; O'Connor C, 2005, PSYCHOL REP, V97, P169, DOI 10.2466/PR0.97.5.169-179; Ommaya AK., 1985, BIOMECHANICS TRAUMA, P245; Panzer MB, 2016, INT J AUTOMOT ENG, V7, P37, DOI 10.20485/jsaeijae.7.1_37; Post A, 2015, NEUROSURGERY, V76, P81, DOI 10.1227/NEU.0000000000000554; Post A, 2014, J BIOMECH, V47, P1074, DOI 10.1016/j.jbiomech.2013.12.026; Post A, 2012, P I MECH ENG P-J SPO, V226, P290, DOI 10.1177/1754337112436629; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Rowson S, 2011, J APPL BIOMECH, V27, P8, DOI 10.1123/jab.27.1.8; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Saboori P, 2011, IMECE 2011, V2, P89; SHUCK LZ, 1972, J BASIC ENG-T ASME, V94, P905, DOI 10.1115/1.3425588; Sosin DM, 1996, BRAIN INJURY, V10, P47; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; Takhounts E. G., 2011, P 22 ENH SAF VEH C; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Trosseille X., 1992, DEV FEM HUMAN HEAD A; Versace J, 1971, SAE TECHNICAL PAPER; Ward CC., 1977, INTRACRANIAL PRESSUR; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Zhou C, 1997, INT IRCOBI C BIOM IM	50	1	1	0	8	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1678-5878	1806-3691		J BRAZ SOC MECH SCI	J. Braz. Soc. Mech. Sci. Eng.	OCT	2017	39	10					3729	3741		10.1007/s40430-017-0830-9			13	Engineering, Mechanical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	FH4LY	WOS:000411127300002					2022-02-06	
J	Behmanesh, B; Bartels, M; Gessler, F; Filmann, N; Seifert, V; Setzer, M; Freiman, TM				Behmanesh, Bedjan; Bartels, Marco; Gessler, Florian; Filmann, Natalie; Seifert, Volker; Setzer, Matthias; Freiman, Thomas M.			Noninvasive Transfontanelle Monitoring of the Intracerebral Pressure in Comparison With an Invasive Intradural Intracranial Pressure Device: A Prospective Study	OPERATIVE NEUROSURGERY			English	Article						Noninvasive ICP monitoring; Children; Traumatic brain injury; Transfontanelle ICP monitoring; External ventricle drain; Subdural ICP device	SEVERE HEAD-INJURY; CHILDREN	BACKGROUND: We previously introduced a novel noninvasive technique of intracranial pressure (ICP) monitoring in children with open fontanelles. OBJECTIVE: To compare the ICP obtained by our new technique to the ICP derived from an intradurally implanted ICP measurement device (external ventricular drain, subdural ICP device). METHODS: Children with open fontanelles and need of intracranial monitoring were included in this study. A standard ICP probe was placed upon the frontal fontanelle and datawere compared with the values recorded by an already invasively implanted subdural ICP technique. The 2 methods of ICP measurement were evaluated using the correlation coefficient, Bland and Altman method and method comparison by Carstensen. RESULTS: Five children under the age of 1 year with an open frontal fontanelle were included in this study. Three were male and 2 were female. Mean age was 7 months. A total of 139 pairs of measurements were assessed. Mean transfontanelle ICP was 7.6 mm Hg. Mean ICP measured subdurally was 5.4 mm Hg. The correlation analysis showed a correlation coefficient of 0.7. The Bland-Altman plot revealed a good accuracy of the new method with >95% of the values within the limits of agreement. An additional method comparison analysis confirmed the finding of accurate ICP measurements between both applied methods. CONCLUSION: The noninvasive transfontanelle ICP monitoring method displayed a high validity and reliability as proven by correlation analysis. This novel technique might therefore be an interesting and promising tool for noninvasive ICP monitoring in children. But further research is necessary to evaluate the accuracy of this technique in children with elevated ICP.	[Behmanesh, Bedjan; Gessler, Florian; Seifert, Volker; Setzer, Matthias; Freiman, Thomas M.] Goethe Univ, Dept Neurosurg, Frankfurt, Germany; [Bartels, Marco] Goethe Univ, Dept Neuropediat, Frankfurt, Germany; [Filmann, Natalie] Goethe Univ, Inst Biostat & Math Modeling, Frankfurt, Germany		Behmanesh, B (corresponding author), Univ Hosp Frankfurt, Dept Neurosurg, Schleusenweg 2-16, D-60528 Frankfurt, Germany.	bedjan.behmanesh@gmail.com	Freiman, Thomas/AAV-8494-2021	Freiman, Thomas/0000-0002-2591-2829; Filmann, Natalie/0000-0003-0424-2317			Anderson RCE, 2004, J NEUROSURG, V101, P53, DOI 10.3171/ped.2004.101.2.0053; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Behmanesh B, 2016, J NEUROSURG-PEDIATR, V18, P372, DOI 10.3171/2016.3.PEDS15701; Bratton SL, 2007, J NEUROTRAUMA S1, V24, pS45, DOI DOI 10.1089/NEU.2007.9989; Carstensen B, 2008, INT J BIOSTAT, V4, P16, DOI DOI 10.2202/1557-4679.1107; Chambers IR, 2001, J NEUROL NEUROSUR PS, V71, P383, DOI 10.1136/jnnp.71.3.383; Lang JM, 2003, NEUROSURGERY, V52, P1455, DOI 10.1227/01.NEU.0000065136.70455.6F; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; NORTH B, 1986, NEUROSURGERY, V18, P730, DOI 10.1227/00006123-198606000-00009; Raabe A, 1998, NEUROSURGERY, V43, P306, DOI 10.1097/00006123-199808000-00073; Raboel PH, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/950393; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Roumeliotis N, 2015, CHILD NERV SYST, V31, P2011, DOI 10.1007/s00381-015-2837-9; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Schmidt B, 1997, STROKE, V28, P2465, DOI 10.1161/01.STR.28.12.2465; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Vukic M, 1999, ACTA NEUROCHIR, V141, P1203, DOI 10.1007/s007010050419	20	1	1	0	6	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	2332-4252	2332-4260		OPER NEUROSURG	Oper. Neurosurg.	OCT	2017	13	5					609	613		10.1093/ons/opx024			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FI9DO	WOS:000412304400011	28922874				2022-02-06	
J	Chen, KY; Huang, SW; Lin, YN; Liao, CD; Hou, WH; Liou, TH; Chiang, YH; Tsai, SH; Chiu, WT; Hsu, WC; Lin, LF				Chen, Kai-Yun; Huang, Shih-Wei; Lin, Yen-Nung; Liao, Chun-De; Hou, Wen-Hsuan; Liou, Tsan-Hon; Chiang, Yung-Hsiao; Tsai, Shin-Han; Chiu, Wen-Ta; Hsu, Wei-Chun; Lin, Li-Fong			Postural Stability Assessment in Patients with Mild Traumatic Brain Injury Complaining of Dizziness	JOURNAL OF MEDICAL AND BIOLOGICAL ENGINEERING			English	Article						Balance function; Postural stability; Sensory integration; Mild traumatic brain injury (mTBI)	FUNCTIONAL SOMATIC SYNDROMES; BALANCE DISORDERS; HANDICAP INVENTORY; OUTCOME MEASURES; PERFORMANCE; CONCUSSION; SYMPTOMS; HEAD	We compared subjective and objective measurements of symptoms of dizziness and postural stability in patients with mild traumatic brain injury (mTBI) during the first week following the injury. We recruited 244 patients with mTBI and 105 controls. The Dizziness Handicap Inventory (DHI) and modified Clinical Test of Sensory Integration and Balance were used as the subjective and objective measures of dizziness and ability to perform daily activities, respectively. All four DHI subscores significantly differed among the three mTBI subgroups (low, middle, and high; P = 0.00). The predictor of postural stability and sensory integration in all three DHI subgroups was the eyes closed while standing on a firm surface (ECFIS) condition (P = 0.03). A significant relationship was observed between the emotional (r = 0.14, P = 0.028) and total (r = 0.13, P = 0.048) aspects of the DHI and sensory integration indices (ECFIS). Compared with the healthy controls, balance, postural stability, and sensory integration were considerably impaired in the patients with mTBIs. However, a low correlation was observed between subjective (DHI) and objective balance measurements.	[Chen, Kai-Yun; Chiang, Yung-Hsiao] Taipei Med Univ, Grad Inst Neural Regenerat Med, Coll Med Sci & Technol, Taipei 110, Taiwan; [Chen, Kai-Yun; Chiang, Yung-Hsiao] Taipei Med Univ, Ctr Neurotrauma & Neuroregenerat, Taipei 110, Taiwan; [Huang, Shih-Wei; Liao, Chun-De; Liou, Tsan-Hon; Lin, Li-Fong] Taipei Med Univ, Shuang Ho Hosp, Dept Phys Med & Rehabil, 291 Zhongzheng Rd, New Taipei 23561, Taiwan; [Huang, Shih-Wei; Hou, Wen-Hsuan; Liou, Tsan-Hon] Taipei Med Univ, Sch Med, Dept Phys Med & Rehabil, Coll Med, Taipei 110, Taiwan; [Lin, Yen-Nung] Taipei Med Univ, Dept Phys Med & Rehabil, Wan Fang Med Ctr, Taipei 110, Taiwan; [Lin, Yen-Nung; Liou, Tsan-Hon; Tsai, Shin-Han; Chiu, Wen-Ta] Taipei Med Univ, Grad Inst Injury Prevent & Control, Taipei 110, Taiwan; [Liao, Chun-De] Natl Taiwan Univ, Sch & Grad Inst Phys Therapy, Coll Med, Taipei 110, Taiwan; [Hou, Wen-Hsuan] Taipei Med Univ, Coll Nursing, Master Program Long Term Care, Taipei 110, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ Hosp, Dept Neurosurg, Taipei 110, Taiwan; [Hsu, Wei-Chun] Natl Taiwan Univ Sci & Technol, Inst Biomed Engn, Taipei, Taiwan; [Hou, Wen-Hsuan; Lin, Li-Fong] Taipei Med Univ, Sch Gerontol Hlth Management, Coll Nursing, Taipei 110, Taiwan		Lin, LF (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Phys Med & Rehabil, 291 Zhongzheng Rd, New Taipei 23561, Taiwan.; Lin, LF (corresponding author), Taipei Med Univ, Sch Gerontol Hlth Management, Coll Nursing, Taipei 110, Taiwan.	08168@s.tmu.edu.tw	Hou, Wen-Hsuan/ABB-2903-2021; Liao, Chun-De/AAW-5990-2020; Huang, ShihWei/S-9278-2019; Liou, Tsan-Hon/I-8808-2019; Lin, Li-Fong/AAU-4368-2021	Hou, Wen-Hsuan/0000-0002-4376-6298; Liao, Chun-De/0000-0002-1930-4915; Liou, Tsan-Hon/0000-0002-0959-4023; Lin, Yen-Nung/0000-0002-7350-503X	Ministry of Health and Welfare Grant [MOHW105-TDU-B212-133018]; Taipei Medical University Grant [TMU102-AE1-B27]; Taipei Medical University - National Taiwan University of Science and Technology Joint Research Program [TMU-NTUST-104-03]; Shuang Ho Hospital, Taipei Medical University [105-SHH-HCP-06]	This study was supported by research grants from Ministry of Health and Welfare Grant (MOHW105-TDU-B212-133018), Taipei Medical University Grant (TMU102-AE1-B27), Taipei Medical University - National Taiwan University of Science and Technology Joint Research Program (TMU-NTUST-104-03), Shuang Ho Hospital, Taipei Medical University (105-SHH-HCP-06).	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Arciniegas DB, 2001, BRAIN INJURY, V15, P649, DOI 10.1080/02699050010019800; Arnold BL, 1998, J ATHL TRAINING, V33, P323; Barsky AJ, 1999, ANN INTERN MED, V130, P910, DOI 10.7326/0003-4819-130-11-199906010-00016; Brewin CR, 2005, J TRAUMA STRESS, V18, P53, DOI 10.1002/jts.20007; Chlu WT, 2007, J CLIN NEUROSCI, V14, P930, DOI 10.1016/j.jocn.2006.08.004; Crooks Carol Y, 2007, Phys Med Rehabil Clin N Am, V18, P681, DOI 10.1016/j.pmr.2007.06.005; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Fong E, 2015, ARCH PHYS MED REHAB, V96, P357, DOI 10.1016/j.apmr.2014.09.017; Gottshall K, 2003, LARYNGOSCOPE, V113, P1746, DOI 10.1097/00005537-200310000-00016; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; LEHMANN JF, 1990, ARCH PHYS MED REHAB, V71, P955; Lin LF, 2015, BRAIN INJURY, V29, P41, DOI 10.3109/02699052.2014.955881; Loughran T, 2006, OTOL NEUROTOL, V27, P86, DOI 10.1097/01.mao.0000187237.48959.5f; Pape MM, 2016, J HEAD TRAUMA REHAB, V31, P339, DOI 10.1097/HTR.0000000000000179; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; RUBIN AM, 1995, AM J OTOL, V16, P216; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; Vereeck L, 2007, OTOL NEUROTOL, V28, P87, DOI 10.1097/01.mao.0000247821.98398.0d; Wessely S, 1999, LANCET, V354, P936, DOI 10.1016/S0140-6736(98)08320-2; Whitney SL, 2004, OTOL NEUROTOL, V25, P139, DOI 10.1097/00129492-200403000-00010; Yardley L, 2001, J ANXIETY DISORD, V15, P107, DOI 10.1016/S0887-6185(00)00045-1	29	1	1	0	3	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1609-0985	2199-4757		J MED BIOL ENG	J. Med. Biol. Eng.	OCT	2017	37	5					730	738		10.1007/s40846-017-0285-6			9	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	FI2SC	WOS:000411792400011					2022-02-06	
J	Choi, HY; Shin, J; Oh, CJ; Bae, JH				Choi, Hyung Yun; Shin, Jaeho; Oh, Chang Jin; Bae, Jin Ho			Occupant injury risk analysis at NASS/CDS database	INTERNATIONAL JOURNAL OF AUTOMOTIVE TECHNOLOGY			English	Article						NASS/CDS; Airbag; Seat belt; Inner trim; Injury source	COLLISIONS; PATTERNS; AIRBAG	Injury information for vehicle occupants from the body regions of the head, thorax, abdomen, and upper and lower extremities, due to the restraints and interior parts of the vehicle, were extracted from the 2009 similar to 2012 NASS/CDS database. For those cases with high occurrence frequency, a detailed and comprehensive data analysis was performed to find the relationship between the accident, occupant, vehicle, and injury data. A numerical frontal impact sled model with the Hybrid III dummy and the GHBMC human body model was constructed to simulate and identify those injury risks according to NASS/CDS. Among the 5,734 injuries to the aforementioned body regions from frontal crashes are, listed by frequency of occurrence, the lower extremity (27.8 %), upper extremity (21.3 %), thorax (15.1 %), face (10.9 %), spine (8.7 %), head (7.3 %), and abdomen (6.9 %). The main injury sources to the head were the windshield, side structure, and steering wheel. For the thorax and abdomen they were the seat belt and steering wheel. For the lower extremity it was the instrument panel. The main injury patterns for the head were the concussion and the contusion. For the thorax they were vessel laceration and lung contusion. For the abdomen they were laceration and contusion of the organs. For the lower extremity they were bone fracture and ligament rupture. The steering wheel and seat positions were main factors affecting head and thorax injury risks. From the sled impact simulation, high injury risks of the head and thorax were assessed respectively at conditions of steering column tilt down and rear most seat position, which correlated well with the findings from the NASS/CDS data analysis.	[Choi, Hyung Yun] Hongik Univ, Dept Mech & Syst Design Engn, Seoul 04066, South Korea; [Shin, Jaeho] Kyungil Univ, Sch Mech & Automot Engn, Gyeongbuk 38428, South Korea; [Oh, Chang Jin; Bae, Jin Ho] Hyundai & Kia Motor Co, Div Res & Dev, 150 Hyundaiyeonguso Ro, Hwaseong Si 18280, Gyeonggi, South Korea		Shin, J (corresponding author), Kyungil Univ, Sch Mech & Automot Engn, Gyeongbuk 38428, South Korea.	jhshin@kiu.kr					Barnes J. S., 2001, ARSRPE C; Bostrom O., 2011, 22 ENH SAF VEH C WAS; Cuerden R., 2001, P IRCOBI C ISL MAN; Davis RP, 2004, J TRAUMA, V56, P64, DOI 10.1097/01.TA.0000094428.99903.12; Duma SM, 2003, OPHTHAL PLAST RECONS, V19, P107, DOI 10.1097/01.IOP.0000056021.24630.A6; Frampton R. J., 2000, P IRCOBI C MONTP FRA; Han M. Y., 2014, KOR AUT SAF ASS AUT; Huber C D, 2005, Traffic Inj Prev, V6, P170, DOI 10.1080/15389580590931644; Murphy RX, 2000, PLAST RECONSTR SURG, V105, P516, DOI 10.1097/00006534-200002000-00005; Pintar F. A., 2000, 44 AAAM ANN C; Untaroiu C., 2011, P IRCOBI C KRAK POL; Wallis LA, 2002, EMERG MED J, V19, P490, DOI 10.1136/emj.19.6.490; Yue N, 2014, TRAFFIC INJ PREV, V15, P513, DOI 10.1080/15389588.2013.840884	13	1	2	0	16	KOREAN SOC AUTOMOTIVE ENGINEERS-KSAE	SEOUL	#1301, PARADISE VENTURE TOWER, 52-GIL 21, TEHERAN-RO, GANGNAM-GU, SEOUL 135-919, SOUTH KOREA	1229-9138	1976-3832		INT J AUTO TECH-KOR	Int. J. Automot. Technol.	OCT	2017	18	5					851	860		10.1007/s12239-017-0083-8			10	Engineering, Mechanical; Transportation Science & Technology	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Transportation	FA2AF	WOS:000405242200010					2022-02-06	
J	Griffiths, H; Goyal, MS; Pineda, JA				Griffiths, Heidi; Goyal, Manu S.; Pineda, Jose A.			Brain metabolism and severe pediatric traumatic brain injury	CHILDS NERVOUS SYSTEM			English	Article						Traumatic brain injury; Brain metabolism; Secondary injury	CEREBRAL PERFUSION-PRESSURE; MAGNETIC-RESONANCE SPECTROSCOPY; INTRACRANIAL-PRESSURE; CEREBROVASCULAR RESPONSE; THERAPEUTIC HYPOTHERMIA; HEAD-INJURY; CHILDREN; OUTCOMES; OXYGENATION; THRESHOLDS	Age-dependent changes in brain metabolism may influence the response to and tolerance of secondary insults, potentially affecting outcomes. More complete characterization of brain metabolism across the clinical trajectory of severe pediatric TBI is needed to improve our ability to measure and better mitigate the impact of secondary insults. Better management of secondary insults will impact clinical care and the probability of success of future neuroprotective clinical trials. Improved bedside monitoring and imaging technologies will be required to achieve these goals. Effective and sustained integration of brain metabolism information into the pediatric critical care setting will be equally challenging and important.	[Griffiths, Heidi] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Goyal, Manu S.] Washington Univ, Sch Med, Dept Neuroradiol, St Louis, MO USA; [Pineda, Jose A.] Washington Univ, Sch Med, Dept Pediat & Neurol, St Louis, MO 63130 USA		Pineda, JA (corresponding author), Washington Univ, Sch Med, Dept Pediat & Neurol, St Louis, MO 63130 USA.	pineda_j@wustl.edu	Pineda, Jose/W-2806-2019; Goyal, Manu/N-5073-2019	Goyal, Manu/0000-0003-1970-4270	Saint Louis Children&apos;s Hospital Foundation [PR-2016-190] Funding Source: Medline		Adelson PD, 2011, CHILD NERV SYST, V27, P1465, DOI 10.1007/s00381-011-1476-z; Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Allen BB, 2014, PEDIATR CRIT CARE ME, V15, P62, DOI 10.1097/PCC.0b013e3182a556ea; Araki T, 2017, NEUROL MED-CHIR, V57, P82, DOI 10.2176/nmc.ra.2016-0191; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Ashwal S, 2000, PEDIATR NEUROL, V23, P114, DOI 10.1016/S0887-8994(00)00176-4; Ashwal S, 2014, J CHILD NEUROL, V29, P1704, DOI 10.1177/0883073814538504; Babikian T, 2006, J MAGN RESON IMAGING, V24, P801, DOI 10.1002/jmri.20696; Bell MJ, 2013, CRIT CARE CLIN, V29, P223, DOI 10.1016/j.ccc.2012.11.004; Bennett KS, 2017, PEDIATR CRIT CARE ME, V18, P54, DOI 10.1097/PCC.0000000000000948; Bennett TD, 2016, PEDIATR CRIT CARE ME, V17, P1147, DOI 10.1097/PCC.0000000000000934; Brooks GA, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00408; Brooks WM, 2001, J HEAD TRAUMA REHAB, V16, P149, DOI 10.1097/00001199-200104000-00005; Carpenter KLH, 2017, CURR OPIN CRIT CARE, V23, P103, DOI 10.1097/MCC.0000000000000400; Centers for Disease and Control, 2016, TRAUM BRAIN INJ CONC; Chambers IR, 2006, J NEUROL NEUROSUR PS, V77, P234, DOI 10.1136/jnnp.2005.072215; Chambers IR, 2005, CHILD NERV SYST, V21, P195, DOI 10.1007/s00381-004-1060-x; Charalambides C, 2010, CHILD NERV SYST, V26, P215, DOI 10.1007/s00381-009-1031-3; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; Chong SL, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/719476; Clark JB, 1998, DEV NEUROSCI-BASEL, V20, P271, DOI 10.1159/000017321; Curry R, 2008, PEDIATR CRIT CARE ME, V9, P141, DOI 10.1097/PCC.0B013e318166870e; Czosnyka M, 2014, NEUROCRIT CARE, V21, P95, DOI 10.1007/s12028-014-0046-0; Davies DJ, 2015, J NEUROTRAUM, V32, P933, DOI 10.1089/neu.2014.3748; Dietrich WD, 2016, BRAIN RES, V1640, P94, DOI 10.1016/j.brainres.2015.12.034; Dobrachinski F, 2017, J NEUROTRAUM, V34, P1318, DOI 10.1089/neu.2016.4563; Feng JZ, 2017, J TRAUMA ACUTE CARE, V83, P296, DOI 10.1097/TA.0000000000001522; Ferguson NM, 2017, CRIT CARE MED, V45, P1398, DOI 10.1097/CCM.0000000000002378; Figaji AA, 2009, SURG NEUROL, V72, P389, DOI 10.1016/j.surneu.2009.02.012; Figaji AA, 2009, CHILD NERV SYST, V25, P1325, DOI 10.1007/s00381-009-0822-x; Friess SH, 2011, NEUROSURGERY, V69, P1139, DOI 10.1227/NEU.0b013e3182284aa1; Gajavelli S, 2015, J BIOENERG BIOMEMBR, V47, P133, DOI 10.1007/s10863-014-9589-1; Gardner AJ, 2016, HAND CLINIC, V138, P207, DOI 10.1016/B978-0-12-802973-2.00012-4; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Goyal MS, 2014, CELL METAB, V19, P49, DOI 10.1016/j.cmet.2013.11.020; Guerguerian AM, 2009, CURR OPIN PEDIATR, V21, P737, DOI 10.1097/MOP.0b013e328332d11c; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Hutchison JS, 2010, DEV NEUROSCI-BASEL, V32, P406, DOI 10.1159/000323260; Jaeger M, 2010, CRIT CARE MED, V38, P1343, DOI 10.1097/CCM.0b013e3181d45530; Kochanek PM, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00040; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kozlov AV, 2017, BBA-MOL BASIS DIS, V1863, P2627, DOI 10.1016/j.bbadis.2016.12.020; Kramer DR, 2016, J CLIN NEUROSCI, V24, P22, DOI 10.1016/j.jocn.2015.08.004; LaRovere KL, 2016, J NEUROTRAUM, V33, P2105, DOI 10.1089/neu.2015.4344; Lazaridis C, 2017, J CRIT CARE, V37, P230, DOI 10.1016/j.jcrc.2016.09.027; Lazaridis C, 2014, J NEUROSURG, V120, P893, DOI 10.3171/2014.1.JNS131292; Mannino C, 2018, J NEUROSCI RES, V96, P696, DOI 10.1002/jnr.24097; Mtaweh H, 2014, PEDIATR CRIT CARE ME, V15, P242, DOI 10.1097/PCC.0000000000000041; Needham E, 2017, J NEUROTRAUM, V34, P963, DOI 10.1089/neu.2016.4450; O'Lynnger TM, 2016, J NEUROSURG-PEDIATR, V17, P19, DOI 10.3171/2015.5.PEDS1544; Oddo M, 2014, NEUROCRIT CARE, V21, P103, DOI 10.1007/s12028-014-0024-6; Perez Augusto, 2003, Pediatr Crit Care Med, V4, P33; Pineda JA, 2013, LANCET NEUROL, V12, P45, DOI 10.1016/S1474-4422(12)70269-7; Ragan DK, 2013, J CEREBR BLOOD F MET, V33, P48, DOI 10.1038/jcbfm.2012.130; Ragan DK, 2012, PEDIATR RES, V71, P199, DOI 10.1038/pr.2011.31; Rivera-Lara L, 2017, CRIT CARE MED, V45, P695, DOI 10.1097/CCM.0000000000002251; Robertson CL, 2009, EXP NEUROL, V218, P371, DOI 10.1016/j.expneurol.2009.04.030; Rohlwink UK, 2012, NEUROSURGERY, V70, P1220, DOI 10.1227/NEU.0b013e318243fc59; ROSTAMI E, 2014, FRONT NEUROL, V5; Schrieff-Elson LE, 2015, CHILD NERV SYST, V31, P2257, DOI 10.1007/s00381-015-2892-2; Skippen P, 1997, CRIT CARE MED, V25, P1402, DOI 10.1097/00003246-199708000-00031; Smith RL, 2012, PEDIATR CRIT CARE ME, V13, P85, DOI 10.1097/PCC.0b013e3182192c30; Spaite DW, 2017, JAMA SURG, V152, P360, DOI 10.1001/jamasurg.2016.4686; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Stockwell JA, 2012, COMPREHENSIVE CRITIC; Tasker RC, 2014, SEMIN PEDIATR NEUROL, V21, P255, DOI 10.1016/j.spen.2014.10.004; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa P, 2012, CRIT CARE MED, V40, P1923, DOI 10.1097/CCM.0b013e31824e0fcc; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Young AMH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148817; Young B, 2016, CRIT CARE NURS CLIN, V28, P109, DOI 10.1016/j.cnc.2015.09.005	75	1	1	1	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	OCT	2017	33	10					1719	1726		10.1007/s00381-017-3514-y			8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	FG1LZ	WOS:000409558900015	29149384				2022-02-06	
J	Hendrickson, MA; Obeya, E; Wey, AR; Gaillard, PR				Hendrickson, Marissa A.; Obeya, Eta; Wey, Andrew R.; Gaillard, Philippe R.			Community Primary Care Provider Preferences for Emergency Department Follow-up Recommendations A Regional Study	PEDIATRIC EMERGENCY CARE			English	Article						discharge instructions; follow-up; primary care	TRIAL	Background: Childrenwho present to emergency departments (EDs) for care are frequently advised to follow up with their primary care providers (PCPs) after discharge; little is known about whether PCPs agree that follow-up advised by EDs is appropriate for their patients. Objectives: The aims of this study were to determine PCP preferences for follow-up recommendations given to their pediatric patients at the time of ED visits and to compare these preferences to reported emergency medicine provider (EMP) practice. Methods: This was an online survey of PCPs and EMPs in a regional health system assessing preferred timing for ED follow-up recommendations for 15 common pediatric conditions and whether the follow-up should be definite or contingent. Results: Ninety PCPs and 36 EMPs responded to the survey. In patients with community-acquired pneumonia, probability of recommending follow-up after 5 or more days was 33% in PCPs and 8% in EMPs (P = 0.001). In all conditions with significant differences, PCPs favored longer follow-up. In upper respiratory tract infection and acute otitis media, PCPs had a higher probability than EMPs of selecting as-needed versus definite follow-up (P = 0.0002 and P = 0.01, respectively). In asthma, concussion, and pneumonia, PCPs had a significantly lower probability of selecting as-needed follow-up than EMPs. Conclusions: In this regional survey, PCPs preferred longer times between ED visit and follow-up than EMPs for a number of conditions. Differences were also found in preference for as-needed or definite follow-up, varying by condition. These discrepancies could result in overuse or underuse of clinic resources, suggesting a possible quality improvement target for emergency medicine practice.	[Hendrickson, Marissa A.] Univ Minnesota, Sch Med, Dept Pediat, Div Pediat Emergency Med, Minneapolis, MN 55455 USA; [Hendrickson, Marissa A.] Univ Minnesota, Mason Childrens Hosp, Minneapolis, MN USA; [Obeya, Eta] Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA; [Wey, Andrew R.] Univ Hawaii, Biostat & Data Management Core, John A Burns Sch Med, Honolulu, HI 96822 USA; [Gaillard, Philippe R.] Auburn Univ, Dept Math & Stat, Auburn, AA USA		Hendrickson, MA (corresponding author), Dept Pediat, Div Pediat Emergency Med, M653 E Bldg,2450 Riverside Ave S, Minneapolis, MN 55454 USA.	mhendric@umn.edu	Gaillard, Philippe/E-7256-2019; Hendrickson, Marissa/ABA-7225-2021	Hendrickson, Marissa/0000-0002-1545-0982	NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR000114] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000114] Funding Source: NIH RePORTER		Centers for Disease Control and Prevention National Center for Health Statistics, 2010, NAT HOSP AMB MED CAR; Diggle P., 2002, ANAL LONGITUDINAL DA; Hsiao AL, 2009, JT COMM J QUAL PATIE, V35, P467, DOI 10.1016/S1553-7250(09)35065-5; Ishimine P, 2007, EMERG MED CLIN N AM, V25, P1087, DOI 10.1016/j.emc.2007.07.012; Klein J, 2014, ACUTE OTITIS MEDIA C; Lu S, 2012, ACAD PEDIATR, V12, P436, DOI 10.1016/j.acap.2012.06.006; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; *NCHS, 2009, NAT HOSP DISCH SURV; Racine AD, 2009, ARCH PEDIAT ADOL MED, V163, P505, DOI 10.1001/archpediatrics.2009.45; Roberts KB, 2011, PEDIATRICS, V128, P595, DOI 10.1542/peds.2011-1330; Smith LC, 2009, J EMERG NURS, V35, P412, DOI 10.1016/j.jen.2008.09.008; Williams KW, 2013, CLIN PEDIATR, V52, P612, DOI 10.1177/0009922813479163; Withy Kelley, 2008, Ethn Dis, V18, pS2; Yeh DD, 2013, WORLD J SURG, V37, P2081, DOI 10.1007/s00268-013-2092-8; Zorc JJ, 2009, PEDIATRICS, V124, P1135, DOI 10.1542/peds.2008-3352	15	1	1	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	OCT	2017	33	10					690	693		10.1097/PEC.0000000000001068			4	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	FI7YG	WOS:000412215500015	28277413	Green Accepted			2022-02-06	
J	Homberg, V				Hoemberg, Volker			Pharmacological Aspects of Neurorehabilitation	AKTUELLE NEUROLOGIE			German	Article						neurorehabilitation; pharmacology; brain recovery; neuroprotection; detrimental drugs; neuroprotection	TRAUMATIC BRAIN-INJURY; PLACEBO-CONTROLLED TRIAL; VISUAL-CORTEX ABLATION; ACUTE ISCHEMIC-STROKE; AMPHETAMINE-INDUCED RECOVERY; BINOCULAR DEPTH-PERCEPTION; DOUBLE-BLIND; MULTIPLE-SCLEROSIS; POSTSTROKE DEPRESSION; MOTOR-PERFORMANCE	Doctors in neurological rehabilitation are concerned with various aspects of pharmacological treatment. In addition to the choice of adequate antihypertensive, anticonvulsive or anticoagulant treatment, novel aspects of pharmacological interventions positively or negatively influencing brain recovery are also emerging. Of great importance is the avoidance of so-called detrimental drugs from whose pharmacological profile it is clear that they negatively affect the brain recovery and brain reorganization. These include the classical anticonvulsants such as phenytoin and barbiturates but also benzodiazepines, butophynones and anti-hypertensives such as clonidine and prazosin. If possible, the use of these substances should be avoided after acute neurological brain damage. Larger randomized controlled studies have shown fluoxetine and cerebrolysin to improve function after stroke. Both substances apparently act on multiple molecular mechanisms of brain recovery. In general, the use of antidepressants (especially SSRI) after stroke can also be recommended for non-depressive stroke patients to promote functional recovery. The use of dopaminergic substances also showed positive effects on the functional recovery after stroke in small studies. Because of low potential for side effects, the probatory use of L-Dopa (100/mg per day) in the subacute phase after stroke can be recommended. The use of antidepressants for improving the quality of life is also recommended in MS patients. A large randomized controlled trial demonstrated transient efficacy of amantadine in patients with limited arousal (vegetative state, minimal conscious state). The use of amantadine can therefore be recommended for improving the level of consciousness in these patients.	[Hoemberg, Volker] SRH Gesundheitszentrum Bad Wimpfen, Neurol, Bad Wimpfen, Germany		Homberg, V (corresponding author), SRH Gesundheitszentrum Bad Wimpfen, Neurol, Bei Alten Saline 2, D-74206 Bad Wimpfen, Germany.	volker.hoemberg@srh.de					Achiron A, 2015, MULT SCLER J, V21, P767, DOI 10.1177/1352458514554053; Acler M, 2009, RESTOR NEUROL NEUROS, V27, P277, DOI 10.3233/RNN-2009-0477; Asano M, 2014, MULT SCLER INT, V2014, DOI 10.1155/2014/798285; ASTROM M, 1993, STROKE, V24, P976, DOI 10.1161/01.STR.24.7.976; Baviera M, 2008, PSYCHOPHARMACOLOGY, V196, P269, DOI 10.1007/s00213-007-0959-9; BRAILOWSKY S, 1986, BRAIN RES, V376, P71, DOI 10.1016/0006-8993(86)90900-5; Brefel-Courbon C, 2007, ANN NEUROL, V62, P102, DOI 10.1002/ana.21110; Breitenstein C, 2006, J NEUROL SCI, V248, P42, DOI 10.1016/j.jns.2006.05.012; Butefisch CM, 2002, ANN NEUROL, V51, P59, DOI 10.1002/ana.10056; Canadian MS, 1987, CAN J NEUROL SCI, V14, P273; Chang WH, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0553-z; Chollet F, 2011, LANCET NEUROL, V10, P123, DOI 10.1016/S1474-4422(10)70314-8; CHWEH AY, 1986, PHARMACOL BIOCHEM BE, V24, P1301, DOI 10.1016/0091-3057(86)90188-7; COHEN RA, 1989, ARCH NEUROL-CHICAGO, V46, P676, DOI 10.1001/archneur.1989.00520420096030; Cohen SI, 2008, AM J PHYS MED REHAB, V87, P229, DOI 10.1097/PHM.0b013e318161971b; Cramer SC, 2009, STROKE, V40, P3034, DOI 10.1161/STROKEAHA.109.552075; CRISOSTOMO EA, 1988, ANN NEUROL, V23, P94, DOI 10.1002/ana.410230117; Dam M, 1996, STROKE, V27, P1211, DOI 10.1161/01.STR.27.7.1211; Dilg Peter, 1986, DTSCH APOTHEKERZEITU, V126, P2677; Dinse HR, 2003, SCIENCE, V301, P91, DOI 10.1126/science.1085423; DOLIN R, 1982, NEW ENGL J MED, V307, P580, DOI 10.1056/NEJM198209023071002; Du B, 2014, AM J MED SCI, V347, P178, DOI 10.1097/MAJ.0b013e318287c79c; ENDERBY P, 1994, CLIN NEUROPHARMACOL, V17, P320, DOI 10.1097/00002826-199408000-00003; FEENEY DM, 1990, CAN J PSYCHOL, V44, P233, DOI 10.1037/h0084243; FEENEY DM, 1985, BRAIN RES, V342, P352, DOI 10.1016/0006-8993(85)91135-7; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; FEENEY DM, 1981, P W PHARMACOL SOC, V24, P15; Floel A, 2005, ANN NEUROL, V58, P121, DOI 10.1002/ana.20536; Fredrikson S, 2003, NEUROEPIDEMIOLOGY, V22, P146, DOI 10.1159/000068746; Fridman EA, 2010, BRAIN INJURY, V24, P636, DOI 10.3109/02699051003610433; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Gladstone DJ, 2006, STROKE, V37, P179, DOI 10.1161/01.STR.0000195169.42447.78; GOLD PE, 1984, BRAIN RES, V305, P103, DOI 10.1016/0006-8993(84)91124-7; Goldstein L B, 1990, Restor Neurol Neurosci, V1, P311, DOI 10.3233/RNN-1990-1501; Goldstein LB, 2002, NEUROREHAB NEURAL RE, V16, P321, DOI 10.1177/154596830201600402; Goldstein LB, 1997, CURR OPIN NEUROL, V10, P52, DOI 10.1097/00019052-199702000-00011; GOLDSTEIN LB, 1990, BRAIN RES, V508, P305, DOI 10.1016/0006-8993(90)90413-6; Grade C, 1998, ARCH PHYS MED REHAB, V79, P1047, DOI 10.1016/S0003-9993(98)90169-1; Greener J, 2010, PHARM TREATMENT APHA, DOI [10.1002/14651858.CD000424, DOI 10.1002/14651858]; Gungor L, 2011, BRAIN LANG, V117, P23, DOI 10.1016/j.bandl.2010.11.003; Hammond FM, 2015, J NEUROTRAUM, V32, P1230, DOI 10.1089/neu.2014.3803; Heiss WD, 2012, STROKE, V43, P630, DOI 10.1161/STROKEAHA.111.628537; HERNANDEZ TD, 1994, BRAIN RES, V635, P300, DOI 10.1016/0006-8993(94)91451-6; HOVDA DA, 1984, BRAIN RES, V298, P358, DOI 10.1016/0006-8993(84)91437-9; HOVDA DA, 1989, BEHAV NEUROSCI, V103, P574, DOI 10.1037/0735-7044.103.3.574; HOVDA DA, 1985, P W PHARMACOL SOC, V28, P209; Huber W, 1997, ARCH PHYS MED REHAB, V78, P245, DOI 10.1016/S0003-9993(97)90028-9; Jha A, 2008, J HEAD TRAUMA REHAB, V23, P52, DOI 10.1097/01.HTR.0000308721.77911.ea; JOFFE RT, 1987, ARCH NEUROL-CHICAGO, V44, P376, DOI 10.1001/archneur.1987.00520160018007; Jorge RE, 2003, AM J PSYCHIAT, V160, P1823, DOI 10.1176/appi.ajp.160.10.1823; Kakuda W, 2011, INT J NEUROSCI, V121, P373, DOI 10.3109/00207454.2011.560314; Kauhanen ML, 1999, STROKE, V30, P1875, DOI 10.1161/01.STR.30.9.1875; Kaur H, 2013, PHARMACOLOGY, V92, P324, DOI 10.1159/000356320; Kessler J, 2000, STROKE, V31, P2112, DOI 10.1161/01.STR.31.9.2112; KORNHUBER J, 1994, J NEURAL TRANSM-SUPP, P91; Kraus MF, 2005, BRAIN INJURY, V19, P471, DOI 10.1080/02699050400025059; Kraus MF, 1997, J NEUROPSYCH CLIN N, V9, P222; Krimchansky BZ, 2004, BRAIN INJURY, V18, P1099, DOI 10.1080/02699050310001646206; KRUPP LB, 1995, NEUROLOGY, V45, P1956, DOI 10.1212/WNL.45.11.1956; Leemann B, 2011, NEUROREHAB NEURAL RE, V25, P43, DOI 10.1177/1545968310376938; Leone H, 2005, J CLIN PHARM THER, V30, P101, DOI 10.1111/j.1365-2710.2005.00628.x; Lokk J, 2011, ACTA NEUROL SCAND, V123, P266, DOI 10.1111/j.1600-0404.2010.01395.x; Martin RT, 2007, AM J PHYS MED REHAB, V86, P613, DOI 10.1097/PHM.0b013e3181154a84; Martinsson L, 2003, CEREBROVASC DIS, V16, P338, DOI 10.1159/000072555; Martinsson L, 2003, STROKE, V34, P475, DOI 10.1161/01.STR.0000050161.38263.AE; Masihuzzaman A M, 2011, Mymensingh Med J, V20, P689; MAZAGRI R, 1995, CAN J NEUROL SCI, V22, pS25; MEYER PM, 1963, J COMP PHYSIOL PSYCH, V56, P402, DOI 10.1037/h0049297; Meythaler JM, 2001, BRAIN INJURY, V15, P321, DOI 10.1080/026990501750111274; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Muller W E, 2016, PSYCHOPHARMAKOTHERAP, V23, P230; Muresanu DF, 2016, STROKE, V47, P151, DOI 10.1161/STROKEAHA.115.009416; MURRAY TJ, 1985, CAN J NEUROL SCI, V12, P251, DOI 10.1017/S0317167100047107; Narushima K, 2003, AM J PSYCHIAT, V160, P1157, DOI 10.1176/appi.ajp.160.6.1157; NICKELS JL, 1994, BRAIN INJURY, V8, P709, DOI 10.3109/02699059409151025; Orgogozo JM, 1999, PHARMACOPSYCHIATRY, V32, P25, DOI 10.1055/s-2007-979233; Pariente J, 2001, ANN NEUROL, V50, P718, DOI 10.1002/ana.1257; Passler MA, 2001, ARCH PHYS MED REHAB, V82, P311, DOI 10.1053/apmr.2001.20831; Patrick PD, 2003, BRAIN INJURY, V17, P497, DOI 10.1080/0269905031000070279; Patrick PD, 2006, J CHILD NEUROL, V21, P879, DOI 10.1177/08830738060210100901; Platz T, 2005, RESTOR NEUROL NEUROS, V23, P271; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; Plewnia C, 2004, NEUROLOGY, V62, P2124, DOI 10.1212/01.WNL.0000128041.92710.17; Rammohan KW, 2002, J NEUROL NEUROSUR PS, V72, P179, DOI 10.1136/jnnp.72.2.179; REDING MJ, 1986, ARCH NEUROL-CHICAGO, V43, P763, DOI 10.1001/archneur.1986.00520080011011; Reinhard DL, 1996, ARCH PHYS MED REHAB, V77, P80, DOI 10.1016/S0003-9993(96)90225-7; Resterneyer C, 2007, RESTOR NEUROL NEUROS, V25, P143; Rosser N, 2008, ARCH PHYS MED REHAB, V89, P1633, DOI 10.1016/j.apmr.2008.02.030; Rogalewski A, 2006, STROKE, V37, P1129, DOI 10.1161/01.STR.0000209330.73175.34; Sawyer E, 2006, J CLIN PHARM THER, V30, P101; SCHALLERT T, 1986, BRAIN RES, V379, P104, DOI 10.1016/0006-8993(86)90261-1; SCHALLERT T, 1992, PHYS MED REHABIL, V6, P375; Scheidtmann K, 2001, LANCET, V358, P787, DOI 10.1016/S0140-6736(01)05966-9; Schneider WN, 1999, BRAIN INJURY, V13, P863; SCHWAB RS, 1972, J AMER MED ASSOC, V222, P792, DOI 10.1001/jama.222.7.792; Seniow J, 2009, J NEUROL SCI, V283, P214, DOI 10.1016/j.jns.2009.02.336; Singh R, 2008, BRAIN INJURY, V22, P103, DOI 10.1080/02699050701829704; Sonde L, 2007, ACTA NEUROL SCAND, V115, P55, DOI 10.1111/j.1600-0404.2006.00728.x; Sonde L, 2001, CEREBROVASC DIS, V12, P253, DOI 10.1159/000047712; Stankoff B, 2005, NEUROLOGY, V64, P1139, DOI 10.1212/01.WNL.0000158272.27070.6A; STEPHENS J, 1986, ARCH PHYS MED REHAB, V67, P666; Stroemer RP, 1998, STROKE, V29, P2381, DOI 10.1161/01.STR.29.11.2381; SUTTON RL, 1992, RESTOR NEUROL NEUROS, V4, P1, DOI 10.3233/RNN-1992-4101; Teitelman E, 2001, AM J PSYCHIAT, V158, P1341, DOI 10.1176/ajp.158.8.1341; Thonnard M, 2013, FUNCT NEUROL, V28, P259, DOI 10.11138/FNeur/2013.28.4.259; Tran DA, 2016, AM J PHYS MED REHAB, V95, P459, DOI 10.1097/PHM.0000000000000438; Treig T, 2003, CLIN REHABIL, V17, P590, DOI 10.1191/0269215503cr653oa; Tymianski M, 2013, STROKE, V44, P2942, DOI 10.1161/STROKEAHA.113.000731; VACHALATHITI R, 2001, J NEUROL SCI S1, V187, pS253; Veauthier C, 2016, NERVENARZT, V87, P1310, DOI 10.1007/s00115-016-0128-7; WALKERBATSON D, 1995, STROKE, V26, P2254, DOI 10.1161/01.STR.26.12.2254; Wang LE, 2011, ANN NEUROL, V69, P375, DOI 10.1002/ana.22237; WATANABE Y, 1992, EUR J PHARMACOL, V222, P157, DOI 10.1016/0014-2999(92)90830-W; WATSON CW, 1945, J NEUROPHYSIOL, V8, P221; WEINSHENKER BG, 1992, NEUROLOGY, V42, P1468, DOI 10.1212/WNL.42.8.1468; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002; Whyte J, 2014, AM J PHYS MED REHAB, V93, P101, DOI 10.1097/PHM.0000000000000069; Xu SY, 2013, MED SCI MONIT BASIC, V19, P37, DOI 10.12659/MSMBR.883750; Zafonte RD, 1998, BRAIN INJURY, V12, P617; Zafonte RD, 2001, J HEAD TRAUMA REHAB, V16, P112, DOI 10.1097/00001199-200102000-00014; Zittel S, 2007, J NEUROL, V254, P197, DOI 10.1007/s00415-006-0326-5	122	1	1	1	3	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0302-4350	1438-9428		AKTUEL NEUROL	Aktuelle Neurol.	OCT	2017	44	8					568	577		10.1055/s-0043-116377			10	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	FJ2LX	WOS:000412560300005					2022-02-06	
J	Kim, WH; Lee, J; Bezyak, J				Kim, Won Ho; Lee, Juyoung; Bezyak, Jill			Five-Year Quality of Life Trajectories for Persons With Disabilities	REHABILITATION COUNSELING BULLETIN			English	Article						people with disabilities; quality of life; trajectories; growth mixture model	TRAUMATIC BRAIN-INJURY; FIT INDEXES; SELF-ESTEEM; PEOPLE; SATISFACTION; INDIVIDUALS; NUMBER; COMPONENTS; CRITERIA; PRAYER	The current study identified the longitudinal quality of life (QOL) trajectories of individuals with disabilities as well as the predictors of those trajectories. It examined a secondary data set, the Panel Survey of Employment for the Disabled (PSED), conducted by the Korea Employment Agency for the Disabled (KEAD). Data were gathered over 5 years from individuals with disabilities and analyzed using growth mixture modeling to identify the best QOL trajectory model. Covariates, physical dependence, experience of discrimination, emotional stability, self-esteem, religion, and degenerative type of disability were explored as trajectory predictors. Analysis revealed four latent classes: a high and stable QOL class, a high and varied QOL class, a low and stable QOL class, and a low and varied QOL class. Analysis of predictors indicated degenerative type of disability, physical dependence, discrimination, emotional stability, and self-esteem differentiated the high and stable QOL group from other groups. Significance, limitations, and implications for future practice and research are also discussed.	[Kim, Won Ho] Penn State Univ, University Pk, PA 16802 USA; [Lee, Juyoung] Honam Univ, Eodeung Daero 417, Gwangju 62399, South Korea; [Bezyak, Jill] Univ Northern Colorado, Greeley, CO USA		Lee, J (corresponding author), Honam Univ, Eodeung Daero 417, Gwangju 62399, South Korea.	sweetstrawberrylee@gmail.com			Honam University	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by research fund from Honam University, 2015.	Abu Tariah H, 2006, PHYS OCCUP THER GERI, V25, P33, DOI 10.1300/J148v25n02_03; Akaike H, 1983, INT STAT I, V22, P277, DOI DOI 10.1086/PHOS.50.4.187553; Akaike H., 1973, P 2 INT S INF THEOR, V1973, P267, DOI 10.1007/978-1-4612-1694-0; [Anonymous], 1998, WHOQOL US MAN; Ansbacher H.L., 1956, INDIVIDUAL PSYCHOL A; Bishop M, 2005, REHABIL COUNS BULL, V48, P219, DOI 10.1177/00343552050480040301; Boswell BB, 1998, J REHABIL, V64, P27; Breslin MJ, 2008, MENT HEALTH RELIG CU, V11, P9, DOI 10.1080/13674670701491449; Brown M, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199808000-00002; Chan F, 2003, INT J REHABIL RES, V26, P335, DOI 10.1097/00004356-200312000-00014; Chan F., 2009, UNDERSTANDING PSYCHO, P333; Chapin MH, 2010, REHABIL COUNS BULL, V54, P6, DOI 10.1177/0034355210367685; COYLE CP, 1994, REHABIL PSYCHOL, V39, P95, DOI 10.1037/0090-5550.39.2.95; CREWE NM, 1980, MINN MED, V63, P586; Degeneffe CE, 2010, J REHABIL, V76, P27; Dlugonski D, 2012, REHABIL PSYCHOL, V57, P35, DOI 10.1037/a0027176; DOWNEWAMBOLDT BL, 1995, WESTERN J NURS RES, V17, P250, DOI 10.1177/019394599501700302; Ehrhardt JJ, 2000, J HAPPINESS STUD, V1, P177, DOI DOI 10.1023/A:1010084410679; Ferris DL, 2011, PERS PSYCHOL, V64, P137, DOI 10.1111/j.1744-6570.2010.01204.x; Frisch M. B., 2004, USE PSYCHOL TESTING, P1277; Germano D, 2001, J CLIN PSYCHOL MED S, V8, P253, DOI 10.1023/A:1011964729100; Glover-Graf NM, 2007, REHABIL COUNS BULL, V51, P21, DOI 10.1177/00343552070510010501; Gonzalez-Salvador T, 2000, INT J GERIATR PSYCH, V15, P181, DOI 10.1002/(SICI)1099-1166(200002)15:2<181::AID-GPS96>3.0.CO;2-I; Gorzkowski JA, 2010, REHABIL PSYCHOL, V55, P58, DOI 10.1037/a0018275; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Hewlett S, 1995, Arthritis Care Res, V8, P4, DOI 10.1002/art.1790080104; Holt-Ashley M, 2000, AACN Clin Issues, V11, P60, DOI 10.1097/00044067-200002000-00008; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hu LT, 1998, PSYCHOL METHODS, V3, P424, DOI 10.1037/1082-989X.3.4.424; Jeon B, 1974, YONSEI J, V11, P107; Jeong S.-W., 2012, DISABILITY EMPLOYME, V22, P323, DOI [10.15707/disem.2012.22.4.013, DOI 10.15707/DISEM.2012.22.4.013]; Johnstone B, 2007, DISABIL REHABIL, V29, P1153, DOI 10.1080/09638280600955693; Jones J, 1996, INT J REHABIL RES, V19, P219, DOI 10.1097/00004356-199609000-00003; Jung T, 2008, SOC PERSONAL PSYCHOL, V2, P302, DOI 10.1111/j.1751-9004.2007.00054.x; Kaplan D., 2004, SAGE HDB QUANTITATIV, P345, DOI DOI 10.4135/9781412986311.N19; Kemp BJ, 1999, ASSIST TECHNOL, V11, P158, DOI 10.1080/10400435.1999.10131999; Kortte KB, 2010, REHABIL PSYCHOL, V55, P40, DOI 10.1037/a0018624; Krause JS, 2014, REHABIL PSYCHOL, V59, P176, DOI 10.1037/a0035778; KUYKEN W, 1995, SOC SCI MED, V41, P1403, DOI 10.1016/0277-9536(95)00112-k; Lee GK, 2008, REHABIL COUNS BULL, V51, P177, DOI 10.1177/0034355207311318; Lee J. S., 2009, J KOREAN ASS GOVERNA, V16, P79; Lee Jee Soo, 2011, 사회과학연구, V27, P277; LIANG MH, 1984, ARTHRITIS RHEUM, V27, P522, DOI 10.1002/art.1780270507; LIEBERMA.LR, 1970, PSYCHOL REP, V27, P75, DOI 10.2466/pr0.1970.27.1.75; Lo YT, 2001, BIOMETRIKA, V88, P767, DOI 10.1093/biomet/88.3.767; Lustig D. C., 2000, J APPL REHABILITATIO, V31, P22; Lykken D., 1999, HAPPINESS WHAT STUDI; Marini I., 2010, PSYCHOSOCIAL ASPECTS; Maslow A. H., 1964, TRANSACTION, V1, P17; MCLACHLAN GJ, 1987, J R STAT SOC C-APPL, V36, P318; McLachlan GJ., 2000, WILEY SER PROB STAT, DOI 10.1002/0471721182; Min SK, 2002, QUAL LIFE RES, V11, P593, DOI 10.1023/A:1016351406336; Munoz M, 2011, PSYCHIAT RES, V186, P402, DOI 10.1016/j.psychres.2010.06.019; Muthen B, 2000, ALCOHOL CLIN EXP RES, V24, P882, DOI 10.1111/j.1530-0277.2000.tb02070.x; Muthen L. K., 2018, MPLUS USERS GUIDE; Nemec PB, 2005, J APPL REHABILITATIO, V36, P4; Nicolson P, 2003, BRIT J HEALTH PSYCH, V8, P251, DOI 10.1348/135910703322370842; NIEMI ML, 1988, STROKE, V19, P1101, DOI 10.1161/01.STR.19.9.1101; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Power M, 1998, SOC SCI MED, V46, P1569, DOI 10.1016/s0277-9536(98)00009-4; [郝元涛 HAO YuanTao], 2006, [中国心理卫生杂志, Chinese Mental Health Journal], V20, P71; Resch JA, 2009, REHABIL PSYCHOL, V54, P51, DOI 10.1037/a0015051; Reyes-Ortiz CA, 2006, SOUTH MED J, V99, P1172, DOI 10.1097/01.smj.0000242805.02180.63; Rodriguez VJ, 2013, REHABIL COUNS BULL, V56, P215, DOI 10.1177/0034355213477477; ROESSLER RT, 1990, REHABIL COUNS BULL, V34, P82; ROGERS CR, 1963, PSYCHOTHER-THEOR RES, V1, P17, DOI 10.1037/h0088567; Rosenberg M., 1965, SOC ADOLESCENT CHILD; Schwartz CE, 2007, ARCH PHYS MED REHAB, V88, P529, DOI 10.1016/j.apmr.2006.12.032; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shrivastava A, 2013, INDIAN J PSYCHIAT, V55, P178, DOI 10.4103/0019-5545.111459; Staring ABP, 2009, SCHIZOPHR RES, V115, P363, DOI 10.1016/j.schres.2009.06.015; Tofighi D, 2008, ADVANCES IN LATENT VARIABLE MIXTURE MODELS, P317; van Leeuwen CMC, 2012, SPINAL CORD, V50, P174, DOI 10.1038/sc.2011.120; Viemero V, 1998, PSYCHOTHER PSYCHOSOM, V67, P317, DOI 10.1159/000012297; Wang J., 2012, STRUCTURAL EQUATION	75	1	1	0	11	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0034-3552	1538-4853		REHABIL COUNS BULL	Rehabil. Couns. Bull.	OCT	2017	61	1					8	19		10.1177/0034355216662201			12	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	FG1YJ	WOS:000409862800001					2022-02-06	
J	Paget, LM; Dupont, A; Pedrono, G; Lasbeur, L; Thelot, B				Paget, L. -M.; Dupont, A.; Pedrono, G.; Lasbeur, L.; Thelot, B.			Methods of data selection from the French medical information system program for trauma patient's analysis: Burns and traumatic brain injuries	REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE			French	Article						Burns; Traumatic brain injury; Hospitalization; MISP; Epidemiological surveillance; Prevention	INTERNATIONAL CLASSIFICATION	Background. - Data from the French medical information system program in medicine, surgery, obstetrics and dentistry can be adapted in some cases and under certain conditions, to account for hospitalizations for injuries. Two areas have been explored: burn and traumatic brain injury victims. Methods. - An algorithm selecting data from the Medical information system program was established and implemented for several years for the study of burn victims. The methods of selection of stays for traumatic brain injuries, which are the subject of a more recent exploration, are described. Results. - Production of results in routine on the hospitalization for burns. Expected production of results on the hospitalization for traumatic brain injuries. Conclusion. - In both cases, the knowledge obtained from these utilizations of the Medical information system program contributes to epidemiological surveillance and prevention and are useful for health care organization. (C) 2017 Elsevier Masson SAS. All rights reserved.	[Paget, L. -M.; Dupont, A.; Pedrono, G.; Lasbeur, L.; Thelot, B.] Sante Publ France, Unite Traumatismes, Direct Malad Nontransmissibles & Traumatismes, 12 Rue Val dOsne, F-94415 St Maurice, France		Paget, LM (corresponding author), Sante Publ France, Unite Traumatismes, Direct Malad Nontransmissibles & Traumatismes, 12 Rue Val dOsne, F-94415 St Maurice, France.	louis-Marie.paget@santepubliquefrance.fr					Akerlund E, 2007, BURNS, V33, P31, DOI 10.1016/j.burns.2006.10.002; Baker SP, 1992, THE INJURY FACT BOOK, VSecond; Barry Y., 2011, Bulletin Epidemiologique Hebdomadaire, P328; Chan V, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0259-7; Chen AY, 2011, EMERG THEMES EPIDEMI, V8, DOI 10.1186/1742-7622-8-4; Duke J, 2012, AUSTRALAS J AGEING, V31, P83, DOI 10.1111/j.1741-6612.2011.00542.x; Dupont A, 2008, B EPIDEMIOL HEBD, P71; HADDON W, 1972, J TRAUM, V12, P193, DOI 10.1097/00005373-197203000-00002; Larsson J, 2010, SCAND J PUBLIC HEALT, V38, P541, DOI 10.1177/1403494810371143; Lasbeur L, 2007, APPL METHODE CAPTURE; McClure R, 2004, SCI BASIS INJURY PRE; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Oberlin P, 2016, ETUDES RESULT, P948; Onarheim H, 2009, BURNS, V35, P1142, DOI 10.1016/j.burns.2009.06.191; Pedrono G, 2016, RESULTATS 2010 FRANC; Peloso PM, 2004, J REHABIL MED, V36, P22, DOI 10.1080/16501960410023714; Site de Sante publique France, MORT TRAUM FRANC MET; Site de Sante publique France, RES BRUL; Spinks A, 2008, J BURN CARE RES, V29, P482, DOI 10.1097/BCR.0b013e3181776ed9	19	1	1	0	2	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0398-7620	1773-0627		REV EPIDEMIOL SANTE	Rev. Epidemiol. Sante Publique	OCT	2017	65			4			S220	S225		10.1016/j.respe.2017.01.116			6	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	FN4XU	WOS:000416010900009	28372834				2022-02-06	
J	Rasheed, W; Neoh, YY; Bin Hamid, NH; Reza, F; Idris, Z; Tang, TB				Rasheed, Waqas; Neoh, Yee Yik; Bin Hamid, Nor Hisham; Reza, Faruque; Idris, Zamzuri; Tang, Tong Boon			Early visual analysis tool using magnetoencephalography for treatment and recovery of neuronal dysfunction	COMPUTERS IN BIOLOGY AND MEDICINE			English	Article						Default mode connectivity; Functional connectivity; Coherence	FUNCTIONAL CONNECTIVITY; MEG; BRAIN; EEG; COHERENCE; VISUALIZATION; FEASIBILITY; STIMULATION; ARTIFACTS; DIAGNOSIS	Functional neuroimaging modalities play an important role in deciding the diagnosis and course of treatment of neuronal dysfunction and degeneration. This article presents an analytical tool with visualization by exploiting the strengths of the MEG (magnetoencephalographic) neuroimaging technique. The tool automates MEG data import (in tSSS format), channel information extraction, time/frequency decomposition, and circular graph visualization (connectogram) for simple result inspection. For advanced users, the tool also provides magnitude squared coherence (MSC) values allowing personalized threshold levels, and the computation of default model from MEG data of control population. Default model obtained from healthy population data serves as a useful benchmark to diagnose and monitor neuronal recovery during treatment. The proposed tool further provides optional labels with international 10-10 system nomenclature in order to facilitate comparison studies with EEG (electroencephalography) sensor space. Potential applications in epilepsy and traumatic brain injury studies are also discussed.	[Rasheed, Waqas; Bin Hamid, Nor Hisham; Tang, Tong Boon] Univ Teknol PETRONAS, Dept Elect & Elect Engn, CISIR, Bandar Seri Iskandar, Perak, Malaysia; [Neoh, Yee Yik; Reza, Faruque; Idris, Zamzuri] Univ Sains Malaysia, Sch Med Sci, Hosp Univ Sains Malaysia, Dept Neurosci, Hlth Campus, Kota Baharu, Kelantan, Malaysia		Tang, TB (corresponding author), Univ Teknol PETRONAS, Dept Elect & Elect Engn, CISIR, Bandar Seri Iskandar, Perak, Malaysia.	tongboon.tang@utp.edu.my	Idris, Zamzuri/AAB-6764-2022; Reza, Faruque/L-9994-2016	Idris, Zamzuri/0000-0002-9470-0571; Reza, Faruque/0000-0002-0302-6623; Rasheed, Waqas/0000-0002-8268-6960; Tang, Tong Boon/0000-0002-5721-6828	Ministry of Education Malaysia [FRGS/1/2014/TK03/UTP/02/04]; national HiCOE grant to Centre for Intelligent Signal and Imaging Research (CISIR)	The study was partially funded by Ministry of Education Malaysia (Grant no: FRGS/1/2014/TK03/UTP/02/04) and national HiCOE grant to Centre for Intelligent Signal and Imaging Research (CISIR). MEG data has been collected at the Hospital USM, Kelantan, Malaysia (Approval ref. HUSM/11/020/Jld.6).	Al-Dahmash A., 2013, INT J MOD ENG RES, V3, P1566; Baillet S, 2010, IFMBE PROC, V28, P101; BARTH DS, 1986, BRAIN RES, V368, P36, DOI 10.1016/0006-8993(86)91040-1; Biswal BB, 1997, NMR BIOMED, V10, P165, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<165::AID-NBM454>3.0.CO;2-7; Cha YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049560; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Dubarry AS, 2014, NEUROIMAGE, V99, P548, DOI 10.1016/j.neuroimage.2014.05.055; EATON H, 1992, MED BIOL ENG COMPUT, V30, P433, DOI 10.1007/BF02446182; Ewald A, 2012, NEUROIMAGE, V60, P476, DOI 10.1016/j.neuroimage.2011.11.084; Fornito A, 2016, NEUROMETHODS, V119, P283, DOI 10.1007/978-1-4939-5611-1_10; Guggisberg AG, 2008, ANN NEUROL, V63, P193, DOI 10.1002/ana.21224; Harding J. T., 1969, Journal of Applied Physics, V40, DOI 10.1063/1.1657936; Hauk O., 2013, VECTORVIEW DESCRIPTI; Hillebrand A, 2013, CLIN NEUROPHYSIOL, V124, P107, DOI 10.1016/j.clinph.2012.06.013; Hoechstetter K, 2004, BRAIN TOPOGR, V16, P233; Holten D, 2006, IEEE T VIS COMPUT GR, V12, P741, DOI 10.1109/TVCG.2006.147; Ingalhalikar M, 2014, P NATL ACAD SCI USA, V111, P823, DOI 10.1073/pnas.1316909110; Irimia A, 2012, NEUROIMAGE, V60, P1340, DOI 10.1016/j.neuroimage.2012.01.107; Jurcak V, 2007, NEUROIMAGE, V34; Lee L, 2003, NEUROIMAGE, V19, P457, DOI 10.1016/S1053-8119(03)00062-4; Malmivuo J, 1997, IEEE T BIO-MED ENG, V44, P196, DOI 10.1109/10.554766; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Mosher JC, 1999, IEEE T BIO-MED ENG, V46, P245, DOI 10.1109/10.748978; Nandagopalan S., 1994, TECHNOMETRICS, V36, P220; Pfurtscheller G, 1999, J CLIN NEUROPHYSIOL, V16, P512, DOI 10.1097/00004691-199911000-00003; Rampp S, 2007, EXPERT REV MED DEVIC, V4, P335, DOI 10.1586/17434440.4.3.335; Rasheed W., 2014, 2014 5 INT C INT ADV, P1; Rasheed W, 2013, I IEEE EMBS C NEUR E, P545, DOI 10.1109/NER.2013.6695992; Srinivasan R, 2007, J NEUROSCI METH, V166, P41, DOI 10.1016/j.jneumeth.2007.06.026; Struyf G., 2013, SCHEMABALL; Tarapore PE, 2013, J NEUROSURG, V118, P1306, DOI 10.3171/2013.3.JNS12398; Taulu S, 2009, HUM BRAIN MAPP, V30, P1524, DOI 10.1002/hbm.20627; Tewarie P, 2014, NEUROIMAGE, V88, P308, DOI 10.1016/j.neuroimage.2013.10.022; Thaler L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020162; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; van Diessen E, 2015, CLIN NEUROPHYSIOL, V126, P1468, DOI 10.1016/j.clinph.2014.11.018; van Horn JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037454; WANG JZ, 1992, IEEE T BIO-MED ENG, V39, P665, DOI 10.1109/10.142641; Wee CY, 2014, HUM BRAIN MAPP, V35, P3414, DOI 10.1002/hbm.22411; Wolters CH, 2004, INVERSE PROBL, V20, P1099, DOI 10.1088/0266-5611/20/4/007; Zhdanov A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128485	41	1	1	0	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-4825	1879-0534		COMPUT BIOL MED	Comput. Biol. Med.	OCT 1	2017	89						573	583		10.1016/j.compbiomed.2017.05.005			11	Biology; Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Mathematical & Computational Biology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics; Computer Science; Engineering; Mathematical & Computational Biology	FK3HQ	WOS:000413376600056	28551109				2022-02-06	
J	Rowland, MJ; Garry, P; Westbrook, J; Corkill, R; Antoniades, CA; Pattinson, KTS				Rowland, Matthew J.; Garry, Payashi; Westbrook, Jon; Corkill, Rufus; Antoniades, Chrystalina A.; Pattinson, Kyle T. S.			Acute impairment of saccadic eye movements is associated with delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage	JOURNAL OF NEUROSURGERY			English	Article						brain injury; subarachnoid hemorrhage; saccadic eye movement; delayed cerebral ischemia; DCI; cerebral infarction; vascular disorders	TRANSCRANIAL DOPPLER; BRAIN-INJURY; VASOSPASM; SACCADOMETRY; DEFINITION; CONCUSSION; MANAGEMENT; REFLEXIVE; DISEASE; CARE	OBJECTIVE Delayed cerebral ischemia (DCI) causing cerebral infarction remains a significant cause of morbidity and mortality following aneurysmal subarachnoid hemorrhage (aSAH). Early brain injury in the first 72 hours following rupture is likely to play a key role in the pathophysiology underlying DCI but remains difficult to quantify objectively. Current diagnostic modalities are based on the concept of vasoconstriction causing cerebral ischemia and infarction and are either invasive or have a steep learning curve and user variability. The authors sought to determine whether saccadic eye movements are impaired following aSAH and whether this measurement in the acute period is associated with the likelihood of developing DCI. METHODS As part of a prospective, observational cohort study, 24 male and female patients (mean age 53 years old, range 31-70 years old) were recruited. Inclusion criteria included presentation with World Federation of Neurosurgical Societies (WFNS) Grades 1 or 2 ("good grade") aSAH on admission and endovascular treatment within 72 hours of aneurysmal rupture. DCI and DCI-related cerebral infarction were defined according to consensus guidelines. Saccadometry data were collected at 3 time points in patients: in the first 72 hours, between Days 5 and 10, and at 3 months after aSAH. Data from 10 healthy controls was collected on 1 occasion for comparison. RESULTS Age -adjusted saccadic latency in patients was significantly prolonged in the first 72 hours following aSAH when compared with controls (188.7 msec [95% CI 176.9-202.2 msec] vs 160.7 msec [95% CI 145.6-179.4 msec], respectively; p = 0.0054, t-test). By 3 months after aSAH, there was no significant difference in median saccadic latency compared with controls (188.7 msec [95% CI 176.9-202.2 msec] vs 180.0 msec [95% CI 165.1-197.8 msec], respectively; p = 0.4175, t-test). Patients diagnosed with cerebral infarction due to DCI had a significantly higher age-adjusted saccadic latency in the first 72 hours than those without infarction (240.6 msec [95% CI 216.7-270.3 msec] vs 204.1 msec [95% CI 190.7-219.5 msec], respectively; p = 0.0157, t-test). This difference was more pronounced during Days 5-10 following aSAH, the peak incidence for DCI (303.7 msec [95% CI 266.7-352.7 msec] vs 207.6 msec [95% CI 193.7-223.6 msec], respectively; p < 0.0001, t-test). A binary generalized linear model showed that latency in the first 72 hours was the only significant predictor of cerebral infarction (p = 0.0185). CONCLUSIONS This is the first study to use saccadometry to measure the saccadic latency of eye movements in patients with aSAH during the acute period following aneurysm rupture. The results showed that median saccadic latency is associated with the risk of developing cerebral infarction due to DCI and may act as a potential objective biomarker to guide the need for intensive care admission and treatment. Future studies will look to formally validate saccadic latency as a biomarker of DCI in a larger cohort and assess whether the addition of saccades improves current clinical models for predicting patients at risk.	[Rowland, Matthew J.; Garry, Payashi; Westbrook, Jon; Antoniades, Chrystalina A.; Pattinson, Kyle T. S.] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England; [Rowland, Matthew J.; Garry, Payashi; Westbrook, Jon; Corkill, Rufus; Pattinson, Kyle T. S.] Oxford Univ Hosp NHS Trust, Neurosci Intens Care Unit, Oxford, England		Rowland, MJ (corresponding author), Univ Oxford, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England.	matthew.rowland@ndcn.ox.ac.uk		Antoniades, Chrystalina/0000-0002-1192-3834	National Institute for Health Research of Oxford Biomedical Research Centre based at Oxford University Hospitals NHS Trust; University of Oxford; Medical Research Council (UK)UK Research & Innovation (UKRI)Medical Research Council UK (MRC); MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G1100466] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G1100466] Funding Source: researchfish	This research was supported by the National Institute for Health Research of Oxford Biomedical Research Centre based at Oxford University Hospitals NHS Trust and the University of Oxford, and by the Medical Research Council (UK). We would like to acknowledge the assistance of Dr. Daniel Lunn, Department of Statistics, University of Oxford, for his statistical analysis in this paper.	Antoniades CA, 2015, EYE, V29, P200, DOI 10.1038/eye.2014.276; Antoniades CA, 2007, NEUROREPORT, V18, P1133, DOI 10.1097/WNR.0b013e32821c560d; Antoniades CA, 2015, J NEUROSCI, V35, P13043, DOI 10.1523/JNEUROSCI.2317-15.2015; Antoniades CA, 2010, J NEUROL, V257, P1890, DOI 10.1007/s00415-010-5632-2; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Cahill J, 2006, J CEREBR BLOOD F MET, V26, P1463, DOI 10.1038/sj.jcbfm.9600307; Camargo ECS, 2007, RADIOLOGY, V244, P541, DOI 10.1148/radiol.2442061028; Dorsch Nicholas W C, 2002, Curr Opin Crit Care, V8, P128; Ettinger U, 2003, PSYCHOPHYSIOLOGY, V40, P620, DOI 10.1111/1469-8986.00063; Frontera JA, 2009, STROKE, V40, P1963, DOI 10.1161/STROKEAHA.108.544700; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Heitger MH, 2002, PROG BRAIN RES, V140, P433; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; KASSELL NF, 1990, J NEUROSURG, V73, P18, DOI 10.3171/jns.1990.73.1.0018; Kumar G, 2016, J NEUROSURG, V124, P1257, DOI 10.3171/2015.4.JNS15428; LAUN A, 1988, NEUROSURG REV, V11, P137, DOI 10.1007/BF01794677; Leigh RJ, 2004, BRAIN, V127, P460, DOI 10.1093/brain/awh035; Lindvall P, 2009, BRIT J NEUROSURG, V23, P188, DOI 10.1080/02688690802710668; Moppett IK, 2004, BRIT J ANAESTH, V93, P710, DOI 10.1093/bja/aeh205; Muri RM, 2008, BRAIN COGNITION, V68, P284, DOI 10.1016/j.bandc.2008.08.018; Nicoletto Heather A, 2009, Am J Electroneurodiagnostic Technol, V49, P14; Ober JK, 2003, MODELLING MEASUREMEN, P187; Pearson BC, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2007.036731; Rowland MJ, 2012, BRIT J ANAESTH, V109, P315, DOI 10.1093/bja/aes264; Sandsmark DK, 2012, STROKE, V43, P1440, DOI 10.1161/STROKEAHA.111.639906; Schraa-Tam CKL, 2009, EXP BRAIN RES, V192, P175, DOI 10.1007/s00221-008-1569-4; Sehba FA, 2006, NEUROL RES, V28, P381, DOI 10.1179/016164106X114991; Sehba FA, 2012, PROG NEUROBIOL, V97, P14, DOI 10.1016/j.pneurobio.2012.02.003; Straube A, 2001, NEUROLOGY, V57, P2105, DOI 10.1212/WNL.57.11.2105; Topcuoglu MA, 2012, J NEUROCHEM, V123, P39, DOI 10.1111/j.1471-4159.2012.07942.x; Vergouwen MDI, 2010, STROKE, V41, P2391, DOI 10.1161/STROKEAHA.110.589275; WAESPE W, 1992, BRAIN, V115, P1125, DOI 10.1093/brain/115.4.1125; Zils E, 2005, SLEEP, V28, P1109, DOI 10.1093/sleep/28.9.1109	34	1	1	1	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	OCT	2017	127	4					754	760		10.3171/2016.8.JNS16408			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FI1AN	WOS:000411661400007	27935361	Bronze			2022-02-06	
J	Sommer, JB; Bach, A; Mala, H; Stromgaard, K; Mogensen, J; Pickering, DS				Sommer, Jens Bak; Bach, Anders; Mala, Hana; Stromgaard, Kristian; Mogensen, Jesper; Pickering, Darryl S.			Effects of the dimeric PSD-95 inhibitor UCCB01-144 on functional recovery after fimbria-fomix transection in rats	PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR			English	Article						Traumatic brain injury; PSD-95; Neuroprotection; Excitotoxicity; Fimbria-fomix transection; Spatial delayed alternation	TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE SYNTHASE; SPATIAL DELAYED ALTERNATION; FORNIX AND/OR ABLATION; BLOOD-FLOW; PREFRONTAL CORTEX; HIPPOCAMPAL; NEURONS; NEUROPROTECTION; RECEPTOR	Pharmacological inhibition of PSD-95 is a promising therapeutic strategy in the treatment of stroke, and positive effects of monomeric and dimeric PSD-95 inhibitors have been reported in numerous studies. However, whether therapeutic effects will generalize to other types of acute brain injury such as traumatic brain injury (TBI), which has pathophysiological mechanisms in common with stroke, is currently uncertain. We have previously found a lack of neuroprotective effects of dimeric PSD-95 inhibitors in the controlled cortical impact model of TBI in rats. However, as no single animal model is currently able to mimic the complex and heterogeneous pathophysiology of TBI, it is necessary to assess treatment effects across a range of models. In this preliminary study we investigated the neuroprotective abilities of the dimeric PSD-95 inhibitor UCCB01-144 after fimbria-fornix (FF) transection in rats. UCCB01-144 or saline was injected into the lateral tail vein of rats immediately after sham surgery or FF-transection, and effects on spatial delayed alternation in a T-maze were assessed over a 28-day period. Task acquisition was significantly impaired in FF-transected animals, but there were no significant effects of UCCB01-144 on spatial delayed alternation after FF-transection or sham surgery, although decelerated learning curves were seen after treatment with UCCB01-144 in FP-transected animals. The results of the present study are consistent with previous research showing a lack of neuroprotective effects of PSD-95 inhibition in experimental models of TBI.	[Sommer, Jens Bak; Bach, Anders; Stromgaard, Kristian; Pickering, Darryl S.] Univ Copenhagen, Dept Drug Design & Pharmacol, Jagtvej 160, DK-2100 Copenhagen, Denmark; [Sommer, Jens Bak; Mala, Hana; Mogensen, Jesper] Univ Copenhagen, Dept Psychol, UCN, Oster Farimagsgade 2A, DK-1353 Copenhagen, Denmark; [Bach, Anders; Stromgaard, Kristian] Univ Copenhagen, Dept Drug Design & Pharmacol, Jagtvej 162, DK-2100 Copenhagen, Denmark		Sommer, JB (corresponding author), Univ Copenhagen, Dept Drug Design & Pharmacol, Jagtvej 160, DK-2100 Copenhagen, Denmark.	jens.sommer@sund.ku.dk; anders.bach@sund.ku.dk; hana.mala@psy.ku.dk; kristian.stromgaard@sund.ku.dk; jesper.mogensen@psy.ku.dk; picker@sund.ku.dk		Bach, Anders/0000-0003-4305-9910; Mogensen, Jesper/0000-0003-1959-581X; Stromgaard, Kristian/0000-0003-2206-4737; Rytter, Hana Mala/0000-0002-2910-372X			Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Andreasen JT, 2016, EUR J PHARMACOL, V780, P166, DOI 10.1016/j.ejphar.2016.03.045; Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Bach A, 2012, P NATL ACAD SCI USA, V109, P3317, DOI 10.1073/pnas.1113761109; Bell KFS, 2013, J NEUROCHEM, V126, P274, DOI 10.1111/jnc.12176; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Bratane BT, 2011, STROKE, V42, P3265, DOI 10.1161/STROKEAHA.111.618801; Calabrese EJ, 2008, CRIT REV TOXICOL, V38, P557, DOI 10.1080/10408440802014287; Cassel JC, 1997, PROG NEUROBIOL, V51, P663, DOI 10.1016/S0301-0082(97)00009-9; Chen YT, 2015, J CEREBR BLOOD F MET, V35, P739, DOI 10.1038/jcbfm.2015.16; Christopherson KS, 1999, J BIOL CHEM, V274, P27467, DOI 10.1074/jbc.274.39.27467; Dawson VL, 1996, J CHEM NEUROANAT, V10, P179, DOI 10.1016/0891-0618(96)00148-2; DIVAC I, 1978, BRAIN RES, V151, P523, DOI 10.1016/0006-8993(78)91084-3; Dudchenko PA, 2004, NEUROSCI BIOBEHAV R, V28, P699, DOI 10.1016/j.neubiorev.2004.09.002; Elhusseiny A, 2000, J CEREBR BLOOD F MET, V20, P298, DOI 10.1097/00004647-200002000-00011; Ginsberg SD, 2002, J NEUROTRAUM, V19, P99, DOI 10.1089/089771502753460277; Ginsberg SD, 1999, NEUROSCIENCE, V88, P1059, DOI 10.1016/S0306-4522(98)00288-7; Gram MG, 2015, BRAIN RES, V1629, P182, DOI 10.1016/j.brainres.2015.10.019; Guix FX, 2005, PROG NEUROBIOL, V76, P126, DOI 10.1016/j.pneurobio.2005.06.001; Hamel E, 2004, PROG BRAIN RES, V145, P171, DOI 10.1016/S0079-6123(02)45012-7; Hartlage-Rubsamen M, 2001, BRAIN RES, V889, P155, DOI 10.1016/S0006-8993(00)03128-0; Hawkins RD, 1998, PROG BRAIN RES, V118, P155; Holtzman D M, 1994, Neurobiol Dis, V1, P51, DOI 10.1006/nbdi.1994.0007; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Kochanek PM, 2016, J NEUROTRAUM, V33, P606, DOI 10.1089/neu.2015.4133; Kostandy BB, 2012, NEUROL SCI, V33, P223, DOI 10.1007/s10072-011-0828-5; Lau A, 2010, PFLUG ARCH EUR J PHY, V460, P525, DOI 10.1007/s00424-010-0809-1; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Marschner L, 2016, IN VIVO, V30, P77; MOGENSEN J, 1995, NEUROBIOL LEARN MEM, V64, P17, DOI 10.1006/nlme.1995.1040; MOGENSEN J, 1995, NEUROBIOL LEARN MEM, V63, P54, DOI 10.1006/nlme.1995.1005; Mogensen J, 2004, PHARMACOL BIOCHEM BE, V77, P381, DOI 10.1016/j.pbb.2003.11.017; Mogensen J, 2004, BRAIN RES BULL, V63, P217, DOI 10.1016/j.brainresbull.2004.02.008; MOGENSEN J, 1987, ACTA NEUROBIOL EXP, V47, P45; Mogensen J, 1996, HOMEOSTASIS HLTH DIS, V37, P193; Mogensen J, 2015, COGNITIVE PLASTICITY, P3; MOGENSEN J, 1995, HOMEOSTASIS HLTH DIS, V36, P12; Mogensen J, 2008, BEHAV BRAIN RES, V186, P215, DOI 10.1016/j.bbr.2007.08.009; Mogensen J, 2007, BRAIN RES BULL, V73, P86, DOI 10.1016/j.brainresbull.2007.02.006; Mondello S, 2016, J NEUROTRAUM, V33, P595, DOI 10.1089/neu.2015.4132; Montaner J, 2013, DRUG FUTURE, V38, P485, DOI 10.1358/dof.2013.038.07.1980497; Nagura H, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-43; Nikonenko I, 2003, J NEUROSCI, V23, P8498; Nikonenko I, 2008, J CELL BIOL, V183, P1115, DOI 10.1083/jcb.200805132; Sattler R, 1999, SCIENCE, V284, P1845, DOI 10.1126/science.284.5421.1845; Shear D., 2011, SOC NEUR C WASH DC U; Shear D, 2009, J NEUROTRAUM, V26, pA26; Sheng M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005678; Sommer J. B., 2017, NEUROCHEM RES, P1; Sommer JB, 2017, EUR J NEUROSCI, V45, P238, DOI 10.1111/ejn.13483; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Tomaiuolo F, 2004, J NEUROL NEUROSUR PS, V75, P1314, DOI 10.1136/jnnp.2003.017046; Tong XK, 2000, EUR J NEUROSCI, V12, P2769, DOI 10.1046/j.1460-9568.2000.00158.x; Vaucher E, 1997, NEUROSCIENCE, V79, P827, DOI 10.1016/S0306-4522(97)00033-X	56	1	1	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0091-3057			PHARMACOL BIOCHEM BE	Pharmacol. Biochem. Behav.	OCT	2017	161						62	67		10.1016/j.pbb.2017.09.008			6	Behavioral Sciences; Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Pharmacology & Pharmacy	FK3IZ	WOS:000413380100009	28943199				2022-02-06	
J	Thananopavarn, P; Hill, JJ				Thananopavarn, Paul; Hill, James J., III			Rehabilitation of the Complex Burn Patient with Multiple lnjuries or Comorbities	CLINICS IN PLASTIC SURGERY			English	Article						Burn; Rehabilitation; Impairment; Reconstruction; Recovery; Brain injury; Nerve injury; Amputation	TRAUMATIC BRAIN-INJURY; HETEROTOPIC OSSIFICATION; FUNCTIONAL OUTCOMES; PREDICTORS; ANTIPSYCHOTICS; NEUROPATHY; RECOVERY	Patients with complex burn injuries require interdisciplinary rehabilitation to maximize their functional recovery. Successful rehabilitation from burn injuries starts with addressing the loss of the protective, mechanical, and cosmetic function of the skin and underlying structures. However, other injuries, particularly to the nervous and musculoskeletal systems, need to be identified and managed as part of the rehabilitation plan. Burn injuries can cause losses of functional mobility, self-care skills, psychological well-being, and community participation, which require comprehensive rehabilitation interventions throughout the recovery process.	[Thananopavarn, Paul; Hill, James J., III] Univ N Carolina, Dept Phys Med & Rehabil, Chapel Hill, NC USA		Thananopavarn, P (corresponding author), Univ N Carolina, Dept Phys Med & Rehabil, Mem Hosp N1181, 101 Manning Dr,CB 7200, Chapel Hill, NC 27599 USA.	paul_thananopavarn@med.unc.edu		Hill 3rd, James/0000-0001-9504-0993			Al-Mousawi AM, 2009, CLIN PLAST SURG, V36, P547, DOI 10.1016/j.cps.2009.05.015; Baltzer JL, 2002, TOTAL BURN CARE, P1; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P917; Carrougher GJ, 2014, J BURN CARE RES, V35, pS78; Cromes GF, 2002, J BURN CARE REHABIL, V23, P229, DOI 10.1097/00004630-200205000-00016; Davidson GH, 2011, JAMA-J AM MED ASSOC, V305, P1001, DOI 10.1001/jama.2011.259; Elovic EP, 2008, J HEAD TRAUMA REHAB, V23, P132, DOI 10.1097/01.HTR.0000314532.07530.e5; Fergason JR, 2011, PHYS MED REH CLIN N, V22, P277, DOI 10.1016/j.pmr.2011.03.001; Gabriel V, 2016, BRADDOMS PHYS MED RE, P557; Gabriel V, 2009, J BURN CARE RES, V30, P668, DOI 10.1097/BCR.0b013e3181abff6a; Gerrard P, 2013, ARCH PHYS MED REHAB, V94, P1521, DOI 10.1016/j.apmr.2013.02.019; Hasanzadeh P, 2008, CLIN NEUROPHYSIOL, V119, P1824, DOI 10.1016/j.clinph.2008.04.003; Hendricks HT, 2007, CLIN REHABIL, V21, P545, DOI 10.1177/0269215507075260; Kennedy PJ, 2006, J BURN CARE RES, V27, P183, DOI 10.1097/01.BCR.0000203492.89591.A1; Kline AE, 2008, NEUROSCI LETT, V448, P263, DOI 10.1016/j.neulet.2008.10.076; Kowalske K, 2001, J BURN CARE REHABIL, V22, P353, DOI 10.1097/00004630-200109000-00013; Lin SY, 2013, BURNS, V39, P16, DOI 10.1016/j.burns.2012.08.020; Maender C, 2010, J SHOULDER ELB SURG, V19, P1269, DOI 10.1016/j.jse.2010.05.029; Mason ST, 2012, J BURN CARE RES, V33, P101, DOI 10.1097/BCR.0b013e3182374439; MELVIN JL, 1980, ARCH PHYS MED REHAB, V61, P379; Mysiw WJ, 1997, ARCH PHYS MED REHAB, V78, P213, DOI 10.1016/S0003-9993(97)90266-5; Palmieri TL, 2012, J BURN CARE RES, V33, P497, DOI 10.1097/BCR.0b013e31825aeaac; PATTERSON DR, 1993, PSYCHOL BULL, V113, P362, DOI 10.1037/0033-2909.113.2.362; Pham TN, 2015, J BURN CARE RES, V36, P607, DOI 10.1097/BCR.0000000000000216; Schneider JC, 2011, J BURN CARE RES, V32, P294, DOI 10.1097/BCR.0b013e31820aaf56; Serghiou M, 2009, CLIN PLAST SURG, V36, P675, DOI 10.1016/j.cps.2009.05.008; Sliwa JA, 2005, ARCH PHYS MED REHAB, V86, P1920, DOI 10.1016/j.apmr.2005.04.024; Summer GJ, 2007, J PAIN, V8, P533, DOI 10.1016/j.jpain.2007.02.426; Tan WH, 2012, J BURN CARE RES, V33, P110, DOI 10.1097/BCR.0b013e318234d91a	29	1	1	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0094-1298	1558-0504		CLIN PLAST SURG	Clin. Plast. Surg.	OCT	2017	44	4					695	+		10.1016/j.cps.2017.05.002			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	FJ3EV	WOS:000412614200002	28888295				2022-02-06	
J	Thompson, KD; Weiss-Bilka, HE; McGough, EB; Ravosa, MJ				Thompson, Khari D.; Weiss-Bilka, Holly E.; McGough, Elizabeth B.; Ravosa, Matthew J.			Bone up: craniomandibular development and hard-tissue biomineralization in neonate mice	ZOOLOGY			English	Article						Biomineralization; Mammalian cranial bone; Perinatal ontogeny; Intracranial variation		The presence of regional variation in the osteogenic abilities of cranial bones underscores the fact that the mechanobiology of the mammalian skull is more complex than previously recognized. However, the relationship between patterns of cranial bone formation and biomineralization remains incompletely understood. In four strains of mice, micro-computed tomography was used to measure tissue mineral density during perinatal development in three skull regions (calvarium, basicranium, mandible) noted for variation in loading environment, embryological origin, and ossification mode. Biomineralization levels increased during perinatal ontogeny in the mandible and calvarium, but did not increase in the basicranium. Tissue mineral density levels also varied intracranially, with density in the mandible being highest, in the basicranium intermediate, and in the calvarium lowest. Perinatal increases in, and elevated levels of, mandibular biomineralization appear related to the impending postweaning need to resist elevated masticatory stresses. Similarly, perinatal increases in calvarial biomineralization may be linked to ongoing brain expansion, which is known to stimulate sutural bone formation in this region. The lack of perinatal increase in basicranial biomineralization could be a result of earlier developmental maturity in the cranial base relative to other skull regions due to its role in supporting the brain's mass throughout ontogeny. These results suggest that biomineralization levels and age-related trajectories throughout the skull are influenced by the functional environment and ontogenetic processes affecting each region, e.g., onset of masticatory loads in the mandible, whereas variation in embryology and ossification mode may only have secondary effects on patterns of biomineralization. Knowledge of perinatal variation in tissue mineral density, and of normal cranial bone formation early in development, may benefit clinical therapies aiming to correct developmental defects and traumatic injuries in the skull, and more generally characterize loading environments and skeletal adaptations in mammals by highlighting the need for multi-level analyses for evaluating functional performance of cranial bone. (C) 2017 Elsevier GmbH. All rights reserved.	[Thompson, Khari D.; Weiss-Bilka, Holly E.; McGough, Elizabeth B.; Ravosa, Matthew J.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Ravosa, Matthew J.] Univ Notre Dame, Dept Aerosp & Mech Engn, Notre Dame, IN 46556 USA; [Ravosa, Matthew J.] Univ Notre Dame, Dept Anthropol, Notre Dame, IN 46556 USA		Ravosa, MJ (corresponding author), Univ Notre Dame, Dept Biol Sci, Galvin Life Sci Ctr 221, Notre Dame, IN 46556 USA.	Matthew.J.Ravosa.1@nd.edu			Graduate School Dean's Diversity Fellowship, Indiana CTSI (National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award) [TL1TR001107]; Harper Cancer Research Institute; Walther Foundation; University of Notre Dame; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [TL1TR001107, UL1TR001108] Funding Source: NIH RePORTER	Funding for this study was provided by the Graduate School Dean's Diversity Fellowship, Indiana CTSI (Grant TL1TR001107 (A. Shekhar, PI) from the National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award), Harper Cancer Research Institute and Walther Foundation, and the University of Notre Dame. Liz Loughran, other members of the Stack Lab, and Freimann Life Sciences are thanked for generously providing the samples here used. Matt Leevy and NDIIF provided access to the Albira Micro-CT unit and other imaging technology. We thank Olga Panagiotopoulou and Pepe Iriarte-Diaz for the invitation to participate in this special issue on mammalian feeding system design.		0	1	1	3	4	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	0944-2006			ZOOLOGY	Zoology	OCT	2017	124						51	60		10.1016/j.zool.2017.01.002			10	Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Zoology	FS8YQ	WOS:000422701000006	28807504	Green Accepted			2022-02-06	
J	Walker, PB; Mehalick, ML; Glueck, AC; Tschiffely, AE; Cunningham, CA; Norris, JN; Davidson, IN				Walker, Peter B.; Mehalick, Melissa L.; Glueck, Amanda C.; Tschiffely, Anna E.; Cunningham, Craig A.; Norris, Jacob N.; Davidson, Ian N.			A decision tree framework for understanding blast-induced mild Traumatic Brain Injury in a military medical database	JOURNAL OF DEFENSE MODELING AND SIMULATION-APPLICATIONS METHODOLOGY TECHNOLOGY-JDMS			English	Article						Biomedical informatics; graph theory; classification algorithms; clustering algorithms	HEALTH; SYMPTOMS; TESTS; CARE; TBI	Personalized medicine is a ubiquitous term that has come to be used to describe a medical model that proposes the customization of healthcare, such that decisions and/or treatments are tailored to each individual patient. Under this type of clinical practice model, diagnostic and prognostic decisions are often based upon selecting the most appropriate therapy based on a patient's genetic, demographic, and/or other pertinent information. The primary aim of this paper is to use a personalized medicine framework to better understand the relationship between neuropsychological testing and the progression of symptoms in a blast-induced mild Traumatic Brain Injury (mTBI) patient population. In this paper, we extended our earlier work on Constrained Spectral Partitioning (CSP), a graph-based approach that incorporates additional information from separate graphs to help improve the clustering quality on both graphs simultaneously. While our previous work demonstrated the effectiveness of this algorithm in its ability to accurately classify whether symptoms improved or declined over time, that work did not provide any insights into the progression of symptoms. Therefore, this paper sought to identify, from a clinical perspective, whether symptoms increased/decreased over time. To accomplish this, we developed a decision tree classifier to classify symptom progression based on the outputs from our CSP algorithm. We present results from four separate decision tree classifiers that illustrate the adaptability of these algorithms for utilization as decision rules for the treatment of patients following blast-induced mTBI. Decision tree classifier models are useful in the healthcare setting because patient health data (e.g., diagnosis of a condition or a type of treatment) can be imput into the model and, based on the health data variables, a resulting outcome can be suggested, and providers can use this outcome as information to direct their clinical treatment.	[Walker, Peter B.] Naval Med Res Ctr, Operat Undersea Med Directorate, Silver Spring, MD 20910 USA; [Mehalick, Melissa L.; Glueck, Amanda C.] Naval Med Res Ctr, 503 Robert Grant Ave, Silver Spring, MD 20910 USA; [Tschiffely, Anna E.] Naval Med Res Ctr, Neurotrauma Dept, Silver Spring, MD 20910 USA; [Norris, Jacob N.] Naval Med Res Ctr, Warfighter Performance Dept, Silver Spring, MD 20910 USA; [Cunningham, Craig A.] Naval Hosp Portsmouth, Portsmouth, VA USA; [Davidson, Ian N.] Univ Calif Davis, Dept Comp Sci, Davis, CA 95616 USA		Walker, PB (corresponding author), Naval Med Res Ctr, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	peter.b.walker.mil@mail.mil			 [604110HP.4270.001.A1411]	This research was supported by work unit number 604110HP.4270.001.A1411.	Basu S, 2009, CH CRC DATA MIN KNOW, P1; Campolo M, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0196-1; Chen HC, 2005, INT SER I S, V8, P3; Elder GA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00269; Fishbain DA, 2015, PAIN MED, V16, P37, DOI 10.1111/pme.12527; Friedl KE, 2007, ARCH CLIN NEUROPSYCH, V22, pS7, DOI 10.1016/j.acn.2006.10.002; Gilbert KS, 2015, CLIN PSYCHOL REV, V40, P195, DOI 10.1016/j.cpr.2015.05.008; Hamburg MA, 2010, NEW ENGL J MED, V363, P301, DOI 10.1056/NEJMp1006304; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jensen PB, 2012, NAT REV GENET, V13, P395, DOI 10.1038/nrg3208; Kuo CT, 2014, IEEE DATA MINING, P887, DOI 10.1109/ICDM.2014.143; Norris JN, 2014, BRAIN INJURY, V28, P1052, DOI 10.3109/02699052.2014.891761; Norris JN, 2013, MIL MED, V178, P767, DOI 10.7205/MILMED-D-12-00493; Phillips Henry L., 2013, Foundations of Augmented Cognition. 7th International Conference, AC 2013. Held as Part of HCI International 2013. Proceedings, P709, DOI 10.1007/978-3-642-39454-6_76; Reeves DL, 2007, ARCH CLIN NEUROPSYCH, V22, pS15, DOI 10.1016/j.acn.2006.10.013; SAFAVIAN SR, 1991, IEEE T SYST MAN CYB, V21, P660, DOI 10.1109/21.97458; Seidl JNT, 2015, REHABIL PSYCHOL, V60, P335, DOI 10.1037/rep0000064; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; Spira J. L., 2014, J NEUROTRAUM, V31, P1; Walker PB, 2016, IEEE T COMPUT BIOL B; Wang F, 2015, J BIOMED INFORM, V55, P41, DOI 10.1016/j.jbi.2015.01.009; Wang X., 2010, P 16 ACM SIGKDD INT, P563, DOI DOI 10.1145/1835804.1835877; Wang X, 2014, DATA MIN KNOWL DISC, V28, P1, DOI 10.1007/s10618-012-0291-9	23	1	1	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1548-5129	1557-380X		J DEF MODEL SIMUL-AP	J. Def. Model. Simul.-Appl. Methodol. Technol.-JDMS	OCT	2017	14	4			SI		389	398		10.1177/1548512916683841			10	Engineering, Multidisciplinary	Emerging Sources Citation Index (ESCI)	Engineering	FJ3YP	WOS:000412669300006					2022-02-06	
J	Wiseheart, R; Wellington, R				Wiseheart, Rebecca; Wellington, Robin			Identifying Dyslexia Risk in Student-Athletes: A Preliminary Protocol for Concussion Management	JOURNAL OF ATHLETIC TRAINING			English	Article						learning disability; self-report; screening assessment; neuropsychological tests	NEUROCOGNITIVE TEST-PERFORMANCE; DEVELOPMENTAL DYSLEXIA; SELF-REPORT; CHILDREN; DEFICIT; DIFFICULTIES; STATEMENT; CHILDHOOD; VALIDITY; PLAYERS	Learning disability (LD) has been identified as a potential risk factor for a sport-related concussion, yet students with LD are rarely included in concussion research. Here, we draw special attention to dyslexia, a common but often underdiagnosed LD. Reading and learning problems commonly associated with dyslexia are often masked by protective factors, such as high verbal ability or general intelligence. Hence, high-achieving individuals with dyslexia may not be identified as being in a high-risk category. To ensure that students with dyslexia are included in LD concussion research and identified as LD in baseline testing, we provide athletic trainers with an overview of dyslexia and a preliminary screening protocol that is sensitive to dyslexia, even among academically high-achieving students in secondary school and college.	[Wiseheart, Rebecca] St Johns Univ, Dept Commun Sci & Disorders, 8000 Utopia Pkwy, Queens, NY 11349 USA; [Wiseheart, Rebecca; Wellington, Robin] St Johns Univ, Dept Psychol, 8000 Utopia Pkwy, Queens, NY 11349 USA		Wiseheart, R (corresponding author), St Johns Univ, Dept Commun Sci & Disorders, 8000 Utopia Pkwy, Queens, NY 11349 USA.; Wiseheart, R (corresponding author), St Johns Univ, Dept Psychol, 8000 Utopia Pkwy, Queens, NY 11349 USA.	wisehear@stjohns.edu					Albuquerque CP, 2010, SPAN J PSYCHOL, V13, P88, DOI 10.1017/S1138741600003693; Berninger VW, 2006, SCI STUD READ, V10, P165, DOI 10.1207/s1532799xssr1002_3; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Cirino PT, 2005, J LEARN DISABIL-US, V38, P29, DOI 10.1177/00222194050380010301; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Cooper R., 2011, REVISED ADULT DYSLEX; Cortiella C., 2014, STATE LEARNING DISAB; Deacon SH, 2012, ANN DYSLEXIA, V62, P120, DOI 10.1007/s11881-012-0068-2; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Iverson GL, 2016, J ATTEN DISORD; Johnson E, 2014, ARCH CLIN NEUROPSYCH, V29, P590; Kirby JR, 2010, READ RES QUART, V45, P341, DOI 10.1598/RRQ.45.3.4; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Nelson LD, 2016, CLIN J SPORT MED, V26, P120, DOI 10.1097/JSM.0000000000000207; Newman L., 2011, 20113005 NCSER; Nittrouer S, 2010, CURR DIR PSYCHOL SCI, V19, P308, DOI 10.1177/0963721410383976; Norton ES, 2012, ANNU REV PSYCHOL, V63, P427, DOI 10.1146/annurev-psych-120710-100431; Park H, 2013, RES DEV DISABIL, V34, P2946, DOI 10.1016/j.ridd.2013.06.002; Pennington BF, 2005, BL HBK DEV PSYCHOL, P453, DOI 10.1002/9780470757642.ch24; Popoli DM, 2014, CLIN PEDIATR, V53, P217, DOI 10.1177/0009922813499070; Ramus F, 2008, Q J EXP PSYCHOL, V61, P129, DOI 10.1080/17470210701508822; Schatz P, 2014, J ATHL TRAINING, V49, P659, DOI 10.4085/1062-6050-49.3.37; Shaywitz SE, 2008, ANNU REV PSYCHOL, V59, P451, DOI 10.1146/annurev.psych.59.103006.093633; Shaywitz SE, 1999, JAMA-J AM MED ASSOC, V264, P998; Smythe I, ADULT CHECKLIST; Snowling M, 2012, DYSLEXIA, V18, P1, DOI 10.1002/dys.1432; Snyder T., 2016, DIGEST ED STAT 2014; Solomon GS, 2008, ARCH CLIN NEUROPSYCH, V23, P563, DOI 10.1016/j.acn.2008.05.008; STOLL L, 1996, CHANGING OUR SCH LIN; Tamboer P, 2015, DYSLEXIA, V21, P1, DOI 10.1002/dys.1492; Tamboer P, 2014, ANN DYSLEXIA, V64, P34, DOI 10.1007/s11881-013-0085-9; Torgesen JK, 2012, TOWRE TEST WORD READ; van Viersen S, 2016, J LEARN DISABIL-US, V49, P189, DOI 10.1177/0022219414538517; van Viersen S, 2015, ANN DYSLEXIA, V65, P178, DOI 10.1007/s11881-015-0106-y; Wagner R.K., 2013, CTOPP 2 COMPREHENSIV; Wiseheart R, 2009, ANN DYSLEXIA, V59, P151, DOI 10.1007/s11881-009-0028-7; Youman M, 2015, PERSPECT LANG LITERA, V41, P10; Ziegler JC, 2010, DEVELOPMENTAL SCI, V13, pF8, DOI 10.1111/j.1467-7687.2010.00983.x	38	1	1	3	10	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	OCT	2017	52	10					982	986		10.4085/1062-6050-52.10.03			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	FN2LV	WOS:000415824700011	28937789	Green Published, Bronze			2022-02-06	
J	Wu, X; Gao, GY; Feng, JF; Mao, Q; Jiang, JY				Wu, Xiang; Gao, Guoyi; Feng, Junfeng; Mao, Qing; Jiang, Jiyao			A Detailed Protocol for Physiological Parameters Acquisition and Analysis in Neurosurgical Critical Patients	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Intracranial pressure; blood pressure; monitoring; humans; prognosis; neurosurgery	TRAUMATIC BRAIN-INJURY; INTRACRANIAL-PRESSURE; THRESHOLDS; REACTIVITY; AMPLITUDE	Intracranial pressure (ICP) monitoring is now widely used in neurosurgical critical patients. Besides mean ICP value, the ICP derived parameters such as ICP waveform, amplitude of pulse (AMP), the correlation of ICP amplitude and ICP mean (RAP), pressure reactivity index (PRx), ICP and arterial blood pressure (ABP) wave amplitude correlation (IAAC), and so on, can reflect intracranial status, predict prognosis, and can also be used as guidance of proper treatment. However, most of the clinicians focus only on the mean ICP value while ignoring these parameters because of the limitations of the current devices. We have recently developed a multimodality monitoring system to address these drawbacks. This portable, user-friendly system will use a data collecting and storing device to continuously acquire patients' physiological parameters first, i.e., ABP, ICP, and oxygen saturation, and then analyze these physiological parameters. We hope that the multimodality monitoring system will be accepted as a key measure to monitor physiological parameters, to analyze the current clinical status, and to predict the prognosis of the neurosurgical critical patients.	[Wu, Xiang; Gao, Guoyi; Feng, Junfeng; Mao, Qing; Jiang, Jiyao] Shanghai Jiao Tong Univ, Sch Med, Dept Neurosurg, Renji Hosp, Shanghai, Peoples R China; [Wu, Xiang; Gao, Guoyi; Feng, Junfeng; Mao, Qing; Jiang, Jiyao] Shanghai Inst Head Trauma, Shanghai, Peoples R China		Gao, GY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Neurosurg, Renji Hosp, Shanghai, Peoples R China.; Gao, GY (corresponding author), Shanghai Inst Head Trauma, Shanghai, Peoples R China.	gao3@sina.com					Carrera E, 2010, J NEUROTRAUM, V27, P317, DOI 10.1089/neu.2009.0951; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Czosnyka M, 2006, ACTA NEUROCHIR SUPPL, V96, P114; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Czosnyka M, 2001, J NEUROSURG, V94, P482, DOI 10.3171/jns.2001.94.3.0482; Czosnyka Marek, 1800, Neurosurg Focus, V22, pE10; Di Ieva A, 2013, NEUROSCIENTIST, V19, P592, DOI 10.1177/1073858412474845; Eide PK, 2007, NEUROL RES, V29, P798, DOI 10.1179/016164107X224132; Eide PK, 2012, J NEUROSURG, V116, P961, DOI 10.3171/2012.1.JNS111313; Hawthorne C, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00121; Howells T, 2012, INTENS CARE MED, V38, P1061, DOI 10.1007/s00134-012-2571-7; Hu X, 2010, IEEE T BIO-MED ENG, V57, P1070, DOI 10.1109/TBME.2009.2037607; Jiang JY, 2013, INJURY, V44, P1453, DOI 10.1016/j.injury.2012.08.045; Lazaridis C, 2014, J NEUROSURG, V120, P893, DOI 10.3171/2014.1.JNS131292; Lu CW, 2012, BRAIN, V135, P2399, DOI 10.1093/brain/aws155; Nucci CG, 2016, ACTA NEUROCHIR, V158, P581, DOI 10.1007/s00701-015-2672-5; Schuhmann MU, 2008, PEDIATR NEUROSURG, V44, P269, DOI 10.1159/000131675; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Tegtmeyer Ken, 2006, N Engl J Med, V354, pe13, DOI 10.1056/NEJMvcm044149	21	1	1	0	4	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	OCT	2017		128							e56388	10.3791/56388			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8WD	WOS:000415371500073	29155778	Green Published			2022-02-06	
J	Zhu, MQ; Huang, ZH; Ma, C; Li, YL				Zhu, Mengqi; Huang, Zhonghua; Ma, Chao; Li, Yinlin			An Objective Balance Error Scoring System for Sideline Concussion Evaluation Using Duplex Kinect Sensors	SENSORS			English	Article						concussion evaluation; postural stability; balance error scoring system; Kinect sensor	SPORTS-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; ATHLETIC TRAINERS; RELIABILITY; MANAGEMENT; VALIDITY; BOARD	Sports-related concussion is a common sports injury that might induce potential long-term consequences without early diagnosis and intervention in the field. However, there are few options of such sensor systems available. The aim of the study is to propose and validate an automated concussion administration and scoring approach, which is objective, affordable and capable of detecting all balance errors required by the balance error scoring system (BESS) protocol in the field condition. Our approach is first to capture human body skeleton positions using two Microsoft Kinect sensors in the proposed configuration and merge the data by a custom-made algorithm to remove the self-occlusion of limbs. The standing balance errors according to BESS protocol were further measured and accessed automatically by the proposed algorithm. Simultaneously, the BESS test was filmed for scoring by an experienced rater. Two results were compared using Pearson coefficient r, obtaining an excellent consistency (r = 0.93, p < 0.05). In addition, BESS test-retest was performed after seven days and compared using intraclass correlation coefficients (ICC), showing a good test-retest reliability (ICC = 0.81, p < 0.01). The proposed approach could be an alternative of objective tools to assess postural stability for sideline sports concussion diagnosis.	[Zhu, Mengqi; Huang, Zhonghua; Ma, Chao; Li, Yinlin] Beijing Inst Technol, Sch Mechatron Engn, Beijing 100081, Peoples R China		Li, YL (corresponding author), Beijing Inst Technol, Sch Mechatron Engn, Beijing 100081, Peoples R China.	vivian_zmq@yahoo.com; huangzh@bit.edu.cn; 20081124@bit.edu.cn; liyinlin@bit.edu.cn					Alberts JL, 2015, MED SCI SPORT EXER, V47, P2233, DOI 10.1249/MSS.0000000000000656; Alsalaheen BA, 2015, PHYSICIAN SPORTSMED, V43, P221, DOI 10.1080/00913847.2015.1040717; [Anonymous], 2011, MED SCI SPORT EXER, V43, P2412, DOI 10.1249/MSS.0b013e3182342e64; Asteriadis S., 2013, P 6 INT C COMP VIS C; Azis NA, 2015, INT CONF BIG DATA, P170, DOI 10.1109/35021BIGCOMP.2015.7072828; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brown HJ, 2014, MED SCI SPORT EXER, V46, P1610, DOI 10.1249/MSS.0000000000000263; Chang JO, 2014, CLIN J SPORT MED, V24, P256, DOI 10.1097/JSM.0000000000000016; Cicchetti DV, 2001, J CLIN EXP NEUROPSYC, V23, P695, DOI 10.1076/jcen.23.5.695.1249; Dave P. T., 2014, THESIS; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Gao ZQ, 2015, SENSORS-BASEL, V15, P24297, DOI 10.3390/s150924297; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hunt TN, 2009, J ATHL TRAINING, V44, P405, DOI 10.4085/1062-6050-44.4.405; Kaenchan S, 2013, 2013 INTERNATIONAL COMPUTER SCIENCE AND ENGINEERING CONFERENCE (ICSEC), P245, DOI 10.1109/ICSEC.2013.6694787; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; King LA, 2017, ANN BIOMED ENG, V45, P2135, DOI 10.1007/s10439-017-1856-y; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lynall RC, 2013, J ATHL TRAINING, V48, P844, DOI 10.4085/1062-6050-48.6.04; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; Merchant-Borna K, 2017, J ATHL TRAINING, V52, P245, DOI 10.4085/1062-6050-52.1.13; Napoli A., 2017, ANN BIOMED ENG, DOI [10.1007/s10439-017-1911-828856486, DOI 10.1007/S10439-017-1911-828856486]; Napoli A, 2016, IEEE ENG MED BIO, P6090, DOI 10.1109/EMBC.2016.7592118; Putukian M, 2017, J ATHL TRAINING, V52, P236, DOI 10.4085/1062-6050-52.1.08; Ravdin LD, 2003, CLIN J SPORT MED, V13, P21, DOI 10.1097/00042752-200301000-00005; Register-Mihalik JK, 2013, J HEAD TRAUMA REHAB, V28, P274, DOI 10.1097/HTR.0b013e3182585d37; Resch JE., 2016, BMJ OPEN SPORT EXERC, V2, pe000012, DOI DOI 10.1136/BMJSEM-2015-000012; Riemann BL, 1997, J SPORT REHABIL, V6, P283, DOI 10.1123/jsr.6.3.283; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Yeung KY, 2013, J COMPUT INF SCI ENG, V13, DOI 10.1115/1.4025404	35	1	1	0	6	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1424-8220		SENSORS-BASEL	Sensors	OCT	2017	17	10							2398	10.3390/s17102398			13	Chemistry, Analytical; Engineering, Electrical & Electronic; Instruments & Instrumentation	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Engineering; Instruments & Instrumentation	FM3TM	WOS:000414931500240		gold, Green Published, Green Submitted			2022-02-06	
J	Fogleman, ND; Naaz, F; Knight, LK; Stoica, T; Patton, SC; Olson-Madden, JH; Barnhart, MC; Hostetter, TA; Forster, J; Brenner, LA; Banich, MT; Depue, BE				Fogleman, Nicholas D.; Naaz, Farah; Knight, Lindsay K.; Stoica, Teodora; Patton, Samantha C.; Olson-Madden, Jennifer H.; Barnhart, Meghan C.; Hostetter, Trisha A.; Forster, Jeri; Brenner, Lisa A.; Banich, Marie T.; Depue, Brendan E.			Reduced lateral prefrontal cortical volume is associated with performance on the modified Iowa Gambling Task: A surface based morphometric analysis of previously deployed veterans	PSYCHIATRY RESEARCH-NEUROIMAGING			English	Article						Magnetic resonance imaging (MRI); Anatomy Post-traumatic stress disorder (PTSD); Mild traumatic brain injury (mTBI); Modified Iowa Gambling Task (mIGT); Veterans	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; FRONTAL-LOBE DAMAGE; DECISION-MAKING; ANTERIOR CINGULATE; CORTEX; PTSD; ATTENTION; MEMORY; SYMPTOMS	Post-traumatic stress disorder (PTSD) and mild traumatic brain injury (mTBI) are two of the most common consequences of combat deployment. Estimates of comorbidity of PTSD and mTBI are as high as 42% in combat exposed Operation Enduring Freedom, Operation Iraqi Freedom and Operation New Dawn (OEF/OIF/OND) Veterans. Combat deployed Veterans with PTSD and/or mTBI exhibit deficits in classic executive function (EF) tasks. Similarly, the extant neuroimaging literature consistently indicates abnormalities of the ventromedial prefrontal cortex (vmPFC) and amygdala/hippocampal complex in these individuals. While studies examining deficits in classical EF constructs and aberrant neural circuitry have been widely replicated, it is surprising that little research examining reward processing and decision-making has been conducted in these individuals, specifically, because the vmPFC has long been implicated in underlying such processes. Therefore, the current study employed the modified Iowa Gambling Task (mIGT) and structural neuroimaging to assess whether behavioral measures related to reward processing and decision-making were compromised and related to cortical morphometric features of OEF/OIF/OND Veterans with PTSD, mTBI, or co-occurring PTSD/mTBI. Results indicated that gray matter morphometry in the lateral prefrontal cortex (1PFC) predicted performance on the mIGT among all three groups and was significantly reduced, as compared to the control group.	[Fogleman, Nicholas D.; Naaz, Farah; Patton, Samantha C.; Depue, Brendan E.] Univ Louisville, Dept Psychol & Brain Sci, Louisville, KY 40292 USA; [Knight, Lindsay K.; Stoica, Teodora; Depue, Brendan E.] Univ Louisville, Interdisciplinary Program Translat Neurosci, Louisville, KY 40292 USA; [Olson-Madden, Jennifer H.; Barnhart, Meghan C.; Hostetter, Trisha A.; Forster, Jeri; Brenner, Lisa A.] VISN 19 Mental Illness Res Educ & Clin Ctr, Denver, CO USA; [Olson-Madden, Jennifer H.; Barnhart, Meghan C.; Hostetter, Trisha A.; Forster, Jeri; Brenner, Lisa A.] Univ Colorado Denver, Anschutz Med Campus, Aurora, CO USA; [Banich, Marie T.] Univ Colorado, Inst Cognit Sci, Boulder, CO 80309 USA; [Banich, Marie T.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA; [Depue, Brendan E.] Univ Louisville, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA		Depue, BE (corresponding author), Univ Louisville, Dept Psychol & Brain Sci, Louisville, KY 40292 USA.	brendan.depue@louisville.edu	Stoica, Teodora/AAU-6256-2021; Brenner, Lisa A./AAG-2442-2019	Stoica, Teodora/0000-0003-1797-7443; Knight, Lindsay/0000-0002-0120-5556; BANICH, MARIE/0000-0001-9373-9194; Fogleman, Nicholas/0000-0002-7103-2080	Colorado Traumatic Brain Injury Trust Fund Program; Rocky Mountain MIRECC	Support for this project was provided by the Colorado Traumatic Brain Injury Trust Fund Program and The Rocky Mountain MIRECC. The views expressed in this paper are those of the authors and do not necessarily represent the official policy or position of the Department of Veterans Affairs or the US Government.	American Psychiatric Association, 2013, DSM 5, V5th; Ariza M, 2006, J NEUROL NEUROSUR PS, V77, P1191, DOI 10.1136/jnnp.2005.085167; Barbey AK, 2013, CORTEX, V49, P1195, DOI 10.1016/j.cortex.2012.05.022; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1999, J NEUROSCI, V19, P5473; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; Bolla KI, 2004, CEREB CORTEX, V14, P1226, DOI 10.1093/cercor/bhh083; Cauffman E, 2010, DEV PSYCHOL, V46, P193, DOI 10.1037/a0016128; Clark L, 2003, NEUROPSYCHOLOGIA, V41, P1474, DOI 10.1016/S0028-3932(03)00081-2; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Depue BE, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/691505; Depue B. E., 2015, CEREB CORTEX, V324; Depue BE, 2010, PSYCHIAT RES-NEUROIM, V182, P231, DOI 10.1016/j.pscychresns.2010.01.012; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Fellows LK, 2005, CEREB CORTEX, V15, P58, DOI 10.1093/cercor/bhh108; Himanen L, 2005, BRAIN INJURY, V19, P93, DOI 10.1080/02699050410001720031; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Karl A, 2006, NEUROSCI BIOBEHAV R, V30, P1004, DOI 10.1016/j.neubiorev.2006.03.004; Kasai K, 2008, BIOL PSYCHIAT, V63, P550, DOI 10.1016/j.biopsych.2007.06.022; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Killgore WDS, 2008, J PSYCHIATR RES, V42, P1112, DOI 10.1016/j.jpsychires.2008.01.001; Kitayama N, 2005, J AFFECT DISORDERS, V88, P79, DOI 10.1016/j.jad.2005.05.014; Lawrence NS, 2009, CEREB CORTEX, V19, P1134, DOI 10.1093/cercor/bhn154; Leskin LP, 2007, NEUROPSYCHOLOGY, V21, P275, DOI 10.1037/0894-4105.21.3.275; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Levine B, 2005, COGN BEHAV NEUROL, V18, P45, DOI 10.1097/01.wnn.0000152227.13001.c3; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Manes F, 2002, BRAIN, V125, P624, DOI 10.1093/brain/awf049; Mayou RA, 2000, BRIT J PSYCHIAT, V177, P540, DOI 10.1192/bjp.177.6.540; Mollica RF, 2009, ARCH GEN PSYCHIAT, V66, P1221, DOI 10.1001/archgenpsychiatry.2009.127; Nelson LA, 2009, J HEAD TRAUMA REHAB, V24, P32, DOI 10.1097/HTR.0b013e3181957016; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Peters E, 2000, PERS SOC PSYCHOL B, V26, P1465, DOI 10.1177/01461672002612002; Pustilnik A., 2016, ARCH SUICIDE RES, P1; Rauch SL, 2003, NEUROREPORT, V14, P913, DOI 10.1097/01.wnr.0000071767.24455.10; Reuter M, 2010, NEUROIMAGE, V53, P1181, DOI 10.1016/j.neuroimage.2010.07.020; Sailer U, 2008, NEUROPSYCHOLOGIA, V46, P2836, DOI 10.1016/j.neuropsychologia.2008.05.022; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Smith TC, 2008, BMJ-BRIT MED J, V336, P366, DOI 10.1136/bmj.39430.638241.AE; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Street AE, 2013, J GEN INTERN MED, V28, pS556, DOI 10.1007/s11606-013-2333-4; Swick D, 2012, J INT NEUROPSYCH SOC, V18, P917, DOI 10.1017/S1355617712000458; Talati A, 2005, J COGNITIVE NEUROSCI, V17, P981, DOI 10.1162/0898929054475226; Tanabe J, 2013, AM J PSYCHIAT, V170, P1356, DOI 10.1176/appi.ajp.2013.12091257; Thomaes K, 2010, J CLIN PSYCHIAT, V71, P1636, DOI 10.4088/JCP.08m04754blu; UDDO M, 1993, J PSYCHOPATHOL BEHAV, V15, P43, DOI 10.1007/BF00964322; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Vasterling JJ, 2002, NEUROPSYCHOLOGY, V16, P5, DOI 10.1037//0894-4105.16.1.5; Vasterling JJ, 1998, NEUROPSYCHOLOGY, V12, P125, DOI 10.1037/0894-4105.12.1.125; Woodward SH, 2006, BIOL PSYCHIAT, V59, P582, DOI 10.1016/j.biopsych.2005.07.033	54	1	1	3	42	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0925-4927	1872-7506		PSYCHIAT RES-NEUROIM	Psychiatry Res. Neuroimaging	SEP 30	2017	267						1	8		10.1016/j.pscychresns.2017.06.014			8	Clinical Neurology; Neuroimaging; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	FF6UQ	WOS:000409152900001	28672256				2022-02-06	
J	Mota, N; Chaves, E; Antunes, M; Borges, R; Paiva, A; Santos, V				Mota, Nayara; Chaves, Elenilda; Antunes, Marina; Borges, Rudi; Paiva, Andressa; Santos, Vanessa			Contextualized Contribution of Kindness to Favorable Goal- and Circumstantial-Driven Neuropsychological Regulation	FRONTIERS IN PSYCHOLOGY			English	Article						kindness; self-regulation; executive functions; principles; cognition; contextual models	VENTROMEDIAL PREFRONTAL CORTEX; SOMATIC MARKER HYPOTHESIS; TRAUMATIC BRAIN-INJURY; FRONTAL-LOBE; EXECUTIVE FUNCTIONS; DECISION-MAKING; COGNITIVE CONTROL; WORKING-MEMORY; PERFORMANCE; ADOLESCENCE	Kindness involves care and non-judgmental understanding toward someone. As a prosocial inclination, kindness would increase the possibility of favorable interaction with the environment, with a successful adjustment of one's response in novel or challenging circumstances, taking into account rules or goals. This adjustment ability is commonly referred to as executive functions, dependent on the prefrontal and parietal functioning, still under development during late adolescence. This study aimed to investigate if kindness would relate with the executive functions. If so, it would correlate more with measures of self-regulation, mainly dependent on themedial prefrontal corticosubcortical circuits. Also, among self-regulating processes, kindness would be more associated with autonomic responses-choices guided by one's understanding/intention -than with adaptive responses-changes on one's choices triggered by unfavorable circumstances. A sample of 46 (31 female; 18 to 21 years-old) healthy college students from the University of the State of Rio de Janeiro attended a clinical interview and a comprehensive neuropsychological assessment. Kindness was measured by the Compassion Scale subscore. Generalized non-linear models for each neuropsychological variable were executed on R, followed by an estimation of weighted parameters for each factor. Significant models which included kindness (weighted parameter Pc > 74) and all of their psychosocial or sociodemographic factors on their maximum expression (Pc > 74) were identified. In a contextualized joint influence with other psychosocial and sociodemographic factors, kindness fits equally goal-and circumstantial-self-regulation, as well as integrative organization of information. Kindness is a principle that optimizes a refreshing and prosocial interaction with the environment. As it anticipates sharing and cooperation behaviors, it might have a primordial function on individual and social development.	[Mota, Nayara; Chaves, Elenilda; Antunes, Marina; Borges, Rudi; Paiva, Andressa; Santos, Vanessa] Univ Estado Rio De Janeiro, Dept Fundamental Psychol, Rio De Janeiro, Brazil		Mota, N (corresponding author), Univ Estado Rio De Janeiro, Dept Fundamental Psychol, Rio De Janeiro, Brazil.	contato@nayaramota.com			Fundactio de Amparo a Pcsquisa do Rio de Janeiro (PAPERJ) [111.030/2013, 111.529/2013, 100.660/2013, 111.429/2014]	Fundactio de Amparo a Pcsquisa do Rio de Janeiro (PAPERJ): 111.030/2013, 111.529/2013, 100.660/2013, 111.429/2014.	Akkermans SEA, 2018, ADDICT BIOL, V23, P359, DOI 10.1111/adb.12482; Archibald SJ, 1999, CHILD NEUROPSYCHOL, V5, P115, DOI 10.1076/chin.5.2.115.3167; Ashtari M, 2007, NEUROIMAGE, V35, P501, DOI 10.1016/j.neuroimage.2006.10.047; Barkley RA, 2001, NEUROPSYCHOL REV, V11, P1, DOI 10.1023/A:1009085417776; Barr WB, 2003, ARCH CLIN NEUROPSYCH, V18, P91, DOI 10.1016/S0887-6177(01)00185-8; Baskerville K, 2000, SOC SCI J, V37, P293, DOI 10.1016/S0362-3319(00)00062-8; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; Bechara A, 2005, GAME ECON BEHAV, V52, P336, DOI 10.1016/j.geb.2004.06.010; Bechara A, 1999, J NEUROSCI, V19, P5473; Bechara A., 2007, IOWA GAMBLING TASK P; Beebe DW, 2004, APPL NEUROPSYCHOL, V11, P91, DOI 10.1207/s15324826an1102_4; Bergin C, 2003, J ADOLESCENCE, V26, P13, DOI 10.1016/S0140-1971(02)00112-4; Bettcher BM, 2016, NEUROPSYCHOLOGIA, V85, P100, DOI 10.1016/j.neuropsychologia.2016.03.001; Birn RM, 2010, NEUROIMAGE, V49, P1099, DOI 10.1016/j.neuroimage.2009.07.036; Blanton RE, 2001, PSYCHIAT RES-NEUROIM, V107, P29, DOI 10.1016/S0925-4927(01)00091-9; Breukelaar IA, 2017, HUM BRAIN MAPP, V38, P631, DOI 10.1002/hbm.23401; Bryan J, 2001, J CLIN EXP NEUROPSYC, V23, P608, DOI 10.1076/jcen.23.5.608.1250; Buelow MT, 2009, NEUROPSYCHOL REV, V19, P102, DOI 10.1007/s11065-009-9083-4; Bunge SA, 2002, NEURON, V33, P301, DOI 10.1016/S0896-6273(01)00583-9; Burgess P, 1996, BEHAV ASSESSMENT DYS; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Carver CS, 2010, CLIN PSYCHOL REV, V30, P879, DOI 10.1016/j.cpr.2010.01.006; Cipolotti L, 2016, NEUROPSYCHOLOGIA, V93, P1, DOI 10.1016/j.neuropsychologia.2016.09.018; Conklin HM, 2007, DEV NEUROPSYCHOL, V31, P103, DOI 10.1207/s15326942dn3101_6; DAIGNEAULT S, 1992, DEV NEUROPSYCHOL, V8, P99, DOI 10.1080/87565649209540518; Dishion TJ, 2016, J ABNORM CHILD PSYCH, V44, P57, DOI 10.1007/s10802-015-0117-5; Dolcos S, 2016, SOC COGN AFFECT NEUR, V11, P263, DOI 10.1093/scan/nsv106; Donkers FCL, 2004, BRAIN COGNITION, V56, P165, DOI 10.1016/j.bandc.2004.04.005; Dugbartey AT, 1999, CLIN NEUROPSYCHOL, V13, P396, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT396; Dunn BD, 2006, NEUROSCI BIOBEHAV R, V30, P239, DOI 10.1016/j.neubiorev.2005.07.001; Eisenberg, 1998, HDB CHILD PSYCHOL, V3, P701, DOI DOI 10.1002/9780470147658.CHPSY0311; Fair DA, 2007, P NATL ACAD SCI USA, V104, P13507, DOI 10.1073/pnas.0705843104; Ferreira FHG, 2016, J ECON INEQUAL, V14, P141, DOI 10.1007/s10888-016-9326-6; Fox KCR, 2016, NEUROSCI BIOBEHAV R, V65, P208, DOI 10.1016/j.neubiorev.2016.03.021; Franzen M D, 1987, Arch Clin Neuropsychol, V2, P265, DOI 10.1016/0887-6177(87)90014-X; Fuster JM, 2008, PREFRONTAL CORTEX, 4TH EDITION, P1; Galvan A, 2006, J NEUROSCI, V26, P6885, DOI 10.1523/JNEUROSCI.1062-06.2006; Garcia-Molina A, 2012, BRAIN INJURY, V26, P864, DOI 10.3109/02699052.2012.655362; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Giorgio A, 2008, NEUROIMAGE, V39, P52, DOI 10.1016/j.neuroimage.2007.07.043; Golarai G, 2007, NAT NEUROSCI, V10, P512, DOI 10.1038/nn1865; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; Guise BJ, 2014, J NEUROPSYCHOL, V8, P20, DOI 10.1111/jnp.12002; Hawes SW, 2017, NEUROIMAGE, V147, P763, DOI 10.1016/j.neuroimage.2016.12.020; Hooper CJ, 2004, DEV PSYCHOL, V40, P1148, DOI 10.1037/0012-1649.40.6.1148; Hori Y, 2009, J NEUROPHYSIOL, V102, P3530, DOI 10.1152/jn.00104.2009; Houde JF, 1998, SCIENCE, V279, P1213, DOI 10.1126/science.279.5354.1213; Hutz C. S., 2004, AVALIACAO PSICOLOGIC, V3, P83; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Kim H, 2009, J NEUROSCI, V29, P14701, DOI 10.1523/JNEUROSCI.2728-09.2009; Kleibeuker SW, 2013, DEV COGN NEUROS-NETH, V5, P197, DOI 10.1016/j.dcn.2013.03.003; Koffka Kurt, 2013, PRINCIPLES GESTALT P, V44; Layous K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051380; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Lecrubier Y, 1997, EUR PSYCHIAT, V12, P224, DOI 10.1016/S0924-9338(97)83296-8; Li CSR, 2008, NEUROSCIENCE, V155, P1142, DOI 10.1016/j.neuroscience.2008.06.062; Luciana M, 2009, DEV NEUROPSYCHOL, V34, P461, DOI 10.1080/87565640902964540; Manoach DS, 2016, BIOL PSYCHIAT, V80, P599, DOI 10.1016/j.biopsych.2015.10.003; Maruo Y, 2016, BIOL PSYCHOL, V114, P108, DOI 10.1016/j.biopsycho.2015.12.004; Mota N, 2013, DRUG ALCOHOL DEPEN, V133, P108, DOI 10.1016/j.drugalcdep.2013.05.024; Motomura Y, 2015, J PHYSIOL ANTHROPOL, V34, DOI 10.1186/s40101-015-0053-7; Navarro-Cebrian A, 2016, J COGNITIVE NEUROSCI, V28, P1166, DOI 10.1162/jocn_a_00962; NEFF K, 2003, SELF IDENTITY, V2, P85, DOI DOI 10.1080/15298860309032; Neilson WS, 2009, GAME ECON BEHAV, V66, P394, DOI 10.1016/j.geb.2008.04.004; Norris G, 2000, NEUROPSYCHOL REHABIL, V10, P33, DOI 10.1080/096020100389282; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ordaz SJ, 2013, J NEUROSCI, V33, P18109, DOI 10.1523/JNEUROSCI.1741-13.2013; PETRIDES M, 1982, NEUROPSYCHOLOGIA, V20, P249, DOI 10.1016/0028-3932(82)90100-2; Pommier EA, 2010, THESIS; Porter JN, 2011, NEUROIMAGE, V55, P1865, DOI 10.1016/j.neuroimage.2011.01.018; Posner MI, 2012, DEV PSYCHOL, V48, P827, DOI 10.1037/a0025530; Power JD, 2013, CURR OPIN NEUROBIOL, V23, P223, DOI 10.1016/j.conb.2012.12.009; Pujara MS, 2015, NEUROPSYCHOLOGIA, V79, P70, DOI 10.1016/j.neuropsychologia.2015.10.026; R Core Team, 2016, R LANG ENV STAT COMP; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Robertson D, 2007, NEUROPSYCHOLOGIA, V45, P755, DOI 10.1016/j.neuropsychologia.2006.08.014; Sanjuan A, 2010, NEURORADIOLOGY, V52, P407, DOI 10.1007/s00234-010-0667-8; Shapiro S.L, 2000, HDB SELF REGULATION, P253, DOI 10.1016/B978-012109890-2/50037-8; Shimamura A.P., 1994, NEUROPSYCHOLOGY, V8, P408, DOI DOI 10.1037/0894-4105.8.3.408; Shonin E., 2015, MINDFULNESS BUDDHIST; Snook L, 2005, NEUROIMAGE, V26, P1164, DOI 10.1016/j.neuroimage.2005.03.016; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; Sowell ER, 2001, J INT NEUROPSYCH SOC, V7, P312, DOI 10.1017/S135561770173305X; Specht K, 2009, HUM BRAIN MAPP, V30, P1734, DOI 10.1002/hbm.20637; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Takahashi T, 1999, AM J NEURORADIOL, V20, P917; Tranel D, 2008, CLIN NEUROPSYCHOL, V22, P242, DOI 10.1080/13854040701218410; Tschentscher N, 2016, J COGNITIVE NEUROSCI, V28, P1098, DOI 10.1162/jocn_a_00960; Van Leijenhorst L, 2010, NEUROIMAGE, V51, P345, DOI 10.1016/j.neuroimage.2010.02.038; Wechsler D., 2004, WAIS 3 ESCALA INTELI; Weise M, 2002, J CLIN ENDOCR METAB, V87, P5038, DOI 10.1210/jc.2002-020590	92	1	1	0	7	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-1078			FRONT PSYCHOL	Front. Psychol.	SEP 26	2017	8								1643	10.3389/fpsyg.2017.01643			12	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	FI1LY	WOS:000411696500001	29018378	Green Published, gold			2022-02-06	
J	Vainshenker, Y; Zinserling, V; Korotkov, A; Medvedev, S				Vainshenker, Yulia; Zinserling, Vsevolod; Korotkov, Alexander; Medvedev, Svyatoslav			Noncanonical Adult Human Neurogenesis and Axonal Growth as Possible Structural Basis of Recovery From Traumatic Vegetative State	CLINICAL MEDICINE INSIGHTS-CASE REPORTS			English	Article						adult human neurogenesis; axonal growth; functional state of the brain; vegetative state; improvement of consciousness; botulinum; toxin therapy of spasticity	CONSCIOUSNESS; BRAIN; DISORDERS; NEUROPATHOLOGY; INJURY; SCALE	Patient recovering from traumatic vegetative state has suddenly died from cardiac arrest. In-life improvement of consciousness appeared after reduction of generalized spasticity due to botulinum toxin administration. Neuropathologic examination revealed Musashi1+, Nestin+, PCNA+, and Ki67+ cells in the hippocampus, frontal, parietal and occipital cortex, caudate, thalamus, mammillary bodies, brainstem, cerebellum, and near the posterior horn of the lateral ventricle. New neurons with neurite growth (TUC4+) appeared in corpus callosum. At the same time, axonal growth was detected in all areas of interest. New cells whose functional state was continuously improving, as revealed by in-life neurologic and positron emission tomography monitoring, have mainly been found in brain areas without neuropathologic signs of damage. We suggest that the possible role of neurogenesis consists in improvement of the microenvironment and interneuron interactions, whereas the activation of neurogenesis and the induction of neurite growth may be associated with reduction of spasticity.	[Vainshenker, Yulia; Korotkov, Alexander; Medvedev, Svyatoslav] Russian Acad Sci IHB RAS, NP Bechtereva Inst Human Brain, 9 Acad Pavlova St, St Petersburg 197376, Russia; [Zinserling, Vsevolod] St Petersburg State Univ, Dept Pathol, St Petersburg, Russia; [Zinserling, Vsevolod] SP Botkin Clin Infect Dis Hosp, Dept Pathol, St Petersburg, Russia		Korotkov, A (corresponding author), Russian Acad Sci IHB RAS, NP Bechtereva Inst Human Brain, 9 Acad Pavlova St, St Petersburg 197376, Russia.	korotkov@ihb.spb.ru	Korotkov, Alexander D/K-3652-2018	Korotkov, Alexander D/0000-0003-3527-7205	Program of Presidium of Russian Academy of Sciences "Fundamental Sciences to Medicine"	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Monitoring of the patient was funded by the Program of Presidium of Russian Academy of Sciences "Fundamental Sciences to Medicine." Reagents for IHC were provided by Merz Pharmaceuticals GmbH, Frankfurt, Germany.	Adams JH, 1999, J CLIN PATHOL, V52, P804, DOI 10.1136/jcp.52.11.804; Bruno MA, 2012, J NEUROL, V259, P1087, DOI 10.1007/s00415-011-6303-7; Coffield JA, 2009, J PHARMACOL EXP THER, V330, P352, DOI 10.1124/jpet.108.147744; Dolce G., 2002, POSTTRAUMATIC VEGETA; Duus P, 1989, TOPICAL DIAGNOSIS NE; Feliciano DM, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018846; Fuchtner F, 1996, APPL RADIAT ISOTOPES, V47, P61, DOI 10.1016/0969-8043(95)00258-8; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Gomzina N. G., 2002, RADIOCHEMISTRY, V44, P366, DOI DOI 10.1023/A:1020689314452; Gosseries O, 2014, ANNU REV NEUROSCI, V37, P457, DOI 10.1146/annurev-neuro-062012-170339; Gregson JM, 1999, ARCH PHYS MED REHAB, V80, P1013, DOI 10.1016/S0003-9993(99)90053-9; Holmes AP, 1996, J CEREBR BLOOD F MET, V16, P7, DOI 10.1097/00004647-199601000-00002; Jellinger KA, 2013, BRAIN INJURY, V27, P917, DOI 10.3109/02699052.2013.793395; Jiang YQ, 2016, J NEUROSCI, V36, P193, DOI 10.1523/JNEUROSCI.3441-15.2016; Kempermann G, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018929; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Koch C, 2016, NAT REV NEUROSCI, V17, P307, DOI 10.1038/nrn.2016.22; Krasikova R, 2013, CURR ORG CHEM, V17, P2097; Maekawa M, 2009, NEUROSCI RES, V63, P259, DOI 10.1016/j.neures.2008.12.006; Matak I, 2014, PROG NEUROBIOL, V119, P39, DOI 10.1016/j.pneurobio.2014.06.001; Oudega M, 2012, J PHYSIOL-LONDON, V590, P3647, DOI 10.1113/jphysiol.2012.233189; Quinn CC, 2003, J NEUROSCI, V23, P2815; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Sierra A, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00047; Stender J, 2014, LANCET, V384, P514, DOI 10.1016/S0140-6736(14)60042-8; Thibaut A, 2015, EUR J PHYS REHAB MED, V51, P389; Thibaut A, 2012, J REHABIL MED, V44, P487, DOI 10.2340/16501977-0940; Tuszynski MH, 2012, NEURON, V74, P777, DOI 10.1016/j.neuron.2012.05.006; Vainshenker Y, 2015, TOXICON, V93, pS61, DOI [10.1016/j.toxicon.2014.11.199, DOI 10.1016/J.TOXICON.2014.11.199]; Vainshenker Yu I., 2013, Human Physiology, V39, P19, DOI 10.1134/S0362119713010143	31	1	2	0	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1179-5476			CLIN MED INSIGHT-CAS	Clin. Med. Insights-Case Rep.	SEP 25	2017	10								1179547617732040	10.1177/1179547617732040			10	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	FI0KV	WOS:000411615200001	28979176	gold, Green Published			2022-02-06	
J	Antoni, A; Heinz, T; Leitgeb, J				Antoni, A.; Heinz, T.; Leitgeb, J.			Polytrauma and concomitant traumatic brain injury. The role of the trauma surgeon	UNFALLCHIRURG			German	Article						Standardization; Specialization; Outcome; Damage control surgery; Trauma care system	ACUTE SUBDURAL-HEMATOMA; DAMAGE CONTROL; MANAGEMENT; CARE; MORTALITY; NEUROSURGERY; PLACEMENT; COVERAGE; TIME	Concomitant traumatic brain injury (TBI) increases mortality and reduces quality of life of polytrauma patients. These facts demand effective treatment strategies while the growing specialization of medicine is questioning the role of the trauma surgeon in the management of these patients. Which factors influence outcome of polytrauma with concomitant TBI? Who should be responsible for the management of these patients and what is the limit of management? A literature search using Medline via PubMed was performed with Medical Subject Headings and text word search. The crucial factors for outcome are absence of hypotension, adherence to pre- and in-hospital standards like fast transportation to appropriate centers, priority-based diagnostic and therapeutic strategies and strict adherence to principles of damage control surgery. Patients with polytrauma and TBI are treated by different specialties around the world based on the trauma system, geographic circumstances and resources. Investigations of operative and conservative management by different medical specialties showed comparable outcomes. In an age of standardization and a high degree of specialization in the field of medicine, the trauma surgeon still seems to be able to ensure an optimal treatment of polytrauma and concomitant TBI by focusing on priority-based diagnostic and therapeutic strategies and adhering to principles of damage control surgery.	[Antoni, A.; Heinz, T.; Leitgeb, J.] Med Univ Wien, Univ Klin Unfallchirurg, Wahringer Gurtel 18-20, A-1090 Vienna, Austria		Leitgeb, J (corresponding author), Med Univ Wien, Univ Klin Unfallchirurg, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.	johannes.leitgeb@meduniwien.ac.at					Barratt H, 2010, EMERG MED J, V27, P173, DOI 10.1136/emj.2009.075382; Bratton S, 2007, J NEUROTRAUM, V24, P7; Byrne RW, 2011, NEUROSURGERY, V68, P1063, DOI 10.1227/NEU.0b013e318209cde0; CHAMPION HR, 1992, ARCH SURG-CHICAGO, V127, P333; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Ciesla DJ, 2006, AM J SURG, V192, P732, DOI 10.1016/j.amjsurg.2006.08.035; Committee on Trauma American College of Surgeons, 2014, RESOURCES OPTIMAL CA; Cornwell EE, 2003, ARCH SURG-CHICAGO, V138, P838, DOI 10.1001/archsurg.138.8.838; Cummings Garnet E, 2007, CJEM, V9, P105; Demetriades D, 2004, J AM COLL SURGEONS, V198, P20, DOI 10.1016/j.jamcollsurg.2003.09.003; Drobetz H, 2000, ANASTH INTENSIV NOTF, V35, P630, DOI 10.1055/s-2000-7365; Eardley WGP, 2010, ANN ROY COLL SURG, V92, P154, DOI 10.1308/003588410X12518836440045; Ekeh AP, 2014, J TRAUMA ACUTE CARE, V76, P286, DOI 10.1097/TA.0000000000000092; El Mestoui Z, 2017, EUR J EMERG MED, V24, P49, DOI 10.1097/MEJ.0000000000000293; Esposito TJ, 2005, ANN SURG, V242, P364, DOI 10.1097/01.sla.0000179624.50455.db; Fischerstrom A, 2014, ACTA NEUROCHIR, V156, P177, DOI 10.1007/s00701-013-1932-5; Frink M, 2007, ZBL CHIR, V132, P49, DOI 10.1055/s-2006-958706; Garwe T, 2010, ACAD EMERG MED, V17, P1223, DOI 10.1111/j.1553-2712.2010.00918.x; Georgiou A, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-66; Gilligan J, 2017, ANZ J SURG, V87, P80, DOI 10.1111/ans.13583; Gross T, 2012, ACTA ANAESTH SCAND, V56, P1163, DOI 10.1111/j.1399-6576.2012.02724.x; HAAS NP, 1995, CLIN ORTHOP RELAT R, P25; Haut ER, 2006, J TRAUMA, V61, P272, DOI 10.1097/01.ta.0000222939.51147.1c; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Ko K, 2003, J TRAUMA, V55, P480, DOI 10.1097/01.TA.0000074111.04885.28; Lehmann U, 2001, UNFALLCHIRURG, V104, P196, DOI 10.1007/s001130050715; Leitgeb J, 2013, ARCH ORTHOP TRAUM SU, V133, P659, DOI 10.1007/s00402-013-1710-0; Leitgeb J, 2012, J TRAUMA ACUTE CARE, V72, P1263, DOI 10.1097/TA.0b013e318248ed83; Luck T, 2015, ANZ J SURG, V85, P610, DOI 10.1111/ans.13138; McSwain N, 2012, BRIT J SURG, V99, P309, DOI 10.1002/bjs.7734; Montgomery SC, 2015, J TRAUMA ACUTE CARE, V79, P858, DOI 10.1097/TA.0000000000000851; Neurosurgical Society of Australasia Inc, 2009, MAN AC NEUR RUR REM; Pape HC, 2002, AM J SURG, V183, P622, DOI 10.1016/S0002-9610(02)00865-6; Pfeifer R, 2009, INJURY, V40, P907, DOI 10.1016/j.injury.2009.05.006; Pottenger BC, 2015, J TRAUMA ACUTE CARE, V78, P120, DOI 10.1097/TA.0000000000000496; Probst C, 2009, INJURY, V40, P77, DOI 10.1016/j.injury.2008.10.004; Rao MB, 2010, ACAD EMERG MED, V17, P1374, DOI 10.1111/j.1553-2712.2010.00927.x; STONE JL, 1986, J TRAUMA, V26, P445, DOI 10.1097/00005373-198605000-00006; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212	39	1	1	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0177-5537	1433-044X		UNFALLCHIRURG	Unfallchirurg	SEP	2017	120	9					722	727		10.1007/s00113-017-0354-x			6	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	FF2IE	WOS:000408720300002	28612105	hybrid			2022-02-06	
J	Ay, MO; Erenler, AK; Kocak, C; Baydin, A				Ay, Mehmet Oguzhan; Erenler, Ali Kemal; Kocak, Cem; Baydin, Ahmet			Efficiency of Helmet and Protective Clothing Use on Outcomes of Patients with Motorcycle Accidents	JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE			English	Article						Emergency; Helmet; Motorcycle Accident; Protective Clothing; Trauma		Aim: Motor vehicle accidents are a growing public health problem, particularly in developing countries. In this study, we aimed to clarify the role of helmet and protective clothing in prevention from injuries to the head, trunk, and extremities in motorcycle accidents. Material and Method: Patients over 18 years old of both genders who were admitted to the Emergency Department (ED) of Hitit University Corum Training and Research Hospital due to a motorcycle accident between January 1, 2010 and July 1, 2015 were included in this retrospective study. We used their medical records to identify the location of injury, radiographic findings, use of helmet and protective clothing, and whether the patient was consulted, hospitalized, or underwent surgery. Then, patients were divided into two subgroups. Group I: Patients without helmet and protective clothing. Group II: Patients with helmet and protective clothing. The groups were compared statistically. Results: One hundred and twenty patients admitted to our ED due to a motorcycle accident were included in the study. It was determined that 73 (60.8%) of the patients had not used a helmet or protective clothing, whereas 47 (38.2%) had used a helmet or protective clothing. Neurosurgery was found to be the most frequently consulted speciality. When the groups were compared, it was found that 7 of 8 patients with traumatic brain injury were in Group I. This finding was statistically significant. The rate of alcohol intake before the accident of Group 1 (15.1%) was statistically significantly higher than in Group II (6.4%). When the groups were compared according to age, gender, spinal injuries, long bone fractures, and intraabdominal organ injuries, there was not any statistical significance. Discussion: Helmet use is found to be useful to prevent head injuries in motorcycle accidents. However, protective clothing does not contribute to prevention from injuries to the trunk and extremities. Strict laws for helmet use, intake of alcohol prior to driving a motorcycle, and education of motorcyclists may help reduce morbidity and mortality in motorcycle accidents.	[Ay, Mehmet Oguzhan; Erenler, Ali Kemal] Hitit Univ, Dept Emergency Med, Corum Training & Res Hosp, TR-19200 Corum, Turkey; [Kocak, Cem] Hitit Univ, Dept Stat, Corum Training & Res Hosp, Corum, Turkey; [Baydin, Ahmet] Ondokuz Mayis Univ, Sch Med, Dept Emergency Med, Samsun, Turkey		Ay, MO (corresponding author), Hitit Univ, Dept Emergency Med, Corum Training & Res Hosp, TR-19200 Corum, Turkey.	droguzhan2006@mynet.com	BAYDIN, AHMET/AAG-4188-2019; Erenler, Ali Kemal/AAA-2995-2020; Kocak, Cem/AAP-6074-2021; Ay, Mehmet Oguzhan/AAA-5170-2021	BAYDIN, AHMET/0000-0003-4987-0878; Kocak, Cem/0000-0002-7339-7438; Ay, Mehmet Oguzhan/0000-0003-1061-5327			Agnihotri A K, 2006, Int J Inj Contr Saf Promot, V13, P128, DOI 10.1080/17457300500310236; Banthia P, 2006, JNMA J Nepal Med Assoc, V45, P238; Bjornskau T, 2012, ACCIDENT ANAL PREV, V49, P50, DOI 10.1016/j.aap.2011.09.051; Branas CC, 2001, ACCIDENT ANAL PREV, V33, P641, DOI 10.1016/S0001-4575(00)00078-6; Burns Sean T, 2015, F1000Res, V4, P114, DOI 10.12688/f1000research.4995.1; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dandona R, 2006, J SAFETY RES, V37, P149, DOI 10.1016/j.jsr.2005.11.002; Erdogan MO, 2013, EMERG MED INT, V2013, DOI 10.1155/2013/760205; Faryabi J, 2014, ARCH TRAUMA RES, V3, DOI 10.5812/atr.19122; KRAUS JF, 1975, AM J EPIDEMIOL, V102, P74, DOI 10.1093/oxfordjournals.aje.a112136; Kudebong M, 2011, Ghana Med J, V45, P135; Liu BC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004333.pub3; Mascarenhas MDM, 2016, CIENC SAUDE COLETIVA, V21, P3661, DOI 10.1590/1413-812320152112.24332016; Nwadiaro HC, 2011, NIGER J CLIN PRACT, V14, P186, DOI 10.4103/1119-3077.84012; Nzegwu MA, 2008, ANN AFR MED, V7, P82, DOI 10.4103/1596-3519.55675	15	1	1	0	6	DERMAN MEDICAL PUBL	ANKARA	KARTALTEPE MAHALLESI, ATATURK BULVARI, ANKARA, 00000, TURKEY	1309-0720	1309-2014		J CLIN ANAL MED	J. Clin. Anal. Med.	SEP	2017	8	5					383	386		10.4328/JCAM.4872			4	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	FU6BC	WOS:000423935700006		gold			2022-02-06	
J	Chung, JW; Jo, H; Park, J; Cha, J; Cho, JW; Bang, OY				Chung, Jong-Won; Jo, Hyunjin; Park, Jihyung; Cha, Jihoon; Cho, Jin Whan; Bang, Oh Young			Central nervous system superficial siderosis related to spinal lesions	PRECISION AND FUTURE MEDICINE			English	Article						Cerebrospinal fluid leak; Ependymoma; Spine tumor; Superficial siderosis		Superficial siderosis is a rare disease of the central nervous system, which is characterized by chronic intrathecal hemorrhage leading to hemosiderin deposition on the leptomeninges and subpial layers of the brain and spinal cord. Patients with the syndrome typically present with sensorineural hearing loss, myelopathy, cerebellar ataxia, pyramidal signs, and cognitive impairment. The most common etiologies of the disease include bleeding of unknown cause, ruptured aneurysms, arteriovenous malformation, and traumatic injury of the brain. Here, we describe two patients diagnosed with superficial siderosis caused by spinal lesions, which is an unusual cause of chronic bleeding due to the presence of the disease.	[Chung, Jong-Won; Jo, Hyunjin; Park, Jihyung; Cho, Jin Whan; Bang, Oh Young] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, 81 Irwon Ro, Seoul 06351, South Korea; [Cha, Jihoon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul, South Korea		Chung, JW (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, 81 Irwon Ro, Seoul 06351, South Korea.	neurocjw@gmail.com		Cha, Jihoon/0000-0002-1662-8041			Katoh N, 2014, INTERNAL MED, V53, P1863, DOI 10.2169/internalmedicine.53.2378; Koeppen AH, 2008, ACTA NEUROPATHOL, V116, P371, DOI 10.1007/s00401-008-0421-z; Kumar N, 2010, AM J NEURORADIOL, V31, P5, DOI 10.3174/ajnr.A1628; Kumar N, 2007, ARCH NEUROL-CHICAGO, V64, P491, DOI 10.1001/archneur.64.4.491; Levy M, 2007, NAT CLIN PRACT NEURO, V3, P54, DOI 10.1038/ncpneuro0356	5	1	1	0	1	SUNGKYUNKWAN UNIV SCH MEDICINE	SEOUL	115 IRWON-RO, GANGNAM-GU, SEOUL, 06355, SOUTH KOREA	2508-7940	2508-7959		PRECIS FUTURE MED	Precis. Future Med.	SEP	2017	1	3					138	141		10.23838/pfm.2017.00128			4	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	VI3AZ	WOS:000468858700005		gold			2022-02-06	
J	Gather, A; Beisemann, N; Gebhard, E; Gliwitzky, B; Bottcher, M; Geissert, S; Swartman, B; Kreinest, M				Gather, A.; Beisemann, N.; Gebhard, E.; Gliwitzky, B.; Boettcher, M.; Geissert, S.; Swartman, B.; Kreinest, M.			Immobilization of fractures in preclinical emergency medicine. Extremities, pelvic and spinal trauma	NOTFALL & RETTUNGSMEDIZIN			German	Article						Fracture reduction; Orthopedic fixation devices; Patient positioning; Analgesia; Intracranial pressure	CERVICAL-SPINE; INTRACRANIAL-PRESSURE; RING FRACTURES; BLUNT TRAUMA; INJURY; APPLICABILITY; MANAGEMENT; GUIDELINE; PLACEMENT; ANALGESIA	Approximately 2.6 million traffic accidents occur each year in Germany with a relevant number involving trauma to the extremities, pelvis and spine. Following the priority-oriented initial treatment, measures against pain and for prevention of soft tissue damage should be undertaken. In cases of fractures of the extremities, preclinical immobilization should be carried out and, when indicated, repositioning with the patient under analgesia. The placement of a pelvic sling can be indicated. In the case of suspected spinal injuries, palpation, pressure and tapping pain as well as ascertainment of peripheral motor and sensory activity are decisive. The patient is immobilized with the aid of a vacuum mattress. Injuries to the cervical spine region are stabilized using a cervical brace combined with whole body immobilization. In the case of simultaneous traumatic brain injuries it must be tested if the cervical support can be omitted in order to minimize a further increase in intracranial pressure.	[Gather, A.; Beisemann, N.; Swartman, B.; Kreinest, M.] BG Klin Ludwigshafen, Klin Unfallchirurg & Orthopadie, Ludwig Guttmann Str 13, D-67071 Ludwigshafen, Germany; [Gebhard, E.] BG Klin Ludwigshafen, Abt Anasthesie, Ludwigshafen, Germany; [Gliwitzky, B.; Boettcher, M.; Geissert, S.] MegaMed GbR, Maikammer, Germany; [Boettcher, M.; Geissert, S.] DRK Rettungsdienst Sudpfalz GmbH, Landau, Germany		Gather, A (corresponding author), BG Klin Ludwigshafen, Klin Unfallchirurg & Orthopadie, Ludwig Guttmann Str 13, D-67071 Ludwigshafen, Germany.	andreas.gather@bgu-ludwigshafen.de	Kreinest, Michael/ABI-7282-2020				Banerjee M, 2013, INJURY, V44, P1015, DOI 10.1016/j.injury.2012.12.007; Baron R, 2013, PRAKTISCHE SCHMERZME; Bonner TJ, 2011, J BONE JOINT SURG BR, V93B, P1524, DOI 10.1302/0301-620X.93B11.27023; Cannon JW, 2017, J TRAUMA ACUTE CARE, V82, P605, DOI 10.1097/TA.0000000000001333; CHANDLER DR, 1992, ANN EMERG MED, V21, P1185, DOI 10.1016/S0196-0644(05)81743-3; CRAIG GR, 1991, INTENS CARE MED, V17, P504, DOI 10.1007/BF01690778; Culemann U, 2013, CHIRURG, V84, P809, DOI 10.1007/s00104-012-2391-x; Destatis, 2017, VEKEHRSUNFALLE; Deutsche Gesellschaft FUr Un-fallchirurgie, 2016, S3 LEITL POL SCHW BE; Gassauer M, 2015, ORTHOP UNFALLCHIR UP, V10, P391; Gausche-Hill M, 2014, PREHOSP EMERG CARE, V18, P25, DOI 10.3109/10903127.2013.844873; Hamilton Robert S., 1996, Journal of Emergency Medicine, V14, P553, DOI 10.1016/S0736-4679(96)00170-9; Hoffman JR, 2000, NEW ENGL J MED, V343, P94, DOI 10.1056/NEJM200007133430203; Horodyski M, 2011, J EMERG MED, V41, P513, DOI 10.1016/j.jemermed.2011.02.001; Hossfeld B, 2016, ANASTH INTENSIV NOTF, V51, P84, DOI 10.1055/s-0042-101466; Hunt K, 2001, ANAESTHESIA, V56, P511, DOI 10.1046/j.1365-2044.2001.02053.x; Johnson DR, 1996, AM J EMERG MED, V14, P369, DOI 10.1016/S0735-6757(96)90051-0; Kanezaki Shozo, 2016, Eur J Orthop Surg Traumatol, V26, P885; Kreinest M, 2016, NOTFALL RETTUNGSMED, V19, P473, DOI 10.1007/s10049-016-0154-9; Kreinest M, 2015, NOTFALLMEDIZIN UP2DA, V10, P117, DOI [10.1055/s-0033-1358143, DOI 10.1055/S-0033-1358143]; Kreinest M, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0267-7; Kreinest M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143409; Kuhnigk H, 1993, Aktuelle Traumatol, V23, P350; Matthes G, 2015, UNFALLCHIRURG, V118, P652, DOI 10.1007/s00113-015-0042-7; Mobbs RJ, 2002, ANZ J SURG, V72, P389, DOI 10.1046/j.1445-2197.2002.02462.x; Perkins Timothy J, 2007, Emerg Med Serv, V36, P35; Rollmann MF, 2017, ARCH GERONTOL GERIAT, V71, P83, DOI 10.1016/j.archger.2017.03.007; Schweigkofler U, 2013, CHIRURG, V84, P739, DOI 10.1007/s00104-013-2475-2; Scott I, 2013, EMERG MED J, V30, P1070, DOI 10.1136/emermed-2013-203211; Shlamovitz GZ, 2009, J TRAUMA, V66, P815, DOI 10.1097/TA.0b013e31817c96e1; Unfallchirurgie DGF, 2016, S3 LEITL POL SCHW BE; Vaillancourt C, 2009, ANN EMERG MED, V54, P663, DOI 10.1016/j.annemergmed.2009.03.008; Wetsch WA, 2014, KURZLEHRBUCH ANASTHE; Wohlrath B, 2016, Z ORTHOP UNFALLCHIR, V154, P612, DOI 10.1055/s-0042-110797; Yong E, 2016, INJURY, V47, P383, DOI 10.1016/j.injury.2015.08.023	35	1	1	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1434-6222	1436-0578		NOTFALL RETTUNGSMED	Notfall Rettungsmed.	SEP	2017	20	6					543	552		10.1007/s10049-017-0348-9			10	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	FG5WD	WOS:000410418600013					2022-02-06	
J	Hashmi, AM; Han, JY; Demla, V				Hashmi, Ali M.; Han, Jin Y.; Demla, Vishal			Intensive Care and Its Discontents: Psychiatric Illness in the Critically III	PSYCHIATRIC CLINICS OF NORTH AMERICA			English	Article						Intensive care; Critical illness; Delirium; Depression; Anxiety; Sleep problems; Pain	POSTTRAUMATIC-STRESS-DISORDER; QUALITY-OF-LIFE; ALCOHOL-WITHDRAWAL SYNDROME; TERM COGNITIVE IMPAIRMENT; ACUTE LUNG INJURY; RESPIRATORY-DISTRESS-SYNDROME; CONFUSION ASSESSMENT METHOD; TRAUMATIC BRAIN-INJURY; CORONARY-HEART-DISEASE; ILL CANCER-PATIENTS	Critically ill patients can develop a host of cognitive and psychiatric complaints during their intensive care unit (ICU) stay, many of which persist for weeks or months following discharge from the ICU and can seriously affect their quality of life, including their ability to return to work. This article describes some common psychiatric problems encountered by clinicians in the ICU, including their assessment and management. A comprehensive approach is needed to decrease patient suffering, improve morbidity and mortality, and ensure that critically ill patients can return to the highest quality of life after an ICU stay.	[Hashmi, Ali M.] King Edward Med Univ, Mayo Hosp, Dept Psychiat & Behav Sci, Lahore 54700, Pakistan; [Han, Jin Y.] Baylor Coll Med, Dept Family & Community Med, Menninger Dept Psychiat & Behav Sci, 1502 Taub Loop NPC 2nd Floor, Houston, TX 77030 USA; [Demla, Vishal] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Div Crit Care Med, 6431 Fannin,MSB 1-150, Houston, TX 77030 USA		Hashmi, AM (corresponding author), King Edward Med Univ, Mayo Hosp, Dept Psychiat & Behav Sci, Lahore 54700, Pakistan.	ahashmi39@gmail.com					Akechi T, 2004, J CLIN ONCOL, V22, P1957, DOI 10.1200/JCO.2004.08.149; Andersen BL, 2014, J CLIN ONCOL, V32, P1605, DOI 10.1200/JCO.2013.52.4611; Angus DC, 2000, JAMA-J AM MED ASSOC, V284, P2762, DOI 10.1001/jama.284.21.2762; Awissi DK, 2013, CRIT CARE MED, V41, pS57, DOI 10.1097/CCM.0b013e3182a16919; Ayerbe L, 2013, BRIT J PSYCHIAT, V202, P14, DOI 10.1192/bjp.bp.111.107664; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Bienvenu OJ, 2013, PSYCHOL MED, V43, P2657, DOI 10.1017/S0033291713000214; Bienvenu OJ, 2012, AM J RESP CRIT CARE, V185, P900; Bienvenu OJ, 2013, CHEST, V144, P24, DOI 10.1378/chest.12-0908; Bosma KJ, 2009, CRIT CARE, V13, DOI 10.1186/cc7798; Bourne RS, 2004, ANAESTHESIA, V59, P374, DOI 10.1111/j.1365-2044.2004.03664.x; Brummel NE, 2013, CRIT CARE MED, V41, P2196, DOI 10.1097/CCM.0b013e31829a6f1e; Burgess C, 2005, BRIT MED J, V330, P702, DOI 10.1136/bmj.38343.670868.D3; Carlson RW, 2012, CRIT CARE CLIN, V28, P549, DOI 10.1016/j.ccc.2012.07.004; Cavallazzi R, 2012, ANN INTENSIVE CARE, V2, DOI 10.1186/2110-5820-2-49; Center for Behavioral Health Statistics and Quality, 2016, 2015 NAT SURF DRUG U; Chahraoui K, 2015, J CRIT CARE, V30, P599, DOI 10.1016/j.jcrc.2015.02.016; Chan EW, 2013, ANN EMERG MED, V61, P72, DOI 10.1016/j.annemergmed.2012.07.118; Chanques G, 2007, ANESTHESIOLOGY, V107, P858, DOI 10.1097/01.anes.0000287211.98642.51; Colquhoun DM, 2013, MED J AUSTRALIA, V198, P483, DOI 10.5694/mja13.10153; Davydow DS, 2008, PSYCHOSOM MED, V70, P512, DOI 10.1097/PSY.0b013e31816aa0dd; Denehy L, 2012, CURR OPIN CRIT CARE, V18, P503, DOI 10.1097/MCC.0b013e328357f064; Desai SV, 2011, CRIT CARE MED, V39, P371, DOI 10.1097/CCM.0b013e3181fd66e5; Dew MA, 2003, PSYCHOSOM MED, V65, P63, DOI 10.1097/01.PSY.0000039756.23250.7C; Dixit D, 2016, PHARMACOTHERAPY, V36, P797, DOI 10.1002/phar.1770; Dobbels F, 2008, AM J KIDNEY DIS, V51, P819, DOI 10.1053/j.ajkd.2008.01.010; Drouot X, 2008, SLEEP MED REV, V12, P391, DOI 10.1016/j.smrv.2007.11.004; Dunwoody Colleen J, 2008, J Perianesth Nurs, V23, pS15, DOI 10.1016/j.jopan.2007.11.007; Eddleston JM, 2000, CRIT CARE MED, V28, P2293, DOI 10.1097/00003246-200007000-00018; Ely EW, 2001, CRIT CARE MED, V29, P1370, DOI 10.1097/00003246-200107000-00012; Fang F, 2012, NEW ENGL J MED, V366, P1310, DOI 10.1056/NEJMoa1110307; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; Friese RS, 2008, CRIT CARE MED, V36, P697, DOI 10.1097/CCM.0B013E3181643F29; Girard TD, 2008, LANCET, V371, P126, DOI 10.1016/S0140-6736(08)60105-1; Girard TD, 2010, CRIT CARE MED, V38, P1513, DOI 10.1097/CCM.0b013e3181e47be1; Girard TD, 2008, CRIT CARE, V12, DOI 10.1186/cc6149; GLASSMAN AH, 2002, JAMA-J AM MED ASSOC, V288, P1720; Gusmao-Flores D, 2012, CRIT CARE, V16, DOI 10.1186/cc11407; Hackett ML, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003437.pub3; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hopkins RO, 2012, AM J RESP CRIT CARE, V186, P1220, DOI 10.1164/rccm.201206-1022CP; Hopkins RO, 2005, AM J RESP CRIT CARE, V171, P340, DOI 10.1164/rccm.200406-763OC; Huffman JC, 2014, JAMA INTERN MED, V174, P1419, DOI 10.1001/jamainternmed.2014.3393; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Jackson JC, 2014, LANCET RESP MED, V2, P369, DOI 10.1016/S2213-2600(14)70051-7; Jackson JC, 2012, CRIT CARE MED, V40, P1088, DOI 10.1097/CCM.0b013e3182373115; Jackson James C, 2011, Anesthesiol Clin, V29, P751, DOI 10.1016/j.anclin.2011.09.012; Jenkins DH, 2000, SURG CLIN N AM, V80, P1033, DOI 10.1016/S0039-6109(05)70112-2; Jensen JF, 2015, INTENS CARE MED, V41, P763, DOI 10.1007/s00134-015-3689-1; Jiang W, 2005, AM HEART J, V150, P871, DOI 10.1016/j.ahj.2005.01.041; Jones C, 2003, CRIT CARE MED, V31, P2456, DOI 10.1097/01.CCM.0000089938.56725.33; Jorgensen TSH, 2016, JAMA PSYCHIAT, V73, P1032, DOI 10.1001/jamapsychiatry.2016.1932; Jubran A, 2010, INTENS CARE MED, V36, P828, DOI 10.1007/s00134-010-1842-4; Kadiev S, 2008, SLEEP MED CLIN, V3, P569, DOI 10.1016/j.jsmc.2008.08.008; Karnatovskaia LV, 2015, J CRIT CARE, V30, P130, DOI 10.1016/j.jcrc.2014.09.024; Kelly MA, 2010, J CLIN NURS, V19, P691, DOI 10.1111/j.1365-2702.2009.03117.x; Kurella M, 2005, J AM SOC NEPHROL, V16, P774, DOI 10.1681/ASN.2004070550; Larsen KK, 2010, CIRCULATION, V122, P2388, DOI 10.1161/CIRCULATIONAHA.110.956136; Lichtman JH, 2008, CIRCULATION, V118, P1768, DOI 10.1161/CIRCULATIONAHA.108.190769; Long AC, 2014, INTENS CARE MED, V40, P820, DOI 10.1007/s00134-014-3306-8; Lu D, 2013, ANN ONCOL, V24, P3112, DOI 10.1093/annonc/mdt415; Matthews EE, 2011, AACN ADV CRIT CARE, V22, P204, DOI 10.1097/NCI.0b013e31822052cb; Mehlhorn J, 2014, CRIT CARE MED, V42, P1263, DOI 10.1097/CCM.0000000000000148; Mikkelsen ME, 2009, RESPIROLOGY, V14, P76, DOI 10.1111/j.1440-1843.2008.01419.x; Mitchell PH, 2009, STROKE, V40, P3073, DOI 10.1161/STROKEAHA.109.549808; Morandi A, 2011, CURR OPIN CRIT CARE, V17, P43, DOI 10.1097/MCC.0b013e3283427243; Moss M, 2006, LANCET, V368, P2231, DOI 10.1016/S0140-6736(06)69490-7; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; National Comprehensive Cancer Network, 2003, J Natl Compr Canc Netw, V1, P344; Needham DM, 2012, CRIT CARE MED, V40, P502, DOI 10.1097/CCM.0b013e318232da75; Nelson JE, 2001, CRIT CARE MED, V29, P277, DOI 10.1097/00003246-200102000-00010; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; Patel MB, 2016, AM J RESP CRIT CARE, V193, P1373, DOI 10.1164/rccm.201506-1158OC; Peris A, 2011, CRIT CARE, V15, DOI 10.1186/cc10133; Perry EC, 2014, CNS DRUGS, V28, P401, DOI 10.1007/s40263-014-0163-5; Reardon DP, 2015, AM J HEALTH-SYST PH, V72, P1531, DOI 10.2146/ajhp140541; Rivosecchi RM, 2016, J CRIT CARE, V31, P206, DOI 10.1016/j.jcrc.2015.09.031; SELZER ML, 1975, J STUD ALCOHOL, V36, P117, DOI 10.15288/jsa.1975.36.117; Shehabi Y, 2012, AM J RESP CRIT CARE, V186, P724, DOI 10.1164/rccm.201203-0522OC; Society of Critical Care Medicine, CRIT CAR STAT US; Stevenson JE, 2013, J PSYCHOSOM RES, V75, P287, DOI 10.1016/j.jpsychores.2013.06.002; Tetrault JM, 2008, CRIT CARE CLIN, V24, P767, DOI 10.1016/j.ccc.2008.05.005; U. S. Food and Drug Administration, FDA DRUG SAF COMM RE; van Rompaey B, 2009, CRIT CARE, V13, DOI 10.1186/cc7892; van Veldhoven LM, 2011, J NEUROL NEUROSUR PS, V82, P782, DOI 10.1136/jnnp.2010.228254; Wade DM, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0519-8; Walker J, 2014, LANCET PSYCHIAT, V1, P343, DOI 10.1016/S2215-0366(14)70313-X; Weinhouse GL, 2006, SLEEP, V29, P707, DOI 10.1093/sleep/29.5.707; Williams LS, 2007, STROKE, V38, P998, DOI 10.1161/01.STR.0000257319.14023.61; Wunsch H, 2014, JAMA-J AM MED ASSOC, V311, P1133, DOI 10.1001/jama.2014.2137; Yaffe K, 2011, JAMA-J AM MED ASSOC, V305, P261, DOI 10.1001/jama.2010.1995; Yende S, 2014, TRENDS MOL MED, V20, P234, DOI 10.1016/j.molmed.2014.02.005; Ziegelstein RC, 2001, JAMA-J AM MED ASSOC, V286, P1621, DOI 10.1001/jama.286.13.1621	93	1	1	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0193-953X	1558-3147		PSYCHIAT CLIN N AM	Psychiatr. Clin. North Amer.	SEP	2017	40	3					487	+		10.1016/j.psc.2017.05.011			15	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	FG4RL	WOS:000410253100011	28800804				2022-02-06	
J	Koc, G; Akcay, BD; Karadas, O; Yetkin, S				Koc, Guray; Akcay, Bulent Devrim; Karadas, Omer; Yetkin, Sinan			A Case of Pleiosomnia Following Traumatic Brain Injury	JOURNAL OF TURKISH SLEEP MEDICINE-TURK UYKU TIBBI DERGISI			Turkish	Article						Hypersomnia; pleiosomnia; traumatic brain injury	SLEEP-WAKE DISTURBANCES; NEED	Sleep-wake disturbances are highly prevalent and often become persistent sequelae after traumatic brain injury. The most common disturbances are insomnia, excessive daytime sleepiness, and increased sleep need (pleiosomnia). Circadian rhythm sleep-wake disturbances and parasomnias are more rare disturbances. These disorders can affect the treatment process and exacerbate other problems such as cognitive, and psychiatric problems. Among these sleep disturbances, hypersomnia is the most damaging disorder for the patients functionality. In this case report, a patient who was complaining of increased sleep need after traumatic brain injury was presented.	[Koc, Guray; Karadas, Omer] Saglik Bilimleri Univ, Gulhane Egitim & Arastirma Hastanesi, Norol Klin, Ankara, Turkey; [Akcay, Bulent Devrim; Yetkin, Sinan] Saglik Bilimleri Univ, Gulhane Egitim & Arastirma Hastanesi, Psikiyatri Klin, Ankara, Turkey		Koc, G (corresponding author), Saglik Bilimleri Univ, Gulhane Egitim & Arastirma Hastanesi, Norol Klin, Ankara, Turkey.	gurayerhan@gmail.com	Koc, Guray/L-1288-2019	Koc, Guray/0000-0002-2477-5244			Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Carmichael ST, 2002, J NEUROSCI, V22, P6062; Cetas JS, 2009, NEUROSCIENCE, V163, P719, DOI 10.1016/j.neuroscience.2009.06.031; Gao B, 2008, CEREBROVASC DIS, V26, P413, DOI 10.1159/000151683; Gao B, 2010, SLEEP, V33, P879, DOI 10.1093/sleep/33.7.879; Harada M, 1976, Kumamoto Med J, V29, P110; Imbach LL, 2015, BRAIN, V138, P726, DOI 10.1093/brain/awu391; Khoury S, 2013, J NEUROTRAUM, V30, P633, DOI 10.1089/neu.2012.2519; Makley MJ, 2009, NEUROREHAB NEURAL RE, V23, P320, DOI 10.1177/1545968308325268; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P875, DOI 10.1016/j.apmr.2013.01.001; Noain D, 2017, J NEUROTRAUM, V1, P1; Ouellet MC, 2015, LANCET NEUROL, V14, P746, DOI 10.1016/S1474-4422(15)00068-X; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Rao V, 2011, J NEUROPSYCH CLIN N, V23, P201, DOI 10.1176/appi.neuropsych.23.2.201; Sommerauer M, 2013, J SLEEP RES, V22, P634, DOI 10.1111/jsr.12068; Valko PO, 2015, ANN NEUROL, V77, P177, DOI 10.1002/ana.24298	17	1	1	0	1	GALENOS YAYINCILIK	FINDIKZADE	MOLLA GURANI MAHALLESI KACAMAK SOKAK NO 21, FINDIKZADE, ISTANBUL 34093, TURKEY	2148-1504			J TURK SLEEP MED	J. Turk. Sleep Med.	SEP	2017	4	3					90	94		10.4274/jtsm.44153			5	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	FZ1FV	WOS:000427323200006		gold			2022-02-06	
J	Lahner, D; Fritsch, G				Lahner, D.; Fritsch, G.			Pathophysiology of intracranial injuries	UNFALLCHIRURG			German	Article						Traumatic brain injury; Biomarker; Diffuse axonal injury; Epidural hematoma; Subdural hematoma	TRAUMATIC BRAIN-INJURY; MICROGLIAL ACTIVATION; AXONAL INJURY; RAT; NEURODEGENERATION; INFLAMMATION; GLUTAMATE; RECOVERY	Traumatic brain injury (TBI) constitutes a heterogeneous condition that affects the most complex organ of the human body. It is commonly classified by its location as focal injury (e.g. epidural hematoma) and diffuse injury (e.g. diffuse axonal shearing injury) as well as by primary and secondary tissue injury. Accordingly, direct mechanical force causes the primary insult. The tissue damage occurring afterwards is subsumed under the term secondary brain damage. Some of these processes are overlapping and include in the early phase local cerebral ischemia resulting in excitotoxicity, which together with the triggered neuroinflammatory cascade causes the formation of cerebral edema and ultimately increased intracranial pressure once the intracranial compliance is exhausted. In survivors the long-term sequelae of the late stage include seizures caused by synaptic reorganization (incidence depending on the severity of TBI), persistent neuroinflammation promoting further neurodegeneration and increased risk for Alzheimer's disease probably because of TBI-related protein misfolding (tauopathy). Acute phase biomarkers of TBI should ideally originate from the injured brain. They should help distinguish disease severity and predict morbidity and mortality; however, the most commonly used biomarkers (S-100 beta and neurone-specific enolase) show a low specificity. In theory their successors (i. e. GFAP, pNF-H) seem more specific; however, these "new kids on the block" still need to be thoroughly investigated in large scale studies.	[Lahner, D.] Ludwig Boltzmann Inst Expt & Klin Traumatol, Vienna, Austria; [Fritsch, G.] Paracelsus Med Univ Salzburg, Strubergasse 21, A-5020 Salzburg, Austria; [Fritsch, G.] AUVA Unfallkrankenhaus Lorenz Bohler, Vienna, Austria		Fritsch, G (corresponding author), Paracelsus Med Univ Salzburg, Strubergasse 21, A-5020 Salzburg, Austria.	gerhard.fritsch@auva.at		Fritsch, Gerhard/0000-0002-4795-6662			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Godoy DA, 2016, NEUROCRIT CARE, V25, P306, DOI 10.1007/s12028-016-0253-y; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Carson MJ, 2006, IMMUNOL REV, V213, P48, DOI 10.1111/j.1600-065X.2006.00441.x; CHOI DW, 1987, J NEUROSCI, V7, P357; FUJISAWA H, 1994, ACT NEUR S, V60, P193; Hinzman JM, 2012, J NEUROTRAUM, V29, P1197, DOI 10.1089/neu.2011.2261; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; McMahon PJ, 2015, J NEUROTRAUM, V32, P527, DOI 10.1089/neu.2014.3635; Ohrt-Nissen S, 2011, EMERG MED J, V28, P941, DOI 10.1136/emj.2010.091363; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; POVLISHOCK JT, 1992, J NEUROTRAUM, V9, pS189; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; RINK A, 1995, AM J PATHOL, V147, P1575; Shah S, 2016, SEMIN NEUROL, V36, P502, DOI 10.1055/s-0036-1592109; Shibahashi K, 2016, J NEUROTRAUM, V33, P1826, DOI 10.1089/neu.2015.4237; Spitz G, 2013, J NEUROTRAUM, V30, P2038, DOI 10.1089/neu.2013.3021; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Stokum JA, 2015, NEUROCHEM RES, V40, P317, DOI 10.1007/s11064-014-1374-3; Tompkins P, 2013, J NEUROTRAUM, V30, P1888, DOI 10.1089/neu.2012.2674; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Wanke-Jellinek L, 2014, UNFALLCHIRURG, V117, P693, DOI 10.1007/s00113-013-2542-7; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	29	1	1	1	9	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0177-5537	1433-044X		UNFALLCHIRURG	Unfallchirurg	SEP	2017	120	9					728	733		10.1007/s00113-017-0388-0			6	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	FF2IE	WOS:000408720300003	28812113				2022-02-06	
J	Leggieri, MJ; Gupta, RK; Hinds, SR				Leggieri, Michael J.; Gupta, Raj K.; Hinds, Sidney R., II			International State-of-the-Science Meeting Exploring the Potential Relationship between Blast-Related Trauma and the Development of Chronic Traumatic Encephalopathy	JOURNAL OF NEUROTRAUMA			English	Article							BRAIN-INJURY; HEAD-INJURY; CONCUSSION; DISEASE		[Leggieri, Michael J.; Gupta, Raj K.; Hinds, Sidney R., II] US Dept Def, Blast Injury Res Program Coordinating Off, Ft Detrick, MD USA		Gupta, RK (corresponding author), United States Army, Med Res & Mat Command, US Dept Def, Blast Injury Res Program Coordinating Off, 504 Scott St, Ft Detrick, MD 21702 USA.	raj.k.gupta.civ@mail.mil					[Anonymous], DOD WORLDW NUMB TBI; Belanger HG, 2005, J REHABIL RES DEV, V42, P403, DOI 10.1682/JRRD.2004.08.0095; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; DCAS-Home, DEF CAS AN SYST; Hazrati LN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00222; Institute of Medicine, GULF WAR HLTH, V7; Karantzoulis S, 2013, NEUROPSYCHOL REV, V23, P350, DOI 10.1007/s11065-013-9243-4; McCrory P, 2013, BRIT J SPORT MED, V47, P327, DOI 10.1136/bjsports-2013-092248; McKee A. C., 2015, NEUROLOGY, V84, P2; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MILLER H, 1966, P ROY SOC MED, V59, P257, DOI 10.1177/003591576605900327; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Randolph C, 2014, CURR SPORT MED REP, V13, P33, DOI [10.1097/OPX.0000000000000170, 10.1249/JSR.0000000000000022]; Reid MW, 2015, MOL CELL NEUROSCI, V66, P123, DOI 10.1016/j.mcn.2015.03.014; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Wortzel HS, 2013, BEHAV SCI LAW, V31, P721, DOI 10.1002/bsl.2079	18	1	1	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2017	34			1			S1	S3		10.1089/neu.2017.29013.introduction			3	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	FI2DA	WOS:000411746000001	28937956	Bronze			2022-02-06	
J	Lo Bianco, L; Attrotto, MT; Torretta, S; Masellis, R; Rampino, A; D'Ambrosio, E; Di Giorgio, A; Ferranti, L; Fazio, L; Gelao, B; Blasi, G; Bertolino, A				Lo Bianco, Luciana; Attrotto, Maria Teresa; Torretta, Silvia; Masellis, Rita; Rampino, Antonio; D'Ambrosio, Enrico; Di Giorgio, Annabella; Ferranti, Laura; Fazio, Leonardo; Gelao, Barbara; Blasi, Giuseppe; Bertolino, Alessandro			Genetic variation is associated with RTN4R expression and working memory processing in healthy humans	BRAIN RESEARCH BULLETIN			English	Article						rs696884; Nogo receptor; mRNA expression; Prefrontal activity; Working memory	MYELIN-ASSOCIATED GLYCOPROTEIN; TRAUMATIC BRAIN-INJURY; CARDIO-FACIAL SYNDROME; NOGO RECEPTOR 1; AXONAL REGENERATION; OUTGROWTH INHIBITOR; NEURITE OUTGROWTH; ENHANCER-BLOCKING; PREFRONTAL CORTEX; SPATIAL MEMORY	The Nogo receptor (NgR) is implicated in neurodevelopmental processes and it participates in inhibiting axonal growth. Consistent with its high levels of expression in the prefrontal cortex, animal studies indicate that NgR is relevant for prefrontal-related cognitive processing. Given that genetic variation may alter mechanisms of gene expression impacting molecular and systems-level phenotypes, we investigated the association of genetic variation with the expression of the NgR coding gene (RTN4R), as well as with prefrontal correlates at progressively greater biological distance from gene effects. First, we studied the association of single nucleotide polymorphisms (SNPs) with RTN4R mRNA expression in postmortem prefrontal cortex of humans without psychiatric illnesses. Then, we probed in peripheral blood mononuclear cells (PBMCs) the association that we found in prefrontal tissue. Thus, we investigated whether functional genetic variation affecting RTN4R expression is also associated with prefrontal activity during working memory. We found that rs696884 (A/G) predicted these phenotypes. Specifically, the AA genotype was associated with lower RTN4R mRNA expression levels in the prefrontal cortex and PBMCs and inefficient prefrontal activity during working memory compared to the GG genotype. These results suggest that genetic variation associated with RTN4R mRNA expression influences prefrontal physiology in healthy individuals. Furthermore, they highlight the need for further investigations of the role of NgR in the pathophysiology of brain disorders associated with prefrontal dysfunction.	[Lo Bianco, Luciana; Attrotto, Maria Teresa; Torretta, Silvia; Masellis, Rita; Rampino, Antonio; D'Ambrosio, Enrico; Ferranti, Laura; Fazio, Leonardo; Gelao, Barbara; Blasi, Giuseppe; Bertolino, Alessandro] Univ Bari Aldo Moro, Dept Basic Med Sci Neurosci & Sense Organs, Pzza Giuli Cesare 11, I-70124 Bari, Italy; [Di Giorgio, Annabella] IRCCS Casa Sollievo Sofferenza, I-71013 San Giovanni Rotondo, Italy; [D'Ambrosio, Enrico] Kings Coll London, Inst Psychiat Neurol & Neurosci, Dept Psychosis Studies, London WC2R 2L5, England; [Ferranti, Laura] Univ Perugia, Dept Med, I-06132 Perugia, Italy		Bertolino, A (corresponding author), Univ Bari Aldo Moro, Dept Basic Med Sci Neurosci & Sense Organs, Pzza Giuli Cesare 11, I-70124 Bari, Italy.	alessandro.bertolino@uniba.it	Di Giorgio, Annabella/D-7353-2017; Rampino, Antonio/Q-4465-2016; D'Ambrosio, Enrico/K-1942-2015; Di Giorgio, Annabella/AAI-5367-2020; Di Giorgio, Annabella/AAS-1137-2020; Torretta, Silvia/K-7717-2019	Di Giorgio, Annabella/0000-0001-7876-3495; Rampino, Antonio/0000-0002-9654-3266; D'Ambrosio, Enrico/0000-0001-9774-3860; Di Giorgio, Annabella/0000-0001-7876-3495; Torretta, Silvia/0000-0002-9060-7628; Blasi, Giuseppe/0000-0003-0878-1131; Fazio, Leonardo/0000-0003-4000-974X			Akbik F, 2012, EXP NEUROL, V235, P43, DOI 10.1016/j.expneurol.2011.06.006; Antshel KM, 2005, CHILD NEUROPSYCHOL, V11, P5, DOI 10.1080/09297040590911185; Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Barton WA, 2003, EMBO J, V22, P3291, DOI 10.1093/emboj/cdg325; Bearden CE, 2001, J CLIN EXP NEUROPSYC, V23, P447, DOI 10.1076/jcen.23.4.447.1228; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Blasi G, 2013, JAMA PSYCHIAT, V70, P921, DOI 10.1001/jamapsychiatry.2013.1378; Budel S, 2008, J NEUROSCI, V28, P13161, DOI 10.1523/JNEUROSCI.3828-08.2008; Callicott JH, 1999, CEREB CORTEX, V9, P20, DOI 10.1093/cercor/9.1.20; Callicott JH, 2003, AM J PSYCHIAT, V160, P709, DOI 10.1176/appi.ajp.160.4.709; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524; Fournier AE, 2003, J NEUROSCI, V23, P1416, DOI 10.1523/JNEUROSCI.23-04-01416.2003; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Hanell A, 2010, J NEUROTRAUM, V27, P1297, DOI 10.1089/neu.2009.1255; Hoistad M, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.009.2009; Hou CH, 2008, P NATL ACAD SCI USA, V105, P20398, DOI 10.1073/pnas.0808506106; Hsieh SHK, 2006, J NEUROSCI, V26, P1006, DOI 10.1523/JNEUROSCI.2806-05.2006; Hsu R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001234; Josephson A, 2002, J COMP NEUROL, V453, P292, DOI 10.1002/cne.10408; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; Karlen A, 2009, P NATL ACAD SCI USA, V106, P20476, DOI 10.1073/pnas.0905390106; Karlsson TE, 2013, J ALZHEIMERS DIS, V33, P145, DOI 10.3233/JAD-2012-120493; LAI C, 1987, P NATL ACAD SCI USA, V84, P4337, DOI 10.1073/pnas.84.12.4337; Lazar NL, 2011, BEHAV BRAIN RES, V224, P73, DOI 10.1016/j.bbr.2011.05.020; Lee JK, 2004, J NEUROSCI, V24, P6209, DOI 10.1523/JNEUROSCI.1643-04.2004; Li YY, 2013, BMC GENOMICS, V14, DOI [10.1186/1471-2164-14-553, 10.1186/1471-2164-14-579]; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; Meng B., 2005, P NATL ACAD SCI USA, V102, P12; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Mingorance A, 2004, MOL CELL NEUROSCI, V26, P34, DOI 10.1016/j.mcn.2004.01.001; Murphy KC, 1999, ARCH GEN PSYCHIAT, V56, P940, DOI 10.1001/archpsyc.56.10.940; Niederost B, 2002, J NEUROSCI, V22, P10368; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; PULVER AE, 1994, J NERV MENT DIS, V182, P476, DOI 10.1097/00005053-199408000-00010; Sinibaldi Lorenzo, 2004, Hum Mutat, V24, P534, DOI 10.1002/humu.9292; Sobin C, 2005, CHILD NEUROPSYCHOL, V11, P39, DOI 10.1080/09297040590911167; Tong J, 2013, J NEUROTRAUM, V30, P247, DOI 10.1089/neu.2012.2493; van Gaalen MM, 2012, NEUROSCI LETT, V510, P58, DOI 10.1016/j.neulet.2012.01.004; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Wang XX, 2002, J NEUROSCI, V22, P5505; Willi R, 2010, J NEUROSCI, V30, P556, DOI 10.1523/JNEUROSCI.4393-09.2010; Woodin M, 2001, GENET MED, V3, P34, DOI 10.1097/00125817-200101000-00008	43	1	1	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	SEP	2017	134						162	167		10.1016/j.brainresbull.2017.07.015			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FI3HA	WOS:000411847400021	28755979	Green Submitted			2022-02-06	
J	Low, JCM; Shtaya, A; Hettige, S				Low, Jacob Chen Ming; Shtaya, Anan; Hettige, Samantha			Intracranial Hypotension Following Traumatic Brain Injury: A Diagnostic and Therapeutic Challenge	WORLD NEUROSURGERY			English	Article						ICP monitor; Intracranial hypotension; Trauma; Trendelenburg		BACKGROUND: Intracranial hypotension (IH) is a recognized cause of coma; however, the diagnosis is often challenging, especially in patients with superimposed traumatic brain injury. CASE DESCRIPTION: A 67-year-old woman became comatose following evacuation of bilateral acute subdural hematomas with concurrent respiratory failure. Imaging and intraparenchymal intracranial pressure monitoring confirmed secondary IH. She was managed with an epidural blood patch and a 72-hour period in the Trendelenburg position guided by intracranial pressure monitoring and clinical assessment. She subsequently made an excellent neurologic recovery from an initial Glasgow Coma Scale score of 3 to a score of CONCLUSIONS: Secondary IH can easily be missed in patients who have sustained a primary brain injury. In patients with a poor neurologic recovery, clinicians should rule out secondary IH as a potential cause, as immediate treatment can lead to profound clinical improvement.	[Low, Jacob Chen Ming; Shtaya, Anan; Hettige, Samantha] St George Hosp, Dept Neurosurg, London, England		Low, JCM (corresponding author), St George Hosp, Dept Neurosurg, London, England.	Jacob.CM.Low@doctors.org.uk	Shtaya, Anan/AAX-2494-2020	Shtaya, Anan/0000-0001-7459-8437			Alcaide-Leon P, 2016, AM J ROENTGENOL, V206, P817, DOI 10.2214/AJR.15.14872; Couch JR, 2008, CURR TREAT OPTION NE, V10, P3, DOI 10.1007/s11940-008-0001-5; FERRANTE E, 2015, J HEADACHE PAIN S1, V16; Hong M, 2002, NEUROLOGY, V58, P1285, DOI 10.1212/WNL.58.8.1285; Kranz PG, 2016, AM J ROENTGENOL, V207, P1283, DOI 10.2214/AJR.16.16381; Loya JJ, 2012, J NEUROSURG, V117, P615, DOI 10.3171/2012.4.JNS112030; Savoiardo M, 2007, BRAIN, V130, P1884, DOI 10.1093/brain/awm101; Schaltenbrand G., 1938, ZENTRABLBL NEUROCHIR, V3, P290; Schievink WI, 2006, NEUROLOGY, V66, P1777, DOI 10.1212/01.wnl.0000218210.83855.40; Schievink WI, 2003, ARCH NEUROL-CHICAGO, V60, P1713, DOI 10.1001/archneur.60.12.1713; Shah LM, 2013, AM J ROENTGENOL, V200, P400, DOI 10.2214/AJR.12.8611; Smith KA, 2016, J CLIN NEUROSCI, V25, P10, DOI 10.1016/j.jocn.2015.07.009; THORSEN G, 1947, ACTA CHIR SCAND S121, V95, P1; Wicklund MR, 2011, NEUROLOGY, V76, P1377, DOI 10.1212/WNL.0b013e3182166e42	14	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	SEP	2017	105								PMID 1036.e11	10.1016/j.wneu.2017.06.060			3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FH3EJ	WOS:000411027600171		Green Accepted			2022-02-06	
J	Newman, JW; Blunck, JR; Fields, RK; Croom, JE				Newman, Joseph W.; Blunck, Joseph R.; Fields, Ronald K.; Croom, John E.			Fosphenytoin-induced purple glove syndrome: A case report	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Purple glove syndrome; Fosphenytoin; Phenytoin; Antiepileptic drugs; Status epilepticus		Background: Purple glove syndrome (PGS) is a poorly understood severe adverse drug reaction that is typically associated with intravenous phenytoin administration. Although fosphenytoin is thought to circumvent this risk of PGS, we reveal a rare case of PGS in a patient treated with fosphenytoin therapy. Case summary: A 71-year-old male with history of epilepsy was admitted for seizures and traumatic brain injury and intravenous fosphenytoin and levetiracetam were initiated. The patient continued to have seizure activity on continuous electroencephalography for which fosphenytoin dosing was increased with subsequent seizure control. Serum phenytoin levels became elevated with a total level reaching as high as 25.8 ug/mL. Three days into fosphenytoin therapy he developed PGS in both hands. Causation was assessed with the Naranjo adverse drug reaction algorithm that suggested fosphenytoin was probably the cause of PGS. Ten days after discontinuing the fosphenytoin and administering a 7-day course of methylprednisolone, the purple glove syndrome completely resolved. Conclusion: Early recognition and emergent management of PGS are key for optimal recovery. Although fosphenytoin has a significantly reduced risk of associated PGS compared to phenyotin, increased awareness for fosphenytoin-induce PGS can accelerate intervention and minimize morbidity of this rare yet detrimental adverse reaction.	[Newman, Joseph W.; Fields, Ronald K.; Croom, John E.] St Lukes Hosp, Dept Neurol, Epileptol Div, Kansas City, MO 64111 USA; [Blunck, Joseph R.] St Lukes Hosp, Dept Pharm, Neurosci Div, 4401 Wornall Rd, Kansas City, MO 64111 USA		Blunck, JR (corresponding author), St Lukes Hosp, Dept Pharm, Neurosci Div, 4401 Wornall Rd, Kansas City, MO 64111 USA.	jblunck@saint-lukes.org					Boucher BA, 1996, PHARMACOTHERAPY, V16, P777; Food and Drug Administration, 2010, INTR PHEN FOSPH SAF, P53; Garbovsky LA, 2015, J MED TOXICOL, V11, P445, DOI 10.1007/s13181-015-0490-z; Hanna D R, 1992, J Neurosci Nurs, V24, P340; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154	5	1	2	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	SEP	2017	160						50	53		10.1016/j.clineuro.2017.06.006			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FE5YQ	WOS:000408287600011	28648954				2022-02-06	
J	Nica, AS; Constantinovici, M; Miclaus, R				Nica, Adriana Sarah; Constantinovici, Mariana; Miclaus, Roxana			Ethical issues in rehabilitation of the post-traumatic patient	ROMANIAN JOURNAL OF LEGAL MEDICINE			English	Article						rehabilitation ethics; post-traumatic patient	TRAUMATIC BRAIN-INJURY	Physical Medicine and Rehabilitation is a relatively young specialty developed after 1947 based on the needs of patients with functional locomotor sequelae of infectious pathologies (poliomyelitis epidemics) or of various post-traumatic pathologies - interpreted as public health issues related to impairments and disabilities. Restoring maximum locomotor functioning is the main therapeutic objective, thus increasing the degree of physical and psycho-behavioral independence of the post-traumatic patient referred to rehabilitation. Patients are extremely physically and mentally vulnerable most of the time. They may not be psychologically prepared for the long-term therapeutic program and must be informed and motivated to follow a medical routine involving many healthcare professionals. The trauma patient needs empathy and communication for reaching coping, adapting and complying to the rehabilitation program. Patients with dysfunctional locomotor pathologies and disabilities (reffered from orthopedics, neurology or rheumatology) in post-traumatic context, must reasonably understand the goals of the rehabilitation program Also, they must carry out its different sequences by following the given recommendations based on experience and professional competence of the rehabilitation team. In many situations developing conflicts and ethical dilemmas related to the communication and information process, patient monitoring, quality of the relationships and communication in the rehabilitation team. Also, may be related to the presence of specific equipment and infrastructure (for example the hydro-kinesiotherapy infrastructure) or the access to specific assistive devices (eg. orthotics, wheelchair). The particular elements of ethics in Rehabilitation were progressively structured starting from other models such as the US bioethical model and the general principles of medical ethics. To address the specific issues of Ethics in Rehabilitation there might be analyzed various challenging situations related to compliance of physician-patient and patient-family relationship.	[Nica, Adriana Sarah; Constantinovici, Mariana] Carol Davila Univ Med & Pharm, Dept Rehabil Phys Med & Balneol, Bucharest, Romania; [Nica, Adriana Sarah; Constantinovici, Mariana] Natl Inst Rehabil Phys Med & Balneoclimatol, Bucharest, Romania; [Miclaus, Roxana] Transilvania Univ, Fac Med, Brasov, Romania		Nica, AS (corresponding author), Carol Davila Univ Med & Pharm, Dept Rehabil Phys Med & Balneol, Fac Med, 11A Ion Mihalache Bd,Sect 1, Bucharest 011171, Romania.	mariana.isabela.moise@gmail.com	Constantinovici, Mariana I/S-2879-2017; Miclaus, Roxana/AAW-3209-2020; Adriana, Nica Sarah/AAM-4246-2021				[Anonymous], 2010, CODE PROFESSIONAL ET; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Cuccurullo Sara J., 2015, BASIC PRINCIPLES BIO, P933; Hass JF, 2010, DE LISAS PHYS MED RE, VI, P501; Hellweg S, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/768456; Holdcroft A, 2005, ETHICAL STANDARDS GU; HORN LJ, 1992, PHYS MED REHAB CLIN, V3, P475; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Lewis CB, 2008, PEARSON ED INK, V17, P256; Lynne Brady Wagner MA, ETHICAL ISSUES REHAB; Scott R, 2000, ETHICAL LEGAL ISSUE; Scott R, 2007, GERIATRIC REHABILITA, P487; Wharton MA, 2007, ETHICS GERIATRIC REH, P491	13	1	1	1	10	ROMANIAN LEGAL MED SOC	BUCHAREST	SOS VITAN-BIRZESTI 9, BUCHAREST, 75669, ROMANIA	1221-8618			ROM J LEG MED	Rom. J. Leg. Med.	SEP	2017	25	3					309	313		10.4323/rjlm.2017.309			5	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	FO8SE	WOS:000417156800016					2022-02-06	
J	Ozevren, H; Deveci, E				Ozevren, Huseyin; Deveci, Engin			Protective Effects of Ganoderma lucidum on the Changes Made in the Retinal Damage Induced by Traumatic Head Injury	INTERNATIONAL JOURNAL OF MORPHOLOGY			English	Article						Head trauma; Retina; Ganoderma lucidum; Rat	BRAIN-INJURY; CELLS; VEGF	Head trauma affects the optic nerve visual function and visual acuity. As a result of head trauma occurring in the retina of the various biochemical, histological and immunohistochemical effects were investigated. The protective effect of Ganoderma lucidum was evaluated on the damage to the retina of the rats. Sprague-Dawley rats were subjected to traumatic brain injury with a weight-drop device using 300 g-1 m weight-height impact. Thirty rats were divided into three groups as group 1 control, 2 group trauma, 3 group trauma+Gonoderma lucidum (20 mL/kg per day via gastric gavage) Ganoderma lucidum was administered for 7 days after trauma. All rats were decapitated 5 days after the induction of trauma, and the protective effects of Ganoderma lucidum in retina were evaluated by histological, immunohistochemical and biochemical analyses. The antioxidant effect of Ganoderma lucidum on the cellular degeneration extracellular matrix and retinal barrier in retina after head trauma was investigated.	[Ozevren, Huseyin] Dicle Univ, Dept Neurosurg, Sch Med, Diyarbakir, Turkey; [Deveci, Engin] Dicle Univ, Dept Histol & Embryol, Sch Med, Diyarbakir, Turkey		Deveci, E (corresponding author), Dicle Univ, Dept Histol & Embryol, Fac Med, Diyarbakir, Turkey.	engindeveci64@gmail.com	Ozevren, Huseyin/AAC-1236-2021	Ozevren, Huseyin/0000-0002-5437-4003			Bates DO, 2002, VASC PHARMACOL, V39, P225, DOI 10.1016/S1537-1891(03)00011-9; CAGLIERO E, 1991, DIABETES, V40, P102, DOI 10.2337/diabetes.40.1.102; Cheung WMW, 2000, FEBS LETT, V486, P291, DOI 10.1016/S0014-5793(00)02317-6; COHEN G, 1970, ANAL BIOCHEM, V34, P30, DOI 10.1016/0003-2697(70)90083-7; Das A, 1999, INVEST OPHTH VIS SCI, V40, P809; DRAPER HH, 1990, METHOD ENZYMOL, V186, P421; Lai CSW, 2008, BRAIN RES, V1190, P215, DOI 10.1016/j.brainres.2007.10.103; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Malemud CJ, 2006, FRONT BIOSCI-LANDMRK, V11, P1696, DOI 10.2741/1915; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Rajagopalan S, 1996, J CLIN INVEST, V98, P2572, DOI 10.1172/JCI119076; Robertson JV, 2013, MOL VIS, V19, P684; Saint-Geniez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003554; Sarkies N, 2004, EYE, V18, P1122, DOI 10.1038/sj.eye.6701571; SUN Y, 1988, CLIN CHEM, V34, P497; Ucar T, 2006, J TRAUMA, V60, P558, DOI 10.1097/01.ta.0000209172.75637.db; Vincenti MP, 2000, METH MOL B, V151, P121, DOI 10.1385/1-59259-046-2:121; Wang YQ, 2010, INJURY, V41, P707, DOI 10.1016/j.injury.2009.12.003; Zhang XY, 2008, DIABETES, V57, P1026, DOI 10.2337/db07-0982; Zhao HB, 2005, LIFE SCI, V76, P1027, DOI 10.1016/j.lfs.2004.08.013; Zhou Y, 2012, EXP TOXICOL PATHOL, V64, P673, DOI 10.1016/j.etp.2010.12.011	22	1	1	0	6	SOC CHILENA ANATOMIA	TEMUCO	CASILLA 54-D, TEMUCO, 00000, CHILE	0717-9502	0717-9367		INT J MORPHOL	Int. J. Morphol.	SEP	2017	35	3					1063	1068					6	Anatomy & Morphology	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology	FK1GO	WOS:000413228700040					2022-02-06	
J	Pagulayan, KF; O'Neil, M; Williams, RM; Turner, AP; Golshan, S; Roost, MS; Laman-Maharg, B; Huckans, M; Storzbach, D; Twamley, EW				Pagulayan, Kathleen F.; O'Neil, Maya; Williams, Rhonda M.; Turner, Aaron P.; Golshan, Shahrokh; Roost, Mai S.; Laman-Maharg, Benjamin; Huckans, Marilyn; Storzbach, Daniel; Twamley, Elizabeth W.			Mental Health Does Not Moderate Compensatory Cognitive Training Efficacy for Veterans With a History of Mild Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Depression; Brain injuries; cognition; Rehabilitation; Stress disorders; memory; post-traumatic; Substance-related disorders; Veterans	POSTTRAUMATIC-STRESS-DISORDER; COGSMART; USERS	Objective: To examine the potential moderating effects of mental health symptoms on the efficacy of compensatory cognitive training (CCT) for Operation Enduring Freedom/Operation Iraqi Freedom/Operation New Dawn veterans with a history of mild traumatic brain injury (mTBI). Design: Secondary analysis of a randomized controlled trial of CCT. Posttraumatic stress disorder, depression, and substance dependence symptom severity were examined as potential moderators of CCT efficacy for subjective cognitive complaints, use of cognitive strategies, and objective neurocognitive performance. Setting: Three Veterans Affairs medical centers. Participants: Participants included veterans with history of mTBI (N=119): 50 participated in CCT and 69 received usual care (UC). Intervention: CCT is a 10-week group-based (90 minutes per session) manualized cognitive rehabilitation intervention. Main Outcome Measures: Objective (neuropsychological functioning) and subjective (self-report) cognitive functioning and use of cognitive strategies. Results: Baseline mental health symptoms did not moderate CCT efficacy: veterans who received CCT reported significantly greater improvement in cognitive difficulties and use of cognitive strategies compared with the UC group, regardless of baseline mental health symptom severity. The CCT group also demonstrated significant improvements on neuropsychological measures of attention, learning, and executive functioning compared with the UC group, regardless of baseline mental health symptom severity. Conclusions: CCT is efficacious for improving objective cognitive functioning and compensatory strategy use for veterans with a history of mTBI, regardless of the severity of comorbid psychiatric symptoms. (C) 2017 by the American Congress of Rehabilitation Medicine	[Pagulayan, Kathleen F.; Williams, Rhonda M.; Turner, Aaron P.] US Dept Vet Affairs Puget Sound Hlth Care Syst, Seattle, WA USA; [Pagulayan, Kathleen F.] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [O'Neil, Maya; Roost, Mai S.; Laman-Maharg, Benjamin; Huckans, Marilyn; Storzbach, Daniel] US Dept Vet Affairs Portland Hlth Care Syst, Portland, OR USA; [O'Neil, Maya; Huckans, Marilyn; Storzbach, Daniel] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97201 USA; [O'Neil, Maya] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA; [Williams, Rhonda M.; Turner, Aaron P.] Univ Washington, Sch Med, Dept Rehabil Med, Seattle, WA 98195 USA; [Golshan, Shahrokh; Twamley, Elizabeth W.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Storzbach, Daniel] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Twamley, Elizabeth W.] US Dept Vet Affairs San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Twamley, Elizabeth W.] US Dept Vet Affairs San Diego Healthcare Syst, Res Serv, San Diego, CA USA		Pagulayan, KF (corresponding author), VA Puget Sound Hlth Care Syst, 1660 S Columbian Way S-116-MIRECC, Seattle, WA 98108 USA.	kathleen.pagulayan@va.gov	Turner, Aaron/A-7902-2009; Pagulayan, Kati/AAR-9225-2020	Turner, Aaron/0000-0001-6897-8003; 	U.S. Department of Veterans Affairs Merit Review from U.S. Department of Veterans Affairs, Office of Research and Development Rehabilitation Research and Development Program [D7217-R]; U.S. Department of Veterans Affairs, Office of Research and Development Clinical Science R & D Career Development Award Program [IK2CX000516]; Agency for Healthcare Research QualityUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [1 K12 HS019456 01]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K12HS022981, K12HS019456] Funding Source: NIH RePORTER	Supported by the U.S. Department of Veterans Affairs Merit Review (award no. D7217-R) from the U.S. Department of Veterans Affairs, Office of Research and Development Rehabilitation Research and Development Program (clinicaltrials.gov Identifier NCT01040858); the U.S. Department of Veterans Affairs, Office of Research and Development Clinical Science R & D Career Development Award Program (grant no. IK2CX000516): and the Agency for Healthcare Research & Quality-funded Patient-Centered Outcomes Research K-12 award (no. 1 K12 HS019456 01).	Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; GOSSOP M, 1995, ADDICTION, V90, P607, DOI 10.1111/j.1360-0443.1995.tb02199.x; Gould Thomas J, 2010, Addict Sci Clin Pract, V5, P4; Hammar A, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.026.2009; Hanson KL, 2016, J CLIN EXP NEUROPSYC, V38, P1115, DOI 10.1080/13803395.2016.1198468; Scott JC, 2015, PSYCHOL BULL, V141, P105, DOI 10.1037/a0038039; Storzbach D, 2017, J HEAD TRAUMA REHAB, V32, P16, DOI 10.1097/HTR.0000000000000228; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Twamley EW, 2015, J HEAD TRAUMA REHAB, V30, P391, DOI 10.1097/HTR.0000000000000076; Twamley EW, 2014, J REHABIL RES DEV, V51, P59, DOI 10.1682/JRRD.2013.01.0020; U.S. Department of Veterans Affairs, 2016, VA DOD CLIN PRACT GU; Walter KH, 2015, REHABIL PSYCHOL, V60, P303, DOI 10.1037/rep0000049	12	1	1	0	11	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	SEP	2017	98	9					1893	1896		10.1016/j.apmr.2017.04.009			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	FG8XB	WOS:000410720000018	28483653				2022-02-06	
J	Richburg, CM; Atcherson, SR; Findlen, UM; Wakefield, S; Benafield, NJ				Richburg, Cynthia McCormick; Atcherson, Samuel R.; Findlen, Ursula M.; Wakefield, Sarah; Benafield, Natalie J.			(Central) Auditory Processing Disorder Grand Rounds: Multiple Cases, Multiple Causes, Multiple Outcomes	AMERICAN JOURNAL OF AUDIOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; CHILDREN; LESIONS	Purpose: The purpose of this article was to provide multiple examples of how (central) auditory processing disorder ([C]APD) is being evaluated and treated at various audiology clinics throughout the United States. Method: The authors present 5 cases highlighting the diagnosis and treatment of (C)APD in children and adults. Similarities and differences between these cases have been showcased through detailed histories, evaluation protocol, and treatment options. When possible, the rationale for evaluation procedures and intervention processes were described and compared with guidelines and findings within the literature. Results and Conclusions: These cases illustrate the varied processes and clinical protocols by which children and adults are evaluated, diagnosed, counseled, and treated for (C)APD. In addition, similarities and differences between the referral source, evaluation team, developmental history, comorbidities, test battery, recommendations, and remediations were described. The multiple clinic sites, diversity of clinical philosophies, variety of test measures, and diversity of patient populations make these cases ideal for showcasing the assortment of methodologies used with patients who present with histories and characteristics consistent with (C)APD.	[Richburg, Cynthia McCormick] Indiana Univ Penn, Indiana, PA 15705 USA; [Atcherson, Samuel R.] Univ Arkansas Med Sci, Little Rock, AR 72205 USA; [Findlen, Ursula M.] Nationwide Childrens Hosp, Columbus, OH USA; [Wakefield, Sarah] Nova Southeastern Univ, Ft Lauderdale, FL 33314 USA; [Benafield, Natalie J.] Univ Cent Arkansas, Conway, AR USA		Richburg, CM (corresponding author), Indiana Univ Penn, Indiana, PA 15705 USA.	cynthia.richburg@iup.edu					ALHADY MRA, 1990, J LARYNGOL OTOL, V104, P927, DOI 10.1017/S0022215100114410; American Academy of Audiology, 2010, DIAGN TREATM MAN CHI; American Speech-Language-Hearing Association, 2005, TECHNICAL REPORT; Anderson, 1989, SCREENING INSTRUMENT; Bellis T. J., 2003, ASSESSMENT MANAGEMEN; Bergemalm PO, 2001, ACTA OTO-LARYNGOL, V121, P724, DOI 10.1080/00016480152583674; Bjorkdahl A, 2013, BRAIN INJURY, V27, P1658, DOI 10.3109/02699052.2013.830196; Cameron C., 2012, LISN LEARN AUDITORY; Centers for Disease Control and Prevention (CDC), 2014, RAT TBI REL EM DEP V; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Dillon H, 1997, J Am Acad Audiol, V8, P27; Engel AK, 2001, TRENDS COGN SCI, V5, P16, DOI 10.1016/S1364-6613(00)01568-0; Etymotic Research, 2005, BKB SIN SPEECH IN NO; Fabry D. A., 2004, ACCESS ACHIEVING CLE; Ferre J.M., 2015, PERSPECT HEAR HEAR D, V19, P4, DOI [10.1044/hhd19.1.4, DOI 10.1044/HHD19.1.4]; FERRE JM, 2006, INTRO AUDITORY PROCE, P161; Fisher L., 1976, FISHERS AUDITORY PRO; Hamaguchi P., 2003, METACOGNITIVE PROGRA; Hornickel J, 2012, P NATL ACAD SCI USA, V109, P16731, DOI 10.1073/pnas.1206628109; Interactive Metronome, 2007, IM CERT PROV TRAIN M; Jerger J, 2000, J Am Acad Audiol, V11, P467; KATZ J, 1968, J SPEECH HEAR DISORD, V33, P132, DOI 10.1044/jshd.3302.132; KATZ J, 1984, Journal of Auditory Research, V24, P251; Keith R., 1994, AUDITORY CONTINUOUS; Keith R. W., 2009, SCAN 3 ADOLESCENTS A; Keith R. W., 2000, SCAN C TEST AUDITORY; Keith R.W., 2009, SCAN 3 CHILDREN TEST; Kennedy MRT, 2008, NEUROREHABILITATION, V23, P511; Killion MC, 2004, J ACOUST SOC AM, V116, P2395, DOI 10.1121/1.1784440; Kuk F, 2008, J AM ACAD AUDIOL, V19, P465, DOI 10.3766/jaaa.19.6.3; Marschark M, 2000, J HEAD TRAUMA REHAB, V15, P1227, DOI 10.1097/00001199-200012000-00004; Martin N. A., 2005, TEST AUDITORY PROCES; McCroskey R. L., 1996, AUDITORY FUSION TEST; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Moore DR, 2010, PEDIATRICS, V126, pE382, DOI 10.1542/peds.2009-2826; Mueller H. G., 1994, HDB CLIN AUDIOLOGY, P222; Musiek F E, 1994, J Am Acad Audiol, V5, P265; Musiek F. E., 2014, HDB CENTRAL AUDITORY, V1; MUSIEK FE, 1983, EAR HEARING, V4, P79, DOI 10.1097/00003446-198303000-00002; MUSIEK FE, 1987, AUDIOLOGY, V26, P79; MUSIEK FE, 2007, HDB CENTRAL AUDITORY, V1; Musiek Frank E., 1998, Seminars in Hearing, V19, P357, DOI 10.1055/s-0028-1082983; Musiek FE, 2011, J AM ACAD AUDIOL, V22, P342, DOI 10.3766/jaaa.22.6.4; Musiek Frank E, 2004, J Am Acad Audiol, V15, P117, DOI 10.3766/jaaa.15.2.3; Nilsson M.J., 1996, MINIMUM SPEECH TEST; Richard G. J., 2006, DIFFERENTIAL SCREENI; Schochat E, 2010, BRAZ J MED BIOL RES, V43, P777, DOI 10.1590/S0100-879X2010000800011; Sheiner Eyal, 2006, Archives of Gynecology and Obstetrics, V274, P81, DOI 10.1007/s00404-005-0110-2; Shoemaker S. S., 2010, THESIS; Smoski W, 1998, CHILDRENS AUDITORY P; Super Duper Publications, 2013, HEARBUILDER COLL; Sweetow Robert W., 2007, Seminars in Hearing, V28, P133, DOI 10.1055/s-2007-973439; Ventry I M, 1983, ASHA, V25, P37; Weihing J, 2015, J AM ACAD AUDIOL, V26, P652, DOI 10.3766/jaaa.14108; WILLEFORD J, 1978, HDB CLIN AUDIOLOGY, P252	55	1	1	0	12	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1059-0889	1558-9137		AM J AUDIOL	Am. J. Audiol.	SEP	2017	26	3					202	225		10.1044/2017_AJA-16-0074			24	Audiology & Speech-Language Pathology; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Otorhinolaryngology	FI2VQ	WOS:000411806200002	28793354				2022-02-06	
J	Tigno, TA; Armonda, RA; Bell, RS; Severson, MA				Tigno, T. A., Jr.; Armonda, R. A.; Bell, R. S.; Severson, M. A., III			The vestibulocochlear bases for wartime posttraumatic stress disorder manifestations	MEDICAL HYPOTHESES			English	Article						Vestibulocochlear pathway; Wartime; Posttraumatic Stress Disorder (PTSD); Vestibular nerve deafferentation injuries; Vestibular nerve - hippocampal linkage	EVOKED MYOGENIC POTENTIALS; TRAUMATIC BRAIN-INJURY; ANTERIOR CINGULATE CORTEX; SUPERIOR TEMPORAL AREA; HEAD-DIRECTION CELLS; SEXUAL ASSAULT SURVIVORS; COMBAT-RELATED PTSD; VESTIBULAR CORTEX; IMAGERY REHEARSAL; DEFAULT MODE	Preliminary findings based on earlier retrospective studies of 229 wartime head injuries managed by the Walter Reed Army Medical Center (WRAMC)/National Naval Medical Center (NNMC) Neurosurgery Service during the,period 2003-08 detected a threefold rise in Posttraumatic Stress Disorder (PTSD) manifestations (10.45%) among Traumatic Brain Injuries (TBI) having concomitant vestibulocochlear injuries compared to 3% for the TBI group without vestibulo-cochlear damage (VCD), prompting the authors to undertake a more focused study of the vestibulo-auditory pathway in explaining the development of posttraumatic stress disorder manifestations among the mostly Blast-exposed head-injured. The subsequent historical review of PTSD pathophysiology studies, the evidence for an expanded vestibular system and of a dominant vestibular system, the vascular vulnerability of the vestibular nerves in stress states as well as the period of cortical imprinting has led to the formation of a coherent hypotheses utilizing the vestibulocochlear pathway in understanding the development of PTSD manifestations. Neuroimaging and neurophysiologic tests to further validate the vestibulocochlear concept on the development of PTSD manifestations are proposed. (C) 2017 Elsevier Ltd. All rights reserved.	[Tigno, T. A., Jr.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Bell, R. S.; Severson, M. A., III] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA; [Armonda, R. A.] George Washington Univ, Washington, DC USA		Tigno, TA (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Surg, Neurosurgery Lab Sect, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	teodoro.tigno@usuhs.edu			Army Research Organization [60697-LS, W91NF-111-0374]	Sources of support in the form of Grants: Army Research Organization Proposal Number ARO #60697-LS, Award No. W91NF-111-0374.	Abe O, 2006, PSYCHIAT RES-NEUROIM, V146, P231, DOI 10.1016/j.pscychresns.2006.01.004; Acheson DT, 2012, NEUROPHARMACOLOGY, V62, P674, DOI 10.1016/j.neuropharm.2011.04.029; Akin FW, 2012, EAR HEARING, V33, P458, DOI 10.1097/AUD.0b013e3182498c5f; Amaral DG, 2003, NEUROPSYCHOLOGIA, V41, P235, DOI 10.1016/S0028-3932(02)00154-9; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Angelaki DE, 2004, J NEUROPHYSIOL, V92, P20, DOI 10.1152/jn.00047.2004; Ascroft PB, 1943, LANCET, V2, P211; Baguley DM, 2002, CLIN OTOLARYNGOL, V27, P219, DOI 10.1046/j.1365-2273.2002.00566.x; Balaban CD, 2002, PHYSIOL BEHAV, V77, P469, DOI 10.1016/S0031-9384(02)00935-6; Balaban CD, 2001, J ANXIETY DISORD, V15, P53, DOI 10.1016/S0887-6185(00)00042-6; Balaban PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017710; Baloh RW, 2001, CLIN NEUROPHYSIOL, P383; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; BBC One, INS OUT EXTR SHELL S; Bechara A, 2003, ANN NY ACAD SCI, V985, P356, DOI 10.1111/j.1749-6632.2003.tb07094.x; Beebe GW, 1946, BATTLE CASUALTIES IN; BENSON AJ, 1986, AVIAT SPACE ENVIR MD, V57, P1088; BENSON DF, 1976, NEUROLOGY, V26, P147, DOI 10.1212/WNL.26.2.147; Bent LR, 2002, EXP BRAIN RES, V146, P490, DOI 10.1007/s00221-002-1204-8; BICKFORD RG, 1964, ANN NY ACAD SCI, V112, P204, DOI 10.1111/j.1749-6632.1964.tb26749.x; Bissiere S, 2008, BIOL PSYCHIAT, V63, P821, DOI 10.1016/j.biopsych.2007.10.022; Bisson J., 2009, PSYCHOL TREATMENT PO; Bjorkman A, 2005, NEUROREPORT, V16, P517; Bland-Sutton J., 1914, BMJ-BRIT MED J, V28, P938; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Botella C, 2007, CLIN PSYCHOL PSYCHOT, V14, P164, DOI 10.1002/cpp.524; Brandt T, 1999, ANN NY ACAD SCI, V871, P293, DOI 10.1111/j.1749-6632.1999.tb09193.x; Brandt T, 2005, BRAIN, V128, P2732, DOI 10.1093/brain/awh617; BRANDT T, 1994, ANN NEUROL, V35, P403, DOI 10.1002/ana.410350406; Britten KH, 2002, CEREB CORTEX, V12, P692, DOI 10.1093/cercor/12.7.692; Britten KH, 1998, NAT NEUROSCI, V1, P59, DOI 10.1038/259; Bronstein AM, 2004, J NEUROL, V251, P381, DOI 10.1007/s00415-004-0410-7; Bryant RA, 2000, AM J PSYCHIAT, V157, P629, DOI 10.1176/appi.ajp.157.4.629; BURGESS AW, 1974, AM J PSYCHIAT, V131, P981; Campos JL, 2012, NEURAL BASEMULTISE; CHEN LL, 1994, EXP BRAIN RES, V101, P8, DOI 10.1007/BF00243212; Chou YH, 2012, AM J NEURORADIOL, V33, P833, DOI 10.3174/ajnr.A2894; Chowdhury SA, 2009, J NEUROSCI, V29, P12020, DOI 10.1523/JNEUROSCI.0004-09.2009; Ciuman RR, 2010, INT J BIOMED SCI, V6; COLEBATCH JG, 1992, NEUROLOGY, V42, P1635, DOI 10.1212/WNL.42.8.1635; COLEBATCH JG, 1994, J NEUROL NEUROSUR PS, V57, P190, DOI 10.1136/jnnp.57.2.190; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Corbo V, 2005, BIOL PSYCHIAT, V58, P119, DOI 10.1016/j.biopsych.2005.02.032; Curthoys IS, 2012, ACTA OTORHINOLARYNGO, V32, P41; Curthoys I S, 1995, J Vestib Res, V5, P67; Cushing H., 1918, BRIT J SURG, P558; Cuthbert PC, 2000, NEUROREPORT, V11, P1443, DOI 10.1097/00001756-200005150-00018; Damasio A., 1994, DESCARTES ERROR EMOT; Darwin C, 1872, EXPRESSION EMOTION M; Daunton NG, 1996, HDB PHYSL ENV PH S14, DOI 10.1002/cphy.cp040133; Oliveira Aline Cabral de, 2008, Rev. Bras. Otorrinolaringol., V74, P770, DOI [10.1590/S0034-72992008000500020, 10.1016/S1808-8694(15)31389-6]; de Waele C, 2001, EXP BRAIN RES, V141, P541, DOI 10.1007/s00221-001-0894-7; DeAngelis GC, 2012, NEURAL BASES MULTISE; DESTEFANO F, 1988, JAMA-J AM MED ASSOC, V259, P2701; Dicke PW, 2008, EUR J NEUROSCI, V27, P991, DOI 10.1111/j.1460-9568.2008.06054.x; Dieterich M, 2005, BRAIN, V128, P2052, DOI 10.1093/brain/awh551; Dieterich M, 2003, CEREB CORTEX, V13, P994, DOI 10.1093/cercor/13.9.994; Dieterich M, 2008, BRAIN, V131, P2538, DOI 10.1093/brain/awn042; DIJKGRAAF S, 1949, EXPERIENTIA, V5, P90, DOI 10.1007/BF02153744; Doeller CF, 2010, NATURE, V463, P657, DOI 10.1038/nature08704; Duffy CJ, 1997, J NEUROSCI, V17, P2839; Elhai JD, 2008, J CLIN PSYCHIAT, V69, P597, DOI 10.4088/JCP.v69n0411; Elsayed NM, 1997, TOXICOLOGY, V121, P1, DOI 10.1016/S0300-483X(97)03651-2; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Fagelson Marc A, 2007, Am J Audiol, V16, P107, DOI 10.1044/1059-0889(2007/015); Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Fernandez-Miranda JC, 2012, NEUROSURGERY, V71, P430, DOI 10.1227/NEU.0b013e3182592faa; Fernandez-Miranda JC, 2010, J NEUROSURG, V113, P990, DOI 10.3171/2009.10.JNS09933; Finkelstein A, 2014, NATURE; FOA EB, 1989, BEHAV THER, V20, P155, DOI 10.1016/S0005-7894(89)80067-X; Foa EB, 1999, J CLIN PSYCHIAT S16, V60; Forbes D, 2003, J TRAUMA STRESS, V16, P509, DOI 10.1023/A:1025718830026; Franke LM, 2012, J REHABIL RES DEV, V49, P985, DOI 10.1682/JRRD.2011.12.0250; FUTTERMAN S, 1951, AM J PSYCHIAT, V108, P401, DOI 10.1176/ajp.108.6.401; GEISLER CD, 1958, SCIENCE, V128, P1210, DOI 10.1126/science.128.3333.1210; Gibson JJ., 1950, PERCEPTION VISUAL WO; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; Gozke E, 2010, ACTA NEUROL BELG, V110, P321; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Griffin DR., 1958, LISTENING DARK; Grinker Roy R, 1943, WAR NEUROSES N AFRIC; Gu Y, 2012, J NEUROSCI, V32, P2299, DOI 10.1523/JNEUROSCI.5154-11.2012; Gurvich C, 2013, BRAIN RES, V1537, P244, DOI 10.1016/j.brainres.2013.08.058; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hamann SB, 1999, NAT NEUROSCI, V2, P289, DOI 10.1038/6404; Hays SB, 1958, NEUROSURGERY, VI; Helfer TM, 2011, AM J AUDIOL, V20, P33, DOI 10.1044/1059-0889(2011/10-0033); Herringa R, 2012, PSYCHIAT RES-NEUROIM, V203, P139, DOI 10.1016/j.pscychresns.2012.02.005; Hinton DE, 2006, J TRAUMA STRESS, V19, P541, DOI 10.1002/jts.20138; HORII A, 1994, J NEUROPHYSIOL, V72, P605, DOI 10.1152/jn.1994.72.2.605; Horii A, 2004, EXP BRAIN RES, V155, P245, DOI 10.1007/s00221-003-1725-9; HOSOYA M, 1992, BIOCHIM BIOPHYS ACTA, V1129, P199, DOI 10.1016/0167-4781(92)90488-L; Howorth PW, 2000, PSYCHIAT B, V24, P225, DOI DOI 10.1192/PB.24.6.225; Hurst AF, 1919, CONTRIBUTIONS MED BI, P600; Hyman JM, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/neuro.07.002.2010; Jackowski AP, 2008, PSYCHIAT RES-NEUROIM, V162, P256, DOI 10.1016/j.pscychresns.2007.08.006; Jacob RG, 2001, CURR OPIN NEUROL, V14, P41, DOI 10.1097/00019052-200102000-00007; Jacobs J, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0304; James W., 1884, MIND, V9, P188, DOI 10.1093/mind/os-IX.34.188, os-IX; Janzen J, 2008, NEUROIMAGE, V42, P1508, DOI 10.1016/j.neuroimage.2008.06.026; Jauregui-Renaud K, 2008, J NEUROL NEUROSUR PS, V79, P276, DOI 10.1136/jnnp.2007.122119; Jeannerod M., 2006, MOTOR COGNITION WHAT; Jones E, 2000, PSYCHIATRIST, V24, P353; Jones E, 2005, MAUDSLEY MONOGRAPH, V47, P320; Kalueff AV, 2008, BEHAV BRAIN RES, V186, P1, DOI 10.1016/j.bbr.2007.07.032; Kardiner, 1941, TRAUMATIC NEUROSES W, DOI [10.1037/10581-000, DOI 10.1037/10581-000]; Karl A, 2006, BIOL PSYCHOL, V71, P123, DOI 10.1016/j.biopsycho.2005.03.004; Karl A, 2006, NEUROSCI BIOBEHAV R, V30, P1004, DOI 10.1016/j.neubiorev.2006.03.004; Kasai K, 2008, BIOL PSYCHIAT, V63, P550, DOI 10.1016/j.biopsych.2007.06.022; KAUFMAN HH, 1993, J NEUROSURG, V78, P838, DOI 10.3171/jns.1993.78.5.0838; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kijak M, 1982, INT REV PSYCHOANALYS, V9, P25; Kim SJ, 2006, NEUROPSYCHOBIOLOGY, V54, P120, DOI 10.1159/000098262; Kimerling R, 2010, AM J PUBLIC HEALTH, V100, P1409, DOI 10.2105/AJPH.2009.171793; King NS, 2008, BRAIN INJURY, V22, P1, DOI 10.1080/02699050701829696; Kitayama N, 2006, J AFFECT DISORDERS, V90, P171, DOI 10.1016/j.jad.2005.11.006; Koenen KC, 2007, PSYCHOL MED, V37, P181, DOI 10.1017/S0033291706009019; Koenen KC, 2006, ANN NY ACAD SCI, V1071, P255, DOI 10.1196/annals.1364.020; Koenen KC, 2003, J TRAUMA STRESS, V16, P433, DOI 10.1023/A:1025786925483; Kolassa I-T, 2007, BMC PSYCHIATRY, V7, P1; Konen CS, 2008, J NEUROSCI, V28, P8361, DOI 10.1523/JNEUROSCI.1930-08.2008; Krakow B, 2000, J TRAUMA STRESS, V13, P589, DOI 10.1023/A:1007854015481; Krakow B, 2001, JAMA-J AM MED ASSOC, V286, P537, DOI 10.1001/jama.286.5.537; Lange GC, 1885, SINDSHE VAEGELSER PS; Langers DRM, 2011, CEREB CORTEX; LEDOUX JE, 1991, NEUROSCI LETT, V134, P139, DOI 10.1016/0304-3940(91)90526-Y; Lee MH, 2013, AM J NEURORADIOL, V34, P1866, DOI 10.3174/ajnr.A3263; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; Liu S, 2009, J NEUROSCI, V29, P8936, DOI 10.1523/JNEUROSCI.1607-09.2009; Mabry RL, 2000, J TRAUMA, V49, P515, DOI 10.1097/00005373-200009000-00021; Maddock RJ, 1999, TRENDS NEUROSCI, V22, P310, DOI 10.1016/S0166-2236(98)01374-5; Manzari L, 2010, ACTA OTORHINOLARYNGO, V30, P175; Masataka N, 2006, DEVELOPMENTAL SCI, V9, P46, DOI 10.1111/j.1467-7687.2005.00462.x; Mayorga MA, 1997, TOXICOLOGY, V121, P17, DOI 10.1016/S0300-483X(97)03652-4; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; MERZENICH MM, 1984, J COMP NEUROL, V224, P591, DOI 10.1002/cne.902240408; Meyer K, 2010, NAT NEUROSCI, V13, P667, DOI 10.1038/nn.2533; MIZUMORI SJY, 1993, J NEUROSCI, V13, P4015; Monzani D, 2001, J PSYCHOSOM RES, V50, P319, DOI 10.1016/S0022-3999(01)00208-2; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; Moser MB, 2016, SCI AM, V314, P26; MUELLER C, 1994, ACTA ASTRONAUT, V33, P9, DOI 10.1016/0094-5765(94)90102-3; Murofushi T, 1998, ARCH OTOLARYNGOL, V124, P509, DOI 10.1001/archotol.124.5.509; Murofushi T, 1996, ARCH OTOLARYNGOL, V122, P845, DOI 10.1001/archotol.1996.01890200035008; Myers Charles, 1940, SHELL SHOCK FRANCE 1; Myers CS, 1915, LANCET, V1, P316; Myers SO, 1958, TEACHER BLIND, V46, P47; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Nouh A, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00013; Nutt DJ, 2000, J CLIN PSYCHIAT, V61, P24; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; OGAWA S, 1990, MAGNET RESON MED, V16, P9, DOI 10.1002/mrm.1910160103; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1978, EXP BRAIN RES, V31, P573; Olsen RK, 2013, J EXP PSYCHOL GEN, V142, P1335, DOI 10.1037/a0034043; Ozdogmus O, 2004, J ANAT, V205, P65, DOI 10.1111/j.0021-8782.2004.00313.x; Page WK, 1999, J NEUROPHYSIOL, V81, P596, DOI 10.1152/jn.1999.81.2.596; Peruch P, 1999, J VESTIBUL RES-EQUIL, V9, P37; Phelps EA, 2004, CURR OPIN NEUROBIOL, V14, P198, DOI 10.1016/j.conb.2004.03.015; Phillips JS, 2012, JOVE-J VIS EXP, DOI 10.3791/4125; PICTON TW, 1974, ELECTROEN CLIN NEURO, V36, P179, DOI 10.1016/0013-4694(74)90155-2; Piker EG, 2011, J AM ACAD AUDIOL, V22, P222, DOI 10.3766/jaaa.22.4.5; Potegal M., 1982, VESTIBULAR NEOSTRIAT, P361; Rado S, 1942, PSYCHOSOM MED, V4, P362, DOI 10.1097/00006842-194210000-00003; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Ressler KJ, 2011, NATURE, V470, P492, DOI 10.1038/nature09856; Rogan MT, 2005, NEURON, V46, P309, DOI 10.1016/j.neuron.2005.02.017; Rosenbaum RS, 2004, HIPPOCAMPUS, V14, P826, DOI 10.1002/hipo.10218; Rowland DC, 2016, ANNU REV NEUROSCI, V39, P19, DOI 10.1146/annurev-neuro-070815-013824; Roy MJ, 2010, ANN N Y ACAD SCI; Russell NA, 2003, J NEUROSCI, V23, P6490; Russell NA, 2006, J NEUROPHYSIOL, V96, P4, DOI 10.1152/jn.00953.2005; Sadeghi SG, 2012, J NEUROSCI, V32, P14685, DOI 10.1523/JNEUROSCI.2493-12.2012; Sang FYP, 2006, J NEUROL NEUROSUR PS, V77, P760, DOI 10.1136/jnnp.2005.075473; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Sartory G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058150; Schaefer SM, 2002, J COGNITIVE NEUROSCI, V14, P913, DOI 10.1162/089892902760191135; Schautzer F, 2003, ANN NY ACAD SCI, V1004, P316, DOI 10.1196/annals.1303.029; Schuff N, 2011, NEUROIMAGE, V54, pS62, DOI 10.1016/j.neuroimage.2010.05.024; SELYE H, 1956, AM J PSYCHIAT, V113, P423, DOI 10.1176/ajp.113.5.423; Sens E, 2012, J NEUROSCI, V32, P11773, DOI 10.1523/JNEUROSCI.5912-11.2012; Sheykholeslami K, 2002, HEARING RES, V165, P62, DOI 10.1016/S0378-5955(02)00278-2; Shin SS, 2012, J NEUROSURG, V116, P1062, DOI 10.3171/2012.1.JNS111282; Shumyatsky GP, 2002, CELL, V111, P905, DOI 10.1016/S0092-8674(02)01116-9; Simpson William A., 1993, Spatial Vision, V7, P35, DOI 10.1163/156856893X00036; Smith PF, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00084; Smith PF, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00678; Souman JL, 2006, EXP BRAIN RES, V171, P448, DOI 10.1007/s00221-005-0287-4; SOUTHWICK SM, 1993, ARCH GEN PSYCHIAT, V50, P266; SPANGENBERG DB, 1994, ADV SPACE RES, V14, P239, DOI 10.1016/0273-1177(94)90408-1; SQUIRES NK, 1975, ELECTROEN CLIN NEURO, V38, P387, DOI 10.1016/0013-4694(75)90263-1; Staab JP, 2006, CURR OPIN NEUROL, V19, P41, DOI 10.1097/01.wco.0000198102.95294.1f; Stackman RW, 2002, HIPPOCAMPUS, V12, P291, DOI 10.1002/hipo.1112; STEINBEHRENS B, 1994, J NEUROSCI, V14, P5373; STOKES PE, 1984, ARCH GEN PSYCHIAT, V41, P257; Sylvia FR, 2001, MIL MED, V166, P918, DOI 10.1093/milmed/166.10.918; Takahashi K, 2007, J NEUROSCI, V27, P9742, DOI 10.1523/JNEUROSCI.0817-07.2007; TANAKA K, 1989, J NEUROPHYSIOL, V62, P626, DOI 10.1152/jn.1989.62.3.626; TAUBE JS, 1990, J NEUROSCI, V10, P420; TAUBE JS, 1995, J NEUROSCI, V15, P70; TELFORD L, 1995, EXP BRAIN RES, V104, P502; Terada S, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00177; Tigno TA, 2007, CRANIOPLASTY SYNDROM; Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308, DOI 10.1176/jnp.10.3.308; Turnbull GJ, 1998, INJURY, V29, P87, DOI 10.1016/S0020-1383(97)00131-9; United States Army in World War II, 1942, US ARM WORLD WAR 2 T, P330; VA-DoD Clinical Practice Guideline for the Management of Posttraumatic Stress, 2004, VA DOD CLIN PACT GUI; Van Boven RW, 2009, J REHABIL RES DEV, V46, P717, DOI 10.1682/JRRD.2008.12.0161; VANKAMPEN M, 1986, J NERV MENT DIS, V174, P137, DOI 10.1097/00005053-198603000-00002; Viaud-Delmon I, 2006, EUR PSYCHIAT, V21, P501, DOI 10.1016/j.eurpsy.2004.10.004; Vitte E, 1996, EXP BRAIN RES, V112, P523; WARR WB, 1975, J COMP NEUROL, V161, P159, DOI 10.1002/cne.901610203; Welgampola MS, 2005, NEUROLOGY, V64, P1682, DOI 10.1212/01.WNL.0000161876.20552.AA; Welsh RL, 1997, ONLINE FDN ORIENTATI; Werhahn KJ, BRAIN, V1402-1413; Wightman JM, 2001, ANN EMERG MED, V37, P664, DOI 10.1067/mem.2001.114906; WILSON JP, 1994, J TRAUMA STRESS, V7, P681, DOI 10.1007/BF02103015; Xydakis MS, 2007, NEW ENGL J MED, V357, P830, DOI 10.1056/NEJMc076071; Yates BJ, 2005, J VESTIBUL RES-EQUIL, V15, P119; YEHUDA R, 1995, ARCH GEN PSYCHIAT, V52, P583; YEHUDA R, 1993, AM J PSYCHIAT, V150, P83; Yin Y, 2011, BRAIN RES, V1411, P98, DOI 10.1016/j.brainres.2011.07.016; Zhang B, 2011, VISION RES, V51, P2139, DOI 10.1016/j.visres.2011.08.011; Zhang L, 2011, J AFFECT DISORDERS, V133, P294, DOI 10.1016/j.jad.2011.03.040; Zhang T, 2011, J NEUROSCI, V31, P2569, DOI 10.1523/JNEUROSCI.5520-10.2011; Zhong Y, 2014, ACTA RADIOL	229	1	1	1	5	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	SEP	2017	106						44	56		10.1016/j.mehy.2017.06.027			13	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine	FF8TL	WOS:000409290600011	28818271				2022-02-06	
J	Weisz, HA; Boone, DR; Sell, SL; Hellmich, HL				Weisz, Harris A.; Boone, Deborah R.; Sell, Stacy L.; Hellmich, Helen L.			Stereotactic Atlas-Guided Laser Capture Microdissection of Brain Regions Affected by Traumatic Injury	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Neuroscience; Issue 127; Traumatic brain injury; laser capture microdissection; brain regions; microRNA; gene expression; rat brain atlas	GENE-EXPRESSION; RECEPTOR SUBUNITS; THALAMUS	The ability to isolate specific brain regions of interest can be impeded in tissue disassociation techniques that do not preserve their spatial distribution. Such techniques also potentially skew gene expression analysis because the process itself can alter expression patterns in individual cells. Here we describe a laser capture microdissection (LCM) method to selectively collect specific brain regions affected by traumatic brain injury (TBI) by using a modified Nissl (cresyl violet) staining protocol and the guidance of a rat brain atlas. LCM provides access to brain regions in their native positions and the ability to use anatomical landmarks for identification of each specific region. To this end, LCM has been used previously to examine brain region specific gene expression in TBI. This protocol allows examination of TBI-induced alterations in gene and microRNA expression in distinct brain areas within the same animal. The principles of this protocol can be amended and applied to a wide range of studies examining genomic expression in other disease and/or animal models.	[Weisz, Harris A.; Boone, Deborah R.; Sell, Stacy L.; Hellmich, Helen L.] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA		Hellmich, HL (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA.	hhellmic@utmb.edu			Moody Project for Translational Traumatic Brain Injury Research;  [RO1NS052532]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS052532] Funding Source: NIH RePORTER	We would like to acknowledge Elizabeth Sumner for her help editing this manuscript. Funding for this project was provided in part by The Moody Project for Translational Traumatic Brain Injury Research and RO1NS052532 to HLH.	Bast T, 2007, REV NEUROSCIENCE, V18, P253; Bewernick BH, 2012, NEUROPSYCHOPHARMACOL, V37, P1975, DOI 10.1038/npp.2012.44; Boone DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127287; Boone DR, 2013, JOVE-J VIS EXP, DOI 10.3791/50308; Boone DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046204; Bota M, 2003, NAT NEUROSCI, V6, P795, DOI 10.1038/nn1096; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Doppenberg EMR, 2004, J NEUROSURG ANESTH, V16, P87, DOI 10.1097/00008506-200401000-00019; Drexel M, 2015, NEUROPHARMACOLOGY, V88, P122, DOI 10.1016/j.neuropharm.2014.08.023; Elstner M, 2011, ACTA NEUROPATHOL, V122, P75, DOI 10.1007/s00401-011-0828-9; Ginsberg SD, 2012, NEUROBIOL DIS, V45, P99, DOI 10.1016/j.nbd.2011.07.013; Hellmich HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053230; Hellmich HL, 2005, ANESTHESIOLOGY, V102, P806, DOI 10.1097/00000542-200504000-00017; Huusko N, 2014, NEUROSCIENCE, V267, P30, DOI 10.1016/j.neuroscience.2014.02.026; Karatsoreos I.N., 2012, CURR NEUROL NEUROSCI; Mills JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078480; Paxinos G., 2013, RAT BRAIN STEREOTAXI; Rojo DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023111; Shah SA, 2006, EXP GERONTOL, V41, P1201, DOI 10.1016/j.exger.2006.07.006; Shearer J., 2015, AGING CLIN EXP RES; Shimamura M, 2004, MOL BRAIN RES, V122, P47, DOI 10.1016/j.molbrainres.2003.11.015; Truettner JS, 2013, BRAIN RES, V1533, P122, DOI 10.1016/j.brainres.2013.08.011; Wang SY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-163	23	1	1	0	2	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	SEP	2017		127							e56134	10.3791/56134			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8VR	WOS:000415370200062	28930995	Green Submitted, Green Published, Bronze			2022-02-06	
J	Williams, RM; Rice, T; Lam, K; McLeod, TV				Williams, Richelle M.; Rice, Trevor; Lam, Kenneth; McLeod, Tamara Valovich			A Cross-Sectional Study of Age Differences and Postural Control in Male Athletes Using the Stability Evaluation Test (SET)	INTERNATIONAL JOURNAL OF ATHLETIC THERAPY & TRAINING			English	Article						balance; age; postural sway; concussion; rehabilitation	CONCUSSION INCREASES; SPORT CONCUSSION; INJURY; CHILDREN; ADAPTATION; STATEMENT; STANCE; SWAY	Postural control is an integral part of sport participation and is often measured when assessing concussion and rehabilitating musculoskeletal injuries. The purpose of this study was to determine whether developmental differences in postural control, as measured by the Stability Evaluation Test protocol, exist between multiple male age groups (9-25-years-old). Significant differences were present across age groups, suggesting pediatric males demonstrated higher sway velocity scores than older males. We also found that preadolescent males showed increased postural sway when compared with older populations. Overall, it was found that age-related differences exist in postural control, with older males demonstrating less sway, and therefore better postural control.	[Williams, Richelle M.; Rice, Trevor; Lam, Kenneth; McLeod, Tamara Valovich] AT Still Univ, Mesa, AZ 63501 USA		Williams, RM (corresponding author), AT Still Univ, Mesa, AZ 63501 USA.	rmwilliams@atsu.edu	Lam, Kenny/ABB-9733-2020; Valovich McLeod, Tamara/AAU-9435-2020	Valovich McLeod, Tamara/0000-0001-9082-8722; Lam, Kenneth/0000-0002-2185-0990; Williams, Richelle/0000-0003-4728-7443			Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Cross M, 2016, BRIT J SPORT MED, V50, P926, DOI 10.1136/bjsports-2015-094982; Davisson C, 2014, TEST RETEST RELIABIL; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Godoi D, 2008, DEV PSYCHOBIOL, V50, P77, DOI 10.1002/dev.20272; HIRABAYASHI S, 1995, BRAIN DEV-JPN, V17, P111, DOI 10.1016/0387-7604(95)00009-Z; Iverson GL, 2013, REHABIL RES PRACT, V2013, DOI 10.1155/2013/846418; Lee AJY, 2007, J APPL BIOMECH, V23, P173, DOI 10.1123/jab.23.3.173; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Maurer C, 2006, EXP BRAIN RES, V171, P231, DOI 10.1007/s00221-005-0256-y; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; NASHNER LM, 1982, J NEUROSCI, V2, P536; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; RIACH CL, 1987, DEV MED CHILD NEUROL, V29, P650; Riemann BL, 2000, J ATHL TRAINING, V35, P19	18	1	1	0	0	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	2157-7277	2157-7285		INT J ATHL THER TRAI	Int. J. Athl. Ther. Train.	SEP	2017	22	5					39	43		10.1123/ijatt.2016-0095			5	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	FQ6PA	WOS:000418485300007					2022-02-06	
J	Yang, LK; Wang, YH; Feng, Y				Yang, Likun; Wang, Yuhai; Feng, Yi			Intraoperative ultrasonography in intraoperative acute brain swelling (IABS)	INTERDISCIPLINARY NEUROSURGERY-ADVANCED TECHNIQUES AND CASE MANAGEMENT			English	Article							DECOMPRESSIVE CRANIECTOMY; SURGERY; HEMATOMA; INJURY	We present two cases of acute intraoperative brain swelling during decompression for traumatic brain injury, in which delayed contralateral hemorrhage was rapidly detected by ultrasound and proved by consequent CT scan. The ultrasound findings provided surgeons with rapid information for decision making in a critical situation. (C) 2017 The Authors. Published by Elsevier B.V.	[Yang, Likun; Wang, Yuhai; Feng, Yi] 101 Hosp Army, Beijing, Peoples R China		Feng, Y (corresponding author), 101 Hosp Army, Beijing, Peoples R China.	fengyijoe@gmail.com					Chen K. T., 2016, WORLD NEUROSURG; Gao YZ, 2012, CRIT CARE, V16, DOI 10.1186/cc11509; Gong JB, 2016, J CRANIOFAC SURG, V27, pE159, DOI 10.1097/SCS.0000000000002404; He W, 2013, CLIN IMAG, V37, P983, DOI 10.1016/j.clinimag.2013.08.001; Heppner P, 2006, J NEUROSURG, V104, P738, DOI 10.3171/jns.2006.104.5.738; Park J, 2012, ACTA NEUROCHIR, V154, P1869, DOI 10.1007/s00701-012-1467-1; Su TM, 2008, J TRAUMA, V65, P1298, DOI 10.1097/TA.0b013e31815885d9; Suarez JI, 2001, REV NEUROLOGIA, V32, P275, DOI 10.33588/rn.3203.2000519	8	1	1	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2214-7519			INTERDISCIP NEUROSUR	Interdiscip. Neurosurg.	SEP	2017	9						14	16		10.1016/j.inat.2017.02.001			3	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	FH0WH	WOS:000410860800004		gold			2022-02-06	
J	Young, LR; Yu, WK; Holloway, M; Rodgers, BN; Chapman, SB; Krawczyk, DC				Young, Leanne R.; Yu, Weikei; Holloway, Michael; Rodgers, Barry N.; Chapman, Sandra B.; Krawczyk, Daniel C.			Amygdala activation as a marker for selective attention toward neutral faces in a chronic traumatic brain injury population	NEUROPSYCHOLOGIA			English	Article						Face perception; Amygdala; fMRI; Selective attention	DYNAMIC FACIAL EXPRESSIONS; VENTRAL TEMPORAL CORTEX; WORKING-MEMORY; EMOTIONAL EXPRESSIONS; NEURAL RESPONSES; FMRI-ADAPTATION; PERCEPTION; TRUSTWORTHINESS; RECOGNITION; OBJECTS	There has been great interest in characterizing the response of the amygdala to emotional faces, especially in the context of social cognition. Although amygdala activation is most often associated with fearful or angry stimuli, there is considerable evidence that the response of the amygdala to neutral faces is both robust and reliable. This characteristic of amygdala function is of particular interest in the context of assessing populations with executive function deficits, such as traumatic brain injuries, which can be evaluated using fMRI attention modulation tasks that evaluate prefrontal control over representations, notably faces. The current study tested the hypothesis that the amygdala may serve as a marker of selective attention to neutral faces. Using fMRI, we gathered data within a chronic traumatic brain injury population. Blood Oxygenation Level Dependent (BOLD) signal change within the left and right amygdalae and fusiform face areas was measured while participants viewed neutral faces and scenes, under conditions requiring participants to (1) categorize pictures of faces and scenes, (2) selectively attend to either faces or scenes, or (3) attend to both faces and scenes. Findings revealed that the amygdala is an effective marker for selective attention to neutral faces and, furthermore, it was more face-specific than the fusiform face area.	[Young, Leanne R.; Yu, Weikei; Holloway, Michael; Rodgers, Barry N.; Chapman, Sandra B.; Krawczyk, Daniel C.] Univ Texas Dallas, Ctr Brain Hlth, 2200 Mockingbird Lane, Dallas, TX 75235 USA		Young, LR (corresponding author), Univ Texas Dallas, Ctr Brain Hlth, 2200 Mockingbird Lane, Dallas, TX 75235 USA.	lay130030@utdallas.edu; weikei.x.yu@gmail.com; michae1981inc@gmail.com; bnr130330@utdallas.edu; schapman@utdallas.edu; daniel.krawczuk@utdallas.edu			US Department of Defense (DOD) through the program in Psychological Health/Traumatic Brain Injury (PH/TBI) of the Congressionally Directed Medical Research Programs (CDMRP) Cognitive Rehabilitation [W81XWH-11-2-0194, W81XWH-11-2-01945]	This study is funded by the US Department of Defense (DOD) through the program in Psychological Health/Traumatic Brain Injury (PH/TBI) of the Congressionally Directed Medical Research Programs (CDMRP) Cognitive Rehabilitation for TBI Clinical Trial Award (Award W81XWH-11-2-0194 to DCK) and (Award W81XWH-11-2-01945 to SBC). The authors would like to express appreciation to Angela Martinelli for her support during this study. The authors would also like to express appreciation to Dr. Jeff Spence, for his assistance in the statistical analyses reported herein. Neuroimaging was performed at the University of Texas Southwestern Advanced Imaging Research Center.	Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Adolphs R, 1998, NATURE, V393, P470, DOI 10.1038/30982; ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; Adolphs R, 2006, CURR DIR PSYCHOL SCI, V15, P222, DOI 10.1111/j.1467-8721.2006.00440.x; Ashley V, 2004, NEUROREPORT, V15, P211, DOI 10.1097/00001756-200401190-00041; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; Brett M., 2002, NEUROIMAGE, V16, P5497; Calder AJ, 2005, NAT REV NEUROSCI, V6, P641, DOI 10.1038/nrn1724; Chen AJW, 2006, J HEAD TRAUMA REHAB, V21, P107, DOI 10.1097/00001199-200603000-00004; Chen AJW, 2011, BRAIN, V134, P1541, DOI 10.1093/brain/awr067; Chen CJ, 2012, RADIOLOGY, V264, P844, DOI 10.1148/radiol.12112154; Cooney RE, 2006, PSYCHIAT RES-NEUROIM, V148, P55, DOI 10.1016/j.pscychresns.2006.05.003; Cunningham WA, 2004, PSYCHOL SCI, V15, P806, DOI 10.1111/j.0956-7976.2004.00760.x; Davies-Thompson J, 2012, J NEUROPHYSIOL, V108, P3087, DOI 10.1152/jn.01171.2011; Dolan RJ, 1996, NEUROIMAGE, V4, P194, DOI 10.1006/nimg.1996.0070; Dricot L, 2008, NEUROIMAGE, V40, P318, DOI 10.1016/j.neuroimage.2007.11.012; Engell AD, 2007, J COGNITIVE NEUROSCI, V19, P1508, DOI 10.1162/jocn.2007.19.9.1508; Engell AD, 2013, NEUROIMAGE, V74, P140, DOI 10.1016/j.neuroimage.2013.02.025; Engell AD, 2010, PERCEPTION, V39, P931, DOI 10.1068/p6633; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Fried I, 1997, NEURON, V18, P753, DOI 10.1016/S0896-6273(00)80315-3; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gazzaley A, 2005, J COGNITIVE NEUROSCI, V17, P507, DOI 10.1162/0898929053279522; Gazzaley A, 2005, NAT NEUROSCI, V8, P1298, DOI 10.1038/nn1543; Gothard KM, 2007, J NEUROPHYSIOL, V97, P1671, DOI 10.1152/jn.00714.2006; Habel U, 2007, NEUROPSYCHOLOGIA, V45, P2369, DOI 10.1016/j.neuropsychologia.2007.01.023; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Holmes A, 2003, COGNITIVE BRAIN RES, V16, P174, DOI 10.1016/S0926-6410(02)00268-9; Hughes KC, 2011, EXPERT REV NEUROTHER, V11, P275, DOI [10.1586/ern.10.198, 10.1586/ERN.10.198]; Ishai A, 2005, BRAIN RES BULL, V67, P87, DOI 10.1016/j.brainresbull.2005.05.027; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kanwisher N, 2006, PHILOS T R SOC B, V361, P2109, DOI 10.1098/rstb.2006.1934; Kilts CD, 2003, NEUROIMAGE, V18, P156, DOI 10.1006/nimg.2002.1323; Krawczyk DC, 2007, BRAIN RES, V1141, P168, DOI 10.1016/j.brainres.2007.01.052; Krawczyk DC, 2013, HUM BRAIN MAPP, V34, P762, DOI 10.1002/hbm.21472; Krawczyk DC, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-29; Kuo BC, 2011, NEUROPSYCHOLOGIA, V49, P1589, DOI 10.1016/j.neuropsychologia.2010.12.043; Liu BC, 1999, BRAIN TOPOGR, V11, P291, DOI 10.1023/A:1022258620435; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maldjian JA, 2004, NEUROIMAGE, V21, P450, DOI 10.1016/j.neuroimage.2003.09.032; Mattavelli G, 2012, NEUROPSYCHOLOGIA, V50, P2205, DOI 10.1016/j.neuropsychologia.2012.05.024; Mende-Siedlecki P, 2013, J COGNITIVE NEUROSCI, V25, P2086, DOI 10.1162/jocn_a_00469; Miller BT, 2005, NEURON, V48, P535, DOI 10.1016/j.neuron.2005.11.002; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; O'Toole AJ, 2005, J COGNITIVE NEUROSCI, V17, P580, DOI 10.1162/0898929053467550; Pessoa L, 2002, P NATL ACAD SCI USA, V99, P11458, DOI 10.1073/pnas.172403899; Phillips ML, 2001, HUM BRAIN MAPP, V12, P193, DOI 10.1002/1097-0193(200104)12:4<193::AID-HBM1015>3.0.CO;2-A; Rossion B, 2012, BRAIN COGNITION, V79, P138, DOI 10.1016/j.bandc.2012.01.001; Rutishauser U, 2015, TRENDS NEUROSCI, V38, P295, DOI 10.1016/j.tins.2015.03.001; Rutishauser U, 2011, CURR BIOL, V21, P1654, DOI 10.1016/j.cub.2011.08.035; Said CP, 2011, PHILOS T R SOC B, V366, P1660, DOI 10.1098/rstb.2010.0351; Sato W, 2004, COGNITIVE BRAIN RES, V20, P81, DOI 10.1016/j.cogbrainres.2004.01.008; Schuyler BS, 2014, SOC COGN AFFECT NEUR, V9, P176, DOI 10.1093/scan/nss131; Spiridon M, 2002, NEURON, V35, P1157, DOI 10.1016/S0896-6273(02)00877-2; Stanley DA, 2012, PHILOS T R SOC B, V367, P744, DOI 10.1098/rstb.2011.0300; Todorov A, 2008, COGN NEUROPSYCHOL, V25, P395, DOI 10.1080/02643290802044996; Todorov A, 2012, MOTIV EMOTION, V36, P16, DOI 10.1007/s11031-011-9238-5; Todorov A, 2008, SOC COGN AFFECT NEUR, V3, P303, DOI 10.1093/scan/nsn033; Tottenham N, 2014, SOC COGN AFFECT NEUR, V9, P106, DOI 10.1093/scan/nst050; Trautmann SA, 2009, BRAIN RES, V1284, P100, DOI 10.1016/j.brainres.2009.05.075; Tsuchiya N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003892; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Whalen PJ, 2001, EMOTION, V1, P70, DOI 10.1037/1528-3542.1.1.70; Wheeler ME, 2005, PSYCHOL SCI, V16, P56, DOI 10.1111/j.0956-7976.2005.00780.x; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Winston JS, 2003, NEUROIMAGE, V20, P84, DOI 10.1016/S1053-8119(03)00303-3; Winston JS, 2002, NAT NEUROSCI, V5, P277, DOI 10.1038/nn816; Winston JS, 2004, J NEUROPHYSIOL, V92, P1830, DOI 10.1152/jn.00155.2004	71	1	2	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	SEP	2017	104						214	222		10.1016/j.neuropsychologia.2017.08.026			9	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	FK6LR	WOS:000413615700019	28844425				2022-02-06	
J	Prasetyo, E; Asadul Islam, A; Hatta, M; Widodo, D; Pattelongi, I				Prasetyo, Eko; Asadul Islam, Andi; Hatta, Mochammad; Widodo, Djoko; Pattelongi, Ilhamjaya			The Profile of MMP-9, MMP-9 mRNA Expression,-1562 C/T Polymorphism and Outcome in High-risk Traumatic Brain Injury: The Effect of Therapeutic Mild Hypothermia	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						mild hypothermia therapy; MMP-9; TBI	MATRIX-METALLOPROTEINASE; INCREASED MATRIX-METALLOPROTEINASE-9; EXPERIMENTAL STROKE; TISSUE INHIBITOR; GENE-EXPRESSION; ISCHEMIC-STROKE; COMA SCALE; ACTIVATION; RATS; SUSCEPTIBILITY	The aim of this study was to investigate the effect of mild hypothermia therapy (34-36 degrees C) and the alterations of matrix metalloproteinase-9 (MMP-9) in 20 patients with high-risk traumatic brain injury (TBI). The neurologic status and outcome were assessed using Full Outline of UnResponsiveness (FOUR) score and Glasgow Coma Scale (GCS). A prospective randomized control study involved patients with high-risk TBI (FOUR score <= 7). Patients were randomized into two groups, with and without mild hypothermia therapy which were investigated within 24 and 72 h. The MMP-9 level, MMP-9 mRNA expression and -1562 C/T polymorphism were estimated using enzyme-linked immune sorbent assay (ELISA), reversing transcription polymerase chain reaction (RT-PCR) and PCR-restriction fragment length polymorphism (PCR-RFLP). Different levels of these variables were compared in the two groups. In the hypothermia group, the expression of MMP-9 mRNA and the level of serum MMP-9 were significantly decreased (P < 0.05) within 72 h. There was a highly significant correlation between the expression of MMP-9 mRNA and the level of MMP-9 protein (R-2 = 0.741, r = 0.861, P < 0.05). The study did not find in -1562 C/T polymorphism. The patients' outcome was improved significantly after mild hypothermia therapy (P < 0.05). The data obtained from this study show that mild hypothermia therapy down regulated the expression of MMP-9 mRNA, the MMP-9 protein level and increased the FOUR score and GCS in high-risk TBI patients within 72 h.	[Prasetyo, Eko; Asadul Islam, Andi; Hatta, Mochammad; Widodo, Djoko; Pattelongi, Ilhamjaya] Univ Hasanuddin, Fac Med, Makassar, Indonesia; [Prasetyo, Eko] Univ Sam Ratulangi, Dept Surg, Div Neurosurg, Fac Med, Manado, Indonesia; [Asadul Islam, Andi; Widodo, Djoko] Univ Hasanuddin, Dept Surg, Div Neurosurg, Fac Med, Makassar, Indonesia; [Hatta, Mochammad] Univ Hasanuddin, Mol Biol & Immunol Lab, Fac Med, Jl Perintis Kemerdekaan Kampus Tamalanrea Km 10, Makassar 90245, Indonesia; [Pattelongi, Ilhamjaya] Univ Hasanuddin, Dept Physiol, Fac Med, Makassar, Indonesia		Hatta, M (corresponding author), Univ Hasanuddin, Mol Biol & Immunol Lab, Fac Med, Jl Perintis Kemerdekaan Kampus Tamalanrea Km 10, Makassar 90245, Indonesia.	hattaram@yahoo.com	Hatta, Mochammad/D-3742-2019	Hatta, Mochammad/0000-0002-8456-4203			Andresen M, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0121-3; Atkins CM, 2007, EUR J NEUROSCI, V26, P810, DOI 10.1111/j.1460-9568.2007.05720.x; Barr TL, 2010, STROKE, V41, pE123, DOI 10.1161/STROKEAHA.109.570515; Bramlett HM, 2012, THER HYPOTHERMIA TEM, V2, P14, DOI 10.1089/ther.2012.0002; Campbell NE, 2010, J ONCOL, V2010, DOI 10.1155/2010/586905; Castellanos M, 2003, STROKE, V34, P40, DOI 10.1161/01.STR.0000046764.57344.31; Clifton GL, 2002, J NEUROTRAUM, V19, P293, DOI 10.1089/089771502753594864; Clifton GL, 2009, J NEUROTRAUM, V26, P393, DOI 10.1089/neu.2008.0556; Falo MC, 2006, J NEUROSCI RES, V84, P768, DOI 10.1002/jnr.20986; Fini ME, 1998, BIOL EXTRAC, P299; Fornage M, 2007, HUM GENET, V120, P671, DOI 10.1007/s00439-006-0236-8; Fox JL, 2010, CAN J EMERG MED, V12, P355; Gardner A, 2014, J NEUROTRAUM, V31, P1, DOI 10.1089/neu.2013.3079; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Hadass O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076904; Han HS, 2003, J CEREBR BLOOD F MET, V23, P589, DOI 10.1097/01.WCB.0000059566.39780.8D; Han HS, 2012, CURR NEUROPHARMACOL, V10, P80, DOI 10.2174/157015912799362751; Hayashi N, 2006, MINIMALLY INVASIVE NEUROSURGERY AND MULTIDISCIPLINARY NEUROTRAUMATOLOGY, P328, DOI 10.1007/4-431-28576-8_49; Jia F, 2014, J NEUROTRAUM, V31, P387, DOI 10.1089/neu.2008.0814; Jia F, 2010, J NEUROTRAUM, V27, P1059, DOI 10.1089/neu.2009.1067; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; Jiang JY, 2006, J CEREBR BLOOD F MET, V26, P771, DOI 10.1038/sj.jcbfm.9600253; Jusuf WRA, 2012, BALI MED J, V1, P71; Kaplan RC, 2008, ATHEROSCLEROSIS, V201, P130, DOI 10.1016/j.atherosclerosis.2008.01.003; Kolar M, 2008, ACTA NEUROCHIR SUPPL, V102, P373, DOI 10.1007/978-3-211-85578-2_71; Lee JE, 2005, J NEUROSURG, V103, P289, DOI 10.3171/jns.2005.103.2.0289; Liu CL, 2014, TURK NEUROSURG, V24, P363, DOI 10.5137/1019-5149.JTN.8551-13.0; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Michaluk P, 2007, CELL DEATH DIFFER, V14, P1255, DOI 10.1038/sj.cdd.4402141; Mori T, 2002, J NEUROTRAUM, V19, P1411, DOI 10.1089/089771502320914642; Pagenstecher A, 1998, AM J PATHOL, V152, P729; Polderman KH, 2004, INTENS CARE MED, V30, P556, DOI 10.1007/s00134-003-2152-x; Rosell A, 2006, STROKE, V37, P1399, DOI 10.1161/01.STR.0000223001.06264.af; Sadaka F, 2012, BRAIN INJURY, V26, P899, DOI 10.3109/02699052.2012.661120; Schmitt KRL, 2007, J NEUROIMMUNOL, V189, P7, DOI 10.1016/j.jneuroim.2007.06.010; Suehiro E, 2004, J NEUROTRAUM, V21, P1706, DOI 10.1089/0897715042664957; Vu TH, 1998, BIOL EXTRAC, P115; Wang XY, 2002, J NEUROTRAUM, V19, P615, DOI 10.1089/089771502753754082; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Webster CM, 2009, NEUROBIOL DIS, V33, P301, DOI 10.1016/j.nbd.2008.11.001; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Yaglom J, 2003, MOL CELL BIOL, V23, P3813, DOI 10.1128/MCB.23.11.3813-3824.2003; Yasmin, 2006, ARTERIOSCL THROM VAS, V26, P1799, DOI 10.1161/01.ATV.0000227717.46157.32; Ye S, 2000, MATRIX BIOL, V19, P623, DOI 10.1016/S0945-053X(00)00102-5; Zhang HQ, 2010, NEUROSCIENTIST, V16, P156, DOI 10.1177/1073858409355830	47	1	4	0	2	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	AUG 15	2017	57	11					612	619		10.2176/nmc.oa.2016-0322			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FN9VL	WOS:000416390900007	28966304	Green Published, gold, Green Submitted			2022-02-06	
J	Darwish, S; Parang, K; Marshall, J; Goebel, DJ; Tiwari, R				Darwish, Shaban; Parang, Keykavous; Marshall, John; Goebel, Dennis J.; Tiwari, Rakesh			Efficient synthesis of CN2097 using in situ activation of sulfhydryl group	TETRAHEDRON LETTERS			English	Article						CN2097; Disulfide; Fmoc/tBu; Polyarginine; PDZ domain; Solid-phase chemistry	ISCHEMIC BRAIN-DAMAGE; PDZ DOMAINS; PROTEIN; BINDING; PEPTIDES; PSD-95	CN2097 (R7CS-sCYK[KTE(beta-Ala)]V) is a rationally designed peptidomimetic that shows effectiveness in preclinical models for the treatment of neurological disorders, such as Angelman syndrome, traumatic brain injury (TEI), and stroke. Because of its potential therapeutic activity for the treatment of human CNS disorders, there was an urgent need to develop an efficient strategy for large-scale synthesis of CN2097. The synthesis of CN2097 was accomplished using Fmoc/tBu solid phase chemistry in multiple steps. Two different peptide fragments (activated polyarginine peptide Npys-sCR(7) and CYK[KTE(beta-Ala)] V) were synthesized, followed by solution phase coupling in water. Activation of the polyarginine (CR7) was achieved in situ during cleavage of protected peptide (C(Trt)R(Pbf)(7)) from the Rink amide resin using 5 equiv. of 2,2-dithopyridine in TFA:TIS:H2O (95:2.5:2.5, v/v/v) for 4 h. The disulfide coupling was efficient which provided a 60% yield. (C) 2017 Elsevier Ltd. All rights reserved.	[Darwish, Shaban; Parang, Keykavous; Tiwari, Rakesh] Chapman Univ, Sch Pharm, Dept Biomed & Pharmaceut Sci, Ctr Targeted Drug Delivery, Harry & Diane Rinker Hlth Sci Campus, Irvine, CA 92618 USA; [Marshall, John] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Goebel, Dennis J.] Wayne State Univ, Dept Anat & Cell Biol, Detroit, MI USA; [Darwish, Shaban] Natl Res Ctr, Organometall & Organometalloid Chem Dept, El Bohouth St, Giza, Egypt		Tiwari, R (corresponding author), Chapman Univ, Sch Pharm, Dept Biomed & Pharmaceut Sci, Ctr Targeted Drug Delivery, Harry & Diane Rinker Hlth Sci Campus, Irvine, CA 92618 USA.	tiwari@chapman.edu	Parang, Keykavous/ABC-1584-2021	Parang, Keykavous/0000-0001-8600-0893	Chapman University School of Pharmacy; Alexion Pharmaceuticals, Inc; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 5R01NS094440, R21 MH104252-02]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R21MH104252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094440] Funding Source: NIH RePORTER	The authors greatly acknowledge financial support for this research from Chapman University School of Pharmacy and partial support from Alexion Pharmaceuticals, Inc. Funding for this work also came from the NINDS R01 5R01NS094440 and R21 MH104252-02 (J.M).	Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Bach A, 2008, J MED CHEM, V51, P6450, DOI 10.1021/jm800836w; Bach A, 2012, P NATL ACAD SCI USA, V109, P3317, DOI 10.1073/pnas.1113761109; Cao C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001478; Chi CN, 2012, BIOFACTORS, V38, P338, DOI 10.1002/biof.1031; Dev KK, 2003, NEUROPHARMACOLOGY, V45, P1, DOI 10.1016/S0028-3908(02)00337-4; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Hill MD, 2012, LANCET NEUROL, V11, P942, DOI 10.1016/S1474-4422(12)70225-9; Jemth P, 2007, BIOCHEMISTRY-US, V46, P8701, DOI 10.1021/bi7008618; KENNEDY MB, 1995, TRENDS BIOCHEM SCI, V20, P350, DOI 10.1016/S0968-0004(00)89074-X; Kiyono T, 1997, P NATL ACAD SCI USA, V94, P11612, DOI 10.1073/pnas.94.21.11612; Koo TH, 2002, ONCOGENE, V21, P4080, DOI 10.1038/sj.onc.1205514; Li T, 2004, BIOORG MED CHEM LETT, V14, P1385, DOI 10.1016/j.bmcl.2003.09.103; Marshall J, 2014, Patent, Patent No. [8,673,857, 8673857]; Marshall J, 2015, J BIOL CHEM, V290, P22030, DOI 10.1074/jbc.M115.662791; Nguyen ML, 2003, J VIROL, V77, P6957, DOI 10.1128/JVI.77.12.6957-6964.2003; Niethammer M, 1998, NEURON, V20, P693, DOI 10.1016/S0896-6273(00)81009-0; Roche KW, 2004, TRENDS NEUROSCI, V27, P699, DOI 10.1016/j.tins.2004.09.002; Tymianski M, 2011, NAT NEUROSCI, V14, P1369, DOI 10.1038/nn.2951	19	1	1	0	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0040-4039			TETRAHEDRON LETT	Tetrahedron Lett.	AUG 2	2017	58	31					3053	3056		10.1016/j.tetlet.2017.06.066			4	Chemistry, Organic	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Chemistry	FC1BF	WOS:000406571700012	28824209	Green Accepted, Green Published			2022-02-06	
J	Shen, L; Qiu, S; Su, ZZ; Ma, XD; Yan, RF				Shen, Liang; Qiu, Sheng; Su, Zhongzhou; Ma, Xudong; Yan, Renfu			Lumbar puncture as possible cause of sudden paradoxical herniation in patient with previous decompressive craniectomy: report of two cases	BMC NEUROLOGY			English	Article						Case report; Lumbar puncture; Herniation; Decompressive craniectomy	SKIN FLAP SYNDROME; INTRACRANIAL HYPOTENSION; DRAINAGE	Background: Lumbar puncture is often used for the diagnosis and treatment of subarchnoid hemorrhage, infection of Cerebro-spinal Fluid (CSF), hydrocephalus in neurosurgery department patients. It is general that paradoxical herniation followed by lumbar puncture is quite rare in decompressive craniectomy cases; the related reports are very few. Moreover, most of the paradoxical herniation cases are chronic, which often occur weeks or even months after the lumbar puncture, to date, barely no reports on the acute onset paradoxical herniation have been found. Case presentation: Two traumatic brain injury patients with decompressive craniectomy (DC) and hydrocephalus suffered from a sudden paradoxical herniation after lumbar puncture. The symptoms of herniation were improved by treated with Trendelenburg position and rapid intravenous infusion. Conclusions: Lumbar puncture may have a potential risk of inducing sudden paradoxical herniation in patients with DC. CSF drainage during lumbar puncture should be in small volume for patients with DC. Once a paradoxical herniation occurs after lumbar puncture, an immediate Trendelenburg position and rapid intravenous infusion treatment may be effective.	[Shen, Liang; Qiu, Sheng; Su, Zhongzhou; Ma, Xudong; Yan, Renfu] Huzhou Cent Hosp, Dept Neurosurg, 198 Hongqi Rd, Huzhou 313000, Zhejiang, Peoples R China; [Yan, Renfu] Huzhou Univ, Sch Med, 759 East Second Ring Rd, Huzhou 313000, Zhejiang, Peoples R China		Yan, RF (corresponding author), Huzhou Cent Hosp, Dept Neurosurg, 198 Hongqi Rd, Huzhou 313000, Zhejiang, Peoples R China.; Yan, RF (corresponding author), Huzhou Univ, Sch Med, 759 East Second Ring Rd, Huzhou 313000, Zhejiang, Peoples R China.	yanrenfu62@163.com					Akins PT, 2008, NEUROCRIT CARE, V9, P269, DOI 10.1007/s12028-007-9033-z; Annan M, 2015, BRIT J NEUROSURG, V29, P314, DOI 10.3109/02688697.2015.1012047; Chen WQ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002837; Creutzfeldt CJ, 2015, J NEUROSURG, V123, P1170, DOI 10.3171/2014.11.JNS141810; Fields JD, 2006, NEUROLOGY, V67, P1513, DOI 10.1212/01.wnl.0000242889.02957.b6; NAKAMURA T, 1980, Neurologia Medico-Chirurgica, V20, P89, DOI 10.2176/nmc.20.89; Nasi D, 2016, WORLD NEUROSURG, V91, DOI 10.1016/j.wneu.2016.04.041; Oyelese AA, 2005, NEUROSURGERY, V57, P594, DOI 10.1227/01.NEU.0000170437.79760DF; Samadani U, 2003, NEUROSURGERY, V52, P148, DOI 10.1097/00006123-200301000-00019; Schievink WI, 2006, JAMA-J AM MED ASSOC, V295, P2286, DOI 10.1001/jama.295.19.2286; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Vilela MD, 2008, SURG NEUROL, V69, P293, DOI 10.1016/j.surneu.2007.01.027; Zhao JC, 2015, CLIN NEUROL NEUROSUR, V133, P6, DOI 10.1016/j.clineuro.2015.03.010	13	1	3	0	7	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2377			BMC NEUROL	BMC Neurol.	AUG 2	2017	17								147	10.1186/s12883-017-0931-1			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FC5FE	WOS:000406866500001	28768486	gold, Green Published			2022-02-06	
J	Addison, PS; Antunes, A; Montgomery, D; Borg, UR				Addison, Paul S.; Antunes, Andre; Montgomery, Dean; Borg, Ulf R.			Gradient adjustment method for better discriminating correlating and non-correlating regions of physiological signals: application to the partitioning of impaired and intact zones of cerebral autoregulation	JOURNAL OF CLINICAL MONITORING AND COMPUTING			English	Article						Cerebral autoregulation; Regional oxygen saturation; Blood pressure	NEAR-INFRARED SPECTROSCOPY; TRAUMATIC BRAIN-INJURY; BLOOD-FLOW; CEREBROVASCULAR AUTOREGULATION; CARDIOPULMONARY BYPASS; TRANSCRANIAL DOPPLER; PERFUSION-PRESSURE; REACTIVITY; BEDSIDE	Cerebral blood flow (CBF) is regulated over a range of systemic blood pressures by the cerebral autoregulation (CA) control mechanism. This range lies within the lower and upper limits of autoregulation (LLA, ULA), beyond which blood pressure drives CBF, and CA function is considered impaired. A standard method to determine autoregulation limits noninvasively using NIRS technology is via the COx measure: a moving correlation index between mean arterial pressure and regional oxygen saturation. In the intact region, there should be no correlation between these variables whereas in the impaired region, the correlation index should approximate unity. In practice, however, the data may be noisy and/or the intact region may often exhibit a slightly positive relationship. This positive relationship may render traditional autoregulation limit calculations difficult to perform, resulting in the need for manual interpretation of the data using arbitrary thresholds. Further, the underlying mathematics of the technique are asymmetric in terms of the results produced for impaired and intact regions and are, in fact, not computable for the ideal case within the intact region. In this work, we propose a novel gradient adjustment method (GACOx) to enhance the differences in COx values observed in the intact and impaired regions. Results from a porcine model (N = 8) are used to demonstrate that GACOx is successful in determining LLA values where traditional methods fail. It is shown that the derived GACOx indices exhibit a mean difference between the intact/impaired regions of 1.54 +/- 0.26 (mean +/- SD), compared to 0.14 +/- 0.10 for the traditional COx method. The GACOx effectively polarizes the COx data in order to better differentiate the intact and impaired zones and, in doing so, makes the determination of the LLA and ULA points a simpler and more consistent task. The method lends itself to the automation of the robust determination of autoregulation zone limits.	[Addison, Paul S.; Antunes, Andre; Montgomery, Dean] Medtron Resp & Monitoring Solut, Edinburgh, Midlothian, Scotland; [Borg, Ulf R.] Medtron Resp & Monitoring Solut, Boulder, CO USA		Addison, PS (corresponding author), Medtron Resp & Monitoring Solut, Edinburgh, Midlothian, Scotland.	paul.addison@medtronic.com		Antunes, Andre/0000-0002-9428-8759; Addison, Paul/0000-0002-6925-0935; Montgomery, Dean/0000-0001-5200-3439	MedtronicMedtronic	The authors are all employees of Medtronic. The research was sponsored by Medtronic.	Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Aries MJH, 2010, STROKE, V41, P2697, DOI 10.1161/STROKEAHA.110.594168; Brady KM, 2007, STROKE, V38, P2818, DOI 10.1161/STROKEAHA.107.485706; Brady K, 2010, STROKE, V41, P1951, DOI 10.1161/STROKEAHA.109.575159; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Dias C, 2015, NEUROCRIT CARE, V23, P92, DOI 10.1007/s12028-014-0103-8; Dohmen C, 2007, STROKE, V38, P56, DOI 10.1161/01.STR.0000251642.18522.b6; Donnelly J, 2015, EXPERT REV NEUROTHER, V15, P169, DOI 10.1586/14737175.2015.996552; Gilmore MM, 2011, J PERINATOL, V31, P722, DOI 10.1038/jp.2011.17; HEISTAD DD, 1983, HDB PHYSL 2, P137; Jaeger M, 2010, CRIT CARE MED, V38, P1343, DOI 10.1097/CCM.0b013e3181d45530; Joshi B, 2012, ANESTH ANALG, V114, P503, DOI 10.1213/ANE.0b013e31823d292a; Lang EW, 2002, J NEUROL NEUROSUR PS, V72, P583, DOI 10.1136/jnnp.72.5.583; Lang EW., 2005, ANAESTH AUSTRALAS, P161; LASSEN NA, 1959, PHYSIOL REV, V39, P183, DOI 10.1152/physrev.1959.39.2.183; Lee JK, 2009, STROKE, V40, P1820, DOI 10.1161/STROKEAHA.108.536094; Lewis PM, 2015, PEDIATR CRIT CARE ME, V16, P739, DOI 10.1097/PCC.0000000000000471; Lucas SJE, 2010, HYPERTENSION, V55, P698, DOI 10.1161/HYPERTENSIONAHA.109.146290; Moerman AT, 2015, ANESTHESIOLOGY, V123, P327, DOI 10.1097/ALN.0000000000000715; Montgomery D, 2015, J CLIN MONIT COMPUT, P1; Santos E, 2011, ACTA NEUROCHIR, V153, P2189, DOI 10.1007/s00701-011-1148-5; Soul JS, 2007, PEDIATR RES, V61, P467, DOI 10.1203/pdr.0b013e31803237f6; Willie CK, 2011, J NEUROSCI METH, V196, P221, DOI 10.1016/j.jneumeth.2011.01.011; Willie CK, 2014, J PHYSIOL-LONDON, V592, P841, DOI 10.1113/jphysiol.2013.268953; Zheng YY, 2012, NEUROCRIT CARE, V17, P77, DOI 10.1007/s12028-012-9721-1	26	1	1	0	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1387-1307	1573-2614		J CLIN MONIT COMPUT	J. Clin. Monitor. Comp.	AUG	2017	31	4					727	737		10.1007/s10877-016-9913-x			11	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	EZ8ZO	WOS:000405018900010	27496051	Green Published, hybrid			2022-02-06	
J	Avanali, R; Bhadran, B; Panchal, S; Kumar, PK; Vijayan, A; Aneeze, MM; Harison, G				Avanali, Raghunath; Bhadran, Biju; Panchal, Sunil; Kumar, P. Krishna; Vijayan, Abhisek; Aneeze, M. Musthafa; Harison, G.			Formulation of a Three-Tier Cisternal Grade as a Predictor of In-Hospital Outcome from a Prospective Study of Patients with Traumatic Intracranial Hematoma	WORLD NEUROSURGERY			English	Article						Basal cisterns; Prediction scores in TBI; Traumatic intracerebral hematoma	BRAIN-INJURY; CLASSIFICATION; MODERATE; SYSTEM; CT	OBJECTIVE: Outcome prediction is of paramount importance in traumatic brain injury. Our objective of conducting this prospective study was to identify the predictors needed to formulate a prognostic score. METHODS: Clinical and radiologic characteristics of 100 patients with traumatic intracranial hematoma were analyzed. Key measurements were taken in the midbrain and pontine regions and the status of each of the 9 basal cisterns was noted, by giving a score of 1 if they were visible and 0 if not. All the predictors were analyzed for outcome. RESULTS: Total cisternal score was found to be an independent predictor of outcome. A grade was formulated by dividing the score into 3 levels. CONCLUSIONS: The model based on cisternal status described in the study is technically simple and conveys the information regarding the outcome to the treating neurosurgeon. Because the score obtained seems to have low interobserver variation, we believe that it can be a useful tool not only in recording data in case files and interphysician communication but also in research into traumatic brain injury.	[Avanali, Raghunath; Bhadran, Biju; Panchal, Sunil; Kumar, P. Krishna; Vijayan, Abhisek; Aneeze, M. Musthafa; Harison, G.] Govt TD Med Coll, Alappuzha, Kerala, India		Avanali, R (corresponding author), Govt TD Med Coll, Alappuzha, Kerala, India.	raghunimhans@yahoo.co.in		Avanali, Raghunath/0000-0001-9686-0977			Barthelemy EJ, 2016, WORLD NEUROSURG, V88, P411, DOI 10.1016/j.wneu.2015.12.044; Iaccarino C, 2014, J NEUROSURG, V120, P908, DOI 10.3171/2013.12.JNS131090; Jacobs B, 2013, NEUROCRIT CARE, V19, P79, DOI 10.1007/s12028-012-9795-9; Jacobs B, 2010, J NEUROTRAUM, V27, P331, DOI 10.1089/neu.2009.1105; JENNETT B, 1975, LANCET, V1, P480; Kim JJ, 2011, NEUROTHERAPEUTICS, V8, P39, DOI 10.1007/s13311-010-0003-3; Kubal WS, 2012, RADIOL CLIN N AM, V50, P15, DOI 10.1016/j.rcl.2011.08.010; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Munakomi S, 2016, CHIN J TRAUMATOL, V19, P25, DOI 10.1016/j.cjtee.2015.12.005; Munakomi Sunil, 2016, Surg Neurol Int, V7, P23, DOI 10.4103/2152-7806.177125; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Raj R, 2014, NEUROSURGERY, V75, P632, DOI 10.1227/NEU.0000000000000533; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; Swanson JO, 2012, PEDIATR RADIOL, V42, P974, DOI 10.1007/s00247-012-2372-8; Talari HR, 2016, WORLD NEUROSURG, V87, P195, DOI 10.1016/j.wneu.2015.11.055; Tasaki O, 2009, J TRAUMA, V66, P304, DOI 10.1097/TA.0b013e31815d9d3f; Wing, 2015, GOV IND MIN ROAD TRA; Yuh EL, 2008, J NEUROTRAUM, V25, P1163, DOI 10.1089/neu.2008.0590; Zador Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158762	21	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	AUG	2017	104						848	855		10.1016/j.wneu.2017.05.054			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FD7NP	WOS:000407713100109	28552701				2022-02-06	
J	Ciuffreda, KJ; Yadav, NK; Thiagarajan, P; Ludlam, DP				Ciuffreda, Kenneth J.; Yadav, Naveen K.; Thiagarajan, Preethi; Ludlam, Diana P.			A Novel Computer Oculomotor Rehabilitation (COR) Program for Mild Traumatic Brain Injury (mTBI)	BRAIN SCIENCES			English	Article						eye movements; traumatic brain injury (TBI); vision therapy; vision rehabilitation; reading; visual scanning; perceptual and motor learning; neuroplasticity; computer-based therapy	RESPONSIVITY; VERGENCE	Individuals with traumatic brain injury (TBI) manifest a wide range of visual dysfunctions. One of the most prevalent involves the oculomotor system, which includes version, vergence, and accommodation. However, until recently, there has been no comprehensive, computer-based program for remediation of these oculomotor deficits. We present such an oculomotor rehabilitation program that has been tested in a clinical trial in patients having TBI with a high degree of success based on before-and-after objective system recordings, performance measures, and related visual symptomotology. The basic program components include a versatile stimulus package incorporating the attentional paradigm of rapid serial visual presentation (RSVP), the ability to add a visual and/or auditory distractor to the training to increase difficulty level (task loading), automated assessment of RSVP errors, and automated assessment of visual performance over the training period. Program limitations and future directions are also considered.	[Ciuffreda, Kenneth J.; Thiagarajan, Preethi; Ludlam, Diana P.] SUNY Coll Optometry, Dept Biol & Vis Sci, New York, NY 10016 USA; [Yadav, Naveen K.] Midwestern Univ, Chicago Coll Optometry, Downers Grove, IL 60515 USA		Ciuffreda, KJ (corresponding author), SUNY Coll Optometry, Dept Biol & Vis Sci, New York, NY 10016 USA.	kciuffreda@sunyopt.edu; nyadav@midwestern.edu; preethi.thiagarajan@gmail.com; dianaeye@aol.com					Ciuffreda K. J., 2016, COMPENDIUM WORKS VIS, V1; Ciuffreda K. J., 2017, COMPENDIUM WORKS VIS, V2; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Ciuffreda KJ, 2006, NEUROREHABILITATION, V21, P9; Ciuffreda Kenneth J, 2008, Optometry, V79, P18, DOI 10.1016/j.optm.2007.10.004; Ciuffreda Kenneth J, 2002, Optometry, V73, P735; Ciuffreda KJ, 2002, MODELS VISUAL SYSTEM, P741; Green W, 2010, J REHABIL RES DEV, V47, P183, DOI 10.1682/JRRD.2009.04.0041; Han Y, 2004, BRAIN RES PROTOC, V14, P1, DOI 10.1016/j.brainresprot.2004.06.002; Kapoor N, 2004, ARCH PHYS MED REHAB, V85, P1667, DOI 10.1016/j.apmr.2003.12.044; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; LEIGH RJ, 1991, NEUROLOGY EYE MOVEME; POTTER MC, 1976, J EXP PSYCHOL-HUM L, V2, P509, DOI 10.1037/0278-7393.2.5.509; RON S, 1978, SCAND J REHABIL MED, V10, P39; STARK L, 1977, AM J OPTOM PHYS OPT, V54, P85; Suchoff IB, 2001, VISUAL VESTIBULAR CO; Suter PS, 2011, VISION REHABILITATION: MULTIDISCIPLINARY CARE OF THE PATIENT FOLLOWING BRAIN INJURY, P1, DOI 10.1201/b10524; Szymanowicz D, 2012, J REHABIL RES DEV, V49, P1083, DOI 10.1682/JRRD.2010.07.0129; Tannen B., 1995, EYE MOVEMENT BASICS; Taylor E. A., 1966, FUNDAMENTAL READING; Thiagarajan P., 2014, OPTOM VIS PERF, V2, P280; Thiagarajan P., 2012, THESIS; Thiagarajan P, 2015, BRAIN INJURY, V29, P1475, DOI 10.3109/02699052.2015.1070905; Thiagarajan P, 2014, J REHABIL RES DEV, V51, P175, DOI 10.1682/JRRD.2013.01.0027; Thiagarajan P, 2014, BRAIN INJURY, V28, P930, DOI 10.3109/02699052.2014.888761; Thiagarajan P, 2014, NEUROREHABILITATION, V34, P129, DOI 10.3233/NRE-131025; Thiagarajan P, 2013, J REHABIL RES DEV, V50, P1223, DOI 10.1682/JRRD.2012.12.0235; Yadav NK, 2014, BRAIN INJURY, V28, P922, DOI 10.3109/02699052.2014.887227; Zasler N., 2007, BRAIN INJURY MED PRI; [No title captured]	30	1	1	0	5	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	AUG	2017	7	8							99	10.3390/brainsci7080099			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FF4DL	WOS:000408881300007	28792451	Green Published, gold, Green Submitted			2022-02-06	
J	Jabaut, JM; Kotora, J; Ambrosio, A				Jabaut, Joshua M.; Kotora, Joseph; Ambrosio, Art			MANDIBULAR DEGLOVING: A CASE REPORT AND LITERATURE REVIEW	JOURNAL OF EMERGENCY MEDICINE			English	Article						mandible; degloving; facial trauma; occult injury	INJURY	Background: Degloving injuries of the extremities are well documented; however, there are few reports of degloving injuries to the mandible. A literature review demonstrates several cases of mandibular degloving in pediatric patients. However, no isolated mandibular degloving injuries have been reported in adults. Case Report: We report a case of a 21-year-old male who presented to the emergency department with facial trauma after a motorcycle accident. Initial examination of the head and neck showed ecchymosis and edema overlying the left periorbital area, eye closure secondary to periorbital edema, upper eyelid and lower eyelid superficial lacerations, as well as a left oral commissural and lower intraoral lacerations. Following completion of maxillofacial computed tomography after primary and secondary survey, the intraoral lesion was found to be a degloving injury of the mandible. This injury was irrigated with bacitracin and betadine before closure. It was ultimately closed in a layered fashion with deep layers reconstructing the sheared attachments of the overlying tissue to the periosteum, followed by gingivobuccal mucosal apposition superficially. Why Should an Emergency Physician Be Aware of This?: Facial trauma is a common presentation in the emergency department. It is important that the emergency physician complete a thorough head and neck evaluation, including the oral mucosa and gingivobuccal sulcus, as mandibular degloving injuries may be occult. Without a high level of suspicion, such lesions may be missed, increasing the risk of subsequent infection and obligate healing by secondary intention leading to increased morbidity. Published by Elsevier Inc.	[Jabaut, Joshua M.] Walter Reed Natl Mil Med Ctr, Dept Otolaryngol Head & Neck Surg, 8901 Wisconsin Ave, Bethesda, MD 20889 USA; [Kotora, Joseph] Naval Hosp Camp Lejeune, Dept Emergency Med, Jacksonville, NC USA; [Ambrosio, Art] Naval Med Ctr San Diego, Dept Otolaryngol Head & Neck Surg, San Diego, CA USA; [Ambrosio, Art] Naval Hosp Camp Pendleton, Dept Otolaryngol Head & Neck Surg, Oceanside, CA USA		Jabaut, JM (corresponding author), Walter Reed Natl Mil Med Ctr, Dept Otolaryngol Head & Neck Surg, 8901 Wisconsin Ave, Bethesda, MD 20889 USA.						Berbaum K. S., 1994, EMERG RADIOL, V1, P242, DOI [10.1007/ bf02614935, DOI 10.1007/BF02614935]; DULA DJ, 1984, ANN EMERG MED, V13, P630, DOI 10.1016/S0196-0644(84)80295-4; McLaughlin P P, 2000, Int J Paediatr Dent, V10, P234, DOI 10.1046/j.1365-263x.2000.00197.x; Olateju OS, 2007, J NATL MED ASSOC, V99, P810; Panse N, 2014, WORLD J PLAST SURG, V3, P64; Perumal Colin, 2013, Ann Maxillofac Surg, V3, P87, DOI 10.4103/2231-0746.110073; Pollock RA, 2011, CRANIOMAX TRAUM REC, V4, P137, DOI 10.1055/s-0031-1286116; Rahpeyma Amin, 2013, J Surg Tech Case Rep, V5, P35, DOI 10.4103/2006-8808.118622; Sethi RKV, 2014, OTOLARYNG HEAD NECK, V151, P776, DOI 10.1177/0194599814546112	9	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0736-4679	1090-1280		J EMERG MED	J. Emerg. Med.	AUG	2017	53	2					262	264		10.1016/j.jemermed.2017.03.022			3	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	FE0VZ	WOS:000407939100019	28477971				2022-02-06	
J	Lacarra, B; Guyet-Job, S; Pedrono, G; Le Rouzic, MA; Dufour, D; Thelot, B; Le Roux, P				Lacarra, B.; Guyet-Job, S.; Pedrono, G.; Le Rouzic, M. A.; Dufour, D.; Thelot, B.; Le Roux, P.			Home and recreational injuries in children under 1 year: 10 years of experience	ARCHIVES DE PEDIATRIE			French	Article							AGE	Background. There is little research on the prevalence and characteristics of home and recreational injuries in infants under 12 months of age. However, domestic accidents result in an average of 50 infant deaths in France every year. Methods. A descriptive and retrospective study was conducted, based on data from the permanent investigation on home and recreational injuries in infants under 12 months of age (EPAC) published by the Institute for Public Health. Data were collected from 2004 to 2013 in the pediatric emergency department of Le Havre hospital. A global quantitative analysis was carried out, as well as age-group-based analyses (groups of infants of similar age within a specific range of 3 months of age). Results. A total of 3708 infants under 1 year of age were victims of home and recreational injuries. The incidence of domestic accidents was found to be an average of one case per day (gender ratio, 1.12). Up to 85% of reported injuries were found to occur in the home. Falls were the leading cause of home accidents or injuries (73% of the total number of reported accidents), 7% of which resulted from a fall from stairs. Children frequently suffered from concussion or contusions (65%). The neck and head were affected in 73% of cases. A higher proportion of foreign body injuries occurred after 6 months of age (RR = 2.9, p < 0.001). The number of hospitalizations decreasedwith age: 21% of accidents occurred before 3 months of age; 7% occurred between 9 and 11 months of age (RR = 0.32, p < 0.001). Falling from a changing table accounted for 9% of fall-related hospitalizations. Conclusions. This survey characterized for the first time the occurrence of home and recreational injuries in infants under 12 months of age in France. (C) 2017 Elsevier Masson SAS. All rights reserved.	[Lacarra, B.; Guyet-Job, S.; Le Rouzic, M. A.; Dufour, D.; Le Roux, P.] Grp Hosp Havre, Urgences Pediat, 29 Ave Pierre Mendes, F-76290 Montivilliers, France; [Pedrono, G.; Thelot, B.] Sante Publ France, Unite Traumatismes, 12 Rue Val dOsne, F-94415 St Maurice, France		Lacarra, B (corresponding author), Grp Hosp Havre, Urgences Pediat, 29 Ave Pierre Mendes, F-76290 Montivilliers, France.	boris.lacarra@gmail.com					Ablewhite J, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2252-x; Agran PF, 2003, PEDIATRICS, V111, pE683, DOI 10.1542/peds.111.6.e683; Barry Y., 2011, Bulletin Epidemiologique Hebdomadaire, P328; Charles MA, 2016, COURS; Claudet I, 2013, ARCH PEDIATRIE, V20, P484, DOI 10.1016/j.arcped.2013.02.071; Dabis F., 2012, EPIDEMIOLOGIE TERRAI; Herbert HK, 2012, J TRAUMA ACUTE CARE, V73, P168, DOI 10.1097/TA.0b013e31824d67c3; Jung JH, 2015, J KOREAN MED SCI, V30, P1625, DOI 10.3346/jkms.2015.30.11.1625; Lasbeur L., 2017, Bulletin Epidemiologique Hebdomadaire, P2; Lasbeur L, 2014, ARCH PEDIATRIE, V21, P1180, DOI 10.1016/j.arcped.2014.08.019; Lasbeur L, 2016, MORTALITE ACCIDENT V; MacKay M, 2006, AMSTERDAM EUR CHILD; Richard JB, 2010, ACCIDENTS FRANCE RES; Thelot B, 2014, ARCH PEDIATR, V1, P283; Thelot B, 2004, ROSEAU EPAC SAINT MA, P138; Towner E, 2005, INJURIES CHILDREN AG; WHO, 2016, GLOB BURD DIS 2004	17	1	1	2	3	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS	23 RUE LINOIS, 75724 PARIS, FRANCE	0929-693X	1769-664X		ARCH PEDIATRIE	Arch. Pediatr.	AUG	2017	24	8					703	711		10.1016/j.arcped.2017.05.005			9	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	FH9OI	WOS:000411541200002	28689685				2022-02-06	
J	Marquardt, RJ; Buletko, AB; Russman, AN				Marquardt, Robert J.; Buletko, Andrew Blake; Russman, Andrew Neil			Neurologic Injuries in Noncontact Sports	NEUROLOGIC CLINICS			English	Article						Noncontact sports; Muscle injury; Cervicocephalic dissection; Concussion; Return to play; Spinal cord injury	REGIONAL PAIN SYNDROME; CAUDA-EQUINA SYNDROME; SYNDROME TYPE-I; EXERTIONAL RHABDOMYOLYSIS; REPETITIVE EXERCISE; ARTERY DISSECTIONS; SPINAL STENOSIS; MEDICAL THERAPY; HEAT ILLNESS; NEURAPRAXIA	Noncontact sports are associated with a variety of neurologic injuries. Concussion, vascular injury (arterial dissection), and spinal cord trauma may be less common in noncontact sports, but require special attention from the sports neurologist. Complex regional pain disorders, muscle injury from repetitive use, dystonia, heat exposure, and vascular disorders (patent foramen ovale), occur with similar frequency in noncontact and contact sports. Management of athletes with these conditions requires an understanding of the neurologic consequences of these disorders, the risk of injury with return to play, and consideration for the benefits of exercise in health restoration and disease prevention.	[Marquardt, Robert J.; Buletko, Andrew Blake; Russman, Andrew Neil] Cleveland Clin, Dept Neurol, 9500 Euclid Ave, Cleveland, OH 44195 USA		Russman, AN (corresponding author), Cleveland Clin, Dept Neurol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	russmaa@ccf.org					Adler CH, 2005, NEUROLOGY, V64, P1813, DOI 10.1212/01.WNL.0000162024.05514.03; Anderson FA, 2003, CIRCULATION, V107, pI9, DOI 10.1161/01.CIR.0000078469.07362.E6; Bagley WH, 2007, INTERN EMERG MED, V2, P210, DOI 10.1007/s11739-007-0060-8; Bagot CN, 2008, BRIT J HAEMATOL, V143, P180, DOI 10.1111/j.1365-2141.2008.07323.x; Birklein F, 2000, ACTA NEUROL SCAND, V101, P262, DOI 10.1034/j.1600-0404.2000.101004262x./; BOUCHAMA A, 1991, CRIT CARE MED, V19, P176, DOI 10.1097/00003246-199102000-00011; Bouchama A, 2002, NEW ENGL J MED, V346, P1978, DOI 10.1056/NEJMra011089; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Bussa M, 2015, ACTA ANAESTH SCAND, V59, P685, DOI 10.1111/aas.12489; Carroll JD, 2013, NEW ENGL J MED, V368, P1092, DOI 10.1056/NEJMoa1301440; Castro FP, 2003, CLIN SPORT MED, V22, P483, DOI 10.1016/S0278-5919(02)00094-7; Chowdhury MM, 2015, EUR J VASC ENDOVASC, V50, P148, DOI 10.1016/j.ejvs.2015.04.034; Clark AJ, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.7.FOCUS11173; Conidi Frank, 2014, Continuum (Minneap Minn), V20, P1645, DOI 10.1212/01.CON.0000458969.48271.1f; Coris EE, 2004, SPORTS MED, V34, P9, DOI 10.2165/00007256-200434010-00002; Corradini C, 2015, CLIN CASES MINER BON, V12, P21, DOI 10.11138/ccmbm/2015.12.3s.021; Cutsforth-Gregory JK, 2016, PARKINSONISM RELAT D, V27, P74, DOI 10.1016/j.parkreldis.2016.03.013; de Mos M, 2007, PAIN, V129, P12, DOI 10.1016/j.pain.2006.09.008; Debette S, 2011, NEUROLOGY, V77, P1174, DOI 10.1212/WNL.0b013e31822f03fc; DeFilippis EM, 2014, SPORTS HEALTH, V6, P333, DOI 10.1177/1941738114522957; Dharmasaroja P, 2008, NEUROLOGIST, V14, P307, DOI 10.1097/NRL.0b013e31816d65cd; Do KD, 2007, CLIN J SPORT MED, V17, P78, DOI 10.1097/JSM.0b013e31802b4fc8; Ekrol I, 2014, J BONE JOINT SURG AM, V96A, P1451, DOI 10.2106/JBJS.M.00268; Engelter ST, 2009, STROKE, V40, P3772, DOI 10.1161/STROKEAHA.109.555953; Fuso FAF, 2013, ACTA ORTOP BRAS, V21, P159, DOI 10.1590/S1413-78522013000300006; Furlan AJ, 2012, NEW ENGL J MED, V366, P991, DOI 10.1056/NEJMoa1009639; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Harden RN, 2010, PAIN, V150, P268, DOI 10.1016/j.pain.2010.04.030; Herman Martin J, 2006, Instr Course Lect, V55, P641; Hummel K, 2016, PHYSICIAN SPORTSMED, V44, P195, DOI 10.1080/00913847.2016.1170582; Iwamoto J, 2011, OPEN ACCESS J SPORTS, V2, P25, DOI 10.2147/OAJSM.S17523; Joaquim AF, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15560; JONES TS, 1982, JAMA-J AM MED ASSOC, V247, P3327, DOI 10.1001/jama.247.24.3327; Katz M, 2013, PARKINSONISM RELAT D, V19, P1033, DOI 10.1016/j.parkreldis.2013.07.013; Kennedy F, 2012, NEUROLOGY, V79, P686, DOI 10.1212/WNL.0b013e318264e36b; Keogh JWL, 2017, SPORTS MED, V47, P479, DOI 10.1007/s40279-016-0575-0; Kingery WS, 1997, PAIN, V73, P123, DOI 10.1016/S0304-3959(97)00049-3; Klampfl MK, 2015, J SPORT SCI, V33, P655, DOI 10.1080/02640414.2014.961026; Knochel JP, 1994, MAXWELL KLEEMANS CLI, V5, P1549; Leddy J, 2016, PM&R, V8, pS91, DOI 10.1016/j.pmrj.2015.10.017; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Maroon JC, 2007, J NEUROSURG-SPINE, V6, P356, DOI 10.3171/spi.2007.6.4.13; Maroon JC, 2007, SURG NEUROL, V67, P163, DOI 10.1016/j.surneu.2006.03.045; McClinton S, 2012, J ORTHOP SPORT PHYS, V42, P688, DOI 10.2519/jospt.2012.3892; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meena Sanjay, 2015, Eur J Orthop Surg Traumatol, V25, P637, DOI 10.1007/s00590-014-1573-2; O'Connell NE, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004598.pub4; O'Connor FG, 2008, CURR SPORT MED REP, V7, P328, DOI 10.1249/JSR.0b013e31818f0317; Page S, 2004, SOUTH MED J, V97, P766, DOI 10.1097/00007611-200408000-00015; Pryor RR, 2015, PREHOSP DISASTER MED, V30, P297, DOI 10.1017/S1049023X15004628; Salahadin M D P.Abdi, 2016, COMPLEX REGIONAL PAI, V2016; Salardini A, 2016, HOSP NEUROLOGY BOOK; Sandroni P, 2003, PAIN, V103, P199, DOI 10.1016/S0304-3959(03)00065-4; Shanker Vicki, 2016, Continuum (Minneap Minn), V22, P1227, DOI 10.1212/CON.0000000000000352; Shapiro S, 2000, SPINE, V25, P348, DOI 10.1097/00007632-200002010-00015; Smith AM, 2003, SPORTS MED, V33, P13, DOI 10.2165/00007256-200333010-00002; Taruilli AW, 2007, NEUROL CLIN, V25, P387, DOI 10.1016/j.ncl.2007.01.008; Tarulli Andrew W, 2015, Continuum (Minneap Minn), V21, P146, DOI 10.1212/01.CON.0000461090.09736.45; Tietze DC, 2014, SPORTS HEALTH, V6, P336, DOI 10.1177/1941738114523544; Todd NV, 2005, BRIT J NEUROSURG, V19, P301, DOI 10.1080/02688690500305324; Torg JS, 1996, J BONE JOINT SURG AM, V78A, P1308, DOI 10.2106/00004623-199609000-00003; Wasner G, 2001, BRAIN, V124, P587, DOI 10.1093/brain/124.3.587; Winston P, 2016, PAIN RES MANAG, V2016, DOI 10.1155/2016/7019196; Wu LJC, 2006, J NEUROL SCI, V251, P73, DOI 10.1016/j.jns.2006.09.003	65	1	1	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0733-8619	1557-9875		NEUROL CLIN	Neurol. Clin.	AUG	2017	35	3					573	+		10.1016/j.ncl.2017.03.004			16	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FC4OI	WOS:000406819500014	28673417				2022-02-06	
J	Wallace, D; Heffernan, K				Wallace, Duncan; Heffernan, Kristi			The changing face of posttraumatic stress disorder in modern warfare	AUSTRALASIAN PSYCHIATRY			English	Article						posttraumatic stress disorder; mild traumatic brain injury; unmanned aerial vehicle; women in combat	TRAUMATIC BRAIN-INJURY; FORCE DRONE OPERATORS; MILITARY PERSONNEL; GENDER-DIFFERENCES; SYMPTOMS; FEMALE; RISK; IRAQ	Objectives: This study examined aspects of modern warfare and determined whether they have changed the clinical presentation of posttraumatic stress disorder (PTSD). Conclusions: The relationship between PTSD, mild traumatic brain injury, unmanned aerial vehicle operations and women in combat examined. It was concluded that there are significant changes in how contemporary combat veterans may present with PTSD.	[Wallace, Duncan] Australian Def Force Ctr Mental Hlth, HMAS Penguin, Mosman, NSW 2088, Australia; [Wallace, Duncan] Univ New South Wales, Sch Psychiat, Sydney, NSW, Australia; [Heffernan, Kristi] Australian Def Force, Australian Army Psychol Corps, Randwick, NSW, Australia		Wallace, D (corresponding author), Australian Def Force Ctr Mental Hlth, HMAS Penguin, Mosman, NSW 2088, Australia.	d_wallace@ozemail.com.au		Heffernan, Kristi/0000-0002-7460-8225; Wallace, Duncan/0000-0002-2636-2814			Bryant RA, 2015, BRIT J PSYCHIAT, V206, P417, DOI 10.1192/bjp.bp.114.145516; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Chappelle W, 2012, PREVALENCE HIGH EMOT; Chappelle W, 2014, J ANXIETY DISORD, V28, P480, DOI 10.1016/j.janxdis.2014.05.003; Chappelle WL, 2014, MIL MED, V179, P63, DOI 10.7205/MILMED-D-13-00501; Coetzee R H, 2010, J R Army Med Corps, V156, P196; Department of Defence, 2016, DEF WHIT PAP; Fear NT, 2013, CURRENT TOPICS OCCUP, P65; Goodwin L, 2012, J NERV MENT DIS, V200, P429, DOI 10.1097/NMD.0b013e31825322fe; Gwadz MV, 2007, J ADOLESCENCE, V30, P117, DOI 10.1016/j.adolescence.2006.01.004; Hannah Fischer, 2015, GUIDE US MILITARY CA; Hawley CA, 2015, J HEAD TRAUMA REHAB, V30, pE47, DOI 10.1097/HTR.0000000000000023; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Institute of Medicine, 2014, LONG TERM EFF BLAST, V9; Jones E, 2006, PHILOS T R SOC B, V361, P533, DOI 10.1098/rstb.2006.1814; Lilly MM, 2009, J ANXIETY DISORD, V23, P767, DOI 10.1016/j.janxdis.2009.02.015; Maguen S, 2012, J PSYCHIATR RES, V46, P311, DOI 10.1016/j.jpsychires.2011.11.007; McFarlane A., 2011, MENTAL HLTH AUSTR DE; McFarlane AC, 2015, OCCUP ENVIRON MED, V72, P241, DOI 10.1136/oemed-2014-102684; McLaughlin A, 2014, AUSTR AVIATION  1203; McPhedran I, 2015, AUSTR GOVT IS SPEND; Rivera Jessica C, 2015, US Army Med Dep J, P74; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Street AE, 2009, CLIN PSYCHOL REV, V29, P685, DOI 10.1016/j.cpr.2009.08.007; The Brookings Institution, REV ONC MOR UNM SYST; The Progressive Inc, PEAC ACT ARR ANT PRO; Tolin DF, 2006, PSYCHOL BULL, V132, P959, DOI 10.1037/0033-2909.132.6.959; Vogt D, 2011, J ABNORM PSYCHOL, V120, P819, DOI 10.1037/a0024457; Wallace D, J MIL VETER IN PRESS	29	1	1	0	17	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1039-8562	1440-1665		AUSTRALAS PSYCHIATRY	Australas. Psychiatry	AUG	2017	25	4					336	338		10.1177/1039856217695707			3	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	FC1ST	WOS:000406618400004	28747109				2022-02-06	
J	Wang, YC; Sherchan, P; Huang, L; Akyol, O; McBride, DW; Zhang, JH				Wang, Yuechun; Sherchan, Prativa; Huang, Lei; Akyol, Onat; McBride, Devin W.; Zhang, John H.			Naja sputatrix Venom Preconditioning Attenuates Neuroinflammation in a Rat Model of Surgical Brain Injury via PLA2/5LOX/LTB4 Cascade Activation	SCIENTIFIC REPORTS			English	Article							CYTOSOLIC PHOSPHOLIPASE A(2); CEREBRAL-ISCHEMIA; INFLAMMATORY RESPONSE; TRAUMATIC INJURY; IMMUNE-RESPONSE; CELLS; EXPRESSION; INHIBITION; MANOALIDE; EDEMA	Inflammatory preconditioning is a mechanism in which exposure to small doses of inflammatory stimuli prepares the body against future massive insult by activating endogenous protective responses. Phospholipase A2/5-lipoxygenase/leukotriene-B4 (PLA2/5-LOX/LTB4) axis is an important inflammatory signaling pathway. Naja sputatrix (Malayan spitting cobra) venom contains 15% secretory PLA2 of its dry weight. We investigated if Naja sputatrix venom preconditioning (VPC) reduces surgical brain injury (SBI)-induced neuroinflammation via activating PLA2/5-LOX/LTB4 cascade using a partial frontal lobe resection SBI rat model. Naja sputatrix venom sublethal dose was injected subcutaneously for 3 consecutive days prior to SBI. We observed that VPC reduced brain edema and improved neurological function 24 h and 72 h after SBI. The expression of pro-inflammatory mediators in peri-resection brain tissue was reduced with VPC. Administration of Manoalide, a PLA2 inhibitor or Zileuton, a 5-LOX inhibitor with VPC reversed the protective effects of VPC against neuroinflammation. The current VPC regime induced local skin inflammatory reaction limited to subcutaneous injection site and elicited no other toxic effects. Our findings suggest that VPC reduces neuroinflammation and improves outcomes after SBI by activating PLA2/5-LOX/LTB4 cascade. VPC may be beneficial to reduce post-operative neuroinflammatory complications after brain surgeries.	[Wang, Yuechun; Sherchan, Prativa; Huang, Lei; Akyol, Onat; McBride, Devin W.; Zhang, John H.] Loma Linda Univ, Sch Med, Dept Physiol & Pharmacol, Loma Linda, CA 92354 USA; [Wang, Yuechun] Jinan Univ, Dept Physiol, Sch Med, Guangzhou, Guangdong, Peoples R China; [Huang, Lei; Zhang, John H.] Loma Linda Univ, Dept Anesthesiol, Sch Med, Loma Linda, CA 92354 USA		Zhang, JH (corresponding author), Loma Linda Univ, Sch Med, Dept Physiol & Pharmacol, Loma Linda, CA 92354 USA.; Zhang, JH (corresponding author), Loma Linda Univ, Dept Anesthesiol, Sch Med, Loma Linda, CA 92354 USA.	johnzhang3910@yahoo.com	akyol, onat oa/N-8005-2016	akyol, onat oa/0000-0003-1316-7160; Sherchan, Prativa/0000-0002-2909-283X	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS084921, NS082184, NS43338]; Guangdong Province Science and Technology Plan Projects [2012B060300020]; Central University Basic Scientific Research Professional Expenses Special Fund [101201221612427]; Guangdong medical scientific research fund [A2016010]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS084921, R01NS043338, P01NS082184] Funding Source: NIH RePORTER	This study was partially supported by NIH grants (NS084921, NS082184 and NS43338), Guangdong Province Science and Technology Plan Projects (2012B060300020), Central University Basic Scientific Research Professional Expenses Special Fund (101201221612427) and Guangdong medical scientific research fund (A2016010).	Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Altznauer F, 2004, J BIOL CHEM, V279, P5947, DOI 10.1074/jbc.M308576200; Ayer RE, 2012, J NEUROSURG, V116, P246, DOI 10.3171/2011.8.JNS11883; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; BRINT S, 1988, J CEREBR BLOOD F MET, V8, P474, DOI 10.1038/jcbfm.1988.88; Chen S, 2013, NEUROBIOL DIS, V58, P296, DOI 10.1016/j.nbd.2013.06.011; Chen Wenjian, 2013, Zhejiang Da Xue Xue Bao Yi Xue Ban, V42, P61; Cher CDN, 2005, CELL MOL LIFE SCI, V62, P105, DOI 10.1007/s00018-004-4352-0; Cher CDN, 2003, J BIOL CHEM, V278, P31352, DOI 10.1074/jbc.M302446200; Clemens JA, 1996, STROKE, V27, P527, DOI 10.1161/01.STR.27.3.527; Dirnagl U, 2009, LANCET NEUROL, V8, P398, DOI 10.1016/S1474-4422(09)70054-7; Farias SE, 2007, J NEUROCHEM, V103, P1310, DOI 10.1111/j.1471-4159.2007.04830.x; Fritsch G, 1997, TRANSFUSION, V37, P775, DOI 10.1046/j.1537-2995.1997.37897424398.x; Futosi K, 2013, INT IMMUNOPHARMACOL, V17, P1185, DOI 10.1016/j.intimp.2013.11.010; Geering B, 2011, CELL DEATH DIFFER, V18, P1457, DOI 10.1038/cdd.2011.75; GLASER KB, 1988, BIOCHEM PHARMACOL, V37, P3639, DOI 10.1016/0006-2952(88)90396-6; GLASER KB, 1986, BIOCHEM PHARMACOL, V35, P449, DOI 10.1016/0006-2952(86)90218-2; Gonca Ersoz, 2013, Curr Ther Res Clin Exp, V75, P27, DOI 10.1016/j.curtheres.2013.06.001; Grange E, 1998, NEUROCHEM RES, V23, P1251, DOI 10.1023/A:1020788031720; Guo JS, 2009, NANOMED-NANOTECHNOL, V5, P345, DOI 10.1016/j.nano.2008.12.001; Harris JB, 2000, EXP NEUROL, V161, P517, DOI 10.1006/exnr.1999.7275; Hermosilla C, 2014, PARASITOLOGY, V141, P1489, DOI 10.1017/S0031182014000316; Hickey E, 2011, PEDIATR RES, V70, P10, DOI 10.1203/PDR.0b013e31821d02aa; Huang L, 2015, J NEUROSCI, V35, P10390, DOI 10.1523/JNEUROSCI.0546-15.2015; Jadhav V, 2009, STROKE, V40, P3139, DOI 10.1161/STROKEAHA.109.549774; Kim DY, 2010, J IMMUNOL, V185, P273, DOI 10.4049/jimmunol.1000991; KLEBANOFF SJ, 1975, SEMIN HEMATOL, V12, P117; Kudo I, 2002, PROSTAG OTH LIPID M, V68-9, P3, DOI 10.1016/S0090-6980(02)00020-5; Kumral A, 2012, BRAIN RES, V1489, P81, DOI 10.1016/j.brainres.2012.10.015; Li XQ, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0069-7; LOMBARDO D, 1985, J BIOL CHEM, V260, P7234; LUNA K.P.O., 2011, INT J INTERF CYTOK M, V3, P9, DOI DOI 10.2147/IJICMR.S14331; Ma D, 2002, BIOCHEM J, V366, P35, DOI 10.1042/bj20020437; McCoy A.M., 2010, J VIS EXP, V59; Moura-Da-Silva AM, 2007, CURR PHARM DESIGN, V13, P2893, DOI 10.2174/138161207782023711; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Nassar NN, 2012, NEUROCHEM RES, V37, P614, DOI 10.1007/s11064-011-0651-7; Nguyen H. X., 2011, JOVE-J VIS EXP, V9, P50; Pardridge William M, 2005, NeuroRx, V2, P3; Pardridge William M, 2003, Mol Interv, V3, P90, DOI 10.1124/mi.3.2.90; Phillis John W., 2003, Critical Reviews in Neurobiology, V15, P61, DOI 10.1615/CritRevNeurobiol.v15.i1.30; Saiwai H, 2010, AM J PATHOL, V176, P2352, DOI 10.2353/ajpath.2010.090839; Santos-Beneit AM, 2000, J LEUKOCYTE BIOL, V67, P712, DOI 10.1002/jlb.67.5.712; Schuhmann MU, 2003, NEUROL RES, V25, P481, DOI 10.1179/016164103101201896; Sherchan P, 2016, NEUROBIOL DIS, V85, P164, DOI 10.1016/j.nbd.2015.11.003; Simao F, 2012, NEUROCHEM INT, V61, P659, DOI 10.1016/j.neuint.2012.06.009; TAMBOURGI DV, 1994, BRIT J PHARMACOL, V112, P723, DOI 10.1111/j.1476-5381.1994.tb13137.x; TAN NH, 1989, BIOCHEM INT, V18, P785; TAN NH, 1989, BIOCHEM INT, V19, P803; Teixeira CDP, 2005, MEM I OSWALDO CRUZ, V100, P181, DOI 10.1590/S0074-02762005000900031; Tompkins P, 2013, J NEUROTRAUM, V30, P1888, DOI 10.1089/neu.2012.2674; Toyoda T, 2000, J NEUROSURG, V92, P435, DOI 10.3171/jns.2000.92.3.0435; Trahanas DM, 2015, SHOCK, V43, P255, DOI 10.1097/SHK.0000000000000291; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; von Vietinghoff S, 2008, J IMMUNOL, V181, P5183, DOI 10.4049/jimmunol.181.8.5183; Wang Hailian, 2011, Front Biosci (Elite Ed), V3, P604; Weber JT, 2001, J BIOL CHEM, V276, P1800, DOI 10.1074/jbc.M009209200; Yamaguchi M, 2007, NEUROSURGERY, V61, P1067, DOI 10.1227/01.neu.0000303203.07866.18; Yap MKK, 2013, TOXICON, V68, P18, DOI 10.1016/j.toxicon.2013.02.017; Yin W, 2007, STROKE, V38, P1017, DOI 10.1161/01.STR.0000258102.18836.ca; YOUNG PR, 1991, EUR J PHARMACOL, V205, P259, DOI 10.1016/0014-2999(91)90907-8; Zhang L, 2006, NEUROPATHOLOGY, V26, P99, DOI 10.1111/j.1440-1789.2006.00658.x; Zhou Y, 2006, LIFE SCI, V79, P1645, DOI 10.1016/j.lfs.2006.05.022	63	1	2	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 14	2017	7								5466	10.1038/s41598-017-05770-7			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5EA	WOS:000405464200103	28710425	Green Published, gold			2022-02-06	
J	David, HN; Haelewyn, B; Blatteau, JE; Risso, JJ; Vallee, N; Abraini, JH				David, Helene N.; Haelewyn, Benoit; Blatteau, Jean-Eric; Risso, Jean-Jacques; Vallee, Nicolas; Abraini, Jacques H.			Xenon-helium gas mixture at equimolar concentration of 37.5% protects against oxygen and glucose deprivation-induced injury and inhibits tissue plasminogen activator	MEDICAL GAS RESEARCH			English	Article						xenon; helium; inert gases; gas mixtures; synergistic effects; neuroprotection; tissue plasminogen activator	TRAUMATIC BRAIN-INJURY; TRANSIENT CEREBRAL-ISCHEMIA; RECEPTOR GLYCINE SITE; NEURONAL INJURY; NITROUS-OXIDE; RAT MODEL; ARTERY OCCLUSION; CELL-CULTURE; NEUROPROTECTION; ANTAGONISTS	Xenon (Xe) is considered to be the golden standard neuroprotective gas. However, Xe has a higher molecular weight and lower thermal conductivity and specific heat than those of nitrogen, the main diluent of oxygen in air. These physical characteristics could impair or at least reduce the intrinsic neuroprotective action of Xe by increasing the patient's respiratory workload and body temperature. In contrast, helium (He) is a cost-efficient gas with a lower molecular weight and higher thermal conductivity and specific heat than those of nitrogen, but is far less potent than Xe. In this study, we hypothesized that mixing Xe and He could allow obtaining a neuroprotective gas mixture with advantageously reduced molecular weight and increased thermal conductivity. We found that Xe and He at the equimolar concentration of 37.5% reduced oxygen-glucose deprivation-induced increase in lactate dehydrogenase in brain slices, an ex vivo model of acute ischemic stroke. These results together with the effects of Xe-He on the thrombolytic efficiency of tissue plasminogen activator are discussed.	[David, Helene N.] Apricot Inhalotherapeut, Quebec City, PQ, Canada; [Haelewyn, Benoit] Univ Caen Normandie, Ctr Cyceron, Caen, France; [Blatteau, Jean-Eric] Hop Instruct Armees HIA St Anne, Serv Med Hyperbare & Expertise Plongee, Toulon, France; [Risso, Jean-Jacques; Vallee, Nicolas; Abraini, Jacques H.] Inst Rech Biomed Armees, Equipe Residente Rech, Subaquat Operat, Toulon, France; [Abraini, Jacques H.] Univ Laval, Fac Med, Dept Anesthesiol, Quebec City, PQ, Canada; [Abraini, Jacques H.] Univ Caen Normandie, Caen, France		Abraini, JH (corresponding author), Inst Rech Biomed Armees, Equipe Residente Rech, Subaquat Operat, Toulon, France.; Abraini, JH (corresponding author), Univ Laval, Fac Med, Dept Anesthesiol, Quebec City, PQ, Canada.; Abraini, JH (corresponding author), Univ Caen Normandie, Caen, France.	jh.abraini@gmail.com					Abraini JH, 2005, ANN NY ACAD SCI, V1053, P289, DOI 10.1196/annals.1344.025; Baumert JH, 2002, BRIT J ANAESTH, V88, P540, DOI 10.1093/bja/88.4.540; Campos-Pires R, 2015, CRIT CARE MED, V43, P149, DOI 10.1097/CCM.0000000000000624; Coburn M, 2008, CRIT CARE MED, V36, P588, DOI 10.1097/01.CCM.0B013E3181611F8A6; David HN, 2008, FASEB J, V22, P1275, DOI 10.1096/fj.07-9420com; David HN, 2010, J CEREBR BLOOD F MET, V30, P718, DOI 10.1038/jcbfm.2009.275; David HN, 2009, J CEREBR BLOOD F MET, V29, P1159, DOI 10.1038/jcbfm.2009.40; David HN, 2003, J CEREBR BLOOD F MET, V23, P1168, DOI 10.1097/01.WCB.0000087342.31689.18; Dingley J, 2006, STROKE, V37, P501, DOI 10.1161/01.STR.0000198867.31134.ac; Franks NP, 1998, NATURE, V396, P324, DOI 10.1038/24525; GOLDBERG MP, 1993, J NEUROSCI, V13, P3510; Haelewyn B, 2016, CRIT CARE MED, V44, pE383, DOI 10.1097/CCM.0000000000001424; Harris K, 2013, ANESTHESIOLOGY, V119, P1137, DOI 10.1097/ALN.0b013e3182a2a265; Homi HM, 2003, ANESTHESIOLOGY, V99, P876, DOI 10.1097/00000542-200310000-00020; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; Ma D, 2002, BRIT J ANAESTH, V89, P739, DOI 10.1093/bja/aef258; Ma DQ, 2006, J CEREBR BLOOD F MET, V26, P199, DOI 10.1038/sj.jcbfm.9600184; Ma DQ, 2003, ANESTHESIOLOGY, V98, P690, DOI 10.1097/00000542-200303000-00017; MONYER H, 1989, BRAIN RES, V483, P347, DOI 10.1016/0006-8993(89)90179-0; Palmer GC, 2000, AMINO ACIDS, V19, P151, DOI 10.1007/s007260070043; Pan Y, 2007, EXP NEUROL, V205, P587, DOI 10.1016/j.expneurol.2007.03.023; Pan Y, 2011, NEUROSCI LETT, V497, P144, DOI 10.1016/j.neulet.2011.04.048; Parsons CG, DRUG NEWS PERSPECT; Petzelt C, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-55; Petzelt C, 2003, LIFE SCI, V72, P1909, DOI 10.1016/S0024-3205(02)02439-6; PRIESTLEY T, 1990, BRAIN RES, V531, P183, DOI 10.1016/0006-8993(90)90772-4; ROGAWSKI MA, 1993, TRENDS PHARMACOL SCI, V14, P325, DOI 10.1016/0165-6147(93)90005-5; Rueckoldt H, 1999, ACTA ANAESTH SCAND, V43, P1060, DOI 10.1034/j.1399-6576.1999.431016.x; Wilhelm S, ANESTHESIOLOGY; Yamakura T, 2000, ANESTHESIOLOGY, V93, P1095, DOI 10.1097/00000542-200010000-00034	30	1	1	0	3	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	2045-9912			MED GAS RES	Med. Gas Res.	JUL-SEP	2017	7	3					181	185		10.4103/2045-9912.215747			5	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	FK3DK	WOS:000413365100005	29152211	Green Published			2022-02-06	
J	Gupta, D; Raheja, A				Gupta, Deepak; Raheja, Amol			Correlation of biomarkers with cognitive deficits in young adults with mild traumatic brain injury	NEUROLOGY INDIA			English	Article							PROTEIN; S100B		[Gupta, Deepak; Raheja, Amol] All India Inst Med Sci, Dept Neurosurg, New Delhi, India		Gupta, D (corresponding author), All India Inst Med Sci, Ctr Neurosci, Dept Neurosurg, New Delhi, India.; Gupta, D (corresponding author), All India Inst Med Sci, JPN Apex Trauma Ctr, New Delhi, India.	drdeepakgupta@gmail.com					Datta SGS, 2009, NEUROL INDIA, V57, P594, DOI 10.4103/0028-3886.57810; Dey S, 2017, NEUROL INDIA, V65, P761, DOI 10.4103/neuroindia.NI_884_15; Kleindienst A, 2006, J NEUROTRAUM, V23, P1185, DOI 10.1089/neu.2006.23.1185; Li J, 2015, AM J EMERG MED, V33, P1191, DOI 10.1016/j.ajem.2015.05.023; Massenburg BB, 2017, NEUROL INDIA, V65, P305, DOI 10.4103/neuroindia.NI_719_16; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Posti JP, 2017, J NEUROTRAUM, V34, P1427, DOI 10.1089/neu.2016.4442; Welch RD, 2016, J NEUROTRAUM, V33, P203, DOI 10.1089/neu.2015.4149	8	1	1	0	3	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	0028-3886	1998-4022		NEUROL INDIA	Neurol. India	JUL-AUG	2017	65	4					767	769		10.4103/neuroindia.NI_524_17			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EZ9ZK	WOS:000405089100018	28681748				2022-02-06	
J	Hall, T; Morissette, MP; Cordingley, D; Leiter, J				Hall, Thomas; Morissette, Marc P.; Cordingley, Dean; Leiter, Jeff			Reliability of a Novel Technique for the Measurement of Neck Strength	INTERNATIONAL JOURNAL OF ATHLETIC THERAPY & TRAINING			English	Article						muscle testing; cervical assessment; injury; rehabilitation	HIGH-SCHOOL; ISOMETRIC STRENGTH; CERVICAL STRENGTH; HEAD ACCELERATION; MUSCLE STRENGTH; HAND-HELD; AGED 20; REPRODUCIBILITY; CONCUSSIONS; FOOTBALL	Reliable assessment of neck strength is required to fully understand the role of decreased neck strength as a risk factor for concussion. The purpose of this study was to assess the intrarater and interrater reliability of a standardized isometric neck-strength-testing protocol using a custom-designed frame, and a digital force gauge. Assessment of intrarater and interrater reliability of a custom neck-strength-testing frame and protocol yielded intraclass correlation values >.890 and >.900 when using maximum peak and average peak values of neck strength, respectively. Our neck-strength-testing frame and protocol provided data of good to excellent reliability, and may be used in future studies to investigate the relationship between neck strength and incidence of injuries.	[Hall, Thomas; Morissette, Marc P.; Cordingley, Dean; Leiter, Jeff] Pan Am Clin Fdn, Winnipeg, MB, Canada		Hall, T (corresponding author), Pan Am Clin Fdn, Winnipeg, MB, Canada.						Almosnino S, 2010, J ATHL TRAINING, V45, P453, DOI 10.4085/1062-6050-45.5.453; Barnsley L, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5966; Beckerman H, 2001, QUAL LIFE RES, V10, P571, DOI 10.1023/A:1013138911638; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Dvir Z, 2008, J MANIP PHYSIOL THER, V31, P518, DOI 10.1016/j.jmpt.2008.08.008; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Kumar S, 2001, CLIN BIOMECH, V16, P380, DOI 10.1016/S0268-0033(01)00023-7; Lisman PJ, 2009, SLOW ISOINERTIAL CER; Mihalik JP, 2011, CLIN J SPORT MED, V21, P416, DOI 10.1097/JSM.0B013E31822C8A5C; Netto K, 2010, PHYS THER SPORT, V11, P75, DOI 10.1016/j.ptsp.2010.02.006; Peolsson A, 2001, Physiother Res Int, V6, P15, DOI 10.1002/pri.210; Phillips BA, 2000, ARCH PHYS MED REHAB, V81, P653, DOI 10.1016/S0003-9993(00)90050-9; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Salo PK, 2006, J ORTHOP SPORT PHYS, V36, P495, DOI 10.2519/jospt.2006.2122; Scott DA, 2004, ARCH PHYS MED REHAB, V85, P598, DOI 10.1016/j.apmr.2003.07.013; Shechtman O, 2001, J Hand Ther, V14, P188; STRATFORD P, 1989, PHYS THER, V69, P299, DOI 10.1093/ptj/69.4.299a; Strimpakos N, 2004, ARCH PHYS MED REHAB, V85, P1309, DOI 10.1016/j.apmr.2003.08.104; Suryanarayana L, 2005, CLIN BIOMECH, V20, P138, DOI 10.1016/j.clinbiomech.2004.10.003; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Tierney RT, 2008, J ATHL TRAINING, V43, P578, DOI 10.4085/1062-6050-43.6.578; Walter SD, 1998, STAT MED, V17, P101, DOI 10.1002/(SICI)1097-0258(19980115)17:1<101::AID-SIM727>3.3.CO;2-5; Watkins MP, 2009, FDN CLIN RES APPL PR, P585; Ylinen J, 2004, ARCH PHYS MED REHAB, V85, P1303, DOI 10.1016/j.apmr.2003.09.018; Ylinen JJ, 1999, CLIN BIOMECH, V14, P217, DOI 10.1016/S0268-0033(98)00063-1	27	1	1	0	4	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	2157-7277	2157-7285		INT J ATHL THER TRAI	Int. J. Athl. Ther. Train.	JUL	2017	22	4					43	50		10.1123/ijatt.2016-0070			8	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	FC2QJ	WOS:000406682800007					2022-02-06	
J	Kimberley, TJ; Novak, I; Boyd, L; Fowler, E; Larsen, D				Kimberley, Teresa Jacobson; Novak, Iona; Boyd, Lara; Fowler, Eileen; Larsen, Deborah			Stepping Up to Rethink the Future of Rehabilitation: IV STEP Considerations and Inspirations	PEDIATRIC PHYSICAL THERAPY			English	Article						IV STEP; participation; personalized; plasticity; prediction; prevention	RANDOMIZED CONTROLLED-TRIAL; TRANSCRANIAL MAGNETIC STIMULATION; NEUROMUSCULAR RECOVERY SCALE; INDUCED MOVEMENT THERAPY; TRAUMATIC BRAIN-INJURY; UPPER-LIMB RECOVERY; SPINAL-CORD-INJURY; CEREBRAL-PALSY; PHYSICAL-ACTIVITY; AEROBIC EXERCISE	Background and Purpose: The IV STEP conference challenged presenters and participants to consider the state of science in rehabilitation, highlighting key area of progress since the previous STEP conference related to prediction, prevention, plasticity, and participation in rehabilitation. Key Points: Emerging from the thought-provoking discussions was recognition of the progress we have made as a profession and a call for future growth. In this summary article, we present a recap of the key points and call for action. We review the information presented and the field at large as it relates to the 4 Ps: prediction, prevention, plasticity, and participation. Recommendations for Practice: Given that personalized medicine is an increasingly important approach that was clearly woven throughout the IV STEP presentations, we took the liberty of adding a fifth "P," Personalized, in our discussion of the future direction of the profession.	[Kimberley, Teresa Jacobson] Univ Minnesota, Dept Phys Med, Div Phys Therapy & Rehabil Sci, MMC 388,420 Church St SE, Minneapolis, MN 55455 USA; [Novak, Iona] Univ Sydney, Discipline Child & Adolescent Hlth, Cerebral Palsy Alliance, Camperdown, NSW, Australia; [Boyd, Lara] Univ British Columbia, Dept Phys Therapy, Vancouver, BC, Canada; [Boyd, Lara] Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC, Canada; [Fowler, Eileen] Univ Calif Los Angeles, Dept Orthopaed Surg, Ctr Cerebral Palsy, Los Angeles, CA USA; [Larsen, Deborah] Ohio State Univ, Sch Hlth & Rehabil Sci, Columbus, OH 43210 USA		Kimberley, TJ (corresponding author), Univ Minnesota, Dept Phys Med, Div Phys Therapy & Rehabil Sci, MMC 388,420 Church St SE, Minneapolis, MN 55455 USA.	tjk@umn.edu	Kimberley, Teresa/AAL-1893-2020; Novak, Iona E/B-3061-2014	Kimberley, Teresa/0000-0001-6397-4054; Novak, Iona E/0000-0001-6001-4867	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R13HD089695] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R13 HD089695] Funding Source: Medline		American Physical Therapy Association, WHIT PAP PHYS THER P; Ardolino EM, 2016, PEDIATR PHYS THER, V28, P416, DOI 10.1097/PEP.0000000000000285; Barker RN, 2007, DISABIL REHABIL, V29, P981, DOI 10.1080/09638280500243570; Barnes ML, 1991, P 2 STEP C 2 STEP C; Behrman AL, 2012, ARCH PHYS MED REHAB, V93, P1518, DOI 10.1016/j.apmr.2011.04.027; Bernhardt J, 2015, LANCET, V386, P46, DOI 10.1016/S0140-6736(15)60690-0; Bjornson KF, 2014, DISABIL REHABIL, V36, P1279, DOI 10.3109/09638288.2013.845254; Boaz Annette, 2011, BMC Res Notes, V4, P212, DOI 10.1186/1756-0500-4-212; Carey JR, 2014, RESTOR NEUROL NEUROS, V32, P323, DOI 10.3233/RNN-130358; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; Cassidy JM, 2015, BRAIN STIMUL, V8, P1074, DOI 10.1016/j.brs.2015.06.007; Cheng ST, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-016-0721-2; Cieza A, 2008, EUR J PHYS REHAB MED, V44, P303; Corbetta M, 2015, NEURON, V85, P927, DOI 10.1016/j.neuron.2015.02.027; Coster W, 2008, DISABIL REHABIL, V30, P639, DOI 10.1080/09638280701400375; Demuth SK, 2012, DEV MED CHILD NEUROL, V54, P654, DOI 10.1111/j.1469-8749.2012.04321.x; Deng HQ, 2013, PHYS THER, V93, P649, DOI 10.2522/ptj.20120121; Deutch J, 2016, 4 STEP M AM PHYS THE; Di Lazzaro V, 2015, BRAIN STIMUL, V8, P92, DOI 10.1016/j.brs.2014.08.006; Doman CA, 2016, AM J OCCUP THER, V70, DOI 10.5014/ajot.2016.020891; Duchesne C, 2015, BRAIN COGNITION, V99, P68, DOI 10.1016/j.bandc.2015.07.005; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; English C, 2015, INT J STROKE, V10, P594, DOI 10.1111/ijs.12470; Fowler EG, 2007, PHYS THER, V87, P1495, DOI 10.2522/ptj.20060116; Fuchikami M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023881; Gannotti M, 2016, 4 STEP M AM PHYS THE; Gannotti ME, 2014, PHYS THER, V94, P411, DOI 10.2522/ptj.20130022; Geertsen SS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161960; Gillick BT, 2014, DEV MED CHILD NEUROL, V56, P44, DOI 10.1111/dmcn.12243; Groot C, 2016, AGEING RES REV, V25, P13, DOI 10.1016/j.arr.2015.11.005; Gunduz B., 2015, TURK J PHYS MED R S1, V61, P525; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Hanna SE, 2008, PHYS THER, V88, P596, DOI 10.2522/ptj.20070314; Harkema SJ, 2016, J NEUROTRAUM, V33, P2181, DOI 10.1089/neu.2015.4213; Hayes SM, 2014, CURR GERIATR REP, V3, P282, DOI 10.1007/s13670-014-0101-x; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1136/bmj.g1687, 10.1055/s-0041-111066]; Horner RH, 2005, EXCEPT CHILDREN, V71, P165, DOI 10.1177/001440290507100203; Imms C, 2009, DISABIL REHABIL, V31, P2204, DOI 10.3109/09638280902971406; Jayaraman A., 2016, 4 STEP M AM PHYS THE; Jones MJ, 2015, AGING CELL, V14, P924, DOI 10.1111/acel.12349; Keller S, 2010, ARCH GEN PSYCHIAT, V67, P258, DOI 10.1001/archgenpsychiatry.2010.9; Kimberley TJ, 2015, ARCH PHYS MED REHAB, V96, pS122, DOI 10.1016/j.apmr.2014.07.426; Kimberley TJ, 2010, J REHABIL RES DEV, V47, P851, DOI 10.1682/JRRD.2010.02.0019; Kimberley TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015155; Koh CL, 2006, J REHABIL MED, V38, P375, DOI 10.1080/16501970600803252; Krishnan C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077370; L C, 2016, 4 STEP M AM PHYS THE; Lang CE, 2016, ANN NEUROL, V80, P342, DOI 10.1002/ana.24734; Lang CE, 2009, ARCH PHYS MED REHAB, V90, P1692, DOI 10.1016/j.apmr.2009.04.005; Layne AS, 2016, ARCH PHYS MED REHABI; Litmanovitz I, 2007, CALCIFIED TISSUE INT, V80, P39, DOI 10.1007/s00223-006-0149-5; Lohse KR, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00153; Lohse KR, 2014, STROKE, V45, P2053, DOI 10.1161/STROKEAHA.114.004695; Mang CS, 2016, MED SCI SPORT EXER, V48, P2477, DOI 10.1249/MSS.0000000000001040; Mang CS, 2015, CLIN NEUROPHYSIOL, V126, P1959, DOI 10.1016/j.clinph.2014.12.018; Mang CS, 2014, J APPL PHYSIOL, V117, P1325, DOI 10.1152/japplphysiol.00498.2014; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Mo C, 2015, NEUROSCI BIOBEHAV R, V52, P178, DOI 10.1016/j.neubiorev.2015.03.003; Morgan D., 2016, 4 STEP M AM PHYS THE; Novak I, 2013, LIFE QUALITY OUTCOME, P265; Palisano RJ, 2012, DISABIL REHABIL, V34, P1041, DOI 10.3109/09638288.2011.628740; Pearson-Fuhrhop KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061197; Popendikyte V, 1999, NEUROREPORT, V10, P1249, DOI 10.1097/00001756-199904260-00018; Raithatha R, 2016, NEUROREHABILITATION, V38, P15, DOI 10.3233/NRE-151291; Rejc E., 2016, J NEUROTRAUMA; Ryan JM, 2015, PHYS THER, V95, P1609, DOI 10.2522/ptj.20140337; Scheets PL, 2007, PHYS THER, V87, P654, DOI 10.2522/ptj.20050349; Slaman J, 2015, DEV MED CHILD NEUROL, V57, P159, DOI 10.1111/dmcn.12602; Stinear CM, 2012, BRAIN, V135, P2527, DOI 10.1093/brain/aws146; Stinear CM, 2016, F1000 RES, V5, P1; Talelli P, 2012, NEUROREHAB NEURAL RE, V26, P976, DOI 10.1177/1545968312437940; Tester NJ, 2016, NEUROREHAB NEURAL RE, V30, P528, DOI 10.1177/1545968315605181; Voelcker-Rehage C, 2013, NEUROSCI BIOBEHAV R, V37, P2268, DOI 10.1016/j.neubiorev.2013.01.028; Winstein CJ, 2016, JAMA-J AM MED ASSOC, V315, P571, DOI 10.1001/jama.2016.0276; Wolf SL, 2006, JAMA-J AM MED ASSOC, V296, P2095, DOI 10.1001/jama.296.17.2095; Wood E, 2000, DEV MED CHILD NEUROL, V42, P292, DOI 10.1017/S0012162200000529	76	1	1	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-5669	1538-005X		PEDIATR PHYS THER	Pediatr. Phys. Ther.	JUL	2017	29	3		S			S76	S85		10.1097/PEP.0000000000000435			10	Pediatrics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Rehabilitation	EZ7LX	WOS:000404907300011	28654481	Green Accepted			2022-02-06	
J	Lim, SW; Ao, KH; Ho, CH; Tseng, CJ; Wang, JJ; Chio, CC; Kuo, JR				Lim, Sher-Wei; Ao, Kam-Hou; Ho, Chung-Han; Tseng, Chien-Jen; Wang, Jhi-Joung; Chio, Chung-Ching; Kuo, Jinn-Rung			The Association Between Ventriculo-Peritoneal Shunt and Acute Appendicitis in Patients with Traumatic Brain Injury: A 14-Year, Population-Based Study	WORLD NEUROSURGERY			English	Article						Acute appendicitis; Central nervous system infection; Population-based; Traumatic brain injury; Ventriculo-peritoneal shunt	CEREBROSPINAL-FLUID SHUNTS; PEDIATRIC HYDROCEPHALUS; RETROSPECTIVE ANALYSIS; INFECTION; RISK; PREVENTION; DIAGNOSIS; CHILDREN; SURGERY; DISEASE	OBJECTIVE: The association between preexisting ventriculoperitoneal (VP) shunt and the risk of new-onset acute appendicitis in patients with traumatic brain injury (TBI) is not well established. The aim of the present study was to determine the relationships between VP shunt and acute appendicitis in patients with TBI. METHODS: A longitudinal cohort study matched by a propensity score in patients with TBI with (4781 patients) or without (9562 patients) VP shunt was conducted using the National Health Insurance Research Database in Taiwan between January 1993 and December 2013. RESULTS: The main outcome studied was diagnosis of acute appendicitis. The cumulative probability of acute appendicitis was not different between these 2 groups (P = 0.6244). A Cox model showed central nervous system (CNS) infection to be an independent predictor of acute appendicitis with an adjusted hazard ratio of 2.98. Patients with TBIwith both a VP shunt and a CNS infection had a greater risk of developing new-onset acute appendicitis (hazard ratio 4.25; 95% confidence interval 1.84-9.81) compared patients with TBI without a VP shunt or CNS infection. CONCLUSIONS: We concluded that VP shunt is not a risk factor in the development of appendicitis in patients with TBI. Patients with TBI with a shunt and a CNS infection may have a greater risk of developing acute appendicitis. Therefore, care in avoiding CNS infection is a key for the prevention acute appendicitis in this patient population.	[Lim, Sher-Wei] Chi Mei Hosp, Dept Neurosurg, Tainan, Taiwan; [Lim, Sher-Wei] Min Hwei Coll Hlth Care Management, Dept Nursing, Tainan, Taiwan; [Ao, Kam-Hou; Chio, Chung-Ching; Kuo, Jinn-Rung] Chi Mei Med Ctr, Dept Neurosurg, Tainan, Taiwan; [Ho, Chung-Han; Wang, Jhi-Joung; Kuo, Jinn-Rung] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Ho, Chung-Han] Chia Nan Univ Pharm & Sci, Dept Pharm, Tainan, Taiwan; [Tseng, Chien-Jen] Chi Mei Hosp, Dept Gen Surg, Tainan, Taiwan; [Kuo, Jinn-Rung] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan		Kuo, JR (corresponding author), Chi Mei Med Ctr, Dept Neurosurg, Tainan, Taiwan.; Kuo, JR (corresponding author), Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan.; Kuo, JR (corresponding author), Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan.	kuojinnrung@gmail.com		Ho, Chung-Han/0000-0001-5925-8477	Chi-Mei Medical Center [CMFHR10532]	This study was based in part on data from the National Health Insurance Research Database provided by the Bureau of National Health Insurance, Department of Health, and managed by National Health Research Institutes. The interpretation and conclusions contained herein do not represent those of the Bureau of National Health Insurance, Department of Health, or National Health Research Institutes. In addition, this work was supported by Chi-Mei Medical Center grant number CMFHR10532.	Azodi OS, 2009, BRIT J SURG, V96, P1336, DOI 10.1002/bjs.6736; BALTAS I, 1994, NEUROSURGERY, V35, P422, DOI 10.1227/00006123-199409000-00009; Barina AR, 2007, J SURG RES, V141, P40, DOI 10.1016/j.jss.2007.02.039; Bhangu A, 2015, LANCET, V386, P1278, DOI 10.1016/S0140-6736(15)00275-5; Bondurant CP, 1995, PEDIATR NEUROSURG, V23, P254, DOI 10.1159/000120968; CARDOSO ER, 1985, SURG NEUROL, V23, P261, DOI 10.1016/0090-3019(85)90092-8; Conen A, 2008, CLIN INFECT DIS, V47, P73, DOI 10.1086/588298; Drake JM, 1998, NEUROSURGERY, V43, P294, DOI 10.1097/00006123-199808000-00068; Ein SH, 2006, J PEDIATR SURG, V41, P1255, DOI 10.1016/j.jpedsurg.2006.03.004; FANHAVARD P, 1987, CLIN PHARMACY, V6, P866; Faul M, 2010, TRAUMATIC BRAIN INJU, V2, P1; Haussler B, 2001, EUR J PEDIATR SURG, V11, pS55; Krassoudakis A, 2002, Minerva Pediatr, V54, P321; Lamps LW, 2010, INFECT DIS CLIN N AM, V24, P995, DOI 10.1016/j.idc.2010.07.012; Leibrock L, 1976, Surg Neurol, V5, P105; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; McAllister PJ, 1996, HYDROCEPHALUS, V1, P4; McGirt MJ, 2007, CHILD NERV SYST, V23, P289, DOI 10.1007/s00381-006-0226-0; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Mwangombe NJM, 1999, AFR J NEUROL SCI, V18, P9; Nor MAM, 2013, MALAYS J MED SCI, V20, P95; POPLE IK, 1992, J NEUROSURG, V77, P29, DOI 10.3171/jns.1992.77.1.0029; Pumberger W, 1998, PEDIATR NEUROSURG, V28, P21, DOI 10.1159/000028613; Reddy GK, 2012, WORLD NEUROSURG, V78, DOI 10.1016/j.wneu.2011.10.034; SCHIMKE RT, 1961, NEW ENGL J MED, V264, P264, DOI 10.1056/NEJM196102092640602; Shoshan Y, 1996, EUR J SURG, V162, P343; Simon TD, 2009, J NEUROS-PEDIATR, V4, P156, DOI 10.3171/2009.3.PEDS08215; Stewart B, 2014, BRIT J SURG, V101, pE9, DOI 10.1002/bjs.9329; Wang KW, 2004, JPN J INFECT DIS, V57, P44; Wu X, 2015, INT J CLIN EXP MED, V8, P19775	30	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUL	2017	103						106	113		10.1016/j.wneu.2017.03.122			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FA5JR	WOS:000405479900015	28377254				2022-02-06	
J	McCain, K; Shearin, S				McCain, Karen; Shearin, Staci			A Clinical Framework for Functional Recovery in a Person With Chronic Traumatic Brain Injury: A Case Study	JOURNAL OF NEUROLOGIC PHYSICAL THERAPY			English	Article						gait; human movement system; locomotor; practice intensity; task-specific training	SPINAL-CORD-INJURY; BODY-WEIGHT SUPPORT; ELECTRICAL-STIMULATION; NEURAL PLASTICITY; PHYSICAL-THERAPY; GAIT; REHABILITATION; STROKE; LOCOMOTION; AMBULATION	Background and Purpose: This case study describes a task-specific training program for gait walking and functional recovery in a young man with severe chronic traumatic brain injury. Case Description: The individual was a 26-year-old man 4 years post-traumatic brain injury with severe motor impairments who had not walked outside of therapy since his injury. He had received extensive gait training prior to initiation of services. His goal was to recover the ability to walk. Intervention: The primary focus of the interventions was the restoration of walking. A variety of interventions were used, including locomotor treadmill training, electrical stimulation, orthoses, and specialized assistive devices. A total of 79 treatments were delivered over a period of 62 weeks. Outcomes: At the conclusion of therapy, the client was able to walk independently with a gait trainer for approximately 1km (over 3000 ft) and walked in the community with the assistance of his mother using a rocker bottom crutch for distances of 100m (330 ft). Discussion: Specific interventions were intentionally selected in the development of the treatment plan. The program emphasized structured practice of the salient task, that is, walking, with adequate intensity and frequency. Given the chronicity of this individual's injury, the magnitude of his functional improvements was unexpected. Video Abstract available for additional insights from the Authors (see Video, Supplemental Digital Content 1, available at: http://links.lww.com/JNPT/A175).	[McCain, Karen] UT Southwestern Sch Hlth Profess, Dept Phys Therapy, Dallas, TX 75390 USA; [McCain, Karen; Shearin, Staci] UT Southwestern Sch Hlth Profess, David M Crowley Rehabil Res Lab, Dallas, TX 75390 USA; [McCain, Karen] UT Southwestern Sch Hlth Profess, Neurol Phys Therapy Residency, 5323 Harry Hines Blvd, Dallas, TX 75390 USA		McCain, K (corresponding author), UT Southwestern Sch Hlth Profess, Neurol Phys Therapy Residency, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.; McCain, K (corresponding author), UT Southwestern Sch Hlth Profess, Dept Phys Therapy, David M Crowley Rehabil Res Lab, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	karen.mccain@utsouthwestern.edu		McCain, Karen/0000-0003-1031-4225	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Wellcome TrustWellcome TrustEuropean Commission; Howard Hughes Medical InstituteHoward Hughes Medical Institute	There were no intramural or extramural funding sources for this manuscript (including funds from the NIH, Wellcome Trust, or Howard Hughes Medical Institute).	Baker LL, 2000, NEUROMUSCULAR ELECT, P177; Bland DC, 2011, BRAIN INJURY, V25, P664, DOI 10.3109/02699052.2011.576306; Breceda EY, 2013, CURR OPIN NEUROL, V26, P595, DOI 10.1097/WCO.0000000000000024; Brown DA, 2005, PHYS THER, V85, P159, DOI 10.1093/ptj/85.2.159; Brown TH, 2005, J HEAD TRAUMA REHAB, V20, P402, DOI 10.1097/00001199-200509000-00002; Cramer SC, 2011, BRAIN, V134, P1591, DOI 10.1093/brain/awr039; Creasey Graham H, 2004, J Spinal Cord Med, V27, P365; Dawson DR, 2007, DISABIL REHABIL, V29, P301, DOI 10.1080/09638280600756687; Esquenazi A, 2013, PM&R, V5, P280, DOI 10.1016/j.pmrj.2012.10.009; Gardner MB, 1998, PHYS THER, V78, P361, DOI 10.1093/ptj/78.4.361; Glinsky J, 2007, PHYSIOTHER RES INT, V12, P175, DOI 10.1002/pri.375; GROSWASSER Z, 1990, Brain Injury, V4, P161, DOI 10.3109/02699059009026161; Katz DI, 2004, ARCH PHYS MED REHAB, V85, P865, DOI 10.1016/j.apmr.2003.11.020; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); Kleim JA, 2011, J COMMUN DISORD, V44, P521, DOI 10.1016/j.jcomdis.2011.04.006; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; MacKay-Lyons M, 2002, PHYS THER, V82, P69, DOI 10.1093/ptj/82.1.69; McCulloch KL, 2016, J NEUROL PHYS THER, V40, P269, DOI 10.1097/NPT.0000000000000145; Nabors N, 2002, BRAIN INJURY, V16, P1039, DOI 10.1080/02699050210155285; Nudo RJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00887; Oostra K, 1997, BRAIN INJURY, V11, P761, DOI 10.1080/026990597123133; Perry J, 2010, GAIT ANALYSIS: NORMAL AND PATHOLOGICAL FUNCTION, SECOND EDITION, P19; Pickelsimer EE, 2006, J HEAD TRAUMA REHAB, V21, P491, DOI 10.1097/00001199-200611000-00004; Querry, 2012, J PROSTHET ORTHOT, V24, P111; Ragnarsson KT, 2008, SPINAL CORD, V46, P255, DOI 10.1038/sj.sc.3102091; Sadowsky CL, 2013, J SPINAL CORD MED, V36, P623, DOI 10.1179/2045772313Y.0000000101; Scherer M, 2007, BRAIN INJURY, V21, P93, DOI 10.1080/02699050601149104; Seif-Naraghi AH, 1999, J HEAD TRAUMA REHAB, V14, P146, DOI 10.1097/00001199-199904000-00005; Visintin M, 1998, STROKE, V29, P1122, DOI 10.1161/01.STR.29.6.1122; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Williams G, 2009, ARCH PHYS MED REHAB, V90, P587, DOI 10.1016/j.apmr.2008.10.013; Wilson DJ, 2006, AM J PHYS MED REHAB, V85, P68, DOI 10.1097/01.phm.0000193507.28759.37; Wilson DJ, 2002, BRAIN INJURY, V16, P259, DOI 10.1080/02699050110103922; Winstein C, 2014, J NEUROL PHYS THER, V38, P190, DOI 10.1097/NPT.0000000000000046	34	1	1	1	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1557-0576	1557-0584		J NEUROL PHYS THER	J. Neurol. Phys. Ther.	JUL	2017	41	3					173	181		10.1097/NPT.0000000000000190			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EZ8FC	WOS:000404959100005	28628551				2022-02-06	
J	McDaniel, S; Golla, S; Moore, AN; DaCorta, J; Bode, A; Pati, S; Dash, PK; Zhao, J				McDaniel, Steven; Golla, Stephanie; Moore, Anthony N.; DaCorta, Joe; Bode, Arthur; Pati, Shibani; Dash, Pramod K.; Zhao, Jing			Resuscitation of Hypotensive Traumatic Brain Injured Animals With Spray-Dried Plasma Does Not Adversely Alter Physiology and Improves Blood-Brain Barrier Function\	MILITARY MEDICINE			English	Article							FLUID RESUSCITATION; CEREBRAL-ISCHEMIA; HEMORRHAGE; RATS	Introduction: According to the Defense and Veterans Brain Injury Center and the Armed Forces Health Surveillance Center, the number of soldiers who have sustained a traumatic brain injury (TBI) has risen dramatically over the past decade. Studies have shown that brain damage can be exacerbated if blood loss occurs (often occurring in polytrauma). As blood supply is critical for brain function and survival, TBI patients must be properly resuscitated to maintain blood volume, blood pressure, and cerebral perfusion. Recent studies have suggested that blood loss can damage the vascular endothelium and enhance blood-brain barrier (BBB) permeability. Brain endothelial cells and the tight junctions between them are key structural components of the BBB. As the BBB is critical for isolating the brain from potential pathogens and for regulating the influx of molecules into the brain, evaluation of resuscitation fluids for their efficacy to improve BBB function has clinical relevance. Although whole blood and fresh frozen plasma (FFP) contain the essential coagulation factors, ions, and other factors, the transport and storage of these products in remote, austere environments can be challenging. The use of spray-dried plasma (SDP) has several advantages including storage at ambient temperature, can be readily reconstituted before use, and infectious materials can be inactivated during the drying process. In this study, we compared FFP and SDP for their effects on blood pressure, cerebral blood flow, BBB integrity, and markers of endothelial cells and tight junction proteins, in TBI animals with blood loss. Materials and methods: All procedures were reviewed and approved by the UTHealth animal welfare committee. Sprague Dawley rats received controlled cortical impact brain injury followed by removal of 25% blood volume. Animals were resuscitated 40 minutes later with either FFP or concentrated SDP (Resusix) Heart rate and blood pressure were monitored continuously using catheters implanted into the femoral artery. Cerebral perfusion was assessed using a scanning laser Doppler device. Twenty-four hours after the injury and resuscitation with either FFP or SDP, BBB integrity were monitored by measuring the amount of Evans Blue dye in the injured brain following its intravenous administration. As this dye is excluded from the uninjured brain, its presence in the injured brain is an indicator of BBB breakdown. In addition, von Willebrand Factor immunohistochemistry was used to examine endothelial cell loss, whereas claudin-5 immunohistochemistry was used to assess the loss of tight junctions, in FFP- and SDP-resuscitated TBI animals. Results: Our results show that post-TBI resuscitation with FFP and SDP had similar influences on cardiovascular physiology and cerebral perfusion. Resuscitation with SDP after TBI was found to decrease BBB permeability as indicated by reduced Evans Blue dye extravasation, and increased levels of von Willebrand Factor and claudin-5, as compared to resuscitation with FFP. Conclusions: These preclinical results show that resuscitation with SDP may be superior to FFP, and support the further evaluation of this product as a resuscitation fluid for polytrauma patients with TBI.	[McDaniel, Steven] 440th Blood Support Detachment Bldg, El Paso, TX 79916 USA; [Golla, Stephanie] Walter Reed Natl Mil Med Ctr, 8901 Wisconsin Ave, Bethesda, MD 20889 USA; [Moore, Anthony N.; Dash, Pramod K.; Zhao, Jing] Univ Texas McGovern Med Sch Houston, Dept Neurobiol & Anat, 6431 Fannin, Houston, TX 77030 USA; [DaCorta, Joe] Entegrion Inc, 79 TW Alexander Dr, Res Triangle Pk, NC 27709 USA; [Bode, Arthur] Cellphire Inc, 9430 Key West Ave, Rockville, MD 20850 USA; [Pati, Shibani] Blood Syst Res Inst, 270 Mason Ave, San Francisco, CA 94118 USA		McDaniel, S (corresponding author), 440th Blood Support Detachment Bldg, El Paso, TX 79916 USA.			Dash, Pramod/0000-0001-6746-1002	Entegrion Inc.; University of Texas Health science Center at Houston	The authors are saddened to report the passing of Dr. Arthur Bode and dedicate this manuscript to his memory. This work was supported by a contract between Entegrion Inc., and The University of Texas Health science Center at Houston.	CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Etemadrezaie H, 2007, CLIN NEUROL NEUROSUR, V109, P166, DOI 10.1016/j.clineuro.2006.09.001; Glassberg E, 2013, SHOCK, V40, P444, DOI 10.1097/SHK.0000000000000047; Hawkins BE, 2013, BRAIN RES, V1496, P28, DOI 10.1016/j.brainres.2012.12.027; Ivascu FA, 2005, J TRAUMA, V59, P1131, DOI 10.1097/01.ta.0000189067.16368.83; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; Leung Lai Yee, 2015, J Trauma Acute Care Surg, V79, pS130, DOI 10.1097/TA.0000000000000785; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Navarro JC, 2012, J NEUROTRAUM, V29, P322, DOI 10.1089/neu.2011.1979; Sailliol A, 2013, TRANSFUSION, V53, p65S, DOI 10.1111/trf.12038; Spinella PC, 2011, J TRAUMA, V71, pS343, DOI 10.1097/TA.0b013e318227ef2d; Tan PG, 2011, EMERG MED AUSTRALAS, V23, P665, DOI 10.1111/j.1742-6723.2011.01455.x; Van Aken HK, 2012, CURR OPIN ANESTHESIO, V25, P563, DOI 10.1097/ACO.0b013e3283572274; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Zhao J, 2007, J NEUROSCI, V27, P10240, DOI 10.1523/JNEUROSCI.1683-07.2007	15	1	1	1	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JUL-AUG	2017	182	7					E1706	E1711		10.7205/MILMED-D-16-00185			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FF2MZ	WOS:000408732800010	28810961	Bronze			2022-02-06	
J	Odle, TG				Odle, Teresa G.			Neuroimaging of Sports Concussions	RADIOLOGIC TECHNOLOGY			English	Article							HEAD COMPUTED-TOMOGRAPHY; BRAIN-INJURY; POSITION STATEMENT; WHITE-MATTER; HIGH-SCHOOL; MANAGEMENT; EPIDEMIOLOGY; RETURN; YOUTH; PLAY		[Odle, Teresa G.] Amer Soc Radiol Technologists, Publicat Dept, 15000 Cent Ave NE, Albuquerque, NM 87123 USA		Odle, TG (corresponding author), Amer Soc Radiol Technologists, Publicat Dept, 15000 Cent Ave NE, Albuquerque, NM 87123 USA.						Amen DG, 2016, J ALZHEIMERS DIS, V53, P237, DOI 10.3233/JAD-160207; American Academy of Pediatrics, 2015, POL STAT TACKL YOUTH; American College of Radiology appropriateness criteria, HEAD TRAUM; American College of Radiology Head Injury Institute, STAND TBI RADS; Asadollahi S, 2016, BRAIN INJURY, V30, P172, DOI 10.3109/02699052.2015.1091504; Berlin L, 2014, AM J ROENTGENOL, V202, pW408, DOI 10.2214/AJR.14.12686; Bernhardt DT, CONCUSSION SPORT SPE; Bharadwaj S, 2016, CURR OPIN PEDIATR, V28, P121, DOI 10.1097/MOP.0000000000000297; Brook EM, 2016, PHYSICIAN SPORTSMED, V44, P20, DOI 10.1080/00913847.2016.1142834; Carl RL, 2014, CLIN PEDIATR, V53, P689, DOI 10.1177/0009922814526979; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Centers for Disease Control and Prevention, MAN RET ACT; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Choe MC, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0573-9; Choe MC, 2015, SEMIN NEUROL, V35, P29, DOI 10.1055/s-0035-1544243; Clark MD, 2017, AM J SPORT MED, V45, P929, DOI 10.1177/0363546516677793; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Czerniak SM, 2015, BRAIN IMAGING BEHAV, V9, P323, DOI 10.1007/s11682-014-9312-1; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Dettwiler A, 2014, J NEUROTRAUM, V31, P180, DOI 10.1089/neu.2013.2983; Dimou S, 2014, J NEUROTRAUM, V31, P413, DOI 10.1089/neu.2013.3050; Eckner JT, 2014, BRIT J SPORT MED, V48, P112, DOI 10.1136/bjsports-2012-091579; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00061; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P241, DOI 10.3171/2015.1.PEDS14510; Finkbeiner NWB, 2016, CAN J PSYCHIAT, V61, P270, DOI 10.1177/0706743716644953; Forrest W., 2016, BRAIN MRI SHOWS LING; Forrest W, 2016, MRI SHOWS PROMISE DI; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Henry LC, 2016, NEUROSCIENTIST; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; Ketcham CJ, 2014, JOVE-J VIS EXP, DOI 10.3791/52046; Kinnaman KA, 2014, PEDIATR EMERG CARE, V30, P458, DOI 10.1097/PEC.0000000000000161; Kroshus E, 2015, J ATHL TRAINING, V50, P944, DOI 10.4085/1062-6050-50.6.03; Lange RT, 2015, ARCH CLIN NEUROPSYCH, V30, P7, DOI 10.1093/arclin/acu060; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McMains V., 2016, SIGNS BRAIN INJURIES; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Morgan CD, 2015, CHILD NERV SYST, V31, P2305, DOI 10.1007/s00381-015-2916-y; National Collegiate Athletic Association, CONC; National Safety Council, CONC CAR BEL TOP EV; Papa L, 2015, J NEUROTRAUM, V32, P661, DOI 10.1089/neu.2014.3655; Purcell L, 2016, CLIN PEDIATR, V55, P452, DOI 10.1177/0009922815589915; Resch JE, 2015, J CHILD NEUROL, V30, P1686, DOI 10.1177/0883073815574335; Rigotti DJ, 2007, AM J NEURORADIOL, V28, P1843, DOI 10.3174/ajnr.A0774; Rose SC, 2017, BRAIN INJURY, V31, P260, DOI 10.1080/02699052.2016.1235285; Rose SC, 2015, PEDIATR NEUROL, V53, P108, DOI 10.1016/j.pediatrneurol.2015.04.003; Safe Kids Worldwide, 2013, GAM CHANG STATS STOR; Schmidle N, 2017, NEW YORKER; Sharp David J, 1800, Pract Neurol, V15, P172, DOI 10.1136/practneurol-2015-001087; Shetty T, 2016, SPORTS HEALTH, V8, P26, DOI 10.1177/1941738115588745; Sports Concussion Institute, CONC FACTS; Stoller J, 2014, CAN FAM PHYSICIAN, V60, P548; Strain JF, 2015, JAMA NEUROL, V72, P773, DOI 10.1001/jamaneurol.2015.0206; Tremblay S, 2014, BRAIN, V137, P2997, DOI 10.1093/brain/awu236; Underwood E, 2016, SCIENCE, V352, P881, DOI 10.1126/science.352.6288.881; USA Football, US FOOTB COMM RES; USA Football, HEADS UP FOOTB; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537; White PE, 2014, BRIT J SPORT MED, V48, P119, DOI 10.1136/bjsports-2013-092785; Wintermark M, 2015, AM J NEURORADIOL, V36, pE12, DOI 10.3174/ajnr.A4254; Wintermark M, 2015, AJNR Am J Neuroradiol, V36, pE1, DOI 10.3174/ajnr.A4181; Wintermark M, 2015, AM COLL RAD HEAD INJ; Wintermark Max, 2015, J Am Coll Radiol, V12, pe1, DOI 10.1016/j.jacr.2014.10.014; Zonfrillo MR, 2015, ACAD EMERG MED, V22, P872, DOI 10.1111/acem.12696	68	1	1	0	0	AMER SOC RADIOLOGIC TECHNOLOGISTS	ALBUQUERQUE	15000 CENTRAL AVE, SE, ALBUQUERQUE, NM 87123 USA	0033-8397	1943-5657		RADIOL TECHNOL	Radiol. Technol.	JUL-AUG	2017	88	6					621CT	642CT					22	Radiology, Nuclear Medicine & Medical Imaging	Emerging Sources Citation Index (ESCI)	Radiology, Nuclear Medicine & Medical Imaging	VI1RP	WOS:000461505700005	28900059				2022-02-06	
J	Reddy, P; Dupree, L				Reddy, Pramod; Dupree, Lori			Practical Approach to VTE Management in Hospitalized Patients	AMERICAN JOURNAL OF THERAPEUTICS			English	Article						DVT; PE; massive PE; IVC filters; thromboprophylaxis	VENA-CAVA FILTERS; DEEP-VEIN THROMBOSIS; INTERMITTENT PNEUMATIC COMPRESSION; ACUTE VENOUS THROMBOEMBOLISM; CANCER-ASSOCIATED THROMBOSIS; SUPERFICIAL FEMORAL VEIN; TRAUMATIC BRAIN-INJURY; UPPER EXTREMITY DEEP; PULMONARY-EMBOLISM; ORAL ANTICOAGULANTS	Venous thromboembolism (VTE) is a commonly feared life-threatening complication in hospitalized patients. Physicians are frequently consulted to diagnose and manage VTE in obstetrics, neurology, and surgical services. VTE should be treated irrespective of the presentation (incidental or symptomatic), etiology (provoked vs. unprovoked), and location of the venous thrombosis (extremities, abdomen, or cerebral). In patients with high clinical suspicion for VTE, physicians are encouraged to empirically start anticoagulant therapy while awaiting diagnostic testing. Thrombolytic therapy is underused by physicians, which is proven to improve the mortality in hypotensive patients with pulmonary embolism. Retrievable inferior vena cava filters have an important role in the prophylaxis and management of selective groups of VTE patients. Physicians should not hesitate to place retrievable inferior vena cava filters when clinically indicated but also should make every effort to remove them when no longer needed. This article extensively reviews various diagnostic and management options based on several clinical situations.	[Reddy, Pramod] Univ Florida, Coll Med, Dept Med, 653-1 West Eighth St, Jacksonville, FL 32209 USA; [Dupree, Lori] Univ Florida, Coll Pharm, 653-1 West Eighth St, Jacksonville, FL 32209 USA		Reddy, P (corresponding author), Univ Florida, Dept Med, 653-1 West Eighth St, Jacksonville, FL 32209 USA.	pramod.reddy@jax.ufl.edu					Aarab R, 2013, NETH J MED, V71, P466; Adams DM, 2013, AM J MED, V126, P36, DOI 10.1016/j.amjmed.2012.05.028; Ageno W, 2015, THROMB RES, V135, P666, DOI 10.1016/j.thromres.2015.02.001; Agnelli G, 1998, NEW ENGL J MED, V339, P80, DOI 10.1056/NEJM199807093390204; Akpinar EE, 2013, J THORAC DIS, V5, P430, DOI 10.3978/j.issn.2072-1439.2013.07.34; Al-Yaseen E, 2005, J THROMB HAEMOST, V3, P100, DOI 10.1111/j.1538-7836.2004.01053.x; Alberio L, 2014, SEMIN HEMATOL, V51, P152, DOI 10.1053/j.seminhematol.2014.03.002; Alvarado G, 2012, MELANOMA RES, V22, P310, DOI 10.1097/CMR.0b013e328353efd8; Alving BM, 2003, BLOOD, V101, P31, DOI 10.1182/blood-2002-04-1089; Arabi YM, 2013, CHEST, V144, P152, DOI 10.1378/chest.12-2028; Arnsten JH, 1997, AM J MED, V103, P11, DOI 10.1016/S0002-9343(97)90048-6; Bahloul M, 2015, CLIN RESPIR J, V9, P270, DOI 10.1111/crj.12131; Baig M, 2014, WORLD J CARDIOL, V6, P107, DOI 10.4330/wjc.v6.i3.107; Baldwin MJ, 2013, J THROMB HAEMOST, V11, P795, DOI 10.1111/jth.12180; Barleben A, 2013, SEMIN VASC SURG, V26, P111, DOI 10.1053/j.semvascsurg.2014.01.001; Barrera LM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008303.pub2; Bauersachs RM, 2013, HAMOSTASEOLOGIE, V33, P232, DOI 10.5482/HAMO-13-04-0027; Bickel A, 2014, J CARD FAIL, V20, P739, DOI 10.1016/j.cardfail.2014.07.004; Birdwell BG, 2000, ARCH INTERN MED, V160, P309, DOI 10.1001/archinte.160.3.309; Blann AD, 2014, BRIT J BIOMED SCI, V71, P158, DOI 10.1080/09674845.2014.11669981; Bleker SM, 2014, BLOOD REV, V28, P123, DOI 10.1016/j.blre.2014.03.005; Blondon M, 2012, CHEST, V142, P697, DOI 10.1378/chest.11-2694; Boonyawat K, 2015, SEMIN THROMB HEMOST, V41, P68, DOI 10.1055/s-0034-1398386; Bouman AC, 2014, PHLEBOLOGY, V29, P78, DOI 10.1177/0268355514528131; Brodie J, 2014, J CLIN ULTRASOUND, V42, P472, DOI 10.1002/jcu.22171; BUNDENS WP, 1995, JAMA-J AM MED ASSOC, V274, P1296; Burns SK, 2012, CARDIOL REV, V20, P15, DOI 10.1097/CRD.0b013e31822d2a6a; Bushnell Cheryl, 2014, Continuum (Minneap Minn), V20, P335, DOI 10.1212/01.CON.0000446105.67173.a8; Carrier M, 2012, J THROMB HAEMOST, V10, P1486, DOI 10.1111/j.1538-7836.2012.04804.x; Chalikias G, 2014, CURR VASC PHARMACOL, V12, P393, DOI 10.2174/157016111203140518154535; Cham MD, 2005, RADIOLOGY, V234, P591, DOI 10.1148/radiol.2342021656; Chan WS, 2010, CAN MED ASSOC J, V182, P657, DOI 10.1503/cmaj.091692; Cohn DM, 2007, SEMIN THROMB HEMOST, V33, P573, DOI 10.1055/s-2007-985753; Comerota AJ, 1997, ANN SURG, V226, P306, DOI 10.1097/00000658-199709000-00010; Comerota AJ, 2013, EXPERT REV CARDIOVAS, V11, P1631, DOI 10.1586/14779072.2013.852955; Conti E, 2014, J THROMB THROMBOLYS, V37, P251, DOI 10.1007/s11239-013-0941-9; Dager WE, 2010, ADV CHRONIC KIDNEY D, V17, P420, DOI 10.1053/j.ackd.2010.06.002; Decousus H, 2005, CIRCULATION, V112, P416, DOI 10.1161/CIRCULATIONHA.104.512834; Dennis M, 2011, J THROMB HAEMOST, V9, P2193, DOI 10.1111/j.1538-7836.2011.04486.x; Di Nisio M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008500.pub3; Douketis JD, 1998, JAMA-J AM MED ASSOC, V279, P458, DOI 10.1001/jama.279.6.458; Dudley RR, 2010, J NEUROTRAUM, V27, P2165, DOI 10.1089/neu.2010.1366; Dunn AS, 2006, THROMB HAEMOSTASIS, V95, P758, DOI 10.1160/TH06-02-0089; Elyamany G, 2014, CLIN MED INSIGHTS-ON, V8, P129, DOI 10.4137/CMO.S18991; Fallouh N, 2015, AM J MED; Freeman A, 2012, AM J HEMATOL, V87, P740, DOI 10.1002/ajh.23228; Fukuda T, 2013, THROMB RES, V131, P540, DOI 10.1016/j.thromres.2013.04.016; Galanaud JP, 2014, J THROMB HAEMOST, V12, P436, DOI 10.1111/jth.12512; Gandara E, 2014, THROMB J, V12, DOI 10.1186/1477-9560-12-12; Geerts W, 2014, HEMATOL-AM SOC HEMAT, P306, DOI 10.1182/asheducation-2014.1.306; Goldhaber SZ, 2002, EUR RESPIR J, V35, p22s; Goodman LR, 2007, AM J ROENTGENOL, V189, P1071, DOI 10.2214/AJR.07.2388; GREENBERGER PA, 1986, J ALLERGY CLIN IMMUN, V77, P630, DOI 10.1016/0091-6749(86)90357-X; Greenfield L, 2003, ARCH SURG-CHICAGO, V138, P1245, DOI 10.1001/archsurg.138.11.1245; Gupta S, 2008, BJOG-INT J OBSTET GY, V115, P785, DOI 10.1111/j.1471-0528.2008.01704.x; Guyatt GH, 2012, CHEST, V141, p7S, DOI 10.1378/chest.1412S3; Harmon JP, 2013, CURR OPIN NEPHROL HY, V22, P624, DOI 10.1097/MNH.0b013e328365adca; Harvey JJ, 2013, CLIN RADIOL, V68, P721, DOI 10.1016/j.crad.2013.01.001; Harvey RL, 2004, ARCH PHYS MED REHAB, V85, P1070, DOI 10.1016/j.apmr.2003.09.012; Henry JC, 2014, VASC ENDOVASC SURG, V48, P396, DOI 10.1177/1538574414541704; Heye S, 2006, RADIOLOGY, V241, P291, DOI 10.1148/radiol.2411050714; Hirschl M, 2014, VASA, V43, P353, DOI 10.1024/0301-1526/a000373; Ho KM, 2015, BRIT J ANAESTH, V114, P63, DOI 10.1093/bja/aeu195; Hull RD, 2010, ANN INTERN MED, V153, P8, DOI 10.7326/0003-4819-153-1-201007060-00004; Imberti D, 2014, THROMB HAEMOSTASIS, V111, P618, DOI 10.1160/TH13-11-0938; Imberti D, 2012, SEMIN RESP CRIT CARE, V33, P176, DOI 10.1055/s-0032-1311796; Jamal MH, 2015, SURG ENDOSC, V29, P376, DOI 10.1007/s00464-014-3678-4; Jenkins EO, 2010, J THROMB HAEMOST, V8, P221, DOI 10.1111/j.1538-7836.2009.03690.x; Jenkins JS, 2014, OCHSNER J, V14, P633; Castro DJ, 2007, THROMB RES, V121, P153, DOI 10.1016/j.thromres.2007.03.028; Kalva SP, 2008, J VASC INTERV RADIOL, V19, P1041, DOI 10.1016/j.jvir.2008.03.026; Kearon C, 1998, ANN INTERN MED, V129, P1044, DOI 10.7326/0003-4819-129-12-199812150-00009; Kearon C, 2014, BLOOD, V123, P1794, DOI 10.1182/blood-2013-12-512681; Kim HS, 2006, J VASC INTERV RADIOL, V17, P815, DOI 10.1097/01.RVI.0000209341.88873.26; Kim MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100154; Klitfod L, 2013, INT ANGIOL, V32, P447; Klok FA, 2008, ARCH INTERN MED, V168, P2131, DOI 10.1001/archinte.168.19.2131; LASSER EC, 1987, NEW ENGL J MED, V317, P845, DOI 10.1056/NEJM198710013171401; Laurence IJ, 2012, CLIN RADIOL, V67, P941, DOI 10.1016/j.crad.2012.04.007; Le Gal G, 2015, J THROMB HAEMOST, V13, P563, DOI 10.1111/jth.12851; Lee YJ, 2013, CHINESE MED J-PEKING, V126, P2049, DOI 10.3760/cma.j.issn.0366-6999.20130385; Leon L, 2005, ANN VASC SURG, V19, P442, DOI 10.1007/s10016-005-0025-1; LEVINE MN, 1994, ARCH INTERN MED, V154, P49, DOI 10.1001/archinte.154.1.49; Lieberman JR, 2013, J BONE JOINT SURG AM, V95A, P1801, DOI 10.2106/JBJS.L.01328; Lilly CM, 2014, CHEST, V146, P51, DOI 10.1378/chest.13-2160; Lisman T, 2013, J HEPATOL, V59, P358, DOI 10.1016/j.jhep.2013.03.027; Liu Y, 2012, J VASC SURG, V55, P1042, DOI 10.1016/j.jvs.2011.10.107; Lovenstein Scott, 2014, Skinmed, V12, P207; Macovei L, 2015, CARDIOL J, V22, P467, DOI 10.5603/CJ.a2014.0103; Magnus N, 2013, SEMIN THROMB HEMOST, V39, P881, DOI 10.1055/s-0033-1357483; Masotti L, 2012, CLIN APPL THROMB-HEM, V18, P393, DOI 10.1177/1076029612441055; Matzdorff A, 2013, SEMIN HEMATOL, V50, P83, DOI DOI 10.1053/J.SEMINHEMAT0L.2013.03.020; McCullough P, 2006, CATHETER CARDIO INTE, V67, P335, DOI 10.1002/ccd.20658; McKenzie SE, 2014, CURR OPIN HEMATOL, V21, P380, DOI 10.1097/MOH.0000000000000066; Mebazaa A, 2014, CIRCULATION, V130, P410, DOI 10.1161/CIRCULATIONAHA.113.003126; Meinel FG, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/859328; Meunier B, 2013, Rev Med Liege, V68, P465; Mismetti P, 2000, THROMB HAEMOSTASIS, V83, P14; Mookadam F, 2010, CARDIOL REV, V18, P29, DOI 10.1097/CRD.0b013e3181c09443; Moten MA, 2013, CLIN TRANSPLANT, V27, P852, DOI 10.1111/ctr.12240; Muriel A, 2014, J AM COLL CARDIOL, V63, P1675, DOI 10.1016/j.jacc.2014.01.058; Nadolski GJ, 2013, J VASC SURG, V57, P593, DOI 10.1016/j.jvs.2012.10.009; Nagler M, 2012, THROMB RES, V129, P407, DOI 10.1016/j.thromres.2011.10.037; Naik RP, 2014, J THROMB HAEMOST, V12, P2010, DOI 10.1111/jth.12744; Noble S, 2012, BMJ SUPPORT PALLIAT, V2, P163, DOI 10.1136/bmjspcare-2011-000166; Northup PG, 2013, CLIN GASTROENTEROL H, V11, P1064, DOI 10.1016/j.cgh.2013.02.026; Nose Y, 2010, J CARDIOL, V55, P384, DOI 10.1016/j.jjcc.2010.01.002; Oger E, 2002, THROMB HAEMOSTASIS, V88, P592; Orensky IA, 2005, PHARMACOTHERAPY, V25, P1801, DOI 10.1592/phco.2005.25.12.1801; Owens CA, 2010, J VASC INTERV RADIOL, V21, P779, DOI 10.1016/j.jvir.2010.02.021; Parasrampuria DA, 2015, THROMB HAEMOSTASIS, P113; Patel JP, 2011, BRIT J HAEMATOL, V155, P137, DOI 10.1111/j.1365-2141.2011.08826.x; Pathak R, 2015, AM J CARDIOL, V115, P323, DOI 10.1016/j.amjcard.2014.10.042; Pelliccia F, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/410341; Phelan HA, 2013, SEMIN THROMB HEMOST, V39, P541, DOI 10.1055/s-0033-1343356; Prisco D, 2014, CLIN CASES MINER BON, V11, P192, DOI 10.11138/ccmbm/2014.11.3.192; Pulivarthi S, 2014, N AM J MED SCI, V6, P491, DOI 10.4103/1947-2714.143278; Raja K, 2014, J CLIN EXP HEPATOL, V4, P320, DOI 10.1016/j.jceh.2013.12.003; Revel MP, 2008, J THROMB HAEMOST, V6, P1478, DOI 10.1111/j.1538-7836.2008.03078.x; Righini M, 2014, THROMB HAEMOSTASIS, P113; Ringley CD, 2002, AM SURGEON, V68, P286; Rolston JD, 2014, J NEUROSURG, V121, P908, DOI 10.3171/2014.6.JNS131419; Rowland SP, 2015, ANN SURG, V261, P35, DOI 10.1097/SLA.0000000000000621; Saad WEA, 2007, RADIOL CLIN N AM, V45, P423, DOI 10.1016/j.rcl.2007.04.011; Sachdeva A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001484.pub3; Salemis NS, 2014, AM J EMERG MED, V32, DOI 10.1016/j.ajem.2014.05.026; Sardar P, 2014, CAN J CARDIOL, V30, P888, DOI 10.1016/j.cjca.2014.04.015; Sartori M, 2015, THROMB RES, V135, P673, DOI 10.1016/j.thromres.2015.02.007; Sasaki H, 2014, INT ORTHOP, V38, P525, DOI 10.1007/s00264-013-2132-x; SCHIFF D, 1994, CANCER, V73, P493, DOI 10.1002/1097-0142(19940115)73:2<493::AID-CNCR2820730240>3.0.CO;2-D; Sciascia S, 2014, CURR OPIN RHEUMATOL, V26, P269, DOI 10.1097/BOR.0000000000000051; Scott G, 2015, BRIT J HAEMATOL, V168, P639, DOI 10.1111/bjh.13255; Shapira-Rootman M, 2015, EMERG RADIOL, V22, P257, DOI 10.1007/s10140-014-1280-7; Sivananthan G, 2014, J ULTRAS MED, V33, P2137, DOI 10.7863/ultra.33.12.2137; Somarouthu B, 2011, J NEUROINTERV SURG, V3, P141, DOI 10.1136/jnis.2010.004564; Srivastava G, 2009, J THORAC ONCOL, V4, P333, DOI 10.1097/JTO.0b013e318194fad4; Stein PD, 2013, THROMB HAEMOSTASIS, V109, P897, DOI 10.1160/TH13-01-0006; Stein PD, 2012, AM J MED, V125, P465, DOI 10.1016/j.amjmed.2011.10.015; Stein PD, 2012, AM J MED, V125, P478, DOI 10.1016/j.amjmed.2011.05.025; Stein PD, 2004, ARCH INTERN MED, V164, P1541, DOI 10.1001/archinte.164.14.1541; Strom RG, 2013, SPINE, V38, pE1498, DOI 10.1097/BRS.0b013e3182a4408d; SULLIVAN KL, 1995, CARDIOVASC INTER RAD, V18, P141; Tainter CR, 2015, J EMERG MED, V48, P158, DOI 10.1016/j.jemermed.2014.10.006; Theodorou SJ, 2003, CLIN IMAG, V27, P180, DOI 10.1016/S0899-7071(02)00517-X; Thomas SM, 2008, CLIN RADIOL, V63, P299, DOI 10.1016/j.crad.2007.09.010; Tufano A, 2011, SEMIN THROMB HEMOST, V37, P267, DOI 10.1055/s-0031-1273090; Van Gent JM, 2014, J TRAUMA ACUTE CARE, V77, P238, DOI 10.1097/TA.0000000000000294; van Ryn J, 2010, THROMB HAEMOSTASIS, V103, P1116, DOI 10.1160/TH09-11-0758; Velander AJ, 2012, CURR ATHEROSCLER REP, V14, P373, DOI 10.1007/s11883-012-0250-3; Verde F, 2012, J RADIOL CASE REP, V6, P23, DOI 10.3941/jrcr.v6i9.1062; Vlieg AV, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2921; Volturo GA, 2001, EMERG MED CLIN N AM, V19, P877, DOI 10.1016/S0733-8627(05)70224-8; Wang TF, 2014, THROMB HAEMOSTASIS, V111, P88, DOI 10.1160/TH13-01-0042; Watson HG, 2006, BRIT J HAEMATOL, V135, P269, DOI 10.1111/j.1365-2141.2006.06290.x; Wells PS, 2000, THROMB HAEMOSTASIS, V83, P416; Wharin C, 2014, BLOOD REV, V28, P1, DOI 10.1016/j.blre.2013.11.001; Wool GD, 2013, AM J CLIN PATHOL, V140, P623, DOI 10.1309/AJCPR3JTOK7NKDBJ; Yoon SH, 2015, ALLERGY, V70, P625, DOI 10.1111/all.12589; Zhang J, 2013, THORAX, V68, P442, DOI 10.1136/thoraxjnl-2012-202592	159	1	4	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1075-2765	1536-3686		AM J THER	Am. J. Ther.	JUL-AUG	2017	24	4					E442	E467		10.1097/MJT.0000000000000285			26	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	FA4TP	WOS:000405436400011	26049254				2022-02-06	
J	Yalcin, A; Baydin, A; Tuncel, OK; Erenler, AK; Cokluk, C; Guzel, M; Tomak, L				Yalcin, Anil; Baydin, Ahmet; Tuncel, Ozgur Korhan; Erenler, Ali Kemal; Cokluk, Cengiz; Guzel, Murat; Tomak, Leman			Diagnostic values of proenkephalin and S100B protein in traumatic brain injury	LABORATORIUMSMEDIZIN-JOURNAL OF LABORATORY MEDICINE			English	Article						emergency department; proenkephalin; S100B; traumatic brain injury	NEUROPEPTIDE PROENKEPHALIN; HEAD-INJURY; INTRACEREBRAL HEMORRHAGE; COMPUTERIZED-TOMOGRAPHY; LESIONS; LEVEL	Background: The primary aim of this study was to investigate the diagnostic values of serum S100 calcium-binding protein B (S100B) and proenkephalin (P-ENK) levels in brain damage caused by traumatic brain injury (TBI). Methods: We prospectively collected serum blood samples of 58 adult patients admitted to our emergency department due to TBI. Serum S100B and P-ENK levels were measured and compared according to clinical findings and outcomes of the patients. Results: When patients with brain injury were compared to controls, statistical significance was determined in both S100B and P-ENK levels. According to the receiver operating characteristic (ROC) analysis, cut-off values for serum S100B and P-ENK levels for the differential diagnosis of patients with and without brain damage were found to be 785.944 ng/mL and 2.445 ng/mL, respectively. There was a statistical significance in both S100B and P-ENK levels when patients who were discharged and those who died were compared. Conclusions: Serum S100B and P-ENK levels are found to be elevated in patients with TBI when compared to controls. Additionally, serum levels of both markers are found to be elevated in patients with multiple lesions when compared to patients with a single lesion. Serum S100B and P-ENK levels may also be used as predictors of mortality in patients with TBI.	[Baydin, Ahmet] Ondokuz Mayis Univ, Emergency Med, Fac Med, TR-55139 Kurupelit, Samsun, Turkey; [Yalcin, Anil; Guzel, Murat] Samsun Educ & Res Hosp, Dept Emergency Med, Samsun, Turkey; [Tuncel, Ozgur Korhan] Ondokuz Mayis Univ, Dept Med Biochem, Fac Med, Samsun, Turkey; [Erenler, Ali Kemal] Hitit Univ, Corum Educ & Res Hosp, Dept Emergency Med, Corum, Turkey; [Cokluk, Cengiz] Ondokuz Mayis Univ, Dept Neurosurg, Fac Med, Samsun, Turkey; [Tomak, Leman] Ondokuz Mayis Univ, Dept Biostat, Fac Med, Samsun, Turkey		Baydin, A (corresponding author), Ondokuz Mayis Univ, Emergency Med, Fac Med, TR-55139 Kurupelit, Samsun, Turkey.	ahmetbaydn@yahoo.com	Cokluk, Cengiz/B-1394-2018; guzel, murat/Q-3326-2016; BAYDIN, AHMET/AAG-4188-2019; Erenler, Ali Kemal/AAA-2995-2020	Cokluk, Cengiz/0000-0003-2146-3621; BAYDIN, AHMET/0000-0003-4987-0878; 			Burlew CC, 2010, SCHWARTZS PRINCIPLES, V7, P161; Cameron P, 2016, EMERGENCY MED COMPER, P1681; Cervellin G, 2012, CLIN BIOCHEM, V45, P408, DOI 10.1016/j.clinbiochem.2012.01.006; Chen XL, 2014, PEPTIDES, V56, P111, DOI 10.1016/j.peptides.2014.04.001; Dalbayrak S, 2011, TURK NEUROSURG, V21, P591, DOI [10.5137/1019-5149.JTN .3570-10.2, 10.5137/1019-5149.JTN.3570-10.2]; Delgado P, 2006, STROKE, V37, P2837, DOI 10.1161/01.STR.0000245085.58807.ad; Di Battista AP, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00110; Gao JB, 2014, PEPTIDES, V58, P42, DOI 10.1016/j.peptides.2014.06.006; Goyal A, 2013, J NEUROTRAUM, V30, P946, DOI 10.1089/neu.2012.2579; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Laribi S, 2014, CLIN CHEM LAB MED, V52, P527, DOI 10.1515/cclm-2013-0621; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; Melenson SW, 2010, EMERGENCY MED COMPER, P5141; Sezer AA, 2012, ULUS TRAVMA ACIL CER, V18, P411, DOI 10.5505/tjtes.2012.76736; Sieswerda-Hoogendoorn T, 2012, EUR J PEDIATR, V171, P415, DOI 10.1007/s00431-011-1598-z; Yang XG, 2014, PEPTIDES, V58, P47, DOI 10.1016/j.peptides.2014.06.005	16	1	1	0	8	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0342-3026	1439-0477		LABORATORIUMSMEDIZIN	LaboratoriumsMedizin	JUL	2017	41	3					123	128		10.1515/labmed-2016-0045			6	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	FA8RX	WOS:000405714700003					2022-02-06	
J	Gallant, C; Drumheller, A; McKelvie, SJ				Gallant, Caitlyn; Drumheller, Andrea; McKelvie, Stuart J.			Effect of Improper Soccer Heading on Serial Reaction Time Task Performance	CURRENT PSYCHOLOGY			English	Article						Heading training; Purposeful heading; Sub-concussive trauma; Serial reaction time task	CHRONIC TRAUMATIC ENCEPHALOPATHY; CONCUSSIVE BRAIN-INJURY; NEUROPSYCHOLOGICAL PERFORMANCE; POSTURAL CONTROL; FREQUENCY; FEMALE; PLAYERS; S-100B; DAMAGE; SKILL	Using the Serial Reaction Time Task (SRTT), which measures implicit learning, the present experiment investigated the consequences of sub-concussive impacts in soccer from trained and untrained heading techniques. Fifty-one participants were (n = 25) or were not (n = 26) given training in proper heading after which they were tested on a head-ball task. The SRTT was administered before (pre-test) and after (post-test) the training and testing. There was some evidence of implicit learning on the pre-test, and clear evidence of continued implicit learning on the post-test. Most importantly, improper heading did not disrupt test performance. Strengths and weaknesses of the present experiment are presented and suggestions are made for future research.	[Gallant, Caitlyn; Drumheller, Andrea; McKelvie, Stuart J.] Bishops Univ, Sherbrooke, PQ J1M 1Z7, Canada		McKelvie, SJ (corresponding author), Bishops Univ, Sherbrooke, PQ J1M 1Z7, Canada.	smckelvi@ubishops.ca					Abbas K, 2015, DEV NEUROPSYCHOL, V40, P51, DOI 10.1080/87565641.2014.990455; Asken M. J., 1998, HEADACHE, V12, P2; Beaulieu C, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-102; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Boyer M, 2005, PSYCHOL RES-PSYCH FO, V69, P383, DOI 10.1007/s00426-004-0207-4; Broglio SP, 2004, BRIT J SPORT MED, V38, P561, DOI 10.1136/bjsm.2003.004887; Cernich AN, 2007, ARCH CLIN NEUROPSYCH, V22, pS39, DOI 10.1016/j.acn.2006.10.004; Cohen J, 1977, STAT POWER ANAL BEHA; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Day A. L., 2001, NEUROLOGICAL SPORTS; De Beaumont L, 2012, CEREB CORTEX, V22, P112, DOI 10.1093/cercor/bhr096; DeCoster J, 2011, J MOTOR BEHAV, V43, P263, DOI 10.1080/00222895.2011.574171; DeRight J, 2015, CLIN NEUROPSYCHOL, V29, P101, DOI 10.1080/13854046.2014.989267; FIFA, 2006, FIFA BIG COUNT 2006; Francis G., 2008, COGLAB CD VERSION 2; Fu F. H., 1994, SPORTS INJURIES MECH; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Jackson & Jackson, 1995, PSYCHE, V2; Kaminski TW, 2008, RES Q EXERCISE SPORT, V79, P235; Kaminski TW, 2007, J CLIN EXP NEUROPSYC, V29, P742, DOI 10.1080/13825580600976911; Kemeny F, 2011, J GEN PSYCHOL, V138, P110, DOI 10.1080/00221309.2010.542509; Kirkendall DT, 2001, J ATHL TRAINING, V36, P328; Kontos AP, 2011, BRAIN INJURY, V25, P1234, DOI 10.3109/02699052.2011.608209; MACFLYNN G, 1984, J NEUROL NEUROSUR PS, V47, P1326, DOI 10.1136/jnnp.47.12.1326; Maher ME, 2014, BRAIN INJURY, V28, P271, DOI 10.3109/02699052.2013.865269; McCrory PR, 2003, BRIT MED J, V327, P351, DOI 10.1136/bmj.327.7411.351; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Norman G, 2000, BIOSTATISTICS BARE E; Perez MA, 2007, J NEUROSCI, V27, P1045, DOI 10.1523/JNEUROSCI.4128-06.2007; Poole VN, 2015, DEV NEUROPSYCHOL, V40, P12, DOI 10.1080/87565641.2014.984810; Putukian M, 2000, CLIN J SPORT MED, V10, P104, DOI 10.1097/00042752-200004000-00004; Putukian M., 2001, CLIN J SPORT MED, V11; Rieder C, 2011, ARCH CLIN NEUROPSYCH, V26, P583, DOI 10.1093/arclin/acr055; Robertson EM, 2007, J NEUROSCI, V27, P10073, DOI 10.1523/JNEUROSCI.2747-07.2007; Ross T. P., 2015, ARCH CLIN NEUROPSYCH; Rutherford A, 2005, APPL COGNITIVE PSYCH, V19, P477, DOI 10.1002/acp.1091; Rutherford A, 2003, NEUROPSYCHOL REV, V13, P153, DOI 10.1023/A:1025525613477; Schmitt DM, 2004, INT J SPORTS MED, V25, P326, DOI 10.1055/s-2004-819941; Shultz SR, 2012, BEHAV BRAIN RES, V229, P145, DOI 10.1016/j.bbr.2011.12.015; Stalnacke BM, 2004, BRAIN INJURY, V18, P899, DOI 10.1080/02699050410001671865; Stalnacke BM, 2008, BIOMARK INSIGHTS, V3, P87; Stickgold R, 2007, SLEEP MED, V8, P331, DOI 10.1016/j.sleep.2007.03.011; Talavage TM, 2010, J NEUROTRAUMA; Tang YP, 1997, J NEUROTRAUM, V14, P851, DOI 10.1089/neu.1997.14.851; TYSVAER AT, 1989, AM J SPORT MED, V17, P573, DOI 10.1177/036354658901700421; Urry K, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01158; Webbe FM, 2003, APPL NEUROPSYCHOL, V10, P31, DOI 10.1207/S15324826AN1001_5; Witol AD, 2003, ARCH CLIN NEUROPSYCH, V18, P397, DOI 10.1016/S0887-6177(02)00151-8; Woitalla M., 2015, US SOCCER NO HEADING; Zhang MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057364	52	1	1	0	9	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1046-1310	1936-4733		CURR PSYCHOL	Curr. Psychol.	JUN	2017	36	2					286	296		10.1007/s12144-016-9414-6			11	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	EY0IK	WOS:000403641400011					2022-02-06	
J	Gurria, JP; Haas, L; Troutt, M; Bhuiyan, MAN; Hossain, MM; Moody, S; Falcone, RA				Gurria, Juan P.; Haas, Lynn; Troutt, Misty; Bhuiyan, Mohammad Alfrad Nobel; Hossain, Md. Monir; Moody, Suzanne; Falcone, Richard A., Jr.			Pediatric trauma undertriage in Ohio	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Pediatric trauma; undertriage; Ohio; statewide analysis	CENTER CARE; INJURED CHILDREN; UNITED-STATES; BRAIN-INJURY; SYSTEM; MORTALITY; ACCESS; CENTERS; CALIFORNIA; TRANSPORT	BACKGROUND: Appropriate and timely triage is an essential component of a trauma system. In the state of Ohio, there are 6 verified pediatric trauma centers (PTCs) across 8 state regions. The purpose of this study was to better understand the pediatric undertriage rates in the state. METHODS: We used the Ohio Trauma Registry from 2007 to 2012, consisting of 14,045 records of children younger than 16 years admitted to a hospital for more than 48 hours or who sustained a traumatic death. Pediatric undertriage was defined as not being directly transported to a PTC when one was available within 30 minutes or not being transferred to a PTC within 2 hours of injury. RESULTS: The state pediatric undertriage rate was 52%, only decreasing to 35% when up to a 4-hour transfer time was allowed. Across state trauma regions, undertriage rates varied from 94% to 40%. More than 28% of injured children had access to a PTC within 30 minutes of their home. A trauma center (adult or pediatric) was within 30 minutes for 66% of the children, yet 32% of the children went to a nontrauma center first. Overall, 29% of children never made it to a PTC, and 4% of children remained at a nontrauma center, with regional variation from 5% to 0.5%. Statewide mortality was nearly 3%, with regional variations between 5% and 0.4%. Mortality rate within the appropriately triaged group was 5.3%, while mortality rate in the undertriage group was only 0.7%. Overall, 53% of transferred patients had a more than 2-hour transfer time. CONCLUSIONS: Despite the significant number of PTCs in Ohio, there remains a high undertriage rate with significant regional variations and long transfer times. Continued analysis will be useful in furthering trauma system development for the injured child. Copyright (C) 2017 Wolters Kluwer Health, Inc. All rights reserved.	[Gurria, Juan P.; Haas, Lynn; Troutt, Misty; Bhuiyan, Mohammad Alfrad Nobel; Hossain, Md. Monir; Moody, Suzanne; Falcone, Richard A., Jr.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA		Falcone, RA (corresponding author), MLC 2023,3333 Burnet Ave, Cincinnati, OH 45229 USA.	Richard.falcone@cchmc.org	Bhuiyan, Mohammad/R-1947-2018; Bhuiyan, Mohammad/O-9863-2019	Bhuiyan, Mohammad/0000-0002-6011-2624; Bhuiyan, Mohammad/0000-0002-6011-2624	Ohio Department of Public Safety	This research study was funded by the Ohio Department of Public Safety, Ohio Trauma EMS Research Grant, EMS Funding Priority #2, 2015-2016. The authors acknowledge Schuyler Schmidt, epidemiologist from the Ohio Department of Public Safety, for his assistance with this database.	Abdullah F, 2014, J AM COLL SURGEONS, V218, P479, DOI 10.1016/j.jamcollsurg.2013.10.028; Acosta CD, 2010, ACAD EMERG MED, V17, P1364, DOI 10.1111/j.1553-2712.2010.00926.x; Baez AA, 2003, J TRAUMA, V54, P344, DOI 10.1097/01.TA.0000046258.81127.E1; Branas CC, 2005, JAMA-J AM MED ASSOC, V293, P2626, DOI 10.1001/jama.293.21.2626; Chatoorgoon K, 2010, PEDIATR EMERG CARE, V26, P481, DOI 10.1097/PEC.0b013e3181e5bef3; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Doumouras AG, 2012, PREHOSP EMERG CARE, V16, P456, DOI 10.3109/10903127.2012.695431; Fahy AS, 2016, J PEDIATR SURG, V51, P323, DOI 10.1016/j.jpedsurg.2015.10.055; Gomez D, 2012, J TRAUMA ACUTE CARE, V73, P1288, DOI 10.1097/TA.0b013e318265cec2; Gonzalez RP, 2006, J TRAUMA, V61, P404, DOI 10.1097/01.ta.0000229816.16305.94; Haas B, 2012, J TRAUMA ACUTE CARE, V72, P1510, DOI 10.1097/TA.0b013e318252510a; Harrington DT, 2005, ANN SURG, V241, P961, DOI 10.1097/01.sla.0000164178.62726.f1; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Jones CMC, 2016, PREHOSP EMERG CARE, V20, P6, DOI 10.3109/10903127.2015.1025157; Kassam-Adams N, 2013, JAMA PEDIATR, V167, P1158, DOI 10.1001/jamapediatrics.2013.2741; Lerner EB, 2003, ACAD EMERG MED, V10, P949, DOI 10.1197/S1069-6563(03)00313-0; Livingston MH, 2014, INJURY, V45, P164, DOI 10.1016/j.injury.2013.06.009; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Myers SR, 2011, J TRAUMA, V71, P1428, DOI 10.1097/TA.0b013e31821b0ce9; Nance ML, 2009, ARCH PEDIAT ADOL MED, V163, P512, DOI 10.1001/archpediatrics.2009.65; Nathens AB, 2004, J TRAUMA, V56, P173, DOI 10.1097/01.TA.0000056159.65396.7C; Nathens AB, 2003, J TRAUMA, V55, P444, DOI 10.1097/01.TA.0000047809.64699.59; Odetola FO, 2016, PREHOSP DISASTER MED, V31, P4, DOI 10.1017/S1049023X15005191; Potoka DA, 2001, J TRAUMA, V51, P824, DOI 10.1097/00005373-200111000-00002; Pracht EE, 2008, J PEDIATR SURG, V43, P212, DOI 10.1016/j.jpedsurg.2007.09.047; Rogers FB, 1999, J TRAUMA, V46, P328, DOI 10.1097/00005373-199902000-00022; Sathya C, 2015, JAMA SURG, V150, P874, DOI 10.1001/jamasurg.2015.1121; Segui-Gomez M, 2003, J PEDIATR SURG, V38, P1162, DOI 10.1016/S0022-3468(03)00262-8; Soundappan SVS, 2007, J TRAUMA, V62, P1229, DOI 10.1097/01.ta.0000219893.99386.fc; Vassar MJ, 2003, J AM COLL SURGEONS, V197, P717, DOI 10.1016/S1072-7515(03)00749-X; Vavilala MS, 2003, J TRAUMA, V55, P1039, DOI 10.1097/01.TA.0000101759.23607.57; Wang NE, 2013, J TRAUMA ACUTE CARE, V75, P704, DOI 10.1097/TA.0b013e31829a0a65; Xiang HY, 2014, AM J EMERG MED, V32, P997, DOI 10.1016/j.ajem.2014.05.038	33	1	1	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUN	2017	82	6					1007	1013		10.1097/TA.0000000000001439			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	EV5MV	WOS:000401811900005	28520684				2022-02-06	
J	Helfen, T; Lefering, R; Moritz, M; Bocker, W; Grote, S				Helfen, T.; Lefering, R.; Moritz, M.; Boecker, W.; Grote, S.		Traumaregister DGU	Characterization of the seriously injured cyclist. An evaluation of the injury and treatment focus areas of 2817 patients	UNFALLCHIRURG			German	Article						Bicyclists; ISS; TBI; Polytrauma; Traumaregistry	SEVERITY SCORE; BICYCLISTS; PEDESTRIANS; HELICOPTER	Background. Transport statistics classify bicyclists in a separate road user collective. For medical reasons, this differentiation is applied as well. Much literature is published in this field. Nevertheless there is a lack of literature regarding the overall injury patterns in a defined injury severity collective. Most literature is about isolated injured regions in combination with a heterogeneous injury severity. Further parameters, such as injury patterns, epidemiological aspects, treatment focal points and characteristic outcomes, have also been studied. The aim of the present study was to evaluate and characterize injury patterns in a standardized and representative collective of severely injured bicyclists. Methods We analysed data from the Traumaregister DGU (R) from 2002 to 2010. In total, 2817 severely injured (ISS >= 9 and additional intensive/intermediate care unit) bicyclists were included. The primary endpoint was evaluation of injury patterns and injury focal points. In addition to that we analysed parameters like epidemiological aspects, circumstances of accident, treatment focal points and outcome. Result. The mean age was 50.3 +/- 20.9 years. Males accounted for 68.9 % (n = 1940). The mean ISS was 23.7 +/- 12.6. The mean AIS regions were the head 71.9 % (n = 2025), the chest with 44.9 % (n = 1264) and the upper extremities 33.6 % (947). In 68.2 % of all cases an ISS >= 9 was achieved by a traumatic brain injury; 21.1 % of all cases were mono-injuries. A characteristic distribution of age and a characteristic prevalence of the accidents in relation to the weekday and the month could be shown. Conclusion. The present study analysed the largest ever published collective of severely injured bicyclists. Traumatic brain injury could clearly be shown as the main injury in this collective. Moreover, one of five cases achieved the state "severely injured" due to mono-injury.	[Helfen, T.; Moritz, M.; Boecker, W.] LMU Munchen, Klin Allgemeine Unfall & Wiederherstellungschirur, Nussbaumstr 20, D-80336 Munich, Germany; [Lefering, R.] Univ Witten Herdecke, IFOM, Dept Humanmed, Lehrstuhl Chirurg Forsch,Fak Gesundheit, Cologne, Germany; [Grote, S.] Klinikum St Elisabeth Straubing GmbH, Klin Orthopadie & Unfallchirurg, Straubing, Germany; [Traumaregister DGU] AUC Akad Unfallchirurg GmbH, Munich, Germany		Helfen, T (corresponding author), LMU Munchen, Klin Allgemeine Unfall & Wiederherstellungschirur, Nussbaumstr 20, D-80336 Munich, Germany.	tobias.helfen@med.uni-muenchen.de	Helfen, Tobias/AAG-7498-2021				Airaksinen N, 2016, SCAND J SURG, V105, P49, DOI 10.1177/1457496915571401; Andruszkow H, 2013, CRIT CARE, V17, DOI 10.1186/cc12796; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; CHAMPION HR, 1990, J TRAUMA, V30, P1356, DOI 10.1097/00005373-199011000-00008; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Doong JL, 2012, TRAFFIC INJ PREV, V13, P249, DOI 10.1080/15389588.2011.647140; Eid H. O., 2007, SMJ Singapore Medical Journal, V48, P884; Eid HO, 2009, INJURY, V40, P703, DOI 10.1016/j.injury.2008.07.012; Eker C, 1998, CRIT CARE MED, V26, P1881, DOI 10.1097/00003246-199811000-00033; GENNARELLI TA, 1994, J TRAUMA, V37, P962, DOI 10.1097/00005373-199412000-00016; Helfen T, 2013, NOTFALL RETTUNGSMED, V16, P274, DOI 10.1007/s10049-013-1721-y; Lustenberger T, 2010, J TRAUMA, V69, P1120, DOI 10.1097/TA.0b013e3181d0f68b; McCartt AT, 2011, J SAFETY RES, V42, P177, DOI 10.1016/j.jsr.2011.05.003; MENDELOW AD, 1983, BRIT J SURG, V70, P641, DOI 10.1002/bjs.1800701102; Mommsen P, 2012, TECHNOL HEALTH CARE, V20, P49, DOI 10.3233/THC-2011-0655; Subcommittee A, 2013, J TRAUMA ACUTE CARE, V74, P1363; Teisch LF, 2015, PEDIAT SURG INT, DOI [10.1007/s00383-015-3756-2, DOI :10.1007/S00383-015-3756-2]; Zwipp H, 2012, UNFALLCHIRURG, V115, P554, DOI 10.1007/s00113-011-2045-3	18	1	1	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0177-5537	1433-044X		UNFALLCHIRURG	Unfallchirurg	JUN	2017	120	5					403	408		10.1007/s00113-016-0208-y			6	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	EU6DK	WOS:000401124000010	27357351				2022-02-06	
J	Joosub, N; Cassimjee, N; Cramer, A				Joosub, Noorjehan; Cassimjee, Nafisa; Cramer, Annelies			The relationship between neuropsychological performance and depression in patients with traumatic brain injury	SOUTH AFRICAN JOURNAL OF PSYCHOLOGY			English	Article						Cognitive impairment; depression; neuropsychological assessment; neuropsychology; traumatic brain injury	SOUTH-AFRICA; PSYCHIATRIC-DISORDERS; COGNITIVE IMPAIRMENT; OLDER-ADULTS; MILD; SYMPTOMS; MEMORY; REHABILITATION; INTELLIGENCE; ATTENTION	Traumatic brain injury is a multi-faceted condition that affects individuals on physical, cognitive, and emotional levels. The study investigated the relationship between depression and neuropsychological performance in a group with traumatic brain injury. A retrospective review was conducted on 75 participants who completed neuropsychological assessments. Information on clinical characteristics, sociodemographic information, neuropsychological outcomes, and Beck Depression Inventory scores were included in the analysis. Results indicated that 36% of the participants reported experiencing severe symptoms of depression, 28% moderate symptoms of depression, and 36% mild/minimal symptoms of depression. Performance on the Rey Auditory Verbal Learning Test indicated inverse relationships with depression scores suggesting that traumatic brain injury patients with lower depression scores perform better on verbal memory tasks. Similarly, findings for the written and oral versions of the Symbol Digit Modalities Test reflected inverse correlations with depression scores, indicating that lower depression scores are correlated with increased processing speed and capacity. A significant positive association between the time taken to complete the Trail Making Test Trail A and Trail B and depression scores was found, suggesting that higher depression scores in this sample were related to slower performance speed and lower executive performance. When specific clinical and sociodemographic variables were included as covariates in a partial correlational analysis, neuropsychological performance indicators and depression scores remained significant for Symbol Digit Modalities Test (oral and written), the Rey Auditory Verbal Learning Test Retrieval and Recognition trials, and Trail Making Test (Trail B). This study indicates that in a traumatic brain injury cohort, depression levels are significantly associated with specific neuropsychological performance measures. The findings of this study have implications for psychosocial treatment planning after a traumatic brain injury and contribute to our understandings of the inter-relationship between cognition and emotion.	[Joosub, Noorjehan] Univ Johannesburg, Dept Psychol, Kingsway Campus, ZA-2006 Auckland Pk, South Africa; [Cassimjee, Nafisa; Cramer, Annelies] Univ Pretoria, Dept Psychol, Pretoria, South Africa		Joosub, N (corresponding author), Univ Johannesburg, Dept Psychol, Kingsway Campus, ZA-2006 Auckland Pk, South Africa.	noorjehaan@gmail.com					Anderson J. M., 2009, J CONTROVERSIAL MEDI, V16, P5; Armstrong CL, 2010, HANDBOOK OF MEDICAL NEUROPSYCHOLOGY: APPLICATIONS OF COGNITIVE NEUROSCIENCE, P33, DOI 10.1007/978-1-4419-1364-7_3; Ayotte BJ, 2009, INT J GERIATR PSYCH, V24, P1010, DOI 10.1002/gps.2213; Baune BT, 2012, J AFFECT DISORDERS, V141, P441, DOI 10.1016/j.jad.2012.02.041; Baune BT, 2009, PSYCHIAT CLIN NEUROS, V63, P392, DOI 10.1111/j.1440-1819.2009.01971.x; Beblo T, 2011, NEUROPSYCHOL REV, V21, P337, DOI 10.1007/s11065-011-9171-0; Bryan-Hancock C, 2010, INJURY PREV, V16, pA17, DOI 10.1136/ip.2010.029215.61; Clarke C., 2009, BRIT J NEUROSCIENCE, V5, P216; Clarke LA, 2012, BRAIN INJURY, V26, P298, DOI 10.3109/02699052.2012.654588; Cunningham WA, 2012, EMOT REV, V4, P369, DOI 10.1177/1754073912445820; Deb S, 2007, BRAIN INJURY, V21, P301, DOI 10.1080/02699050701253137; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; Doumas M, 2012, NEUROPSYCHOLOGY, V26, P110, DOI 10.1037/a0026181; Farrin L, 2003, J NEUROPSYCH CLIN N, V15, P98, DOI 10.1176/appi.neuropsych.15.1.98; Fichman Helenice Charchat, 2010, Psychol. Neurosci., V3, P79, DOI 10.3922/j.psns.2010.1.010; Fleminger S, 2008, EUR J ANAESTH, V25, P123, DOI 10.1017/S0265021507003250; Fleminger S, 2003, NEUROPSYCHOL REHABIL, V13, P65, DOI 10.1080/09602010244000354; Fonseca Rochele Paz, 2012, Psychol. Neurosci., V5, P183, DOI 10.3922/j.psns.2012.2.08; Friedman NP, 2006, PSYCHOL SCI, V17, P172, DOI 10.1111/j.1467-9280.2006.01681.x; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Himanen L, 2009, BRAIN INJURY, V23, P220, DOI 10.1080/02699050902748323; Hoofien D, 2001, BRAIN INJURY, V15, P189; Jurado Noboa M. B., 2009, THESIS; Kamphaus RW, 2005, CLIN ASSESSMENT CHIL; Keiski MA, 2007, CLIN NEUROPSYCHOL, V21, P744, DOI 10.1080/13854040600775346; Kinsella GJ, 2011, BRAIN IMPAIR, V12, P71, DOI 10.1375/brim.12.1.71; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Laher S, 2014, S AFR J PSYCHOL, V44, P303, DOI 10.1177/0081246314533634; Levin K, 2004, DISABIL REHABIL, V26, P306, DOI 10.1080/0963828032000174089; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Marazziti D, 2010, EUR J PHARMACOL, V626, P83, DOI 10.1016/j.ejphar.2009.08.046; Mauri MC, 2014, ASIAN J PSYCHIATR, V12, P118, DOI 10.1016/j.ajp.2014.07.003; McLean AM, 2014, DISABIL REHABIL, V36, P1409, DOI 10.3109/09638288.2013.834986; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Osborn AJ, 2014, NEUROSCI BIOBEHAV R, V47, P1, DOI 10.1016/j.neubiorev.2014.07.007; Pessoa L., 2015, BEHAV BRAIN SCI, V38, P1, DOI DOI 10.1017/S0140525X14001083; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Rapoport MJ, 2012, CNS DRUGS, V26, P111, DOI 10.2165/11599560-000000000-00000; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; RASKIN SA, 2000, NEUROPSYCHOLOGICAL M; Rosselli M, 2009, AGING NEUROPSYCHOL C, V16, P721, DOI 10.1080/13825580902912739; Rozencwajg P., 2008, CURRENT PSYCHOL LETT, V24, P81; Ruff RM, 1996, ARCH CLIN NEUROPSYCH, V11, P329, DOI 10.1016/0887-6177(95)00033-X; Ryan JJ, 2000, ARCH CLIN NEUROPSYCH, V15, P311, DOI 10.1016/S0887-6177(99)00019-0; Sbordone R. J., 2007, NEUROPSYCHOLOGY PSYC; Schonberger M, 2011, BRAIN INJURY, V25, P543, DOI 10.3109/02699052.2011.565013; Silver J. M., 2012, CLIN MANUAL NEUROPSY, P119; Soeker MS, 2012, WORK, V43, P171, DOI 10.3233/WOR-2012-1413; Soldatovic-Stajic B, 2014, EUR REV MED PHARMACO, V18, P1632; Spitz G, 2013, J HEAD TRAUMA REHAB, V28, P116, DOI 10.1097/HTR.0b013e3182452f4f; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Uttl B, 2001, CLIN NEUROPSYCHOL, V15, P521, DOI 10.1076/clin.15.4.521.1881; Van der Merwe J.D., 2004, THESIS; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; Watt N, 2000, S AFR J PSYCHOL, V30, P27, DOI 10.1177/008124630003000305; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Wilson BA, 2009, NEUROPSYCHOLOGICAL REHABILITATION: THEORY, MODELS, THERAPY AND OUTCOME, P1, DOI 10.1017/CBO9780511581083	58	1	1	1	8	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0081-2463	2078-208X		S AFR J PSYCHOL	South Afr. J. Psychol.	JUN	2017	47	2					171	183		10.1177/0081246316654327			13	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	EV4OP	WOS:000401740900005		Green Submitted			2022-02-06	
J	Kayipmaz, AE; Erdem, R; Yilmaz, C; Deniz, EE; Kavalci, C; Ozdemir, A; Guler, I; Caferoglu, E; Kalyoncu, FS; Guven, O				Kayipmaz, Afsin Emre; Erdem, Remzi; Yilmaz, Cem; Deniz, Emine Ebru; Kavalci, Cemil; Ozdemir, Alperen; Guler, Irem; Caferoglu, Eda; Kalyoncu, Fatma Serra; Guven, Ozgur			The Effect of Pycnogenol (R) on Spatial Learning and Memory in Rats with Experimental Closed Head Injury	HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI			English	Article						Antioxidant; pycnogenol; secondary brain damage	TRAUMATIC BRAIN-INJURY; MODEL	Aim: Trauma is a leading cause of emergency admissions. In this study, we investigated the effect of Pycnogenol (R) on spatial learning and memory (SLM) function in rats subjected to closed head injury. Methods: The study was a randomized, experimental study of four groups, each containing six rats. Pycnogenol (R) was administered to rats in two groups (group three and four) daily for five days starting on day one. A Barnes maze was used to test SLM in the rats in all four groups. Group 1: These rats did not have a closed head injury and were not administered Pycnogenol (R). Group 2: On the day three, closed head trauma was inflicted. Group 3: Pycnogenol (R) was administered to the rats. On day three, closed head trauma was inflicted. Group 4: Only Pycnogenol (R) was administered. At the end of day five, the brain tissue of the 24 rats was removed. Results: There were no significant differences between the groups in mean SLM durations on days one through five. No significant differences were detected in the pathological examination between of the four groups. Conclusion: Future studies that employ biochemical markers and free radical levels in the brain are needed.	[Kayipmaz, Afsin Emre; Kavalci, Cemil] Baskent Univ, Fac Med, Dept Emergency Med, Ankara, Turkey; [Erdem, Remzi] Baskent Univ, Fac Med, Dept Med Pharmacol, Ankara, Turkey; [Yilmaz, Cem] Baskent Univ, Fac Med, Dept Neurosurg, Ankara, Turkey; [Deniz, Emine Ebru] Baskent Univ, Fac Med, Dept Med Pathol, Ankara, Turkey; [Ozdemir, Alperen; Guler, Irem; Caferoglu, Eda; Kalyoncu, Fatma Serra; Guven, Ozgur] Baskent Univ, Fac Med, Ankara, Turkey		Kayipmaz, AE (corresponding author), Baskent Univ, Fac Med, Dept Emergency Med, Ankara, Turkey.	aekayipmaz@baskent.edu.tr	Kayipmaz, Afsin Emre/AAC-2597-2020; yilmaz, cem/AAK-2948-2021	yilmaz, cem/0000-0002-2353-8044			Ansari MA, 2013, J NEUROTRAUM, V30, P1542, DOI 10.1089/neu.2013.2910; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Coban E, 2015, MARMARA MED J, V28, P27, DOI 10.5472/MMJ.2015.03555.2; Durdu T, 2014, J CLIN ANAL MED, V5, P182, DOI 10.4328/JCAM.1279; Hasegawa N, 2009, PHYTOTHER RES, V23, P840, DOI 10.1002/ptr.2702; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Huang GY, 2015, INT J CLIN EXP MED, V8, P10893; Kavalci C, 2013, HEALTHMED, V7, P148; Kavalci C, 2014, WORLD J EMERG SURG, V9, DOI 10.1186/1749-7922-9-31; Kavalci C, 2012, TURK J EMERG MED, V12, P112, DOI 10.5505/1304.7361.2012.26576; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Norris CM, 2016, EXP NEUROL, V276, P5, DOI 10.1016/j.expneurol.2015.11.006; Puskulluoglu S, 2015, CUKUROVA MED J, V40, P569; Scheff SW, 2013, EXP NEUROL, V239, P183, DOI 10.1016/j.expneurol.2012.09.019; Tataranno ML, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/108251; vanJaarsveld H, 1996, RES COMMUN MOL PATH, V91, P65; Yilmaz ER, 2011, TURK NOROSIRURJI DER, V21, P242	17	1	1	0	3	GALENOS YAYINCILIK	FINDIKZADE	ERKAN MOR, MOLLA GURANI CAD 21-1, FINDIKZADE, ISTANBUL 34093, TURKEY	1302-0072	2147-2688		HASEKI TIP BUL	Haseki Tip Bul.	JUN	2017	55	2					101	105		10.4274/haseki.3446			5	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	FB5RG	WOS:000406199000002		gold, Green Submitted			2022-02-06	
J	Lee, K; Kim, SI; Lee, Y; Won, JK; Park, SH				Lee, Kyuho; Kim, Seong-Ik; Lee, Yujin; Won, Jae Kyung; Park, Sung-Hye			An Autopsy Proven Child Onset Chronic Traumatic Encephalopathy	EXPERIMENTAL NEUROBIOLOGY			English	Article						Pathology; Traumatic encephalopathy; chronic; children; dementia	BRAIN-INJURY; HEAD-INJURY; NEUROPATHOLOGY; DISEASE; PATHOLOGY	Here we present an autopsy case of chronic traumatic encephalopathy (CTE) in a 36-year-old man. He had a history of febrile seizures at the age of four and was severely demented at age 10 when he was admitted to a mental hospital. He had suffered repetitive self-harm, such as frequent banging of the head on the wall in his hospital record, but he had no clear history between the ages of four and ten. Autopsy revealed global cerebral atrophy, including the basal ganglia, thalamus, hippocampus, amygdala, mammilary bodies and lateral geniculate bodies. This case showed typical pathological features of CTE. Phosphorylated tau (p-tau)-positive neurofibrillary tangles (NFTs) and neuropil threads (NT) we are widely distributed in the brain, especially in the depth of the cerebral sulci. NFT and NT were also found in the basal ganglia, thalamus, amygdala and brainstem. Scanty beta-amyloid deposits were found in the motor and sensory cortices, but alpha-synuclein was completely negative in the brain. This example showed that CTE can occur in young ages and that even children can experience CTE dementia.	[Lee, Kyuho; Kim, Seong-Ik; Lee, Yujin; Won, Jae Kyung; Park, Sung-Hye] Seoul Natl Univ Hosp, Coll Med, Dept Pathol, Seoul 03080, South Korea; [Won, Jae Kyung; Park, Sung-Hye] Seoul Natl Univ Hosp, Coll Med, Brain Bank, Seoul 03080, South Korea; [Park, Sung-Hye] Seoul Natl Univ, Neurosci Res Inst, Seoul 03080, South Korea		Park, SH (corresponding author), Seoul Natl Univ Hosp, Coll Med, Dept Pathol, Seoul 03080, South Korea.	shparknp@snu.ac.kr		Won, Jae-Kyung/0000-0003-1459-8093	Korean governmentKorean Government	This work was funded by the Korean government-sponsored Korea Brain Bank network.	CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Critchley M, 1949, NEUROCHIRURG HOMMAGE, P131; Edwards G, 2017, BIOCHEM BIOPH RES CO, V483, P1137, DOI 10.1016/j.bbrc.2016.07.123; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Grinberg LT, 2016, J ALZHEIMERS DIS, V54, P169, DOI 10.3233/JAD-160312; Jellinger KA, 2007, ACTA NEUROPATHOL, V113, P107, DOI 10.1007/s00401-006-0156-7; Lakis N, 2013, NEUROL RES, V35, P290, DOI 10.1179/1743132813Y.0000000177; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mez J, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0148-8; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Noy S, 2016, J NEUROPATH EXP NEUR, V75, P1145, DOI 10.1093/jnen/nlw092; Zhang J, 2015, J CEREBR BLOOD F MET, V35, P443, DOI 10.1038/jcbfm.2014.216	16	1	1	1	6	KOREAN SOC BRAIN & NEURAL SCIENCE, KOREAN SOC NEURODEGENERATIVE DISEASE	SEOUL	EXPERIMENTAL NEUROBIOLOGY,  SEOUL NATL UNIV, RM 410, BLDG 152-1, SEOUL, 151-742, SOUTH KOREA	1226-2560	2093-8144		EXP NEUROBIOL	Exp. Neurobiol.	JUN	2017	26	3					172	177		10.5607/en.2017.26.3.172			6	Medicine, Research & Experimental; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Neurosciences & Neurology	FC5EA	WOS:000406863400008	28680303	Green Submitted, Green Published			2022-02-06	
J	Lin, LM; Paff, M; Xu, RS; Jiang, BW; Colby, GP; Coon, AL				Lin, Li-Mei; Paff, Michelle; Xu, Risheng; Jiang, Bowen; Colby, Geoffrey P.; Coon, Alexander L.			Chronic anticoagulation with warfarin is associated with decreased functional outcome and increased length of stay following craniotomy for acute subdural hematoma	INTERDISCIPLINARY NEUROSURGERY-ADVANCED TECHNIQUES AND CASE MANAGEMENT			English	Article						Acute subdural hematoma; Anticoagulation; Warfarin; Coumadin	TRAUMATIC BRAIN INJURY; CENTRAL-NERVOUS-SYSTEM; ACTIVATED FACTOR-VII; INTRACRANIAL HEMORRHAGE; MORTALITY; MANAGEMENT; THERAPY; PATIENT; CHARGES; AGE	Introduction: With the continued rise of the aging population, the incidence of acute subdural hematoma (ASDH) in the setting of chronic oral anticoagulation with warfarin is expected to increase. No study has directly addressed the risks of poorer outcomes in chronically anticoagulated patients after ASDH evacuation. Methods: We reviewed retrospectively 94 consecutive cases of ASDH at a single institution with fresh frozen plasma and craniotomy. The outcomes of patients with ASDH in the setting of chronic oral anticoagulation were compared to those of patients with ASDH not taking oral anticoagulation. Results: There were 22 patients receiving chronic anticoagulation (11 male, 11 female, mean age 63.7 +/- 4 years) with ASDH requiring craniotomy for evacuation. These patients had significantly lower mean discharge Glasgow Outcome Scores (GOS) when compared to control subjects (2.3 +/- 0.3 versus 3.0 +/- 0.2). Despite presentation with higher Glasgow Coma Scores (GCS), ASDH size tended to be larger in anticoagulated patients, although not significant. Overall mortality was nearly double, that is 55% in anticoagulated patients compared to 29% in those without anticoagulation. Of previously anticoagulated patients alive at discharge, hospital length of stay was longer compared to controls (31.9 +/- 8.5 days versus 21.1 +/- 2.4 days). Conclusions: These data suggest that ASDH evacuation in chronically anticoagulated patients is associated with higher mortality rates, decreased likelihood of independent function, and increased length of hospital stay. Further research is needed to determine if the effect of chronic anticoagulation on outcome is independent of co-founders, such as age and medical comorbidities. These data may help practitioners and families create treatment plans and furthermore serve as the gold standard for the future evaluation of novel anticoagulation reversal agents such as factor VIIa. Published by Elsevier B.V.	[Lin, Li-Mei; Paff, Michelle] Univ Calif Irvine, Med Ctr, Dept Neurosurg, Orange, CA 92868 USA; [Xu, Risheng; Jiang, Bowen; Colby, Geoffrey P.; Coon, Alexander L.] Johns Hopkins Univ Hosp, Dept Neurosurg, Baltimore, MD 21287 USA		Lin, LM (corresponding author), Univ Calif Irvine, Sch Med, UC Irvine Med Ctr, Dept Neurosurg, 200 S Manchester Ave,Suite 210, Orange, CA 92868 USA.	limei.lin@uci.edu	; Colby, Geoffrey/G-2526-2017	Coon, Alexander/0000-0002-1105-4333; Colby, Geoffrey/0000-0002-3376-0933			Brummel KE, 2001, CIRCULATION, V104, P2311, DOI 10.1161/hc4401.098492; Butler AC, 1998, BLOOD REV, V12, P35, DOI 10.1016/S0268-960X(98)90028-5; Chai SJ, 2002, SEMIN HEMATOL, V39, P179, DOI 10.1053/shem.2002.34089; Cooper P R, 1976, Surg Neurol, V5, P25; DENT DL, 1995, J TRAUMA, V39, P36, DOI 10.1097/00005373-199507000-00005; Diamond T, 1988, Br J Neurosurg, V2, P351, DOI 10.3109/02688698809001006; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Hatashita Shizuo, 1993, Neurologia Medico-Chirurgica, V33, P13, DOI 10.2176/nmc.33.13; HOWARD MA, 1989, J NEUROSURG, V71, P858, DOI 10.3171/jns.1989.71.6.0858; JAMIESON KG, 1972, J NEUROSURG, V37, P137, DOI 10.3171/jns.1972.37.2.0137; Karni A, 2001, AM SURGEON, V67, P1098; Kawamata T, 1995, SURG NEUROL, V44, P438, DOI 10.1016/0090-3019(95)00249-9; Koc RK, 1997, NEUROSURG REV, V20, P239, DOI 10.1007/BF01105894; Kreutzer JS, 2001, BRAIN INJURY, V15, P763, DOI 10.1080/02699050010025786; Lin J, 2003, J NEUROSURG, V98, P737, DOI 10.3171/jns.2003.98.4.0737; MATTLE H, 1989, J NEUROL NEUROSUR PS, V52, P829, DOI 10.1136/jnnp.52.7.829; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; Mina AA, 2003, J TRAUMA, V54, P842, DOI 10.1097/01.TA.0000063271.05829.15; RICHARDS T, 1974, SURGERY, V75, P253; ROZZELLE CJ, 1995, J AM GERIATR SOC, V43, P240, DOI 10.1111/j.1532-5415.1995.tb07329.x; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Sorensen B, 2003, BLOOD COAGUL FIBRIN, V14, P469, DOI 10.1097/00001721-200307000-00007; STONE JL, 1986, J TRAUMA, V26, P445, DOI 10.1097/00005373-198605000-00006; WIENER LM, 1962, ARCH NEUROL-CHICAGO, V6, P282, DOI 10.1001/archneur.1962.00450220024004; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; WINTZEN AR, 1982, ARCH NEUROL-CHICAGO, V39, P69, DOI 10.1001/archneur.1982.00510140003001; YUE CP, 1983, INJURY, V14, P489, DOI 10.1016/0020-1383(83)90051-7	28	1	1	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2214-7519			INTERDISCIP NEUROSUR	Interdiscip. Neurosurg.	JUN	2017	8						35	39		10.1016/j.inat.2017.01.011			5	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	FH0VI	WOS:000410858300010		gold			2022-02-06	
J	Renganathan, R; Paul, PJ; Anandan, H				Renganathan, R.; Paul, P. John; Anandan, Heber			A Comprehensive Study on Post Traumatic Temporal Contusion in Adults	INTERNATIONAL JOURNAL OF SCIENTIFIC STUDY			English	Article						Brain injury; Oculocephalic reflex; Traumatic temporal contusion	BRAIN-INJURY; RISK-FACTORS; HEAD-INJURY; PROGRESSION	Introduction: The brain undergoes various types of strain during injury. The strain may be in the form of compression, tensile strain or shear strain. More than one type of mechanics and more than one type of strain are involved in most head injuries. Aim: To study the epidemiology, clinical features, radiological findings, management and outcome of traumatic temporal contusion in brain injury. Methods: Patients admitted in the head injury ward and diagnosed as having temporal lobe contusion were included. 106 patients were enrolled for this study. Results: The overall mortality is 18.9% in traumatic temporal contusion. This study shows that 62.2% of the patients survived and 30.8% of the patients expired with surgical management. Seizure, abnormal pupillary response to light, oculocephalic reflex abnormality and the status of the basal cistern, midline shift and volume of the lesion are the significant factors, in this study. Conclusion: Patients with a head injury in motor vehicle accidents, presenting with seizure, abnormal pupillary response to light, abnormal oculocephalic reflex, and bradycardia must have intensive neurosurgical care. Temporal contusion quickly contributes to mortality because of its adjacent location to the brain stem.	[Renganathan, R.] Tirunelveli Med Coll, Dept Neurosurg, Tirunelveli, Tamil Nadu, India; [Paul, P. John] Madras Med Coll & Govt Gen Hosp, Dept Neurosurg, Chennai, Tamil Nadu, India; [Anandan, Heber] Dr Agarwals Healthcare Ltd, Dept Clin Res, Tirunelveli, Tamil Nadu, India		Paul, PJ (corresponding author), Madras Med Coll & Govt Gen Hosp, Dept Neurosurg, Chennai, Tamil Nadu, India.	renganatha23@gmail.com	David, Heber A/AAD-5191-2020; Anandan, Heber/S-4379-2019	Anandan, Heber/0000-0002-5850-301X			[Anonymous], 2014, ADSI REP; BULLOCK R, 1989, SURG NEUROL, V32, P181, DOI 10.1016/0090-3019(89)90176-6; CHOKSEY M, 1993, BRIT J NEUROSURG, V7, P611, DOI 10.3109/02688699308995090; Kim JJ, 2011, NEUROTHERAPEUTICS, V8, P39, DOI 10.1007/s13311-010-0003-3; Kumar S, 2017, INDIAN J FORENSIC ME, V11, P77; Marion DW, 2006, NEUROSURGERY, V58, P655; MCDONALD CM, 1994, ARCH PHYS MED REHAB, V75, P328, DOI 10.1016/0003-9993(94)90038-8; Motah M, 2014, J NEUROINFECT DIS, V5, P136; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; Silver J, 2005, TXB TRAUMATIC BRAIN, P27; TANDON PN, 1978, ACTA NEUROCHIR, V41, P205, DOI 10.1007/BF01809150; White CL, 2009, J TRAUMA, V67, P508, DOI 10.1097/TA.0b013e3181b2519f	12	1	1	0	0	INT JOURNAL SCIENTIFIC STUDY-IJSS	MAHARASHTRA	9-2, SATYALOK BUILDING, GADITAL, HADAPSAR, PUNE, MAHARASHTRA, 411028, INDIA	2321-6379	2321-595X		INT J SCI STUDY	Int. J. Sci. Study	JUN	2017	5	3					303	307		10.17354/ijss/2017/318			5	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	FL9HO	WOS:000414564500062					2022-02-06	
J	Vignesh, RS; Ramkumar, RR; Anandan, H				Vignesh, Raja S.; Ramkumar, R. R.; Anandan, Heber			Clinical Outcome of Borderline Subdural Hematoma with 5-9 mm Thickness and/or Midline Shift 2-5 mm	INTERNATIONAL JOURNAL OF SCIENTIFIC STUDY			English	Article						Midline shift; Subdural hematoma; Trauma	NONOPERATIVE MANAGEMENT; COMATOSE PATIENTS; MORTALITY	Introduction: Patients with a subdural hematoma (SDH) and midline shift (MLS) of <10 mm on the computed tomography scans and with a Glasgow coma scale (GCS) score of 15 initially might be treated conservatively under close observation, reserving urgent craniotomy, and evacuation of the SDH for those with deteriorating neurological conditions. Aim: The aim is to study the clinical outcome in management of borderline acute subdural hematoma with 5-9 mm thickness and/or MLS 2-5 mm. Materials and Methods: Patients with head injury and acute SDH were screened. SDH thickness 5-9 mm, MLS 2-5 mm, GCS score >8, time since injury within 6 h of trauma, volume of contusion <20 ml, and loss of consciousness <1 h duration were included in the study. Results: SDH thickness and outcome, it was observed that out of 17 cases with SDH thickness <5 mm, 15 were alive and 2 cases expired with a survival rate of 88%. In 83 patients with SDH thickness >5 mm, survival rate was 76% with 63 survivors and 20 deaths. In the group with MLS 2-5 mm and SDH thickness <5 mm, there was only one death among 17 patients with 16 survivors. In the group with MLS 2-5 mm and SDH thickness 5-9 mm, there were 19 deaths with 9 survivors. The survival rate was 47%. Conclusion: The mortality rate among those taken up for surgery after initial conservative management was significantly higher and thus emphasizing the need for close monitoring of conservatively managed patients and also to take up for primary surgery at the slightest degree of suspicion regarding conservative management in patients with associated contusion or subarachnoid hemorrhage.	[Vignesh, Raja S.] Tuticorin Med Coll Hosp, Dept Neurosurg, Thoothukudi, Tamil Nadu, India; [Ramkumar, R. R.] Govt Kanyakumari Med Coll Hosp, Dept Neurosurg, Kanyakumari, Tamil Nadu, India; [Anandan, Heber] Dr Agarwals Healthcare Ltd, Dept Clin Res, Tiruneveli, Tamil Nadu, India		Ramkumar, RR (corresponding author), Govt Kanyakumari Med Coll Hosp, Dept Neurosurg, Kanyakumari, Tamil Nadu, India.	ramkgmc@gmail.com	Anandan, Heber/S-4379-2019; David, Heber A/AAD-5191-2020	Anandan, Heber/0000-0002-5850-301X; 			Bagchi A., 1980, INTRO HEAD INJURIES, P58; DENT DL, 1995, J TRAUMA, V39, P36, DOI 10.1097/00005373-199507000-00005; KOTWICA Z, 1993, ACTA NEUROCHIR, V121, P95, DOI 10.1007/BF01809257; MATHEW P, 1993, ACTA NEUROCHIR, V121, P100, DOI 10.1007/BF01809258; Patel NY, 2000, J TRAUMA, V48, P367, DOI 10.1097/00005373-200003000-00001; Ramamurthi B., 1976, HDB CLIN NEUROLOGY I, P275; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; WONG CW, 1995, ACTA NEUROCHIR, V135, P38, DOI 10.1007/BF02307412	9	1	1	0	1	INT JOURNAL SCIENTIFIC STUDY-IJSS	MAHARASHTRA	9-2, SATYALOK BUILDING, GADITAL, HADAPSAR, PUNE, MAHARASHTRA, 411028, INDIA	2321-6379	2321-595X		INT J SCI STUDY	Int. J. Sci. Study	JUN	2017	5	3					227	231		10.17354/ijss/2017/300			5	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	FL9HO	WOS:000414564500045					2022-02-06	
J	Wasylynko, DE				Wasylynko, David E.			Chiropractic Care of a 10-Year-Old Boy With Nonorganic Gait Disorder: A Case Report	JOURNAL OF CHIROPRACTIC MEDICINE			English	Article						Postconcussion Syndrome; Chiropractic; Psychomotor Disorders	PSYCHOGENIC MOVEMENT-DISORDERS; CERVICAL-SPINE MANIPULATION; DUAL SOMATOSENSORY INPUT; MOTOR PARALYSIS DISORDER; SUBCLINICAL NECK PAIN; CENTRAL INTEGRATION; CHILDREN; REHABILITATION; ADOLESCENTS	Objective: The purpose of this case report is to describe the multidisciplinary management of a boy with nonorganic gait disorder. Clinical Features: A 10-year-old boy presented to a chiropractic clinic having had a concussion 1 week prior. He presented with lower limb muscle weakness and ataxia while weight bearing. He was referred immediately to the emergency department, from which he was sent to a neurologist at a children's hospital. The neurologist's diagnosis was nonorganic gait disorder. Intervention/Outcome: Treatment consisted of physiotherapy, occupational therapy, and a psychiatric assessment. Chiropractic care including manipulative therapy was initiated 6 months after diagnosis. After 1 year, the gait disorder was resolved. Conclusion: The addition of chiropractic care to conventional treatment may have been supportive in the recovery process for this patient. The condition required 1 year to resolve, with questions remaining as to whether the symptom resolution was a result of treatment or natural history.			Wasylynko, DE (corresponding author), 102 10366 136A St, Surrey, BC V3T5R3, Canada.	nscclnc@telus.net					Ahmed MAS, 2008, DEV MED CHILD NEUROL, V50, P300, DOI 10.1111/j.1469-8749.2008.02043.x; Brazier DK, 1997, BRIT J RHEUMATOL, V36, P594; CAMPO JV, 1994, J AM ACAD CHILD PSY, V33, P1223, DOI 10.1097/00004583-199411000-00003; Canavese C, 2012, MOVEMENT DISORD, V27, P1153, DOI 10.1002/mds.24947; Czarnecki K, 2012, PARKINSONISM RELAT D, V18, P247, DOI 10.1016/j.parkreldis.2011.10.011; Daligadu J, 2013, J MANIP PHYSIOL THER, V36, P527, DOI 10.1016/j.jmpt.2013.08.003; Dishman JD, 2002, J MANIP PHYSIOL THER, V25, P318, DOI 10.1067/mmt.2002.124420; Edwards MJ, 2012, LANCET NEUROL, V11, P250, DOI 10.1016/S1474-4422(11)70310-6; FACTOR SA, 1995, J NEUROL NEUROSUR PS, V59, P406, DOI 10.1136/jnnp.59.4.406; Ferrara J, 2008, MOVEMENT DISORD, V23, P1875, DOI 10.1002/mds.22220; Fryer G, 2012, J MANIP PHYSIOL THER, V35, P86, DOI 10.1016/j.jmpt.2011.09.010; Gupta A, 2009, CURR OPIN NEUROL, V22, P430, DOI 10.1097/WCO.0b013e32832dc169; Haavik H, 2011, J MANIP PHYSIOL THER, V34, P88, DOI 10.1016/j.jmpt.2010.12.009; Haavik Taylor H, 2010, CHIROPR J AUST, V40, P37; Heruti RJ, 2002, SPINAL CORD, V40, P327, DOI 10.1038/sj.sc.3101308; Heruti RJ, 2002, SPINAL CORD, V40, P335, DOI 10.1038/sj.sc.3101307; Holt KR, 2012, J MANIP PHYSIOL THER, V35, P227, DOI 10.1016/j.jmpt.2012.01.007; Kirsch DB, 2004, PEDIATR NEUROL, V30, P1, DOI 10.1016/j.pediatrneurol.2003.07.001; Morgante Francesca, 2013, Continuum (Minneap Minn), V19, P1383, DOI 10.1212/01.CON.0000436160.41071.79; REGAN J, 1984, AM J PSYCHIAT, V141, P1279; Schwingenschuh P, 2008, MOVEMENT DISORD, V23, P1882, DOI 10.1002/mds.22280; Stone J, 2009, J PSYCHOSOM RES, V66, P383, DOI 10.1016/j.jpsychores.2008.07.010; Taylor HH, 2008, J MANIP PHYSIOL THER, V31, P115, DOI 10.1016/j.jmpt.2007.12.011; Taylor HH, 2010, J MANIP PHYSIOL THER, V33, P261, DOI 10.1016/j.jmpt.2010.03.004; Taylor HH, 2010, J MANIP PHYSIOL THER, V33, P178, DOI 10.1016/j.jmpt.2010.01.005; Williams D, 1995, BEHAV NEUROL MOV DIS, P65	26	1	1	0	8	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	0899-3467	1556-3715		J CHIROPR MED	J. Chiropr. Med.	JUN	2017	16	2					175	179		10.1016/j.jcm.2017.02.003			5	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	EX3DE	WOS:000403111400012	28559759	Green Published			2022-02-06	
J	Weiner, MF; Silver, J				Weiner, M-F; Silver, J.			St Hugh's Military Hospital (Head Injuries), Oxford 1940-1945	JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH			English	Article						Cairns; head injuries; neurology; rehabilitation; St Hugh's Military Hospital	ELECTROENCEPHALOGRAM; NEUROSURGERY; CONCUSSION; BRAIN	Despite being open for only five years, St Hugh's Military Hospital (Head Injuries) has a seminal place in the history of neurology, neurosurgery and rehabilitation medicine. At its peak, during the Normandy campaign of 1944, it provided 430 beds for the treatment of service personnel. Between 1940 and 1945, 13,000 patients were referred to St Hugh's providing a unique opportunity for ground-breaking research into the management of head injuries. The doctors at St Hugh's collaborated with research scientists at Oxford University in many areas of fundamental research including the treatment of infection, the mechanics of brain injury, brain surgery, neuropsychiatry and rehabilitation, and the use of electroencephalograms. This paper documents these scientific advances and considers their influence on the practice of neurology and neurosurgery in the UK.	[Silver, J.] Stoke Mandeville Hosp, Natl Spinal Injuries Ctr, Aylesbury, Bucks, England		Silver, J (corresponding author), Akeman Business Pk,81-82 Akeman St, Tring HP23 6AF, England.	jrussellsilver@btconnect.com					[Anonymous], 1944, J NEUROSURG, V1, P201; [Anonymous], 2014, GAZETTE SOC SOCIAL H, V67, P26; AZIZ TZ, 1995, NEUROSURGERY, V37, P505, DOI 10.1227/00006123-199509000-00020; Brown DD, 1942, NEW ENGL J MED, V227, P771; Cairns H, 1940, LANCET, V2, P123; Cairns H, 1944, LANCET, V1, P655; Cairns H, 1947, BR J SURG, P198; Cope Z., 1953, HIST 2 WORLD WAR SUR, P377; Cushing H, 1918, BRIT J SURG, V5, P558; Finger S, 2010, HDB CLIN NEUROLOGY, P200; Hughes J T, 2001, J Med Biogr, V9, P236; Hughes J T, 2004, J Med Biogr, V12, P18; Macdonald WI, 1993, MUNKS ROLL, P196; Russell W.R., 1961, TRAUMATIC APHASIA ST; Schurr P H, 1988, J R Army Med Corps, V134, P146; SCHURR PH, 1990, J NEUROL NEUROSUR PS, V53, P188, DOI 10.1136/jnnp.53.3.188; Silver JR, 2013, J ROY COLL PHYS EDIN, V43, P270, DOI 10.4997/JRCPE.2013.316; Silver JR, 2003, HIST TREATMENT SPINA, P68; Small JM, 1947, BR J SURG, P62; Stanworth PA, 2016, J ROY ARMY MED CORPS, V162, P139, DOI 10.1136/jramc-2015-000477; Stone JL, 2016, J NEUROSURG, V125, P1301, DOI 10.3171/2015.8.JNS142613; Symonds C., 1970, STUDIES NEUROLOGY, P18; Symonds C., 1939, COMMUNICATION; Williams D, 1941, BRAIN, V64, P223, DOI 10.1093/brain/64.4.223; Williams D, 1944, J NEUROL NEUROSUR PS, V7, P103, DOI 10.1136/jnnp.7.3-4.103; Williams D, 1941, J NEUROL PSYCHIATRY, V4, P107, DOI 10.1136/jnnp.4.2.107; Williams D., 1945, ANATOMY COURAGE L MO, pxiv; [No title captured]	28	1	1	0	0	ROYAL COLL PHYSICIANS EDINBURGH	EDINBURGH	9 QUEEN ST, EDINBURGH, EH2 1JQ, ENGLAND	1478-2715	2042-8189		J ROY COLL PHYS EDIN	J. Roy. Coll. Phys. Edinb.	JUN	2017	47	2					183	189		10.4997/JRCPE.2017.219			7	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	GT1HJ	WOS:000444218200019	28675196	gold			2022-02-06	
J	Zhang, LM; Zeng, J; Ma, YY; Tan, M; Zhou, M; Fang, H; Bengmark, S; Zhu, JC				Zhang, Limei; Zeng, Jing; Ma, Yuanyuan; Tan, Min; Zhou, Min; Fang, Huan; Bengmark, Stig; Zhu, Jingci			Effects of Synbiotic2000((TM)) Forte on the Intestinal Motility and Interstitial Cells of Cajal in TBI Mouse Model	PROBIOTICS AND ANTIMICROBIAL PROTEINS			English	Article						Traumatic brain injury; Synbiotics; Contractile; activity; Intestinal cells of Cajal	TRAUMATIC BRAIN-INJURY; SMOOTH-MUSCLE-CELLS; SEVERE HEAD-INJURY; ADULT GUINEA-PIGS; PACEMAKER ACTIVITY; CONTROLLED TRIAL; EARLY NUTRITION; LACTOBACILLUS; INFLAMMATION; RHAMNOSUS	The main objective of this study was to investigate the effects of Synbiotic2000 T Forte on the intestinal motility and interstitial cells of Cajal (ICC) in traumatic brain injury (TBI) mousemodel. Kunmingmice were randomly divided into sham operation group (S group), enteral nutrition group with TBI (E group), and Synbiotic2000 T Forte group with TBI (P group). The contractile activity of the intestinal smooth muscle, densities and ultrastructure of the ICC, kit protein concentration, weight, and defecation of mice were monitored and analyzed. TBI markedly suppressed contractile activity of the intestinal smoothmuscle (P < 0.01), which led to a reduction of defecation (P < 0.01) and weight (P < 0.01). However, application of Synbiotic2000(TM) Forte significantly improved contractile activity of the small intestine (P < 0.01), which may be related to protective effects to the interstitial cells of Cajal, smooth muscle cells, and enteric neurons. TBI impaired ICC networks and densities (P < 0.01), events that were protected by the application of Synbiotic2000 T Forte. Synbiotic2000 T Forte may attenuate TBI-mediated inhibition of the kit protein pathway. Synbiotic2000 T Forte may improve intestinal motility and protect the ICC in the TBI mouse. These findings provide a novel support for the application of Synbiotic2000 T Forte in intestinal motility disturbance after TBI.	[Zhang, Limei; Zeng, Jing] Chengdu Med Coll, Sch Nursing, Chengdu 610083, Sichuan, Peoples R China; [Zhang, Limei; Ma, Yuanyuan; Tan, Min; Zhou, Min; Fang, Huan; Zhu, Jingci] Third Mil Med Univ, Sch Nursing, Chongqing 400038, Peoples R China; [Bengmark, Stig] UCL, Div Surg & Intervent Sci, London E16 2SE, England		Zhu, JC (corresponding author), Third Mil Med Univ, Sch Nursing, Chongqing 400038, Peoples R China.; Bengmark, S (corresponding author), UCL, Div Surg & Intervent Sci, London E16 2SE, England.	stig@bengmark.se; zhujingci2009@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81272079]	We are grateful to associate professor Feng Mei from the Third Military Medical University, China, who provided experimental instruction and the others who gave selfless assistance to the experiments. We thank LetPub (www.letpub.com) for its linguistic assistance during the preparation of this manuscript. This work was supported by the National Natural Science Foundation of China (81272079).	An HM, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-5; Ball ER, 2012, CELL TISSUE RES, V349, P483, DOI 10.1007/s00441-012-1434-4; Bansal T, 2010, P NATL ACAD SCI USA, V107, P228, DOI 10.1073/pnas.0906112107; BARAJASLOPEZ C, 1989, AM J PHYSIOL, V257, pC830, DOI 10.1152/ajpcell.1989.257.4.C830; Bengmark S, 2013, PHARMACOL RES, V69, P87, DOI 10.1016/j.phrs.2012.09.002; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS77; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bu LN, 2007, PEDIATR INT, V49, P485, DOI 10.1111/j.1442-200X.2007.02397.x; Du P, 2010, BIOPHYS J, V98, P1772, DOI 10.1016/j.bpj.2010.01.009; Fang HW, 2010, J MED MICROBIOL, V59, P573, DOI 10.1099/jmm.0.009662-0; Farhad K, 2013, J NEUROTRAUM, V30, P84, DOI 10.1089/neu.2011.2283; Giamarellos-Bourboulis EJ, 2009, J TRAUMA, V67, P815, DOI 10.1097/TA.0b013e31819d979e; Guarino MPL, 2008, J CLIN GASTROENTEROL, V42, pS185, DOI 10.1097/MCG.0b013e31817e1cac; Hartl R, 2008, J NEUROSURG, V109, P50, DOI 10.3171/JNS/2008/109/7/0050; Herbert MK, 2008, CLIN NUTR, V27, P25, DOI 10.1016/j.clnu.2007.08.001; Heyland DK, 1998, CRIT CARE CLIN, V14, P423, DOI 10.1016/S0749-0704(05)70009-9; Huang X, 2010, EUR J PHARMACOL, V643, P63, DOI 10.1016/j.ejphar.2010.06.011; Huizinga JD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4326; HUIZINGA JD, 1995, NATURE, V373, P347, DOI 10.1038/373347a0; HUIZINGA JD, 1990, CAN J PHYSIOL PHARM, V68, P447, DOI 10.1139/y90-063; Huizinga JD, 1999, MICROSC RES TECHNIQ, V47, P239, DOI 10.1002/(SICI)1097-0029(19991115)47:4<239::AID-JEMT3>3.0.CO;2-0; Huizinga JD, 1998, AM J PATHOL, V153, P2008, DOI 10.1016/S0002-9440(10)65715-X; Indrio F, 2008, J PEDIATR-US, V152, P801, DOI 10.1016/j.jpeds.2007.11.005; Koutelidakis IM, 2010, INT J ANTIMICROB AG, V36, P90, DOI 10.1016/j.ijantimicag.2010.02.012; Liu DQ, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/164986; Liu ZH, 2014, MOL BIOL REP, V41, P8037, DOI 10.1007/s11033-014-3701-9; Mei F, 2006, VIRCHOWS ARCH, V449, P348, DOI 10.1007/s00428-006-0258-6; Mei F, 2009, VIRCHOWS ARCH, V454, P401, DOI 10.1007/s00428-009-0739-5; Ojetti V, 2014, J GASTROINTEST LIVER, V23, P387, DOI 10.15403/jgld.2014.1121.234.elr; Oomen S P, 2001, Hematol J, V2, P322, DOI 10.1038/sj.thj.6200121; Pawelka AJ, 2015, AM J PHYSIOL-GASTR L, V308, pG427, DOI 10.1152/ajpgi.00409.2014; Perel P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001530.pub2; Rayes N, 2002, TRANSPLANTATION, V74, P123, DOI 10.1097/00007890-200207150-00021; SACKS GS, 1995, JPEN-PARENTER ENTER, V19, P387, DOI 10.1177/0148607195019005387; Sun B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128214; Tan M, 2011, BRIT J NEUROSURG, V25, P2, DOI 10.3109/02688697.2010.522745; Todd SR, 2008, CURR OPIN CRIT CARE, V14, P690, DOI 10.1097/MCC.0b013e3283196562; van Hoffen E, 2010, INT ARCH ALLERGY IMM, V152, P159, DOI 10.1159/000265537; Verdu EF, 2004, GASTROENTEROLOGY, V127, P826, DOI 10.1053/j.gastro.2004.06.007; Wang B., 2010, NEUROGASTROENT MOTIL, V22, pe133; Wang XY, 2005, AM J PATHOL, V167, P437, DOI 10.1016/S0002-9440(10)62988-4; WARD SM, 1994, J PHYSIOL-LONDON, V480, P91, DOI 10.1113/jphysiol.1994.sp020343; Yu XY, 2011, NUTRITION, V27, P100, DOI 10.1016/j.nut.2010.01.010; Zhu YF, 2014, PFLUG ARCH EUR J PHY, V466, P1467, DOI 10.1007/s00424-013-1374-1	44	1	1	1	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1867-1306	1867-1314		PROBIOTICS ANTIMICRO	Probiotics Antimicrob. Proteins	JUN	2017	9	2					172	181		10.1007/s12602-017-9266-x			10	Biotechnology & Applied Microbiology; Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Microbiology	FA8NV	WOS:000405703600010	28303478				2022-02-06	
J	Aykanat, O; Karakoyun, DO; Turkoglu, ME; Dinc, C				Aykanat, Omer; Karakoyun, Durmus Oguz; Turkoglu, Mehmet Erhan; Dinc, Cem			Anti-edematous, anti-inflammatory and neuroprotective effect of etanercept in acute stage in experimental head injury	ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY			English	Article						Brain edema; etanercept; head injury	NECROSIS-FACTOR-ALPHA; TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; INFLAMMATORY CYTOKINES; GLUTAMATE; MODEL; OPPORTUNITIES; MECHANISMS; CHILDREN; DAMAGE	BACKGROUND: To study the anti-edematous, anti-inflammatory, and neuroprotective effect of etanercept in the model of experimental head injury. METHODS: In this study, 40 male-adult Spraque-Dawley rats, with weight ranging from 250g to 300g, were used. The rats are divided into groups as control; non-penetrating trauma; trauma + NS; post-traumatic normal saline; trauma + D; post-traumatic dexamethasone and trauma + E. All medicines were given into peritoneum. After applying trauma and medicine, rats were decapitated in the 24th hour and the samples were studied histopathologically. RESULTS: In the study, a statistically significant difference was observed between the groups of trauma + NS and trauma dexamethasone according to the variables of edema and inflammation, but no difference was observed according to the variables of neuronal damage, astrocytic damage, and glial apoptosis. Moreover, a significant difference was observed between groups of Trauma + NS and trauma+ etanercept and between the groups of trauma + dexamethasone and trauma + etanercept in terms of all variables. CONCLUSION: It was observed that etanercept has anti-edematous, anti-inflammatory, and neuroprotective effect on the rats which experienced traumatic brain injury.	[Aykanat, Omer; Karakoyun, Durmus Oguz] Dr Ersin Arslan Training & Res Hosp, Dept Neurosurg, Gaziantep, Turkey; [Turkoglu, Mehmet Erhan] Diskapi Yildirim Beyazit Training & Res Hosp, Dept Neurosurg, Ankara, Turkey; [Dinc, Cem] Duzce Univ, Dept Neurosurg, Fac Med, Duzce, Turkey		Aykanat, O (corresponding author), Binevler Mah,52 Nolu Sok,39-5, Sahinbey, Gaziantep, Turkey.	yomeycik@hotmail.com	KARAKOYUN, DURMUS OGUZ/AAU-7370-2021	KARAKOYUN, DURMUS OGUZ/0000-0002-1306-7584			Aden U, 2010, BRAIN BEHAV IMMUN, V24, P747, DOI 10.1016/j.bbi.2009.10.010; Campbell SJ, 2007, J NEUROCHEM, V103, P2245, DOI 10.1111/j.1471-4159.2007.04928.x; Chen KB, 2011, SPINE, V36, P1350, DOI 10.1097/BRS.0b013e3181f014ec; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Errante LD, 2003, SEIZURE-EUR J EPILEP, V12, P300, DOI 10.1016/S1059-1311(02)00295-9; Faden AI, 2007, ARCH NEUROL-CHICAGO, V64, P794, DOI 10.1001/archneur.64.6.794; FEUERSTEIN GZ, 1994, CEREBROVAS BRAIN MET, V6, P341; Francis J, 2004, AM J PHYSIOL-HEART C, V286, pH2264, DOI 10.1152/ajpheart.01072.2003; Genovese T, 2006, J PHARMACOL EXP THER, V316, P1006, DOI 10.1124/jpet.105.097188; Greenberg MS, 2001, HDB NEUROSURGERY, P677; Hailer NP, 2005, EUR J NEUROSCI, V21, P2347, DOI 10.1111/j.1460-9568.2005.04067.x; Jiang Y, 2008, NEUROBIOL DIS, V32, P125, DOI 10.1016/j.nbd.2008.06.017; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kato K, 2010, J NEUROSCI RES, V88, P360, DOI 10.1002/jnr.22202; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; KONTOS HA, 1989, CHEM-BIOL INTERACT, V72, P229, DOI 10.1016/0009-2797(89)90001-X; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Lloyd DA, 1997, LANCET, V349, P821, DOI 10.1016/S0140-6736(96)09356-7; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Meyer P, 1999, CHILD NERV SYST, V15, P732, DOI 10.1007/s003810050462; Rostworowski M, 1997, J NEUROSCI, V17, P3664; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001	25	1	1	0	1	TURKISH ASSOC TRAUMA EMERGENCY SURGERY	ISTANBUL	KOPRULU MEHMET PASA SOC, DENIZ ABDAL MAH, DADASOGLU AP, 25-1 SEHREMINI, ISTANBUL, 00000, TURKEY	1306-696X			ULUS TRAVMA ACIL CER	Ulus. Travma Acil Cerrahi Derg.	MAY	2017	23	3					173	180		10.5505/tjtes.2016.43692			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	EX9PG	WOS:000403589400001	28530785	Green Published, Bronze			2022-02-06	
J	Drake, DF; Hudak, AM; Robbins, W				Drake, David F.; Hudak, Anne M.; Robbins, William			Integrative Medicine in Traumatic Brain Injury	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Integrative medicine; Traumatic brain injury; Complementary and integrative health	QUALITY-OF-LIFE; TAI CHI; NICOTINAMIDE TREATMENT; DOCOSAHEXAENOIC ACID; MANTRAM REPETITION; CREATINE; ACUPUNCTURE; SUPPLEMENTATION; MINDFULNESS; SYMPTOMS	Complementary and alternative medicine (CAM) is a group of diverse medical and health care systems, practices, and products that are not presently considered to be a part of conventional medicine. Integrative medicine combines treatment with conventional medical practices and elements of CAM in which there is strong evidence in efficacy and safety. Although there is growing interest in the integrative medical approach in treating the patient population with traumatic brain injury, there is a paucity in high-quality clinical trials supporting its use. This article reviews the background and current clinical data concerning some of the more common CAM interventions.	[Drake, David F.; Hudak, Anne M.; Robbins, William] Richmond VAMC, Dept Phys Med & Rehabil, 1201 Broad Rock Blvd, Richmond, VA 23249 USA; [Drake, David F.; Hudak, Anne M.; Robbins, William] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, 1223 East Marshall St,4th Floor,POB 980677, Richmond, VA 23298 USA		Drake, DF (corresponding author), Richmond VAMC, Dept Phys Med & Rehabil, Intervent Pain & Integrat Med, 1201 Broad Rock Blvd, Richmond, VA 23249 USA.	David.drake4@va.gov					Adhihetty PJ, 2008, NEUROMOL MED, V10, P275, DOI 10.1007/s12017-008-8053-y; Ahsin S, 2009, PAIN, V147, P60, DOI 10.1016/j.pain.2009.08.004; Aminmansour Bahram, 2012, Adv Biomed Res, V1, P58, DOI 10.4103/2277-9175.100176; Andres RH, 2008, BRAIN RES BULL, V76, P329, DOI 10.1016/j.brainresbull.2008.02.035; Azulay J, 2013, J HEAD TRAUMA REHAB, V28, P323, DOI 10.1097/HTR.0b013e318250ebda; Bazan NG, 2011, ANNU REV NUTR, V31, P321, DOI 10.1146/annurev.nutr.012809.104635; Beal MF, 2011, AMINO ACIDS, V40, P1305, DOI 10.1007/s00726-011-0851-0; Bedard M, 2003, DISABIL REHABIL, V25, P722, DOI 10.1080/0963828031000090489; Bingel U, 2002, PAIN, V99, P313, DOI 10.1016/S0304-3959(02)00157-4; Bormann JE, 2006, J BEHAV MED, V29, P359, DOI 10.1007/s10865-006-9063-6; Bormann JE, 2012, INT J BEHAV MED, V19, P496, DOI 10.1007/s12529-011-9186-1; Bormann JE, 2013, PSYCHOL TRAUMA-US, V5, P259, DOI 10.1037/a0027522; Bornhovd K, 2002, BRAIN, V125, P1326, DOI 10.1093/brain/awf137; Braissant O, 2012, J INHERIT METAB DIS, V35, P655, DOI 10.1007/s10545-011-9433-2; Braissant O, 2011, AMINO ACIDS, V40, P1315, DOI 10.1007/s00726-011-0852-z; Carlsson CPO, 2000, J PAIN SYMPTOM MANAG, V20, P273, DOI 10.1016/S0885-3924(00)00185-8; Chan WL, 2012, ALTERN THER HEALTH M, V18, P34; Cho E, 2010, NEUROTOX RES, V17, P156, DOI 10.1007/s12640-009-9085-2; Choi BY, 2014, J TRACE ELEM MED BIO, V28, P474, DOI 10.1016/j.jtemb.2014.07.007; Dolder M, 2003, J BIOL CHEM, V278, P17760, DOI 10.1074/jbc.M208705200; Ernst E, 2010, RHEUMATOLOGY, V49, P1957, DOI 10.1093/rheumatology/keq180; Fink M, 2002, RHEUMATOLOGY, V41, P205, DOI 10.1093/rheumatology/41.2.205; Gahche Jamie, 2011, NCHS Data Brief, P1; Gao Q, 2014, CLIN REHABIL, V28, P748, DOI 10.1177/0269215514521044; Gower-Winter SD, 2012, BIOFACTORS, V38, P186, DOI 10.1002/biof.1012; Haake M, 2007, ARCH INTERN MED, V167, P1892, DOI 10.1001/archinte.167.17.1892; Haar CV, 2016, BRAIN RES, V1640, P114, DOI 10.1016/j.brainres.2015.12.030; Hanna-Pladdy B, 2001, CLIN NEUROPSYCHOL, V15, P289, DOI 10.1076/clin.15.3.289.10272; Hasadsri L, 2013, J NEUROTRAUM, V30, P897, DOI 10.1089/neu.2012.2672; Hoane MR, 2008, NEUROSCIENCE, V154, P861, DOI 10.1016/j.neuroscience.2008.04.044; Hoane MR, 2006, BRAIN RES, V1125, P185, DOI 10.1016/j.brainres.2006.10.019; Hoane MR, 2006, NEUROSCI LETT, V408, P35, DOI 10.1016/j.neulet.2006.07.011; Holland MA, 2008, J NEUROTRAUM, V25, P140, DOI 10.1089/neu.2007.0312; Hui K, 1997, NEUROIMAGE, V5, P226; Hui KKS, 2000, HUM BRAIN MAPP, V9, P13, DOI 10.1002/(SICI)1097-0193(2000)9:1<13::AID-HBM2>3.0.CO;2-F; Ishaq GM, 2013, J NEUROSCI RURAL PRA, V4, P292, DOI 10.4103/0976-3147.118784; Jahnke Roger, 2010, Am J Health Promot, V24, pe1, DOI 10.4278/ajhp.081013-LIT-248; Jamall OA, 2016, CLIN ENDOCRINOL, V85, P636, DOI 10.1111/cen.13045; Jasmin L, 2003, NATURE, V424, P316, DOI 10.1038/nature01808; Johansson K, 2011, FAM PRACT, V28, P355, DOI 10.1093/fampra/cmq119; KABATZINN J, 1982, GEN HOSP PSYCHIAT, V4, P33, DOI 10.1016/0163-8343(82)90026-3; Kim Young-Dae, 2013, Evid Based Complement Alternat Med, V2013, P615857, DOI 10.1155/2013/615857; Langevin Helene M., 2002, Anatomical Record, V269, P257, DOI 10.1002/ar.10185; Lauche R, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/635182; Lee A, 1999, ANESTH ANALG, V88, P1362, DOI 10.1097/00000539-199906000-00031; Li FZ, 2012, NEW ENGL J MED, V366, P511, DOI 10.1056/NEJMoa1107911; Lim SM, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/870398; Linde K, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007587.pub2; Linde K, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001218.pub2; Ling J, 2009, BEHAV PHARMACOL, V20, P673, DOI 10.1097/FBP.0b013e3283323c2a; Saraiva ALL, 2012, BRAIN RES BULL, V87, P180, DOI 10.1016/j.brainresbull.2011.10.010; Lynch M, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3931; Maiese K, 2009, MOLECULES, V14, P3446, DOI 10.3390/molecules14093446; Manko G, 2013, MED SCI MONITOR, V19, P767, DOI 10.12659/MSM.889480; Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026; McMorris T, 2006, PSYCHOPHARMACOLOGY, V185, P93, DOI 10.1007/s00213-005-0269-z; Meyer LE, 2006, J BIOL CHEM, V281, P37361, DOI 10.1074/jbc.M604123200; Mills JD, 2011, NEUROSURGERY, V68, P474, DOI 10.1227/NEU.0b013e3181ff692b; Morris DR, 2013, CURR OPIN CLIN NUTR, V16, P708, DOI 10.1097/MCO.0b013e328364f39c; Oh B, 2010, ANN ONCOL, V21, P608, DOI 10.1093/annonc/mdp479; Oman D, 2015, PSYCHOL RELIG SPIRIT, V7, P34, DOI 10.1037/a0037994; Rae C, 2003, P ROY SOC B-BIOL SCI, V270, P2147, DOI 10.1098/rspb.2003.2492; Razmkon Ali, 2011, Clin Neurosurg, V58, P133; Sakellaris G, 2006, J TRAUMA, V61, P322, DOI 10.1097/01.ta.0000230269.46108.d5; Sakellaris G, 2008, ACTA PAEDIATR, V97, P31, DOI 10.1111/j.1651-2227.2007.00529.x; Scheff SW, 2004, NEUROCHEM RES, V29, P469, DOI 10.1023/B:NERE.0000013753.22615.59; Scrimgeour AG, 2014, J NEUROTRAUM, V31, P989, DOI 10.1089/neu.2013.3234; Sestili P, 2011, AMINO ACIDS, V40, P1385, DOI 10.1007/s00726-011-0875-5; Sharma S, 2009, NEUROSCIENCE, V161, P1037, DOI 10.1016/j.neuroscience.2009.04.042; Shear DA, 2016, J NEUROTRAUM, V33, P523, DOI 10.1089/neu.2015.4115; Signoretti S, 2010, MOL CELL BIOCHEM, V333, P269, DOI 10.1007/s11010-009-0228-9; Silverthorne Colin, 2012, Int J Yoga Therap, P47; Stephenson KR, 2017, J CLIN PSYCHOL, V73, P201, DOI 10.1002/jclp.22323; Suh SW, 2009, J CEREBR BLOOD F MET, V29, P1579, DOI 10.1038/jcbfm.2009.80; Sullivan PG, 2000, ANN NEUROL, V48, P723, DOI 10.1002/1531-8249(200011)48:5&lt;723::AID-ANA5&gt;3.0.CO;2-W; Swan AA, 2011, J NEUROTRAUM, V28, P431, DOI 10.1089/neu.2010.1519; Telles S, 2013, J ALTERN COMPLEM MED, V19, P35, DOI 10.1089/acm.2011.0282; Tiedemann A, 2013, J GERONTOL A-BIOL, V68, P1068, DOI 10.1093/gerona/glt087; Tsang WWN, 2013, J PHYSIOTHER, V59, P55, DOI 10.1016/S1836-9553(13)70148-6; Tur JA, 2012, BRIT J NUTR, V107, pS23, DOI 10.1017/S0007114512001456; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; Wang CC, 2011, RHEUM DIS CLIN N AM, V37, P19, DOI 10.1016/j.rdc.2010.11.002; Wang CW, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/716094; Wang T, 2013, RESTOR NEUROL NEUROS, V31, P647, DOI 10.3233/RNN-130316; Watanabe A, 2002, NEUROSCI RES, V42, P279, DOI 10.1016/S0168-0102(02)00007-X; Wei GX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061038; Wong V, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007700.pub2; Wu AG, 2011, NEUROREHAB NEURAL RE, V25, P332, DOI 10.1177/1545968310397706; Wu AG, 2010, NEUROREHAB NEURAL RE, V24, P290, DOI 10.1177/1545968309348318; Wu MT, 1999, RADIOLOGY, V212, P133, DOI 10.1148/radiology.212.1.r99jl04133; Wu MT, 2002, NEUROIMAGE, V16, P1028, DOI 10.1006/nimg.2002.1145; YANG MS, 1985, J NEUROSURG, V63, P617, DOI 10.3171/jns.1985.63.4.0617; Yu LS, 2015, AM J MED SCI, V349, P521, DOI 10.1097/MAJ.0000000000000457; Zald DH, 2003, BRAIN RES REV, V41, P88, DOI 10.1016/S0165-0173(02)00248-5; Zeidan F, 2011, J NEUROSCI, V31, P5540, DOI 10.1523/JNEUROSCI.5791-10.2011; Zhang WT, 2003, BRAIN RES, V982, P168, DOI 10.1016/S0006-8993(03)02983-4; Zhu HT, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-59	97	1	1	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651	1558-1381		PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	MAY	2017	28	2					363	+		10.1016/j.pmr.2016.12.011			18	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	EU5AJ	WOS:000401043700013	28390519				2022-02-06	
J	Hawkins, JR; Gonzalez, KE; Heumann, KJ				Hawkins, Jeremy R.; Gonzalez, Kayla E.; Heumann, Kristin J.			The Effectiveness of Hyperbaric Oxygen Therapy as a Treatment for Postconcussion Symptoms	JOURNAL OF SPORT REHABILITATION			English	Article						therapeutic modality; atmospheric pressure; mild traumatic brain injury	TRAUMATIC BRAIN-INJURY	Clinical Scenario: Concussions are a prevalent topic in medicine. Concussion symptoms include headaches, dizziness, nausea, neuropsychiatric symptoms, and cognitive impairments, the persistence of which is referred to as postconcussion syndrome. Hyperbaric oxygen therapy (HBOT) has been proposed and evaluated as an additional treatment of these symptoms. HBOT is an innovative approach that has been considered by many but has received both criticism and acceptance. Clinical Question: Is HBOT an effective means of reducing symptoms for individuals suffering from postconcussion syndrome (persistence of symptoms for > 3 mo)? Summary of Search: The literature was searched for studies that were relevant to the clinical question. Literature provided 5 level 1 studies that were relevant enough to be considered. Clinical Bottom Line: Based on the research that is available, the authors conclude that there is more evidence to refute the use of HBOT for postconcussion syndrome than to support it. Strength of Recommendation: Four studies disprove the use of HBOT; 1 study supported the use of HBOT. These 5 studies are the same level of evidence (level 1) and provide significant findings in their studies. The strength of this recommendation is a B according to the Centre for Evidence-Based Medicine.	[Hawkins, Jeremy R.; Gonzalez, Kayla E.; Heumann, Kristin J.] Colorado Mesa Univ, Dept Kinesiol, Grand Junction, CO 81501 USA		Hawkins, JR (corresponding author), Colorado Mesa Univ, Dept Kinesiol, Grand Junction, CO 81501 USA.	jrhawkins@coloradomesa.edu					Babul S, 2000, SPORTS MED, V30, P395, DOI 10.2165/00007256-200030060-00002; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Boussi-Gross R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079995; Cifu DX, 2014, J REHABIL RES DEV, V51, P1047, DOI 10.1682/JRRD.2014.01.0013; Cifu DX, 2014, ANN NEUROL, V75, P277, DOI 10.1002/ana.24067; Cifu DX, 2014, J HEAD TRAUMA REHAB, V29, P11, DOI 10.1097/HTR.0b013e3182a6aaf0; Knight KL, 2013, THERAPEUTIC MODALITI, P74; Pittman R. N., 2011, REGULATION TISSUE OX; Wolf G, 2012, J NEUROTRAUM, V29, P2606, DOI 10.1089/neu.2012.2549	9	1	1	0	1	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	MAY	2017	26	3					290	294		10.1123/jsr.2015-0087			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	FC3HO	WOS:000406729900014	27834587				2022-02-06	
J	Hou, MS; Cao, J; Chen, B; Liu, XB				Hou, Ming-Shan; Cao, Jie; Chen, Bo; Liu, Xiao-Bin			Down-Regulation of IRF6 Protects Cortical Neurons Against Traumatic Neuronal Injury Through Activating Akt-eNOS Pathway	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						IRF6; TBI; Oxidative stress; Akt; eNOS	BRAIN-INJURY; REPERFUSION INJURY; MOUSE-BRAIN; PHOSPHORYLATION; INFLAMMATION; EXPRESSION; CYTOKINES; ISCHEMIA; CELLS; MICE	Interferon regulatory factor 6 (IRF6) is a novel and unique member of the IRF family of transcription factors, and the regulation and function of IRF6 remain unknown. Recently, IRF6 was shown to be upregulated after TBI and could promote neuronal apoptosis under oxidative stress conditions. This study aimed to investigate the role of IRF6 in traumatic neuronal injury (TNI) in primary cultured mouse cortical neurons. We found that the expression of IRF6 was significantly increased within 48 after TNI, and peaked at 24 h. Knockdown of IRF6 using specific targeted small interfering RNA (siRNA) attenuated TNI-induced loss of neuronal viability and release of lactate dehydrogenase. The results of TUNEL staining showed that IRF6 knockdown markedly reduced neuronal apoptosis, which was accompanied by decreased activity of caspase-3. Furthermore, downregulation of IRF6 inhibited lipid peroxidation, promoted the activity of endogenous antioxidative enzymes, and differently regulated the expression of inflammatory cytokines after TNI. In addition, IRF6 knockdown significantly increased phosphorylation of Akt and endothelial nitric oxide synthase (eNOS), whereas blocking Akt-eNOS pathway via selective antagonists partly prevented the protective effects of IRF6 knockdown. These data show that downregulation of IRF6 affords protection against TNI through Akt-eNOS pathway-mediated antioxidative and anti-inflammatory activity.	[Hou, Ming-Shan; Cao, Jie; Chen, Bo; Liu, Xiao-Bin] Xi An Jiao Tong Univ, Shaanxi Prov Peoples Hosp, Affiliated Hosp 3, Dept Neurosurg,Affiliated Hosp, Xian 710068, Shaanxi, Peoples R China		Hou, MS (corresponding author), Xi An Jiao Tong Univ, Shaanxi Prov Peoples Hosp, Affiliated Hosp 3, Dept Neurosurg,Affiliated Hosp, Xian 710068, Shaanxi, Peoples R China.	houmingshan_xjtu@163.com					Alexander M, 2003, ACTA NEUROPATHOL, V105, P420, DOI 10.1007/s00401-002-0658-x; Chen T, 2017, CELL MOL NEUROBIOL, V37, P43, DOI 10.1007/s10571-016-0341-8; Chen T, 2012, FREE RADICAL BIO MED, V52, P208, DOI 10.1016/j.freeradbiomed.2011.10.451; Chen T, 2011, BRAIN RES BULL, V84, P163, DOI 10.1016/j.brainresbull.2010.11.015; Chen WJ, 2010, CELL SIGNAL, V22, P883, DOI 10.1016/j.cellsig.2009.12.005; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Dai SH, 2014, INT J MOL SCI, V15, P14591, DOI 10.3390/ijms150814591; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Faden AI, 2001, EXP NEUROL, V167, P435, DOI 10.1006/exnr.2000.7577; Ferretti E, 2011, DEV CELL, V21, P627, DOI 10.1016/j.devcel.2011.08.005; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; Lin YC, 2016, CELL MOL NEUROBIOL, V36, P27, DOI 10.1007/s10571-015-0217-3; Liu HQ, 2012, BRAIN RES BULL, V89, P65, DOI 10.1016/j.brainresbull.2012.06.010; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Ooboshi H, 2005, CIRCULATION, V111, P913, DOI 10.1161/01.CIR.0000155622.68580.DC; Pang L, 2001, STROKE, V32, P544, DOI 10.1161/01.STR.32.2.544; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Redell JB, 2013, J NEUROTRAUM, V30, P752, DOI 10.1089/neu.2012.2437; Rochfort KD, 2015, BIOCHEM SOC T, V43, P702, DOI 10.1042/BST20140319; Takaoka A, 2008, CANCER SCI, V99, P467, DOI 10.1111/j.1349-7006.2007.00720.x; Vecil GG, 2000, J NEUROSCI RES, V61, P212, DOI 10.1002/1097-4547(20000715)61:2<212::AID-JNR12>3.0.CO;2-9; Xiang M, 2014, J NEUROCHEM, V129, P988, DOI 10.1111/jnc.12682; Xu JG, 2014, BRAIN RES, V1582, P237, DOI 10.1016/j.brainres.2014.07.042; Yang CJ, 2013, CARDIOVASC RES, V97, P33, DOI 10.1093/cvr/cvs287; Zhao GN, 2015, BBA-MOL BASIS DIS, V1852, P365, DOI 10.1016/j.bbadis.2014.04.030; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	26	1	1	0	3	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	MAY	2017	37	4					587	594		10.1007/s10571-016-0394-8			8	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	ER7SK	WOS:000399013600002	27306759				2022-02-06	
J	Khalatbari, S; Aghakhani, K; Taftachi, F; Memarian, A; Faress, F; Hayati, F; Behzadi, A; Soltanmohammadi, A; Keyvan, M				Khalatbari, Sepehrdad; Aghakhani, Kamran; Taftachi, Farrokh; Memarian, Azadeh; Faress, Fouroozan; Hayati, Faranak; Behzadi, Alireza; Soltanmohammadi, Azra; Keyvan, Morteza			Epidemiology of Craniofacial Injuries in a Tertiary University Hospital in Tehran, 2013-14	TRAUMA MONTHLY			English	Article						Wounds and Injuries; Causes; Craniofacial; Iran	LIFE-SUPPORT ATLS; ONE SIZE FIT; MAXILLOFACIAL INJURIES; FACIAL FRACTURES; TRAUMA; MANAGEMENT; DILEMMAS; ACCIDENT; PATTERNS; OUTCOMES	Background: Craniofacial injuries are a major cause of trauma-related disability and damage. Knowledge of the common causes of injuries to the head and facial areas and the resulting effects on the bone structures or brain tissue will be useful for healthcare personnel. Objectives: The aim was to investigate the common causes of injuries in patients with craniofacial trauma, and to describe the resulting bone and soft tissue injuries. Methods: In this one-year cross-sectional study (2013-14) which was carried out in a tertiary referral hospital, 416 patients who suffered from various forms of craniofacial traumatic injuries (resulting from traffic accidents, assaults, falls, etc.) were enrolled in the study on a consecutive basis. Their medical records and radiographs were examined, and interviews were conducted with the patients and their family members to determine the exact causes of the injuries. Results: Of the 416 cases, 356 were males (85.6%). Mean (SD) age was 33.1 (21.1) years. The most common cause of injury was falls (137 cases, 32.9%) followed by motorcycle accidents (86 cases, 20.7%). Of the 206 patients with skull fractures (49.5% of the sample), 125 (58.4% of the group) were in non-motor vehicle accidents versus 81 patients (40.1%) who were in the motor vehicle accident group (P < 0.0001). Facial bone fractures were more common among those with non-motor vehicle accident injuries (28.5%) versus those who had been in motor vehicle accidents (12.4%, P < 0.0001). Conversely, intracranial hemorrhage (74.3% vs. 58.9%, P = 0.001) and brain tissue injuries including a contusion, edema, herniation, or burst lobe (44.6% vs. 24.8%, P < 0.0001) were respectively more prevalent in motor vehicle accident traumas than in non-vehicle motor accident injuries. At follow-up, 34 patients had died during hospitalization, 69 patients had undergone cranial surgery, and 67 required facial surgery. Conclusions: Craniofacial injuries were more common in males in their thirties, with falls and motorcycle accidents as the most common causes. In motor vehicle accidents, we observed a significantly higher proportion of intracranial hemorrhages and brain tissue injuries. In non-motor vehicle accidents (including falls, assaults, accidentally hitting the head/face with a sharp/hard object, etc.), skull/facial bone fractures were more common. These findings can be considered by clinicians as well as forensic medicine specialists.	[Khalatbari, Sepehrdad; Aghakhani, Kamran; Taftachi, Farrokh; Memarian, Azadeh; Faress, Fouroozan; Hayati, Faranak; Behzadi, Alireza; Soltanmohammadi, Azra; Keyvan, Morteza] Iran Univ Med Sci, Dept Forens Med, Tehran, Iran		Khalatbari, S (corresponding author), Iran Univ Med Sci, Hazrat Rasoul Hosp, Niyayesh St,Sattar Khan Ave, Tehran, Iran.	sepehrdad.khalatbari@yahoo.com	Memarian, Azadeh/D-2602-2019	Memarian, Azadeh/0000-0002-6872-1870; Faress, Foroozan/0000-0002-5057-6388			Abiodun A, 2012, ANN AFR MED, V11, P131, DOI 10.4103/1596-3519.96860; Aghakhani N, 2013, IRAN RED CRESCENT ME, V15, P173, DOI 10.5812/ircmj.2090; Alvi A, 2003, LARYNGOSCOPE, V113, P102, DOI 10.1097/00005537-200301000-00019; Ardekian L, 1998, INJURY, V29, P253, DOI 10.1016/S0020-1383(97)00209-X; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Caroli M, 2001, SURG NEUROL, V56, P82, DOI 10.1016/S0090-3019(01)00540-7; Gassner R, 2004, J ORAL MAXIL SURG, V62, P399, DOI 10.1016/j.joms.2003.05.013; Gassner R, 2003, J CRANIO MAXILL SURG, V31, P51, DOI 10.1016/S1010-5182(02)00168-3; Girotto JA, 2001, PLAST RECONSTR SURG, V108, P312, DOI 10.1097/00006534-200108000-00005; Hashim H, 2011, DENT TRAUMATOL, V27, P19, DOI 10.1111/j.1600-9657.2010.00958.x; Hassan NA, 2010, J FORENSIC LEG MED, V17, P26, DOI 10.1016/j.jflm.2009.07.008; Hogg NJV, 2000, J TRAUMA, V49, P425, DOI 10.1097/00005373-200009000-00007; Imahara SD, 2008, J AM COLL SURGEONS, V207, P710, DOI 10.1016/j.jamcollsurg.2008.06.333; Katzen JT, 2003, J TRAUMA, V54, P1026, DOI 10.1097/01.TA.0000066180.14666.8B; Klenk G, 2003, J CRANIOFAC SURG, V14, P78, DOI 10.1097/00001665-200301000-00014; MacIsaac ZM, 2013, PLAST RECONSTR SURG, V131, P1339, DOI 10.1097/PRS.0b013e31828bd191; Moharamzad Y, 2008, CHIN J TRAUMATOL, V11, P329, DOI 10.1016/S1008-1275(08)60067-X; Oginni FO, 2006, J ORAL MAXIL SURG, V64, P56, DOI 10.1016/j.joms.2005.09.027; Pappachan B, 2006, J ORAL MAXIL SURG, V64, P1023, DOI 10.1016/j.joms.2006.03.021; Parreira JG, 2010, REV ASSOC MED BRAS, V56, P660, DOI 10.1590/S0104-42302010000600013; Perry M, 2008, INT J ORAL MAX SURG, V37, P309, DOI 10.1016/j.ijom.2007.11.002; Perry M, 2008, INT J ORAL MAX SURG, V37, P209, DOI 10.1016/j.ijom.2007.11.003; Perry M, 2005, INJURY, V36, P875, DOI 10.1016/j.injury.2004.09.018; Ramli R, 2011, DENT TRAUMATOL, V27, P122, DOI 10.1111/j.1600-9657.2010.00968.x; Rasouli MR, 2011, PUBLIC HEALTH, V125, P727, DOI 10.1016/j.puhe.2011.07.006; Leles JLR, 2010, J APPL ORAL SCI, V18, P23, DOI 10.1590/S1678-77572010000100006	26	1	1	0	6	NATL CENTER TRAUMA RESEARCH	TEHRAN	NATL CENTER TRAUMA RESEARCH, TEHRAN, IRAN	2251-7464	2251-7472		TRAUMA MON	Trauma Mon.	MAY	2017	22	3							e33050	10.5812/traumamon.33050			6	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	FJ0US	WOS:000412426500005		hybrid			2022-02-06	
J	Lau, C				Lau, Chris			LEADERS AND LAGGARDS: TACKLING STATE LEGISLATIVE RESPONSES TO THE YOUTH SPORTS CONCUSSION EPIDEMIC	FORDHAM LAW REVIEW			English	Article							HIGH-SCHOOL	In 2009, state legislatures began to enact concussion safety laws to protect youth athletes suffering from traumatic brain injuries sustained during the course of play. By 2014, all fifty states and the District of Columbia had enacted some form of youth sports concussion legislation. Yet these statutes vary widely across states in terms of the protections offered to youth athletes. This Note provides an analysis of state legislation by classifying all fifty-one statutes among distinct tiers ranging from least to most protective. These laws have generally targeted the secondary risks of concussions, which emerge after a youth athlete has suffered a traumatic brain injury. While the prevention of secondary risks is an important element of concussion management, future legislators should also consider the primary risks of concussions by focusing on reducing the risk of injury before it occurs. This Note advocates that, to ensure the adequate protection of all youth athletes, future legislators must continue to prevent secondary risks by expanding coverage and strengthening enforcement mechanisms. In addition, legislators must address the primary risks of concussions by mandating certain rule changes, which, over time, may begin to transform societal attitudes toward the seriousness of sports-related concussions. While many youth sports organizations and even professional sports leagues have begun to implement certain rule changes to increase player safety, these changes would gain greater efficacy if backed by the force of law. This Note lays out recommendations for a model statute to provide guidance for future legislators.	[Lau, Chris] Fordham Univ, Sch Law, Bronx, NY 10458 USA		Lau, C (corresponding author), Fordham Univ, Sch Law, Bronx, NY 10458 USA.		Berger, Emily/N-7268-2017	Berger, Emily/0000-0001-5550-807X			Abrams D. E., 2015, J BUSINESS TECHNOLOG, V10, P1; Abrams Douglas E., 2015, J BUS TECH L, V10, P5; Adams Taylor, 2016, SCHOLAR, V18, P291; Adams Taylor, 2016, SCHOLAR, V18, P285; Amberg P., 2012, MARQUETTE SPORTS LAW, V23, P171; Amberg Phoebe Anne, 2012, MARQ SPORTS L REV, V23, P183; Anderson Chantal, 2009, SEATTLE TIMES; [Anonymous], 2012, POP WARNER; [Anonymous], 2010, LYST LAW CONC SURV J; [Anonymous], 2012, MEMO EXPLAINS POLICY; [Anonymous], 2016, NFHS HDB 2016 17, P55; [Anonymous], 2012, NEW NFL RULES DESIGN; Baugh CM, 2014, J LAW MED ETHICS, V42, P297, DOI 10.1111/jlme.12147; Baugh Christine M., 2014, J LAW MED ETHICS, V42, P303; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bell Jarrett, 2011, US TODAY; Belson K, 2016, NY TIMES; Bender SD, 2004, STUD NEUROPSYCHOL DE, P3; Brandwein K., 2013, WILLAMETTE SPORTS LA, V10, P28; Brandwein Kevin, 2013, WILLAMETTE SPORTS LJ, V10, P53; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Carrabis Andrew B., 2011, HARV J SPORTS ENT L, V2, P386; Carrabis Andrew B., 2011, HARV J SPORTS ENT L, V2, P371; CARROLL LINDA, 2011, CONCUSSION CRISIS, P35; Cook A, 2014, J LAW MED ETHICS, V42, P284, DOI 10.1111/jlme.12145; Fendrich Howard, 2015, AP ANAL YOUTH CONCUS; Frollo Joe, 2014, MISSISSIPPI BECOMES; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Graham Robert, 2014, SPORTS RELATED CONCU, V7, P43; Green L., 2014, LEGAL PERSPECTIVES R; Grier Kevin, 2012, GRANTLAND; Guthrie Patricia, 2015, WEBMD           1021; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Harvey Hosea H, 2014, Yale J Health Policy Law Ethics, V14, P66; Hosea H., 2014, YALE J HLTH POLY L E, V14, P113; Hunsucker Josh, 2014, MCGEORGE L REV, V45, P832; Hunsucker Josh, 2014, MCGEORGE L REV, V45, P801; Klein J. Z., 2011, NY TIMES; Koller Dionne L., 2016, PEPP L REV, V43, P681; Koller Dionne L., 2016, PEPP L REV, V43, P718; Koloup Elisabeth, 2012, U BALT LF, V42, P207; Koloup Elisabeth, 2012, U BALT LF, V42, P223; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lowrey Kerri M., 2015, J BUS TECH L, V10, P66; Lowrey KM, 2014, J LAW MED ETHICS, V42, P290, DOI 10.1111/jlme.12146; Lowrey Kerri McGowan, 2016, SUMMARY MATRIX STATE; Lowrey KM., 2015, J BUS TECHNOL LAW, V10, P61; Lueke L, 2011, J LEGAL MED, V32, P483, DOI 10.1080/01947648.2011.632710; Lueke Lesley, 2011, J LEGAL MED, V32, P495; Marvez Alex, 2012, FOX SPORTS; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McGuine Timothy A., 2015, AM ACAD PEDIAT; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mickool Sheila, 2013, SEATTLE MAG     0409; Nat'l Ctr. for Injury Prevention & Control Ctrs. for Disease Control & Prevention U.S. Dep't of Health & Human Servs, 2015, REP C TRAUM INJ US E; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; National Centre for Injury Prevention and Control Division of Unintentional Injury Prevention (US), 2013, GET HEADS CONC SPORT; NFL, 2012, NFL NCAA LOBBY CONCU; Obama B, 2014, COMMUNICATION; Reinberg Steven, 2012, TEENS MAY FARE WORSE; Schwarz A., 2016, NY TIMES; Straus Lindsey Barton, 2013, BODY CHECKING BANNED; Tuite PJ, 2007, SEMIN NEUROL, V27, P113, DOI 10.1055/s-2007-971174; U.S. Soccer Provides Additional Information About Upcoming Player Safety Campaign, 2015, US SOCCER PROVIDES A; Wilson M-F, 2010, MARQ SPORTS L REV, V21, P241; Wilson Marie-France, 2010, MARQ SPORTS L REV, V21, P288; Zirkel Perry A., 2016, PHYS DISABILITIES, V35, P3	68	1	1	0	1	FORDHAM UNIV SCHOOL LAW	NEW YORK	140 W 62ND STREET, NEW YORK, NY 10023 USA	0015-704X			FORDHAM LAW REV	Fordham Law Rev.	MAY	2017	85	6					2879	2913					35	Law	Social Science Citation Index (SSCI)	Government & Law	EX5YI	WOS:000403318600017					2022-02-06	
J	Marinho, CDSR; Leite, RB; Morais, LA; Martin, QCS; Valenca, CN; Bay, OD; da Silva, ITS; Araujo, MFS; Tavora, RCD; do Rego, MSF; Fernandes, FCGD; da Silva, MLP; de Oliveira, RFS				Marinho, Cristiane da Silva Ramos; Leite, Rayane Batista; Morais Filho, Luiz Alves; Soares Martin, Quenia Camille; Valenca, Cecilia Nogueira; Bay Junior, Osvaldo de Goes; Soares da Silva, Ilisdayne Thallita; Silva Araujo, Mayonara Fabiola; de Oliveira Tavora, Rafaela Carolini; Fernandes do Rego, Mayara Silva; Gomes de Morais Fernandes, Fabia Cheyenne; Paiva da Silva, Maria Leonor; Sousa de Oliveira, Renata Fonseca			EPIDEMIOLOGICAL PROFILE OF TRAUMATIC BRAIN INJURY VICTIMS OF A GENERAL HOSPITAL IN A BRAZILIAN CAPITAL	BIOSCIENCE JOURNAL			English	Article						Injuries stroke; Glasgow coma scale; Epidemiology		In Brazil, the accidents and urban violence, the external causes, build a public health problem that has taken big proportions and transcendence, with a big impact on the population's lives. In the set of injuries resulting from external causes, the Traumatic brain injury (TBI) stands out in terms of magnitude, both among dead and injured, being one of the most frequent injuries. Thus, it is important to know epidemiological profile of traumatic brain injury victims, local characteristics, in order to take more effective prevention actions based on this reality, since the primary causes of TBI can vary according to the people involved. The objective of this study was to know the epidemiological profile of traumatic brain injury victims, the type of causative event and the severity of the trauma. Exploratory, cross-sectional, quantitative and descriptive research, conducted with 372 patients suffering from traumatic brain injury. Data were collected from form itself, semi-Structured form, and analyzed using the SPSS 20.0 software. The research had the project approved by the Research Ethics Committee, CAAE 30487514.6.0000.5568. There was a predominance of males, aged 18-30 years. The cause of the most common brain injury was traffic accident with a prevalence of moderate traumatic brain injury. It is necessary to the development of preventive actions as well as the development of public policies that contribute to the reduction of morbidity and mortality from TEC and qualified assistance to victims.	[Marinho, Cristiane da Silva Ramos; Morais Filho, Luiz Alves; Soares Martin, Quenia Camille; Bay Junior, Osvaldo de Goes; de Oliveira Tavora, Rafaela Carolini; Fernandes do Rego, Mayara Silva; Gomes de Morais Fernandes, Fabia Cheyenne; Paiva da Silva, Maria Leonor] Univ Fed Rio Grande Norte FACISA UFRN, Fac Ciencias Saude Trairi, Curso Enfermagem, Natal, RN, Brazil; [Leite, Rayane Batista] Univ Fed Rio Grande Norte FACISA UFRN, Fac Ciencias Saude Trairi, Saude Colet, Natal, RN, Brazil; [Valenca, Cecilia Nogueira] Univ Fed Rio Grande Norte FACISA UFRN, Fac Ciencias Saude Trairi, Curso Posgrad Saude Colet, Natal, RN, Brazil; [Soares da Silva, Ilisdayne Thallita] Univ Fed Rio Grande Norte FACISA UFRN, Fac Ciencias Saude Trairi, Enfermagem, Natal, RN, Brazil; [Silva Araujo, Mayonara Fabiola] Univ Fed Rio Grande Norte FACISA UFRN, Fac Ciencias Saude Trairi, Saude Publ, Natal, RN, Brazil; [Sousa de Oliveira, Renata Fonseca] Univ Fed Rio Grande Norte FACISA UFRN, Fac Ciencias Saude Trairi, Programa Posgrad Saude Colet, Natal, RN, Brazil		Marinho, CDSR (corresponding author), Univ Fed Rio Grande Norte FACISA UFRN, Fac Ciencias Saude Trairi, Curso Enfermagem, Natal, RN, Brazil.	cristiane_ramos@hotmail.com	Morais, Leonardo Antonio/AAN-2450-2021				Andrade LM, 2009, REV RENE, V10, P52; [Anonymous], 2013, RIO GRAND DO NORT; BARBOSA S. L., 2010, REV BAIANA SAUDE PUB, V34, P240; BRASIL. Ministerio da Saude. Departamento de Informatica do SUS (DATASUS), 2010, INF SAUD EST VIT; BRASIL. Portal da Saude. Radar Saude Congresso, 2013, B INF MIN SAUD DEST, V3; Canova JCM, 2010, ARQ CIENC SAUDE, V17, P9; Settervall CHC, 2012, ACTA PAUL ENFERM, V25, P364, DOI 10.1590/S0103-21002012000300008; de Andrade AF, 2009, REV ASSOC MED BRAS, V55, P75, DOI 10.1590/S0104-42302009000100020; Eloia SC, 2011, REV SANARE, V10, P34; Farias GM, 2009, REV ENFERM UFPE LINE, V3, P898; FERIANI G., 2013, PRE HOSPITALAR GRAU; GENTILE J. K. A., 2011, REV BRAS CLIN MED, V9, P74; GOMES S. L., 2014, REV ENFERM UFPE LINE, V8, P2004; Lopes RD, 2013, REV BRASILEIRA NEURO, V7, P80; Abreu AMM, 2010, REV LAT-AM ENFERM, V18, P513, DOI 10.1590/S0104-11692010000700005; Pereira N, 2011, REV INTERDISC NOVAFA, V4, P60; SANCHES S., 2008, REV SAUDE SOC, V18, P95; Smeltzer SC, 2011, TRATADO ENFERMAGEM M; SOARES J. S., 2012, REV PIAUIENSE SAUDE, V1, P17; Sousa RMC, 2006, REV ESC ENFERM USP, V40, P203, DOI DOI 10.1590/S0080-62342006000200008; Vieira Rita de Cássia Almeida, 2011, Rev. esc. enferm. USP, V45, P1359	21	1	1	0	1	UNIV FEDERAL UBERLANDIA	UBERLANDIA	AV PARA, 1720 CAMPUS UMUARAMA, UBERLANDIA, 38400-902, BRAZIL	1981-3163			BIOSCI J	Biosci. J.	MAY-JUN	2017	33	3					779	787					9	Agriculture, Multidisciplinary; Agronomy; Biology	Science Citation Index Expanded (SCI-EXPANDED)	Agriculture; Life Sciences & Biomedicine - Other Topics	EW0TP	WOS:000402204400026					2022-02-06	
J	McGuire, JA; Sherman, PM; Dean, E; Bernot, JM; Rowland, LM; McGuire, SA; Kochunov, PV				McGuire, Jennifer A.; Sherman, Paul M.; Dean, Erica; Bernot, Jeremy M.; Rowland, Laura M.; McGuire, Stephen A.; Kochunov, Peter V.			Utilization of MRI for Cerebral White Matter Injury in a Hypobaric Swine Model-Validation of Technique	MILITARY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; HIGH-ALTITUDE PILOTS; AXONAL INJURY; DECOMPRESSION-SICKNESS; COGNITIVE IMPAIRMENT; MOUSE MODEL; DIFFUSION; HYPERINTENSITIES; INTEGRITY; LESIONS	Background: Repetitive hypobaric exposure in humans induces subcortical white matter change, observable on magnetic resonance imaging (MRI) and associated with cognitive impairment. Similar findings occur in traumatic brain injury (TBI). We are developing a swine MRI-driven model to understand the pathophysiology and to develop treatment interventions. Methods: Five miniature pigs (Sus scrofa domestica) were repetitively exposed to nonhypoxic hypobaria (30,000 feet/FIO2 100%/ transcutaneous PO2 >90%) while under general anesthesia. Three pigs served as controls. Pre-exposure and postexposure MRIs were obtained that included structural sequences, dynamic contrast perfusion, and diffusion tensor quantification. Statistical comparison of individual subject and group change was performed utilizing a two-tailed t test. Findings: No structural imaging change was noted on T2-weighted or three-dimensional fluid-attenuated inversion recovery imaging between MRI 1 and MRI 2. No absolute difference in dynamic contrast perfusion was observed. A trend (p = 0.084) toward increase in interstitial extra-axonal fluid was noted. When individual subjects were examined, this trend toward increased extra-axonal fluid paralleled a decrease in contrast perfusion rate. Discussion/Impact/Recommendations: This study demonstrates high reproducibility of quantitative noninvasive MRI, suggesting MRI is an appropriate assessment tool for TBI and hypobaric-induced injury research in swine. The lack of fluid-attenuated inversion recovery change may be multifactorial and requires further investigation. A trend toward increased extra-axonal water content that negatively correlates with dynamic contrast perfusion implies generalized axonal injury was induced. This study suggests this is a potential model for hypobaric-induced injury as well as potentially other axonal injuries such as TBI in which similar subcortical white matter change occurs. Further development of this model is necessary.	[McGuire, Jennifer A.; Rowland, Laura M.; Kochunov, Peter V.] Univ Maryland, Sch Med, Maryland Psychiat Res Ctr, Conte Ctr, 55 Wade Ave, Catonsville, MD 21228 USA; [McGuire, Jennifer A.] Emory Univ, Oxford Coll, 810 Whatcoat St, Oxford, GA 30054 USA; [Sherman, Paul M.; Dean, Erica; McGuire, Stephen A.] US Air Force, Sch Aerosp Med, Aeromed Res Dept, 2510 5th St,Bldg 840, Wright Patterson AFB, OH 45433 USA; [Sherman, Paul M.; Bernot, Jeremy M.] Dept Neuroradiol, 59th Med Wing,2200 Bergquist Dr,Suite 1,Room 7A45, Joint Base San Antonio L, TX 78236 USA; Clin Res Dept, 59th Med Wing,2200 Bergquist Dr,Suite 1, Joint Base San Antonio L, TX 78236 USA; [McGuire, Stephen A.] Dept Neurol, 59th Med Wing,2200 Bergquist Dr,Suite 1, Joint Base San Antonio L, TX 78236 USA		McGuire, JA (corresponding author), Univ Maryland, Sch Med, Maryland Psychiat Res Ctr, Conte Ctr, 55 Wade Ave, Catonsville, MD 21228 USA.; McGuire, JA (corresponding author), Emory Univ, Oxford Coll, 810 Whatcoat St, Oxford, GA 30054 USA.		Rowland, Laura M/K-8425-2015	Rowland, Laura M/0000-0002-6795-4269	Conte Summer Undergraduate Research Program [P50MH103222]; U.S. Air Force Surgeon General grant [711HPW FA8650-10-D-6052 0048]; 59th Medical Wing, Clinical Research Division, Graduate Medical Education grant; National Institute of Biomedical Imaging and Bioengineering grant [R01EB015611]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB015611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [P50MH103222] Funding Source: NIH RePORTER	The authors wish to thank Elaine "Sandy" Kawano, U.S. Air Force School of Aerospace Medicine, 711th Human Performance Wing, Wright-Patterson AFB, Ohio, for scientific editorial assistance, and they also acknowledge radiology, neurology, and pathology resident participation in swine research project. This research was supported by P50MH103222 (Conte Summer Undergraduate Research Program to J.A.M.), a U.S. Air Force Surgeon General grant (711HPW FA8650-10-D-6052 0048) and 59th Medical Wing, Clinical Research Division, Graduate Medical Education grant to P.M.S., and a National Institute of Biomedical Imaging and Bioengineering grant (R01EB015611) to P.V.K.	Alexander DC, 2010, NEUROIMAGE, V52, P1374, DOI 10.1016/j.neuroimage.2010.05.043; Balldin UI, 2004, AVIAT SPACE ENVIR MD, V75, P969; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Clark CA, 2002, MAGNET RESON MED, V47, P623, DOI 10.1002/mrm.10118; Connolly DM, 2015, AEROSP MED HUM PERF, V86, P928, DOI 10.3357/AMHP.4392.2015; Fakhran S, 2013, RADIOLOGY, V269, P249, DOI 10.1148/radiol.13122343; FAZEKAS F, 1993, NEUROLOGY, V43, P1683, DOI 10.1212/WNL.43.9.1683; Foster PP, 2009, J APPL PHYSIOL, V106, P678, DOI 10.1152/japplphysiol.91099.2008; Gilman S, 1998, NEW ENGL J MED, V338, P812, DOI 10.1056/NEJM199803193381207; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; HAMBERG LM, 1993, STROKE, V24, P444, DOI 10.1161/01.STR.24.3.444; Hamedani AG, 2013, NEUROLOGY, V81, P1308, DOI 10.1212/WNL.0b013e3182a8235b; Hou DJ, 2007, J NEUROTRAUM, V24, P1558, DOI 10.1089/neu.2007.0339; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Kennedy KM, 2009, BRAIN RES, V1297, P41, DOI 10.1016/j.brainres.2009.08.058; Kim H, 2013, SLEEP, V36, P709, DOI 10.5665/sleep.2632; Kloppenborg RP, 2014, NEUROLOGY, V82, P2127, DOI 10.1212/WNL.0000000000000505; Kluytmans M, 1998, RADIOLOGY, V209, P675, DOI 10.1148/radiology.209.3.9844658; Kochunov P, 2013, NEUROIMAGE-CLIN, V3, P18, DOI 10.1016/j.nicl.2013.06.019; Kochunov P, 2008, HUM BRAIN MAPP, V29, P36, DOI 10.1002/hbm.20369; Kochunov P, 2010, NEUROREPORT, V21, P716, DOI 10.1097/WNR.0b013e32833b5047; Kottke R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141097; Lawrence AJ, 2014, NEUROLOGY, V83, P304, DOI 10.1212/WNL.0000000000000612; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; McGuire S, 2013, NEUROLOGY, V81, P729, DOI 10.1212/WNL.0b013e3182a1ab12; McGuire SA, 2016, AEROSP MED HUM PERF, V87, P983, DOI 10.3357/AMHP.4585.2016; McGuire SA, 2014, ANN NEUROL, V76, P719, DOI 10.1002/ana.24264; McGuire SA, 2014, NEUROLOGY, V83, P638, DOI 10.1212/WNL.0000000000000694; McGuire SA, 2012, AVIAT SPACE ENVIR MD, V83, P1117, DOI 10.3357/ASEM.3395.2012; Moen KG, 2012, J NEUROL NEUROSUR PS, V83, P1193, DOI 10.1136/jnnp-2012-302644; Nasel C, 2000, AM J NEURORADIOL, V21, P1195; Navarathna DHMLP, 2013, NMR BIOMED, V26, P1125, DOI 10.1002/nbm.2926; Nowrangi MA, 2015, J ALZHEIMERS DIS, V44, P585, DOI 10.3233/JAD-141937; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Sukstanskii AL, 2004, J MAGN RESON, V170, P56, DOI 10.1016/j.jmr.2004.05.020; Sukstanskii AL, 2003, MAGNET RESON MED, V50, P735, DOI 10.1002/mrm.10586; Thom SR, 2011, J APPL PHYSIOL, V110, P340, DOI 10.1152/japplphysiol.00811.2010; Vann RD, 2011, LANCET, V377, P153, DOI 10.1016/S0140-6736(10)61085-9; Webb JT, 2005, AVIAT SPACE ENVIR MD, V76, P778; Wintermark M, 2015, AJNR Am J Neuroradiol, V36, pE1, DOI 10.3174/ajnr.A4181; Wong SH, 2004, NEUROLOGY, V62, P335, DOI 10.1212/01.WNL.0000103440.64964.86; Wu X, 2016, RADIOLOGY, V279, P693, DOI 10.1148/radiol.16142535; Wu YC, 2011, NEUROIMAGE, V54, P1840, DOI 10.1016/j.neuroimage.2010.09.067; Yablonskiy DA, 2010, NMR BIOMED, V23, P661, DOI 10.1002/nbm.1520; Zhang HY, 2012, HIGH ALT MED BIOL, V13, P118, DOI 10.1089/ham.2011.1073	48	1	1	0	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAY-JUN	2017	182	5-6					E1757	E1764		10.7205/MILMED-D-16-00188			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW4RC	WOS:000402487600019	29087921	Bronze, Green Accepted			2022-02-06	
J	Poppl, D; Marheineke, J; Deck, R				Poeppl, Dominik; Marheineke, Judit; Deck, Ruth			Participation after Stroke and Traumatic Brain Injury: Results of a Pilot Study in Outpatient Neurorehabilitation in Vorarlberg	AKTUELLE NEUROLOGIE			German	Article						traumatic brain injury; measurement of outcomes; stroke; outpatient neurological rehabilitation	REHABILITATION; SINGER; SCALE	Objective A multicentric study has reported on the sustained effects of outpatient neurorehabilitation in Germany. Different to Germany, the biopsychosocial model of disability, as described in the International Classification of Functioning, Disability and Health (published by the World Health Organization), is not incorporated into Austrian law. There is a need for objective measurement instruments for routine outcome evaluation of outpatient neurorehabilitation in Austria. The present study examines the extent to which the instruments used for the German multicentric study are applicable in the Austrian rehabilitation context and if there are similar rehabilitation effects over time. Method In a multicentric observational study, patients of 4 Austrian outpatient neurorehabilitation centers for stroke or traumatic brain injury were asked to fill in a questionnaire. This was carried out four times throughout the program: on admission and discharge as well as on month 4 and 12 post rehabilitation. Additionally, clinical experts were asked to rate the patients' status at admission and discharge. Results and conclusions The results of 4 outpatient neuro-rehabilitation centers in Vorarlberg (Austria) suggest that the used measurement instruments are reasonable for the evaluation of outpatient neurorehabilitation in Austria, based on the ultimate goal "participation and self-determined conduct of life". For routine outcome evaluation, fewer instruments should be used and adjustments should be made while assessing more severely affected patients.	[Poeppl, Dominik] St Elizabeth Hosp, Geilenkirchen, Germany; [Marheineke, Judit] Ambulante Reha Krankenhaus, Geilenkirchen, Germany; [Deck, Ruth] Univ Lubeck, Inst Sozialmed Lubeck, Lubeck, Germany		Poppl, D (corresponding author), Ambulante Reha Krankenhaus, St Elisabeth Krankenhaus, Martin Heyden Str 32, D-52511 Geilenkirchen, Germany.	poeppl@neuro-therapie.de					Banks JL, 2007, STROKE, V38, P1091, DOI 10.1161/01.STR.0000258355.23810.c6; Bortz J., 1999, STAT SOZIALWISSENSCH; Bundesministerium fur Arbeit, 2010, ERST STAAT OST, P1; Busch MA, 2013, BUNDESGESUNDHEITSBLA, V56, P656, DOI 10.1007/s00103-012-1659-0; Cohen J., 2013, STAT POWER ANAL BEHA; Deck R, 2015, REHABILITATION, V54, P402, DOI 10.1055/s-0035-1559670; Deck R, 2004, REHABILITATION NACHS, P55; DECK R, 1999, VERBAND DTSCH RENTEN, P84; Devlin NJ, 2013, EUR J HEALTH ECON, V14, pS1, DOI 10.1007/s10198-013-0502-3; Dijkers MP, 2010, ARCH PHYS MED REHAB, V91, pS5, DOI 10.1016/j.apmr.2009.10.036; Ewert T, 2005, NEUROL REHABIL, V11, P179; Faller H, 1999, FORDERSCHWERPUNKT RE, P13; Farin E, 2012, REHABILITATION, V51, pS3, DOI 10.1055/s-0032-1327725; Freidel K, 2011, TAG ZUM 20 REH K DRV, P90; Funke N, 2009, SINGER MANUAL STUFEN; Gerdes N, 2012, REHABILITATION, V51, P289, DOI 10.1055/s-0031-1287805; Gerdes N, 2009, REHABILITATION, V48, P190, DOI 10.1055/s-0029-1231061; Girardi P, 1998, Rehabilitation (Stuttg), V37, P229; Huappe, 2007, PRAXIS KLIN VERHALTE, V76, P113; Huff W, 2003, NERVENARZT, V74, P104, DOI 10.1007/s00115-002-1417-x; Johnston SC, 2009, LANCET NEUROL, V8, P345, DOI 10.1016/S1474-4422(09)70023-7; Leonhart R, 2004, Rehabilitation (Stuttg), V43, P241; Ludwig Boltzmann Institut, AMB NEUR TEH ERR DEF; Mairhofer H., ANWENDUNG ICF OSTERR; Poppl D, 2014, AKTUEL NEUROL, V41, P335, DOI 10.1055/s-0034-1384541; Poppl D, 2016, AKTUEL NEUROL, V43, P14, DOI 10.1055/s-0041-110202; Poppl D, 2015, REHABILITATION, V54, P22, DOI 10.1055/s-0034-1394451; Poppl D, 2014, REHABILITATION, V53, P168, DOI 10.1055/s-0033-1353193; Poppl D, 2013, FORTSCHR NEUROL PSYC, V81, P570, DOI 10.1055/s-0033-1335916; Poppl D, 2012, EVALUATION ERGEBNISQ; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Reuther P, 2015, NEUROL REHABIL, V21, P275; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Schneider K, 2009, NERVENHEILKUNDE, V28, P114, DOI 10.1055/s-0038-1628584; Schussler M, 2002, ESA SPEC PUBL, V477, P3; TEASDALE G, 1974, LANCET, V2, P81; Verband Deutscher Rentenversicherungstrager, 1995, REHABILITATION, V34, P119; Waanders R, 2004, J NEUROL NEUROCHIR P, V5, P24; Wirtz M, 2004, Rehabilitation (Stuttg), V43, P109	39	1	1	0	2	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0302-4350	1438-9428		AKTUEL NEUROL	Aktuelle Neurol.	MAY	2017	44	4					243	251		10.1055/s-0043-101512			9	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	EZ2KY	WOS:000404539400003					2022-02-06	
J	Smith, ME; Smith, M				Smith, Malcolm E.; Smith, Martin			Neuromonitoring	ANAESTHESIA AND INTENSIVE CARE MEDICINE			English	Article						Cerebral autoregulation; cerebral microdialysis; cerebral oxygenation; electroencephalography; intracranial pressure; multi modal neuromonitoring; near infrared spectroscopy; neurointensive care	TRAUMATIC BRAIN-INJURY; THERAPY; CARE; RECOMMENDATIONS; STATEMENT	Management of acute brain injury is based on a central concept that prevention of secondary hypoxic/ischaemic injury is associated with improved outcomes. While clinical assessment of neurological state remains fundamental to neuromonitoring, several techniques are available for global and regional brain monitoring that provide assessment of cerebral perfusion, oxygenation and metabolic status, and early warning of impending brain hypoxia/ischaemia. Developments in multimodality monitoring have enabled an individually tailored approach to patient management in which treatment decisions are guided by monitored changes in physiological variables rather than pre-defined, generic thresholds. Any impact of monitor-guided therapy on outcomes is entirely dependent on the threshold to initiative intervention and subsequent management in response to change in a particular monitored variable, and these remain undefined in many circumstances. This review describes current neuromonitoring techniques used during the critical care management of acute brain injury.	[Smith, Malcolm E.] Univ Coll London Hosp, Natl Hosp Neurol & Neurosurg, Neuroanaesthesia & Neurocrit Care, London, England; [Smith, Martin] Univ Coll London Hosp, Natl Hosp Neurol & Neurosurg, Neurocrit Care, London, England		Smith, ME (corresponding author), Univ Coll London Hosp, Natl Hosp Neurol & Neurosurg, Neuroanaesthesia & Neurocrit Care, London, England.				National Institute for Health Research via the UCLH/UCL Comprehensive Biomedical Research Centre	MS is part funded by the National Institute for Health Research via the UCLH/UCL Comprehensive Biomedical Research Centre.	Bouzat P, 2014, CURR OPIN CRIT CARE, V20, P153, DOI 10.1097/MCC.0000000000000071; Citerio G, 2015, CURR OPIN CRIT CARE, V21, P113, DOI 10.1097/MCC.0000000000000179; Ghosh A, 2012, ANESTH ANALG, V115, P1373, DOI 10.1213/ANE.0b013e31826dd6a6; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Kirkman MA, 2014, BRIT J ANAESTH, V112, P35, DOI 10.1093/bja/aet418; Kirkman Matthew A, 2016, Anesthesiol Clin, V34, P537, DOI 10.1016/j.anclin.2016.04.007; Le Roux P, 2014, NEUROCRIT CARE, V21, P282, DOI 10.1007/s12028-014-0077-6; Makarenko S, 2016, J CLIN NEUROSCI, V26, P8, DOI 10.1016/j.jocn.2015.05.065; Nangunoori R, 2012, NEUROCRIT CARE, V17, P131, DOI 10.1007/s12028-011-9621-9; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6	10	1	1	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1472-0299	1878-7584		ANAEST INTENS CARE M	Anaesth. Intensiv. Care Med.	MAY	2017	18	5					224	229		10.1016/j.mpaic.2017.02.009			6	Anesthesiology	Emerging Sources Citation Index (ESCI)	Anesthesiology	EZ5FB	WOS:000404737300002					2022-02-06	
J	Su, M; Seki, D; Moheet, AM				Su, Michael; Seki, David; Moheet, Asma M.			Pharmacologic cardioversion with intravenous amiodarone is likely safe in neurocritically Ill patients	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Brain injuries; complications; Atrial fibrillation; Amiodarone; Arrhythmias, cardiac; Sympathetic nervous system, pathology; Cardioversion	ATRIAL-FIBRILLATION; RHYTHM CONTROL; SINUS-RHYTHM	Neurological injury is often associated with cardiac abnormalities, including electrophysiological issues. Cardioversion of acute atrial fibrillation (<48 h' duration) without anticoagulation carries about a 0.7% risk of thromboembolism. There is limited data on managing acute atrial fibrillation specifically in the neuroscience intensive care unit (NSICU) setting. We sought to determine the safety of using intravenous (IV) amiodarone for restoring sinus rhythm in patients with presumed new onset atrial or ventricular tachycardia after neurological injury. We conducted a retrospective review of consecutive patients admitted to our NSICU between June 2011 and March 2015 with a primary neurological diagnosis and new onset tachyarrhythmias who received IV amiodarone. Baseline demographics and presence of known risk factors for atrial fibrillation were recorded. The primary end point was new onset stroke. 48 patients were included for the final analysis. No patients developed new stroke after receiving IV amiodarone. The average follow up period was 14.0 days. The majority of patients did not have the pre identified risk factors for atrial fibrillation. lschemic stroke and traumatic brain injury were the most common admitting diagnoses. We conclude that in patients with primary neurological injury, use of IV amiodarone for rhythm control of acute onset atrial fibrillation carries a low risk of cardioembolic stroke in the first 2 weeks. Further investigation, including prospective studies, with larger samples and longer follow up periods is warranted. (C) 2017 Elsevier Ltd. All rights reserved.	[Su, Michael; Moheet, Asma M.] Cedars Sinai Med Ctr, Dept Neurol, 127 S San Vicente Blvd,Suite A6600, Los Angeles, CA 90048 USA; [Su, Michael; Moheet, Asma M.] Cedars Sinai Med Ctr, Dept Neurocrit Care, 127 S San Vicente Blvd,Suite A6600, Los Angeles, CA 90048 USA; [Seki, David] Cedars Sinai Med Ctr, Dept Pharm, 8700 Beverly Blvd,Room A903, Los Angeles, CA 90048 USA; [Su, Michael] Rancho Los Amigos Natl Rehabil Ctr, 7601 E Imperial Highway, Downey, CA 90242 USA		Moheet, AM (corresponding author), Cedars Sinai Med Ctr, Dept Neurol, 127 S San Vicente Blvd,Suite A6600, Los Angeles, CA 90048 USA.; Moheet, AM (corresponding author), Cedars Sinai Med Ctr, Dept Neurocrit Care, 127 S San Vicente Blvd,Suite A6600, Los Angeles, CA 90048 USA.	Asma.Moheet@cshs.org	Moheet, Asma/AAR-3235-2020	Moheet, Asma/0000-0001-9133-4660			Airaksinen KEJ, 2013, J AM COLL CARDIOL, V62, P1187, DOI 10.1016/j.jacc.2013.04.089; Anter E, 2009, CIRCULATION, V120, P1436, DOI 10.1161/CIRCULATIONAHA.108.824847; Boland TA, 2015, CRIT CARE MED, V43, P686, DOI 10.1097/CCM.0000000000000851; Bruder N, 2011, NEUROCRIT CARE, V15, P257, DOI 10.1007/s12028-011-9598-4; Gregory T, 2011, CRIT CARE PAIN; Grunsfeld Alexander, 2005, Curr Neurol Neurosci Rep, V5, P488, DOI 10.1007/s11910-005-0039-7; January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI [10.1161/CIR.0000000000000142, 10.1161/CIR.0000000000000041, 10.1016/j.jacc.2014.03.022]; Kamel H, 2013, STROKE, V44, P1550, DOI 10.1161/STROKEAHA.113.001118; Kirchhof P., 2016, EUR J CARDIO THORACI; Piccini JP, 2016, LANCET, V388, P829, DOI 10.1016/S0140-6736(16)31277-6; Raad Bassel, 2011, Continuum (Minneap Minn), V17, P13, DOI 10.1212/01.CON.0000394671.36878.ce; Samuels MA, 2007, CIRCULATION, V116, P77, DOI 10.1161/CIRCULATIONAHA.106.678995; Van Gelder IC, 2002, NEW ENGL J MED, V347, P1834, DOI 10.1056/NEJMoa021375; Van Gelder IC, 2016, LANCET, V388, P818, DOI 10.1016/S0140-6736(16)31258-2; Wyse DG, 2009, CIRCULATION, V120, P1444, DOI 10.1161/CIRCULATIONAHA.109.884387	15	1	1	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	MAY	2017	39						59	61		10.1016/j.jocn.2017.01.014			3	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ET0ND	WOS:000399958200011	28209460				2022-02-06	
J	Tupper, DE				Tupper, David E.			Neuropsychological Disorders Across the Lifespan: Overview and Implications	PSYCHIATRIC ANNALS			English	Article							ADHD; ADULT; MODEL	Neuropsychological disorders vary in prevalence, base rates, types of impairments, and functional changes over the course of a person's lifespan, with different immediate and late effects as well as expected outcomes. This article provides an overview of the important issues, concepts, and processes involved in a lifespan approach to understanding and managing neurobehavioral disorders from birth to death. Brief case examples of children and adults with attention-deficit/hyperactivity disorder and traumatic brain injury illustrate the effects and needs of patients with developmental and acquired disorders at different ages and phases in life. It is hoped that practitioners can benefit from using a lifespan perspective whether the focus is on pediatric, adult, or geriatric conditions.	[Tupper, David E.] Hennepin Cty Med Ctr, Neuropsychol Sect, G8,701 Pk Ave, Minneapolis, MN 55415 USA; [Tupper, David E.] Univ Minnesota, Med Sch, Neurol Dept, Minneapolis, MN 55455 USA		Tupper, DE (corresponding author), Hennepin Cty Med Ctr, Neuropsychol Sect, G8,701 Pk Ave, Minneapolis, MN 55415 USA.	tuppe001@umn.edu					American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Bernstein J. H., 2013, PEDIATRIC NEUROPSYCH, P377; Bialystock E, 2006, LIFESPAN COGNITION M; Brickman AM, 2006, BIOL PSYCHIAT, V60, P444, DOI 10.1016/j.biopsych.2006.01.011; BUCKNER RL, 2006, LIFESPAN COGNITION M, P27; Costa L, 1996, CLIN NEUROPSYCHOL, V10, P365, DOI 10.1080/13854049608406697; Dalsgaard S, 2015, LANCET, V385, P2190, DOI 10.1016/S0140-6736(14)61684-6; Denes G, 2016, NEURAL PLASTICITY LI; Diehl M., 2015, HDB INTRAINDIVIDUAL; Donders J, 2010, PRINCIPLES PRACTICE, P357; Donders J, 2010, PRINCIPLES PRACTICE; Faraone SV, 2015, LANCET, V385, P2132, DOI 10.1016/S0140-6736(14)61822-5; Gluckman P, 2006, DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE, P1, DOI 10.2277/ 0521847435; Goldman PS, 1974, PLASTICITY RECOVERY; Goodman DW, 2011, POSTGRAD MED, V123, P14, DOI 10.3810/pgm.2011.09.2456; Greydanus DE, 2007, DM-DIS MON, V53, P70, DOI 10.1016/j.disamonth.2007.01.001; Griffen J., 2014, HDB NEUROPSYCHOLOGY, P25; Halperin JM, 2010, PRINCIPLES PRACTICE, P113; Horton AM, 1990, NEUROPSYCHOLOGY LIFE; Jaglal SB, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-409; Johnson MH, 2003, BIOL PSYCHIAT, V54, P1312, DOI 10.1016/S0006-3223(03)00426-8; Johnson MH, 2001, NAT REV NEUROSCI, V2, P475, DOI 10.1038/35081509; Kirkwood MW, 2013, PEDIATRIC NEUROPSYCH, P302; Kolb B., 1995, BRAIN PLASTICITY BEH; Longstreth WT, 2000, PROGNOSIS NEUROLOGIC, P40; Miller TW, 2010, HANDBOOK OF STRESSFUL TRANSITIONS ACROSS THE LIFESPAN, P1, DOI 10.1007/978-1-4419-0748-6; Nunan-Saah J, 2015, MULT SCLER J, V21, P1355, DOI 10.1177/1352458515586088; Oberman L, 2013, PROG BRAIN RES, V207, P91, DOI 10.1016/B978-0-444-63327-9.00016-3; Owens EB, 2015, ATTENTION DEFICIT HY; Pascual-Leone A, 2011, BRAIN TOPOGR, V24, P183, DOI 10.1007/s10548-011-0197-7; Rawson MB, 1995, DYSLEXIA LIFESPPAN F; Rey-Casserly C., 2013, PEDIATRIC NEUROPSYCH; Richards M, 2007, COGNITIVE RESERVE TH, P36; Roberts W., 2015, ATTENTION DEFICIT HY, P51; Roebuck-Spencer T., 2014, HDB NEUROPSYCHOLOGY, P3; Salthouse TA, 2006, DEV REV, V26, P31, DOI 10.1016/j.dr.2005.09.001; Seidman LJ, 2006, CLIN PSYCHOL REV, V26, P466, DOI 10.1016/j.cpr.2006.01.004; Shutter LA, 2000, PROGNOSIS NEUROLOGIC, P335; Smith J., 2011, HDB LIFESPAN DEV, P213; Sparrow EP, 2014, ESSENTIALS ADHD ASSE; Spencer TR, 2010, PRINCIPLES PRACTICE, P329; Stern Y, 2007, COGNITIVE RESERVE TH; Torno, 2015, HDB LONG TERM CARE C; Turgay A, 2012, J CLIN PSYCHIAT, V73, P192, DOI 10.4088/JCP.10m06628; Valenzuela MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002598; Warner-Rogers J, 2002, OUTCOMES NEURODEVELO, P1	47	1	1	0	3	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0048-5713	1938-2456		PSYCHIAT ANN	Psychiatr. Ann.	MAY	2017	47	5					272	279		10.3928/00485713-20170405-01			8	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	EW4JW	WOS:000402468800009					2022-02-06	
J	Walker, PB; Norris, JN; Tschiffely, AE; Mehalick, ML; Cunningham, CA; Davidson, IN				Walker, Peter B.; Norris, Jacob N.; Tschiffely, Anna E.; Mehalick, Melissa L.; Cunningham, Craig A.; Davidson, Ian N.			Applications of Transductive Spectral Clustering Methods in a Military Medical Concussion Database	IEEE-ACM TRANSACTIONS ON COMPUTATIONAL BIOLOGY AND BIOINFORMATICS			English	Article						Biomedical informatics; graph theory; classification algorithms; clustering algorithms	TRAUMATIC BRAIN-INJURY	Traumatic brain injury (TBI) is one of the most common forms of neurotrauma that has affected more than 250,000 military service members over the last decade alone. While in battle, service members who experience TBI are at significant risk for the development of normal TBI symptoms, as well as risk for the development of psychological disorders such as Post-Traumatic Stress Disorder (PTSD). As such, these service members often require intense bouts of medication and therapy in order to resume full return-to-duty status. The primary aim of this study is to identify the relationship between the administration of specific medications and reductions in symptomology such as headaches, dizziness, or light-headedness. Service members diagnosed with mTBI and seen at the Concussion Restoration Care Center (CRCC) in Afghanistan were analyzed according to prescribed medications and symptomology. Here, we demonstrate that in such situations with sparse labels and small feature sets, classic analytic techniques such as logistic regression, support vector machines, naive Bayes, random forest, decision trees, and k-nearest neighbor are not well suited for the prediction of outcomes. We attribute our findings to several issues inherent to this problem setting and discuss several advantages of spectral graph methods.	[Walker, Peter B.; Norris, Jacob N.; Tschiffely, Anna E.; Mehalick, Melissa L.] Naval Med Res Ctr, 503 Robert Grant Ave, Silver Spring, MD 20910 USA; [Cunningham, Craig A.] Naval Hosp Portsmouth, Portsmouth, VA 23708 USA; [Davidson, Ian N.] Univ Calif Davis, Dept Comp Sci, Davis, CA 95616 USA		Walker, PB (corresponding author), Naval Med Res Ctr, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	peter.b.walker.mil@mail.mil; jacob.n.norris.mil@mail.mil; anna.e.schlappal.ctr@mail.mil; melissa.l.mehalick.mil@mail.mil; craig.a.cunningham2.mil@mail.mil; davidson@cs.ucdavis.edu			Office of Naval ResearchOffice of Naval Research [NAVY 00014-09-0712]; Defense Medical Research Program [DM130137]; USUHS [HU0001-08-0001]	This work was supported by the Office of Naval Research Grant NAVY 00014-09-0712, Defense Medical Research Program Grant DM130137, and USUHS Grant HU0001-08-0001. The opinions of the authors do not necessarily reflect those of the United States Navy or the University of California Davis. Several authors were military service members. This work was prepared as part of their official duties. Title 17 U.S.C. 101 defines US Government work as work prepared by a military service member or employee of the US Government as part of that person's official duties. This study protocol was approved by the Naval Medical Research Center (NMRC) Institutional Review Board in compliance with all applicable Federal regualations governing the protection of human subjects.	Basu S, 2009, CH CRC DATA MIN KNOW, P1; Chen HC, 2005, INT SER I S, V8, P3; Davidson I, 2012, DATA MIN KNOWL DISC, V25, P635, DOI 10.1007/s10618-012-0269-7; De Leon S. F., 2007, EXPLORING SYNDROME D, V4; Doshi-Velez F, 2014, PEDIATRICS, V133, pE54, DOI 10.1542/peds.2013-0819; Dunham M.H, 2002, DATA MINING INTRO AD; Elder GA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00269; Fayyad U, 1996, AI MAG, V17, P37; Friedl KE, 2007, ARCH CLIN NEUROPSYCH, V22, pS7, DOI 10.1016/j.acn.2006.10.002; Hamilton P. W., 1995, Pathologica (Genoa), V87, P237; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jensen PB, 2012, NAT REV GENET, V13, P395, DOI 10.1038/nrg3208; Kotwal RS, 2004, ANN EMERG MED, V44, P121, DOI 10.1016/j.annemergmed.2004.03.025; Kuo CT, 2015, KDD'15: PROCEEDINGS OF THE 21ST ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P617, DOI 10.1145/2783258.2783318; Kuo CT, 2014, IEEE DATA MINING, P887, DOI 10.1109/ICDM.2014.143; Perez JM, 2008, IEEE T KNOWL DATA EN, V20, P940, DOI 10.1109/TKDE.2007.190746; Norris JN, 2014, BRAIN INJURY, V28, P1052, DOI 10.3109/02699052.2014.891761; Norris JN, 2013, MIL MED, V178, P767, DOI 10.7205/MILMED-D-12-00493; Phillips Henry L., 2013, Foundations of Augmented Cognition. 7th International Conference, AC 2013. Held as Part of HCI International 2013. Proceedings, P709, DOI 10.1007/978-3-642-39454-6_76; Reeves DL, 2007, ARCH CLIN NEUROPSYCH, V22, pS15, DOI 10.1016/j.acn.2006.10.013; Spira J. L., 2014, J NEUROTRAUM, V31, P1; Swisher D., 2015, CLIN J SPORT MED, V25, P43; Wang F, 2015, J BIOMED INFORM, V55, P41, DOI 10.1016/j.jbi.2015.01.009; Wang X., 2010, P 16 ACM SIGKDD INT, P563, DOI DOI 10.1145/1835804.1835877; Wang X, 2014, DATA MIN KNOWL DISC, V28, P1, DOI 10.1007/s10618-012-0291-9; Zupan B, 2001, METHOD INFORM MED, V40, P25	26	1	1	0	4	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	1545-5963	1557-9964		IEEE ACM T COMPUT BI	IEEE-ACM Trans. Comput. Biol. Bioinform.	MAY-JUN	2017	14	3					534	544		10.1109/TCBB.2016.2591549			11	Biochemical Research Methods; Computer Science, Interdisciplinary Applications; Mathematics, Interdisciplinary Applications; Statistics & Probability	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Computer Science; Mathematics	EX0NR	WOS:000402918600005	27455527				2022-02-06	
J	Kraeutler, MJ; Belk, JW; McCarty, EC				Kraeutler, Matthew J.; Belk, John W.; McCarty, Eric C.			The Effect of the Number of Carries Among College Running Backs on Future Injury Risk and Performance in the National Football League	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						National Football League; National Collegiate Athletic Association; football; running back; injury	BASEBALL PITCHERS; IMPACT; PLAYERS; FREQUENCY; OUTCOMES	Background: There has been speculation that running backs with an excessive number of carries in college are less likely to be successful in the National Football League (NFL). Purpose: To determine whether there is a correlation between number of carries by college running backs and future performance and injury risk in the NFL. Study Design: Cohort study; Level of evidence, 3. Methods: Using the ESPN archives of National Collegiate Athletic Association and NFL running backs, the following inclusion criteria were used: running backs who played their last college season from 1999 through 2012 and who were drafted in the first 4 rounds of the NFL draft following their college career. Players were grouped by number of carries during their final college season (group A, 100-200 carries; group B, 250+ carries). Performance and injury risk were compared between groups during the first 3 eligible seasons in the NFL. Groups were compared based on total number of carries, mean yards per carry, number of games missed due to injury, and the specific injuries resulting in missed playing time. Results: During the seasons studied, a total of 103 running backs were included (group A, n = 42; group B, n = 61). There was a trend toward a significantly greater mean total number of carries through 3 NFL seasons in group B (group A, n = 276 carries; group B, n = 376 carries; P = .058). Mean yards per carry did not differ between groups (group A, n = 3.9 yards/carry; group B, n = 4.0 yards/carry; P = .67). Groups A and B missed a mean 5.8 and 5.7 games, respectively, due to injury during their first 3 NFL seasons (P = .98). A significantly greater proportion of players in group A suffered a concussion compared with group B (P = .014). Conclusion: There is no correlation between the number of carries by college running backs and future injury risk or performance during their early NFL career.	[Kraeutler, Matthew J.; Belk, John W.; McCarty, Eric C.] Univ Colorado, Sch Med, CU Sports Med & Performance Ctr, Dept Orthoped, Boulder, CO 80309 USA; [Kraeutler, Matthew J.; Belk, John W.; McCarty, Eric C.] Univ Colorado, Sch Med, Dept Orthoped, Aurora, CO USA		Kraeutler, MJ (corresponding author), CU Sports Med & Performance Ctr, 2150 Stadium Dr,2nd Floor, Boulder, CO 80309 USA.	matthew.kraeutler@ucdenver.edu	mccarty, eric/AAA-1821-2019	mccarty, eric/0000-0002-8948-5862	Biomet and Elsevier; Biomet; Mitek; Smith Nephew; Stryker	One or more of the authors has declared the following potential conflict of interest or source of funding: E.C.M. receives royalties from Biomet and Elsevier; is a paid consultant for Biomet; and receives research support from Biomet, Mitek, Smith & Nephew, and Stryker.	Aune KT, 2014, AM J SPORT MED, V42, P1865, DOI 10.1177/0363546514535069; Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Bradbury JC, 2012, J STRENGTH COND RES, V26, P1181, DOI 10.1519/JSC.0b013e31824e16fe; Bradley James, 2008, Am J Orthop (Belle Mead NJ), V37, P310; Broglio SP, 2013, AM J SPORT MED, V41, P2877, DOI 10.1177/0363546513502458; Casson IR, 2011, SPORTS HEALTH, V3, P11, DOI 10.1177/1941738110391413; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Kaplan Lee D, 2011, Am J Orthop (Belle Mead NJ), V40, P40; Kraeutler MJ, 2016, ORTHOP J SPORTS MED, V5; Mai HT, 2016, AM J SPORT MED, V44, P2255, DOI 10.1177/0363546516651426; Teramoto M, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115620365; Whiteside D, 2016, AM J SPORT MED, V44, P2202, DOI 10.1177/0363546516643812; Yukutake T, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967114566788	13	1	1	1	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2325-9671			ORTHOP J SPORTS MED	Orthop. J. Sports Med.	APR 21	2017	5	4							2325967117703054	10.1177/2325967117703054			4	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	ET5OB	WOS:000400332100001	28491886	Green Published, gold			2022-02-06	
J	Guo, L; Hou, JM; Zhong, JF; Liu, J; Sun, TS; Liu, HL				Guo, Lei; Hou, Jingming; Zhong, Jianfeng; Liu, Jia; Sun, Tiansheng; Liu, Hongliang			Association between injury severity and amyloid beta protein levels in serum and cerebrospinal fluid in rats with traumatic spinal cord injury	MOLECULAR MEDICINE REPORTS			English	Article						spinal cord injury; amyloid-beta; injury severity; cerebrospinal fluid; serum; biomarker	TRANSGENIC MOUSE MODEL; BRAIN-INJURY; NEUROLOGICAL STATUS; PATHOLOGY; DISEASE; CONTRIBUTES; SECRETASES; BIOMARKERS; CONTUSION; SYSTEM	The aim of the present study was to determine whether amyloid-beta (A beta) protein could be detected in the serum and cerebrospinal fluid (CSF) of rats with traumatic spinal cord injury (SCI) and whether A beta protein levels in serum and CSF correlated with the injury severity. A total of 140 adult female Sprague-Dawley rats were randomly divided into four groups: Sham, mild injury, moderate injury and severe injury. Serum and CSF samples were collected at 12 h, 1, 3, 7, 14, 21 and 28 days post-injury. ELISA analysis for serum and CSF A beta protein was performed. Locomotor function of all animals was assessed using the Basso, Beattie and Bresnahan (BBB) locomotor rating scale. Following SCI, the protein levels of A beta in serum and CSF samples from SCI groups significantly increased from 12 h (P<0.05) and peaked 3 days after injury. A significant increase of A beta levels in serum and CSF in the severe SCI group was also observed at 28 days after injury (P<0.05). At 28 days after injury the protein levels of A beta in serum and CSF were significantly correlated with the severity of injury (serum, R-2=-0.806, P<0.01; CSF, R-2=-0.694, P<0.01). A significant correlation between A beta protein level in serum and CSF and neurological deficits (BBB score) was also observed (P<0.01). The protein level of A beta in serum and CSF was severity and time-dependent during the acute phase in rats with traumatic SCI. Monitoring the level of A beta protein in serum may improve the evaluation of SCI severity and the neuron functional status following SCI.	[Guo, Lei] PLA 252 Hosp, Dept Spine Surg, Baoding 071000, Hebei, Peoples R China; [Guo, Lei; Zhong, Jianfeng; Liu, Jia; Sun, Tiansheng] Chinese PLA Beijing Army Gen Hosp, Dept Orthoped, 5 Nanmencang, Beijing 100700, Peoples R China; [Hou, Jingming; Liu, Hongliang] Third Mil Med Univ, Southwest Hosp, Dept Rehabil, 30 Gaotanyan Ctr St, Chongqing 400038, Peoples R China		Sun, TS (corresponding author), Chinese PLA Beijing Army Gen Hosp, Dept Orthoped, 5 Nanmencang, Beijing 100700, Peoples R China.; Liu, HL (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Rehabil, 30 Gaotanyan Ctr St, Chongqing 400038, Peoples R China.	suntiansheng-@163.com; liuhongliangkf@163.com		Hou, Jingming/0000-0002-4991-7587	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81301679, 81671211]	The present study was supported by the National Natural Science Foundation of China (grants nos. 81301679 and 81671211).	Agrawal G, 2010, SPINE, V35, P1122, DOI 10.1097/BRS.0b013e3181be5fa7; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Brody DL, 2008, SCIENCE, V321, P1221, DOI 10.1126/science.1161591; Bryson JB, 2012, HUM MOL GENET, V21, P3871, DOI 10.1093/hmg/dds215; Byrnes KR, 2007, BRAIN, V130, P2977, DOI 10.1093/brain/awm179; Chen LH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088402; Cheran S, 2011, J NEUROTRAUM, V28, P1881, DOI 10.1089/neu.2010.1741; Hou JM, 2014, NEUROSCIENCE, V266, P208, DOI 10.1016/j.neuroscience.2014.02.013; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Kobayashi S, 2010, NEUROCHEM INT, V56, P387, DOI 10.1016/j.neuint.2009.11.005; Krishna V, 2014, J NEUROTRAUM, V31, P215, DOI 10.1089/neu.2013.2982; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li K, 2014, J NEUROSCI, V34, P7622, DOI 10.1523/JNEUROSCI.4690-13.2014; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Matsuoka Y, 2001, AM J PATHOL, V158, P1345, DOI 10.1016/S0002-9440(10)64085-0; Mondello S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06446; Pajoohesh-Ganji A, 2014, BRAIN RES, V1560, P73, DOI 10.1016/j.brainres.2014.02.049; Pouw MH, 2014, SPINAL CORD, V52, P428, DOI 10.1038/sc.2014.26; Pouw MH, 2009, SPINAL CORD, V47, P519, DOI 10.1038/sc.2008.176; Selkoe DJ, 2004, ANN INTERN MED, V140, P627, DOI 10.7326/0003-4819-140-8-200404200-00047; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Silva NA, 2014, PROG NEUROBIOL, V114, P25, DOI 10.1016/j.pneurobio.2013.11.002; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Ward RE, 2014, NEUROSCIENCE, V260, P227, DOI 10.1016/j.neuroscience.2013.12.024; WRATHALL JR, 1985, EXP NEUROL, V88, P108, DOI 10.1016/0014-4886(85)90117-7; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; Yokobori S, 2015, WORLD NEUROSURG, V83, P867, DOI 10.1016/j.wneu.2013.03.012	29	1	1	2	5	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	APR	2017	15	4					2241	2246		10.3892/mmr.2017.6261			6	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	EP2HE	WOS:000397203200100	28259979	Bronze			2022-02-06	
J	Jang, SH; Yeo, SS				Jang, Sung Ho; Yeo, Sang Seok			The differences of the precommissural and postcommissural fornix in the hippocampal location: a diffusion tensor tractography study	NEURORADIOLOGY			English	Article						Diffusion tensor imaging; Precommissural fornix; Postcommissural fornix; Hippocampus; Anatomical location	TRAUMATIC BRAIN-INJURY; AXONAL INJURY; FIBER TRACTOGRAPHY; PATIENT; DEGENERATION; ORGANIZATION; CONNECTIONS; IMPAIRMENT; LESIONS; RATS	Purpose The precommissural fornix and postcommissural fornix have different connections to the basal forebrain and septal region, and mammillary body, respectively. However, little is known about the differences of the precommissural fornix and postcommissural fornix in the hippocampal location. In this study, using diffusion tensor tractography, we investigated the differences of the precommissural fornix and postcommissural fornix in the hippocampal location. Methods We recruited 25 healthy volunteers for this study. For reconstruction of the precommissural fornix and postcommissural fornix, we placed the seed region of interest on the septal nucleus, and the mammillary body, respectively. The target regions of interest (ROI) was given on the crus of the fornix on the coronal image. Evaluations of the anatomical location of the precommissural fornix and postcommissural fornix were performed using the highest probabilistic location in the hippocampal formation. Results The precommissural fornix and postcommissural fornix were located at an average of 83.9 and 87.5% between the lateral margin of the red nucleus and collateral sulcus on the axial plane, and 77.2 and 81.4% between the lateral margin of the midbrain and the inferior longitudinal fasciculus on the coronal plane. Significant differences of location in the medio-lateral direction were observed in the axial and coronal plane (p < 0.05). However, no significant differences of location in the antero-posterior direction were observed between precommissrual and postcommissural fornix (p > 0.05). Conclusions The reconstructed precommissural fornix and postcommissural fornix were connected to the cornu ammonis 1(CA1) of the hippocampus, and the precommissural fornix was located more laterally to the postcommissural fornix in the CA1.	[Jang, Sung Ho] Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, Namku 705717, Daegu, South Korea; [Yeo, Sang Seok] Dankook Univ, Dept Phys Therapy, Coll Hlth Sci, 119 Dandae Ro, Cheonan Si 3116, Chungnam, South Korea		Yeo, SS (corresponding author), Dankook Univ, Dept Phys Therapy, Coll Hlth Sci, 119 Dandae Ro, Cheonan Si 3116, Chungnam, South Korea.	eangbul@hanmail.net			Yeungnam University Research Grant	This work was funded by a 2015 Yeungnam University Research Grant.	Brisch R, 2011, EUR ARCH PSY CLIN N, V261, P47, DOI 10.1007/s00406-010-0119-9; Chang MC, 2010, NEUROREHABILITATION, V26, P347, DOI 10.3233/NRE-2010-0572; Dawe RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026286; Fletcher E, 2013, JAMA NEUROL, V70, P1389, DOI 10.1001/jamaneurol.2013.3263; HENDERSON J, 1977, BRAIN RES BULL, V2, P123, DOI 10.1016/0361-9230(77)90008-9; Hong JH, 2010, J REHABIL MED, V42, P979, DOI 10.2340/16501977-0603; Hunsaker MR, 2009, BEHAV BRAIN RES, V201, P192, DOI 10.1016/j.bbr.2009.02.012; Jang SH, 2009, ARCH NEUROL-CHICAGO, V66, P1424, DOI 10.1001/archneurol.2009.242; Lee DY, 2012, FRONT AGING NEUROSCI, V4, DOI 10.3389/fnagi.2012.00001; Lee SK, 2005, RADIOGRAPHICS, V25, P68; Lee SK, 2005, RADIOGRAPHICS, V25, P53, DOI 10.1148/rg.251045085; McNaughton N, 2004, NEUROSCI BIOBEHAV R, V28, P285, DOI 10.1016/j.neubiorev.2004.03.005; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Parker GJM, 2005, PHILOS T R SOC B, V360, P893, DOI 10.1098/rstb.2005.1639; Sheehan TP, 2004, BRAIN RES REV, V46, P71, DOI 10.1016/j.brainresrev.2004.04.009; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sugiyama K, 2007, BRAIN INJURY, V21, P413, DOI 10.1080/02699050701311042; SWANSON LW, 1977, J COMP NEUROL, V172, P49, DOI 10.1002/cne.901720104; Takei K, 2008, SCHIZOPHR RES, V103, P52, DOI 10.1016/j.schres.2008.03.008; THOMAS GJ, 1978, J COMP PHYSIOL PSYCH, V92, P1128, DOI 10.1037/h0077522; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Wolk DA, 2010, BEHAV NEUROL, V16, P15; Yamada K, 2009, MAGN RESON MED SCI, V8, P165, DOI 10.2463/mrms.8.165; Yeo SS, 2013, J REHABIL MED, V45, P1078, DOI 10.2340/16501977-1232; Yeo SS, 2013, J REHABIL MED, V45, P595, DOI 10.2340/16501977-1145; Yeo SS, 2013, YONSEI MED J, V54, P315, DOI 10.3349/ymj.2013.54.2.315	26	1	1	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0028-3940	1432-1920		NEURORADIOLOGY	Neuroradiology	APR	2017	59	4					397	401		10.1007/s00234-017-1817-z			5	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	ES6WJ	WOS:000399690900011	28303377	Green Published, hybrid			2022-02-06	
J	Kim, JK; Kim, NY; Kim, YW				Kim, Je Kyung; Kim, Na Young; Kim, Yong Wook			Predictors for Depressive Mood in Geriatric Patients After Traumatic Brain Injury: A Retrospective Cross-Sectional Study	ANNALS OF REHABILITATION MEDICINE-ARM			English	Article						Depression; Geriatric; Brain injuries; Risk factors	KOREAN VERSION; PRIMARY-CARE; COMORBIDITY; DISORDERS; EMOTION; RELIABILITY; VALIDATION; LESIONS; IMPACT; MODEL	Objective To identify predictors for depressive mood in geriatric patients after traumatic brain injury (TBI). Methods A retrospective review of patients' medical charts was performed in TBI patients who were older than 60 years and referred to the Department of Rehabilitation Medicine at Severance Hospital in 2002-2016. The patients were classified into two groups based on the Geriatric Depression Scale (GDS): non-depressive group (0 <= GDS <= 16) and depressive group (17 <= GDS <= 30). Data was collected on demographic, socioeconomic, comorbidities, and trauma-related factors, as well as the pathophysiology of TBI, localization of lesion, post-traumatic complications, functional level, and cognitive and linguistic function. Significant variables from univariate analysis were analyzed using logistic regression. Results Forty-two patients were included, of whom 64.3% displayed a depressive mood. Patients in the depressive group had higher comorbidity scores (p=0.03), lower Functional Independence Measure (FIM) totals (p=0.03) and FIM motor (p=0.03) scores, higher modified Rankin Scale scores (p=0.04), and frequently had a bilateral or left side brain lesion (p=0.002). Higher comorbidity scores (odds ratio [OR], 1.764; 95% confidence interval [CI], 1.047-2.971), bilateral lesions (OR, 13.078; 95% CI, 1.786-95.780), and left side lesions (OR, 46.074; 95% CI, 3.175-668.502) were independently associated with a depressive mood in the multiple logistic regression analysis. Conclusion The risk of depressive mood in geriatric patients after TBI is associated with comorbidity, functional limitation, and the horizontal distribution of brain lesions. The most significant determining factors were comorbidity and the horizontal distribution of brain lesions. Early detection of risk factors is important to prevent and manage depressive mood in geriatric patients after TBI.	[Kim, Yong Wook] Yonsei Univ, Coll Med, Dept Rehabil Med, 50-1 Yonsei Ro, Seoul 03722, South Korea; [Kim, Yong Wook] Yonsei Univ, Coll Med, Res Inst Rehabil Med, 50-1 Yonsei Ro, Seoul 03722, South Korea		Kim, YW (corresponding author), Yonsei Univ, Coll Med, Dept Rehabil Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.; Kim, YW (corresponding author), Yonsei Univ, Coll Med, Res Inst Rehabil Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.	ywkim1@yuhs.ac		KIM, YONGWOOK/0000-0002-5234-2454			Alexopoulos GS, 1996, INT J GERIATR PSYCH, V11, P397, DOI 10.1002/(SICI)1099-1166(199605)11:5<397::AID-GPS493>3.0.CO;2-Y; Bowen A, 1998, BRAIN INJURY, V12, P177, DOI 10.1080/026990598122656; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Davidson RJ, 1998, COGNITION EMOTION, V12, P307, DOI 10.1080/026999398379628; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; FLORHENRY P, 1979, BIOL PSYCHIAT, V14, P677; Goldstein LB, 2004, STROKE, V35, P1941, DOI 10.1161/01.STR.0000135225.80898.1c; Hart T, 2012, ARCH PHYS MED REHAB, V93, P1343, DOI 10.1016/j.apmr.2012.03.036; Hoffman JM, 2007, AM J PHYS MED REHAB, V86, P962, DOI 10.1097/PHM.0b013e31815b5ee5; HOLDEN MK, 1984, PHYS THER, V64, P35, DOI 10.1093/ptj/64.1.35; Hudak A, 2011, PSYCHIAT RES-NEUROIM, V191, P160, DOI 10.1016/j.pscychresns.2010.10.003; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kim H, 2004, J CLIN EXP NEUROPSYC, V26, P1011, DOI 10.1080/13803390490515397; Kim JY, 2008, PSYCHIAT INVEST, V5, P232, DOI 10.4306/pi.2008.5.4.232; Levin, 1997, Semin Clin Neuropsychiatry, V2, P207; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; LIPSEY JR, 1983, BRIT J PSYCHIAT, V143, P266, DOI 10.1192/bjp.143.3.266; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; Menzel JC, 2008, BRAIN INJURY, V22, P375, DOI 10.1080/02699050802001492; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pagulayan KF, 2008, ARCH PHYS MED REHAB, V89, P1887, DOI 10.1016/j.apmr.2008.03.019; Park M, 2011, PSYCHIAT CLIN N AM, V34, P469, DOI 10.1016/j.psc.2011.02.009; Pudelek Barbara, 2002, AACN Clin Issues, V13, P61; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P100, DOI 10.1176/appi.neuropsych.22.1.100; Rapoport MJ, 2012, CNS DRUGS, V26, P111, DOI 10.2165/11599560-000000000-00000; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; SILBERMAN EK, 1986, BRAIN COGNITION, V5, P322, DOI 10.1016/0278-2626(86)90035-7; STARKSTEIN SE, 1987, BRAIN, V110, P1045, DOI 10.1093/brain/110.4.1045; STARKSTEIN SE, 1988, ARCH NEUROL-CHICAGO, V45, P725, DOI 10.1001/archneur.1988.00520310031013; Sullivan-Singh SJ, 2014, ARCH PHYS MED REHAB, V95, P1100, DOI 10.1016/j.apmr.2014.02.001; Thompson HJ, 2012, J NEUROTRAUM, V29, P1864, DOI 10.1089/neu.2011.2284; Tokutomi T, 2008, J NEUROTRAUM, V25, P1407, DOI 10.1089/neu.2008.0577; TUCKER DM, 1981, PSYCHOL BULL, V89, P19, DOI 10.1037/0033-2909.89.1.19; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604	40	1	1	0	0	KOREAN ACAD REHABILITATION MEDICINE	SEOUL	5F, YOUNGHAN BLDG, 742-22 BANPO-DONG, SEOCHO-GU, SEOUL, 137-040, SOUTH KOREA	2234-0645	2234-0653		ANN REHABIL MED-ARM	Ann. Rehabil. Med.-ARM	APR	2017	41	2					279	289		10.5535/arm.2017.41.2.279			11	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	FH0BH	WOS:000410803600016	28503462	Green Submitted, gold, Green Published			2022-02-06	
J	Mendoza, AE; Wybourn, CA; Knudson, MM				Mendoza, A. E.; Wybourn, C. A.; Knudson, M. M.			High-risk mechanism of injury: A new indication for screening for blunt cerebrovascular injury?	TRAUMA-ENGLAND			English	Article						Blunt; cerebrovascular; screening	VASCULAR INJURY; DIAGNOSIS; GUIDELINES; TRAUMA	Blunt cerebrovascular injury is a rare but catastrophic injury. Screening for blunt cerebrovascular injury after high-impact mechanism remains ill-defined but several associated lesions have been identified as high risk for concomitant blunt cerebrovascular injury and are used to prompt further investigation for early identification and intervention. We describe a case of a large cerebral infarction caused by a high cervical internal carotid dissection after a motorcycle collision. Upon presentation, the patient had a Glasgow coma scale of 14 and an open pelvic fracture, which was immediately addressed in the operating room. His subsequent imaging revealed a nasal fracture, bilateral rib fractures, bilateral pubic rami fractures and left acetabular fracture without evidence of traumatic brain injury, cervical spine injury or extensive facial fractures. After 48h, he displayed a depressed sensorium and an abnormal pupillary exam. He was diagnosed by computed tomography angiogram with a carotid dissection resulting in a large infarct of the right hemisphere with herniation requiring emergent craniectomy. This case suggests screening for blunt cerebrovascular injury beyond the current recommendations especially in patients with high-impact mechanism.	[Mendoza, A. E.; Wybourn, C. A.; Knudson, M. M.] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA		Mendoza, AE (corresponding author), San Francisco Gen Hosp, UCSF Dept Surg, 1001 Potrero Ave,Ward 3A, San Francisco, CA 94110 USA.	aprilmendoza0322@gmail.com					Bromberg WJ, 2010, J TRAUMA, V68, P471, DOI 10.1097/TA.0b013e3181cb43da; Bruns BR, 2014, J TRAUMA ACUTE CARE, V76, P691, DOI 10.1097/TA.0b013e3182ab1b4d; Burlew CC, 2012, J TRAUMA ACUTE CARE, V72, P539; Burlew CC, 2012, J TRAUMA ACUTE CARE, V72, P330, DOI 10.1097/TA.0b013e31823de8a0; Burlew CC, 2011, SURG CLIN N AM, V91, P217, DOI 10.1016/j.suc.2010.10.004; Cothren CC, 2005, AM J SURG, V190, P845, DOI 10.1016/j.amsurg.2005.08.007; Eastman AL, 2009, J TRAUMA, V67, P551, DOI 10.1097/TA.0b013e3181b84408; Fabian TC, 1996, ANN SURG, V223, P513, DOI 10.1097/00000658-199605000-00007; Jacobson LE, 2015, WORLD J EMERG SURG, V10, DOI 10.1186/s13017-015-0040-7; Kobayashi K, 2015, NAGOYA J MED SCI, V77, P507; Laser A, 2015, SURGERY, V158, P627, DOI 10.1016/j.surg.2015.03.063; MEARS G D, 1988, Journal of Emergency Medicine, V6, P281, DOI 10.1016/0736-4679(88)90363-0; MORGAN MK, 1987, J NEUROSURG, V66, P192, DOI 10.3171/jns.1987.66.2.0192; Opeskin K, 1997, AM J FOREN MED PATH, V18, P251, DOI 10.1097/00000433-199709000-00005	14	1	1	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1460-4086	1477-0350		TRAUMA	Trauma	APR	2017	19	2					146	149		10.1177/1460408616655834			4	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	EM6GB	WOS:000395409700011					2022-02-06	
J	Pandey, S; Singh, K; Pandey, D; Chand, G; Sharma, V; Jha, RP; Singh, R; Rai, SK; Gupta, R				Pandey, Sharad; Singh, Kulwant; Pandey, Deepa; Chand, Gian; Sharma, Vivek; Jha, Ravi Prakash; Singh, Royana; Rai, Sunil Kumar; Gupta, Rashmi			"Cleaved Tau Protein": A Novel Biomarker Candidate in Mild Neurotrauma in Emergency Settings	INDIAN JOURNAL OF NEUROTRAUMA			English	Article						serum cleaved tau protein; mild traumatic brain injury; emergency; diagnostic; prognostic marker	TRAUMATIC BRAIN-INJURY; DAMAGE; DIAGNOSIS	Background Neurotrauma has been labeled as a "silent epidemic" affecting both the developed and the developing nations. Traumatic brain injury (TBI) in humans leads to the proteolytic cleavage of tau protein called cleaved tau (C-tau) protein. The objectives of the study are to the role of serum cleaved tau (C-tau/tC) protein as a biomarker in patients with mild TBI and correlate it with the clinical progression (GCS) and clinical outcome (GOS) in emergency settings. Materials and Methods The study has been approved by the institutional ethical committee. The study included 40 cases with mild TBI and 40 controls. C-tau protein levels were measured in venous samples in emergency using human cleaved microtubule-associated protein tau ELISA kit (by CUSABIO). Results The mean serum C-tau protein level in cases was 44.76 +/- 23.10 pg/mL (range: 12.32-96.44, 95% CI: 37.37-52.15) and controls was 33.82 +/- 13.65 pg/mL, (range: 2.48-66.54, 95% CI: 29.46-38.19, p = 0.091). At admission the mean serum C-tau level was 65.15 +/- 22.41, 43.87 +/- 9.67, 26.15 +/- 9.13 pg/mL in patients with GCS 13, 14, and 15, respectively. Serum cleaved tau protein levels in the good outcome group were significantly lower, that is, 40.77 +/- 19.63 pg/mL (mean +/- SD) (range: 12.32-88.71, 95% CI: 34.13-47.42) compared with the poor-outcome group 80.66 +/- 23.10 pg/mL (mean +/- SD) (range: 46.55-96.44, 95% CI: 43.88-117.43, p = 0.004). Conclusion In this study, serum C-tau levels in patients with mild TBI were comparatively higher than those in the controls. Reaching a definitive conclusion will be too early and beyond the scope of this study. Thus, more studies are required in identifying its role as a diagnostic and prognostic marker in mild TBI.	[Pandey, Sharad; Singh, Kulwant; Chand, Gian; Sharma, Vivek] Banaras Hindu Univ, Inst Med Sci, Sir Sunder Lal Hosp, Dept Neurosurg, Varanasi, Uttar Pradesh, India; [Pandey, Deepa] Cent Hosp, Dept Clin Microbiol, Diesel Locomot Works, Varanasi, Uttar Pradesh, India; [Jha, Ravi Prakash] Banaras Hindu Univ, Inst Med Sci, Sir Sunder Lal Hosp, Dept Community Med,Div Biostat, Varanasi, Uttar Pradesh, India; [Singh, Royana; Rai, Sunil Kumar; Gupta, Rashmi] Banaras Hindu Univ, Inst Med Sci, Sir Sunder Lal Hosp, Dept Anat, Varanasi, Uttar Pradesh, India		Pandey, S (corresponding author), Dr Ram Manohar Lohia Hosp, Dept Neurosurg, Post Grad Inst Med Educ & Res, New Delhi 110001, India.	drsharad23@yahoo.com	Jha, Ravi Prakash/ABC-6588-2020; PANDEY, SHARAD/AAE-1404-2020	Jha, Ravi Prakash/0000-0001-5230-1436; PANDEY, SHARAD/0000-0002-3542-5864			Bettermann K, 2012, RSC DRUG DISCOV, V24, P1, DOI 10.1039/9781849734745-00001; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bulut M, 2006, ADV THER, V23, P12, DOI 10.1007/BF02850342; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; Greenberg M S, 2010, HDB NEUROSURGERY, V85, P929; Gururaj G, 1999, NIMHANS J, V17, P407; Guzel A, 2010, AM J EMERG MED, V28, P399, DOI 10.1016/j.ajem.2008.12.025; Health Policy Advisory Committee on Technology, 2013, BIOM DIAGN MAN TRAUM; Irazuzta JE, 2001, BRAIN RES, V913, P95, DOI 10.1016/S0006-8993(01)02764-0; Kavalci C, 2007, AM J EMERG MED, V25, P391, DOI 10.1016/j.ajem.2006.10.008; Kovesdi E, 2010, ACTA NEUROCHIR, V152, P1, DOI 10.1007/s00701-009-0463-6; Ma M, 2008, AM J EMERG MED, V26, P763, DOI 10.1016/j.ajem.2007.10.029; Odero W, 1997, TROP MED INT HEALTH, V2, P445, DOI 10.1046/j.1365-3156.1997.d01-296.x; Papa Linda, 2008, Expert Opin Med Diagn, V2, P937, DOI 10.1517/17530059.2.8.937; Shaw GJ, 2002, ANN EMERG MED, V39, P254, DOI 10.1067/mem.2002.121214; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TROJANOWSKI JQ, 1989, J HISTOCHEM CYTOCHEM, V37, P209, DOI 10.1177/37.2.2492045; Wuthisuthimethawee P, 2013, EUR J TRAUMA EMERG S, V39, P293, DOI 10.1007/s00068-013-0263-9; Zemlan FP, 1999, J NEUROCHEM, V72, P741, DOI 10.1046/j.1471-4159.1999.0720741.x; Zemlan FP, 2002, BRAIN RES, V947, P131, DOI 10.1016/S0006-8993(02)02920-7	20	1	1	0	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0973-0508	2213-3739		INDIAN J NEUROTRAUM	Indian J. Neurotrauma	APR	2017	14	1					26	34		10.1055/s-0037-1604486			9	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	FG2XF	WOS:000409994500005					2022-02-06	
J	Graves, JM; Klein, TA				Graves, Janessa M.; Klein, Tracy A.			The impact of patient characteristics on nurse practitioners' assessment and management of adolescent concussion	JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS			English	Article						Nurse practitioners; traumatic brain injury; concussion; sports medicine; adolescents; education; injury	SPORTS-RELATED CONCUSSION; STATES HIGH-SCHOOL; EMERGENCY-MEDICINE; SEX-DIFFERENCES; BASE-LINE; KNOWLEDGE; CARE; GUIDELINES; ATTITUDES; GENDER	Background and purpose: To evaluate the effect of patient sex and type of activity on concussion assessment and management recommendations. Methods: We administered a web-based survey to all nurse practitioners (NPs) actively licensed in Washington and Oregon. Participants were randomized to view one of four standardized patient scenario videos of an adolescent seeking care for a concussion, portraying the same symptomology but differing by sex and activity (soccer/hiking). Respondents provided assessment and management recommendations. Conclusions: In total, 1021 NPs provided sufficient data for analysis. Most NPs correctly identified the injury as a concussion (92.8%); fewer identified it as a mild traumatic brain injury (55.3%). NPs who viewed hiking videos were 40% more likely to indicate that the patient was definitely or likely safe to return to activity in 1 week, compared to a soccer player, after adjusting for covariates (RR = 1.40, 95% CI [1.16, 1.68]). Implications for practice: While most assessment and management recommendations did not vary according to patient sex, providers may manage concussions differently based on etiology. Appropriate and consistent concussion assessment and management is important, as NPs are authorized to assess adolescents with concussions and make determinations regarding return to activity or school.	[Graves, Janessa M.] Washington State Univ Spokane, Coll Nursing, POB 1495, Spokane, WA 99210 USA; [Klein, Tracy A.] Washington State Univ Vancouver, Coll Nursing, Vancouver, WA USA		Graves, JM (corresponding author), Washington State Univ Spokane, Coll Nursing, POB 1495, Spokane, WA 99210 USA.	janessa.graves@wsu.edu	Graves, Janessa M./J-2596-2019	Graves, Janessa M./0000-0002-7659-2634; Klein, Tracy/0000-0002-6618-3538	Washington State University New Faculty Seed Grant; American Nurses Foundation/Western Institute of Nursing Grant	Preliminary results of this research were presented at the American Public Health Association 143rd Annual Meeting on November 4, 2015. This research was funded by the Washington State University New Faculty Seed Grant and the American Nurses Foundation/Western Institute of Nursing Grant. The authors gratefully acknowledge Thom Allen, Rose Krebill-Prather, and the Social and Economic Sciences Research Center at Washington State University for assistance in the data collection process. They also thank the actors in the video (Zoe Bolenus, Barb Wallace, Stephanie Lynch, and Patrick Lynch) and Jerry Reynolds and Mike Lynch for their multimedia assistance. Finally, the authors acknowledge all study participants for contributing to this research. Both authors jointly developed the research project, conducted the study, and revised the manuscript for final submission. Tracy Klein generated the standardized patient scenario. Janessa Graves conducted analyses and drafted the initial draft of the manuscript. Both authors revised and approved of the manuscript for final submission.	Arbogast KB, 2013, CLIN PEDIATR, V52, P397, DOI 10.1177/0009922813478160; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Bazarian JJ, 2001, CLIN PEDIATR, V40, P207, DOI 10.1177/000992280104000405; Berz K, 2013, PHYSICIAN SPORTSMED, V41, P58, DOI 10.3810/psm.2013.05.2015; Bloodgood B, 2013, J ADOLESCENT HEALTH, V53, P34, DOI 10.1016/j.jadohealth.2013.01.022; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Brooks BL, 2014, J HEAD TRAUMA REHAB, V29, P257, DOI 10.1097/HTR.0000000000000016; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Carl RL, 2014, CLIN PEDIATR, V53, P689, DOI 10.1177/0009922814526979; Centers for Disease Control and Prevention, 2015, HEADS YOUTH SPORTS; Centers for Disease Control and Prevention (CDC), 2015, FACTS CONC BRAIN INJ; Chapman EN, 2013, J GEN INTERN MED, V28, P1504, DOI 10.1007/s11606-013-2441-1; Chrisman SP, 2011, CLIN PEDIATR, V50, P1031, DOI 10.1177/0009922811410970; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Covassin T, 2011, CLIN SPORT MED, V30, P125, DOI 10.1016/j.csm.2010.08.001; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Dehlendorf C, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.05.009; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P64, DOI 10.1017/S1355617712001464; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gibson TB, 2015, JAMA PEDIATR, V169, P163, DOI 10.1001/jamapediatrics.2014.2320; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Gioia GA, 2012, PEDIATR ANN, V41, P198, DOI 10.3928/00904481-20120426-10; Graves JM, 2015, AM J PUBLIC HEALTH, V105, pE35, DOI 10.2105/AJPH.2015.302744; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; HARDEN RM, 1975, BRIT MED J, V1, P447, DOI 10.1136/bmj.1.5955.447; Hooker RS, 2006, MED J AUSTRALIA, V185, P4, DOI 10.5694/j.1326-5377.2006.tb00438.x; Itriyeva K, 2016, J ADOLESCENT HEALTH, V58, pS71, DOI 10.1016/j.jadohealth.2015.10.155; Kinnaman KA, 2014, PEDIATR EMERG CARE, V30, P458, DOI 10.1097/PEC.0000000000000161; Kostyun RO, 2015, SPORTS HEALTH, V7, P52, DOI 10.1177/1941738114555075; Kurowski B, 2014, J TRAUMA ACUTE CARE, V77, pS12, DOI 10.1097/TA.0000000000000316; Lin AC, 2015, SPORTS HEALTH, V7, P124, DOI 10.1177/1941738115571570; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Martelli MF, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P1415; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKinlay JB, 2007, J GEN INTERN MED, V22, P289, DOI 10.1007/s11606-006-0075-2; Miyashita TL, 2016, SPORTS HEALTH, V8, P359, DOI 10.1177/1941738116651856; Mookherjee S, 2013, MED TEACH, V35, P883, DOI 10.3109/0142159X.2013.809408; Onate JA., 2009, ATHLETIC TRAINING SP, V1, DOI [DOI 10.3928/19425864-20090427-07, 10.3928/19425864-20090427-07]; Ono KE, 2016, AM J SPORT MED, V44, P748, DOI 10.1177/0363546515617746; Pleacher MD, 2006, BRIT J SPORT MED, V40, DOI 10.1136/bjsm.2005.019067; Raukar NP, 2014, ACAD EMERG MED, V21, P1370, DOI 10.1111/acem.12535; Schulman KA, 1999, NEW ENGL J MED, V340, P618, DOI 10.1056/NEJM199902253400806; Stern RA, 2017, J NEUROTRAUM, V34, P861, DOI 10.1089/neu.2016.4475; Stevenson B, 2007, CONTEMP ECON POLICY, V25, P486, DOI 10.1111/j.1465-7287.2007.00080.x; Taylor AM, 2015, J PEDIATR-US, V167, P738, DOI 10.1016/j.jpeds.2015.05.036; White PE, 2014, BRIT J SPORT MED, V48, P119, DOI 10.1136/bjsports-2013-092785; Xiang J, 2014, AM J SPORT MED, V42, P2082, DOI 10.1177/0363546514539914; Zemek R, 2014, PAED CHILD HEALT-CAN, V19, P474, DOI 10.1093/pch/19.9.475; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431; Zuckerbraun NS, 2014, PEDIATRICS, V133, P635, DOI 10.1542/peds.2013-2600; Zuckerman SL, 2014, J NEUROSURG-PEDIATR, V13, P72, DOI 10.3171/2013.9.PEDS13257	56	1	1	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2327-6886	2327-6924		J AM ASSOC NURSE PRA	J. Am. Assoc. Nurs. Pract.	MAR	2017	29	3					136	148		10.1002/2327-6924.12431			13	Health Care Sciences & Services; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Nursing	EO0RR	WOS:000396406100004	27910267				2022-02-06	
J	Hsiao, KY; Li, WC; Chang, CH; Lin, MHC; Yang, JT; Wang, PC; Chen, KH				Hsiao, K. Y.; Li, W. C.; Chang, C. H.; Lin, M. H. C.; Yang, J. T.; Wang, P. C.; Chen, K. H.			An evaluation of the ACEP guideline for mild head injuries in Taiwan	HONG KONG JOURNAL OF EMERGENCY MEDICINE			English	Article						Adult; computed tomography; decision support system; guidelines adherence; sensitivity and specificity	TRAUMATIC BRAIN-INJURY; NEW-ORLEANS CRITERIA; COMPUTED-TOMOGRAPHY; RULE; MANAGEMENT	Introduction: Traumatic brain injury (TBI) is an important issue in the emergency department. In the United States, the American College of Emergency Physicians (ACEP) published clinical guideline to select patients with mild head injuries for head computed tomography (CT) scans in 2008. The aim of this study was to identify the possible benefits of compliance with these guidelines for mild head injury patients in Taiwan. Method: This was a secondary analysis on our previous study published for association of hypertension and head injuries. In our previous study, we collected data about 1290 patients with head injuries who received brain CT scans in the emergency department from September 2012 to August 2013 for a study regarding the association between head injury and hypertension. In present study, we subjected this data to further analysis to try to validate the ACEP clinical policy for mild head injuries. Results: Of these 1,290 patients, 154 were found to have brain haemorrhage on the initial brain CT scan, and 5 were in need of neurosurgical intervention. A total of 859 patients met the ACEP guideline criteria, and 117 of these had brain haemorrhages. The sensitivity and specificity of the ACEP guideline to predict brain haemorrhage were 75.97% (95% confidence interval [CI], 68.44% to 82.48%) and 34.68% (95% CI, 31.91% to 37.53%), respectively. In predicting neurosurgical intervention, the sensitivity and specificity of the guideline were 100% (95% CI, 47.82% to 100%) and 33.54% (95% CI, 30.96% to 36.2%), respectively. Conclusion: Although adoption of the ACEP clinical policy may reduce the number of brain CT scans in mild head injury patients who may need neurosurgical interventions, it is not a good selection tool in Taiwan.	[Chen, K. H.] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Chen, K. H.] Chang Gung Mem Hosp, Dept Phys Med & Rehabil, Chiayi, Taiwan; [Hsiao, K. Y.] Chang Gung Mem Hosp, Dept Emergency Med, Taipei, Taiwan; [Li, W. C.] Chang Gung Mem Hosp, Dept Occupat Med, Taipei, Taiwan; [Chang, C. H.] Chang Gung Univ Sci & Technol, Coll Nursing, Chiayi Campus, Chiayi, Taiwan; [Chang, C. H.] Chang Gung Univ Sci & Technol, Chron Dis & Hlth Promot Res Ctr, Chiayi Campus, Chiayi, Taiwan; [Lin, M. H. C.; Yang, J. T.] Chang Gang Mem Hosp, Dept Neurosurg, Chiayi, Taiwan; [Yang, J. T.] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Wang, P. C.] Chang Gung Mem Hosp, Dept Cardiol, Chiayi, Taiwan		Chen, KH (corresponding author), Chang Gung Univ, Coll Med, Tao Yuan, Taiwan.; Chen, KH (corresponding author), Chang Gung Mem Hosp, Dept Phys Med & Rehabil, Chiayi, Taiwan.	karenkhchen@mail2000.com.tw		Wang, pochang/0000-0002-2961-4917	Chang Gung Memorial Hospital, Chiayi [CMRPG6B0251]	We are thankful that this research was supported by Chang Gung Memorial Hospital, Chiayi, Grant CMRPG6B0251. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. In addition, there is no competing financial interests exist in this study. Part of our result was presented at Taiwan Society of Emergency Medicine Winter Conference 2014.	Baumann BM, 2011, ANN EMERG MED, V58, P1, DOI 10.1016/j.annemergmed.2010.10.018; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Faul M, 2010, TRAUMATIC BRAIN INJU; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Holmes MW, 2012, INJURY, V43, P1423, DOI 10.1016/j.injury.2011.07.017; Hsiao KY, 2015, INJURY, V46, P859, DOI 10.1016/j.injury.2014.11.025; Ibanez J, 2004, J NEUROSURG, V100, P825, DOI 10.3171/jns.2004.100.5.0825; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Korley FK, 2013, ACAD EMERG MED, V20, P463, DOI 10.1111/acem.12136; National Institute for Health and Care Excellence, 2014, HEAD INJ TRIAG ASS I; Rohacek M, 2012, INJURY, V43, P1415, DOI 10.1016/j.injury.2012.01.001; Smits M, 2007, J NEUROL NEUROSUR PS, V78, P1359, DOI 10.1136/jnnp.2007.117143; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Statistics Department Ministry of Interior Taiwan, 2014, PEOPL AND STRUCT; STEIN SC, 1992, J NEUROSURG, V77, P562, DOI 10.3171/jns.1992.77.4.0562; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X	17	1	1	0	4	MEDCOM LTD	CHAI WAN	ROOM 504-5, CHEUNG TAT CENTRE, 18 CHEUNG LEE ST, CHAI WAN, HONG KONG 00000, PEOPLES R CHINA	1024-9079			HONG KONG J EMERG ME	Hong Kong J. Emerg. Med.	MAR	2017	24	2					73	78					6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	ET6RK	WOS:000400419200002					2022-02-06	
J	Lee, B				Lee, Bryant			Knocked Unconscionable: College Football Scholarships and Traumatic Brain Injury	GEORGE WASHINGTON LAW REVIEW			English	Article								Each year, thousands of athletes play college football and are at risk of incurring a traumatic brain injury ("TBI"). TBI can take many forms including concussion, Second-Impact Syndrome, Chronic Traumatic Encephalopathy ("CTE"), early-onset Alzheimer's, dementia, and other brain conditions. These injuries, which many experts believe can be caused by an athlete's participation in competitive football, can take years to manifest. But while college football players face these risks, universities in the National Collegiate Athletic Association ("NCAA") have benefited from the billions of dollars produced each year by the sport. Nevertheless, schools are not required to provide any medical care for athletes who suffer from TBI as a result of playing college football. This Note argues that when considering the risk of TBI to college football players, the current terms of the athletic scholarship are so one-sidedly favorable to the NCAA and its member institutions that the athletic scholarship offered to football players is unconscionable. This Note examines the two pronged approach to unconscionability that has been" adopted by many states and argues that the athletic scholarship, considering the manner in which it is offered and the effect of its substantive terms, satisfies both prongs. Finally, this Note recommends different measures the NCAA and its member institutions should take to lessen the degree of unconscionability in the athletic scholarship for football players.	[Lee, Bryant] George Washington Univ, Sch Law, Washington, DC 20052 USA		Lee, B (corresponding author), George Washington Univ, Sch Law, Washington, DC 20052 USA.						Allen Frederick E., 2012, FORBES; [Anonymous], 2008, SEATTLE TIMES; [Anonymous], 2014, NOLA            0414; [Anonymous], 2015, YOUTUBE; [Anonymous], 2012, NATL C PLAYERS  0927; [Anonymous], 2009, FAMILIES US; Anorga Omar, 2003, WHITTIER L REV, V24, P739; Anorga Omar, 2003, WHITTIER L REV, V24, P745; Aoun Joseph E., 2010, AM COUNCIL ED    FAL; Aschwanden Christie, 2015, FIVETHIRTYEIGHT 0402; Associated Press, 2013, NFL             0829; Baker III Thomas A., 2012, MARQ SPORTS L REV, V22, P619; Baugh CM, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0306-5; Baugh Christine M., 2014, CURRENT TREATMENT OP, V16, P313; Belson Ken, 2014, NY TIMES; Breck Andrew W., 2012, IND HLTH L REV, V9, P224; Breck Andrew W., 2012, IND HLTH L REV, V9, P215; Breech John, 2016, CBS SPORTS      0315; Breslow J. M., 2015, PBS; BROWN EL, 2000, COM LJ, V105, P287; Brown Evelyn L., 2000, COM L J, V105, P298; Carter W. Burlette, 2006, VAND J ENT TECH L, V8, P215; Carter W. Burlette, 2006, VAND J ENT TECH L, V8, P211; Castillo Jorge, 2011, NY TIMES; Craton N, 2014, CLIN J SPORT MED, V24, P93, DOI 10.1097/JSM.0000000000000023; DARR FP, 1994, HOUS L REV, V30, P1819; Darr Frank P., 1994, HOUS L REV, V30, P1844; Davis Jr Christopher, 2013, OKLA L REV, V65, P605; Dimatteo Larry A., 2006, FLA ST U L REV, V33, P1073; Dodd Dennis, 2012, CBS SPORTS      1009; Durkin Erin, 2012, US TODAY SPORTS 0515; Edmonds Chandi, 2015, NW U NW NOW     1228; Emmert Mark, 2014, PORTLAND PRESS  0624; ESPN.com News Services, 2014, ESPN            0729; Fainaru Steve, 2016, ESPN; Fainaru-Wada Mark, 2013, ESPN; Fetters Chris, 2015, SCOUT           0527; Fitzpatrick Frank, 2015, NCAA            1215; Floyd Brian, 2010, SB NATION       1120; Friedman Stephen E., 2010, GA L REV, V44, P345; Friedman Stephen E., 2010, GA L REV, V44, P317; Gaines Cork, 2015, BUS INSIDER; Ganim Sara, 2014, CNN             0408; Gartland Dan, 2015, SPORTS ILLUSTRA 1014; Hanlon Sean, 2008, VILL SPORTS ENT LJ, V15, P277; Hanlon Sean, 2008, VILL SPORTS ENT LJ, V15, P241; Hanlon Sean M., 2006, SPORTS LAW J, V13, P44; Hanlon Sean M., 2006, SPORT LAW J, V13, P41; Howard Michael E., 2007, DAMAGES TORT ACTIONS, V10; Huma Ramogi, 2012, 6 BILLION HEIST ROBB, P3; Hutchins Andy, 2015, SB NATION       0609; Jacobs Peter, 2015, BUS INSIDER     0127; Jaslow Ryan, 2013, CBS NEWS; Jessop Alicia, 2012, FORBES; Johnson K. K., 2012, SPORTS LAW J, V19, P1; Johnson Kendall K., 2012, SPORTS LAW J, V19, P24; Korobkin R, 2003, U CHICAGO LAW REV, V70, P1203, DOI 10.2307/1600574; Korobkin Russell, 2003, U CHICAGO LAW REV, V70, P1273; Kounang Nadia, 2016, CNN             0111; LEFF AA, 1967, U PENN LAW REV, V115, P485, DOI 10.2307/3310882; Leff Arthur Allen, 1967, U PENN LAW REV, V115, P487; Llewellyn KN, 1939, HARVARD LAW REV, V52, P700, DOI 10.2307/1334280; Llewellyn K. N., 1939, HARVARD LAW REV, V52, P703; Lush Greg, 2015, S CAL INTERDISC L J, V24, P787; Lush Greg, 2015, S CAL INTERDISC L J, V24, P767; Maghamez John A., 2015, LIBERTY U L REV, V9, P313; Maghamez John A., 2015, LIBERTY U L REV, V9, P319; Malagrino Dylan Oliver, 2013, OKLA L REV, V65, P607; McCaskey Anthony S., 1996, SETON HALL J SPORT L, V6, P39; MCCASKEY AS, 1996, SETON HALL J SPORT L, V6, P7; McCormick RA, 2006, WASH LAW REV, V81, P71; McCoy Blake, 2015, NBC NEWS; Meier B, 2015, NY TIMES; Meyer Craig, 2015, PITT POSTGAZETT 1026; Meyer Stacey, 2004, MARQ SPORTS L REV, V15, P227; Meyer Stacey, 2004, MARQ SPORTS L REV, V15, P230; MITTEN MJ, 1993, U PITT LAW REV, V55, P129; MURRAY JR JOHN EDWARD, 1990, MURRAY ON CONTRACTS, P489; Myerberg Paul, 2013, US TODAY SPORTS 0307; Nagy Tibor, 2005, MARQ SPORTS L REV, V15, P331; Nagy Tibor, 2005, MARQ SPORTS L REV, V15, P332; NCAA, 2015, 2015 16 NCAA DIVISIO; Niemeyer John, 2015, PEPP L REV, V42, P891; Niemeyer John, 2015, PEPP L REV, V42, P883; Nocera Joe, 2016, THEPOSTGAME     0316; Oster Emily, 2014, FIVETHIRTYEIGHT 1216; Peterson Kristina, 2009, NY TIMES; Porto Brian L., 2014, VA SPORTS ENT L J, V13, P243; Porto Brian L., 2014, VA SPORTS ENT L J, V13, P240; Pretty KA, 2014, NOTRE DAME LAW REV, V89, P2359; Rakoff Todd D., 1983, HARVARD LAW REV, V96, P1179; Ramsey MD, 2006, MIL LAW REV, V188, P1; Ramsey Matthew D., 2006, MIL L REV, V188, P34; Reilly C. L., 2012, UCLA ENTERTAINMENT L, V19, P245; Reilly Cailyn M., 2012, UCLA ENT L REV, V19, P252; Reuveni E, 2007, INDIANA LAW J, V82, P261; Reuveni Erez, 2007, IND LJ, V82, P301; Rich Bruce Louis, 2006, FLA ST U L REV, V33, P1067; Rich S., 2015, WASH POST; Rosenthal L.J., 2003, SETON HALL J SPORT L, V13, P321; Rosenthal Lindsay J., 2003, SETON HALL J SPORT L, V13, P322; Samuel Ebenezer, 2014, NY DAILY NEWS S 0329; Scovel Shannon, 2015, US TODAY COLL   0509; Silberman James, 2015, FANSIDED        0518; Smith Chris, 2014, FORBES; Snyder Audrey, 2015, PITT POSTGAZETT 0901; Solomon Jon, 2012, AL              0219; Solomon Jon, 2013, AL              0105; Solomon Jon, 2016, CBS SPORTS      0119; Solomon Jon, 2014, CBS SPORTS      1002; Solomon Jon, 2015, CBS SPORTS      0826; Staff Mayo Clinic, 2014, MAYO CLIN       0515; Steele Michael, 2015, MARQ L REV, V99, P511; Steele Michael, 2015, MARQ L REV, V99, P534; Strachan Maxwell, 2015, HUFFINGTON POST; Strauss B., 2014, NY TIMES; Thamel P., 2006, NY TIMES; Tracy M., 2015, NY TIMES; Trahan Kevin, 2014, VICE SPORTS     1205; Vanderford Ryan, 2015, S CAL INTERDISC L J, V24, P809; Vanderford Ryan, 2015, S CAL INTERDISC L J, V24, P805; Walker Yuri Nicholas, 2005, MARQ SPORTS L REV, V15, P601; Walker Yuri Nicholas, 2005, MARQ SPORTS L REV, V15, P631; Walsh M, 2013, ATLANTIC; Watford Paul, 1994, COLUM VLA J L ARTS, V18, P287; Watford Paul, 1994, COLUM VLA JL ARTS, V18, P269; Wexler Evan, 2013, PBS; Wieberg S., 2008, US TODAY; Willis Gerri, 2009, CNN MONEY; WILLISTON, 2013, NYU J INTELL PROP EN, V3, P106; WILLISTON, 2013, NYU J INTELL PROP EN, V3, P119; WILLISTON SAMUEL, 2010, TREATISE LAW CONTRAC; Winters Michelle A., 2013, MARQ SPORTS L REV, V24, P295; Winters Michelle A., 2013, MARQ SPORTS L REV, V24, P300; Wong Leslie E., 2010, TEX TECH L REV, V42, P1073; Wong Leslie E., 2010, TEX TECH L REV, V42, P1069; Wood Kyle R., 2013, IND HLTH L REV, V10, P601; Wood Kyle R., 2013, IND HLTH L REV, V10, P561; Woodiel Carter, 2016, WTMJ            0820; [No title captured]; [No title captured]	141	1	1	0	19	GEORGE WASHINGTON UNIV	WASHINGTON	2000 H STREET N W, WASHINGTON, DC 20052 USA	0016-8076			GEORGE WASH LAW REV	George Wash. Law Rev.	MAR	2017	85	2					613	644					32	Law	Social Science Citation Index (SSCI)	Government & Law	EQ7EB	WOS:000398245300006					2022-02-06	
J	Manee, FS; Nadar, MS; Jassem, Z; Chavan, SR				Manee, Fahad S.; Nadar, Mohammed Sh.; Jassem, Zainab; Chavan, Shashidhar Rao			Survey of cognitive rehabilitation practices in the state of Kuwait	SCANDINAVIAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						Cognitive therapy; health care professionals; resources; standardized assessments	TRAUMATIC BRAIN-INJURY; MINI-MENTAL-STATE; STROKE; PERFORMANCE; IMPAIRMENT; RECOMMENDATIONS; MANAGEMENT	Background Rehabilitation professionals must be astute at recognizing, assessing, and treating individuals with cognitive deficits. No research is available to examine cognitive rehabilitation practices applied to individuals with neurological conditions in Kuwait. Objectives: To identify the use of cognitive assessments, the availability of resources, and the barriers to cognitive rehabilitation practices in Kuwait. Methods Face-to-face interviews were conducted with health care professionals working with adult individuals with neurological conditions. These professionals included occupational therapists, speech-language pathologists, psychiatrists, and neurologists. Results The most commonly used cognitive based assessments are MMSE (41%), and MoCA and LOTCA (15.2%). The only clinical assessment used is the Line-Bisection Test (2.2%). The most used occupation-based assessments are FIM (6.5%), COPM (4.3%), the Interest Checklist (2.2%), and the Barthel Index (2.2%). Resources related to cognitive rehabilitation in Kuwait that are unavailable to practitioners include journal clubs (91%), special interest groups (89%), and continuing education programmes (82.6%). Barriers to cognitive rehabilitation practice included lack of sufficient funds for continuing education, lack of time, lack of standardized assessments, and lack of inter-professional teamwork. Conclusion Many adults in Kuwait live with cognitive impairment. There is a need to develop appropriate evidence-based cognitive rehabilitation clinical guidelines in Kuwait.	[Manee, Fahad S.; Nadar, Mohammed Sh.; Jassem, Zainab; Chavan, Shashidhar Rao] Kuwait Univ, Fac Allied Hlth Sci, Occupat Therapy Dept, Kuwait, Kuwait		Nadar, MS (corresponding author), Kuwait Univ, Fac Allied Hlth Sci, Occupat Therapy Dept, Kuwait, Kuwait.	ot_nadar@hsc.edu.kw	Nadar, Mohammed Sh./AAX-4825-2020	Nadar, Mohammed Sh./0000-0003-4281-5630; Jasem, Zainab/0000-0001-5894-5718			BAUM C, 1993, AM J OCCUP THER, V47, P431, DOI 10.5014/ajot.47.5.431; Bayley MT, 2014, J HEAD TRAUMA REHAB, V29, P290, DOI 10.1097/HTR.0000000000000070; Bennett S, 2003, AM J OCCUP THER, V57, P635, DOI 10.5014/ajot.57.6.635; Bour A, 2010, J NEUROL, V257, P630, DOI 10.1007/s00415-009-5387-9; Brain Injury Association of America, 2007, COGN REH EV FUND CAS; Clare L, 2011, CLIN GERONTOLOGIST, V34, P220, DOI 10.1080/07317115.2011.555937; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; Hilton K, 2001, BRIT J OCCUPATIONAL, V64, P135, DOI DOI 10.1177/030802260106400305; Intercollegiate Stroke Working Party, 2012, NAT CLIN GUID STROK; Itzkovich M, 2000, LOTCA COGNITIVE ASSE; Jenkinson N, 2007, BRAIN INJURY, V21, P1283, DOI 10.1080/02699050701739531; Koh C. W., 2008, THESIS; Koh CL, 2009, AUST OCCUP THER J, V56, P324, DOI 10.1111/j.1440-1630.2008.00764.x; Korner-Bitensky N, 2011, AUST OCCUP THER J, V58, P241, DOI 10.1111/j.1440-1630.2011.00943.x; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Lindsay P, 2008, CAN MED ASSOC J, V179, pS1, DOI 10.1503/cmaj.081148.R2; Morrison MT, 2013, AM J OCCUP THER, V67, P460, DOI 10.5014/ajot.2013.007880; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Phipps S, 2007, AM J OCCUP THER, V61, P328, DOI 10.5014/ajot.61.3.328; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P321, DOI 10.1097/HTR.0000000000000072; Rahman TTA, 2009, GERIATR GERONTOL INT, V9, P54, DOI 10.1111/j.1447-0594.2008.00509.x; Rogers J, 1984, PERFORMANCE ASSESSME; Salter K, 2009, COGNITIVE DISORDERS; Skidmore E, 2011, ARCH PHYS MED REHAB, V92, P1717; Skidmore ER, 2012, ARCH PHYS MED REHAB, V93, pe11; Stuifbergen AK, 2012, CLIN REHABIL, V26, P882, DOI 10.1177/0269215511434997; Tomas P., 2010, REV INT PSICOL TER P, V10, P191; TUPPER DE, 1990, NEUROPSYCHOLOGY EVER; Ziviani J, 2003, AUST OCCUP THER J, V50, P13, DOI DOI 10.1046/J.1440-1630.2003.00341.X; Zwecker M, 2002, ARCH PHYS MED REHAB, V83, P342, DOI 10.1053/apmr.2002.29641	31	1	1	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1103-8128	1651-2014		SCAND J OCCUP THER	Scand. J. Occup. Ther.	MAR	2017	24	2					83	88		10.3109/11038128.2016.1139176			6	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	EM1VR	WOS:000395105700001	26853687				2022-02-06	
J	Onuigbo, MAC; Agbasi, N				Onuigbo, Macaulay Amechi Chukwukadibia; Agbasi, Nneoma			Severe symptomatic acute hyponatremia in traumatic brain injury responded very rapidly to a single 15 mg dose of oral tolvaptan; a Mayo Clinic Health System hospital experience - need for caution with tolvaptan in younger patients with preserved renal function	JOURNAL OF RENAL INJURY PREVENTION			English	Article						Hyponatremia; Renal function; Subarachnoid hemorrhage; Syndrome of inappropriate anti-diuretic hormone (SIADH); Tolvaptan	ANTIDIURETIC-HORMONE; HEART-FAILURE; SECRETION	Tolvaptan is now well established as a potent pharmaceutical agent for symptomatic hyponatremia from syndrome of inappropriate antidiuretic hormone secretion (SIADH), congestive heart failure and liver cirrhosis. Previous studies had recruited older (63-65 years) patients with mild renal impairment (serum creatinine, 1.3-1.4 mg/dl). A 2012 report in the Journal of Neurology, Neurosurgery & Psychiatry described tolvaptan as a "lifesaving drug". A major outcome concern in the treatment of chronic hyponatremia is potentially fatal pontine demyelination from over-rapid correction of serum sodium > 0.5 mEq/dL/h. The maximum reported correction of serum sodium within 24 hours was 13 mEq/L in a case of SIADH. We recently experienced the dramatic correction of hyponatremia at 1 mEq/dL/h over 18 hours, following 15 mg of oral tolvaptan in a 32-year old male patient with normal kidney function (serum creatinine 0.76 mg/dL), following traumatic brain injury (TBI). Tolvaptan is indeed an effective and life-saving drug for post-TBI hyponatremia. However, we strongly recommend the use of lower doses of tolvaptan (<= 15 mg/d) in younger patients with more preserved renal function to avoid the development of life-threatening pontine demyelination.	[Onuigbo, Macaulay Amechi Chukwukadibia] Mayo Clin Hlth Syst, Dept Nephrol, Eau Claire, WI 54702 USA; [Agbasi, Nneoma] North East London NHS Fdn Trust, Rainham, England		Onuigbo, MAC (corresponding author), Mayo Clin Hlth Syst, Dept Nephrol, Eau Claire, WI 54702 USA.	onuigbo.macaulay@mayo.edu					Berl T, 2010, J AM SOC NEPHROL, V21, P705, DOI 10.1681/ASN.2009080857; De Luca L, 2005, AM J CARDIOL, V96, p19L, DOI 10.1016/j.amjcard.2005.09.066; DEVITA MV, 1990, CLIN NEPHROL, V34, P163; Graziani G, 2012, J NEUROL NEUROSUR PS, V83, P510, DOI 10.1136/jnnp-2011-300576; Konstam MA, 2007, JAMA-J AM MED ASSOC, V297, P1319, DOI 10.1001/jama.297.12.1319; Lehrich RW, 2013, AM J KIDNEY DIS, V62, P364, DOI 10.1053/j.ajkd.2013.01.034; Schrier RW, 2006, NEW ENGL J MED, V355, P2099, DOI 10.1056/NEJMoa065181; Schrier RW, 2010, NAT REV NEPHROL, V6, P185, DOI 10.1038/nrneph.2010.21; Torres Andrea C, 2011, Endocr Pract, V17, pe97, DOI 10.4158/EP10386.CR; Upadhyay A, 2006, AM J MED, V119, pS30, DOI 10.1016/j.amjmed.2006.05.005; Verbalis JG, 2011, EUR J ENDOCRINOL, V164, P725, DOI 10.1530/EJE-10-1078; Wu CC, 2006, CLIN NEPHROL, V65, P28	12	1	1	0	0	NIKAN RESEARCH INST	ISFAHAN	NO 8, 23 LN, FARABI NORTH ST, FREIBURG AVE, PO BOX 81655-963, ISFAHAN, 81687-95341, IRAN	2345-2781			J RENAL INJ PREV	J. Renal Inj. Prev.	MAR	2017	6	1					26	29		10.15171/jrip.2017.05			4	Urology & Nephrology	Emerging Sources Citation Index (ESCI)	Urology & Nephrology	GV7HV	WOS:000446294800005	28487868	Green Published, Green Submitted, hybrid			2022-02-06	
J	Pikstra, ARA; Metting, Z; Fock, JM; van der Naalt, J				Pikstra, Angelina R. A.; Metting, Zwany; Fock, Johanna M.; van der Naalt, Joukje			The juvenile head trauma syndrome Deterioration after mild TBI: Diagnosis and clinical presentation at the Emergency Department	EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY			English	Article						Traumatic brain injury; Deterioration; Juvenile head trauma syndrome; Diagnosis; Features; Children	FAMILIAL HEMIPLEGIC MIGRAINE; SPREADING DEPRESSION; BRAIN-INJURY; DELAYED DETERIORATION; COMPUTED-TOMOGRAPHY; TRIGGERED MIGRAINE; CHILDREN; COMA; EDEMA	Background: Annually 14.000 children with traumatic brain injury (TBI) are admitted to the Emergency Depathuent (ED) in the Netherlands. Presentation varies and a specific entity comprises the juvenile head trauma syndrome (JHTS) with secondary deterioration after a mild trauma. As outcome of JHTS can be fatal, early recognition is essential. Aim: To outline the epidemiology and clinical features of JHTS, in comparison to paediatric mild TBI patients without JHTS. Methods: Retrospective study of 570 patients with mild TBI admitted to the ED of a level-one trauma centre from 2008 to 2014. Diagnosis of JHTS by experienced neurologists was compared with diagnosis by physicians at the ED. Results: Physicians at the ED diagnosed JHTS more frequently (14%) compared to experienced neurologists (8%). JHTS occurred after a lucid interval varying from 5 to 225 min (mean 44 (SD 64)) with changes in consciousness. JHTS patients were younger compared to mild TBI patients (4.1 (SD 2.4) vs. 7.3 (SD 5.7), p < 0.01), (range: 1-10 years). Falls occurred more often in JHTS (84% vs. 69%, p = 0.03) and at presentation, vomiting (42% vs. 22%, p < 0.01) and changed behaviour (29% vs. 1%, p = 0.03) were more present compared to the mild TBI group. Conclusion and discussion: JHTS occurs more often in children up to 10 years with falls as major cause of injury. Clues for recognition of this syndrome comprise changes in consciousness and vomiting or changed behaviour on presentation at the ED. For clinical practice, these factors should guide the decision for hospital admission or discharge. (C) 2016 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.	[Pikstra, Angelina R. A.; van der Naalt, Joukje] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Hanzepl 1, NL-9713 GZ Groningen, Netherlands; [Metting, Zwany; Fock, Johanna M.] Univ Groningen, Univ Med Ctr Groningen, Dept Paediat Neurol, Hanzepl 1, NL-9713 GZ Groningen, Netherlands		van der Naalt, J (corresponding author), Univ Med Ctr Groningen, Dept Neurol, Hanzepl 1, NL-9713 GZ Groningen, Netherlands.	a.r.a.pikstra@umcg.nl; z.metting@umcg.nl; j.m.fock@umcg.nl; j.van.der.naalt@umcg.nl		van der Naalt, Joukje/0000-0001-9873-2418			ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; Colomer CB, 2012, PEDIATR NEUROSURG, V48, P205, DOI 10.1159/000343385; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; BRUCE DA, 1984, BRIT MED J, V289, P715, DOI 10.1136/bmj.289.6447.715; Colantonio A, 2010, CAN J NEUROL SCI, V37, P783, DOI 10.1017/S0317167100051441; Curtain RP, 2006, PEDIATR NEUROL, V34, P329, DOI 10.1016/j.pediatrneurol.2005.08.033; Eikermann-Haerter K, 2009, J CLIN INVEST, V119, P99, DOI 10.1172/JCI36059; GRUNDL PD, 1994, J NEUROTRAUM, V11, P135, DOI 10.1089/neu.1994.11.135; HAAS DC, 1988, J NEUROSURG, V68, P181, DOI 10.3171/jns.1988.68.2.0181; Haas DC, 1975, ARCH NEUROL-CHICAGO, V32, P178; Hartings JA, 2014, ANN NEUROL, V76, P681, DOI 10.1002/ana.24256; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Kirkham FJ, 2008, DEV MED CHILD NEUROL, V50, P267, DOI 10.1111/j.1469-8749.2008.02042.x; KISSOON N, 1990, CAN MED ASSOC J, V142, P27; Kors EE, 2001, ANN NEUROL, V49, P753, DOI 10.1002/ana.1031; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Mack J, 2009, PEDIATR RADIOL, V39, P200, DOI 10.1007/s00247-008-1084-6; OKA H, 1977, BRAIN, V100, P287, DOI 10.1093/brain/100.2.287; Sakas DE, 1997, NEUROSURGERY, V41, P661, DOI 10.1097/00006123-199709000-00031; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; SNOEK JW, 1984, BRAIN, V107, P15, DOI 10.1093/brain/107.1.15; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Stam AH, 2009, J NEUROL NEUROSUR PS, V80, P1125, DOI 10.1136/jnnp.2009.177279; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Udomphorn Y, 2008, PEDIATR NEUROL, V38, P225, DOI 10.1016/j.pediatrneurol.2007.09.012; van der Veek EMJ, 2015, NEUROPEDIATRICS, V46, P116, DOI 10.1055/s-0035-1547344; van Pelt ED, 2011, EUR J PAEDIATR NEURO, V15, P519, DOI 10.1016/j.ejpn.2011.05.005; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Wintermark M, 2004, PEDIATRICS, V113, P1642, DOI 10.1542/peds.113.6.1642	31	1	1	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1090-3798	1532-2130		EUR J PAEDIATR NEURO	Eur. J. Paediatr. Neurol.	MAR	2017	21	2					344	349		10.1016/j.ejpn.2016.09.005			6	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	EN4CE	WOS:000395954600018	27707655				2022-02-06	
J	Reb, AM; Saum, NS; Murphy, DA; Breckenridge-Sproat, ST; Su, XG; Bormann, JE				Reb, Anne Marie; Saum, Nancy Seaby; Murphy, Deborah Ann; Breckenridge-Sproat, Sara Todd; Su, Xiaogang; Bormann, Jill Ellen			Qigong in Injured Military Service Members A Feasibility Study	JOURNAL OF HOLISTIC NURSING			English	Article						Qigong; stress; sleep; posttraumatic stress disorder; rehabilitation; complementary and integrative therapies	POSTTRAUMATIC-STRESS-DISORDER; RANDOMIZED CONTROLLED-TRIAL; TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; TAI CHI; ANXIETY DISORDERS; SLEEP; VETERANS; SYMPTOMS; INTERVENTION	Background:Wounded, ill, and injured (WII) Military Service members experience significant stress and are at risk for developing chronic conditions including posttraumatic stress disorder and depression. Qigong, a meditative movement practice, may positively affect their ability to engage in successful rehabilitation. Purpose: We assessed the feasibility of Qigong practice in WII Service members returning from combat; effects on stress, sleep, and somatic symptoms; satisfaction; and participants' experience with the practice. Design: Single-group, pre- and posttest, mixed methods approach. Method: Twenty-six WII were enrolled. The program was designed to include 20 classes over 10 weeks. Participants completed self-report questionnaires, practice logs, and an exit interview. Findings: Average attendance was 8.14 classes (SD = 4.9); mean engagement was 5.7 (SD = 3.5) weeks. Participants endorsed a high level of satisfaction with the practice. Qualitative themes included coping with stress; feeling more resilient and empowered; improvement in symptoms including sleep and physical function; and factors affecting practice. Participant-reported facilitators included accessibility and portability of the practice; barriers included scheduling conflicts and personal challenges. Participants recommended offering shorter programs with flexible scheduling options, increasing program awareness, and including significant others in future classes. Conclusion: Qigong was safe, portable, and easily adapted for WII Service members.	[Reb, Anne Marie] Henry M Jackson Fdn, John P Murtha Canc Ctr, Walter Reed Natl Mil Med Ctr, Bethesda, MD USA; [Saum, Nancy Seaby] Inst Integral Qigong & Tai Chi, Goleta, CA USA; [Murphy, Deborah Ann] Cherokee Nation Technol Solut, Tulsa, OK USA; [Breckenridge-Sproat, Sara Todd] Reg Hlth Command Europe, Bethesda, MD USA; [Su, Xiaogang] Univ Texas El Paso, Dept Math Sci, Stat, El Paso, TX 79968 USA; [Bormann, Jill Ellen] Univ San Diego, Hahn Sch Nursing & Hlth Sci, Beyster Inst Nursing Res, San Diego, CA 92110 USA; [Bormann, Jill Ellen] VA Ctr Excellence Stress & Mental Hlth CESAMH, San Diego, CA USA		Reb, AM (corresponding author), Walter Reed Natl Mil Med Ctr, 4954 North Palmer Rd,Bldg 19,Room 3423, Bethesda, MD 20889 USA.	Anne.m.reb.ctr@mail.mil	Su, Xiaogang/B-7340-2009		TriService Nursing Research Program [HU0001-09-1-TS13]	The views expressed in this article are those of the authors and do not reflect the official policy of the Department of Army/Navy/Air Force, Department of Defense, Department of Veterans Affairs or U.S. Government. With sincere appreciation to COL (Ret) Richard Ricciardi, PhD, NP, FAANP, for supporting this study from its conception, contributing to the study design, and review of an early draft of the article; Janice Agazio, PhD, CRNP, FAANP, FAAN, and Linda Larkey, PhD, CRTT, for review and comments on the final draft; and Ms. Denise Wright for administrative support. Funding was received from TriService Nursing Research Program Grant HU0001-09-1-TS13 (period of study: from January 9, 2009, to August 31, 2012).	Abbott R, 2013, PSYCHIAT CLIN N AM, V36, P109, DOI 10.1016/j.psc.2013.01.011; Banerjee B, 2007, INTEGR CANCER THER, V6, P242, DOI 10.1177/1534735407306214; Benedict AL, 2009, MENT HEALTH RELIG CU, V12, P485, DOI 10.1080/13674670902788908; Benson H., 2000, RELAXATION RESPONSE; Bhasin MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062817; Blake H, 2009, CLIN REHABIL, V23, P589, DOI 10.1177/0269215508101736; BORKOVEC TD, 1988, J CONSULT CLIN PSYCH, V56, P877, DOI 10.1037/0022-006X.56.6.877; Borkovec TD, 2002, J CONSULT CLIN PSYCH, V70, P288, DOI 10.1037//0022-006X.70.2.288; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Capaldi VF, 2011, MIL MED, V176, P879, DOI 10.7205/MILMED-D-10-00440; Chen KW, 2010, J ALTERN COMPLEM MED, V16, P875, DOI 10.1089/acm.2009.0443; Chen Z, 2013, CANCER-AM CANCER SOC, V119, P1690, DOI 10.1002/cncr.27904; Chow YWY, 2007, J ALTERN COMPLEM MED, V13, P831, DOI 10.1089/acm.2007.7166; Creswell JW., 2014, RES DESIGN QUALITATI, V4; Derogatis LR, 2000, BSI 18 ADM SCORING P; Devilly GJ, 2000, J BEHAV THER EXP PSY, V31, P73, DOI 10.1016/S0005-7916(00)00012-4; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Esch Tobias, 2003, Med Sci Monit, V9, pRA23; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Galvin Jennifer A, 2006, Complement Ther Clin Pract, V12, P186, DOI 10.1016/j.ctcp.2006.02.004; Gelis LA, 2010, MIL MED, V175, P567, DOI 10.7205/MILMED-D-09-00123; Ginzburg K, 2011, PSYCHOL MED, V41, P353, DOI 10.1017/S0033291710000528; Hertzog MA, 2008, RES NURS HEALTH, V31, P180, DOI 10.1002/nur.20247; Hoge CW, 2011, JAMA-J AM MED ASSOC, V306, P549, DOI 10.1001/jama.2011.1096; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Hui PN, 2006, J ALTERN COMPLEM MED, V12, P373, DOI 10.1089/acm.2006.12.373; Hwang EY, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-113; Jacobs GD, 2001, J ALTERN COMPLEM MED, V7, pS93; Jahnke R., 1997, THE HEALER WITHIN; Jahnke Roger, 2010, Am J Health Promot, V24, pe1, DOI 10.4278/ajhp.081013-LIT-248; Jahnke Roger, 2002, HEALING PROMISE QI C; Johansson M., 2008, INT J STRESS MANAGE, V15, P199, DOI DOI 10.1037/1072-5245.15.2.199; Jones KD, 2012, CLIN RHEUMATOL, V31, P1205, DOI 10.1007/s10067-012-1996-2; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Larsen D L, 1979, Eval Program Plann, V2, P197, DOI 10.1016/0149-7189(79)90094-6; Lee TI, 2006, AM J CHINESE MED, V34, P37, DOI 10.1142/S0192415X06003618; Lewis V, 2009, MIL MED, V174, P948, DOI 10.7205/MILMED-D-04-0208; Lynch M, 2012, ARTHRITIS RES THER, V14, P1, DOI DOI 10.1186/AR3931.RETRIEVED; McLay RN, 2010, MIL MED, V175, P759, DOI 10.7205/MILMED-D-10-00193; Ng BHP, 2009, PSYCHOPHYSIOLOGY, V46, P257, DOI 10.1111/j.1469-8986.2008.00763.x; Office of The Army Surgeon General, 2010, PAIN MAN TASK FORC R; Oh B, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/134737; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; R Foundation for Statistical Computing, 2012, R LANG ENV STAT COMP; Roberti JW, 2006, J COLL COUNS, V9, P135, DOI 10.1002/j.2161-1882.2006.tb00100.x; Rogers CE, 2009, WESTERN J NURS RES, V31, P245, DOI 10.1177/0193945908327529; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Sayer NA, 2009, J REHABIL RES DEV, V46, P703, DOI 10.1682/JRRD.2009.01.0008; Schnurr PR, 2007, J TRAUMA STRESS, V20, P779, DOI 10.1002/jts.20292; Thabane L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-1; Tsang HWH, 2006, INT J GERIATR PSYCH, V21, P890, DOI 10.1002/gps.1582; Wahbeh H, 2011, J ALTERN COMPLEM MED, V17, P175, DOI 10.1089/acm.2010.0316; WALTZ J, 1993, J CONSULT CLIN PSYCH, V61, P620, DOI 10.1037/0022-006X.61.4.620; Wang CW, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/716094; Wu WW, 2015, J ALTERN COMPLEM MED, V21, P509, DOI 10.1089/acm.2014.0251; Yang Y, 2007, MED SCI MONITOR, V13, pCR339; Yeh SCJ, 2012, J ALTERN COMPLEM MED, V18, P567, DOI 10.1089/acm.2011.0133; Yost TL, 2013, EXPLORE-NY, V9, P142, DOI 10.1016/j.explore.2013.02.002	59	1	1	0	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0898-0101	1552-5724		J HOLIST NURS	J. Holist. Nurs.	MAR	2017	35	1					10	24		10.1177/0898010116638159			15	Nursing	Emerging Sources Citation Index (ESCI)	Nursing	FI3FP	WOS:000411843700004	27021358				2022-02-06	
J	Surmelioglu, O; Sencar, L; Ozdemir, S; Tarkan, O; Dagkiran, M; Surmelioglu, N; Tuncer, U; Polat, S				Surmelioglu, O.; Sencar, L.; Ozdemir, S.; Tarkan, O.; Dagkiran, M.; Surmelioglu, N.; Tuncer, U.; Polat, S.			Effects of agmatine sulphate on facial nerve injuries	JOURNAL OF LARYNGOLOGY AND OTOLOGY			English	Article						Facial Nerve; Agmatine; Nerve Regeneration	ORNITHINE-DECARBOXYLASE; SYMPATHETIC NEURONS; FUNCTIONAL RECOVERY; REGENERATION; RAT; GRAFTS; DEGENERATION; ISCHEMIA; ARGININE; BRAIN	Objective: To evaluate the effect of agmatine sulphate on facial nerve regeneration after facial nerve injury using electron and light microscopy. Methods: The study was performed on 30 male Wistar albino rats split into: a control group, a sham-treated group, a study control group, an anastomosis group, and an anastomosis plus agmatine sulphate treatment group. The mandibular branch of the facial nerve was dissected, and a piece was removed for histological and electron microscopic examination. Results: Regeneration was better in the anastomosis group than in the study control group. However, the best regeneration findings were seen in the agmatine sulphate treatment group. There was a significant difference between the agmatine group and the others in terms of median axon numbers (p < 0.004) and diameters (p < 0.004). Conclusion: Agmatine sulphate treatment with anastomosis in traumatic facial paralysis may enhance nerve regeneration.	[Surmelioglu, O.; Ozdemir, S.; Tarkan, O.; Dagkiran, M.; Tuncer, U.] Cukurova Univ, Fac Med, Dept Otorhinolaryngol, Adana, Turkey; [Sencar, L.; Polat, S.] Cukurova Univ, Fac Med, Dept Histol, Adana, Turkey; [Surmelioglu, N.] Cukurova Univ, Fac Pharm, Dept Clin Pharm, Adana, Turkey		Surmelioglu, O (corresponding author), Cukurova Univ, Fac Med, Dept Otorhinolaryngol, Adana, Turkey.	surmeli2004@yahoo.com	POLAT, Sait/J-3812-2018; SURMELIOGLU, NURSEL/K-1025-2018	POLAT, Sait/0000-0003-1646-8831; 			Berenholz L, 2005, J PERIPHER NERV SYST, V10, P319, DOI 10.1111/j.1085-9489.2005.10310.x; de Faria Simone Damasceno, 2006, Braz J Otorhinolaryngol, V72, P341; DORNAY M, 1986, EXP NEUROL, V92, P665, DOI 10.1016/0014-4886(86)90307-9; Fairbanks CA, 2000, P NATL ACAD SCI USA, V97, P10584, DOI 10.1073/pnas.97.19.10584; FISCH U, 1980, J LARYNGOL OTOL, V94, P129, DOI 10.1017/S0022215100088575; FU SY, 1995, J NEUROSCI, V15, P3886; GILAD GM, 1983, EXP NEUROL, V81, P158, DOI 10.1016/0014-4886(83)90165-6; GILAD GM, 1995, LIFE SCI, V58, pPL41, DOI 10.1016/0024-3205(95)02274-0; Gilad GM, 2000, NEUROSCI LETT, V296, P97, DOI 10.1016/S0304-3940(00)01625-6; Gilad GM, 1996, NEUROSCI LETT, V216, P33; Gilad VH, 1996, BRAIN RES, V724, P141, DOI 10.1016/0006-8993(96)00287-9; HAAS CA, 1993, NEUROSCIENCE, V53, P91, DOI 10.1016/0306-4522(93)90287-P; Hirata K, 2002, MICROSC RES TECHNIQ, V57, P541, DOI 10.1002/jemt.10108; NACHEMSON AK, 1985, SCAND J PLAST RECONS, V19, P255, DOI 10.3109/02844318509074512; National Research Council of The National Academies, 2011, GUIDE CARE USE LAB A; Oble DA, 2004, EXP NEUROL, V189, P105, DOI 10.1016/j.expneurol.2004.05.024; Pagnotta A, 2002, MICROSURG, V22, P300, DOI 10.1002/micr.10053; PFEIFFER B, 1981, H-S Z PHYSIOL CHEM, V362, P1331, DOI 10.1515/bchm2.1981.362.2.1331; Raasch W, 2001, BRIT J PHARMACOL, V133, P755, DOI 10.1038/sj.bjp.0704153; Regunathan S, 2000, J NEUROCHEM, V74, P2201, DOI 10.1046/j.1471-4159.2000.0742201.x; Siemionow M, 2004, NEUROL RES, V26, P218, DOI 10.1179/016164104225013860; SPECTOR JG, 1995, ANN OTO RHINOL LARYN, V104, P875, DOI 10.1177/000348949510401110; SPECTOR JG, 1991, LARYNGOSCOPE, V101, P537; Spector JG, 2000, LARYNGOSCOPE, V110, P660, DOI 10.1097/00005537-200004000-00023; Stoll G, 1999, BRAIN PATHOL, V9, P313; SUN MK, 1995, CLIN EXP HYPERTENS, V17, P115, DOI 10.3109/10641969509087059; TETZLAFF W, 1985, EXP NEUROL, V89, P679, DOI 10.1016/0014-4886(85)90016-0; Yian CH, 2001, LARYNGOSCOPE, V111, P786, DOI 10.1097/00005537-200105000-00006	28	1	1	0	3	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	0022-2151	1748-5460		J LARYNGOL OTOL	J. Laryngol. Otol.	MAR	2017	131	3					221	226		10.1017/S0022215117000147			6	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	EM7KB	WOS:000395488800006	28122652				2022-02-06	
J	Twedt, M; Pfeifer, C; Thorell, W; Bashford, G				Twedt, Max; Pfeifer, Chase; Thorell, William; Bashford, Greg			Measuring Hemodynamic Changes in the Ophthalmic Artery During Applied Force for Noninvasive Intracranial Pressure Monitoring: Test Results in a Porcine Model	MILITARY MEDICINE			English	Article							CEREBROSPINAL-FLUID PRESSURE; TRANSCRANIAL DOPPLER	Possible traumatic brain injury victims would greatly benefit from a handheld, noninvasive intracranial pressure (ICP) monitoring tool, which a medic could operate in a remote area. Such a device would also benefit the transport of injured soldiers during en route medical care and critical care air transport. This study demonstrates the use of noninvasive blood flow measurements in the eye by ultrasound as a proxy for ICP. ICP was artificially raised in a porcine model and resultant blood flow change in the ophthalmic artery was measured. In addition, the ultrasound transducer itself was used to compress the eye further altering ophthalmic hemodynamics. Blood flow velocities at a range of applied forces and ICP were compared. It was found that 3.25 N of force applied to the cornea was sufficient to produce significant changes in ophthalmic artery blood dynamics regardless of the ICP value. Specifically, the change in resistivity index (RI) and pulsatility index (PI) as force was applied to the cornea correlated with ICP levels. In multiple animal experiments, the magnitude of PI/RI percent change was inversely related to differences in ICP. Force applied to the cornea at baseline ICP resulted in a 15% increase in PI/RI. Results indicate that as ICP increases, the percent change in PI/RI while force is applied decreases. The consistency of data collected indicates that a trend line developed with this data and from similar experiments could be used as a predictive measurement of ICP.	[Twedt, Max; Bashford, Greg] Univ Nebraska, Dept Biol Syst Engn, Biomed Imaging & Biosignal Anal Lab, 230 Chase Hall, Lincoln, NE 68583 USA; [Pfeifer, Chase] Ctr Adv Surg Technol, 986245 Nebraska Med Ctr, Omaha, NE 68198 USA; [Thorell, William] Univ Nebraska Med Ctr, Cerebrovasc Neurosurg, 42nd & Emile St, Omaha, NE 68198 USA		Twedt, M (corresponding author), Univ Nebraska, Dept Biol Syst Engn, Biomed Imaging & Biosignal Anal Lab, 230 Chase Hall, Lincoln, NE 68583 USA.				NASA Nebraska Space Grant Consortium; Layman Fund; University of Nebraska Foundation; University of Nebraska Medical Center Core Facilities Grant	This work was funded by NASA Nebraska Space Grant Consortium; Layman Fund, University of Nebraska Foundation; and University of Nebraska Medical Center Core Facilities Grant.	Ashwini C. A., 2008, NEUROANATOMY, V7, P54; Bhatia A, 2007, INTENS CARE MED, V33, P1263, DOI 10.1007/s00134-007-0678-z; Bruce BB, 2014, J NEURO-OPHTHALMOL, V34, P288, DOI 10.1097/WNO.0000000000000153; de Riva N, 2012, NEUROCRIT CARE, V17, P58, DOI 10.1007/s12028-012-9672-6; GOSLING RG, 1974, P ROY SOC MED, V67, P447, DOI 10.1177/00359157740676P113; Hawks JA, 2015, J MED DEVICES, V9, DOI 10.1115/1.4030119; Jonas JB, 2012, CLIN EXP OPHTHALMOL, V40, pE233, DOI 10.1111/j.1442-9071.2011.02625.x; Ketchem T, 2015, J MED DEVICES, V9, DOI 10.1115/1.4029810; Miller MM, 2009, J CHILD NEUROL, V24, P30, DOI 10.1177/0883073808321050; Morgan WH, 2008, J GLAUCOMA, V17, P408, DOI 10.1097/IJG.0b013e31815c5f7c; Nusbaum DM, 2011, AVIAT SPACE ENVIR MD, V82, P1080, DOI 10.3357/ASEM.3137.2011; Pourcelot L, 1974, VELOCIMETRIE ULTRASO, V34, P213; Ragauskas A, 2012, NEUROLOGY, V78, P1684, DOI 10.1212/WNL.0b013e3182574f50; Ren RJ, 2010, OPHTHALMOLOGY, V117, P259, DOI 10.1016/j.ophtha.2009.06.058; Taibbi G, 2013, SURV OPHTHALMOL, V58, P155, DOI 10.1016/j.survophthal.2012.04.002; Yang Y, 2010, MED HYPOTHESES, V74, P31, DOI 10.1016/j.mehy.2009.08.024	16	1	1	0	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR	2017	182			1			72	77		10.7205/MILMED-D-16-00198			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER6VN	WOS:000398947100013	28291455	Bronze			2022-02-06	
J	Yeldon, J; Pitter, R				Yeldon, Jacqueline; Pitter, Robert			Making Sense of Pain in Boys' Competitive Minor Ice Hockey	BOYHOOD STUDIES-AN INTERDISCIPLINARY JOURNAL			English	Article						ice hockey; injury; pain; sense-making; sport ethic; youth sport	INJURY RATES; SPORT; SOCIALIZATION; HEAD; BODY; HURT; PARTICIPATION; NORMALIZATION; METAANALYSIS; TOLERANCE	The study on which this article is built identifies psychosocial factors that come into play when boys experience pain and, more specifically, how these particular boys attribute meaning to such experience. Twelve male competitive ice hockey players aged nine to thirteen years participated in small focus-group sessions. Pain from exertion/ fatigue, acute pain, chronic pain, and pain from a head injury were examined. The older boys had a more advanced understanding of pain but all the boys engaged in sense-making strategies to play through pain. They were all well informed about concussions and many exercised a greater level of caution towards symptoms of a head injury compared to chronic pain or discomfort from exertion. Educating young athletes and adults about the implications of pain and injury both in and beyond the sport itself may help deconstruct the false sense of invulnerability associated with being a competitive athlete.	[Pitter, Robert] Acadia Univ, Sch Kinesiol, Wolfville, NS, Canada			yeldon89@gmail.com; robert.pitter@acadiau.ca					Bach Greg, 2008, PARKS RECREATION, V43, P24; Bay R. C., 2010, ATHLETIC TRAINING SP, V2, P208, DOI DOI 10.3928/19425864-20100524-03; Chou R, 2009, LANCET, V373, P463, DOI 10.1016/S0140-6736(09)60172-0; Cosh Colby, 2013, MACLEANS MAGAZINE; Craig KD, 2010, J PAIN, V11, P101, DOI 10.1016/j.jpain.2009.08.008; CURRY TJ, 1994, SOCIOL SPORT J, V11, P195, DOI 10.1123/ssj.11.2.195; CURRY TJ, 1993, SYMB INTERACT, V16, P273, DOI 10.1525/si.1993.16.3.273; Cusimano MD, 2017, CLIN J SPORT MED, V27, P375, DOI 10.1097/JSM.0000000000000372; Darling SR, 2011, BRIT J SPORT MED, V45, P492, DOI 10.1136/bjsm.2009.063693; Docherty S, 1999, RES NURS HEALTH, V22, P177, DOI 10.1002/(SICI)1098-240X(199904)22:2<177::AID-NUR9>3.3.CO;2-8; Emery CA, 2006, CLIN J SPORT MED, V16, P20, DOI 10.1097/01.jsm.0000184638.72075.b7; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Esteve R, 2012, CHILD CARE HLTH DEV, V38, P441, DOI 10.1111/j.1365-2214.2011.01297.x; Fenton LT, 2010, RES Q EXERCISE SPORT, V81, P212; GAFFNEY A, 1986, PAIN, V26, P105, DOI 10.1016/0304-3959(86)90177-6; HARBECK C, 1992, CHILD DEV, V63, P138, DOI 10.1111/j.1467-8624.1992.tb03602.x; HARRIS AC, 1993, CHILD DEV; Howe Gordie, 2015, MR HOCKEY MY STORY; Howe P. D., 2001, International Review for the Sociology of Sport, V36, P289, DOI 10.1177/101269001036003003; HUGHES R, 1991, SOCIOL SPORT J, V8, P307, DOI 10.1123/ssj.8.4.307; JAREMKO ME, 1981, PSYCHOL REC, V31, P265, DOI 10.1007/BF03394739; Kelly KD, 2001, CLIN J SPORT MED, V11, P77, DOI 10.1097/00042752-200104000-00003; Kortesluoma Riitta-Liisa, 2004, J Child Health Care, V8, P210, DOI 10.1177/1367493504045822; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Malcom NL, 2006, J CONTEMP ETHNOGR, V35, P495, DOI 10.1177/0891241605283571; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Messner M. A, 2003, TAKING FIELD WOMEN M; Messner MA, 2014, SOCIOL SPORT J, V31, P102, DOI 10.1123/ssj.2013-0111; Nemeth RL, 2005, CHILD CARE HLTH DEV, V31, P615, DOI 10.1111/j.1365-2214.2005.00530.x; Nixon H. L. II, 1992, Journal of Sport and Social Issues, V16, P127, DOI 10.1177/019372359201600208; NIXON HL, 1993, SOCIOL SPORT J, V10, P183, DOI 10.1123/ssj.10.2.183; Pike ECJ, 2004, SPORTING BODIES DAMA, P151; Roderick M., 2000, International Review for the Sociology of Sport, V35, P165, DOI 10.1177/101269000035002003; RYAN ED, 1966, PERCEPT MOTOR SKILL, V22, P383, DOI 10.2466/pms.1966.22.2.383; Safai P, 2003, SOCIOL SPORT J, V20, P127, DOI 10.1123/ssj.20.2.127; Singer Rhonda L, 2004, SPORTING BODIES DAMA, P223; Stafford A, 2013, CHILD ABUSE REV, V22, P287, DOI 10.1002/car.2289; STUART MJ, 1995, MAYO CLIN PROC, V70, P350, DOI 10.4065/70.4.350; TAJETFOXELL B, 1995, BRIT J SPORT MED, V29, P31, DOI 10.1136/bjsm.29.1.31; Tesarz J, 2012, PAIN, V153, P1253, DOI 10.1016/j.pain.2012.03.005; Theberge N, 2008, SOCIOL SPORT J, V25, P206, DOI 10.1123/ssj.25.2.206; Willer B, 2005, MED SCI SPORT EXER, V37, P1658, DOI 10.1249/01.mss.0000181839.86170.06; Young, 2004, SPORTING BODIES DAMA, P59; Young K., 1995, Journal of Sport and Social Issues, V19, P45, DOI 10.1177/019372395019001004; YOUNG K, 1994, SOCIOL SPORT J, V11, P175, DOI 10.1123/ssj.11.2.175; Young K., 2012, SPORT VIOLENCE SOC	46	1	1	0	2	BERGHAHN JOURNALS	BROOKLYN	20 JAY ST, SUITE 512, BROOKLYN, NY 11201 USA	2375-9240	2375-9267		BOYHOOD STUD	Boyhood Stud.	SPR	2017	10	1			SI		4	21		10.3167/bhs.2017.100102			18	Social Sciences, Interdisciplinary	Emerging Sources Citation Index (ESCI)	Social Sciences - Other Topics	FN0EU	WOS:000415651900002					2022-02-06	
J	Zaman, A; Dubiel, R; Driver, S; Bennett, M; Diggs, V; Callender, L				Zaman, Anwar; Dubiel, Randi; Driver, Simon; Bennett, Monica; Diggs, Vincent; Callender, Librada			Seizure Prophylaxis Guidelines Following Traumatic Brain Injury: An Evaluation of Compliance	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						acute; adherence; epilepsy; guidelines; head injury; institutional; pharmaceutical; posttraumatic; protocol; rehabilitation	LATE POSTTRAUMATIC SEIZURES; PREVENTION; PHENYTOIN; RISK	Objective: To determine degree of adherence to guidelines for seizure prophylaxis following traumatic brain injury (TBI). Setting: Tertiary care level 1 trauma center and affiliated inpatient rehabilitation facility. Participants: A total of 173 individuals with TBI who required inpatient rehabilitation from January 1, 2007, to December 31, 2013. Design: Retrospective medical record review. Main Measures: Overutilization rate of prophylactic antiepileptic drugs (AEDs); failure to stop rate of AED utilization upon admission to and during inpatient rehabilitation; and duration of overutilization. Results: Of the 173 participants included, 77 were started on seizure prophylaxis at hospital presentation and 96 were not. Of the 77 participants, 11 had a posttraumatic seizure. Of the 66 remaining, 18 participants (10.4%) were continued on AEDs for more than 7 days after injury. Of these 18 participants, 12 were continued on AEDs without indication upon admission to inpatient rehabilitation. Finally, 8 of the 12 were continued on AEDs at discharge from rehabilitation, resulting in a failure to stop rate of 66.67%. Conclusion: Despite existing guidelines for stopping seizure prophylaxis after TBI, some patients remain on AEDs and may be inappropriately exposed to possible medication side effects. These findings highlight the importance of communication at the time of rehabilitation transfer and the need for ongoing education about AED guidelines.	[Zaman, Anwar; Dubiel, Randi; Driver, Simon; Callender, Librada] Baylor Inst Rehabil, Dept Phys Med & Rehabil, 909 N Washington Ave, Dallas, TX 75246 USA; [Bennett, Monica; Diggs, Vincent] Baylor Scott & White Hlth, Off Chief Qual Officer, Dallas, TX USA		Driver, S (corresponding author), Baylor Inst Rehabil, Dept Phys Med & Rehabil, 909 N Washington Ave, Dallas, TX 75246 USA.	sjdriver@bir-rehab.com		driver, simon/0000-0003-2356-432X	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90DP0045-01-0]; Ginger Murchison Foundation	The contents of this article were developed in part under a grant from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR grant no. 90DP0045-01-0). NIDILRR is a center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The project was also supported by the Ginger Murchison Foundation. The authors thank Samantha Cleveland (clinical research associate) and Shayan Noorani (graduate student intern) for their help extracting data.	Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS83; Bushnik T, 2012, J HEAD TRAUMA REHAB, V27, pE36, DOI 10.1097/HTR.0b013e318273375c; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Choosing Wisely, PROM CONV PROV PAT; Ciric IS, 2013, WORLD NEUROSURG, V80, P691, DOI 10.1016/j.wneu.2012.10.021; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; DIKMEN SS, 1991, JAMA-J AM MED ASSOC, V265, P1271, DOI 10.1001/jama.265.10.1271; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Haltiner AM, 1997, ARCH PHYS MED REHAB, V78, P835, DOI 10.1016/S0003-9993(97)90196-9; Klein P, 2012, ARCH NEUROL-CHICAGO, V69, P1290, DOI 10.1001/archneurol.2012.445; Kruer RM, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.11.020; Kruer RM, 2013, CRIT CARE, V28; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; YABLON SA, 1993, ARCH PHYS MED REHAB, V74, P983	14	1	1	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2017	32	2					E13	E17		10.1097/HTR.0000000000000243			5	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EN3YU	WOS:000395944700001	27323218				2022-02-06	
J	Hedberg, AL; Pauksens, K; Enblad, P; Soderberg, J; Johansson, B; Kayhty, H; Sjolin, J				Hedberg, Anna Ljunghill; Pauksens, Karlis; Enblad, Per; Soderberg, Jessika; Johansson, Bjorn; Kayhty, Helena; Sjolin, Jan			Pneumococcal polysaccharide vaccination administered early after neurotrauma or neurosurgery	VACCINE			English	Article						Pneumococcal polysaccharide vaccine; Neurotrauma; Neurosurgery	CONJUGATE VACCINE; ADULTS; SEPSIS; IMMUNOGENICITY; RESPONSES; TRAUMA; SAFETY; AGE; IMMUNOSUPPRESSION; MENINGITIS	Objectives: Pneumococcal vaccination is recommended to lower the risk of posttraumatic meningitis, and early vaccination may be of importance. After both trauma and central nervous system injury, immune suppression may occur, which could affect T-cell function and the response to T-cell dependent vaccines. We therefore aimed to investigate the response to early vaccination with a T-cell independent pneumococcal polysaccharide vaccine (PPSV). Methods: Thirty-three patients with basilar skull fracture and 23 patients undergoing transsphenoidal pituitary gland surgery were vaccinated with PPSV within 10 days after neurotrauma or neurosurgery. Twenty-nine neurosurgical patients vaccinated >= 3 weeks after neurotrauma or neurosurgery served as controls. Serotype-specific anti-polysaccharide binding IgG antibody levels to serotypes 4, 6B, 9V, 14, 18C, 19F and 23F were determined by enzyme immunoassay. Results: The vaccination was safe and a highly significant antibody response was found against all serotypes in all groups (p < 0.001 for each of the serotypes). There were no differences between groups or in the group by time interaction in any of the serotypes. After early and late vaccination, protective levels were found in >80% for serotypes 9V, 14, 18C, 19F and 23F and in 70% and 50% for serotypes 6B and 4, respectively. Conclusion: Patients vaccinated with PPSV within 10 days after neurotrauma or neurosurgery respond similarly to those vaccinated after >= 3 weeks, indicating that PPSV can be administered early after neurotrauma or neurosurgery. (C) 2016 Elsevier Ltd. All rights reserved.	[Hedberg, Anna Ljunghill; Pauksens, Karlis; Sjolin, Jan] Uppsala Univ, Infect Dis Sect, Dept Med Sci, SE-75185 Uppsala, Sweden; [Enblad, Per] Uppsala Univ, Sect Neurosurg, Dept Neurosci, Uppsala, Sweden; [Soderberg, Jessika] Uppsala Univ, Infect Dis Sect, Dept Med Sci, Uppsala, Sweden; [Johansson, Bjorn] Uppsala Univ, Sect Rehabil Med, Dept Neurosci, Uppsala, Sweden; [Kayhty, Helena] Natl Inst Hlth & Welf, Helsinki, Finland		Hedberg, AL (corresponding author), Uppsala Univ, Infect Dis Sect, Dept Med Sci, SE-75185 Uppsala, Sweden.	anna.ljunghill_hedberg@medsci.uu.se			Research and Development funds of Uppsala University Hospital; Olinder-Nielsen Family fund	This work was supported by Research and Development funds of Uppsala University Hospital and the Olinder-Nielsen Family fund.	[Anonymous], 2015, FOLKHALSOMYNDIGHETEN; Bryant KA, 2015, VACCINE, V33, P5854, DOI 10.1016/j.vaccine.2015.08.080; CHEADLE WG, 1993, J TRAUMA, V35, P844, DOI 10.1097/00005373-199312000-00007; Cohen-Inbar OKA, 2015, J NEUROSURG SCI; de Roux A, 2008, CLIN INFECT DIS, V46, P1015, DOI 10.1086/529142; Eftekhar B, 2004, J NEUROSURG, V101, P757, DOI 10.3171/jns.2004.101.5.0757; Friedman JA, 2001, WORLD J SURG, V25, P1062, DOI 10.1007/s00268-001-0059-7; Gladstone RA, 2015, VACCINE, V33, P2015, DOI 10.1016/j.vaccine.2015.03.012; GLARNER H, 1994, J TRAUMA, V36, P198, DOI 10.1097/00005373-199402000-00009; Goldblatt D, 2009, CLIN INFECT DIS, V49, P1318, DOI 10.1086/606046; HAND WL, 1970, ANN INTERN MED, V73, P862, DOI 10.7326/0003-4819-73-5-862; Hedberg AL, 2015, J INFECT; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Jackson LA, 2013, VACCINE, V31, P3585, DOI 10.1016/j.vaccine.2013.05.010; Kasten KR, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-4; Kobayashi M, 2015, MMWR-MORBID MORTAL W, V64, P944, DOI 10.15585/mmwr.mm6434a4; Lee H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-60; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; MMWR, 2012, MMWR MORBIDITY MORTA, V61, P816; Musher DM, 2008, J INFECT DIS, V198, P1019, DOI 10.1086/591629; Musher DM, 2011, HUM VACCINES, V7, P919, DOI 10.4161/hv.7.9.15996; Mylona V, 2011, PANCREATOLOGY, V11, P475, DOI 10.1159/000329460; Pletz MW, 2008, INT J ANTIMICROB AG, V32, P199, DOI 10.1016/j.ijantimicag.2008.01.021; QUATTROCCHI K B, 1991, Neurological Research, V13, P13; Ratilal BO, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004884, 10.1002/14651858.CD004884.pub3]; Samii M, 2002, NEUROL RES, V24, P147, DOI 10.1179/016164102101199693; Santos SF, 2011, ACTA MEDICA PORT, V24, P391; Siber GR, 2007, VACCINE, V25, P3816, DOI 10.1016/j.vaccine.2007.01.119; Simell B, 2008, CLIN VACCINE IMMUNOL, V15, P1391, DOI 10.1128/CVI.00110-08; SMIT P, 1977, JAMA-J AM MED ASSOC, V238, P2613, DOI 10.1001/jama.238.24.2613; Song JY, 2013, J INFECT CHEMOTHER, V19, P412, DOI 10.1007/s10156-013-0601-1; Wolach B, 2001, J NEUROSURG, V94, P706, DOI 10.3171/jns.2001.94.5.0706; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354	35	1	1	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0264-410X	1873-2518		VACCINE	Vaccine	FEB 7	2017	35	6					909	915		10.1016/j.vaccine.2016.12.065			7	Immunology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Research & Experimental Medicine	EK8SX	WOS:000394196000010	28069358				2022-02-06	
J	Borsari, B; Apodaca, TR; Yurasek, A; Monti, PM				Borsari, Brian; Apodaca, Timothy R.; Yurasek, Ali; Monti, Peter M.			Does mental status impact therapist and patient communication in emergency department brief interventions addressing alcohol use?	JOURNAL OF SUBSTANCE ABUSE TREATMENT			English	Article						Motivational interviewing; Emergency departments; Mental status; Alcohol use; Brief intervention	TRAUMATIC BRAIN-INJURY; RANDOMIZED CONTROLLED-TRIAL; CLIENT CHANGE TALK; CARE; LANGUAGE; CONSUMPTION; METAANALYSIS; ADOLESCENTS; MECHANISMS; DISORDERS	Motivational interviewing (MI) is often incorporated into screening, brief intervention, and referral to treatment (SBIRT) interventions in critical care settings to address alcohol and other drug use. However, cognitive status has been linked to differential response to MI sessions in emergency department (ED) settings. The current study examined one possible explanation for this differential response: whether higher versus lower mental status impacts patient response to clinician statements during MI sessions conducted in an ED. Participants were 126 patients receiving an MI-based single-session alcohol brief intervention, and 13 therapists who provided treatment. Participants completed a mental status exam (MSE) as part of the screening process. Intervention sessions were audio-taped, and transcribed and coded using the Motivational Interviewing Skills Code (MISC 2.0; Miller, Moyers, Ernst, & Amrhein, 2003). The MISC 2.0 coded therapist behaviors that are related to the use of motivational interviewing, and patient language reflecting movement toward (change talk) or away from (sustain talk) changing personal alcohol use. Overall, patients responded in a similar manner to therapist MI behaviors regardless of high versus low level of mental functioning at the time of the intervention. Group differences emerged on patient response to only three specific therapist skills: giving information, open questions, and complex reflection. Thus, the differential effects of SBIRT in critical care settings do not appear to be a result of differences in the therapist and patient communication process. (C) 2016 Elsevier Inc. All rights reserved.	[Borsari, Brian] San Francisco VA Med Ctr, Mental Hlth Serv 116B, 4150 Clement St, San Francisco, CA 94121 USA; [Borsari, Brian; Yurasek, Ali; Monti, Peter M.] Brown Univ, Dept Behav & Social Sci, Box G-S121-4, Providence, RI 02912 USA; [Borsari, Brian; Yurasek, Ali; Monti, Peter M.] Brown Univ, Ctr Alcohol & Addict Studies, Box G-S121-4, Providence, RI 02912 USA; [Borsari, Brian] Univ Calif San Francisco, Dept Psychiat, 401 Parnassus Ave, San Francisco, CA 94143 USA; [Apodaca, Timothy R.] Childrens Mercy Kansas City, 2401 Gillham Rd, Kansas City, MO 64108 USA; [Apodaca, Timothy R.] Univ Missouri, Kansas City Sch Med, 3901 Rainbow Blvd, Kansas City, KS 66103 USA		Borsari, B (corresponding author), San Francisco VA Med Ctr 116B, Bldg 8,Room 108,4150 Clement St, San Francisco, CA 94121 USA.	Brian.Borsari.sfva.ucsf@gmail.com		BORSARI, BRIAN/0000-0002-1491-7771	National Institute on Alcohol Abuse and AlcoholismUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA017427, K23AA015595, K05AA019681]; National Institute on Drug AbuseUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [T32 DA016184]; VISN1 Career Development Award [V1CDA2012-18]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [K23AA015595, K05AA019681, R01AA009892, R01AA017427] Funding Source: NIH RePORTER	This manuscript was the result of a symposium presented at the Research Society on Alcoholism in June 2014 (Drs. Sayko-Adams, Organizer/Chair, Dr. Douglas Zatzick, Chair, Dr. Alana Conti, and Dr. Dennis Donovan, Discussant). This work was supported by National Institute on Alcohol Abuse and Alcoholism grants R01AA017427 to B. Borsari K23AA015595 to T. Apodaca, K05AA019681 to P. Monti, National Institute on Drug Abuse grant T32 DA016184 to A. Yurasek, and VISN1 Career Development Award V1CDA2012-18 to B. Borsari. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute on Alcohol Abuse and Alcoholism or the National Institutes of Health, or the Department of Veterans Affairs or the United States Government. The authors would like to thank the patients and therapists from the parent intervention trial who allowed their audiotapes to be utilized for this study. We also wish to acknowledge the efforts of our diligent team of coders.	Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; American College of Surgeons U.S. Department of Health and Human Services & Department of Transportation, 2010, ALC SCREEN BRIEF INT; Amrhein PC, 2003, J CONSULT CLIN PSYCH, V71, P862, DOI 10.1037/0022-006X.71.5.862; Apodaca TR, 2016, J SUBST ABUSE TREAT, V61, P60, DOI 10.1016/j.jsat.2015.09.001; Apodaca TR, 2013, J CONSULT CLIN PSYCH, V81, P35, DOI 10.1037/a0030881; Apodaca TR, 2009, ADDICTION, V104, P705, DOI 10.1111/j.1360-0443.2009.02527.x; Bakeman R., 2011, SEQUENTIAL ANAL OBSE; Barnett E, 2014, PSYCHOL ADDICT BEHAV, V28, P1212, DOI 10.1037/a0036227; Bombardier CH, 1999, REHABIL PSYCHOL, V44, P52, DOI 10.1037/0090-5550.44.1.52; Brooke P, 1999, INT J GERIATR PSYCH, V14, P936, DOI 10.1002/(SICI)1099-1166(199911)14:11<936::AID-GPS39>3.3.CO;2-T; Cherpitel CJ, 2012, J STUD ALCOHOL DRUGS, V73, P454, DOI 10.15288/jsad.2012.73.454; CHERPITEL CJ, 1994, DRUG ALCOHOL DEPEN, V36, P167, DOI 10.1016/0376-8716(94)90142-2; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Cohen E, 2007, DRUG ALCOHOL DEPEN, V86, P214, DOI 10.1016/j.drugalcdep.2006.06.008; Cox WM, 2003, J ADDICT DIS, V22, P93, DOI 10.1300/J069v22n01_07; Dobber J, 2015, J PSYCHOSOM RES, V78, P268, DOI 10.1016/j.jpsychores.2014.10.010; Ewing SWF, 2016, BEHAV BRAIN RES, V297, P359, DOI 10.1016/j.bbr.2015.09.041; Ewing SWF, 2014, ADDICT BEHAV, V39, P1904, DOI 10.1016/j.addbeh.2014.07.035; Ewing SWF, 2013, PSYCHOL ADDICT BEHAV, V27, P510, DOI 10.1037/a0029767; Ewing SWF, 2011, J STUD ALCOHOL DRUGS, V72, P903, DOI 10.15288/jsad.2011.72.903; Field CA, 2010, ALCOHOL CLIN EXP RES, V34, P2004, DOI 10.1111/j.1530-0277.2010.01297.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gaume J, 2008, ADDICTION, V103, P1793, DOI 10.1111/j.1360-0443.2008.02337.x; Gaume J, 2010, J SUBST ABUSE TREAT, V39, P272, DOI 10.1016/j.jsat.2010.06.010; Grant BF, 2004, DRUG ALCOHOL DEPEN, V74, P223, DOI 10.1016/j.drugalcdep.2004.02.004; Greenfield TK, 1999, ADDICTION, V94, P1735, DOI 10.1046/j.1360-0443.1999.9411173510.x; HILTON ME, 1989, BRIT J ADDICT, V84, P1085; Houck J. M, 2010, ELICIT MISC 2 UNPUB; Houck JM, 2013, PSYCHOL ADDICT BEHAV, V27, P489, DOI 10.1037/a0029896; Hsieh MY, 2012, NEUROPSYCHOL REHABIL, V22, P585, DOI 10.1080/09602011.2012.678860; Lundahl B, 2013, PATIENT EDUC COUNS, V93, P157, DOI 10.1016/j.pec.2013.07.012; Magill M, 2014, J CONSULT CLIN PSYCH, V82, P973, DOI 10.1037/a0036833; Martino S, 2002, J SUBST ABUSE TREAT, V23, P297, DOI 10.1016/S0740-5472(02)00295-7; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; McHugh ML, 2009, BIOCHEM MEDICA, V19, P120; Medley AR, 2010, NEUROPSYCHOL REHABIL, V20, P481, DOI 10.1080/09602010903529610; Miller W, 2013, HELPING PEOPLE CHANG; Miller W. R., 2003, MOTIVATIONAL INTERVI; Miller W.R., 1995, PROJECT MATCH MONOGR, V4; Monti PM, 2007, ADDICTION, V102, P1234, DOI 10.1111/j.1360-0443.2007.01878.x; Monti PM, 2014, J CONSULT CLIN PSYCH, V82, P936, DOI 10.1037/a0037658; Monti PM, 1999, J CONSULT CLIN PSYCH, V67, P989, DOI 10.1037/0022-006X.67.6.989; Moyers TB, 2006, J SUBST ABUSE TREAT, V30, P245, DOI 10.1016/j.jsat.2005.12.003; Nilsen P, 2008, J SUBST ABUSE TREAT, V35, P184, DOI 10.1016/j.jsat.2007.09.008; Romano M, 2016, PSYCHOTHER RES, V26, P220, DOI 10.1080/10503307.2014.954154; Sander AM, 2012, J HEAD TRAUMA REHAB, V27, P319, DOI 10.1097/HTR.0b013e318269838c; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Tweedly L, 2012, J HEAD TRAUMA REHAB, V27, P331, DOI 10.1097/HTR.0b013e318262200a; Wirtz P. W., 2001, PROJECT MATCH HYPOTH, V8; Zatzick D, 2014, ADDICTION, V109, P754, DOI 10.1111/add.12492	50	1	1	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0740-5472			J SUBST ABUSE TREAT	J. Subst. Abus. Treat.	FEB	2017	73						1	8		10.1016/j.jsat.2016.10.002			8	Psychology, Clinical; Substance Abuse	Social Science Citation Index (SSCI)	Psychology; Substance Abuse	EJ5OJ	WOS:000393267300001	28017179	Green Published, Green Accepted			2022-02-06	
J	Brenner, S; Eich, C; Rellensmann, G; Schuhmann, MU; Nicolai, T; Hoffmann, F				Brenner, S.; Eich, C.; Rellensmann, G.; Schuhmann, M. U.; Nicolai, T.; Hoffmann, F.			Recommendation on Temperature Management after Cardiopulmonary Arrest and severe Traumatic Brain Injury in Childhood beyond the Neonatal Period Statement of the German Society for Neonatology and Pediatric Intensive Care Medicine (GNPI) and the scientific Working Group for Paediatric Anaesthesia (WAKKA) of the German Society of Anaesthesiology and Intensive Care (DGAI)	ANAESTHESIST			German	Article							WHOLE-BODY HYPOTHERMIA; RESUSCITATION COUNCIL GUIDELINES; HYPOXIC-ISCHEMIC ENCEPHALOPATHY; 2015 INTERNATIONAL CONSENSUS; HOSPITAL CARDIAC-ARREST; THERAPEUTIC HYPOTHERMIA; MODERATE HYPOTHERMIA; PERINATAL ASPHYXIA; INTRACRANIAL HYPERTENSION; SYSTEMIC HYPOTHERMIA	The available data on the effectiveness of therapeutic hypothermia in different patient groups are heterogeneous. Although the benefits have been proven for some collectives, recommendations for the use of hypothermia treatment in other groups are based on less robust data and conclusions by analogy. This article gives a review of the current evidence of temperature management in all age groups and based on this state of knowledge, recommends active temperature management with the primary aim of strict normothermia (36-36.5 A degrees C) for 72 hours after cardiopulmonary arrest or severe traumatic brain injury for children beyond the neonatal period.	[Brenner, S.] Tech Univ Dresden, Univ Klinikum Carl Gustav Carus, Neonatol & Padiatr Intens Med, Klin Kinder & Jugendmed, Fetscherstr 74, D-01307 Dresden, Germany; [Eich, C.] Kinder & Jugendkrankenhaus BULT, Abt Anasthesie Kinderintensiv & Notfallmed, Hannover, Germany; [Rellensmann, G.] Univ Klinikum Munster, Neonatol & Padiatr Intens Med, Klin Kinder & Jugendmed Allgemeine Padiatrie, Munster, Germany; [Schuhmann, M. U.] Univ Klinikum Tubingen, Bereich Padiatr Neurochirurg, Klin Neurochirurg, Tubingen, Germany; [Nicolai, T.; Hoffmann, F.] Klinikum Univ Munchen, Kinderklin & Kinderpoliklin Dr Haunerschen Kinder, Interdisziplinare Kinderintensivstat, Munich, Germany		Brenner, S (corresponding author), Tech Univ Dresden, Univ Klinikum Carl Gustav Carus, Neonatol & Padiatr Intens Med, Klin Kinder & Jugendmed, Fetscherstr 74, D-01307 Dresden, Germany.	sebastian.brenner@uniklinikum-dresden.de					Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Akisu M, 2003, PROSTAG LEUKOTR ESS, V69, P45, DOI 10.1016/S0952-3278(03)00055-3; Andrews PJD, 2016, NEW ENGL J MED, V374, P1385, DOI 10.1056/NEJMc1600339; Arrich J, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010570.pub2; Arrich J, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004128.pub4; Azzopardi D, 2014, NEW ENGL J MED, V371, P140, DOI 10.1056/NEJMoa1315788; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; Beca J, 2015, CRIT CARE MED, V43, P1458, DOI 10.1097/CCM.0000000000000947; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bistritz JF, 2015, PEDIATR EMERG CARE, V31, P296, DOI 10.1097/PEC.0000000000000407; Biswas AK, 2002, CRIT CARE MED, V30, P2742, DOI 10.1097/00003246-200212000-00020; Bonds BW, 2015, BRAIN INJURY, V29, P1642, DOI 10.3109/02699052.2015.1075157; Bourdages M, 2010, PEDIATR CRIT CARE ME, V11, P408, DOI 10.1097/PCC.0b013e3181c51dea; Bustos R, 2012, AN PEDIATR, V76, P98, DOI 10.1016/j.anpedi.2011.07.017; Callaway CW, 2015, CIRCULATION, V132, pS84, DOI 10.1161/CIR.0000000000000273; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Diringer MN, 2004, CRIT CARE MED, V32, P559, DOI 10.1097/01.CCM.0000108868.97433.3F; Doherty DR, 2009, CIRCULATION, V119, P1492, DOI 10.1161/CIRCULATIONAHA.108.791384; Eicher DJ, 2005, PEDIATR NEUROL, V32, P18, DOI 10.1016/j.pediatrneurol.2004.06.015; Fink EL, 2010, PEDIATR CRIT CARE ME, V11, P66, DOI 10.1097/PCC.0b013e3181c58237; Flynn LMC, 2015, THER HYPOTHERMIA TEM, V5, P143, DOI 10.1089/ther.2015.0002; Gebhardt K, 2013, RESUSCITATION, V84, P1062, DOI 10.1016/j.resuscitation.2013.03.038; Georgiou AP, 2013, BRIT J ANAESTH, V110, P357, DOI 10.1093/bja/aes500; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Guillet R, 2012, PEDIATR RES, V71, P205, DOI 10.1038/pr.2011.30; Gunn AJ, 1997, J CLIN INVEST, V99, P248, DOI 10.1172/JCI119153; Gunn AJ, 1998, PEDIATRICS, V102, P885, DOI 10.1542/peds.102.4.885; Henker RA, 1998, NEUROSURGERY, V42, P1071, DOI 10.1097/00006123-199805000-00071; Hifumi T, 2016, J NEUROTRAUM, V33, P1047, DOI 10.1089/neu.2015.4033; Hoffmann F, 2011, DIVI, V2, P20; Holzer M, 2002, NEW ENGL J MED, V346, P549; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; Jacobs SE, 2011, ARCH PEDIAT ADOL MED, V165, P692, DOI 10.1001/archpediatrics.2011.43; Kessler SK, 2011, NEUROCRIT CARE, V14, P37, DOI 10.1007/s12028-010-9450-2; Kim F, 2014, JAMA-J AM MED ASSOC, V311, P45, DOI 10.1001/jama.2013.282173; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Kurinczuk JJ, 2010, EARLY HUM DEV, V86, P329, DOI 10.1016/j.earlhumdev.2010.05.010; Laptook AR, 2013, ANN NEUROL, V73, P520, DOI 10.1002/ana.23843; Leary M, 2013, RESUSCITATION, V84, P1056, DOI 10.1016/j.resuscitation.2012.11.003; Li H, 2009, J NEUROTRAUM, V26, P1905, DOI [10.1089/neu.2008.0828, 10.1089/neu.2008-0828]; Lin JJ, 2013, PEDIATR NEUROL, V48, P285, DOI 10.1016/j.pediatrneurol.2012.12.021; Lin ZL, 2006, J PERINATOL, V26, P180, DOI 10.1038/sj.jp.7211412; Ma CK, 2013, CHILD NERV SYST, V29, P979, DOI 10.1007/s00381-013-2076-x; Maconochie IK, 2015, RESUSCITATION, V95, P223, DOI 10.1016/j.resuscitation.2015.07.028; Madden LK, 2015, J NEUROSCI NURS, V47, P190, DOI 10.1097/JNN.0000000000000142; Maekawa T, 2015, J NEUROTRAUM, V32, P422, DOI 10.1089/neu.2013.3197; Maznyczka AM, 2015, HEART, V101, P1265, DOI 10.1136/heartjnl-2014-307411; Moler F, 2016, CRIT CARE MED S1, V44, P89; Moler FW, 2015, NEW ENGL J MED, V372, P1898, DOI 10.1056/NEJMoa1411480; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Nielsen N, 2011, INT J CARDIOL, V151, P333, DOI 10.1016/j.ijcard.2010.06.008; Nolan JP, 2015, RESUSCITATION, V95, P202, DOI 10.1016/j.resuscitation.2015.07.018; Rellensmann G, 2012, INTENSIVMED UP2DATE, V8, P193; Sadaka F, 2012, BRAIN INJURY, V26, P899, DOI 10.3109/02699052.2012.661120; Salonia R, 2010, J NEUROTRAUM, V27, P1819, DOI 10.1089/neu.2010.1402; Scholefield B, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009442.pub2; Scholefield BR, 2013, EMERG MED J, V30, P24, DOI 10.1136/emermed-2011-200348; Scholefield BR, 2010, ARCH DIS CHILD, V95, P796, DOI 10.1136/adc.2009.176735; Shankaran S, 2002, PEDIATRICS, V110, P377, DOI 10.1542/peds.110.2.377; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Shankaran S, 2014, JAMA-J AM MED ASSOC, V312, P2629, DOI 10.1001/jama.2014.16058; Shankaran S, 2012, NEW ENGL J MED, V366, P2085, DOI 10.1056/NEJMoa1112066; Simbruner G, 2010, PEDIATRICS, V126, pE771, DOI 10.1542/peds.2009-2441; Smith CM, 2011, PEDIATR CRIT CARE ME, V12, P449, DOI 10.1097/PCC.0b013e3181f390dd; Titus DJ, 2015, EXP NEUROL, V263, P254, DOI 10.1016/j.expneurol.2014.10.020; Topjian A, 2011, PEDIATR CRIT CARE ME, V12, pE127, DOI 10.1097/PCC.0b013e3181e28717; Wang H, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00307; Winters SA, 2013, RESUSCITATION, V84, P1245, DOI 10.1016/j.resuscitation.2013.03.027; Wyllie J, 2015, RESUSCITATION, V95, pE169, DOI 10.1016/j.resuscitation.2015.07.045; Zhou WH, 2010, J PEDIATR-US, V157, P367, DOI 10.1016/j.jpeds.2010.03.030	72	1	1	0	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0003-2417	1432-055X		ANAESTHESIST	Anaesthesist	FEB	2017	66	2					128	133		10.1007/s00101-016-0256-2			6	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	EL0NZ	WOS:000394320400008	28091756				2022-02-06	
J	Eilbacher, K				Eilbacher, Kristina			Nonpharmacological Treatment of Postconcussion Syndrome	PSYCHIATRIC ANNALS			English	Article							BRAIN-INJURY; CONCUSSION; SPORTS	A concussion is a mild form of traumatic brain injury that results in symptoms of headache, dizziness, fatigue, and concentration or memory difficulty. Postconcussion syndrome is defined as the persistence of these symptoms beyond 3 months. These initial symptoms can be debilitating and can lead to further physiological or psychological impairments such as depression, slowed processing speed, and gait imbalances. Although pharmacological interventions with antidepressants and stimulants may be useful, some patients may not accept or adequately respond to these interventions. A nonpharmacological approach to treating postconcussion syndrome uses a holistic approach to treat both the mind and body. Nonprescription therapies include vestibular rehabilitation for dizziness, vertigo, and balance/gait difficulties, as well as cognitive-behavioral therapy for both somatic and neuropsychiatric symptoms. The timing and ratio of rest versus rehabilitation through activity is case specific and a matter of ongoing clinical judgment given the uniqueness of each injury and the variety of postconcussive presentations.	[Eilbacher, Kristina] Duke Univ Hosp, Dept Neurosurg, 2301 Erwin Rd, Durham, NC 27710 USA		Eilbacher, K (corresponding author), Duke Univ Hosp, Dept Neurosurg, 2301 Erwin Rd, Durham, NC 27710 USA.	Keilbacher24@gmail.com					Bradbury CL, 2008, ARCH PHYS MED REHAB, V89, pS61, DOI 10.1016/j.apmr.2008.08.210; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; Kelly JP, 1997, NEUROLOGY, V48, P581; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Moran B, 2015, SOUTH MED J, V108, P553, DOI 10.14423/SMJ.0000000000000340; Mott TF, 2012, AM FAM PHYSICIAN, V86, P1045; Quintana LM, 2016, WORLD NEUROSURG, V91, P647, DOI 10.1016/j.wneu.2016.04.035; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267	9	1	1	0	6	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0048-5713	1938-2456		PSYCHIAT ANN	Psychiatr. Ann.	FEB	2017	47	2					88	91		10.3928/00485713-20161228-01			4	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	EP3HW	WOS:000397274400007					2022-02-06	
J	Elliott, CA; Ramaswamy, V; Jacob, FD; Sankar, T; Mehta, V				Elliott, Cameron A.; Ramaswamy, Vijay; Jacob, Francois D.; Sankar, Tejas; Mehta, Vivek			Early diffusion restriction of white matter in infants with small subdural hematomas is associateLd with delayed atrophy	CHILDS NERVOUS SYSTEM			English	Article						Non-accidental trauma; MRI; Traumatic brain injury; Pediatrics	ABUSIVE HEAD TRAUMA; SHAKEN-BABY SYNDROME; PARTIAL STATUS EPILEPTICUS; HYPOXIC-ISCHEMIC INJURY; YOUNG-CHILDREN; BRAIN-INJURY; WEIGHTED MRI; VULNERABILITY; DIAGNOSIS; PERFUSION	Background Traumatic brain injury (TBI) is a major cause of infant morbidity and mortality. In these patients, magnetic resonance imaging (MRI) including diffusion-weighted imaging (DWI) is the test of choice to describe the extent of microstructural injury. Case presentation and discussion In this case series, we describe novel acute and chronic MRI findings in four infants (6-19 months) with small, unilateral subdural hematomas in whom the etiology of head injury was suspicious for nonaccidental trauma (NAT). Acute (<1-week post-injury) DWI revealed extensive areas of restricted diffusion isolated to the cerebral white matter predominantly ipsilateral to the subdural hematoma. After prolonged pediatric intensive care treatment including subdural evacuation (n = 2) or decompressive craniectomy (n = 1), all patients survived albeit with significant motor and cognitive deficits. Delayed structural MRI (69- year post-injury) demonstrated cortical and subcortical atrophy well-correlated with areas of acute restricted diffusion. Conclusion These four cases highlight that relatively small subdural hematomas can be associated with extensive white matter injury-detectable only by early DWI-which have long-term structural and functional consequences.	[Elliott, Cameron A.; Sankar, Tejas; Mehta, Vivek] Univ Alberta, Div Neurosurg, Edmonton, AB, Canada; [Ramaswamy, Vijay] Hosp Sick Children, Div Hematol Oncol, Toronto, ON, Canada; [Jacob, Francois D.] Univ Alberta, Div Pediat, Edmonton, AB, Canada		Mehta, V (corresponding author), Univ Alberta, Div Neurosurg, Edmonton, AB, Canada.	Vivek.Mehta@albertahealthservices.ca		Ramaswamy, Vijay/0000-0002-6557-895X; Sankar, Tejas/0000-0002-8821-7049	Izaak Walton Killam scholarship	The authors report no conflict of interest. We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this report is consistent with those guidelines. CE is supported by a Izaak Walton Killam scholarship.	Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Ashwal S, 2010, DEV NEUROSCI-BASEL, V32, P343, DOI 10.1159/000316801; Barnes PD, 2011, RADIOL CLIN N AM, V49, P205, DOI 10.1016/j.rcl.2010.08.001; Bastin ME, 2000, NEUROREPORT, V11, P2867, DOI 10.1097/00001756-200009110-00008; Biousse V, 2002, AM J OPHTHALMOL, V133, P249, DOI 10.1016/S0002-9394(01)01366-6; Bonnier C, 2003, PEDIATRICS, V112, P808, DOI 10.1542/peds.112.4.808; Bonnier Christine, 2004, Pediatr Rehabil, V7, P165, DOI 10.1080/13638490410001703325; BRIERLEY JB, 1966, BRAIN, V89, P269, DOI 10.1093/brain/89.2.269; Chalela JA, 2001, NEUROLOGY, V56, P481, DOI 10.1212/WNL.56.4.481; Chatzikonstantinou A, 2011, EPILEPSY RES, V97, P45, DOI 10.1016/j.eplepsyres.2011.07.002; Cole AJ, 2004, EPILEPSIA, V45, P72, DOI 10.1111/j.0013-9580.2004.04014.x; Donaire A, 2006, J NEUROL NEUROSUR PS, V77, P104, DOI 10.1136/jnnp.2004.058701; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; Durkin MS, 1998, NEUROSURGERY, V42, P300, DOI 10.1097/00006123-199802000-00052; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; Goldstein JL, 2011, NEUROCRIT CARE, V15, P63, DOI 10.1007/s12028-010-9468-5; Heiniger P, 2002, NEURORADIOLOGY, V44, P475, DOI 10.1007/s00234-002-0785-z; Hergan K, 2002, EUR RADIOL, V12, P2536, DOI 10.1007/s00330-002-1333-2; HIRANO A, 1971, J NEUROPATH EXP NEUR, V30, P325, DOI 10.1097/00005072-197107000-00002; Ichord RN, 2007, J NEUROTRAUM, V24, P106, DOI 10.1089/neu.2006.0087; Imagawa KK, 2014, J NEUROTRAUM, V31, P1632, DOI 10.1089/neu.2013.3228; Jagannathan P, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E6; Kemp AM, 2009, CLIN RADIOL, V64, P473, DOI 10.1016/j.crad.2008.11.011; Kemp AM, 2003, ARCH DIS CHILD, V88, P472, DOI 10.1136/adc.88.6.472; Lansberg MG, 1999, NEUROLOGY, V52, P1021, DOI 10.1212/WNL.52.5.1021; MARCOUX FW, 1982, STROKE, V13, P339, DOI 10.1161/01.STR.13.3.339; McKinney AM, 2008, PEDIATR RADIOL, V38, P164, DOI 10.1007/s00247-007-0673-0; Moritani T, 2005, DIFFUSION WEIGHTED I, P216; Pantoni L, 1996, STROKE, V27, P1641, DOI 10.1161/01.STR.27.9.1641; Parizel PM, 2005, EUR RADIOL, V15, P569, DOI 10.1007/s00330-004-2558-z; Pierce MC, 2002, NEUROSURG CLIN N AM, V13, P155, DOI 10.1016/S1042-3680(01)00006-7; Rennebaum F, 2016, EPILEPSY RES, V120, P55, DOI 10.1016/j.eplepsyres.2015.12.004; Schwedemberg TH, 1957, J NEUROPATHOL EXP NE, V18, P597; Senn P, 2003, NEURORADIOLOGY, V45, P246, DOI 10.1007/s00234-002-0850-7; Suh DY, 2001, NONACCIDENTAL PEDIAT, P49; Szabo K, 2005, BRAIN, V128, P1369, DOI 10.1093/brain/awh454; Vazquez E, 2014, PEDIATR RADIOL, V44, P589, DOI 10.1007/s00247-014-3216-5; Zimmerman RA, 2007, J NEURORADIOLOGY, V34, P109, DOI 10.1016/j.neurad.2007.01.124	40	1	1	1	9	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	FEB	2017	33	2					289	295		10.1007/s00381-016-3271-3			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	EO7XT	WOS:000396904100015	27766468				2022-02-06	
J	Farah, A				Farah, Andrew			Pharmacology and Natural Therapies for Postconcussion Syndrome	PSYCHIATRIC ANNALS			English	Article							TRAUMATIC BRAIN-INJURY; N-ACETYLCYSTEINE; HEAD	Despite the high prevalence of traumatic brain injury, and the subsequent occurrence of neuropsychiatric sequelae, our evidence-based treatment strategies are thus far confined to physical therapy and rehabilitation medicine. Further, there are no standardized medication or natural-based recommendations for patients with postconcussion syndrome (PCS). Yet, clinicians are often presented with patients who have PCS seeking relief and who are anxious about their futures. Prescription-based treatment has traditionally been limited to attempts at symptomatic relief, yet at least 20% of PCS patients will have persistent symptoms for more than 6 months, and a subset will face indefinite issues. Thus, clinicians should also be aware of neuroprotective strategies aimed at reducing the risk of prolonged deficits and future dementias as the result of multiple concussive injuries. Treatment of PCS should involve not only symptomatic relief, but also neuroprotective strategies, and both modalities should begin at initial patient encounters. This article reviews the pharmacotherapy aimed at ameliorating specific complaints, as well as the natural, neuroprotective strategies recommended for long-term use.	[Farah, Andrew] Univ North Carolina Healthcare, High Point Div, Psychiat Sect, High Point, NC USA		Farah, A (corresponding author), Univ North Carolina Healthcare, 320 Blvd, High Point, NC 27262 USA.	Brian.farah@unchealth.unc.edu			AltheaDx	Andrew Farah discloses grant/research support from AltheaDx (a genetic testing company); is a consultant for Jaymac Pharmaceuticals; and serves on the speaker's bureaus for Otsuka (a pharmaceutical company) and Jaymac Pharmaceuticals.	Bolander-Gouaille C, 2007, HOMOCYSTEINE RELATED, P15, DOI DOI 10.1007/978-2-287-69375-5_2; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; Chen G, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/716458; de Azevedo AA, 2007, PROG BRAIN RES, V166, P273, DOI 10.1016/S0079-6123(07)66025-7; Doig RLO, 2016, NEUROSCIENCE, V339, P450, DOI 10.1016/j.neuroscience.2016.10.005; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; ELLIS EF, 1991, J NEUROSURG, V75, P774, DOI 10.3171/jns.1991.75.5.0774; Girgis F, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00008; Hall RCW, 2005, PSYCHOSOMATICS, V46, P195, DOI 10.1176/appi.psy.46.3.195; Hicdonmez T, 2006, NEUROCHEM RES, V31, P473, DOI 10.1007/s11064-006-9040-z; Hoffer ME, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054163, 10.1371/journal.pone.0060061]; Jha A, 2008, J HEAD TRAUMA REHAB, V23, P52, DOI 10.1097/01.HTR.0000308721.77911.ea; Lay CL, 1999, HEADACHE, V39, P275, DOI 10.1046/j.1526-4610.1999.3904275.x; Lewis MD, 2016, J AM COLL NUTR, V35, P469, DOI 10.1080/07315724.2016.1150796; Mazereeuw G, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.12.014; McCauley SR, 2005, J NERV MENT DIS, V193, P540, DOI 10.1097/01.nmd.0000172592.05801.71; Mech AW, 2016, J CLIN PSYCHIAT, V77, pE668, DOI 10.4088/JCP.15m10166; Naziroglu M, 2014, CELL MOL NEUROBIOL, V34, P895, DOI 10.1007/s10571-014-0069-2; Pompella A, 2003, BIOCHEM PHARMACOL, V66, P1499, DOI 10.1016/S0006-2952(03)00504-5; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; WEISS HD, 1991, HEADACHE, V31, P451, DOI 10.1111/j.1526-4610.1991.hed3107451.x; Whelan F J, 2000, Ann Clin Psychiatry, V12, P131; ZEE DS, 1985, ARCH OTOLARYNGOL, V111, P609; Zollman FS., MANUAL TRAUMATIC BRA	25	1	1	0	2	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0048-5713	1938-2456		PSYCHIAT ANN	Psychiatr. Ann.	FEB	2017	47	2					83	87		10.3928/00485713-20170103-02			5	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	EP3HW	WOS:000397274400006					2022-02-06	
J	Kim, EH; Chien, JH; Liu, CC; Oishi, K; Oishi, K; Sebastian, R; Demsky, C; Lenz, F; Hillis, AE				Kim, Eun Hye; Chien, Jui-Hong; Liu, Chang-Chia; Oishi, Kumiko; Oishi, Kenichi; Sebastian, Rajani; Demsky, Cornelia; Lenz, Frederick; Hillis, Argye E.			Stroke of bad luck?	NEUROCASE			English	Article						Empathy; autonomic nervous system; emotions; social cognition; stroke	INFERIOR FRONTAL GYRUS; TRAUMATIC BRAIN-INJURY; EMOTIONAL EMPATHY; COGNITIVE NEUROSCIENCE; INDIVIDUAL-DIFFERENCES; PREFRONTAL CORTEX; SOCIAL COGNITION; NEURAL BASIS; MIND; DEFICITS	We hypothesized that distinct acute right hemisphere lesions disrupt separate components of valuation and emotional response to winning and losing money and of emotional empathy in observing a partner win or lose money. We measured skin conductance response (SCR) and ratings of emotions when acute right hemisphere stroke patients or healthy controls won or lost money in roulette, or when they watched a partner win or lose. Our results showed that percentage of damage after stroke to right anterior insula and frontal operculum negatively correlated with both SCR to winning and losing and difference between rating wins versus losses.	[Kim, Eun Hye; Sebastian, Rajani; Demsky, Cornelia; Hillis, Argye E.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Chien, Jui-Hong; Liu, Chang-Chia; Lenz, Frederick] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA; [Oishi, Kumiko] Johns Hopkins Univ, Whiting Sch Engn, Baltimore, MD USA; [Oishi, Kenichi] Johns Hopkins Univ, Sch Med, Dept Radiol, Baltimore, MD 21205 USA; [Hillis, Argye E.] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD 21218 USA; [Hillis, Argye E.] Johns Hopkins Univ, Dept Cognit Sci, Baltimore, MD 21218 USA		Hillis, AE (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.; Hillis, AE (corresponding author), Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD 21218 USA.; Hillis, AE (corresponding author), Johns Hopkins Univ, Dept Cognit Sci, Baltimore, MD 21218 USA.	argye@jhmi.edu	Oishi, Kenichi/H-1371-2013	Oishi, Kenichi/0000-0002-1200-8611	National Institutes of Health (National Institute of Neurological Disorders and Stroke)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS47691, R01DC05375, R01NS38493]; National Institute on Deafness and Communication DisordersUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01DC05375]; NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD065955]	This work was supported by the National Institutes of Health (National Institute of Neurological Disorders and Stroke) under grants R01NS47691, R01DC05375 (to AEH) and R01NS38493 (to FAL); National Institute on Deafness and Communication Disorders under grant R01DC05375 and NICHD under grant R01 HD065955.	Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; BaronCohen S, 1997, J CHILD PSYCHOL PSYC, V38, P813, DOI 10.1111/j.1469-7610.1997.tb01599.x; Barrett AM, 2006, J COGNITIVE NEUROSCI, V18, P1223, DOI 10.1162/jocn.2006.18.7.1223; Beissner F, 2013, J NEUROSCI, V33, P10503, DOI 10.1523/JNEUROSCI.1103-13.2013; Blake ML, 2013, AM J SPEECH-LANG PAT, V22, P146, DOI 10.1044/1058-0360(2012/12-0021); Bramham J, 2009, J NEUROPSYCHOL, V3, P125, DOI 10.1348/174866408X293994; Bzdok D, 2012, BRAIN STRUCT FUNCT, V217, P783, DOI 10.1007/s00429-012-0380-y; Chakrabarti B, 2006, SOC NEUROSCI-UK, V1, P364, DOI 10.1080/17470910601041317; Cox CL, 2012, SOC COGN AFFECT NEUR, V7, P727, DOI 10.1093/scan/nsr051; Croxson PL, 2009, J NEUROSCI, V29, P4531, DOI 10.1523/JNEUROSCI.4515-08.2009; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Decety J, 2007, NEUROSCIENTIST, V13, P580, DOI 10.1177/1073858407304654; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; Dziobek I, 2008, J AUTISM DEV DISORD, V38, P464, DOI 10.1007/s10803-007-0486-x; Eslinger PJ, 2011, J NEUROPSYCH CLIN N, V23, P74, DOI 10.1176/appi.neuropsych.23.1.74; Eslinger PJ, 2005, J NEUROL NEUROSUR PS, V76, P1630, DOI 10.1136/jnnp.2004.053157; Eslinger PJ, 2000, BEHAVIOR AND MOOD DISORDERS IN FOCAL BRAIN LESIONS, P217; Eslinger PJ, 2002, CURR OPIN NEUROL, V15, P91, DOI 10.1097/00019052-200202000-00014; Fellows LK, 2005, J COGNITIVE NEUROSCI, V17, P850, DOI 10.1162/0898929054021139; Ferre P, 2011, REHABIL RES PRACT, V2011, DOI 10.1155/2011/131820; Grattan, 1996, J INT NEUROPSYCH SOC, V2, P15; Gu XS, 2012, BRAIN, V135, P2726, DOI 10.1093/brain/aws199; HANEY JN, 1976, BEHAV THER, V7, P494, DOI 10.1016/S0005-7894(76)80169-4; Hooker CI, 2011, BIOL PSYCHIAT, V70, P1169, DOI 10.1016/j.biopsych.2011.07.027; Hurlemann R, 2010, J NEUROSCI, V30, P4999, DOI 10.1523/JNEUROSCI.5538-09.2010; Jabbi M, 2007, NEUROIMAGE, V34, P1744, DOI 10.1016/j.neuroimage.2006.10.032; Jabbi M, 2008, EMOTION, V8, P775, DOI 10.1037/a0014194; Kurniawan IT, 2013, J NEUROSCI, V33, P6160, DOI 10.1523/JNEUROSCI.4777-12.2013; Lamm C, 2011, NEUROIMAGE, V54, P2492, DOI 10.1016/j.neuroimage.2010.10.014; Lee J, 2011, PSYCHOL MED, V41, P2297, DOI 10.1017/S0033291711000614; Leigh R, 2013, BRAIN, V136, P2539, DOI 10.1093/brain/awt177; Levy DJ, 2012, CURR OPIN NEUROBIOL, V22, P1027, DOI 10.1016/j.conb.2012.06.001; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; Meriau K, 2009, BRAIN COGNITION, V69, P73, DOI 10.1016/j.bandc.2008.05.006; MESULAM MM, 1982, J COMP NEUROL, V212, P1, DOI 10.1002/cne.902120102; Narvid J, 2009, NEUROCASE, V15, P190, DOI 10.1080/13554790802632967; Neumann D, 2012, ARCH PHYS MED REHAB, V93, P1414, DOI 10.1016/j.apmr.2012.03.009; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; Oishi K, 2009, NEUROIMAGE, V46, P486, DOI 10.1016/j.neuroimage.2009.01.002; Olson IR, 2007, BRAIN, V130, P1718, DOI 10.1093/brain/awm052; Ota H, 2001, NEUROLOGY, V57, P2064, DOI 10.1212/WNL.57.11.2064; Piche M, 2010, PAIN, V149, P453, DOI 10.1016/j.pain.2010.01.005; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Rankin KP, 2006, BRAIN, V129, P2945, DOI 10.1093/brain/awl254; Rankin KP, 2005, COGN BEHAV NEUROL, V18, P28, DOI 10.1097/01.wnn.0000152225.05377.ab; Ross ED, 2008, BRAIN LANG, V104, P51, DOI 10.1016/j.bandl.2007.04.007; Rushworth MFS, 2011, NEURON, V70, P1054, DOI 10.1016/j.neuron.2011.05.014; Samson D, 2005, BRAIN, V128, P1102, DOI 10.1093/brain/awh464; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Schnell K, 2011, NEUROIMAGE, V54, P1743, DOI 10.1016/j.neuroimage.2010.08.024; Shamay-Tsoory SG, 2004, J CLIN EXP NEUROPSYC, V26, P1113, DOI 10.1080/13803390490515531; Shamay-Tsoory SG, 2005, COGN BEHAV NEUROL, V18, P55, DOI 10.1097/01.wnn.0000152228.90129.99; Shamay-Tsoory SG, 2003, J COGNITIVE NEUROSCI, V15, P324, DOI 10.1162/089892903321593063; Shamay-Tsoory SG, 2007, NEUROPSYCHOLOGIA, V45, P3054, DOI 10.1016/j.neuropsychologia.2007.05.021; Shamay-Tsoory SG, 2011, NEUROSCIENTIST, V17, P18, DOI 10.1177/1073858410379268; Shamay-Tsoory SG, 2009, BRAIN, V132, P617, DOI 10.1093/brain/awn279; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Sokol-Hessner P, 2009, P NATL ACAD SCI USA, V106, P5035, DOI 10.1073/pnas.0806761106; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Squire LR, 2007, NAT REV NEUROSCI, V8, P872, DOI 10.1038/nrn2154; Stone VE, 2003, NEUROPSYCHOLOGIA, V41, P209, DOI 10.1016/S0028-3932(02)00151-3; Sugrue LP, 2005, NAT REV NEUROSCI, V6, P363, DOI 10.1038/nrn1666; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; Tranel D., 2000, SER AFFECTIVE SCI, P192	64	1	1	0	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1355-4794	1465-3656		NEUROCASE	Neurocase	FEB	2017	23	1					70	78		10.1080/13554794.2017.1296578			9	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	ES6GK	WOS:000399644200012	28376690				2022-02-06	
J	Petchprapai, N				Petchprapai, Nutthita			Quality of Life Among Mild Traumatic Brain-Injured Adults	JOURNAL OF NURSING RESEARCH			English	Article						mild traumatic brain injury; mild head injury; quality of life; social support	SOCIAL SUPPORT; DEPRESSION; STRESS; PREDICTORS; CAREGIVER; SURVIVORS; SYMPTOMS; STROKE; HEALTH; INDEX	Background: Mild traumatic brain injury (MTBI) is a stressful life event that may impact various dimensions of life. Challenges to daily activities after MTBI may produce significant effects on quality of life (QOL). Purpose: The purposes of this cross-sectional descriptive study were to (a) explore QOL after experiencing MTBI, (b) determine the extent of social supports, and (c) identify factors that are associated with QOL in post-MTBI patients. Methods: A descriptive research method was used. Potential subjects were interviewed by telephone after they signed the consent forms. Results: The average score of total social support was 73, the average availability subscale score was 40, and the average satisfaction subscale score was 33. The average score of total QOL was 24, the average health and functioning domain score was 22, the average psychological and spiritual domain score was 25, the average social and economic domain score was 25, and the average family domain score was 27. QOL was then regressed simultaneously on all factors after adjustment of the outliers. The model was supported (adjusted R-2 = .246, F = 4.160, p < .001). The contribution of all the stimuli explained 24.6% of the variance in QOL (p < .0125). Social support was the most significant variable affecting the variance in QOL (the unstandardized regression coefficient = 1.105, the standardized regression coefficient = 0.414, t = 5.041, p < .001). Conclusions: This study identified social support as the most powerful predictor for QOL. Several measures used in this study were reliable and may be used within the Thai cultural context. Further study to better understand why a small but clinically important percentage of subjects experience ongoing disability after MTBI is needed.	[Petchprapai, Nutthita] Suranaree Univ Technol, Inst Nursing, Dept Adult & Elderly Nursing, Nakhon Ratchasima, Thailand		Petchprapai, N (corresponding author), 111 Univ Dr, Muang 30000, Nakhonratchasim, Thailand.	nutthita@sut.ac.th					Bay E, 2002, J NURS SCHOLARSHIP, V34, P221, DOI 10.1111/j.1547-5069.2002.00221.x; Bedard M, 2003, DISABIL REHABIL, V25, P722, DOI 10.1080/0963828031000090489; Bell BD, 1999, ARCH CLIN NEUROPSYCH, V14, P389, DOI 10.1016/S0887-6177(98)00020-1; Bennett SJ, 2001, QUAL LIFE RES, V10, P671, DOI 10.1023/A:1013815825500; Berger E, 1999, RESTOR NEUROL NEUROS, V14, P93; BIGLER ED, 1995, ARCH CLIN NEUROPSYCH, V10, P159, DOI 10.1016/0887-6177(94)E0003-8; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Brown SA, 2004, APPL NEUROPSYCHOL, V11, P54, DOI 10.1207/s15324826an1101_7; Busch CR, 1998, NEUROPSYCHOL REV, V8, P95, DOI 10.1023/A:1025661200911; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Ergh TC, 2003, J CLIN EXP NEUROPSYC, V25, P1090, DOI 10.1076/jcen.25.8.1090.16735; Farmer JE, 2003, J HEAD TRAUMA REHAB, V18, P116, DOI 10.1097/00001199-200303000-00003; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Ferrans C E, 1990, Oncol Nurs Forum, V17, P15; Ferrans C. E., 2014, QUALITY LIFE INDEX R; FERRANS CE, 1992, RES NURS HEALTH, V15, P29, DOI 10.1002/nur.4770150106; FERRANS CE, 1985, ADV NURS SCI, V8, P15, DOI 10.1097/00012272-198510000-00005; Gasquoine PG, 1997, NEUROPSYCHOL REV, V7, P77, DOI 10.1023/B:NERV.0000005945.58251.c0; HALEY WE, 1987, PSYCHOL AGING, V2, P323, DOI 10.1037/0882-7974.2.4.323; Hartlage LC, 2001, ARCH CLIN NEUROPSYCH, V16, P561, DOI 10.1016/S0887-6177(00)00067-6; Jittimanee S., 2005, THESIS; Kim P, 1999, QUAL LIFE RES, V8, P293, DOI 10.1023/A:1008927431300; King RB, 1996, STROKE, V27, P1467, DOI 10.1161/01.STR.27.9.1467; Kleinpell RM, 2002, RES NURS HEALTH, V25, P212, DOI 10.1002/nur.10035; Levin H.S., 1989, MILD HEAD INJURY; Martelli MF, 1998, NEUROREHABILITATION, V11, P51, DOI 10.1016/S1053-8135(98)00009-2; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McHugh T. S., 2002, MASTERS ABSTRACTS IN, V42, P687; Petchprapai N., 1998, THESIS; SARASON IG, 1987, J SOC PERS RELAT, V4, P497, DOI 10.1177/0265407587044007; SARASON IG, 1978, J CONSULT CLIN PSYCH, V46, P932, DOI 10.1037/0022-006X.46.5.932; Schutt L. M., 1999, DISS ABSTR INT, V62, P1127; Srisaeng P., 2003, DISS ABSTR INT, V64, P4867; [No title captured]	35	1	1	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1682-3141			J NURS RES	J. Nurs. Res.	FEB	2017	25	1					51	58		10.1097/jnr.0000000000000119			8	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	EI9PH	WOS:000392840100007	27310604				2022-02-06	
J	Rowland, T				Rowland, Thomas			Cardiovascular Physiology and Disease in Youth-2016	PEDIATRIC EXERCISE SCIENCE			English	Article							SUDDEN CARDIAC DEATH; EXERCISE; VARIABILITY; DYSFUNCTION; CONCUSSION	The two articles in the area of cardiovascular physiology and disease in youth were chosen for commentary because of their exploration of new approaches to the diagnosis and management of cardiovascular derangements in young persons. The first, by Hinds et al., describes the potential clinical importance of detection of cardiovascular changes during exercise testing in adolescent athletes following concussions. This approach might prove useful in establishing safe return-to-play guidelines. The second, a review article by Van De Schoor et al, evaluates the frequency of myocardial scarring in athletes, some of adolescent age, which is a recognized risk factor for sudden cardiac death. These findings support other evidence indicating that sports participation per se might rarely increase the risk of such tragedies. Clearly more research is indicated by the information raised in both of these articles, but their importance to clinical medicine is obvious.	[Rowland, Thomas] Baystate Med Ctr, Dept Pediat, Springfield, MA 01199 USA		Rowland, T (corresponding author), Baystate Med Ctr, Dept Pediat, Springfield, MA 01199 USA.	Thomas.Rowland@baystatehealth.org					Blake T, 2014, BRIT J SPORT MED, V48, P569, DOI [10.1136/bjsports-2014-093494.26, DOI 10.1136/BJSPORTS-2014-093494.26]; Breuckmann F, 2009, RADIOLOGY, V251, P50, DOI 10.1148/radiol.2511081118; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Henschen S., 1899, MITT MED KLIN UPSALA, V2, P15; La Fountaine MF, 2011, J ATHL TRAINING, V46, P230; La Gerche A, 2012, EUR HEART J, V33, P998, DOI 10.1093/eurheartj/ehr397; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Oxborough D, 2011, CIRC-CARDIOVASC IMAG, V4, P253, DOI 10.1161/CIRCIMAGING.110.961938; Rowland T, 2011, SPORTS MED, V41, P401, DOI 10.2165/11583940-000000000-00000; Rowland T, 2011, MED SPORT SCI, V56, P171, DOI 10.1159/000320647; ROWLAND TW, 1973, PEDIATRICS, V51, P1083; Wilson M, 2011, J APPL PHYSIOL, V110, P1622, DOI 10.1152/japplphysiol.01280.2010	13	1	1	1	5	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	0899-8493	1543-2920		PEDIATR EXERC SCI	Pediatr. Exerc. Sci.	FEB	2017	29	1			SI		53	56		10.1123/pes.2017-0014			4	Pediatrics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Physiology; Sport Sciences	EP4LO	WOS:000397352200013	28271806				2022-02-06	
J	Smith, ST				Smith, Sydney T.			Postconcussion Syndrome: An Overview for Clinicians	PSYCHIATRIC ANNALS			English	Article							TRAUMATIC BRAIN-INJURY; INTERNATIONAL-CONFERENCE; ENCEPHALOPATHY; CONCUSSION; STATEMENT; SPORT	Postconcussion syndrome (PCS) remains one of the most challenging neuropsychiatric illnesses to evaluate and address clinically. Despite the fact that mild traumatic brain injury (or concussion) accounts for 75% of all head injuries, and that approximately 20% of patients will report a variety of symptoms lasting for months to years (sometimes indefinitely), our understanding of PCS is still evolving and there are few evidence-based treatment options for this condition. PCS involves a cluster of symptoms that are highly variable, not only in populations of patients with PCS, but also with regard to a person's presentation over time. Common symptoms include headache, dizziness, tinnitus, light and noise sensitivity, memory deficits, movement disorders, sleep disturbances, and cognitive impairment, as well as depression, anxiety, and other neuropsychiatric symptoms. This article reviews the latest understanding of the epidemiology, pathophysiology, and risk factors associated with PCS. Possible symptoms, potential short-and long-term comorbidities, PCS diagnostic criteria, and the evaluation of athletes suspected of concussive injury are also reviewed.	[Smith, Sydney T.] Univ North Carolina Reg Healthcare, High Point, NC USA		Smith, ST (corresponding author), Univ North Carolina Reg Healthcare, Highpoint Div, 320 Blvd St, High Point, NC 27262 USA.	Stsmith3@uncg.edu					American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, P760; American Psychiatric Association DSM-5 Task Force., 2013, DIAGNOSTIC STAT MANU, V5th, P624; Baldwin G, 2015, C TRAUM BRAIN INJ US; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Cepelewicz J, 2016, SCI AM; Collins MW, 2006, BRAIN INJURY MED PRI, P415; Coronado VG, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P84; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Deb S, 1999, AM J PSYCHIAT, V156, P374; Drake AI, 2006, BRAIN INJURY, V20, P469, DOI 10.1080/02699050600676370; Faul M, 2010, TRAUMATIC BRAIN INJU; Girgis F, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00008; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Hall RCW, 2005, PSYCHOSOMATICS, V46, P195, DOI 10.1176/appi.psy.46.3.195; Iverson GL, 2016, J NEUROPSYCH CLIN N, V28, P9, DOI 10.1176/appi.neuropsych.15070172; Kelly JP, 1997, NEUROLOGY, V48, P581; Kraus J F, 2000, Neurosurg Focus, V8, pe5; List J, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00228; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; Maskell F, 2006, BRAIN INJURY, V20, P293, DOI 10.1080/02699050500488041; McAllister TW, 2002, NEUROREHABILITATION, V17, P265; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Padgett CR, 2016, NEUROPSYCHOLOGY, V30, P775, DOI 10.1037/neu0000270; Paniak C, 2002, ARCH CLIN NEUROPSYCH, V17, P319, DOI 10.1016/S0887-6177(01)00115-9; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Silver JM, 2005, TXB TRAUMATIC BRAIN, P10; Tavazzi B, 2007, NEUROSURGERY, V61, P390, DOI 10.1227/01.NEU.0000255525.34956.3F; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Wetjen NM, 2010, J AM COLL SURGEONS, V211, P553, DOI 10.1016/j.jamcollsurg.2010.05.020; World Health Organization, 2004, ICD 10 INT STAT CLAS; Yao ES, 2016, MED SCI MONITOR, V22, P3268, DOI 10.12659/MSM.900010	35	1	1	0	6	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0048-5713	1938-2456		PSYCHIAT ANN	Psychiatr. Ann.	FEB	2017	47	2					77	82		10.3928/00485713-20161222-01			6	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	EP3HW	WOS:000397274400005					2022-02-06	
J	von Dercks, N; Melz, R; Hepp, P; Theopold, J; Marquass, B; Josten, C				von Dercks, N.; Melz, R.; Hepp, P.; Theopold, J.; Marquass, B.; Josten, C.			Seasonal distribution of clinical case codes (DOC study)	UNFALLCHIRURG			German	Article						Diagnosis-related groups; Main diagnosis; Needs assessment; Relative value; Coding	WOMEN; DRG	The German diagnosis-related groups remuneration system (G-DRG) was implemented in 2004 and patient-related diagnoses and procedures lead to allocation to specific DRGs. This system includes several codes, such as case mix (CM), case mix index (CMI) and number of cases. Seasonal distribution of these codes as well as distribution of diagnoses and DRGs may lead to logistical consequences for clinical management. From 2004 to 2013 all the main diagnoses and DRGs for inpatients were recorded. Monthly and seasonal distributions were analyzed using ANOVA. The average monthly number of cases was 265 +/- 25 cases, the average CM was 388.50 +/- 51.75 and the average CMI was 1.46 +/- 0.15 with no significant seasonal differences (p > 0.1). Concussion was the most frequently occurring main diagnosis (3739 cases) followed by fractures of the humeral head (699). Significant distribution differences could be shown for humeral head fractures in monthly (p = 0.018) and seasonal comparisons (p = 0.006) with a maximum in winter. Radius (p = 0.01) and ankle fractures (p <= 0.001) also occurred most frequently in winter. Non-bony lesions of the shoulder were significantly less in spring (p = 0.04). The DRGs showed no evidence of a monthly or seasonal clustering (p > 0.1). The significant clustering of injuries in specific months and seasons should lead to logistic consequences (e.g. operating room slots, availability of nursing and anesthesia staff). For a needs assessment the analysis of main diagnoses is more appropriate than DRGs.	[von Dercks, N.; Hepp, P.; Theopold, J.; Marquass, B.; Josten, C.] Univ Klinikum Leipzig, Klin & Poliklin Unfall Wiederherstellungs & Plast, Liebigstr 20, D-04103 Leipzig, Germany; [Melz, R.] Cassidian Air Syst, Stat Anal Eurofighter, Manching, Germany		von Dercks, N (corresponding author), Univ Klinikum Leipzig, Klin & Poliklin Unfall Wiederherstellungs & Plast, Liebigstr 20, D-04103 Leipzig, Germany.	nikolaus.vondercks@medizin.uni-leipzig.de	Theopold, Jan/AAA-1575-2021	Theopold, Jan/0000-0003-2884-8030			Fetter R B, 1985, Pathologist, V39, P17; Flinkkila T, 2011, OSTEOPOROSIS INT, V22, P2307, DOI 10.1007/s00198-010-1463-3; Furstenberg T, 2013, ENDBERICHT DRITTEN F; Gronskag AB, 2010, BONE, V46, P1294, DOI 10.1016/j.bone.2009.11.024; MCMAHON LF, 1986, HOSP HEALTH SERV ADM, V31, P62; Sens B, 2010, MONITOR VERSORGUNGSF; Thompson PW, 2004, INJURY, V35, P462, DOI 10.1016/S0020-1383(03)00117-7; von Dercks N, 2011, UNFALLCHIRURG, V114, P1029, DOI 10.1007/s00113-011-2108-5	8	1	1	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0177-5537	1433-044X		UNFALLCHIRURG	Unfallchirurg	FEB	2017	120	2					147	152		10.1007/s00113-015-0096-6			6	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	EK9IN	WOS:000394237800009	26495452				2022-02-06	
J	Wang, Z; Shen, MF; Qiao, MZ; Zhang, HY; Tang, ZX				Wang, Zhuo; Shen, Meifen; Qiao, Meizhen; Zhang, Haiyin; Tang, Zaixiang			Clinical factors and incidence of prolonged fever in neurosurgical patients	JOURNAL OF CLINICAL NURSING			English	Article						antibiotic therapy; central venous catheter; neurosurgical patients; prolonged fever; prolonged mechanical ventilation	VENTILATOR-ASSOCIATED PNEUMONIA; TRAUMATIC BRAIN-INJURY; TUMOR-NECROSIS-FACTOR; INTENSIVE-CARE-UNIT; RISK-FACTORS; TEMPERATURE; HYPERTHERMIA; INFECTION; OUTCOMES	Aims and objectives. To describe the incidence of prolonged fever in patients admitted to the neurosurgery department, and the corresponding risk indicators. Background. Prolonged fever was defined as a temperature higher than 38.3 degrees C lasting more than five days. Prolonged fever is a common phenomenon and could lead to worsened outcomes in specific patient groups, especially for those with brain injury. However, the studies on prolonged fever in neurosurgical patients are limited and insufficient. Design. A retrospective observational study. Methods. Retrospective data were collected from 1 January 2014 to 31 December 2014, at the neurosurgical department of a large teaching hospital. We performed univariate and multivariate analyses to identify independent indicators for prolonged fever vs. short-term fever. Results. Among 2845 patients, prolonged fever occurred in 466 (16%). The older patients were associated with longer duration of mechanical ventilation and hospital stay. It predominantly occurred in patients with subarachnoid haemorrhage (SAH) and traumatic brain injury. Patients receiving antibiotic treatment tended to manifest prolonged fever more frequently. Multivariate analysis revealed that the use of antibiotics, central venous catheter and prolonged mechanical ventilation were independent risk predictors for prolonged fever. Patients diagnosed with brain tumour seemed to be not associated with prolonged fever. Conclusions. Prolonged fever is the common complication in neurosurgical patients. The risks of prolonged fever in patients are attributed to antibiotic therapy, use of central venous catheter and prolonged mechanical ventilation. Indicators of prolonged fever are helpful for better identification of high-risk patients and fever control. Relevance to clinical practice. A better reveal on the epidemiology and predictable factors of prolonged fever in neurosurgical patients will provide a better understanding on those patients who are most at risk, and therefore contribute to fever control and better outcome.	[Wang, Zhuo] Huzhou Univ, Coll Med, Sch Nursing, Huzhou, Peoples R China; [Shen, Meifen] Soochow Univ, Coll Med, Sch Nursing, Suzhou, Peoples R China; [Shen, Meifen; Zhang, Haiyin] Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, 188 Shizi St, Suzhou 215000, Peoples R China; [Qiao, Meizhen] Soochow Univ, Affiliated Hosp 1, Dept Infect Control, Suzhou, Peoples R China; [Tang, Zaixiang] Soochow Univ, Coll Med, Sch Publ Hlth, Dept Epidemiol & Biostat, Suzhou, Peoples R China		Shen, MF (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, 188 Shizi St, Suzhou 215000, Peoples R China.	meifenshen@suda.edu.cn		, Meifen/0000-0002-2126-908X; Shen, Meifen/0000-0001-9048-8959			Albrecht RF, 1998, MAYO CLIN PROC, V73, P629; Baena RC, 1997, NEUROLOGY, V48, P768, DOI 10.1212/WNL.48.3.768; Barie Philip S, 2004, Surg Infect (Larchmt), V5, P145, DOI 10.1089/1096296041839534; Bota DP, 2004, INTENS CARE MED, V30, P811, DOI 10.1007/s00134-004-2166-z; Circiumaru B, 1999, INTENS CARE MED, V25, P668, DOI 10.1007/s001340050928; Commichau C, 2003, NEUROLOGY, V60, P837, DOI 10.1212/01.WNL.0000047344.28843.EB; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; Diringer MN, 2004, CRIT CARE MED, V32, P1489, DOI 10.1097/01.CCM.0000129484.61912.84; Hocker SE, 2013, JAMA NEUROL, V70, P1499, DOI 10.1001/jamaneurol.2013.4354; Holzer M, 2002, NEW ENGL J MED, V346, P549; Hui X, 2013, J SURG RES, V184, P438, DOI 10.1016/j.jss.2013.05.072; Jovanovic B, 2015, INT J INFECT DIS, V38, P46, DOI 10.1016/j.ijid.2015.07.005; Kanegaye JT, 2016, PEDIATR INFECT DIS J, V35, P50, DOI 10.1097/INF.0000000000000923; Kiekkas P, 2012, CRIT CARE, V16, DOI 10.1186/cc11683; Kilpatrick MM, 2000, NEUROSURGERY, V47, P850, DOI 10.1097/00006123-200010000-00011; Laupland KB, 2008, CRIT CARE MED, V36, P1531, DOI 10.1097/CCM.0b013e318170efd3; Lipitz-Snyderman A, 2014, J CLIN ONCOL, V32, P2351, DOI 10.1200/JCO.2013.53.3018; Lord AS, 2014, STROKE, V45, P3535, DOI 10.1161/STROKEAHA.114.006435; Mizuno T, 2000, AM J PHYSIOL-REG I, V278, pR157, DOI 10.1152/ajpregu.2000.278.1.R157; Niven DJ, 2015, ANN INTERN MED, V163, P768, DOI 10.7326/M15-1150; Plurad DS, 2013, J SURG RES, V183, P371, DOI 10.1016/j.jss.2013.01.036; Rabinstein AA, 2007, J NEUROL NEUROSUR PS, V78, P1278, DOI 10.1136/jnnp.2006.112730; Rehman T, 2014, CHEST, V145, P158, DOI 10.1378/chest.12-2843; Rincon F, 2015, J INTENSIVE CARE MED, V30, P107, DOI 10.1177/0885066613508266; Rossi S, 2001, J NEUROL NEUROSUR PS, V71, P448, DOI 10.1136/jnnp.71.4.448; See D, 2002, IMMUNOL INVEST, V31, P137, DOI 10.1081/IMM-120004804; Seguin P, 2012, CRIT CARE, V16, DOI 10.1186/cc11465; Thompson Hilaire J, 2007, J Neurosci Nurs, V39, P196; Vespa PM, 2014, JAMA-J AM MED ASSOC, V312, P1456, DOI 10.1001/jama.2014.12492; Wilson TJ, 2013, CLIN NEUROL NEUROSUR, V115, P879, DOI 10.1016/j.clineuro.2012.08.025; Zygun DA, 2006, NEUROCRIT CARE, V5, P108, DOI 10.1385/NCC:5:2:108	31	1	2	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0962-1067	1365-2702		J CLIN NURS	J. Clin. Nurs.	FEB	2017	26	3-4					411	417		10.1111/jocn.13409			7	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	EO1TB	WOS:000396479700011	27240113				2022-02-06	
J	Woischneck, D; Kapapa, T				Woischneck, Dieter; Kapapa, Thomas			The prognostic reliability of intracranial pressure monitoring and MRI data in severe traumatic brain injury	MAGNETIC RESONANCE IMAGING			English	Article						Prognosis; Midbrain; Pons; Intensive care; Outcome	HEAD-INJURY; PREDICTIVE-VALUE; ICP; CLASSIFICATION	Objective: The predictive quality of intracranial pressure (ICP) monitoring has for many years been a matter of debate. We correlate ICP data comparing MRI data with the outcome after severe traumatic brain injury to evaluate their prognostic potency. Methods: This study compares the results of ICP monitoring, MRI, coma duration and outcome according to Glasgow Outcome Scale obtained in 32 patients having suffered severe TBI. Level of significance was set to p <= 0.05 in statistical tests. Results: The MRI results were closely correlated with coma duration and Glasgow Outcome Scale, but the ICP measurements were not. With the exception of severe, bipontine lesions, there is no other region of the brain in which increased evidence of traumatogenic lesions emerges as the intracranial pressure rises. Just bipontine lesions that proof to be infaust correlate with elevated ICP values. Conclusion: ICP monitoring does not allow individual prognostic conclusions to be made. Implantation of an intracranial pressure sensor alone for making a prognostic estimate is not advisable. The use of intracranial pressure measurements in the retrospective appraisal of disease progress is highly problematic. However, MRI diagnostic in patients with severe TBI improves prognostic potency of clinical parameters. (C) 2016 Elsevier Inc. All rights reserved.	[Woischneck, Dieter] Klinikum Landshut, Neurochirurg Klin, Robert Koch Str 1, D-84034 Landshut, Germany; [Kapapa, Thomas] Univ Ulm Klinikum, Neurochirurg Klin, Albert Einstein Allee 23, D-89081 Ulm, Germany		Woischneck, D (corresponding author), Klinikum Landshut, Neurochirurg Klin, Robert Koch Str 1, D-84034 Landshut, Germany.	dieter.woischneck@klinikum-landshut.de; Thomas.Kapapa@uniklinik-ulm.de					Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; Firsching R, 2008, ACTA NEUROCHIR SUPPL, V102, P237, DOI 10.1007/978-3-211-85578-2_45; Firsching R, 2001, ACTA NEUROCHIR, V143, P263; FROWEIN RA, 1976, ACTA NEUROCHIR, V34, P5, DOI 10.1007/BF01405858; JENNETT B, 1975, LANCET, V1, P480; Morgalla MH, 1999, J MED ENG TECHNOL, V23, P144; Pauli S, 2014, NEUROL REHABIL, V20, P17; SCHWARZ N, 1992, UNFALLCHIRURG, V95, P113; Servadei F, 1997, ACTA NEUROCHIR, V139, P279, DOI 10.1007/BF01808822; Unterhamscheidt F, 1993, TRAUMATOLOGIE HIRN R; Wallesch CW, 2005, AKTUEL NEUROL, V32, P279, DOI 10.1055/s-2004-834574; Woischneck D, 1997, NEUROL RES, V19, P305, DOI 10.1080/01616412.1997.11740817; Woischneck D., 2010, Intensivmedizin und Notfallmedizin, V47, P59, DOI 10.1007/s00390-009-0045-0; Woischneck D, 1997, J NEUROSURG, V87, P134; Woischneck D, 2010, CRANIAL MAGNETIC RES, V62, P20; Yanagawa Y, 2009, J TRAUMA, V66, P162, DOI 10.1097/TA.0b013e3181469857; Yuan Q, 2013, BRAIN INJURY, V27, P664, DOI 10.3109/02699052.2013.775497	17	1	1	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0730-725X	1873-5894		MAGN RESON IMAGING	Magn. Reson. Imaging	FEB	2017	36						210	215		10.1016/j.mri.2016.10.033			6	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	EJ9HB	WOS:000393536100026	27816745				2022-02-06	
J	Yagci, I; Kivrak, Y				Yagci, Ibrahim; Kivrak, Yuksel			Neurocognitive disorder due to traumatic brain injury and depression: a case report	ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY			Turkish	Article						Depression; traumatic brain injury; cognitive disorders		Traumatic brain injury (TBI) is an injury that results in physical, cognitive and psychosocial dysfunctions. Depression, behavioral and emotional changes are usually present as well as other typical symptoms such as headache, loss of consciousness, nausea, motor and cognitive impairments. Physical and mental conditions including learning, the ability to understand and communicate, movement skills and maintaining daily activities, self-care and social behaviors are usually affected in these patients. These symptoms may vary in accordance with the severity of the injury or due to personal changes. Our case was reported to have a good functionality before the accident, and showed personality changes and impairment in intellectual functions, therefore depression with neurocognitive impairment due to traumatic brain injury seemed to be the most possible diagnosis. In this study, we aimed to present a case of traumatic brain injury with concurrent depression and improvements in patient's functionality after successful diagnosis and treatment processes.	[Yagci, Ibrahim] Kars Harakani Devlet Hastanesi, Psikiyatri Klin, Kars, Turkey; [Kivrak, Yuksel] Kafkas Univ, Tip Fak, Psikiyatri ABD, Kars, Turkey		Yagci, I (corresponding author), Kars Harakani Devlet Hastanesi, Psikiyatri Klin, Kars, Turkey.	ibrahimyagci53@hotmail.com					Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Brooks N, 1988, Acta Neurochir Suppl (Wien), V44, P59; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P41, DOI 10.1097/00001199-199508000-00005; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; Gokalp HZ, 1988, NOROSIRURJI DERS KIT, P202; Gungen Can, 2002, Turk Psikiyatri Derg, V13, P273; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kaya A, 2001, TURK FIZ TIP REHAB D, V47, P7; Kivrak Y, 2014, B CLIN PSYCHOPHARMAC, V24, P220; Koroglu E, 2013, RUHS BOZ TAN VE SAYI; Kraus J. F., 1999, REHABILITATION ADULT, P3; Mesulam MM, 2004, MENTAL DURUMUN NOROP, P160; Mohr WK, 2001, ARCH PSYCHIAT NURS, V15, P171, DOI 10.1053/apnu.2001.25416; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Whelan-Goodinson R, 2008, J REHABIL MED, V40, P850, DOI 10.2340/16501977-0271	15	1	1	0	2	CUMHURIYET UNIV TIP FAK PSIKIYATRI ANABILIM DALI	SIVAS	CUMHURIYET UNIV TIP FAK PSIKIYATRI ABD, SIVAS, 58140, TURKEY	1302-6631			ANADOLU PSIKIYATR DE	Anadolu Psikiyatr. Derg.	FEB	2017	18			1			19	22		10.5455/apd.245070			4	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Psychiatry	EM8BN	WOS:000395536300005					2022-02-06	
J	Armstrong, MJ; Gronseth, GS; Dubinsky, R; Potrebic, S; Murray, RP; Getchius, TSD; Rheaume, C; Gagliardi, AR				Armstrong, Melissa J.; Gronseth, Gary S.; Dubinsky, Richard; Potrebic, Sonja; Murray, Rebecca Penfold; Getchius, Thomas S. D.; Rheaume, Carol; Gagliardi, Anna R.			Naturalistic study of guideline implementation tool use via evaluation of website access and physician survey	BMC MEDICAL INFORMATICS AND DECISION MAKING			English	Article						Practice guidelines; Guideline implementation; Information dissemination; Internet; Surveys and questionnaires	CLINICAL-PRACTICE GUIDELINES; DEVELOPMENT SUBCOMMITTEE; AMERICAN ACADEMY; DISEASE REPORT; SUPPORT; QUALITY; ASTHMA; APPS	Background: Clinical guidelines support decision-making at the point-of-care but the onus is often on individual users such as physicians to implement them. Research shows that the inclusion of implementation tools in or with guidelines (GItools) is associated with guideline use. However, there is little research on which GItools best support implementation by individual physicians. The purpose of this study was to investigate naturalistic access and use of GItools produced by the American Academy of Neurology (AAN) to inform future tool development. Methods: Website accesses over six months were summarized for eight AAN guidelines and associated GItools published between July 2012 and August 2013. Academy members were surveyed about use of tools accompanying the sport concussion guideline. Data were analyzed using summary statistics and the Chi-square test. Results: The clinician summary was accessed more frequently (29.0%, p < 0.001) compared with the slide presentation (26.8%), patient summary (23.2%) or case study (20.9%), although this varied by guideline topic. For the sport concussion guideline, which was accompanied by a greater variety of GItools, the mobile phone quick reference check application was most frequently accessed, followed by the clinician summary, patient summary, and slide presentation. For the sports concussion guideline survey, most respondents (response rate 21.8%, 168/ 797) were aware of the guideline (88.1%) and had read the guideline (78.6%). For GItool use, respondents indicated reading the reference card (51.2%), clinician summary (45.2%), patient summary (28.0%), mobile phone application (26.2%), and coach/ athletic trainer summary (20.2%). Patterns of sports concussion GItool use were similar between respondents who said they had and had not yet implemented the guideline. Conclusions: Developers faced with resource limitations may wish to prioritize the development of printable or mobile application clinician summaries, which were accessed significantly more than other types of GItools. Further research is needed to understand how to optimize the design of such GItools.	[Armstrong, Melissa J.] Univ Florida, Coll Med, Dept Neurol, Gainesville, FL 32611 USA; [Armstrong, Melissa J.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Gronseth, Gary S.; Dubinsky, Richard] Univ Kansas, Med Ctr, Dept Neurol, Kansas City, KS 66103 USA; [Potrebic, Sonja] Kaiser Permanente, Los Angeles Med Ctr, Dept Neurol, Los Angeles, CA USA; [Murray, Rebecca Penfold; Getchius, Thomas S. D.; Rheaume, Carol] Amer Acad Neurol, Minneapolis, MN USA; [Gagliardi, Anna R.] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada		Armstrong, MJ (corresponding author), Univ Florida, Coll Med, Dept Neurol, Gainesville, FL 32611 USA.; Armstrong, MJ (corresponding author), Univ Maryland, Sch Med, Baltimore, MD 21201 USA.	Melissa.Armstrong@neurology.ufl.edu		Armstrong, Melissa/0000-0002-2163-1907			Abroms LC, 2013, AM J PREV MED, V45, P732, DOI 10.1016/j.amepre.2013.07.008; Armstrong MJ, 2013, NEUROLOGY, V80, P2065, DOI 10.1212/WNL.0b013e318294b32d; Armstrong MJ, 2012, NEUROLOGY, V79, P597, DOI 10.1212/WNL.0b013e318263c443; Baiardini I, 2009, CURR OPIN ALLERGY CL, V9, P228, DOI 10.1097/ACI.0b013e32832b4651; Baird RA, 2013, NEUROLOGY, V80, P1424, DOI 10.1212/WNL.0b013e31828c2f3e; Bhidayasiri R, 2013, NEUROLOGY, V81, P463, DOI 10.1212/WNL.0b013e31829d86b6; Dearing JW, 2009, RES SOCIAL WORK PRAC, V19, P503, DOI 10.1177/1049731509335569; Francke AL, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-38; Gagliardi AR, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007047; Gagliardi Anna R, 2015, CMAJ Open, V3, pE127, DOI 10.9778/cmajo.20140064; Gagliardi AR, 2014, IMPLEMENT SCI, V9, DOI 10.1186/s13012-014-0098-8; Gagliardi AR, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-404; Gagliardi AR, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-67; Giguere A, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-72; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Greenhalgh T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3725; Gronseth GS, 2012, NEUROLOGY, V79, P2209, DOI 10.1212/WNL.0b013e318275978c; Harris JS, 2000, J OCCUP ENVIRON MED, V42, P377, DOI 10.1097/00043764-200004000-00009; Huckvale K, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0303-x; Jones NE, 2007, NUTR CLIN PRACT, V22, P449, DOI 10.1177/0115426507022004449; Kastner M, 2015, J CLIN EPIDEMIOL, V68, P498, DOI 10.1016/j.jclinepi.2014.12.013; Kastner M, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-19; Kryworuchko J, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-49; Lavis JN, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-55; LEVITON LC, 1981, EVALUATION REV, V5, P525, DOI 10.1177/0193841X8100500405; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; McKillop Ann, 2012, Prim Health Care Res Dev, V13, P48, DOI 10.1017/S1463423611000405; Mickan S, 2011, POSTGRAD MED J, V87, P670, DOI 10.1136/pgmj.2010.116012; Morris GL, 2013, NEUROLOGY, V81, P1453, DOI 10.1212/WNL.0b013e3182a393d1; Muayqil T, 2012, NEUROLOGY, V79, P1499, DOI 10.1212/WNL.0b013e31826d5fc3; Murthy L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009401.pub2; Okelo SO, 2013, PEDIATRICS, V132, P517, DOI 10.1542/peds.2013-0779; Patel VL, 2001, J BIOMED INFORM, V34, P52, DOI 10.1006/jbin.2001.1002; Pronovost PJ, 2013, JAMA-J AM MED ASSOC, V310, P2501, DOI 10.1001/jama.2013.281334; Runciman WB, 2012, MED J AUSTRALIA, V197, P100, DOI 10.5694/mja12.10510; Shekelle P, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-62; Sheldon TA, 2004, BRIT MED J, V329, P999, DOI 10.1136/bmj.329.7473.999; Solberg L I, 2000, Jt Comm J Qual Improv, V26, P525; Versloot J, 2015, INT J EVID-BASED HEA, V13, P52, DOI 10.1097/XEB.0000000000000036; WEISS CH, 1979, PUBLIC ADMIN REV, V39, P426, DOI 10.2307/3109916; Zeuner R, 2015, HEALTH EXPECT, V18, P2465, DOI 10.1111/hex.12216	41	1	1	0	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1472-6947			BMC MED INFORM DECIS	BMC Med. Inform. Decis. Mak.	JAN 13	2017	17								9	10.1186/s12911-016-0404-2			8	Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Medical Informatics	EH8NF	WOS:000392028100001	28086771	Green Published, gold			2022-02-06	
J	Vathanalaoha, K; Oearsakul, T; Tunthanathip, T				Vathanalaoha, Karin; Oearsakul, Thakul; Tunthanathip, Thara			Predictive Factors of Survival and 6-Month Favorable Outcome of Very Severe Head Trauma Patients; a Historical Cohort Study	EMERGENCY			English	Article						Glasgow coma scale; head injuries; closed; prognosis; treatment outcome; outcome assessment	COMA SCALE SCORE; DILATED PUPILS; INJURY	Introduction: Very severe head trauma cases, defined as Glasgow Coma Scale (GCS) scores of less than 6, have a higher mortality rate and poorer outcome. The purpose of this study was to recognize factors associated with survival and 6-month favorable outcome of very severe head trauma patients presenting to emergency department. Methods: In this historical cohort study, the authors retrospectively reviewed medical records of head trauma patients who were admitted to the emergency department with post-resuscitation GCS scores of less than 6. Both univariate and multivariate analyses were used to test the association between various parameters with survival and 6-month outcome. Results: 103 cases with themean age of 39 +/- 16.5 years were studied (80% male). The overall survival rate was 41.7% and the rate of 6-month favorable outcome was 28.2%. Inmultivariate analysis, brisk pupil light reaction on admission and patent basal cistern on brain computed tomography (CT) scan were significant factors associated with both survival (OR 5.20, 95% CI 1.57-17.246, p =0.007 and OR 3.65, 95% CI 1.22-10.91, p=0.02 respectively) and favorable outcome (OR 4.07, 95% CI 1.35-12.24, p=0.01 and OR 3.54, 95% CI 1.22-10.26, p 0.02), respectively. Conclusion: Based on the results of present study, the survival rate of patientswith very severe head trauma (GCS < 6) was 41.7%. The strong predictors of survival and 6-month favorable outcome of these patients were brisk pupillary reactivity and patent cistern on brain CT scan. It seems that very severe head trauma patients still have a reasonable chance to survive and aggressive management should be continued.	[Vathanalaoha, Karin; Oearsakul, Thakul; Tunthanathip, Thara] Prince Songkla Univ, Songklanagarind Hosp, Fac Med, Neurosurg Unit,Dept Surg, Hat Yai, Songkhla, Thailand		Tunthanathip, T (corresponding author), Fac Med, Dept Surg, Neurosurg Unit, Hat Yai 90112, Songkhla, Thailand.	tsus4@hotmail.com					Brazinova A, 2010, J NEUROTRAUM, V27, P1549, DOI 10.1089/neu.2010.1315; Chaudhuri K, 2009, INJURY, V40, P28, DOI 10.1016/j.injury.2008.09.004; Demetriades D, 2004, ARCH SURG-CHICAGO, V139, P1066, DOI 10.1001/archsurg.139.10.1066; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; HULTBORN H, 1978, BRAIN RES, V159, P255, DOI 10.1016/0006-8993(78)90533-4; Jain S, 2008, INJURY, V39, P598, DOI 10.1016/j.injury.2007.06.003; JENNETT B, 1975, LANCET, V1, P480; Lieberman JD, 2003, J TRAUMA, V55, P437, DOI 10.1097/01.TA.0000081882.79587.17; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mauritz W, 2009, EUR J EMERG MED, V16, P153, DOI 10.1097/MEJ.0b013e32832a0864; Phuenpathom N, 2000, J CLIN NEUROSCI, V7, P223, DOI 10.1054/jocn.1999.0203; Quigley MR, 1997, J TRAUMA, V42, P7, DOI 10.1097/00005373-199701000-00003; Ritter AM, 1999, NEUROSURGERY, V44, P941, DOI 10.1097/00006123-199905000-00005; SAKAS DE, 1995, J NEUROSURG, V82, P961, DOI 10.3171/jns.1995.82.6.0961; TEASDALE G, 1974, LANCET, V2, P81; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Tien HC, 2006, J TRAUMA, V60, P274, DOI 10.1097/01.ta.0000197177.13379.f4; TOUTANT SM, 1984, J NEUROSURG, V61, P691, DOI 10.3171/jns.1984.61.4.0691	18	1	1	0	0	SHAHID BEHESHTI UNIV MEDICAL SCIENCES, FAC MED	TEHRAN	SCH MEDICINE, KOODAK-YAR ST, PO BOX 19359, TEHRAN, 4618, IRAN	2345-4571			EMERGENCY	Emergency	JAN 10	2017	5	1							e24				9	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	FQ8UA	WOS:000418637500003	28286831				2022-02-06	
J	Aji, YK; Apriawan, T; Bajamal, AH				Aji, Yunus Kuntawi; Apriawan, Tedy; Bajamal, Abdul Hafid			Conservative treatment of corpus callosum hemorrhage in severe traumatic brain injury: a case report	BALI MEDICAL JOURNAL			English	Article						corpus callosum hemorrhage; traumatic brain injury	HEMATOMA; SPLENIUM	Background: Hemorrhage in the corpus callosum (CC) potentially has a poor prognosis. Surgical treatment can lead to high morbidity and mortality. Patients with CC hemorrhage may improve clinically and radiologically with conservative treatment. Case: A child with multiple traumas including severe traumatic brain injury presented to our emergency room with a decrease of consciousness, aphasia, and seizure. On admission, her Glasgow Coma Scale score was E2V1M5 (8/15). The brain CT Scan showed hemorrhage in the body of the corpus callosum. We treated the patient conservatively in close observation in the intensive care unit. The patient showed significant improvement on day 4 and day 11 both clinically and radiologically. The patient was discharged from the hospital on day 20 in a stable neurological condition. Conclusion: Rather than surgery, a conservative treatment can be a better option for a patient with corpus callosum hemorrhage.	[Aji, Yunus Kuntawi] Univ Airlangga, Dr Soetomo Hosp, Fac Med, Dept Neurosurg, Surabaya, Indonesia; [Apriawan, Tedy; Bajamal, Abdul Hafid] Univ Airlangga, Dr Soetomo Hosp, Fac Med, Dept Neurosurg,Neurotrauma Div, Surabaya, Indonesia		Aji, YK (corresponding author), Univ Airlangga, Dr Soetomo Hosp, Fac Med, Dept Neurosurg, Surabaya, Indonesia.	yunus.neurosurgery@gmail.com					Abud Thiago Giansante, 2016, Radiol Bras, V49, P268, DOI 10.1590/0100-3984.2015.0130; El Sayed AM, 2016, NAT PROD RES, V30, P2813, DOI 10.1080/14786419.2016.1166494; Huang Y, 2013, NEUROCASE, V19, P377, DOI 10.1080/13554794.2012.690420; Kim IH, 2014, ANN REHABIL MED-ARM, V38, P871, DOI 10.5535/arm.2014.38.6.871; Kulkarni GB, 2014, NEUROL INDIA, V62, P563, DOI 10.4103/0028-3886.144497; Lemaire A, 2012, ASIAN CARDIOVASCULAR, V21, P605; Matsukawa H, 2012, J NEUROSURG, V117, P334, DOI 10.3171/2012.5.JNS112318; Perez-Bovet J, 2013, BRIT J NEUROSURG, V27, P827, DOI 10.3109/02688697.2013.799121; Sorimachi T, 2010, NEUROL MED-CHIR, V50, P209, DOI 10.2176/nmc.50.209	9	1	1	0	0	UNIV UDAYANA	BALI	KAMPUS UNUD SUDIRMAN, DENPASAR, BALI, 00000, INDONESIA	2089-1180	2302-2914		BALI MED J	Bali Med. J.		2017	6	3			SI		S97	S99		10.15562/bmj.v3i3.684			3	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	FQ6LG	WOS:000418475400022					2022-02-06	
J	Bakker, K; Catroppa, C; Anderson, V				Bakker, Kathleen; Catroppa, Cathy; Anderson, Vicki			The relationship between olfactory dysfunction and executive function in children with traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Traumatic brain injury; child; anosmia; olfactory dysfunction; executive function	ANOSMIA; IDENTIFICATION; PERFORMANCE; DISCRIMINATION; CHILDHOOD; RECOVERY; OUTCOMES; MRI; AGE	Introduction: Olfactory dysfunction (OD) has been suggested as a possible marker of executive function (EF) deficits after traumatic brain injury (TBI) in adults. Little is known about the relationship between EF and OD in pediatric TBI (pTBI). This study aimed to investigate EF, explore the relationship between OD and EF, and determine the utility of olfactory performance as a marker of later EF in pTBI. It was hypothesized that (i) children with TBI would perform more poorly on EF measures relative to normative expectation; (ii) children with OD would perform more poorly on tests of EF than those with normal olfaction after TBI; and (iii) acute olfactory function would predict later EF for children with TBI.Method: This was a prospective longitudinal study. Twenty seven children aged 8-16 with TBI completed olfactory assessment using the University of Pennsylvania Smell Identification Test at 0-3, 8 and 18months post injury. Assessment of EF occurred at 8 and 18month follow-up.Results: At 8month follow-up the pTBI cohort did not demonstrate a consistent pattern of impairment in EF, contrary to our first hypothesis. Children with OD showed significantly poorer performance on a single EF measure of Fluency when compared to those with normal olfaction at 8months post injury, partially supporting our second hypothesis. Acute olfactory function did not significantly predict EF outcomes at either 8 or 18months post injury.Conclusions: Overall our findings provide little support for a significant relationship between EF and OD in pTBI. In particular, there was no strong evidence that acute olfactory function is an accurate predictor of later EF in pTBI. Given the dearth of pediatric research, the limitations of our study and the potential significance of acute olfactory performance as an early marker of later EF deficits in children, further investigation is warranted.	[Bakker, Kathleen; Catroppa, Cathy; Anderson, Vicki] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Bakker, Kathleen; Catroppa, Cathy; Anderson, Vicki] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Catroppa, Cathy; Anderson, Vicki] Royal Childrens Hosp, Dept Psychol, Melbourne, Vic, Australia; [Catroppa, Cathy; Anderson, Vicki] Univ Melbourne, Sch Psychol Sci, Melbourne, Vic, Australia; [Bakker, Kathleen] Royal Childrens Hosp, Victorian Paediat Rehabil Serv, Melbourne, Vic, Australia		Bakker, K (corresponding author), Royal Childrens Hosp, Victorian Paediat Rehabil Serv, Flemington Rd, Parkville, Vic 3052, Australia.	kath.bakker@rch.org.au	Catroppa, Cathy/AAX-9458-2021	Catroppa, Cathy/0000-0002-9750-0436	Victorian Neurotrauma Initiative; Murdoch Childrens Research Institute; Victorian Government Operational Infrastructure Scheme; University of Melbourne, AustraliaUniversity of Melbourne	This work was supported through funding from the Victorian Neurotrauma Initiative, Murdoch Childrens Research Institute, the Victorian Government Operational Infrastructure Scheme and The University of Melbourne, Australia.	Anderson VA, 2002, CHILD NEUROPSYCHOL, V8, P231, DOI 10.1076/chin.8.4.231.13509; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bakker K, 2016, J NEUROTRAUM, V33, P777, DOI 10.1089/neu.2015.4075; Bakker K, 2016, BRAIN INJURY, V30, P191, DOI 10.3109/02699052.2015.1089597; Bakker K, 2014, J NEUROTRAUM, V31, P308, DOI 10.1089/neu.2013.3045; Barresi M, 2012, J NEUROL SCI, V323, P16, DOI 10.1016/j.jns.2012.08.028; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Callahan CD, 2002, J HEAD TRAUMA REHAB, V17, P251, DOI 10.1097/00001199-200206000-00006; Callahan CD, 1999, J HEAD TRAUMA REHAB, V14, P581, DOI 10.1097/00001199-199912000-00006; Costanzo R. M., 1992, J HEAD TRAUMA REHAB, V7, P15, DOI DOI 10.1097/00001199-199203000-00005; Crowe LM, 2012, J PEDIATR PSYCHOL, V37, P745, DOI 10.1093/jpepsy/jss070; Crowe SF, 2013, J CLIN EXP NEUROPSYC, V35, P298, DOI 10.1080/13803395.2013.771616; de Kruijk JR, 2003, BRAIN INJURY, V17, P73, DOI 10.1080/0269905021000010221; Delis DC., 2001, DELIS KAPLAN EXECUTI; Doty RL, 1995, SMELL IDENTIFICATION, Vthird; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Dudova I, 2011, EUR CHILD ADOLES PSY, V20, P333, DOI 10.1007/s00787-011-0177-1; Fujiwara E, 2008, NEUROPSYCHOLOGIA, V46, P461, DOI 10.1016/j.neuropsychologia.2007.08.027; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA IP, 2000, BEHAV RATING INVENTO; Green P, 2003, BRAIN INJURY, V17, P479, DOI 10.1080/0269905031000070242; Greiffenstein MF, 2002, J CLIN EXP NEUROPSYC, V24, P705, DOI 10.1076/jcen.24.5.705.1011; Hedner M, 2010, J CLIN EXP NEUROPSYC, V32, P1062, DOI 10.1080/13803391003683070; HOLM S, 1979, SCAND J STAT, V6, P65; JACOBI G, 1986, Acta Paediatrica Hungarica, V27, P173; JonesGotman M, 1997, BRAIN, V120, P1845, DOI 10.1093/brain/120.10.1845; Karsz FR, 2008, J CLIN PSYCHIAT, V69, P1462, DOI 10.4088/JCP.v69n0914; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Mackay-Sim A, 2001, AUSTR J OTOLARYNGOLO, V4, P174; Mackay-Sim A, 2006, OLFACTION AND THE BRAIN, P3, DOI 10.1017/CBO9780511543623.003; Manly T., 1998, TEST EVERYDAY ATTENT; MARTZKE JS, 1991, NEUROPSYCHOLOGY, V0005, P00213, DOI DOI 10.1037/0894-4105.5.3.213; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Muscara F, 2009, NEUROPSYCHOL REHABIL, V19, P541, DOI 10.1080/09602010802365223; Neumann D, 2012, ARCH PHYS MED REHAB, V93, P1414, DOI 10.1016/j.apmr.2012.03.009; Pink B, 2011, SOC IND AR SEIFA; Roberts G, 2008, J PAEDIATR CHILD H, V44, P276, DOI 10.1111/j.1440-1754.2007.01251.x; Roberts M A, 1996, Appl Neuropsychol, V3, P86, DOI 10.1207/s15324826an0302_7; Roberts MA, 1997, ARCH CLIN NEUROPSYCH, V12, P449, DOI 10.1016/S0887-6177(96)00039-X; Sandford AA, 2006, INT J PEDIATR OTORHI, V70, P1015, DOI 10.1016/j.ijporl.2005.10.013; Schofield PW, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00005; Sigurdardottir S, 2016, NEUROPSYCHOLOGY, V30, P98, DOI 10.1037/neu0000206; Sigurdardottir S, 2010, NEUROPSYCHOLOGY, V24, P504, DOI 10.1037/a0018934; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Tabachnick B.G., 2001, USING MULTIVARIATE S; TEASDALE G, 1974, LANCET, V2, P81; VARNEY NR, 1988, J CLIN EXP NEUROPSYC, V10, P250, DOI 10.1080/01688638808408239; Volker MA, 2006, PSYCHOL SCHOOLS, V43, P653, DOI 10.1002/pits.20176; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D, 2005, WECHSLER INTELLIGENC; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Yousem DM, 1996, AM J NEURORADIOL, V17, P1171; [No title captured]	57	1	2	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2017	39	9					876	889		10.1080/13803395.2016.1277184			14	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	FH1DM	WOS:000410879900005	28122475				2022-02-06	
J	Balyabin, AV; Tikhobrazova, OP; Gladkov, AA; Muravyova, MS; Klyuyev, YA; Mukhina, IV				Balyabin, A. V.; Tikhobrazova, O. P.; Gladkov, A. A.; Muravyova, M. S.; Klyuyev, Y. A.; Mukhina, I. V.			Transplantation of Neural Progenitor Cells within Hyaluronic Acid Hydrogel in Traumatic Brain Injury in Experiment	SOVREMENNYE TEHNOLOGII V MEDICINE			English	Article						autologous neural progenitor cells; hyaluronic acid hydrogel; traumatic brain injury; TBI; functional recovery	RECOVERY; MICE; RAT	The aim of the study was to evaluate the possibilities of transplantation of autologous neural progenitor cells from C57BL/6 mouse nasal olfactory lamina propria in the hydrogel based on low-,medium-, and high-molecular weight hyaluronic acid during a reconstructive operation after an open traumatic brain injury (TBI) in experiment. Materials and Methods. A reconstructive therapy was performed on the model of an open traumatic brain injury using the autologous neural progenitor cells from C57BL/6 mouse nasal olfactory lamina propria in a hydrogel based on high, medium, and low molecular hyaluronic acid 7 days after injury. Short-term and long-term impairments of neurological functions and memory due to TBI were assessed using a series of behavioral and cognitive tests (modified neurological severity score (mNSS), open field test, novel object recognition test and passive avoidance behavior). High-field magnetic resonance tomography was used for visualization of a lesion cavity. Results. Implantation of autologous neural progenitor cells in the hydrogel based on high-molecular weight hyaluronic acid in contrast to low- and medium-molecular weight had a protective effect reducing neurological deficit and restoring motor functions, short-term and long-term memory in the posttraumatic period. The effect of hydrogel molecular weight on the morphological characteristics of the injury cavity was less effective during the autologous neural progenitor cells transplantation after TBI. Conclusion. Transplantation of autologous neural progenitor cells from C57BL/6 mouse nasal olfactory lamina propria in the hydrogel based on high-molecular weight hyaluronic acid into the injury focus after open brain trauma promotes functional recovery of reflex and cognitive behavior of animals in the posttraumatic period.	[Balyabin, A. V.] Minist Hlth Russian Federat, Privolzhsky Fed Res Med Ctr, Neurosurg Dept, 18 Verkhne Volzhskaya Naberezhnaya, Nizhnii Novgorod 603155, Russia; [Mukhina, I. V.] Minist Hlth Russian Federat, Privolzhsky Fed Res Med Ctr, Biotechnol Grp, 18 Verkhne Volzhskaya Naberezhnaya, Nizhnii Novgorod 603155, Russia; [Tikhobrazova, O. P.] Nizhny Novgorod State Med Acad, Expt Modeling Dept, Cent Res Lab, 10-1 Minin & Pozharsky Sq, Nizhnii Novgorod 603005, Russia; [Gladkov, A. A.] Nizhny Novgorod State Med Acad, Mol & Cellular Technol Dept, Cent Res Lab, 10-1 Minin & Pozharsky Sq, Nizhnii Novgorod 603005, Russia; [Klyuyev, Y. A.] Nizhny Novgorod State Med Acad, Dept Radiodiagnost, Fac Adv Med Training, 10-1 Minin & Pozharsky Sq, Nizhnii Novgorod 603005, Russia; [Mukhina, I. V.] Nizhny Novgorod State Med Acad, Cent Res Lab, 10-1 Minin & Pozharsky Sq, Nizhnii Novgorod 603005, Russia; [Mukhina, I. V.] Nizhny Novgorod State Med Acad, Dept Normal Physiol, 10-1 Minin & Pozharsky Sq, Nizhnii Novgorod 603005, Russia; [Gladkov, A. A.] Lobacheysky State Univ Nizhni Novgorod, Lab Neuroengn, Ctr Translat Technol, 23 Prospeirt Gagarina, Nizhnii Novgorod 603950, Russia; [Muravyova, M. S.] Lobacheysky State Univ Nizhni Novgorod, 23 Prospeirt Gagarina, Nizhnii Novgorod 603950, Russia; [Muravyova, M. S.] Lobacheysky State Univ Nizhni Novgorod, Neurotechnol Dept, Inst Biol & Biomed, 23 Prospeirt Gagarina, Nizhnii Novgorod 603950, Russia; [Muravyova, M. S.] Lobacheysky State Univ Nizhni Novgorod, Ctr Translat Technol, 23 Prospeirt Gagarina, Nizhnii Novgorod 603950, Russia		Tikhobrazova, OP (corresponding author), Nizhny Novgorod State Med Acad, Expt Modeling Dept, Cent Res Lab, 10-1 Minin & Pozharsky Sq, Nizhnii Novgorod 603005, Russia.	olga.tikhobrazova@gmail.com	Gladkov, Arseniy A/B-7451-2013; Mukhina, Irina/E-3257-2014	Gladkov, Arseniy A/0000-0002-1831-808X; Mukhina, Irina/0000-0002-8811-0049	Federal Target Program "Research and development in priority areas of the development of the scientific and technological complex of Russia" of the Ministry of Education and Science of Russia [RFMEFI60715X0117]	The research was supported by the Federal Target Program "Research and development in priority areas of the development of the scientific and technological complex of Russia for 2014-2020" of the Ministry of Education and Science of Russia (Project ID RFMEFI60715X0117).	Balyabin AV, 2016, SOVREM TEHNOL MED, V8, P198, DOI 10.17691/stm2016.8.4.25; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Beni-Adani L., 2000, REST NEUROL NEUROSCI, V16, P242; Bures J., 1991, METODIKI OSNOVNYE EK; Cao Z., 2010, THESIS; Crompton KE, 2007, BIOMATERIALS, V28, P441, DOI 10.1016/j.biomaterials.2006.08.044; Dobrowolski S., 2013, AM J NEUROSCIENCE, V4, P13, DOI DOI 10.3844/AMJNSP.2013.13.24; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Gusev E. I., 2009, NEVROLOGIYA; Huang TN, 2014, NAT NEUROSCI, V17, P240, DOI 10.1038/nn.3626; Levy A, 2009, J NEUROTRAUM, V26, P1521, DOI 10.1089/neu.2008.0746; Liao HM, 2008, ACTA BIOMATER, V4, P1161, DOI 10.1016/j.actbio.2008.04.013; Marion DW, 2006, NEUROSURGERY, V58, P655; Mayo Clinic Staff, 2014, TRAUMATIC BRAIN INJU; Mo LH, 2010, BIOMATERIALS, V31, P2184, DOI 10.1016/j.biomaterials.2009.11.078; Moscardo E, 2012, MEASURING BEHAV, V2012, P476; Tate CC, 2009, J TISSUE ENG REGEN M, V3, P208, DOI 10.1002/term.154; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Vedunova M, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00149; Wlodarczyk J, 2011, DEV NEUROBIOL, V71, P1040, DOI 10.1002/dneu.20958	21	1	1	3	4	NIZHNIY NOVGOROD STATE MEDICAL ACAD	NIZHNIY NOVGOROD	MININ & POZHARSKY SQUARE, 10-1, NIZHNIY NOVGOROD, 603005, RUSSIA	2076-4243			SOVREM TEHNOL MED	Sovrem. Tehnol. Med.		2017	9	4					106	113		10.17691/stm2017.9.4.13			8	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	FS2ON	WOS:000419618100013		gold			2022-02-06	
J	Basson, WJ; Essack, FA				Basson, Wilna J.; Essack, Fathima A.			Neurobehavioural profile following cumulative mild traumatic brain injury in adolescent rugby players in South Africa	JOURNAL OF PSYCHOLOGY IN AFRICA			English	Article						adolescent; executive function; mild traumatic brain injury; neurobehavioral; rugby	CONCUSSION; RECOMMENDATIONS; HEAD	The study investigated the neurobehavioural components of executive dysfunction following sport-related Mild Traumatic Brain Injury (MTBI) in Grade 12 adolescent rugby players over a rugby season. In a non-equivalent quasi-experimental design, a rugby group (n = 90) were compared with demographically equivalent noncontact sport controls (n = 59). The Behaviour Rating Inventory of Executive Functions -Self Report (BRIEF-SR) was employed to assess the neurobehavioural component of executive functions. Independent and dependent t-test analyses were conducted to compare the groups at baseline and end-of-season intervals. The overall findings suggest more pronounced deleterious effects on executive functioning from exposure to the concussive and sub-concussive events among the rugby group. High school rugby players experience adverse neurobehavioural effects in executive dysfunction from contact rugby sport injuries.	[Basson, Wilna J.; Essack, Fathima A.] Sefako Makgatho Hlth Sci Univ, Dept Psychol, Ga Rankuwa, South Africa		Basson, WJ (corresponding author), Sefako Makgatho Hlth Sci Univ, Dept Psychol, Ga Rankuwa, South Africa.	wilna.basson@smu.ac.za					Bender SD, 2004, STUD NEUROPSYCHOL DE, P3; Boffano P, 2011, J CRANIOFAC SURG, V22, P2053, DOI 10.1097/SCS.0b013e318231988d; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Green MF, 2000, SCHIZOPHRENIA BULL, V26, P119, DOI 10.1093/oxfordjournals.schbul.a033430; Guy SC, 2004, BRIEF SR BEHAV RATIN; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; McIntosh AS, 2010, BRIT J SPORT MED, V44, P188, DOI 10.1136/bjsm.2007.041400; Murray IR, 2015, CLIN J SPORT MED, V25, P75, DOI 10.1097/JSM.0000000000000134; Nicol A, 2011, J PUBLIC HEALTH-UK, V33, P256, DOI 10.1093/pubmed/fdq047; Schwartz A., 2010, NEW YORK TIMES  0726; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461	13	1	1	1	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1433-0237	1815-5626		J PSYCHOL AFR	J. Psychol. Afr.		2017	27	6					553	556		10.1080/14330237.2017.1399547			4	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	FS3PO	WOS:000419694600015					2022-02-06	
J	Bires, AM; Leonard, AL; Thurber, B				Bires, Angela Macci; Leonard, Amanda L.; Thurber, Brandon			Educating Providers in Return-to-Play Suggested Guidelines Postconcussion	CRITICAL CARE NURSING QUARTERLY			English	Article						concussion; provider comfort levels; return-to-play guidelines	CONCUSSION; SPORTS; MANAGEMENT; STATEMENT; IMPACT	treat concussed individuals properly to prevent further complications or death. The primary purpose of this study was to compare a provider's current awareness and comfort level as it relates to the return-to-play guidelines for concussions. A secondary aim was to evaluate current protocols that are in use and determine whether they coincide with the suggested guidelines. An educational intervention was implemented to assess the knowledge and confidence of health care providers. The study design was a quantitative, convenient sample, pretest/posttest questionnaire. The questionnaire was administered to participants who were nurse practitioners prior to an educational PowerPoint presentation. At 8 weeks, the posttest was administered. Approximately 19% of individuals were not aware of a graded return-to-play protocols. The findings suggest that the educational intervention increased their confidence levels in making a diagnosis of a concussion, in assessing danger signs, and in understanding when to refer to a specialist. Additional supporting evidence from this study indicates that the educational intervention allowed the participants to achieve a greater comfort level in finding appropriate resources for them and their patients.	[Bires, Angela Macci] Robert Morris Univ, Dept Hlth Sci, 6001 Univ Blvd, Moon Township, PA 15108 USA; [Leonard, Amanda L.] Manor Care Hlth Serv, Heartland Care Partners, Pittsburgh, PA USA; [Thurber, Brandon] Management Sci Associates, Informat Management Solut, Pittsburgh, PA USA		Bires, AM (corresponding author), Robert Morris Univ, Dept Hlth Sci, 6001 Univ Blvd, Moon Township, PA 15108 USA.	bires@rmu.edu					Centers for Disease Control and Prevention, 2013, CONC MILD TBI WHAT I; Centers for Disease Control and Prevention NCfIPaC, 2011, HEADS FACTS PHYS MIL; Cobb Sarah, 2004, J Sch Nurs, V20, P262; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Fjordbak BS., 2011, AM SPEECH LANG HEAR, V16, P7; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Kushner DS, 2001, AM FAM PHYSICIAN, V64, P1007; Makdissi M, 2010, AUST FAM PHYSICIAN, V39, P12; Martineau Chad, 2007, JAAPA, V20, P22; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McCroy P, 2012, J ATHL TRAINING, V85, P434; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Scorza KA, 2012, AM FAM PHYSICIAN, V85, P123; Tator CH, 2013, CAN MED ASSOC J, V185, P975, DOI 10.1503/cmaj.120039; Yard EE, 2009, BRAIN INJURY, V23, P888, DOI 10.1080/02699050903283171	15	1	1	0	72	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0887-9303	1550-5111		CRIT CARE NURS Q	Crit. Care Nurs. Q.	JAN-MAR	2017	40	1					49	58		10.1097/CNQ.0000000000000141			10	Critical Care Medicine	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	EF3WX	WOS:000390256700009	27893509				2022-02-06	
J	Bloom, BM; Kinsella, K; Pott, J; Patel, HC; Harris, T; Lecky, F; Pearse, R				Bloom, Benjamin M.; Kinsella, Kathryn; Pott, Jason; Patel, Hiren C.; Harris, Tim; Lecky, Fiona; Pearse, Rupert			Short-term neurocognitive and symptomatic outcomes following mild traumatic brain injury: A prospective multi-centre observational cohort study	BRAIN INJURY			English	Article						Mild traumatic brain injury; closed head injury; concussion; neurocognitive outcome; neuropsychological outcome	SPORT-RELATED CONCUSSION; EMERGENCY-DEPARTMENT; HEAD-INJURY; POSTCONCUSSIVE SYMPTOMS; STANDARDIZED ASSESSMENT; FOOTBALL PLAYERS; EPIDEMIOLOGY; SEVERITY; RECOVERY; SAMPLE	Objective: To determine the short-term cognitive and symptomatic outcome following mild traumatic brain injury. Methods: Setting:. Emergency Departments of two UK tertiary referral hospitals. Participants: Adult patients presenting to the Emergency Departments of the Royal London Hospital and Salford Royal Hospital with suspetted traumatic brain injury within 24 hours and Glasgow Coma Score >8. A non-TBI comparison group included adult patients with no head or neck injury. Design: Prospective multi-centre cohort study. Main measures: The Standardized Assessment of Concussion (SAC), the Concussion Symptom Inventory (CSI) and total number of symptoms, measured at baseline and 72 hours. Results: This study enrolled 189 patients with and 51 patients without TBI. Patients with TBI had marked cognitive impairment which persisted at 72 hours (SAC score at baseline = 25 [23-27] vs 72 hours = 25 [22-27]; p = 0.1). Patients with TBI had persistent high symptom severity, although this had decreased at 72 hours (CSI score at baseline = 9 [4-22] vs 72 hours = 5 [1-19], p = 0.002). A similar pattern was observed with the total number of symptoms (baseline = 4 [2-8] vs 72 hours = 0 [0-4]; p < 0.001). Patients with TBI had worse neurocognitive function, higher overall symptom severity and higher total number of symptoms compared with patients without TBI. Patients without TBI' neurocognitive function and symptom severity remained constant, but the number of symptoms reduced between baseline and 72 hours. Conclusion: There is a cognitive deficit and symptom burden in patients with mild TBI presenting to the Emergency Department which persists at 72 hours.	[Bloom, Benjamin M.; Harris, Tim; Pearse, Rupert] Queen Mary Univ London, William Harvey Inst, London, England; [Bloom, Benjamin M.; Pott, Jason; Harris, Tim] Royal London Hosp, Dept Emergency Med, London, England; [Kinsella, Kathryn; Lecky, Fiona] Salford Royal Fdn Trust, Salford Healthcare Directorate, Dept Emergency Med, Salford, Lancs, England; [Patel, Hiren C.] Salford Royal NHS Fdn Trust, Dept Neurosurg, Salford, Lancs, England; [Lecky, Fiona] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England; [Lecky, Fiona] Univ Manchester, Inst Populat Hlth, Trauma Audit & Res Network, Manchester, Lancs, England		Bloom, BM (corresponding author), Royal London Hosp, Emergency Dept, Res Off, London E1 1BB, England.	ben.bloom@nhs.net	Pott, Jason D/A-9077-2015; Patel, Hiren/AAL-3811-2021; Pearse, Rupert/H-5426-2011	Pott, Jason D/0000-0003-2068-0560; Patel, Hiren/0000-0002-1439-8801; Pearse, Rupert/0000-0002-4373-5934; Bloom, Ben/0000-0002-3016-4925	BrainScope Co, Inc. (Bethesda, MD); National Institute for Health ResearchNational Institute for Health Research (NIHR) [RP_2014-04-022, CS/08/08/17] Funding Source: researchfish	The authors report no conflicts of interest. Funding was received from BrainScope Co, Inc. (Bethesda, MD) for conducting the study. The funder had no role in the collection or analysis of the data or of the drafting of the manuscript.	Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Dean PJA, 2012, BRAIN INJURY, V26, P14, DOI 10.3109/02699052.2011.635354; Faul M, 2010, TRAUMATIC BRAIN INJU; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Haboubi NHJ, 2001, DISABIL REHABIL, V23, P635; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P196, DOI 10.1097/00001199-200505000-00003; Luoto TM, 2014, J NEUROTRAUM, V31, P728, DOI 10.1089/neu.2013.3174; Mannix R, 2013, NEUROSURGERY, V73, P129, DOI 10.1227/01.neu.0000429846.14579.41; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrea M, 2001, J ATHL TRAINING, V36, P274; Mounce LTA, 2013, J HEAD TRAUMA REHAB, V28, P397, DOI 10.1097/HTR.0b013e318252dd75; National Institute for Health and Care Excellence Head injury, 2014, TRIAG ASS INV EARL M; Naunheim RS, 2008, J HEAD TRAUMA REHAB, V23, P116, DOI 10.1097/01.HTR.0000314530.30401.70; Peterson SE, 2009, ANN EMERG MED, V53, P796, DOI 10.1016/j.annemergmed.2008.10.015; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Randolph C, 2005, J ATHL TRAINING, V40, P139; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Rickels E, 2010, BRAIN INJURY, V24, P1491, DOI 10.3109/02699052.2010.498006; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Sheedy J, 2009, J HEAD TRAUMA REHAB, V24, P333, DOI 10.1097/HTR.0b013e3181aea51f; Silverberg ND, 2014, BRAIN INJURY, V28, P1590, DOI 10.3109/02699052.2014.943287; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413	27	1	2	1	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	3					304	311		10.1080/02699052.2016.1256501			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EQ3WY	WOS:000398005900004	28156140	Green Accepted			2022-02-06	
B	Bogoslovsky, T; Bernstock, JD; Kenney, K; Moore, C; Diaz-Arrastia, R		Heidenreich, KA		Bogoslovsky, T.; Bernstock, J. D.; Kenney, K.; Moore, C.; Diaz-Arrastia, R.			Erythropoietin and Its Derivatives: Mechanisms of Neuroprotection and Challenges in Clinical Translation	NEW THERAPEUTICS FOR TRAUMATIC BRAIN INJURY: PREVENTION OF SECONDARY BRAIN DAMAGE AND ENHANCEMENT OF REPAIR AND REGENERATION			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; RECOMBINANT-HUMAN-ERYTHROPOIETIN; ELEVATION MYOCARDIAL-INFARCTION; ENDOTHELIAL PROGENITOR CELLS; CARBAMYLATED ERYTHROPOIETIN; RECEPTOR EXPRESSION; DOUBLE-BLIND; ENHANCES NEUROGENESIS; NEUROLOGICAL RECOVERY; CEREBRAL-ISCHEMIA		[Bogoslovsky, T.; Kenney, K.; Moore, C.; Diaz-Arrastia, R.] Uniformed Serv Univ Hlth Sci USUHS, Rockville, MD 20855 USA; [Bernstock, J. D.] NIH, Bldg 10, Bethesda, MD 20892 USA		Bogoslovsky, T (corresponding author), Uniformed Serv Univ Hlth Sci USUHS, Rockville, MD 20855 USA.			Bernstock, Joshua/0000-0002-7814-3867			Adembri C, 2008, CRIT CARE MED, V36, P975, DOI 10.1097/CCM.0B013E3181644343; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asher SR, 2013, J NEUROSURG ANESTH, V25, P168, DOI 10.1097/ANA.0b013e318283d350; Assaraf MI, 2007, J NEUROPATH EXP NEUR, V66, P389, DOI 10.1097/nen.0b013e3180517b28; Bahlmann FH, 2004, BLOOD, V103, P921, DOI 10.1182/blood-2003-04-1284; Banks WA, 2004, EUR J PHARMACOL, V505, P93, DOI 10.1016/j.ejphar.2004.10.035; Bogoslovsky T, 2010, NEUROLOGY, V75, P2059, DOI 10.1212/WNL.0b013e318200d741; Bogoslovsky T., 2012, AM SOC NEUROCHEMISTR; Brines M, 2014, MOL MED, V20, P658, DOI 10.2119/molmed.2014.00215; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Chaichana KL, 2010, WORLD NEUROSURG, V73, P22, DOI 10.1016/j.surneu.2009.05.027; Chateauvieux S, 2011, BIOCHEM PHARMACOL, V82, P1291, DOI 10.1016/j.bcp.2011.06.045; Chen SJ, 2010, CLIN EXP IMMUNOL, V162, P210, DOI 10.1111/j.1365-2249.2010.04238.x; Chong ZZ, 2002, J HEMATOTH STEM CELL, V11, P863, DOI 10.1089/152581602321080529; Corwin HL, 2002, JAMA-J AM MED ASSOC, V288, P2827, DOI 10.1001/jama.288.22.2827; Corwin HL, 2007, NEW ENGL J MED, V357, P965, DOI 10.1056/NEJMoa071533; D'Ambra MN, 1997, ANN THORAC SURG, V64, P1686, DOI 10.1016/S0003-4975(97)00839-4; Dalla Costa D, 2015, NEUROL SCI, V36, P1567, DOI 10.1007/s10072-015-2182-5; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; Ehrenreich H, 2007, MOL PSYCHIATR, V12, P206, DOI 10.1038/sj.mp.4001907; Ehrenreich H, 2004, SCIENCE, V305, P184, DOI 10.1126/science.1100891; Ehrenreich H, 2002, MOL MED, V8, P495, DOI 10.1007/BF03402029; Ehrenreich H, 2011, MOL MED, V17, P1306, DOI 10.2119/molmed.2011.00259; Ehrenreich H, 2009, STROKE, V40, pE647, DOI 10.1161/STROKEAHA.109.564872; Erbayraktar S, 2003, P NATL ACAD SCI USA, V100, P6741, DOI 10.1073/pnas.1031753100; Chamorro ME, 2013, BBA-MOL CELL RES, V1833, P1960, DOI 10.1016/j.bbamcr.2013.04.006; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Fisher JW, 2003, EXP BIOL MED, V228, P1; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Genc S, 2002, NEUROSCI LETT, V321, P73, DOI 10.1016/S0304-3940(02)00041-1; Genc S, 2001, NEUROSCI LETT, V298, P139, DOI 10.1016/S0304-3940(00)01716-X; Ghezzi P, 2004, CELL DEATH DIFFER, V11, pS37, DOI 10.1038/sj.cdd.4401450; Grasso G, 2006, J NEUROSURG-SPINE, V4, P310, DOI 10.3171/spi.2006.4.4.310; Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481; Habgood MD, 2007, EUR J NEUROSCI, V25, P231, DOI 10.1111/j.1460-9568.2006.05275.x; Heeschen C, 2003, BLOOD, V102, P1340, DOI 10.1182/blood-2003-01-0223; Jaquet K, 2002, MICROVASC RES, V64, P326, DOI 10.1006/mvre.2002.2426; Keogh CL, 2007, J PHARMACOL EXP THER, V322, P521, DOI 10.1124/jpet.107.121392; Knoblach SM, 2002, J NEUROTRAUM, V19, P1155, DOI 10.1089/08977150260337967; Lafrenaye AD, 2012, J CEREBR BLOOD F MET, V32, P1919, DOI 10.1038/jcbfm.2012.95; Larner SF, 2005, J NEUROCHEM, V94, P97, DOI 10.1111/j.1471-4159.2005.03172.x; Leist M, 2004, SCIENCE, V305, P239, DOI 10.1126/science.1098313; Lewczuk P, 2000, NEUROREPORT, V11, P3485, DOI 10.1097/00001756-200011090-00017; Li F, 2006, CURR NEUROVASC RES, V3, P187, DOI 10.2174/156720206778018758; Li Y, 2007, NEUROCHEM RES, V32, P2132, DOI 10.1007/s11064-007-9387-9; Lin CS, 1996, GENE DEV, V10, P154, DOI 10.1101/gad.10.2.154; Liu C, 1997, J BIOL CHEM, V272, P32395, DOI 10.1074/jbc.272.51.32395; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Maiese K, 2005, JAMA-J AM MED ASSOC, V293, P90, DOI 10.1001/jama.293.1.90; Marklund N, 2009, NEUROSCIENCE, V163, P540, DOI 10.1016/j.neuroscience.2009.06.042; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; Marti HH, 2004, J EXP BIOL, V207, P3233, DOI 10.1242/jeb.01049; Marti HH, 1997, KIDNEY INT, V51, P416, DOI 10.1038/ki.1997.55; Marti HH, 1996, EUR J NEUROSCI, V8, P666, DOI 10.1111/j.1460-9568.1996.tb01252.x; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; Mennini T, 2006, MOL MED, V12, P153, DOI 10.2119/2006-00045.Mennini; Minnerup J, 2009, STROKE, V40, P3113, DOI 10.1161/STROKEAHA.109.555789; Miskowiak KW, 2014, J CLIN PSYCHIAT, V75, P1347, DOI 10.4088/JCP.13m08839; Miskowiak KW, 2014, NEUROPSYCHOPHARMACOL, V39, P1399, DOI 10.1038/npp.2013.335; Morganti-Kossmann MC, 2010, INJURY, V41, P10, DOI 10.1016/j.injury.2010.03.032; Morishita E, 1997, NEUROSCIENCE, V76, P105, DOI 10.1016/s0306-4522(96)00306-5; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Nirula R, 2010, CRIT CARE RES PRACT, V2010, DOI 10.1155/2010/209848; Oddo M, 2011, NEUROSURGERY, V69, P1037, DOI 10.1227/NEU.0b013e3182287ca7; Ott I, 2010, CIRC-CARDIOVASC INTE, V3, P408, DOI 10.1161/CIRCINTERVENTIONS.109.904425; Patel NSA, 2012, CRIT CARE, V16, DOI 10.1186/cc11315; Peng WJ, 2014, J NEUROSURG, V121, P653, DOI 10.3171/2014.6.JNS132577; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Price CD, 2010, CLIN EXP PHARMACOL P, V37, P185, DOI 10.1111/j.1440-1681.2009.05257.x; Prunier F, 2012, AM HEART J, V163, P200, DOI 10.1016/j.ahj.2011.11.005; Ramirez R, 2009, J MOL CELL CARDIOL, V47, P781, DOI 10.1016/j.yjmcc.2009.09.005; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Sanchez PE, 2009, P NATL ACAD SCI USA, V106, P9848, DOI 10.1073/pnas.0901840106; Sanchez PE, 2009, J COMP NEUROL, V514, P403, DOI 10.1002/cne.22020; Schoch KM, 2012, NEUROTHERAPEUTICS, V9, P323, DOI 10.1007/s13311-012-0107-z; Sinor AD, 2000, NEUROSCI LETT, V290, P213, DOI 10.1016/S0304-3940(00)01361-6; Siren AL, 2001, ACTA NEUROPATHOL, V101, P271, DOI 10.1007/s004010000297; Sobrino T, 2007, STROKE, V38, P2759, DOI 10.1161/STROKEAHA.107.484386; Sugawa M, 2002, NEUROSCI RES, V44, P391, DOI 10.1016/S0168-0102(02)00161-X; Swartjes M, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-13; Talving P, 2010, ANN SURG, V251, P1, DOI 10.1097/SLA.0b013e3181b844fa; Urao N, 2006, CIRC RES, V98, P1405, DOI 10.1161/01.RES.0000224117.59417.f3; van Velzen M, 2014, EXPERT OPIN INV DRUG, V23, P541, DOI 10.1517/13543784.2014.892072; Villa P, 2003, J EXP MED, V198, P971, DOI 10.1084/jem.20021067; Villa P, 2007, J CEREBR BLOOD F MET, V27, P552, DOI 10.1038/sj.jcbfm.9600370; Voors AA, 2010, EUR HEART J, V31, P2593, DOI 10.1093/eurheartj/ehq304; Wang L, 2004, STROKE, V35, P1732, DOI 10.1161/01.STR.0000132196.49028.a4; Wang L, 2007, J BIOL CHEM, V282, P32462, DOI 10.1074/jbc.M706880200; Wang Y, 2007, BRIT J PHARMACOL, V151, P1377, DOI 10.1038/sj.bjp.0707285; Wustenberg T, 2011, MOL PSYCHIATR, V16, P26, DOI 10.1038/mp.2010.51; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Yamaji R, 1996, EUR J BIOCHEM, V239, P494, DOI 10.1111/j.1432-1033.1996.0494u.x; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Yip HK, 2011, CRIT CARE, V15, DOI 10.1186/cc10002; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008; Yu XB, 2002, DEVELOPMENT, V129, P505; Zhang YL, 2009, BRAIN RES, V1294, P153, DOI 10.1016/j.brainres.2009.07.077; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	99	1	1	0	0	ACADEMIC PRESS LTD-ELSEVIER SCIENCE LTD	LONDON	125 LONDON WALL, LONDON EC2Y 5AS, ENGLAND			9780-1-28-02701-1; 9780-1-28-02686-1				2017							57	77		10.1016/B978-0-12-802686-1.00004-3			21	Clinical Neurology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BI5ZM	WOS:000413002900007					2022-02-06	
S	Brauge, D; Adam, P; Julia, M; Chaynes, P; Bernard, P; Sol, JC		Roger, B; Guermazi, A; Skaf, A		Brauge, David; Adam, Philippe; Julia, Marc; Chaynes, Patrick; Bernard, Pierre; Sol, Jean Christophe			The Protective Role of Cervical Spinal Muscle Masses in Sports Related Trauma	MUSCLE INJURIES IN SPORT ATHLETES: CLINICAL ESSENTIALS AND IMAGING FINDINGS	Sports and Traumatology		English	Article; Book Chapter							HUMAN NECK MUSCLES; CORD-INJURY; RUGBY UNION; ICE HOCKEY; STRENGTH; HEAD; FOOTBALL; PLAYERS; BIOMECHANICS; IMPACT	The cervical spine is an anatomically complex structure whose essential roles are to orient the head and the sensory system and to protect the spinal cord. In developed countries, sports related accidents constitute the fourth most common cause of spinal cord trauma. They are the second most frequent case of spinal cord injuries for those under the age of 30. All sports are potentially affected even though it would seem that highly kinetic physical activities or contact sports would be the most concerned. In this chapter, we will first review the anatomy of the cervical spine and then describe the biomechanical basis of the protective effect of the cervical musculature and the neurophysiological aspects of trauma prevention. We will describe how cervical muscles can be evaluated and close with a brief overview of preventative strategies of the French Rugby Federation will be described.	[Brauge, David; Chaynes, Patrick; Sol, Jean Christophe] CHU Purpan, Serv Neurochirurg, Toulouse, France; [Adam, Philippe] Clin Medipole Garonne, Toulouse, France; [Julia, Marc] CHU Lapeyronnie, Serv Med Phys & Readaptat, Montpellier, France; [Bernard, Pierre] Ctr Aquitain dos, Bordeaux, France		Brauge, D (corresponding author), CHU Purpan, Serv Neurochirurg, Toulouse, France.	brauge.d@chu-toulouse.fr					Anderson JS, 2005, SPINE, V30, pE86, DOI 10.1097/01.brs.0000153700.97830.02; Bernard P, 2009, J TRAUMATOL SPORT, V26, P148; Bernhardt P, 1999, CLIN BIOMECH, V14, P32, DOI 10.1016/S0268-0033(98)00031-X; Berry JG, 2006, AUST NZ J PUBL HEAL, V30, P268, DOI 10.1111/j.1467-842X.2006.tb00869.x; Bexander CSM, 2005, EXP BRAIN RES, V167, P422, DOI 10.1007/s00221-005-0048-4; Blouin JS, 2007, J NEUROPHYSIOL, V98, P920, DOI 10.1152/jn.00183.2007; Boden BP, 2006, AM J SPORT MED, V34, P1223, DOI 10.1177/0363546506288306; Bohu Y, 2009, AM J SPORT MED, V37, P319, DOI 10.1177/0363546508325926; Borst J, 2011, CLIN BIOMECH, V26, P343, DOI 10.1016/j.clinbiomech.2010.11.019; Brault JR, 2000, CLIN BIOMECH, V15, P426, DOI 10.1016/S0268-0033(99)00097-2; Brisswalter J, 2013, SPORTS MED, V43, P51, DOI 10.1007/s40279-012-0006-9; Burnett Angus F, 2005, Work, V25, P205; Couvet S., 2012, THESIS FACULTE MED B; Dengel DR, 2014, J STRENGTH COND RES, V28, P1, DOI 10.1519/JSC.0000000000000299; DeVivo MJ, 2012, SPINAL CORD, V50, P365, DOI 10.1038/sc.2011.178; Dietzen C J, 1999, Phys Med Rehabil Clin N Am, V10, P159; Dvir Z, 2008, J MANIP PHYSIOL THER, V31, P518, DOI 10.1016/j.jmpt.2008.08.008; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Franz T, 2008, BRIT J SPORT MED, V42, DOI 10.1136/bjsm.2007.038166; Fuller CW, 2007, CLIN J SPORT MED, V17, P10, DOI 10.1097/JSM.0b013e31802e9c28; Georgeson EC, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001400; Gobbi A, 2004, KNEE SURG SPORT TR A, V12, P574, DOI 10.1007/s00167-004-0510-z; Hedenstierna S, 2009, SPINE, V34, P2626, DOI 10.1097/BRS.0b013e3181b46bdd; Ivancic PC, 2012, J ATHL TRAINING, V47, P489, DOI 10.4085/1062-6050-47.4.06; Jordan A, 1999, SPINE, V24, P1343, DOI 10.1097/00007632-199907010-00012; Kamibayashi LK, 1998, SPINE, V23, P1314, DOI 10.1097/00007632-199806150-00005; KATAOKA J, 1975, J HUMAN ERGOLOGY, V4, P3; Kettler A, 2002, J BIOMECH, V35, P339, DOI 10.1016/S0021-9290(01)00206-8; Kim DH, 2003, CLIN SPORT MED, V22, P501, DOI 10.1016/S0278-5919(02)00105-9; Krueger H, 2013, CHRON DIS INJ CAN, V33, P113; Kruse D, 2009, CURR SPORT MED REP, V8, P20, DOI 10.1249/JSR.0b013e3181967ca6; Kumar S, 2004, CLIN BIOMECH, V19, P543, DOI 10.1016/j.clinbiomech.2004.03.008; Kumar S, 2002, EUR SPINE J, V11, P27, DOI 10.1007/s005860100318; Li F, 2014, J MAGN RESON IMAGING, V39, P1411, DOI 10.1002/jmri.24326; Lin CY, 2011, AM J SPORT MED, V39, P2441, DOI 10.1177/0363546511419280; Mall NA, 2012, AM J SPORT MED, V40, P1755, DOI 10.1177/0363546512448355; Mansell J, 2005, J ATHL TRAINING, V40, P310; MAYOUXBENHAMOU MA, 1989, ERGONOMICS, V32, P513, DOI 10.1080/00140138908966121; MICHAEL D B, 1989, Journal of Neurotrauma, V6, P177; Mihalik JP, 2011, CLIN J SPORT MED, V21, P416, DOI 10.1097/JSM.0B013E31822C8A5C; Moorhouse KM, 2007, J BIOMECH, V40, P1058, DOI 10.1016/j.jbiomech.2006.04.018; MORONEY SP, 1988, J ORTHOPAED RES, V6, P713, DOI 10.1002/jor.1100060514; Nightingale RW, 1996, J BONE JOINT SURG AM, V78A, P412, DOI 10.2106/00004623-199603000-00013; Olivier PE, 2008, J SCI MED SPORT, V11, P96, DOI 10.1016/j.jsams.2007.01.009; PETROFSKY JS, 1982, AVIAT SPACE ENVIR MD, V53, P365; Portero P, 2001, EUR J APPL PHYSIOL, V84, P540, DOI 10.1007/s004210100399; Portero R, 2013, J BIOMECH, V46, P925, DOI 10.1016/j.jbiomech.2012.12.009; Rihn JA, 2009, SPORTS MED, V39, P697, DOI 10.2165/11315190-000000000-00000; ROAF R, 1960, J BONE JOINT SURG BR, V42, P810, DOI 10.1302/0301-620X.42B4.810; Schomacher J, 2012, J NEUROPHYSIOL, V107, P3078, DOI 10.1152/jn.00953.2011; Seacrist T, 2012, CLIN BIOMECH, V27, P326, DOI 10.1016/j.clinbiomech.2011.10.012; Secin FP, 1999, BRIT J SPORT MED, V33, P33, DOI 10.1136/bjsm.33.1.33; Shelly MJ, 2006, J BONE JOINT SURG BR, V88B, P771, DOI 10.1302/0301-620X.88B6; Siegmund GP, 2003, SPINE, V28, P671, DOI 10.1097/00007632-200304010-00010; Siegmund GP, 2007, J BIOMECH ENG-T ASME, V129, P66, DOI 10.1115/1.2401185; Stemper BD, 2011, SPINE, V36, pS180, DOI 10.1097/BRS.0b013e3182387d98; Strimpakos N, 2011, J BODYW MOV THER, V15, P417, DOI 10.1016/j.jbmt.2010.10.001; Swain Michael S, 2010, Chiropr Osteopat, V18, P18, DOI 10.1186/1746-1340-18-18; Tator CH, 2009, CLIN J SPORT MED, V19, P451, DOI 10.1097/JSM.0b013e3181bd0db6; Thelen DG, 1996, J AM GERIATR SOC, V44, P804, DOI 10.1111/j.1532-5415.1996.tb03737.x; Torg JS, 2009, SPORTS HEALTH, V1, P376, DOI 10.1177/1941738109343161; TORG JS, 1993, AM J SPORT MED, V21, P640, DOI 10.1177/036354659302100502; Vasavada AN, 1998, SPINE, V23, P412, DOI 10.1097/00007632-199802150-00002; Vasavada AN, 2008, J BIOMECH, V41, P114, DOI 10.1016/j.jbiomech.2007.07.007; YOGANANDAN N, 1986, SPINE, V11, P855, DOI 10.1097/00007632-198611000-00001	65	1	1	0	4	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	2105-0759		978-3-319-43344-8; 978-3-319-43342-4	SPORT TRAUMATOL			2017							203	217		10.1007/978-3-319-43344-8_12	10.1007/978-3-319-43344-8		15	Rehabilitation; Sport Sciences	Book Citation Index – Science (BKCI-S)	Rehabilitation; Sport Sciences	BI8AX	WOS:000414947200014					2022-02-06	
B	Carmichael, JD		Melmed, S		Carmichael, John D.			Anterior Pituitary Failure	PITUITARY, 4TH EDITION			English	Article; Book Chapter							GROWTH-HORMONE GH; TRAUMATIC BRAIN-INJURY; CLINICAL-PRACTICE GUIDELINE; BONE-MINERAL DENSITY; ISOLATED HYPOGONADOTROPIC HYPOGONADISM; ADULT HYPOPITUITARY PATIENTS; INSULIN-INDUCED HYPOGLYCEMIA; CARDIOVASCULAR RISK-FACTORS; ISOKINETIC MUSCLE STRENGTH; PLACEBO-CONTROLLED TRIAL		[Carmichael, John D.] USC, Keck Sch Med, Los Angeles, CA 90033 USA		Carmichael, JD (corresponding author), USC, Keck Sch Med, Los Angeles, CA 90033 USA.						Abele TA, 2012, CLIN RADIOL, V67, P821, DOI 10.1016/j.crad.2012.01.001; Agarwal G, 2000, J CLIN ENDOCR METAB, V85, P4556, DOI 10.1210/jc.85.12.4556; Agha A, 2006, CLIN ENDOCRINOL, V64, P481, DOI 10.1111/j.1365-2265.2006.02517.x; Aimaretti G, 1998, J CLIN ENDOCR METAB, V83, P1615, DOI 10.1210/jc.83.5.1615; Aimaretti G, 2000, EUR J ENDOCRINOL, V142, P347, DOI 10.1530/eje.0.1420347; Alatzoglou KS, 2009, EARLY HUM DEV, V99, P4712; Alexopoulou O, 2004, EUR J ENDOCRINOL, V150, P1, DOI 10.1530/eje.0.1500001; Andersen B, 2001, ENDOCR REV, V22, P2, DOI 10.1210/er.22.1.2; Arafah BM, 2006, J CLIN ENDOCR METAB, V91, P3725, DOI 10.1210/jc.2006-0674; Arafah BM, 2000, J CLIN ENDOCR METAB, V85, P1789, DOI 10.1210/jc.85.5.1789; Arlt W, 2009, J CLIN ENDOCR METAB, V94, P1059, DOI 10.1210/jc.2009-0032; Atmaca H, 2007, THYROID, V17, P529, DOI 10.1089/thy.2006.0311; Attanasio AF, 2002, J CLIN ENDOCR METAB, V87, P1600, DOI 10.1210/jc.87.4.1600; Bachmann G, 2002, FERTIL STERIL, V77, P660, DOI 10.1016/S0015-0282(02)02969-2; Barkhoudarian G, 2014, WORLD NEUROSURG, V82, pS138, DOI 10.1016/j.wneu.2014.07.017; Barrande G, 2000, J CLIN ENDOCR METAB, V85, P3779, DOI 10.1210/jc.85.10.3779; Beishuizen A, 2001, INTENS CARE MED, V27, P1584, DOI 10.1007/s001340101073; BENGTSSON BA, 1993, J CLIN ENDOCR METAB, V76, P309, DOI 10.1210/jc.76.2.309; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Beshyah SA, 1999, CLIN ENDOCRINOL, V50, P1, DOI 10.1046/j.1365-2265.1999.00682.x; Bhasin S, 2001, ENDOCRIN METAB CLIN, V30, P749, DOI 10.1016/S0889-8529(05)70210-3; Bhasin S, 2006, J CLIN ENDOCR METAB, V91, P1995, DOI 10.1210/jc.2005-2847; Biermasz NR, 2000, J CLIN ENDOCR METAB, V85, P2476, DOI 10.1210/jc.85.7.2476; Bihan H, 2007, MEDICINE, V86, P259, DOI 10.1097/MD.0b013e31815585aa; Biller BMK, 2002, J CLIN ENDOCR METAB, V87, P2067, DOI 10.1210/jcem.87.5.8509; Bin-Abbas B, 1999, J PEDIATR-US, V134, P579, DOI 10.1016/S0022-3476(99)70244-1; Biondi B, 2014, ENDOCR REV, V35, P433, DOI 10.1210/er.2013-1083; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; Bondanelli M, 2008, PITUITARY, V11, P187, DOI 10.1007/s11102-008-0112-8; Borson-Chazot F, 1999, J CLIN ENDOCR METAB, V84, P1329, DOI 10.1210/jc.84.4.1329; Braunstein GD, 2005, ARCH INTERN MED, V165, P1582, DOI 10.1001/archinte.165.14.1582; Bravenboer N, 1997, J CLIN ENDOCR METAB, V82, P1818, DOI 10.1210/jc.82.6.1818; Broersen LHA, 2015, J CLIN ENDOCR METAB, V100, P2171, DOI 10.1210/jc.2015-1218; Brooke AM, 2006, J CLIN ENDOCR METAB, V91, P3773, DOI 10.1210/jc.2006-0316; Bulow B, 1997, CLIN ENDOCRINOL, V46, P75, DOI 10.1046/j.1365-2265.1997.d01-1749.x; Burman P, 1997, J CLIN ENDOCR METAB, V82, P550, DOI 10.1210/jc.82.2.550; Burman P, 2013, J CLIN ENDOCR METAB, V98, P1466, DOI 10.1210/jc.2012-4059; Capatina C, 2015, EUR J ENDOCRINOL, V172, pR179, DOI 10.1530/EJE-14-0794; Carmichael JD, 2012, CURR OPIN ENDOCRINOL, V19, P314, DOI 10.1097/MED.0b013e32835430ed; Carpinteri R, 2009, BEST PRACT RES CL EN, V23, P639, DOI 10.1016/j.beem.2009.05.009; Castinetti F, 2009, J CLIN ENDOCR METAB, V94, P3400, DOI 10.1210/jc.2008-2772; Caturegli P, 2005, ENDOCR REV, V26, P599, DOI 10.1210/er.2004-0011; Chrisoulidou A, 2000, J CLIN ENDOCR METAB, V85, P3762, DOI 10.1210/jc.85.10.3762; Clayton PE, 2005, EUR J ENDOCRINOL, V152, P165, DOI 10.1530/eje.1.01829; Clement K, 2008, J CLIN ENDOCR METAB, V93, P4955, DOI 10.1210/jc.2008-1164; Cohen J, 2006, INTENS CARE MED, V32, P1901, DOI 10.1007/s00134-006-0389-x; Cohen LE, 2012, CURR OPIN ENDOCRINOL, V19, P33, DOI 10.1097/MED.0b013e32834ed639; COHEN LE, 1995, J CLIN ENDOCR METAB, V80, P679, DOI 10.1210/jc.80.2.679; Colao A, 2004, J CLIN ENDOCR METAB, V89, P5998, DOI 10.1210/jc.2004-1042; Colao A, 1999, J CLIN ENDOCR METAB, V84, P1919, DOI 10.1210/jc.84.6.1919; Colao A, 2006, GROWTH HORM IGF RES, V16, pS41, DOI 10.1016/j.ghir.2006.03.006; Conceicao FL, 2003, J ENDOCRINOL INVEST, V26, P1065, DOI 10.1007/BF03345251; Cook DM, 1999, J CLIN ENDOCR METAB, V84, P3956, DOI 10.1210/jc.84.11.3956; Corneli G, 2005, EUR J ENDOCRINOL, V153, P257, DOI 10.1530/eje.1.01967; Corneli G, 2007, PITUITARY, V10, P141, DOI 10.1007/s11102-007-0031-0; Corsello SM, 2013, J CLIN ENDOCR METAB, V98, P1361, DOI 10.1210/jc.2012-4075; Courtney CH, 2000, CLIN ENDOCRINOL, V53, P431, DOI 10.1046/j.1365-2265.2000.01106.x; CUNEO RC, 1991, J APPL PHYSIOL, V70, P695, DOI 10.1152/jappl.1991.70.2.695; Dallapiazza RF, 2015, ENDOCRIN METAB CLIN, V44, P105, DOI 10.1016/j.ecl.2014.10.010; Danaher PJ, 2009, ORTHOPEDICS, V32, P450, DOI 10.3928/01477447-20090511-28; De Marinis L, 2005, J CLIN ENDOCR METAB, V90, P5471, DOI 10.1210/jc.2005-0288; DEBOER H, 1995, ENDOCR REV, V16, P63, DOI 10.1210/er.16.1.63; Degros V, 2003, EUR J ENDOCRINOL, V149, P23, DOI 10.1530/eje.0.1490023; Deladoey J, 1999, J CLIN ENDOCR METAB, V84, P1645, DOI 10.1210/jc.84.5.1645; Delemarre EM, 2008, EUR J ENDOCRINOL, V159, pS9, DOI 10.1530/EJE-08-0314; Diaczok D, 2008, J CLIN ENDOCR METAB, V93, P4351, DOI 10.1210/jc.2008-1189; Dichtel LE, 2014, J CLIN ENDOCR METAB, V99, P4712, DOI 10.1210/jc.2014-2830; Dorin RI, 2003, ANN INTERN MED, V139, P194, DOI 10.7326/0003-4819-139-3-200308050-00009; Drake WM, 2001, CLIN ENDOCRINOL, V54, P525, DOI 10.1046/j.1365-2265.2001.01246.x; DUNKEL L, 1985, J CLIN ENDOCR METAB, V60, P333, DOI 10.1210/jcem-60-2-333; Dutta Pinaki, 2006, Pituitary, V9, P267, DOI 10.1007/s11102-006-8327-z; Elgzyri T, 2004, CLIN ENDOCRINOL, V61, P113, DOI 10.1111/j.1365-2265.2004.02080.x; Erfurth EM, 2013, J CLIN ENDOCR METAB, V98, P4219, DOI 10.1210/jc.2013-2415; Escobar-Morreale HF, 2005, J CLIN ENDOCR METAB, V90, P4946, DOI 10.1210/jc.2005-0184; Fatemi N, 2008, NEUROSURGERY S2, V63, P56; Fatemi N, 2008, NEUROSURGERY, V63, P244, DOI 10.1227/01.NEU.0000327025.03975.BA; Fernandez A, 2009, ENDOCR-RELAT CANCER, V16, P733, DOI 10.1677/ERC-08-0231; Ferretti E, 1999, J CLIN ENDOCR METAB, V84, P924, DOI 10.1210/jc.84.3.924; FINKEL DM, 1985, NEW ENGL J MED, V313, P651, DOI 10.1056/NEJM198509123131102; FINKELSTEIN JS, 1989, J CLIN ENDOCR METAB, V69, P776, DOI 10.1210/jcem-69-4-776; Fukuoka H, 2015, ENDOCRIN METAB CLIN, V44, P143, DOI 10.1016/j.ecl.2014.10.011; Gaillard RC, 2012, EUR J ENDOCRINOL, V166, P1069, DOI 10.1530/EJE-11-1028; Gasco V, 2008, EUR J ENDOCRINOL, V159, pS45, DOI 10.1530/EJE-08-0293; Gazzaruso C, 2014, J CLIN ENDOCR METAB, V99, P18, DOI 10.1210/jc.2013-2394; GHIGO E, 1990, J CLIN ENDOCR METAB, V71, P1481, DOI 10.1210/jcem-71-6-1481; Ghigo E, 1996, EUR J ENDOCRINOL, V134, P352, DOI 10.1530/eje.0.1340352; Gibney J, 1999, J CLIN ENDOCR METAB, V84, P2596, DOI 10.1210/jc.84.8.2596; Gleeson HK, 2003, J CLIN ENDOCR METAB, V88, P2106, DOI 10.1210/jc.2002-020969; Gomez JM, 2002, CLIN ENDOCRINOL, V56, P329, DOI 10.1046/j.1365-2265.2002.01472.x; Grumbach MM, 2005, J CLIN ENDOCR METAB, V90, P3122, DOI 10.1210/jc.2004-2465; Hackney AC, 2003, EUR J APPL PHYSIOL, V89, P198, DOI 10.1007/s00421-003-0794-6; Hamrahian AH, 2004, NEW ENGL J MED, V350, P1629, DOI 10.1056/NEJMoa020266; Hanak BW, 2012, J NEUROSURG, V116, P164, DOI 10.3171/2011.9.JNS11380; Harrington J, 2012, J CLIN ENDOCR METAB, V97, P3056, DOI 10.1210/jc.2012-1598; Hartman ML, 2002, J CLIN ENDOCR METAB, V87, P477, DOI 10.1210/jc.87.2.477; Hartoft-Nielsen ML, 2004, HORM RES, V61, P53, DOI 10.1159/000075239; Haugen BR, 2009, BEST PRACT RES CL EN, V23, P793, DOI 10.1016/j.beem.2009.08.003; He WZ, 2015, PITUITARY, V18, P159, DOI 10.1007/s11102-014-0552-2; Hernandez LM, 2007, PITUITARY, V10, P351, DOI 10.1007/s11102-007-0073-3; Hickey M, 2005, LANCET, V366, P409, DOI 10.1016/S0140-6736(05)66519-1; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; Hoffman AR, 2004, J CLIN ENDOCR METAB, V89, P3224, DOI 10.1210/jc.2003-032082; Hoffman AR, 2004, J CLIN ENDOCR METAB, V89, P2048, DOI 10.1210/jc.2003-030346; Howlett TA, 1997, CLIN ENDOCRINOL, V46, P263, DOI 10.1046/j.1365-2265.1997.1340955.x; Hoybye C, 2009, PITUITARY, V12, P211, DOI 10.1007/s11102-008-0163-x; Isidori AM, 2008, PITUITARY, V11, P171, DOI 10.1007/s11102-008-0111-9; Jodar E, 2003, CLIN ENDOCRINOL, V58, P617, DOI 10.1046/j.1365-2265.2003.01761.x; Johannsson G, 1996, J CLIN ENDOCR METAB, V81, P2865, DOI 10.1210/jc.81.8.2865; Johannsson G, 1997, J CLIN ENDOCR METAB, V82, P2877, DOI 10.1210/jc.82.9.2877; Johannsson G, 2015, CLIN ENDOCRINOL, V82, P2, DOI 10.1111/cen.12603; Jonklaas J, 2008, JAMA-J AM MED ASSOC, V299, P769, DOI 10.1001/jama.299.7.769; JORGENSEN JOL, 1994, CLIN ENDOCRINOL, V41, P609, DOI 10.1111/j.1365-2265.1994.tb01826.x; Karavitaki N, 2006, CLIN ENDOCRINOL, V65, P524, DOI 10.1111/j.1365-2265.2006.02627.x; Karavitaki N, 2006, ENDOCR REV, V27, P371, DOI 10.1210/er.2006-0002; Kazlauskaite R, 2008, J CLIN ENDOCR METAB, V93, P4245, DOI 10.1210/jc.2008-0710; Klose M, 2013, J CLIN ENDOCR METAB, V98, P3802, DOI 10.1210/jc.2013-1610; Klose M, 2015, J CLIN MED, V4, P1480, DOI 10.3390/jcm4071480; Kokshoorn NE, 2012, PITUITARY, V15, P436, DOI 10.1007/s11102-011-0344-x; Kokshoorn NE, 2010, EUR J ENDOCRINOL, V162, P11, DOI 10.1530/EJE-09-0601; Kristrom B, 2009, J CLIN ENDOCR METAB, V94, P1154, DOI 10.1210/jc.2008-0325; Lamolet B, 2001, CELL, V104, P849, DOI 10.1016/S0092-8674(01)00282-3; Lania A, 2008, PITUITARY, V11, P181, DOI 10.1007/s11102-008-0122-6; Lania A, 2012, BEST PRACT RES CL EN, V26, P395, DOI [10.1016/j.beem.2011.10.009, 10.1007/s11102-013-0517-x]; Larson A, 2015, DISCOV MED, V19, P175; Layman LC, 2007, ENDOCRIN METAB CLIN, V36, P283, DOI 10.1016/j.ecl.2007.03.010; Lee CC, 2014, J CLIN ENDOCR METAB, V99, P1273, DOI 10.1210/jc.2013-3743; Leporati P, 2011, J CLIN ENDOCR METAB, V96, P1971, DOI 10.1210/jc.2010-2970; Leung KC, 2004, ENDOCR REV, V25, P693, DOI 10.1210/er.2003-0035; Lewis AS, 2009, PITUITARY, V12, P273, DOI 10.1007/s11102-008-0090-x; LITTLEY MD, 1989, Q J MED, V70, P145; Machinis K, 2005, J CLIN ENDOCR METAB, V90, P5456, DOI 10.1210/jc.2004-2332; Maghnie M, 2005, EUR J ENDOCRINOL, V152, P735, DOI 10.1530/eje.1.01911; Mah PM, 2005, J CLIN ENDOCR METAB, V90, P5964, DOI 10.1210/jc.2005-1207; Maison P, 2003, CIRCULATION, V108, P2648, DOI 10.1161/01.CIR.0000100720.01867.1D; Maison P, 2004, J CLIN ENDOCR METAB, V89, P2192, DOI 10.1210/jc.2003-030840; Mamelak AN, 2013, PITUITARY, V16, P393, DOI 10.1007/s11102-012-0437-1; Marik PE, 2002, CHEST, V122, P1784, DOI 10.1378/chest.122.5.1784; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; McCord MW, 1997, INT J RADIAT ONCOL, V39, P437, DOI 10.1016/S0360-3016(97)00335-0; McDermott JH, 2005, J CLIN ENDOCR METAB, V90, P2451, DOI 10.1210/jc.2004-0980; Mehta A, 2008, BEST PRACT RES CL EN, V22, P191, DOI 10.1016/j.beem.2007.07.007; Menon Dileep V, 2006, Treat Endocrinol, V5, P37, DOI 10.2165/00024677-200605010-00005; Miller J, 2006, PEDIATR NEUROL, V34, P242, DOI 10.1016/j.pediatrneurol.2005.08.032; Miller KK, 2006, J CLIN ENDOCR METAB, V91, P1683, DOI 10.1210/jc.2005-2596; Miller KK, 2001, J CLIN ENDOCR METAB, V86, P561, DOI 10.1210/jc.86.2.561; Minniti G, 2009, REV ENDOCR METAB DIS, V10, P135, DOI 10.1007/s11154-008-9106-0; Mirocha S, 2009, CLIN EXP IMMUNOL, V155, P403, DOI 10.1111/j.1365-2249.2008.03828.x; Molitch ME, 2007, HORM RES, V68, P145, DOI 10.1159/000110611; Molitch ME, 2011, J CLIN ENDOCR METAB, V96, P1587, DOI 10.1210/jc.2011-0179; MOLITCH ME, 1990, ANN INTERN MED, V112, P925, DOI 10.7326/0003-4819-112-12-925; Mullis PE, 2005, EUR J ENDOCRINOL, V152, P11, DOI 10.1530/eje.1.01797; Murray RD, 2002, J CLIN ENDOCR METAB, V87, P4427, DOI 10.1210/jc.2002-020430; Murray RD, 1999, CLIN ENDOCRINOL, V51, P565, DOI 10.1046/j.1365-2265.1999.00838.x; Nater A, 2012, ENDOCR PATHOL, V23, P205, DOI 10.1007/s12022-012-9214-y; Netchine I, 2000, NAT GENET, V25, P182, DOI 10.1038/76041; Newman CB, 2015, PITUITARY, V18, P297, DOI 10.1007/s11102-014-0571-z; Nielsen EH, 2007, CLIN ENDOCRINOL, V67, P693, DOI 10.1111/j.1365-2265.2007.02947.x; Nomikos P, 2004, ACTA NEUROCHIR, V146, P27, DOI 10.1007/s00701-003-0174-3; Ntali G, 2015, ENDOCRIN METAB CLIN, V44, P117, DOI 10.1016/j.ecl.2014.10.009; Palmert MR, 2012, NEW ENGL J MED, V366, P443, DOI 10.1056/NEJMcp1109290; Parasrampuria J, 1998, JAMA-J AM MED ASSOC, V280, P1565, DOI 10.1001/jama.280.18.1565; Pokrajac A, 2007, CLIN ENDOCRINOL, V67, P65, DOI 10.1111/j.1365-2265.2007.02836.x; Ragge NK, 2005, AM J HUM GENET, V76, P1008, DOI 10.1086/430721; Rasmussen MH, 2010, MOL CELL ENDOCRINOL, V316, P147, DOI 10.1016/j.mce.2009.08.017; Reimondo G, 2008, PITUITARY, V11, P147, DOI 10.1007/s11102-008-0108-4; Reiter EO, 2006, J CLIN ENDOCR METAB, V91, P2047, DOI 10.1210/jc.2005-2284; Reynolds RM, 2006, CLIN ENDOCRINOL, V64, P82, DOI 10.1111/j.1365-2265.2005.02421.x; Richmond EJ, 2008, PITUITARY, V11, P115, DOI 10.1007/s11102-008-0105-7; Roberts CGP, 2004, LANCET, V363, P793, DOI 10.1016/S0140-6736(04)15696-1; Romero C, 2009, TRENDS ENDOCRINOLOGY; ROSEN T, 1990, LANCET, V336, P285, DOI 10.1016/0140-6736(90)91812-O; Rosenbloom AL, 1999, J CLIN ENDOCR METAB, V84, P50, DOI 10.1210/jc.84.1.50; ROSENFELD RG, 1995, J CLIN ENDOCR METAB, V80, P1532, DOI 10.1210/jc.80.5.1532; Rosilio M, 2004, J CLIN ENDOCR METAB, V89, P1684, DOI 10.1210/jc.2003-030134; Salvatori R, 2005, JAMA-J AM MED ASSOC, V294, P2481, DOI 10.1001/jama.294.19.2481; Schmidt IL, 2003, J CLIN ENDOCR METAB, V88, P4193, DOI 10.1210/jc.2002-021897; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2007, LANCET, V369, P1461, DOI 10.1016/S0140-6736(07)60673-4; Selva KA, 2002, J PEDIATR-US, V141, P786, DOI 10.1067/mpd.2002.128887; Sesmilo G, 2001, J CLIN ENDOCR METAB, V86, P1518, DOI 10.1210/jc.86.4.1518; Sesmilo G, 2000, ANN INTERN MED, V133, P111, DOI 10.7326/0003-4819-133-2-200007180-00010; Skouby SO, 2005, MATURITAS, V51, P8, DOI 10.1016/j.maturitas.2005.02.019; Smith JC, 2002, CLIN ENDOCRINOL, V56, P493, DOI 10.1046/j.1365-2265.2002.01514.x; Snead FE, 2008, INT J RADIAT ONCOL, V71, P994, DOI 10.1016/j.ijrobp.2007.11.057; Stanworth RD, 2009, FRONT HORM RES, V37, P74, DOI 10.1159/000176046; Suliman AM, 2002, CLIN ENDOCRINOL, V56, P533, DOI 10.1046/j.1365-2265.2002.01509.x; Svensson J, 2003, J CLIN ENDOCR METAB, V88, P2061, DOI 10.1210/jc.2002-020901; TANNER JM, 1985, J PEDIATR-US, V107, P317, DOI 10.1016/S0022-3476(85)80501-1; Thaler LM, 1998, J CLIN ENDOCR METAB, V83, P2726, DOI 10.1210/jc.83.8.2726; Tomlinson JW, 2001, LANCET, V357, P425, DOI 10.1016/S0140-6736(00)04006-X; Tordjman K, 2000, CLIN ENDOCRINOL, V52, P633, DOI 10.1046/j.1365-2265.2000.00984.x; Turton JPG, 2005, J CLIN ENDOCR METAB, V90, P4762, DOI 10.1210/jc.2005-0570; van Bunderen CC, 2011, J CLIN ENDOCR METAB, V96, P3151, DOI 10.1210/jc.2011-1215; Verhelst J, 2009, EUR J ENDOCRINOL, V161, pS41, DOI 10.1530/EJE-09-0291; Vi TN, 2009, PITUITARY, V12, P125, DOI 10.1007/s11102-008-0101-y; Wallace I, 2009, ANN CLIN BIOCHEM, V46, P351, DOI 10.1258/acb.2009.009101; Webb EA, 2010, EUR J HUM GENET, V18, P393, DOI 10.1038/ejhg.2009.125; Wierman ME, 2006, J CLIN ENDOCR METAB, V91, P3697, DOI 10.1210/jc.2006-1121; Wood L, 2008, ANN CLIN BIOCHEM, V45, P380, DOI 10.1258/acb.2007.007119; Woodhouse LJ, 1999, J CLIN ENDOCR METAB, V84, P4570, DOI 10.1210/jc.84.12.4570; WU FCW, 1993, J CLIN ENDOCR METAB, V76, P26, DOI 10.1210/jc.76.1.26; Wuster C, 2001, J BONE MINER RES, V16, P398, DOI 10.1359/jbmr.2001.16.2.398; Wyatt A, 2008, HUM MUTAT, V29, pE278, DOI 10.1002/humu.20869; Yamamoto M, 2011, J CLIN INVEST, V121, P113, DOI 10.1172/JCI44073; Yong TY, 2008, PITUITARY, V11, P77, DOI 10.1007/s11102-007-0021-2; Yuen KCJ, 2009, J CLIN ENDOCR METAB, V94, P2702, DOI 10.1210/jc.2009-0299; Zada G, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS09318; Zhang FL, 2009, J CLIN NEUROSCI, V16, P1273, DOI 10.1016/j.jocn.2009.01.003	209	1	1	0	0	ACADEMIC PRESS LTD-ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL ROAD, LONDON NW1 7DX, ENGLAND			978-0-12-813421-4; 978-0-12-804169-7				2017							329	364		10.1016/B978-0-12-804169-7.00010-6			36	Endocrinology & Metabolism	Book Citation Index – Science (BKCI-S)	Endocrinology & Metabolism	BJ3WP	WOS:000424462900011					2022-02-06	
B	Cebak, JE; Singh, IN; Wang, JA; Hill, RL; Kulbe, JR; Hall, ED		Heidenreich, KA		Cebak, J. E.; Singh, I. N.; Wang, J. A.; Hill, R. L.; Kulbe, J. R.; Hall, E. D.			Carbonyl Scavenging as an Antioxidant Neuroprotective Strategy for Acute Traumatic Brain Injury	NEW THERAPEUTICS FOR TRAUMATIC BRAIN INJURY: PREVENTION OF SECONDARY BRAIN DAMAGE AND ENHANCEMENT OF REPAIR AND REGENERATION			English	Article; Book Chapter							SPINAL-CORD-INJURY; INDUCED OXIDATIVE DAMAGE; ACUTE MITOCHONDRIAL DYSFUNCTION; NERVOUS-SYSTEM TRAUMA; LIPID-PEROXIDATION; ALZHEIMERS-DISEASE; IMPAIRED MITOCHONDRIAL; REACTIVE ALDEHYDES; ACROLEIN; STRESS		[Cebak, J. E.; Singh, I. N.; Wang, J. A.; Hill, R. L.; Kulbe, J. R.; Hall, E. D.] Univ Kentucky, Coll Med, Lexington, KY 40506 USA		Cebak, JE (corresponding author), Univ Kentucky, Coll Med, Lexington, KY 40506 USA.		Hall, Edward D/F-8930-2013				Azbill RD, 1997, BRAIN RES, V765, P283, DOI 10.1016/S0006-8993(97)00573-8; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Burcham PC, 2008, MINI-REV MED CHEM, V8, P319, DOI 10.2174/138955708783955953; Burcham PC, 2004, MOL PHARMACOL, V65, P655, DOI 10.1124/mol.65.3.655; Burcham PC, 2006, MOL PHARMACOL, V69, P1056, DOI 10.1124/mol.105.018168; Burcham PC, 2002, TOXICOLOGY, V181, P229, DOI 10.1016/S0300-483X(02)00287-1; Calingasan NY, 1999, J NEUROCHEM, V72, P751, DOI 10.1046/j.1471-4159.1999.0720751.x; Carrico KM, 2009, J NEUROTRAUM, V26, P1369, DOI 10.1089/neu.2008-0870; Cebak J, 2015, J NEUROTRAUM, V32, pA118; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; Galvani S, 2008, FREE RADICAL BIO MED, V45, P1457, DOI 10.1016/j.freeradbiomed.2008.08.026; Hall E D, 1994, Adv Pharmacol, V28, P221, DOI 10.1016/S1054-3589(08)60497-4; Hall E.D., 2015, BRAIN NEUROTRAUMA MO, P49; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hamann K, 2008, J NEUROCHEM, V104, P708, DOI 10.1111/j.1471-4159.2007.05002.x; Hamann K, 2009, J NEUROCHEM, V111, P1348, DOI 10.1111/j.1471-4159.2009.06395.x; Lovell MA, 2001, NEUROBIOL AGING, V22, P187, DOI 10.1016/S0197-4580(00)00235-9; Luo H, 2004, NEUROCHEM INT, V44, P475, DOI 10.1016/j.neuint.2003.09.006; Luo J, 2005, NEUROCHEM INT, V46, P243, DOI 10.1016/j.neuint.2004.09.001; Luo J, 2005, NEUROCHEM RES, V30, P291, DOI 10.1007/s11064-005-2602-7; Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6; Markesbery WR, 1998, NEUROBIOL AGING, V19, P33, DOI 10.1016/S0197-4580(98)00009-8; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; Mbye LH, 2008, EXP NEUROL, V209, P243, DOI 10.1016/j.expneurol.2007.09.025; Mustafa AG, 2010, J NEUROCHEM, V114, P271, DOI 10.1111/j.1471-4159.2010.06749.x; Park J, 2014, NEURAL REGEN RES, V9, P677, DOI 10.4103/1673-5374.131564; Shi R, 2002, NEUROSCIENCE, V115, P337, DOI 10.1016/S0306-4522(02)00457-8; Shi RY, 2011, MOL NUTR FOOD RES, V55, P1320, DOI 10.1002/mnfr.201100217; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Singh IN, 2013, J CEREBR BLOOD F MET, V33, P593, DOI 10.1038/jcbfm.2012.211; Song MS, 2010, J NEUROCHEM, V114, P1405, DOI 10.1111/j.1471-4159.2010.06857.x; Springer JE, 1997, J NEUROCHEM, V68, P2469; Sullivan PG, 2007, J NEUROTRAUM, V24, P991, DOI 10.1089/neu.2006.0242; Sullivan PG, 2011, J NEUROTRAUM, V28, P311, DOI 10.1089/neu.2010.1646; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Vaishnav RA, 2010, J NEUROTRAUM, V27, P1311, DOI 10.1089/neu.2009.1172; Williams TI, 2006, NEUROBIOL AGING, V27, P1094, DOI 10.1016/j.neurobiolaging.2005.06.004; Wondrak GT, 2002, BIOCHEM PHARMACOL, V63, P361, DOI 10.1016/S0006-2952(01)00915-7; Wood PL, 2006, BRAIN RES, V1122, P184, DOI 10.1016/j.brainres.2006.09.003; Xiong Y, 2005, J NEUROCHEM, V95, P732, DOI 10.1111/j.1471-4159.2005.03412.x; Xiong YQ, 2007, J NEUROCHEM, V100, P639, DOI 10.1111/j.1471-4159.2006.04312.x; Xiong YQ, 2009, FREE RADICAL RES, V43, P604, DOI 10.1080/10715760902977432	43	1	1	0	2	ACADEMIC PRESS LTD-ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL ROAD, LONDON NW1 7DX, ENGLAND			9780-1-28-02701-1; 9780-1-28-02686-1				2017							211	224		10.1016/B978-0-12-802686-1.00013-4			14	Clinical Neurology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BI5ZM	WOS:000413002900016					2022-02-06	
J	Choi, WW; Lee, K; Lee, BJ; Park, SU; Park, JM; Ko, CN; Bu, Y				Choi, Won-Woo; Lee, Kyungjin; Lee, Beom-Joon; Park, Seong-Uk; Park, Jung-Mi; Ko, Chang-Nam; Bu, Youngmin			The Effects of Chunghyul-Dan, an Agent of Korean Medicine, on a Mouse Model of Traumatic Brain Injury	EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE			English	Article							TRADITIONAL CHINESE MEDICINE; CONTROLLED CORTICAL IMPACT; MEMORY; NEUROPROTECTION; RATS; NEURODEGENERATION; DYSFUNCTION; IMPAIRMENTS; GENIPOSIDE; EXPRESSION	Chunghyul-Dan (CHD) is the first choice agent for the prevention and treatment of stroke at the Kyung Hee Medical Hospital. To date, CHD has been reported to have beneficial effects on brain disease in animals and humans, along with antioxidative and antiinflammatory effects. The aim of this study was to evaluate the pharmacological effects of CHD on a traumatic brain injury (TBI) mouse model to explore the possibility of CHD use in patients with TBI. The TBI mouse model was induced using the controlled cortical impact method. CHD was orally administered twice a day for 5 d after TBI induction; mice were assessed for brain damage, brain edema, blood-brain barrier (BBB) damage, motor deficits, and cognitive impairment. Treatment with CHD reduced brain damage seen on histological examination and improvedmotor and cognitive functions. However, CHDdid not reduce brain edema and BBB damage. In conclusion, CHD could be a candidate agent in the treatment of patients with TBI. Further studies are needed to assess the exact mechanisms of the effects during the acute-subacute phase and pharmacological activity during the chronicconvalescent phase of TBI.	[Choi, Won-Woo] Kyung Hee Univ, Grad Sch, Dept Clin Korean Med, Seoul 02447, South Korea; [Lee, Beom-Joon; Park, Seong-Uk; Park, Jung-Mi; Ko, Chang-Nam; Bu, Youngmin] Kyung Hee Univ, Coll Korean Med, Seoul 02447, South Korea		Bu, Y (corresponding author), Kyung Hee Univ, Coll Korean Med, Seoul 02447, South Korea.	ymbu@khu.ac.kr	Park, SeongUk/AAH-9248-2020	Park, SeongUk/0000-0002-4617-2719; Lee, Beom-Joon/0000-0003-4205-1175; Park, Seong-Uk/0000-0002-8611-568X	Korea Health Technology R&D Project through Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI15C0116]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2016R1A2B4012546]	This research was supported by a grant of Korea Health Technology R&D Project through Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (Grant no. HI15C0116), and by a grant of Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (Grant no. 2016R1A2B4012546).	Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Arvin KL, 2002, ANN NEUROL, V52, P54, DOI 10.1002/ana.10242; Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Chen YM, 2015, EUR J PHARMACOL, V768, P21, DOI 10.1016/j.ejphar.2015.09.029; Cho KH, 2005, AM J CHINESE MED, V33, P241, DOI 10.1142/S0192415X05002898; Cho KH, 2004, BIOL PHARM BULL, V27, P1810, DOI 10.1248/bpb.27.1810; Cho K, 2008, NEUROL RES, V30, P655, DOI 10.1179/174313208X305382; Choi JG, 2011, NEUROBIOL LEARN MEM, V96, P306, DOI 10.1016/j.nlm.2011.06.004; Du YS, 2001, P NATL ACAD SCI USA, V98, P14669, DOI 10.1073/pnas.251341998; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; GOLDSTEIN LB, 1990, J NEUROSCI METH, V31, P101, DOI 10.1016/0165-0270(90)90154-8; HAMM RJ, 1992, NEUROSURGERY, V31, P1072, DOI 10.1227/00006123-199212000-00013; Homsi S, 2009, BRAIN RES, V1291, P122, DOI 10.1016/j.brainres.2009.07.031; Hughes RH, 2014, BRAIN RES, V1543, P308, DOI 10.1016/j.brainres.2013.11.020; KIM GH, 2009, J ORIENTAL NEUROPSYC, V20, P21; Kim HG, 2014, CAN J PHYSIOL PHARM, V92, P429, DOI 10.1139/cjpp-2013-0229; Kim HG, 2010, BASIC CLIN PHARMACOL, V107, P958, DOI 10.1111/j.1742-7843.2010.00612.x; Kim YS, 2002, BIOL PHARM BULL, V25, P1442, DOI 10.1248/bpb.25.1442; Ko CN, 2013, CHIN J INTEGR MED, V19, P940, DOI 10.1007/s11655-013-1657-6; Kong XY, 2014, NEURAL REGEN RES, V9, P2066, DOI 10.4103/1673-5374.147933; Lee B, 2012, KOREAN J PHYSIOL PHA, V16, P79, DOI 10.4196/kjpp.2012.16.2.79; Li FH, 2016, J ETHNOPHARMACOL, V185, P77, DOI 10.1016/j.jep.2016.03.025; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lu K, 2015, MOL MED REP, V12, P2689, DOI 10.3892/mmr.2015.3693; LYETH BG, 1993, J NEUROTRAUM, V10, P57, DOI 10.1089/neu.1993.10.57; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Matthew CB, 2002, CAN J PHYSIOL PHARM, V80, P233, DOI 10.1139/Y02-044; Messier C, 1997, NEUROBIOL LEARN MEM, V67, P172, DOI 10.1006/nlme.1996.3755; Miao GX, 2014, NEURAL REGEN RES, V9, P1592, DOI 10.4103/1673-5374.141784; Nam Y, 2013, J TRADIT CHIN MED, V33, P223, DOI 10.1016/S0254-6272(13)60129-6; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; Oshima N, 2013, J NAT MED-TOKYO, V67, P281, DOI 10.1007/s11418-012-0679-2; Park SU, 2006, AM J CHINESE MED, V34, P553, DOI 10.1142/S0192415X06004090; 조기호, 2005, [Journal of Korean Medicine, 대한한의학회지], V26, P77; Park SU, 2005, CAN J PHYSIOL PHARM, V83, P1101, DOI 10.1139/y05-106; Park YK, 2007, INT IMMUNOPHARMACOL, V7, P955, DOI 10.1016/j.intimp.2006.03.018; Quintard H, 2014, NEUROSCIENCE, V277, P72, DOI 10.1016/j.neuroscience.2014.06.047; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Shang YZ, 2013, NEURAL REGEN RES, V8, P514, DOI 10.3969/j.issn.1673-5374.2013.06.004; Shin SS, 2015, J NEUROTRAUM, V32, P1429, DOI 10.1089/neu.2014.3445; Singleton RH, 2010, J NEUROTRAUM, V27, P1091, DOI 10.1089/neu.2010.1291; Tsai MC, 2015, J NEUROIMMUNE PHARM, V10, P45, DOI 10.1007/s11481-014-9570-0; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Wang WZ, 2016, MOL NEUROBIOL, V53, P4809, DOI 10.1007/s12035-015-9385-x; Wee SS, 2005, BIOL PHARM BULL, V28, P1079, DOI 10.1248/bpb.28.1079; Wood NI, 1996, BEHAV BRAIN RES, V78, P113, DOI 10.1016/0166-4328(95)00237-5; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yang ST, 2014, AM J CHINESE MED, V42, P1357, DOI 10.1142/S0192415X14500852; Yun SP, 2005, AM J CHINESE MED, V33, P357, DOI 10.1142/S0192415X05002977; Zhang Q, 2012, ACTA PHYSIOL HUNG, V99, P311, DOI 10.1556/APhysiol.99.2012.3.8; Zhu FQ, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-78; Zhu Kun-Jie, 2014, Zhongguo Zhong Yao Za Zhi, V39, P4007	55	1	1	0	3	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1741-427X	1741-4288		EVID-BASED COMPL ALT	Evid.-based Complement Altern. Med.		2017	2017								7326107	10.1155/2017/7326107			9	Integrative & Complementary Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Integrative & Complementary Medicine	EX4YK	WOS:000403241700001	28684970	gold, Green Submitted, Green Published			2022-02-06	
J	Cripps, A; Livingston, SC				Cripps, Andrea; Livingston, Scott C.			Differentiating Concussion From Intracranial Pathology in Athletes	JOURNAL OF SPORT REHABILITATION			English	Article						mild traumatic brain injury; sports; epidura/subdural hematoma; signs and symptoms	MILD HEAD-INJURY; COMPUTED-TOMOGRAPHY; SPORT; METAANALYSIS; RELIABILITY; MANAGEMENT; PREDICTORS; CHILDREN; NEED	Clinical Scenario: A cerebral concussion is a traumatically induced transient disturbance of brain function characterized by a complex pathophysiologic process and is classified as a subset of mild traumatic brain injury. The occurrence of intracranial lesions after sport-related head injury is relatively uncommon, but the possibility of serious intracranial injury (ICI) should be included in the differential diagnosis. ICIs are potentially life threatening and necessitate urgent medical management; therefore, prompt recognition and evaluation are critical to proper medical management. One of the primary objectives of the initial evaluation is to determine if the concussed athlete has an acute traumatic ICI. Athletic trainers must be able promptly recognize clinical signs and symptoms that will enable them to accurately differentiate between a concussion (ie, a closed head injury not associated with significant ICI) and an ICI. The identification of predictors of intracranial lesions is, however, relatively broad. Focused Clinical Question: Which clinical examination findings (ie, clinical signs and symptoms) indicate possible intracranial pathology in individuals with acute closed head injuries?	[Cripps, Andrea] Bowling Green State Univ, Athlet Training Program, Bowling Green, OH 43403 USA; [Livingston, Scott C.] Def & Vet Brain Injury Ctr, Def Ctr Excellence, Silver Spring, MD USA		Cripps, A (corresponding author), Bowling Green State Univ, Athlet Training Program, Bowling Green, OH 43403 USA.	acripps@bgsu.edu					Alexander D, 2003, PEDIATR EMERG CARE, V19, P185; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bailes JE, 2001, J ATHL TRAINING, V36, P236; Broglio SP, 2009, SPORTS HEALTH, V1, P361, DOI 10.1177/1941738109343158; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Da Dalt L, 2006, EUR J PEDIATR, V165, P142, DOI 10.1007/s00431-005-0019-6; Dunning J, 2004, J NEUROTRAUM, V21, P877, DOI 10.1089/0897715041526122; Dunning J, 2004, ARCH DIS CHILD, V89, P653, DOI 10.1136/adc.2003.027722; Fabbri A, 2011, J TRAUMA, V70, pE79, DOI 10.1097/TA.0b013e3181d4885a; Falimirski ME, 2003, J TRAUMA, V55, P1, DOI 10.1097/01.TA.0000071295.67263.A2; Fung M, 2006, BRAIN INJURY, V20, P889, DOI 10.1080/02699050600831934; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hofman PAM, 2000, J NEUROL NEUROSUR PS, V68, P416, DOI 10.1136/jnnp.68.4.416; Ibanez J, 2004, J NEUROSURG, V100, P825, DOI 10.3171/jns.2004.100.5.0825; Jagoda AS, 2010, PSYCHIAT CLIN N AM, V33, P797, DOI 10.1016/j.psc.2010.09.004; Jagoda AS, 2002, ANN EMERG MED, V40, P231, DOI [10.1067/mem.2002.125782, 10.1016/j.jen.2008.12.010]; Jamaluddin S, 2011, SINGAP MED J, V52, P681; Koc RK, 1997, NEUROSURG REV, V20, P239, DOI 10.1007/BF01105894; McCrory PR, 1998, SPORTS MED, V25, P131, DOI 10.2165/00007256-199825020-00005; Mueller FO, 2001, J ATHL TRAINING, V36, P312; Oman JA, 2006, PEDIATRICS, V117, pE238, DOI 10.1542/peds.2005-1063; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; PHUENPATHOM N, 1993, SURG NEUROL, V40, P22, DOI 10.1016/0090-3019(93)90164-V; Piland SG, 2003, J ATHL TRAINING, V38, P104; Sanders MJ, 2011, MOSBYS PARAMEDIC TXB; Vaughan N, 1997, BRAIN INJURY, V11, P815, DOI 10.1080/026990597123025	27	1	1	0	4	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	JAN	2017	26	1					101	108		10.1123/jsr.2015-0043			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	EN4EH	WOS:000395960300013	27834566				2022-02-06	
S	Cummings, L		Poggi, F; Capone, A		Cummings, Louise			Pragmatic Disorders in Forensic Settings	PRAGMATICS AND LAW: PRACTICAL AND THEORETICAL PERSPECTIVES	Perspectives in Pragmatics Philosophy and Psychology		English	Article; Book Chapter						Attention deficit hyperactivity disorder; Autism spectrum disorder; Conduct disorder; Courtroom examination; Intellectual disability; Police interview; Pragmatic disorder; Rehabilitation; Schizophrenia; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; FRAGILE-X-SYNDROME; DEFICIT HYPERACTIVITY DISORDER; HIGH-FUNCTIONING AUTISM; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; SOCIAL COMMUNICATION DEFICITS; ASPERGER-SYNDROME; WILLIAMS-SYNDROME; PSYCHIATRIC-DISORDERS; SPECTRUM DISORDERS	Clients with pragmatic disorders are over-represented in the criminal justice system in comparison to the general population. Many of these disorders occur as part of conditions which are well recognised for their pragmatic impairments, including autism spectrum disorder, intellectual disability and schizophrenia. Others arise as a result of conditions which are somewhat less well known in clinical pragmatics, but in which there is increasing evidence of impairment in the areas of pragmatics and discourse (e.g. non-Alzheimer's dementias). This chapter will examine the pragmatic disorders in these clinical populations. This examination will consider a number of factors that complicate the presentation, assessment and treatment of pragmatic impairments within forensic settings. These factors include the role of co-morbid conditions such as substance use disorders, the involvement of cognitive deficits such as theory of mind impairments in pragmatic disorders and societal prejudice against incarcerated individuals. These factors limit provision of, and reduce compliance with, pragmatic language assessments and interventions. The chapter will also address some of the implications of pragmatic disorders for the many verbally mediated interactions that defendants and inmates must comply with in the criminal justice system. These interactions include police arrest and interviews, legal examinations in courtrooms and prison rehabilitation programs which aim to reduce rates of re-offending behaviour. The specific pragmatic demands of these interactions will be considered, as will the ability of defendants and inmates with pragmatic disorders to meet these demands. Examples of the types of pragmatic skills which are integral to these interactions will be examined. The chapter concludes by arguing for an improved level of clinical language services with a focus on pragmatic language skills in prisons and other correctional facilities. It is contended that the substantial investment, which would be needed to achieve this improvement, would be offset by significant gains in the rehabilitation outcomes of incarcerated adults and young people.	[Cummings, Louise] Nottingham Trent Univ, Sch Arts & Humanities, Linguist, Nottingham, England		Cummings, L (corresponding author), Nottingham Trent Univ, Sch Arts & Humanities, Linguist, Nottingham, England.	louise.cummings@ntu.ac.uk		Cummings, Louise/0000-0002-8947-8195			Abbecluto L, 2008, AM J MENT RETARD, V113, P214, DOI 10.1352/0895-8017(2008)113[214:SNOLAC]2.0.CO;2; Abbeduto L, 2006, AM J MENT RETARD, V111, P170, DOI 10.1352/0895-8017(2006)111[170:CIRCCO]2.0.CO;2; Adachi T, 2004, BRAIN DEV-JPN, V26, P301, DOI 10.1016/S0387-7604(03)00170-0; Adams C, 2002, J CHILD PSYCHOL PSYC, V43, P679, DOI 10.1111/1469-7610.00056; American Psychiatric Association, 2013, DIAGN STAT MANUAL ME; Anckarsater H, 2008, NORD J PSYCHIAT, V62, P160, DOI 10.1080/08039480801957269; Annaz D, 2009, INT J LANG COMM DIS, V44, P962, DOI 10.3109/13682820802525005; AUDIT COMMISSION, 2004, YOUTH JUST 2004 REV; Baillargeon J, 2003, ANN EPIDEMIOL, V13, P606, DOI 10.1016/S1047-2797(03)00061-9; Baillargeon J, 2009, J AM ACAD PSYCHIATRY, V37, P188; Baron-Cohen S, 1999, J AUTISM DEV DISORD, V29, P407, DOI 10.1023/A:1023035012436; Berk -Seligson S., 1988, MULTILINGUA, V7, P411; Bishop DVM, 1998, J CHILD PSYCHOL PSYC, V39, P879, DOI 10.1017/S0021963098002832; Bletzer K. V., 2013, OPEN AREA STUDIES J, V5, P1; Bogart E, 2012, BRAIN INJURY, V26, P221, DOI 10.3109/02699052.2011.648711; Bosco FM, 2012, J COMMUN DISORD, V45, P181, DOI 10.1016/j.jcomdis.2012.01.005; Bozikas VP, 2011, SCHIZOPHR RES, V130, P130, DOI 10.1016/j.schres.2011.04.025; Brune M, 2005, SCHIZOPHR RES, V75, P233, DOI 10.1016/j.schres.2004.11.006; Bryan K, 2007, INT J LANG COMM DIS, V42, P505, DOI 10.1080/13682820601053977; Buhler E, 2011, J AUTISM DEV DISORD, V41, P1718, DOI 10.1007/s10803-011-1205-1; Buitelaar JK, 1999, DEV PSYCHOPATHOL, V11, P39, DOI 10.1017/S0954579499001947; Cahill BS, 2012, BEHAV SCI LAW, V30, P154, DOI 10.1002/bsl.2004; Castellino N, 2011, CONSCIOUS COGN, V20, P1612, DOI 10.1016/j.concog.2011.08.011; Champagne-Lavau Maud, 2009, Cogn Neuropsychiatry, V14, P217, DOI 10.1080/13546800903004114; Clark A., 2012, BULLETIN, V718, P20; Colle L, 2008, J AUTISM DEV DISORD, V38, P28, DOI 10.1007/s10803-007-0357-5; Committee J., 2013, 7 REP SESS 2012 13 Y; Copur M, 2005, PSYCHIAT CLIN NEUROS, V59, P151, DOI 10.1111/j.1440-1819.2005.01350.x; Cornish K, 2005, J INTELL DISABIL RES, V49, P372, DOI 10.1111/j.1365-2788.2005.00678.x; Cummings L., 2014, CAMBRIDGE HDB COMMUN, P559; Cummings L., 2012, HDB PRAGMATICS, V4, P291; CUMMINGS L, 2005, PRAGMATICS MULTIDISC; Cummings L., 2012, LODZ PAPERS PRAGMATI, V8, P61; Cummings L., 2009, CLIN PRAGMATICS; Cummings L., 2014, COMMUNICATION DISORD; Cummings L., 2012, WHAT IS CONTEXT LING, P55, DOI DOI 10.1075/LA.196.06CUM; Cummings L., 2014, PRAGMATIC DISORDERS; Cummings L., 2016, ROUTLEDGE HDB PRAGMA; Cummings L., 2016, OXFORD HDB PRAGMATIC, P346; Cummings L, 2007, LANG COMMUN, V27, P396, DOI 10.1016/j.langcom.2007.06.001; Cummings L, 2016, PERSP PRAGMAT PHILO, V5, P31, DOI 10.1007/978-3-319-21395-8_3; Cummings L, 2016, PERSP PRAGMAT PHILO, V4, P179, DOI 10.1007/978-3-319-12616-6_6; Cummings L, 2013, PERSP PRAGMAT PHILO, V2, P23, DOI 10.1007/978-3-319-01014-4_2; Cummings L, 2011, PRAGMAT SOC, V2, P17, DOI 10.1075/ps.2.1.02cum; Cummings Louise, 2008, CLIN LINGUISTICS; Dardier V, 2011, J COMMUN DISORD, V44, P359, DOI 10.1016/j.jcomdis.2011.02.001; Davies RC, 2012, J HEAD TRAUMA REHAB, V27, pE21, DOI 10.1097/HTR.0b013e31825360da; de Marchena A, 2010, AUTISM RES, V3, P311, DOI 10.1002/aur.159; Dias S, 2013, AUST NZ J PSYCHIAT, V47, P938, DOI 10.1177/0004867413492220; Donno R, 2010, BRIT J PSYCHIAT, V196, P282, DOI 10.1192/bjp.bp.108.061341; Doubleday G., 2012, HAVE YOU AGREED WRIT; Douglas JM, 2010, J SPEECH LANG HEAR R, V53, P365, DOI 10.1044/1092-4388(2009/08-0205); Elsegood KJ, 2010, SEX ABUSE-J RES TR, V22, P112, DOI 10.1177/1079063209359926; Every Child a Chance Trust, 2009, LONG TERM COSTS LITE; Falissard B, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-33; Fazel S, 2008, INT J LAW PSYCHIAT, V31, P369, DOI 10.1016/j.ijlp.2008.06.001; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Gaines P, 2011, J PRAGMATICS, V43, P3291, DOI 10.1016/j.pragma.2011.06.005; Gilmour J, 2004, J CHILD PSYCHOL PSYC, V45, P967, DOI 10.1111/j.1469-7610.2004.t01-1-00289.x; Ginsberg Y, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-112; Godbee K, 2013, INT J LANG COMM DIS, V48, P651, DOI 10.1111/1460-6984.12037; Gold R, 2010, BRAIN LANG, V113, P124, DOI [10.1016/j.band1.2010.03.002, 10.1016/j.bandl.2010.03.002]; Grant CM, 2007, J ABNORM CHILD PSYCH, V35, P17, DOI 10.1007/s10802-006-9077-0; Green BC, 2014, INT J LANG COMM DIS, V49, P15, DOI 10.1111/1460-6984.12056; Greenbaum RL, 2009, ALCOHOL CLIN EXP RES, V33, P1656, DOI 10.1111/j.1530-0277.2009.01003.x; Gregory J., 2009, EVALUATION LEEDS SPE; Hale Sandra, 1999, FORENSIC LINGUIST, V6, P57, DOI DOI 10.1558/SLL.1999.6.1.57; Hamilton AFD, 2009, COGNITION, V113, P37, DOI 10.1016/j.cognition.2009.07.007; Hansen MBM, 2008, J PRAGMATICS, V40, P1392, DOI 10.1016/j.pragma.2008.02.012; Happe F, 1996, BRIT J DEV PSYCHOL, V14, P385, DOI 10.1111/j.2044-835X.1996.tb00713.x; Harzke AJ, 2012, J CORRECT HEALTH CAR, V18, P143, DOI 10.1177/1078345811436000; Hassiotis A, 2011, BRIT J PSYCHIAT, V199, P156, DOI 10.1192/bjp.bp.110.088039; Haworth K., 2010, ROUTLEDGE PRAGMATICS, P325; Haworth K., 2009, ANAL POLICE INTERVIE; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; Herrington V, 2009, J INTELL DISABIL RES, V53, P397, DOI 10.1111/j.1365-2788.2008.01150.x; Heydon G, 2011, J PRAGMATICS, V43, P2308, DOI 10.1016/j.pragma.2011.01.003; HM Government, 2005, RED REOFF SKILLS EMP; Jacobsen B, 2008, INTERPRETING, V10, P128, DOI 10.1075/intp.10.1.08jac; John AE, 2009, AJIDD-AM J INTELLECT, V114, P85, DOI 10.1352/2009.114.85-99; Jones CD, 2009, J AUTISM DEV DISORD, V39, P432, DOI 10.1007/s10803-008-0642-y; Kaiser, 2000, COMMUNICATION DISORD, V21, P154, DOI [DOI 10.1177/152574010002100304, 10.1177/152574010002100304]; Kutscher S, 2009, FORTSCHR NEUROL PSYC, V77, P91, DOI 10.1055/s-0028-1109080; Lakoff R.T., 1989, MULTILINGUA, V8, P101; Langdon R, 2002, PSYCHOL MED, V32, P1273, DOI 10.1017/S0033291702006396; Laws G, 2004, INT J LANG COMM DIS, V39, P45, DOI 10.1080/13682820310001615797; Lincoln TM, 2011, SCHIZOPHRENIA BULL, V37, pS23, DOI 10.1093/schbul/sbr066; Lind SE, 2010, J AUTISM DEV DISORD, V40, P479, DOI 10.1007/s10803-009-0889-y; Losh M, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00266; Loukusa S, 2007, J AUTISM DEV DISORD, V37, P1049, DOI 10.1007/s10803-006-0247-2; Maenner MJ, 2014, JAMA PSYCHIAT, V71, P292, DOI 10.1001/jamapsychiatry.2013.3893; Marini A, 2008, SCHIZOPHR RES, V105, P144, DOI 10.1016/j.schres.2008.07.011; Martin I, 2004, J AUTISM DEV DISORD, V34, P311, DOI 10.1023/B:JADD.0000029553.52889.15; Martinovski B, 2006, J PRAGMATICS, V38, P2065, DOI 10.1016/j.pragma.2006.08.006; Marton I, 2009, J ABNORM CHILD PSYCH, V37, P107, DOI 10.1007/s10802-008-9262-4; Mathers Margaret E, 2006, J Atten Disord, V9, P523, DOI 10.1177/1087054705282437; Mazza M, 2008, PSYCHOPATHOLOGY, V41, P254, DOI 10.1159/000128324; Meilijson SR, 2004, J SPEECH LANG HEAR R, V47, P695, DOI 10.1044/1092-4388(2004/053); Milders M, 2006, NEUROPSYCHOLOGY, V20, P400, DOI 10.1037/0894-4105.20.4.400; Mo SL, 2008, PSYCHIAT RES, V157, P21, DOI 10.1016/j.psychres.2006.04.002; Montag C, 2011, PSYCHIAT RES, V186, P203, DOI 10.1016/j.psychres.2010.09.006; Moseley D., 2006, DEV ORAL COMMUNICATI; Mullen P. E., 2003, NATL FORENSIC MENTAL; Muller F, 2010, CORTEX, V46, P1088, DOI 10.1016/j.cortex.2009.08.014; Murphy MM, 2007, J INTELL DISABIL RES, V51, P387, DOI 10.1111/j.1365-2788.2006.00888.x; Nilsen ES, 2013, J SPEECH LANG HEAR R, V56, P590, DOI 10.1044/1092-4388(2012/12-0013); O'Brien G, 2004, AUTISM, V8, P125, DOI 10.1177/1362361304042718; Papagno C, 2001, J INT NEUROPSYCH SOC, V7, P516, DOI 10.1017/S1355617701744086; Pelc K, 2006, PEDIATR NEUROL, V35, P93, DOI 10.1016/j.pediatrneurol.2006.01.014; Penman Robyn., 1990, J LANG SOC PSYCHOL, V9, P15; Perlini C, 2012, ACTA PSYCHIAT SCAND, V126, P363, DOI 10.1111/j.1600-0447.2012.01864.x; Polimeni JO, 2010, J PSYCHIATR RES, V44, P434, DOI 10.1016/j.jpsychires.2009.10.003; Rousseaux M, 2010, EUR J NEUROL, V17, P922, DOI 10.1111/j.1468-1331.2009.02945.x; Sarlon E, 2012, REV EPIDEMIOL SANTE, V60, P197, DOI 10.1016/j.respe.2011.11.001; Schenkel LS, 2005, J PSYCHIATR RES, V39, P499, DOI 10.1016/j.jpsychires.2005.01.001; Schofield P, 2011, BRAIN INJURY, V25, P74, DOI 10.3109/02699052.2010.531690; SCRAGG P, 1994, BRIT J PSYCHIAT, V165, P679, DOI 10.1192/bjp.165.5.679; Seidel EM, 2013, PSYCHIAT RES, V210, P1168, DOI 10.1016/j.psychres.2013.08.027; Shiroma Eric J, 2010, J Correct Health Care, V16, P147, DOI 10.1177/1078345809356538; Siponmaa L, 2001, J AM ACAD PSYCHIATRY, V29, P420; Skills Funding Agency, 2011, ANN REP ACC 2010 11; Slaughter B, 2003, BRAIN INJURY, V17, P731, DOI 10.1080/0269905031000088649; Snow PC, 2011, INT J SPEECH-LANG PA, V13, P480, DOI 10.3109/17549507.2011.578661; Sondenaa E, 2008, J INTELL DISABIL RES, V52, P1129, DOI 10.1111/j.1365-2788.2008.01072.x; Staikova E, 2013, J CHILD PSYCHOL PSYC, V54, P1275, DOI 10.1111/jcpp.12082; Stokoe E, 2008, DISCOURSE STUD, V10, P89, DOI 10.1177/1461445607085592; Stubbs Julie, 2007, CRIMINOLOGY CRIMINAL, V7, P169, DOI DOI 10.1177/1748895807075570; Sudhalter V, 2001, AM J MENT RETARD, V106, P389, DOI 10.1352/0895-8017(2001)106<0389:CCOCWF>2.0.CO;2; Sullivan K, 2003, DEV NEUROPSYCHOL, V23, P85, DOI 10.1207/S15326942DN231&2_5; Surian L, 1996, Cogn Neuropsychiatry, V1, P55, DOI 10.1080/135468096396703; Tavano A, 2008, SCHIZOPHR RES, V102, P53, DOI 10.1016/j.schres.2008.02.008; Tenyi T, 2002, PSYCHOPATHOLOGY, V35, P25, DOI 10.1159/000056212; The Princes Trust, 2010, COST EXCL COUNT COST; Thoma P, 2009, PSYCHIAT RES, V170, P132, DOI 10.1016/j.psychres.2009.01.026; Uekermann J, 2010, NEUROSCI BIOBEHAV R, V34, P734, DOI 10.1016/j.neubiorev.2009.10.009; Usher AM, 2013, INT J LAW PSYCHIAT, V36, P311, DOI 10.1016/j.ijlp.2013.04.005; Van Herwegen J, 2013, J COMMUN DISORD, V46, P440, DOI 10.1016/j.jcomdis.2013.10.002; Webster Stephen D, 2002, Sex Abuse, V14, P281, DOI 10.1023/A:1019984202619; Williams D, 2010, DEVELOPMENTAL SCI, V13, P307, DOI 10.1111/j.1467-7687.2009.00885.x; Williams WH, 2010, BRAIN INJURY, V24, P1184, DOI 10.3109/02699052.2010.495697; Yirmiya N, 1996, J CHILD PSYCHOL PSYC, V37, P1003, DOI 10.1111/j.1469-7610.1996.tb01497.x; Zhou Jiansong, 2012, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V37, P217, DOI 10.3969/j.issn.1672-7347.2012.03.001	142	1	1	0	3	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	2214-3807		978-3-319-44601-1; 978-3-319-44599-1	PERSP PRAGMAT PHILO			2017	10						349	377		10.1007/978-3-319-44601-1_14	10.1007/978-3-319-44601-1		29	Language & Linguistics; Philosophy; Political Science	Book Citation Index – Social Sciences & Humanities (BKCI-SSH)	Linguistics; Philosophy; Government & Law	BI5LF	WOS:000412522500015					2022-02-06	
B	Detalle, L; Vanheusden, K; Sargentini-Maier, ML; Stohr, T		Chackalamannil, S; Rotella, D; Ward, SE; Buschmann, H; Handler, N; Wolkerstorfer, A		Detalle, L.; Vanheusden, K.; Sargentini-Maier, M. L.; Stoehr, T.			Translational Aspects in Drug Discovery	COMPREHENSIVE MEDICINAL CHEMISTRY III, VOL 2: DRUG DISCOVERY TECHNOLOGIES			English	Article; Book Chapter							ACUTE ISCHEMIC-STROKE; CELL LUNG-CANCER; TRAUMATIC BRAIN-INJURY; SURROGATE END-POINTS; SYNCYTIAL VIRUS RSV; ANIMAL-MODELS; RHEUMATOID-ARTHRITIS; DISEASE SEVERITY; DOSE SELECTION; COMBINATION IMMUNOTHERAPY		[Detalle, L.; Vanheusden, K.; Sargentini-Maier, M. L.] Ablynx Technol Pk, Zwijnaarde, Belgium; [Stoehr, T.] A2M Pharma GmbH, Monheim, Germany		Detalle, L (corresponding author), Ablynx Technol Pk, Zwijnaarde, Belgium.						Aarons L, 2005, BRIT J CLIN PHARMACO, V60, P581, DOI 10.1111/j.1365-2125.2005.02560.x; Abanades S, 2011, J CEREBR BLOOD F MET, V31, P944, DOI 10.1038/jcbfm.2010.175; Agdeppa ED, 2009, AAPS J, V11, P286, DOI 10.1208/s12248-009-9104-5; Agid O, 2007, NEUROPSYCHOPHARMACOL, V32, P1209, DOI 10.1038/sj.npp.1301242; Agoram BM, 2009, BRIT J CLIN PHARMACO, V67, P153, DOI 10.1111/j.1365-2125.2008.03297.x; Ahmad AS, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00172; Allred DC, 2010, MODERN PATHOL, V23, pS52, DOI 10.1038/modpathol.2010.55; Amur S, 2008, BIOMARK MED, V2, P305, DOI 10.2217/17520363.2.3.305; Amur SG, 2015, BIOMARK MED, V9, P1095, DOI 10.2217/bmm.15.90; Angel H, 2013, CURR OPIN IMMUNOL, V25, P261, DOI 10.1016/j.coi.2013.03.004; [Anonymous], 2006, EMEACHMPPGXWP2019142; Ansell S, 2013, J IMMUNOTHER CANC S1, V1, pP259, DOI DOI 10.1186/2051-1426-1-S1-P259; Ansell SM, 2015, NEW ENGL J MED, V372, P311, DOI 10.1056/NEJMoa1411087; Ascierto ML, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-146; Ashworth S, 2010, J NUCL MED, V51, P1021, DOI 10.2967/jnumed.109.071753; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Baillie R., 2011, AM C PHARM ACOP SAB; Baker K, 2011, STROKE, V42, P1787, DOI 10.1161/STROKEAHA.110.608505; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Behan PO, 2014, MULT SCLER RELAT DIS, V3, P565, DOI 10.1016/j.msard.2014.06.003; Bem RA, 2011, AM J PHYSIOL-LUNG C, V301, pL148, DOI 10.1152/ajplung.00065.2011; Bender AT, 2013, AM J TRANSL RES, V5, P92; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Binkofski F, 1996, ANN NEUROL, V39, P460, DOI 10.1002/ana.410390408; Bleavins M. R., 2010, BIOMARKERS DRUG DEV; Bleavins M. R., 2010, PHARM SCI ENCY, V37, P1; Boini S, 2001, ANN RHEUM DIS, V60, P817; Borras JM, 2014, EUR J CANCER, V50, P475, DOI 10.1016/j.ejca.2013.11.012; Boumpas DT, 2003, ARTHRITIS RHEUM-US, V48, P719, DOI 10.1002/art.10856; Braff DL, 2001, SCHIZOPHR RES, V49, P171, DOI 10.1016/S0920-9964(00)00139-0; Brooks David J, 2005, NeuroRx, V2, P226; Brown DC, 2009, PAIN MED, V10, P133, DOI 10.1111/j.1526-4637.2008.00513.x; Buckingham SC, 2000, PEDIATR INFECT DIS J, V19, P113, DOI 10.1097/00006454-200002000-00006; Butler D, 2008, NATURE, V453, P840, DOI 10.1038/453840a; Byrd LG, 1997, CLIN INFECT DIS, V25, P1363, DOI 10.1086/516152; Campion S, 2013, EXPERT OPIN DRUG MET, V9, P1391, DOI 10.1517/17425255.2013.827170; Catani M, 2005, BRAIN, V128, P2224, DOI 10.1093/brain/awh622; Ceriello A, 2005, DIABETES CARE, V28, P266, DOI 10.2337/diacare.28.2.266; Chamberlain C., ACR ARHP ANN M; Chavez-Galan L, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00263; Cherry S R, 2001, ILAR J, V42, P219; Coller BS, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000265; Cortinez LI, 2014, ANAESTHESIA, V69, P399, DOI 10.1111/anae.12642; Couto P.J., 2015, INT J ALZHEIMERS DIS, V2015, DOI [10.1155/2015/575078, DOI 10.1155/2015/575078]; Couzin J, 2005, SCIENCE, V307, P1712, DOI 10.1126/science.307.5716.1712; Cummings J, 2010, DRUG DISCOV TODAY, V15, P816, DOI 10.1016/j.drudis.2010.07.006; Dancey JE, 2010, CLIN CANCER RES, V16, P1745, DOI 10.1158/1078-0432.CCR-09-2167; Danhof M, 2008, TRENDS PHARMACOL SCI, V29, P186, DOI 10.1016/j.tips.2008.01.007; Danhof M, 2007, ANNU REV PHARMACOL, V47, P357, DOI 10.1146/annurev.pharmtox.47.120505.105154; Deambrosis I, 2009, J MOL MED, V87, P181, DOI 10.1007/s00109-008-0416-1; Delyon J, 2015, SEMIN ONCOL, V42, P387, DOI 10.1053/j.seminoncol.2015.02.005; Derscheid RJ, 2014, BIORESEARCH OPEN ACC, V3, P60, DOI 10.1089/biores.2013.0044; Derscheid RJ, 2012, VIRUSES-BASEL, V4, P2359, DOI 10.3390/v4102359; Detalle L, 2016, ANTIMICROB AGENTS CH, V60, P6, DOI 10.1128/AAC.01802-15; DeVincenzo JP, 2010, AM J RESP CRIT CARE, V182, P1305, DOI 10.1164/rccm.201002-0221OC; DeVincenzo JP, 2005, J INFECT DIS, V191, P1861, DOI 10.1086/430008; DeVincenzo JP, 2004, PEDIATR RES, V56, P914, DOI 10.1203/01.PDR.0000145255.86117.6A; Drake CG, 2012, ANN ONCOL, V23, P41, DOI 10.1093/annonc/mds262; Duff G, 2006, EXPERT SCI GROUP PHA, P60; Dwivedi G, 2014, CPT-PHARMACOMET SYST, V3, DOI 10.1038/psp.2013.64; Eiland Lea S, 2009, J Pediatr Pharmacol Ther, V14, P75, DOI 10.5863/1551-6776-14.2.75; EMA, 2014, QUAL NOV DRUG DEV GU; EMEA/CHMP, 2007, GUID STRAT ID MIT RI; Espie P, 2009, DRUG METAB REV, V41, P391, DOI 10.1080/10837450902891360; ESR, 2010, INSIGHTS IMAGING, V1, P42, DOI [10.1007/s13244-009-0008-9, 10.1007/s13244-010-0025-8]; European Medicines Agency, 2011, REFL PAP METH ISS PH; European Medicines Agency, 2012, EMACHMP20595REV; European Medicines Agency, 2008, REFL PAP PHARM ONC D; European Medicines Agency, 2010, EMACHMP6412982008; European Medicines Agency (EMA), QUAL NOV METH MED DE; Falcoz C., PKPD MODELING BRAIN; FDA, 2005, GUID IND E14 CLIN EV; FDA, BIOM QUAL PROGR; FDA, 2014, GUID IND FDA STAFF Q; FDA, 2009, REV QUAL DAT BIOM NE; FDA, 2014, GUID IND FDA STAFF I; FDA, LAB INF BLINC; [FDA Food and Drug Administration US Department of Health and Human Services], 2004, INN STAGN CHALL OPP; Fischer K, 2011, J NUCL MED, V52, P1133, DOI 10.2967/jnumed.110.086942; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; Fong L, 2009, CANCER RES, V69, P609, DOI 10.1158/0008-5472.CAN-08-3529; Food and Drug Administration, 2006, INN STAGN CRIT PATH; Friedman JN, 2014, PAED CHILD HEALT-CAN, V19, P484, DOI 10.1093/pch/19.9.485; Fu Q, 2010, PROTEOM CLIN APPL, V4, P271, DOI 10.1002/prca.200900217; Fuchs TC, 2011, AAPS J, V13, P615, DOI 10.1208/s12248-011-9301-x; Galon J, 2014, J PATHOL, V232, P199, DOI 10.1002/path.4287; Galon J, 2013, IMMUNITY, V39, P11, DOI 10.1016/j.immuni.2013.07.008; Galon J, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-205; Gao H, 2015, NAT MED, V21, P1318, DOI 10.1038/nm.3954; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Geerts H, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00198; Germani M., 2014, PHYSS BASED PHARMACO; Geyer MA, 2008, NEUROTOX RES, V14, P71, DOI 10.1007/BF03033576; Gibson CL, 2008, BRAIN, V131, P318, DOI 10.1093/brain/awm183; Goense L, 2015, J NUCL MED, V56, P995, DOI 10.2967/jnumed.115.155580; Gonzalez L, 2013, IMMUNOL RES, V57, P326, DOI 10.1007/s12026-013-8471-2; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Graff-Guerrero A, 2015, JAMA PSYCHIAT, V72, P927, DOI 10.1001/jamapsychiatry.2015.0891; Grebe Stefan Kg, 2011, Clin Biochem Rev, V32, P5; Gross JL, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001844; Guermazi A, 2004, SEMIN MUSCULOSKEL R, V8, P269, DOI 10.1055/s-2004-861575; Guerreiro-Cacais AO, 2015, J INFLAMM RES, V8, P211, DOI 10.2147/JIR.S76707; Guo YW, 2013, TROP J PHARM RES, V12, P1097, DOI 10.4314/tjpr.v12i6.35; Hamanishi J, 2015, J CLIN ONCOL, V33, P4015, DOI 10.1200/JCO.2015.62.3397; Harrison JK, 2013, CLIN INTERV AGING, V8, P201, DOI 10.2147/CIA.S32405; He HY, 2015, CAN ASSOC RADIOL J, V66, P356, DOI 10.1016/j.carj.2015.03.005; Health U.S.N.I.o, 2014, MULT STUD OTH HLTH I; Hedna VS, 2013, J REHABIL RES DEV, V50, P1113, DOI 10.1682/JRRD.2012.10.0194; Herbst RS, 2015, CLIN CANCER RES, V21, P1514, DOI 10.1158/1078-0432.CCR-13-3473; Heyder J., 2002, DRUG DELIVERY LUNG; Hillman EMC, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2789693; Hillman EMC, 2011, PHILOS T R SOC A, V369, P4620, DOI 10.1098/rsta.2011.0264; Horig H, 2005, NAT MED, V11, P705, DOI 10.1038/nm0705-705; Hsia CCW, 2004, AM J RESP CRIT CARE, V170, P319, DOI 10.1164/rccm.200209-1062ST; Huang SM, 2012, CLIN PHARMACOL THER, V91, P542, DOI 10.1038/clpt.2011.320; Hunter DJ, 2010, CURR DRUG TARGETS, V11, P536; Iadevaia S, 2010, CANCER RES, V70, P6704, DOI 10.1158/0008-5472.CAN-10-0460; Ito A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/605478; Ivashko IN, 2016, AM J HEALTH-SYST PH, V73, P193, DOI 10.2146/ajhp140768; Janssens HM, 2001, J AEROSOL MED, V14, P433, DOI 10.1089/08942680152744640; Jennings M, 2015, COMPUT MATH METHOD M, V2015, DOI 10.1155/2015/415923; Jin KT, 2010, CLIN TRANSL ONCOL, V12, P473, DOI 10.1007/s12094-010-0540-6; Johnson M, 2011, PHARM RES-DORDR, V28, P2490, DOI 10.1007/s11095-011-0477-7; Jones HM, 2013, AAPS J, V15, P377, DOI 10.1208/s12248-012-9446-2; Vaquero JJ, 2015, ANNU REV BIOMED ENG, V17, P385, DOI 10.1146/annurev-bioeng-071114-040723; Kahle MP, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/374098; Kalia LV, 2015, MOVEMENT DISORD, V30, P1442, DOI 10.1002/mds.26354; Kaplan Robert C, 2008, J Stroke Cerebrovasc Dis, V17, P344, DOI 10.1016/j.jstrokecerebrovasdis.2008.04.006; Khoja L, 2015, J IMMUNOTHER CANCER, V3, DOI 10.1186/s40425-015-0078-9; Kingsmore SF, 2006, NAT REV DRUG DISCOV, V5, P310, DOI 10.1038/nrd2006; Kozielska M, 2012, PHARM RES-DORDR, V29, P1932, DOI 10.1007/s11095-012-0722-8; Kraus VB, 2011, OSTEOARTHR CARTILAGE, V19, P515, DOI 10.1016/j.joca.2010.08.019; Kuhn C, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001830; Lange V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.61; Langer F, 2005, THROMB HAEMOSTASIS, V93, P1137, DOI 10.1160/TH04-12-0774; Langhauser F, 2014, STROKE, V45, P1799, DOI 10.1161/STROKEAHA.114.005000; Laskowitz DT, 2009, STROKE, V40, P77, DOI 10.1161/STROKEAHA.108.516377; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Lee JW, 2006, PHARM RES, V23, P312, DOI 10.1007/s11095-005-9045-3; Legendre A., SILICO SIMULATOR STU; Leist M, 2008, ALTEX-ALTERN TIEREXP, V25, P17; Lieberthal AS, 2006, PEDIATRICS, V118, P1774, DOI 10.1542/peds.2006-2223; Liesz A, 2011, BRAIN, V134, P704, DOI 10.1093/brain/awr008; LILLRANK SM, 1995, CLIN NEUROSCI, V3, P98; Lim KS, 2007, CLIN PHARMACOL THER, V81, P252, DOI 10.1038/sj.clpt.6100049; Lin JB, 2015, INT J MOL SCI, V16, P11131, DOI 10.3390/ijms160511131; Llovera G, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa9853; Lodygensky GA, 2008, INT J DEV NEUROSCI, V26, P13, DOI 10.1016/j.ijdevneu.2007.08.018; Long GV, 2014, NEW ENGL J MED, V371, P1877, DOI 10.1056/NEJMoa1406037; Lowe PJ, 2007, XENOBIOTICA, V37, P1331, DOI 10.1080/00498250701648008; Lynch TJ, 2012, J CLIN ONCOL, V30, P2046, DOI 10.1200/JCO.2011.38.4032; Macleod MR, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002273; Mahgoub MA, 1998, MOL CELL BIOCHEM, V180, P59, DOI 10.1023/A:1006834922035; Malkesman O, 2009, DIS MODEL MECH, V2, P238, DOI 10.1242/dmm.001628; Manes NP, 2015, JOVE-J VIS EXP, DOI 10.3791/52959; Marquez-Rodas I, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.10.27; McElroy MC, 2013, INHAL TOXICOL, V25, P219, DOI 10.3109/08958378.2013.769037; Meeusen EN, 2009, DRUG DISCOV TODAY DI, V6, P101, DOI [DOI 10.1016/J.DDMOD.2009.12.002, DOI 10.1016/J.DDM0D.2009.12.002]; Meibohm B, 1997, INT J CLIN PHARM TH, V35, P401; Mirabet M, 2008, MOL IMMUNOL, V45, P937, DOI 10.1016/j.molimm.2007.08.006; Miyahira AK, 2016, PROSTATE, V76, P125, DOI 10.1002/pros.23107; Moffat BA, 2009, NEUROIMAG CLIN N AM, V19, P517, DOI 10.1016/j.nic.2009.08.008; Mora AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143580; Motallebnezhad M, 2016, TUMOR BIOL, V37, P1387, DOI 10.1007/s13277-015-4477-9; Nada Adel, 2007, Am J Ther, V14, P594, DOI 10.1097/MJT.0b013e31813737dd; Niendorf T, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00255; Nishikawa H, 2014, CURR OPIN IMMUNOL, V27, P1, DOI 10.1016/j.coi.2013.12.005; Nishimoto N, 2008, BLOOD, V112, P3959, DOI 10.1182/blood-2008-05-155846; O'Hara DM, 2011, J IMMUNOL METHODS, V363, P120, DOI 10.1016/j.jim.2010.09.036; Oliver V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097882; Olivier A, 2009, INT J EXP PATHOL, V90, P431, DOI 10.1111/j.1365-2613.2009.00643.x; Ory PA, 2003, ANN RHEUM DIS, V62, P597, DOI 10.1136/ard.62.7.597; Pages F, 2010, ONCOGENE, V29, P1093, DOI 10.1038/onc.2009.416; Patel SP, 2015, MOL CANCER THER, V14, P847, DOI 10.1158/1535-7163.MCT-14-0983; PENDERGRAST WJ, 1976, JNCI-J NATL CANCER I, V57, P539, DOI 10.1093/jnci/57.3.539; Peng WJ, 2014, J NEUROSURG, V121, P653, DOI 10.3171/2014.6.JNS132577; Pickles RJ, 2015, J PATHOL, V235, P266, DOI 10.1002/path.4462; Picotti P, 2012, NAT METHODS, V9, P555, DOI [10.1038/NMETH.2015, 10.1038/nmeth.2015]; Plisson C, 2009, J NUCL MED, V50, P2064, DOI 10.2967/jnumed.109.062919; Poggesi I, 2014, EXPERT OPIN DRUG MET, V10, P631, DOI 10.1517/17425255.2014.888058; Prescott JW, 2013, J DIGIT IMAGING, V26, P97, DOI 10.1007/s10278-012-9465-7; PriceWaterhouseCoopers, 2005, PHARM 2005 SIL RALL; Redman MW, 2015, SEMIN ONCOL, V42, P724, DOI 10.1053/j.seminoncol.2015.07.009; Richmond Jon, 2002, ILAR J, V43 Suppl, pS63; Richter SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016461; Richter SH, 2009, NAT METHODS, V6, P257, DOI [10.1038/NMETH.1312, 10.1038/nmeth.1312]; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robinson AP, 2014, HAND CLINIC, V122, P173, DOI 10.1016/B978-0-444-52001-2.00008-X; Robles-Carrillo L, 2010, J IMMUNOL, V185, P1577, DOI 10.4049/jimmunol.0903888; Rullmann JAC, 2005, IEE P SYST BIOL, V152, P256, DOI 10.1049/ip-syb:20050053; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Salem KA, 2002, IEEE T MED IMAGING, V21, P1310, DOI 10.1109/TMI.2002.806270; Salter K., 2013, OUTCOME MEASURES STR; Sams-Dodd F, 2006, DRUG DISCOV TODAY, V11, P465, DOI 10.1016/j.drudis.2006.03.015; Scannell JW, 2012, NAT REV DRUG DISCOV, V11, P191, DOI 10.1038/nrd3681; Scheerlinck JPY, 2008, TRENDS BIOTECHNOL, V26, P259, DOI 10.1016/j.tibtech.2008.02.002; Schmidt BJ, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-221; Schou M, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyv036; Schumacher M, 2014, PROG NEUROBIOL, V113, P6, DOI 10.1016/j.pneurobio.2013.09.004; Seah S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110432; Segal N., 2014, J CLIN ONCOL, V32, P36; SEGRE G, 1968, FARMACO-ED SCI, V23, P907; Seitz R. J., 2012, NEUROIMAGINGD METHOD; Seitz RJ, 2009, NEURORADIOLOGY, V51, P865, DOI 10.1007/s00234-009-0576-x; Seror R, 2015, ANN RHEUM DIS, V74, P859, DOI 10.1136/annrheumdis-2013-204615; Seror R, 2011, ANN RHEUM DIS, V70, P968, DOI 10.1136/ard.2010.143743; Shakeri M, 2013, CLIN NEUROL NEUROSUR, V115, P2019, DOI 10.1016/j.clineuro.2013.06.013; Sheikhbahaei S, 2015, AM J ROENTGENOL, V205, P629, DOI 10.2214/AJR.14.14166; Sheiner LB, 1997, CLIN PHARMACOL THER, V61, P275, DOI 10.1016/S0009-9236(97)90160-0; SHEINER LB, 1979, CLIN PHARMACOL THER, V25, P358; Shibata M, 2004, STROKE, V35, P2598, DOI 10.1161/01.STR.0000143725.19053.60; Shock A, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0757-4; Shoda L, 2010, CLIN EXP IMMUNOL, V161, P250, DOI 10.1111/j.1365-2249.2010.04166.x; Shultz LD, 2012, NAT REV IMMUNOL, V12, P786, DOI 10.1038/nri3311; Siolas D, 2013, CANCER RES, V73, P5315, DOI 10.1158/0008-5472.CAN-13-1069; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Smith JJ, 2003, RADIOLOGY, V227, P633, DOI 10.1148/radiol.2273020518; Smith WS, 2006, AM J NEURORADIOL, V27, P1177; Snyder A, 2015, CURR OPIN GENET DEV, V30, P7, DOI 10.1016/j.gde.2014.12.003; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Sommer OJ, 2005, RADIOGRAPHICS, V25, P381, DOI 10.1148/rg.252045111; Song J, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00195; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Sorge RE, 2014, NAT METHODS, V11, P629, DOI [10.1038/NMETH.2935, 10.1038/nmeth.2935]; Sriram S, 2005, ANN NEUROL, V58, P939, DOI 10.1002/ana.20743; Stoeckel MC, 2007, J NEUROIMAGING, V17, P131, DOI 10.1111/j.1552-6569.2007.00102.x; Strom JO, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-41; 't Hart BA, 2015, EUR J PHARMACOL, V759, P14, DOI 10.1016/j.ejphar.2015.03.030; 't Hart BA, 2014, DRUG DISCOV TODAY, V19, P1394, DOI 10.1016/j.drudis.2014.03.023; Tang C, 2014, CANCER IMMUNOL RES, V2, P831, DOI 10.1158/2326-6066.CIR-14-0069; Tchekmedyian N, 2015, ONCOLOGY WILLISTON P, V29, P12; Teff KL, 2013, DIABETES, V62, P3232, DOI 10.2337/db13-0430; Tocoian A, 2015, LUPUS, V24, P1045, DOI 10.1177/0961203315574558; TRANZER JP, 1968, EXPERIENTIA, V24, P155, DOI 10.1007/BF02146956; Tsamandouras N, 2015, BRIT J CLIN PHARMACO, V79, P48, DOI 10.1111/bcp.12234; UNGERSTEDT U, 1968, EUR J PHARMACOL, V5, P107, DOI 10.1016/0014-2999(68)90164-7; UNGERSTEDT U, 1970, Brain Research, V24, P485, DOI 10.1016/0006-8993(70)90187-3; US Food and Drug Administration, 2005, GUID IND EST MAX SAF; van de Looij Y, 2015, INT J DEV NEUROSCI, V45, P29, DOI 10.1016/j.ijdevneu.2015.03.009; van der Veldt AAM, 2013, CLIN CANCER RES, V19, P4163, DOI 10.1158/1078-0432.CCR-12-3779; Van Heeke G., 2016, PHARMACOL THERAPEUT, V16, P30102; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; van Miert C, 2014, J ADV NURS, V70, P2353, DOI 10.1111/jan.12387; Van Roy M, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0651-0; van Waarde A, 2000, CURR PHARM DESIGN, V6, P1593, DOI 10.2174/1381612003398951; Vrinten DH, 2003, PAIN, V102, P203, DOI 10.1016/S0304-3959(02)00382-2; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Wagner C, 2015, CPT-PHARMACOMET SYST, V4, P226, DOI 10.1002/psp4.33; Wagner CC, 2011, ADV DRUG DELIVER REV, V63, P539, DOI 10.1016/j.addr.2010.09.011; Wagner CC, 2011, CLIN PHARMACOKINET, V50, P111, DOI 10.2165/11537250-000000000-00000; Wagner JA, 2002, DIS MARKERS, V18, P41, DOI 10.1155/2002/929274; Wakefield IR, 2010, ARTHRITIS RHEUM, V62, P1243, DOI DOI 10.1002/ART.29009; Waldron AM, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0158-6; Wang C, 2014, NEUROSCIENCE, V264, P186, DOI 10.1016/j.neuroscience.2013.09.018; Wang J, 2009, AAPS J, V11, P385, DOI 10.1208/s12248-009-9115-2; Weissmuller S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149093; WILLNER P, 1986, PROG NEURO-PSYCHOPH, V10, P677, DOI 10.1016/0278-5846(86)90051-5; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Xu Y, 2015, CPT-PHARMACOMET SYST, V4, P507, DOI 10.1002/psp4.12003; Yokota T, 2012, ANTI-CANCER AGENT ME, V12, P163, DOI 10.2174/187152012799014968; Yun Jun-Won, 2015, Lab Anim Res, V31, P155, DOI 10.5625/lar.2015.31.4.155; Zamuner S, 2010, CLIN PHARMACOL THER, V87, P563, DOI 10.1038/clpt.2010.9; Zhang Xuan, 2012, Curr Protoc Cytom, VChapter 12, DOI 10.1002/0471142956.cy1227s60; Zhang YM, 2012, J BIOMED RES, V26, P69, DOI 10.1016/S1674-8301(12)60014-1; Zhao P, 2012, CLIN PHARMACOL THER, V92, P17, DOI 10.1038/clpt.2012.68; Zhao P, 2011, CLIN PHARMACOL THER, V89, P259, DOI 10.1038/clpt.2010.298; Zhou QJ, 2014, CANCER LETT, V344, P13, DOI 10.1016/j.canlet.2013.10.015	269	1	1	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS			978-0-12-803200-8				2017							495	529		10.1016/B978-0-12-409547-2.12335-2			35	Chemistry, Medicinal; Pharmacology & Pharmacy	Book Citation Index – Science (BKCI-S)	Pharmacology & Pharmacy	BO5NL	WOS:000518431100021					2022-02-06	
J	Dong, XY; Wei, TQ; Papa, EV; Feng, Z				Dong, Xiaoyang; Wei, Tianqi; Papa, Evan V.; Feng, Zhen			Median nerve electrical stimulation causes wake-promotion by downregulating the expression of gamma-aminobutyric acid b receptor via orexins pathway in comatose rats caused by traumatic brain injury	INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE			English	Article						GABAb receptor; orexins; median nerve electrical stimulation; coma; traumatic brain injury	GABA(B) RECEPTORS; SLEEP; MECHANISMS; CONSCIOUSNESS; NEURONS; MODEL	Our previous studies have shown that median nerve electrical stimulation (MNS) causes wake-promotion by activating the orexins system in traumatic brain injury (TBI) induced comatose rats. To better understand the mechanism of MNS induced wake promotion, the purpose of this experiment was to investigate the expression of gamma-aminobutyric acid b receptor (GABAbR) in the prefrontal cortex after MNS in comatose rats, as well as the relationship between GABAbR and the orexins system. One hundred and twenty Sprague Dawley rats were divided into four groups: control group, TBI group, stimulated group and an antagonist group. We established TBI models by free fall drop. In the stimulated group, the TBI induced comatose rats were stimulated by the median nerve. In the antagonist group, comatose rats were given SB334867, an orexin receptor 1 antagonist, by intracerebroventricular injection and MNS. Then, the behavior changes were evaluated and the expression of GABAbR was detected by the western-blot and immunohistochemistry at 6 h, 12 h and 24 h. Results showed that 5 of 30 rats were awakened in the TBI group, 22 of 30 awakened in the stimulated group and 13 of 30 rats were awakened in the antagonist group. The expression of GABAbR in the prefrontal cortex in different groups was as follows: control group < stimulated group < antagonist group < TBI group (P < 0.05). Taken together, these data indicated that MNS has wake-promoting effects in comatose rats caused by TBI. One possible mechanism is that MNS might decrease the expression of GABAbR via the orexins pathway.	[Dong, Xiaoyang; Feng, Zhen] Nanchang Univ, Affiliated Hosp 1, Dept Rehabil Med, 17 Yongwai St, Nanchang, Jiangxi, Peoples R China; [Wei, Tianqi] Suzhou Sci & Technol City Hosp, Dept Rehabil Med, Suzhou, Jiangsu, Peoples R China; [Papa, Evan V.] Idaho State Univ, Meridian Hlth Sci Ctr, Dept Phys Therapy, Meridian, ID USA		Feng, Z (corresponding author), Nanchang Univ, Affiliated Hosp 1, Dept Rehabil Med, 17 Yongwai St, Nanchang, Jiangxi, Peoples R China.	feng-zhenly@sina.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81260295]; Natural Science Foundation of Jiangxi Province of ChinaNatural Science Foundation of Jiangxi Province [20132BAB205063]	This study was funded by the National Natural Science Foundation of China (No. 81260295), andthe Natural Science Foundation of Jiangxi Province of China (No. 20132BAB205063).	Akioka Naoki, 2007, J Stroke Cerebrovasc Dis, V16, P109, DOI 10.1016/j.jstrokecerebrovasdis.2006.11.007; Black SW, 2014, J NEUROSCI, V34, P6485, DOI 10.1523/JNEUROSCI.0080-14.2014; Boss C, 2015, BIOORG MED CHEM LETT, V25, P2875, DOI 10.1016/j.bmcl.2015.05.012; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Chang VC, 2015, AM J IND MED, V58, P353, DOI 10.1002/ajim.22418; Cooper EB, 2005, NEUROPSYCHOL REHABIL, V15, P389, DOI 10.1080/09602010443000317; Cossu G, 2014, BRIT J NEUROSURG, V28, P187, DOI 10.3109/02688697.2013.841845; Feng Z, 2016, NEURAL REGEN RES, V11, P951, DOI 10.4103/1673-5374.184494; Feng Z, 2015, NEURAL REGEN RES, V10, P594, DOI 10.4103/1673-5374.155433; Figini M, 2015, MAGN RESON IMAGING, V33, P296, DOI 10.1016/j.mri.2014.11.001; Gao GY, 2011, J NEUROTRAUM, V28, pA39; Hong KB, 2016, LIFE SCI, V150, P42, DOI 10.1016/j.lfs.2016.02.086; Kalsbeek A, 1999, NEUROSCIENCE, V91, P453, DOI 10.1016/S0306-4522(98)00635-6; Kantrowitz J, 2009, CNS DRUGS, V23, P681, DOI 10.2165/00023210-200923080-00005; Lei J, 2015, J NEUROTRAUM, V32, P1584, DOI 10.1089/neu.2014.3768; Liepert J, 2016, CURR OPIN NEUROL, V29, P700, DOI 10.1097/WCO.0000000000000381; LIN FH, 1995, J NEUROCHEM, V65, P2087; LIN FH, 1993, BRAIN RES, V608, P101, DOI 10.1016/0006-8993(93)90779-M; Liu JT, 2003, ACTA NEUROCHIR SUPPL, V87, P11; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Matsuki T, 2009, P NATL ACAD SCI USA, V106, P4459, DOI 10.1073/pnas.0811126106; Pigeon WR, 2010, SLEEP MED, V11, P816, DOI 10.1016/j.sleep.2010.06.002; Pinard A, 2010, ADV PHARMACOL, V58, P231, DOI 10.1016/S1054-3589(10)58010-4; Saito YC, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00192; Sakurai Takeshi, 2015, Nihon Rinsho, V73, P1023; Schwartz MD, 2015, PSYCHIAT CLIN N AM, V38, P615, DOI 10.1016/j.psc.2015.07.002; Soslow RA, 2000, CANCER, V89, P2637, DOI 10.1002/1097-0142(20001215)89:12<2637::AID-CNCR17>3.0.CO;2-B; STEPHENS JR, 1994, EPILEPSIA, V35, P164, DOI 10.1111/j.1528-1157.1994.tb02928.x; Terao A, 2008, JPN J VET RES, V55, P75; Vazquez-DeRose J, 2016, BRAIN STRUCT FUNCT, V221, P923, DOI 10.1007/s00429-014-0946-y; Vienne J, 2010, J NEUROSCI, V30, P14194, DOI 10.1523/JNEUROSCI.3145-10.2010; Wang ML, 2016, J NEUROL SCI, V370, P244, DOI 10.1016/j.jns.2016.09.049; Xie XM, 2006, J PHYSIOL-LONDON, V574, P399, DOI 10.1113/jphysiol.2006.108266; Zhong YJ, 2015, MOL MED REP, V12, P4441, DOI 10.3892/mmr.2015.3898	34	1	2	2	11	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	1940-5901			INT J CLIN EXP MED	Int. J. Clin. Exp. Med.		2017	10	10					14571	14578					8	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	FL5QD	WOS:000414299700046					2022-02-06	
J	Faheem, M; Jaiswal, M; Ojha, BK; Chandra, A; Singh, SK; Srivastava, C; Saba, NU				Faheem, Mohd; Jaiswal, Manish; Ojha, Bal Krishna; Chandra, Anil; Singh, Sunil Kumar; Srivastava, Chhitij; Saba, Noor Us			Disappearance of the Hemorrhagic Component of the Frontal Contusion Possibly due to Redistribution of the Hematoma within the Subarachnoid Space: A Case Report	PEDIATRIC NEUROSURGERY			English	Article						Contusion; Spontaneous resolution; Posttraumatic hemorrhagic contusion; Traumatic brain injury	EPIDURAL HEMATOMA; RESOLUTION	Posttraumatic hemorrhagic contusions are a common sequel of traumatic brain injuries. They occur in around 8% of all traumatic brain injuries. Spontaneous resolution of acute subdural and acute extradural hematomas, although rare, is a recognized entity, but spontaneous resolution of the hemorrhagic component of a contusion within 24 h has not been reported in the literature. We present a patient in whom the hemorrhagic component of her contusion resolved spontaneously over a period of 24 h after injury. The rarity of this case prompted us to this study. (C) 2017 S. Karger AG, Basel	[Faheem, Mohd; Jaiswal, Manish; Ojha, Bal Krishna; Chandra, Anil; Singh, Sunil Kumar; Srivastava, Chhitij] King Georges Med Univ, Dept Neurosurg, Lucknow 226003, Uttar Pradesh, India; [Saba, Noor Us] King Georges Med Univ, Dept Anat, Lucknow, Uttar Pradesh, India		Faheem, M (corresponding author), King Georges Med Univ, Dept Neurosurg, Lucknow 226003, Uttar Pradesh, India.	faheemjnmc@gmail.com	Jaiswal, Manish/J-1591-2019; FAHEEM, MOHD/AAI-2075-2021	Jaiswal, Manish/0000-0002-1300-3716; 			AOKI N, 1988, J NEUROSURG, V68, P149, DOI 10.3171/jns.1988.68.1.0149; BULLOCK R, 1989, SURG NEUROL, V32, P181, DOI 10.1016/0090-3019(89)90176-6; Kang SH, 2005, NEUROL MED-CHIR, V45, P462, DOI 10.2176/nmc.45.462; KUROIWA T, 1993, J NEUROSURG, V78, P126, DOI 10.3171/jns.1993.78.1.0126; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; Marion DW, 2006, NEUROSURGERY, V58, P655; SERVADEI F, 1989, J TRAUMA, V29, P880, DOI 10.1097/00005373-198906000-00030; SOLONIUK D, 1986, J TRAUMA, V26, P787, DOI 10.1097/00005373-198609000-00003	8	1	1	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291	1423-0305		PEDIATR NEUROSURG	Pediatr. Neurosurg.		2017	52	4					268	270		10.1159/000475532			3	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	FC9QS	WOS:000407176800008	28601873				2022-02-06	
J	Fakhry, SM; Ferguson, PL; Johnson, EE; Wilson, DA				Fakhry, Samir M.; Ferguson, Pamela L.; Johnson, Emily E.; Wilson, Dulaney A.			Hospitalization in low-level trauma centres after severe traumatic brain injury: review of a population-based emergency department data base	BRAIN INJURY			English	Article						TBI; brain injuries; trauma centres; United States	MAJOR TRAUMA; CENTER CARE; MORTALITY; UNDERTRIAGE; TRANSPORT; ACCESS; SYSTEM; TRIAGE; IMPACT; CALIFORNIA	Objective: To achieve the best possible recovery, individuals with severe TBI should be treated at Level I/II trauma centres (I/II TC). Increased morbidity and mortality can result when injured patients are admitted to facilities that may not have the appropriate resources or expertise to treat the injury. The purpose of this study was to estimate the proportion of severe TBI visits resulting in hospitalization in lower-level trauma centres (OTH) and evaluate the characteristics associated with such hospitalizations.Methods: The 2012 National Emergency Department Sample (NEDS) data set was analysed. Weighted descriptive analysis and multivariable logistic regression were used to describe the association of hospitalization in OTH with demographic, clinical and hospital characteristics.Results: Of visits for severe TBI, 112 208 were admitted to I/II TC and 43 294 admitted to OTH. The adjusted odds of hospitalization in OTH were higher for isolated TBI, falls, women, in those with 3 chronic conditions and increasing age.Conclusions: An estimated 19.5% of visits for severe TBI resulted in hospitalization in OTH. These findings show the need to further evaluate the relationship between sex, age and mechanism of injury to inform efforts to appropriately triage individuals with TBI to ensure the best possible recovery.	[Fakhry, Samir M.; Ferguson, Pamela L.; Wilson, Dulaney A.] Med Univ South Carolina, Dept Surg, Div Gen Surg, Trauma Serv, Charleston, SC 29425 USA; [Johnson, Emily E.] Med Univ South Carolina, Coll Nursing, Charleston, SC 29425 USA; [Wilson, Dulaney A.] Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA		Wilson, DA (corresponding author), 135 Cannon St,Suite 303,MSC 835, Charleston, SC 29425 USA.	wilsonda@musc.edu			South Carolina Clinical & Translational Research (SCTR) Institute through NIH-NCATS [UL1 TR001450]; MUSC Office of the Provost	This publication was partially supported by the South Carolina Clinical & Translational Research (SCTR) Institute, with an academic home at the Medical University of South Carolina, through NIH-NCATS Grant Number UL1 TR001450. Data analytic support for the study was provided through support for the CEDAR core funded by the MUSC Office of the Provost.	Allareddy V, 2012, INJURY, V43, P2051, DOI 10.1016/j.injury.2011.10.040; American College of Surgeons Committee on Trauma, 2014, RESOURCES OPTIMAL CA; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Berlot G, 2009, EUR J EMERG MED, V16, P312, DOI 10.1097/MEJ.0b013e32832d3aa1; Chang DC, 2008, ARCH SURG-CHICAGO, V143, P776, DOI 10.1001/archsurg.143.8.776; Durham R, 2006, ANN SURG, V243, P775, DOI 10.1097/01.sla.0000219644.52926.f1; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Faul M, 2016, PREHOSP EMERG CARE, V20, P594, DOI 10.3109/10903127.2016.1149651; Gabbe BJ, 2011, ANN SURG, V253, P138, DOI 10.1097/SLA.0b013e3181f6685b; Garwe T, 2011, J TRAUMA, V70, P1118, DOI 10.1097/TA.0b013e3181e243b8; Glance LG, 2009, ANN SURG, V249, P1032, DOI 10.1097/SLA.0b013e3181a38f28; Gomez D, 2012, SURGERY, V152, P179, DOI 10.1016/j.surg.2012.04.006; Greenland S, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1981; Haas B, 2012, J TRAUMA ACUTE CARE, V72, P1510, DOI 10.1097/TA.0b013e318252510a; Haas B, 2010, J AM COLL SURGEONS, V211, P804, DOI 10.1016/j.jamcollsurg.2010.08.014; Haider AH, 2012, J TRAUMA ACUTE CARE, V72, P1695, DOI 10.1097/TA.0b013e318256a010; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Healthcare Cost and Utilization Project (HCUP), 2012, INTR HCUP NAT EM DEP; Hsia RY, 2010, J TRAUMA, V68, P217, DOI 10.1097/TA.0b013e3181a0e66d; Joosse P, 2012, J TRAUMA ACUTE CARE, V72, P487, DOI 10.1097/TA.0b013e318226ed59; Kodadek LM, 2015, J SURG RES, V199, P220, DOI 10.1016/j.jss.2015.05.017; Lane P, 2003, ACAD EMERG MED, V10, P244, DOI 10.1197/aemj.10.3.244; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; MACKENZIE EJ, 1990, J TRAUMA, V30, P681, DOI 10.1097/00005373-199006000-00005; Nathens AB, 2004, J TRAUMA, V56, P173, DOI 10.1097/01.TA.0000056159.65396.7C; Nathens AB, 2003, J TRAUMA, V55, P444, DOI 10.1097/01.TA.0000047809.64699.59; Phillips S, 1996, J TRAUMA, V40, P278, DOI 10.1097/00005373-199602000-00018; Pickering A, 2015, J TRAUMA ACUTE CARE, V78, P164, DOI 10.1097/TA.0000000000000483; Rhee P, 2014, ANN SURG, V260, P13, DOI 10.1097/SLA.0000000000000600; SAS Institute, 2012, STAT AN SOFTW VERS 9; Staudenmayer K, 2016, AM SURGEON, V82, P356; Staudenmayer K, 2016, J TRAUMA ACUTE CARE, V80, P412, DOI 10.1097/TA.0000000000000956; Staudenmayer K, 2014, J TRAUMA ACUTE CARE, V76, P1041, DOI 10.1097/TA.0000000000000197; Taylor CA, 2015, J HEAD TRAUMA REHAB, V30, P150, DOI 10.1097/HTR.0000000000000105; Tepas JJ, 2013, J TRAUMA ACUTE CARE, V74, P143, DOI 10.1097/TA.0b013e3182788b5a; Vassar MJ, 2003, J AM COLL SURGEONS, V197, P717, DOI 10.1016/S1072-7515(03)00749-X; Vickers BP, 2015, AM J EMERG MED, V33, P1158, DOI 10.1016/j.ajem.2015.05.010; Xiang HY, 2014, AM J EMERG MED, V32, P997, DOI 10.1016/j.ajem.2014.05.038; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	39	1	1	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	11					1486	1493		10.1080/02699052.2017.1376762			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FN4GB	WOS:000415961200011	28980837				2022-02-06	
J	Fry, JP				Fry, Jeffrey P.			Two Kinds of Brain Injury in Sport	SPORT ETHICS AND PHILOSOPHY			English	Article						Brain injury; emotional trauma; neuroethics		After years of skepticism and denials regarding the significance of concussions in sport, the issue is now front and center. This is fitting, given that the impact of concussions in sport is profound. Thus, it is with trepidation that one ventures to direct some attention onto brain injuries other than concussions incurred through sport. Given a closer look, however, it may be that considering various kinds of brain injuries, with different causes, will help us better understand the range and seriousness of brain injuries in sport. My focus is on emotional trauma in sport. I argue that severe emotional pathology is evidence of underlying brain injury. Any attempt to minimize the significance of emotional disturbance that results from emotional trauma as 'merely' psychological in nature is thus misguided.	[Fry, Jeffrey P.] Ball State Univ, Philosophy & Religious Studies, Muncie, IN 47306 USA		Fry, JP (corresponding author), Ball State Univ, Philosophy & Religious Studies, Muncie, IN 47306 USA.	jfry@bsu.edu					Agassi A., 2010, OPEN AUTOBIOGRAPHY; [Anonymous], 2002, CNN             0125; cantu r, 2013, CONCUSSION OUR KIDS; Carroll Linda, 2012, CONCUSSION CRISIS AN; Corkin S., 2013, PERMANENT PRESENT TE; Cozolino L., 2014, NEUROSCIENCE HUMAN R, V2nd; davidson k, 2015, CHICAGO TRIBUNE; Descartes R., 1993, MEDITATIONS 1 PHILOS; Doidge N., 2015, BRAINS WAY HEALING R; Doidge Norman, 2007, BRAIN CHANGES ITSELF; Duckworth A, 2016, GRIT POWER PASSION P; Fainaru-Wada Mark, 2013, LEAGUE DENIAL NFL CO; Feinberg J, 1987, MORAL LIMITS CRIMINA, V1; FINGER S., 1994, ORIGINS NEUROSCIENCE; Fry J. P., 2013, ETHICS COACHING SPOR, P151; Glannon W., 2013, BRAIN BODY MIND NEUR; Heil J., 2013, PHILOS MIND CONT INT; Jensen FrancesE., 2015, TEENAGE BRAIN NEUROS; Johnston E., 2015, FEELING BRAIN BIOL P; Kapur N., 2011, PARADOXICAL BRAIN, P40; Kim J., 2011, PHILOS MIND; Leder Drew, 1990, ABSENT BODY; LeDoux J.E., 2015, ANXIOUS USING BRAIN; LeDoux J. E., 2003, SYNAPTIC SELF OUR BR; LeDoux J.E., 1998, EMOTIONAL BRAIN MYST; Lurie Y, 2005, ETHICS SPORT, P200; Malabou C, 2012, FORM LIVING, P1; Nack W., 1999, SPORTS ILLUSTRATED, V91, P40; Nagel T, 1974, PHILOS MIND GUIDE AN; NUWAR R., 2016, SCI AM MIND BEHA JUL, P38; Paton H.J., 1964, GROUNDWORK METAPHYSI; Paul LA, 2014, TRANSFORMATIVE EXPER; ROBINSON L, 1998, CROSSING LINE VIOLEN; Ryan J., 2000, LITTLE GIRLS PRETTY; Sapolsky R.M., 2004, WHY ZEBRAS DONT GET, V3; Seung S., 2013, CONNECTOME BRAINS WI; SEY J, 2008, CHALKED INSIDE ELITE; SHIELDS D., 2010, RETHINKING COMPETITI; Tinley S., 2012, THESIS; van der Kolk B.A., 2014, BODY KEEPS SCORE BRA; wolf a., 2015, SPORTS ILLUSTRATED, P50	41	1	1	1	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1751-1321	1751-133X		SPORT ETHICS PHILOS	Sport Ethics Philos.		2017	11	3			SI		294	306		10.1080/17511321.2017.1343374			13	Ethics	Emerging Sources Citation Index (ESCI)	Social Sciences - Other Topics	FQ6PF	WOS:000418485800004					2022-02-06	
J	Gaylor, L; Junge, M; Abanteriba, S				Gaylor, Luke; Junge, Mirko; Abanteriba, Sylvester			Efficacy of seat-mounted thoracic side airbags in the German vehicle fleet	TRAFFIC INJURY PREVENTION			English	Article						Side airbags; statistical evaluation; injury association; nearside crashes; matched pairs	IMPACT CRASHES; AIR BAGS; INJURY; RISK; DIMENSIONS; VELOCITY; CIREN; NASS	Objective: Thoracic side airbags (tSABs) deploy within close proximity to the occupant. Their primary purpose is to provide a protective cushion between the occupant and the intruding door. To date, various field studies investigating their injury mitigation has been limited and contradicting. The research develops efficacy estimations associated for seat-mounted tSABs in their ability to mitigate injury risk from the German collision environment.Methods: A matched cohort study using German In-Depth Accident Study (GIDAS) data was implemented and aims to investigate the efficacy of seat-mounted tSAB units in preventing thoracic injury. Inclusion in the study required a nearside occupant involved in a lateral collision where the target vehicle exhibited a design year succeeding 1990. Collisions whereby a tSAB deployed were matched on a 1:n basis to collisions of similar severity where no airbag was available in the target vehicle. The outcome of interest was an incurred bodily or thoracic regional injury. Through conditional logistic regression, an estimated efficacy value for the deployed tSAB was determined.Results: A total of 255 collisions with the deployed tSAB matched with 414 collisions where no tSAB was present. For the given sample, results indicated that the deployed tSAB was not able to provide an unequivocal benefit to the occupant thoracic region, because individuals exposed to the deployed tSAB were at equal risk of injury (Thorax Maximum Abbreviated Injury Scale (Tho.MAIS)2+ odds ratio [OR] = 1.04, 95% confidence interval [CI], 0.41-2.62; Tho.MAIS3+ OR = 1.15, 95% CI, 0.41-3.18). When attempting to isolate an effect for skeletal injuries, a similar result was obtained. Yet, when the tSAB was coupled with a head curtain airbag, a protective effect became apparent, most noticeable for head/face/neck (HFN) injuries (OR = 0.59, 95% CI, 0.21-1.65).Conclusion: The reduction in occupant HFN injury risk associated with the coupled tSAB and curtain airbag may be attributable to its ability to provide coverage over previous mechanisms of injury. Yet, the sole presence of the tSAB showed no ability to provide additional benefit for the occupant's thoracic region. Future work should identify mechanisms of injury in tSAB cases and attempt to quantify improvements in the vehicle's ability to resist intrusion.	[Gaylor, Luke; Junge, Mirko] Volkswagen AG, Konzernforschung K GERFK U, Wolfsburg, Germany; [Gaylor, Luke; Abanteriba, Sylvester] RMIT Univ, Sch Aerosp Mech & Mfg Engn, Melbourne, Vic, Australia		Gaylor, L (corresponding author), Volkswagen AG, Unfallforsch, Berliner Ring 2, D-38440 Wolfsburg, Germany.	luke.gaylor@student.rmit.edu.au		Abanteriba, Sylvester/0000-0003-0110-3135			Arbogast KB, 2005, ARCH PEDIAT ADOL MED, V159, P342, DOI 10.1001/archpedi.159.4.342; Association for the Advancement of Automotive Medicine, 1998, ABBR INJ SCAL AIS; Augenstein J, 1999, 19990301 SAE; Bellemare F, 2003, AM J RESP CRIT CARE, V168, P305, DOI 10.1164/rccm.200208-876OC; Bellemare JF, 2001, CHEST, V119, P376, DOI 10.1378/chest.119.2.376; Braver ER, 2004, AM J EPIDEMIOL, V159, P556, DOI 10.1093/aje/kwh087; Burg H, 1980, EES EIN HILFSMITTEL; Careme LMM., 1991, 910316 SAE; Crandall J, 2000, Annu Proc Assoc Adv Automot Med, V44, P235; D'Elia A, 2013, ACCIDENT ANAL PREV, V54, P67, DOI 10.1016/j.aap.2013.02.020; Davila A, 2011, ENH SAF VEH C WASH D; Donlon JP, 2015, J BIOMECH, V48, P529, DOI 10.1016/j.jbiomech.2014.12.042; Esfahani ES, 2011, INT J CRASHWORTHINES, V16, P309, DOI 10.1080/13588265.2011.566474; EVANS L, 1993, ACCIDENT ANAL PREV, V25, P213, DOI 10.1016/0001-4575(93)90062-2; Evans L., 2004, TRAFFIC SAFETY; Farmer CM, 1997, ACCIDENT ANAL PREV, V29, P399, DOI 10.1016/S0001-4575(97)00006-7; Fildes BN, 1994, 14 C ENH SAF VEH MUN; GORDON JE, 1949, AM J PUBLIC HEALTH, V39, P504, DOI 10.2105/AJPH.39.4.504; Griffin R, 2012, J TRAUMA ACUTE CARE, V73, P914, DOI 10.1097/TA.0b013e31825a7636; Haland Y, 1996, J BIOMECH ENG-T ASME, V118, P412, DOI 10.1115/1.2796025; Harms PL, 1987, 11 ENH SAF VEH C WAS; Hartemann F, 1976, STAPP CAR CRASH J, V20, P363; Hayashi S, 2006, IRCOBI C MADR SPAIN; Hayashi S, 2008, STAPP CAR C, V52, P363; Iraeus J, 2014, TRAFFIC INJ PREV, V15, P56, DOI 10.1080/15389588.2013.793796; Kahane CJ, 2007, 809004 DOT HS NHTSA; Kent Richard, 2005, Stapp Car Crash J, V49, P231; Keogh RH, 2014, INST MATH STAT MG, V4, P1, DOI 10.1017/CBO9781139094757; Kim T, 2016, ACCIDENT ANAL PREV, V90, P140, DOI 10.1016/j.aap.2016.02.010; Kimpara Hideyuki, 2005, Stapp Car Crash J, V49, P251; Kleinbaum DG., 2010, LOGISTIC REGRESSION, V3rd ed; Kompass K, 1998, 16 ENH SAF VEH C WIN; Lee EL, 2014, INCREASE VEHICLE FRO; Levine E., 1999, MATURE MED CANADA, V2, P239; Loftis Kathryn L, 2011, Ann Adv Automot Med, V55, P81; LOZZI A, 1981, INT J VEHICLE DES, V2, P470; Lund AK, 2000, RECOMMENDED PROCEDUR; Luzon-Narro J, 2014, INT J CRASHWORTHINES, V19, P209, DOI 10.1080/13588265.2013.802938; McCartt Anne T, 2007, Traffic Inj Prev, V8, P162, DOI 10.1080/15389580601173875; McGwin G, 2004, J TRAUMA, V56, P512, DOI 10.1097/01.TA.0000114272.37352.21; MIETTINEN OS, 1969, BIOMETRICS, V25, P339, DOI 10.2307/2528794; Morris AP, 1997, IRCOBI C HANN GERM; NHTSA, 2015, NEW CAR ASS PROGR; Noland RB, 2005, ENERG POLICY, V33, P2183, DOI 10.1016/j.enpol.2004.04.016; O'Neill B, 2009, TRAFFIC INJ PREV, V10, P113, DOI 10.1080/15389580802486225; Otte D, 2003, 18 C ENH SAF VEH NAG; Page Y, 2006, ESAR C HANN GERM; Pilhall S, 1994, 14 C ENH SAF VEH MUN; Pipkorn B, 2014, TRAFFIC INJ PREV, V15, pS231, DOI 10.1080/15389588.2014.933818; REIDELBACH W, 1983, 830460 SAE; Samaha RR, 2003, 18 C ENH SAF VEH NAG; Society of Automotive Engineers, 1980, COLL DEFCLASS J224 1; STEIN ID, 1976, CALC TISS RES, V20, P61, DOI 10.1007/BF02546398; Stigson H, 2011, 22 ENH SAF VEH C WAS; Strandroth J, 2016, IRCOBI C MAL SPAIN; Sunnevang C, 2015, TRAFFIC INJ PREV, V16, pS117, DOI 10.1080/15389588.2015.1022895; Sunnevang Cecilia, 2010, Ann Adv Automot Med, V54, P159; Tencer AF, 2005, ACCIDENT ANAL PREV, V37, P287, DOI 10.1016/j.aap.2004.09.005; Tencer Allan F, 2005, Traffic Inj Prev, V6, P372, DOI 10.1080/15389580500256813; Thor Craig P, 2008, Biomed Sci Instrum, V44, P292; TROXEL LA, 1991, TRANSPORT RES REC, V1302, P32; van Ratingen M, 2016, CHIN J TRAUMATOL, V19, P63, DOI 10.1016/j.cjtee.2015.11.016; Welsh R, 2009, IRCOBI C YORK UK; Yoganandan N, 1998, J BIOMECH ENG-T ASME, V120, P100, DOI 10.1115/1.2834288; Yoganandan N, 2005, ACCIDENT ANAL PREV, V37, P495, DOI 10.1016/j.aap.2004.12.007; YOGANANDAN N, 1995, J BIOMECH ENG-T ASME, V117, P48, DOI 10.1115/1.2792269; Yoganandan N, 2005, IRCOBI C PRAG CZECH; Yoganandan N, 2007, ACCIDENT ANAL PREV, V39, P22, DOI 10.1016/j.aap.2006.05.014; Zaouk AK, 2001, 2001010723 SAE	69	1	1	1	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-9588	1538-957X		TRAFFIC INJ PREV	Traffic Inj. Prev.		2017	18	8					852	858		10.1080/15389588.2017.1316843			7	Public, Environmental & Occupational Health; Transportation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Transportation	FL0NQ	WOS:000413908500012	28557622				2022-02-06	
J	Gezici, AR; Kilic, G; Firat, T; Cancan, SE; Kukner, A; Ozkan, N; Dagistan, Y				Gezici, Ali Riza; Kilic, Guven; Firat, Tulin; Cancan, Seckin Emre; Kukner, Aysel; Ozkan, Nezih; Dagistan, Yasar			The therapeutic effects of cyclosporin-A on experimental spinal cord injury.	BIOMEDICAL RESEARCH-INDIA			English	Article						Animals; Cyclosporine; Immunosuppressive agents; Motor activity; Spinal cord injuries; Thoracic vertebrae	PERIPHERAL BENZODIAZEPINE RECEPTOR; TRAUMATIC BRAIN-INJURY; INFLAMMATORY RESPONSE; RAT; ISCHEMIA; CELLS; CYCLOOXYGENASE-2; ACTIVATION; MICROGLIA; PATHWAY	Background: According to the experiments, neutrophils and microglial cells are the first to attend the early phase of events in inflammatory response to SCI. Those pilot cells are seen in the first 12-24 hours and disappear about 3-5 days. The neutrophil accumulation and activation are steered by many cytokines such as TNF-alpha, IL-1 and IL-6. Neutrophils do accompany to the modulation of secondary injury mechanisms via neutrophil proteases and reactive oxygen molecules. When those processes are taken into account, depletion of neutrophils or depression of their functions may derive neuro-protection and neurological healing. Purpose: To investigate the therapeutic and neuroprotective effects of Cyclosporin-A (CSA) on recovery processes using clinical and histopathological tests, which has not been used very frequently in clip compression spinal cord injury (SCI) models. Material and methods: Twenty-four Spraque-Dawley rats were divided into three groups: group 1 [Sham-control, n=8], group 2 [SCI+2 mL saline intramuscular (i.m.), n=8], group 3 [SCI+5 mg/kg CSA (i.p.) 1 h after SCI and for the following three days, n=8]. Rats were evaluated 1st, 3rd, 5th and 10th days after SCI, clinically by Drummond and Moore scale and under light microscopy and by TUNEL test; after scarification on 10th day. Results: Clinical and histopathological results of treatment group were found significantly better than the results of the trauma group. Conclusion: CSA can depress apoptosis and necrosis rates in a statistically significant manner and carry out the statistical difference in clinical results.	[Gezici, Ali Riza; Kilic, Guven; Cancan, Seckin Emre; Ozkan, Nezih; Dagistan, Yasar] Abant Izzet Baysal Univ, Sch Med, Dept Neurosurg, Bolu, Turkey; [Firat, Tulin; Kukner, Aysel] Abant Izzet Baysal Univ, Sch Med, Dept Histol & Embriyol, Bolu, Turkey		Cancan, SE (corresponding author), Abant Izzet Baysal Univ, Sch Med, Dept Neurosurg, Bolu, Turkey.		Cancan, Seckin Emre/E-9295-2017	Cancan, Seckin Emre/0000-0002-3260-7419			Alessandri B, 2002, J NEUROTRAUM, V19, P829, DOI 10.1089/08977150260190429; BECK KD, 2010, BRAIN; Bethea JR, 2002, CURR OPIN NEUROL, V15, P355, DOI 10.1097/00019052-200206000-00021; Bethea JR, 1998, J NEUROSCI, V18, P3251; BLACK P, 1986, NEUROSURGERY, V19, P752, DOI 10.1227/00006123-198611000-00006; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; Capano M, 2002, BIOCHEM J, V363, P29, DOI 10.1042/bj3630029; Choi HB, 2002, J NEUROCHEM, V83, P546, DOI 10.1046/j.1471-4159.2002.01122.x; Conti A, 2003, J Neurosurg Sci, V47, P89; Diaz-Ruiz A, 1999, NEUROSCI LETT, V266, P61, DOI 10.1016/S0304-3940(99)00255-4; DRUMMOND JC, 1989, ANESTHESIOLOGY, V70, P64, DOI 10.1097/00000542-198901000-00014; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Gong C, 2000, BRAIN RES, V871, P57, DOI 10.1016/S0006-8993(00)02427-6; Hailer NP, 2008, PROG NEUROBIOL, V84, P211, DOI 10.1016/j.pneurobio.2007.12.001; Hamada Y, 1996, J NEUROCHEM, V66, P1525; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Herman ZS, 2004, POL J PHARMACOL, V56, P129; Iadecola C, 1999, ACTA NEUROPATHOL, V98, P9, DOI 10.1007/s004010051045; Ibarra A, 2004, EUR J NEUROSCI, V19, P2984, DOI 10.1111/j.0953-816X.2004.03402.x; Jayakumar AR, 2002, J NEUROCHEM, V83, P1226, DOI 10.1046/j.1471-4159.2002.01261.x; KAYAALP SO, 2002, RASYONAL TEDAVI YONU; Lockhart BP, 1998, BRIT J PHARMACOL, V123, P879, DOI 10.1038/sj.bjp.0701664; Lu HZ, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-127; Lulic D, 2011, NEUROSURGERY, V68, P1172, DOI 10.1227/NEU.0b013e31820c6cdc; McTigue DM, 1998, J NEUROSCI RES, V53, P368, DOI 10.1002/(SICI)1097-4547(19980801)53:3<368::AID-JNR11>3.0.CO;2-1; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; Palladini G, 1995, J HIRNFORSCH, V37, P145; Pineau I, 2007, J COMP NEUROL, V500, P267, DOI 10.1002/cne.21149; Pyrzynska B, 2001, NEUROCHEM INT, V38, P409, DOI 10.1016/S0197-0186(00)00105-4; Rabchevsky AG, 2001, J NEUROTRAUM, V18, P513, DOI 10.1089/089771501300227314; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Sheehan J, 2006, NEUROSURG FOC, V20, P1; SHIGA Y, 1992, BRAIN RES, V595, P145, DOI 10.1016/0006-8993(92)91465-Q; Taoka Y, 1997, NEUROSCIENCE, V79, P1177, DOI 10.1016/S0306-4522(97)00011-0; Teichner A, 1993, J Hirnforsch, V34, P343	36	1	1	0	5	SCIENTIFIC PUBLISHERS INDIA	ALIGARH	87-GREATER AZAD ENCLAVE, P O QUARSI, ALIGARH, 00000, INDIA	0970-938X	0976-1683		BIOMED RES-INDIA	Biomed. Res.-India		2017	28	8					3755	3762					8	Engineering, Biomedical; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Research & Experimental Medicine	EX7UN	WOS:000403454800078					2022-02-06	
B	Giustina, A; Frara, S; Spina, A; Mortini, P		Melmed, S		Giustina, Andrea; Frara, Stefano; Spina, Alfio; Mortini, Pietro			The Hypothalamus	PITUITARY, 4TH EDITION			English	Article; Book Chapter							PRADER-WILLI-SYNDROME; GROWTH-HORMONE DEFICIENCY; TRAUMATIC BRAIN-INJURY; BARDET-BIEDL SYNDROME; GERM-CELL TUMORS; SEPTO-OPTIC DYSPLASIA; QUALITY-OF-LIFE; SIMULATING IDIOPATHIC HYPOPITUITARISM; NEUROLEPTIC MALIGNANT SYNDROME; CENTRAL DIABETES-INSIPIDUS		[Giustina, Andrea; Frara, Stefano] Univ Brescia, Brescia, Italy; [Spina, Alfio; Mortini, Pietro] Univ Vita Salute San Raffaele, Milan, Italy		Giustina, A (corresponding author), Univ Brescia, Brescia, Italy.		Giustina, Andrea/AAN-5938-2020; Spina, Alfio/AAA-2175-2019; mortini, pietro/AAB-1292-2019	Spina, Alfio/0000-0003-2096-8871; MORTINI, Pietro/0000-0003-2320-2281; Frara, Stefano/0000-0002-1308-5598			Alatzoglou KS, 2014, ENDOCR REV, V35, P376, DOI 10.1210/er.2013-1067; Alqahtani AR, 2016, SURG OBES RELAT DIS, V12, P100, DOI 10.1016/j.soard.2015.07.014; Alshail E, 1997, BRAIN PATHOL, V7, P799; Andre A, 2016, NEUROSURGERY, V78, P370, DOI 10.1227/NEU.0000000000001049; Angulo MA, 2015, J ENDOCRINOL INVEST, V38, P1249, DOI 10.1007/s40618-015-0312-9; Anthony J, 2016, PITUITARY, V19, P19, DOI 10.1007/s11102-015-0678-x; Arita K, 2005, NEUROL MED-CHIR, V45, P221, DOI 10.2176/nmc.45.221; Arnulf I, 2012, LANCET NEUROL, V11, P918, DOI 10.1016/S1474-4422(12)70187-4; ASA SL, 1984, ANN INTERN MED, V101, P789, DOI 10.7326/0003-4819-101-6-789; Badalian-Very G, 2013, ANNU REV PATHOL-MECH, V8, P1, DOI 10.1146/annurev-pathol-020712-163959; Ball SG, 1997, CLIN ENDOCRINOL, V47, P405, DOI 10.1046/j.1365-2265.1997.2591079.x; Bassiouni H, 2006, SURG NEUROL, V66, P37, DOI 10.1016/j.surneu.2005.11.059; BAUER HG, 1959, J NERV MENT DIS, V128, P323, DOI 10.1097/00005053-195912840-00005; BAUER HG, 1954, J CLIN ENDOCR METAB, V14, P13, DOI 10.1210/jcem-14-1-13; Bereket A, 2012, OBES REV, V13, P780, DOI 10.1111/j.1467-789X.2012.01004.x; Bergman JEH, 2011, J MED GENET, V48, P334, DOI 10.1136/jmg.2010.087106; Bianco SDC, 2009, NAT REV ENDOCRINOL, V5, P569, DOI 10.1038/nrendo.2009.177; Biesecker LG, 1996, J MED GENET, V33, P585, DOI 10.1136/jmg.33.7.585; Bihan H, 2007, MEDICINE, V86, P259, DOI 10.1097/MD.0b013e31815585aa; BILLER BMK, 1992, J CLIN ENDOCR METAB, V75, P1303, DOI 10.1210/jc.75.5.1303; Bingham Nathan C, 2012, Front Endocrinol (Lausanne), V3, P23, DOI 10.3389/fendo.2012.00023; Binning Mandy J, 2007, Neurosurg Focus, V23, pE2; Bomer I, 2015, J PEDIATR ENDOCR MET, V28, P1305, DOI 10.1515/jpem-2015-0167; Braunstein G. D, 2016, ENDOCRINOLOGY ADULT, P174; Braunstein GD, 2010, ENDOCRINOLOGY ADULT; Braunstein GD, 2002, THE PITUITARY, P303; Brinckman DD, 2013, AM J MED GENET A, V161, P2964, DOI 10.1002/ajmg.a.36245; Bruesch SR, 1984, HYPOTHALAMUS, P1; Buscher AK, 2012, PEDIATR NEPHROL, V27, P2065, DOI 10.1007/s00467-012-2220-y; Bunin G R, 1997, Neurosurg Focus, V3, pe1; Burman P, 2001, ENDOCR REV, V22, P787, DOI 10.1210/er.22.6.787; BURR IM, 1976, J PEDIATR-US, V88, P439, DOI 10.1016/S0022-3476(76)80260-0; Butler MG, 2007, AM J MED GENET A, V143A, P449, DOI 10.1002/ajmg.a.31507; Calaminus G, 2005, NEUROPEDIATRICS, V36, P71, DOI 10.1055/s-2005-837582; Carmel P W, 1980, Clin Neurosurg, V27, P133; Carpinteri R, 2009, BEST PRACT RES CL EN, V23, P639, DOI 10.1016/j.beem.2009.05.009; Casanueva FF, 2006, CLIN ENDOCRINOL, V65, P265, DOI 10.1111/j.1365-2265.2006.02562.x; Cassidy SB, 2012, GENET MED, V14, P10, DOI 10.1038/gim.0b013e31822bead0; Chattopadhyay A, 2003, J PEDIATR SURG, V38, P1390, DOI 10.1016/S0022-3468(03)00403-2; Cohen M, 2013, NEURO-ONCOLOGY, V15, P767, DOI 10.1093/neuonc/not026; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; Coll AP, 2004, J CLIN ENDOCR METAB, V89, P2557, DOI 10.1210/jc.2004-0428; Collin GB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037925; COMITE F, 1984, J CLIN ENDOCR METAB, V59, P888, DOI 10.1210/jcem-59-5-888; Costa-Barbosa FA, 2013, J CLIN ENDOCR METAB, V98, pE943, DOI 10.1210/jc.2012-4116; COSTIN G, 1988, AM J DIS CHILD, V142, P847, DOI 10.1001/archpedi.1988.02150080053022; Crowne E, 2015, LANCET DIABETES ENDO, V3, P568, DOI 10.1016/S2213-8587(15)00008-X; Dattani M, 2004, LANCET, V363, P1977, DOI 10.1016/S0140-6736(04)16413-1; Deal CL, 2013, J CLIN ENDOCR METAB, V98, pE1072, DOI 10.1210/jc.2012-3888; Doga M, 2005, REV ENDOCR METAB DIS, V6, P63, DOI 10.1007/s11154-005-5226-y; Doga M, 2001, ANN ONCOL, V12, pS89, DOI 10.1093/annonc/12.suppl_2.S89; Donadieu J, 2004, J CLIN ENDOCR METAB, V89, P604, DOI 10.1210/jc.2003-030907; Duff JM, 2000, NEUROSURGERY, V46, P291, DOI 10.1097/00006123-200002000-00007; EDWARDS JA, 1976, AM J MED, V60, P23, DOI 10.1016/0002-9343(76)90529-5; Eldar-Geva T, 2013, AM J MED GENET A, V161, P3030, DOI 10.1002/ajmg.a.36152; Ellison DH, 2007, NEW ENGL J MED, V356, P2064, DOI 10.1056/NEJMcp066837; Elowe-Gruau E, 2013, J CLIN ENDOCR METAB, V98, P2376, DOI 10.1210/jc.2012-3928; Erfurth EM, 2013, PITUITARY, V16, P46, DOI 10.1007/s11102-012-0428-2; Feigerlova E, 2008, J CLIN ENDOCR METAB, V93, P2800, DOI 10.1210/jc.2007-2138; Fife SK, 1996, NEUROENDOCRINOLOGY, V64, P131, DOI 10.1159/000127109; Fleischman A, 2005, PEDIATRICS, V115, pE742, DOI 10.1542/peds.2004-2237; Fukuoka H, 2015, ENDOCRIN METAB CLIN, V44, P143, DOI 10.1016/j.ecl.2014.10.011; Garcia ML, 2006, J CHILD NEUROL, V21, P949, DOI 10.2310/7010.2006.00241; Garcia-Filion P, 2013, CURR TREAT OPTION NE, V15, P78, DOI 10.1007/s11940-012-0209-2; Gazzaruso C, 2014, J CLIN ENDOCR METAB, V99, P18, DOI 10.1210/jc.2013-2394; Gerganov V, 2014, J NEUROSURG, V120, P559, DOI 10.3171/2013.9.JNS122133; Girschikofsky M, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-72; Giustina A, 2001, J CLIN ENDOCR METAB, V86, P4567, DOI 10.1210/jc.86.10.4567; Giustina A, 1998, ENDOCR REV, V19, P717, DOI 10.1210/er.19.6.717; GIUSTINA A, 1994, AM J PHYSIOL, V266, pE57, DOI 10.1152/ajpendo.1994.266.1.E57; Giustina A, 2014, NAT REV ENDOCRINOL, V10, P243, DOI 10.1038/nrendo.2014.21; Gohlke BC, 2002, EUR J PEDIATR, V161, P250, DOI 10.1007/s00431-002-0952-6; Goodden J, 2014, J NEUROSURG-PEDIATR, V13, P1, DOI 10.3171/2013.8.PEDS12546; GREEN JS, 1989, NEW ENGL J MED, V321, P1002, DOI 10.1056/NEJM198910123211503; Guo DF, 2011, TRENDS ENDOCRIN MET, V22, P286, DOI 10.1016/j.tem.2011.02.009; HALL JG, 1980, AM J MED GENET, V7, P47, DOI 10.1002/ajmg.1320070110; Hall JG, 2014, AM J MED GENET C, V166, P414, DOI 10.1002/ajmg.c.31419; Hardesty DA, 2012, NEUROCRIT CARE, V17, P382, DOI 10.1007/s12028-011-9618-4; Haupt R, 2013, PEDIATR BLOOD CANCER, V60, P175, DOI 10.1002/pbc.24367; HAYEK A, 1982, PEDIATRICS, V70, P275; Hellwig D, 2003, NEUROSURGERY, V52, P525, DOI 10.1227/01.NEU.0000047671.27057.55; Herrera BM, 2011, MATURITAS, V69, P41, DOI 10.1016/j.maturitas.2011.02.018; HOCHMAN HI, 1981, PEDIATRICS, V67, P236; Hofmann BM, 2012, J NEUROSURG, V116, P373, DOI 10.3171/2011.6.JNS081451; HORN E, 1988, AM J PSYCHIAT, V145, P617; Hsieh S, 2011, J CLIN ENDOCR METAB, V96, pE925, DOI 10.1210/jc.2011-0015; Hussain I, 2013, J NEUROSURG, V119, P106, DOI 10.3171/2013.3.JNS122214; Imber BS, 2015, PITUITARY, V18, P630, DOI 10.1007/s11102-014-0622-5; JENNINGS MT, 1985, J NEUROSURG, V63, P155, DOI 10.3171/jns.1985.63.2.0155; Jeon C, 2011, J CLIN NEUROSCI, V18, P1621, DOI 10.1016/j.jocn.2011.03.028; Karavitaki N, 2006, CLIN ENDOCRINOL, V64, P556, DOI 10.1111/j.1365-2265.2006.02508.x; Karavitaki N, 2005, CLIN ENDOCRINOL, V62, P397, DOI 10.1111/j.1365-2265.2005.02231.x; Karavitaki N, 2006, ENDOCR REV, V27, P371, DOI 10.1210/er.2006-0002; Khan SA, 2016, CLIN GENET, V90, P3, DOI 10.1111/cge.12737; King BA, 2006, PHYSIOL BEHAV, V87, P221, DOI 10.1016/j.physbeh.2005.10.007; KLOOS RT, 1995, MEDICINE, V74, P268, DOI 10.1097/00005792-199509000-00004; Kokshoorn NE, 2010, EUR J ENDOCRINOL, V162, P11, DOI 10.1530/EJE-09-0601; Kreier F, 2002, J CLIN INVEST, V110, P1243, DOI 10.1172/JCI200215736; Kurtulmus N, 2015, ENDOCRINE, V48, P949, DOI 10.1007/s12020-014-0408-6; Kyriakakis N, 2016, CLIN ENDOCRINOL, V84, P372, DOI 10.1111/cen.12969; Langrand C, 2012, QJM-INT J MED, V105, P981, DOI 10.1093/qjmed/hcs121; Lawson EA, 2013, EUR J ENDOCRINOL, V169, P639, DOI 10.1530/EJE-13-0433; Layden BT, 2011, PITUITARY, V14, P194, DOI 10.1007/s11102-008-0166-7; Layman LC, 2007, ENDOCRIN METAB CLIN, V36, P283, DOI 10.1016/j.ecl.2007.03.010; Lee CC, 2014, J NEUROSURG, V121, P167, DOI 10.3171/2014.8.GKS141411; Lee HS, 2013, J PEDIATR ENDOCR MET, V26, P1201, DOI 10.1515/jpem-2013-0040; Lena G, 2005, CHILD NERV SYST, V21, P778, DOI 10.1007/s00381-005-1207-4; MacKenzie MA, 1997, ANN NY ACAD SCI, V813, P738, DOI 10.1111/j.1749-6632.1997.tb51776.x; Maghnie M, 2000, NEW ENGL J MED, V343, P998, DOI 10.1056/NEJM200010053431403; Maghnie M, 2006, CLIN ENDOCRINOL, V65, P470, DOI 10.1111/j.1365-2265.2006.02616.x; Makras P, 2007, TRENDS ENDOCRIN MET, V18, P252, DOI 10.1016/j.tem.2007.06.003; Mancini T, 2008, ENDOCRIN METAB CLIN, V37, P67, DOI 10.1016/j.ecl.2007.10.013; Mazziotti G, 2016, ENDOCRINE, V52, P103, DOI 10.1007/s12020-015-0738-z; Mazziotti G, 2013, NAT REV ENDOCRINOL, V9, P265, DOI 10.1038/nrendo.2013.5; McCabe MJ, 2011, BEST PRACT RES CL EN, V25, P115, DOI 10.1016/j.beem.2010.06.008; McCrea HJ, 2016, J CHILD NEUROL, V31, P1367, DOI 10.1177/0883073815620671; McDermott MW, 2003, NEUROSURG FOCUS, V14, pE6, DOI [DOI 10.3171/FOC.2003.14.6.6, DOI 10.3171/foc.2003.14.6.6]; McKenna K, 1998, CLIN ENDOCRINOL, V49, P139; MCLEOD JF, 1993, J CLIN ENDOCR METAB, V77, pA599, DOI 10.1210/jcem.77.3.8370682; Mehta A, 2003, J CLIN ENDOCR METAB, V88, P5696, DOI 10.1210/jc.2003-030943; Melmed S, 2009, J CLIN ENDOCR METAB, V94, P1509, DOI 10.1210/jc.2008-2421; Melmed S, 2015, J CLIN INVEST, V125, P2275, DOI 10.1172/JCI82061; Miller JL, 2007, AM J MED GENET A, V143A, P476, DOI 10.1002/ajmg.a.31508; Miller JL, 2011, AM J MED GENET A, V155A, P1040, DOI 10.1002/ajmg.a.33951; Minamida Y, 2005, J NEUROSURG, V103, P224, DOI 10.3171/jns.2005.103.2.0224; Mittal S, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2013.3.FOCUS1356; Mohney BG, 2013, JAMA OPHTHALMOL, V131, P898, DOI 10.1001/jamaophthalmol.2013.65; MOORE RY, 1979, ENDOCRINE RHYTHMS, P63; Moreau OK, 2013, J NEUROTRAUM, V30, P998, DOI 10.1089/neu.2012.2705; Mortini P, 2016, ENDOCRINE, V51, P148, DOI 10.1007/s12020-015-0683-x; Mortini P, 2013, CRIT REV ONCOL HEMAT, V88, P514, DOI 10.1016/j.critrevonc.2013.07.013; Mortini P, 2013, WORLD NEUROSURG, V80, P160, DOI 10.1016/j.wneu.2012.06.042; Mortini P, 2012, CLIN NEUROL NEUROSUR, V114, P597, DOI 10.1016/j.clineuro.2011.12.021; Mortini P, 2011, J NEUROSURG, V114, P1350, DOI 10.3171/2010.11.JNS10670; Muller HL, 2016, CURR OPIN ENDOCRINOL, V23, P81, DOI 10.1097/MED.0000000000000214; Muller HL, 2014, ENDOCR REV, V35, P513, DOI 10.1210/er.2013-1115; Muller HL, 2013, NAT REV ENDOCRINOL, V9, P447, DOI 10.1038/nrendo.2013.125; Muir A, 2006, PEDIATR REV, V27, P373, DOI 10.1542/pir.27-10-373; Munoz A, 2013, CURR OPIN ENDOCRINOL, V20, P354, DOI 10.1097/MED.0b013e32836318ba; Munoz MT, 2002, EUR J ENDOCRINOL, V147, P275, DOI 10.1530/eje.0.1470275; Murray MJ, 2015, LANCET ONCOL, V16, pE470, DOI 10.1016/S1470-2045(15)00244-2; Musella M, 2014, J INVEST SURG, V27, P102, DOI 10.3109/08941939.2013.832824; NICHOLS CR, 1991, HEMATOL ONCOL CLIN N, V5, P1189, DOI 10.1016/S0889-8588(18)30378-2; Nishino S, 2007, SLEEP MED, V8, P373, DOI 10.1016/j.sleep.2007.03.008; Novas R, 2015, FEBS LETT, V589, P3479, DOI 10.1016/j.febslet.2015.07.031; Ntali G, 2015, ENDOCRIN METAB CLIN, V44, P117, DOI 10.1016/j.ecl.2014.10.009; Oatman OJ, 2015, INT J PEDIATR ENDOCR, DOI 10.1186/s13633-015-0005-3; Ono N, 1996, SURG NEUROL, V46, P370, DOI 10.1016/S0090-3019(96)00216-9; Opocher E, 2006, EUR J CANCER, V42, P1807, DOI 10.1016/j.ejca.2006.02.022; PAAKKO E, 1994, AM J NEURORADIOL, V15, P537; PACKER RJ, 1988, ANN NEUROL, V23, P79, DOI 10.1002/ana.410230113; PAGE SR, 1989, POSTGRAD MED J, V65, P163, DOI 10.1136/pgmj.65.761.163; Paz G, 2011, OBES REV, V12, pe315, DOI 10.1111/j.1467-789X.2010.00840.x; Pedavally S, 2014, NEUROCRIT CARE, V21, P108, DOI 10.1007/s12028-013-9914-2; PELLETIER G, 1983, NEUROSCI LETT, V41, P259, DOI 10.1016/0304-3940(83)90460-3; Pelletier G, 1980, ENDOCRINE FUNCTIONS, P155; Perry PJ, 2012, ANN CLIN PSYCHIATRY, V24, P155; Persani L, 2000, J CLIN ENDOCR METAB, V85, P3631, DOI 10.1210/jc.85.10.3631; Pinkney J, 2002, Obes Rev, V3, P27, DOI 10.1046/j.1467-789X.2002.00052.x; POWELL GF, 1967, NEW ENGL J MED, V276, P1279, DOI 10.1056/NEJM196706082762302; POWELL GF, 1967, NEW ENGL J MED, V276, P1271, DOI 10.1056/NEJM196706082762301; Pradilla Gustavo, 2007, Neurosurg Focus, V22, pE7; Prodam F, 2013, GROWTH HORM IGF RES, V23, P109, DOI 10.1016/j.ghir.2013.04.001; Provini F, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0341-8; Putoux A, 2012, PEDIATR NEPHROL, V27, P7, DOI 10.1007/s00467-010-1751-3; RAANANI P, 1994, CANCER, V73, P2312, DOI 10.1002/1097-0142(19940501)73:9<2312::AID-CNCR2820730912>3.0.CO;2-I; Radicioni AF, 2012, CLIN ENDOCRINOL, V76, P72, DOI 10.1111/j.1365-2265.2011.04161.x; Richmond E, 2014, ENDOCRINE, V45, P3, DOI 10.1007/s12020-013-0049-1; Rocha CF, 2014, GENET MOL RES, V13, P2290, DOI 10.4238/2014.March.31.9; RODRIGUEZ LA, 1990, NEUROSURGERY, V26, P242, DOI 10.1227/00006123-199002000-00010; ROESSMANN U, 1987, J NEUROPATH EXP NEUR, V46, P597, DOI 10.1097/00005072-198709000-00008; Rolston JD, 2016, NEUROSURG CLIN N AM, V27, P59, DOI 10.1016/j.nec.2015.08.007; Romano S, 2013, CLIN ENDOCRINOL, V79, P529, DOI 10.1111/cen.12180; Romanovsky AA, 2007, AM J PHYSIOL-REG I, V292, pR37, DOI 10.1152/ajpregu.00668.2006; Roth CL, 2015, J CLIN MED, V4, P1774, DOI 10.3390/jcm4091774; Roth P, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-013-0277-y; Rusyniak DE, 2006, CLIN LAB MED, V26, P165, DOI 10.1016/j.cll.2006.01.007; Saleem SN, 2007, RADIOGRAPHICS, V27, P1087, DOI 10.1148/rg.274065123; Salehi P, 2015, PEDIATR ENDOCR REV P, V12, P297; SAMAAN NA, 1987, J LAB CLIN MED, V109, P364; SANFORD RA, 1991, NEUROL CLIN, V9, P453, DOI 10.1016/S0733-8619(18)30296-2; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Sathyapalan T, 2012, EXPERT REV ANTICANC, V12, P669, DOI [10.1586/ERA.12.27, 10.1586/era.12.27]; Schneider HJ, 2011, J NEUROTRAUM, V28, P1693, DOI 10.1089/neu.2011.1887; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Seetho IW, 2011, DIABETES RES CLIN PR, V92, pE1, DOI 10.1016/j.diabres.2010.12.009; SHALET SM, 1993, NEW ENGL J MED, V328, P131, DOI 10.1056/NEJM199301143280211; Sharma P.R., 1987, J POSTGRAD MED, V33, P1; Sheehan JP, 2014, J NEUROSURG, V120, P1268, DOI 10.3171/2014.2.JNS13139; Sheikh AB, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.06.024; Shen L, 2015, NEUROL SCI, V36, P1859, DOI 10.1007/s10072-015-2269-z; Shi XE, 2008, CLIN NEUROL NEUROSUR, V110, P151, DOI 10.1016/j.clineuro.2007.10.013; Shioda Y, 2011, INT J HEMATOL, V94, P545, DOI 10.1007/s12185-011-0965-x; Shofty B, 2015, ADV TECH STAND NEURO, V42, P123, DOI 10.1007/978-3-319-09066-5_7; Siemensma EPC, 2012, J CLIN ENDOCR METAB, V97, P2307, DOI 10.1210/jc.2012-1182; Signorini SG, 2012, DEV MED CHILD NEUROL, V54, P1018, DOI 10.1111/j.1469-8749.2012.04404.x; Singhal V, 2014, CURR OPIN ENDOCRINOL, V21, P64, DOI 10.1097/MED.0000000000000026; SKLAR CA, 1994, PEDIATR NEUROSURG, V21, P18, DOI 10.1159/000120856; Souweidane MM, 2010, J NEUROSURG-PEDIATR, V6, P125, DOI 10.3171/2010.5.PEDS09112; Sterkenburg AS, 2015, NEURO-ONCOLOGY, V17, P1029, DOI 10.1093/neuonc/nov044; Stevenson DA, 2007, J PEDIATR GASTR NUTR, V45, P272, DOI 10.1097/MPG.0b013e31805b82b5; Stevenson DA, 2007, AM J MED GENET A, V143A, P484, DOI 10.1002/ajmg.a.31502; Stosel H., 1991, ENDOCRINOLOGIST, V1, P393; Striano S, 2005, SEIZURE-EUR J EPILEP, V14, P232, DOI 10.1016/j.seizure.2005.01.004; Szota A, 2013, PHARMACOL REP, V65, P279, DOI 10.1016/S1734-1140(13)71004-1; Tanriverdi F, 2010, PITUITARY, V13, P111, DOI 10.1007/s11102-009-0204-0; Thompson C, 2012, BEST PRACT RES CL EN, V26, pS7, DOI 10.1016/S1521-690X(12)70003-9; Thompson HJ, 2003, NEUROBIOL DIS, V12, P163, DOI 10.1016/S0969-9961(02)00030-X; TRIULZI F, 1994, PEDIATRICS, V93, P409; Turcu AF, 2013, J CLIN ENDOCR METAB, V98, P1812, DOI 10.1210/jc.2012-4171; VALDUEZA JM, 1994, NEUROSURGERY, V34, P949, DOI 10.1227/00006123-199406000-00001; Verbalis JG, 2003, BEST PRACT RES CL EN, V17, P471, DOI 10.1016/S1521-690X(03)00049-6; Verbalis Joseph G, 2002, Pituitary, V5, P119, DOI 10.1023/A:1022368615879; VESELY DL, 1989, SOUTHERN MED J, V82, P758, DOI 10.1097/00007611-198906000-00021; Wamstad JB, 2013, BRAIN INJURY, V27, P200, DOI 10.3109/02699052.2012.672786; Wattchow N, 2015, AUSTRALAS PSYCHIATRY, V23, P63, DOI 10.1177/1039856214563844; Wehrenberg WB, 1999, HDB PHYSL 7, P299; Weiss N, 2009, NEUROLOGY, V72, P193, DOI 10.1212/01.wnl.0000339102.12168.ee; Wolfgram PM, 2013, CURR OPIN PEDIATR, V25, P509, DOI 10.1097/MOP.0b013e328362c7a2; Woodmansee WW, 2013, EUR J ENDOCRINOL, V168, P565, DOI 10.1530/EJE-12-0967; Xu ZY, 2011, J NEURO-ONCOL, V104, P305, DOI 10.1007/s11060-010-0494-0; Yadav YR, 2015, TURK NEUROSURG, V25, P362, DOI 10.5137/1019-5149.JTN.11086-14.1; Yang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072640; Yano S, 2016, WORLD NEUROSURG, V85, P153, DOI 10.1016/j.wneu.2015.08.059; Yu T, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.06.015; Zacharia BE, 2012, NEURO-ONCOLOGY, V14, P1070, DOI 10.1093/neuonc/nos142; Zada G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076562; Zhang Q, 2012, INT J DEV NEUROSCI, V30, P479, DOI 10.1016/j.ijdevneu.2012.05.005; Zuccaro G, 2005, CHILD NERV SYST, V21, P679, DOI 10.1007/s00381-005-1201-x	229	1	1	0	0	ACADEMIC PRESS LTD-ELSEVIER SCIENCE LTD	LONDON	125 LONDON WALL, LONDON EC2Y 5AS, ENGLAND			978-0-12-813421-4; 978-0-12-804169-7				2017							291	327		10.1016/B978-0-12-804169-7.00009-X			37	Endocrinology & Metabolism	Book Citation Index – Science (BKCI-S)	Endocrinology & Metabolism	BJ3WP	WOS:000424462900010					2022-02-06	
J	Gokdemir, GS; Gokdemir, MT; Karakilcik, AZ				Goekdemir, Guel Sahika; Gokdemir, Mehmet Tahir; Karakilcik, Ali Ziya			TOTAL OXIDATIVE STRESS, TOTAL ANTIOXIDANT STATUS AND ERYTHROCYTES STATUS IN PATIENTS WITH ACUTE ISCHEMIC STROKE	ACTA MEDICA MEDITERRANEA			English	Article						Total Oxidative stress; Total antioxidant status; Erythrocytes indices; Acute ischemic stroke; Emergency department	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; GLUTATHIONE; PATHOPHYSIOLOGY; RADICALS; DISEASE; RISK	Objectives: In this prospective study, we attempted to determine the initial oxidative-antioxidative status using a new automated measurement method. Serum total oxidant status (TOS), total antioxidant status (TAS), oxidative stress index (OSI) levels and erythrocyte status in patients with acute ischemic stroke (AIS) were detect and compared to those in controls. Methods: In total, 51 patients with AIS and 49 sex-and-age matched healthy participant as controls were enrolled the study. With the new automated extent practice developed by Erel, Serum TOS, TAS and OSI was measured. In addition serum erythrocytes level were measured. Results: Subjects suffering AIS had higher TOS and OSI level than those control subjects. In contrast the TAS level were moderate higher in the controls than patients. In addition serum Mean corpuscular volume (MCV) and Red cell distribution width (RDW) levels were higher in patients with AIS in accordance with the controls. Conclusions: Patients with AIS are subjected to oxidative stress and thus, erythrocyte indices have a significant impact on this type of patients. However, further studies are needed to confirm this relationship.	[Goekdemir, Guel Sahika; Karakilcik, Ali Ziya] Harran Univ, Sch Med, Dept Physiol, Sanliurfa, Turkey; [Gokdemir, Mehmet Tahir] Harran Univ, Sch Med, Emergency Med, Sanliurfa, Turkey		Gokdemir, MT (corresponding author), Harran Univ, Sch Med, Emergency Med, Sanliurfa, Turkey.						Aygul R, 2006, J INT MED RES, V34, P413, DOI 10.1177/147323000603400411; Cherubini A, 2005, FREE RADICAL BIO MED, V39, P841, DOI 10.1016/j.freeradbiomed.2005.06.025; Cojocaru Inimioara Mihaela, 2013, Rom J Intern Med, V51, P97; Cooper AJL, 1997, BIOL CHEM, V378, P793; Demirkaya S, 2001, EUR J NEUROL, V8, P43, DOI 10.1046/j.1468-1331.2001.00166.x; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; El Kossi MMH, 2000, STROKE, V31, P1889, DOI 10.1161/01.STR.31.8.1889; Erel O, 2004, CLIN BIOCHEM, V37, P112, DOI 10.1016/j.clinbiochem.2003.10.014; Erel O, 2005, CLIN BIOCHEM, V38, P1103, DOI 10.1016/j.clinbiochem.2005.08.008; Facchinetti F, 1998, CELL MOL NEUROBIOL, V18, P667, DOI 10.1023/A:1020221919154; Fukui S, 2002, FREE RADICAL BIO MED, V32, P289, DOI 10.1016/S0891-5849(01)00804-8; Ghaffari S, 2008, ANTIOXID REDOX SIGN, V10, P1923, DOI 10.1089/ars.2008.2142; Gokdemir MT, 2012, J INT MED RES, V40, P167, DOI 10.1177/147323001204000117; Gokdemir MT, 2013, ANATOL J CARDIOL, V13, P131, DOI 10.5152/akd.2013.037; Hackam DG, 2003, JAMA-J AM MED ASSOC, V290, P932, DOI 10.1001/jama.290.7.932; Hohl A, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.06.007; Kaya H, 2013, HONG KONG J EMERG ME, V20, P225, DOI 10.1177/102490791302000406; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Moustafa RR, 2008, BRIT J PHARMACOL, V153, pS44, DOI 10.1038/sj.bjp.0707530; Nayak C, 2007, CLIN CHEM LAB MED, V45, P629, DOI 10.1515/CCLM.2007.123; Nayak CD, 2008, NEUROL INDIA, V56, P31, DOI 10.4103/0028-3886.39309; Osborn MF, 2014, J STROKE CEREBROVASC, V23, P1477, DOI 10.1016/j.jstrokecerebrovasdis.2013.12.017; Skjelbakken T, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001109; SMITH SL, 1994, J NEUROTRAUM, V11, P393, DOI 10.1089/neu.1994.11.393; Sogut O, 2012, TURK J MED SCI, V42, P1010, DOI 10.3906/sag-1109-35; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Woodruff TM, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-11; Zimmermann C, 2004, EUR NEUROL, V51, P157, DOI 10.1159/000077662	30	1	1	0	6	CARBONE EDITORE	PALERMO	VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY	0393-6384	2283-9720		ACTA MEDICA MEDITERR	Acta Medica Mediterr.		2017	33	1					157	163		10.19193/0393-6384_2017_1_024			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP2PY	WOS:000397226800024					2022-02-06	
B	Grant, G; Burns, K; Harrington, R; Vines, P; Kendall, E; Maujean, A		Barker, K; Fairweather, K; Grantham, R		Grant, Genevieve; Burns, Kylie; Harrington, Rosamund; Vines, Prue; Kendall, Elizabeth; Maujean, Annick			When Lump Sums Run Out: Disputes at the Borderlines of Tort Law, Injury Compensation and Social Security	PRIVATE LAW IN THE 21ST CENTURY	Hart Studies in Private Law		English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; WORKERS-COMPENSATION		[Grant, Genevieve] Monash Univ, Law, Fac Law, Clayton, Vic, Australia; [Burns, Kylie] Griffith Univ, Griffith Law Sch, Nathan, Qld, Australia; [Burns, Kylie; Harrington, Rosamund; Maujean, Annick] RECOVER Injury Res Ctr, Herston, Qld, Australia; [Harrington, Rosamund] Australian Catholic Univ, Occupat Therapy, Sydney, NSW, Australia; [Vines, Prue] UNSW, Law, Sydney, NSW, Australia; [Kendall, Elizabeth] Griffith Univ, Griffith Hlth Inst, Sch Human Serv & Social Work, Nathan, Qld, Australia; [Maujean, Annick] Griffith Univ, Sch Allied Hlth Sci, Menzies Hlth Inst, Nathan, Qld, Australia		Grant, G (corresponding author), Monash Univ, Law, Fac Law, Clayton, Vic, Australia.			Grant, Genevieve/0000-0001-7071-6707; Kendall, Elizabeth/0000-0003-2399-1460			Australasian Legal Information Institute, ADM APP TRIB DAT; Australian Bureau of Statistics, 2013, WORK REL INJ AUSTR J; Australian Lawyers Alliance, NAT INJ INS SCHEM WO; Babener J, 2009, NEW YORK U J LAW BUS, V61, P127; Bismark MM, 2006, MED J AUSTRALIA, V185, P203, DOI 10.5694/j.1326-5377.2006.tb00532.x; Bombardier CH, 2004, ARCH PHYS MED REHAB, V85, P1749, DOI 10.1016/j.apmr.2004.07.348; Cane P, 2007, POLITICAL EC PERSONA, P5; CCH Australia, 2016, AUSTR TORTS COMM; Coumarelos C, 2012, LEGAL AUSTR WIDE SUR; Deguise E, 2008, J HEAD TRAUMA REHAB, V23, P294, DOI 10.1097/01.HTR.0000336842.53338.f4; Department of Treasury (South Australia), 2012, STAT FOOD POIS JAP 2, P9; Freckelton I, 2005, J LAW MED, V13, P5; Grant GM, 2015, MONASH UNIV LAW REV, V41, P618; Grant GM, 2014, JAMA PSYCHIAT, V71, P446, DOI 10.1001/jamapsychiatry.2013.4023; Groah SL, 2012, AM J PHYS MED REHAB, V91, P80, DOI 10.1097/PHM.0b013e31821f70bc; Hall MA, 2008, CALIF LAW REV, V96, P63; Head, 2008, PUBLIC POLICY, V3, P101, DOI DOI 10.1128/MCB.00567-07; Henley G., 2016, TRENDS SERIOUS INJUR; Hitzig SL, 2008, AM J PHYS MED REHAB, V87, P545, DOI 10.1097/PHM.0b013e31817c16d6; Hodgins DC, 2005, J GAMBL STUD, V21, P255, DOI 10.1007/s10899-005-3099-3; Hoofien D, 2001, BRAIN INJURY, V15, P189; Kirkham TL, 2011, OCCUP ENVIRON MED, V68, P30, DOI 10.1136/oem.2009.048629; Krause JS, 2009, ARCH PHYS MED REHAB, V90, P95, DOI 10.1016/j.apmr.2008.07.012; Labi MLC, 2003, BRAIN INJURY, V17, P265, DOI 10.1080/0269905021000038410; Law Commission (UK), 1994, 255 LAW COMM, pxx; Lewis R, 2000, DEDUCTING BENEFITS D, P115; Lewis R, 2012, TORT LAW LEGISLATURE, P285; Lewis R, 2014, J PERS INJ L, V4, P209; Luntz H, 2013, TORTS CASES COMMENTA, P521; Luntz H, 2013, TORTS LAW J, V20, P153; McDonald Hugh M, 2016, 23 LAW JUST FDN NEW; Motor Accident Insurance Commission, STAT INF 1 JAN 30 JU; NEAVE M, 1992, 5 U AD AD LAW REV AS; NSW Government State Insurance Regulatory Authority, 2016, ROAD BETT CTP SCHEM, P14; NSW Law Reform Commission, 1984, 43 NSW LAW REF COMM, P94; O'Leary Paul, 2012, Soc Secur Bull, V72, P1; Perry V, 2006, J CONSUM AFF, V39, P299; Productivity Commission, 2011, 54 PROD COMM, V2, P809; Pryor E, 2008, REV LITIGATION, V27, P309; Pryor ES, 2008, REV LITIGATION, V27, P307; QLD Education Tourism Innovation and Small Business Committee, 2016, 11 QLD ED TOUR INN S, P53; Seabury SA, 2014, AM J IND MED, V57, P1165, DOI 10.1002/ajim.22362; StataCorp, 2011, STAT STAT SOFTW REL; Submission to Department of Treasury, 2015, CONSULTATION R UNPUB, P16; Sutherland Peter, 2013, SOCIAL SECURITY FAMI; Tompa E, 2014, INT J DISABILITY MAN, V9, P22; Tranter K, 2014, INT J SEMIOTIC LAW, V27, P713, DOI 10.1007/s11196-013-9342-9; Tranter Kieran, 2014, J SOCIAL SECURITY LA, V22, P32; Victorian Law Reform Commission, 2008, 14 VICT LAW REF COMM	49	1	1	0	3	HART PUBL	PORTLAND	C/O INTERNATIONAL SPECIALIZED BOOK SERVICES, 5804 NE HASSALO STREET, PORTLAND, OR 97213-3644 USA			978-1-50990-860-8; 978-1-50990-858-5	HART STUD PRIV LAW			2017	19						301	322					22	Law	Book Citation Index – Social Sciences & Humanities (BKCI-SSH)	Government & Law	BI4QD	WOS:000411887400016					2022-02-06	
J	Guo, DW; Li, DP; Li, JH; Li, YF; Hu, X; Guan, FX; Yang, B				Guo, Dewei; Li, Dongpeng; Li, Jinghong; Li, Yunfeng; Hu, Xiang; Guan, Fangxia; Yang, Bo			Topical application of the hematostatic agent Surgiflo (R) could attenuate brain injury in experimental TBI mice	NEUROLOGICAL RESEARCH			English	Article						Traumatic brain injury; Surgiflo; S100 beta; haemostat; neuroprotection	CEREBROSPINAL-FLUID; S100B; EFFICACY; PROTEIN; MECHANISMS; MATRIX; SAFETY	Object: The pathologies resulting from traumatic brain injury (TBI) have been thoroughly studied, but rarely have the effects of bleeding and coagulation in the early stage of TBI been considered. In this study, we investigated the effects of topical Surgiflo (R) application on brain injury in experimental TBI mice using S100 beta, MAP-2 and mNSS scores. Methods: TBI was induced by modified weight drop injury in male C57BL/6 mice. The mice were then randomly divided into (i) the sham group, (ii) TBI mice applied with saline (vehicle), and (iii) TBI mice applied with Surgiflo (R) in the same volume. Modified neurological severity scores (mNSS) were measured on days 0 (before surgery), 1, 3, 7, and 28 to evaluate neurologic functional deficits. At day 28, the mice were sacrificed, and the forebrains were sliced. The effects of Surgiflo (R) on microtubule-associated protein 2 and serum S100 beta protein were examined by immunohistochemistry and electro-chemiluminescence immunoassay. Results: Serum S100 beta protein levels were significantly elevated at different time points (24h, 3days, 7days) in the TBI groups (p<0.01) compared to normal control groups. Surgiflo (R) induced a lower concentration of serum S100 beta protein levels at day 3 (p<0.05) and day 7 (p<0.05) compared to the TBI group applied with saline. H&E staining showed that Surgiflo (R) treatment led to a 45% decrease in cortical brain lesion volume and in subcortical white matter 28days after TBI. Compared with the saline-treated group, the number of MAP2-positive cells was significantly increased in the perilesional area of the Surgiflo (R)-treated group. The Surgiflo (R)-treated group exhibited lower mNSS scores on days 7 and 28 than did the saline-treated group. Discussion: Surgiflo (R) treatment produced a significant decrease in serum S100 beta protein levels in TBI mouse models, which may lead to an improvement in the recovery of TBI models.	[Guo, Dewei; Li, Dongpeng; Yang, Bo] Zhengzhou Univ, Dept Neurosurg, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China; [Li, Jinghong] Zhengzhou Univ, Dept Neurol, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China; [Li, Yunfeng] Xuchang Vocat Tech Coll, Dept Neurol Rehabil Lab, Xuchang, Peoples R China; [Hu, Xiang] Shenzhen Beike Cell Engn Inst, Dept Neurol Rehabil Lab, Shenzhen, Peoples R China; [Guan, Fangxia] Zhengzhou Univ, Dept Bioengn, Zhengzhou, Henan, Peoples R China		Yang, B (corresponding author), Zhengzhou Univ, Dept Neurosurg, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China.	yangbo96@126.com			Research Fund for the Doctoral Program of Higher EducationResearch Fund for the Doctoral Program of Higher Education of China (RFDP) [20114101110004]; Collaborative Innovation Center of Stem Cell and Regenerative Medicine of Zhengzhou University	This study was supported by the Research Fund for the Doctoral Program of Higher Education [20114101110004] and Collaborative Innovation Center of Stem Cell and Regenerative Medicine of Zhengzhou University.	Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; [Anonymous], 2012, SURGIFLO HEMOSTATIC; Bannister M, 2014, BRIT J ORAL MAX SURG, V52, pE134, DOI 10.1016/j.bjoms.2014.05.014; Bloomfield SM, 2007, NEUROCRIT CARE, V6, P121, DOI 10.1007/s12028-007-0008-x; Brandner S, 2012, Acta Neurochir Suppl, V114, P217, DOI 10.1007/978-3-7091-0956-4_42; Cao SL, 2016, STROKE, V47, P1626, DOI 10.1161/STROKEAHA.116.013146; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Cheng T, 2015, CELL MOL NEUROBIOL, V35, P641, DOI 10.1007/s10571-015-0159-9; Dardiotis E, 2012, CURR OPIN PSYCHIATR, V25, P231, DOI 10.1097/YCO.0b013e3283523c0e; Dardiotis E, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09215; Goyal A, 2013, J NEUROTRAUM, V30, P946, DOI 10.1089/neu.2012.2579; Guo D, 2016, TRANSL STROKE RES, V8, P1; Kirchhoff C, 2008, EUR J MED RES, V13, P511; Kleindienst A, 2006, J NEUROTRAUM, V23, P1185, DOI 10.1089/neu.2006.23.1185; Kleindienst Andrea, 2010, Cardiovasc Psychiatry Neurol, V2010, P801295, DOI 10.1155/2010/801295; Landi A, 2016, J NEUROL SURG PART A, V77, P139, DOI 10.1055/s-0035-1558413; Li DP, 2016, CELL MOL NEUROBIOL, V36, P1045, DOI 10.1007/s10571-015-0295-2; Okubo Shuichi, 2013, Acta Neurochir Suppl, V118, P83, DOI 10.1007/978-3-7091-1434-6_14; Petzold A, 2003, BRAIN RES BULL, V61, P281, DOI 10.1016/S0361-9230(03)00091-1; Quintard H, 2014, NEUROSCIENCE, V277, P72, DOI 10.1016/j.neuroscience.2014.06.047; Rajiv S, 2013, ACTA NEUROCHIR, V155, P1361, DOI 10.1007/s00701-013-1767-0; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; TAFT WC, 1993, J CEREBR BLOOD F MET, V13, P796, DOI 10.1038/jcbfm.1993.101; TAFT WC, 1992, J NEUROTRAUM, V9, P281, DOI 10.1089/neu.1992.9.281; TAKAYASU M, 1985, J NEUROSURG, V63, P417, DOI 10.3171/jns.1985.63.3.0417; Weaver SM, 2012, NEUROSCIENTIST, V18, P631, DOI 10.1177/1073858411435706; Woodworth BA, 2009, AM J OTOLARYNG, V30, P49, DOI 10.1016/j.amjoto.2007.11.008; Wu H, 2012, NEUROBIOL DIS, V45, P388, DOI 10.1016/j.nbd.2011.08.028; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Zeng X, 2012, CURR GERIATR REP, V1, P167, DOI 10.1007/s13670-012-0018-1; Zhao JB, 2014, TRANSL STROKE RES, V5, P586, DOI 10.1007/s12975-014-0353-y	33	1	2	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.		2017	39	9					830	836		10.1080/01616412.2017.1330815			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FD5FB	WOS:000407555200009	28566060				2022-02-06	
J	Gutierrez, L; Arruga, J; Sanchez, JJ; Munoz, S; Puyalto-de-Pablo, P				Gutierrez, Laura; Arruga, Jorge; Sanchez, Juan J.; Munoz, Silvia; Puyalto-de-Pablo, Paloma			Axonal Injury in the Lateral Geniculate Body: Radiological Diagnosis	NEURO-OPHTHALMOLOGY			English	Article						Diffuse axonal injury; lateral geniculate body; tractography	HOMONYMOUS HEMIANOPIA; SECTORANOPIA; INFARCTION	Damage to the lateral geniculate body by diffuse axonal injury in brain trauma is uncommon. The authors present the clinical case and in vivo fibre tractography using diffusion tensor magnetic resonance imaging of this lesion in a patient presenting with homonymous sectoranopia after a traumatic head injury.	[Gutierrez, Laura; Arruga, Jorge; Munoz, Silvia] Hosp Univ Bellvitge, Hosp Llobregat, Dept Ophthalmol, Barcelona, Spain; [Arruga, Jorge] Inst Catala Retina, Barcelona, Spain; [Sanchez, Juan J.; Puyalto-de-Pablo, Paloma] Univ Int Catalunya, Med Fac, Barcelona, Spain		Gutierrez, L (corresponding author), Hosp Univ Bellvitge, Hosp Llobregat, Carrer Feixa Llarga S-N, Barcelona 08907, Spain.	laura.gutierrez.benitez@gmail.com	Puyalto, Paloma/AAZ-4750-2021	Munoz, Silvia/0000-0002-3551-8200; Sanchez, Juan Jose/0000-0003-0677-3680; Puyalto, Paloma/0000-0002-0767-9752			BORRUAT FX, 1995, NEUROLOGY, V45, P590, DOI 10.1212/WNL.45.3.590; Chavhan GB, 2009, RADIOGRAPHICS, V29, P1433, DOI 10.1148/rg.295095034; FLECKENSTEIN JL, 1991, RADIOLOGY, V179, P499, DOI 10.1148/radiology.179.2.2014300; Grabe HM, 2012, J NEURO-OPHTHALMOL, V32, P38, DOI 10.1097/WNO.0b013e318223d0a9; GROCHOWICKI M, 1991, BRIT J OPHTHALMOL, V75, P624, DOI 10.1136/bjo.75.10.624; Han YS, 2009, EUR NEUROL, V61, P371, DOI 10.1159/000210550; Mulholland C, 2010, J AAPOS, V14, P435, DOI 10.1016/j.jaapos.2010.06.010; Rizzo JF, 2005, WALSH HOYTS CLIN NEU, V1, P1; Saeki N, 2003, CLIN NEUROL NEUROSUR, V106, P28, DOI 10.1016/j.clineuro.2003.08.002; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shibata K, 2009, CLIN NEUROL NEUROSUR, V111, P713, DOI 10.1016/j.clineuro.2009.07.003; Siedler DG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00429; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7	13	1	2	1	7	TAYLOR & FRANCIS AS	OSLO	KARL JOHANS GATE 5, NO-0154 OSLO, NORWAY	0165-8107	1744-506X		NEURO-OPHTHALMOLOGY	Neuro-Ophthalmol.		2017	41	4					215	218		10.1080/01658107.2017.1287202			4	Clinical Neurology; Ophthalmology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology; Ophthalmology	FN0VY	WOS:000415700200009	29344063	Green Published			2022-02-06	
S	Hamblin, MR		Lapchak, PA; Yang, GY		Hamblin, Michael R.			Photobiomodulation for Stroke	TRANSLATIONAL RESEARCH IN STROKE	Translational Medicine Research		English	Article; Book Chapter						Photobiomodulation; Low-level laser therapy; Mechanism of action; Acute stroke; Animal studies; Clinical trials	LEVEL LASER THERAPY; NEAR-INFRARED LIGHT; TRAUMATIC BRAIN-INJURY; TRANSCRANIAL LASER; MOUSE MODEL; NEUROTHERA EFFECTIVENESS; MYOCARDIAL-INFARCTION; ISCHEMIC-STROKE; EMBOLIC STROKES; LED THERAPY	Photobiomodulation (PBM) or low-level laser (light) therapy (LLLT) describes the use of red or near-infrared light from lasers or LEDs to heal, stimulate, and protect damaged tissues. It was first used for wound healing and pain relief but in recent years has been extensively investigated for brain disorders. One of the first applications of transcranial PBM in the brain was for acute stroke. The mechanisms of action of PBM are multifunctional. PBM applied to the head can increase cerebral blood flow by releasing nitric oxide and improve tissue oxygenation in the brain. It can stimulate mitochondrial metabolism and increase ATP production. Protective mechanisms are activated that can reduce neuronal cell death and oxidative stress occurring as a result of hypoxia, while neuroinflammation is also reduced. PBM can stimulate the formation of new neurons from neuroprogenitor cells in the hippocampus and subventricular zone. Finally, PBM can stimulate synaptogenesis and neuroplasticity (formation of new connections between existing neurons). This chapter will cover animal studies of PBM for acute stroke (caused by a variety of techniques) carried out in rats, rabbits, and dogs. The three major clinical trials for acute stroke in human patients (NEST-1, NEST-2, NEST-3) and the reasons for the eventual failure of NEST-3 will be discussed. Finally, the possibility of using PBM for rehabilitation of chronic stroke patients will be addressed.	[Hamblin, Michael R.] Massachusetts Gen Hosp, Wellman Ctr Photomed, BAR414,40 Blossom St, Boston, MA 02114 USA; [Hamblin, Michael R.] Harvard Med Sch, Dept Dermatol, Boston, MA 02115 USA; [Hamblin, Michael R.] Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA		Hamblin, MR (corresponding author), Massachusetts Gen Hosp, Wellman Ctr Photomed, BAR414,40 Blossom St, Boston, MA 02114 USA.; Hamblin, MR (corresponding author), Harvard Med Sch, Dept Dermatol, Boston, MA 02115 USA.; Hamblin, MR (corresponding author), Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA.	hamblin@helix.mgh.harvard.edu	Hamblin, Michael R/H-2758-2019	Hamblin, Michael R/0000-0001-6431-4605			Ad N, 2001, INT J CARDIOL, V80, P109, DOI 10.1016/S0167-5273(01)00503-4; Ahern RJ, 2013, EUR J PHARM SCI, V50, P400, DOI 10.1016/j.ejps.2013.08.026; Aimbire F, 2006, PHOTOMED LASER SURG, V24, P33, DOI 10.1089/pho.2006.24.33; Berman Marvin H, 2017, J Neurol Neurosci, V8, DOI 10.21767/2171-6625.1000176; Boonswang NA, 2012, BMJ CASE REP, V2012; Cassano Paolo, 2015, Psychiatry J, V2015, P352979, DOI 10.1155/2015/352979; Cassano P, 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.3.031404; Chen ACH, 2011, PHOTOMED LASER SURG, V29, P383, DOI 10.1089/pho.2010.2837; Chen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020333; Chen SD, 2017, INT J MOL SCI, V18, pE545; Cheng A, 2010, MITOCHONDRIA, V2; Chu JR, 2010, CANCER LETT, V297, P207, DOI 10.1016/j.canlet.2010.05.013; Carvalho JLC, 2016, J BIOPHOTONICS, V9, P1208, DOI 10.1002/jbio.201600061; Cui X, 2011, NEUROIMAGE, V54, P2808, DOI 10.1016/j.neuroimage.2010.10.069; Darlot F, 2016, ANN NEUROL, V79, P59, DOI 10.1002/ana.24542; de Freitas LF, 2016, IEEE J SEL TOP QUANT, V22, DOI 10.1109/JSTQE.2016.2561201; DeTaboada L, 2006, LASER SURG MED, V38, P70, DOI 10.1002/lsm.20256; Doidge N., 2015, BRAINS WAY HEALING R; Farfara D, 2015, J MOL NEUROSCI, V55, P430, DOI 10.1007/s12031-014-0354-z; Feng Q, 2014, CURR TOP MEMBR, V74, P19, DOI 10.1016/B978-0-12-800181-3.00002-6; Fisher M, 2008, CURR OPIN DRUG DISC, V11, P626; GAM AN, 1993, PAIN, V52, P63, DOI 10.1016/0304-3959(93)90114-5; Hacke W, 2014, STROKE, V45, P3187, DOI 10.1161/STROKEAHA.114.005795; Haeussinger FB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026377; Hamblin MR, 2016, BBA CLIN, V6, P113, DOI 10.1016/j.bbacli.2016.09.002; Hamblin MR., 2016, BIOCHEMIST, V38, P24, DOI [10.1042/BIO03806024, DOI 10.1042/BIO03806024]; Hamblin MR, 2016, HDB LOW LEVEL LASER; Henderson TA, 2016, NEURAL REGEN RES, V11, P563, DOI 10.4103/1673-5374.180737; Hennessy M, 2017, J OPTICS-UK, V19, DOI 10.1088/2040-8986/19/1/013003; Hood DA, 2016, BIOCHEM J, V473, P2295, DOI 10.1042/BCJ20160009; Hopkins JT, 2004, J ATHL TRAINING, V39, P223; Huisa BN, 2013, INT J STROKE, V8, P315, DOI 10.1111/j.1747-4949.2011.00754.x; Ilic S, 2006, PHOTOMED LASER SURG, V24, P458, DOI 10.1089/pho.2006.24.458; Iwashita T, 2003, J NEURO-ONCOL, V64, P265, DOI 10.1023/A:1025684903137; Jagdeo JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047460; Janzadeh A, 2016, LASER MED SCI, V31, P1863, DOI 10.1007/s10103-016-2062-0; Johnstone DM, 2014, NEUROSCIENCE, V274, P93, DOI 10.1016/j.neuroscience.2014.05.023; Johnstone DM, 2015, NEURAL REGEN RES, V10, P349, DOI 10.4103/1673-5374.153673; Kasner SE, 2013, STROKE, V44, P2025, DOI 10.1161/STROKEAHA.113.000870; Khuman J, 2012, J NEUROTRAUM, V29, P408, DOI 10.1089/neu.2010.1745; KOVACS IB, 1974, EXPERIENTIA, V30, P1275; Kozlov AV, 2017, BIOCH BIOPHYS ACTA; Kumar S, 2017, BIOMED PHARMACOTHER, V85, P182, DOI 10.1016/j.biopha.2016.11.125; Lampl Y, 2007, STROKE, V38, P1843, DOI 10.1161/STROKEAHA.106.478230; Lapchak PA, 2007, NEUROSCIENCE, V148, P907, DOI 10.1016/j.neuroscience.2007.07.002; Lapchak PA, 2004, STROKE, V35, P1985, DOI 10.1161/01.STR.0000131808.69640.b7; Lapchak PA, 2008, STROKE, V39, P3073, DOI 10.1161/STROKEAHA.108.516393; Lapchak PA, 2016, ACTA NEUROCHIR SUPPL, V121, P7, DOI 10.1007/978-3-319-18497-5_2; Silveira PCL, 2016, FREE RADICAL RES, V50, P503, DOI 10.3109/10715762.2016.1147649; Naeser M, 2012, PROCD SOC BEHV, V61, P138, DOI 10.1016/j.sbspro.2012.10.116; Naeser M.A., 2014, J NEUROTRAUMA; Naeser MA, 2016, PHOTOMED LASER SURG, V34, P610, DOI 10.1089/pho.2015.4037; Naeser MA, 2015, PHOTOMED LASER SURG, V33, P443, DOI 10.1089/pho.2015.3986; Naeser MA, 2011, PHOTOMED LASER SURG, V29, P443, DOI 10.1089/pho.2011.9908; Naeser MA, 2011, PHOTOMED LASER SURG, V29, P351, DOI 10.1089/pho.2010.2814; Okada E, 2003, APPL OPTICS, V42, P2915, DOI 10.1364/AO.42.002915; Oron A, 2016, PHOTOMED LASER SURG; Oron A, 2006, STROKE, V37, P2620, DOI 10.1161/01.STR.0000242775.14642.b8; Oron U, 2001, LASER SURG MED, V28, P204, DOI 10.1002/lsm.1039; Oron U, 2001, CIRCULATION, V103, P296; Proft Juliane, 2012, Commun Integr Biol, V5, P227, DOI 10.4161/cib.21148; Purushothuman S, 2013, BRAIN RES, V1535, P61, DOI 10.1016/j.brainres.2013.08.047; Rajah GB, 2017, NEUROSURG FOCUS, V42, DOI 10.3171/2017.1.FOCUS16497; Rojas JC, 2013, BIOCHEM PHARMACOL, V86, P447, DOI 10.1016/j.bcp.2013.06.012; Salgado ASI, 2015, LASER MED SCI, V30, P339, DOI 10.1007/s10103-014-1669-2; Saltmarche A. E., 2017, PHOTOMED LASER SURG; Schiffer F, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-46; Stemer Andrew B, 2010, Curr Cardiol Rep, V12, P29, DOI 10.1007/s11886-009-0071-3; Strangman GE, 2014, NEUROIMAGE, V85, P136, DOI 10.1016/j.neuroimage.2013.04.090; Streeter J, 2004, MITOCHONDRION, V4, P569, DOI 10.1016/j.mito.2004.07.037; Tedford CE, 2015, LASER SURG MED, V47, P312, DOI 10.1002/lsm.22343; Thunshelle C, 2016, PHOTOMED LASER SURG, V34, P587, DOI 10.1089/pho.2015.4051; Valero T, 2014, CURR PHARM DESIGN, V20, P5507, DOI 10.2174/138161282035140911142118; Wei YH, 2015, BIOL REV, V90, P167, DOI 10.1111/brv.12103; Wu JY, 2013, INT J ORAL SCI, V5, P85, DOI 10.1038/ijos.2013.38; Xuan WJ, 2015, J BIOPHOTONICS, V8, P502, DOI 10.1002/jbio.201400069; Xuan WJ, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.10.108003; Yaakobi T, 1985, J APPL PHYSIOL, V2001, P2411; Zecha JA, 2016, LOW LEVEL LASER THER; Zecha JAEM, 2016, SUPPORT CARE CANCER, V24, P2781, DOI 10.1007/s00520-016-3152-z; Zhang Q, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf4964; Zivin JA, 2014, INT J STROKE, V9, P950, DOI 10.1111/j.1747-4949.2012.00896.x; Zivin JA, 2009, STROKE, V40, P1359, DOI 10.1161/STROKEAHA.109.547547	83	1	1	0	6	SPRINGER-VERLAG SINGAPORE PTE LTD	SINGAPORE	152 BEACH ROAD, #21-01/04 GATEWAY EAST, SINGAPORE, 189721, SINGAPORE	2451-991X	2451-9928	978-981-10-5804-2; 978-981-10-5803-5	TRANSL MED RES			2017							397	414		10.1007/978-981-10-5804-2_18	10.1007/978-981-10-5804-2		18	Medicine, Research & Experimental; Clinical Neurology	Book Citation Index – Science (BKCI-S)	Research & Experimental Medicine; Neurosciences & Neurology	BL0TG	WOS:000446654400018					2022-02-06	
J	Hendricks, DJ; Sampson, E				Hendricks, D. J.; Sampson, Elaine			Accommodating individuals with traumatic brain injury: An analysis of employer-initiated cases handled by the Job Accommodation Network	WORK-A JOURNAL OF PREVENTION ASSESSMENT & REHABILITATION			English	Article						Business type; job type; employers	RETURN; WORK	BACKGROUND: The Job Accommodation Network (JAN) has provided customized accommodation information to employers, individuals with disabilities, and their representatives (e.g., family, rehabilitation counselors, union representatives) since 1983. For each inquiry where such information is sought, detailed records are maintained regarding the type of inquiries made and the information provided. OBJECTIVE: The objective of the current study is to present a descriptive analysis of the employer-initiated cases related to Traumatic Brain Injury (TBI) handled by the accommodation specialists at JAN during the five years from 2012 through 2016. METHODS: Records related to instances of TBI as recorded by the JAN accommodation specialists were reviewed. Information pertaining to the type of business, occupational category, limitations being experienced by the individual, and issues discussed with the accommodation specialist are presented. RESULTS: The type of businesses and the occupational categories indicated by the employer were broad ranging, although there was a preponderance of cases in the area of Public Administration. Limitations related to cognition were the most frequent for which employers sought accommodation information. The largest category for the type of issues discussed was related to the Americans with Disabilities Act and other disability-pertinent legislation. CONCLUSIONS: The incidence of employers seeking accommodation information for individuals who have incurred a TBI is very low (0.5%). Findings support those of other authors such as Ponsford and Spitz (2015), in that accommodation information was most frequently requested for individuals in professional (i.e., office-type jobs), rather than for laborer positions.	[Hendricks, D. J.; Sampson, Elaine] West Virginia Univ, Morgantown, WV USA		Hendricks, DJ (corresponding author), POB 6080, Morgantown, WV 26506 USA.	hendricks@jan.wvu.edu					Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Andelic N, 2012, BRAIN INJURY, V26, P261, DOI 10.3109/02699052.2012.654589; Centers for Disease Control and Prevention, TRAUM BRAIN INJ CONC; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P160, DOI 10.1097/HTR.0000000000000090; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Donker-Cools BHPM, 2016, BRAIN INJURY, V30, P113, DOI 10.3109/02699052.2015.1090014; Gary KW, 2010, J VOCAT REHABIL, V33, P65, DOI 10.3233/JVR-2010-0516; Harris JE, 2016, WORK, V53, P561, DOI 10.3233/WOR-152223; Materne M, 2017, WORK, V56, P125, DOI 10.3233/WOR-162468; Ponsford JL, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000033; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737	13	1	1	0	0	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1051-9815	1875-9270		WORK	Work		2017	58	1					29	34		10.3233/WOR-172594			6	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	FJ0XW	WOS:000412435600005	28922173	Bronze			2022-02-06	
B	Hernandez-Tejada, MA; Brawman-Mintzer, O		Heidenreich, KA		Hernandez-Tejada, M. A.; Brawman-Mintzer, O.			Interventional Drugs for TBI Rehabilitation of Cognitive Impairment: The Cholinesterase Inhibitor Rivastigmine	NEW THERAPEUTICS FOR TRAUMATIC BRAIN INJURY: PREVENTION OF SECONDARY BRAIN DAMAGE AND ENHANCEMENT OF REPAIR AND REGENERATION			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; CLOSED-HEAD INJURY; OPERATION-IRAQI-FREEDOM; MEMORY DYSFUNCTION; NECK INJURIES; ATTENTION; DONEPEZIL; DEFICITS; MECHANISMS; EFFICACY		[Hernandez-Tejada, M. A.; Brawman-Mintzer, O.] Ralph H Johnson VA Med Ctr, Charleston, SC 29401 USA; [Hernandez-Tejada, M. A.; Brawman-Mintzer, O.] Med Univ South Carolina, Charleston, SC 29425 USA		Hernandez-Tejada, MA (corresponding author), Ralph H Johnson VA Med Ctr, Charleston, SC 29401 USA.; Hernandez-Tejada, MA (corresponding author), Med Univ South Carolina, Charleston, SC 29425 USA.						Arciniegas D, 1999, BRAIN INJURY, V13, P1, DOI 10.1080/026990599121827; Arciniegas DB, 2006, BEHAV NEUROL, V17, P25, DOI 10.1155/2006/460592; Arciniegas David B, 2004, Phys Med Rehabil Clin N Am, V15, P177, DOI 10.1016/S1047-9651(03)00104-9; Arciniegas David B, 2003, Curr Psychiatry Rep, V5, P391, DOI 10.1007/s11920-003-0074-5; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Barker-Collo S, 2008, NZ MED J, V121, P2903; Bhalerao U, 2013, BRAIN INJURY, V27, P767, DOI 10.3109/02699052.2013.793396; Brawman-Mintzer O., 2012, RIVASTIGMINE PATCH V; CAREY ME, 1987, MIL MED, V152, P6; Centers for Disease Control and Prevention, 2006, NAT CTR INJ PREV CON; Chan RCK, 2000, BRAIN INJURY, V14, P227, DOI 10.1080/026990500120709; Chen Y, 1998, J NEUROTRAUM, V15, P231, DOI 10.1089/neu.1998.15.231; Coupland RM, 1999, BRIT MED J, V319, P410, DOI 10.1136/bmj.319.7207.410; Cummings J, 2007, NEUROLOGY, V69, pS10, DOI 10.1212/01.wnl.0000281846.40390.50; DEANGELIS MM, 1994, BRAIN RES, V653, P39, DOI 10.1016/0006-8993(94)90369-7; DIXON CE, 1994, NEUROSCI LETT, V180, P127, DOI 10.1016/0304-3940(94)90503-7; Donat CK, 2007, BRAIN INJURY, V21, P1031, DOI 10.1080/02699050701630359; Fortin S, 2003, CORTEX, V39, P273, DOI 10.1016/S0010-9452(08)70109-6; Frenette AJ, 2012, J NEUROTRAUM, V29, P1, DOI 10.1089/neu.2011.1812; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Harvey PD, 2007, SCHIZOPHRENIA BULL, V33, P1138, DOI 10.1093/schbul/sbm040; Hellawell DJ, 1999, BRAIN INJURY, V13, P489; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lippert-Gruener M, 2007, BRAIN INJURY, V21, P1001, DOI 10.1080/02699050701468933; Masanic CA, 2001, ARCH PHYS MED REHAB, V82, P896, DOI 10.1053/apmr.2001.23833; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; Morey CE, 2003, BRAIN INJURY, V17, P809, DOI 10.1080/0269905031000088586; Murdoch I, 1998, J NEUROTRAUM, V15, P295, DOI 10.1089/neu.1998.15.295; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Ommaya AK, 1996, J TRAUMA, V41, P972, DOI 10.1097/00005373-199612000-00005; Ommaya AK, 1996, J TRAUMA, V40, P211, DOI 10.1097/00005373-199602000-00007; Robinson L, 2011, BEHAV BRAIN RES, V221, P443, DOI 10.1016/j.bbr.2011.01.055; SAIJA A, 1988, BRAIN RES, V452, P303, DOI 10.1016/0006-8993(88)90034-0; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Silver JM, 2006, NEUROLOGY, V67, P748, DOI 10.1212/01.wnl.0000234062.98062.e9; Silver JM, 2009, BRAIN INJURY, V23, P123, DOI 10.1080/02699050802649696; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; Spikman JM, 2000, J CLIN EXP NEUROPSYC, V22, P325, DOI 10.1076/1380-3395(200006)22:3;1-V;FT325; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Taverni JP, 1998, BRAIN INJURY, V12, P77; Tenovuo O, 2005, PROG NEURO-PSYCHOPH, V29, P61, DOI 10.1016/j.pnpbp.2004.10.006; Tenovuo O, 2009, BRAIN INJURY, V23, P548, DOI 10.1080/02699050902926275; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; THURMAN D, 2001, HEAD TRAUMA BASIC PR; Trovato M, 2006, BRAIN INJURY, V20, P339, DOI 10.1080/02699050500487811; Wade AL, 2007, J TRAUMA, V63, P836, DOI 10.1097/01.ta.0000251453.54663.66; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Winblad B, 2007, NEUROLOGY, V69, pS14, DOI 10.1212/01.wnl.0000281847.17519.e0; Winblad B, 2007, INT J GERIATR PSYCH, V22, P456, DOI 10.1002/gps.1788; Xydakis MS, 2005, OTOLARYNG HEAD NECK, V133, P497, DOI 10.1016/j.otohns.2005.07.003; Zhang L, 2004, ARCH PHYS MED REHAB, V85, P1050, DOI 10.1016/j.apmr.2003.10.014; Zouris JM, 2006, MIL MED, V171, P246, DOI 10.7205/MILMED.171.3.246	58	1	2	0	2	ACADEMIC PRESS LTD-ELSEVIER SCIENCE LTD	LONDON	125 LONDON WALL, LONDON EC2Y 5AS, ENGLAND			9780-1-28-02701-1; 9780-1-28-02686-1				2017							273	285		10.1016/B978-0-12-802686-1.00017-1			13	Clinical Neurology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BI5ZM	WOS:000413002900020					2022-02-06	
B	Hersh, DS; Simard, JM; Eisenberg, HM		Heidenreich, KA		Hersh, D. S.; Simard, J. M.; Eisenberg, H. M.			The Application of Glibenclamide in Traumatic Brain Injury	NEW THERAPEUTICS FOR TRAUMATIC BRAIN INJURY: PREVENTION OF SECONDARY BRAIN DAMAGE AND ENHANCEMENT OF REPAIR AND REGENERATION			English	Article; Book Chapter							RAT MODEL; ATP; EDEMA; SUR1; TRANSCRIPTION; INHIBITION; HEMORRHAGE; ISCHEMIA		[Hersh, D. S.; Simard, J. M.; Eisenberg, H. M.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA		Hersh, DS (corresponding author), Univ Maryland, Sch Med, Baltimore, MD 21201 USA.			Hersh, David/0000-0003-1177-2201			[Anonymous], 2010, SAFETY STUDY RP 1127; [Anonymous], 2015, GLYBURIDE RP 1127 TR; Boggs DH, 2014, EXPERT REV NEUROTHER, V14, P379, DOI 10.1586/14737175.2014.890891; Chen MK, 2001, J NEUROSCI, V21, P6512, DOI 10.1523/JNEUROSCI.21-17-06512.2001; Davis ME, 2004, J BIOL CHEM, V279, P163, DOI 10.1074/jbc.M307528200; Ding J, 2013, CLIN NEUROL NEUROSUR, V115, P2166, DOI 10.1016/j.clineuro.2013.08.010; Korenaga R, 2001, AM J PHYSIOL-HEART C, V280, pH2214, DOI 10.1152/ajpheart.2001.280.5.H2214; Kunte H, 2007, STROKE, V38, P2526, DOI 10.1161/STROKEAHA.107.482216; Kunte H, 2012, ANN NEUROL, V72, P799, DOI 10.1002/ana.23680; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Kurland DB, 2013, PHARMACEUTICALS, V6, P1287, DOI 10.3390/ph6101287; Narayan RK, 2008, NEUROSURGERY, V62, P776, DOI 10.1227/01.NEU.0000297095.04013.C4; Ortega FJ, 2012, EXP NEUROL, V235, P282, DOI 10.1016/j.expneurol.2012.02.010; Pasternak O, 2009, MAGN RESON MED, V62, P717, DOI 10.1002/mrm.22055; Patel AD, 2010, J NEUROPATH EXP NEUR, V69, P1177, DOI 10.1097/NEN.0b013e3181fbf6d6; Simard JM, 2008, CURR OPIN PHARMACOL, V8, P42, DOI 10.1016/j.coph.2007.10.004; Simard JM, 2007, J CLIN INVEST, V117, P2105, DOI 10.1172/JCI32041; Simard JM, 2012, ANN NY ACAD SCI, V1268, P95, DOI 10.1111/j.1749-6632.2012.06705.x; Simard JM, 2012, J CEREBR BLOOD F MET, V32, P1699, DOI 10.1038/jcbfm.2012.91; Simard JM, 2012, TRANSL STROKE RES, V3, P286, DOI 10.1007/s12975-012-0149-x; Simard JM, 2012, EXP NEUROL, V233, P829, DOI 10.1016/j.expneurol.2011.11.048; Simard JM, 2012, EXP NEUROL, V233, P566, DOI 10.1016/j.expneurol.2011.11.044; Simard JM, 2010, J NEUROSURG, V113, P622, DOI 10.3171/2009.11.JNS081052; Simard JM, 2010, STROKE, V41, P531, DOI 10.1161/STROKEAHA.109.572644; Simard JM, 2009, J NEUROTRAUM, V26, P2257, DOI 10.1089/neu.2009.1021; Simard JM, 2009, J CEREBR BLOOD F MET, V29, P317, DOI 10.1038/jcbfm.2008.120; Simard JM, 2009, STROKE, V40, P604, DOI 10.1161/STROKEAHA.108.522409; Simard JM, 2006, NAT MED, V12, P433, DOI 10.1038/nm1390; Thompson EM, 2013, NEOPLASIA, V15, P535, DOI 10.1593/neo.13164; Tosun C, 2013, STROKE, V44, P3522, DOI 10.1161/STROKEAHA.113.002904; Tosun C, 2013, BRAIN SCI, V3, P215, DOI 10.3390/brainsci3010215; Yun SS, 2002, J BIOL CHEM, V277, P34808, DOI 10.1074/jbc.M205417200; Zweckberger K, 2014, NEUROSCIENCE, V272, P199, DOI 10.1016/j.neuroscience.2014.04.040	33	1	1	0	3	ACADEMIC PRESS LTD-ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL ROAD, LONDON NW1 7DX, ENGLAND			9780-1-28-02701-1; 9780-1-28-02686-1				2017							95	107		10.1016/B978-0-12-802686-1.00006-7			13	Clinical Neurology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BI5ZM	WOS:000413002900009					2022-02-06	
J	Hosseini, N; Hosseini, L; Noorafshan, A				Hosseini, Najmeh; Hosseini, Leila; Noorafshan, Ali			Management of Castor Bean Seed-Associated Intraventricular Hemorrhage with Fresh Frozen Plasma: A Case Report	IRANIAN RED CRESCENT MEDICAL JOURNAL			English	Article						Castor Bean; Cerebral Ventricles; Hemorrhage; Biological Warfare Agents; Blood Plasma	TRAUMATIC BRAIN-INJURY; RICIN; RESUSCITATION; PROTECTION; SHOCK; DOGS	Introduction: Castor bean seed is used to control some medical conditions including diabetes mellitus due to popular belief in its effectiveness. However it may cause severe poisoning in humans and animals and its components (ricin) might be used as a biological weapon. In the present case, a rare intra-ventricular hemorrhage followed by unconsciousness had occurred after poisoning with caster bean. Because there is no direct antidote or reversal agent for this condition, fresh frozen plasma (FFP) was prescribed to control the hemorrhage and good results were achieved. Case Presentation: A63-year-old female taking castor bean seed as a treatment for her diabetes was admitted to the emergencyward for a comatose state. A computed tomography image of her head demonstrated an intraventricular hemorrhage. Symptomatic and supporting care was prescribed. After two weeks without significant improvement, the patient was administered five units of FFP. However, the patient's neurological status dramatically improved and remained stable. Conclusions: Intraventricular hemorrhage followed by comatose state is a rare finding of the castor bean seed ingestion. The patient's condition improved dramatically after FFP transfusion.	[Hosseini, Najmeh] Shiraz Univ Med Sci, Ali Asghar Hosp, Shiraz, Iran; [Hosseini, Leila] Shiraz Univ Med Sci, Dept Tradit Med, Shiraz, Iran; [Noorafshan, Ali] Shiraz Univ Med Sci, Histomorphometry & Stereol Res Ctr, Shiraz, Iran		Noorafshan, A (corresponding author), Shiraz Univ Med Sci, Histomorphometry & Stereol Res Ctr, Shiraz, Iran.	noora@sums.ac.ir		Hossein, Leila/0000-0001-8043-6952; Noorafshan, Ali/0000-0003-1082-011X			Al-Tamimi Faisal A, 2008, Sultan Qaboos Univ Med J, V8, P83; Alipour M, 2013, DRUG CHEM TOXICOL, V36, P224, DOI 10.3109/01480545.2012.710624; [Anonymous], 2007, INT J TOXICOL S3, V26, P31, DOI [10.1080/1091581071663150, DOI 10.1080/10915810701663150]; Aslani MR, 2007, TOXICON, V49, P400, DOI 10.1016/j.toxicon.2006.10.010; Audi J, 2005, JAMA-J AM MED ASSOC, V294, P2342, DOI 10.1001/jama.294.18.2342; Botha CJ, 2009, J S AFR VET ASSOC, V80, P63; Bradberry Sally M., 2003, Toxicological Reviews, V22, P65, DOI 10.2165/00139709-200322010-00007; Dani C, 2009, TRANSFUSION, V49, P2637, DOI 10.1111/j.1537-2995.2009.02328.x; Emsley J, 2008, MOL MURDER CRIMINAL; Godoy MG, 2011, J IND MICROBIOL BIOT, V38, P945, DOI 10.1007/s10295-010-0865-8; Griffiths GD, 2007, INHAL TOXICOL, V19, P873, DOI 10.1080/08958370701432124; Jena J., 2012, INT J PHARM PHARM SC, V4, P25; Kuperman AA, 2015, J MATERN-FETAL NEO M, V28, P2265, DOI 10.3109/14767058.2013.796165; Mabley JG, 2009, MOL MED, V15, P166, DOI 10.2119/molmed.2008.00105; Olsnes S, 2004, TOXICON, V44, P361, DOI 10.1016/j.toxicon.2004.05.003; Roels S, 2010, J VET DIAGN INVEST, V22, P466, DOI 10.1177/104063871002200325; Roy CJ, 2015, P NATL ACAD SCI USA, V112, P3782, DOI 10.1073/pnas.1502585112; Sillesen M, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0046-2; Sillesen M, 2013, SURGERY, V154, P197, DOI 10.1016/j.surg.2013.04.002; Thornton SL, 2014, CLIN TOXICOL, V52, P265, DOI 10.3109/15563650.2014.892124; Worbs S, 2011, TOXINS, V3, P1332, DOI 10.3390/toxins3101332	21	1	1	0	2	KOWSAR PUBL	HOENSBROEK	PATERSWEG 22,, HOENSBROEK, LIMBURG 6431 GC, NETHERLANDS	2074-1804	2074-1812		IRAN RED CRESCENT ME	Iran. Red Crescent Med. J.	JAN	2017	19	1							e27834	10.5812/ircmj.27834			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV6DD	WOS:000401859200001					2022-02-06	
B	Hughes, N; Williams, H; Chitsabesan, P		Bailey, S; Chitsabesan, P; Tarbuck, P		Hughes, Nathan; Williams, Huw; Chitsabesan, Prathiba			The Influence of Neurodevelopmental Impairment on Youth Crime	FORENSIC CHILD AND ADOLESCENT MENTAL HEALTH: MEETING THE NEEDS OF YOUNG OFFENDERS			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; ALCOHOL SPECTRUM DISORDERS; NEUROPSYCHOLOGICAL MEASURES; INTELLECTUAL DISABILITY; EXECUTIVE DYSFUNCTION; LEARNING-DISABILITIES; ANTISOCIAL-BEHAVIOR; CHILDREN; EMOTION; PREDICTORS		[Hughes, Nathan] Univ Birmingham, Sch Social Policy, Birmingham, W Midlands, England; [Hughes, Nathan] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Williams, Huw] Exeter Univ, Clin Neuropsychol, Exeter, Devon, England; [Williams, Huw] Exeter Univ, Ctr Clin Neuropsychol Res, Exeter, Devon, England; [Chitsabesan, Prathiba] Pennine Care NHS Trust, Manchester, Lancs, England; [Chitsabesan, Prathiba] Univ Manchester, Ctr Mental Hlth & Risk, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England		Hughes, N (corresponding author), Univ Birmingham, Sch Social Policy, Birmingham, W Midlands, England.; Hughes, N (corresponding author), Murdoch Childrens Res Inst, Melbourne, Vic, Australia.						American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Bailey S., 2008, HLTH NEEDS IDENTIFIC; Baldry E., 2011, NAT LEG AID C DARW 2; Barnes C., 1991, DISABLED PEOPLE BRIT; Baumeister AL, 2008, CHILD ADOLESC SOC WO, V25, P11, DOI 10.1007/s10560-007-0109-6; Botting N., 2000, CHILD LANG TEACH THE, V16, P105, DOI [DOI 10.1177/026565900001600201, DOI 10.1191/026565900668565128]; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; British Psychological Society, 2001, LEARN DIS DEF CONT; Burd L, 2004, ADDICT BIOL, V9, P169, DOI 10.1080/13556210410001717060; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Catroppa C, 2009, FUTUR NEUROL, V4, P811, DOI 10.2217/FNL.09.52; Chartrand Larry N, 2003, Health Law J, V11, P35; Chitsabesan P, 2015, J HEAD TRAUMA REHAB, V30, P106, DOI 10.1097/HTR.0000000000000129; Chitsabesan P, 2007, J CHILD SERV, V2, P4, DOI 10.1108/17466660200700032; Conti-Ramsden G, 2004, J SPEECH LANG HEAR R, V47, P145, DOI 10.1044/1092-4388(2004/013); Davidson RJ, 2000, SCIENCE, V289, P591, DOI 10.1126/science.289.5479.591; Dockrell J. E., 2007, RAISING ACHIEVEMENTS; DOWSE L, 2009, AUSTR J HUMAN RIGHTS, V15, P29, DOI DOI 10.1080/1323238X.2009.11910860; Fairchild G, 2011, AM J PSYCHIAT, V168, P624, DOI 10.1176/appi.ajp.2010.10081184; Farrington DP, 2007, SAVING CHILDREN LIFE; Faul M, 2010, TRAUMATIC BRAIN INJU; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Fazel S, 2008, J AM ACAD CHILD PSY, V47, P1010, DOI [10.1097/CHI.ObO13e31817eecf3, 10.1097/CHI.0b013e31817eeef3]; Ferguson PL, 2012, J HEAD TRAUMA REHAB, V27, pE11, DOI 10.1097/HTR.0b013e31824e5f47; Funahashi S, 2001, NEUROSCI RES, V39, P147, DOI 10.1016/S0168-0102(00)00224-8; Ganesalingam K, 2007, J INT NEUROPSYCH SOC, V13, P298, DOI 10.1017/S1355617707070324; Green JH, 2007, J SCHOOL HEALTH, V77, P103, DOI 10.1111/j.1746-1561.2007.00178.x; Greenbaum RL, 2009, ALCOHOL CLIN EXP RES, V33, P1656, DOI 10.1111/j.1530-0277.2009.01003.x; Hare D.J., 1997, CLIN PSYCHOL FORUM, V110, P5; Harrington R., 2005, MENTAL HLTH NEEDS EF; Hayes SC, 2002, J APPL RES INTELLECT, V15, P120, DOI 10.1046/j.1468-3148.2002.00113.x; Herrington V, 2009, J INTELL DISABIL RES, V53, P397, DOI 10.1111/j.1365-2788.2008.01150.x; Hughes N., 2010, SOCIAL POLICY SOC, V9, P527; Jolliffe D, 2004, AGGRESS VIOLENT BEH, V9, P441, DOI 10.1016/j.avb.2003.03.001; Jolliffe D., 2010, SAGE HDB CRIMINOLOGI, P40; KUPERSMIDT JB, 1995, DEV PSYCHOPATHOL, V7, P825, DOI 10.1017/S0954579400006866; Kurowski BG, 2011, PM&R, V3, P836, DOI 10.1016/j.pmrj.2011.05.016; Law J, 2013, INT J LANG COMM DIS, V48, P486, DOI 10.1111/1460-6984.12027; Meltzer L., 2007, EXECUTIVE FUNCTION E; Mishna F, 2003, J LEARN DISABIL-US, V36, P336, DOI 10.1177/00222194030360040501; Morgan AB, 2000, CLIN PSYCHOL REV, V20, P113, DOI 10.1016/S0272-7358(98)00096-8; Mounce L., 2012, NOBODY MADE CONNECTI; Murphy D, 2010, J FORENSIC PSYCHI PS, V21, P462, DOI 10.1080/14789940903426885; Murphy K.R., 2009, J ADHD RELATED DISOR, V1, P5, DOI [10.1176/appi.ajp.2010.10081172, DOI 10.1176/APPI.AJP.2010.10081172]; Murray G.C., 2000, J LEARNING DISABILIT, V4, P153, DOI 10.1177/146900470000400206; National Institute for Health and Care Excellence, 2011, AUT REC REF DIAGN CH; National Institute for Health and Care Excellence, 2008, ATT DEF HYP DIS DIAG; National Institute for Health and Care Excellence, 2013, ANT BEH COND DIS CHI; Offender Health Research Network, 2013, COMPR HLTH ASS TOOL; Ogilvie JM, 2011, CRIMINOLOGY, V49, P1063, DOI 10.1111/j.1745-9125.2011.00252.x; Patel DR, 2011, NEURODEVELOPMENTAL DISABILITIES: CLINICAL CARE FOR CHILDREN AND YOUNG ADULTS, P1, DOI 10.1007/978-94-007-0627-9; PATTERSON GR, 1989, AM PSYCHOL, V44, P329, DOI 10.1037/0003-066X.44.2.329; PATTERSON GR, 1996, FRONTIERS DEV PSYCHO, P00081; Pfiffner L., 2006, ATTENTION DEFICIT HY; Prizent B., 1992, TOP LANG DISORD, V10, P11; Ryan NP, 2014, J NEUROTRAUM, V31, P649, DOI 10.1089/neu.2013.3153; Ryan NP, 2013, INT J DEV NEUROSCI, V31, P811, DOI 10.1016/j.ijdevneu.2013.10.002; Schmidt S, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-58; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Snow PC, 2011, INT J SPEECH-LANG PA, V13, P480, DOI 10.3109/17549507.2011.578661; Snow PC, 2005, PSYCHOL CRIME LAW, V11, P239, DOI 10.1080/1068316042000209323; Snow PC, 2012, AUSTR I CRIMINOL APR, V435, P421; Stevenson M., 2006, YOUNG PEOPLE OFFENDI; Talbot J, 2010, TIZARD LEARN DISABIL, V15, P33, DOI 10.5042/tldr.2010.0403; Tonks J, 2011, BRAIN INJURY, V25, P870, DOI 10.3109/02699052.2011.581641; Tonks J, 2009, DEV MED CHILD NEUROL, V51, P8, DOI 10.1111/j.1469-8749.2008.03219.x; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Wade SL, 2003, J HEAD TRAUMA REHAB, V18, P164, DOI 10.1097/00001199-200303000-00007; Williams, 2010, J PSYCHIAT LAW, V38, P559, DOI [10.1177/009318531003800408, DOI 10.1177/009318531003800408]; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613; Williams WH, 2013, REPAIRING SHATTERED; Wishart JG, 2007, J INTELL DISABIL RES, V51, P551, DOI 10.1111/j.1365-2788.2006.00947.x; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Youth Justice Board, 2006, BARR ENG ED TRAIN EM; [No title captured]	77	1	1	0	1	CAMBRIDGE UNIV PRESS	CAMBRIDGE	THE PITT BUILDING, TRUMPINGTON ST, CAMBRIDGE CB2 1RP, CAMBS, ENGLAND			978-1-107-00364-4				2017							68	81			10.1017/9780511777127		14	Behavioral Sciences; Criminology & Penology; Psychology, Developmental; Pediatrics; Psychiatry	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Behavioral Sciences; Criminology & Penology; Psychology; Pediatrics; Psychiatry	BL2CP	WOS:000448864100008					2022-02-06	
J	Inge, KJ; Graham, CW; McLaughlin, JW; Erickson, D; Wehman, P; Seward, HE				Inge, Katherine J.; Graham, Carolyn W.; McLaughlin, James W.; Erickson, Doug; Wehman, Paul; Seward, Hannah E.			Evaluating the effectiveness of Facebook to impact the knowledge of evidence-based employment practices by individuals with traumatic brain injury: A knowledge translation random control study	WORK-A JOURNAL OF PREVENTION ASSESSMENT & REHABILITATION			English	Article						Social media; vocational rehabilitation; VR; supported employment; employment of people with disabilities	WORK; RETURN	BACKGROUND: Individuals with traumatic brain injury (TBI) experience difficulty with obtaining and maintaining employment post-injury. Although vocational rehabilitation (VR) can be one option to provide individuals with TBI support and services to lead to successful employment outcomes, information about these services can be difficult and confusing to navigate. Providing information on evidence-based employment practices to individuals with TBI through social media could be an effective approach. OBJECTIVE: The objective of this study was to compare the effect of a knowledge translation (KT) strategy and the use of a secret Facebook group, on the knowledge of evidence-based employment research by individuals with traumatic brain injury (TBI). METHODS: The study used a randomized pretest-posttest control group design. Sixty individuals with TBI were recruited through clubhouse programs in the state where the authors resided as well as through support groups nationally for individuals with TBI, and were randomly assigned to one of two groups. Both groups received information on evidence-based employment practices for individuals with traumatic brain injury (TBI) over a three month period. One group received the information via participation in a secret Facebook group while the comparison group received information as an "e-news" email blast. Participants were assessed pre- and post-intervention with a Likert-scale instrument designed to measure knowledge of evidenced-based employment information for TBI. RESULTS: Both groups gained a significant amount of knowledge between baseline and post-intervention. However, there were no significant differences between groups in knowledge gained at post-intervention. CONCLUSION: While the study did not identify the most effective means of delivering information to individuals with TBI, it does provide some guidance for future KT research.	[Inge, Katherine J.; Erickson, Doug; Wehman, Paul; Seward, Hannah E.] Virginia Commonwealth Univ, Rehabil Res & Training Ctr, POB 842011, Richmond, VA 23284 USA; [Graham, Carolyn W.] Virginia Commonwealth Univ, Ctr Rehabil Sci & Engn, Med Coll Virginia Campus, Richmond, VA 23284 USA; [McLaughlin, James W.] NewFaze, Richmond, VA USA		Inge, KJ (corresponding author), Virginia Commonwealth Univ, Rehabil Res & Training Ctr, POB 842011, Richmond, VA 23284 USA.	kinge@vcu.edu		Seward, Hannah/0000-0002-7358-7274	Center on Knowledge Translation for Employment Research [90DP0009]; affiliate of American Institutes for Research, from the National Institute on Disability, Independent Living; Rehabilitation Research (NIDILRR) in the U.S. Department of Health and Human Services (HHS), Administration for Community Living	This study was supported by the Center on Knowledge Translation for Employment Research through grant 90DP0009 (formerly ED #H133A100026) to SEDL, an affiliate of American Institutes for Research, from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) in the U.S. Department of Health and Human Services (HHS), Administration for Community Living. However, the contents of this article do not necessarily represent the policy of the U.S. Department of HHS, and you should not assume endorsement by the Federal Government.	[Anonymous], 2015, C TRAUM BRAIN INJ US; Inge KJ., 2016, J VOCAT REHABIL, V45, P107, DOI DOI 10.3233/JVR-160815; Neumann D, 2002, COGNITIVE PROBLEMS T; Olmstead K, 2016, SOCIAL MEDIA WORKPLA; Protalinski E., 2015, FACEBOOK PASSES 1 44; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Shpigelman CN, 2014, J COMPUT-MEDIAT COMM, V19, P610, DOI 10.1111/jcc4.12059; Smith C., 2016, NUMBERS 200 AMAZING; Tsaousides T, 2011, BRAIN INJURY, V25, P1155, DOI 10.3109/02699052.2011.613086; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001; [No title captured]	12	1	1	1	4	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1051-9815	1875-9270		WORK	Work		2017	58	1					73	81		10.3233/WOR-172595			9	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	FJ0XW	WOS:000412435600010	28922174	Bronze			2022-02-06	
J	Jang, SH; Lee, HD				Jang, Sung Ho; Lee, Han Do			Traumatic axonal injury despite clinical phenotype of mild traumatic brain injury: a case report	BRAIN INJURY			English	Article						Mild traumatic brain injury; traumatic axonal injury; diffusion tensor tractography; airbag	DIFFUSION TENSOR TRACTOGRAPHY; CORTICOSPINAL TRACT; AIRBAG DEPLOYMENT; HEAD-INJURY	Objectives: We report on a patient who suffered traumatic axonal injury (TAI) of various neural tracts despite airbag deployment following mild traumatic brain injury (TBI), which was demonstrated by diffusion tensor tractography (DTT).Case description: A 58-year-old female patient suffered from head trauma resulting from an in-car traffic accident. At the time of head trauma, her head and face hit the deployed airbag after flexion-hyperextension-rotation injury. The patient's Glasgow Coma Scale score was 15. Since the day of head trauma, she began to feel headache and upper back pain at the mid-thoracic area. At 7 days after onset, she began to feel pain on the left hand, which spread to the right hand and leg: throbbing and cold pain without allodynia or hyperalgesia (visual analogue scale score: 5). She also felt mild weakness of all four extremities and mild memory impairment. On 4-week DTT, the corticospinal tract showed partial tearing at the subcortical white matter level in both hemispheres . The right fornical crus and right anterior cingulum were discontinued, and narrowing and partial tearing were observed in both spinothalamic tracts.Conclusions: TAI of four kinds of neural tracts was demonstrated in a patient with mild TBI despite airbag deployment, using DTT.	[Jang, Sung Ho; Lee, Han Do] Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, 317-1 Daemyungdong, Taegu 705717, South Korea		Lee, HD (corresponding author), Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, 317-1 Daemyungdong, Taegu 705717, South Korea.	lhd890221@hanmail.net			National Research Foundation (NRF) of Korea - Korean Government (MSIP) [2015R1A2A2A01004073]	The authors report no conflicts of interest. This work was supported by the National Research Foundation (NRF) of Korea grant funded by the Korean Government (MSIP) (number 2015R1A2A2A01004073).	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Cunningham K, 2000, J ACCID EMERG MED, V17, P139; de Kruijk JR, 2001, BRAIN INJURY, V15, P99, DOI 10.1080/026990501458335; Hollands CM, 1996, J TRAUMA, V41, P920, DOI 10.1097/00005373-199611000-00033; Huber C D, 2005, Traffic Inj Prev, V6, P170, DOI 10.1080/15389580590931644; Jang SH, 2016, J NEUROTRAUM, V33, P1790, DOI 10.1089/neu.2015.4298; Jang SH, 2016, AM J PHYS MED REHAB, V95, pE26, DOI 10.1097/PHM.0000000000000397; Jang SH, 2016, AM J PHYS MED REHAB, V95, pE14, DOI 10.1097/PHM.0000000000000390; Kim JH, 2015, J HEAD TRAUMA REHAB, V30, pE40, DOI 10.1097/HTR.0000000000000121; Kwon HG, 2014, NEUROREPORT, V25, P710, DOI 10.1097/WNR.0000000000000170; Matsushita H, 2014, J OBSTET GYNAECOL RE, V40, P599, DOI 10.1111/jog.12188; Miller M D, 1993, Fam Pract Res J, V13, P15; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Pintar F A, 2000, Annu Proc Assoc Adv Automot Med, V44, P149; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Seo JP, 2015, BRAIN INJURY, V29, P110, DOI 10.3109/02699052.2014.973447; Urban JE, 2012, J NEUROTRAUM, V29, P2774, DOI 10.1089/neu.2012.2373; Wechler D., 1981, MANUAL WECHSLER ADUL; Williams JM., 1991, MAS MEMORY ASSESSMEN	20	1	1	1	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	11					1534	1537		10.1080/02699052.2017.1376754			4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FN4GB	WOS:000415961200018	28956660				2022-02-06	
J	Jodoin, M; Rouleau, DM; Larson-Dupuis, C; Benoit, B; Leduc, S; Laflamme, GY; Gosselin, N; Sabir, M; De Beaumont, L				Jodoin, Marianne; Rouleau, Dominique M.; Larson-Dupuis, Camille; Benoit, Benoit; Leduc, Stephane; Laflamme, G-Yves; Gosselin, Nadia; Sabir, Meriem; De Beaumont, Louis			Effects of concomitant mild traumatic brain injury on resuming work after suffering from an isolated limb fracture: A cohort study	BRAIN INJURY			English	Article						Mild traumatic brain injury; fracture; return to work	ORTHOPEDIC INJURY; RETURN; COMPENSATION; RISK; EMPLOYMENT; OUTCOMES; CLAIMS; HAND	Background: The objective is to explore the effects of concomitant mild traumatic brain injury (mTBI) on return to work (RTW), among patients suffering from an isolated limb fracture. This follow-up study included a total of 170 working age subjects with an isolated limb fracture, and was conducted in a phone interview approximately 1-year post trauma. 41 had experienced an mTBI and 129 did not. Methods: Data were obtained through a phone interview conducted on average 20.7 months (SD = 9.6 months) post-accident. The main outcome measure was the number of days taken to RTW after the injury. Demographic information was also gathered during the phone interview. Workers' compensation status was obtained through the hospitals' orthopaedic clinic data. Results: The mTBI group took on average 329.7 days (SD = 298.0) to RTW after the injury, as opposed to 150.3 days (SD = 171.3) for the control group (p < 0.001). After excluding patients who received workers' compensation, the mTBI group still missed significantly more days of work (M = 299.4 days; SD = 333.0) than the control group (M = 105.2 days; SD = 121.6) (p < 0.0001). Conclusion: This study shows that mTBI increases work disability by preventing working-age individuals from rapidly returning to work.	[Jodoin, Marianne; Larson-Dupuis, Camille; Gosselin, Nadia; Sabir, Meriem] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Jodoin, Marianne; Rouleau, Dominique M.; Larson-Dupuis, Camille; Benoit, Benoit; Leduc, Stephane; Laflamme, G-Yves; Gosselin, Nadia; Sabir, Meriem; De Beaumont, Louis] Montreal Sacred Heart Hosp, Res Ctr, C2095-5400 Blvd Gouin Ouest, Montreal, PQ H4J 1C5, Canada; [De Beaumont, Louis] Univ Montreal, Dept Surg, Montreal, PQ, Canada		Rouleau, DM (corresponding author), Montreal Sacred Heart Hosp, Res Ctr, C2095-5400 Blvd Gouin Ouest, Montreal, PQ H4J 1C5, Canada.	dominique.rouleau@umontreal.ca			UQTR Research Chair on the Neurobiology of Mild Traumatic Brain Injury	UQTR Research Chair on the Neurobiology of Mild Traumatic Brain Injury awarded to LDB.	Bergen GS., 2008, INJURY US 2007 CHART; Borgna SC, 2013, PLAST RECONSTR SURG, V132, P1525, DOI 10.1097/PRS.0b013e3182a8069d; Bouchard A, 2014, ORTHOP TRAUMATOL-SUR, V100, pS365, DOI 10.1016/j.otsr.2014.09.006; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Buck PW, 2011, HEALTH SOC WORK, V36, P299, DOI 10.1093/hsw/36.4.299; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Claes L, 2012, NAT REV RHEUMATOL, V8, P133, DOI 10.1038/nrrheum.2012.1; Clay FJ, 2010, INJURY, V41, P787, DOI 10.1016/j.injury.2010.04.005; Das De S, 2013, J BONE JOINT SURG AM, V95A, P76, DOI 10.2106/JBJS.L.00064; De Beaumont L, 2012, CEREB CORTEX, V22, P112, DOI 10.1093/cercor/bhr096; de Putter CE, 2012, J BONE JOINT SURG AM, V94A, DOI 10.2106/JBJS.K.00561; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Fort E, 2011, J REHABIL MED, V43, P283, DOI 10.2340/16501977-0670; Harrison Kate, 2003, Work, V21, P141; Hou WH, 2008, J REHABIL MED, V40, P440, DOI 10.2340/16501977-0194; Jodoin M, 2017, INJURY, V48, P1927, DOI 10.1016/j.injury.2017.06.025; Jodoin M, 2016, INJURY, V47, P1835, DOI 10.1016/j.injury.2016.05.036; MacIntyre NJ, 2016, J HAND THER, V29, P136, DOI 10.1016/j.jht.2016.03.003; Miller NR, 2014, BRAIN INJURY, V28, P1270, DOI 10.3109/02699052.2014.915987; Mollayeva T, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005917; Morris BJ, 2015, J SHOULDER ELB SURG, V24, P453, DOI 10.1016/j.jse.2014.07.009; Murgatroyd DF, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1019-6; Ootes Daan, 2012, Hand (N Y), V7, P18, DOI 10.1007/s11552-011-9383-z; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Parker TM, 2007, BRIT J SPORT MED, V41, P868, DOI 10.1136/bjsm.2006.033761; Pynsent P, 2004, OUTCOME MEASURES ORT; Quebec R., 2013, REVENU TOTAL PARTICU; Reynolds S, 2003, J HEAD TRAUMA REHAB, V18, P139, DOI 10.1097/00001199-200303000-00005; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Shi QY, 2014, J HAND THER, V27, P55, DOI 10.1016/j.jht.2013.10.001; Shields E, 2016, J SHOULDER ELB SURG, V25, P1115, DOI 10.1016/j.jse.2016.02.004; Sluys KP, 2016, INJURY, V47, P824, DOI 10.1016/j.injury.2016.02.019; Surgeons ACo, 2004, NEED ADV TRAUM LIF S; Urquhart DM, 2006, ANZ J SURG, V76, P600, DOI 10.1111/j.1445-2197.2006.03785.x; van der Noordt M, 2014, OCCUP ENVIRON MED, V71, P730, DOI 10.1136/oemed-2013-101891; Vikane E, 2016, BEHAV NEUROL, V2016, DOI 10.1155/2016/8026414; Waljas M, 2014, J HEAD TRAUMA REHAB, V29, P443, DOI 10.1097/HTR.0000000000000002; Williamson OD, 2009, J ORTHOP TRAUMA, V23, P139, DOI 10.1097/BOT.0b013e3181962e29	42	1	1	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	12					1683	1688		10.1080/02699052.2017.1341644			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FN4KB	WOS:000415973200017	28876146				2022-02-06	
B	Kidd, D		Jarman, M; Monaghan, L; Harkin, AQ		Kidd, Douglas			My Brother's Traumatic Brain Injury and Its Effect on Me	BARRIERS AND BELONGING: PERSONAL NARRATIVES OF DISABILITY			English	Article; Book Chapter									[Kidd, Douglas] Undistracted Driving Advocacy LLC, Toledo, OH 43606 USA; [Kidd, Douglas] Greater Toledo Brain Injury Support Grp, Toledo, OH USA; [Kidd, Douglas] Toledo Lucas Cty Commiss Disabil, Toledo, OH USA; [Kidd, Douglas] Abil Ctr Greater Toledo, Board Trustees, Sylvania, OH 43560 USA		Kidd, D (corresponding author), Undistracted Driving Advocacy LLC, Toledo, OH 43606 USA.; Kidd, D (corresponding author), Greater Toledo Brain Injury Support Grp, Toledo, OH USA.; Kidd, D (corresponding author), Toledo Lucas Cty Commiss Disabil, Toledo, OH USA.; Kidd, D (corresponding author), Abil Ctr Greater Toledo, Board Trustees, Sylvania, OH 43560 USA.						Keller D., 2011, OPTIONS TOMORROW R K	1	1	1	0	0	TEMPLE UNIV PRESS	PHILADELPHIA	BROAD & OXFORD ST, PHILADELPHIA, PA 19122 USA			978-1-4399-1389-5				2017							87	93					7	Cultural Studies; Social Sciences, Interdisciplinary	Book Citation Index – Social Sciences & Humanities (BKCI-SSH)	Cultural Studies; Social Sciences - Other Topics	BJ7UO	WOS:000427704600016					2022-02-06	
J	Kiessling, JW; Hertzler, DA; Drucker, DEM; Spader, HS				Kiessling, J. Willis; Hertzler, Dean A., II; Drucker, David E. M.; Spader, Heather S.			Traumatic Frontal Epidural Hematoma Caused by Multiple Arterial Injuries in the Anterior Fossa	WORLD NEUROSURGERY			English	Article						Anterior fossa; Epidural; Ethmoid artery; Pediatric	EXTRADURAL HEMATOMA; CHILDREN; EXPERIENCE	BACKGROUND: This case report illustrates the need to evaluate the possibility of multiple arterial sources when presented with a frontal epidural hematoma associated with facial trauma. CASE DESCRIPTION: The patient presented after being struck in the face by a baseball. Computed tomography of the brain revealed a large frontal epidural hematoma. Intraoperatively, bleeding from a frontal branch of the middle meningeal artery was encountered and cauterized, and the hematoma was removed. Routine follow-up imaging performed the next day showed a residual frontal hematoma; however, the epidural hematoma was in a more medial location than the initial hematoma. The patient was taken back to the operating room; after frontal lobe retraction and extensive exploration, a different source of bleeding from posterior ethmoidal artery feeders was encountered. After the second operation, the patient's hematoma did not recur, and he was discharged home with no neurologic deficits 3 days later. CONCLUSIONS: We report a case of an epidural hematoma caused by 2 distinct arterial feeders. We discuss radiologic review and operative management of anterior fossa epidural hematomas and stress the importance of considering arterial bleeding from sources other than the middle meningeal artery in anterior fossa epidural hematomas. We discuss the utility of preoperative angiography for these patients and reinforce the need for acute postoperative imaging to ensure successful operative and patient outcomes.	[Kiessling, J. Willis] Nova Southeastern Univ Coll Osteopath Med, Davie & Div, Davie, FL USA; [Hertzler, Dean A., II; Spader, Heather S.] Joe DiMaggio Childrens Hosp, Pediat Surg, Davie, FL USA; [Drucker, David E. M.] Joe DiMaggio Childrens Hosp, Davie, FL USA		Spader, HS (corresponding author), Joe DiMaggio Childrens Hosp, Pediat Surg, Davie, FL USA.	hspader@mhs.net					Ahn E, 2015, INTRACRANIAL EPIDURA; Bortoluzzi M, 2006, INTERV NEURORADIOL, V12, P233, DOI 10.1177/159101990601200305; BRICOLO AP, 1984, NEUROSURGERY, V14, P8, DOI 10.1227/00006123-198401000-00003; BULLOCK R, 1990, J NEUROSURG, V72, P9, DOI 10.3171/jns.1990.72.1.0009; Cheung PSY, 2007, INJURY, V38, P76, DOI 10.1016/j.injury.2006.08.059; Gerlach R, 2009, PEDIATR EMERG CARE, V25, P164, DOI 10.1097/PEC.0b013e31819a8966; Gupta SS, 2010, AM J EMERG MED, V28; Jung SW, 2012, J KOREAN NEUROSURG S, V51, P215, DOI 10.3340/jkns.2012.51.4.215; KAUFMAN HH, 1980, NEUROSURGERY, V7, P445, DOI 10.1227/00006123-198011000-00003; Nath PC, 2015, J PEDIATR NEUROSCI, V10, P114, DOI 10.4103/1817-1745.159192; PATERNITI S, 1994, ACTA NEUROCHIR, V131, P207, DOI 10.1007/BF01808614; Rocchi G, 2005, J CHILD NEUROL, V20, P569, DOI 10.1177/08830738050200070501; STEPHANOV S, 1992, SURG NEUROL, V37, P329, DOI 10.1016/0090-3019(92)90162-G	13	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JAN	2017	97								757.e19	10.1016/j.wneu.2016.10.017			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EO1HO	WOS:000396449400138	27751928				2022-02-06	
J	Klein, TA; Graves, JM				Klein, Tracy A.; Graves, Janessa M.			A Comparison of Psychiatric and Nonpsychiatric Nurse Practitioner Knowledge and Management Recommendations Regarding Adolescent Mild Traumatic Brain Injury	JOURNAL OF THE AMERICAN PSYCHIATRIC NURSES ASSOCIATION			English	Article						concussion; nurse practitioner; adolescents; adolescence; brain injury	SPORT-RELATED CONCUSSION; ACTIVITY LEVEL; FOLLOW-UP; PHYSICIANS; CHILDREN; SYMPTOMS; RETURN; PREDICTORS; DEPRESSION; DURATION	BACKGROUND: Nurse practitioners (NPs) are statutorily authorized to provide assessment and cognitive recommendations for concussion in most states. Their scope of practice includes assessment and management of concussion sequalae including anxiety, insomnia, and depression, as well as return to school and activity guidance. OBJECTIVES: Analysis of symptom-based diagnosis of mild traumatic brain injury (TBI) in adolescents, including return to school and school workload recommendations comparing psychiatric and nonpsychiatric NPs. DESIGN: Cross-sectional Web-based survey with embedded videos using standardized actors and scripts randomized for patient sex and sport. A total of 4,849 NPs licensed in Oregon or Washington were invited by e-mail to view and respond to this study, with a response rate of 23%. RESULTS: Psychiatric mental health nurse practitioners (PMHNPs) were 44% less likely than family NPs to report using standardized concussion tools. 17% had completed continuing education on mild TBI compared to 54.5% of family NPs. Seven PMHNPs provided additional feedback related to discomfort in completing the survey due to lack of comfort or experience. Return to school recommendations and reduced workload advice did not significantly differ by NP type. CONCLUSION: PMHNPs may support individualized assessment through concussion evaluation, use of standardized tools, and differential consideration of TBI for mental health symptoms. More research is required related to the role and contribution of cognitive rest to full recovery.	[Klein, Tracy A.] Washington State Univ Vancouver, Vancouver, WA USA; [Graves, Janessa M.] Washington State Univ Spokane, Spokane, WA USA		Klein, TA (corresponding author), Washington State Univ Vancouver, Coll Nursing, 14204 NE Salmon Creek Ave, Vancouver, WA 98686 USA.	taklein@wsu.edu	Graves, Janessa M./J-2596-2019	Graves, Janessa M./0000-0002-7659-2634; Klein, Tracy/0000-0002-6618-3538	Washington State University New Faculty Seed Grant; American Nurses Foundation/Western Institute of Nursing Grant	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was funded by the Washington State University New Faculty Seed Grant and the American Nurses Foundation/Western Institute of Nursing Grant.	American Nurses Credentialing Center, 2013, TEST CONT PSYCH MENT; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Belanger HG, 2016, J HEAD TRAUMA REHAB, V31, P204, DOI 10.1097/HTR.0000000000000168; Black AM, 2017, CLIN J SPORT MED, V27, P52, DOI 10.1097/JSM.0000000000000308; BMJ Best Practice, 2015, EV TRAUM BRAIN INJ A; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Centers for Disease Control and Prevention, 2009, FACTS PHYS MILD TRAU; Centers for Disease Control and Prevention, 2015, INT CLASS DIS; Centers for Disease Control and Prevention, RAT TBI REL HOSP AG; Centers for Disease Control and Prevention, HEADS SCH KNOW YOUR; Centers for Disease Control and Prevention, RET SCH CONC FACT SH; Centers for Medicare and Medicaid Services, 2014, MENT HLTH SERV; Chrisman SP, 2011, CLIN PEDIATR, V50, P1031, DOI 10.1177/0009922811410970; Chrisman SPD, 2014, J ADOLESCENT HEALTH, V54, P582, DOI 10.1016/j.jadohealth.2013.10.006; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Dehlendorf C, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.05.009; DeMatteo C, 2015, CLIN PEDIATR, V54, P783, DOI 10.1177/0009922814567305; Dillman DA., 2014, INTERNET PHONE MAIL, V4th; Dykema J, 2013, EVAL HEALTH PROF, V36, P352, DOI 10.1177/0163278713496630; Echemendia RJ, 2015, BRAIN INJURY, V29, P185, DOI 10.3109/02699052.2014.965212; Edwards PJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000008.pub4; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Gilchrist J., 2011, MMWR-MORBID MORTAL W, V60, P1337; Gioia G, 2006, ACUTE CONCUSSION EVA; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Gioia GA, 2016, J CHILD NEUROL, V31, P93, DOI 10.1177/0883073814555604; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Glaviano NR, 2015, CLIN J SPORT MED, V25, P373, DOI 10.1097/JSM.0000000000000154; Grubenhoff' JA, 2015, BRAIN INJURY, V29, P1186, DOI 10.3109/02699052.2015.1035325; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Hooper LM, 2012, J BEHAV HEALTH SER R, V39, P103, DOI 10.1007/s11414-011-9268-5; Howell DR, 2016, AM J SPORT MED, V44, P1040, DOI 10.1177/0363546515625045; KESSLER RC, 1995, EPIDEMIOL REV, V17, P192, DOI 10.1093/oxfordjournals.epirev.a036176; Kinnaman KA, 2014, PEDIATR EMERG CARE, V30, P458, DOI 10.1097/PEC.0000000000000161; Lee LK, 2007, PEDIATR EMERG CARE, V23, P580, DOI 10.1097/PEC.0b013e31813444ea; Max JE, 2013, J NEUROPSYCH CLIN N, V25, P272, DOI 10.1176/appi.neuropsych.12040078; Max JE, 2012, INT J DEV NEUROSCI, V30, P239, DOI 10.1016/j.ijdevneu.2011.12.005; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Nalliah RP, 2014, PEDIATR EMERG CARE, V30, P511, DOI 10.1097/PEC.0000000000000180; Ono KE, 2016, AM J SPORT MED, V44, P748, DOI 10.1177/0363546515617746; Rabinowitz AR, 2015, J NEUROTRAUM, V32, P1488, DOI 10.1089/neu.2014.3555; Rabinowitz AR, 2014, ANNU REV PSYCHOL, V65, P301, DOI 10.1146/annurev-psych-010213-115103; Reisner A, 2015, CLIN PEDIATR, V54, P1031, DOI 10.1177/0009922815573468; Sarmiento K, 2010, J SCHOOL HEALTH, V80, P112, DOI 10.1111/j.1746-1561.2010.00491.x; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Schulman KA, 1999, NEW ENGL J MED, V340, P618, DOI 10.1056/NEJM199902253400806; Scott KL, 2016, CLIN NEUROPSYCHOL, V30, P66, DOI 10.1080/13854046.2015.1127427; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, pE29, DOI 10.1097/HTR.0000000000000095; VanGeest JB, 2007, EVAL HEALTH PROF, V30, P303, DOI 10.1177/0163278707307899; West TA, 2014, J NEUROTRAUM, V31, P159, DOI 10.1089/neu.2013.3031; Williamson Richard W, 2014, Neurosurgery, V75 Suppl 4, pS131, DOI 10.1227/NEU.0000000000000482; Zemek R, 2014, PAED CHILD HEALT-CAN, V19, P474, DOI 10.1093/pch/19.9.475; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	57	1	1	0	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1078-3903	1532-5725		J AM PSYCHIAT NURSES	J. Am. Psych. Nurses Assoc.	JAN-FEB	2017	23	1					37	49		10.1177/1078390316668992			13	Nursing; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing; Psychiatry	EL1EL	WOS:000394363200004	27601433				2022-02-06	
J	Konin, JG				Konin, Jeff G.			Knowledge and Behavioral Patterns of Youth Ice Hockey Parents Regarding Sport Concussion: A Pilot Study	INTERNET JOURNAL OF ALLIED HEALTH SCIENCES AND PRACTICE			English	Article							EDUCATION; PLAYERS; EPIDEMIOLOGY; LEGISLATION; ATTITUDES; LAW	Purpose: There is an abundance of available concussion education programs for parents of youth ice hockey players. Parents play a vital role in recognizing signs and symptoms of a concussion sustained by a child, and therefore their knowledge and retention of such information is deemed to be very important. The purpose of the pilot survey is identify the general knowledge parents of youth ice hockey players possess regarding concussion. Methods: A survey of a sample of convenience was utilized. Forty-five parents (40 to 49 years of age) of youth ice hockey players were asked to complete a one-page survey to assess their knowledge of concussion. The ages of their children ranged from seven through ten, and all parents were recruited to participate while attending a team practice session at a local ice hockey arena. Results: Parents generally were aware of common concussion related symptoms (headache 98%, difficulty with concentrating 96%, mental confusion 91%, vomiting 91%, sensitivity to light 91%, and blurred vision 82%) while not so familiar with symptoms such as tinnitus (62%) and agitated behaviors (47%). Fifty percent of those surveyed were unaware if their youth hockey organization had a concussion policy. Conclusion: Parents of youth ice hockey players seem to fail to retain information learned from concussion education programs. Barriers to learning retention may include the ages of the youth participating, the abundance of informal and inconsistent information that is available, and the lack of organizational administration of concussion education programs. Parents appear to be receptive to receiving more information regarding the safety of their children. Parental recognition of the signs and symptoms of a concussion sustained while playing youth ice hockey may lead to more appropriate and timely management of the injury.	[Konin, Jeff G.] Univ Rhode Isl, Phys Therapy Dept, Kingston, RI 02881 USA		Konin, JG (corresponding author), Univ Rhode Isl, Phys Therapy Dept, Kingston, RI 02881 USA.	jeffkonin@hotmail.com					Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Cusimano MD, 2014, BRIT J SPORT MED, V48, P141, DOI 10.1136/bjsports-2012-091660; Echlin PS, 2012, NEUROSURG FOCUS, V33, P1, DOI DOI 10.3171/2012.10.F0CUS12286; Jones NS, 2014, CLIN J SPORT MED, V24, P284, DOI 10.1097/JSM.0000000000000031; Kay MC, 2015, J SPORT REHABIL, V24, P210, DOI 10.1123/jsr.2013-0132; Kroshus E, 2015, ANN BEHAV MED, V49, P95, DOI 10.1007/s12160-014-9636-5; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Kurowski BG, 2015, J TRAUMA ACUTE CARE, V79, pS21, DOI 10.1097/TA.0000000000000675; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; Noble JM, 2013, NEUROPSYCHOL REV, V23, P273, DOI 10.1007/s11065-013-9239-0; O'Kane JW, 2014, PHYSICIAN SPORTSMED, V42, P39, DOI 10.3810/psm.2014.09.2074; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Shenouda C, 2012, PM&R, V4, P427, DOI 10.1016/j.pmrj.2012.02.016; Yorke AM, 2016, PHYS THER, V96, P1018, DOI 10.2522/ptj.20140598; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	16	1	1	0	5	NOVA SOUTHEASTERN UNIV	FORT LAUDERDALE	3200 S UNIVERSITY DR, FORT LAUDERDALE, FL 33328 USA	1540-580X			INTERNET J ALLIED HE	Internet J. Allied Health Sci. Pract.		2017	15	2											7	Health Care Sciences & Services	Emerging Sources Citation Index (ESCI)	Health Care Sciences & Services	ES3TV	WOS:000399453100008					2022-02-06	
B	Krasny-Pacini, A; Limond, J; Chevignard, M		Wilson, BA; Winegardner, J; VanHeugten, CM; Ownsworth, T		Krasny-Pacini, Agata; Limond, Jenny; Chevignard, Mathilde			Children	NEUROPSYCHOLOGICAL REHABILITATION: THE INTERNATIONAL HANDBOOK			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; EXECUTIVE DYSFUNCTION; FRONTAL-LOBE; DYSEXECUTIVE SYNDROME; REHABILITATION; INTERVENTIONS; PROGRAM; SKILLS; MANAGEMENT; CHILDHOOD		[Krasny-Pacini, Agata] Univ Rehabil Inst Clemenceau Strasbourg, Strasbourg, France; [Limond, Jenny] Univ Exeter, Exeter, Devon, England; [Chevignard, Mathilde] St Maurice Hosp, St Maurice, France		Krasny-Pacini, A (corresponding author), Univ Rehabil Inst Clemenceau Strasbourg, Strasbourg, France.						Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; Antonini TN, 2014, BEHAV THER, V45, P455, DOI 10.1016/j.beth.2014.02.003; Armengol CG, 2000, BRAIN INJURY, V14, P237, DOI 10.1080/026990500120718; BADDELEY A, 1988, BRAIN COGNITION, V7, P212, DOI 10.1016/0278-2626(88)90031-0; Bennett PC, 2005, J INT NEUROPSYCH SOC, V11, P606, DOI 10.1017/S1355617705050721; Bjorklund D. F., 2011, CHILDRENS THINKING C; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Boelen DHE, 2009, NEUROPSYCHOL REHABIL, V19, P625, DOI 10.1080/09602010802613853; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess P.W., 2005, EFFECTIVENESS REHABI, P211, DOI DOI 10.1093/ACPROF:OSO/9780198526544.001.0001; BURKE W H, 1991, Brain Injury, V5, P241, DOI 10.3109/02699059109008095; Butler RW, 2008, J CONSULT CLIN PSYCH, V76, P367, DOI 10.1037/0022-006X.76.3.367; Chan DYK, 2011, DISABIL REHABIL, V33, P2023, DOI 10.3109/09638288.2011.556207; Chevignard M, 2010, CHILD CARE HLTH DEV, V36, P31, DOI 10.1111/j.1365-2214.2009.00949.x; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cipolotti L, 2015, NEUROPSYCHOLOGIA, V68, P21, DOI 10.1016/j.neuropsychologia.2014.12.025; Crova C, 2014, J SPORT SCI, V32, P201, DOI 10.1080/02640414.2013.828849; Devinski O., 1992, BEHAV NEUROLOGY 100; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Diamond A, 2011, SCIENCE, V333, P959, DOI 10.1126/science.1204529; Duffau H, 2012, CORTEX, V48, P120, DOI 10.1016/j.cortex.2011.04.029; Duncan J, 1996, COGNITIVE PSYCHOL, V30, P257, DOI 10.1006/cogp.1996.0008; Dunning DL, 2014, MEM COGNITION, V42, P854, DOI 10.3758/s13421-014-0410-5; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; Feeney TJ, 2010, J HEAD TRAUMA REHAB, V25, P416, DOI 10.1097/HTR.0b013e3181fbc0a2; Giles GM, 1997, AM J OCCUP THER, V51, P256, DOI 10.5014/ajot.51.4.256; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Goldstein B, 2004, BRAIN COGNITION, V54, P110, DOI 10.1016/S0278-2626(03)00269-0; Herpertz-Dahlmann B, 2015, EUR CHILD ADOLES PSY, V24, P1153, DOI 10.1007/s00787-015-0748-7; Hillman CH, 2014, PEDIATRICS, V134, pE1063, DOI 10.1542/peds.2013-3219; Jacob R, 2015, REV EDUC RES, V85, P512, DOI 10.3102/0034654314561338; Jacobs R, 2011, CORTEX, V47, P808, DOI 10.1016/j.cortex.2010.06.002; Jolles DD, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00076; Kesler SR, 2011, BRAIN INJURY, V25, P101, DOI 10.3109/02699052.2010.536194; Krasny-Pacini A, 2014, J HEAD TRAUMA REHAB, V29, pE49, DOI 10.1097/HTR.0000000000000015; Krasny-Pacini A, 2014, DISABIL REHABIL, V36, P105, DOI 10.3109/09638288.2013.777807; Kurowski BG, 2013, PEDIATRICS, V132, pE158, DOI 10.1542/peds.2012-4040; Lakes KD, 2004, J APPL DEV PSYCHOL, V25, P283, DOI 10.1016/j.appdev.2004.04.002; Lamberts KF, 2010, J CLIN EXP NEUROPSYC, V32, P56, DOI 10.1080/13803390902806550; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Levy JA, 2007, J GERIATR PSYCH NEUR, V20, P227, DOI 10.1177/0891988707308806; LEZAK MD, 1982, INT J PSYCHOL, V17, P281, DOI 10.1080/00207598208247445; Limond J, 2014, CLIN NEUROPSYCHOL, V28, P181, DOI 10.1080/13854046.2013.873083; Mateer C A, 1999, Semin Clin Neuropsychiatry, V4, P50; Missiuna C, 2010, PHYS OCCUP THER PEDI, V30, P205, DOI 10.3109/01942631003761554; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Norman DA., 1986, CONSCIOUSNESS SELF R, P1, DOI [10.1007/978-1-4757-0629-1_1, DOI 10.1007/978-1-4757-0629-1_1]; Norris G, 2000, NEUROPSYCHOL REHABIL, V10, P33, DOI 10.1080/096020100389282; Parker D.R., 2009, LEARN DISABIL RES PR, V24, P204, DOI DOI 10.1111/J.1540-5826.2009.00294.X; Pohjasvaara T, 2002, EUR J NEUROL, V9, P269, DOI 10.1046/j.1468-1331.2002.00396.x; Pontifex MB, 2013, J PEDIATR-US, V162, P543, DOI 10.1016/j.jpeds.2012.08.036; Rabbitt P., 1998, METHODOLOGY FRONTAL, P1; Raggi VL, 2006, CLIN CHILD FAM PSYCH, V9, P85, DOI 10.1007/s10567-006-0006-0; Robinson KE, 2014, J PEDIATR PSYCHOL, V39, P846, DOI 10.1093/jpepsy/jsu031; Ross KA, 2011, DEV MED CHILD NEUROL, V53, P692, DOI 10.1111/j.1469-8749.2011.03976.x; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Simpson A, 2012, DEVELOPMENTAL SCI, V15, P62, DOI 10.1111/j.1467-7687.2011.01105.x; Sohlberg M., 2001, COGNITIVE REHABILITA; Sohlberg M.M., 2011, OPTIMIZING COGNITIVE; Spikman JM, 2013, NEUROPSYCHOL REHABIL, V23, P824, DOI 10.1080/09602011.2013.826138; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; Spikman JM, 2000, J CLIN EXP NEUROPSYC, V22, P325, DOI 10.1076/1380-3395(200006)22:3;1-V;FT325; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Stuss DT, 2011, J INT NEUROPSYCH SOC, V17, P759, DOI 10.1017/S1355617711000695; Tate R, 2014, J HEAD TRAUMA REHAB, V29, P338, DOI 10.1097/HTR.0000000000000068; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; VILKKI J, 1994, J CLIN EXP NEUROPSYC, V16, P325, DOI 10.1080/01688639408402643; VONCRAMON DY, 1994, NEUROPSYCHOL REHABIL, V4, P399, DOI 10.1080/09602019408401608; Wade SL, 2011, PEDIATRICS, V128, pE947, DOI 10.1542/peds.2010-3721; Wilson BA, 2009, DEV NEUROREHABIL, V12, P421, DOI 10.3109/17518420903200573; Wood RL, 2006, ARCH CLIN NEUROPSYCH, V21, P429, DOI 10.1016/j.acn.2005.06.014; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009; Ylvisaker M., 1998, TRAUMATIC BRAIN INJU, Vxiv; Ylvisaker M., 1998, COLLABORATIVE BRAIN, Vxii; Ylvisaker M. E., 1998, TRAUMATIC BRAIN INJU	75	1	1	1	1	ROUTLEDGE	ABINGDON	2 PARK SQ, MILTON PARK, ABINGDON OX14 4RN, OXFORD, ENGLAND			978-1-138-64311-6; 978-1-315-62953-7; 978-1-138-64309-3				2017							213	219			10.4324/9781315629537		7	Psychology, Clinical; Clinical Neurology; Psychology; Rehabilitation	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Psychology; Neurosciences & Neurology; Rehabilitation	BO7UU	WOS:000525648500030		Green Submitted			2022-02-06	
B	Laricchiuta, D; Markett, S; Reuter, M; Montag, C		Petrosini, L		Laricchiuta, Daniela; Markett, Sebastian; Reuter, Martin; Montag, Christian			Premorbid Personality Traits and Brain Recovery: Another Aspect of Resilience	NEUROBIOLOGICAL AND PSYCHOLOGICAL ASPECTS OF BRAIN RECOVERY	Contemporary Clinical Neuroscience		English	Article; Book Chapter						Attachment style; Brain damage; Depression; Personality models; Resilience factors; Risk factors; Stroke; Temperamental traits; Traumatic brain injury	UNIFIED BIOSOCIAL THEORY; COGNITIVE RESERVE; POSTSTROKE DEPRESSION; PARKINSONS-DISEASE; ATTACHMENT-STYLE; PSYCHOLOGICAL SYMPTOMS; INJURY SEVERITY; HARM AVOIDANCE; FOLLOW-UP; TEMPERAMENT	The concept of "reserve" is defined as the resources being available to deal with adverse environmental influences on the human brain, and it has been proposed to account for the mismatch between brain pathology and clinical expression. New multidimensional approaches take into account the complexity and dynamic relation between the construct of reserve and post-damage neurobehavioral changes associated with negative consequences of neurological damage on functional outcomes, caregiver distress, and social reintegration following the traumatic event. In this framework, environmental factors, emotional aspects, and premorbid personality traits have increasingly been considered as potential moderators of traumatic brain damage. The present work constitutes a preliminary attempt to define and characterize the role of premorbid personality within the context of resilience against the detrimental effects of traumatic brain damage on adaptive functioning. Premorbid personality features appear to be a relevant factor of resilience that predicts brain recovery efficiency.	[Laricchiuta, Daniela] IRCCS Fdn Santa Lucia, Via Fosso Fiorano 64, I-00143 Rome, Italy; [Laricchiuta, Daniela] Univ Sapienza Rome, Fac Med & Psychol, Dept Dynam & Clin Psychol, Rome, Italy; [Markett, Sebastian; Reuter, Martin] Univ Bonn, Neurogenet Lab, Bonn, Germany; [Markett, Sebastian; Reuter, Martin] Univ Bonn, Dept Psychol, Bonn, Germany; [Markett, Sebastian; Reuter, Martin] Univ Bonn, Ctr Econ & Neurosci, Bonn, Germany; [Montag, Christian] Ulm Univ, Inst Psychol & Educ, Ulm, Germany; [Montag, Christian] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Med Informat Ctr, Key Lab NeuroInformat, Chengdu, Sichuan, Peoples R China		Laricchiuta, D (corresponding author), IRCCS Fdn Santa Lucia, Via Fosso Fiorano 64, I-00143 Rome, Italy.	daniela.laricchiuta@uniroma1.it	Markett, Sebastian/G-6328-2018; Montag, Christian/H-6536-2019	Markett, Sebastian/0000-0002-0841-3163; Montag, Christian/0000-0001-8112-0837			Aben I, 2002, STROKE, V33, P2391, DOI 10.1161/01.STR.0000029826.41672.2E; Afanasiev S, 2013, AM J GERIAT PSYCHIAT, V21, P832, DOI 10.1016/j.jagp.2013.04.012; Ainsworth M. D. S., 1978, PATTERNS ATTACHMENT, DOI 10.1037/t28248-000; Archer N, 2007, AM J GERIAT PSYCHIAT, V15, P202, DOI 10.1097/01.JGP.0000232510.77213.10; Ardelt M, 2000, SOC PSYCHOL QUART, V63, P392, DOI 10.2307/2695848; Arnould A, 2015, BRAIN INJURY, V29, P1597, DOI 10.3109/02699052.2015.1075156; Ayerbe L, 2011, STROKE, V42, P1907, DOI 10.1161/STROKEAHA.110.605808; Benedetti MD, 2000, NEUROLOGY, V55, P1350, DOI 10.1212/WNL.55.9.1350; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bogg T, 2004, PSYCHOL BULL, V130, P887, DOI 10.1037/0033-2909.130.6.887; Bowlby J., 1973, ATTACHMENT LOSS SEPA; Bowlby J, 1969, ATTACHMENT LOSS ATTA; BRYER JB, 1992, J NEUROPSYCH CLIN N, V4, P440; Campbell-Sills L, 2006, BEHAV RES THER, V44, P585, DOI 10.1016/j.brat.2005.05.001; CHATTERJEE A, 1992, ARCH NEUROL-CHICAGO, V49, P486, DOI 10.1001/archneur.1992.00530290070014; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; Cloninger CR, 2006, J AFFECT DISORDERS, V92, P35, DOI 10.1016/j.jad.2005.12.034; Cloninger CR, 1998, J AFFECT DISORDERS, V51, P21, DOI 10.1016/S0165-0327(98)00153-0; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; CLONINGER CR, 1986, PSYCHIAT DEV, V4, P167; CLONINGER CR, 1988, PSYCHIAT DEV, V6, P83; Cowen PJ, 2008, TRENDS PHARMACOL SCI, V29, P433, DOI 10.1016/j.tips.2008.05.004; Davey M, 2003, J ADOLESCENT RES, V18, P347, DOI 10.1177/0743558403018004002; Davis KL, 2011, NEUROSCI BIOBEHAV R, V35, P1946, DOI 10.1016/j.neubiorev.2011.04.004; DeYoung CG, 2010, PSYCHOL SCI, V21, P820, DOI 10.1177/0956797610370159; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; Faul M, 2010, TRAUMATIC BRAIN INJU; FISKE DW, 1949, J ABNORM SOC PSYCH, V44, P329, DOI 10.1037/h0057198; Friborg O, 2005, INT J METH PSYCH RES, V14, P29, DOI 10.1002/mpr.15; Friedman HS, 2000, J PERS, V68, P1089, DOI 10.1111/1467-6494.00127; Gil S, 2006, PSYCHOSOM MED, V68, P904, DOI 10.1097/01.psy.0000242124.21796.f8; GLOSSER G, 1995, MOVEMENT DISORD, V10, P201, DOI 10.1002/mds.870100211; Gould SL, 2004, PSYCHOL REP, V95, P1072, DOI 10.2466/pr0.95.3f.1072-1078; Hackett ML, 2005, STROKE, V36, P1330, DOI 10.1161/01.STR.0000165928.19135.35; Hatcher MB, 2009, BRIT J HEALTH PSYCH, V14, P541, DOI 10.1348/135910708X373445; Hernan MA, 2002, ANN NEUROL, V52, P276, DOI 10.1002/ana.10277; Holst G, 1997, ARCH PSYCHIAT NURS, V11, P147, DOI 10.1016/S0883-9417(97)80038-6; HUBBLE JP, 1993, J NERV MENT DIS, V181, P657, DOI 10.1097/00005053-199311000-00001; Hwang SI, 2011, ANN REHABIL MED-ARM, V35, P328, DOI 10.5535/arm.2011.35.3.328; Ishihara L, 2006, MOVEMENT DISORD, V21, P1066, DOI 10.1002/mds.20980; Jang KL, 1996, J PERS, V64, P577, DOI 10.1111/j.1467-6494.1996.tb00522.x; Jia HG, 2006, STROKE, V37, P2796, DOI 10.1161/01.STR.0000244783.53274.a4; Jumisko E, 2007, DISABIL REHABIL, V29, P1535, DOI 10.1080/09638280601055816; Kaasinen V, 2005, NEUROIMAGE, V24, P315, DOI 10.1016/j.neuroimage.2004.09.017; Kendler KS, 1999, BRIT J PSYCHIAT, V175, P351, DOI 10.1192/bjp.175.4.351; Kendler KS, 2004, AM J PSYCHIAT, V161, P631, DOI 10.1176/appi.ajp.161.4.631; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; Lahey BB, 2009, AM PSYCHOL, V64, P241, DOI 10.1037/a0015309; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Laricchiuta D, 2015, BRAIN STRUCT FUNCT, V220, P2275, DOI 10.1007/s00429-014-0790-0; Laricchiuta D, 2014, HUM BRAIN MAPP, V35, P285, DOI 10.1002/hbm.22174; Laricchiuta D, 2014, BRAIN STRUCT FUNCT, V219, P793, DOI 10.1007/s00429-013-0535-5; Levi Y, 2013, J INT NEUROPSYCH SOC, V19, P664, DOI 10.1017/S1355617713000192; Low LF, 2013, AM J GERIAT PSYCHIAT, V21, P713, DOI 10.1016/j.jagp.2012.08.004; Low LF, 2002, INT J GERIATR PSYCH, V17, P779, DOI 10.1002/gps.697; Lykou E, 2013, ALZ DIS ASSOC DIS, V27, P258, DOI 10.1097/WAD.0b013e31826e5504; Macmillan PJ, 2002, BRAIN INJURY, V16, P41, DOI 10.1080/0269905011008812; Magai C, 1997, INT J GERIATR PSYCH, V12, P1092; Malec JF, 2004, REHABIL PSYCHOL, V49, P55, DOI 10.1037/0090-5550.49.1.55; Mathiesen KS, 2006, EUR J DEV PSYCHOL, V3, P357, DOI 10.1080/17405620600557797; Mathiesen KS, 2000, J ABNORM CHILD PSYCH, V28, P15, DOI 10.1023/A:1005165916906; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; McCrae RR, 2000, J PERS SOC PSYCHOL, V78, P173, DOI 10.1037/0022-3514.78.1.173; MCCRAE RR, 1992, J PERS, V60, P175, DOI 10.1111/j.1467-6494.1992.tb00970.x; Meins W, 1998, Int Psychogeriatr, V10, P369, DOI 10.1017/S1041610298005468; Meins W, 2000, INT J GERIATR PSYCH, V15, P120; Menza M A, 1990, J Neuropsychiatry Clin Neurosci, V2, P282; Mikulincer M, 1998, J PERS SOC PSYCHOL, V75, P420, DOI 10.1037/0022-3514.75.2.420; Mikulincer M, 2009, J PERS SOC PSYCHOL, V97, P615, DOI 10.1037/a0015649; MISCHEL W, 1995, PSYCHOL REV, V102, P246, DOI 10.1037/0033-295X.102.2.246; Montag C, 2014, ADV BIOL; Montag C, 2014, NEUROSCI BIOBEHAV R, V43, P228, DOI 10.1016/j.neubiorev.2014.04.006; Montag C, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00243; Montag C, 2013, REV NEUROSCIENCE, V24, P167, DOI 10.1515/revneuro-2012-0085; Montag C, 2012, CNS NEUROL DISORD-DR, V11, P236, DOI 10.2174/187152712800672382; Nelson LD, 1998, ARCH CLIN NEUROPSYCH, V13, P549, DOI 10.1016/S0887-6177(97)00052-8; Petrosini L, 2016, CEREBELLUM; Petrosini L, 2015, CEREBELLUM, V14, P43, DOI 10.1007/s12311-014-0631-y; Picerni E, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00133; POEWE W, 1990, ADV NEUROL, V53, P339; Poynter B, 2009, PSYCHOSOMATICS, V50, P563, DOI 10.1176/appi.psy.50.6.563; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Prigatano GP, 1999, J HEAD TRAUMA REHAB, V14, P308, DOI 10.1097/00001199-199906000-00009; PRIGATANO GP, 1987, J LEARN DISABIL-US, V20, P603, DOI 10.1177/002221948702001006; Quilty LC, 2010, PSYCHOTHER PSYCHOSOM, V79, P116, DOI 10.1159/000276372; Ragonese P, 2003, NEUROEPIDEMIOLOGY, V22, P297, DOI 10.1159/000071193; Ramasubbu R, 2006, J NEUROPSYCH CLIN N, V18, P96, DOI 10.1176/appi.neuropsych.18.1.96; Rassovsky Y, 2006, J CLIN EXP NEUROPSYC, V28, P581, DOI 10.1080/13803390500434474; Rassovsky Y, 2006, J CLIN EXP NEUROPSYC, V28, P567, DOI 10.1080/13803390500434466; Rickards H, 2006, CURR OPIN PSYCHIATR, V19, P294, DOI 10.1097/01.yco.0000218601.17722.5b; Ropacki MT, 2003, ARCH CLIN NEUROPSYCH, V18, P643, DOI 10.1016/S0887-6177(02)00153-1; Rush BK, 2006, REHABIL PSYCHOL, V51, P257, DOI 10.1037/0090-5550.51.3.257; Santos PM, 2009, BRAIN RES BULL, V80, P327, DOI 10.1016/j.brainresbull.2009.09.007; Satz P, 2011, J CLIN EXP NEUROPSYC, V33, P121, DOI 10.1080/13803395.2010.493151; Schretlen D, 2000, J ABNORM PSYCHOL, V109, P134, DOI 10.1037/0021-843X.109.1.134; Sela-Kaufman M, 2013, J CLIN EXP NEUROPSYC, V35, P584, DOI 10.1080/13803395.2013.799123; Soldz S, 1999, J RES PERS, V33, P208, DOI 10.1006/jrpe.1999.2243; Sollberger M, 2009, NEUROPSYCHOLOGIA, V47, P2812, DOI 10.1016/j.neuropsychologia.2009.06.006; Solomon Z, 2008, PSYCHOL MED, V38, P1427, DOI 10.1017/S0033291708002808; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stern Y, 2006, ALZ DIS ASSOC DIS, V20, P112, DOI 10.1097/01.wad.0000213815.20177.19; Storor DL, 2006, INT PSYCHOGERIATR, V18, P457, DOI 10.1017/S1041610206003188; Strauss ME, 1997, ARCH NEUROL-CHICAGO, V54, P257, DOI 10.1001/archneur.1997.00550150021010; Svanberg OG., 1998, J MENTAL HLTH, V7, P543, DOI DOI 10.1080/09638239817716; Tate RL, 2003, NEUROPSYCHOL REHABIL, V13, P43, DOI 10.1080/09602010244000372; Tate RL, 1999, PSYCHOL MED, V29, P713, DOI 10.1017/S0033291799008466; Tsai SJ, 2003, NEUROPSYCHOBIOLOGY, V48, P68, DOI 10.1159/000072879; von Gunten A, 2009, BRAIN RES BULL, V80, P179, DOI 10.1016/j.brainresbull.2009.07.004; WELLEFORD EA, 1995, EXP AGING RES, V21, P295, DOI 10.1080/03610739508253986; Whittle S, 2006, NEUROSCI BIOBEHAV R, V30, P511, DOI 10.1016/j.neubiorev.2005.09.003; Wilson RS, 2008, ARCH GEN PSYCHIAT, V65, P439, DOI 10.1001/archpsyc.65.4.439; Wilson RS, 2004, J NEUROL NEUROSUR PS, V75, P191; Yamasue H, 2008, CEREB CORTEX, V18, P46, DOI 10.1093/cercor/bhm030; Zasler ND, 2013, PHYS MED REH CLIN N, V24, P445, DOI 10.1016/j.pmr.2013.03.009	115	1	1	0	1	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND			978-3-319-52067-4; 978-3-319-52065-0	CONTEMP CLIN NEUROSC			2017							269	283		10.1007/978-3-319-52067-4_14	10.1007/978-3-319-52067-4		15	Neurosciences; Psychology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Psychology	BM1WY	WOS:000460665900015					2022-02-06	
J	Lintern, TO; Nash, MP; Kelly, P; Bloomfield, FH; Taberner, AJ; Nielsen, PMF				Lintern, T. O.; Nash, M. P.; Kelly, P.; Bloomfield, F. H.; Taberner, A. J.; Nielsen, P. M. F.			Probabilistic description of infant head kinematics in abusive head trauma	COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING			English	Article						Abusive head trauma; rigid-body computational modelling; head kinematics; probabilistic modelling	SHAKEN-BABY SYNDROME; OPERATIONAL CASE-DEFINITION; DIFFUSE AXONAL INJURY; OPEN-SOURCE SOFTWARE; CERVICAL-SPINE; CEREBRAL CONCUSSION; CHILD-ABUSE; BIOMECHANICS; SHAKING; MODEL	Abusive head trauma (AHT) is a potentially fatal result of child abuse, but the mechanisms by which injury occur are often unclear. To investigate the contention that shaking alone can elicit the injuries observed, effective computational models are necessary. The aim of this study was to develop a probabilistic model describing infant head kinematics in AHT. A deterministic model incorporating an infant's mechanical properties, subjected to different shaking motions, was developed in OpenSim. A Monte Carlo analysis was used to simulate the range of infant kinematics produced as a result of varying both the mechanical properties and the type of shaking motions. By excluding physically unrealistic shaking motions, worst-case shaking scenarios were simulated and compared to existing injury criteria for a newborn, a 4.5month-old, and a 12month-old infant. In none of the three cases were head kinematics observed to exceed previously-estimated subdural haemorrhage injury thresholds. The results of this study provide no biomechanical evidence to demonstrate how shaking by a human alone can cause the injuries observed in AHT, suggesting either that additional factors, such as impact, are required, or that the current estimates of injury thresholds are incorrect.	[Lintern, T. O.; Nash, M. P.; Taberner, A. J.; Nielsen, P. M. F.] Univ Auckland, Auckland Bioengn Inst, Auckland, New Zealand; [Nash, M. P.; Taberner, A. J.; Nielsen, P. M. F.] Univ Auckland, Dept Engn Sci, Auckland, New Zealand; [Kelly, P.] Starship Childrens Hosp, Te Puaruruhau Child Abuse Assessment Unit, Auckland, New Zealand; [Bloomfield, F. H.] Univ Auckland, Liggins Inst, Auckland, New Zealand		Nash, MP (corresponding author), Univ Auckland, Auckland Bioengn Inst, Auckland, New Zealand.; Nash, MP (corresponding author), Univ Auckland, Dept Engn Sci, Auckland, New Zealand.	martyn.nash@auckland.ac.nz	Nash, Martyn P/F-6982-2012	Nash, Martyn P/0000-0002-6466-4936; Taberner, Andrew/0000-0002-0452-0308; Kelly, Patrick/0000-0002-8813-8877	CureKids New Zealand; Health Research Council of New Zealand Maori Health Doctoral scholarship	We would like to acknowledge the support of CureKids New Zealand, the Health Research Council of New Zealand Maori Health Doctoral scholarship (T.O. Lintern), Dr. Metcalfe from Starship Children's Health, Auckland, New Zealand for providing the anatomical images of infants, and Associate Professor Brittany Coats from the University of Utah for sharing results from experimental studies on shaking of surrogates.	Adamsbaum C, 2010, PEDIATRICS, V126, P546, DOI 10.1542/peds.2009-3647; AMIS AA, 1980, J BIOMECH, V13, P825, DOI 10.1016/0021-9290(80)90170-0; Bondy M, 2014, COMPUT METHOD BIOMEC, V17, P149, DOI 10.1080/10255842.2012.672563; Coats B, 2008, J NEUROSURG-PEDIATR, V2, P321, DOI 10.3171/PED.2008.2.11.321; Cory CZ, 2003, MED SCI LAW, V43, P317, DOI 10.1258/rsmmsl.43.4.317; Delp SL, 2007, IEEE T BIO-MED ENG, V54, P1940, DOI 10.1109/TBME.2007.901024; Dibb AT, 2014, TRAFFIC INJ PREV, V15, P386, DOI 10.1080/15389588.2013.824568; Dibb AT, 2011, PEDIAT HEAD NECK DYN; DOBBING J, 1973, ARCH DIS CHILD, V48, P757, DOI 10.1136/adc.48.10.757; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Esernio-Jenssen D, 2011, PEDIATRICS, V127, P649, DOI 10.1542/peds.2010-1770; Geddes J F, 2004, Pediatr Rehabil, V7, P261, DOI 10.1080/13638490412331280435; Geddes JF, 2003, NEUROPATH APPL NEURO, V29, P14, DOI 10.1046/j.1365-2990.2003.00434.x; GEDDES JF, 2001, I PATTERNS OF BRAIN, V124, P1290; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Haldar A., 2000, PROBABILITY RELIABIL; Harding B, 2004, BMJ-BRIT MED J, V328, P720, DOI 10.1136/bmj.328.7442.720; Holbourn AHS, 1943, LANCET, V2, P438; Holzbaur KRS, 2007, J BIOMECH, V40, P742, DOI 10.1016/j.jbiomech.2006.11.011; Holzbaur KRS, 2007, J BIOMECH, V40, P2442, DOI 10.1016/j.jbiomech.2006.11.013; Holzbaur KRS, 2005, ANN BIOMED ENG, V33, P829, DOI 10.1007/s10439-005-3320-7; HORTOBAGYI T, 1990, EUR J APPL PHYSIOL, V60, P395, DOI 10.1007/BF00713506; HUNT KH, 1975, J APPL MECH-T ASME, V42, P440, DOI 10.1115/1.3423596; Jun OY, 2005, SPINE, V30, pE716, DOI 10.1097/01.brs.0000192280.53831.70; Laz PJ, 2010, P I MECH ENG H, V224, P927, DOI 10.1243/09544119JEIM739; Lintern TO, 2015, J BIOMECH, V48, P3123, DOI 10.1016/j.jbiomech.2015.07.016; Loyd Andre M, 2010, Stapp Car Crash J, V54, P167; Luck J. F., 2012, BIOMECHANICS PERINAT; Luck JF, 2013, SPINE, V38, pE1, DOI 10.1097/BRS.0b013e3182793873; Luck JF, 2008, STAPP CAR C, V52, P107; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; Nightingale RW, 2002, J BIOMECH, V35, P725, DOI 10.1016/S0021-9290(02)00037-4; NIGHTINGALE RW, 1998, ANNU PROC ASSOC ADV, V42, P153; Nuckley DJ, 2006, J BIOMECH, V39, P3045, DOI 10.1016/j.jbiomech.2005.10.014; Nuckley DJ, 2005, J BIOMECH, V38, P2266, DOI 10.1016/j.jbiomech.2004.09.021; Ommaya A.K., 1968, JAMA-J AM MED ASSOC, V204, P75; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Parks S, 2012, INJURY PREV, V18, P392, DOI 10.1136/injuryprev-2011-040234; Parks SE, 2012, INJURY PREV, V18, P193, DOI 10.1136/injuryprev-2011-040128; Pierce MC, 2008, ANNU REV BIOMED ENG, V10, P85, DOI 10.1146/annurev.bioeng.9.060906.151907; Prange MT, 2003, J NEUROSURG, V99, P143, DOI 10.3171/jns.2003.99.1.0143; Punt J, 2004, Pediatr Rehabil, V7, P173, DOI 10.1080/13638490410001711515; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; Saltelli A, 2004, SENSITIVITY ANAL PRA; Sherman MA, 2011, PROC IUTAM, V2, P241, DOI 10.1016/j.piutam.2011.04.023; Smith C, 2008, DEV MED CHILD NEUROL, V50, P6, DOI 10.1111/j.1469-8749.2007.00006.x; Squier W, 2008, DEV MED CHILD NEUROL, V50, P10, DOI 10.1111/j.1469-8749.2007.02004.x; Steele KM, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00105; The World Health Organistation, 2006, BIRTH 24 MONTHS BOYS; Thibault KL, 1998, J BIOMECH, V31, P1119, DOI 10.1016/S0021-9290(98)00122-5; Tsai A, 2012, J BIOMECH, V45, P1861, DOI 10.1016/j.jbiomech.2012.05.049; WESTING SH, 1988, EUR J APPL PHYSIOL O, V58, P100, DOI 10.1007/BF00636611; Wolfson DR, 2005, P I MECH ENG H, V219, P63, DOI 10.1243/095441105X9237	55	1	1	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1025-5842	1476-8259		COMPUT METHOD BIOMEC	Comput. Methods Biomech. Biomed. Eng.		2017	20	16					1633	1642		10.1080/10255842.2017.1403593			10	Computer Science, Interdisciplinary Applications; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Computer Science; Engineering	FP4GR	WOS:000417575600001	29160091				2022-02-06	
J	Lucke-Wold, BP; Phillips, M; Turner, RC; Logsdon, AF; Smith, KE; Huber, JD; Rosen, CL; Regele, JD				Lucke-Wold, Brandon P.; Phillips, Michael; Turner, Ryan C.; Logsdon, Aric F.; Smith, Kelly E.; Huber, Jason D.; Rosen, Charles L.; Regele, Jonathan D.			Elucidating the role of compression waves and impact duration for generating mild traumatic brain injury in rats	BRAIN INJURY			English	Article						Finite volume modelling; compression wave; traumatic brain injury; apoptosis; pre-clinical model	MODEL; ENCEPHALOPATHY; STRESS; SLEEP	Background: In total, 3.8 million concussions occur each year in the US leading to acute functional deficits, but the underlying histopathologic changes that occur are relatively unknown. In order to improve understanding of acute injury mechanisms, appropriately designed pre-clinical models must be utilized. Methods:The clinical relevance of compression wave injury models revolves around the ability to produce consistent histopathologic deficits. Mild traumatic brain injuries activate similar neuroinflammatory cascades, cell death markers and increases in amyloid precursor protein in both humans and rodents. Humans, however, infrequently succumb to mild traumatic brain injuries and, therefore, the intensity and magnitude of impacts must be inferred. Understanding compression wave properties and mechanical loading could help link the histopathologic deficits seen in rodents to what might be happening in human brains following concussions. Results: While the concept of linking duration and intensity of impact to subsequent histopathologic deficits makes sense, numerical modelling of compression waves has not been performed in this context. In this interdisciplinary work, numerical simulations were performed to study the creation of compression waves in an experimental model. Conclusion: This work was conducted in conjunction with a repetitive compression wave injury paradigm in rats in order to better understand how the wave generation correlates with histopathologic deficits.	[Lucke-Wold, Brandon P.; Turner, Ryan C.; Rosen, Charles L.] West Virginia Univ, Dept Neurosurg, Morgantown, WV 26506 USA; [Lucke-Wold, Brandon P.; Logsdon, Aric F.; Smith, Kelly E.] West Virginia Univ, Sch Med, Ctr Neurosci, Morgantown, WV 26506 USA; [Phillips, Michael; Regele, Jonathan D.] Iowa State Univ, Coll Engn, Dept Aerosp Engn, Ames, IA USA; [Logsdon, Aric F.; Smith, Kelly E.; Huber, Jason D.] West Virginia Univ, Sch Pharm, Dept Pharmaceut Sci, Morgantown, WV 26506 USA		Turner, RC (corresponding author), Hlth Sci Ctr, Dept Neurosurg, Suite 4300,POB 9183, Morgantown, WV 26506 USA.	rcturner@hsc.wvu.edu	Lucke-Wold, Brandon/AAW-1881-2021; Lucke-Wold, Brandon/AAW-3525-2021	Lucke-Wold, Brandon/0000-0001-6577-4080; Turner, Ryan/0000-0001-5523-0645	Neurosurgery Research and Education Foundation Medical Student Summer Fellowship; American Medical Association Foundation Seed Grant; Sigma Xi; American Foundation of Pharmaceutical Education Pre-doctoral Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U54GM104942] Funding Source: NIH RePORTER	A Neurosurgery Research and Education Foundation Medical Student Summer Fellowship, an American Medical Association Foundation Seed Grant, a Sigma Xi Grants-in-Aid of Research and an American Foundation of Pharmaceutical Education Pre-doctoral Fellowship supported Brandon Lucke-Wold. The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.	Ammari H, 2010, P C MATH MATH PHYS F, P365; Bailes Julian E, 2015, Neurosurgery, V62 Suppl 1, P15, DOI 10.1227/NEU.0000000000000811; Banks SJ, 2014, J NEUROPSYCH CLIN N, V26, P44, DOI 10.1176/appi.neuropsych.12070185; Boulet T, 2011, J NEUROSCI METH, V201, P296, DOI 10.1016/j.jneumeth.2011.08.019; Celander H., 1955, FORKRISTEN JUL ENLIG, P91; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Ganpule S, 2013, BIOMECH MODEL MECHAN, V12, P511, DOI 10.1007/s10237-012-0421-8; Gupta RK, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00059; Hua Y, 2015, COMPUT MATH METHOD M, V2015, DOI 10.1155/2015/928236; Huang H, 2008, SPE J, V13, P112, DOI 10.2118/102715-PA; Jean A, 2014, P NATL ACAD SCI USA, V111, P15310, DOI 10.1073/pnas.1415743111; Logsdon AF, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00421; Lucke-Wold BP, 2015, SEIZURE-EUR J EPILEP, V33, P13, DOI 10.1016/j.seizure.2015.10.002; Lucke-Wold BP, 2015, TRANSL RES, V166, P509, DOI 10.1016/j.trsl.2015.08.005; Lucke-Wold BP, 2015, MOL NEUROBIOL, V52, P1119, DOI 10.1007/s12035-014-8902-7; Lucke-Wold BP, 2015, NEUROSCI BIOBEHAV R, V55, P68, DOI 10.1016/j.neubiorev.2015.04.010; Lucke-Wold BP, 2014, J NEUROTRAUM, V31, P1129, DOI 10.1089/neu.2013.3303; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Needham CE, 2010, SHOCK WAVE HIGH PRES, P1, DOI 10.1007/978-3-642-05288-0; Panzer Matthew B, 2012, Front Neurol, V3, P46, DOI 10.3389/fneur.2012.00046; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Su E, 2016, TRANSLATIONAL RES TR; Tompkins P, 2013, J NEUROTRAUM, V30, P1888, DOI 10.1089/neu.2012.2674; Turner RC, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00222; Turner RC, 2013, EXP NEUROL, V248, P520, DOI 10.1016/j.expneurol.2013.07.008; Wasserman L, 2008, BRAIN INJURY, V22, P811, DOI 10.1080/02699050802372166; Weiss JM, 1999, AIAA J, V37, P29, DOI 10.2514/2.689	29	1	1	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	1					98	105		10.1080/02699052.2016.1218547			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EJ5KT	WOS:000393257600013	27880054	Green Accepted			2022-02-06	
J	Marya, J; Dhirawani, RB; Dube, G; Pathak, S; Dausage, P; Sethi, JK				Marya, Jayant; Dhirawani, Rajesh B.; Dube, Gunjan; Pathak, Sanyog; Dausage, Priyanka; Sethi, Jasveen Kaur			Impact of compulsory helmet legislation on mortality rate and types of head and facial injuries in Jabalpur	JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY MEDICINE AND PATHOLOGY			English	Article						Head and facial injuries; Compulsory helmet law; Jabalpur; Motorized two-wheeler; Road traffic accidents	MOTORCYCLE CRASHES; PATTERNS; DRIVERS; RIDERS; INDIA; HOSPITALIZATION; ACCIDENTS; BEHAVIOR; DEATHS; COSTS	Background: Motorized two-wheeler users make up a high proportion of overall traffic injuries and deaths, particularly in India. Injuries to the head and neck are the main cause of death and severe disability among them. The objective of this study was to quantify the impact of compulsory helmet law imposed in Jabalpur city, for those driving two-wheelers, in reducing mortality, and head and facial injuries including the types of injuries often seen in road traffic accidents. Materials and methods: People of all ages involved in motorcycle-moped-scooter accidents who reported to emergency department of eight major hospitals and trauma centers of Jabalpur city or were brought in dead to these hospitals during the eight months before and after helmet legislation were included in this study. The data were compiled into overall deaths and types of head and facial injuries noted in these hospitals before and after helmet legislation. Results: Highly significant reduction in contused lacerated wounds of the scalp and face, upper and middle 1/3 facial fractures and head and traumatic brain injuries was noted in motorized two-wheeler accidents since September 2014 after compulsory helmet legislation. A significant reduction was also observed in cranial vault fractures with no significant reduction in lower 1/3 facial fractures and mortality rate after helmet law. Conclusion: It has been confirmed through this study that mandatory use of helmets, with compulsory helmet law, is an effective measure for reducing soft tissue, head, brain and upper and middle 1/3 facial injuries in motorized two-wheeler accidents. (C) 2016 Asian AOMS, ASOMP, JSOP, JSOMS, JSOM, and JAMI. Published by Elsevier Ltd. All rights reserved.	[Marya, Jayant; Dhirawani, Rajesh B.; Dube, Gunjan; Pathak, Sanyog] Hitkarini Dent Coll & Hosp, Dept Oral & Maxillofacial Surg, Jabalpur, MP, India; [Dausage, Priyanka] Hitkarini Dent Coll & Hosp, Dept Pedodont & Prevent Dent, Jabalpur, MP, India; [Sethi, Jasveen Kaur] Hitkarini Dent Coll & Hosp, Dept Conservat Dent, Jabalpur, MP, India		Marya, J (corresponding author), Hitkarini Dent Coll & Hosp, Dept Oral & Maxillofacial Surg, Jabalpur, MP, India.	marya_jayant@yahoo.com; rajeshdhirawani@hotmail.com; gunjandube@rediffmail.com; pathak_sanyog@yahoo.com; pdausage@yahoo.co.in; jasveensethikaur@gmail.com					[Anonymous], 2001, MOT SAF HELM COST 32; Banerjee K K, 1998, Indian J Med Sci, V52, P395; BEGG DJ, 1994, ACCIDENT ANAL PREV, V26, P157, DOI 10.1016/0001-4575(94)90085-X; Blincoe L, 2000, 809446 DOT HS NAT HI; Branas CC, 2000, ACCID ANAL PREV; DALL G, 1983, S AFR MED J, V64, P161; Dandona R, 2006, J SAFETY RES, V37, P149, DOI 10.1016/j.jsr.2005.11.002; Fitzharris M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-11; Gopalakrishna G, 1998, ANN EMERG MED, V32, P425, DOI 10.1016/S0196-0644(98)70170-2; HOLUBOWYCZ OT, 1995, J STUD ALCOHOL, V56, P513, DOI 10.15288/jsa.1995.56.513; JOHNSON RM, 1995, J TRAUMA, V38, P876, DOI 10.1097/00005373-199506000-00008; KRAUS JF, 1988, B NEW YORK ACAD MED, V64, P788; KRAUS JF, 1991, AM J PUBLIC HEALTH, V81, P172, DOI 10.2105/AJPH.81.2.172; Lin MR, 2001, J TRAUMA, V50, P24, DOI 10.1097/00005373-200101000-00004; Liu B, 2005, COCHRANE DATABASE SY; McSwain NE, 1990, J TRAUMA; MOHAN Dinesh, 2002, J TRANSPORT INFRASTR, V9, P79; Murray C., 1996, GLOBAL BURDEN DIS; National Crimes Record Bureau, 2006, ACC DEATHS SUIC IND; Peden M., 2004, WORLD REPORT ROAD TR; PLASENCIA A, 1995, ACCIDENT ANAL PREV, V27, P591, DOI 10.1016/0001-4575(95)00007-M; Rowland J, 1996, AM J PUBLIC HEALTH, V86, P41, DOI 10.2105/AJPH.86.1.41; Senelick RC, HEAD INJURIES WHY MO; Servadei F, 2003, INJURY PREV, P9; SHANKAR BS, 1992, ACCIDENT ANAL PREV, V24, P385, DOI 10.1016/0001-4575(92)90051-J; Sharma Rahul, 2007, Indian J Med Sci, V61, P656; SOOD S, 1988, J TRAUMA, V28, P530, DOI 10.1097/00005373-198804000-00021; SOSIN DM, 1990, JAMA-J AM MED ASSOC, V264, P2395, DOI 10.1001/jama.264.18.2395; Sreedharan Jayadevan, 2010, J Inj Violence Res, V2, P49, DOI 10.5249/jivr.v2i1.26; Suriyawongpaisal Paibul, 2003, Inj Control Saf Promot, V10, P95, DOI 10.1076/icsp.10.1.95.14110; TAGGI F, 1988, LANCET, V1, P182; Toroyan T, 2007, YOUTH ROAD SAFETY; Umar R., 2002, P 2 WORLD ENG C; WANG YC, 1995, CHINESE MED J, V55, P50	34	1	1	1	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	2212-5558	2212-5566		J ORAL MAX SURG MED	J. Oral Maxillofac. Surg. Med. Pathol.	JAN	2017	29	1					24	28		10.1016/j.ajoms.2016.08.008			5	Dentistry, Oral Surgery & Medicine	Emerging Sources Citation Index (ESCI)	Dentistry, Oral Surgery & Medicine	EO0GE	WOS:000396375500005					2022-02-06	
J	Mateo, J; Payen, D; Ghout, I; Vallee, F; Lescot, T; Welschbillig, S; Tazarourte, K; Azouvi, P; Weiss, JJ; Aegerter, P; Vigue, B				Mateo, Joaquim; Payen, Didier; Ghout, Idir; Vallee, Fabrice; Lescot, Thomas; Welschbillig, Stephane; Tazarourte, Karim; Azouvi, Philippe; Weiss, Jean-Jacques; Aegerter, Philippe; Vigue, Bernard			Impact of extended monitoring-guided intensive care on outcome after severe traumatic brain injury: A prospective multicentre cohort study (PariS-TBI study)	BRAIN INJURY			English	Article						Multimodal monitoring; outcome; traumatic brain injury	CEREBRAL PERFUSION-PRESSURE; JUGULAR VENOUS OXIMETRY; INTRACRANIAL-PRESSURE; NEUROCRITICAL CARE; CLINICAL-TRIALS; HEAD-INJURY; HYPERTENSION; OXYGENATION; FUTURE	Objective: We evaluated whether an integrated monitoring with systemic and specific monitoring affect mortality and disability in adults with severe traumatic brain injury (sTBI).Methods: Adults with severeTBI (Glasgow Coma Scale [GCS] 8) admitted alive in intensive care units (ICUs) were prospectively included. Primary endpoints were in-hospital 30-day mortality and extended Glasgow outcome score (GOSE) at 3 years. Association with the intensity of monitoring and outcome was studied by comparing a high level of monitoring (HLM) (systemic and 3 specific monitoring) and low level of monitoring (LLM) (systemic and 0-2 specific monitoring) and using inverse probability weighting procedure.Results: 476 patients were included and IPW was used to improve the balance between the two groups of treatments (HLM/LMM). Overall hospital mortality (at 30 days) was 43%, being significantly lower in HLM than LLM group (27% vs. 53%: RR, 1.63: 95% CI: 1.23-2.15). The 14-day hospital mortality was also lower in the HLM group than expected, based upon the CRASH prediction model (35%). At 3 years, disability was not significantly different between the monitoring groups.Conclusions: After adjustment, HLM group improved short-term mortality but did not show any improvement in the 3-year outcome compared with LLM.	[Mateo, Joaquim; Payen, Didier; Vallee, Fabrice; Welschbillig, Stephane] Univ Paris 7 Diderot, Lariboisiere Univ Hosp, AP HP, Dept Anesthesiol & Crit Care, Paris, France; [Ghout, Idir] Hop Ambroise Pare, AP HP, Unite Rech Clin Paris Ouest, Boulogne, France; [Lescot, Thomas] Univ Paris 06, Pitie Salpetriere Univ Hosp, AP HP, Dept Anesthesiol & Crit Care, Paris, France; [Tazarourte, Karim] Marc Jacquet Hosp, Mobile Care Unit, SAMU 77, Melun, France; [Azouvi, Philippe] Hop Raymond Poincare, AP HP, Dept Phys Med & Rehabil, Garches, France; [Weiss, Jean-Jacques] Ctr Ressources Francilien Traumatisme Cranien, Dept Publ Hlth, Paris, France; [Aegerter, Philippe] Univ Versailles St Quentin, INSERM, UMR S 1168, Paris, France; [Vigue, Bernard] Univ Paris Sud, Bicetre Univ Hosp, AP HP, Dept Anesthesiol & Intens Care, Le Kremlin Bicetre, France		Mateo, J (corresponding author), Hop Lariboisiere, Dept Anesthesie Reanimat, 2 Rue Ambroise Pare, F-75010 Paris, France.	joaquim.mateo@lrb.aphp.fr	AEGERTER, Philippe/AAY-6003-2021	AEGERTER, Philippe/0000-0002-9156-5028; tazarourte, karim/0000-0002-3376-1258	French Ministry of Health (Programme Hospitalier de Recherche Clinique) - AP-HP (Departement de la Recherche Clinique et du Developement) [AOM04084]; Unite de Recherche Clinique Paris-Ouest; French Ministry of Health	This study was funded by a grant from the French Ministry of Health (Programme Hospitalier de Recherche Clinique 2004, AOM04084), sponsored by AP-HP (Departement de la Recherche Clinique et du Developement), and carried out with the support of Unite de Recherche Clinique Paris-Ouest. The sponsor of the study (French Ministry of Health) had no role in the data collection, data analysis, data interpretation, or writing of the report. All the authors had full access to all data and assumed final responsibility for the decision to submit the paper for publication.	ANDREWS PJD, 1993, ANESTH ANALG, V76, P460; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; BISHOP CCR, 1986, STROKE, V17, P913, DOI 10.1161/01.STR.17.5.913; Boer C, 2012, CURR OPIN ANESTHESIO, V25, P556, DOI 10.1097/ACO.0b013e328357225c; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS87; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS55; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS71; Citerio G, 2008, INTENS CARE MED, V34, P1173, DOI 10.1007/s00134-008-1080-1; Clifton GL, 2001, J NEUROSURG, V95, P751, DOI 10.3171/jns.2001.95.5.0751; Cole SR, 2004, COMPUT METH PROG BIO, V75, P45, DOI 10.1016/j.cmpb.2003.10.004; Coles JP, 2007, CRIT CARE MED, V35, P568, DOI 10.1097/01.CCM.0000254066.37187.88; Czosnyka M, 1998, J NEUROSURG, V88, P802, DOI 10.3171/jns.1998.88.5.0802; Doppenberg EMR, 2004, J NEUROSURG ANESTH, V16, P87, DOI 10.1097/00008506-200401000-00019; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Farahvar A, 2011, J NEUROSURG, V114, P1471, DOI 10.3171/2010.11.JNS101116; Farahvar A, 2011, CURR OPIN ANESTHESIO, V24, P209, DOI 10.1097/ACO.0b013e328344016d; Gupta AK, 1999, ANESTH ANALG, V88, P549, DOI 10.1097/00000539-199903000-00016; Hemphill JC, 2011, NAT REV NEUROL, V7, P451, DOI 10.1038/nrneurol.2011.101; Kelly DF, 1996, J NEUROSURG, V85, P762, DOI 10.3171/jns.1996.85.5.0762; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; Martini RP, 2009, J NEUROSURG, V111, P644, DOI 10.3171/2009.2.JNS08998; Mauritz W, 2008, INTENS CARE MED, V34, P1208, DOI 10.1007/s00134-008-1079-7; Mulvey JM, 2004, NEUROCRIT CARE, V1, P391, DOI 10.1385/NCC:1:3:391; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perez Augusto, 2003, Pediatr Crit Care Med, V4, P33; Plaisance P, 1999, NEW ENGL J MED, V341, P569, DOI 10.1056/NEJM199908193410804; Robins J.M., 1998, 1997 P AM STAT ASS S, P1, DOI DOI 10.1097/EDE.0B013E318245847E; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Shakur H, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-109; Smith M, 2008, ANESTH ANALG, V106, P240, DOI 10.1213/01.ane.0000297296.52006.8e; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Stocchetti N, 2004, INTENS CARE MED, V30, P517, DOI 10.1007/s00134-003-2142-z; Stocchetti N, 2009, ANESTH ANALG, V109, P1726, DOI 10.1213/ANE.0b013e3181bdca25; Stover JF, 2006, CRIT CARE MED, V34, P1582, DOI 10.1097/01.CCM.0000216697.37348.FC; Stover JF, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13245; Tisdall MM, 2007, BRIT J ANAESTH, V99, P61, DOI 10.1093/bja/aem143; van Buuren S, 2011, J STAT SOFTW, V45, P1; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; White H, 2002, CAN J ANAESTH, V49, P623, DOI 10.1007/BF03017393; White H, 2008, ANESTH ANALG, V107, P979, DOI 10.1213/ane.0b013e31817e7b1a	41	1	1	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	12					1642	1650		10.1080/02699052.2017.1370554			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FN4KB	WOS:000415973200011	28925746				2022-02-06	
J	Matsuda, S; Yoshimura, H; Hamano, T; Sano, K				Matsuda, Shinpei; Yoshimura, Hitoshi; Hamano, Tadanori; Sano, Kazuo			Post-Traumatic Trigeminal Neuropathy Caused by an Orbital Stab Wound	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Needle electromyography; occlusal abnormalities; orbital stab wound; trigeminal neuropathy	MOTOR NEUROPATHY; MUSCLE ATROPHY; NERVE; EXERCISE	Sensory and motor neuropathy of the trigeminal nerve due to trauma is quite rare. Furthermore, there have been no detailed reports on occlusal abnormalities and trismus associated with post-traumatic trigeminal motor neuropathy. Here, the authors report a case of trigeminal motor neuropathy and trigeminal sensory neuropathy in all 3 divisions caused by an orbital stab wound. During kendo practice, a 61-year-old man was injured in his right medial canthus with the splinter of a broken bamboo sword. Imaging examinations did not show a brain injury or orbital bone fracture. Intraoral and extraoral examination and needle electromyography revealed trismus, posterior open bite, and denervation of the right masseter. After the injury, the patient strived to use the right molars during mastication and began chewing exercises in the right molar region. A follow-up examination 7 months after the injury revealed an improvement of the functional problems in the masticatory system. Although slight facial numbness in the right ophthalmic division remained, the patient was satisfied with the present status. Further knowledge concerning the natural history of trigeminal neuropathy as well as the treatment of choice should be explored in the future.	[Matsuda, Shinpei; Yoshimura, Hitoshi; Sano, Kazuo] Univ Fukui, Dept Sensory & Locomotor Med, Div Dent & Oral Surg, Fukui, Japan; [Hamano, Tadanori] Univ Fukui, Dept Internal Med 2, Fac Med Sci, Fukui, Japan			wantahappylife@live.jp					Bathla G, 2013, CLIN RADIOL, V68, P203, DOI 10.1016/j.crad.2012.05.019; Hurst JE, 2003, J APPL PHYSIOL, V95, P1405, DOI 10.1152/japplphysiol.00516.2002; JEFFERSON G, 1955, BRIT J SURG, V42, P561, DOI 10.1002/bjs.18004217602; Kawahara Y, 2008, J PHYS THER SCI, V20, P39, DOI 10.1589/jpts.20.39; KO KF, 1995, CLIN NEUROL NEUROSUR, V97, P199, DOI 10.1016/0303-8467(95)00027-H; NEMETH PM, 1982, MUSCLE NERVE, V5, P134, DOI 10.1002/mus.880050210; Ratilal B, 2006, SURG NEUROL, V66, P200, DOI 10.1016/j.surneu.2005.11.030; Wilson MH, 2016, BRIT J ORAL MAX SURG, V54, pE13, DOI 10.1016/j.bjoms.2015.08.265; Yanamadala V, 2012, J CLIN NEUROSCI, V19, P585, DOI 10.1016/j.jocn.2011.09.007	9	1	1	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	JAN	2017	28	1					E28	E30		10.1097/SCS.0000000000003175			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	EI2EJ	WOS:000392299200087	27875513				2022-02-06	
J	McCulloch, KL; Cecchini, AS; Radomski, MV; Scherer, MR; Smith, L; Cleveland, C; McMillan, HP; Davidson, LF; Weightman, MM				McCulloch, Karen L.; Cecchini, Amy S.; Radomski, Mary V.; Scherer, Matthew R.; Smith, Laurel; Cleveland, Caroline; McMillan, Henry P.; Davidson, Leslie F.; Weightman, Margaret M.			Military-Civilian Collaborations for mTBI Rehabilitation Research in an Active Duty Population: Lessons Learned From the Assessment of Military Multitasking Performance Project	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						active duty military; mTBI; project administration; research planning	TRAUMATIC BRAIN-INJURY; SERVICE MEMBERS; RECOMMENDATIONS; CULTURE; THERAPY; RETURN	This article describes lessons learned in the planning, development, and administration of a collaborative military-civilian research project, the Assessment of Military Multitasking Performance, which was designed to address a gap in clinical assessment for active duty service members with mild traumatic brain injury who wish to return to active duty. Our team worked over the course of multiple years to develop an assessment for military therapists to address this need. Insights gained through trial and error are shared to provide guidance for civilian researchers who may wish to collaborate with active duty researchers.	[McCulloch, Karen L.; Cleveland, Caroline] Univ North Carolina Chapel Hill, Div Phys Therapy, Dept Allied Hlth Sci, Sch Med, Chapel Hill, NC USA; [Cecchini, Amy S.] Def & Vet Brain Injury Ctr, Ft Bragg, NC USA; [Radomski, Mary V.; Weightman, Margaret M.] Allina Hlth, Courage Kenny Res Ctr, Minneapolis, MN USA; [Scherer, Matthew R.] US Army, Med Res & Mat Command, Clin & Rehabilitat Med Res Program, Ft Detrick, MD USA; [Smith, Laurel] US Army, Res Inst Environm Med, Natick, MA USA; [McMillan, Henry P.] Womack Army Med Ctr, Ft Bragg, NC USA; [Davidson, Leslie F.] George Washington Univ, Dept Clin Res & Leadership, Sch Med & Hlth Sci, Washington, DC USA		McCulloch, KL (corresponding author), Univ North Carolina Chapel Hill, Dept Allied Hlth Sci, Sch Med, Phys Therapy, 321 S Columbia St,Bondurant Hall,Ste 3024, Chapel Hill, NC 27599 USA.	kmac@med.unc.edu					[Anonymous], MIL CULT COR COMP HL; [Anonymous], 2015, C DIR MED RES PROGR; Blanton S, 2006, PHYS THER, V86, P1520, DOI 10.2522/ptj.20060091; Coll JE, 2011, SOC WORK HEALTH CARE, V50, P487, DOI 10.1080/00981389.2010.528727; Hall LK, 2011, SOC WORK HEALTH CARE, V50, P4, DOI 10.1080/00981389.2010.513914; Helmick KM, 2015, BRAIN IMAGING BEHAV, V9, P358, DOI 10.1007/s11682-015-9399-z; McCulloch KL, 2015, J HEAD TRAUMA REHAB, V30, P56, DOI 10.1097/HTR.0000000000000104; Radomski MV, 2014, AM J OCCUP THER, V68, P422, DOI 10.5014/ajot.2014.011445; Radomski MV, 2013, MIL MED, V178, P246, DOI 10.7205/MILMED-D-12-00144; Radomski MV, 2009, AM J OCCUP THER, V63, P646, DOI 10.5014/ajot.63.5.646; Resnik L., 2013, VA DOD COLLABORATION; Roth, 2014, MILD TRAUMATIC BRAIN, P321; Scherer MR, 2013, PHYS THER, V93, P1254, DOI 10.2522/ptj.20120143; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Weightman MM, 2010, J HEAD TRAUMA REHAB, V25, P206, DOI 10.1097/HTR.0b013e3181dc82d3; Weightman MM, 2015, ASSESSMENT MILITARY	16	1	1	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2017	32	1					70	78		10.1097/HTR.0000000000000272			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EI2GH	WOS:000392304400007	28060056	Green Submitted			2022-02-06	
J	Meissner, TW; Friedrich, P; Ocklenburg, S; Genc, E; Weigelt, S				Meissner, Tobias W.; Friedrich, Patrick; Ocklenburg, Sebastian; Genc, Erhan; Weigelt, Sarah			Tracking the Functional Development of the Corpus Callosum in Children Using Behavioral and Evoked Potential Interhemispheric Transfer Times	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; SEXUAL-DIMORPHISM; BIMANUAL COORDINATION; TRANSMISSION TIME; YOUNG-CHILDREN; LIFE-SPAN; AGE; ADOLESCENCE; CHILDHOOD; HUMANS	Visual functions requiring interhemispheric transfer exhibit a long developmental trajectory up to age 12, which might be constrained by corpus callosum maturation. Here, we use electrophysiological and behavioral crossed-uncrossed differences (CUDs) in a visual Poffenberger paradigm to estimate the interhemispheric transfer time (IHTT)a measure of corpus callosum maturationin 7-year-old children and adults. Adults' electrophysiological CUDs were faster than 7-year-olds'. Behavioral CUDs did not differ and proved to be unreliable in a 6-month follow-up test. These findings suggest that the corpus callosum still undergoes development at the age of 7 that can only reliably be traced with neuroscientific methods.	[Meissner, Tobias W.; Weigelt, Sarah] Ruhr Univ Bochum, Dept Psychol, Dev Neuropsychol, Univ Str 150, D-44801 Bochum, Germany; [Friedrich, Patrick; Ocklenburg, Sebastian; Genc, Erhan] Ruhr Univ Bochum, Inst Cognit Neurosci, Dept Psychol, Biopsychol, Bochum, Germany		Meissner, TW (corresponding author), Ruhr Univ Bochum, Dept Psychol, Dev Neuropsychol, Univ Str 150, D-44801 Bochum, Germany.	tobias.meissner@rub.de	Friedrich, Patrick/Y-1778-2019; Ocklenburg, Sebastian/O-5867-2017; Weigelt, Sarah B/N-1846-2018; Genc, Erhan/T-9376-2018	Friedrich, Patrick/0000-0001-5120-5880; Ocklenburg, Sebastian/0000-0001-5882-3200; Genc, Erhan/0000-0001-6514-5479; Meissner, Tobias Waldemar/0000-0003-3972-5386			ALLEN LS, 1991, J NEUROSCI, V11, P933; BELMONTE M, 1995, NEUROREPORT, V6, P1253, DOI 10.1097/00001756-199506090-00006; Bishop KM, 1997, NEUROSCI BIOBEHAV R, V21, P581, DOI 10.1016/S0149-7634(96)00049-8; Bocci T, 2011, NEUROSCIENCE, V187, P43, DOI 10.1016/j.neuroscience.2011.04.050; Bocci T, 2016, CLIN NEUROPHYSIOL, V127, P3353, DOI 10.1016/j.clinph.2016.06.013; Bocci T, 2014, REV NEUROSCIENCE, V25, P113, DOI 10.1515/revneuro-2013-0025; BRIZZOLARA D, 1994, BEHAV BRAIN RES, V64, P179, DOI 10.1016/0166-4328(94)90130-9; Brouwer RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032316; BROWN WS, 1994, NEUROPSYCHOLOGIA, V32, P439, DOI 10.1016/0028-3932(94)90089-2; BROWN WS, 1993, NEUROPSYCHOLOGIA, V31, P1267, DOI 10.1016/0028-3932(93)90097-J; Cantlon JF, 2011, LEARN INDIVID DIFFER, V21, P672, DOI 10.1016/j.lindif.2011.09.003; Chicoine AJ, 2000, DEV NEUROPSYCHOL, V18, P73, DOI 10.1207/S15326942DN1801_5; CLARKE JM, 1989, BRAIN, V112, P849, DOI 10.1093/brain/112.4.849; CLARKE S, 1989, J COMP NEUROL, V280, P213, DOI 10.1002/cne.902800205; COWELL PE, 1992, DEV BRAIN RES, V66, P187, DOI 10.1016/0165-3806(92)90079-C; DAVID AS, 1993, J ABNORM PSYCHOL, V102, P573, DOI 10.1037/0021-843X.102.4.573; Dubb A, 2003, NEUROIMAGE, V20, P512, DOI 10.1016/S1053-8119(03)00313-6; Ellis MU, 2016, J NEUROTRAUM, V33, P990, DOI 10.1089/neu.2015.4023; Fagard J, 2001, J EXP CHILD PSYCHOL, V80, P1, DOI 10.1006/jecp.2000.2623; Fornari E, 2007, NEUROIMAGE, V38, P511, DOI 10.1016/j.neuroimage.2007.07.010; Genc E, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00161; Genc E, 2011, CURR BIOL, V21, P1494, DOI 10.1016/j.cub.2011.08.003; GENTRY LR, 1988, AM J NEURORADIOL, V9, P1129; Giedd JN, 1999, PROG NEURO-PSYCHOPH, V23, P571; Hadad BS, 2006, PERCEPT PSYCHOPHYS, V68, P1264, DOI 10.3758/BF03193726; Hadad BS, 2011, DEVELOPMENTAL SCI, V14, P1330, DOI 10.1111/j.1467-7687.2011.01078.x; Hagelthorn KM, 2000, DEV NEUROPSYCHOL, V18, P11, DOI 10.1207/S15326942DN1801_2; Hasan KM, 2008, BRAIN RES, V1227, P52, DOI 10.1016/j.brainres.2008.06.030; Hasan KM, 2009, BRAIN RES, V1249, P91, DOI 10.1016/j.brainres.2008.10.026; HOLLOWAY RL, 1993, AM J PHYS ANTHROPOL, V92, P481, DOI 10.1002/ajpa.1330920407; Horowitz A, 2015, BRAIN STRUCT FUNCT, V220, P1791, DOI 10.1007/s00429-015-1031-x; Hossiep R., 2001, BOMAT ADV SHORT VERS; HYND GW, 1991, J LEARN DISABIL, V24, P141, DOI 10.1177/002221949102400302; Iacoboni M, 2000, NEUROPSYCHOLOGIA, V38, P535, DOI 10.1016/S0028-3932(99)00121-9; Imperati D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023437; Ipata A, 1997, ARCH ITAL BIOL, V135, P169; JEEVES MA, 1988, DEV NEUROPSYCHOL, V4, P305, DOI 10.1080/87565648809540415; Kim EY, 2007, INT J DEV NEUROSCI, V25, P409, DOI 10.1016/j.ijdevneu.2007.05.005; Kovacs I, 1999, P NATL ACAD SCI USA, V96, P12204, DOI 10.1073/pnas.96.21.12204; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Larocque C, 2001, BRAIN COGNITION, V46, P188, DOI 10.1016/S0278-2626(01)80062-2; Laule C, 2007, NEUROTHERAPEUTICS, V4, P460, DOI 10.1016/j.nurt.2007.05.004; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Lebel C, 2011, J NEUROSCI, V31, P10937, DOI 10.1523/JNEUROSCI.5302-10.2011; Lebel C, 2010, NEUROIMAGE, V52, P20, DOI 10.1016/j.neuroimage.2010.03.072; Lenroot RK, 2007, NEUROIMAGE, V36, P1065, DOI 10.1016/j.neuroimage.2007.03.053; Lenroot RK, 2006, NEUROSCI BIOBEHAV R, V30, P718, DOI 10.1016/j.neubiorev.2006.06.001; Lewis TL, 2004, PERCEPTION, V33, P409, DOI 10.1068/p5189; Luders E, 2010, J NEUROSCI, V30, P10985, DOI 10.1523/JNEUROSCI.5122-09.2010; Marion SD, 2003, DEV NEUROPSYCHOL, V23, P399, DOI 10.1207/S15326942DN2303_6; McLaughlin NCR, 2007, INT J DEV NEUROSCI, V25, P215, DOI 10.1016/j.ijdevneu.2007.03.008; MENDELSOHN DB, 1992, NEURORADIOLOGY, V34, P384, DOI 10.1007/BF00596495; Mondloch CJ, 2003, J EXP CHILD PSYCHOL, V84, P20, DOI 10.1016/S0022-0965(02)00161-3; Muetzel RL, 2008, NEUROIMAGE, V39, P1918, DOI 10.1016/j.neuroimage.2007.10.018; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Poffenberger A.T., 1912, ARCH PSYCHOL, V12, P1; PUJOL J, 1993, ANN NEUROL, V34, P71, DOI 10.1002/ana.410340113; RAINE A, 1990, ARCH GEN PSYCHIAT, V47, P1060; Ratinckx E, 1997, BEHAV BRAIN RES, V86, P161, DOI 10.1016/S0166-4328(96)02261-9; RAUCH RA, 1994, BEHAV BRAIN RES, V64, P65, DOI 10.1016/0166-4328(94)90119-8; Raven J. C., 1998, STANDARD PROGR MAATR; SALAMY A, 1978, SCIENCE, V200, P1409, DOI 10.1126/science.208144; SARON CD, 1989, BEHAV NEUROSCI, V103, P1115, DOI 10.1037/0735-7044.103.5.1115; Saron CD, 2003, ASYMMETRICAL BRAIN, P341; Scherf KS, 2009, CHILD DEV, V80, P162, DOI 10.1111/j.1467-8624.2008.01252.x; Schulte T, 2005, CEREB CORTEX, V15, P1384, DOI 10.1093/cercor/bhi020; STEESESEDA D, 1995, DEV NEUROPSYCHOL, V11, P181, DOI 10.1080/87565649509540612; Thompson PM, 2000, NATURE, V404, P190, DOI 10.1038/35004593; Unterberger I, 2016, SEIZURE-EUR J EPILEP, V37, P55, DOI 10.1016/j.seizure.2016.02.012; van der Knaap LJ, 2011, BEHAV BRAIN RES, V223, P211, DOI 10.1016/j.bbr.2011.04.018; van Grunsven W, 2009, PERCEPT MOTOR SKILL, V109, P3, DOI 10.2466/PMS.109.1.3-29; Westerhausen R, 2006, NEUROSCI LETT, V409, P140, DOI 10.1016/j.neulet.2006.09.028; Westerhausen R, 2016, NEUROIMAGE, V139, P17, DOI 10.1016/j.neuroimage.2016.06.008; Westerhausen R, 2011, CEREB CORTEX, V21, P1012, DOI 10.1093/cercor/bhq165; Wunderle T, 2013, CEREB CORTEX, V23, P900, DOI 10.1093/cercor/bhs081	75	1	1	0	11	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	8756-5641	1532-6942		DEV NEUROPSYCHOL	Dev. Neuropsychol.		2017	42	3					172	186		10.1080/87565641.2017.1315582			15	Psychology, Developmental; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	EW6FK	WOS:000402603900004	28498015				2022-02-06	
J	Mo, YC; Lou, YY; Chen, CY; Zhang, R; Zhang, AQ; Qian, MZ; Zheng, B; Zhang, MY; Ren, YL; Wang, JL				Mo, Yunchang; Lou, Yingying; Chen, Chengyu; Zhang, Rong; Zhang, Anqi; Qian, Meizi; Zheng, Bo; Zhang, Minyuan; Ren, Yelong; Wang, Junlu			Human tissue kallikrein alleviates microcirculation dysfunction of symptomatic cerebral vasospasm via eNOS upregulation in rabbits	INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE			English	Article						CD34; cerebral vasospasm; endothelial nitric oxide synthase; human tissue kallikrein; microcirculation	ANEURYSMAL SUBARACHNOID HEMORRHAGE; TRAUMATIC BRAIN-INJURY; EARLY MICROVASOSPASM; RAT MODEL	Cerebral microcirculation dysfunction might play an important role in symptomatic cerebral vasospasm (CVS), and this study was to investigate whether human tissue kallikrein (HTK) can alleviate it. In this study, forty-four rabbits were randomly divided into sham-operated, subarachnoid hemorrhage-operated (SAH), SAH+HTK groups and SAH+HTK+L-NNA groups (n = 11/group). Neurological function and food intake were evaluated on the day before and for 7 days after SAH. Three-dimensional computed tomography angiography was used to determine the diameter of the basilar artery. Western blotting and immunohistochemistry were used to determine the expression of hippocampal endothelial nitric oxide synthase (eNOS) and CD34 respectively. Finally, the microvascular area ratio and field microvessel density (MVD) were quantitated. SAH reduced food intake and caused neurological dysfunction, which were countered by HTK administration. HTK also significantly increased the basilar artery diameter and reduced CVS following SAH. The microvascular area ratio and MVD were reduced in the SAH group, which was countered by HTK treatment. Moreover, HTK treatment increased eNOS expression. Moreover, N-nitro-l-arginine(L-NNA) prevented the protection of HTK; the L-NNA group showed reduced basilar artery diameter, microvascular area ratio, MVD, and eNOS. During post-SAH symptomatic CVS, capillary numbers and the open area of the microcirculation in the hippocampus declined. HTK improved the microcirculation status of symptomatic CVS and upregulated cerebral perfusion pressure by increasing capillary neogenesis and expanding spasmodic microvessels. HTK may exert its action via upregulation of eNOS, which may cause release of more nitric oxide within the hippocampus.	[Mo, Yunchang; Lou, Yingying; Chen, Chengyu; Zhang, Rong; Zhang, Anqi; Qian, Meizi; Zheng, Bo; Zhang, Minyuan; Ren, Yelong; Wang, Junlu] Wenzhou Med Univ, Affiliated Hosp 1, Dept Anesthesia, Wenzhou 325000, Zhejiang, Peoples R China		Wang, JL (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Anesthesia, Wenzhou 325000, Zhejiang, Peoples R China.	wangjunlu973@163.com		Mo, Yunchang/0000-0001-8671-6322	National Foundation of Natural Science of ChinaNational Natural Science Foundation of China (NSFC) [81603685, 81573742, 81273926]; Natural Science Foundation of Zhejiang Province of ChinaNatural Science Foundation of Zhejiang Province [LY15H290006, LY15H27001]; Wenzhou Science and Technology Project [Y20150229, Y20140706]	This work was supported by the National Foundation of Natural Science of China, No. 81603685, 81573742 and 81273926; the Natural Science Foundation of Zhejiang Province of China, No. LY15H290006 and LY15H27001; the Wenzhou Science and Technology Project, No. Y20150229 and Y20140706. The authors thank Dr. Hu Zhangyong for technical assistance with CTA.	Brown RJ, 2013, NEUROSURGERY, V72, P702, DOI 10.1227/NEU.0b013e318285c3db; Chao J, 2010, BIOL CHEM, V391, P345, DOI 10.1515/BC.2010.042; Chen G, 2009, CYTOKINE, V45, P162, DOI 10.1016/j.cyto.2008.11.015; Dempsey RJ, 2003, NEUROSURGERY, V52, P1315; DORSCH NWC, 1995, BRIT J NEUROSURG, V9, P403, DOI 10.1080/02688699550041403; Emanueli C, 2004, CIRCULATION, V110, P1638, DOI 10.1161/01.CIR.0000142051.36244.83; ENDO S, 1988, STROKE, V19, P1420, DOI 10.1161/01.STR.19.11.1420; Etminan N, 2011, J CEREBR BLOOD F MET, V31, P1443, DOI 10.1038/jcbfm.2011.7; Flynn L., 2015, F1000RESEARCH, V4, P1200, DOI [10.12688/f1000research.6635.1, DOI 10.12688/F1000RESEARCH.6635.1]; Friedrich B, 2012, J CEREBR BLOOD F MET, V32, P447, DOI 10.1038/jcbfm.2011.154; Hopp S, 2015, NEURAL REGEN RES, V10, P885, DOI 10.4103/1673-5374.158339; Jin XL, 2014, MICROCIRCULATION, V21, P696, DOI 10.1111/micc.12150; Kuhn AL, 2013, CNS NEUROL DISORD-DR, V12, P233; Li Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep22070; Lovelock CE, 2010, NEUROLOGY, V74, P1494, DOI 10.1212/WNL.0b013e3181dd42b3; Lucke-Wold BP, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040497; Maeda K, 1996, CANCER, V77, P858, DOI 10.1002/(SICI)1097-0142(19960301)77:5<858::AID-CNCR8>3.0.CO;2-A; Mo YC, 2015, NEUROL RES, V37, P1082, DOI 10.1080/01616412.2015.1110305; Nagano Hiroshi, 1992, In Vivo (Attiki), V6, P497; Ohkuma H, 2000, STROKE, V31, P1621, DOI 10.1161/01.STR.31.7.1621; Park KW, 2001, ANESTH ANALG, V92, P990; Rhoades RA aGA, 1995, MED PHYSL, P279; Sabri M, 2012, NEUROSCIENCE, V224, P26, DOI 10.1016/j.neuroscience.2012.08.002; Santhanam AVR, 2005, STROKE, V36, P2731, DOI 10.1161/01.STR.0000190021.85035.5b; Uhl E, 2003, NEUROSURGERY, V52, P1307, DOI 10.1227/01.NEU.0000065154.04824.9E; Vatter H, 2011, J NEUROL NEUROSUR PS, V82, P876, DOI 10.1136/jnnp.2010.219592; Wan H, 2011, J NEUROSURG SCI, V55, P329; Wang YD, 2011, EUR NEUROL, V65, P208, DOI 10.1159/000325735; Yan JH, 2011, EXP NEUROL, V230, P240, DOI 10.1016/j.expneurol.2011.04.022; Yu YY, 2014, NEUROL SCI, V35, P1413, DOI 10.1007/s10072-014-1730-8	30	1	1	1	5	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	1940-5901			INT J CLIN EXP MED	Int. J. Clin. Exp. Med.		2017	10	9					14015	14021					7	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	FL5PK	WOS:000414297600139					2022-02-06	
B	Mtaweh, H; Simon, D; Bell, MJ		Heidenreich, KA		Mtaweh, H.; Simon, D.; Bell, M. J.			Hypothermia for Traumatic Brain Injury: Current Evidence and Future Directions	NEW THERAPEUTICS FOR TRAUMATIC BRAIN INJURY: PREVENTION OF SECONDARY BRAIN DAMAGE AND ENHANCEMENT OF REPAIR AND REGENERATION			English	Article; Book Chapter							RANDOMIZED CONTROLLED-TRIAL; THERAPEUTIC HYPOTHERMIA; MODERATE HYPOTHERMIA; MILD HYPOTHERMIA; CHILDREN; TEMPERATURE; ACTIVATION; INFANTS; ADULTS; FEVER		[Mtaweh, H.] Univ Toronto, Hosp Sick Children, Toronto, ON, Canada; [Simon, D.; Bell, M. J.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA		Mtaweh, H (corresponding author), Univ Toronto, Hosp Sick Children, Toronto, ON, Canada.						Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Bayir H, 2009, CRIT CARE MED, V37, P689, DOI 10.1097/CCM.0b013e318194abf2; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Biswas AK, 2002, CRIT CARE MED, V30, P2742, DOI 10.1097/00003246-200212000-00020; BOHN DJ, 1986, CRIT CARE MED, V14, P529, DOI 10.1097/00003246-198606000-00002; Bregy A, 2012, EXP NEUROL, V233, P821, DOI 10.1016/j.expneurol.2011.12.008; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Crossley S, 2014, CRIT CARE, V18, DOI 10.1186/cc13835; Diringer MN, 2004, CRIT CARE MED, V32, P559, DOI 10.1097/01.CCM.0000108868.97433.3F; Dixon CE, 1998, J NEUROTRAUM, V15, P95, DOI 10.1089/neu.1998.15.95; DREW CE, 1959, LANCET, V1, P748; Fink EL, 2012, PEDIATR CRIT CARE ME, V13, P80, DOI 10.1097/PCC.0b013e3181fe27c7; Finkelstein Robert A, 2010, J Intensive Care Med, V25, P205, DOI 10.1177/0885066610366919; Harris OA, 2009, J NEUROSURG, V110, P1256, DOI 10.3171/2009.1.JNS081320; Henker RA, 1998, NEUROSURGERY, V42, P1071, DOI 10.1097/00006123-199805000-00071; Hinz J, 2007, J NEUROSURG ANESTH, V19, P130, DOI 10.1097/ANA.0b013e318032a208; Hoedemaekers CW, 2007, CRIT CARE, V11, DOI 10.1186/cc6104; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Jiang JY, 2006, J CEREBR BLOOD F MET, V26, P771, DOI 10.1038/sj.jcbfm.9600253; Li H, 2009, J NEUROTRAUM, V26, P1905, DOI [10.1089/neu.2008.0828, 10.1089/neu.2008-0828]; Liu WG, 2006, J INT MED RES, V34, P58, DOI 10.1177/147323000603400107; Lotocki G, 2006, EUR J NEUROSCI, V24, P2283, DOI 10.1111/j.1460-9568.2006.05123.x; Maekawa T, 2015, J NEUROTRAUM, V32, P422, DOI 10.1089/neu.2013.3197; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Markgraf CG, 2001, J NEUROSURG, V95, P979, DOI 10.3171/jns.2001.95.6.0979; Miyauchi T, 2014, J NEUROTRAUM, V31, P773, DOI 10.1089/neu.2013.3181; Sandestig A, 2014, THER HYPOTHERMIA TEM, V4, P10, DOI 10.1089/ther.2013.0024; Saxena M, 2014, COCHRANE DB SYST REV, V8; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Smith CM, 2011, PEDIATR CRIT CARE ME, V12, P449, DOI 10.1097/PCC.0b013e3181f390dd; Suehiro E, 2004, J NEUROTRAUM, V21, P1706, DOI 10.1089/0897715042664957; Sydenham E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001048.pub4; Truettner JS, 2005, J CEREBR BLOOD F MET, V25, P1505, DOI 10.1038/sj.jcbfm.9600150; Whalen MJ, 1997, J NEUROTRAUM, V14, P561, DOI 10.1089/neu.1997.14.561	39	1	1	0	0	ACADEMIC PRESS LTD-ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL ROAD, LONDON NW1 7DX, ENGLAND			9780-1-28-02701-1; 9780-1-28-02686-1				2017							19	30		10.1016/B978-0-12-802686-1.00002-X			12	Clinical Neurology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BI5ZM	WOS:000413002900005					2022-02-06	
J	Nel, K; Govender, S; Rapetsoa, M; Nel, C				Nel, Kathryn; Govender, Saraswathie; Rapetsoa, Mokgadi; Nel, Christopher			Cumulative mild head injury (CMHI) among college rugby players: A replication and extension study	JOURNAL OF PSYCHOLOGY IN AFRICA			English	Article						backline; Cumulative Mild Head Injury (CMHI); forwards; rugby	TRAUMATIC BRAIN-INJURY; FOOTBALL SOCCER PLAY; NEUROPSYCHOLOGICAL IMPAIRMENT; CONCUSSION; CONSEQUENCE	We investigated the prevalence of cumulative mild head injury (CMHI) symptoms among college student rugby players pre-and post-season. The players completed a number of neuropsychological tests known to be sensitive to CMHI effects: vocabulary, working memory, motor coordination, and a self-report Post Concussive Symptomology (PCS) checklist. A total of 18 rugby players registered at a South African university were participants (age range 18 to 24 years, SD = 2.02 years). Data were analysed utilising Fishers Exact Test comparisons of pre-and post-season mean scores There was significant variability on mean scores between the rugby forwards and backline players in terms of verbal memory and concept formation, cognitive flexibility, working memory, and visual motor-processing speed Poorer overall scores from the rugby forwards may also be indicative of depression as they reported more insomnia and anger on the PCS than the backline players.	[Nel, Kathryn; Govender, Saraswathie; Rapetsoa, Mokgadi] Univ Limpopo, Dept Psychol, Polokwane, South Africa; Univ Zululand, Dept Human Movement Sci, Kwa Dlangezwa, South Africa		Nel, K (corresponding author), Univ Limpopo, Dept Psychol, Polokwane, South Africa.	Kathryn.Nel@ul.ac.za	Nel, Kathryn/ABE-6909-2021	Nel, Kathryn/0000-0001-8892-4176			Alloway TP, 2010, J EXP CHILD PSYCHOL, V106, P20, DOI 10.1016/j.jecp.2009.11.003; Camargo AV, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01729; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hillhouse M., 2013, INJURY SURVEILLANCE; Kaux JF, 2015, SPORTS, V3, P21, DOI 10.3390/sports3010021; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Kriel M.G., 2012, THESIS; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Maite P, 2016, J PSYCHOL AFR, V26, P555, DOI 10.1080/14330237.2016.1250415; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Nel C.R., 2015, AFRICAN J PHYS HLTH, V21, P92; Packard RC, 2008, CURR PAIN HEADACHE R, V12, P67, DOI 10.1007/s11916-008-0013-6; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rutherford A, 2005, J CLIN EXP NEUROPSYC, V27, P299, DOI 10.1080/13803390490515504; Sharp David J, 1800, Pract Neurol, V15, P172, DOI 10.1136/practneurol-2015-001087; Slemmer JE, 2002, BRAIN, V125, P2699, DOI 10.1093/brain/awf271; Stephens R, 2005, CHILD NEUROPSYCHOL, V11, P513, DOI 10.1080/092970490959629; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Viljoen W, 2012, BRIT J SPORT MED, V46, P692, DOI 10.1136/bjsports-2012-091278; WAIS IV, 1997, WESCHL AD INT SCAL	20	1	1	0	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1433-0237	1815-5626		J PSYCHOL AFR	J. Psychol. Afr.		2017	27	6					549	552		10.1080/14330237.2017.1399571			4	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	FS3PO	WOS:000419694600014					2022-02-06	
J	Okoye, EC; Awhen, PA; Akosile, CO; Maruf, FA; Iheukwumere, N; Egwuonwu, AV				Okoye, Emmanuel Chiebuka; Awhen, Peter Agba; Akosile, Christopher Olusanjo; Maruf, Fatai Adesina; Iheukwumere, Ngozi; Egwuonwu, Afamefuna Victor			Caregiver-proxy reliability of the Igbo-culture adapted Maleka Stroke Community Reintegration Measure: a validation study	TOPICS IN STROKE REHABILITATION			English	Article						Maleka Stroke Community Reintegration Measure; stroke survivors; caregivers; proxy reliability; Igbo; Nigeria	QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; SELF-REPORT; SEX-DIFFERENCES; AGREEMENT; INTEGRATION; REHABILITATION; PARTICIPATION; ASSESSMENTS; BURDEN	Objectives: This study was designed to determine the caregiver-proxy reliability of the Igbo-culture adapted urban version of the Maleka Stroke Community Reintegration Measure (I-MSCRIM). Methods: This was a validation study involving 74 consenting stroke survivors and their 74 primary informal caregivers consecutively recruited from selected tertiary hospitals in South-East Nigeria (Igboland). The I-MSCRIM was researcher-administered to the participants. Obtained data was analyzed using frequency counts, percentages, range, mean, standard deviation, Spearman rank order correlation, Mann-Whitney U test, Kruskal-Wallis test and Intra-class Correlation Coefficient. Alpha level was set at 0.05. Results: The mean ages of the stroke survivors (55.4% males) and their primary informal caregivers (41.9% males) were 50.1412.24 and 31.93 +/- 10.9years respectively. There was no significant difference in the community reintegration (CR) scores as rated by stroke survivors and their primary informal caregivers (p>0.05). The correlations between stroke survivors' and primary informal caregivers' rated CR scores were all adequate and acceptable (ICC=0.602-0.917). The discrepancy in the total CR scores between the two ratings was significantly influenced by primary informal caregivers' educational attainment (k=13.15; p<0.01). Conclusion: The I-MSCRIM has acceptable caregiver-proxy reliability among Igbo stroke survivors in South-East Nigeria. This suggests that primary informal caregivers of stroke survivors can reliably estimate the CR of their care recipients when I-MSCRIM is administered to them. This will be useful when a stroke survivor cannot respond to I-MSCRIM.	[Okoye, Emmanuel Chiebuka; Awhen, Peter Agba; Akosile, Christopher Olusanjo; Maruf, Fatai Adesina; Iheukwumere, Ngozi; Egwuonwu, Afamefuna Victor] Nnamdi Azikiwe Univ, Dept Med Rehabil, Coll Hlth Sci, Nnewi, Nigeria		Okoye, EC (corresponding author), Nnamdi Azikiwe Univ, Dept Med Rehabil, Coll Hlth Sci, Nnewi, Nigeria.	bukanuel2004@yahoo.com	Okoye, Emmanuel/V-8033-2019; Akosile, Christopher Olusanjo/ABC-4311-2021	Okoye, Emmanuel/0000-0003-2244-6866; 			Ahasic AM, 2015, AGE AGEING, V44, P506, DOI 10.1093/ageing/afu163; Akinpelu AO, 2007, SOUTH AFR J PHYSIOTH, V63, P3; Akosile CO, 2011, QUAL LIFE RES, V20, P1379, DOI 10.1007/s11136-011-9876-9; Akosile CO., 2013, HLTH CARE CURRENT RE, V1, P105, DOI DOI 10.4172/HCCR.1000105; Akosile CO, 2009, AFR J NEUROL SCI, V28, P2; Appelros P, 2009, STROKE, V40, P1082, DOI 10.1161/STROKEAHA.108.540781; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Bhogal Sanjit K, 2003, Top Stroke Rehabil, V10, P107; Bodenheimer CF, 2004, ARCH PHYS MED REHAB, V85, pS23, DOI 10.1016/j.apmr.2004.03.009; Bouffioulx E, 2011, ARCH PHYS MED REHAB, V92, P1404, DOI 10.1016/j.apmr.2011.03.031; Corrigan JA, 2008, ARCH PHYS MED REHAB, V89, P912, DOI 10.1016/j.apmr.2007.12.027; Department of Health, 2007, NAT STROK STRAT; Department of Health, 2005, RED BRAIN DAM FAST A; Griffen JA, 2010, REHABIL PSYCHOL, V55, P292, DOI 10.1037/a0020503; Hilari K, 2007, J NEUROL NEUROSUR PS, V78, P1072, DOI 10.1136/jnnp.2006.111476; Kersten P, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-26; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Laurie B., 2007, LANGUAGE ARTS CULTUR; Lim Y, 2014, QUAL LIFE RES, V23, P1945, DOI 10.1007/s11136-014-0642-7; Maleka M, 2008, SAJPA, V64, P2; Maleka MED., 2010, DEV OUTCOME MEASURE; McKevitt C, 2011, STROKE, V42, P1398, DOI 10.1161/STROKEAHA.110.598839; Moyle W, 2012, J ADV NURS, V68, P2237, DOI 10.1111/j.1365-2648.2011.05912.x; Nicholson S, 2013, INT J STROKE, V8, P357, DOI 10.1111/j.1747-4949.2012.00880.x; Nir Z, 2009, J NEUROSCI NURS, V41, P92, DOI 10.1097/JNN.0b013e318193456b; Norrving B, 2013, NEUROLOGY, V80, pS5, DOI 10.1212/WNL.0b013e3182762397; Okoye EC., 2016, INT J HLTH SCI RES, V6, P254; Palm F, 2012, CEREBROVASC DIS, V33, P69, DOI 10.1159/000333417; Pang MYC, 2011, J REHABIL MED, V43, P243, DOI 10.2340/16501977-0660; Poulin V, 2008, J REHABIL MED, V40, P28, DOI 10.2340/16501977-0115; Sander AM, 2010, J HEAD TRAUMA REHAB, V25, P121, DOI 10.1097/HTR.0b013e3181cd1635; Sarre S, 2014, DISABIL REHABIL, V36, P716, DOI 10.3109/09638288.2013.814724; Sheldrick RC, 2012, QUAL LIFE RES, V21, P53, DOI 10.1007/s11136-011-9916-5; Soulakova Julia N, 2013, J Subst Abus Alcohol, V1, P1001; Sudlow CLM, 1996, STROKE, V27, P550, DOI 10.1161/01.STR.27.3.550; Tooth LR, 2003, CLIN REHABIL, V17, P656, DOI 10.1191/0269215503cr661oa; Walsh ME, 2015, DISABIL REHABIL, V37, P1599, DOI 10.3109/09638288.2014.974834; Walsh ME, 2015, DISABIL REHABIL, V37, P1834, DOI 10.3109/09638288.2014.981302; Williams LS, 2006, STROKE, V37, P2081, DOI 10.1161/01.STR.0000230583.10311.9f; Zhang YN, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/436125	40	1	1	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1074-9357	1945-5119		TOP STROKE REHABIL	Top. Stroke Rehabil.		2017	24	6					422	427		10.1080/10749357.2017.1305656			6	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	FF7HG	WOS:000409186500003	28361604				2022-02-06	
B	Olindo, S; Sibon, I		Badaut, J; Plesnila, N		Olindo, Stephane; Sibon, Igor			Cerebral Edema in Cerebrovascular Diseases	BRAIN EDEMA: FROM MOLECULAR MECHANISMS TO CLINICAL PRACTICE			English	Article; Book Chapter							ACUTE ISCHEMIC-STROKE; PREDICTS HEMORRHAGIC TRANSFORMATION; EARLY NEUROLOGICAL DETERIORATION; LARGE HEMISPHERIC INFARCTION; ARTERY TERRITORY INFARCTION; TRAUMATIC BRAIN-INJURY; INTRACRANIAL-PRESSURE; CEREBELLAR INFARCTION; DECOMPRESSIVE HEMICRANIECTOMY; EXTRACELLULAR CONCENTRATIONS		[Olindo, Stephane; Sibon, Igor] CNRS Univ Bordeaux, Bordeaux, France		Olindo, S (corresponding author), CNRS Univ Bordeaux, Bordeaux, France.		SIBON, IGOR/AAJ-2503-2020	Sibon, igor/0000-0002-1171-4215			Adler DE, 2002, J NEUROSURG, V96, P1103, DOI 10.3171/jns.2002.96.6.1103; Aksoy D, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000161; Albers GW, 1998, NEUROLOGY, V51, pS47, DOI 10.1212/WNL.51.3_Suppl_3.S47; ALEXANDER E, 1982, SURG NEUROL, V17, P107, DOI 10.1016/S0090-3019(82)80031-1; AMES A, 1968, AM J PATHOL, V52, P437; [Anonymous], 2013, COCHRANE DATABASE SY; Poca MA, 2010, J NEUROSURG, V112, P648, DOI 10.3171/2009.7.JNS081677; Arenillas JF, 2002, STROKE, V33, P2197, DOI 10.1161/01.STR.0000027861.75884.DF; Ayata C, 2002, J CLIN NEUROSCI, V9, P113, DOI 10.1054/jocn.2001.1031; Badiatia N, 2009, CURR OPIN CRIT CARE, V15, P79, DOI 10.1097/MCC.0b013e32832922e9; Balami JS, 2012, LANCET NEUROL, V11, P101, DOI 10.1016/S1474-4422(11)70264-2; Bardutzky J, 2007, STROKE, V38, P3084, DOI 10.1161/STROKEAHA.107.490193; Battey TWK, 2014, STROKE, V45, P3643, DOI 10.1161/STROKEAHA.114.006884; Beard DJ, 2015, J CEREBR BLOOD F MET, V35, P861, DOI 10.1038/jcbfm.2015.2; Beck C, 2014, J NEUROL, V261, P1097, DOI 10.1007/s00415-014-7324-9; Bejot Y, 2007, J NEUROL SCI, V262, P85, DOI 10.1016/j.jns.2007.06.025; Bereczki D, 2007, COCHRANE DB SYST REV; Berrouschot J, 2000, CRIT CARE MED, V28, P2956, DOI 10.1097/00003246-200008000-00045; Bosche B, 2003, STROKE, V34, P2908, DOI 10.1161/01.STR.0000100158.51986.EB; Burghaus L, 2007, CLIN NEUROL NEUROSUR, V109, P45, DOI 10.1016/j.clineuro.2006.06.003; Butzkueven H, 2008, J CLIN NEUROSCI, V15, P130, DOI 10.1016/j.jocn.2007.02.089; Castellanos M, 2004, STROKE, V35, P1671, DOI 10.1161/01.STR.0000131656.47979.39; Castellanos M, 2003, STROKE, V34, P40, DOI 10.1161/01.STR.0000046764.57344.31; Chen R, 2015, J STROKE CEREBROVASC, V24, P958, DOI 10.1016/j.jstrokecerebrovasdis.2014.12.016; Cho AH, 2014, STROKE, V45, P602, DOI 10.1161/STROKEAHA.113.003792; CHRISTENSEN MS, 1972, EUR NEUROL, V8, P137, DOI 10.1159/000114566; D'Amelio M, 2014, J STROKE CEREBROVASC, V23, P649, DOI 10.1016/j.jstrokecerebrovasdis.2013.06.005; Dankbaar JW, 2011, J NEURORADIOLOGY, V38, P161, DOI 10.1016/j.neurad.2010.08.001; De Guio F, 2015, STROKE, V46, P258, DOI 10.1161/STROKEAHA.114.007018; DECOURTENMYERS G, 1992, ANN EMERG MED, V21, P120, DOI 10.1016/S0196-0644(05)80144-1; Diringer MN, 2011, NEUROCRIT CARE, V14, P11, DOI 10.1007/s12028-010-9465-8; Diringer MN, 2004, NEUROCRIT CARE, V1, P219, DOI 10.1385/NCC:1:2:219; Dohmen C, 2003, STROKE, V34, P2152, DOI 10.1161/01.STR.0000083624.74929.32; Dohmen C, 2012, CEREBROVASC DIS, V33, P1, DOI 10.1159/000330648; FAIRBURN B, 1956, BMJ-BRIT MED J, V1, P1335, DOI 10.1136/bmj.1.4979.1335; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Fisher M, 2015, LANCET NEUROL, V14, P758, DOI 10.1016/S1474-4422(15)00054-X; FRANK JI, 1995, NEUROLOGY, V45, P1286, DOI 10.1212/WNL.45.7.1286; GARCIA JH, 1994, AM J PATHOL, V145, P728; Georgiadis D, 2005, Curr Treat Options Neurol, V7, P119, DOI 10.1007/s11940-005-0021-3; Gerriets T, 2004, STROKE, V35, P566, DOI 10.1161/01.STR.0000113692.38574.57; Gilmore RM, 2006, NEUROCRIT CARE, V5, P153, DOI 10.1385/NCC:5:2:153; Hacke W, 1996, ARCH NEUROL-CHICAGO, V53, P309, DOI 10.1001/archneur.1996.00550040037012; Heiss WD, 2000, STROKE, V31, P366, DOI 10.1161/01.STR.31.2.366; Heiss WD, 2001, BRAIN, V124, P20, DOI 10.1093/brain/124.1.20; Henning EC, 2008, STROKE, V39, P3405, DOI 10.1161/STROKEAHA.108.520304; Heye AK, 2014, NEUROIMAGE-CLIN, V6, P262, DOI 10.1016/j.nicl.2014.09.002; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Iliff JJ, 2013, STROKE, V44, pS93, DOI 10.1161/STROKEAHA.112.678698; Information NC for B Pike USNL of M 8600 R MD B & USA 20894, 1996, MALIGNANT MIDDLE CER; Jaramillo A, 2006, NEUROLOGY, V66, P815, DOI 10.1212/01.wnl.0000203649.60211.0e; Jauss M, 1999, J NEUROL, V246, P257, DOI 10.1007/s004150050344; Juttler E, 2014, NEW ENGL J MED, V370, P1091, DOI 10.1056/NEJMoa1311367; Kablau M, 2011, CEREBROVASC DIS, V32, P334, DOI 10.1159/000331702; KASE CS, 1993, STROKE, V24, P76, DOI 10.1161/01.STR.24.1.76; Kasner SE, 2001, STROKE, V32, P2117, DOI 10.1161/hs0901.095719; Kassner A, 2005, AM J NEURORADIOL, V26, P2213; Kassner A, 2011, NEUROIMAG CLIN N AM, V21, P315, DOI 10.1016/j.nic.2011.01.004; Kernagis DN, 2012, ANN NEUROL, V71, P289, DOI 10.1002/ana.22553; Kimelberg HK, 2004, ADV EXP MED BIOL, V559, P157; Kleffner I, 2008, STROKE, V39, P1333, DOI 10.1161/STROKEAHA.107.500785; KOH MG, 2000, J STROKE CEREBROVASC, V31, P2062; Krieger DW, 1999, STROKE, V30, P287, DOI 10.1161/01.STR.30.2.287; Kucinski T, 1998, AM J NEURORADIOL, V19, P839; Lee SH, 2010, J NEUROL NEUROSUR PS, V81, P1316, DOI 10.1136/jnnp.2009.197335; Leigh R, 2014, STROKE, V45, P2030, DOI 10.1161/STROKEAHA.114.005249; Leigh R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052656; Linares G, 2009, CRIT CARE MED, V37, pS243, DOI 10.1097/CCM.0b013e3181aa5de1; Liu FD, 2009, J CEREBR BLOOD F MET, V29, P792, DOI 10.1038/jcbfm.2009.5; Manno EM, 2003, MAYO CLIN PROC, V78, P156, DOI 10.4065/78.2.156; Marion DW, 2002, CRIT CARE MED, V30, P2619, DOI 10.1097/00003246-200212000-00001; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; Miao YY, 2014, EXPERT REV NEUROTHER, V14, P173, DOI 10.1586/14737175.2014.875471; Michinaga S, 2015, INT J MOL SCI, V16, P9949, DOI 10.3390/ijms16059949; Minnerup J, 2011, STROKE J CEREB CIRC, V42, P3403; Missler U, 1997, STROKE, V28, P1956, DOI 10.1161/01.STR.28.10.1956; Mlynash M, 2011, STROKE, V42, P1270, DOI 10.1161/STROKEAHA.110.601609; Modrego Pedro J, 2008, Int J Med Sci, V5, P18; MOULIN DE, 1985, STROKE, V16, P282, DOI 10.1161/01.STR.16.2.282; Neugebauer H, 2014, INT J STROKE, V9, P460, DOI 10.1111/ijs.12211; Neugebauer H, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2013.2.FOCUS12363; Ogden AT, 2005, NEUROSURGERY, V57, P207, DOI 10.1227/01.NEU.0000166533.79031.D8; Oppenheim C, 2000, STROKE, V31, P2175, DOI 10.1161/01.STR.31.9.2175; Ostwaldt AC, 2014, CEREBROVASC DIS, V37, P141, DOI 10.1159/000357422; Paczynski RP, 2000, STROKE, V31, P1702, DOI 10.1161/01.STR.31.7.1702; Pantoni L, 1996, STROKE, V27, P1641, DOI 10.1161/01.STR.27.9.1641; Pantoni L., 1996, STROKE, V27, P1647; PULSINELLI WA, 1982, NEUROLOGY, V32, P1239, DOI 10.1212/WNL.32.11.1239; Qizilbash N, 2002, COCHRANE DB SYST REV; Rahme R, 2012, J NEUROSURG, V117, P749, DOI 10.3171/2012.6.JNS111140; Righetti E, 2004, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD000096.PUB2, 10.1002/14651858.CD000096.pub2]; ROPPER AH, 1984, ARCH NEUROL-CHICAGO, V41, P26, DOI 10.1001/archneur.1984.04050130032017; Schwab S, 1997, NEUROLOGY, V48, P1608, DOI 10.1212/WNL.48.6.1608; Schwab S, 1996, NEUROLOGY, V47, P393, DOI 10.1212/WNL.47.2.393; Schwab S, 2005, Cerebrovasc Dis, V20 Suppl 2, P169, DOI 10.1159/000089371; Seners P, 2015, J NEUROL NEUROSUR PS, V86, P87, DOI 10.1136/jnnp-2014-308327; Seners P, 2014, STROKE, V45, P2004, DOI 10.1161/STROKEAHA.114.005426; Serena Joaquin, 2006, Cerebrovasc Dis, V21 Suppl 2, P80, DOI 10.1159/000091707; Simard D, 1973, Trans Am Neurol Assoc, V98, P309; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; Steiner T, 2001, STROKE, V32, P2500, DOI 10.1161/hs1101.097400; Thomalla GJ, 2003, STROKE, V34, P1892, DOI 10.1161/01.STR.0000081985.44625.B6; Thomalla G, 2010, ANN NEUROL, V68, P435, DOI 10.1002/ana.22125; TOMSICK TA, 1994, AM J NEURORADIOL, V15, P16; Toung TJK, 2002, CRIT CARE MED, V30, P644, DOI 10.1097/00003246-200203000-00025; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Vella J, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00108; VONKUMMER R, 1994, AM J NEURORADIOL, V15, P9; Wang CX, 2007, PROG NEUROBIOL, V83, P140, DOI 10.1016/j.pneurobio.2007.07.006; Wijdicks EFM, 2014, STROKE, V45, P1222, DOI 10.1161/01.str.0000441965.15164.d6; Yang J, 2015, STROKE, V46, P1009, DOI 10.1161/STROKEAHA.114.007154; Yang Y, 2011, STROKE, V42, P3323, DOI 10.1161/STROKEAHA.110.608257; Yoo AJ, 2013, J STROKE CEREBROVASC, V22, P742, DOI 10.1016/j.jstrokecerebrovasdis.2012.01.002; Zha AM, 2015, CURR OPIN CRIT CARE, V21, P91, DOI 10.1097/MCC.0000000000000184; Zhao JW, 2012, NEUROCRIT CARE, V17, P161, DOI 10.1007/s12028-012-9703-3	115	1	1	0	0	ACADEMIC PRESS LTD-ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL ROAD, LONDON NW1 7DX, ENGLAND			978-0-12-803197-1; 978-0-12-803196-4				2017							431	456		10.1016/B978-0-12-803196-4.00022-9			26	Clinical Neurology; Neurosciences	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BJ4BW	WOS:000424808700023					2022-02-06	
J	Otten, EJ; Dorlac, WC				Otten, Edward J.; Dorlac, Warren C.			Managing Traumatic Brain Injury: Translating Military Guidelines to the Wilderness	WILDERNESS & ENVIRONMENTAL MEDICINE			English	Article; Proceedings Paper	Conference on Tactical Combat Casualty Care - Transitioning Battlefield Lessons Learned to Other Austere Environments in conjunction with the 7th World Congress of Mountain and Wilderness Medicine	JUL 30-AUG 04, 2016	Wilderness Med Soc, Telluride, CO		Wilderness Med Soc	traumatic brain injury; concussion; head trauma; intracranial pressure; prehospital; wilderness	CEREBRAL PERFUSION-PRESSURE; PREHOSPITAL MANAGEMENT; HEAD-INJURY; MORTALITY; OUTCOMES; SCORE; DEATH; FIELD	Traumatic brain injury (TBI) is a common injury on the battlefield. Much of what medics do to manage these injuries on the battlefield can be translated to other austere environments, such as wilderness or disaster settings. The recognition and diagnosis of TBI can be difficult even in the hospital, but basic understanding of how to define a TBI and prevent secondary injuries can be accomplished with relatively few resources and little training. This article outlines what a TBI is and how to manage it in the field.	[Otten, Edward J.] Univ Cincinnati, Cincinnati, OH 45220 USA; [Dorlac, Warren C.] Univ Colorado, Med Ctr Rockies, Loveland, CO USA		Otten, EJ (corresponding author), Univ Cincinnati, Cincinnati, OH 45220 USA.	Edward.otten@uc.edu					Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Bauer Derek, 2015, Semin Neurol, V35, pe14, DOI 10.1055/s-0035-1549095; Blackbourne Lorne H, 2008, US Army Med Dep J, P50; Boer C, 2012, CURR OPIN ANESTHESIO, V25, P556, DOI 10.1097/ACO.0b013e328357225c; Boyd J, 2009, CAN MED ASSOC J, V180, P507, DOI 10.1503/cmaj.081327; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Centers for Disease Control and Prevention, 2001, RAT TBI REL EM DEP V; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Christensen ML, 2012, WILDERNESS ENV MED, V24, P81; Cohen L, 2015, ANN EMERG MED, V65, P43, DOI 10.1016/j.annemergmed.2014.06.018; DuBose JJ, 2011, J TRAUMA, V70, P11, DOI 10.1097/TA.0b013e318207c563; Eastridge BJ, 2010, AM J SURG, V200, P724, DOI 10.1016/j.amjsurg.2010.08.006; Federiuk CS, 2002, WILD ENVIRON MED, V13, P245, DOI 10.1580/1080-6032(2002)013[0245:SSASII]2.0.CO;2; GENTILE DA, 1992, ANN EMERG MED, V21, P853, DOI 10.1016/S0196-0644(05)81034-0; Gerberding JL, REP C MILD TRAUM BRA; Haider AH, 2012, J TRAUMA ACUTE CARE, V73, P1340, DOI 10.1097/TA.0b013e318270bbca; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Huang SJ, 2006, J CLIN NEUROSCI, V13, P818, DOI 10.1016/j.jocn.2005.11.034; Mena JH, 2011, J TRAUMA, V71, P1185, DOI 10.1097/TA.0b013e31823321f8; Jaffee MS, 2009, J REHABIL RES DEV, V46, P655, DOI 10.1682/JRRD.2008.09.0114; Johnson SM, 2001, WILD ENVIRON MED, V12, P244, DOI 10.1580/1080-6032(2001)012[0244:ATACHI]2.0.CO;2; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Knuth T., 2005, GUIDELINES FIELD MAN; Kronisch RL, 2002, SPORTS MED, V32, P523, DOI 10.2165/00007256-200232080-00004; Kupersmith J, 2009, J REHABIL RES DEV, V46, pVII, DOI 10.1682/JRRD.2009.06.0079; Majdan M, 2015, J NEUROTRAUM, V32, P101, DOI 10.1089/neu.2014.3438; McIntosh SE, 2007, WILD ENVIRON MED, V18, P293, DOI 10.1580/07-WEME-OR-092R1.1; Meyer MJ, 2010, BRAIN INJURY, V24, P694, DOI 10.3109/02699051003692118; Minardi J, 2009, MT SINAI J MED, V76, P138, DOI 10.1002/msj.20105; Montalvo R, 1998, WESTERN J MED, V168, P248; National Assoication of Emergency Medical Technicians (NAEMT), 2016, PHTLS PREH TRAUM LIF; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Reid MW, 2015, MOL CELL NEUROSCI, V66, P123, DOI 10.1016/j.mcn.2015.03.014; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Rockswold GL, 2009, NEUROSURGERY, V65, P1035, DOI 10.1227/01.NEU.0000359533.16214.04; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; Ropper AH, 2012, NEW ENGL J MED, V367, P746, DOI 10.1056/NEJMct1206321; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Stephens BD, 2005, WILD ENVIRON MED, V16, P192, DOI 10.1580/1080-6032(2005)16[192:RIIWSN]2.0.CO;2; Stiver SI, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E5; Thompson HJ, 2003, NEUROBIOL DIS, V12, P163, DOI 10.1016/S0969-9961(02)00030-X; Vargyas G., 2015, WILDERNESS ENV MED, V27, P181; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Warner KJ, 2007, J TRAUMA, V62, P1330, DOI 10.1097/TA.0b013e31804a8032; Weisbrod AB, 2012, J TRAUMA ACUTE CARE, V73, P1525, DOI 10.1097/TA.0b013e318270e179; Wijayatilake DS, 2015, CURR OPIN ANESTHESIO, V28, P517, DOI 10.1097/ACO.0000000000000233	50	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1080-6032	1545-1534		WILD ENVIRON MED	Wildern. Environ. Med.		2017	28	2		S	SI		S117	S123		10.1016/j.wem.2017.02.008			7	Public, Environmental & Occupational Health; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Public, Environmental & Occupational Health; Sport Sciences	EY6HB	WOS:000404082000017	28501413	Bronze			2022-02-06	
B	Parker, G; Haslam, C; Fleming, J; Shum, D		Wilson, BA; Winegardner, J; VanHeugten, CM; Ownsworth, T		Parker, Giverny; Haslam, Catherine; Fleming, Jennifer; Shum, David			REHABILITATION OF MEMORY DISORDERS IN ADULTS AND CHILDREN	NEUROPSYCHOLOGICAL REHABILITATION: THE INTERNATIONAL HANDBOOK			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; RANDOMIZED CONTROLLED-TRIAL; EVERYDAY MEMORY; COGNITIVE REHABILITATION; PAGING SYSTEM; ERRORLESS; DEFICITS; INDIVIDUALS; IMPAIRMENTS; ATTENTION		[Parker, Giverny; Shum, David] Griffith Univ, Sch Appl Psychol, Brisbane, Qld, Australia; [Parker, Giverny; Shum, David] Griffith Univ, Menzies Hlth Inst Queensland, Brisbane, Qld, Australia; [Haslam, Catherine; Fleming, Jennifer] Univ Queensland, Brisbane, Qld, Australia		Parker, G (corresponding author), Griffith Univ, Sch Appl Psychol, Brisbane, Qld, Australia.; Parker, G (corresponding author), Griffith Univ, Menzies Hlth Inst Queensland, Brisbane, Qld, Australia.		Haslam, Catherine/Y-5763-2018	Haslam, Catherine/0000-0003-0124-9601; Parker, Giverny Jayne/0000-0002-7665-8736			Abrahams Joel P., 1993, Clinical Gerontologist, V12, P57, DOI 10.1300/J018v12n03_06; BADDELEY A, 1994, NEUROPSYCHOLOGIA, V32, P53, DOI 10.1016/0028-3932(94)90068-X; Baddeley A. D., 2002, HDB MEMORY DISORDERS, V2nd; Bird M, 1996, PSYCHOL AGING, V11, P45, DOI 10.1037/0882-7974.11.1.45; Bourgeois MS, 2007, BRAIN INJURY, V21, P1245, DOI 10.1080/02699050701727452; BRUSH JA, 1998, CLIN GERONTOLOGIST, V19, P51, DOI DOI 10.1300/J018V19N01_; Camp CJ, 1996, APPL COGNITIVE PSYCH, V10, P193, DOI 10.1002/(SICI)1099-0720(199606)10:3<193::AID-ACP374>3.0.CO;2-4; Catroppa C, 2015, BRAIN INJURY, V29, P1317, DOI 10.3109/02699052.2015.1043345; Cepeda NJ, 2006, PSYCHOL BULL, V132, P354, DOI 10.1037/0033-2909.132.3.354; Charters E., 2014, NEUROPSYCHOL REHABIL, V25, P82; Cherry KE, 2010, J GENET PSYCHOL, V171, P168, DOI 10.1080/00221320903548118; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Clare L, 1999, NEUROCASE, V5, P37, DOI 10.1080/13554799908404063; Clare L, 2008, NEUROPSYCHOL REV, V18, P1, DOI 10.1007/s11065-008-9051-4; Crowe J, 2013, PHYS OCCUP THER GERI, V31, P254, DOI 10.3109/02703181.2013.796037; das Nair R, 2012, CLIN REHABIL, V26, P894, DOI 10.1177/0269215511435424; DePompei R, 2008, NEUROREHABILITATION, V23, P487; Donovan JJ, 1999, J APPL PSYCHOL, V84, P795, DOI 10.1037/0021-9010.84.5.795; Ehlhardt LA, 2008, NEUROPSYCHOL REHABIL, V18, P300, DOI 10.1080/09602010701733190; Evald L., 2014, NEUROPSYCHOL REHABIL, V25, P283; Evans JJ, 2000, NEUROPSYCHOL REHABIL, V10, P67, DOI 10.1080/096020100389309; Fish JE, 2015, NEUROPSYCHOL REHABIL, V25, P159, DOI 10.1080/09602011.2014.921204; Fleming J. M., 2015, INT HDB OCCUPATIONAL, P463; Fleming JM, 2005, BRAIN INJURY, V19, P1, DOI 10.1080/02699050410001720059; Fleming JM, 1996, BRAIN INJURY, V10, P1; Glang A, 2008, J HEAD TRAUMA REHAB, V23, P243, DOI 10.1097/01.HTR.0000327256.46504.9f; Grandmaison E, 2003, J NEUROPSYCH CLIN N, V15, P130, DOI 10.1176/appi.neuropsych.15.2.130; Grieve J., 2008, NEUROPSYCHOLOGY OCCU; Haslam C., 2015, NEUROPSYCHOL REHABIL, P1; Haslam C, 2006, NEUROPSYCHOL REHABIL, V16, P505, DOI 10.1080/09602010500231867; Haslam C, 2012, NEUROPSYCHOL REHABIL, V22, P697, DOI 10.1080/09602011.2012.686820; Haslam C, 2011, J CLIN EXP NEUROPSYC, V33, P432, DOI 10.1080/13803395.2010.533155; Haslam C, 2010, J CLIN EXP NEUROPSYC, V32, P973, DOI 10.1080/13803391003662686; Hendriks C.M., 1996, AMAT C MANUAL WORKBO; Hendriks CM, 1996, EUROPEAN CANC SOC NE, V5, P13; Ho J, 2011, NEUROPSYCHOL REHABIL, V21, P183, DOI 10.1080/09602011.2010.547345; Hunkin NM, 1998, NEUROPSYCHOL REHABIL, V8, P433, DOI 10.1080/713755581; Kirsch NL, 2004, BRAIN INJURY, V18, P725, DOI 10.1080/02699050310001646161; Laatsch L, 2007, J HEAD TRAUMA REHAB, V22, P248, DOI 10.1097/01.HTR.0000281841.92720.0a; Lajiness-O'Neill R, 2010, APPL NEUROPSYCHOL, V17, P83, DOI 10.1080/09084281003708837; Lajiness-ONeill R., 2013, NEUROPSYCHOL REHABIL, P81; Landis J, 2006, ARCH PHYS MED REHAB, V87, P799, DOI 10.1016/j.apmr.2006.02.017; Lannin N, 2014, CLIN REHABIL, V28, P470, DOI 10.1177/0269215513512216; Materne CJ, 2014, CLIN GERONTOLOGIST, V37, P475, DOI 10.1080/07317115.2014.907591; McDonald A, 2011, NEUROPSYCHOL REHABIL, V21, P784, DOI 10.1080/09602011.2011.598405; Melton AK, 2005, APHASIOLOGY, V19, P353, DOI 10.1080/02687030444000804; Metzler-Baddeley C, 2005, J CLIN EXP NEUROPSYC, V27, P1070, DOI 10.1080/13803390490919164; Miller L., 2015, HDB COGNITIVE NEUROS, P434; Miller LA, 2014, NEUROPSYCHOL REHABIL, V24, P721, DOI 10.1080/09602011.2014.894479; Nadar MS, 2010, OCCUP THER HEALTH CA, V24, P274, DOI 10.3109/07380577.2010.483269; Neulinger K., 2002, BRAIN IMPAIR, V3, P1, DOI [10.1375/brim.3.1.1, DOI 10.1375/BRIM.3.1.1]; Oren S, 2014, J SPEECH LANG HEAR R, V57, P247, DOI 10.1044/1092-4388(2013/12-0352); Ownsworth T, 2008, J REHABIL MED, V40, P81, DOI 10.2340/16501977-0124; Ownsworth T, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-369; Ownsworth T, 2010, NEUROPSYCHOL REHABIL, V20, P59, DOI 10.1080/09602010902949223; Ownsworth TL, 1999, BRAIN INJURY, V13, P605, DOI 10.1080/026990599121340; Pritchard S., 2015, THESIS U QUEENSLAND; Radford K, 2012, J INT NEUROPSYCH SOC, V18, P738, DOI 10.1017/S1355617712000379; Radford K, 2011, EPILEPSY BEHAV, V22, P272, DOI 10.1016/j.yebeh.2011.06.021; SANDER AM, 2014, HDB NEUROPSYCHOLOGY, P173, DOI DOI 10.1007/978-1-4939-0784-7_9; Schaffer Y, 2016, NEUROPSYCHOL REHABIL, V26, P286, DOI 10.1080/09602011.2015.1016537; Shum D, 2011, J REHABIL MED, V43, P216, DOI 10.2340/16501977-0647; Sjo NM, 2010, ACTA PAEDIATR, V99, P230, DOI 10.1111/j.1651-2227.2009.01587.x; Slomine B, 2009, DEV DISABIL RES REV, V15, P133, DOI 10.1002/ddrr.56; Sohlberg MM, 2007, J MED SPEECH-LANG PA, V15, pXV; Stapleton S, 2007, BRAIN INJURY, V21, P401, DOI 10.1080/02699050701252030; Tailby R, 2003, NEUROPSYCHOLOGIA, V41, P1230, DOI 10.1016/S0028-3932(03)00036-8; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Tulving E., 2000, OXFORD HDB MEMORY; van den Broek MD, 2000, BRAIN INJURY, V14, P455; Van't Hooft I, 2005, BRAIN INJURY, V19, P511, DOI 10.1080/02699050400025224; van't Hooft I, 2003, ACTA PAEDIATR, V92, P935, DOI 10.1080/08035250310004586; van 't Hooft I, 2007, NEUROREHABILITATION, V22, P109; Velikonja D, 2014, J HEAD TRAUMA REHAB, V29, P369, DOI 10.1097/HTR.0000000000000069; Ward H, 2004, BRAIN INJURY, V18, P471, DOI 10.1080/02699050310001646107; Wilson B, 2009, MEMORY REHABILITATIO; WILSON BA, 1994, NEUROPSYCHOL REHABIL, V4, P307, DOI 10.1080/09602019408401463; Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477; Wilson BA, 2009, DEV NEUROREHABIL, V12, P421, DOI 10.3109/17518420903200573; Wykle M., 1989, MEMORY AGING THEORY, P212; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009	81	1	1	0	0	ROUTLEDGE	ABINGDON	2 PARK SQ, MILTON PARK, ABINGDON OX14 4RN, OXFORD, ENGLAND			978-1-138-64311-6; 978-1-315-62953-7; 978-1-138-64309-3				2017							196	206					11	Psychology, Clinical; Clinical Neurology; Psychology; Rehabilitation	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Psychology; Neurosciences & Neurology; Rehabilitation	BO7UU	WOS:000525648500027					2022-02-06	
B	Pereira, AP; Fish, J; Malley, D; Bateman, A		Wilson, BA; Winegardner, J; VanHeugten, CM; Ownsworth, T		Pereira, Ana Paula; Fish, Jessica; Malley, Donna; Bateman, Andrew			THE IMPORTANCE OF CULTURE IN HOLISTIC NEUROPSYCHOLOGICAL REHABILITATION Suggestions for improving cultural competence	NEUROPSYCHOLOGICAL REHABILITATION: THE INTERNATIONAL HANDBOOK			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; PERFORMANCE; PSYCHOLOGY		[Pereira, Ana Paula] Univ Fed Parana, Sao Paulo, Brazil; [Fish, Jessica; Malley, Donna; Bateman, Andrew] Oliver Zangwill Ctr Neuropsychol Rehabil, Ely, England		Pereira, AP (corresponding author), Univ Fed Parana, Sao Paulo, Brazil.				CAPESCoordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [BEX 1379/14-3]	This work was completed during Ana Paula de Pereira's sabbatical at the Oliver Zangwill Centre funded by CAPES(BEX 1379/14-3).	Agranovich AV, 2011, J INT NEUROPSYCH SOC, V17, P692, DOI 10.1017/S1355617711000592; American Educational Research Association American Psychological Association National Council on Measurement in Education, 1999, STAND ED PSYCH TEST; Cavanna AE, 2010, EPILEPSY BEHAV, V19, P89, DOI 10.1016/j.yebeh.2010.07.002; Diller, 2011, HDB HOLISTIC NEUROPS; European Commission, 2008, QUAL EQ ACC HLTHC SE; Ferraro R., 2016, MINORITY CROSSCULTUR, P11; Ferraro R, 2016, J HIGH ENERGY PHYS, DOI 10.1007/JHEP02(2016)002; Fyffe DC, 2011, J INT NEUROPSYCH SOC, V17, P625, DOI 10.1017/S1355617711000476; Gavett B. E., 2005, J FORENSIC NEUROPSYC, V4, P49, DOI [10.1300/j151v04n02_05, DOI 10.1300/J151V04N02_05]; Improving Access to Psychological Therapies, 2009, BLACK MIN ETH BME PO; Jetten J., 2012, SOCIAL CURE IDENTITY; Johnson J.D., 2012, REPORT APA TASK FORC; Johnson SB, 2013, AM PSYCHOL, V68, P311, DOI 10.1037/a0033591; Kielhofner G, 2002, MODEL HUMAN OCCUPATI; Lehti A., 2009, BMC FAMILY PRACTICE, V10, P1; Mbakile-Mahlanza L, 2015, NEUROPSYCHOL REHABIL, V25, P936, DOI 10.1080/09602011.2014.999000; Multicultural Committee of the US Psychiatric Rehabilitation Association (USPRA), PRINC MULT PSYCH REH; Ownsworth T., 2014, SELF IDENTITY BRAIN; Patel DR, 2008, PEDIATR CLIN N AM, V55, P1375, DOI 10.1016/j.pcl.2008.09.002; Siedlecki KL, 2012, J INT NEUROPSYCH SOC, V18, P223, DOI 10.1017/S135561771100155X; Sue DW, 1999, AM PSYCHOL, V54, P1061, DOI 10.1037/0003-066X.54.12.1061; Trexler L.E., 2000, INT HDB NEUROPSYCHOL; Uzzell B.P., 2007, INT HDB CROSS CULTUR; Whyte J, 2014, ARCH PHYS MED REHAB, V95, pS17, DOI 10.1016/j.apmr.2013.02.029; Williams MW, 2014, REHABIL PSYCHOL, V59, P298, DOI 10.1037/a0037164; WILSON B, 1989, J CLIN EXP NEUROPSYC, V11, P855, DOI 10.1080/01688638908400940; Wilson BA, 2009, NEUROPSYCHOLOGICAL REHABILITATION: THEORY, MODELS, THERAPY AND OUTCOME, P1, DOI 10.1017/CBO9780511581083; WILSON BA, 2003, BRAIN IMPAIR, V4, P25, DOI DOI 10.1375/BRIM.4.1.25.27030; World Health Organization, 2007, INT CLASS FUNCT DIS; World Health Organization (WHO), 2016, DIS REH; Yalom I. D., 2005, THEORY PRACTICE GROU, V5th; [No title captured]	32	1	1	0	0	ROUTLEDGE	ABINGDON	2 PARK SQ, MILTON PARK, ABINGDON OX14 4RN, OXFORD, ENGLAND			978-1-138-64311-6; 978-1-315-62953-7; 978-1-138-64309-3				2017							492	499					8	Psychology, Clinical; Clinical Neurology; Psychology; Rehabilitation	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Psychology; Neurosciences & Neurology; Rehabilitation	BO7UU	WOS:000525648500053					2022-02-06	
J	Proescholdt, MA; Faltermeier, R; Bele, S; Brawanski, A				Proescholdt, Martin A.; Faltermeier, Rupert; Bele, Sylvia; Brawanski, Alexander			Detection of Impaired Cerebral Autoregulation Using Selected Correlation Analysis: A Validation Study	COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; CEREBROVASCULAR PRESSURE-REACTIVITY; NEUROCRITICAL CARE; PERFUSION-PRESSURE; HEAD-INJURY; DECOMPRESSIVE CRANIECTOMY; INTRACRANIAL-PRESSURE; UNIT	Multimodal brain monitoring has been utilized to optimize treatment of patients with critical neurological diseases. However, the amount of data requires an integrative tool set to unmask pathological events in a timely fashion. Recently we have introduced a mathematical model allowing the simulation of pathophysiological conditions such as reduced intracranial compliance and impaired autoregulation. Utilizing a mathematical tool set called selected correlation analysis (sca), correlation patterns, which indicate impaired autoregulation, can be detected in patient data sets (scp). In this study we compared the results of the sca with the pressure reactivity index (PRx), an established marker for impaired autoregulation. Mean PRx values were significantly higher in time segments identified as scp compared to segments showing no selected correlations (nsc). The sca based approach predicted cerebral autoregulation failure with a sensitivity of 78.8% and a specificity of 62.6%. Autoregulation failure, as detected by the results of both analysis methods, was significantly correlated with poor outcome. Sca of brain monitoring data detects impaired autoregulation with high sensitivity and sufficient specificity. Since the sca approach allows the simultaneous detection of both major pathological conditions, disturbed autoregulation and reduced compliance, it may become a useful analysis tool for brain multimodal monitoring data.	[Proescholdt, Martin A.; Faltermeier, Rupert; Bele, Sylvia; Brawanski, Alexander] Univ Hosp Regensburg, Dept Neurosurg, Regensburg, Germany		Proescholdt, MA (corresponding author), Univ Hosp Regensburg, Dept Neurosurg, Regensburg, Germany.	martin.proescholdt@ukr.de		Dr. Bele, Sylvia/0000-0001-9887-3165			Barone DG, 2014, SCI WORLD J, DOI 10.1155/2014/795762; Bohm M, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.062711; Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; Budohoski KP, 2012, NEUROSURGERY, V71, P652, DOI 10.1227/NEU.0b013e318260feb1; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Citerio G, 2015, CURR OPIN CRIT CARE, V21, P113, DOI 10.1097/MCC.0000000000000179; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 1998, ACT NEUR S, V71, P74; Faltermeier R., 2015, COMP MATH MATH PHYS, V2015; Faltermeier R., 2015, COMP MATH MATH PHYS, V2015; Faltermeier Rupert, 2012, Acta Neurochir Suppl, V114, P35, DOI 10.1007/978-3-7091-0956-4_7; Ho CL, 2008, J NEUROSURG, V108, P943, DOI 10.3171/JNS/2008/108/5/0943; Johnson U, 2014, NEUROCRIT CARE, V21, P259, DOI 10.1007/s12028-014-9954-2; Josephson SA, 2010, J NEUROSURG, V112, P626, DOI 10.3171/2009.8.JNS09441; Jung A, 2005, J MATH BIOL, V51, P491, DOI 10.1007/s00285-005-0343-5; Kramer AH, 2014, CURR OPIN CRIT CARE, V20, P174, DOI 10.1097/MCC.0000000000000076; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; Lee JK, 2009, STROKE, V40, P1820, DOI 10.1161/STROKEAHA.108.536094; Macdonald RL, 2012, STROKE, V43, P1463, DOI 10.1161/STROKEAHA.111.648980; Morris A, 1992, PRINCIPLES CRITICAL, P500; Muizelaar JP, 2015, CRIT CARE MED, V43, P506, DOI 10.1097/CCM.0000000000000792; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Oddo M, 2012, CURR OPIN CRIT CARE, V18, P111, DOI 10.1097/MCC.0b013e32835132a5; Smielewski P, 2008, ACTA NEUROCHIR SUPPL, V102, P145, DOI 10.1007/978-3-211-85578-2_30; Steiner LA, 2003, STROKE, V34, P2404, DOI 10.1161/01.STR.0000089014.59668.04; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Timofeev I, 2011, J NEUROTRAUM, V28, P849, DOI 10.1089/neu.2010.1656; Wang EC, 2006, BRIT J NEUROSURG, V20, P24, DOI 10.1080/02688690600598257; Weersink CSA, 2015, CRIT CARE MED, V43, P1952, DOI 10.1097/CCM.0000000000001165; Zweifel C, 2014, MED ENG PHYS, V36, P638, DOI 10.1016/j.medengphy.2014.03.002	31	1	1	0	2	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1748-670X	1748-6718		COMPUT MATH METHOD M	Comput. Math. Method Med.		2017	2017								8454527	10.1155/2017/8454527			7	Mathematical & Computational Biology	Science Citation Index Expanded (SCI-EXPANDED)	Mathematical & Computational Biology	EL8HO	WOS:000394861100001	28255331	Green Published, gold, Green Submitted			2022-02-06	
B	Rajagopal, S; Ponnusamy, M	Rajagopal, S; Ponnusamy, M			Rajagopal, Senthilkumar; Ponnusamy, Murugavel	Rajagopal, S; Ponnusamy, M		Calcium Signalling in Neurological Disorders	CALCIUM SIGNALING: FROM PHYSIOLOGY TO DISEASES			English	Article; Book Chapter						Acetylcholine; Biogenic amines; Epilepsy; Fragile X syndrome; Neurotransmitters	SELECTIVE MOTONEURON VULNERABILITY; SPONTANEOUS GLUTAMATE RELEASE; MITOCHONDRIAL DYSFUNCTION; NEUROTRANSMITTER RELEASE; MOLECULAR-MECHANISMS; ALZHEIMERS-DISEASE; MOUSE MODEL; HUNTINGTIN; CA2+; NEURONS	Neurotransmitters are broadly classified as excitatory neurotransmitters and inhibitory neurotransmitters based on their function. Ca2+ has a fundamental role in the neuronal physiology and brain function by governing the synthesis and secretion of neurotransmitters. The intracellular Ca2+ concentration is not only important for the release of neurotransmitters but also essential for the regulation of their action potential in postsynaptic membranes. Ca2+ signalling has been implicated in almost all neural activities including neural cell membrane excitability, synaptic transmission, synaptogenesis and dendrite development and most importantly in learning, memory processing and storage. Molecular studies found that the Ca2+-dependent astrocyte hyperactivity is associated with the development of many neurodegenerative disorders including Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), Huntington's disease (HD), fragile X syndrome (FXS) and Parkinson's disease (PD). In addition, persistent Ca2+ waves in astrocytes in acute conditions such as stroke, traumatic brain injury and epilepsy cause neurological problems by increasing gliotransmitter (glutamate and ATP)-induced neural cell death. Although the secretion of neurotransmitters is normal, the impairment of Ca2+ activity-dependent responders is also associated with the development and progression of several neurodegenerative diseases. In this chapter, we focus on regulatory function of calcium in neurological disorders.	[Rajagopal, Senthilkumar] Rayalaseema Univ, Dept Biochem, Kurnool, AP, India; [Ponnusamy, Murugavel] Qingdao Univ, Inst Translat Med, Ctr Dev Cardiol, Qingdao, Shandong, Peoples R China		Rajagopal, S (corresponding author), Rayalaseema Univ, Dept Biochem, Kurnool, AP, India.						ALEXIANU ME, 1994, ANN NEUROL, V36, P846, DOI 10.1002/ana.410360608; Atherton J, 2014, AGING CELL, V13, P49, DOI 10.1111/acel.12148; Bal M, 2013, NEURON, V80, P934, DOI 10.1016/j.neuron.2013.08.024; Bano D, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.112; Beqollari D, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0094-6; Bezprozvanny I, 2004, BIOCHEM BIOPH RES CO, V322, P1310, DOI 10.1016/j.bbrc.2004.08.035; Bezprozvanny IB, 2010, ACTA NATURAE, V2, P72, DOI 10.32607/20758251-2010-2-1-72-80; Bossy-Wetzel E, 2008, TRENDS NEUROSCI, V31, P609, DOI 10.1016/j.tins.2008.09.004; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Cali T, 2014, CELL TISSUE RES, V357, P439, DOI 10.1007/s00441-014-1866-0; Cali T, 2011, BIOFACTORS, V37, P228, DOI 10.1002/biof.159; Cattaneo E, 2005, NAT REV NEUROSCI, V6, P919, DOI 10.1038/nrn1806; Costa V, 2012, EMBO J, V31, P1853, DOI 10.1038/emboj.2012.65; De Mario Agnese, 2016, PLoS Curr, V8, DOI 10.1371/currents.hd.37fcb1c9a27503dc845594ee4a7316c3; Eguiagaray JG, 2004, NEUROCIRUGIA, V15, P109; Ermolyuk YS, 2013, NAT NEUROSCI, V16, P1754, DOI 10.1038/nn.3563; Ganguly G, 2017, DRUG DES DEV THER, V11, P797, DOI 10.2147/DDDT.S130514; Gardoni F, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00025; Giacomello M, 2013, PRION, V7, P76, DOI 10.4161/pri.23581; Grosskreutz J, 2010, CELL CALCIUM, V47, P165, DOI 10.1016/j.ceca.2009.12.002; Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536; Harada K, 2016, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00499; Jaiswal Manoj Kumar, 2014, Mol Cell Ther, V2, P26, DOI 10.1186/2052-8426-2-26; Jorquera RA, 2012, J NEUROSCI, V32, P18234, DOI 10.1523/JNEUROSCI.3212-12.2012; Kaeser PS, 2014, ANNU REV PHYSIOL, V76, P333, DOI 10.1146/annurev-physiol-021113-170338; Kavalali ET, 2015, NAT REV NEUROSCI, V16, P5, DOI 10.1038/nrn3875; Kawahara Y, 2003, J NEUROCHEM, V85, P680, DOI 10.1046/j.1471-4159.2003.01703.x; Kawamoto EM, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00061; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; Liu G., 2012, ENV CHEM TOXICOLOGY, V1, P1; Lombardo S, 2015, NEUROPHARMACOLOGY, V96, P255, DOI 10.1016/j.neuropharm.2014.11.018; Magi S, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/6701324; Peters JH, 2010, NEURON, V65, P657, DOI 10.1016/j.neuron.2010.02.017; Pieri M, 2013, EXP NEUROL, V247, P349, DOI 10.1016/j.expneurol.2012.11.002; Prell T, 2012, EUR J NEUROSCI, V35, P652, DOI 10.1111/j.1460-9568.2012.08008.x; Prell T, 2013, CELL CALCIUM, V54, P132, DOI 10.1016/j.ceca.2013.05.007; Quik M, 2012, MOVEMENT DISORD, V27, P947, DOI 10.1002/mds.25028; Raingo J, 2012, NAT NEUROSCI, V15, P738, DOI 10.1038/nn.3067; Rcom-H'cheo-Gauthier A, 2014, BIOMOLECULES, V4, P795, DOI 10.3390/biom4030795; Reiner A, 2003, MOL NEUROBIOL, V28, P259, DOI 10.1385/MN:28:3:259; Ribeiro FM, 2014, EXPERT OPIN THER TAR, V18, P1293, DOI 10.1517/14728222.2014.948419; Rivero-Rios P, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00053; Sandebring A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005701; Schulte Joost, 2011, Curr Trends Neurol, V5, P65; Shoudai K, 2010, J NEUROSCI, V30, P14470, DOI 10.1523/JNEUROSCI.2557-10.2010; Song C, 2003, J BIOL CHEM, V278, P33364, DOI 10.1074/jbc.M304240200; Sudhof TC, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011353; Supnet C, 2010, J ALZHEIMERS DIS, V20, pS487, DOI 10.3233/JAD-2010-100306; Supnet C, 2010, CELL CALCIUM, V47, P183, DOI 10.1016/j.ceca.2009.12.014; Tang TS, 2003, NEURON, V39, P227, DOI 10.1016/S0896-6273(03)00366-0; Thayer DA, 2013, P NATL ACAD SCI USA, V110, P1482, DOI 10.1073/pnas.1220978110; Van Damme P, 2005, J NEUROPATH EXP NEUR, V64, P605, DOI 10.1097/01.jnen.0000171647.09589.07; von Lewinski F, 2005, TRENDS NEUROSCI, V28, P494, DOI 10.1016/j.tins.2005.07.001; Vyleta NP, 2011, J NEUROSCI, V31, P4593, DOI 10.1523/JNEUROSCI.6398-10.2011; Wang HM, 2009, HUM MOL GENET, V18, P737, DOI 10.1093/hmg/ddn404; Wen H, 2013, ELIFE, V2, DOI 10.7554/eLife.01206; Williams C, 2012, NAT NEUROSCI, V15, P1195, DOI 10.1038/nn.3162; Yao J, 2011, CELL, V147, P666, DOI 10.1016/j.cell.2011.09.046; Yoshihara M, 2010, P NATL ACAD SCI USA, V107, P14869, DOI 10.1073/pnas.1000606107; ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009; Zundorf G, 2011, J NEUROCHEM, V119, P1194, DOI 10.1111/j.1471-4159.2011.07527.x	62	1	1	1	1	SPRINGER-VERLAG SINGAPORE PTE LTD	SINGAPORE	152 BEACH ROAD, #21-01/04 GATEWAY EAST, SINGAPORE, 189721, SINGAPORE			978-981-10-5160-9; 978-981-10-5159-3				2017							43	60		10.1007/978-981-10-5160-9_4	10.1007/978-981-10-5160-9		18	Biochemistry & Molecular Biology; Medicine, Research & Experimental	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology; Research & Experimental Medicine	BO8YR	WOS:000530351500007					2022-02-06	
J	Roman, AY; Kovrazhkina, EA; Razinskaya, OD; Kukharsky, MS; Maltsev, AV; Ovchinnikov, RK; Lytkina, OA; Smirnov, AP; Moskovtsev, AA; Borodina, YV; Surguchov, AP; Ustyugov, AA; Ninkina, NN; Skvortsova, VI				Roman, A. Yu.; Kovrazhkina, E. A.; Razinskaya, O. D.; Kukharsky, M. S.; Maltsev, A. V.; Ovchinnikov, R. K.; Lytkina, O. A.; Smirnov, A. P.; Moskovtsev, A. A.; Borodina, Yu. V.; Surguchov, A. P.; Ustyugov, A. A.; Ninkina, N. N.; Skvortsova, V. I.			Detection of autoantibodies to potentially amyloidogenic protein, gamma-synuclein, in the serum of patients with amyotrophic lateral sclerosis and cerebral circulatory disorders	DOKLADY BIOCHEMISTRY AND BIOPHYSICS			English	Article							TRAUMATIC BRAIN-INJURY; TRANSGENIC MICE; ALPHA-SYNUCLEIN; PATHOLOGY	In this study, we analyzed serum for the presence of antibodies to gamma-synuclein in patients with amyotrophic lateral sclerosis (ALS) compared to the control group of patients with other neurological diseases and healthy control donors. As a result, antibodies against gamma-synuclein are not an ALS-specific feature and have been identified in patients with ALS as well as in the control group patients. Patients with the impaired cerebral circulation showed increased incidence of autoantibodies to gamma-synuclein, yet the difference lacks statistical representativeness due to limited sample size.	[Roman, A. Yu.; Kukharsky, M. S.; Maltsev, A. V.; Ovchinnikov, R. K.; Lytkina, O. A.; Ninkina, N. N.; Skvortsova, V. I.] Russian Acad Sci, Inst Physiol Act Cpds, Chernogolovka 142432, Moscow Oblast, Russia; [Kovrazhkina, E. A.; Razinskaya, O. D.; Smirnov, A. P.] Pirogov Russian Natl Res Med Univ, Minist Healthcare Russian Federat, Moscow 117997, Russia; [Roman, A. Yu.] Aix Marseille Univ, INSERM, Marseille, France; [Moskovtsev, A. A.; Skvortsova, V. I.] Res Inst Gen Pathol & Pathophysiol, Moscow 125315, Russia; [Borodina, Yu. V.] Russian Acad Sci, Res Ctr Hosp, Chernogolovka, Moscow Oblast, Russia; [Surguchov, A. P.] Univ Kansas, Med Ctr, Lawrence, KS 66045 USA		Maltsev, AV (corresponding author), Russian Acad Sci, Inst Physiol Act Cpds, Chernogolovka 142432, Moscow Oblast, Russia.	maltsevandro@mail.ru; ninkina@ipac.ac.ru	Ninkina, Natalia N/A-1732-2011; Moskovtsev, Alexey/AAF-8121-2021; Kukharsky, Michail S/L-6754-2013; Maltsev, Andrey/I-2538-2017; Ustyugov, Aleksey/AAA-8286-2019; Lytkina, Olga/H-3118-2014; Roman, Andrei Yu./H-3113-2014; Kovrazhkina, Elena/AAR-2425-2021	Kukharsky, Michail S/0000-0001-5080-2544; Maltsev, Andrey/0000-0002-1956-0839; Ustyugov, Aleksey/0000-0003-1977-4797; Lytkina, Olga/0000-0003-3015-6447; Roman, Andrei Yu./0000-0002-2498-0803; 	Russian Science FoundationRussian Science Foundation (RSF) [14-14-01138]	This work was supported by the Russian Science Foundation (project no. 14-14-01138).	Acosta SA, 2015, J CELL PHYSIOL, V230, P1024, DOI 10.1002/jcp.24830; Bachurin SO, 2012, NEUROTOX RES, V22, P33, DOI 10.1007/s12640-011-9299-y; Ninkina N, 2012, J BIOL CHEM, V287, P44471, DOI 10.1074/jbc.M112.422402; Ninkina N, 2009, HUM MOL GENET, V18, P1779, DOI 10.1093/hmg/ddp090; Peters OM, 2015, ANN CLIN TRANSL NEUR, V2, P29, DOI 10.1002/acn3.143; Peters OM, 2013, J ALZHEIMERS DIS, V33, P1041, DOI 10.3233/JAD-2012-121732; Peters OM, 2012, NEUROBIOL DIS, V48, P124, DOI 10.1016/j.nbd.2012.06.016; Shelkovnikova TA, 2012, MOL BIOL+, V46, P362, DOI 10.1134/S0026893312020161; Shevtzova EF, 2001, B EXP BIOL MED+, V132, P1173, DOI 10.1023/A:1014559331402; Smith DH, 2003, NEUROMOL MED, V4, P59, DOI 10.1385/NMM:4:1-2:59; Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Surgucheva I, 2014, MOL CELL NEUROSCI, V63, P114, DOI 10.1016/j.mcn.2014.10.005; Surgucheva I, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0132-8; Uryu K, 2003, EXP NEUROL, V184, P214, DOI 10.1016/S0014-4886(03)00245-0	15	1	1	0	1	MAIK NAUKA/INTERPERIODICA/SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013-1578 USA	1607-6729	1608-3091		DOKL BIOCHEM BIOPHYS	Dokl. Biochem. Biophys.	JAN	2017	472	1					64	67		10.1134/S1607672917010197			4	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	ES6WI	WOS:000399690800017	28421431				2022-02-06	
B	Romeika, J; Wurzelmann, M; Sun, D		Heidenreich, KA		Romeika, J.; Wurzelmann, M.; Sun, D.			TrkB Receptor Agonist 7,8-Dihydroxyflavone and Its Therapeutic Potential for Traumatic Brain Injury	NEW THERAPEUTICS FOR TRAUMATIC BRAIN INJURY: PREVENTION OF SECONDARY BRAIN DAMAGE AND ENHANCEMENT OF REPAIR AND REGENERATION			English	Article; Book Chapter							MOUSE MODEL; NEUROTROPHIC FACTOR; SYNAPTIC PLASTICITY; PROTEIN-SYNTHESIS; MEMORY DEFICITS; BDNF; NEURONS; MEDIATORS; GLUTAMATE; SURVIVAL		[Romeika, J.; Wurzelmann, M.; Sun, D.] Virginia Commonwealth Univ, Richmond, VA 23284 USA		Romeika, J (corresponding author), Virginia Commonwealth Univ, Richmond, VA 23284 USA.						Agrawal R, 2015, BBA-MOL BASIS DIS, V1852, P862, DOI 10.1016/j.bbadis.2015.01.018; Autry AE, 2012, PHARMACOL REV, V64, P238, DOI 10.1124/pr.111.005108; BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; Baseri B, 2012, PHYS MED BIOL, V57, pN65, DOI 10.1088/0031-9155/57/7/N65; Bollen E, 2013, BEHAV BRAIN RES, V257, P8, DOI 10.1016/j.bbr.2013.09.029; Castello N., 2013, PLOS ONE, V9; Chen J, 2011, NEUROSCI LETT, V499, P181, DOI 10.1016/j.neulet.2011.05.054; Chen L, 2015, J NEUROPATH EXP NEUR, V74, P557, DOI 10.1097/NEN.0000000000000199; Chiaretti A, 2008, EUR J PAEDIATR NEURO, V12, P195, DOI 10.1016/j.ejpn.2007.07.016; Devi L, 2012, NEUROPSYCHOPHARMACOL, V37, P434, DOI 10.1038/npp.2011.191; Faul M., 2010, CTR DIS CONTROL PREV; Gao X, 2009, EXP NEUROL, V215, P178, DOI 10.1016/j.expneurol.2008.10.009; Gomazkov OA, 2012, NEUROCHEM J+, V6, P163, DOI 10.1134/S1819712412030075; Griesbach GS, 2002, J NEUROTRAUM, V19, P803, DOI 10.1089/08977150260190401; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Jang SW, 2010, P NATL ACAD SCI USA, V107, P2687, DOI 10.1073/pnas.0913572107; Jiang ML, 2013, HUM MOL GENET, V22, P2462, DOI 10.1093/hmg/ddt098; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Korkmaz OT, 2014, NEUROSCI LETT, V566, P286, DOI 10.1016/j.neulet.2014.02.058; Lai KO, 2012, NAT NEUROSCI, V15, P1506, DOI 10.1038/nn.3237; Leal G, 2014, NEUROPHARMACOLOGY, V76, P639, DOI 10.1016/j.neuropharm.2013.04.005; Liu S, 2014, BRAIN INJURY, V28, P133, DOI 10.3109/02699052.2013.860479; Liu X, 2014, J BIOL CHEM, V289, P27571, DOI 10.1074/jbc.M114.562561; Liu X, 2012, J MED CHEM, V55, P8524, DOI 10.1021/jm301099x; Liu X, 2010, J MED CHEM, V53, P8274, DOI 10.1021/jm101206p; Lu Y, 2008, NEUROBIOL LEARN MEM, V89, P312, DOI 10.1016/j.nlm.2007.08.018; Marco-Salazar P, 2014, J COMP PATHOL, V150, P449, DOI 10.1016/j.jcpa.2013.11.209; Minichiello L, 1998, NEURON, V21, P335, DOI 10.1016/S0896-6273(00)80543-7; Minichiello L, 2009, NAT REV NEUROSCI, V10, P850, DOI 10.1038/nrn2738; Otal R, 2005, CELL TISSUE RES, V319, P349, DOI 10.1007/s00441-004-1020-5; Park HY, 2014, INT J MOL MED, V33, P1027, DOI 10.3892/ijmm.2014.1652; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Poduslo JF, 1996, MOL BRAIN RES, V36, P280, DOI 10.1016/0169-328X(95)00250-V; Sconce MD, 2015, NEUROSCIENCE, V290, P454, DOI 10.1016/j.neuroscience.2014.12.080; Tsao J., 2012, TRAUMATIC BRAIN INJU; Veenith Tonny, 2009, World J Emerg Surg, V4, P7, DOI 10.1186/1749-7922-4-7; Wagner Amy K, 2013, Pathophysiology, V20, P39, DOI 10.1016/j.pathophys.2012.02.007; Wang B, 2014, J MOL HISTOL, V45, P129, DOI 10.1007/s10735-013-9539-y; Wang R, 2010, PROG NEURO-PSYCHOPH, V34, P147, DOI 10.1016/j.pnpbp.2009.10.016; Waterhouse EG, 2009, MOL CELL NEUROSCI, V42, P81, DOI 10.1016/j.mcn.2009.06.009; Wu CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113397; Yang C, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu121; Yang YJ, 2014, PHARMACOL BIOCHEM BE, V122, P30, DOI 10.1016/j.pbb.2014.03.013; Zeng Y, 2012, J NEUROCHEM, V122, P800, DOI 10.1111/j.1471-4159.2012.07830.x; Zhang ZT, 2014, NEUROPSYCHOPHARMACOL, V39, P638, DOI 10.1038/npp.2013.243; Zhang ZT, 2013, J CELL BIOCHEM, V114, P144, DOI 10.1002/jcb.24311; Zhao S., 2015, MOLECULAR NEUROBIOLO; Zhao S., 2016, J NEUROTRAUMA   0428	48	1	1	0	2	ACADEMIC PRESS LTD-ELSEVIER SCIENCE LTD	LONDON	125 LONDON WALL, LONDON EC2Y 5AS, ENGLAND			9780-1-28-02701-1; 9780-1-28-02686-1				2017							225	234		10.1016/B978-0-12-802686-1.00014-6			10	Clinical Neurology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BI5ZM	WOS:000413002900017					2022-02-06	
J	Sabel, M; Kalm, M; Bjork-Eriksson, T; Lannering, B; Blomgren, K				Sabel, Magnus; Kalm, Marie; Bjork-Eriksson, Thomas; Lannering, Birgitta; Blomgren, Klas			Hypothermia after cranial irradiation protects neural progenitor cells in the subventricular zone but not in the hippocampus	INTERNATIONAL JOURNAL OF RADIATION BIOLOGY			English	Article						Radiotherapy; neurogenesis; granule cell layer; Iba1; phospho-histone H3; brain	TRAUMATIC BRAIN-INJURY; WHOLE-BODY HYPOTHERMIA; CENTRAL-NERVOUS-SYSTEM; ADULT MAMMALIAN BRAIN; LONG-TERM SEQUELAE; PRECURSOR CELLS; CEREBROSPINAL-FLUID; CRANIOSPINAL IRRADIATION; PROVIDES PROTECTION; CASPASE INHIBITION	Purpose: To explore if hypothermia can reduce the harmful effects of ionizing radiation on the neurogenic regions of the brain in young rats. Materials and methods: Postnatal day 9 rats were randomized into two treatment groups, hypo- and normothermia, or a control group. Treatment groups were placed in chambers submerged in temperature-controlled water baths (30 degrees C and 36 degrees C) for 8h, after receiving a single fraction of 8Gy to the left hemisphere. Seven days' post-irradiation, we measured the sizes of the subventricular zone (SVZ) and the granule cell layer (GCL) of the hippocampus, and counted the number of proliferating (phospho-histone H3+) cells and microglia (Iba1+cells). Results: Irradiation caused a 53% reduction in SVZ size in the normothermia group compared to controls, as well as a reduction of proliferating cell numbers by >50%. These effects were abrogated in the hypothermia group. Irradiation reduced the number of microglia in both treatment groups, but resulted in a lower cell density of Iba1 + cells in the SVZs of the hypothermia group. In the GCL, irradiation decreased both GCL size and the proliferating cell numbers, but with no difference between the treatment groups. The number of microglia in the GCL did not change. Conclusions: Hypothermia immediately after irradiation protects the SVZ and its proliferative cell population but the GCL is not protected, one week post-irradiation.	[Sabel, Magnus; Lannering, Birgitta] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Pediat, Gothenburg, Sweden; [Sabel, Magnus; Lannering, Birgitta] Queen Silvia Childrens Hosp, Childhood Canc Ctr, Gothenburg, Sweden; [Kalm, Marie] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Pharmacol, Gothenburg, Sweden; [Bjork-Eriksson, Thomas] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Reg Canc Ctr West, Gothenburg, Sweden; [Blomgren, Klas] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Blomgren, Klas] Karolinska Univ Hosp, Dept Pediat Oncol, Stockholm, Sweden		Blomgren, K (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden.	klas.blomgren@ki.se	Sabel, Magnus/AAX-7660-2021; Sabel, Magnus/Q-2816-2016	Sabel, Magnus/0000-0002-3072-657X; Sabel, Magnus/0000-0002-3072-657X; Blomgren, Klas/0000-0002-0476-7271; Kalm, Marie/0000-0002-0680-5040; Bjork-Eriksson, Thomas/0000-0003-3680-5196	Swedish Research CouncilSwedish Research CouncilEuropean Commission [2003-4723]; Swedish Childhood Cancer FoundationEuropean Commission [PROJ05-076]; Frimurare Barnhusfonden; Swedish Cancer Foundation; Governmental grants to scientists working in health care (ALF) in Gothenburg	This work was supported by the Swedish Research Council under Grant (no. 2003-4723 to KB), the Swedish Childhood Cancer Foundation under Grant (no. PROJ05-076 to KB), Governmental grants to scientists working in health care (ALF) in Gothenburg, the Frimurare Barnhusfonden, and the Swedish Cancer Foundation.	Abayomi OK, 1996, ACTA ONCOL, V35, P659, DOI 10.3109/02841869609083995; Abayomi OK, 2002, ACTA ONCOL, V41, P346, DOI 10.1080/028418602760169389; Achanta P, 2012, STEM CELLS, V30, P2548, DOI 10.1002/stem.1214; [Anonymous], 2016, INT PROSP STUD CLIN, P10; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; Baird BJ, 2011, MUTAT RES-FUND MOL M, V711, P142, DOI 10.1016/j.mrfmmm.2010.12.006; BAJERSKA A, 1969, INT J RADIAT BIOL RE, V16, P483, DOI 10.1080/09553006914551521; Bao L, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-306; Bentzen SM, 2006, NAT REV CANCER, V6, P702, DOI 10.1038/nrc1950; Bergmann O, 2012, NEURON, V74, P634, DOI 10.1016/j.neuron.2012.03.030; BLOCH M, 1961, LANCET, V2, P906; BLOCH M, 1966, BRIT J CANCER, V20, P722, DOI 10.1038/bjc.1966.83; Blomstrand M, 2014, INT J RADIAT BIOL, V90, P807, DOI 10.3109/09553002.2014.942015; Bostrom M, 2013, J CEREBR BLOOD F MET, V33, P935, DOI 10.1038/jcbfm.2013.34; BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; Burton SA, 1997, CRYOBIOLOGY, V35, P70, DOI 10.1006/cryo.1997.2027; Chodobski A, 2001, MICROSC RES TECHNIQ, V52, P65; COLBOURNE F, 1994, BRAIN RES, V654, P265, DOI 10.1016/0006-8993(94)90488-X; Curlik DM, 2011, J COGNITIVE NEUROSCI, V23, P2159, DOI 10.1162/jocn.2010.21597; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; Dang L, 2012, INT J RADIAT BIOL, V88, P507, DOI 10.3109/09553002.2012.679383; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; DUFFNER PK, 1983, CANCER, V51, P233, DOI 10.1002/1097-0142(19830115)51:2<233::AID-CNCR2820510211>3.0.CO;2-8; Edwards AD, 1995, BIOCHEM BIOPH RES CO, V217, P1193, DOI 10.1006/bbrc.1995.2895; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Ernst A, 2014, CELL, V156, P1072, DOI 10.1016/j.cell.2014.01.044; FOWLER JF, 1989, BRIT J RADIOL, V62, P679, DOI 10.1259/0007-1285-62-740-679; Fukuda A, 2005, J NEUROCHEM, V94, P1604, DOI 10.1111/j.1471-4159.2005.03313.x; Fukuda A, 2005, J NEUROCHEM, V92, P569, DOI 10.1111/j.1471-4159.2004.02894.x; Fukuda H, 2004, CELL DEATH DIFFER, V11, P1166, DOI 10.1038/sj.cdd.4401472; Fukuda H, 2001, BRAIN RES, V910, P187, DOI 10.1016/S0006-8993(01)02659-2; Goldwein JW, 1996, INT J RADIAT ONCOL, V34, P899, DOI 10.1016/0360-3016(95)02080-2; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Graciarena M, 2010, BRAIN BEHAV IMMUN, V24, P1301, DOI 10.1016/j.bbi.2010.06.005; Gudkov AV, 2003, NAT REV CANCER, V3, P117, DOI 10.1038/nrc992; Gustafsson G., 2013, CHILDHOOD CANC INCID; Han W, 2016, ONCOTARGET, V7, P82305, DOI 10.18632/oncotarget.12929; Hans F, 2001, ONCOGENE, V20, P3021, DOI 10.1038/sj.onc.1204326; Hellstraom NAK, 2009, STEM CELLS, V27, P634, DOI 10.1634/stemcells.2008-0732; Huang X, 2010, P NATL ACAD SCI USA, V107, P8422, DOI 10.1073/pnas.0911838107; HULTBORN R, 1990, ACTA ONCOL, V29, P941, DOI 10.3109/02841869009096394; Inder T E, 2000, Semin Neonatol, V5, P3, DOI 10.1053/siny.1999.0112; Jacobs S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub2; Jakacki RI, 2004, INT J RADIAT ONCOL, V60, P531, DOI 10.1016/j.ijrobp.2004.03.027; Jeong Hey-Kyeong, 2013, Exp Neurobiol, V22, P59, DOI 10.5607/en.2013.22.2.59; Jin KL, 2006, P NATL ACAD SCI USA, V103, P13198, DOI 10.1073/pnas.0603512103; Kalm M, 2009, J NEUROIMMUNOL, V206, P70, DOI 10.1016/j.jneuroim.2008.11.002; Kalm M, 2009, RADIAT RES, V171, P66, DOI 10.1667/RR1269.1; Krzywinski M, 2014, NAT METHODS, V11, P119, DOI 10.1038/nmeth.2813; LANNERING B, 1990, MED PEDIATR ONCOL, V18, P304, DOI 10.1002/mpo.2950180410; Limoli CL, 2004, RADIAT RES, V161, P17, DOI 10.1667/RR3112; Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802; Lundgren-Eriksson L, 2001, ANTICANCER RES, V21, P3269; Ma H, 2012, CURR MOL MED, V12, P1282, DOI 10.2174/156652412803833517; Mercier F, 2002, J COMP NEUROL, V451, P170, DOI 10.1002/cne.10342; Mizumatsu S, 2003, CANCER RES, V63, P4021; Monje ML, 2007, ANN NEUROL, V62, P515, DOI 10.1002/ana.21214; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; MULHERN RK, 1992, MED PEDIATR ONCOL, V20, P181, DOI 10.1002/mpo.2950200302; Osman AM, 2016, ONCOTARGET, V7, P2239, DOI 10.18632/oncotarget.6803; Otsuka S, 2006, RADIAT RES, V165, P582, DOI 10.1667/RR3539.1; PACKER RJ, 1987, MED PEDIATR ONCOL, V15, P241, DOI 10.1002/mpo.2950150505; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; REDPATH JL, 1994, RADIAT RES, V137, P323, DOI 10.2307/3578706; Redzic ZB, 2005, CURR TOP DEV BIOL, V71, P1, DOI 10.1016/S0070-2153(05)71001-2; Samuelsson M, 2011, NEUROPEPTIDES, V45, P287, DOI 10.1016/j.npep.2011.05.004; Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; Shapiro LA, 2009, BRAIN RES, V1266, P29, DOI 10.1016/j.brainres.2009.02.031; SHERWOOD NM, 1970, STEREOTAXIC ATLAS DE; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Thoresen M, 1996, ARCH DIS CHILD-FETAL, V74, pF3, DOI 10.1136/fn.74.1.F3; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; VANRIJN J, 1985, RADIAT RES, V101, P292, DOI 10.2307/3576395; Wang CM, 2011, CELL RES, V21, P1534, DOI 10.1038/cr.2011.83; Xing YL, 2014, J NEUROSCI, V34, P14128, DOI 10.1523/JNEUROSCI.3491-13.2014; YAGER JY, 1992, PEDIATR RES, V31, P138, DOI 10.1203/00006450-199202000-00009; Yenari MA, 2012, NAT REV NEUROSCI, V13, P267, DOI 10.1038/nrn3174; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	82	1	2	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0955-3002	1362-3095		INT J RADIAT BIOL	Int. J. Radiat. Biol.		2017	93	8					771	783		10.1080/09553002.2017.1321810			13	Biology; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	FC3DH	WOS:000406718000004	28452566				2022-02-06	
S	Saldert, C		Cummings, L		Saldert, Charlotta			Pragmatic Assessment and Intervention in Adults	RESEARCH IN CLINICAL PRAGMATICS	Perspectives in Pragmatics Philosophy and Psychology		English	Article; Book Chapter						Aphasia; Cognition; Communication; Dementia; Pragmatic assessment; Pragmatic disorder; Pragmatic intervention; Right hemisphere damage; Social interaction; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; INTERACTION-FOCUSED INTERVENTION; TRAINING COMMUNICATION PARTNERS; COARSE CODING DEFICIT; HIGH-LEVEL LANGUAGE; CONVERSATION THERAPY; EVERYDAY CONVERSATIONS; SUPPORTED CONVERSATION; ACQUIRED DYSARTHRIA; PARKINSONS-DISEASE	This chapter describes current clinical practice in assessment and intervention in adults with pragmatic deficit associated with acquired brain damage. The chapter focuses on the management of communication disorders in people with left or right hemisphere damage following a stroke, traumatic brain injury or dementia. Other progressive conditions such as Parkinson's disease and multiple sclerosis are also mentioned. Various techniques and instruments that are used in clinical settings are discussed in relation to current views on the nature of cognitive-communication disorders, pragmatics and functional communication. Finally, the chapter offers a brief description of research-based intervention methods used to address pragmatic aspects of communication and examines treatment outcomes in specific populations.	[Saldert, Charlotta] Univ Gothenburg, Div Speech Language Pathol, Inst Neurosci & Physiol, Gothenburg, Sweden		Saldert, C (corresponding author), Univ Gothenburg, Div Speech Language Pathol, Inst Neurosci & Physiol, Gothenburg, Sweden.	charlotta.saldert@neuro.gu.se	Saldert, Charlotta/ABH-1746-2020	Saldert, Charlotta/0000-0001-8808-3610			Ahlsen E., 1995, GOTHENBURG PAPERS TH, P77; American Speech-Language-Hearing Association, 2016, EVID BAS PRACT; American Speech-Language-Hearing Association, 1990, FUNCT COMM MEAS PROJ; American Speech-Language-Hearing Association, 2015, PRACT PORT FOR SPEEC; Angeleri R, 2012, BEHAV RES METHODS, V44, P845, DOI 10.3758/s13428-011-0174-9; Armstrong E, 2011, APHASIOLOGY, V25, P1347, DOI 10.1080/02687038.2011.577204; Armstrong L, 2007, APHASIOLOGY, V21, P355, DOI 10.1080/02687030600911310; Atkinson M., 1984, STRUCTURES SOCIAL IN; Australian Aphasia Rehabilitation Pathway, 2014, BEST PRACTICE APHASI; Barnes S, 2010, CLIN LINGUIST PHONET, V24, P55, DOI 10.3109/02699200903349734; Beckley F, 2013, INT J LANG COMM DIS, V48, P220, DOI 10.1111/j.1460-6984.2012.00204.x; Beeke S, 2003, CLIN LINGUIST PHONET, V17, P109, DOI 10.1080/0269920031000061786; Beeke S., 2013, BETTER CONVERSATIONS; Beeke S, 2008, CLIN LINGUIST PHONET, V22, P317, DOI 10.1080/02699200801918911; Beeke S, 2014, RES LANG SOC INTERAC, V47, P292, DOI 10.1080/08351813.2014.925667; Beeman M, 1998, RIGHT HEMISPHERE LANGUAGE COMPREHENSION, P255; Behn N, 2012, BRAIN INJURY, V26, P1702, DOI 10.3109/02699052.2012.722258; Berg E, 2003, CLIN LINGUIST PHONET, V17, P63, DOI 10.1080/0269920021000055540; Bernstein-Ellis E, 2007, GROUP TREATMENT NEUR, P71; Blake ML, 2015, NEUROPSYCHOL REHABIL, V25, P15, DOI 10.1080/09602011.2014.932290; Blake ML, 2013, AM J SPEECH-LANG PAT, V22, P146, DOI 10.1044/1058-0360(2012/12-0021); Bloch S, 2015, INT J SPEECH-LANG PA, V17, P373, DOI 10.3109/17549507.2014.979879; Bloch S, 2011, INT J LANG COMM DIS, V46, P510, DOI 10.1111/j.1460-6984.2011.00076.x; Bloch S, 2009, INT J LANG COMM DIS, V44, P769, DOI 10.1080/13682820802546969; BLOMERT L, 1994, APHASIOLOGY, V8, P381, DOI 10.1080/02687039408248666; Body R., 2006, BRAIN IMPAIR, V7, P212, DOI DOI 10.1375/BRIM.7.3.212; Brady MC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000425.pub3; Brookshire R. H., 1997, DISCOURSE COMPREHENS; Broughton M, 2011, INT J NURS STUD, V48, P1436, DOI 10.1016/j.ijnurstu.2011.05.007; Bryan K. L., 1994, RIGHT HEMISPHERE LAN; Centeno J. G., 2013, APHASIA RELATED NEUR, P275; Cherney L. R., 2010, UPDATED EVIDENCEBASE; Christie J, 1986, MOUNT WILGA HIGH LEV; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; College of Audiologists and Speech-Language Pathologists of Ontario (CASLPO), 2012, PRACTICE STANDARDS G; Crosson B., 1996, ECOLOGICAL VALIDITY, P243; Cummings L., 2014, PRAGMATIC DISORDERS; Cummings Louise, 2007, Seminars in Speech and Language, V28, P96, DOI 10.1055/s-2007-970568; D'hondt S, 2009, HANDB PRAGMAT HIGHL, V4, P1; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; Damico J. S., 1985, COMMUNICATION SKILLS, P165; Davis A. G, 1985, ADULT APHASIA REHABI; Davis GA, 2005, APHASIOLOGY, V19, P21, DOI 10.1080/02687030444000598; Difrancesco S, 2012, APHASIOLOGY, V26, P1317, DOI 10.1080/02687038.2012.705815; Douglas JM, 2007, APHASIOLOGY, V21, P1181, DOI 10.1080/02687030600980950; Douglas JM, 2007, J HEAD TRAUMA REHAB, V22, P31, DOI 10.1097/00001199-200701000-00004; Douglas JM, 2014, BRAIN IMPAIR, V15, P190, DOI 10.1017/BrImp.2014.25; Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Egan Mary, 2010, Int J Alzheimers Dis, V2010, DOI 10.4061/2010/906818; Eggenberger E, 2013, INT PSYCHOGERIATR, V25, P345, DOI 10.1017/S1041610212001664; Ellmo W, 1995, MEASURE COGNITIVE LI; Elman RJ, 1999, J SPEECH LANG HEAR R, V42, P411, DOI 10.1044/jslhr.4202.411; Eriksson K, 2014, J INTERACT RES COM D, V5, P245, DOI 10.1558/jircd.v5i2.245; Eriksson K, 2016, DISABIL REHABIL, V38, P1187, DOI 10.3109/09638288.2015.1089952; Forsgren E, 2013, LOGOP PHONIATR VOCO, V38, P82, DOI 10.3109/14015439.2012.731081; Frattali C, 1995, FUNCTIONAL ASSESSMEN; Frith M, 2014, BRAIN INJURY, V28, P1657, DOI 10.3109/02699052.2014.947619; Gabbatore I, 2015, J HEAD TRAUMA REHAB, V30, pE14, DOI 10.1097/HTR.0000000000000087; Goodglass H., 1983, BOSTON DIAGNOSTIC AP; Goodwin C., 2003, CONVERSATION BRAIN D; Grice H. P., 1975, SYNTAX SEMANTICS, P41; Griffiths S, 2015, INT J LANG COMM DIS, V50, P814, DOI 10.1111/1460-6984.12178; Griffiths S, 2012, SEMIN SPEECH LANG, V33, P27, DOI 10.1055/s-0031-1301161; Hartelius Lena, 2011, ISRN Neurol, V2011, P256406, DOI 10.5402/2011/256406; Heart and Stroke Foundation, 2013, CANADIAN STROKE BEST; Hinckley JJ, 2005, APHASIOLOGY, V19, P965, DOI 10.1080/02687030544000173; Hinckley JJ, 2001, APHASIOLOGY, V15, P463, DOI 10.1080/02687040042000340; Holland A., 1998, COMMUNICATION ACTIVI; Holland AL, 1991, J NEUROLINGUISTICS, V6, P197, DOI DOI 10.1016/0911-6044(91)90007-6; Hopper T, 2002, APHASIOLOGY, V16, P745, DOI 10.1080/02687030244000059; Hopper T, 2007, CAN J SPEECH-LANG PA, V31, P114; Jones HN, 2009, J MED SPEECH-LANG PA, V17, P45; Kagan A, 1998, APHASIOLOGY, V12, P816, DOI 10.1080/02687039808249575; Kagan A, 2001, J SPEECH LANG HEAR R, V44, P624, DOI 10.1044/1092-4388(2001/051); Kagan Aura, 2004, Top Stroke Rehabil, V11, P67; Kertesz A., 1982, W APHASIA BATTERY; Kolb D. A, 1984, EXPERIENTIAL LEARNIN; Laakso K, 2000, CLIN LINGUIST PHONET, V14, P329, DOI 10.1080/02699200050051065; Legg C, 2005, APHASIOLOGY, V19, P559, DOI 10.1080/02687030544000029; Lethlean JB, 1997, APHASIOLOGY, V11, P39, DOI 10.1080/02687039708248454; Liddle J, 2012, INT PSYCHOGERIATR, V24, P1927, DOI 10.1017/S1041610212001366; Lock S, 2001, SUPPORTING PARTNERS; LOMAS J, 1989, J SPEECH HEAR DISORD, V54, P113, DOI 10.1044/jshd.5401.113; Lundgren K, 2011, APHASIOLOGY, V25, P456, DOI 10.1080/02687038.2010.500809; MacDonald S, 2010, BRAIN INJURY, V24, P486, DOI 10.3109/02699050903518118; Mahendra N., 2013, APHASIA RELATED NEUR, P397; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S., 2011, AWARENESS SOCIAL INF; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; McVicker S, 2009, APHASIOLOGY, V23, P52, DOI 10.1080/02687030701688783; Muller N., 2008, HDB CLIN LINGUISTICS, P3; Myers P.S., 1999, RIGHT HEMISPHERE DAM; Nykanen A, 2013, APHASIOLOGY, V27, P1159, DOI 10.1080/02687038.2013.802284; Olness GS, 2012, SEMIN SPEECH LANG, V33, P55, DOI 10.1055/s-0031-1301163; PENN C, 1988, CLIN LINGUIST PHONET, V2, P179, DOI 10.1080/02699208808985255; Perkins L, 1998, J NEUROLINGUIST, V11, P33, DOI 10.1016/S0911-6044(98)00004-9; Perkins L., 1997, CONVERSATION ANAL PR; Perkins Michael R., 2007, PRAGMATIC IMPAIRMENT; Prins R, 2004, APHASIOLOGY, V18, P1075, DOI 10.1080/02687030444000534; PRUTTING CA, 1987, J SPEECH HEAR DISORD, V52, P105, DOI 10.1044/jshd.5202.105; PULVERMULLER F, 1991, APHASIOLOGY, V5, P39, DOI 10.1080/02687039108248518; Rautakoski P, 2011, APHASIOLOGY, V25, P344, DOI 10.1080/02687038.2010.530671; Ripich D. N., 1999, CLIN GERONTOLOGIST, V21, P37, DOI DOI 10.1300/J018V21N01; Ripich D.N., 1998, CLIN GERONTOLOGIST, V19, P37; RIPICH DN, 1995, GERIATR NURS, V16, P15, DOI 10.1016/S0197-4572(05)80073-4; Rose ML, 2013, APHASIOLOGY, V27, P1090, DOI 10.1080/02687038.2013.805726; Rosenbek JC, 2006, J REHABIL RES DEV, V43, P379, DOI 10.1682/JRRD.2005.01.0029; Royal College of Speech and Language Therapists, 2005, RCSLT CLIN GUID; Sacco K, 2008, J COGN SCI, V9, P111; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Saldert C., 2006, INFERENCE CONVERSATI; Saldert C, 2015, APHASIOLOGY, V29, P378, DOI 10.1080/02687038.2014.948803; Saldert C, 2014, INT J LANG COMM DIS, V49, P710, DOI 10.1111/1460-6984.12105; Saldert C, 2012, J INTERACT RES COM D, V3, P141, DOI 10.1558/jircd.v3i2.141; Saldert C, 2013, APHASIOLOGY, V27, P271, DOI 10.1080/02687038.2012.710317; Saldert C, 2011, DISABIL REHABIL, V33, P253, DOI 10.3109/09638288.2010.514971; Samuelsson C, 2011, AM J ALZHEIMERS DIS, V26, P563, DOI 10.1177/1533317511428152; Savage MC, 2014, APHASIOLOGY, V28, P616, DOI 10.1080/02687038.2013.843153; Sidnell J., 2010, CONVERSATION ANAL IN; Simmons-Mackie N, 2014, INT J LANG COMM DIS, V49, P511, DOI 10.1111/1460-6984.12097; Simmons-Mackie N, 2010, ARCH PHYS MED REHAB, V91, P1814, DOI 10.1016/j.apmr.2010.08.026; Skinner C., 1984, EDINBURGH FUNCTIONAL; Spreen O., 2003, ASSESSMENT APHASIA; Stahl B, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01526; Struchen MA, 2008, BRAIN INJURY, V22, P940, DOI 10.1080/02699050802425410; TAYLOR M L, 1965, Arch Phys Med Rehabil, V46, P101; Togher L, 2004, APHASIOLOGY, V18, P313, DOI 10.1080/02687030344000535; TOGHER L, 1999, BRAIN DAM B, P113; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Togher L, 2013, J REHABIL MED, V45, P637, DOI 10.2340/16501977-1173; Togher L, 2010, APHASIOLOGY, V24, P914, DOI 10.1080/02687030903422478; Tomoeda C., 1993, ARIZONA BATTERY COMM; Tompkins C., 2013, APHASIA RELATED NEUR, P345; Tompkins C., 2013, APHASIA RELATED NEUR, P297; Tompkins C.A., 1995, RIGHT HEMISPHERE COM; Tompkins CA, 2000, J SPEECH LANG HEAR R, V43, P62, DOI 10.1044/jslhr.4301.62; Tompkins CA, 2012, APHASIOLOGY, V26, P689, DOI 10.1080/02687038.2012.676869; Tompkins CA, 2011, APHASIOLOGY, V25, P789, DOI 10.1080/02687038.2010.539784; Turkstra L, 2005, J MED SPEECH-LANG PA, V13, pIX; Vogel AP, 2010, J EVAL CLIN PRACT, V16, P1183, DOI 10.1111/j.1365-2753.2009.01291.x; Whitworth A., 1997, CONVERSATION ANAL PR; Wiig E. H., 1989, TEST LANGUAGE COMPET; Wilkinson R, 2014, RES LANG SOC INTERAC, V47, P219, DOI 10.1080/08351813.2014.925659; Wilkinson R, 2010, J INTERACT RES COM D, V1, P45, DOI 10.1558/jircd.v1i1.45; Wilkinson R, 2011, INT J SPEECH-LANG PA, V13, P74, DOI 10.3109/17549507.2011.551140; Wirz S.L, 1990, REVISED EDINBURGH FU; World Health Organization, 2001, INT CLASS FUNCT DIS; Ylvisaker M., 2006, BRAIN IMPAIR, V7, P246, DOI [10.1375/brim.7.3.246, DOI 10.1375/BRIM.7.3.246]; Zientz J, 2007, J MED SPEECH-LANG PA, V15, pLIII; [No title captured]	152	1	1	0	7	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	2214-3807		978-3-319-47489-2; 978-3-319-47487-8	PERSP PRAGMAT PHILO			2017	11						527	558		10.1007/978-3-319-47489-2_20	10.1007/978-3-319-47489-2		32	Audiology & Speech-Language Pathology; Communication; Linguistics; Rehabilitation	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Audiology & Speech-Language Pathology; Communication; Linguistics; Rehabilitation	BI8BR	WOS:000414965000021					2022-02-06	
B	Schober, ME		Heidenreich, KA		Schober, M. E.			Docosahexaenoic Acid and Omega 3 Fatty Acids	NEW THERAPEUTICS FOR TRAUMATIC BRAIN INJURY: PREVENTION OF SECONDARY BRAIN DAMAGE AND ENHANCEMENT OF REPAIR AND REGENERATION			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; POLYUNSATURATED FATTY-ACIDS; COGNITIVE PERFORMANCE; LIPID-PEROXIDATION; DIETARY-INTAKE; ETHYL DOCOSAHEXAENOATE; MEMBRANE-FLUIDITY; OXIDATIVE STRESS; FETAL BRAIN; DNA-DAMAGE		[Schober, M. E.] Univ Utah, Sch Med, Salt Lake City, UT 84112 USA		Schober, ME (corresponding author), Univ Utah, Sch Med, Salt Lake City, UT 84112 USA.						Abdel-Wahab BA, 2015, NEUROSCI LETT, V584, P173, DOI 10.1016/j.neulet.2014.10.003; Abdullah L, 2014, FASEB J, V28, P5311, DOI 10.1096/fj.14-258228; Adibhatla RM, 2008, BMB REP, V41, P560, DOI 10.5483/BMBRep.2008.41.8.560; Anthonymuthu TS, 2016, BRAIN RES, V1640, P57, DOI 10.1016/j.brainres.2016.02.006; Atakisi O, 2013, EUR REV MED PHARMACO, V17, P467; Bailes JE, 2010, J NEUROTRAUM, V27, P1617, DOI 10.1089/neu.2009.1239; BEAUGE F, 1992, ALCOHOL ALCOHOLISM, V27, P257; Begum G, 2014, J NEUROSCI, V34, P3743, DOI 10.1523/JNEUROSCI.2872-13.2014; BOURRE JM, 1993, PROSTAG LEUKOTR ESS, V48, P5, DOI 10.1016/0952-3278(93)90003-F; Calder PC, 2011, EUR J PHARMACOL, V668, pS50, DOI 10.1016/j.ejphar.2011.05.085; Calder PC, 2009, BIOCHIMIE, V91, P791, DOI 10.1016/j.biochi.2009.01.008; Campoy C, 2012, BRIT J NUTR, V107, pS85, DOI 10.1017/S0007114512001493; Carlson SJ, 2013, JPEN-PARENTER ENTER, V37, P15, DOI 10.1177/0148607112467821; Carson MJ, 2006, CLIN NEUROSCI RES, V6, P237, DOI 10.1016/j.cnr.2006.09.004; Chen CT, 2013, J LIPID RES, V54, P2410, DOI 10.1194/jlr.M038505; Chen SL, 2014, SCI REP-UK, V4, DOI 10.1038/srep07458; Corser-Jensen CE, 2014, EXP NEUROL, V256, P7, DOI 10.1016/j.expneurol.2014.03.008; DeGiorgio CM, 2015, J NEUROL NEUROSUR PS, V86, P65, DOI 10.1136/jnnp-2014-307749; Delpech J. C, 2014, NEUROPSYCHOPHARMACOL; Desai AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085237; Dijck-Brouwer DAJ, 2005, PROSTAG LEUKOTR ESS, V72, P21, DOI 10.1016/j.plefa.2004.08.002; Dullemeijer C, 2007, AM J CLIN NUTR, V86, P1479, DOI 10.1093/ajcn/86.5.1479; Eldho NV, 2003, J AM CHEM SOC, V125, P6409, DOI 10.1021/ja029029o; Farias SE, 2011, J TRAUMA, V71, P1211, DOI 10.1097/TA.0b013e3182092c62; Galano JM, 2013, PROSTAG OTH LIPID M, V107, P95, DOI 10.1016/j.prostaglandins.2013.04.003; Green P, 2001, BBA-MOL CELL BIOL L, V1531, P156, DOI 10.1016/S1388-1981(01)00101-9; Green P, 2001, BBA-MOL CELL BIOL L, V1532, P203, DOI 10.1016/S1388-1981(01)00132-9; Harris WS, 2015, J PERINATOL, V35, P1, DOI 10.1038/jp.2014.195; Harrison JL, 2015, BRAIN BEHAV IMMUN, V47, P131, DOI 10.1016/j.bbi.2015.01.001; Hashimoto M, 2006, CLIN EXP PHARMACOL P, V33, P934, DOI 10.1111/j.1440-1681.2006.04467.x; Herchi W, 2014, J OLEO SCI, V63, P681, DOI 10.5650/jos.ess14006; Hoffman DR, 1999, LIPIDS, V34, P337, DOI 10.1007/s11745-999-0371-y; Homayoun P, 2000, NEUROCHEM RES, V25, P269, DOI 10.1023/A:1007583806138; Igarashi M, 2015, J NEUROSCI, V35, P6079, DOI 10.1523/JNEUROSCI.4102-14.2015; Innis SM, 2008, BRAIN RES, V1237, P35, DOI 10.1016/j.brainres.2008.08.078; Itoh T, 2008, N-S ARCH PHARMACOL, V377, P541, DOI 10.1007/s00210-007-0251-x; Jain V, 2010, J CEREBR BLOOD F MET, V30, P1598, DOI 10.1038/jcbfm.2010.49; Kalmijn S, 2004, NEUROLOGY, V62, P275, DOI 10.1212/01.WNL.0000103860.75218.A5; Katz DP, 1996, NUTRITION, V12, P334, DOI 10.1016/S0899-9007(96)80056-6; Kitson AP, 2012, PROSTAG LEUKOTR ESS, V87, P1, DOI 10.1016/j.plefa.2012.06.001; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lee SH, 2011, TRAFFIC, V12, P878, DOI 10.1111/j.1600-0854.2011.01195.x; Lewis M, 2013, AM J EMERG MED, V31, DOI 10.1016/j.ajem.2012.05.014; Lien EL, 2009, PROSTAG LEUKOTR ESS, V81, P125, DOI 10.1016/j.plefa.2009.05.004; Martinez M, 1998, J NEUROCHEM, V71, P2528; Mills JD, 2011, NEUROSURGERY, V68, P474, DOI 10.1227/NEU.0b013e3181ff692b; Muller CP, 2015, BBA-MOL CELL BIOL L, V1851, P1052, DOI 10.1016/j.bbalip.2014.12.014; Niemoller TD, 2010, PROSTAG OTH LIPID M, V91, P85, DOI 10.1016/j.prostaglandins.2009.09.005; Nordgren TM, 2014, NUTRIENTS, V6, P5434, DOI 10.3390/nu6125434; Nordmann C, 2014, J NEUROCHEM, V131, P163, DOI 10.1111/jnc.12789; Nurk E, 2007, AM J CLIN NUTR, V86, P1470, DOI 10.1093/ajcn/86.5.1470; Ong WY, 2015, ACS CHEM NEUROSCI, V6, P814, DOI 10.1021/acschemneuro.5b00073; Pilitsis JG, 2003, NEUROSCI LETT, V349, P136, DOI 10.1016/S0304-3940(03)00803-6; Pu HJ, 2013, J CEREBR BLOOD F MET, V33, P1474, DOI 10.1038/jcbfm.2013.108; Rapoport SI, 2011, PROSTAG OTH LIPID M, V96, P109, DOI 10.1016/j.prostaglandins.2011.06.003; Rapoport SI, 2009, PROSTAG LEUKOTR ESS, V81, P119, DOI 10.1016/j.plefa.2009.05.021; Recchiuti A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00298; Richardson AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043909; Roy J, 2015, BIOCHIMIE; Russell KL, 2014, PROSTAG LEUKOTR ESS, V90, P5, DOI 10.1016/j.plefa.2013.11.003; Russell KL, 2013, PROSTAG LEUKOTR ESS, V89, P97, DOI 10.1016/j.plefa.2013.05.004; Sanders TAB, 2009, PROSTAG LEUKOTR ESS, V81, P137, DOI 10.1016/j.plefa.2009.05.013; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Shin SS, 2011, NEUROSCI LETT, V496, P168, DOI 10.1016/j.neulet.2011.04.009; Smith JA, 2013, NEUROCHEM INT, V62, P764, DOI 10.1016/j.neuint.2013.02.013; Stillwell W, 2005, REPROD NUTR DEV, V45, P559, DOI 10.1051/rnd:2005046; Stonehouse W, 2014, NUTRIENTS, V6, P2730, DOI 10.3390/nu6072730; Suzuki H, 1998, MECH AGEING DEV, V101, P119, DOI 10.1016/S0047-6374(97)00169-3; van Gelder BM, 2007, AM J CLIN NUTR, V85, P1142, DOI 10.1093/ajcn/85.4.1142; Wang T, 2013, RESTOR NEUROL NEUROS, V31, P647, DOI 10.3233/RNN-130316; Welch AA, 2010, AM J CLIN NUTR, V92, P1040, DOI 10.3945/ajcn.2010.29457; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Wu A, 2013, NEUROSCIENCE, V248, P655, DOI 10.1016/j.neuroscience.2013.06.041; Wu AG, 2014, NEUROREHAB NEURAL RE, V28, P75, DOI 10.1177/1545968313498650; Wu AG, 2011, J NEUROTRAUM, V28, P2113, DOI 10.1089/neu.2011.1872; Yurko-Mauro K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120391; Zapata-Gonzalez F, 2008, J LEUKOCYTE BIOL, V84, P1172, DOI 10.1189/jlb.1007688; Zhao GX, 2005, BIOCHEM BIOPH RES CO, V336, P909, DOI 10.1016/j.bbrc.2005.08.204	78	1	1	0	3	ACADEMIC PRESS LTD-ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL ROAD, LONDON NW1 7DX, ENGLAND			9780-1-28-02701-1; 9780-1-28-02686-1				2017							287	306		10.1016/B978-0-12-802686-1.00018-3			20	Clinical Neurology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BI5ZM	WOS:000413002900021					2022-02-06	
B	Schrieff-Elson, L; Thomas, K		Wilson, BA; Winegardner, J; VanHeugten, CM; Ownsworth, T		Schrieff-Elson, Leigh; Thomas, Kevin			Rehabilitation in South Africa	NEUROPSYCHOLOGICAL REHABILITATION: THE INTERNATIONAL HANDBOOK			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; UTILITY; TESTS		[Schrieff-Elson, Leigh] Univ Cape Town, Dept Psychol, Cape Town, South Africa; [Thomas, Kevin] Univ Cape Town, Cape Town, South Africa		Schrieff-Elson, L (corresponding author), Univ Cape Town, Dept Psychol, Cape Town, South Africa.		Schrieff, Leigh/AAQ-5577-2020	Schrieff, Leigh/0000-0003-0192-4830			Abdullah Jafri Malin, 2005, Asian J Surg, V28, P163, DOI 10.1016/S1015-9584(09)60334-1; [Anonymous], 2016, GINI IND WORLD BANK; Ardila A, 2013, INT HDB CROSS CULTUR, P23; de la Rey C, 2014, PSYCHOLOGY EDUCATION AND TRAINING: A GLOBAL PERSPECTIVE, P182; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Ferrett HL, 2014, METAB BRAIN DIS, V29, P395, DOI 10.1007/s11011-014-9495-6; Ferrett HL, 2010, DRUG ALCOHOL DEPEN, V110, P8, DOI 10.1016/j.drugalcdep.2010.01.019; Levin K, 2004, DISABIL REHABIL, V26, P306, DOI 10.1080/0963828032000174089; Levin Karen, 2006, Pediatr Rehabil, V9, P285, DOI 10.1080/13638490500293358; Lewis CE, 2015, ALCOHOL CLIN EXP RES, V39, P724, DOI 10.1111/acer.12671; Marais S, 2014, SAMJ S AFR MED J, V104, P895, DOI 10.7196/SAMJ.9060; Mbakile-Mahlanza L, 2015, NEUROPSYCHOL REHABIL, V25, P936, DOI 10.1080/09602011.2014.999000; New World Health, 2015, W20 20 WEALTH COUNTR; Nxumalo N, 2011, J PUBLIC HEALTH POL, V32, pS124, DOI 10.1057/jphp.2011.26; Ozler B, 2007, ECON DEV CULT CHANGE, V55, P487, DOI 10.1086/511191; Phaswana-Mafuya N, 2008, INT J HEALTH CARE Q, V21, P611, DOI 10.1108/09526860810900745; Robbins RN, 2013, CLIN NEUROPSYCHOL, V27, P437, DOI 10.1080/13854046.2012.759627; Schrieff L E, 2013, SAMJ, S. Afr. med. j., V103, P616, DOI 10.7196/samj.7137; Skuy M, 2001, PERS INDIV DIFFER, V30, P1413, DOI 10.1016/S0191-8869(00)00123-9; Soderqvist S., 2016, COGMED WORKING MEMOR; Statistics South Africa, 2015, MID YEAR POP EST 201; The World Bank, 2016, S AFR; Wilson A., 2015, AFRICAN J DISABILITY, V4; Witten J.A., 2015, CLIN NEUROPSYCHOL, V9, P1; World Health Organization (WHO), 2003, WHO FACTSH 134 MED	25	1	1	0	0	ROUTLEDGE	ABINGDON	2 PARK SQ, MILTON PARK, ABINGDON OX14 4RN, OXFORD, ENGLAND			978-1-138-64311-6; 978-1-315-62953-7; 978-1-138-64309-3				2017							526	529					4	Psychology, Clinical; Clinical Neurology; Psychology; Rehabilitation	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Psychology; Neurosciences & Neurology; Rehabilitation	BO7UU	WOS:000525648500063					2022-02-06	
J	Shukla, A; Alqadri, S; Ausmus, A; Bell, R; Nattanmai, P; Newey, CR				Shukla, Anukrati; Alqadri, Syeda; Ausmus, Ashley; Bell, Robert; Nattanmai, Premkumar; Newey, Christopher R.			Vasopressin Bolus Protocol Compared to Desmopressin (DDAVP) for Managing Acute, Postoperative Central Diabetes Insipidus and Hypovolemic Shock	CASE REPORTS IN ENDOCRINOLOGY			English	Article							HYPONATREMIA	Introduction. Management of postoperative central diabetes insipidus (DI) can be challenging from changes in volume status and serum sodium levels. We report a case successfully using a dilute vasopressin bolus protocol in managing hypovolemic shock in acute, postoperative, central DI. Case Report. Patient presented after bifrontal decompressive craniotomy for severe traumatic brain injury. He developed increased urine output resulting in hypovolemia and hypernatremia. He was resuscitated with intravenous fluids including a dilute vasopressin bolus protocol. This protocol consisted of 1 unit of vasopressin in 1 liter of 0.45% normal saline. This protocol was given in boluses based on the formula: urine output minus one hundred. Initial serum sodium was 148 mmol/L, and one-hour urine output was 1 liter. After 48 hours, he transitioned to 1-desamino-8-D-arginine vasopressin (DDAVP). Pre-DDAVP serum sodium was 149 mmol/L and one-hour urine output 320 cc. Comparing the bolus protocol to the DDAVP protocol, the average sodium was 143.8 +/- 3.2 and 149.6 +/- 3.2mmol/L (p = 0.0001), average urine output was 433.2 +/- 354.4 and 422.3 +/- 276.0 cc/hr (p = 0.90), and average specific gravity was 1.019 +/- 0.009 and 1.016 +/- 0.01 (p = 0.42), respectively. Conclusion. A protocol using dilute vasopressin bolus can be an alternative for managing acute, central DI postoperatively, particularly in setting of hypovolemic shock resulting in a consistent control of serum sodium.	[Shukla, Anukrati; Alqadri, Syeda; Nattanmai, Premkumar; Newey, Christopher R.] Univ Missouri, Dept Neurol, Columbia, MO 65211 USA; [Ausmus, Ashley] Univ Missouri, Dept Pharm, Columbia, MO USA; [Bell, Robert] Univ Missouri, Dept Neurosurg, Columbia, MO USA		Newey, CR (corresponding author), Univ Missouri, Dept Neurol, Columbia, MO 65211 USA.	neweyc@health.missouri.edu					Abla AA, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2010.12.FOCUS10235; Achinger SG, 2014, NEPHROL DIAL TRANSPL, V29, P2310, DOI 10.1093/ndt/gfu263; Di Iorgi N, 2012, HORM RES PAEDIAT, V77, P69, DOI 10.1159/000336333; EDWARDS CRW, 1973, BRIT MED J, V3, P375, DOI 10.1136/bmj.3.5876.375; Hoorn EJ, 2010, CLIN KIDNEY J, V3, P42, DOI 10.1093/ndtplus/sfp117; Katz K, 2000, RESUSCITATION, V47, P33, DOI 10.1016/S0300-9572(00)00196-9; MILLER M, 1970, ANN INTERN MED, V73, P721, DOI 10.7326/0003-4819-73-5-721; RALSTON C, 1990, ARCH DIS CHILD, V65, P896, DOI 10.1136/adc.65.8.896; Robertson G. L., 2015, HARRISONS PRINCIPLES; SEIF SM, 1978, J CLIN ENDOCR METAB, V46, P381, DOI 10.1210/jcem-46-3-381	10	1	1	1	3	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-6501	2090-651X		CASE REP ENDOCRINOL	Case Rep. Endocrinol.		2017	2017								3052102	10.1155/2017/3052102			4	Endocrinology & Metabolism	Emerging Sources Citation Index (ESCI)	Endocrinology & Metabolism	EH4OG	WOS:000391749900001	28127476	Green Published, gold, Green Submitted			2022-02-06	
B	Sinnamon, G		Petherick, W; Sinnamon, G		Sinnamon, Grant			Psychopathology as a Mediator of Antisocial and Criminal Behavior	PSYCHOLOGY OF CRIMINAL AND ANTISOCIAL BEHAVIOR: VICTIM AND OFFENDER PERSPECTIVES			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; MAJOR MENTAL-DISORDERS; PERSONALITY-DISORDERS; FRONTOTEMPORAL DEMENTIA; INTELLECTUAL DISABILITY; CORPORATE PSYCHOPATHY; PERSECUTORY IDEATIONS; BIPOLAR DISORDER; VIOLENCE; STALKING		[Sinnamon, Grant] Bond Univ, Gold Coast, Qld, Australia; [Sinnamon, Grant] Bela Menso Brain & Behav Ctr, Varsity Lakes, Qld, Australia		Sinnamon, G (corresponding author), Bond Univ, Gold Coast, Qld, Australia.; Sinnamon, G (corresponding author), Bela Menso Brain & Behav Ctr, Varsity Lakes, Qld, Australia.						Adinkrah M., 1999, VIOLENCE AGAINST WOM, V5, P1294, DOI [10.1177/10778019922183381, DOI 10.1177/10778019922183381]; Adinkrah M, 2008, J CRIM JUST, V36, P209, DOI 10.1016/j.jcrimjus.2008.04.002; Aggarwal M, 2012, ASIAN J PSYCHIATR, V5, P220, DOI 10.1016/j.ajp.2011.11.008; Almond P, 2009, PERSPECT PUBLIC HEAL, V129, P221, DOI 10.1177/1757913909343882; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Appelbaum PS, 2000, AM J PSYCHIAT, V157, P566, DOI 10.1176/appi.ajp.157.4.566; Arseneault L, 2000, ARCH GEN PSYCHIAT, V57, P979, DOI 10.1001/archpsyc.57.10.979; Babiak P, 2010, BEHAV SCI LAW, V28, P174, DOI 10.1002/bsl.925; Batts S, 2009, BEHAV SCI LAW, V27, P261, DOI 10.1002/bsl.857; BECK JC, 1994, HARVARD REV PSYCHIAT, V2, P1, DOI 10.3109/10673229409017107; Blazic M., 2002, INFORMATOLOGIA, V35, P187; Borges L. M., 2005, PRAT PSYCHOL, V11, P47; Brennan PA, 2000, ARCH GEN PSYCHIAT, V57, P494, DOI 10.1001/archpsyc.57.5.494; Brock G. W., 1917, J ABNORM PSYCHOL, V12, P232; BRONFENBRENNER U, 1994, PSYCHOL REV, V101, P568, DOI 10.1037/0033-295X.101.4.568; Brown M., 2012, INT J DIVERSITY ORGA, V11, P99; Brown RG, 2000, TRENDS NEUROSCI, V23, P412, DOI 10.1016/S0166-2236(00)01626-X; Butler JC, 2013, INT J PSYCHOL, V48, P18, DOI 10.1080/00207594.2012.698392; Caligor E, 2015, AM J PSYCHIAT, V172, P415, DOI 10.1176/appi.ajp.2014.14060723; Carabellese F, 2013, MED SCI LAW, V53, P123, DOI 10.1177/0025802413477397; Carabellese F, 2014, J FORENSIC LEG MED, V21, P9, DOI 10.1016/j.jflm.2013.10.012; Chase Alex, 2015, Nat Rev Neurol, V11, P67, DOI 10.1038/nrneurol.2015.1; Chevignard MP, 2014, PEDIATR RADIOL, V44, P548, DOI 10.1007/s00247-014-3169-8; Cipriani G., 2015, GERIATRICS GERONTOLO; Cockram J, 2005, J INTELLECT DEV DIS, V30, P3, DOI 10.1080/13668250500033177; Cohen S, 1996, BRIT J SOCIOL, V47, P1, DOI 10.2307/591113; Coid JW, 2015, INT J LAW PSYCHIAT, V38, P68, DOI 10.1016/j.ijlp.2015.01.009; COMER R, 2005, FUNDAMENTALS ABNORMA; Crail-Melendez D, 2013, NEUROCASE, V19, P22, DOI 10.1080/13554794.2011.654211; Crocker AG, 2007, J INTELLECT DEV DIS, V32, P143, DOI 10.1080/13668250701314053; Cullen F.T., 1994, JUSTICE Q, V11, P527, DOI [https://doi.org/10.1080/07418829400092421, 10.1080/07418829400092421, DOI 10.1080/07418829400092421]; Daff E, 2014, SOC PSYCH PSYCH EPID, V49, P1985, DOI 10.1007/s00127-014-0882-4; Davis J A, 1997, J Clin Forensic Med, V4, P166, DOI 10.1016/S1353-1131(97)90026-2; DelBello MP, 1999, PSYCHIAT RES, V89, P281, DOI 10.1016/S0165-1781(99)00112-2; Deloitte Access Economics, 2012, COST PER DEPR AUSTR; Di Girolamo F, 1981, Rass Penititenziaria Crim, V3, P481; Echavarri C, 2013, J ALZHEIMERS DIS, V33, P715, DOI 10.3233/JAD-2012-121003; Elbogen EB, 2009, ARCH GEN PSYCHIAT, V66, P152, DOI 10.1001/archgenpsychiatry.2008.537; Eronen M, 1996, SCHIZOPHRENIA BULL, V22, P83, DOI 10.1093/schbul/22.1.83; Every-Palmer S, 2013, AUST NZ J PSYCHIAT, V47, P961, DOI 10.1177/0004867413479409; Fazel S, 2008, INT J LAW PSYCHIAT, V31, P369, DOI 10.1016/j.ijlp.2008.06.001; Fazel S, 2006, AM J PSYCHIAT, V163, P1397, DOI 10.1176/appi.ajp.163.8.1397; Fazel S, 2015, LANCET PSYCHIAT, V2, P224, DOI 10.1016/S2215-0366(14)00128-X; Fazel S, 2009, J NEUROL, V256, P1591, DOI 10.1007/s00415-009-5134-2; Fountoulakis KN, 2008, CURR OPIN PSYCHIATR, V21, P84, DOI 10.1097/YCO.0b013e3282f31137; Friedman SH, 2012, PSYCHIAT CLIN N AM, V35, P781, DOI 10.1016/j.psc.2012.08.002; Friedman SH, 2012, BEHAV SCI LAW, V30, P585, DOI 10.1002/bsl.2034; Gauffin H, 2014, NEUROPSYCH DIS TREAT, V10, P2183, DOI 10.2147/NDT.S68438; Glaser B., 1996, PSYCHIAT LAW, P194; Glaser W, 1999, INT J OFFENDER THER, V43, P338, DOI 10.1177/0306624X99433007; GOTTLIEB P, 1987, ACTA PSYCHIAT SCAND, V76, P285, DOI 10.1111/j.1600-0447.1987.tb02897.x; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Grann M, 1999, LAW HUMAN BEHAV, V23, P205, DOI 10.1023/A:1022372902241; Gross H., 1911, CRIMINAL PSYCHOL MAN; Haddad PM, 2014, PATIENT-RELAT OUTCOM, V5, P43, DOI 10.2147/PROM.S42735; HARPER D., 2013, ONLINE ETYMOLOGY DIC; Healy W, 1915, PATHOLOGICAL LYING A; Hengartner MP, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00087; HIRSCHI T, 1977, AM SOCIOL REV, V42, P571, DOI 10.2307/2094556; HODGINS S, 1992, ARCH GEN PSYCHIAT, V49, P476, DOI 10.1001/archpsyc.1992.01820060056009; Hodgins S, 2010, CAN J PSYCHIAT, V55, P784, DOI 10.1177/070674371005501206; Hogue Todd, 2006, Crim Behav Ment Health, V16, P13, DOI 10.1002/cbm.52; Holland S, 2011, PSYCHOL CRIME LAW, V17, P25, DOI 10.1080/10683160903392285; Jha MK, 2015, J CLIN PSYCHOPHARM, V35, P732, DOI 10.1097/JCP.0000000000000414; Jones G. P., 1990, PREVALENCE INTELLECT; Kane JM, 2013, WORLD PSYCHIATRY, V12, P216, DOI 10.1002/wps.20060; Lancaster, 2007, BRIT J LEARN DISABIL, V35, P162, DOI [DOI 10.1111/J.1468-3156.2007.00461.X, 10.1111/j.1468-3156.2007.00461.x]; Lelandais GE, 2013, CITIZENSHIP STUD, V17, P817, DOI 10.1080/13621025.2013.834134; Liljegren M, 2015, JAMA NEUROL, V72, P295, DOI 10.1001/jamaneurol.2014.3781; LINDQVIST P, 1990, BRIT J PSYCHIAT, V157, P345, DOI 10.1192/bjp.157.3.345; Lombroso C, 1895, FEMALE OFFENDER; Marzuk PM, 1996, ARCH GEN PSYCHIAT, V53, P483; Mathieu C, 2015, ASSESSMENT, V22, P267, DOI 10.1177/1073191114545490; Maudsley H, 1876, RESPONSIBILITY MENTA; McDonald A., 1905, MAN ABNORMAL MAN INC; McEwan TE, 2013, AUST NZ J PSYCHIAT, V47, P546, DOI 10.1177/0004867413479408; McGuire B, 2000, J FORENSIC PSYCHIATR, V11, P316, DOI 10.1080/09585180050142543; McIlwain D, 1988, PREVALENCE INTELLECT; McKenzie K., 2006, SOCIAL CAPITAL MENTA; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P507, DOI 10.1097/HTR.0000000000000000; Miller L, 2012, AGGRESS VIOLENT BEH, V17, P495, DOI 10.1016/j.avb.2012.07.001; Monahan J, 2000, BRIT J PSYCHIAT, V176, P312, DOI 10.1192/bjp.176.4.312; Mouzos J., 2011, WOMENS EXPERIENCES M, V56; Muller JL, 2003, PSYCHIAT PRAX, V30, pS221; Nestor PG, 2002, AM J PSYCHIAT, V159, P1973, DOI 10.1176/appi.ajp.159.12.1973; New South Wales Law Reform Commission, 1996, PEOPL INT DIS CRIM J; Nicholls J, 2014, PSYCHIAT RES, V220, P909, DOI 10.1016/j.psychres.2014.08.040; Norris SM, 2011, VIOLENCE VICTIMS, V26, P103, DOI 10.1891/0886-6708.26.1.103; Parees I, 2013, MOVEMENT DISORD, V28, P1622, DOI 10.1002/mds.25544; Paterson B, 2001, J Psychiatr Ment Health Nurs, V8, P257, DOI 10.1046/j.1365-2850.2001.00392.x; Paulson JF, 2010, JAMA-J AM MED ASSOC, V303, P1961, DOI 10.1001/jama.2010.605; Peterson J, 2010, PSYCHIAT SERV, V61, P1217, DOI 10.1176/ps.2010.61.12.1217; Petherick W., 2013, MOTIVATIONS OFFENDER, P393; PETURSSON H, 1981, ACTA PSYCHIAT SCAND, V64, P363, DOI 10.1111/j.1600-0447.1981.tb00795.x; Pinkofsky HB, 1997, PSYCHIATR SERV, V48, P1197; Quanbeck CD, 2004, J CLIN PSYCHIAT, V65, P198; Raposo A, 2011, SOC COGN AFFECT NEUR, V6, P260, DOI 10.1093/scan/nsq033; Rezansoff SN, 2013, PSYCHOL PUBLIC POL L, V19, P443, DOI 10.1037/a0033907; Ritchie EC, 2013, J AM ACAD PSYCHIATRY, V41, P224; Romero-Martinez A, 2013, REV NEUROLOGIA, V57, P515, DOI 10.33588/rn.5711.2013141; Seitz RJ, 2006, NEUROPSYCHOLOGY, V20, P743, DOI 10.1037/0894-4105.20.6.743; Shackelford TK, 2005, J INTERPERS VIOLENCE, V20, P1310, DOI 10.1177/0886260505278606; Signorelli MS, 2013, BMJ CASE REPORTS, DOI 10.1136/BCR-2013-010080; Silva JA, 2000, J FORENSIC SCI, V45, P77; Sinnamon G., 2015, APPL CRIME ANAL SOCI; Spencer J, 2013, AUSTRALAS PSYCHIATRY, V21, P147, DOI 10.1177/1039856212470501; Steadman HJ, 1998, ARCH GEN PSYCHIAT, V55, P393, DOI 10.1001/archpsyc.55.5.393; SWANSON JW, 1990, HOSP COMMUNITY PSYCH, V41, P761; Swanson JW, 1994, VIOLENCE MENTAL DISO; Thompson CM, 2013, CRIM JUSTICE BEHAV, V40, P850, DOI 10.1177/0093854813489955; Tiihonen J, 1997, AM J PSYCHIAT, V154, P840; Van Dongen JDM, 2012, CRIM BEHAV MENT HEAL, V22, P350, DOI 10.1002/cbm.1836; van Dongen JDM, 2012, PSYCHIAT RES, V200, P779, DOI 10.1016/j.psychres.2012.05.016; Vaughn MG, 2010, ANN EPIDEMIOL, V20, P281, DOI 10.1016/j.annepidem.2009.11.011; Vicens E, 2011, CRIM BEHAV MENT HEAL, V21, P321, DOI 10.1002/cbm.815; Vogenthaler D R, 1987, Brain Inj, V1, P113; Volavka J., 2011, PLOS MED, V8; Vorspan F, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-014-0544-y; Wallace C, 2004, AM J PSYCHIAT, V161, P716, DOI 10.1176/appi.ajp.161.4.716; Wallace C, 1998, BRIT J PSYCHIAT, V172, P477, DOI 10.1192/bjp.172.6.477; WHITMAN S, 1984, NEUROLOGY, V34, P775, DOI 10.1212/WNL.34.6.775; Whittington R., 2013, HLTH TECHNOLOGY ASSE, V17; Wilcox D. E., 1985, AM J FORENSIC PSYCH, V6, P3; Williams M, 2010, AUST FEMINIST STUD, V25, P281, DOI 10.1080/08164649.2010.504293; Williams WH, 2015, J HEAD TRAUMA REHAB, V30, P69, DOI 10.1097/HTR.0000000000000134; World Health Organization, 2010, ICD 10 CLASS MENT BE; World Health Organization, 2004, ICD 10 INT STAT CLAS; Yamagishi T, 2014, PSYCHOL SCI, V25, P1699, DOI 10.1177/0956797614538065; Zugman A, 2013, SCHIZOPHR RES, V144, P151, DOI 10.1016/j.schres.2012.11.036	129	1	1	0	5	ELSEVIER ACADEMIC PRESS INC	SAN DIEGO	525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA			978-0-12-809577-5; 978-0-12-809287-3				2017							1	50		10.1016/B978-0-12-809287-3.00001-8			50	Psychology, Clinical; Criminology & Penology; Psychology, Multidisciplinary	Book Citation Index – Social Sciences & Humanities (BKCI-SSH)	Psychology; Criminology & Penology	BJ5YN	WOS:000426404100002					2022-02-06	
J	Sousa, KD; de Oliveira, WIF; Alves, EA; Gama, ZAD				Sousa, Kelienny de Meneses; Fonsesa de Oliveira, Wagner Ivan; Alves, Emanuel Augusto; da Silva Gama, Zenewton Andre			Factors associated with access to physical rehabilitation for victims of traffic accidents	REVISTA DE SAUDE PUBLICA			English	Article						Accidents, Traffic; Rehabilitation Services; Health Services Accessibility; Quality of Health Care	HEALTH; BRAZIL; CARE	OBJECTIVE: Evaluate the level of access to physical rehabilitation for survivors of traffic accidents and the associated factors. METHODS: A cross-sectional study performed in Natal, Northeastern Brazil, through a telephone survey of 155 victims of traffic accidents admitted to an emergency hospital between January and August of 2013, with a diagnosis of fracture, traumatic brain injury or amputation. Participants were identified in the database of the reference hospital for care of traffic accident victims. We calculated point estimates and confidence interval (95%CI) for the frequency of subjects who had access, in addition to multivariate analysis (logistic regression) between access (dependent variable) and sociodemographic, clinical, and assistance variables. RESULTS: Among the 155 respondents, the majority were adolescents and adults between 15-29 years of age (47.7%), men (82.6%), education up to high school (92.3%), income of up to two minimum wages (78.0%) and bikers (75.5%). Although 85.8% of traffic accident survivors reported the need for physical rehabilitation, there was little access (51.6%; 95% CI 43.7-59.4) and a delay to start the physical rehabilitation (average = 67 days). We classified factors associated with access to physical rehabilitation as: (i) unmodifiable individuals in the short term - family income greater than two minimum wages (OR = 3.7), informal worker (OR = 0.11) or unemployed (OR = 0.15) and possession of a private health care plan (OR = 0.07); and (ii) assistance modifiable by service management -written referral for physical rehabilitation (OR = 27.5) and perceived need of physical rehabilitation (OR = 10). CONCLUSIONS: This study found a low and slow access to physical rehabilitation for individuals potentially in need. The associated factors were the organizational processes of health care (health information and referral) and social determinants (income, occupation and private health care plan).	[Sousa, Kelienny de Meneses] Univ Fed Rio Grande do Norte, Programa Posgrad Saude Colet, Natal, RN, Brazil; [Fonsesa de Oliveira, Wagner Ivan] Inst Fed Educ Ciencia & Tecnol Rio Grande do Nort, Sao Paulo Do Potengi, RN, Brazil; [Alves, Emanuel Augusto] Univ Fed Rio Grande do Norte, Curso Med, Natal, RN, Brazil; [da Silva Gama, Zenewton Andre] Univ Fed Rio Grande do Norte, Dept Saude Colet, Natal, RN, Brazil		Sousa, KD (corresponding author), Univ Fed Rio Grande do Norte, Ctr Ciencias Saude, Dept Saude Colet, Campus Cent Ctr Ciencias Saude, BR-59078970 Natal, RN, Brazil.	kelienny@gmail.com		Da Silva Gama, Zenewton Andre/0000-0003-0818-9680; Ivan Fonseca de Oliveira, Wagner/0000-0002-5273-6525; Sousa, Kelienny/0000-0001-6842-7033	Improvement Commission for Higher Education Personnel (CAPES - master's scholarship)	Improvement Commission for Higher Education Personnel (CAPES - master's scholarship).	Aday LA, 1974, HEALTH SERV RES, V9, P208; Bacchieri G, 2011, REV SAUDE PUBL, V45, P949, DOI 10.1590/S0034-89102011005000069; Barata RB, 2008, SAO PAULO PERSPECT, V22, P19; Bettger JAP, 2013, ARCH PHYS MED REHAB, V94, P38, DOI 10.1016/j.apmr.2012.06.029; Boff BM, 2002, REV SAUDE PUBL, V36, P337, DOI 10.1590/S0034-89102002000300013; Brito, 2012, REV BAIANA SAUDE PUB, V36, P699, DOI [10.22278/2318-2660.2012.v36.n3.a548, DOI 10.22278/2318-2660.2012.V36.N3.A548]; Buss Paulo M., 2006, Cad. Saúde Pública, V22, P2005, DOI 10.1590/S0102-311X2006000900033; Deslandes Suely Ferreira, 2006, Ciênc. saúde coletiva, V11, P385, DOI 10.1590/S1413-81232006000200016; Feijo M C, 2001, Cad Saude Publica, V17, P627, DOI 10.1590/S0102-311X2001000300017; Gawryszewski Ana Raquel Bonder, 2012, Physis, V22, P119; Gawryszewski VP, 2009, REV SAUDE PUBL, V43, P275, DOI 10.1590/S0034-89102009000200008; Glina D M, 2001, Cad Saude Publica, V17, P607; Kassouf Ana Lúcia, 2005, Rev. Econ. Sociol. Rural, V43, P29, DOI 10.1590/S0103-20032005000100002; de Lima MLLT, 2012, CIENC SAUDE COLETIVA, V17, P33, DOI 10.1590/S1413-81232012000100006; Mendoza-Sassi R, 2003, REV SAUDE PUBL, V37, P372, DOI 10.1590/S0034-89102003000300017; Oliveira Evangelina Xavier Gouveia de, 2011, Ciênc. saúde coletiva, V16, P3649; Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8; Chiavegatto ADP, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049005246; Salzwedel A, 2014, EUR J PREV CARDIOL, V21, P172, DOI 10.1177/2047487312469475; Sousa KD, 2017, DISABIL REHABIL, V39, P568, DOI 10.3109/09638288.2016.1152606; Stucki G, 2005, DISABIL REHABIL, V27, P353, DOI 10.1080/09638280400014105; Tôrres Aleide Karine Vieira, 2011, Rev. Bras. Saude Mater. Infant., V11, P427, DOI 10.1590/S1519-38292011000400009; TRAVASSOS C, 2000, CIENC SAUDE COLETIVA, V5, P133, DOI DOI 10.1590/S1413-81232000000100012; Travassos Cláudia, 2002, Rev Panam Salud Publica, V11, P365, DOI 10.1590/S1020-49892002000500011; Waiselfisz JJ, 2013, MAPA VIOLENCIA 2013; WHO, 2006, QUAL CAR PROC MAK ST; World Health Organization, 2013, GLOB STAT REP ROAD S; Yin ZJ, 2007, DISABIL REHABIL, V29, P825, DOI 10.1080/09638280600919657	28	1	2	4	6	REVISTA DE SAUDE PUBLICA	SAO PAULO	FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO, BRAZIL	0034-8910	1518-8787		REV SAUDE PUBL	Rev. Saude Publica		2017	51								54	10.1590/S1518-8787.2017051006429			12	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	FG7OJ	WOS:000410607300004	28658365	gold, Green Published, Green Submitted			2022-02-06	
J	Stam, D; Fernandez, J				Stam, Daniel; Fernandez, Jennifer			Robotic gait assistive technology as means to aggressive mobilization strategy in acute rehabilitation following severe diffuse axonal injury: a case study	DISABILITY AND REHABILITATION-ASSISTIVE TECHNOLOGY			English	Article						Assistive technology; gait; neuroplasticity; traumatic brain injury	TRAUMATIC BRAIN-INJURY; NEUROPLASTICITY; CONSCIOUSNESS; RECOVERY; TIME	Introduction: Diffuse axonal injury is a prominent cause of disablement post-traumatic brain injury. Utilization of the rapid expansion of our current scientific knowledge base combined with greater access to neurological and assistive technology as adjuncts to providing sensorimotor experience may yield innovative new approaches to rehabilitation based upon a dynamic model of brain response following injury. Case description: A 24-year-old female who sustained a traumatic brain injury, bilateral subdural hemorrhage, subarachnoid hemorrhage and severe diffuse axonal injury secondary to a motor vehicle collision. Discussion and conclusions: Evidence-based appraisal of present literature suggests a link between graded intensity of aerobic activity to facilitation of neuro-plastic change and up-regulation of neurotrophins essential to functional recovery post-diffuse axonal injury. Following resolution of paroxysmal autonomic instability with dystonia, aggressive early mobilization techniques were progressed utilizing robotic assistive gait technology in combination with conventional therapy. This approach allowed for arguably greater repetition and cardiovascular demands across a six-month inpatient rehabilitation stay. Outcomes in this case suggest that the use of assistive technology to adjunct higher level and intensity rehabilitation strategies may be a safe and effective means towards reduction of disablement following severe traumatic brain and neurological injury.	[Stam, Daniel] Mayo Clin, Rochester, MN 55905 USA; [Fernandez, Jennifer] Brooks Inst Higher Learning, Jacksonville, FL USA		Stam, D (corresponding author), Mayo Clin, Rochester, MN 55905 USA.	destam@alumni.nmu.edu					Baguley IJ, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P874; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; Cramer SC, 2011, BRAIN, V134, P1591, DOI 10.1093/brain/awr039; DeJong G, 2011, PHYS THER, V91, P1826, DOI 10.2522/ptj.20100424; Ding YC, 2001, NEUROL RES, V23, P193, DOI 10.1179/016164101101198334; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Kothari S, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P248; Lopez-Larson MP, 2011, DEV COGN NEUROS-NETH, V1, P187, DOI 10.1016/j.dcn.2010.10.001; Park SJ, 2009, J KOREAN NEUROSURG S, V46, P205, DOI 10.3340/jkns.2009.46.3.205; Schendan HE, 2003, NEURON, V37, P1013, DOI 10.1016/S0896-6273(03)00123-5; Schneider EB, 2014, NEUROLOGY, V82, P1636, DOI 10.1212/WNL.0000000000000379; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Swain RA, 2012, BRAIN SCI, V2, P709, DOI 10.3390/brainsci2040709; Yokobori S, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P137; Yu Y, 2011, NEURAL REGEN RES, V6, P1942, DOI 10.3969/j.issn.1673-5374.2011.25.004	17	1	1	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1748-3107	1748-3115		DISABIL REHABIL-ASSI	Disabil. Rehabil.-Assist. Technol.		2017	12	5					543	549		10.3109/17483107.2016.1139633			7	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	EX6ZQ	WOS:000403392700015	27049732				2022-02-06	
J	Steele, JJ				Steele, John Joseph, III			Single Neurosurgeon Operative Experience at Craig Joint Theater Hospital During the Afghanistan Surge (November 2010 to April 2011), Part II: Humanitarian Cases	MILITARY MEDICINE			English	Article								Background: The Afghanistan Surge saw NATO troops working with their Afghan partners to remove Taliban governance and replace it with a more democratic model. As part of this endeavor, medical support for both trauma and humanitarian cases was needed. Objective: Identify and discuss disease trends to better prepare for future combat medical treatments. Methods: Retrospective review of operative experience from a neurosurgeon from November 2010 to April 2011. Results: 63 cases were performed on 20 NATO and 43 Afghan patients. Combat-related neurotrauma represented 73% (46/63) of cases and humanitarian cases represented the remainder. The most common diseases among humanitarian cases were benign tumors (29%, 5/17), cranioplasty (23%, 4/17), obstructive hydrocephalus (11%, 2/17), nonobstructive hydrocephalus (11%, 2/17), hemifacial spasm (11%, 2/17), and cerebral angiography (11%, 2/17). There was 1 death from ventriculitis for a complication rate of 6%. Conclusion: In select well-nourished, patients with minimal risk of needing tracheostomy, humanitarian neurosurgery can be safely performed in theater with a complication rate (6%) no worse than patients operated on in the United States.	[Steele, John Joseph, III] Wright Patterson Med Ctr, Dept Neurol Surg, 4881 Sugar Maple Dr, Wright Patterson AFB, OH 45433 USA		Steele, JJ (corresponding author), Wright Patterson Med Ctr, Dept Neurol Surg, 4881 Sugar Maple Dr, Wright Patterson AFB, OH 45433 USA.						Central Intelligence Agency, 2012, WORLD FACTB INF MORT; Hawley JS, 2012, MIL MED, V177, P121, DOI 10.7205/MILMED-D-11-00229; Whitbread J, 2010, SAVE CHILDREN STATE; YOUNG RF, 1987, J NEUROSURG, V66, P701, DOI 10.3171/jns.1987.66.5.0701	4	1	1	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JAN-FEB	2017	182	1-2							e1614	10.7205/MILMED-D-15-00590			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER6VA	WOS:000398945500017	28051982	Bronze			2022-02-06	
J	Su, BY; Guo, NW; Chen, NC; Lin, SS; Chuang, MT; Liao, YC; Kuo, CM; Lin, CW; Chou, W; Kuo, JR; Yen, SY				Su, Bei-Yi; Guo, Nai-Wen; Chen, Nan-Chun; Lin, Sheng-Sian; Chuang, Ming-Tsung; Liao, Yu-Chi; Kuo, Chia-Min; Lin, Cheng-Wei; Chou, Willy; Kuo, Jinn-Rung; Yen, Shih-Yin			Brain contusion as the main risk factor of memory or emotional complaints in chronic complicated mild traumatic brain injury	BRAIN INJURY			English	Article						Complicated mild traumatic brain injury; contusion; emotion; memory; return to work	PERSISTENT POSTCONCUSSION SYNDROME; HEAD-INJURY; ORBITOFRONTAL CORTEX; WORKING-MEMORY; DEPRESSION; CRITERIA; RETURN; PREDICTORS; ICD-10	Objective: To investigate the risk factors for memory or emotional complaints in patients with complicated mild traumatic brain injury (mTBI).Methods: Retrospective analysis of medical records was conducted by physicians in a teaching hospital in Southern Taiwan, and complicated mTBI had been identified by means of computed tomography. Psychological complaints, including problems with memory and emotions, were collected by structured telephone interviews, 10-15 minutes long, and were held with subjects who agreed to participate in our study. Among 327 patients who were injured for more than two years, 190 agreed to join this study (mean age: 41.6 years; male: 60.5%; stably employed: 50.0%). We used demographic data and neurological factors to predict memory or emotional complaints without muscle power or response speed (MEMR) complaints.Results: Only the presence or absence of cerebral contusions predicted memory or emotional complaints without MEMR complaints in different employed status, and the odds ratio was 4.82-13.50 times higher for those with cerebral contusions than for those without.Conclusions: Cerebral contusions were the primary risk factor for MEMR complaints in chronic complicated mTBI. Early preventive psychological intervention might be necessary for patients with complicated mTBI and cerebral contusions.	[Su, Bei-Yi; Guo, Nai-Wen; Liao, Yu-Chi] Natl Cheng Kung Univ, Inst Allied Hlth Sci, Coll Med, 1 Univ Rd, Tainan 701, Taiwan; [Guo, Nai-Wen; Chen, Nan-Chun; Lin, Sheng-Sian; Kuo, Chia-Min] Natl Cheng Kung Univ, Inst Behav Med, Coll Med, 1 Univ Rd, Tainan 701, Taiwan; [Chuang, Ming-Tsung] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Dept Diagnost Radiol, Coll Med, Tainan, Taiwan; [Lin, Cheng-Wei] Natl Cheng Kung Univ Hosp, Dept Orthoped, Tainan, Taiwan; [Chou, Willy; Yen, Shih-Yin] Chi Mei Med Ctr, Dept Phys Med & Rehabil, Tainan, Taiwan; [Chou, Willy] Chia Nan Univ Pharm & Sci, Recreat Management Dept, Tainan, Taiwan; [Kuo, Jinn-Rung] Chi Mei Med Ctr, Dept Neurosurg, Tainan, Taiwan; [Kuo, Jinn-Rung] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan		Guo, NW (corresponding author), Natl Cheng Kung Univ, Inst Allied Hlth Sci, Coll Med, 1 Univ Rd, Tainan 701, Taiwan.; Guo, NW (corresponding author), Natl Cheng Kung Univ, Inst Behav Med, Coll Med, 1 Univ Rd, Tainan 701, Taiwan.	austing@mail.ncku.edu.tw	Liao, Yu-Chi/AAT-1357-2021	Liao, Yu-Chi/0000-0002-7616-949X	Ministry of Science and Technology MOSTMinistry of Science and Technology, China [104-2314-B-006-033]; Chi-Mei Medical Center [CMNCKU10319]	The authors declare no conflicts of interest. This research was funded by the grants of Ministry of Science and Technology MOST 104-2314-B-006-033, and the Chi-Mei Medical Center CMNCKU10319.	ALTMAN DG, 1991, PRACTICAL STAT MED R, P404; American Psychiatric Association, 2013, DIAGN STAT MAN MENT; Barbey AK, 2011, CEREB CORTEX, V21, P789, DOI 10.1093/cercor/bhq153; Beer JS, 2003, J PERS SOC PSYCHOL, V85, P594, DOI 10.1037/0022-3514.85.4.594; Boake C, 2004, J NEUROPSYCH CLIN N, V16, P493, DOI 10.1176/appi.neuropsych.16.4.493; Bohnen N., 1992, Brain Injury, V6, P481, DOI 10.3109/02699059209008145; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Carroll Linda J., 2004, Journal of Rehabilitation Medicine Supplement, P113; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; Chlu WT, 2007, J CLIN NEUROSCI, V14, P930, DOI 10.1016/j.jocn.2006.08.004; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cicerone KD, 1997, ARCH CLIN NEUROPSYCH, V12, P173, DOI 10.1016/S0887-6177(96)00022-4; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Gerberding JLBS, 2003, REP C MILD TRAUM BRA; Ghawami H, 2016, APPL NEUROPSYCH-ADUL, P2327; Godbolt Alison K, 2014, Arch Phys Med Rehabil, V95, pS245, DOI 10.1016/j.apmr.2013.06.036; Hynes CA, 2006, NEUROPSYCHOLOGIA, V44, P374, DOI 10.1016/j.neuropsychologia.2005.06.011; Iaccarino C, 2014, J NEUROSURG, V120, P908, DOI 10.3171/2013.12.JNS131090; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Kashluba S, 2006, J INT NEUROPSYCH SOC, V12, P111, DOI 10.1017/S1355617706060036; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS295, DOI 10.1016/j.apmr.2013.08.296; Lange RT, 2009, BRAIN INJURY, V23, P83, DOI 10.1080/02699050802635281; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; LoPresti ML, 2008, J NEUROSCI, V28, P3718, DOI 10.1523/JNEUROSCI.0464-08.2008; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McCauley SR, 2005, J NERV MENT DIS, V193, P540, DOI 10.1097/01.nmd.0000172592.05801.71; McCullagh S, 2003, J NEUROL NEUROSUR PS, V74, P39, DOI 10.1136/jnnp.74.1.39; Nolin P, 2006, J HEAD TRAUMA REHAB, V21, P514, DOI 10.1097/00001199-200611000-00006; Ramus SJ, 2007, ANN NY ACAD SCI, V1121, P216, DOI 10.1196/annals.1401.038; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P100, DOI 10.1176/appi.neuropsych.22.1.100; Ruffolo CF, 1999, ARCH PHYS MED REHAB, V80, P392, DOI 10.1016/S0003-9993(99)90275-7; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Smits M, 2008, AM J NEURORADIOL, V29, P506, DOI 10.3174/ajnr.A0852; Stuss DT, 2000, PSYCHOL RES-PSYCH FO, V63, P289, DOI 10.1007/s004269900007; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Waljas M, 2014, J HEAD TRAUMA REHAB, V29, P443, DOI 10.1097/HTR.0000000000000002; Watkins MP., 2015, FDN CLIN RES APPL PR, V3rd; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Yellinek S, 2016, J CLIN NEUROSCI, V25, P111, DOI 10.1016/j.jocn.2015.10.012	42	1	1	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	5					601	606		10.1080/02699052.2016.1267800			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EV8OA	WOS:000402039900004	28350185				2022-02-06	
J	Swaine, B; Dassa, C; Kone, A; Dutil, E; Demers, L; Trempe, C				Swaine, Bonnie; Dassa, Clement; Kone, Anna; Dutil, Elisabeth; Demers, Louise; Trempe, Claire			The PQRS-Montreal: a measure of patients' perceptions of the quality of rehabilitation services for persons with a traumatic brain injury	DISABILITY AND REHABILITATION			English	Article						Measurement; outcome; quality; service delivery; traumatic brain injury; the PQSR-Montreal	HEALTH-CARE; SATISFACTION; NEEDS; INDIVIDUALS; EXPERIENCES; ADOLESCENTS; VALIDATION; FAMILIES; IMPACT	Purpose To determine the factorial validity, internal consistency, criterion-related and concurrent validity of the Perception of Quality of Rehabilitation Services - Montreal (PQRS-Montreal) questionnaire for persons receiving traumatic brain injury (TBI) rehabilitation services. Design Cross-sectional study. Setting Seventeen facilities providing acute care and intensive inpatient and outpatient TBI adult rehabilitation. Participants Five-hundred thirty adults (GCS=3-15; mean age =41.5 +/- 16.9 years) who received rehabilitation were administered the questionnaire during an interview near time of discharge. Subjects responded to the 61 PQRS-Montreal items (five-point scale of agreement) and to the Client Satisfaction Question (CSQ8). Results Exploratory and confirmatory factor analyses identified three potential subscales (one- and two-factor solutions) explaining 26.1-41% of the variance (ecological approach, quality of team, service organization). The subscales' internal structures were interpretable and their internal consistency varied from 0.51 to 0.90 (Cronbach's alpha). Rehabilitation phase significantly and positively impacted factor scores and all factor scores were significantly and moderately correlated with CSQ8 scores. Conclusions The PQRS-Montreal possesses adequate psychometric properties supporting its use as a valid tool to measure patients' perception of the quality of TBI rehabilitation services. This tool could help guide the development and monitoring of TBI rehabilitation service delivery.	[Swaine, Bonnie; Dutil, Elisabeth; Demers, Louise] Univ Montreal, Ecole Readaptat, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada; [Swaine, Bonnie; Dutil, Elisabeth; Trempe, Claire] Ctr Interdisciplinary Res Rehabil Greater Montrea, Montreal, PQ, Canada; [Dassa, Clement] Univ Montreal, Ecole Sante Publ, Montreal, PQ, Canada; [Kone, Anna] Univ Montreal, GRIS, Montreal, PQ, Canada; [Demers, Louise] Inst Univ Geriatrie Montreal, Res Ctr, Montreal, PQ, Canada; [Trempe, Claire] Univ Montreal, Inst Nazareth & Louis Braille, Montreal, PQ, Canada		Swaine, B (corresponding author), Univ Montreal, Ecole Readaptat, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	bonnie.swaine@umontreal.ca			Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [F086429]; Fonds de recherche en sante du QuebecFonds de la Recherche en Sante du Quebec [6168]	Funding was obtained from the Canadian Institutes of Health Research (grant number F086429) and of the Fonds de recherche en sante du Quebec (grant number 6168). The authors report no conflict of interest.	Bienvenue N, 2004, TOR ABI NETW C 18 19; Bier N, 2009, J HEAD TRAUMA REHAB, V24, P187, DOI 10.1097/HTR.0b013e3181a0b15a; Bond A Elaine, 2003, Crit Care Nurse, V23, P63; COPE DN, 1995, BRAIN INJURY, V9, P649, DOI 10.3109/02699059509008224; Cullen N, 2007, BRAIN INJURY, V21, P113, DOI 10.1080/02699050701201540; de Guise E, 2005, CAN J NEUROL SCI, V32, P186, DOI 10.1017/S0317167100003954; DeVellis R.F., 1991, SCALE DEV; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; Dillman DA, 1978, MAIL TELEPHONE SURVE, V19; Dutil E, 1998, EVALUATION FONCTIONN; Dutil E, 1998, CANADIAN J REHABILIT, V11, P268; Gagnon I, 2008, BRAIN INJURY, V22, P161, DOI 10.1080/02699050701867381; Grilli Lisa, 2007, Healthc Policy, V2, pe171; Haggerty J, 2007, ANN FAM MED, V5, P336, DOI 10.1370/afm.682; Heinemann AW, 2002, ARCH PHYS MED REHAB, V83, P1052, DOI 10.1053/apmr.2002.34283; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jaipaul CK, 2003, J GEN INTERN MED, V18, P23, DOI 10.1046/j.1525-1497.2003.20114.x; Jenkinson C, 2002, QUAL SAF HEALTH CARE, V11, P335, DOI 10.1136/qhc.11.4.335; Keith RA, 1998, ARCH PHYS MED REHAB, V79, P1122, DOI 10.1016/S0003-9993(98)90182-4; Kolakowsky-Hayner SA, 2000, NEUROREHABILITATION, V14, P151; KREUTZER JS, 1994, J HEAD TRAUMA REHAB, V9, P104, DOI 10.1097/00001199-199409000-00009; Krumholz HM, 2000, STROKE, V31, P1002, DOI 10.1161/01.STR.31.4.1002; Lamontagne ME, 2010, BRAIN INJURY, V24, P812, DOI 10.3109/02699051003789252; Larsen D L, 1979, Eval Program Plann, V2, P197, DOI 10.1016/0149-7189(79)90094-6; Maizes V, 2009, EXPLORE-NY, V5, P277, DOI 10.1016/j.explore.2009.06.008; Man DWK, 2004, BRAIN INJURY, V18, P577, DOI 10.1080/02699050310001646143; Moules S, 1999, BRAIN INJURY, V13, P983; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Panting A, 1972, REHABILITATION, V38, P33; Pegg PO, 2005, REHABIL PSYCHOL, V50, P366, DOI 10.1037/0090-5550.50.4.366; Petersen C, 2006, BRAIN INJURY, V20, P321, DOI 10.1080/02699050500488108; Pound P, 1999, STROKE, V30, P49, DOI 10.1161/01.STR.30.1.49; Quintana JM, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-102; Rossi P. H., 2004, EVALUATION SYSTEMATI; Schermelleh-Engel K., 2003, METHODS PSYCHOL RES, V8, P23; Sitzia J, 1997, SOC SCI MED, V45, P1829, DOI 10.1016/S0277-9536(97)00128-7; Sohlberg McKay Moore, 2000, Seminars in Speech and Language, V21, P135; Stewart M, 2000, J FAM PRACTICE, V49, P796; Streiner D.L., 2008, BIOSTATISTICS BARE E; Swaine BR, 2008, BRAIN INJURY, V22, P581, DOI 10.1080/02699050802189701; Swaine BR, 2003, BRAIN INJURY, V17, P575, DOI 10.1080/0269905031000088568; Thi PLN, 2002, SOC SCI MED, V54, P493; VANCAMPEN C, 1995, MED CARE RES REV, V52, P109, DOI 10.1177/107755879505200107; WAALAND PK, 1993, BRAIN INJURY, V7, P135, DOI 10.3109/02699059309008167; Wallace SE, 2007, BRAIN INJURY, V21, P1371, DOI 10.1080/02699050701785088; Wensing M, 2002, QUAL SAF HEALTH CARE, V11, P153, DOI 10.1136/qhc.11.2.153; Wressle E, 2006, SCAND J CARING SCI, V20, P135, DOI 10.1111/j.1471-6712.2006.00390.x	47	1	1	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2017	39	1					59	72		10.3109/09638288.2016.1140828			14	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	EC9WG	WOS:000388494400007	26883098				2022-02-06	
S	Sworn, G		Kaneda, I		Sworn, Graham			Rheology Modifiers for the Management of Dysphagia	RHEOLOGY OF BIOLOGICAL SOFT MATTER: FUNDAMENTALS AND APPLICATIONS	Soft and Biological Matter		English	Article; Book Chapter						Dysphagia; Swallowing; Hydrocolloids; Xanthan; Viscosity; Rheology	EXTRACELLULAR POLYSACCHARIDE; FOOD; BEVERAGES; VELOCITY; PHARYNX; VISCOSITY; BEHAVIOR; STEADY; FLUIDS	Dysphagia is the medical term used to describe swallowing problems resulting from a disorder in the mechanics of swallowing which can lead to impairment in the safety, efficiency or quality of eating and drinking. Dysphagia can be caused by many disorders including neurological disorders, stroke, traumatic brain injury, Huntington's disease, multiple sclerosis, Parkinson's disease and cerebral palsy. Many of these conditions are associated with the elderly and, with the continuing demographic shift, dysphagia is a growing problem. The rheological properties of the bolus significantly influence the effectiveness and safety of the swallowing process, and the use of hydrocolloids to control the rheology can greatly help in the management of dysphagia. To be an effective thickener for this application, the following properties are important: Easy dispersion at low mixing speeds Fast hydration (cold and hot) Fast hydration in different media (water, tea, coffee, fruit juices) Stable viscosity as a function of: Time Temperature Creating instant viscosity under suboptimal mixing conditions and choosing the right rheological properties pose a number of challenges for the use of hydrocolloids in this application, and the factors influencing their choice and performance will be reviewed.	[Sworn, Graham] DuPont Co Inc, 20 Rue Brunel, F-75017 Paris, France		Sworn, G (corresponding author), DuPont Co Inc, 20 Rue Brunel, F-75017 Paris, France.	graham.sworn@dupont.com					Bridget Penney, 2014, Nurs Times, V110, P16; Brown A, 1998, CONSULT DIET, V23, P1; Cichero JAY, 2000, DYSPHAGIA, V15, P188, DOI 10.1007/s004550000027; Cichero Julie A Y, 2013, Curr Phys Med Rehabil Rep, V1, P280; Coster S. T., 1987, DYSPHAGIA, V1, P93; COX WP, 1958, J POLYM SCI, V28, P619, DOI 10.1002/pol.1958.1202811812; CROSS MM, 1965, J COLL SCI IMP U TOK, V20, P417, DOI 10.1016/0095-8522(65)90022-X; de Saint-Aubert C., 2012, GUMS STABILISERS FOO, V17, P359; Garin N, 2014, DYSPHAGIA, V29, P483, DOI 10.1007/s00455-014-9533-x; Germain I, 2006, J FOOD ENG, V73, P64, DOI 10.1016/j.jfoodeng.2005.01.006; GLICKSMAN M., 1983, FOOD HYDROCOLLOIDS, VII; Glicksman M., 1983, FOOD HYDROCOLLOIDS, V3; Glicksman M., 1983, FOOD HYDROCOLLOIDS, V1; Goulding R., 2000, CLIN REHABIL, V14, P99; Hanson B, 2012, DYSPHAGIA, V27, P10, DOI 10.1007/s00455-011-9330-8; Hasegawa A, 2005, J JPN SOC FOOD SCI, V52, P441, DOI 10.3136/nskkk.52.441; Hasegawa A, 2008, J JPN SOC FOOD SCI, V55, P330, DOI 10.3136/nskkk.55.330; Hawdon JM, 2000, DEV MED CHILD NEUROL, V42, P235, DOI 10.1017/S0012162200000402; Hooke R., 1678, POTENTIABESTITUTIVA; IDDSI, 2015, DET DESCR TEST METH; IMESON A, 1999, THICKENING GELLING A; JANSSON PE, 1975, CARBOHYD RES, V45, P275, DOI 10.1016/S0008-6215(00)85885-1; Kamiya T., 2013, 35 ANN INT C IEEE EM, P2992; Kamiya T, 2013, IEEE ENG MED BIO, P4454, DOI 10.1109/EMBC.2013.6610535; Kool MM, 2013, CARBOHYD POLYM, V98, P914, DOI 10.1016/j.carbpol.2013.07.003; Leonard RJ, 2014, J ACAD NUTR DIET, V114, P590, DOI 10.1016/j.jand.2013.07.037; Longmann J. A., 1983, EVALUATION TREATMENT; Mackley MR, 2013, J RHEOL, V57, P1533, DOI 10.1122/1.4820494; Mann LL, 1996, J AM DIET ASSOC, V96, P585, DOI 10.1016/S0002-8223(96)00160-5; Matta Z, 2006, J AM DIET ASSOC, V106, P1049, DOI 10.1016/j.jada.2006.04.022; MELTON LD, 1976, CARBOHYD RES, V46, P245, DOI 10.1016/S0008-6215(00)84296-2; Mills H., 1999, NUTR CLIN PRACT, V14, P52, DOI DOI 10.1177/0884533699014005S11; Mitchell J. R., 1979, POLYSACCHARIDES FOOD, P51; Mitchell J. R., 2008, GUMS STABILISERS FOO, P29; Moret-Tatay A, 2015, FOOD HYDROCOLLOID, V51, P318, DOI 10.1016/j.foodhyd.2015.05.019; Morris E. R., 1981, Carbohydrate Polymers, V1, P5, DOI 10.1016/0144-8617(81)90011-4; Morris E. R., 1989, FRONTIERS CARBOHYDRA, P132; MORRIS ER, 1984, GUMS STABILISERS FOO, V2, P57; Nakauma M., 2009, FOOD HYDROCOLLOIDS, V25, P965; Newman LA, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.6.e106; Newton I., 1687, PHILOS NATURALIS PRI; Nishinari K, 2011, FOOD HYDROCOLLOID, V25, P1737, DOI 10.1016/j.foodhyd.2011.03.016; Paik NJ, 2004, ARCH PHYS MED REHAB, V85, P857, DOI 10.1016/j.apmr.2003.08.079; Payne P., 2009, DYSPHAGIA, V26, P27; Penney B., 2014, NURS TIMES, V90, P12; ROSSMURPHY SB, **NON-TRADITIONAL**; Sasaki CT, 2015, DYSPHAGIA, V30, P586, DOI 10.1007/s00455-015-9640-3; Seo CW, 2013, DYSPHAGIA, V28, P205, DOI 10.1007/s00455-012-9433-x; Shama F., 1973, J TEXTURE STUD, V4, P91; Sliwinski E. L., 2009, CLIN NUTR S, V4, P135; Smith TL, 2004, J AM DIET ASSOC, V104, P969, DOI 10.1016/j.jada.2004.03.025; Standing M., 2015, ANN T NORDIC RHEOLOG, V23, P63; Steele CM, 2015, DYSPHAGIA, V30, P2, DOI 10.1007/s00455-014-9578-x; Sworn G., 2008, GUMS STABILISERS FOO, V14, P392; Sworn G., 2007, HDB IND WATER SOLUBL, DOI [10.1002/9780470988701.ch2, DOI 10.1002/9780470988701.CH2]; Tashiro A, 2010, BIOSCI BIOTECH BIOCH, V74, P1598, DOI 10.1271/bbb.100192; Wendin K, 2010, FOOD NUTR RES, V54, DOI 10.3402/fnr.v54i0.5134; Wood F.W, 1968, SCI MONOGRAPH NO 27, P40; Yamagata Y, 2012, FOOD SCI TECHNOL RES, V18, P363, DOI 10.3136/fstr.18.363; 2009, HDB HYDROCOLLOIDS, P1	60	1	1	1	6	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG E, 3-8-1 NISHI-KANDA CHIYODA-KU, TOKYO, 101-0065, JAPAN	2213-1736	2213-1744	978-4-431-56080-7; 978-4-431-56078-4	SOFT BIOL MATTER			2017							233	263		10.1007/978-4-431-56080-7_9	10.1007/978-4-431-56080-7		31	Biology; Food Science & Technology	Book Citation Index – Science (BKCI-S)	Life Sciences & Biomedicine - Other Topics; Food Science & Technology	BM1XR	WOS:000460674300010					2022-02-06	
J	Takanashi, S; Sakka, M; Sato, I; Watanabe, S; Tanaka, S; Ooshio, A; Saito, N; Kamibeppu, K				Takanashi, Shiho; Sakka, Mariko; Sato, Iori; Watanabe, Shu; Tanaka, Shota; Ooshio, Ayumi; Saito, Nobuhito; Kamibeppu, Kiyoko			Factors influencing mother-child communication about fathers with neurobehavioural sequelae after brain injury	BRAIN INJURY			English	Article						Behavioural symptoms; brain injury; cognitive impairment; family; stroke	PARENTS; CANCER; EXPERIENCE; FAMILIES; RISK; CARE	Objective: The present study clarified factors related to mother-child communication, openness when fathers suffer neurobehavioural sequelae after stroke or traumatic brain injury. Research design: A cross-sectional study using self-report anonymous questionnaires was conducted. Methods and procedures: Forty-one mothers with 6-22-year-old children participated. The questionnaire examined personal factors (mother's psychological distress), social/family factors (family support functioning), illness-related factors (father's time at home and neurobehavioural sequelae severity) and mother's perceived level of open communication. Multiple regression was used to analyse factors related to mother-child communication openness. Results: Mother-child open, communication was explained by family support functioning (beta = 0.449), father's time at home (beta = -0325) and mother's psychological distress (beta = -0.303). Neurobehavioural sequelae severity was not associated with mother-child open communication. Conclusions: Personal, social/family and illness-related factors were related to mother-child communication about paternal illness. Professionals should promote optimal family support functioning, connect families with external resources and assess families' interaction processes.	[Takanashi, Shiho; Sakka, Mariko; Sato, Iori; Kamibeppu, Kiyoko] Univ Tokyo, Grad Sch Med, Div Hlth Sci & Nursing, Dept Family Nursing,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan; [Watanabe, Shu] Jikei Univ, Dept Rehabil Med, Sch Med, Minato Ku, Tokyo, Japan; [Tanaka, Shota; Saito, Nobuhito] Univ Tokyo, Dept Neurosurg, Fac Med, Bunkyo Ku, Tokyo, Japan; [Ooshio, Ayumi] Kitahara Int Hosp, Hachioji, Tokyo, Japan		Kamibeppu, K (corresponding author), Univ Tokyo, Grad Sch Med, Div Hlth Sci & Nursing, Dept Family Nursing,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	kkamibeppu-tky@umin.ac.jp	Kamibeppu, Kiyoko/AAF-1332-2019	Sato, Iori/0000-0001-6244-6591	Mental Health Okamoto Memorial Foundation	The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper. This study was funded by a 2014 Grant from the Mental Health Okamoto Memorial Foundation awarded to Shiho Takanashi.	[Anonymous], 2008, REP SURV ACT SIT PEO; [Anonymous], 2011, PAT SURV 2011; [Anonymous], 2008, GUID SUPP PERS HIGH; [Anonymous], 2011, REP SURV LIF TIM JAP; [Anonymous], 2003, PROJ REP SUPP MOD PE; Beardslee WR, 1998, J AM ACAD CHILD PSY, V37, P1134, DOI 10.1097/00004583-199811000-00012; Butera-Prinzi F, 2004, BRAIN INJURY, V18, P83, DOI 10.1080/0269905031000118500; Charles N, 2007, NEUROREHABILITATION, V22, P61; den Heijer M, 2011, PSYCHO-ONCOLOGY, V20, P1317, DOI 10.1002/pon.1850; Endo T., 2002, JAPANESE ASS REHABIL, V39, P797; Fukui R, 2005, JAPANESE J NURSING R, V28, P260; Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242; Harris D, 2006, HLTH SA GESONDHEID, V11, P46; Ikukata K, 2011, HDB NEUROBEHAVIOURAL, P183; Ishida T., 2005, TRAUMATIC BRAIN INJU, P27; Itakura K, 2013, ANN B GRADUATE SCH E, V62, P273; Kieffer-Kristensen R, 2011, BRAIN INJURY, V25, P752, DOI 10.3109/02699052.2011.579933; Kokubu M, 2013, DEV FAMILY FUNCTIONI, V34; Kornblith AB, 2006, PSYCHO-ONCOL, V15, P780, DOI 10.1002/pon.1004; Kubo Y, 2007, SOGO RIHABIRITESHON, V35, P921; Liss M, 1990, Int J Rehabil Res, V13, P309, DOI 10.1097/00004356-199012000-00004; MAHONEY F I, 1965, Md State Med J, V14, P61; Morriss E, 2013, AUST J REHABIL COUNS, V19, P119, DOI 10.1017/jrc.2013.15; Nakagawa Y, 2013, MANUAL JAPANESE VERS; Nakajima Y, REPORT STUDY PROMOTI, P2; Nakamura H, 2006, PEOPLE BRAIN INJURY; Niemela M, 2014, GEN HOSP PSYCHIAT, V36, P337, DOI 10.1016/j.genhosppsych.2013.12.012; NOLLER P, 1992, J ADOLESCENCE, V15, P101, DOI 10.1016/0140-1971(92)90041-3; Northouse LL, 2000, SOC SCI MED, V50, P271, DOI 10.1016/S0277-9536(99)00281-6; Oda T, 2004, JAPANESE J OCCUPATIO, V52, P335; Ogawa Takeki, 2010, Brain and Nerve (Tokyo), V62, P13; PESSAR LF, 1993, BRAIN INJURY, V7, P231, DOI 10.3109/02699059309029675; Sato E, 1995, FAMILY COMMUNICATION; SMILKSTEIN G, 1978, J FAM PRACTICE, V6, P1231; Song LX, 2012, PSYCHO-ONCOLOGY, V21, P72, DOI 10.1002/pon.1861; Stanescu D. F., 2011, PSYCHOLOGY, V2, P681, DOI DOI 10.4236/PSYCH.2011.27104; Toyota A., 2010, J OCCUP MED TRAUMATO, V58, P89; Yamazaki A, 2008, FAMILY NURSING 19 PR, P18; Yusa Y, 2002, INTRO BOOK FAMILY TH	39	1	1	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	3					312	318		10.1080/02699052.2016.1225986			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EQ3WY	WOS:000398005900005	28156141				2022-02-06	
J	Tennant, A; Gill-Thwaites, H				Tennant, A.; Gill-Thwaites, H.			A study of the internal construct and predictive validity of the SMART assessment for emergence from vegetative state	BRAIN INJURY			English	Article						Vegetative state; minimally conscious state; Rasch; SMART	RASCH ANALYSIS; RECOVERY; SCALE; CONSCIOUSNESS; MODEL	Objective: The Sensory Modality Assessment and Rehabilitation Technique (SMART) was developed to assess the levels of awareness, functional, sensory and communicative abilities of adults in vegetative (VS) or minimally-conscious states following severe brain injury. The current study seeks to ascertain if a total score can be derived from the individual assessments contained within SMART and to test the internal construct and predictive validity of that total score.Subjects: Persons in VS were recruited over a 3-year period and current status was determined after a 17-year follow-up.Design: Data were evaluated by fit to the Rasch model. Predictive validity for emergence from VS was ascertained through an Area-Under-the-Curve [AUC] analysis.Results: Sixty people in VS were assessed on several occasions. Average age on admission was 38.8 years; 30 had anoxic brain damage; 21 traumatic injury. The Rasch analysis indicated the raw score was a sufficient statistic for awareness. Over half [55%] failed to emerge from VS. For those with anoxic brain injury, a SMART cut point of 85 gave an AUC of 0.966 (95% CI = 0.910-1.00) for emergence, as did a cut point of 68 for those with traumatic brain injury.Discussion: The current analysis suggests that SMART may have important predictive attributes for emergence (or lack thereof). No change in status of those discharged in VS has been reported to this present day.	[Tennant, A.] Swiss Parapleg Res, Nottwil, Switzerland; [Gill-Thwaites, H.] Royal Hosp Neurodisabil, Occupat Therapy Dept, West Hill, London SW15 3SW, England		Gill-Thwaites, H (corresponding author), Royal Hosp Neurodisabil, Occupat Therapy Dept, West Hill, London SW15 3SW, England.	helen@helengill.co.uk					Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; Andrich D., 2009, RUMM2030 RASCH UNIDI; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572; da Rocha NS, 2013, J PSYCHIATR RES, V47, P141, DOI 10.1016/j.jpsychires.2012.09.014; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Gill-Thwaites H, 2004, BRAIN INJURY, V18, P1255, DOI 10.1080/02699050410001719952; GillThwaites H, 1997, BRAIN INJURY, V11, P723, DOI 10.1080/026990597123098; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; IBM Corp Released, 2011, IBM SPSS STAT WIND V; La Porta F, 2013, ARCH PHYS MED REHAB, V94, P527, DOI 10.1016/j.apmr.2012.09.035; Mallinson, 2011, RASCH MEAS T, V251, P1317; Marais Ida, 2008, J Appl Meas, V9, P105; MASTERS GN, 1982, PSYCHOMETRIKA, V47, P149, DOI 10.1007/BF02296272; MERBITZ C, 1989, ARCH PHYS MED REHAB, V70, P308; Rasch G., 1960, PROBABILISTIC MODELS; Royal College of Physicians, 2013, PROL DIS CONSC NAT C; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Shiel A, 2000, CLIN REHABIL, V14, P408, DOI 10.1191/0269215500cr326oa; Smith Everett V Jr, 2002, J Appl Meas, V3, P205; Stepan C, 2004, EUR J NEUROL, V11, P461, DOI 10.1111/j.1468-1331.2004.00817.x; Tennant A, 2007, ARTHRIT RHEUM-ARTHR, V57, P1358, DOI 10.1002/art.23108; Viera AJ, 2005, FAM MED, V37, P360	24	1	2	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	2					185	192		10.1080/02699052.2016.1225983			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EM2RO	WOS:000395163500005	27936939				2022-02-06	
B	Tobinick, E; Rodriguez-Romanacce, H; Kinssies, R; Kim, N		Heidenreich, KA		Tobinick, E.; Rodriguez-Romanacce, H.; Kinssies, R.; Kim, N.			Perispinal Etanercept for Traumatic Brain Injury	NEW THERAPEUTICS FOR TRAUMATIC BRAIN INJURY: PREVENTION OF SECONDARY BRAIN DAMAGE AND ENHANCEMENT OF REPAIR AND REGENERATION			English	Article; Book Chapter							TUMOR-NECROSIS-FACTOR; DYSFUNCTION SCIENTIFIC RATIONALE; TNF-ALPHA; MICROGLIAL ACTIVATION; TARGETED ETANERCEPT; ISCHEMIC-STROKE; SPINAL-CORD; PAIN; INFLAMMATION; RESPONSES		[Tobinick, E.; Rodriguez-Romanacce, H.; Kim, N.] Inst Neurol Recovery INR, Los Angeles, CA 90025 USA; [Tobinick, E.; Rodriguez-Romanacce, H.; Kinssies, R.] Inst Neurol Recovery INR PLLC, Boca Raton, FL 33432 USA		Tobinick, E (corresponding author), Inst Neurol Recovery INR, Los Angeles, CA 90025 USA.; Tobinick, E (corresponding author), Inst Neurol Recovery INR PLLC, Boca Raton, FL 33432 USA.						Arango-Davila CA, 2015, INT J NEUROSCI, V125, P936, DOI 10.3109/00207454.2014.980906; Batson OV, 1940, ANN SURG, V112, P138, DOI 10.1097/00000658-194007000-00016; BATSON OV, 1957, AMER J ROENTGENOL RA, V78, P195; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Breschet G., 1829, RECHERCHES ANATOMIQU; Buchhave P, 2010, NEUROBIOL AGING, V31, P1877, DOI 10.1016/j.neurobiolaging.2008.10.012; Camara MI, 2015, NEUROPSYCHOPHARMACOL, V40, P502, DOI 10.1038/npp.2014.199; CDC, 2011, MORB MORT WEEKL REP; Cheng X, 2014, DRUG DISCOV TODAY, V19, P1822, DOI 10.1016/j.drudis.2014.06.029; Cheong CU, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/620837; Chio CC, 2010, J NEUROCHEM, V115, P921, DOI 10.1111/j.1471-4159.2010.06969.x; Clark IA, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/358263; Clark IA, 2010, PHARMACOL THERAPEUT, V128, P519, DOI 10.1016/j.pharmthera.2010.08.007; Clausen BH, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0203-6; Detrait ER, 2014, NEUROCHEM INT, V72, P10, DOI 10.1016/j.neuint.2014.04.001; Doll DN, 2015, J NEUROCHEM, V132, P443, DOI 10.1111/jnc.13008; Faingold C. L., 2014, NEURONAL NETWORKS BR; Feng P, 2015, BRAIN BEHAV IMMUN, V49, P32, DOI 10.1016/j.bbi.2015.04.001; Folkersma H, 2011, J NUCL MED, V52, P1235, DOI 10.2967/jnumed.110.084061; Freeman BJC, 2013, SPINE, V38, P1986, DOI 10.1097/01.brs.0000435140.61593.4c; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Gerhard A, 2005, NEUROIMAGE, V24, P591, DOI 10.1016/j.neuroimage.2004.09.034; GOODMAN JC, 1990, J NEUROIMMUNOL, V30, P213; Griessenauer CJ, 2015, CLIN ANAT, V28, P75, DOI 10.1002/ca.22354; Griffin W. S., 2008, J NEUROINFLAMM, V5, P3; Hess A, 2011, P NATL ACAD SCI USA, V108, P3731, DOI 10.1073/pnas.1011774108; Ignatowski TA, 2014, CNS DRUGS, V28, P1207, DOI 10.1007/s40263-014-0212-0; Ignatowski TA, 2014, CNS DRUGS, V28, P679, DOI 10.1007/s40263-014-0174-2; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; Lei BL, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-103; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Nadeau S, 1999, NEUROSCIENCE, V93, P1449, DOI 10.1016/S0306-4522(99)00225-0; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Nathoo N, 2011, NEUROSURGERY, V69, P1007, DOI 10.1227/NEU.0b013e3182274865; Nygard M, 2009, NEUROREPORT, V20, P213, DOI 10.1097/WNR.0b013e32831f1ca2; Ohtori S, 2015, YONSEI MED J, V56, P1379, DOI 10.3349/ymj.2015.56.5.1379; Ohtori S, 2012, SPINE, V37, P439, DOI 10.1097/BRS.0b013e318238af83; Olmos G, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/861231; Pappata S, 2000, NEUROLOGY, V55, P1052, DOI 10.1212/WNL.55.7.1052; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; ROSS SA, 1994, BRIT J NEUROSURG, V8, P419, DOI 10.3109/02688699408995109; Rossi D, 2011, CNS DRUGS, V25, P641, DOI 10.2165/11593090-000000000-00000; Sainoh T, 2016, PAIN MED, V17, P40, DOI 10.1111/pme.12892; Santello M, 2012, TRENDS NEUROSCI, V35, P638, DOI 10.1016/j.tins.2012.06.001; Scott G, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0445-y; Shen CH, 2011, ANESTH ANALG, V112, P454, DOI 10.1213/ANE.0b013e3182025b15; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Tarkowski E, 2003, J NEUROL NEUROSUR PS, V74, P1200, DOI 10.1136/jnnp.74.9.1200; Tobinick E, 2004, CURR MED RES OPIN, V20, P1075, DOI 10.1185/030079903125004286; Tobinick E, 2007, CURR ALZHEIMER RES, V4, P550, DOI 10.2174/156720507783018217; Tobinick Edward, 2006, MedGenMed, V8, P25; Tobinick Edward, 2006, MedGenMed, V8, P53; Tobinick E, 2014, CLIN DRUG INVEST, V34, P361, DOI 10.1007/s40261-014-0186-1; Tobinick E, 2012, CNS DRUGS, V26, P1051, DOI 10.1007/s40263-012-0013-2; Tobinick E, 2012, CURR ALZHEIMER RES, V9, P99, DOI 10.2174/156720512799015073; Tobinick E, 2011, CNS DRUGS, V25, P145, DOI 10.2165/11588400-000000000-00000; Tobinick E, 2010, EXPERT REV NEUROTHER, V10, P985, DOI 10.1586/ERN.10.52; Tobinick E, 2009, DRUG DISCOV TODAY, V14, P168, DOI 10.1016/j.drudis.2008.10.005; Tobinick EL, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-2; Tobinick Edward L, 2009, BMC Res Notes, V2, P28; Tobinick EL, 2003, CLIN THER, V25, P2279, DOI 10.1016/S0149-2918(03)80219-9; Tobinick EL, 2003, SWISS MED WKLY, V133, P170; Tobinick EL, 2003, CLIN THER, V25, P1211, DOI 10.1016/S0149-2918(03)80077-2; Tuttolomondo A, 2014, DRUG DES DEV THER, V8, P2221, DOI 10.2147/DDDT.S67655; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Wang Y, 2008, ALZHEIMER DEMENT S, V4, pT749; Waters RJ, 2013, J NEUROTRAUM, V30, P1710, DOI 10.1089/neu.2012.2792; WEN TS, 1994, J APPL PHYSIOL, V77, P1081, DOI 10.1152/jappl.1994.77.3.1081; Wu MH, 2016, MOL NEUROBIOL, V53, P4961, DOI 10.1007/s12035-015-9418-5; Ye J, 2014, J INFECT DIS, V210, P875, DOI 10.1093/infdis/jiu179; Youn DH, 2008, J NEUROSCI RES, V86, P2867, DOI 10.1002/jnr.21726; Zhang BF, 2015, NEUROCHEM RES, V40, P591, DOI 10.1007/s11064-014-1506-9	75	1	1	0	1	ACADEMIC PRESS LTD-ELSEVIER SCIENCE LTD	LONDON	125 LONDON WALL, LONDON EC2Y 5AS, ENGLAND			9780-1-28-02701-1; 9780-1-28-02686-1				2017							109	129		10.1016/B978-0-12-802686-1.00007-9			21	Clinical Neurology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BI5ZM	WOS:000413002900010					2022-02-06	
J	Tsai, NT; Goodwin, JS; Semler, ME; Kothera, RT; Van Horn, M; Wolf, BJ; Garner, DP				Tsai, Nancey Trevanian; Goodwin, Jesse S.; Semler, Mark E.; Kothera, Ronald T.; Van Horn, Mark; Wolf, Bethany J.; Garner, Dena P.			Development of a Non-Invasive Blink Reflexometer	IEEE JOURNAL OF TRANSLATIONAL ENGINEERING IN HEALTH AND MEDICINE			English	Article						Blink; brain; reflex; concussion; diagnostic; imaging; neurology	EYELID MOVEMENTS	Qualitative assessments of the blink reflex are used clinically to assess neurological status in critical care, operating room, and rehabilitative settings. Despite decades of literature supporting the use of quantitative measurements of the blink reflex in the evaluation of multiple neurological disorders, clinical adoption has failed. Thus, there remains an unmet clinical need for an objective, portable, non-invasive metric of neurological health that can be used in a variety of settings. We have developed a high-speed videography-based device to trigger, record, and analyze a blink reflex. A pilot study was performed to compare the device's measurements to the published literature of electromyographic measurements, currently the gold standard. The study results indicate that the device is a viable tool to obtain fast, objective, and quantitative metrics of a blink reflex, and has promise as a non-invasive diagnostic assessment of neurological health.	[Tsai, Nancey Trevanian] Med Univ South Carolina, Dept Neurosurg, Charleston, SC 29425 USA; [Goodwin, Jesse S.; Semler, Mark E.; Kothera, Ronald T.] Zucker Inst Appl Neurosci, Charleston, SC 29425 USA; [Van Horn, Mark] Med Univ South Carolina, Dept Radiol & Radiol Sci, Charleston, SC 29425 USA; [Wolf, Bethany J.] Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA; [Garner, Dena P.] The Citadel, Dept Hlth Exercise & Sport Sci, Charleston, SC 29409 USA		Goodwin, JS (corresponding author), Zucker Inst Appl Neurosci, Charleston, SC 29425 USA.	goodwijs@musc.edu		Wolf, Bethany/0000-0002-7124-5158	Zucker Institute for Applied Neurosciences	This work was supported by the Zucker Institute for Applied Neurosciences.	Bour LJ, 2000, J NEUROPHYSIOL, V83, P166, DOI 10.1152/jn.2000.83.1.166; Esteban A, 1999, NEUROPHYSIOL CLIN, V29, P7, DOI 10.1016/S0987-7053(99)80039-2; Esteban A, 2004, NEUROPHYSIOL CLIN, V34, P3, DOI 10.1016/j.neucli.2004.01.002; Formisano R, 2009, MED SCI MONITOR, V15, pCR101; Haerich P, 1998, BEHAV RES METH INS C, V30, P661, DOI 10.3758/BF03209484; HAERICH P, 1994, PSYCHOL SCI, V5, P407, DOI 10.1111/j.1467-9280.1994.tb00294.x; Helmchen C, 2007, Dev Ophthalmol, V40, P110; KUGELBERG E, 1952, BRAIN, V75, P385, DOI 10.1093/brain/75.3.385; Kwon KA, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0227; Mak F. H., 2016, J R SOC INTERFACE, V13; Reeb-Sutherland BC, 2009, J AM ACAD CHILD PSY, V48, P610, DOI 10.1097/CHI.0b013e31819f70fb; Sforza C, 2008, OPHTHAL PHYSL OPT, V28, P345, DOI 10.1111/j.1475-1313.2008.00577.x; SHAHANI BT, 1972, NEUROLOGY, V22, P149, DOI 10.1212/WNL.22.2.149; STAVA MW, 1994, INVEST OPHTH VIS SCI, V35, P3966; VanderWerf F, 2003, J NEUROPHYSIOL, V89, P2784, DOI 10.1152/jn.00557.2002	15	1	1	1	2	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2168-2372			IEEE J TRANSL ENG HE	IEEE J. Transl. Eng. Health Med.-JTEHM		2017	5								3800204	10.1109/JTEHM.2017.2782669			4	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	FS4FE	WOS:000419742600001	29285420	Green Published, gold			2022-02-06	
B	Tsaousides, T; Ashman, T		Wilson, BA; Winegardner, J; VanHeugten, CM; Ownsworth, T		Tsaousides, Theo; Ashman, Teresa			TECHNOLOGY-BASED DELIVERY OF NEUROPSYCHOLOGICAL REHABILITATION	NEUROPSYCHOLOGICAL REHABILITATION: THE INTERNATIONAL HANDBOOK			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; SCHEDULED TELEPHONE INTERVENTION; COGNITIVE-BEHAVIORAL THERAPY; INCREASING PHYSICAL-ACTIVITY; RANDOMIZED CONTROLLED-TRIAL; MULTIPLE-SCLEROSIS; VIRTUAL-REALITY; TELEREHABILITATION PROGRAM; INTERNET INTERVENTION; STROKE PATIENTS		[Tsaousides, Theo] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Ashman, Teresa] Univ Delaware, Newark, DE USA		Tsaousides, T (corresponding author), Icahn Sch Med Mt Sinai, New York, NY 10029 USA.						Amatya B, 2015, MULT SCLER RELAT DIS, V4, P358, DOI 10.1016/j.msard.2015.06.011; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; Bergquist T, 2009, BRAIN INJURY, V23, P790, DOI 10.1080/02699050903196688; Bogdanova Y., 2015, J HEAD TRAUMA REHABI; Bombardier CH, 2009, J HEAD TRAUMA REHAB, V24, P230, DOI 10.1097/HTR.0b013e3181ad65f0; Boter H, 2004, STROKE, V35, P2867, DOI 10.1161/01.STR.0000147717.57531.e5; Bourgeois MS, 2007, BRAIN INJURY, V21, P1245, DOI 10.1080/02699050701727452; Bradbury CL, 2008, ARCH PHYS MED REHAB, V89, pS61, DOI 10.1016/j.apmr.2008.08.210; Brennan David M, 2011, Telemed J E Health, V17, P662, DOI 10.1089/tmj.2011.0036; Brunner M, 2015, DISABIL REHABIL, V37, P1511, DOI 10.3109/09638288.2015.1045992; Cantor J, 2014, ARCH PHYS MED REHAB, V95, P1, DOI 10.1016/j.apmr.2013.08.005; Chen J, 2015, J STROKE CEREBROVASC, V24, P2660, DOI 10.1016/j.jstrokecerebrovasdis.2015.09.014; Chumbler NR, 2012, STROKE, V43, P2168, DOI 10.1161/STROKEAHA.111.646943; Dlugonski D, 2012, PSYCHOL HEALTH MED, V17, P636, DOI 10.1080/13548506.2011.652640; Dlugonski D, 2011, J REHABIL RES DEV, V48, P1129, DOI 10.1682/JRRD.2010.09.0192; Egner A, 2003, NEUROREHABILITATION, V18, P125; Fann JR, 2015, J NEUROTRAUM, V32, P45, DOI 10.1089/neu.2014.3423; Finkelstein J, 2008, J REHABIL RES DEV, V45, P1361, DOI 10.1682/JRRD.2008.01.0001; Finlayson M, 2011, MULT SCLER J, V17, P1130, DOI 10.1177/1352458511404272; Forducey PG, 2012, PSYCHOL SERV, V9, P144, DOI 10.1037/a0028112; Frevel D., 2014, EUROPEAN J PHYS REHA, V51, P23; Hall M. J., 2012, 95 NCHS; Huijgen BCH, 2008, J TELEMED TELECARE, V14, P249, DOI 10.1258/jtt.2008.080104; Khan F, 2015, EUR J PHYS REHAB MED, V51, P311; Kim BR, 2011, ANN REHABIL MED-ARM, V35, P450, DOI 10.5535/arm.2011.35.4.450; Larson EB, 2014, NEUROREHABILITATION, V34, P759, DOI 10.3233/NRE-141078; Laver KE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010255.pub2; Linder SM, 2015, AM J OCCUP THER, V69, DOI 10.5014/ajot.2015.015636; Llorens R, 2015, ARCH PHYS MED REHAB, V96, P418, DOI 10.1016/j.apmr.2014.10.019; Man DWK, 2006, BRAIN INJURY, V20, P959, DOI 10.1080/02699050600909789; Mayo NE, 2008, AGE AGEING, V37, P32, DOI 10.1093/ageing/afm133; Motl RW, 2011, MULT SCLER J, V17, P116, DOI 10.1177/1352458510383148; Ng EMW, 2013, BRAIN INJURY, V27, P548, DOI 10.3109/02699052.2013.766927; Gutierrez RO, 2013, NEUROREHABILITATION, V33, P545, DOI 10.3233/NRE-130995; Paul L, 2014, CLIN REHABIL, V28, P924, DOI 10.1177/0269215514527995; Pilutti LA, 2014, ARCH PHYS MED REHAB, V95, P1283, DOI 10.1016/j.apmr.2014.03.015; Sandroff BM, 2014, J NEUROL, V261, P363, DOI 10.1007/s00415-013-7204-8; Smith GC, 2012, REHABIL PSYCHOL, V57, P196, DOI 10.1037/a0029587; Topolovec-Vranic J, 2010, BRAIN INJURY, V24, P762, DOI 10.3109/02699051003709599; Tsaousides T, 2014, NEUROPSYCHOL REHABIL, V24, P784, DOI 10.1080/09602011.2014.907186; Tsaousides T, 2011, BRAIN INJURY, V25, P1155, DOI 10.3109/02699052.2011.613086; Wade SL, 2006, J CONSULT CLIN PSYCH, V74, P445, DOI 10.1037/0022-006X.74.3.445; Wade SL, 2011, PEDIATRICS, V128, pE947, DOI 10.1542/peds.2010-3721	43	1	1	0	0	ROUTLEDGE	ABINGDON	2 PARK SQ, MILTON PARK, ABINGDON OX14 4RN, OXFORD, ENGLAND			978-1-138-64311-6; 978-1-315-62953-7; 978-1-138-64309-3				2017							447	457					11	Psychology, Clinical; Clinical Neurology; Psychology; Rehabilitation	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Psychology; Neurosciences & Neurology; Rehabilitation	BO7UU	WOS:000525648500049					2022-02-06	
S	Tu, SC; Tu, J		VanPham, P		Tu, Sicong; Tu, Jian			Stem Cell Therapy in Traumatic Brain Injury	NEUROLOGICAL REGENERATION	Stem Cells in Clinical Applications		English	Article; Book Chapter							SPINAL-CORD-INJURY; CLOSED-HEAD INJURY; RECOMBINANT-HUMAN-ERYTHROPOIETIN; PLACEBO-CONTROLLED TRIAL; CENTRAL-NERVOUS-SYSTEM; SEX STEROID-HORMONES; ATTENTION DEFICIT/HYPERACTIVITY DISORDER; POTENTIAL NEUROPROTECTIVE MECHANISM; ANEURYSMAL SUBARACHNOID HEMORRHAGE; CHRONIC METHYLPHENIDATE TREATMENT		[Tu, Sicong] Neurosci Res Australia, Randwick, NSW, Australia; [Tu, Jian] Univ New South Wales, Prince Wales Clin Sch, Sydney, NSW 2031, Australia		Tu, J (corresponding author), Univ New South Wales, Prince Wales Clin Sch, Sydney, NSW 2031, Australia.	s.tu@neura.edu.au; j.tu@unsw.edu.au	Tu, Sicong/AAA-4056-2019	Tu, Sicong/0000-0002-6914-6660			Abrahamson EE, 2009, ANN NEUROL, V66, P407, DOI 10.1002/ana.21731; Alban JP, 2004, AM J PHYS MED REHAB, V83, P131, DOI 10.1097/01.phm.0000112308.68586.1d; Albert-WeiSSenberger Christiane, 2012, Exp Transl Stroke Med, V4, P1, DOI 10.1186/2040-7378-4-1; Alessandri B, 2002, J NEUROTRAUM, V19, P829, DOI 10.1089/08977150260190429; Alvarez-Buylla A, 2000, Prog Brain Res, V127, P1; Amen DG, 2011, J PSYCHOACTIVE DRUGS, V43, P1, DOI 10.1080/02791072.2011.566489; Anderson GD, 2011, J NEUROTRAUM, V28, P1827, DOI 10.1089/neu.2011.1911; [Anonymous], 2003, J NEUROPSYCH CLIN N, V15, P383, DOI 10.1176/appi.neuropsych.15.3.383; Atif F, 2013, NEUROPHARMACOLOGY, V67, P78, DOI 10.1016/j.neuropharm.2012.10.004; Atkuri KR, 2007, CURR OPIN PHARMACOL, V7, P355, DOI 10.1016/j.coph.2007.04.005; Baki SGA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012490; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Ballas N, 2005, CURR OPIN NEUROBIOL, V15, P500, DOI 10.1016/j.conb.2005.08.015; Ballesteros J, 2008, J HEAD TRAUMA REHAB, V23, P171, DOI 10.1097/01.HTR.0000319935.99837.96; Bambakidis NC, 2003, J NEUROSURG, V99, P70, DOI 10.3171/spi.2003.99.1.0070; Barami K, 2000, NEUROSURGERY, V47, P691; Barha CK, 2011, EXP NEUROL, V231, P72, DOI 10.1016/j.expneurol.2011.05.016; Barlind A, 2010, GROWTH HORM IGF RES, V20, P49, DOI 10.1016/j.ghir.2009.09.001; Bellus SB, 1996, BRAIN INJURY, V10, P849, DOI 10.1080/026990596123954; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Berg C, 2010, EXP CLIN ENDOCR DIAB, V118, P139, DOI 10.1055/s-0029-1225611; Beziaud T, 2011, CRIT CARE MED, V39, P2300, DOI 10.1097/CCM.0b013e3182227e4a; Bian XX, 2010, NEUROL MED-CHIR, V50, P361, DOI 10.2176/nmc.50.361; Biegon A, 2004, CURR PHARM DESIGN, V10, P2177, DOI 10.2174/1381612043384196; Blount PJ, 2002, J HEAD TRAUMA REHAB, V17, P314, DOI 10.1097/00001199-200208000-00005; Boimel M, 2009, J NEUROPATH EXP NEUR, V68, P314, DOI 10.1097/NEN.0b013e31819ac3cb; Bourgeois JA, 2002, J NEUROPSYCH CLIN N, V14, P463, DOI 10.1176/appi.neuropsych.14.4.463; Brustovetsky N, 2000, J NEUROSCI, V20, P8229, DOI 10.1523/JNEUROSCI.20-22-08229.2000; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Bymaster FP, 2002, NEUROPSYCHOPHARMACOL, V27, P699, DOI 10.1016/S0893-133X(02)00346-9; Campbell JN, 2012, J NEUROTRAUM, V29, P201, DOI 10.1089/neu.2011.1761; Cao QL, 2001, EXP NEUROL, V167, P48, DOI 10.1006/exnr.2000.7536; CARDENAS DD, 1994, BRAIN INJURY, V8, P579, DOI 10.3109/02699059409151010; Casha S, 2012, BRAIN, V135, P1224, DOI 10.1093/brain/aws072; Cekic M, 2012, RESTOR NEUROL NEUROS, V30, P115, DOI 10.3233/RNN-2011-0628; Chang CP, 2013, CLIN SCI, V124, P165, DOI 10.1042/CS20120226; Chauhan NB, 2010, BRAIN RES, V1360, P177, DOI 10.1016/j.brainres.2010.09.010; Chen G, 2008, J SURG RES, V147, P92, DOI 10.1016/j.jss.2007.05.029; Chen G, 2008, ANN CLIN LAB SCI, V38, P65; Chen G, 2007, NEUROSCI LETT, V425, P177, DOI 10.1016/j.neulet.2007.08.022; Chen G, 2009, EXP NEUROL, V216, P398, DOI 10.1016/j.expneurol.2008.12.019; Chen G, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/716458; Chen G, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/93431; Chen XR, 2008, J PHARMACOL EXP THER, V326, P966, DOI 10.1124/jpet.108.140368; Chen Y, 1998, BRAIN RES, V784, P18, DOI 10.1016/S0006-8993(97)00982-7; Chen Y, 1998, J NEUROTRAUM, V15, P231, DOI 10.1089/neu.1998.15.231; Cherian L, 2011, J PHARMACOL EXP THER, V337, P451, DOI 10.1124/jpet.110.176602; Chow SY, 2000, BRAIN RES, V874, P87, DOI 10.1016/S0006-8993(00)02443-4; Colley BS, 2010, EXP NEUROL, V224, P241, DOI 10.1016/j.expneurol.2010.03.026; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Creyghton Wouter M, 2004, Semin Vasc Med, V4, P167, DOI 10.1055/s-2004-835375; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; Cutler SM, 2006, PHARMACOL BIOCHEM BE, V84, P420, DOI 10.1016/j.pbb.2006.05.029; Dash PK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024648; Demling R, 1999, NEW ENGL J MED, V341, P837, DOI 10.1056/NEJM199909093411110; Demling Robert H, 2005, J Burns Wounds, V4, pe2; Devesa J, 2013, HORM BEHAV, V63, P331, DOI 10.1016/j.yhbeh.2012.02.022; Dixon CE, 1999, RESTOR NEUROL NEUROS, V14, P285; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Dodd S, 2008, EXPERT OPIN BIOL TH, V8, P1955, DOI [10.1517/14728220802517901, 10.1517/14728220802517901 ]; Doulah AH, 2009, NEUROSCI LETT, V466, P47, DOI 10.1016/j.neulet.2009.09.016; Eaker S, 2013, STEM CELL TRANSL MED, DOI [10.5966/sctm.20130050, DOI 10.5966/SCTM.20130050]; Eckford PDW, 2006, BIOCHEM CELL BIOL, V84, P1022, DOI 10.1139/O06-196; Ehrenreich H, 2009, STROKE, V40, pE647, DOI 10.1161/STROKEAHA.109.564872; Empey PE, 2006, J NEUROTRAUM, V23, P109, DOI 10.1089/neu.2006.23.109; Fan Y, 2005, NEUROSCI LETT, V374, P222, DOI 10.1016/j.neulet.2004.10.063; FDA, 2010, GUID IND QUAL PROC D; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; Foster M, 2008, J NEUROPSYCH CLIN N, V20, P106, DOI 10.1176/jnp.2008.20.1.106; FRISEN J, 1995, J CELL BIOL, V131, P453, DOI 10.1083/jcb.131.2.453; Fujiki M, 2008, J CLIN NEUROSCI, V15, P791, DOI 10.1016/j.jocn.2007.07.002; Fujiki M, 2006, NEUROSCI LETT, V405, P226, DOI 10.1016/j.neulet.2006.07.005; Gage FH, 2005, CURR OPIN NEUROBIOL, V15, P497, DOI 10.1016/j.conb.2005.08.010; Galani R, 2001, RESTOR NEUROL NEUROS, V18, P161; Garcia-Estrada J, 1999, INT J DEV NEUROSCI, V17, P145, DOI 10.1016/S0736-5748(98)00065-3; GARCIAESTRADA J, 1993, BRAIN RES, V628, P271, DOI 10.1016/0006-8993(93)90964-O; Gensert JM, 1997, NEURON, V19, P197, DOI 10.1016/S0896-6273(00)80359-1; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; GIANUTSOS G, 1985, EUR J PHARMACOL, V110, P357, DOI 10.1016/0014-2999(85)90564-3; Gijtenbeek JMM, 1999, J NEUROL, V246, P339, DOI 10.1007/s004150050360; Gilmer LK, 2008, J NEUROTRAUM, V25, P593, DOI 10.1089/neu.2007.0477; Giordano Giulio, 2005, Pituitary, V8, P227, DOI 10.1007/s11102-006-6045-1; GLENN MB, 1989, AM J PHYS MED REHAB, V68, P221, DOI 10.1097/00002060-198910000-00004; Goforth PB, 1999, J NEUROSCI, V19, P7367, DOI 10.1523/JNEUROSCI.19-17-07367.1999; Gonzalez FF, 2007, DEV NEUROSCI-BASEL, V29, P321, DOI 10.1159/000105473; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Grimbert P, 1999, NEPHROL DIAL TRANSPL, V14, P2489, DOI 10.1093/ndt/14.10.2489; Grossman KJ, 2011, BEHAV BRAIN RES, V217, P202, DOI 10.1016/j.bbr.2010.09.029; Grossman KJ, 2004, BRAIN RES, V1008, P29, DOI 10.1016/j.brainres.2004.02.022; Gualtieri C T, 1988, Brain Inj, V2, P273, DOI 10.3109/02699058809150898; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; HAAS JF, 1985, ARCH PHYS MED REHAB, V66, P472; HALE MS, 1982, J NERV MENT DIS, V170, P362, DOI 10.1097/00005053-198206000-00006; HAMMOND GL, 1983, J STEROID BIOCHEM, V18, P185, DOI 10.1016/0022-4731(83)90086-9; Hanci V, 2010, ULUS TRAVMA ACIL CER, V16, P15; Hartley CE, 2008, J NEUROSURG, V109, P708, DOI 10.3171/JNS/2008/109/10/0708; Hatton J, 2008, J NEUROSURG, V109, P699, DOI 10.3171/JNS/2008/109/10/0699; Hayashida K, 2007, ANESTHESIOLOGY, V106, P1213, DOI 10.1097/01.anes.0000267605.40258.98; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; Heeschen C, 2003, BLOOD, V102, P1340, DOI 10.1182/blood-2003-01-0223; HERNDON DN, 1990, ANN SURG, V212, P424, DOI 10.1097/00000658-199010000-00005; Hicdonmez T, 2006, NEUROCHEM RES, V31, P473, DOI 10.1007/s11064-006-9040-z; High WM, 2010, J NEUROTRAUM, V27, P1565, DOI 10.1089/neu.2009.1253; Hinzman JM, 2012, J NEUROTRAUM, V29, P1197, DOI 10.1089/neu.2011.2261; Hoffer ME, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054163, 10.1371/journal.pone.0060061]; Homsi S, 2010, J NEUROTRAUM, V27, P911, DOI 10.1089/neu.2009.1223; Hua F, 2012, HORM BEHAV, V61, P642, DOI 10.1016/j.yhbeh.2012.02.017; Hua F, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-42; Iannotti C, 2004, EXP NEUROL, V189, P317, DOI 10.1016/j.expneurol.2004.05.033; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Indraswari F, 2012, J NEUROTRAUM, V29, P1388, DOI 10.1089/neu.2011.2117; Jendelova P, 2004, J NEUROSCI RES, V76, P232, DOI 10.1002/jnr.20041; Jin W, 2011, ANN CLIN LAB SCI, V41, P25; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Jones NC, 2005, EUR J NEUROSCI, V21, P1547, DOI 10.1111/j.1460-9568.2005.03995.x; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; Kasturi BS, 2009, RESTOR NEUROL NEUROS, V27, P265, DOI [10.3233/RNN-2009-0475, 10.3233/RNN-2009-0476]; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Kelso ML, 2012, CURR DRUG TARGETS, V13, P631, DOI 10.2174/138945012800398964; Keramaris NC, 2008, INJURY, V39, P643, DOI 10.1016/j.injury.2008.01.051; Khateb A, 2005, EUR NEUROL, V54, P39, DOI 10.1159/000087718; Kieburtz K, 2008, CLIN NEUROPHARMACOL, V31, P141, DOI 10.1097/WNF.0b013e3181342f32; Kilbaugh TJ, 2011, J NEUROTRAUM, V28, P763, DOI 10.1089/neu.2010.1635; Kim HS, 2009, BEHAV BRAIN RES, V196, P168, DOI 10.1016/j.bbr.2008.09.040; Kim J, 2012, PSYCHOPHARMACOLOGY, V222, P47, DOI 10.1007/s00213-011-2622-8; Kim YH, 2006, CLIN REHABIL, V20, P24, DOI 10.1191/0269215506cr927oa; Kline AE, 2000, NEUROSCI LETT, V280, P163, DOI 10.1016/S0304-3940(00)00797-7; Koda K, 2010, J NEUROCHEM, V114, P259, DOI 10.1111/j.1471-4159.2010.06750.x; KOENIG HL, 1995, SCIENCE, V268, P1500, DOI 10.1126/science.7770777; Kojima A, 2000, J NEUROPATH EXP NEUR, V59, P687, DOI 10.1093/jnen/59.8.687; Kojima A, 2002, J NEUROTRAUM, V19, P223, DOI 10.1089/08977150252806974; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; Kunte H, 2007, STROKE, V38, P2526, DOI 10.1161/STROKEAHA.107.482216; LACROIX C, 1987, J STEROID BIOCHEM, V28, P317, DOI 10.1016/0022-4731(87)91025-9; LANTHIER A, 1986, J STEROID BIOCHEM, V25, P445, DOI 10.1016/0022-4731(86)90259-1; Lee H, 2005, HUM PSYCHOPHARM CLIN, V20, P97, DOI 10.1002/hup.668; Lee YS, 2004, J NEUROPATH EXP NEUR, V63, P233, DOI 10.1093/jnen/63.3.223-a; Leite DFP, 2007, BIOCHEM PHARMACOL, V73, P665, DOI 10.1016/j.bcp.2006.11.005; Li B, 2009, NEUROSURGERY, V65, P179, DOI 10.1227/01.NEU.0000346272.76537.DC; Li G, 2007, GENOMICS, V89, P385, DOI 10.1016/j.ygeno.2006.07.015; Li J, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005592.pub2; Liao ZB, 2009, NEUROL INDIA, V57, P722, DOI 10.4103/0028-3886.59466; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Liepert J, 2008, CURR OPIN NEUROL, V21, P639, DOI 10.1097/WCO.0b013e32831897a3; Lieutaud T, 2008, J NEUROTRAUM, V25, P1179; Lin TT, 2006, CELL RES, V16, P857, DOI 10.1038/sj.cr.7310107; Ling FA, 2007, GROWTH HORM IGF RES, V17, P336, DOI 10.1016/j.ghir.2007.04.012; Liu LF, 2009, ENDOCRINOLOGY, V150, P3186, DOI 10.1210/en.2008-1447; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lok J, 2011, J NEUROCHEM, V118, P248, DOI 10.1111/j.1471-4159.2011.07294.x; Lombardi F, 2008, EUR J ANAESTH, V25, P131, DOI 10.1017/S0265021507003316; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Lu DY, 2004, J NEUROSURG, V101, P822, DOI 10.3171/jns.2004.101.5.0822; Lu DY, 2004, J NEUROTRAUM, V21, P21, DOI 10.1089/089771504772695913; Lu DY, 2004, J NEUROSURG, V101, P813, DOI 10.3171/jns.2004.101.5.0813; Luo X, 2000, Hua Xi Yi Ke Da Xue Xue Bao, V31, P399; Luoma JI, 2012, J STEROID BIOCHEM, V131, P30, DOI 10.1016/j.jsbmb.2011.11.002; Luoma JI, 2011, STEROIDS, V76, P845, DOI 10.1016/j.steroids.2011.02.013; Luskin MB, 1997, MOL CELL NEUROSCI, V8, P351, DOI 10.1006/mcne.1996.0592; Maas AIR, 2001, EXPERT OPIN INV DRUG, V10, P753, DOI 10.1517/13543784.10.4.753; Mahalick DM, 1998, PEDIATR NEUROSURG, V29, P121, DOI 10.1159/000028705; Mammis A, 2009, SURG NEUROL, V71, P527, DOI 10.1016/j.surneu.2008.02.040; Marsteller DA, 2002, NEUROPSYCHOPHARMACOL, V27, P163, DOI 10.1016/S0893-133X(02)00288-9; Martens DJ, 2002, EUR J NEUROSCI, V16, P1045, DOI 10.1046/j.1460-9568.2002.02181.x; Masanic CA, 2001, ARCH PHYS MED REHAB, V82, P896, DOI 10.1053/apmr.2001.23833; Mazzeo AT, 2008, ACTA NEUROCHIR, V150, P1019, DOI 10.1007/s00701-008-0021-7; Mazzeo AT, 2006, J NEUROTRAUM, V23, P962, DOI 10.1089/neu.2006.23.962; Mazzeo AT, 2009, J NEUROTRAUM, V26, P2195, DOI 10.1089/neu.2009.1012; Mbye LH, 2009, J CEREBR BLOOD F MET, V29, P87, DOI 10.1038/jcbfm.2008.93; McLean A Jr, 1987, Brain Inj, V1, P145, DOI 10.3109/02699058709034453; Mejia ROS, 2001, NEUROSURGERY, V48, P1393, DOI 10.1097/00006123-200106000-00051; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Miskowiak KW, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-97; Moein H, 2006, CLIN NEUROL NEUROSUR, V108, P539, DOI 10.1016/j.clineuro.2005.09.003; Moeller SJ, 2014, CEREB CORTEX, V24, P643, DOI 10.1093/cercor/bhs345; Mohapel P, 2004, PARKINSONISM RELAT D, V10, P259, DOI 10.1016/j.parkreldis.2004.02.013; MOONEY GF, 1993, ARCH PHYS MED REHAB, V74, P153; Morey CE, 2003, BRAIN INJURY, V17, P809, DOI 10.1080/0269905031000088586; Nakamura M, 2003, EXP NEUROL, V184, P313, DOI 10.1016/S0014-4886(03)00361-3; Nakamura M, 2005, CLIN REV ALLERG IMMU, V28, P197, DOI 10.1385/CRIAI:28:3:197; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Namiki J, 2000, J NEUROTRAUM, V17, P1219, DOI 10.1089/neu.2000.17.1219; NAWASHIRO H, 1994, ACTA NEUROCHIR, P440; Noble JM, 2007, NEUROLOGY, V68, P1749, DOI 10.1212/01.wnl.0000266745.86958.ce; Nori Satoshi, 2012, Brain and Nerve (Tokyo), V64, P17; O'Connor CA, 2007, EXP NEUROL, V205, P145, DOI 10.1016/j.expneurol.2007.01.034; Oda Y, 2011, J CEREBR BLOOD F MET, V31, P1143, DOI 10.1038/jcbfm.2010.208; Ogawa Y, 2002, J NEUROSCI RES, V69, P925, DOI 10.1002/jnr.10341; Okada S, 2004, J NEUROSCI RES, V76, P265, DOI 10.1002/jnr.20044; Okano H, 2003, SEMIN CELL DEV BIOL, V14, P191, DOI 10.1016/S1084-9521(03)00011-9; Okano H, 2005, KIDNEY INT, V68, P1927, DOI 10.1111/j.1523-1755.2005.00621.x; Okonkwo DO, 2003, NEUROREPORT, V14, P463, DOI 10.1097/01.wnr.0000058958.85541.d3; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; Oliva AA, 2012, J NEUROCHEM, V120, P710, DOI 10.1111/j.1471-4159.2011.07610.x; Olive MF, 2012, PHARMACOL BIOCHEM BE, V100, P801, DOI 10.1016/j.pbb.2011.04.015; Ortega FJ, 2012, EXP NEUROL, V235, P282, DOI 10.1016/j.expneurol.2012.02.010; Ozisik PA, 2007, SURG NEUROL, V68, P547, DOI 10.1016/j.surneu.2007.01.030; Ozturk E, 2008, PROG NEURO-PSYCHOPH, V32, P81, DOI 10.1016/j.pnpbp.2007.07.016; Pan DS, 2007, BIOMED ENVIRON SCI, V20, P432; Parmelee D X, 1988, Brain Inj, V2, P305, DOI 10.3109/02699058809150900; Patel AD, 2010, J NEUROPATH EXP NEUR, V69, P1177, DOI 10.1097/NEN.0b013e3181fbf6d6; Peterson TC, 2012, J NEUROTRAUM, V29, P2823, DOI 10.1089/neu.2012.2471; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Pevny L, 2005, CURR OPIN NEUROBIOL, V15, P7, DOI 10.1016/j.conb.2005.01.016; Piilgaard H, 2011, J CEREBR BLOOD F MET, V31, P1588, DOI 10.1038/jcbfm.2011.28; Pincus DW, 1998, NEUROSURGERY, V42, P858, DOI 10.1097/00006123-199804000-00103; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; Porcu P, 2009, STEROIDS, V74, P463, DOI 10.1016/j.steroids.2008.12.015; Potapov A A, 2010, Zh Vopr Neirokhir Im N N Burdenko, P54; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Rabchevsky AG, 2000, EXP NEUROL, V164, P280, DOI 10.1006/exnr.2000.7399; Reid WM, 2008, J NEUROTRAUM, V25, P248, DOI 10.1089/neu.2007.0389; Reimunde P, 2011, BRAIN INJURY, V25, P65, DOI 10.3109/02699052.2010.536196; Rhodes JKJ, 2009, J NEUROTRAUM, V26, P507, DOI 10.1089/neu.2008.0686; Robertson CL, 2006, EXP NEUROL, V197, P235, DOI 10.1016/j.expneurol.2005.09.014; ROOF RL, 1992, RESTOR NEUROL NEUROS, V4, P425, DOI 10.3233/RNN-1992-4608; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Rosenberg LJ, 2005, GLIA, V49, P107, DOI 10.1002/glia.20096; Saatman KE, 1997, EXP NEUROL, V147, P418, DOI 10.1006/exnr.1997.6629; Sacktor N, 2011, NEUROLOGY, V77, P1135, DOI 10.1212/WNL.0b013e31822f0412; Saganova K, 2012, LIFE SCI, V91, P77, DOI 10.1016/j.lfs.2012.06.022; Saito T, 2007, NEUROSCI LETT, V414, P35, DOI 10.1016/j.neulet.2006.12.028; Sanders EJ, 2008, GEN COMP ENDOCR, V156, P613, DOI 10.1016/j.ygcen.2008.02.005; Sanders EJ, 2010, GEN COMP ENDOCR, V165, P111, DOI 10.1016/j.ygcen.2009.06.013; Sarkaki AR, 2013, J NEUROTRAUM, V30, P47, DOI 10.1089/neu.2010.1686; Sayeed I, 2006, ANN EMERG MED, V47, P381, DOI 10.1016/j.annemergmed.2005.12.011; Sayeed I, 2009, BRAIN RES, V1263, P165, DOI 10.1016/j.brainres.2009.01.045; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; SCHIFF HB, 1982, AM J PSYCHIAT, V139, P1346; Schneider WN, 1999, BRAIN INJURY, V13, P863; Setkowicz Z, 2007, ACTA NEUROBIOL EXP, V67, P399; Shahrokhi N, 2012, PAK J PHARM SCI, V25, P219; Shahrokhi N, 2010, CAN J PHYSIOL PHARM, V88, P414, DOI [10.1139/Y09-126, 10.1139/y09-126]; Shapira M, 2007, MOL CELL NEUROSCI, V34, P571, DOI 10.1016/j.mcn.2006.12.006; Sharma HS, 2003, ACT NEUR S, V86, P383; Sharov VG, 2007, J MOL CELL CARDIOL, V42, P150, DOI 10.1016/j.yjmcc.2006.09.013; Sierra S, 2011, J ALZHEIMERS DIS, V23, P307, DOI 10.3233/JAD-2010-101179; Signoretti S, 2004, J NEUROTRAUM, V21, P1154, DOI 10.1089/neu.2004.21.1154; Silver JM, 2006, NEUROLOGY, V67, P748, DOI 10.1212/01.wnl.0000234062.98062.e9; Silver JM, 2009, BRAIN INJURY, V23, P123, DOI 10.1080/02699050802649696; Simard JM, 2012, J CEREBR BLOOD F MET, V32, P1699, DOI 10.1038/jcbfm.2012.91; Simard JM, 2009, J NEUROTRAUM, V26, P2257, DOI 10.1089/neu.2009.1021; Singleton RH, 2001, J NEUROTRAUM, V18, P607, DOI 10.1089/089771501750291846; Speech Thomas J., 1993, Brain Injury, V7, P333, DOI 10.3109/02699059309034959; Stoffel M, 2001, J NEUROTRAUM, V18, P425, DOI 10.1089/089771501750171010; Stoica B, 2009, NEUROTHERAPEUTICS, V6, P14, DOI 10.1016/j.nurt.2008.10.029; STOOF JC, 1992, CLIN NEUROL NEUROSUR, V94, pS4; Suehiro E, 2001, J NEUROSURG, V94, P493, DOI 10.3171/jns.2001.94.3.0493; Sugden SG, 2006, NEUROREHABILITATION, V21, P3; Sullivan PG, 2011, J NEUROTRAUM, V28, P311, DOI 10.1089/neu.2010.1646; Sullivan PG, 2000, NEUROSCIENCE, V101, P289, DOI 10.1016/S0306-4522(00)00380-8; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2000, EXP NEUROL, V161, P631, DOI 10.1006/exnr.1999.7282; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Svensson J, 2006, J ENDOCRINOL, V189, P617, DOI 10.1677/joe.1.06631; Swanson CJ, 2006, NEUROPHARMACOLOGY, V50, P755, DOI 10.1016/j.neuropharm.2005.11.022; Takala J, 1999, NEW ENGL J MED, V341, P785, DOI 10.1056/NEJM199909093411102; Tamura Ai, 2006, J Exp Ther Oncol, V6, P1; Taverni JP, 1998, BRAIN INJURY, V12, P77; Tenovuo O, 2005, PROG NEURO-PSYCHOPH, V29, P61, DOI 10.1016/j.pnpbp.2004.10.006; Tenovuo O, 2009, BRAIN INJURY, V23, P548, DOI 10.1080/02699050902926275; Thomale UW, 2006, INTENS CARE MED, V32, P149, DOI 10.1007/s00134-005-2845-4; Thum T, 2007, CIRC RES, V100, P434, DOI 10.1161/01.RES.0000257912.78915.af; Trovato M, 2006, BRAIN INJURY, V20, P339, DOI 10.1080/02699050500487811; Tseng MY, 2009, J NEUROSURG, V111, P171, DOI 10.3171/2009.3.JNS081332; Tu J, 2011, J NEUROSURG-SPINE, V14, P573, DOI 10.3171/2011.1.SPINE09491; Tu J, 2010, SPINE, V35, P1116, DOI 10.1097/BRS.0b013e3181ba6ce4; Turkoglu OF, 2010, BRIT J NEUROSURG, V24, P578, DOI 10.3109/02688697.2010.487126; Ugoya SO, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/141624; Ugoya SO, 2010, CLIN NEUROPHARMACOL, V33, P279, DOI 10.1097/WNF.0b013e3182011070; Urban RJ, 2006, GROWTH HORM IGF RES, V16, pS25, DOI 10.1016/j.ghir.2006.03.017; Valable S, 2010, J CEREBR BLOOD F MET, V30, P361, DOI 10.1038/jcbfm.2009.222; Van den Heuvel C, 2004, J NEUROTRAUM, V21, P1562, DOI 10.1089/0897715042441783; VanLandingham JW, 2007, NEUROSCI LETT, V425, P94, DOI 10.1016/j.neulet.2007.08.045; Verdonck O, 2007, J CEREBR BLOOD F MET, V27, P1369, DOI 10.1038/sj.jcbfm.9600443; Volkow N D, 2002, J Atten Disord, V6 Suppl 1, pS31; Volkow N D, 2001, J Neurosci, V21, pRC121; Volkow ND, 2002, SYNAPSE, V43, P181, DOI 10.1002/syn.10038; Volkow ND, 1998, AM J PSYCHIAT, V155, P1325, DOI 10.1176/ajp.155.10.1325; Volkow ND, 2012, J NEUROSCI, V32, P841, DOI 10.1523/JNEUROSCI.4461-11.2012; Wagner AK, 2007, BEHAV BRAIN RES, V181, P200, DOI 10.1016/j.bbr.2007.04.006; Wagner AK, 2009, J NEUROCHEM, V108, P986, DOI 10.1111/j.1471-4159.2008.05840.x; Wali B, 2011, RESTOR NEUROL NEUROS, V29, P61, DOI 10.3233/RNN-2011-0579; Walker W, 2004, BRAIN INJURY, V18, P739, DOI 10.1080/02699050310001646224; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Wang LS, 2002, BRAIN RES, V949, P162, DOI 10.1016/S0006-8993(02)02977-3; Wang Y, 2012, J NEUROSCI RES, V90, P508, DOI 10.1002/jnr.22775; Wang ZT, 2013, J MOL NEUROSCI, V49, P409, DOI 10.1007/s12031-012-9908-0; Wanger AK, 2009, J NEUROCHEM, V110, P801, DOI 10.1111/j.1471-4159.2009.06155.x; Watanabe J, 2013, NEUROBIOL DIS, V59, P86, DOI 10.1016/j.nbd.2013.06.017; Weill-Engerer S, 2002, J CLIN ENDOCR METAB, V87, P5138, DOI 10.1210/jc.2002-020878; Weinstock M, 2001, ANN NY ACAD SCI, V939, P148; Wheaton P, 2011, J CLIN PSYCHOPHARM, V31, P745, DOI 10.1097/JCP.0b013e318235f4ac; Whelan F J, 2000, Ann Clin Psychiatry, V12, P131; Whitlock JA, 1999, J HEAD TRAUMA REHAB, V14, P424, DOI 10.1097/00001199-199908000-00010; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002; Whyte J, 2005, ARCH PHYS MED REHAB, V86, P453, DOI 10.1016/j.apmr.2004.05.016; Widenfalk J, 2003, NEUROSCIENCE, V120, P951, DOI 10.1016/S0306-4522(03)00399-3; Widenfalk J, 2001, J NEUROSCI, V21, P3457, DOI 10.1523/JNEUROSCI.21-10-03457.2001; Wijdicks EFM, 1996, NEUROLOGY, V47, P1523, DOI 10.1212/WNL.47.6.1523; Wilkinson C. W., 2012, FRONT NEUROL, V3, P11, DOI DOI 10.3389/FNEUR.2012.00011; Williams SE, 1998, J HEAD TRAUMA REHAB, V13, P73, DOI 10.1097/00001199-199806000-00007; Willmott C, 2009, J NEUROL NEUROSUR PS, V80, P552, DOI 10.1136/jnnp.2008.159632; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wustenberg T, 2011, MOL PSYCHIATR, V16, P26, DOI 10.1038/mp.2010.51; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Xiong Y, 2008, BRAIN RES, V1230, P247, DOI 10.1016/j.brainres.2008.06.127; Xiong Y, 2008, J NEUROSURG, V109, P510, DOI 10.3171/JNS/2008/109/9/0510; Xiong Y, 2012, ANN NY ACAD SCI, V1270, P51, DOI 10.1111/j.1749-6632.2012.06683.x; Xiong Y, 2011, J NEUROSURG, V114, P549, DOI 10.3171/2010.10.JNS10925; Xiong Y, 2010, J NEUROSURG, V113, P598, DOI 10.3171/2009.9.JNS09844; Xiong Y, 2010, J NEUROTRAUM, V27, P205, DOI 10.1089/neu.2009.1001; Xiong Y, 2009, NEUROL RES, V31, P496, DOI 10.1179/174313208X353703; Yamamoto S, 2001, J NEUROSCI, V21, P9814, DOI 10.1523/JNEUROSCI.21-24-09814.2001; Yao XL, 2005, J NEUROTRAUM, V22, P656, DOI 10.1089/neu.2005.22.656; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Yi JH, 2005, BRAIN RES, V1033, P13, DOI 10.1016/j.brainres.2004.10.055; Yu FS, 2012, J NEUROTRAUM, V29, P2342, DOI 10.1089/neu.2012.2449; Yu FS, 2012, J NEUROTRAUM, V29, P362, DOI 10.1089/neu.2011.1942; Zhang HY, 2008, CELL MOL NEUROBIOL, V28, P173, DOI 10.1007/s10571-007-9163-z; Zhang L, 2004, ARCH PHYS MED REHAB, V85, P1050, DOI 10.1016/j.apmr.2003.10.014; Zhang YL, 2010, BRAIN RES, V1353, P249, DOI 10.1016/j.brainres.2010.07.046; Zhang YL, 2009, BRAIN RES, V1294, P153, DOI 10.1016/j.brainres.2009.07.077; Zhu JH, 2006, NEW ENGL J MED, V355, P2376, DOI 10.1056/NEJMc055304; Zhu ZF, 2010, BRAIN RES BULL, V83, P272, DOI 10.1016/j.brainresbull.2010.07.008	332	1	1	0	0	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	2365-4198	2365-4201	978-3-319-33720-3; 978-3-319-33719-7	STEM CELL CLIN APPL			2017							13	48		10.1007/978-3-319-33720-3_2	10.1007/978-3-319-33720-3		36	Medicine, Research & Experimental; Clinical Neurology	Book Citation Index – Science (BKCI-S)	Research & Experimental Medicine; Neurosciences & Neurology	BK3AY	WOS:000434630200003					2022-02-06	
S	Tu, SC; Tu, J		VanPham, P		Tu, Sicong; Tu, Jian			Stem Cell Therapy for Spinal Cord Injury	NEUROLOGICAL REGENERATION	Stem Cells in Clinical Applications		English	Article; Book Chapter							EPIDERMAL-GROWTH-FACTOR; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; FUNCTIONAL RECOVERY; CONTUSION INJURY; ADULT RATS; AXONAL REGENERATION; NEUROTROPHIC FACTOR; TISSUE-DAMAGE; BONE-MARROW		[Tu, Sicong; Tu, Jian] Univ New South Wales, Prince Wales Clin Sch, Sydney, NSW 2052, Australia		Tu, J (corresponding author), Univ New South Wales, Prince Wales Clin Sch, Sydney, NSW 2052, Australia.	s.tu@neura.edu.au; j.tu@unsw.edu.au	Tu, Sicong/AAA-4056-2019	Tu, Sicong/0000-0002-6914-6660			Aftab S, 2013, CURR STEM CELL RES T, V8, P456, DOI 10.2174/1574888X1130800064; Alper J, 2009, NAT BIOTECHNOL, V27, P213, DOI 10.1038/nbt0309-213a; Anthony DC, 2014, EXP NEUROL, V258, P105, DOI 10.1016/j.expneurol.2014.03.013; Austin JW, 2012, J NEUROTRAUM, V29, P1838, DOI 10.1089/neu.2012.2354; Baptiste DC, 2006, J NEUROTRAUM, V23, P318, DOI 10.1089/neu.2006.23.318; Barami K, 2000, NEUROSURGERY, V47, P691; Bastien D, 2014, EXP NEUROL, V258, P62, DOI 10.1016/j.expneurol.2014.04.006; BEHRMAN SW, 1995, JPEN-PARENTER ENTER, V19, P41, DOI 10.1177/014860719501900141; Blesch Armin, 2012, Handb Clin Neurol, V109, P563, DOI 10.1016/B978-0-444-52137-8.00035-8; Boyce Vanessa S, 2014, Handb Exp Pharmacol, V220, P443, DOI 10.1007/978-3-642-45106-5_16; Boyd-Kimball D, 2005, J NEUROSCI RES, V79, P707, DOI 10.1002/jnr.20393; Brown SEF, 2013, FRANCISCO BUSIN 0107; Bydon M, 2014, WORLD NEUROSURG, V82, P848, DOI 10.1016/j.wneu.2013.02.062; Cao HQ, 2013, NEUROSCI BULL, V29, P94, DOI 10.1007/s12264-012-1277-8; Cao QL, 2001, EXP NEUROL, V167, P48, DOI 10.1006/exnr.2000.7536; Casha S, 2012, BRAIN, V135, P1224, DOI 10.1093/brain/aws072; Chew DJ, 2014, J PAIN, V15, P664, DOI 10.1016/j.jpain.2014.03.001; Chow SY, 2000, BRAIN RES, V874, P87, DOI 10.1016/S0006-8993(00)02443-4; Cox A, 2015, METAB BRAIN DIS, V30, P473, DOI 10.1007/s11011-014-9547-y; Das AK, 2011, CURR STEM CELL RES T, V6, P93; Davies SJA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017328; Donnelly EM, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt115; Eaker S, 2013, STEM CELL TRANSL MED, V2, P871, DOI 10.5966/sctm.2013-0050; Elkabes S, 2014, EXP NEUROL, V259, P28, DOI 10.1016/j.expneurol.2014.01.008; FDA, 2014, GUID IND QUAL PORC D; Fehlings MG, 2011, J NEUROTRAUM, V28, P787, DOI 10.1089/neu.2011.1765; Gensert JM, 1997, NEURON, V19, P197, DOI 10.1016/S0896-6273(00)80359-1; Gou ZY, 2014, J DRUG TARGET, V22, P365, DOI 10.3109/1061186X.2013.878939; Grossman RG, 2014, J NEUROTRAUM, V31, P239, DOI 10.1089/neu.2013.2969; Hewson SM, 2013, EXPERT REV NEUROTHER, V13, P143, DOI [10.1586/ern.12.157, 10.1586/ERN.12.157]; Hu ZQ, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/831490; Iannotti C, 2004, EXP NEUROL, V189, P317, DOI 10.1016/j.expneurol.2004.05.033; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Jendelova P, 2004, J NEUROSCI RES, V76, P232, DOI 10.1002/jnr.20041; Jones TB, 2014, EXP NEUROL, V258, P78, DOI 10.1016/j.expneurol.2014.03.003; Kabatas S, 2010, TURK NEUROSURG, V20, P103, DOI 10.5137/1019-5149.JTN.2999-10.1; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Keramaris NC, 2008, INJURY, V39, P643, DOI 10.1016/j.injury.2008.01.051; Kojima A, 2000, J NEUROPATH EXP NEUR, V59, P687, DOI 10.1093/jnen/59.8.687; Kojima A, 2002, J NEUROTRAUM, V19, P223, DOI 10.1089/08977150252806974; Kolar MK, 2014, STEM CELLS DEV, V23, P1659, DOI 10.1089/scd.2013.0416; Kraus KH, 1996, SEMIN VET MED SURG, V11, P201; Lang BT, 2015, NATURE, V518, P404, DOI 10.1038/nature13974; Lee YS, 2004, J NEUROPATH EXP NEUR, V63, P233, DOI 10.1093/jnen/63.3.223-a; Maric O, 2008, J NEUROTRAUM, V25, P1303, DOI 10.1089/neu.2008.0583; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; McTigue DM, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt48; Monaco EA, 2013, NEUROSURGERY, V72, pN17, DOI 10.1227/01.neu.0000426215.12831.57; Nakamura M, 2003, EXP NEUROL, V184, P313, DOI 10.1016/S0014-4886(03)00361-3; Namiki J, 2000, J NEUROTRAUM, V17, P1219, DOI 10.1089/neu.2000.17.1219; Ning GZ, 2013, REGEN MED, V8, P271, DOI [10.2217/RME.13.26, 10.2217/rme.13.26]; Nishimura S, 2014, EXP NEUROL, V261, P171, DOI 10.1016/j.expneurol.2014.05.021; Niu TH, 2002, DRUGS, V62, P977, DOI 10.2165/00003495-200262070-00001; Nogradi A, 2011, ANN ANAT, V193, P362, DOI 10.1016/j.aanat.2011.04.001; Ogawa Y, 2002, J NEUROSCI RES, V69, P925, DOI 10.1002/jnr.10341; Okano H, 2003, SEMIN CELL DEV BIOL, V14, P191, DOI 10.1016/S1084-9521(03)00011-9; Perrin FE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015914; Rabchevsky AG, 2000, EXP NEUROL, V164, P280, DOI 10.1006/exnr.2000.7399; Resnick DK, 2004, NEUROREPORT, V15, P837, DOI 10.1097/00001756-200404090-00020; Sabelstrom H, 2013, SCIENCE, V342, P637, DOI 10.1126/science.1242576; Samantaray S, 2011, NEUROCHEM RES, V36, P1809, DOI 10.1007/s11064-011-0498-y; Sharma HS, 2003, ACT NEUR S, V86, P383; Stein R, 2011, WASHINGTON POST 0415; Stenudd M, 2015, JAMA NEUROL, V72, P235, DOI 10.1001/jamaneurol.2014.2927; Taghipour Z, 2012, STEM CELLS DEV, V21, P1794, DOI 10.1089/scd.2011.0408; Taha MF, 2010, CURR STEM CELL RES T, V5, P23, DOI 10.2174/157488810790442778; Teng YD, 2004, P NATL ACAD SCI USA, V101, P3071, DOI 10.1073/pnas.0306239101; Tu J, 2011, J NEUROSURG-SPINE, V14, P573, DOI 10.3171/2011.1.SPINE09491; Tu J, 2010, SPINE, V35, P1116, DOI 10.1097/BRS.0b013e3181ba6ce4; Ugoya SO, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/141624; Vaccari JPD, 2014, J CEREBR BLOOD F MET, V34, P369, DOI 10.1038/jcbfm.2013.227; van den Maagdenberg AMJM, 2004, NEURON, V41, P701, DOI 10.1016/S0896-6273(04)00085-6; Volarevic V, 2013, CELL TRANSPLANT, V22, P1309, DOI 10.3727/096368912X657260; Wang RH, 2014, J NEUROSCI RES, V92, P884, DOI 10.1002/jnr.23371; Wang ZT, 2013, J MOL NEUROSCI, V49, P409, DOI 10.1007/s12031-012-9908-0; Wang ZM, 2015, J NEUROSCI, V35, P3139, DOI 10.1523/JNEUROSCI.2832-14.2015; Wells JEA, 2003, BRAIN, V126, P1628, DOI 10.1093/brain/awg178; WHO, 2013, SPIN CORD INJ; WHO, 2013, SPIN CORD INJ MAN 50; Widenfalk J, 2003, NEUROSCIENCE, V120, P951, DOI 10.1016/S0306-4522(03)00399-3; Wilson JR, 2014, WORLD NEUROSURG, V81, P825, DOI 10.1016/j.wneu.2013.01.001; Wilson JR, 2013, CAN MED ASSOC J, V185, P485, DOI 10.1503/cmaj.121206; Wu Y, 2014, NEUROSCIENCE, V265, P302, DOI 10.1016/j.neuroscience.2014.01.059; Xiao L, 2013, HUM CELL, V26, P91, DOI 10.1007/s13577-013-0069-4; Xiong YQ, 2009, EXP NEUROL, V216, P105, DOI 10.1016/j.expneurol.2008.11.025; Yamada H, 2014, BIOCHEM BIOPH RES CO, V454, P341, DOI 10.1016/j.bbrc.2014.10.082; Zhao JG, 2013, J BIOL CHEM, V288, P164, DOI 10.1074/jbc.M112.433607; Zhu JH, 2006, NEW ENGL J MED, V355, P2376, DOI 10.1056/NEJMc055304	88	1	1	0	1	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	2365-4198	2365-4201	978-3-319-33720-3; 978-3-319-33719-7	STEM CELL CLIN APPL			2017							137	158		10.1007/978-3-319-33720-3_8	10.1007/978-3-319-33720-3		22	Medicine, Research & Experimental; Clinical Neurology	Book Citation Index – Science (BKCI-S)	Research & Experimental Medicine; Neurosciences & Neurology	BK3AY	WOS:000434630200009					2022-02-06	
S	Turkstra, LS; Politis, AM		Cummings, L		Turkstra, Lyn S.; Politis, Adam M.			Traumatic Brain Injury	RESEARCH IN CLINICAL PRAGMATICS	Perspectives in Pragmatics Philosophy and Psychology		English	Article; Book Chapter						Adult with TBI; Child with TBI; Cognitive-communication disorder; Conversation; Language; Pragmatics; Social cognition; Traumatic brain injury	CLOSED-HEAD-INJURY; PRAGMATIC LANGUAGE-SKILLS; QUALITY-OF-LIFE; COMMUNICATION-SKILLS; NARRATIVE DISCOURSE; WORKING-MEMORY; ECOLOGICAL VALIDITY; SOCIAL INTEGRATION; YOUNG-CHILDREN; ADOLESCENTS	Children and adults with traumatic brain injury (TBI) are at high risk for impairments in pragmatic language and social communication more broadly. In this chapter, we provide an overview of epidemiology and outcomes after traumatic brain injury as a context for the study of pragmatics in this group. We then consider models of pragmatics in TBI, and their use in theory and clinical practice, and review findings from illustrative studies in children and adults. Finally, we discuss new approaches to the study of pragmatics in children and adults with TBI, and consider how these approaches can inform research and clinical practice.	[Turkstra, Lyn S.; Politis, Adam M.] Univ Wisconsin Madison, Dept Commun Sci & Disorders, Madison, WI 53706 USA; [Politis, Adam M.] NIH, Dept Rehabil Med, Bethesda, MD 20892 USA		Turkstra, LS (corresponding author), Univ Wisconsin Madison, Dept Commun Sci & Disorders, Madison, WI 53706 USA.	lyn.turkstra@wisc.edu; adam.politis@nih.gov	Sayre, Michael R/E-8383-2017; Turkstra, Lyn/ABC-5831-2021	Sayre, Michael R/0000-0003-0322-3181; Turkstra, Lyn/0000-0002-6948-6921			Adolphs R, 1999, TRENDS COGN SCI, V3, P469, DOI 10.1016/S1364-6613(99)01399-6; American Speech-Language-Hearing Association, 2005, SPEECH LANG PATH PRO; American Speech-Language-Hearing Association, 1991, GUID SPEECH LANGU PA; Anderson M., 2001, HEARSAY, V14, P8; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Barnes MA, 2001, BRAIN LANG, V76, P253, DOI 10.1006/brln.2000.2385; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; BARONCOHEN S, 1989, J CHILD PSYCHOL PSYC, V30, P285, DOI 10.1111/j.1469-7610.1989.tb00241.x; Beauchamp M, 2011, DEV NEUROPSYCHOL, V36, P578, DOI 10.1080/87565641.2011.555572; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Beauchamp MH, 2009, J NEUROTRAUM, V26, P1645, DOI [10.1089/neu.2009.0916, 10.1089/neu.2009-0916]; Bellerose J, 2015, J INT NEUROPSYCH SOC, V21, P483, DOI 10.1017/S1355617715000569; Bellon ML, 2006, BRAIN INJURY, V20, P1069, DOI 10.1080/02699050600909813; Biddle KR, 1996, J COMMUN DISORD, V29, P447, DOI 10.1016/0021-9924(95)00038-0; Breazeal C, 2006, ROBOT AUTON SYST, V54, P385, DOI 10.1016/j.robot.2006.02.004; Brookshire BL, 2000, J INT NEUROPSYCH SOC, V6, P741, DOI 10.1017/S1355617700677019; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Byom Lindsey J, 2013, Front Hum Neurosci, V7, P413, DOI 10.3389/fnhum.2013.00413; Byom LJ, 2012, INT J LANG COMM DIS, V47, P310, DOI 10.1111/j.1460-6984.2011.00102.x; CAMPBELL TF, 1990, J SPEECH HEAR DISORD, V55, P567, DOI 10.1044/jshd.5503.567; CAVELL TA, 1990, J CLIN CHILD PSYCHOL, V19, P111, DOI 10.1207/s15374424jccp1902_2; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Chapman S.B., 2006, BRAIN INJ PROF, V3, P10; Chapman SB, 1998, BRAIN LANG, V61, P420, DOI 10.1006/brln.1997.1885; Chapman SB, 2006, BRAIN LANG, V97, P178, DOI 10.1016/j.bandl.2005.10.002; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; Chapman SB, 2004, DEV NEUROPSYCHOL, V25, P37, DOI 10.1207/s15326942dn2501&2_4; Chapman SB, 2001, J HEAD TRAUMA REHAB, V16, P441, DOI 10.1097/00001199-200110000-00004; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Cherney L. R., 1998, ANAL DISCOURSE COMMU; Coelho C. A., 1994, DISCOURSE ANAL APPL, P81; COELHO CA, 1995, APHASIOLOGY, V9, P409, DOI 10.1080/02687039508248707; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; Cooper JM, 2014, J NEUROTRAUM, V31, P713, DOI 10.1089/neu.2013.3101; Crowe LM, 2011, CLIN PSYCHOL REV, V31, P767, DOI 10.1016/j.cpr.2011.03.008; Crowe LM, 2014, J HEAD TRAUMA REHAB, V29, P217, DOI 10.1097/HTR.0b013e31829babfd; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; DENNIS M, 1991, DEV NEUROPSYCHOL, V7, P327, DOI 10.1080/87565649109540497; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; Dennis M, 2001, BRAIN LANG, V78, P1, DOI 10.1006/brln.2000.2431; Dennis M, 2000, SCI PRACT NEUROPSYCH, P3; Dennis M, 2001, J HEAD TRAUMA REHAB, V16, P456, DOI 10.1097/00001199-200110000-00005; Dennis M, 2000, APHASIOLOGY, V14, P391, DOI 10.1080/026870300401423; Dennis M, 2013, J INT NEUROPSYCH SOC, V19, P338, DOI 10.1017/S1355617712001440; Dennis M, 2012, J INT NEUROPSYCH SOC, V18, P908, DOI 10.1017/S1355617712000756; Dennis M, 2010, CORTEX, V46, P1043, DOI 10.1016/j.cortex.2009.10.008; Despins EH, 2016, ARCH PHYS MED REHAB, V97, pS26, DOI 10.1016/j.apmr.2014.06.023; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Docking K, 2000, BRAIN INJURY, V14, P89, DOI 10.1080/026990500120952; Donovan NJ, 2011, BRAIN INJURY, V25, P348, DOI 10.3109/02699052.2011.556105; Driscoll DM, 2011, J NEUROTRAUM, V28, P319, DOI 10.1089/neu.2010.1523; Duff MC, 2012, SEMIN SPEECH LANG, V33, P44, DOI 10.1055/s-0031-1301162; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Ewing-Cobbs L, 1998, BRAIN LANG, V61, P395, DOI 10.1006/brln.1997.1884; Farrer TJ, 2013, CHILD NEUROPSYCHOL, V19, P225, DOI 10.1080/09297049.2011.647901; FINSET A, 1995, BRAIN INJURY, V9, P141, DOI 10.3109/02699059509008187; FLAVELL JH, 1980, COGNITION, V8, P369, DOI 10.1016/0010-0277(80)90001-3; FLAVELL JH, 1968, DEV ROLE TAKING COMM; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Ginstfeldt T, 2010, BRAIN INJURY, V24, P1123, DOI 10.3109/02699052.2010.506853; Gioia GA IP, 2000, BEHAV RATING INVENTO; Harlow J.M., 1993, PUBLICATIONS MASSACH, V4, P274, DOI [DOI 10.1177/0957154X9300401407, https://doi.org/10.1177/0957154X9300401407]; Hartley L. L, 1995, COGNITIVE COMMUNICAT; Hay E, 2005, AM J SPEECH-LANG PAT, V14, P324, DOI 10.1044/1058-0360(2005/031); Hinchliffe FJ, 1998, BRAIN INJURY, V12, P369, DOI 10.1080/026990598122502; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hough MS, 2003, APHASIOLOGY, V17, P183, DOI 10.1080/02687030244000608; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jordan FM, 1996, BRAIN INJURY, V10, P729, DOI 10.1080/026990596123990; KENNEDY MRT, 1991, COMMUNICATION DISORD, P123; LEMPERS JD, 1977, GENET PSYCHOL MONOGR, V95, P3; LEVIN HS, 1976, J NEUROL NEUROSUR PS, V39, P1062, DOI 10.1136/jnnp.39.11.1062; Linscott RJ, 1996, BRAIN INJURY, V10, P397, DOI 10.1080/026990596124269; Maas Andrew I R, 2015, Handb Clin Neurol, V128, P455, DOI 10.1016/B978-0-444-63521-1.00029-7; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Martin I, 2003, BRAIN LANG, V85, P451, DOI 10.1016/S0093-934X(03)00070-1; MASANGKAY ZS, 1974, CHILD DEV, V45, P357, DOI 10.2307/1127956; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; MCDONALD S, 1993, APHASIOLOGY, V7, P535, DOI 10.1080/02687039308248629; McDonald S, 1998, CLIN LINGUIST PHONET, V12, P237, DOI 10.3109/02699209808985224; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; MCDONALD S, 1995, BRAIN INJURY, V9, P255, DOI 10.3109/02699059509008197; McDonald S, 2006, DISABIL REHABIL, V28, P1529, DOI 10.1080/09638280600646185; McLean AM, 2014, DISABIL REHABIL, V36, P1409, DOI 10.3109/09638288.2013.834986; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Meulenbroek P., 2015, DISABIL REHABIL, V38, P1; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Moran C, 2005, BRAIN INJURY, V19, P743, DOI 10.1080/02699050500110199; Moran C, 2004, BRAIN INJURY, V18, P273, DOI 10.1080/02699050310001617415; Moran CA, 2006, BRAIN INJURY, V20, P417, DOI 10.1080/02699050500488223; Moran C, 2012, LANG SPEECH HEAR SER, V43, P264, DOI 10.1044/0161-1461(2011/10-0114); Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; Mutlu B., 2009, 2009 4th ACM/IEEE International Conference on Human-Robot Interaction (HRI), P61; National Science Foundation, 2016, COGN NEUR COGNEURO; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Perkins M, 2002, INVESTIGATIONS IN CLINICAL PHONETICS AND LINGUISTICS, P1; Perkins M. R., 2014, HDB QUALITATIVE RES, P131; Perkins MR, 2005, CLIN LINGUIST PHONET, V19, P363, DOI 10.1080/02699200400027080; Perkins MR, 1998, J PRAGMATICS, V29, P291, DOI 10.1016/S0378-2166(97)00055-6; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; Riggio S, 2009, MT SINAI J MED, V76, P163, DOI 10.1002/msj.20097; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Rowe AD, 2001, BRAIN, V124, P600, DOI 10.1093/brain/124.3.600; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Ryan NP, 2015, NEUROPSYCHOLOGIA, V66, P32, DOI 10.1016/j.neuropsychologia.2014.10.040; Schilbach L, 2013, BEHAV BRAIN SCI, V36, P393, DOI 10.1017/S0140525X12000660; Schmidt AT, 2010, NEUROPSYCHOLOGIA, V48, P2869, DOI 10.1016/j.neuropsychologia.2010.05.029; Seibert PS, 2002, BRAIN INJURY, V16, P837, DOI 10.1080/02699050210131939; Siegal M, 2002, NAT REV NEUROSCI, V3, P463, DOI 10.1038/nrn844; Sim P, 2013, BRAIN INJURY, V27, P717, DOI 10.3109/02699052.2013.775485; Stephens GJ, 2010, P NATL ACAD SCI USA, V107, P14425, DOI 10.1073/pnas.1008662107; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P4, DOI 10.1097/HTR.0b013e3182048e98; Stuss DT, 2001, BRAIN, V124, P279, DOI 10.1093/brain/124.2.279; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; Tonks J, 2007, BRAIN INJURY, V21, P731, DOI 10.1080/02699050701426899; Topolovec-Vranic J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1059; Towne R.L., 1993, LANG SPEECH HEAR SER, V24, P100; Tu LV, 2011, BRAIN INJURY, V25, P560, DOI 10.3109/02699052.2011.571655; Tucker FM, 1998, BRAIN INJURY, V12, P783, DOI 10.1080/026990598122179; Turkstra L., 2001, J INT NEUROPSYCH SOC, V7, P218; Turkstra LS, 2004, NEUROREHABILITATION, V19, P245; Turkstra LS, 1996, BRAIN INJURY, V10, P329, DOI 10.1080/026990596124359; Turkstra LS, 2008, BRAIN INJURY, V22, P397, DOI 10.1080/02699050802027059; Van Leer E, 1999, J COMMUN DISORD, V32, P327, DOI 10.1016/S0021-9924(99)00008-8; Walz NC, 2012, J NEUROPSYCHOL, V6, P143, DOI 10.1111/j.1748-6653.2011.02020.x; Walz NC, 2009, DEV NEUROPSYCHOL, V34, P507, DOI 10.1080/87565640902964490; Wilson KR, 2011, REHABIL PSYCHOL, V56, P100, DOI 10.1037/a0023446; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387	131	1	2	4	6	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	2214-3807		978-3-319-47489-2; 978-3-319-47487-8	PERSP PRAGMAT PHILO			2017	11						291	322		10.1007/978-3-319-47489-2_12	10.1007/978-3-319-47489-2		32	Audiology & Speech-Language Pathology; Communication; Linguistics; Rehabilitation	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Audiology & Speech-Language Pathology; Communication; Linguistics; Rehabilitation	BI8BR	WOS:000414965000013					2022-02-06	
J	Ustinova, KI				Ustinova, Ksenia I.			Decomposition of postural movements in individuals with mild TBI while reaching to intercept a moving virtual target	PHYSIOTHERAPY THEORY AND PRACTICE			English	Article						Coordination; physical therapy; postural control; virtual reality	POINTING MOVEMENTS; CEREBELLAR-ATAXIA; ARM MOVEMENTS; COORDINATION; INJURY; CONSTRAINTS; HEMIPARESIS; ENVIRONMENT; HEALTHY; TRUNK	The study analyzed postural and arm movement coordinations in patients with traumatic brain injury (TBI) while standing and reaching for a target moving in a 3D virtual environment. Thirteen individuals with mild TBI and 13 height, sex, and age-matched healthy control individuals were involved. While standing in front of the screen, the participants interacted with the projected environment by reaching for virtual targets. Coordination was analyzed as the percentage of reach-to-intercept cycle time during which their movement toward the target was decomposed with 0% indicating simultaneous motion in three planes or 100% indicating motion in one or two planes only. Decomposition was calculated for the postural movements (DIp), arm movements (DIa), and arm-postural coordination (DIa-p). The latter index represented the percentage of reach-to-intercept cycle time during which either the posture or arm moved alone. DIp and DIa-p were larger in the TBI group compared to the control group (p < 0.01). In the TBI group, DIp and DIa-p correlated negatively with postural stability (r = - 0.71 and r = - 0.60; p < 0.01). Results suggest that individuals with TBI decompose postural and arm-postural coordinations during a reach-to-intercept task. This may be either a result of impaired postural control or an effort to compensate for instability. These abnormalities should be taken into consideration while planning physical therapy programs for individuals after brain injury.	[Ustinova, Ksenia I.] Cent Michigan Univ, Doctoral Program Phys Therapy, Mt Pleasant, MI 48859 USA		Ustinova, KI (corresponding author), Cent Michigan Univ, Doctoral Program Phys Therapy, Mt Pleasant, MI 48859 USA.	ustin1k@cmich.edu	Ustinova, Ksenia I/M-8250-2016	Ustinova, Ksenia I/0000-0002-1531-7591	NSF MRI grantNational Science Foundation (NSF)NSF - Office of the Director (OD) [CBET-1337511]	Research project was sponsored by NSF MRI grant CBET-1337511.	Archambault P, 1999, EXP BRAIN RES, V126, P55, DOI 10.1007/s002210050716; Bastian AJ, 1996, J NEUROPHYSIOL, V76, P492, DOI 10.1152/jn.1996.76.1.492; BERG K, 1989, Physiotherapy Canada, V41, P304; Berrigan F, 2006, EXP BRAIN RES, V170, P255, DOI 10.1007/s00221-005-0210-z; Brenner E, 1996, HUM MOVEMENT SCI, V15, P39, DOI 10.1016/0167-9457(95)00036-4; Colarusso RP., 1996, MOTOR FREE VISUAL PE; Earhart GM, 2001, J NEUROPHYSIOL, V85, P759, DOI 10.1152/jn.2001.85.2.759; Fidopiastis C, 2005, PRESENCE-TELEOP VIRT, V14, P550, DOI 10.1162/105474605774918697; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Ghafouri M, 2001, EXP BRAIN RES, V137, P411; Goodkin HP, 1993, CAN J NEUROL SCI S3, V20, P93; Kaminski TR, 2001, EXP BRAIN RES, V136, P439, DOI 10.1007/s002210000604; Katz DI, 2007, BRAIN INJURY MED PRI, P3; KLOCKGETHER T, 1990, J NEUROL NEUROSUR PS, V53, P297, DOI 10.1136/jnnp.53.4.297; Knott M., 1968, PROPRIOCEPTIVE NEURO; Levin MF, 1996, BRAIN, V119, P281, DOI 10.1093/brain/119.1.281; Levin MF, 2002, EXP BRAIN RES, V143, P171, DOI 10.1007/s00221-001-0976-6; Magdalon EC, 2011, ACTA PSYCHOL, V138, P126, DOI 10.1016/j.actpsy.2011.05.015; Meyers JE., 1995, REY COMPLEX FIGURE T; Morton SM, 2003, J NEUROPHYSIOL, V89, P1844, DOI 10.1152/jn.00787.2002; Newton RA, 2001, J GERONTOL A-BIOL, V56, pM248, DOI 10.1093/gerona/56.4.M248; Potts MB, 2009, CEREBELLUM, V8, P211, DOI 10.1007/s12311-009-0114-8; Pozzo T, 2002, EXP BRAIN RES, V144, P343, DOI 10.1007/s00221-002-1052-6; Schafer AY, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-76; Soto-Ares G, 2001, CHILD NERV SYST, V17, P263, DOI 10.1007/s003810000411; Stapley PJ, 1999, EXP BRAIN RES, V129, P134, DOI 10.1007/s002210050944; Thomas JS, 2003, EXP BRAIN RES, V148, P377, DOI 10.1007/s00221-002-1287-2; Topka H, 1998, EXP BRAIN RES, V119, P483, DOI 10.1007/s002210050364; Tresilian JR, 2002, EXP BRAIN RES, V142, P193, DOI 10.1007/s00221-001-0920-9; Ustinova KI, 2010, ACTA PSYCHOL, V133, P180, DOI 10.1016/j.actpsy.2009.11.006; Ustinova KI, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-61; Wrisley DM, 2004, PHYS THER, V84, P906, DOI 10.1093/ptj/84.10.906	32	1	1	2	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0959-3985	1532-5040		PHYSIOTHER THEOR PR	Physiother. Theory Pract.		2017	33	7					527	534		10.1080/09593985.2017.1325958			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	EY4HH	WOS:000403937700002	28557606				2022-02-06	
B	van Heugten, CM		Wilson, BA; Winegardner, J; VanHeugten, CM; Ownsworth, T		van Heugten, Caroline M.			OUTCOME MEASURES	NEUROPSYCHOLOGICAL REHABILITATION: THE INTERNATIONAL HANDBOOK			English	Article; Book Chapter							QUALITY-OF-LIFE; SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; PARTICIPATION MEASURES; POSITIVE PSYCHOLOGY; UTRECHT SCALE; REHABILITATION; VALIDITY; RESPONSIVENESS; DISABILITY		[van Heugten, Caroline M.] Maastricht Univ, Maastricht, Netherlands; [van Heugten, Caroline M.] Maastricht Univ, Med Ctr, Maastricht, Netherlands		van Heugten, CM (corresponding author), Maastricht Univ, Maastricht, Netherlands.; van Heugten, CM (corresponding author), Maastricht Univ, Med Ctr, Maastricht, Netherlands.						Andresen EM, 2000, ARCH PHYS MED REHAB, V81, pS15, DOI 10.1053/apmr.2000.20619; Biering-Sorensen F, 2014, SPINAL CORD, V52, P652, DOI 10.1038/sc.2014.87; Biering-Sorensen Fin, 2012, Top Spinal Cord Inj Rehabil, V18, P23; British Society of Rehabilitation Medicine Royal College of Physicians, 2003, REH FOLL ACQ BRAIN I; Charlifue S, 2012, SPINAL CORD, V50, P672, DOI 10.1038/sc.2012.27; Chung P, 2014, J REHABIL MED, V46, P108, DOI 10.2340/16501977-1257; Correia H, 2015, QUAL LIFE RES, V24, P753, DOI 10.1007/s11136-014-0786-5; Gershon RC, 2012, QUAL LIFE RES, V21, P475, DOI 10.1007/s11136-011-9958-8; Gregorio GW, 2014, J HEAD TRAUMA REHAB, V29, pE30, DOI 10.1097/HTR.0b013e31828f93db; Hicks R., 2013, INT TBI COMMON DATA, V7, P6; Hicks R, 2013, J NEUROTRAUM, V30, P1852, DOI 10.1089/neu.2013.2938; Huber M, 2016, BMJ OPEN, V12, P6; Huber Machteld, 2011, BMJ, V343, pd4163, DOI 10.1136/bmj.d4163; Moniz-Cook E, 2008, AGING MENT HEALTH, V12, P14, DOI 10.1080/13607860801919850; Noonan VK, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-93; Polinder S, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0037-1; Post MW, 2016, SPINAL CORD, V54, P530, DOI 10.1038/sc.2015.188; Post MWM, 2016, SPINAL CORD, V54, P314, DOI 10.1038/sc.2015.99; Post MWM, 2012, DISABIL REHABIL, V34, P478, DOI 10.3109/09638288.2011.608148; Salinas J, 2016, STROKE, V47, P180, DOI 10.1161/STROKEAHA.115.010898; Salsman JM, 2013, QUAL LIFE RES, V22, P2569, DOI 10.1007/s11136-013-0382-0; Salter K., 2013, EVIDENCE BASED REV S; Seligman MEP, 2000, AM PSYCHOL, V55, P5, DOI 10.1037/0003-066X.55.1.5; Stoner CR, 2015, DEMENT GERIATR COGN, V40, P340, DOI 10.1159/000439044; Tate R.L., 2014, UNDERSTANDING TRAUMA; Tate RL, 2013, NEUROREHABILITATION, V32, P729, DOI 10.3233/NRE-130898; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Tulsky DS, 2015, J SPINAL CORD MED, V38, P257, DOI [10.1179/2045772315Y.0000000023, 10.1179/2045772315Y.0000000035]; van der Putten JJMF, 1999, J NEUROL NEUROSUR PS, V66, P480, DOI 10.1136/jnnp.66.4.480; van der Zee CH, 2013, SCAND J OCCUP THER, V20, P201, DOI 10.3109/11038128.2012.754491; van der Zee CH, 2011, J REHABIL MED, V43, P1003, DOI 10.2340/16501977-0879; van der Zee CH, 2010, J REHABIL MED, V42, P752, DOI 10.2340/16501977-0589; van Heugten C.M., 2016, 13 C WFNR SPEC INT G; Van Heugten CM, 2015, CLIN REHABIL, V29, P694, DOI 10.1177/0269215514553012; Victorson D, 2014, EPILEPSY BEHAV, V31, P77, DOI 10.1016/j.yebeh.2013.11.008; Widerstrom-Noga E., 2016, SPINAL CORD     0412, V12; World Health Organization, 2007, INT CLASS FUNCT DIS	37	1	1	1	1	ROUTLEDGE	ABINGDON	2 PARK SQ, MILTON PARK, ABINGDON OX14 4RN, OXFORD, ENGLAND			978-1-138-64311-6; 978-1-315-62953-7; 978-1-138-64309-3				2017							537	546					10	Psychology, Clinical; Clinical Neurology; Psychology; Rehabilitation	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Psychology; Neurosciences & Neurology; Rehabilitation	BO7UU	WOS:000525648500065					2022-02-06	
J	van Noordt, S; Chiappetta, K; Good, D				van Noordt, Stefon; Chiappetta, Katie; Good, Dawn			Moral decision-making in university students with self-reported mild head injury	SOCIAL NEUROSCIENCE			English	Article						Mild head injury; moral dilemmas; university students; ventromedial prefrontal cortex; emotion	TRAUMATIC BRAIN-INJURY; PREFRONTAL CORTEX; COGNITIVE PERFORMANCE; DIAGNOSIS THREAT; FRONTAL-CORTEX; DAMAGE; JUDGMENT; EMOTION; FMRI; UTILITARIAN	Converging evidence shows that the prefrontal cortex is involved in moral decision-making. Individuals who have suffered injury to the ventromedial prefrontal cortex are more willing to endorse personal moral transgressions (e.g., make their decisions faster, and have attenuated sympathetic responses to those violations). We examined whether university students who have experienced a mild head injury (MHI), and are asymptomatic, present with a similar pattern of responding to moral dilemmas. Students reporting a history of MHI responded more quickly when making moral choices and exhibited less reticence toward the endorsement of personal moral transgressions than their non-MHI counterparts. Our results are consistent with studies involving persons with more serious, and evident, neuronal injury, and emphasize the important relationship between head injury and moral decision-making.	[van Noordt, Stefon; Chiappetta, Katie] Brock Univ, Dept Psychol, Neuropsychol Cognit Res Lab, 500 Glenridge Ave, St Catharines, ON L2S 3A1, Canada; [Good, Dawn] Brock Univ, Dept Psychol & Ctr Neurosci, Neuropsychol Cognit Res Lab, St Catharines, ON, Canada		van Noordt, S (corresponding author), Brock Univ, Dept Psychol, Neuropsychol Cognit Res Lab, 500 Glenridge Ave, St Catharines, ON L2S 3A1, Canada.	stefonv0@gmail.com			Ontario Neurotrauma Foundation (ONF) [2008-ABI-SR-603]	This research was supported by grant [2008-ABI-SR-603], afforded to Dr. Dawn Good from the Ontario Neurotrauma Foundation (ONF).	Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Anderson SW, 2006, J INT NEUROPSYCH SOC, V12, P224, DOI 10.1017/S1355617706060346; [Anonymous], 1991, BMJ-BRIT MED J, V302, P1194; Baker JM, 2014, BRAIN INJURY, V28, P51, DOI 10.3109/02699052.2013.857787; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; Beer JS, 2006, J COGNITIVE NEUROSCI, V18, P871, DOI 10.1162/jocn.2006.18.6.871; Bernstein DM, 1999, BRAIN INJURY, V13, P151, DOI 10.1080/026990599121683; Bernstein DM, 2002, J INT NEUROPSYCH SOC, V8, P673, DOI 10.1017/S1355617702801400; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Borg JS, 2006, J COGNITIVE NEUROSCI, V18, P803, DOI 10.1162/jocn.2006.18.5.803; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Ciaramelli E, 2007, SOC COGN AFFECT NEUR, V2, P84, DOI 10.1093/scan/nsm001; D'Zurilla T.J., 2002, SOCIAL PROBLEM SOLVI; D'Zurilla TJ, 2011, PERS INDIV DIFFER, V50, P142, DOI 10.1016/j.paid.2010.09.015; D'Zurilla TJ, 1998, PERS INDIV DIFFER, V25, P241, DOI 10.1016/S0191-8869(98)00029-4; De La Torre MT, 2010, CULT DIVERS ETHN MIN, V16, P501, DOI 10.1037/a0021372; DeBono A., 2008, SOCIAL CONSEQUENCES; Delis DC., 2001, DELIS KAPLAN EXECUTI; Fellows LK, 2003, BRAIN, V126, P1830, DOI 10.1093/brain/awg180; Forbes CE, 2010, ANNU REV NEUROSCI, V33, P299, DOI 10.1146/annurev-neuro-060909-153230; Frijda NH, 2005, COGNITION EMOTION, V19, P473, DOI 10.1080/02699930441000346; Gennarelli TA, 1996, NEUROPATH APPL NEURO, V22, P509, DOI 10.1111/j.1365-2990.1996.tb01126.x; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Greene JD, 2007, TRENDS COGN SCI, V11, P322, DOI 10.1016/j.tics.2007.06.004; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; Harenski CL, 2006, NEUROIMAGE, V30, P313, DOI 10.1016/j.neuroimage.2005.09.034; Harlow JM, 1848, BOSTON MED SURGICAL, V39, P389, DOI DOI 10.1056/NEJM184812130392001; Heekeren HR, 2003, NEUROREPORT, V14, P1215, DOI 10.1097/00001756-200307010-00005; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Laforce R, 2001, PERCEPT MOTOR SKILL, V93, P281, DOI 10.2466/PMS.93.5.281-288; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; Lieberman MD, 2007, ANNU REV PSYCHOL, V58, P259, DOI 10.1146/annurev.psych.58.110405.085654; Mah L, 2004, AM J PSYCHIAT, V161, P1247, DOI 10.1176/appi.ajp.161.7.1247; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Messe A, 2012, BRAIN IMAGING BEHAV, V6, P283, DOI 10.1007/s11682-012-9159-2; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Moll J, 2002, NEUROIMAGE, V16, P696, DOI 10.1006/nimg.2002.1118; Moll J, 2002, J NEUROSCI, V22, P2730, DOI 10.1523/JNEUROSCI.22-07-02730.2002; Moll J, 2005, NAT REV NEUROSCI, V6, P799, DOI 10.1038/nrn1768; Morales D., 2015, BRAIN CONTUSION IMAG; Morera OF, 2006, PERS INDIV DIFFER, V41, P307, DOI 10.1016/j.paid.2005.08.016; Moretto G, 2010, J COGNITIVE NEUROSCI, V22, P1888, DOI 10.1162/jocn.2009.21367; Muscara F, 2008, J NEUROPSYCHOL, V2, P445, DOI 10.1348/174866407X250820; Paulhus D. L., MANUAL HARE IN PRESS; Robertson RH, 2008, NEUROPSYCHOL REHABIL, V18, P236, DOI 10.1080/09602010701734438; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; SEGALOWITZ SJ, 1991, J LEARN DISABIL, V24, P551, DOI 10.1177/002221949102400907; Segalowitz SJ, 2001, BRAIN COGNITION, V45, P342, DOI 10.1006/brcg.2000.1263; SEGALOWITZ SJ, 1995, J LEARN DISABIL, V28, P309, DOI 10.1177/002221949502800507; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Tangney JP, 2007, ANNU REV PSYCHOL, V58, P345, DOI 10.1146/annurev.psych.56.091103.070145; Tellier A, 1999, BRAIN INJURY, V13, P463; Thomas BC, 2011, J COGNITIVE NEUROSCI, V23, P2186, DOI 10.1162/jocn.2010.21591; van Noordt S, 2011, BRAIN INJURY, V25, P707, DOI 10.3109/02699052.2011.580312; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; Yarnell P R, 1988, Brain Inj, V2, P255, DOI 10.3109/02699058809150950; Young L, 2007, BRIT MED BULL, V84, P69, DOI 10.1093/bmb/ldm031; Young L, 2010, NEURON, V65, P845, DOI 10.1016/j.neuron.2010.03.003; Young L, 2009, J COGNITIVE NEUROSCI, V21, P1396, DOI 10.1162/jocn.2009.21137	67	1	1	2	9	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1747-0919	1747-0927		SOC NEUROSCI-UK	Soc. Neurosci.		2017	12	5					541	550		10.1080/17470919.2016.1195773			10	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	FA7GY	WOS:000405614900006	27237576				2022-02-06	
J	Vaz, E; Foster, A; Cusimano, M				Vaz, Eric; Foster, Akeem; Cusimano, Michael			A LOCAL SPATIAL ANALYS IS CRITERION OF POSTTRAUMATIC BRAIN INJURY AND ACCESSIBILITY TO PUBLIC TRANSPORTATION	JOURNAL OF SPATIAL AND ORGANIZATIONAL DYNAMICS			English	Article						GIS; Post-Traumatic Brain Injury; Public Transportation		Reported cases of traumatic brain injuries are increasing among the Canadian population. With an annual rate of 187,000 reported cases a year and growing, there is an extrapolated growth of 239,000 cases of traumatic brain injuries occurring annually by 2036. As Ontario intends to be a completely accessible province for those with disabilities by 2025, this paper utilizes GIS to visualize and better understand the relationship between post- TBI residents living in Brampton and their accessibility to public transportation. As Brampton is currently the most expensive city to insure a vehicle because of frequent collisions occurring within the city, creating a more accessible, reliable, and efficient public transportation system can integrate those who have experienced a traumatic brain injury back into society while reducing the required use of a personal vehicle. This will contribute to a safer city, as there are fewer vehicles on the road at risk of being involved in a road accident. There are also further benefits to this, as it will also reduce levels of congestion in the foreseeable future.	[Vaz, Eric; Foster, Akeem] Ryerson Univ, Dept Geog & Environm Studies, Toronto, ON, Canada; [Vaz, Eric] Univ Algarve, Res Ctr Spatial & Org Dynam, Faro, Portugal; [Cusimano, Michael] Univ Toronto, Dept Neurosurg, Toronto, ON, Canada; [Cusimano, Michael] St Michaels Hosp, Toronto, ON, Canada		Vaz, E (corresponding author), Ryerson Univ, Dept Geog & Environm Studies, Toronto, ON, Canada.; Vaz, E (corresponding author), Univ Algarve, Res Ctr Spatial & Org Dynam, Faro, Portugal.	evaz@ryerson.c; akeem.foster@ryerson.ca; cusimanom@smh.ca	Cusimano, Michael/X-4059-2019				[Anonymous], 2010, UNDP MAL SING AMP BR; [Anonymous], 2015, ICD10CA; [Anonymous], 2015, PREV INC N E ONT BRA; Bivona U., 2012, J HEAD TRAUMA REHAB, P1; Caro Denis, 2011, Healthc Manage Forum, V24, P25; Classen S, 2009, AM J OCCUP THER, V63, P580, DOI 10.5014/ajot.63.5.580; Cullen N., 2013, BRAIN INJ BRAIN INJU, P38; D'apolito A. -C., 2013, Annals of Physical and Rehabilitation Medicine, V56, P63, DOI 10.1016/j.rehab.2012.12.002; Elsayed N., 2011, SOC CARE NEURODISABI, P138; Hopewell CA, 2002, J HEAD TRAUMA REHAB, V17, P48, DOI 10.1097/00001199-200202000-00007; Hulme J, 2008, TRAUMA, V10, P55, DOI 10.1177/1460408608089656; Labbe DR, 2014, J HEAD TRAUMA REHAB, V29, P185, DOI 10.1097/HTR.0b013e3182795211; Linguistic Characteristics of Canadians, 2011, STAT CANADA; Lundqvist A, 2007, BRAIN INJURY, V21, P1109, DOI 10.1080/02699050701651660; Rapport L, 2006, J HEAD TRAUMA REHAB, V21, P34, DOI 10.1097/00001199-200601000-00004; Sherer M, 2000, J HEAD TRAUMA REHAB, V15, P767, DOI 10.1097/00001199-200004000-00002; Vaz E, 2015, J ENVIRON INFORM, V25, P71, DOI 10.3808/jei.201500299; Vaz E, 2015, LAND USE POLICY, V46, P232, DOI 10.1016/j.landusepol.2015.02.014	18	1	1	1	2	CIEO, RESEARCH CENTER SPATIAL & ORGANIZATIONAL DYNAMICS	FARO	UNIV ALGARVE CAMPUS GAMBELAS, BUILDING 9, FARO, 8005-139, PORTUGAL	1647-3183			J SPAT ORGAN DYN	J. Spat. Organ. Dyn.		2017	5	1					27	36					10	Social Sciences, Interdisciplinary	Emerging Sources Citation Index (ESCI)	Social Sciences - Other Topics	ER4YS	WOS:000398809000003					2022-02-06	
J	Vincent, AS; Bailey, CM; Cowan, C; Cox-Fuenzalida, E; Dyche, J; Gorgens, KA; Krawczyk, DC; Young, L				Vincent, Andrea S.; Bailey, Christopher M.; Cowan, Charles; Cox-Fuenzalida, Eugenia; Dyche, Jeff; Gorgens, Kim A.; Krawczyk, Daniel C.; Young, Leanne			Normative data for evaluating mild traumatic brain injury with a handheld neurocognitive assessment tool	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Computerized testing; concussion; handheld computers; neuropsychology; normative study	NEUROPSYCHOLOGICAL ASSESSMENT METRICS; CONCUSSION ASSESSMENT; COGNITIVE FUNCTION; SPORT; PERFORMANCE; BATTERY; UTILITY; TBI; RELIABILITY; VALIDITY	The BrainScope (TM) Ahead (TM) 300 is designed for use by health care professionals to aid in the assessment of patients suspected of a mild traumatic brain injury. The purpose of the current study was to establish normative data for the cognitive test component of the Ahead 300 system and to evaluate the role of demographic factors on test performance. Healthy, community-dwelling adults between the ages of 18 and 80 recruited from five geographically distributed sites were administered Android versions of the ANAM Matching to Sample and Procedural Reaction Time tests that comprise the cognitive test component of the Ahead 300 system by trained personnel. Scores were correlated with age, education, and race. Age accounted for the majority of the variance in test scores with additional significant, but minor, contributions of education and race. Gender did not account for a significant proportion of the variance for either test. Based on these results, the normative data for 551 individuals are presented stratified by age. These are the first available normative data for these tests when administered using the Ahead 300 system and will assist health care professionals in determining the degree to which scores on the cognitive tests reflect impaired performance.	[Vincent, Andrea S.; Cox-Fuenzalida, Eugenia] Univ Oklahoma, Cognit Sci Res Ctr, 350 David L Boren Blvd,Suite 1910, Norman, OK 73019 USA; [Bailey, Christopher M.] Univ Hosp Case Med Ctr, Cleveland, OH USA; [Cowan, Charles; Dyche, Jeff] James Madison Univ, Dept Psychol, Harrisonburg, VA 22807 USA; [Gorgens, Kim A.] Univ Denver, Grad Sch Profess Psychol, Denver, CO USA; [Krawczyk, Daniel C.; Young, Leanne] Univ Texas Dallas, Sch Behav & Brain Sci, Dallas, TX USA		Vincent, AS (corresponding author), Univ Oklahoma, Cognit Sci Res Ctr, 350 David L Boren Blvd,Suite 1910, Norman, OK 73019 USA.	avincent@ou.edu			BrainScope Company, Inc., Bethesda, MD	Funding for this study was provided by BrainScope Company, Inc., Bethesda, MD.	[Anonymous], 2013, ANAM TECHN MAN; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bleiberg J, 1998, J HEAD TRAUMA REHAB, V13, P36, DOI 10.1097/00001199-199804000-00006; Bleiberg J, 1997, NEUROPSY NEUROPSY BE, V10, P247; Bleiberg J, 2000, CLIN NEUROPSYCHOL, V14, P287, DOI 10.1076/1385-4046(200008)14:3;1-P;FT287; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Bryan C, 2012, J HEAD TRAUMA REHAB, V27, P45, DOI 10.1097/HTR.0b013e318238f146; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Cernich A. N., 2004, 32 ANN M INT NEUR SO; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; Coldren RL, 2012, MIL MED, V177, P179, DOI 10.7205/MILMED-D-11-00278; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Craik FIM, 2006, TRENDS COGN SCI, V10, P131, DOI 10.1016/j.tics.2006.01.007; Passos VMD, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0454-6; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Faul M, 2010, TRAUMATIC BRAIN INJU; Gaw CE, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0071-8; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Heaton RK, 1996, NEUROPSYCHOLOGICAL A, P141; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson G. L., 2011, HDB SPORT NEUROPSYCH, P131; Iverson GL, 2015, BRAIN INJURY, V29, P263, DOI 10.3109/02699052.2014.965214; Ivins BJ, 2015, ARCH CLIN NEUROPSYCH, V30, P26, DOI 10.1093/arclin/acu072; Kane RL, 2007, ARCH CLIN NEUROPSYCH, V22, pS115, DOI 10.1016/j.acn.2006.10.006; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kelly MP, 2012, ARCH CLIN NEUROPSYCH, V27, P375, DOI 10.1093/arclin/acs036; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; MacGregor AJ, 2010, J HEAD TRAUMA REHAB, V25, P1, DOI 10.1097/HTR.0b013e3181c2993d; Malhotra R, 2015, GERIATR GERONTOL INT, V15, P372, DOI 10.1111/ggi.12331; Matute E, 2012, INT REV EDUC, V58, P109, DOI 10.1007/s11159-012-9273-9; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Norris JN, 2013, MIL MED, V178, P767, DOI 10.7205/MILMED-D-12-00493; Olejnik S, 2003, PSYCHOL METHODS, V8, P434, DOI 10.1037/1082-989X.8.4.434; Persoon A, 2011, INT J OLDER PEOPLE N, V6, P102, DOI 10.1111/j.1748-3743.2010.00234.x; Prichep LS, 2012, IEEE T NEUR SYS REH, V20, P806, DOI 10.1109/TNSRE.2012.2206609; Resch JE, 2013, NEUROPSYCHOL REV, V23, P335, DOI 10.1007/s11065-013-9242-5; Roebuck-Spencer TM, 2008, MIL PSYCHOL, V20, P187, DOI 10.1080/08995600802118825; Roebuck-Spencer TM, 2013, J ATHL TRAINING, V48, P499, DOI 10.4085/1062-6050-48.3.11; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Schretlen DJ, 2008, J INT NEUROPSYCH SOC, V14, P436, DOI 10.1017/S1355617708080387; Thorne DR, 2006, BEHAV RES METHODS, V38, P569; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Vincent AS, 2008, MIL MED, V173, P836, DOI 10.7205/MILMED.173.9.836; Vincent AS, 2012, MIL MED, V177, P256, DOI 10.7205/MILMED-D-11-00289; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Woodhouse J, 2013, CLIN NEUROPSYCHOL, V27, P376, DOI 10.1080/13854046.2012.762427; Yallampalli R, 2013, J NEUROIMAGING, V23, P224, DOI 10.1111/j.1552-6569.2010.00537.x	51	1	1	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2017	24	6					566	576		10.1080/23279095.2016.1213263			11	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	FQ8ME	WOS:000418616100010	27712105				2022-02-06	
S	Wang, KKW		Wilkesman, J; Kurz, L		Wang, Kevin K. W.			Calpain Zymography: General Methodology and Protocol	ZYMOGRAPHY: Methods and Protocols	Methods in Molecular Biology		English	Article; Book Chapter						Calpain; Caseinolysis; Protease substrates	TRAUMATIC BRAIN-INJURY; MU-CALPAIN; CASEIN ZYMOGRAPHY; RAT; EXPRESSION; FAMILY	Casein zymography has become one of the gold standard assays for monitoring mammalian calcium-activated proteases (calpains) in purified enzyme, cell, or tissue samples. This calpain zymography method takes advantages of (1) casein is an excellent substrate for major isoforms of calpains (Calpain-1, 2 and 3), (2) the embedded casein is digested into small peptides where the calpain bands are located, thus creating a clear zone upon Commassie blue gel staining, and (3) the calpain isoforms have different gel mobility under native gel conditions. Casein zymography is also useful in studying reversibility of inhibitor binding to calpains.	[Wang, Kevin K. W.] Univ Florida, Dept Psychiat, Program Neurotrauma Neuroprote & Biomarker Res, Gainesville, FL 32611 USA; [Wang, Kevin K. W.] Univ Florida, Dept Neurosci, Gainesville, FL 32611 USA; [Wang, Kevin K. W.] Univ Florida, Dept Chem, Gainesville, FL 32611 USA		Wang, KKW (corresponding author), Univ Florida, Dept Psychiat, Program Neurotrauma Neuroprote & Biomarker Res, Gainesville, FL 32611 USA.; Wang, KKW (corresponding author), Univ Florida, Dept Neurosci, Gainesville, FL 32611 USA.; Wang, KKW (corresponding author), Univ Florida, Dept Chem, Gainesville, FL 32611 USA.			Wang, Kevin/0000-0002-9343-6473	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21 NS085455-01]	This study is supported in part by NIH grant R21 NS085455-01 (K.K.W.).	Azuma M, 2000, CURR EYE RES, V21, P710, DOI 10.1076/0271-3683(200009)21:3;1-R;FT710; Giguere CJ, 2008, BIOCHEM BIOPH RES CO, V366, P258, DOI 10.1016/j.bbrc.2007.11.133; Huang YH, 2001, TRENDS MOL MED, V7, P355, DOI 10.1016/S1471-4914(01)02049-4; Ma H, 1998, EXP EYE RES, V67, P221, DOI 10.1006/exer.1998.0515; RASER KJ, 1995, ARCH BIOCHEM BIOPHYS, V319, P211, DOI 10.1006/abbi.1995.1284; Romanic AM, 1998, STROKE, V29, P1020, DOI 10.1161/01.STR.29.5.1020; Sorimachi H, 2011, P JPN ACAD B-PHYS, V87, P287, DOI 10.2183/pjab.87.287; Wang KKW, 2002, CURR PROTOC PROTEIN, DOI 10.1002/471140864.ps2112s27; Wang XY, 2002, J NEUROTRAUM, V19, P615, DOI 10.1089/089771502753754082; Zhao X, 1998, NEUROSCI LETT, V247, P53, DOI 10.1016/S0304-3940(98)00219-5; Zhao XR, 1998, J CEREBR BLOOD F MET, V18, P161, DOI 10.1097/00004647-199802000-00006	11	1	1	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	1064-3745	1940-6029	978-1-4939-7111-4; 978-1-4939-7109-1	METHODS MOL BIOL	Methods Mol. Biol.		2017	1626						279	285		10.1007/978-1-4939-7111-4_26	10.1007/978-1-4939-7111-4		7	Biochemical Research Methods; Biochemistry & Molecular Biology	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology	BS0ZL	WOS:000685679800027	28608220				2022-02-06	
B	Weiss, EL; Hino, D; Canfield, J; Albright, DL		Beder, J		Weiss, Eugenia L.; Hino, Deborah; Canfield, Julie; Albright, David L.			MILITARY FAMILIES: STRENGTHS AND CONCERNS Reintegration and Beyond	CARING FOR THE MILITARY: A GUIDE FOR HELPING PROFESSIONALS			English	Article; Book Chapter							INTIMATE PARTNER VIOLENCE; POSTTRAUMATIC-STRESS-DISORDER; NATIONAL-GUARD SOLDIERS; TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH-SERVICES; WAR VETERANS; SECONDARY TRAUMATIZATION; DOMESTIC VIOLENCE; FEMALE PARTNERS; WOMEN VETERANS		[Weiss, Eugenia L.] Univ Southern Calif, Sch Social Work, Los Angeles, CA 90089 USA; [Weiss, Eugenia L.] Orange Cty Acad Ctr, Irvine, CA 92612 USA; [Canfield, Julie] Boston Coll, Sch Social Work, Families Impacted Mil Serv, Chestnut Hill, MA 02167 USA; [Canfield, Julie] Boston Coll, Sch Social Work, Vet Hlth & Mental Hlth, Chestnut Hill, MA 02167 USA; [Albright, David L.] Univ Alabama, Mental Hlth Res, Tuscaloosa, AL 35487 USA; [Albright, David L.] DVA Corp, Ctr Mil Hlth Policy Res, Tuscaloosa, AL USA; [Albright, David L.] RAND Corp, Ctr Mil Hlth Policy Res, Santa Monica, CA 90406 USA		Weiss, EL (corresponding author), Univ Southern Calif, Sch Social Work, Los Angeles, CA 90089 USA.; Weiss, EL (corresponding author), Orange Cty Acad Ctr, Irvine, CA 92612 USA.						Acion L, 2013, ADDICTION, V108, P1418, DOI 10.1111/add.12161; Basham K., 2013, HDB MILITARY SOCIAL, P443; Bello-Utu CF, 2015, J CHILD ADOL PS NURS, V28, P23, DOI 10.1111/jcap.12099; Black SA, 2011, MIL PSYCHOL, V23, P433, DOI 10.1080/08995605.2011.590409; Bowling U., 2011, OPERATION ENDURING F; Bowling UB, 2008, PROF PSYCHOL-RES PR, V39, P451, DOI 10.1037/0735-7028.39.4.451; Boyd C., 2013, HDB MILITARY SOCIAL, P163; Bradley C, 2007, J FAM VIOLENCE, V22, P197, DOI 10.1007/s10896-007-9072-4; Brendel KE, 2014, RES SOCIAL WORK PRAC, V24, P649, DOI 10.1177/1049731513517143; Brown A, 2014, SOC WORK HEALTH CARE, V53, P714, DOI 10.1080/00981389.2014.944249; Brown DW, 2009, AM J PREV MED, V37, P389, DOI 10.1016/j.amepre.2009.06.021; Bryan CJ, 2012, ARCH SUICIDE RES, V16, P95, DOI 10.1080/13811118.2012.667321; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; Carlson E., 2014, PTSD FAMILY; Cederbaum JA, 2014, J ADOLESCENT HEALTH, V54, P672, DOI 10.1016/j.jadohealth.2013.09.006; Chandra A, 2010, PEDIATRICS, V125, P16, DOI 10.1542/peds.2009-1180; Chavis AZ, 2009, WOMEN THER, V32, P121, DOI 10.1080/02703140802384552; Clark MG, 2013, FAM CONSUM SCI RES J, V42, P110, DOI 10.1111/fcsr.12046; Cohen JA, 2011, J CONTEMP PSYCHOTHER, V41, P219, DOI 10.1007/s10879-011-9178-0; Coll JE, 2011, SOC WORK HEALTH CARE, V50, P487, DOI 10.1080/00981389.2010.528727; Cox J, 2014, SOC WORK MENT HEALTH, V12, P560, DOI 10.1080/15332985.2014.891553; Creech SK, 2014, PROF PSYCHOL-RES PR, V45, P452, DOI 10.1037/a0035055; CRONIN C, 1995, J INTERPERS VIOLENCE, V10, P117, DOI 10.1177/088626095010001008; Currie SL, 2011, J OCCUP HEALTH PSYCH, V16, P38, DOI 10.1037/a0021724; De Jong P., 2013, INTERVIEWING SOLUTIO, V4th; De Shazer S, 1985, KEYS SOLUTION BRIEF; DeCarvalho T. L., 2012, HEALING STRESS MILIT; Dekel R, 2010, AGGRESS VIOLENT BEH, V15, P303, DOI 10.1016/j.avb.2010.03.001; Demers A, 2011, J LOSS TRAUMA, V16, P160, DOI 10.1080/15325024.2010.519281; Di Francescomarino C, 2014, LECT NOTES COMPUT SC, V8831, P32, DOI 10.1007/978-3-662-45391-9_3; Dichter ME, 2011, WOMEN HEALTH ISS, V21, pS190, DOI 10.1016/j.whi.2011.04.008; Dinshtein Y, 2011, J FAM SOC WORK, V14, P109, DOI 10.1080/10522158.2011.544021; Eaton KM, 2008, MIL MED, V173, P1051, DOI 10.7205/MILMED.173.11.1051; Esposito-Smythers C, 2011, J FAM PSYCHOL, V25, P497, DOI 10.1037/a0024534; Fisher M. E., 2008, THESIS SMITH COLL NO; Fisher MP, 2014, SOC SCI MED, V115, P1, DOI 10.1016/j.socscimed.2014.05.051; Flaherty MP, 2010, AFFILIA J WOM SOC WO, V25, P224, DOI 10.1177/0886109910375220; Flake EM, 2009, J DEV BEHAV PEDIATR, V30, P271, DOI 10.1097/DBP.0b013e3181aac6e4; Frances A., 2012, PSYCHIAT TIMES, V29, P1; Franciskovic T, 2007, CROAT MED J, V48, P177; Gerlock AA, 2004, MIL MED, V169, P470, DOI 10.7205/MILMED.169.6.470; Gewirtz AH, 2010, J CONSULT CLIN PSYCH, V78, P599, DOI 10.1037/a0020571; Gibbs D., 2011, CHILD MALTREATMENT M; Gibbs D. A., 2013, MILITARY BEHAV HLTH, V1, P121; Gibbs DA, 2007, JAMA-J AM MED ASSOC, V298, P528, DOI 10.1001/jama.298.5.528; Golding JM, 1999, J FAM VIOLENCE, V14, P99, DOI 10.1023/A:1022079418229; Greene G. J., 2011, SOLUTION ORIENTED SO; GRIFFIN WA, 1988, AM J FAM THER, V16, P14, DOI 10.1080/01926188808250703; Hall L. K., 2008, COUNSELING MILITARY, P215; Hall LK, 2011, PSYCHOSOC STRES, P31; Harrington-LaMorie J., 2012, HDB MILITARY SOCIAL, P383; Hendricks Thomas K., J MILITARY VETERANS; Herzog JR, 2011, CHILD ADOLESC SOC WO, V28, P459, DOI 10.1007/s10560-011-0243-z; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huebner AJ, 2008, PREV RES S, V15, P10; Hyatt K, 2014, MIL MED, V179, P849, DOI 10.7205/MILMED-D-13-00526; Iverson KM, 2013, J TRAUMA STRESS, V26, P767, DOI 10.1002/jts.21867; Joint Chiefs of Staff, 2014, EN COLL SUPP REINT M; Jordan J. R., 2010, GRIEF SUICIDE UNDERS, P19; Jordan J. R., 2010, GRIEF SUICIDE UNDERS, P403; Jordan JR, 2008, PSYCHIAT ANN, V38, P679, DOI 10.3928/00485713-20081001-05; Kaplow JB, 2013, CLIN CHILD FAM PSYCH, V16, P322, DOI 10.1007/s10567-013-0143-1; Kemp J, 2012, SUICIDE DATA REPORT; Kim JS, 2010, FAM SOC, V91, P300, DOI 10.1606/1044-3894.4009; Kim PY, 2010, PSYCHIAT SERV, V61, P582, DOI 10.1176/ps.2010.61.6.582; Klaric M, 2008, CROAT MED J, V49, P491, DOI 10.3325/cmj.2008.4.491; Knobloch LK, 2013, COMMUN MONOGR, V80, P452, DOI 10.1080/03637751.2013.828159; Koblinsky Sally A, 2014, Mil Behav Health, V2, P162; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Kubany ES, 2003, J TRAUMA STRESS, V16, P81, DOI 10.1023/A:1022019629803; Kulka R. A., 1988, NATL VIETNAM VETERAN, VI; Kulka R. A., 1988, NATL VIETNAM VETERAN, VII; LaMotte AD, 2015, PARTN ABUSE, V6, P143, DOI 10.1891/1946-6560.6.2.143; Leskin G. A., 2013, HDB MILITARY SOCIAL, P427441; Lester P, 2010, J AM ACAD CHILD PSY, V49, P310, DOI 10.1016/j.jaac.2010.01.003; Lester PE, 2012, J AM ACAD CHILD PSY, V51, P3, DOI 10.1016/j.jaac.2011.10.008; Mansfield AJ, 2010, NEW ENGL J MED, V362, P101, DOI 10.1056/NEJMoa0900177; Marek LI, 2014, CONTEMP FAM THER, V36, P443, DOI 10.1007/s10591-014-9316-4; Marshall AD, 2005, CLIN PSYCHOL REV, V25, P862, DOI 10.1016/j.cpr.2005.05.009; Mastroianni G.R., 2011, PARAMETERS, V41, P6; McCarroll JE, 2000, MIL MED, V165, P41, DOI 10.1093/milmed/165.1.41; McGuinness TM, 2014, J PSYCHOSOC NURS MEN, V52, P27, DOI 10.3928/02793695-20140304-01; Meis LA, 2010, J TRAUMA STRESS, V23, P564, DOI 10.1002/jts.20560; Melvin K., 2011, THESIS JOHNS HOPKINS; Millegan J, 2013, GEN HOSP PSYCHIAT, V35, P556, DOI 10.1016/j.genhosppsych.2013.04.015; MILLER TW, 1993, MIL MED, V158, P766, DOI 10.1093/milmed/158.12.766; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Mitchell AM, 2009, ARCH PSYCHIAT NURS, V23, P2, DOI 10.1016/j.apnu.2008.02.007; National Council on Interpreting in Health Care, 2001, TACKL OB ENGL; Nelson BS, 1996, J MARITAL FAM THER, V22, P455, DOI 10.1111/j.1752-0606.1996.tb00220.x; Nelson KM, 2007, PUBLIC HEALTH REP, V122, P93, DOI 10.1177/003335490712200113; Paley B, 2013, CLIN CHILD FAM PSYCH, V16, P245, DOI 10.1007/s10567-013-0138-y; Peled E, 2010, RES SOCIAL WORK PRAC, V20, P391, DOI 10.1177/1049731510362225; Phelan SM, 2011, DISABIL HEALTH J, V4, P177, DOI 10.1016/j.dhjo.2011.03.003; Price J., 2014, CHILDS PARENT HAS PT; Renshaw KD, 2014, J TRAUMA STRESS, V27, P283, DOI 10.1002/jts.21916; Riggs SA, 2011, J FAM PSYCHOL, V25, P675, DOI 10.1037/a0025286; Sandza R., 2013, MARINE CORPS TIMES; Sandza R., 2013, ARMY TIMES; Savitsky L, 2009, SOC WORK, V54, P327, DOI 10.1093/sw/54.4.327; Sayers SL, 2011, COGN BEHAV PRACT, V18, P108, DOI 10.1016/j.cbpra.2010.03.002; Sayers SL, 2009, J CLIN PSYCHIAT, V70, P163, DOI 10.4088/JCP.07m03863; Schmaling KB, 2011, MIL PSYCHOL, V23, P685, DOI 10.1080/08995605.2011.616821; Sher L, 2009, MED HYPOTHESES, V73, P215, DOI 10.1016/j.mehy.2008.12.052; Sherman M. D., 2008, SAFE PROGRAM MENTAL; Sherman MD, 2006, J MARITAL FAM THER, V32, P479, DOI 10.1111/j.1752-0606.2006.tb01622.x; Shiner B, 2012, MIL MED, V177, P814, DOI 10.7205/MILMED-D-12-00009; Sklare G.B., 2005, BRIEF COUNSELING WOR; Smolenski DJ, 2013, DODSER DEP DEFENSE S; Straits-Troster K, 2013, PSYCHIAT SERV, V64, P541, DOI 10.1176/appi.ps.001632012; Straus M. A., 1990, PHYS VIOLENCE AM FAM, DOI DOI 10.4324/9781315126401; Sullivan M., 2006, MILITARY DIVORCE HDB; Taft CT, 2009, AM J ORTHOPSYCHIAT, V79, P461, DOI 10.1037/a0016657; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Tinney G, 2014, FAM COURT REV, V52, P400, DOI 10.1111/fcre.12100; US Department of Defense, 2014, DEP DEF Q SUIC REP; US Department of Defense, 2013, DEM 2013 PROF MIL CO; US Department of Defense, 2015, DOM AB INV DOD MIL C; Verdeli H, 2011, J FAM PSYCHOL, V25, P488, DOI 10.1037/a0024525; Waalen J, 2000, AM J PREV MED, V19, P230, DOI 10.1016/S0749-3797(00)00229-4; Weiss E., 2013, HDB MILITARY SOCIAL, P467; Weiss EL, 2010, FAM J, V18, P395, DOI 10.1177/1066480710378479	122	1	1	0	3	ROUTLEDGE	ABINGDON	2 PARK SQ, MILTON PARK, ABINGDON OX14 4RN, OXFORD, ENGLAND			978-1-138-11952-9; 978-1-315-65227-6; 978-1-138-11951-2				2017							72	92					21	Public, Environmental & Occupational Health; Social Work	Book Citation Index – Social Sciences & Humanities (BKCI-SSH)	Public, Environmental & Occupational Health; Social Work	BK6ZZ	WOS:000441072400007					2022-02-06	
J	Wogensen, E; Marschner, L; Gram, MG; Mehlsen, S; Uhre, VHB; Bulow, P; Mogensen, J; Mala, H				Wogensen, Elise; Marschner, Linda; Gram, Marie Gajhede; Mehlsen, Siri; Uhre, Valdemar H. B.; Bulow, Pernille; Mogensen, Jesper; Mala, Hana			Effects of different delayed exercise regimens on cognitive performance in fimbria-fornix transected rats	ACTA NEUROBIOLOGIAE EXPERIMENTALIS			English	Article						voluntary exercise; forced exercise; animal model; brain injury; cognitive performance; hippocampus	TRAUMATIC BRAIN-INJURY; ADULT HIPPOCAMPAL NEUROGENESIS; CHOLINERGIC PROJECTION SYSTEM; CONTROLLED CORTICAL IMPACT; MEDIAL PREFRONTAL CORTEX; RADIAL MAZE PERFORMANCE; FLUID PERCUSSION INJURY; RICH NEURAL GRAFTS; NEUROTROPHIC FACTOR; VOLUNTARY EXERCISE	Studies have shown that exercise can positively influence cognitive performance after brain injury. This study investigated the effects of different exercise regimens on allocentric place learning after fimbria-fornix (FF) transection. One hundred and sixteen pre-shaped rats were subjected either to a mechanical transection of the FF or control sham surgery and divided into following groups: i) no exercise (NE), ii) voluntary exercise in a running wheel (RW), iii) forced swimming exercise administered as interval training of short (3x5 min) duration (FS-SI), iv) forced swimming exercise administered as interval training of long (3x15 min) duration (FS-LI), v) forced swimming exercise administered as one session of short (5 min) duration (FS-SS), and vi) forced swimming exercise administered as one session of long (15 min) duration (FS-LS). The exercise was initiated 21 days post-surgery. Subsequently, all animals were administered 28 acquisition sessions in an 8-arm radial maze. Both sham operated and lesioned animals showed a significant learning response, however, the lesion induced a marked and lasting impairment, which was not alleviated neither by voluntary nor forced (spaced or one-session only) exercise regimens. Exercise regimens had no effect on the place learning of control sham animals. We conclude that the lesion location as well as factors related to the exercise- and cognitive testing protocols can profoundly influence the potential of exercise as a general recovery-promoting method.	[Wogensen, Elise; Marschner, Linda; Gram, Marie Gajhede; Mehlsen, Siri; Uhre, Valdemar H. B.; Bulow, Pernille; Mogensen, Jesper; Mala, Hana] Univ Copenhagen, Dept Psychol, Unit Cognit Neurosci, Copenhagen, Denmark		Mala, H (corresponding author), Univ Copenhagen, Dept Psychol, Unit Cognit Neurosci, Copenhagen, Denmark.	hana.mala@psy.ku.dk		Bulow, Pernille/0000-0003-1884-6189; Rytter, Hana Mala/0000-0002-2910-372X; Mogensen, Jesper/0000-0003-1959-581X; Uhre, Valdemar/0000-0003-4342-4412	Danish Council for Independent ResearchDet Frie Forskningsrad (DFF)	The present study was supported by a grant from the Danish Council for Independent Research. The authors wish to thank Nicoline Balslev Bechmann, Sara Fleischer, Line-Muriel de Ginet, Brian Erik Hansen, Jan Hedegaard, Simone Horwitz, Svend Heini Winther Johnsen, Anna Lindstrom Nielsen, Rasmus Rydbirk, Peter Schack-Nielsen, Marie Svenningsen, Katrine Svaerke and Johanne Asperud Thomsen for their assistance with behavioral training and testing.	AGGLETON JP, 1986, BEHAV BRAIN RES, V19, P133, DOI 10.1016/0166-4328(86)90011-2; Alomari MA, 2013, BEHAV BRAIN RES, V247, P34, DOI 10.1016/j.bbr.2013.03.007; Austin MW, 2014, NEUROSCI RES, V87, P8, DOI 10.1016/j.neures.2014.06.007; Baumann O, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00073; Berchtold NC, 2010, NEUROSCIENCE, V167, P588, DOI 10.1016/j.neuroscience.2010.02.050; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; Boccia M, 2014, NEUROPSYCHOL REV, V24, P236, DOI 10.1007/s11065-014-9247-8; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; Cain DP, 2006, BEHAV BRAIN RES, V170, P241, DOI 10.1016/j.bbr.2006.02.023; Cechetti F, 2012, NEUROBIOL LEARN MEM, V97, P90, DOI 10.1016/j.nlm.2011.09.008; Cetinkaya C, 2013, NEUROSCI LETT, V549, P177, DOI 10.1016/j.neulet.2013.06.012; Chang Q, 2003, J NEUROSCI, V23, P3001; Chen Lin, 2006, Neurosci Bull, V22, P1; Christidi F, 2011, J NEUROTRAUM, V28, P711, DOI 10.1089/neu.2010.1644; Clark PJ, 2008, NEUROSCIENCE, V155, P1048, DOI 10.1016/j.neuroscience.2008.06.051; Conner JM, 2005, NEURON, V46, P173, DOI 10.1016/j.neuron.2005.03.003; de Bruin JPC, 2001, NEUROBIOL LEARN MEM, V75, P164, DOI 10.1006/nlme.2000.3962; Ding Q, 2011, NEUROSCIENCE, V192, P773, DOI 10.1016/j.neuroscience.2011.06.032; Ehninger D, 2003, CEREB CORTEX, V13, P845, DOI 10.1093/cercor/13.8.845; Ekstrom AD, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00803; El-Tamawy MS, 2014, NEUROREHABILITATION, V34, P209, DOI 10.3233/NRE-131020; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Farmer J, 2004, NEUROSCIENCE, V124, P71, DOI 10.1016/j.neuroscience.2003.09.029; Frey LC, 2009, J NEUROSCI METH, V177, P267, DOI 10.1016/j.jneumeth.2008.10.022; GALE SD, 1993, BRAIN RES BULL, V32, P345, DOI 10.1016/0361-9230(93)90198-K; Gaskin S, 2007, HIPPOCAMPUS, V17, P586, DOI 10.1002/hipo.20295; Gilboa A, 2006, HIPPOCAMPUS, V16, P966, DOI 10.1002/hipo.20226; Ginsberg SD, 2002, J NEUROTRAUM, V19, P99, DOI 10.1089/089771502753460277; Ginsberg SD, 1998, NEUROSCIENCE, V86, P1259, DOI 10.1016/S0306-4522(98)00136-5; Ginsberg SD, 1999, NEUROSCIENCE, V88, P1059, DOI 10.1016/S0306-4522(98)00288-7; Gomez-Pinilla F, 2013, COMPR PHYSIOL, V3, P403, DOI 10.1002/cphy.c110063; GomezPinilla F, 1997, BRAIN RES, V764, P1, DOI 10.1016/S0006-8993(97)00375-2; Gram MG, 2016, BRAIN RES BULL, V125, P117, DOI 10.1016/j.brainresbull.2016.06.012; Gram MG, 2016, RESTOR NEUROL NEUROS, V34, P1, DOI 10.3233/RNN-140396; Grealy MA, 1999, ARCH PHYS MED REHAB, V80, P661, DOI 10.1016/S0003-9993(99)90169-7; Greenwood BN, 2013, EUR J NEUROSCI, V37, P469, DOI 10.1111/ejn.12044; Griesbach GS, 2012, J NEUROTRAUM, V29, P1426, DOI 10.1089/neu.2011.2229; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Griesbach GS, 2004, BRAIN RES, V1016, P154, DOI 10.1016/j.brainres.2004.04.079; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Guiney H, 2013, PSYCHON B REV, V20, P73, DOI 10.3758/s13423-012-0345-4; Hartley T, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2012.0510; Herrera-Morales W, 2007, EUR J NEUROSCI, V25, P1581, DOI 10.1111/j.1460-9568.2007.05391.x; Hicks RR, 1998, RESTOR NEUROL NEUROS, V12, P41; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; HODGES H, 1991, NEUROSCIENCE, V45, P609, DOI 10.1016/0306-4522(91)90274-R; HODGES H, 1991, NEUROSCIENCE, V45, P587, DOI 10.1016/0306-4522(91)90273-Q; Hopkins ME, 2012, NEUROSCIENCE, V215, P59, DOI 10.1016/j.neuroscience.2012.04.056; Itoh T, 2011, J NEURAL TRANSM, V118, P1263, DOI 10.1007/s00702-011-0629-2; Itoh T, 2011, J NEURAL TRANSM, V118, P193, DOI 10.1007/s00702-010-0495-3; Ji JF, 2014, BIOCHEM BIOPH RES CO, V443, P646, DOI 10.1016/j.bbrc.2013.12.031; Jin J, 2010, BRAIN INJURY, V24, P533, DOI 10.3109/02699051003610458; Kaplan R, 2014, HIPPOCAMPUS, V24, P740, DOI 10.1002/hipo.22264; Ke Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016643; Khakpai F, 2012, BEHAV BRAIN RES, V231, P1, DOI 10.1016/j.bbr.2012.02.049; Khan NA, 2014, PEDIATR EXERC SCI, V26, P138, DOI 10.1123/pes.2013-0125; Kilgard M, 2003, NEURON, V38, P678, DOI 10.1016/S0896-6273(03)00327-1; Kim BK, 2014, J EXERC REHABIL, V10, P2, DOI 10.12965/jer.140086; Kim DH, 2010, PHYSIOL BEHAV, V101, P660, DOI 10.1016/j.physbeh.2010.09.021; Kleim JA, 2003, NEUROCHEM RES, V28, P1757, DOI 10.1023/A:1026025408742; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); Kwok SC, 2006, HIPPOCAMPUS, V16, P655, DOI 10.1002/hipo.20195; Kwok SC, 2010, HIPPOCAMPUS, V20, P889, DOI 10.1002/hipo.20733; Kwok SC, 2010, HIPPOCAMPUS, V20, P413, DOI 10.1002/hipo.20643; Kwok SC, 2009, BEHAV BRAIN RES, V205, P207, DOI 10.1016/j.bbr.2009.08.016; Laurin D, 2001, ARCH NEUROL-CHICAGO, V58, P498, DOI 10.1001/archneur.58.3.498; Lindsay J, 2002, AM J EPIDEMIOL, V156, P445, DOI 10.1093/aje/kwf074; Luo CX, 2007, J NEUROSCI RES, V85, P1637, DOI 10.1002/jnr.21317; Mala H, 2008, BRAIN RES, V1217, P221, DOI 10.1016/j.brainres.2008.04.005; Mala Hana, 2005, Neural Plasticity, V12, P329, DOI 10.1155/NP.2005.329; Mala H, 2007, J NEUROTRAUM, V24, P1647, DOI 10.1089/neu.2007.0292; Mala H, 2013, PHARMACOL BIOCHEM BE, V109, P50, DOI 10.1016/j.pbb.2013.05.008; Mala H, 2012, BRAIN RES, V1445, P40, DOI 10.1016/j.brainres.2012.01.035; MARKUS EJ, 1994, HIPPOCAMPUS, V4, P410, DOI 10.1002/hipo.450040404; McDonnell MN, 2011, ARCH PHYS MED REHAB, V92, P1044, DOI 10.1016/j.apmr.2011.01.021; Mogensen J, 2005, BRAIN RES BULL, V65, P41, DOI 10.1016/j.brainresbull.2004.11.010; Mogensen J, 2004, PHARMACOL BIOCHEM BE, V77, P381, DOI 10.1016/j.pbb.2003.11.017; Mogensen J, 2004, BRAIN RES BULL, V63, P217, DOI 10.1016/j.brainresbull.2004.02.008; Mogensen J, 2017, ANIMAL MODE IN PRESS; Moscovitch M, 2006, CURR OPIN NEUROBIOL, V16, P179, DOI 10.1016/j.conb.2006.03.013; Mossberg K, 2012, INT BRAIN I IN PRESS, V26, P309; Nishijima T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081245; Oddie SD, 2002, BRAIN RES BULL, V57, P565, DOI 10.1016/S0361-9230(01)00745-6; Okada K, 2010, BEHAV BRAIN RES, V209, P295, DOI 10.1016/j.bbr.2010.02.007; OKeefe J., 1978, HIPPOCAMPUS COGNITIV; Parker A, 1997, J COGNITIVE NEUROSCI, V9, P512, DOI 10.1162/jocn.1997.9.4.512; Parslow DM, 2005, ACTA PSYCHOL, V118, P123, DOI 10.1016/j.actpsy.2004.10.006; Piao CS, 2013, NEUROBIOL DIS, V54, P252, DOI 10.1016/j.nbd.2012.12.017; Pirchl M, 2010, INT J ZOOLOGY, P8; Ploughman M, 2005, NEUROSCIENCE, V136, P991, DOI 10.1016/j.neuroscience.2005.08.037; Ploughman M, 2007, BRAIN RES, V1150, P207, DOI 10.1016/j.brainres.2007.02.065; Poreh A, 2006, NEUROPSYCHOLOGIA, V44, P2241, DOI 10.1016/j.neuropsychologia.2006.05.020; Rogers JL, 2006, BEHAV NEUROSCI, V120, P852, DOI 10.1037/0735-7044.120.4.852; Shen XF, 2013, INT J MOL SCI, V14, P21598, DOI 10.3390/ijms141121598; Shih PC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078163; Sim YJ, 2004, NEUROSCI LETT, V372, P256, DOI 10.1016/j.neulet.2004.09.060; Song MK, 2012, ANN REHABIL MED-ARM, V36, P303, DOI 10.5535/arm.2012.36.3.303; Soya H, 2007, BIOCHEM BIOPH RES CO, V358, P961, DOI 10.1016/j.bbrc.2007.04.173; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Uysal N, 2015, BIOTECH HISTOCHEM, V90, P55, DOI 10.3109/10520295.2014.946968; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; Vaynman S, 2003, NEUROSCIENCE, V122, P647, DOI 10.1016/j.neuroscience.2003.08.001; Wahab RA, 2015, J NEUROSCI METH, V248, P16, DOI 10.1016/j.jneumeth.2015.03.010; Winocur G, 2012, BEHAV BRAIN RES, V227, P464, DOI 10.1016/j.bbr.2011.05.032; Wogensen E, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/830871; Wong-Goodrich SJE, 2010, CANCER RES, V70, P9329, DOI 10.1158/0008-5472.CAN-10-1854; Yallampalli R, 2013, J NEUROIMAGING, V23, P224, DOI 10.1111/j.1552-6569.2010.00537.x; Yau SY, 2012, NEUROSCIENCE, V222, P289, DOI 10.1016/j.neuroscience.2012.07.019; Zhang LY, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-46	111	1	1	0	1	NENCKI INST EXPERIMENTAL BIOLOGY	WARSAW	UL PASTEURA 3, 02-093 WARSAW, POLAND	0065-1400	1689-0035		ACTA NEUROBIOL EXP	Acta Neurobiol. Exp.		2017	77	4					323	336					14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FT0JL	WOS:000422811200005	29369298				2022-02-06	
J	Woodard, TJ; Allen, SN				Woodard, Todd J.; Allen, Shari N.			An Overview of the Management of Concussion	US PHARMACIST			English	Article							BOTULINUM TOXIN-TYPE; REFRACTORY TRIGEMINAL NEURALGIA; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; NEUROPATHIC PAIN; CONTROLLED PHASE; CARBAMAZEPINE; OXCARBAZEPINE; ONABOTULINUMTOXINA; BACLOFEN	Each year, 1.7 million people in the United States sustain a traumatic brain injury (TBI), which is twice as likely in men compared with women. TBI is an injury to the head that results in a disruption of normal functioning of the brain. The terms concussion, the most common form of TBI, and mild TBI are often used interchangeably. A concussion results most often from a blow or jolt to the head that causes the brain to collide with the skull. The signs and symptoms of a concussion may be physical, cognitive, emotional, or relating to sleep. Both pharmacologic approaches (medication management for cognitive, emotional, and neurologic symptoms) and nonpharmacologic approaches (cognitive and physical rest) are essential for treatment.	[Woodard, Todd J.] Peach State Hlth Plan, Atlanta, GA 30339 USA; [Woodard, Todd J.; Allen, Shari N.] Philadelphia Coll Osteopath Med, Sch Pharm, Philadelphia, PA 19131 USA		Woodard, TJ (corresponding author), Peach State Hlth Plan, Atlanta, GA 30339 USA.; Woodard, TJ (corresponding author), Philadelphia Coll Osteopath Med, Sch Pharm, Philadelphia, PA 19131 USA.						Aurora SK, 2010, CEPHALALGIA, V30, P793, DOI 10.1177/0333102410364676; Bajwa ZH, TRIGEMINAL NEURALGIA; CAMPBELL FG, 1966, J NEUROL NEUROSUR PS, V29, P265, DOI 10.1136/jnnp.29.3.265; Chaudhry P, 2014, HEADACHE, V54, P1376, DOI 10.1111/head.12401; Cheshire WP, 2001, J PAIN SYMPTOM MANAG, V21, P506, DOI 10.1016/S0885-3924(01)00269-X; Cruccu G, 2016, NEUROLOGY, V87, P220, DOI 10.1212/WNL.0000000000002840; Devor M, 2002, CLIN J PAIN, V18, P4, DOI 10.1097/00002508-200201000-00002; Devor M, 2002, J NEUROSURG, V96, P532, DOI 10.3171/jns.2002.96.3.0532; Diener HC, 2010, CEPHALALGIA, V30, P804, DOI 10.1177/0333102410364677; FROMM GH, 1984, ANN NEUROL, V15, P240, DOI 10.1002/ana.410150306; Gronseth G, 2008, NEUROLOGY, V71, P1183, DOI 10.1212/01.wnl.0000326598.83183.04; Guleria VS, 2015, INDIAN J PHARMACOL, V47, P459, DOI 10.4103/0253-7613.161279; Hall GC, 2008, BMC FAM PRACT, V9, DOI 10.1186/1471-2296-9-26; Hals EKB, 2011, SCAND J PAIN, V2, P153, DOI 10.1016/j.sjpain.2011.08.003; JANNETTA PJ, 1967, J NEUROSURG, V26, P159, DOI 10.3171/jns.1967.26.1part2.0159; KILLIAN JM, 1968, ARCH NEUROL-CHICAGO, V19, P129, DOI 10.1001/archneur.1968.00480020015001; Koopman JSHA, 2009, PAIN, V147, P122, DOI 10.1016/j.pain.2009.08.023; LECHIN F, 1989, ARCH NEUROL-CHICAGO, V46, P960, DOI 10.1001/archneur.1989.00520450030015; Lin LC, 2009, KAOHSIUNG J MED SCI, V25, P82, DOI 10.1016/S1607-551X(09)70045-2; Liu L, 2014, MED SCI MONITOR, V20, P1481, DOI 10.12659/MSM.890935; Locharernkul C, 2011, J CLIN NEUROSCI, V18, P1289, DOI 10.1016/j.jocn.2010.12.054; Mendlik MT, 2015, CURR TREAT OPTION NE, V17, DOI 10.1007/s11940-015-0381-2; Mintzer S, 2006, EPILEPSIA, V47, P510, DOI 10.1111/j.1528-1167.2006.00460.x; Ney John P, 2007, Neuropsychiatr Dis Treat, V3, P785; Oomens MAEM, 2015, DRUG AGING, V32, P717, DOI 10.1007/s40266-015-0293-6; Perucca E, 2006, BRIT J CLIN PHARMACO, V61, P246, DOI 10.1111/j.1365-2125.2005.02529.x; ROCKLIFF BW, 1966, ARCH NEUROL-CHICAGO, V15, P129, DOI 10.1001/archneur.1966.00470140019003; Shaparin N, 2015, PAIN RES MANAG, V20, P63, DOI 10.1155/2015/482652; Shehata HS, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-92; SOBOTKA JL, 1990, DICP ANN PHARMAC, V24, P1214, DOI 10.1177/106002809002401214; TERRENCE CF, 1981, ARCH NEUROL-CHICAGO, V38, P588, DOI 10.1001/archneur.1981.00510090082011; Wang XQ, 2015, J CLIN NEUROSCI, V22, P1005, DOI 10.1016/j.jocn.2015.01.016; Wu CJ, 2012, CEPHALALGIA, V32, P443, DOI 10.1177/0333102412441721; Wu CJ, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2071-2; Zakrzewska JM, 1997, PAIN, V73, P223, DOI 10.1016/S0304-3959(97)00104-8; Zakrzewska JM, 2010, EXPERT OPIN PHARMACO, V11, P1239, DOI 10.1517/14656561003767449; Zhang HF, 2014, J HEADACHE PAIN, V15, DOI 10.1186/1129-2377-15-65	37	1	1	1	1	JOBSON PUBLISHING LLC	NEW YORK	100 AVE OF THE AMERICAS, NEW YORK, NY 10013-1678 USA	0148-4818	2331-3501		US PHARM	US Pharm.	JAN	2017	42	1					37	44					8	Pharmacology & Pharmacy	Emerging Sources Citation Index (ESCI)	Pharmacology & Pharmacy	EP2GU	WOS:000397202200010					2022-02-06	
B	Worthington, A; Ramos, SD; Oddy, M		Wilson, BA; Winegardner, J; VanHeugten, CM; Ownsworth, T		Worthington, Andrew; Ramos, Sara da Silva; Oddy, Michael			THE COST-EFFECTIVENESS OF NEUROPSYCHOLOGICAL REHABILITATION	NEUROPSYCHOLOGICAL REHABILITATION: THE INTERNATIONAL HANDBOOK			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; RANDOMIZED CONTROLLED-TRIALS; WILLINGNESS-TO-PAY; OF-THE-LITERATURE; COGNITIVE REHABILITATION; INTENSIVE REHABILITATION; ECONOMIC-EVALUATION; BEHAVIORAL-THERAPY; HEAD-INJURY; HOME		[Worthington, Andrew] Longbridge Technol Pk, Headwise Innovat Ctr, Birmingham, W Midlands, England; [Ramos, Sara da Silva; Oddy, Michael] Disabil Trust, Burgess Hill, England		Worthington, A (corresponding author), Longbridge Technol Pk, Headwise Innovat Ctr, Birmingham, W Midlands, England.						Abrams D., 1993, J HEAD TRAUMA REHAB, V8, P59; Albrecht GL, 1999, SOC SCI MED, V48, P977, DOI 10.1016/S0277-9536(98)00411-0; Alves J, 2013, ALZ DIS ASSOC DIS, V27, P195, DOI 10.1097/WAD.0b013e31827bda55; ARONOW HU, 1987, J HEAD INJURY REHABI, V2, P24; ASHLEY MJ, 1990, J INSURANCE MED, V22, P156; Barber JA, 1998, BRIT MED J, V317, P1195, DOI 10.1136/bmj.317.7167.1195; Beecham J, 2009, BRAIN INJURY, V23, P30, DOI 10.1080/02699050802590338; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; Bowen A, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16260; Brusco NK, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-89; Brusco NK, 2014, ARCH PHYS MED REHAB, V95, P94, DOI 10.1016/j.apmr.2013.03.017; Cappa SF, 2005, EUR J NEUROL, V12, P665; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; COLE JR, 1985, ARCH PHYS MED REHAB, V66, P38; COPE D N, 1991, Brain Injury, V5, P127, DOI 10.3109/02699059109008084; Crotty M, 2008, AGE AGEING, V37, P628, DOI 10.1093/ageing/afn141; DEPEDROCUESTA J, 1992, ACTA NEUROL SCAND, V86, P433; Draborg E, 2005, INT J TECHNOL ASSESS, V21, P89, DOI 10.1017/S0266462305050117; EAMES P, 1985, J NEUROL NEUROSUR PS, V48, P613, DOI 10.1136/jnnp.48.7.613; Eames P, 1996, BRAIN INJURY, V10, P631, DOI 10.1080/026990596124061; Engelberts NHJ, 2002, EPILEPSIA, V43, P587, DOI 10.1046/j.1528-1157.2002.29401.x; Evans JJ, 1998, J INT NEUROPSYCH SOC, V4, P399, DOI 10.1017/S1355617798003993; Fann JR, 2015, J NEUROTRAUM, V32, P45, DOI 10.1089/neu.2014.3423; Fenwick E, 2004, HEALTH ECON, V13, P405, DOI 10.1002/hec.903; Graves N, 2002, HEALTH ECON, V11, P735, DOI 10.1002/hec.683; GROSSMAN M, 1972, J POLIT ECON, V80, P223, DOI 10.1086/259880; HALL KM, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199502000-00003; Hashimoto K, 2006, J REHABIL MED, V38, P141, DOI 10.1080/16501970500441690; Humphreys I, 2015, CLIN REHABIL, V29, P30, DOI 10.1177/0269215514537656; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Iskedjian M, 2009, PHARMACOECONOMICS, V27, P149, DOI 10.2165/00019053-200927020-00005; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P238, DOI 10.1053/apmr.2003.50097; Knapp M, 2006, BRIT J PSYCHIAT, V188, P574, DOI 10.1192/bjp.bp.105.010561; Kunik CL, 2006, ARCH PHYS MED REHAB, V87, P1590, DOI 10.1016/j.apmr.2006.09.001; MALEC JF, 1993, BRAIN INJURY, V7, P383, DOI 10.3109/02699059309029682; Mazaux JM, 1998, DISABIL REHABIL, V20, P435, DOI 10.3109/09638289809166108; McGregor K, 1997, SOC SCI MED, V45, P295, DOI 10.1016/S0277-9536(96)00345-0; MCKENNA M, 1992, IS REHABILITATION CO; McLaughlin Ann Marie, 1993, Brain Injury, V7, P71, DOI 10.3109/02699059309008158; Mehlbye J., 1994, BRAIN INJURY NEUROPS, P257; MELIN AL, 1993, AM J PUBLIC HEALTH, V83, P356, DOI 10.2105/AJPH.83.3.356; Oddy M, 2013, BRAIN INJURY, V27, P1500, DOI 10.3109/02699052.2013.830332; Oddy M, 2013, NEUROREHABILITATION, V32, P781, DOI 10.3233/NRE-130902; Parish L, 2007, NEUROPSYCHOL REHABIL, V17, P230, DOI 10.1080/09602010600750675; Peiris CL, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-198; Pepping M, 2003, NEURO S B C, P313; Pierini D, 2014, NEUROREHABILITATION, V34, P65, DOI 10.3233/NRE-131023; Powell J, 2002, J NEUROL NEUROSUR PS, V72, P193, DOI 10.1136/jnnp.72.2.193; Prigatano G. P., 2003, CLIN NEUROPSYCHOLOGY; Prigatano GP, 2010, CLIN NEUROPSYCHOL, V24, P468, DOI 10.1080/13854040802585048; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; Radford K, 2013, BRAIN INJURY, V27, P507, DOI 10.3109/02699052.2013.766929; Ramsey S, 2005, VALUE HEALTH, V8, P521, DOI 10.1111/j.1524-4733.2005.00045.x; ROBINSON R, 1993, BRIT MED J, V307, P859, DOI 10.1136/bmj.307.6908.859; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; Schopp L, 2000, PROF PSYCHOL-RES PR, V31, P179, DOI 10.1037/0735-7028.31.2.179; Sculpher MJ, 2015, METHODS EC EVALUATIO; Shiel A, 2001, CLIN REHABIL, V15, P501, DOI 10.1191/026921501680425225; Turner-Stokes L, 2008, J REHABIL MED, V40, P691, DOI 10.2340/16501977-0265; Turner-Stokes L, 2007, BRAIN INJURY, V21, P1015, DOI 10.1080/02699050701591445; Turner-Stokes L, 2012, DISABIL REHABIL, V34, P1900, DOI 10.3109/09638288.2012.670042; Ustun T.B., 2010, MANUAL WHO DISABILIT; van Eeden M, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008220; van Eeden M, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0522-y; van Eeden M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-122; van Heugten CM, 2011, J REHABIL MED, V43, P647, DOI 10.2340/16501977-0818; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; Watson D.E., 2000, EVALUATING COSTS OUT; Wehman P, 2003, ARCH PHYS MED REHAB, V84, P192, DOI 10.1053/apmr.2003.50027; Wilson BA, 2003, NEURO S B C, P329; Wood RL, 1999, BRAIN INJURY, V13, P69, DOI 10.1080/026990599121746; Worthington A., 2013, CLIN NEUROPSYCHOLOGY, P505; Worthington AD, 2006, CLIN REHABIL, V20, P79, DOI 10.1191/0269215506cr881oa; Worthington AD, 2006, BRAIN INJURY, V20, P947, DOI 10.1080/02699050600888314; YLVISAKER M, 2007, BRAIN IMPAIR, V8, P276, DOI DOI 10.1375/brim.8.3.276; Zhu XL, 2007, BRAIN INJURY, V21, P681, DOI 10.1080/02699050701468941	78	1	1	0	1	ROUTLEDGE	ABINGDON	2 PARK SQ, MILTON PARK, ABINGDON OX14 4RN, OXFORD, ENGLAND			978-1-138-64311-6; 978-1-315-62953-7; 978-1-138-64309-3				2017							469	479					11	Psychology, Clinical; Clinical Neurology; Psychology; Rehabilitation	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Psychology; Neurosciences & Neurology; Rehabilitation	BO7UU	WOS:000525648500051					2022-02-06	
J	Wright, KL; Kirwan, CB; Gale, SD; Levan, AJ; Hopkins, RO				Wright, Kacie L.; Kirwan, C. Brock; Gale, Shawn D.; Levan, Ashley J.; Hopkins, Ramona O.			Long-term cognitive and neuroanatomical stability in patients with anoxic amnesia: A Case Report	BRAIN INJURY			English	Article						Hippocampus; anoxia; memory; amnesia; medial temporal lobe; intelligence	TRAUMATIC BRAIN-INJURY; TEMPORAL-LOBE DAMAGE; YOUNG ONSET DEMENTIA; HIPPOCAMPAL ATROPHY; DEVELOPMENTAL AMNESIA; ALZHEIMERS-DISEASE; SEMANTIC MEMORY; WORKING-MEMORY; FOLLOW-UP; VOLUME	Background: Anoxia can result in selective hippocampal damage with associated impairments in declarative memory. Whilst memory impairments and brain structures are thought to be stable, there are little data regarding the effects of ageing or change over time in patients with amnesia from anoxic brain injury.Methods: To assess change over time, we compared structural magnetic resonance imaging (MRI) with data obtained over ten years previously in two well-characterized patients with amnesia (JRW and RS) who experienced an anoxic brain injury. Six healthy, age-matched control participants were recruited to compare brain volumes with the patients at Time 2. Wechsler adult intelligence scale-revised and Wechsler memory scale-revised scores were compared to scores on the same tests administered 13 and 19 years prior.Results: Patients with amnesia had significantly smaller hippocampal volumes than controls, but comparable medial temporal lobe and ventricular volumes. Memory, intellectual function and brain volumes were stable over time.Conclusion: Patients with an amnesia due to anoxia have memory impairments and smaller hippocampal volumes compared to controls; however, memory, intelligence and structural volumes remain stable over time. At ages 50 and 57, they do not appear to have early age-associated cognitive decline that is sometimes observed in patients with traumatic brain injury.	[Wright, Kacie L.; Kirwan, C. Brock; Gale, Shawn D.; Levan, Ashley J.; Hopkins, Ramona O.] Brigham Young Univ, Dept Psychol, 1022 SWKT, Provo, UT 84093 USA; [Kirwan, C. Brock; Gale, Shawn D.; Hopkins, Ramona O.] Brigham Young Univ, Ctr Neurosci, Provo, UT 84602 USA; [Hopkins, Ramona O.] Intermt Med Ctr, Pulm & Crit Care Div, Dept Med, Murray, UT USA; [Hopkins, Ramona O.] Intermt Healthcare, Ctr Humanizing Crit Care, Murray, UT USA		Hopkins, RO (corresponding author), Brigham Young Univ, Dept Psychol, 1022 SWKT, Provo, UT 84093 USA.	mona_hopkins@byu.edu					Aartsen MJ, 2002, J GERONTOL B-PSYCHOL, V57, pP153, DOI 10.1093/geronb/57.2.P153; Abramets II, 2011, NEUROPHYSIOLOGY+, V43, P103; Allen JS, 2006, J CLIN EXP NEUROPSYC, V28, P457, DOI 10.1080/13803390590949287; Balduini W, 2000, BRAIN RES, V859, P318, DOI 10.1016/S0006-8993(00)01997-1; Bayley PJ, 2006, J NEUROSCI, V26, P13311, DOI 10.1523/JNEUROSCI.4262-06.2006; Bayley PJ, 2005, NEURON, V46, P799, DOI 10.1016/j.neuron.2005.04.034; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Belcher AM, 2006, HIPPOCAMPUS, V16, P361, DOI 10.1002/hipo.20147; Briellmann RS, 2001, EPILEPSIA, V42, P1021, DOI 10.1046/j.1528-1157.2001.0420081021.x; Chow N, 2015, AM J NEURORADIOL, V36, P653, DOI 10.3174/ajnr.A4228; Cooper JM, 2015, CEREB CORTEX, V25, P1469, DOI 10.1093/cercor/bht332; Cooper JM, 2011, NEUROPSYCHOLOGIA, V49, P1843, DOI 10.1016/j.neuropsychologia.2011.03.008; Corkin S, 2002, NAT REV NEUROSCI, V3, P153, DOI 10.1038/nrn726; Cox RW, 2012, NEUROIMAGE, V62, P743, DOI 10.1016/j.neuroimage.2011.08.056; de Haan M, 2006, TRENDS NEUROSCI, V29, P374, DOI 10.1016/j.tins.2006.05.008; Di Paola M, 2008, HIPPOCAMPUS, V18, P719, DOI 10.1002/hipo.20432; Franzen M. D., 1989, RELIABILITY VALIDITY; Franzen M. D., 2000, RELIABILITY VALIDITY; Gale SD, 2004, J INT NEUROPSYCH SOC, V10, P60; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gardner RC, 2014, ANN NEUROL, V75, P339, DOI 10.1002/ana.24121; Gilbert M, 2014, INT PSYCHOGERIATR, V26, P1593, DOI 10.1017/S1041610214000842; Gold JJ, 2005, HIPPOCAMPUS, V15, P79, DOI 10.1002/hipo.20032; Goodrich-Hunsaker NJ, 2010, BEHAV NEUROSCI, V124, P405, DOI 10.1037/a0019193; Goodrich-Hunsaker NJ, 2010, HIPPOCAMPUS, V20, P481, DOI 10.1002/hipo.20651; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; Hopkins R O, 1995, J Int Neuropsychol Soc, V1, P501; Hopkins RO, 2005, NEUROPSYCHOLOGY, V19, P233, DOI 10.1037/0894-4105.19.2.233; Hopkins RO, 2004, NEUROPSYCHOLOGIA, V42, P1877, DOI 10.1016/j.neuropsychologia.2004.05.008; Iampietro M, 2014, NEUROPSYCHOL REV, V24, P252, DOI 10.1007/s11065-014-9259-4; Insausti R, 1998, AM J NEURORADIOL, V19, P659; Insausti R, 2013, P NATL ACAD SCI USA, V110, pE1953, DOI 10.1073/pnas.1306244110; Isaacs EB, 2003, P NATL ACAD SCI USA, V100, P13060, DOI 10.1073/pnas.1233825100; Iverson GL, 2001, ARCH CLIN NEUROPSYCH, V16, P183, DOI 10.1016/S0887-6177(00)00060-3; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Jeneson A, 2012, LEARN MEMORY, V19, P15, DOI 10.1101/lm.024018.111; Jeneson A, 2010, J NEUROSCI, V30, P13624, DOI 10.1523/JNEUROSCI.2895-10.2010; Kesner RP, 2001, NEUROPSYCHOLOGY, V15, P58, DOI 10.1037/0894-4105.15.1.58; Liu RSN, 2003, NEUROIMAGE, V20, P22, DOI 10.1016/S1053-8119(03)00219-2; Lupien SJ, 2007, NEUROIMAGE, V34, P479, DOI 10.1016/j.neuroimage.2006.09.041; Manns JR, 2003, NEURON, V38, P127, DOI 10.1016/S0896-6273(03)00146-6; Manns JR, 2003, NEURON, V37, P171, DOI 10.1016/S0896-6273(02)01147-9; Mu QW, 1999, AM J NEURORADIOL, V20, P207; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Oudman E, 2015, NEUROPSYCHOL REV, V25, P134, DOI 10.1007/s11065-015-9288-7; Pardoe HR, 2009, EPILEPSIA, V50, P2586, DOI 10.1111/j.1528-1167.2009.02243.x; Pfefferbaum A, 2012, NEUROIMAGE, V60, P940, DOI 10.1016/j.neuroimage.2012.01.092; PLASSMAN BL, 1995, NEUROLOGY, V45, P1446, DOI 10.1212/WNL.45.8.1446; Ronnlund M, 2005, PSYCHOL AGING, V20, P3, DOI 10.1037/0882-7974.20.1.3; Salat DH, 2006, HIPPOCAMPUS, V16, P936, DOI 10.1002/hipo.20222; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; Scahill RI, 2003, ARCH NEUROL-CHICAGO, V60, P989, DOI 10.1001/archneur.60.7.989; Schuff N, 1999, NEUROBIOL AGING, V20, P279, DOI 10.1016/S0197-4580(99)00022-6; Scorzin JE, 2008, EPILEPSY RES, V82, P29, DOI 10.1016/j.eplepsyres.2008.06.012; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Sohlberg M., 2001, COGNITIVE REHABILITA; SQUIRE LR, 1982, ANNU REV NEUROSCI, V5, P241, DOI 10.1146/annurev.ne.05.030182.001325; Squire LR, 1996, P NATL ACAD SCI USA, V93, P13515, DOI 10.1073/pnas.93.24.13515; SQUIRE LR, 1986, BEHAV NEUROSCI, V100, P866, DOI 10.1037/0735-7044.100.6.866; Temkin NR, 1999, J INT NEUROPSYCH SOC, V5, P357, DOI 10.1017/S1355617799544068; Tomaszczyk JC, 2014, NEUROPSYCHOL REV, V24, P409, DOI 10.1007/s11065-014-9273-6; Vargha-Khadem F, 2001, PHILOS T R SOC B, V356, P1435, DOI 10.1098/rstb.2001.0951; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Warren DE, 2012, CLIN NEUROPSYCHOL, V26, P335, DOI 10.1080/13854046.2012.655781; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED	67	1	1	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	5					709	716		10.1080/02699052.2017.1285051			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EV8OA	WOS:000402039900017	28350252				2022-02-06	
J	Wu, JZ; Pan, CS; Wimer, BM; Rosen, CL				Wu, John Z.; Pan, Christopher S.; Wimer, Bryan M.; Rosen, Charles L.			An improved finite element modeling of the cerebrospinal fluid layer in the head impact analysis	BIO-MEDICAL MATERIALS AND ENGINEERING			English	Article						Biomechanics of impact; finite element analysis; head-brain impact; cerebrospinal fluid; traumatic brain injury	BRAIN; VOLUMES; BEHAVIOR; SKIN	The finite element (FE) method has been widely used to investigate the mechanism of traumatic brain injuries (TBIs), because it is technically difficult to quantify the responses of the brain tissues to the impact in experiments. One of technical challenges to build a FE model of a human head is the modeling of the cerebrospinal fluid (CSF) of the brain. In the current study, we propose to use membrane elements to construct the CSF layer. Using the proposed approach, we demonstrate that a head model can be built by using existing meshes available in commercial databases, without using any advanced meshing software tool, and with the sole use of native functions of the FE package Abaqus. The calculated time histories of the intracranial pressures at frontal, posterior fossa, parietal, and occipital positions agree well with the experimental data and the simulations in the literature, indicating that the physical effects of the CSF layer have been accounted for in the proposed modeling approach. The proposed modeling approach would be useful for bioengineers to solve practical problems.	[Wu, John Z.; Pan, Christopher S.; Wimer, Bryan M.] NIOSH, Morgantown, WV USA; [Rosen, Charles L.] West Virginia Univ, Dept Neurosurg, Morgantown, WV USA		Pan, CS (corresponding author), NIOSH, Morgantown, WV USA.	cpan@cdc.gov	Lang, Steven/AAE-8102-2021	Lang, Steven/0000-0003-1669-9146	research grant of CDC foundation	This study was supported by a research grant of CDC foundation. We want to express our gratitude to Turner Construction Company, Liberty Mutual Insurance, Zurich Insurance Group, and ACE Group for their generous donations to that research grant via CDC Foundation.	Abaqus theoretical manual V 6. 9, 2009, AB THER MAN V 6 9; Arbogast KB, 1998, J BIOMECH, V31, P801, DOI 10.1016/S0021-9290(98)00068-2; Baeck K, 2011, 8 EUR LS DYNA US C S; Bilston LE, 1996, ANN BIOMED ENG, V24, P67; de Borst R., 2012, NONLINEAR FINITE ELE, V2nd ed; Eppinger R. H., 1996, TRAUMATIC BRAIN INJU, P39; Faul M., 2010, TECHNICAL REPORT; GALFORD JE, 1970, J BIOMECH, V3, P211, DOI 10.1016/0021-9290(70)90007-2; HARDY CH, 1973, J APPL MECH-T ASME, V40, P838, DOI 10.1115/1.3423172; Hendriks FM, 2003, SKIN RES TECHNOL, V9, P274, DOI 10.1034/j.1600-0846.2003.00019.x; Hendriks FM, 2004, SKIN RES TECHNOL, V10, P231, DOI 10.1111/j.1600-0846.2004.00077.x; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; JERNIGAN TL, 1982, PSYCHIAT RES, V7, P9, DOI 10.1016/0165-1781(82)90048-8; KENNER VH, 1972, INT J MECH SCI, V14, P557, DOI 10.1016/0020-7403(72)90056-2; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; KOHN MI, 1991, RADIOLOGY, V178, P115, DOI 10.1148/radiology.178.1.1984289; Long J, 2015, COMPUT METHOD BIOMEC, V18, P24, DOI 10.1080/10255842.2013.774382; Mandell JG, 2015, J NEUROSURG-PEDIATR, V15, P125, DOI 10.3171/2014.9.PEDS12427; Mazuchowski E., 2003, BIOMECHANICAL PROPER; Nahum A., 1977, 21 STAPP CAR CRASH C, DOI DOI 10.4271/770922; Patel A., 2012, COMPARISON INTRACRAN; Ryan J, 2014, NEUROBIOL AGING, V35, P645, DOI 10.1016/j.neurobiolaging.2013.09.026; Schmidt H, 2015, J APPL BIOMATER FUNC, V13, P66, DOI 10.5301/jabfm.5000176; Tiesman HM, 2011, AM J PREV MED, V41, P61, DOI 10.1016/j.amepre.2011.03.007; Voo L, 1996, MED BIOL ENG COMPUT, V34, P375, DOI 10.1007/BF02520009; Willinger R, 1999, ANN BIOMED ENG, V27, P403, DOI 10.1114/1.165; Wu JZ, 2003, BIO-MED MATER ENG, V13, P373; Yamada H., 1970, STRENGTH BIOL MAT; Yan WY, 2011, COMPUT METHOD BIOMEC, V14, P1049, DOI 10.1080/10255842.2010.506435; Zhao W, 2015, BIOMECH MODEL MECHAN, V14, P753, DOI 10.1007/s10237-014-0634-0; Zivkovic V, 2012, MED SCI LAW, V52, P107, DOI 10.1258/msl.2011.011032	31	1	1	1	5	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0959-2989	1878-3619		BIO-MED MATER ENG	Bio-Med. Mater. Eng.		2017	28	2					187	199		10.3233/BME-171666			13	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	EV5HQ	WOS:000401794900009	28372270	Green Accepted			2022-02-06	
J	Yang, XY; Yang, JP; Zhu, LP; Pan, RH; Huang, YN; Li, ZX				Yang, Xi-Yue; Yang, Jin-Ping; Zhu, Lin-Ping; Pan, Rui-Hui; Huang, Yan-Ni; Li, Zhi-Xian			Transorbital ultrasound measurement of optic nerve sheath diameter in normal rabbits	INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE			English	Article						Transorbital ultrasound; optic nerve sheath diameter; intra; and inter-observer reliability; rabbit	TRAUMATIC BRAIN-INJURY; INTRACRANIAL-PRESSURE; NONINVASIVE ASSESSMENT; COMPUTED-TOMOGRAPHY; SONOGRAPHY; CHILDREN; ULTRASONOGRAPHY; ADULTS	Objective: This study aimed to investigate the feasibility and reliability of transorbital ultrasound (TOUS) measurement of optic nerve sheath diameter (ONSD) in healthy rabbits and evaluate the influence of body weight and head circumference on the ONSD biometry. Methods: TOUS was performed to measure the ONSD 3 mm behind the optic disk in 31 adult male New Zealand White rabbits independently by two investigators. The values of the same animal measured by two investigators were compared with paired t test. Relationships between paired samples and the correlations of ONSD with body weight and head circumference were evaluated by Pearson correlation coefficient (r). The intra-observer reliability and agreement between two investigators were evaluated with Cronbach's Alpha and Bland-Altman analysis, respectively. Results: Sixty-two optic nerves from 31 rabbits were well imaged by two observers. The mean ONSD was 1.17 +/- 0.01 mm (95% confidence interval (CI), 1.15-1.19 mm). No significant difference in ONSD was observed between left and right eyes and between two observers. The Pearson's correlation coefficient between two observers was 0.81 and 0.84 for the right and left eye, respectively. Cronbach's alpha was high (0.92 similar to 0.97). The difference between the values obtained by two investigators was 0.02. ONSD had no relationship with body weight (r=0.01, P=0.98) and head circumstance (r=0.02, P=0.56). Conclusion: ONSD measurement with TOUS is feasible and reliable in rabbits, which provides evidence on diagnosis of disorders affecting ONSD.	[Yang, Xi-Yue; Li, Zhi-Xian] Guangxi Med Univ, Affiliated Hosp 1, Dept Diagnost Ultrasound, 6 Shuangyong Rd, Nanning, Guangxi, Peoples R China; [Yang, Jin-Ping; Zhu, Lin-Ping] Guangxi Zhuang Autonomous Reg Inst Occupat Dis Pr, Dept Diagnost Ultrasound, Nanning, Guangxi, Peoples R China; [Pan, Rui-Hui; Huang, Yan-Ni] Guangxi Zhuang Autonomous Reg Inst Occupat Dis Pr, Dept Poisoning & Toxicol Lab, Nanning, Guangxi, Peoples R China		Li, ZX (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Diagnost Ultrasound, 6 Shuangyong Rd, Nanning, Guangxi, Peoples R China.	lizhixi-angx2015@163.com			Scientific Research and Technology Development Fund of Guangxi, China [15248003-10]; Medical and Health Key Research Project of Guangxi [2012042]; Traditional Chinese Medicine Science and Technology Special Research Project of Guangxi [GZPT1244]	This work was supported by the Scientific Research and Technology Development Fund of Guangxi, China (NO. 15248003-10), Medical and Health Key Research Project of Guangxi (NO. 2012042) and Traditional Chinese Medicine Science and Technology Special Research Project of Guangxi (NO. GZPT1244).	Andersson S, 2009, BRIT J OPHTHALMOL, V93, P526, DOI 10.1136/bjo.2008.142315; Bauerle J, 2012, J NEUROIMAGING, V22, P42, DOI 10.1111/j.1552-6569.2010.00546.x; Ballantyne J, 1999, CLIN RADIOL, V54, P740, DOI 10.1016/S0009-9260(99)91176-5; Ballantyne S A, 2002, Eur J Ultrasound, V15, P145, DOI 10.1016/S0929-8266(02)00036-8; Cooley SD, 2016, VET RADIOL ULTRASOUN, V57, P49, DOI 10.1111/vru.12300; Czosnyka M, 1998, J NEUROSURG, V88, P802, DOI 10.3171/jns.1998.88.5.0802; Detorakis ET, 2003, INVEST OPHTH VIS SCI, V44, P4307, DOI 10.1167/iovs.03-0171; Frumin E, 2014, WEST J EMERG MED, V15, P217, DOI 10.5811/westjem.2013.9.16191; Geeraerts T, 2008, INTENS CARE MED, V34, P2062, DOI 10.1007/s00134-008-1149-x; Geeraerts T, 2013, CRIT CARE, V17, DOI 10.1186/cc13012; Goeres P, 2016, J CRIT CARE, V31, P168, DOI 10.1016/j.jcrc.2015.10.009; Hamilton DR, 2011, J ULTRAS MED, V30, P651, DOI 10.7863/jum.2011.30.5.651; Helmke K, 1996, PEDIATR RADIOL, V26, P706, DOI 10.1007/BF01383384; Ilie LA, 2015, AM J VET RES, V76, P724, DOI 10.2460/ajvr.76.8.724; Kalantari H, 2013, AM J EMERG MED, V31, P1595, DOI 10.1016/j.ajem.2013.07.028; Kasapas K, 2014, SCI WORLD J, DOI 10.1155/2014/504248; Kimberly HH, 2008, ACAD EMERG MED, V15, P201, DOI 10.1111/j.1553-2712.2007.00031.x; Lee Hee-Chun, 2003, J Vet Sci, V4, P265; Maissan IM, 2015, J NEUROSURG, V123, P743, DOI 10.3171/2014.10.JNS141197; Maude RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081013; Nusbaum DM, 2013, AVIAT SPACE ENVIR MD, V84, P946, DOI 10.3357/ASEM.3486.2013; Sekhon MS, 2014, INTENS CARE MED, V40, P1267, DOI 10.1007/s00134-014-3392-7; Steinborn M, 2015, ULTRASCHALL MED, V36, P54, DOI 10.1055/s-0034-1385012; VANEY DI, 1976, J COMP NEUROL, V170, P241, DOI 10.1002/cne.901700208; Wang LJ, 2016, ULTRASOUND MED BIOL, V42, P683, DOI 10.1016/j.ultrasmedbio.2015.11.020; Young AMH, 2017, PEDIATR RES, V81, P443, DOI 10.1038/pr.2016.165	26	1	1	0	4	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	1940-5901			INT J CLIN EXP MED	Int. J. Clin. Exp. Med.		2017	10	9					13412	13418					7	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	FL5PK	WOS:000414297600052					2022-02-06	
J	Zhang, H; Han, YH; Wang, RC; Li, ZX; Gao, S; Yu, JY				Zhang, Huan; Han, Yuanhui; Wang, Ruichun; Li, Zhixiong; Gao, Sheng; Yu, Jianyun			Expression of BDNF and Nogo-A after singular and repetitive mild traumatic brain injury in rats	INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY			English	Article						BDNF; Nogo-A; singular mTBI; repetitive mTBI; cognitive impairment	RECOVERY-TIME; MOUSE MODEL; CELL-DEATH; MICE; DEFICITS; IMPROVES	Mild traumatic brain injury (mTBI) potentially causes long-lasting cognitive deficits, emotional difficulties and behavioral disturbances. Owing to a lack of observable damages following mTBI, the early diagnosis and long-term impact of the insult are limited. In the present study, we assessed the effects of singular and repetitive experimental mTBI (smTBI and rmTBI) in rats on the cognitive, motor function and anxiety-like behavior as well as the time-point changes of BDNF and Nogo-A within 24 days following injuries. Experimental brain injury was induced using a concussive head trauma with a weight-drop device. The single and repetitive mTBI injured rats and sham-operated rats were tested for cognitive, motor function and anxiety-like behavior at 1, 7 and 14 days post-trauma. The results showed that smTBI rats showed impaired cognitive, motor function and anxiety-like behavior within one week after injuries. rmTBI resulted in motor functional impairment of rats within one week while the cognitive deficits and anxiety behavior lasted until two weeks after the injury. Furthermore, brain BDNF peaked at day 2 in smTBI hippocampus CA1 sections and at day 4 for rmTBI rats. Meanwhile, the hippocampus Nogo-A significantly decreased at day 4 in smTBI rats and at day 8 for rmTBI rats. Likewise, BDNF and Nogo-A fluctuated at each time point tested in secondary motor cortex M2-1 of the rat post-smTBI and rmTBI. In conclusion, the time-course change of BDNF and Nogo-A might provide clues for the early diagnosis and treatment of single and repetitive mild TBI.	[Zhang, Huan; Li, Zhixiong; Gao, Sheng; Yu, Jianyun] Kunming Med Univ, Sch Forens Med, 1168 Chunrong Western Rd, Kunming 650500, Yunnan, Peoples R China; [Han, Yuanhui] Kunming Med Univ, Affiliated Hosp 2, Dept Ophthalmol, Kunming, Yunnan, Peoples R China; [Wang, Ruichun] Chongqing Municipal Publ Secur Bur, Yuzhong Dist Subbur, Mat Evidence Identificat Ctr, Chongqing, Peoples R China		Yu, JY (corresponding author), Kunming Med Univ, Sch Forens Med, 1168 Chunrong Western Rd, Kunming 650500, Yunnan, Peoples R China.	Jianyunyu@sina.com			Nature Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81360467]; Yunnan Applied Basic Research Projects [2013FB104]	This work was supported by grants from Nature Science Foundation of China (81360467) and Yunnan Applied Basic Research Projects (2013FB104).	Akbik F, 2012, EXP NEUROL, V235, P43, DOI 10.1016/j.expneurol.2011.06.006; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Chytrova G, 2008, EUR J NEUROSCI, V27, P1, DOI 10.1111/j.1460-9568.2007.05982.x; Conte V, 2008, RESTOR NEUROL NEUROS, V26, P45; Darwish H, 2012, BRAIN INJURY, V26, P1763, DOI [10.3109/02699052.2012.741452, 10.3109/02699052.2011.635362]; Di Battista AP, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00110; Failla MD, 2016, NEUROREHAB NEURAL RE, V30, P419, DOI 10.1177/1545968315600525; Fujita M, 2012, J NEUROTRAUM, V29, P2172, DOI 10.1089/neu.2012.2357; Ge XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06718; Gonzenbach RR, 2012, J NEUROTRAUM, V29, P567, DOI 10.1089/neu.2011.1752; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P697, DOI 10.1007/978-0-387-76978-3_22; Korley FK, 2016, J NEUROTRAUM, V33, P215, DOI 10.1089/neu.2015.3949; Luo J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00012; Mannix R, 2014, J NEUROSURG, V121, P1342, DOI 10.3171/2014.7.JNS14272; Marklund N, 2009, NEUROSCIENCE, V163, P540, DOI 10.1016/j.neuroscience.2009.06.042; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Meyer DL, 2012, EXP NEUROL, V235, P574, DOI 10.1016/j.expneurol.2012.03.012; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Raghupathi R, 2002, NEUROSCIENCE, V110, P605, DOI 10.1016/S0306-4522(01)00461-4; Sharma A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112019; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x; Zhang H., 2014, MATH PROBL ENG, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0088909	27	1	1	2	6	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	1936-2625			INT J CLIN EXP PATHO	Int. J. Clin. Exp. Pathol.		2017	10	6					6375	6384					10	Oncology; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Pathology	EZ2NL	WOS:000404545900020					2022-02-06	
B	Zweckberger, K		Badaut, J; Plesnila, N		Zweckberger, Klaus			Traumatic Brain Injury and Edema Treatment	BRAIN EDEMA: FROM MOLECULAR MECHANISMS TO CLINICAL PRACTICE			English	Article; Book Chapter							CONTROLLED CORTICAL IMPACT; POSTTRAUMATIC CEREBRAL INFARCTION; SEVERE HEAD-INJURY; DECOMPRESSIVE CRANIECTOMY; INTRACRANIAL-PRESSURE; BARBITURATE THERAPY; PERFUSION-PRESSURE; COMATOSE PATIENTS; CONTUSION VOLUME; TISSUE		[Zweckberger, Klaus] Heidelberg Univ, Heidelberg, Germany		Zweckberger, K (corresponding author), Heidelberg Univ, Heidelberg, Germany.						Amara SG, 2002, NEUROCHEM INT, V41, P313, DOI 10.1016/S0197-0186(02)00018-9; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; [Anonymous], 2003, REPORTS C MILD TRAUM; Arrich J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004128.pub2; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; Bareyre F, 1997, J NEUROTRAUM, V14, P839, DOI 10.1089/neu.1997.14.839; Baskaya MK, 2000, J NEUROSURG, V92, P448, DOI 10.3171/jns.2000.92.3.0448; Betz AL, 1989, CEREBROVAS BRAIN MET, V1, P133; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; Brain Trauma Foundation, 2016, GUID MAN SEV TRAUM B; Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; BULLOCK R, 1990, ACT NEUR S, V51, P286; Burgess S, 2016, ANN PHARMACOTHER, V50, P291, DOI 10.1177/1060028016628893; Carrera E, 2010, J NEUROL NEUROSUR PS, V81, P793, DOI 10.1136/jnnp.2009.174425; CHENEY JA, 2001, CEREB BLOOD FLOW MET, V21, P396; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Cole TB, 2004, JAMA-J AM MED ASSOC, V291, P2531, DOI 10.1001/jama.291.21.2531; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Diringer MN, 2004, NEUROCRIT CARE, V1, P219, DOI 10.1385/NCC:1:2:219; Diringer MN, 2000, J NEUROSURG, V92, P7, DOI 10.3171/jns.2000.92.1.0007; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; FAY T, 1943, ASS RES NERV MENT DI, V24, P611; Finkelstein E, 2006, INCIDENCE EC BURDON; Firsching R, 2012, J NEUROL SURG PART A, V73, P204, DOI 10.1055/s-0032-1304815; FISHMAN RA, 1975, NEW ENGL J MED, V293, P706, DOI 10.1056/NEJM197510022931407; Fukui S, 2003, ACT NEUR S, V86, P301; Gegelashvili G, 1997, MOL PHARMACOL, V52, P6, DOI 10.1124/mol.52.1.6; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; HOSSMANN KA, 1980, STROKE, V11, P583, DOI 10.1161/01.STR.11.6.583; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Ikeda Y, 2000, ACT NEUR S, V76, P195; Katayama Y, 2003, ACTA NEUROCHIR SUPPL, V86, P323; Kawai N, 2003, J NEUROTRAUM, V20, P649, DOI 10.1089/089771503322144563; Kawamata T, 2000, ACTA NEUROCHIR SUPPL, V76, P9; Kiening KL, 2003, BRIT J NEUROSURG, V17, P311, DOI 10.1080/02688690310001601199; Kiening KL, 1997, NEUROL RES, V19, P233, DOI 10.1080/01616412.1997.11740805; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Lee JH, 2001, J NEUROSURG, V95, P222, DOI 10.3171/jns.2001.95.2.0222; Lei J, 2015, CONTEMP CLIN TRIALS, V40, P9, DOI 10.1016/j.cct.2014.11.008; Leo P, 2016, NCBI BOOKSHELF, P1; Liu SW, 2015, ACTA NEUROCHIR, V157, P1697, DOI 10.1007/s00701-015-2559-5; Lu J, 2005, ACT NEUR S, V95, P281; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Maeda T, 2003, ACT NEUR S, V86, P329; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; MARSHALL LF, 1979, J NEUROSURG, V50, P26, DOI 10.3171/jns.1979.50.1.0026; McKinley BA, 1988, ACTA NEUROCHIR WIE S, V71, P177; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mojtahedzadeh M, 2014, J RES MED SCI, V19, P867; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Nagelhus EA, 1999, GLIA, V26, P47, DOI 10.1002/(SICI)1098-1136(199903)26:1<47::AID-GLIA5>3.0.CO;2-5; Nordstrom Carl-Henrik, 2003, Neurosurg Focus, V15, pE5; Nordstrom CH, 2005, NEUROCRIT CARE, V2, P83, DOI 10.1385/NCC:2:1:083; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Pappius H.M., 1974, HDB CLIN NEUROLOGY 1, V16, P167; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Perez-Barcena J, 2008, CRIT CARE, V12, DOI 10.1186/cc6999; Plesnila N, 2001, J NEUROTRAUM, V18, P1049, DOI 10.1089/08977150152693746; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Prabhakar Hemanshu, 2014, J Anaesthesiol Clin Pharmacol, V30, P318, DOI 10.4103/0970-9185.137260; Rangel-Castilla L, 2010, J NEUROTRAUM, V27, P1853, DOI 10.1089/neu.2010.1339; REA GL, 1983, NEUROSURGERY, V12, P401, DOI 10.1227/00006123-198304000-00005; REESE TS, 1967, J CELL BIOL, V34, P207, DOI 10.1083/jcb.34.1.207; Roberts DJ, 2011, CRIT CARE MED, V39, P2743, DOI 10.1097/CCM.0b013e318228236f; Roberts I, 2012, COCHRANE DB SYST REV, V12; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Sarrafzadeh AS, 2003, BRIT J NEUROSURG, V17, P340, DOI 10.1080/02688690310001601234; Sasoun S, 2003, J CLIN PATHOL, V56, P972; Schneider GH, 1998, ACT NEUR S, V71, P62; SCHNEIDER GH, 1992, CAN J PHYSIOL PHARM, V70, pS334, DOI 10.1139/y92-280; Schneider GH, 2002, ACT NEUR S, V81, P77; Shohami E, 2011, BRIT J PHARMACOL, V163, P1402, DOI 10.1111/j.1476-5381.2011.01343.x; STAUB F, 1993, BRAIN RES, V610, P69, DOI 10.1016/0006-8993(93)91218-H; Stein NR, 2012, NEUROCRIT CARE, V17, P49, DOI 10.1007/s12028-012-9708-y; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Stoop R, 1998, ACTA NEUROCHIR, V71, P303; Stover JF, 2000, J NEUROTRAUM, V17, P1171, DOI 10.1089/neu.2000.17.1171; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tang GH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101413; Tawil I, 2008, J TRAUMA, V64, P849, DOI 10.1097/TA.0b013e318160c08a; Thorat JD, 2008, J CLIN NEUROSCI, V15, P143, DOI 10.1016/j.jocn.2006.08.014; Unterberg AW, 1997, ACT NEUR S, V70, P106; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Unterberg AW, 2000, NEUROSURGERY SCI BAS, P410; van der Worp HB, 2010, J CEREBR BLOOD F MET, V30, P1079, DOI 10.1038/jcbfm.2010.44; Yudofsky S., 2011, TXB TRAUMATIC BRAIN, DOI [10.1176/appi.books.9781585624201.js01, DOI 10.1176/APPI.BOOKS.9781585624201.JS01]; Zweckberger K, 2003, J NEUROTRAUM, V20, P1307, DOI 10.1089/089771503322686102; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	96	1	1	0	1	ACADEMIC PRESS LTD-ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL ROAD, LONDON NW1 7DX, ENGLAND			978-0-12-803197-1; 978-0-12-803196-4				2017							457	475		10.1016/B978-0-12-803196-4.00023-0			19	Clinical Neurology; Neurosciences	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BJ4BW	WOS:000424808700024					2022-02-06	
J	Alway, Y; Ponsford, J; Mckay, A				Alway, Yvette; Ponsford, Jennie; McKay, Adam			The relationship between family expressed emotion, perceived criticism and criticism sensitivity and psychiatric outcomes following traumatic brain injury	PSYCHIATRY RESEARCH			English	Article							DISORDERS; PSYCHOPATHOLOGY; DEPRESSION; VALIDITY; RELAPSE; REHABILITATION; DISTRESS; ANXIETY; MEMBERS; SAMPLE	Family expressed emotion (EE) is a strong predictor of outcome in a range of psychiatric and medical conditions. This study aimed to examine the relationship between family EE-criticism, patient perceived criticism and criticism sensitivity and psychiatric disorders following moderate to severe traumatic brain injury (TBI). Participants were 60 patients with TBI and their family members. Patients were assessed for psychiatric disorders using the Structured Clinical Interview for DSM-IV (SCID-I) and completed the Perceived Criticism Measure (PCM) to determine levels of perceived criticism and criticism sensitivity. Family members completed the Family Questionnaire (FQ) to assess patient directed EE-criticism. Patients were reassessed approximately 12-months post-baseline. After controlling for diagnostic status at baseline, high criticism sensitivity at baseline was associated with greater probability of psychiatric diagnosis at follow-up (odds ratio=3.99, 95% CI=1.15-13.73 Family EE-criticism and perceived criticism were not predictive of patient diagnostic status at follow-up, but patients with high EE-family members were more likely to have a concurrent psychiatric diagnosis at baseline. Findings suggest that sensitivity to interpersonal criticism may have a role in the development and course of psychiatric disorders following TBI.	[Alway, Yvette; Ponsford, Jennie; McKay, Adam] Monash Univ, Sch Psychol Sci, Melbourne, Vic, Australia; [Alway, Yvette; Ponsford, Jennie; McKay, Adam] Monash Univ, Monash Inst Cognit & Clin Neurosci, Melbourne, Vic, Australia; [Alway, Yvette; Ponsford, Jennie; McKay, Adam] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Ponsford, Jennie] Natl Trauma Res Inst, Melbourne, Vic, Australia		Alway, Y (corresponding author), Monash Epworth Rehabil Res Ctr, 185-187 Hoddle St, Richmond, Vic 3121, Australia.	yvette.alway@monash.edu	McKay, Adam/M-6003-2017	McKay, Adam/0000-0002-0479-7681	Transport Accident Commission (TAC), through the Institute for Safety, Compensation and Recovery Research (ISCRR)	This project was funded by the Transport Accident Commission (TAC), through the Institute for Safety, Compensation and Recovery Research (ISCRR).	Alway Y, 2012, NEUROPSYCHOL REHABIL, V22, P374, DOI 10.1080/09602011.2011.648757; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Band R, 2014, HEALTH PSYCHOL, V33, P1092, DOI 10.1037/hea0000086; Bressi C, 2007, SEIZURE-EUR J EPILEP, V16, P417, DOI 10.1016/j.seizure.2007.02.015; Bressi C, 2009, J CARDIOVASC MED, V10, P752, DOI 10.2459/JCM.0b013e32832cae71; Butzlaff RL, 1998, ARCH GEN PSYCHIAT, V55, P547, DOI 10.1001/archpsyc.55.6.547; Chambless DL, 2009, BEHAV THER, V40, P155, DOI 10.1016/j.beth.2008.05.005; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Flanagan DAJ, 1998, BRIT J CLIN PSYCHOL, V37, P431, DOI 10.1111/j.2044-8260.1998.tb01400.x; Gerlsma C, 2014, PSYCHIAT RES, V220, P1102, DOI 10.1016/j.psychres.2014.08.061; Hooley JM, 2007, ANNU REV CLIN PSYCHO, V3, P329, DOI 10.1146/annurev.clinpsy.2.022305.095236; Hooley JM, 2006, J FAM PSYCHOL, V20, P386, DOI 10.1037/0893-3200.20.3.386; Hooley JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044412; HOOLEY JM, 1989, J ABNORM PSYCHOL, V98, P229, DOI 10.1037/0021-843X.98.3.229; Kelly G, 2008, BRAIN INJURY, V22, P457, DOI 10.1080/02699050802060647; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; Medina-Pradas C, 2011, APPETITE, V57, P743, DOI 10.1016/j.appet.2011.08.016; Miklowitz DJ, 2009, J AM ACAD CHILD PSY, V48, P643, DOI 10.1097/CHI.0b013e3181a0ab9d; Miklowitz DJ, 2004, DEV PSYCHOPATHOL, V16, P667, DOI 10.1017/S0954579404004729; Miklowitz DJ, 2005, PSYCHIAT RES, V136, P101, DOI 10.1016/j.psychres.2005.04.005; Rashid N, 2013, BRAIN INJURY, V27, P223, DOI 10.3109/02699052.2012.729287; Renshaw KD, 2008, CLIN PSYCHOL REV, V28, P521, DOI 10.1016/j.cpr.2007.09.002; Rienecke R.D., 2015, J CLIN CHILD ADOLESC, P1; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Rylands AJ, 2011, J NERV MENT DIS, V199, P25, DOI 10.1097/NMD.0b013e3182043b87; Steketee G, 2007, BEHAV RES THER, V45, P11, DOI 10.1016/j.brat.2006.01.018; Traumatic Brain Injury Taskforce, 2008, REP ARM SURG GEN DEP; VAUGHN C, 1976, BRIT J SOC CLIN PSYC, V15, P157, DOI 10.1111/j.2044-8260.1976.tb00021.x; Wearden AJ, 2000, CLIN PSYCHOL REV, V20, P633, DOI 10.1016/S0272-7358(99)00008-2; WEDDELL RA, 1987, SCAND J REHABIL MED, V19, P93; Weddell RA, 2006, BRAIN INJURY, V20, P1221, DOI 10.1080/02699050601049783; Weddell RA, 2010, ARCH PHYS MED REHAB, V91, P897, DOI 10.1016/j.apmr.2010.01.020; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Whelan-Goodinson R, 2008, J REHABIL MED, V40, P850, DOI 10.2340/16501977-0271; White JD, 1998, PSYCHOL REP, V83, P83, DOI 10.2466/PR0.83.5.83-97; Wiedemann G, 2002, PSYCHIAT RES, V109, P265, DOI 10.1016/S0165-1781(02)00023-9	38	1	1	0	6	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-1781			PSYCHIAT RES	Psychiatry Res.	DEC 30	2016	246						827	832		10.1016/j.psychres.2016.10.019			6	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	EG3TT	WOS:000390968300131	27817907				2022-02-06	
J	Zang, L; de Araujo, ACP; Ferreira, MP				Zang, Luciana; Pacheco de Araujo, Ana Cristina; Ferreira, Marcio Poletto			Retrospective Study of Anesthesias in Dogs and Cats Underwent to Neurosurgery	ACTA SCIENTIAE VETERINARIAE			Portuguese	Article						anesthetic complications; hemodynamic; spine surgery; dog; cat	PAIN MANAGEMENT	Background: The goal of anesthesia in patients with neurological diseases is to maintain the homeostasis of the central nervous system, focusing on intracranial pressure and pain during the intraoperative period. The purpose of this study was to evaluate the anesthesia performed between January 2010 and January 2016 at the Veterinary Clinical Hospital at the Federal University of Rio Grande do Sul and correlate the types of surgeries, drugs used in the pre-anesthetic medication, induction, pain control, and the development of complications during the procedure. Materials, Methods & Results: The medical records of 242 patients, who presented with neurological signs of spinal cord compression or traumatic brain injury, were assessed. Only 70 patients who underwent surgery had properly documented and detailed anesthesia records. Of these 70, there were 32 male and 38 female animals, with one feline and 69 canines. Their weights on the day of surgery ranged between 1.5 kg and 38 kg and their ages ranged from six months up to 13 years. We evaluated 74 surgeries because four patients underwent two separate surgeries. There were 38 hemilaminectomies, 14 ventral slots, seven vertebral stabilizations (one atlantoaxial instability and six vertebral fractures), six dorsal laminectomies, four pediculectomies, two fenestrations with hemilaminectomy, one durotomy with hemilaminectomy, one minihemilaminectomy, and one tumor removal. The complications observed were bradycardia (25/74), systemic hypotension (49/74), systemic hypertension, (21/74) and death (4/74). There was a great variation in the pre-anesthetic medication; either combinations of two or more drugs, one drug, or no medication was used. The most common drug used for induction of the patient was propofol, which was used in 46 cases as single agent and in 26 cases in combination with other drugs. In 43 patients, the majority of nociception control during the intraoperative period was achieved with continuous infusions of fentanyl combined with lidocaine, while some used ketamine. Pain control for the remaining 15 patients was accomplished with drug boluses. In two cases, the choice of opioid in the pre-anesthetic medication was repeated. Fourteen patients had remained without analgesia during surgery. No correlation was observed between the frequency of complications and the type of surgery performed, the medications used for induction of the patient, or the method of control of nociceptive stimuli during surgery. Continuous infusions were used frequently for pain control during surgery, however no significant correlation with complications was observed. Discussion: The high prevalence of neurological diseases that affect the spinal cord makes spinal surgery one of the most frequent neurosurgeries. The risk of complications in spinal surgery is affected by hemodynamics of the patient and may lead to death during the procedure. The most frequent complications are bradycardia, hypotension, cardiac electrophysiological changes, apnea, hemorrhage, and death. The survey identified bradycardia, hypotension, hypertension, and death as the major complications. The most frequent method of intraoperative analgesia was a continuous infusion, due to its benefits when compared to other methods of analgesia. When compared to previous studies, the present study showed similar complications that had no correlation wtih the type of surgery or anesthesia protocol.	[Zang, Luciana] Univ Fed Rio Grande do Sul, PPG CV, Porto Alegre, RS, Brazil; [Pacheco de Araujo, Ana Cristina] Univ Fed Rio Grande do Sul, ICBS, DM, Porto Alegre, RS, Brazil; [Ferreira, Marcio Poletto] Univ Fed Rio Grande do Sul, FaVet, DMA, Porto Alegre, RS, Brazil		Zang, L (corresponding author), Rua Lindolfo Henke 230 Apt 111 Bairro Saran, BR-91130230 Porto Alegre, RS, Brazil.	lucianaz_23@yahoo.com.br	Ferreira, Marcio P/I-3453-2015				Arany-Toth A, 2013, VET ANAESTH ANALG, V40, P390, DOI 10.1111/vaa.12019; Brisson BA, 2010, VET CLIN N AM-SMALL, V40, P829, DOI 10.1016/j.cvsm.2010.06.001; Dyson DH, 2008, VET CLIN N AM-SMALL, V38, P1309, DOI 10.1016/j.cvsm.2008.06.006; Godoi DA, 2009, SEMIN-CIENC AGRAR, V30, P171, DOI 10.5433/1679-0359.2009v30n1p171; Harvey R.C., 2007, LUMB JONES VET ANEST, P903; Hellyer P, 2007, J FELINE MED SURG, V9, P466, DOI 10.1016/j.jfms.2007.09.001; Jeffery ND, 2010, VET CLIN N AM-SMALL, V40, P809, DOI 10.1016/j.cvsm.2010.05.004; Joubert KE, 2004, J S AFR VET ASSOC, V75, P85; Ko J., 2013, COLOR HDB SMALL ANIM, P87; Ko J., 2013, COLOR HDB SMALL ANIM, P59; Kunz RE, 2015, VET SURG, V44, P687, DOI 10.1111/j.1532-950X.2014.12319.x; Meji B., 2015, P 14 CHUL U VET C RE, P249; Muir W.W., 2009, HDB VET PAIN MANAGEM, V2nd, pp42; Olby N, 2010, VET CLIN N AM-SMALL, V40, P791, DOI 10.1016/j.cvsm.2010.05.007; Posner LP, 2014, VET ANAESTH ANALG, V41, P137, DOI 10.1111/vaa.12127; Rossmeisl JH, 2013, VET SURG, V42, P795, DOI 10.1111/j.1532-950X.2013.12039.x; Sharp N., 2005, SMALL ANIMAL SPINAL, V2nd ed., P93; Taylor PM, 2012, J FELINE MED SURG, V14, P516, DOI 10.1177/1098612X12440354; Tipold A, 2015, FRONT VET SCI, V2, DOI 10.3389/fvets.2015.00013; Waelbers T, 2010, VLAAMS DIERGEN TIJDS, V79, P179; Waelbers T, 2010, VLAAMS DIERGEN TIJDS, V79, P169; Wendt-Hornickle E, 2015, CANINE AND FELINE ANESTHESIA AND CO-EXISTING DISEASE, P71	22	1	1	0	12	UNIV FED RIO GRANDE DO SUL	PORTO ALEGRE RS	FAC VET, CAIXA POSTAL 15017, PORTO ALEGRE RS, 91501-570, BRAZIL	1678-0345	1679-9216		ACTA SCI VET	Acta Sci. Vet.	DEC 7	2016	44								1417				6	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	EH9KN	WOS:000392090300001					2022-02-06	
J	Germans, MR; Boogaarts, HD; Macdonald, RL				Germans, Menno R.; Boogaarts, Hieronymus D.; Macdonald, R. Loch			Neuroprotection in Critical Care Neurology	SEMINARS IN NEUROLOGY			English	Article						cerebral ischemia; neuroprotection; subarachnoid hemorrhage; traumatic brain injury	CEREBRAL PERFUSION-PRESSURE; TRAUMATIC BRAIN-INJURY; REFRACTORY INTRACRANIAL HYPERTENSION; ANEURYSMAL SUBARACHNOID HEMORRHAGE; DECOMPRESSIVE HEMICRANIECTOMY; DOUBLE-BLIND; BLOOD-FLOW; MORTALITY; THERAPY; STROKE	Ischemic stroke, intracerebral hemorrhage, subarachnoid hemorrhage, and traumatic brain injury all have in common early brain injury due to brain tissue destruction, reduced cerebral blood flow and oxygen delivery, and overall substantial morbidity and mortality. The pathophysiology of brain tissue damage likely includes common cellular mechanisms. Neuroprotection has seldom, if ever, been shown to reduce early brain injury. Secondary brain injury develops after these conditions due to macroscopic events such as increased intracranial pressure and reduced cerebral blood flow, as well as cellular processes including vascular damage, inflammation, and apoptotic/necrotic cell death. Preclinical as well as some human studies show successful neuroprotection with, for example, hypothermia for cardiac arrest. Nevertheless, there remains much room for improvement that will require randomized clinical trials of emerging neuroprotective strategies.	[Germans, Menno R.; Boogaarts, Hieronymus D.] Radboud Univ Nijmegen, Med Ctr, Dept Neurosurg, Nijmegen, Netherlands; [Macdonald, R. Loch] Univ Toronto, Keenan Res Ctr Biomed Sci, Dept Surg, Div Neurosurg, Toronto, ON, Canada; [Macdonald, R. Loch] Univ Toronto, Li Ka Shing Knowledge Inst, Toronto, ON, Canada		Germans, MR (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Neurosurg, Nijmegen, Netherlands.	Menno.Germans@radboudumc.nl	Germans, Menno/AAI-8211-2020; Boogaarts, Jeroen/L-4216-2015	Boogaarts, Jeroen/0000-0001-5855-2447			Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Arrich J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004128.pub3; Bentsen G, 2006, CRIT CARE MED, V34, P2912, DOI 10.1097/01.CCM.0000245665.46789.7C; BLAUSTEIN MP, 1975, MOL PHARMACOL, V11, P369; Bohn D., 1989, CRIT CARE MED, V17, pS118; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS71; Bratton SL, 2007, J NEUROTRAUMA S1, V24, P555, DOI DOI 10.1089/NEU.2007.9988; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Buschmann U, 2007, ACTA NEUROCHIR, V149, P59, DOI 10.1007/s00701-006-1069-x; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; DEMOPOULOS HB, 1977, ACTA NEUROL SCAND, V56, P152; Den Hertog HM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001247.pub2; Dizdarevic K, 2012, CLIN NEUROL NEUROSUR, V114, P142, DOI 10.1016/j.clineuro.2011.10.005; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; FLAMM ES, 1977, ACTA NEUROL SCAND, V56, P150; Forsyth RJ, 2015, COCHRANE DB SYST REV, V11; Gremmelt A, 1995, ANAESTHESIST S3, V44, P5559; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Hanggi D, 2015, NEUROCRIT CARE, V23, P274, DOI 10.1007/s12028-015-0112-2; Han JS, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002827; Hill MD, 2012, LANCET NEUROL, V11, P942, DOI 10.1016/S1474-4422(12)70225-9; Horn P, 1999, NEUROL RES, V21, P758, DOI 10.1080/01616412.1999.11741010; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Karamanos E, 2014, AM J SURG, V208, P363, DOI 10.1016/j.amjsurg.2013.10.026; KASSELL NF, 1980, NEUROSURGERY, V7, P598, DOI 10.1227/00006123-198012000-00011; Kostic Aleksandar, 2011, Med Pregl, V64, P461; Kuramatsu JB, 2015, CEREBROVASC DIS, V40, P228, DOI 10.1159/000439178; Li LYR, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008445.pub2; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Macdonald RL, 2014, NAT REV NEUROL, V10, P44, DOI 10.1038/nrneurol.2013.246; Mack William J, 2003, Neurosurg Focus, V14, pe3; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Marshall L F, 1980, Adv Neurol, V28, P459; Mehta V, 1996, CAN J NEUROL SCI, V23, P40, DOI 10.1017/S0317167100039160; MICHENFE.JD, 1974, ANESTHESIOLOGY, V41, P231, DOI 10.1097/00000542-197409000-00004; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Muehlschlegel S, 2015, J NEUROL NEUROSUR PS, V86, P1029, DOI 10.1136/jnnp-2014-308778; Muroi C, 2012, CURR OPIN CRIT CARE, V18, P119, DOI 10.1097/MCC.0b013e32835075ae; Nagel A, 2009, J NEUROSURG, V111, P94, DOI 10.3171/2009.1.JNS08587; Perez-Barcena J, 2008, CRIT CARE, V12, DOI 10.1186/cc6999; Powers WJ, 2015, STROKE, V46, P3020, DOI 10.1161/STR.0000000000000074; Reilly P, 1997, HEAD INJURY PATHOPHY; Roberts I, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000033.pub2; SAUL TG, 1982, AM SURGEON, V48, P477; SCHALEN W, 1992, ACTA ANAESTH SCAND, V36, P369, DOI 10.1111/j.1399-6576.1992.tb03483.x; Schirmer CM, 2007, STROKE, V38, P987, DOI 10.1161/01.STR.0000257962.58269.e2; Schreiber MA, 2002, ARCH SURG-CHICAGO, V137, P285, DOI 10.1001/archsurg.137.3.285; Seule MA, 2009, NEUROSURGERY, V64, P86, DOI 10.1227/01.NEU.0000336312.32773.A0; SMITH DS, 1980, ANESTHESIOLOGY, V53, P186, DOI 10.1097/00000542-198009000-00002; Stocchetti N, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0887-8; Su SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087432; Suarez JI, 2012, STROKE, V43, P683, DOI 10.1161/STROKEAHA.111.633958; Tagin MA, 2012, ARCH PEDIAT ADOL MED, V166, P558, DOI 10.1001/archpediatrics.2011.1772; Tseng MY, 2007, J NEUROSURG, V107, P274, DOI 10.3171/JNS-07/08/0274; Tymianski M, 2013, STROKE, V44, P2942, DOI 10.1161/STROKEAHA.113.000731; WARD JD, 1985, J NEUROSURG, V62, P383, DOI 10.3171/jns.1985.62.3.0383; Winn HR, 2011, YOUMANS NEUROLOGICAL, P343; Wu TC, 2013, LANCET NEUROL, V12, P275, DOI 10.1016/S1474-4422(13)70013-9; YOSHIDA S, 1983, J NEUROCHEM, V40, P1278, DOI 10.1111/j.1471-4159.1983.tb13567.x; Yuan Q, 2015, J NEUROSURG, V122, P574, DOI 10.3171/2014.10.JNS1460; Zhang BF, 2015, WORLD NEUROSURG, V83, P567, DOI 10.1016/j.wneu.2014.12.010; Zoerle T, 2015, CRIT CARE MED, V43, P168, DOI 10.1097/CCM.0000000000000670	65	1	1	0	2	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.	DEC	2016	36	6					642	648		10.1055/s-0036-1592359			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EE0PT	WOS:000389282100020	27907969				2022-02-06	
J	Handlos, P; Dokoupil, M; Stankova, M; Joukal, M; Dvoracek, I; Uvira, M; Smatanova, M				Handlos, Petr; Dokoupil, Marek; Stankova, Marie; Joukal, Marek; Dvoracek, Igor; Uvira, Matej; Smatanova, Margita			Fluid content in the pleural cavity protects internal structures against heat	FORENSIC SCIENCE MEDICINE AND PATHOLOGY			English	Article						Carbonization; Stab wounds; Stab channel; Hemothorax; Traumatic-hemorrhagic shock	FATALITIES; HOMICIDE; VICTIMS	In this paper we present a case report of two people who were found dead in a holiday cottage after a fire. The cause of death in these cases was clarified by the presence of blood in the left pleural cavity in both bodies. An inspection of the bodies at the scene of the fire and subsequent examination by a medical examiner suggested the deaths were accidental. An autopsy showed that the bodies were those of a man and a woman with severe carbonization of the skin, soft tissues, brain, and some organs of the thoracic and abdominal cavities. There were also isolated stab injuries to the chest, as well as injuries to skeletal structures and intrathoracic organs. The accumulated blood in the pleural cavity had protected the internal organs against thermal destruction and preserved the traumatic findings. To the best of our knowledge this is the first description of the protective effect of hemothorax against thermal damage of the intrathoracic organs.	[Handlos, Petr; Dokoupil, Marek; Stankova, Marie; Dvoracek, Igor; Uvira, Matej; Smatanova, Margita] Univ Hosp Ostrava, Forens Med, Ostrava 70852, Czech Republic; [Handlos, Petr; Dokoupil, Marek; Stankova, Marie; Dvoracek, Igor; Smatanova, Margita] Univ Ostrava, Dept Intens Med & Forens Studies, Ostrava 70300, Czech Republic; [Handlos, Petr; Joukal, Marek] Masaryk Univ, Fac Med, Dept Anat, Brno 62500, Czech Republic		Smatanova, M (corresponding author), Univ Hosp Ostrava, Forens Med, Ostrava 70852, Czech Republic.; Smatanova, M (corresponding author), Univ Ostrava, Dept Intens Med & Forens Studies, Ostrava 70300, Czech Republic.	margita.smatanova@fno.cz	Handlos, Petr/G-7301-2019; Dokoupil, Marek/AAC-4888-2019; Joukal, Marek/AAA-5977-2021; Uvira, Matej/G-7302-2019	Handlos, Petr/0000-0002-0648-0071; Dokoupil, Marek/0000-0002-1565-3595; Joukal, Marek/0000-0002-7013-1693; Uvira, Matej/0000-0002-0918-9351			Buyuk Y, 2009, J FORENSIC LEG MED, V16, P449, DOI 10.1016/j.jflm.2009.05.005; Dettling A, 2003, FORENSIC SCI INT, V134, P142, DOI 10.1016/S0379-0738(03)00139-7; Fanton L, 2006, FORENSIC SCI INT, V158, P87, DOI 10.1016/j.forsciint.2005.04.040; Frishons J, 2012, BASICS DISSECTION TE; Karlsson T, 1998, FORENSIC SCI INT, V93, P21, DOI 10.1016/S0379-0738(98)00025-5; KEMP PM, 1995, J ANAL TOXICOL, V19, P285, DOI 10.1093/jat/19.5.285; KLENDSHOJ NC, 1950, J BIOL CHEM, V183, P297; Koning ED, 2014, MED SCI LAW, V54, P88; MACHATA G, 1972, CLIN CHEM NEWSL, V4, P29; Maeda H, 1996, FORENSIC SCI INT, V81, P201, DOI 10.1016/S0379-0738(96)01952-4; POJER R, 1984, CLIN CHEM, V30, P1377; Spitz W, 2006, SPITZ FISHERS MEDICO, P532; Tumer AR, 2012, J FORENSIC LEG MED, V19, P223, DOI 10.1016/j.jflm.2012.01.001	13	1	1	0	7	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1547-769X	1556-2891		FORENSIC SCI MED PAT	Forensic Sci. Med. Pathol.	DEC	2016	12	4					497	501		10.1007/s12024-016-9814-9			5	Medicine, Legal; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine; Pathology	EF0SN	WOS:000390036400011	27778146				2022-02-06	
J	Hirsch, N; Taylor, C				Hirsch, Nicholas; Taylor, Christopher			Pharmacological and pathological modulation of cerebral physiology	ANAESTHESIA AND INTENSIVE CARE MEDICINE			English	Article						Autoregulation; cerebral blood flow; cerebral ischaemia; cerebral metabolic rate; neuroanaesthesia; subarachnoid haemorrhage; traumatic brain injury		Anaesthesia for neurosurgery aims to provide optimal surgical conditions whilst maintaining adequate cerebral blood flow in order to supply the brain with appropriate amounts of oxygen and glucose. Most anaesthetic drugs influence the normal cerebral physiology either directly or indirectly. They can cause changes in cerebral blood flow by influencing cerebral blood vessel calibre, by interfering with autoregulatory processes and by modifying cerebral metabolism. The brain's limited ability to store oxygen and glucose means that its supply must be continuous if neuronal damage is to be avoided. Ischaemic cerebral damage is the most important pathological mechanism in patients with stroke, subarachnoid haemorrhage and traumatic brain injury. Significant traumatic brain injury causes widespread derangement of cerebral physiology, including changes in cerebral blood flow, autoregulation and cerebral energy dynamics. This article outlines the effect of anaesthesia on cerebral physiology and reviews the pathophysiology of traumatic brain injury and subarachnoid haemorrhage.	[Hirsch, Nicholas; Taylor, Christopher] Natl Hosp Neurol & Neurosurg, Queen Sq, London, England; [Hirsch, Nicholas] Inst Neurol, London, England		Hirsch, N (corresponding author), Natl Hosp Neurol & Neurosurg, Queen Sq, London, England.; Hirsch, N (corresponding author), Inst Neurol, London, England.						Diringer MN, 2011, NEUROCRIT CARE, V15, P211, DOI 10.1007/s12028-011-9605-9; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Matta BF, 2011, CORE TOPICS NEUROANA; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131	4	1	1	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1472-0299	1878-7584		ANAEST INTENS CARE M	Anaesth. Intensiv. Care Med.	DEC	2016	17	12					635	640		10.1016/j.mpaic.2016.09.015			6	Anesthesiology	Emerging Sources Citation Index (ESCI)	Anesthesiology	EG2HS	WOS:000390864900011					2022-02-06	
J	Kang, MH; Park, HM				Kang, M. H.; Park, H. M.			Administration of recombinant human granulocyte colony stimulating factor (rhG-CSF) for the intracranial hemorrhage in two dogs: a case report	IRANIAN JOURNAL OF VETERINARY RESEARCH			English	Article						Granulocyte colony-stimulating factor; Intracranial hemorrhage; Magnetic resonance imaging; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; EDEMA FORMATION; INTRACEREBRAL HEMORRHAGE; BONE-MARROW; ISCHEMIA; MICE; PATHOPHYSIOLOGY; NEUROPROTECTION; MANAGEMENT	Two dogs with generalized seizures were evaluated. The dogs were diagnosed with traumatic intracranial hemorrhages based on the history, neurological examinations, and magnetic resonance imaging (MRI) of the brain. Treatment was started with oxygen, prednisolone and anticonvulsant agents. No further seizure activity was observed after treatment in both dogs, however cushing reflex was detected in case 1 and a left-sided hemi-paresis was detected in case 2. Further supportive treatment with recombinant human granulocyte colony-stimulating factor (rhG-CSF) was attempted. No abnormal signs were noted in either of the dogs and no recurrence was noted 16 and 14 months later, in case 1 and 2, respectively. These cases indicate that a combination of rhG-CSF treatment with previous therapy could be used in dogs with traumatic brain injury.	[Kang, M. H.; Park, H. M.] Konkuk Univ, Coll Vet Med, Dept Vet Internal Med, Seoul 143701, South Korea		Park, HM (corresponding author), Konkuk Univ, Coll Vet Med, Dept Vet Internal Med, Seoul 143701, South Korea.	parkhee@konkuk.ac.kr					BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; Bouzat P, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-23; Dale DC, 2003, AM J HEMATOL, V72, P82, DOI 10.1002/ajh.10255; Diederich K, 2009, J NEUROSCI, V29, P11572, DOI 10.1523/JNEUROSCI.0453-09.2009; England TJ, 2012, STROKE, V43, P405, DOI 10.1161/STROKEAHA.111.636449; FISHMAN RA, 1975, NEW ENGL J MED, V293, P706, DOI 10.1056/NEJM197510022931407; Gibson CL, 2005, J NEUROPATH EXP NEUR, V64, P763, DOI 10.1097/01.jnen.0000179196.10032.dd; Huisman TAGM, 2005, EUR RADIOL, V15, P434, DOI 10.1007/s00330-004-2615-7; Jadhav V, 2008, J NEUROTRAUM, V25, P1099, DOI 10.1089/neu.2008.0518; Khatibi NH, 2011, ACTA NEUROCHIR SUPPL, V111, P265, DOI 10.1007/978-3-7091-0693-8_44; Kitagawa M, 2005, J VET MED SCI, V67, P843, DOI 10.1292/jvms.67.843; Lu CZ, 2006, BIOCHEM SOC T, V34, P1327, DOI 10.1042/BST0341327; Manno EM, 2005, MAYO CLIN PROC, V80, P420, DOI 10.4065/80.3.420; Sande A, 2010, J VET EMERG CRIT CAR, V20, P177, DOI 10.1111/j.1476-4431.2010.00527.x; Sehara Y, 2007, BRAIN RES, V1151, P142, DOI 10.1016/j.brainres.2007.01.149; SHAPIRO HM, 1975, ANESTHESIOLOGY, V43, P445, DOI 10.1097/00000542-197510000-00010; Six I, 2003, EUR J PHARMACOL, V458, P327, DOI 10.1016/S0014-2999(02)02785-1; Sosin DM, 1996, BRAIN INJURY, V10, P47; Xi GH, 2002, NEUROSURG CLIN N AM, V13, P371, DOI 10.1016/S1042-3680(02)00007-4; Xi GH, 2001, STROKE, V32, P2932, DOI 10.1161/hs1201.099820	20	1	1	0	1	SHIRAZ UNIV	SHIRAZ	SCHOOL ENGINEERING, SHIRAZ, 71344, IRAN	1728-1997			IRAN J VET RES	Iran J. Veterinary Res.	WIN	2016	17	1					62	65					4	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	EE6QR	WOS:000389737800013	27656233				2022-02-06	
J	Lancioni, G; Singh, N; O'Reilly, M; Sigafoos, J; D'Amico, F; Sasanelli, G; Denitto, F; Lang, R				Lancioni, Giulio; Singh, Nirbhay; O'Reilly, Mark; Sigafoos, Jeff; D'Amico, Fiora; Sasanelli, Giovanni; Denitto, Floriana; Lang, Russell			Technology-aided leisure and communication: Opportunities for persons with advanced Parkinson's disease	DEVELOPMENTAL NEUROREHABILITATION			English	Article						Communication; leisure engagement; Parkinson's disease; technology-aided programs	RANDOMIZED CONTROLLED-TRIAL; POST-COMA PERSONS; LEVODOPA-INDUCED DYSKINESIA; INTENSIVE VOICE TREATMENT; TRAUMATIC BRAIN-INJURY; ASSISTIVE TECHNOLOGY; ALTERNATIVE COMMUNICATION; MULTIPLE DISABILITIES; OCCUPATIONAL-THERAPY; NONMOTOR SYMPTOMS	Objective: This study investigated whether simple technology-aided programs could be used to promote leisure and communication engagement in three persons with advanced Parkinson's disease. Method: The programs included music and video options, which were combined with (a) text messaging and telephone calls for the first participant, (b) verbal statements/requests, text messaging, and reading for the second participant, and (c) verbal statements/requests and prayers for the third participant. The participants could activate those options via hand movement or vocal emission and specific microswitches. Results: All three participants were successful in activating the options available. The mean cumulative frequencies of option activations were about five per 15-min session for the first two participants and about four per 10-min session for the third participant. Conclusion: The results were considered encouraging and relevant given the limited amount of evidence available on helping persons with advanced Parkinson's disease with leisure and communication.	[Lancioni, Giulio] Univ Bari, Dept Neurosci & Sense Organs, Via Quintino Sella 268, I-7012 Bari, Italy; [Singh, Nirbhay] Georgia Regents Univ, Med Coll Georgia, Augusta, GA USA; [O'Reilly, Mark] Univ Texas Austin, Dept Special Educ, Austin, TX 78712 USA; [Sigafoos, Jeff] Victoria Univ Wellington, Dept Educ Psychol, Wellington, New Zealand; [D'Amico, Fiora; Sasanelli, Giovanni] S Raffaele Med Care Ctr, Alberobello, Italy; [Denitto, Floriana] ISPE Med Care Ctr, Mola Di Bari, Italy; [Lang, Russell] Texas State Univ, Dept Curriculum Instruct, San Marcos, TX USA		Lancioni, G (corresponding author), Univ Bari, Dept Neurosci & Sense Organs, Via Quintino Sella 268, I-7012 Bari, Italy.	giulio.lancioni@uniba.it	Singh, Nouratan/N-9377-2017; D'Amico, Fiora/AAB-8309-2019	Singh, Nouratan/0000-0002-8063-8375; 			Al Dakheel A, 2014, EXPERT OPIN EMERG DR, V19, P415, DOI 10.1517/14728214.2014.955014; Archibald Neil, 2013, Handb Clin Neurol, V110, P435, DOI 10.1016/B978-0-444-52901-5.00037-X; Bachlin M, 2010, METHOD INFORM MED, V49, P88, DOI 10.3414/ME09-02-0003; Barker RA, 2014, J PARKINSON DIS, V4, P651, DOI 10.3233/JPD-140427; Barlow DH., 2009, SINGLE CASE EXPT DES, V3; Baxter S, 2012, INT J LANG COMM DIS, V47, P115, DOI 10.1111/j.1460-6984.2011.00090.x; Bega D, 2014, J PARKINSON DIS, V4, P639, DOI 10.3233/JPD-140382; Behn N, 2012, BRAIN INJURY, V26, P1702, DOI 10.3109/02699052.2012.722258; Borrione Paolo, 2014, World J Methodol, V4, P133, DOI 10.5662/wjm.v4.i3.133; Bunting-Perry L, 2013, J REHABIL RES DEV, V50, P223, DOI 10.1682/JRRD.2011.12.0255; Callahan K, 2008, J AUTISM DEV DISORD, V38, P678, DOI 10.1007/s10803-007-0434-9; Casey KS, 2011, NEUROREHABILITATION, V28, P281, DOI 10.3233/NRE-2011-0656; Dahlin E, 2011, ASSIST TECHNOL RES S, V29, P294, DOI 10.3233/978-1-60750-814-4-294; Dauwerse L, 2014, BRAIN INJURY, V28, P1342, DOI 10.3109/02699052.2014.916417; Dirnberger G, 2013, J NEUROPSYCHOL, V7, P193, DOI 10.1111/jnp.12028; Fasano A, 2014, CLIN NEUROPHARMACOL, V37, P91, DOI 10.1097/WNF.0000000000000034; Ferriero G, 2012, INT J REHABIL RES, V35, P75, DOI 10.1097/MRR.0b013e32834f8c96; Foley A, 2012, J RES SPEC EDUC NEED, V12, P192, DOI 10.1111/j.1471-3802.2011.01230.x; Foster ER, 2014, AM J OCCUP THER, V68, P39, DOI 10.5014/ajot.2014.008706; Fox SH, 2014, BRAIN, V137, P2628, DOI 10.1093/brain/awu212; Franhoff DJ, 2011, TOP STROKE REHABIL, V18, P112, DOI 10.1310/tsr1802-112; Fried-Oken M, 2012, ASSIST TECHNOL, V24, P56, DOI 10.1080/10400435.2011.648713; Gazewood JD, 2013, AM FAM PHYSICIAN, V87, P267; Gibson BE, 2012, DISABIL REHABIL, V34, P1894, DOI 10.3109/09638288.2012.670040; Giugni JC, 2014, CURR OPIN NEUROL, V27, P450, DOI 10.1097/WCO.0000000000000118; Halpern AE, 2012, AM J SPEECH-LANG PAT, V21, P354, DOI 10.1044/1058-0360(2012/11-0125); Hashem SYB, 2014, ASSIST TECHNOL, V26, P96, DOI 10.1080/10400435.2013.845271; Hoppestad BS, 2013, DISABIL REHABIL-ASSI, V8, P190, DOI 10.3109/17483107.2012.723239; Hung AY, 2014, NEUROTHERAPEUTICS, V11, P34, DOI 10.1007/s13311-013-0239-9; Jochems N, 2013, BEHAV INFORM TECHNOL, V32, P902, DOI 10.1080/0144929X.2012.692100; Jumisko E, 2009, J CLIN NURS, V18, P2273, DOI 10.1111/j.1365-2702.2008.02738.x; Kennedy CH., 2005, SINGLE CASE DESIGNS; Lamontagne ME, 2013, AUGMENT ALTERN COMM, V29, P182, DOI 10.3109/07434618.2013.784927; Lancioni GE, 2014, AUT CHILD PSYCHO, P1, DOI 10.1007/978-1-4899-8029-8; Lancioni GE, 2014, PERCEPT MOTOR SKILL, V118, P883, DOI 10.2466/15.PMS.118k24w2; Lancioni GE, 2014, NEUROREHABILITATION, V34, P749, DOI 10.3233/NRE-141075; Lancioni GE, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00048; Lancioni GE, 2013, DEV NEUROREHABIL, V16, P315, DOI 10.3109/17518423.2012.731086; Lancioni GE, 2013, RES DEV DISABIL, V34, P2959, DOI 10.1016/j.ridd.2013.06.006; Lancioni GE, 2013, RES DEV DISABIL, V34, P809, DOI 10.1016/j.ridd.2012.10.008; Lancioni GE, 2012, RES DEV DISABIL, V33, P1605, DOI 10.1016/j.ridd.2012.03.028; Lancioni GE, 2011, DISABIL REHABIL-ASSI, V6, P412, DOI 10.3109/17483107.2011.580899; Lancioni GE, 2006, J DEV PHYS DISABIL, V18, P383, DOI 10.1007/s10882-006-9024-6; Lauretani F, 2014, CURR DRUG TARGETS, V15, P943, DOI 10.2174/1389450115666140826104030; Lee W, 2012, MOVEMENT DISORD, V27, P1243, DOI 10.1002/mds.25113; Lenker JA, 2013, DISABIL REHABIL-ASSI, V8, P373, DOI 10.3109/17483107.2012.749429; Light J, 2014, AUGMENT ALTERN COMM, V30, P99, DOI 10.3109/07434618.2014.906498; Lui M, 2012, DISABIL REHABIL-ASSI, V7, P82, DOI 10.3109/17483107.2011.557467; Mahgoub N, 2012, INT J GERIATR PSYCH, V27, P436, DOI 10.1002/gps.2748; McGilton K, 2011, INT J OLDER PEOPLE N, V6, P13, DOI 10.1111/j.1748-3743.2010.00210.x; Morberg BM, 2014, NEUROREHABILITATION, V35, P291, DOI 10.3233/NRE-141119; Olanow CW, 2013, ANN NEUROL, V74, P337, DOI 10.1002/ana.24011; Ossig C, 2013, J NEURAL TRANSM, V120, P523, DOI 10.1007/s00702-013-1008-y; Ossig C, 2015, NEUROL CLIN, V33, P19, DOI 10.1016/j.ncl.2014.09.009; Parker N, 2013, NEUROREHABILITATION, V33, P323; Petrelli A, 2014, PARKINSONISM RELAT D, V20, P1196, DOI 10.1016/j.parkreldis.2014.08.023; Picelli A, 2013, PARKINSONISM RELAT D, V19, P605, DOI 10.1016/j.parkreldis.2013.02.010; Picelli A, 2012, NEUROREHAB NEURAL RE, V26, P353, DOI 10.1177/1545968311424417; Ramanan Vijay K, 2013, Am J Neurodegener Dis, V2, P145; Ransmayr G, 2011, J NEURAL TRANSM, V118, P773, DOI 10.1007/s00702-011-0622-9; Ripat J, 2011, DISABIL REHABIL-ASSI, V6, P87, DOI 10.3109/17483107.2010.507859; Rispoli M, 2014, AUT CHILD PSYCHO, P21, DOI 10.1007/978-1-4899-8029-8_2; Rispoli MJ, 2010, DEV NEUROREHABIL, V13, P141, DOI 10.3109/17518420903468464; Saleem TZ, 2013, PALLIATIVE MED, V27, P722, DOI 10.1177/0269216312465783; Sapir S, 2011, EXPERT REV NEUROTHER, V11, P815, DOI [10.1586/ERN.11.43, 10.1586/ern.11.43]; Schaeffer E, 2014, CNS DRUGS, V28, P1155, DOI 10.1007/s40263-014-0205-z; Scherer M. J., 2012, ASSISTIVE TECHNOLOGI; Scherer MJ, 2011, DISABIL REHABIL, V33, P811, DOI 10.3109/09638288.2010.511418; Soleimani Mohammad Ali, 2014, Br J Community Nurs, V19, P136; Spaccavento S, 2014, NEUROPSYCH DIS TREAT, V10, P27, DOI 10.2147/NDT.S52357; Sturkenboom IH, 2013, CLIN REHABIL, V27, P99, DOI 10.1177/0269215512448382; Ustinova K, 2011, DISABIL REHABIL-ASSI, V6, P77, DOI 10.3109/17483107.2010.507856; Vanhoutte S, 2012, CLIN LINGUIST PHONET, V26, P863, DOI 10.3109/02699206.2012.711420; Varanese S, 2010, PARKINSONS DIS-US, V2010, DOI 10.4061/2010/480260; Vijverman AC, 2014, EXPERT REV CLIN PHAR, V7, P761, DOI 10.1586/17512433.2014.966812; Wallace J, 2011, NEUROREHABILITATION, V28, P295, DOI 10.3233/NRE-2011-0657; Weerkamp NJ, 2014, J AM MED DIR ASSOC, V15, P90, DOI 10.1016/j.jamda.2013.10.007; Winkler SLH, 2010, MED CARE, V48, P558, DOI 10.1097/MLR.0b013e3181bd4a11; Ziropadja L, 2012, PARKINSONISM RELAT D, V18, P339, DOI 10.1016/j.parkreldis.2011.11.020	79	1	1	0	28	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1751-8423	1751-8431		DEV NEUROREHABIL	Dev. Neurorehabil.	DEC	2016	19	6					398	404		10.3109/17518423.2014.1002637			7	Clinical Neurology; Pediatrics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics; Rehabilitation	EA2OY	WOS:000386435000006	25826719				2022-02-06	
J	Moar, JJ; Hill, L; Stewart, M				Moar, Jacob Joseph; Hill, Lawrence; Stewart, Michael			Histopatholological Findings in a Fatal Case of Rinkhals Envenomation A New Forensic Pathology Finding?	AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY			English	Article						rinkhals; envenomation; histopathological findings; snake bite	TISSUE PLASMINOGEN-ACTIVATOR; TRAUMATIC BRAIN-INJURY; BITES	Although cobra envenomation continues to pose a threat to life and therefore constitutes a major cause of death in Africa, India, and Sri Lanka, the forensic pathology reports are not always histologically well documented or illustrated. The reports in the literature, although providing graphic evidence of the macroscopic appearances of the bite and its ensuing tissue necrosis, should the victim survive, often do not illustrate the histopathological findings to a sufficient degree. We present an unusual case of fatal envenomation by a rinkhals (Hemachatus haemachatus) in which the victim had been bitten a second time after a previous rinkhals' bite. Two issues therefore arose: (a) whether the histopathological findings in the spleen were an acute reaction to the snake bite or were due to immunostimulation as a consequence of the previously inflicted bite, and (b) the previously undocumented finding of extravasation of erythrocytes into the surrounding Virchow-Robin spaces in the brain, a finding usually associated with blunt head trauma and therefore interpreted as a cortical contusion hemorrhage by forensic pathologists.	[Moar, Jacob Joseph; Hill, Lawrence] Univ Witwatersrand, Div Forens Med & Pathol, Johannesburg, South Africa; [Stewart, Michael] Univ Witwatersrand, Dept Chem Pathol, Johannesburg, South Africa; [Stewart, Michael] Univ Witwatersrand, Toxicol Unit, Johannesburg, South Africa		Hill, L (corresponding author), Univ Witwatersrand, Johannesburg, Gauteng, South Africa.	Lawrence.Hill@wits.ac.za		Hill, Lawrence/0000-0001-7385-7054			BENNETT B, 1990, BLOOD, V75, P671; Blaylock R, 2004, TOXICON, V43, P159, DOI 10.1016/j.toxicon.2003.11.019; Chippaux JP, 1998, B WORLD HEALTH ORGAN, V76, P515; Dewar M, 1990, CARE CRIT ILL, V6, P19; FRANCIS RB, 1987, J LAB CLIN MED, V110, P541; Ikonomidou C, 1996, CRIT REV NEUROBIOL, V10, P239; Inglese M, 2005, AM J NEURORADIOL, V26, P719; Kapeller Peter, 2004, Top Magn Reson Imaging, V15, P343, DOI 10.1097/01.rmr.0000172668.02575.18; Meds D, 2002, VENOMOUS POISONOUS A; MIYAKAWA T, 1977, FOLIA PSYCHIAT NEU J, V31, P253; MOLE RH, 1948, J PATHOL BACTERIOL, V60, P413, DOI 10.1002/path.1700600308; Mueller CA, 2003, J NEUROIMMUNOL, V135, P1, DOI 10.1016/S0165-5728(02)00427-7; Nishi Katsuji, 2003, Leg Med (Tokyo), V5 Suppl 1, pS280, DOI 10.1016/S1344-6223(02)00150-5; Vij K, TXB FORENSIC MED TOX, P481; Vos CMP, 2005, NEUROBIOL DIS, V20, P953, DOI 10.1016/j.nbd.2005.06.012; WARRELL DA, 1976, Q J MED, V45, P1; Warrell DA, 1987, OXFORD TXB MED	17	1	1	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-7910	1533-404X		AM J FOREN MED PATH	Am. J. Forensic Med. Pathol.	DEC	2016	37	4					236	240		10.1097/PAF.0000000000000272			5	Medicine, Legal; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine; Pathology	ED8IR	WOS:000389115700005	27655145				2022-02-06	
J	Prange, T; Partlow, JL; Parks, J				Prange, T.; Partlow, J. L.; Parks, J.			Surgical repair of a mandibular degloving injury in a 5-month-old colt	EQUINE VETERINARY EDUCATION			English	Article						horse; mandible; degloving injury; avulsion; laceration	HEAD	A 5-month-old colt sustained a mandibular degloving injury and penetrating cheek wound after catching his cheek on a metal hook. Avulsion of the lower left lip and cheek exposed parts of the underlying labial surface, interalveolar margin and body of the mandible. The injury prevented the colt from closing his mouth completely and food accumulated between the degloved mandible and avulsed soft tissues. Surgical repair included 7 stented, transmandibular mattress sutures placed over the length of the interalveolar margin, closing the dead space and repositioning the avulsed soft tissues. The horse recovered without complications and functional as well as cosmetic outcome were excellent.	[Prange, T.; Partlow, J. L.] North Carolina State Univ, Coll Vet Med, Raleigh, NC 27695 USA; [Parks, J.] Iron Will Mobile Vet Serv, Burlington, NC USA; [Partlow, J. L.] Midatlantic Equine Med Ctr, 40 Frontage Rd, Ringoes, NJ 08551 USA		Prange, T (corresponding author), North Carolina State Univ, Coll Vet Med, Raleigh, NC 27695 USA.	tprange@ncsu.edu			NCSU Veterinary Teaching Hospital Clinical Teaching and Research Fund	Funding for the surgical treatment of the horse was provided by the NCSU Veterinary Teaching Hospital Clinical Teaching and Research Fund.	Barber S., 2008, EQUINE WOUND MANAGEM, P273; Barber SM, 2005, VET CLIN N AM-EQUINE, V21, P191, DOI 10.1016/j.cveq.2004.11.010; Dixon P. M., 2012, EQUINE SURG, P339; Dolente BA, 2008, J VET EMERG CRIT CAR, V18, P298, DOI 10.1111/j.1476-4431.2008.00305.x; Dunning D, 2003, TXB SMALL ANIMAL SUR, P553; Hague BA, 1998, VET CLIN N AM-EQUINE, V14, P333, DOI 10.1016/S0749-0739(17)30201-8; Hanson R. R., 2008, EQUINE WOUND MANAGEM, P427; HOWARD RD, 1993, VET CLIN N AM-EQUINE, V9, P185, DOI 10.1016/S0749-0739(17)30423-6; REITER A. M., 2011, CAT CLIN MED MANAGEM, P329; Schumacher J., 2008, EQUINE WOUND MANAGEM, P375; SPIRO RH, 1995, AM J SURG, V170, P457, DOI 10.1016/S0002-9610(99)80329-8; Tirosh-Levy S, 2013, CAN VET J, V54, P599	12	1	1	0	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0957-7734	2042-3292		EQUINE VET EDUC	Equine Vet. Educ.	DEC	2016	28	12					668	671		10.1111/eve.12442			4	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	EB8RD	WOS:000387657600005					2022-02-06	
J	Yafarova, GG; Andrianov, VV; Yagudin, RK; Shaikhutdinov, II; Gainutdinov, KL				Yafarova, Guzel G.; Andrianov, Vyatcheslav V.; Yagudin, Ramil Kh.; Shaikhutdinov, Ilgiz I.; Gainutdinov, Khalil L.			Nitric Oxide Production in the Rat Spinal Cord, Heart, and Liver After Spinal Cord Injury	BIONANOSCIENCE			English	Article						Nitric oxide; EPR spectroscopy; Spinal cord; Heart; Spinal cord injury; Rat	SYNTHASE; BRAIN	It has been shown that after 5 h of spinal cord injury, there is a decrease of nitric oxide (NO) production in the spinal cord. Seventy-two hours after the spinal cord injury, the level of NO production in the spinal cord and the heart increases by 2.5 times, and in the liver, it increases threefold. In the chronic period of a traumatic spinal cord disease in the spinal cord tissue, the level of NO production was significantly higher than at the control level.	[Yafarova, Guzel G.; Andrianov, Vyatcheslav V.; Gainutdinov, Khalil L.] Kazan Fed Univ, Inst Fundamental Med & Biol, Kazan, Russia; [Yafarova, Guzel G.; Yagudin, Ramil Kh.; Shaikhutdinov, Ilgiz I.] Republican Clin Hosp Tatarstan Republ, Kazan, Russia; [Yafarova, Guzel G.; Andrianov, Vyatcheslav V.; Gainutdinov, Khalil L.] Russian Acad Sci, Zavoisky Phys Tech Inst, Kazan, Russia; [Gainutdinov, Khalil L.] Kazan Fed Univ, Neurobiol Lab, Inst Fundamental Med & Biol, Kazan, Russia		Gainutdinov, KL (corresponding author), Kazan Fed Univ, Inst Fundamental Med & Biol, Kazan, Russia.; Gainutdinov, KL (corresponding author), Russian Acad Sci, Zavoisky Phys Tech Inst, Kazan, Russia.; Gainutdinov, KL (corresponding author), Kazan Fed Univ, Neurobiol Lab, Inst Fundamental Med & Biol, Kazan, Russia.	kh_gainutdinov@mail.ru	Gusel, Yafarova/Q-2838-2019; Andrianov, Viatcheslav V/E-4402-2014; Gainutdinov, Khalil Latypovich/E-4879-2014; Iafarova, Gusel/N-9269-2013	Gusel, Yafarova/0000-0003-3068-3407; Andrianov, Viatcheslav V/0000-0002-2471-5444; 			Boehning D, 2003, ANNU REV NEUROSCI, V26, P105, DOI 10.1146/annurev.neuro.26.041002.131047; Bredt DS, 2003, MOL PHARMACOL, V63, P1206, DOI 10.1124/mol.63.6.1206; Conti A, 2007, BRAIN RES REV, V54, P205, DOI 10.1016/j.brainresrev.2007.01.013; Gainutdinov KL, 2011, APPL MAGN RESON, V40, P267, DOI 10.1007/s00723-011-0207-7; Gainutdinov KhL., 2013, BIOPHYSICS, V58, P203, DOI [10.1134/s0006350913020073, DOI 10.1134/S0006350913020073, 10.1134/S0006350913020073]; Gotoh T, 2006, ARTERIOSCL THROM VAS, V26, P1439, DOI 10.1161/01.ATV.0000223900.67024.15; Hamada Y, 1996, FREE RADICAL BIO MED, V20, P1, DOI 10.1016/0891-5849(95)02017-9; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; Kwak EK, 2005, J KOREAN MED SCI, V20, P663, DOI 10.3346/jkms.2005.20.4.663; Marsala J, 2007, PROG BRAIN RES, V161, P171, DOI 10.1016/S0079-6123(06)61011-X; Mikoyan VD, 1997, BBA-GEN SUBJECTS, V1336, P225, DOI 10.1016/S0304-4165(97)00032-9; Sharma HS, 2005, ANN NY ACAD SCI, V1053, P422, DOI 10.1196/annals.1344.037; Sitdikova G F, 2006, Ross Fiziol Zh Im I M Sechenova, V92, P872; Vanin A.F., 1998, BIOKHIMIYA, V63, P924; Yafarova G. G., 2014, BIOFIZIKA, V59, P1017; Zamora R, 2000, MOL MED, V6, P347, DOI 10.1007/BF03401781	16	1	1	0	8	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	2191-1630	2191-1649		BIONANOSCIENCE	BioNanoScience	DEC	2016	6	4					332	334		10.1007/s12668-016-0229-6			3	Materials Science, Biomaterials	Emerging Sources Citation Index (ESCI)	Materials Science	EF8OF	WOS:000390587700014					2022-02-06	
J	Anke, A; Manskow, US; Friborg, O; Roe, C; Arntzen, C				Anke, Audny; Manskow, Unn Sollid; Friborg, Oddgeir; Roe, Cecilie; Arntzen, Cathrine			The family experiences of in-hospital care questionnaire in severe traumatic brain injury (FECQ-TBI): a validation study	BMC HEALTH SERVICES RESEARCH			English	Article						Parent satisfaction; Patient satisfaction; Family satisfaction; Quality of care; Traumatic brain injury; Rehabilitation	PATIENT SATISFACTION; PARENT EXPERIENCES; PEDIATRIC CARE; 1ST YEAR; QUALITY; NEEDS; UNIT; VALIDITY; LIFE; REHABILITATION	Background: Family members are important for support and care of their close relative after severe traumas, and their experiences are vital health care quality indicators. The objective was to describe the development of the Family Experiences of in-hospital Care Questionnaire for family members of patients with severe Traumatic Brain Injury (FECQ-TBI), and to evaluate its psychometric properties and validity. Methods: The design of the study is a Norwegian multicentre study inviting 171 family members. The questionnaire developmental process included a literature review, use of an existing instrument (the parent experience of paediatric care questionnaire), focus group with close family members, as well as expert group judgments. Items asking for family care experiences related to acute wards and rehabilitation were included. Several items of the paediatric care questionnaire were removed or the wording of the items was changed to comply with the present purpose. Questions covering experiences with the inpatient rehabilitation period, the discharge phase, the family experiences with hospital facilities, the transfer between departments and the economic needs of the family were added. The developed questionnaire was mailed to the participants. Exploratory factor analyses were used to examine scale structure, in addition to screening for data quality, and analyses of internal consistency and validity. Results: The questionnaire was returned by 122 (71%) of family members. Principal component analysis extracted six dimensions (eigenvalues > 1.0): acute organization and information (10 items), rehabilitation organization (13 items), rehabilitation information (6 items), discharge (4 items), hospital facilities-patients (4 items) and hospital facilities-family (2 items). Items related to the acute phase were comparable to items in the two dimensions of rehabilitation: organization and information. All six subscales had high Cronbach's alpha coefficients > 0.80. The construct validity was confirmed. Conclusion: The FECQ-TBI assesses important aspects of in-hospital care in the acute and rehabilitation phases, as seen from a family perspective. The psychometric properties and the construct validity of the questionnaire were good, hence supporting the use of the FECQ-TBI to assess quality of care in rehabilitation departments.	[Anke, Audny; Manskow, Unn Sollid; Arntzen, Cathrine] Univ Hosp North Norway, Dept Rehabil, Sykehusvn 1, N-9038 Tromso, Norway; [Anke, Audny] UiT Arctic Univ Norway, Dept Clin Med, Fac Hlth Sci, Tromso, Norway; [Manskow, Unn Sollid; Arntzen, Cathrine] UiT Arctic Univ Norway, Dept Hlth & Care Sci, Fac Hlth Sci, Tromso, Norway; [Friborg, Oddgeir] UiT Arctic Univ Norway, Dept Psychol, Fac Hlth Sci, Tromso, Norway; [Roe, Cecilie] Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway; [Roe, Cecilie] Univ Oslo, Fac Med, Res Ctr Habilitat & Rehabil Models & Serv CHARM, Inst Hlth & Soc, Oslo, Norway		Anke, A (corresponding author), Univ Hosp North Norway, Dept Rehabil, Sykehusvn 1, N-9038 Tromso, Norway.; Anke, A (corresponding author), UiT Arctic Univ Norway, Dept Clin Med, Fac Hlth Sci, Tromso, Norway.	audny.anke@uit.no		Anke, Audny/0000-0002-2491-2560; Friborg, Oddgeir/0000-0001-6629-0782; Arntzen, Cathrine/0000-0002-8194-0437	North Norwegian Health Authorities [8744/SFP1108-13]	This study was conducted with grants from the North Norwegian Health Authorities, grant number 8744/SFP1108-13.	Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Anke A, 2015, J HEAD TRAUMA REHAB, V30, pE38, DOI 10.1097/HTR.0000000000000080; Arango-Lasprilla JC, 2008, BRAIN INJURY, V22, P565, DOI 10.1080/02699050802172004; Arntzen C, 2015, DISABIL REHABIL, V37, P1626, DOI 10.3109/09638288.2014.972590; Becker F, 2014, NEUROREHABILITATION, V34, P87, DOI 10.3233/NRE-131015; Bjertnaes OA, 2012, BMJ QUAL SAF, V21, P39, DOI 10.1136/bmjqs-2011-000137; Carlsen B, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-26; Cleary P D, 1992, QRB Qual Rev Bull, V18, P53; Crow R, 2002, Health Technol Assess, V6, P1; Dodek PM, 2012, CRIT CARE MED, V40, P1506, DOI 10.1097/CCM.0b013e318241e368; Dodek PM, 2004, CRIT CARE MED, V32, P1922, DOI 10.1097/01.CCM.0000139920.53790.61; Doyle C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001570; Epstein D, 2015, J CRIT CARE, V30, P236, DOI 10.1016/j.jcrc.2014.11.009; Garratt AM, 2007, ACTA PAEDIATR, V96, P246, DOI 10.1111/j.1651-2227.2007.00049.x; Garratt Andrew M, 2011, Child Adolesc Psychiatry Ment Health, V5, P18, DOI 10.1186/1753-2000-5-18; Heyland DK, 2001, J CRIT CARE, V16, P142, DOI 10.1053/jcrc.2001.30163; Iversen HH, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001437; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Kreuger FAF, 2000, EUR J EPIDEMIOL, V16, P641, DOI 10.1023/A:1007695001384; Malterud K, 2012, SCAND J PUBLIC HEALT, V40, P795, DOI 10.1177/1403494812465030; Manskow US, 2015, J HEAD TRAUMA REHAB, V30, P411, DOI 10.1097/HTR.0000000000000085; MitchellDiCenso A, 1996, J CLIN EPIDEMIOL, V49, P313, DOI 10.1016/0895-4356(95)00531-5; Mokkink LB, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-22; Norup A, 2015, BRAIN INJURY, V29, P822, DOI 10.3109/02699052.2015.1016451; Norup A, 2015, NEUROREHABILITATION, V36, P203, DOI 10.3233/NRE-151208; Oltedal S, 2007, SCAND J PUBLIC HEALT, V35, P540, DOI 10.1080/14034940701291724; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; Pettersen KI, 2004, INT J QUAL HEALTH C, V16, P453, DOI 10.1093/intqhc/mzh074; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Schreiber J, 2011, PHYS OCCUP THER PEDI, V31, P225, DOI 10.3109/01942638.2011.565865; Schwarzkopf D, 2013, INTENS CARE MED, V39, P1071, DOI 10.1007/s00134-013-2862-7; Serio CD, 1997, BRAIN INJURY, V11, P1, DOI 10.1080/026990597123764; Solheim E, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-512; Stelfox HT, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-31; Wall RJ, 2007, CRIT CARE MED, V35, P271, DOI 10.1097/01.CCM.0000251122.15053.50; Wang MC, 2015, J AMBUL CARE MANAG, V38, P69, DOI 10.1097/JAC.0000000000000021; Watson J, 2014, ADV NEONAT CARE, V14, P129, DOI 10.1097/ANC.0000000000000046; WILLIAMS B, 1994, SOC SCI MED, V38, P509, DOI 10.1016/0277-9536(94)90247-X; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	39	1	1	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1472-6963		BMC HEALTH SERV RES	BMC Health Serv. Res.	NOV 28	2016	16								675	10.1186/s12913-016-1884-6			11	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	EH6MB	WOS:000391886100001	27894286	Green Published, gold			2022-02-06	
J	Lieutaud, T; Gadegbeku, B; Ndiaye, A; Chiron, M; Viallon, V				Lieutaud, Thomas; Gadegbeku, Blandine; Ndiaye, Amina; Chiron, Mireille; Viallon, Vivian			The Decrease in Traumatic Brain Injury Epidemics Deriving from Road Traffic Collision Following Strengthened Legislative Measures in France	PLOS ONE			English	Article							GLASGOW COMA SCALE; PROGNOSTIC VALUE; HEAD-INJURY; MORTALITY; CASUALTIES; SEVERITY; MODERATE; CRASHES; OUTCOMES; ENGLAND	Background Since 2002, France has been strengthening legislation on road traffic. This study is intended to evaluate the changes in Traumatic Brain Injury (TBI) incidence and mortality resulting from Road Traffic Collision (RTC) in the two 6-year periods before and after 2002. Methods We used a Registry of all RTC casualties in the Rho A ne Department of France. Each casualty was coded according to the Abbreviated Injury Scale (AIS). The study describes changes in demographic variables, TBI (AIS >= 2) incidence and mortality, other body lesions (AIS >= 3) associated with TBI, road user types, seatbelt and helmet wearing. Findings RTC casualty occurrences decreased by 21% (from 64,312 to 50,746) during the period after 2002. TBI occurrence accounted for 8.6% and 6.7% of all RTC in both periods. This corresponds to a reduction of TBI casualty incidence (-42%), which was much more pronounced than RTC casualty incidence (-25%) (p < 0.0001). Severe and critical TBI (AIS-4 and -5) incidences were reduced by half as much (-21%), compared to TBI incidence. TBI mortality rate (among population) and lethality (among TBI related to RTC casualties) decreased 56% and 23%, respectively. This reduction particularly affected car occupants and victims who deceased. TBI incidence decreased 43% in all 10-year age classes until 60 on average, this decrease declining with age in the period after 2002. After adjustment for age, sex, road user types, and severity of lesions at the head and other body regions, logistic regression analysis displayed a protective effect of the period following 2002, on the risk of death after RTC-related TBI. Interpretation The greater reductions in the incidence, severity and mortality of TBI when compared with the reduction of casualty incidence have mainly affected car users. These results should be attributable to the improvements in standards of care, primary safety of the car fleet and general road architecture safety. However, the increased reduction in the TBI epidemics in France, when compared to those observed in other developed countries for the same periods, suggests that the effects should be strongly attributable to changes in road user behaviour induced by law enforcement. The at-risk groups for TBI after RTC are now two-wheel users ( motorized or not) and individuals over 60 years of age.	[Lieutaud, Thomas; Gadegbeku, Blandine; Ndiaye, Amina; Chiron, Mireille; Viallon, Vivian] IFSTTAR, UMRESTTE, UMR T 9405, Bron, France; [Lieutaud, Thomas; Gadegbeku, Blandine; Ndiaye, Amina; Chiron, Mireille; Viallon, Vivian] Univ Lyon, Lyon, France; [Lieutaud, Thomas] Univ Lyon, Univ Claude Bernard Lyon 1, Team TIGER, INSERM,U10128,CNRS,UMR5292,Lyon Neurosci Res Ctr, Lyon, France		Lieutaud, T (corresponding author), IFSTTAR, UMRESTTE, UMR T 9405, Bron, France.; Lieutaud, T (corresponding author), Univ Lyon, Lyon, France.; Lieutaud, T (corresponding author), Univ Lyon, Univ Claude Bernard Lyon 1, Team TIGER, INSERM,U10128,CNRS,UMR5292,Lyon Neurosci Res Ctr, Lyon, France.	thomas.lieutaud@gmail.com	Gadegbeku, Blandine/AAE-3618-2019	Gadegbeku, Blandine/0000-0001-6720-206X	Institut National de Veille sanitaire Ministere de l'equipement	This work was funded by Institut National de Veille sanitaire Ministere de l'equipement.	Amoros E, 2008, EUR J PUBLIC HEALTH, V18, P360, DOI 10.1093/eurpub/ckn018; Amoros E, 2006, ACCIDENT ANAL PREV, V38, P627, DOI 10.1016/j.aap.2005.11.006; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL 1990 R; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Blomberg RD, 2009, J SAFETY RES, V40, P285, DOI 10.1016/j.jsr.2009.07.002; Braver ER, 2003, ACCIDENT ANAL PREV, V35, P295, DOI 10.1016/S0001-4575(01)00106-3; Brown JB, 2010, J TRAUMA, V69, P263, DOI 10.1097/TA.0b013e3181e5d72e; Butcher I, 2007, J NEUROTRAUM, V24, P281, DOI 10.1089/neu.2006.0030; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Clark DE, 2003, ACCIDENT ANAL PREV, V35, P965, DOI 10.1016/S0001-4575(02)00104-5; Coronado VG, 2011, MMWR SURVEILL SUMM, V60, P1; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Edwards P, 2005, LANCET, V365, P1957; Eksler V, 2008, PUBLIC HEALTH, V122, P826, DOI 10.1016/j.puhe.2007.10.003; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Fuller G, 2011, BRIT J NEUROSURG, V25, P414, DOI 10.3109/02688697.2011.570882; Gabbe BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020545; Hetland A, 2014, ANN PHARMACOTHER, V48, P494, DOI 10.1177/1060028014520882; Heyes Gavin J, 2014, Ulster Med J, V83, P55; Jensen P, 2010, TRANSPORT RES D-TR E, V15, P522, DOI 10.1016/j.trd.2010.07.002; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Laumon B, 2005, BRIT MED J, V331, P1371, DOI 10.1136/bmj.38648.617986.1F; Laumon B, 1997, 41 ANN P ASS ADV AUT, P127; Lecky F, 2000, LANCET, V355, P1771, DOI 10.1016/S0140-6736(00)02264-9; Licaj I, 2011, ACCIDENT ANAL PREV, V43, P1617, DOI 10.1016/j.aap.2011.02.003; Lieutaud T, 2012, J NEUROTRAUM, V29, P479, DOI 10.1089/neu.2011.1880; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Machamer J, 2013, J NEUROTRAUM, V30, P1845, DOI 10.1089/neu.2013.2920; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Nash S., 2014, Annals of Physical and Rehabilitation Medicine, V57, P600, DOI 10.1016/j.rehab.2014.08.010; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Pilkington P, 2005, BMJ-BRIT MED J, V330, P331, DOI 10.1136/bmj.38324.646574.AE; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Timmons SD, 2011, J TRAUMA, V71, P1172, DOI 10.1097/TA.0b013e31822b0f4b; van Leeuwen N, 2012, NEUROSURGERY, V70, P811, DOI 10.1227/NEU.0b013e318235d640; Viallon V, 2013, ACCIDENT ANAL PREV, V52, P250, DOI 10.1016/j.aap.2012.12.024; Yeguiayan JM, 2012, CRIT CARE, V16, DOI 10.1186/cc11375	41	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2016	11	11							e0167082	10.1371/journal.pone.0167082			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE3FE	WOS:000389472400080	27893865	Green Published, Green Submitted, gold			2022-02-06	
J	Wang, DM; Wang, SN; Huang, XX; Wang, Q				Wang, Dongmei; Wang, Shengnan; Huang, Xiaoxian; Wang, Qun			Heterotopic ossification following anti-NMDA receptor encephalitis: a case report	BMC NEUROLOGY			English	Article						Heterotopic ossification (HO); Anti-NMDA receptor encephalitis	TRAUMATIC BRAIN-INJURY	Background: Heterotopic ossification (HO) is defined as the formation of true bone tissue in non-osseous tissues. HO may occur under several conditions such as soft tissue injury, central nervous system injury and many other diseases like arthopathies, and vasculopathies. The underlying mechanisms of HO are not well elucidated. Anti-NMDA receptor encephalitis is a newly recognized autoimmune mediated disease which is predominant in young female patients with ovarian teratomas. Encephalitis complicated with HO has rarely been reported. Case presentation: Here we report a case of anti-NMDA receptor encephalitis with severe muscle ossifications. A 15 years old female patient presented with fever, changed mental status of confusion, rigidity of the arms and legs, and oral-facial dyskinesias. Diagnosis of anti-NMDA receptor encephalitis was confirmed by detection of anti-NMDA receptor antibodies both in serum and CSF. Due to the severity of the disease, 3-weeks' intensive care and mechanical ventilation were administrated for the patient. Image of pelvic CT and MRI of the patient showed dynamic changing process of HO. The muscles showed edema and scattered inflammation at the very beginning, and then gradually formed mature bone tissue. Conclusions: Anti-NMDA receptor encephalitis often presents with severe neurologic symptoms and requires long time intensive care and mechanical ventilation, which makes the patient easily complicate with HO. More studies are required to elucidate the mechanisms of HO and more attention should be paid to patients with encephalitis who might develop severe muscle ossifications requiring early interventions.	[Wang, Dongmei; Wang, Shengnan; Huang, Xiaoxian; Wang, Qun] Southern Med Univ, Nanfang Hosp, Dept Neurol, 1838 Northern Guangzhou Ave, Guangzhou 510515, Guangdong, Peoples R China		Wang, Q (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Neurol, 1838 Northern Guangzhou Ave, Guangzhou 510515, Guangdong, Peoples R China.	291296092@qq.com					AN HS, 1987, CLIN ORTHOP RELAT R, P291; Cadosch D, 2010, J BONE JOINT SURG AM, V92A, P645, DOI 10.2106/JBJS.I.00097; Kluger G, 2000, J CHILD NEUROL, V15, P406, DOI 10.1177/088307380001500610; Mavrogenis AF, 2011, ORTHOPEDICS, V34, DOI 10.3928/01477447-20110124-08; Pape HC, 2001, J ORTHOP TRAUMA, V15, P229, DOI 10.1097/00005131-200105000-00001; Saito N, 2004, KNEE, V11, P63, DOI 10.1016/S0968-0160(03)00036-X; Sakellariou VI, 2012, J MUSCULOSKEL NEURON, V12, P230; Sansing LH, 2007, NAT CLIN PRACT NEURO, V3, P291, DOI 10.1038/ncpneuro0493; Stanischewski D, 2013, NERVENARZT, V84, P856, DOI 10.1007/s00115-012-3661-z; Wandinger KP, 2011, J NEUROIMMUNOL, V231, P86, DOI 10.1016/j.jneuroim.2010.09.012; Zhang XH, 2014, BMC SURG, V14, DOI 10.1186/1471-2482-14-74	11	1	1	0	2	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2377			BMC NEUROL	BMC Neurol.	NOV 21	2016	16								232	10.1186/s12883-016-0747-4			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EC4UU	WOS:000388130400001	27871317	Green Published, gold			2022-02-06	
J	Davis, JJ				Davis, Jeremy J.			Reconsidering the Word Memory Test as a Memory Measure in Traumatic Brain Injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Memory; Word memory test; California verbal learning test	NEUROPSYCHOLOGICAL TEST-PERFORMANCE; TEST FAILURE; ADULTS; SYMPTOMS; VETERANS; DISORDER; RATES	Objective: This study examined relationships among traumatic brain injury (TBI) severity, the Word Memory Test (WMT), and California Verbal Learning Test-Second Edition (CVLT-II). Method: Participants (N = 104) passed WMT validity indices and were categorized by TBI severity on the basis of medical records. Outcome measures included norm-referenced scores on the CVLT-II and WMT. Results: Participants grouped by TBI severity significantly differed on the CVLT-II but not WMT. Post-traumatic amnesia (PTA) significantly correlated with the CVLT-II but not WMT. In a non-medicolegal sample subset (N = 61), TBI severity groups significantly differed on CVLT-II and WMT FR; PTA significantly correlated with the CVLT-II and WMT FR. CVLT-II impairment groups differed on all WMT variables. Participants grouped by neuroimaging findings differed on CVLT-II but not WMT. WMT FR predicted two-level TBI severity using logistic regression but did not contribute in a model including the CVLT-II. Conclusion: Overall, WMT memory subtests appeared less sensitive to TBI severity than the CVLT-II.	[Davis, Jeremy J.] Univ Utah, Sch Med, Div Phys Med & Rehabil, 30 North 1900 East,1R55, Salt Lake City, UT 84132 USA		Davis, JJ (corresponding author), Univ Utah, Sch Med, Div Phys Med & Rehabil, 30 North 1900 East,1R55, Salt Lake City, UT 84132 USA.	jeremy.davis@hsc.utah.edu					Armistead-Jehle P, 2015, APPL NEUROPSYCH-ADUL, V22, P415, DOI 10.1080/23279095.2014.953678; Cohen J., 2013, STAT POWER ANAL BEHA; Cooper HM., 1989, INTEGRATING RES GUID; Davis JJ, 2014, ARCH CLIN NEUROPSYCH, V29, P747, DOI 10.1093/arclin/acu030; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P199, DOI 10.1080/13854046.2014.884633; DeJong J, 2010, J CLIN EXP NEUROPSYC, V32, P953, DOI 10.1080/13803391003645640; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC, 1987, CALIFORNIA VERBAL LE; Demakis GJ, 2008, CLIN NEUROPSYCHOL, V22, P879, DOI 10.1080/13854040701564482; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Donders J, 2007, BRAIN INJURY, V21, P319, DOI 10.1080/02699050701253129; Donders J, 2013, J CLIN EXP NEUROPSYC, V35, P827, DOI 10.1080/13803395.2013.824557; Flaro L, 2007, BRAIN INJURY, V21, P373, DOI 10.1080/02699050701311133; GERVAIS RO, 2001, J FORENSIC NEUROPSYC, V2, DOI DOI 10.1300/J151V02N02_01; Gfeller JD, 2013, BEHAV SCI LAW, V31, P833, DOI 10.1002/bsl.2084; Green P, 2009, BRAIN INJURY, V23, P741, DOI 10.1080/02699050903133962; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P, 1999, BRAIN INJURY, V13, P813, DOI 10.1080/026990599121205; Green P., 2003, GREENS WORD MEMORY T; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Iverson G., 1999, J COGNITIVE REHABILI, V17, P4; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Lemeshow S, 2000, APPL LOGISTIC REGRES; Marshall P, 2010, CLIN NEUROPSYCHOL, V24, P1204, DOI 10.1080/13854046.2010.514290; Martins M, 2010, APPL NEUROPSYCHOL, V17, P177, DOI 10.1080/09084281003715709; Merten T, 2009, PSYCHOL INJ LAW, V2, P284, DOI 10.1007/s12207-009-9057-0; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Morel KR, 2008, CLIN NEUROPSYCHOL, V22, P350, DOI 10.1080/13854040701300531; Nelson NW, 2010, ARCH CLIN NEUROPSYCH, V25, P713, DOI 10.1093/arclin/acq075; Orman JA, 2011, TXB TRAUMATIC BRAIN, V2nd, P3; Rienstra A, 2009, ARCH CLIN NEUROPSYCH, V24, P255, DOI 10.1093/arclin/acp035; Rohling ML, 2003, CLIN NEUROPSYCHOL, V17, P289, DOI 10.1076/clin.17.3.289.18086; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Sherer M, 2015, CLIN NEUROPSYCHOL, V29, P522, DOI 10.1080/13854046.2015.1052763; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Suhr J, 2008, ARCH CLIN NEUROPSYCH, V23, P521, DOI 10.1016/j.acn.2008.05.003; Sullivan BK, 2007, APPL NEUROPSYCHOL, V14, P189, DOI 10.1080/09084280701509083	38	1	1	0	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	NOV	2016	31	7					802	810		10.1093/arclin/acw058			9	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	EC2PH	WOS:000387965300011	27538439	Bronze			2022-02-06	
J	Joubert, C; Esnault, P; Veyrieres, JB; Dagain, A				Joubert, C.; Esnault, P.; Veyrieres, J. -B.; Dagain, A.			Posttraumatic retroclival subarachnoid hemorrhage: what to do in an emergency?	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							TRAUMATIC INTRACRANIAL ANEURYSMS; VERTEBRAL ARTERY INJURY; FRACTURE	Posttraumatic subarachnoid hemorrhage from the posterior fossa remains a threatening entity occurring after a high kinetic trauma brain injury involving the occipitocervical junction. Retroclival subarachnoid hemorrhage is a rare posttraumatic feature that may involve vertebrobasilar complex injury, especially when there is no occipitocervical fracture or dislocation associated. In this report, we present radiologic and clinical features of a rare case of early acute subarachnoid hemorrhage without skull base fracture or craniocervical or atlantoaxial dislocation due to posttraumatic aneurysm.	[Joubert, C.; Dagain, A.] Mil Hosp St Anne, Dept Neurosurg, F-83000 Toulon, France; [Esnault, P.] Mil Hosp St Anne, Dept Intens Care, F-83000 Toulon, France; [Veyrieres, J. -B.] Mil Hosp St Anne, Dept Intervent Neuroradiol, F-83000 Toulon, France		Joubert, C (corresponding author), Mil Teaching Hosp St Anne HIA St Anne, F-83000 Toulon, France.	christophe.joubert@neurochirurgie.fr	Esnault, Pierre/AAN-5792-2020; Joubert, Christophe/AAU-4807-2020	dagain, arnaud/0000-0001-8416-1976			BENOIT BG, 1973, J NEUROL NEUROSUR PS, V36, P127, DOI 10.1136/jnnp.36.1.127; CONTOSTAVLOS DL, 1995, FORENSIC SCI INT, V73, P61, DOI 10.1016/0379-0738(95)01700-3; CROOKS DA, 1991, VIRCHOWS ARCH A, V418, P479, DOI 10.1007/BF01606496; Dubey A, 2008, J CLIN NEUROSCI, V15, P609, DOI 10.1016/j.jocn.2007.11.006; El-Fiki M, 2015, WORLD NEUROSURG, V83, P170, DOI 10.1016/j.wneu.2014.11.012; Fulkerson DH, 2010, CHILD NERV SYST, V26, P613, DOI 10.1007/s00381-010-1104-3; Gray JT, 1999, FORENSIC SCI INT, V105, P13, DOI 10.1016/S0379-0738(99)00113-9; Hemphill JC, 1999, CRIT CARE CLIN, V15, P811, DOI 10.1016/S0749-0704(05)70089-0; HOLMES B, 1993, J TRAUMA, V35, P855, DOI 10.1097/00005373-199312000-00009; Kaiser C, 2008, FORENSIC SCI INT, V182, pE15, DOI 10.1016/j.forsciint.2008.10.001; Kim BC, 2014, J KOREAN NEUROSURG S, V56, P428, DOI 10.3340/jkns.2014.56.5.428; Larson P S, 2000, Neurosurg Focus, V8, pe4; Lath R, 2002, J CLIN NEUROSCI, V9, P466, DOI 10.1054/jocn.2001.1050; LEADBEATTER S, 1994, FORENSIC SCI INT, V67, P33, DOI 10.1016/0379-0738(94)90409-X; Lee CK, 2009, AM J FOREN MED PATH, V30, P134, DOI 10.1097/PAF.0b013e318187acb1; MEGURO K, 1985, NEUROSURGERY, V16, P666, DOI 10.1227/00006123-198505000-00015; Miley Jefferson T, 2008, J Vasc Interv Neurol, V1, P79; Nakstad PH, 2008, INTERV NEURORADIOL, V14, P33, DOI 10.1177/159101990801400104; Nishioka T, 2002, ACTA NEUROCHIR, V144, P839, DOI 10.1007/s00701-002-0952-3; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; Servadei F, 2014, WORLD NEUROSURG, V82, pE597, DOI 10.1016/j.wneu.2014.08.034; Uzan M, 1998, NEUROSURGERY, V43, P1314, DOI 10.1097/00006123-199812000-00024; VENTUREYRA ECG, 1994, CHILD NERV SYST, V10, P361, DOI 10.1007/BF00335125; Wong B, 2015, J FORENSIC LEG MED, V29, P18, DOI 10.1016/j.jflm.2014.09.012; YOUNG HA, 1982, J TRAUMA, V22, P914, DOI 10.1097/00005373-198211000-00006	25	1	1	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	NOV	2016	34	11							2257.e3	10.1016/j.ajem.2016.05.048			3	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	EE3SD	WOS:000389517200067	27260554				2022-02-06	
J	Osier, ND; Pham, L; Savarese, A; Sayles, K; Alexander, SA				Osier, Nicole D.; Lan Pham; Savarese, Amanda; Sayles, Kendra; Alexander, Sheila A.			Animal models in genomic research: Techniques, applications, and roles for nurses	APPLIED NURSING RESEARCH			English	Article						Genetics; Genomics; Transgenic; Nursing science; Animal models; Pre-clinical	GIANT AXONAL NEUROPATHY; MEDIATED REPERFUSION INJURY; TRAUMATIC BRAIN-INJURY; MOUSE MODEL; MUSCULAR-DYSTROPHY; CLINICAL-RESEARCH; NURSING PRACTICE; DEVELOPING RATS; FOS EXPRESSION; HUMAN-DISEASE	Animal research has been conducted by scientists for over two millennia resulting in a better understanding of human anatomy, physiology, and pathology, as well as testing of novel therapies. In the molecular genomic era, pre-clinical models represent a key tool for understanding the genomic underpinnings of health and disease and are relevant to precision medicine initiatives. Nurses contribute to improved health by collecting and translating evidence from clinically relevant pre-clinical models. Using animal models, nurses can ask questions that would not be feasible or ethical to address in humans, and establish the safety and efficacy of interventions before translating them to clinical trials. Two advantages of using pre-clinical models are reduced variability between test subjects and the opportunity for precisely controlled experimental exposures. Standardized care controls the effects of diet and environment, while the availability of inbred strains significantly reduces the confounding effects of genetic differences. Outside the laboratory, nurses can contribute to the approval and oversight of animal studies, as well as translation to clinical trials and, ultimately, patient care. This review is intended as a primer on the use of animal models to advance nursing science; specifically, the paper discusses the utility of preclinical models for studying the pathophysiologic and genomic contributors to health and disease, testing interventions, and evaluating effects of environmental exposures. Considerations specifically geared to nurse researchers are also introduced, including discussion of how to choose an appropriate model and controls, potential confounders, as well as legal and ethical concerns. Finally, roles for nurse clinicians in pre-clinical research are also highlighted. (C) 2016 Elsevier Inc. All rights reserved.	[Osier, Nicole D.; Lan Pham; Savarese, Amanda; Sayles, Kendra; Alexander, Sheila A.] Univ Pittsburgh, Sch Nursing, Pittsburgh, PA 15213 USA; [Osier, Nicole D.] Safar Ctr Resuscitat Res, Pittsburgh, PA 15213 USA; [Sayles, Kendra] McGowan Inst Regenerat Med, Pittsburgh, PA 15260 USA; [Alexander, Sheila A.] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15213 USA		Alexander, SA (corresponding author), Univ Pittsburgh, Sch Nursing, Pittsburgh, PA 15213 USA.	salexand@pitt.edu	Osier, Nicole/Q-7913-2017	Osier, Nicole/0000-0002-2903-6774	NIH-NINRUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [1F31NR014957-01, T32NR009759]; Pittsburgh Foundation; Sigma Theta Tau International Eta Chapter; International Society for Nurses in Genetics; American Association of Neuroscience Nursing/Neuroscience Nursing Foundation; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [T32NR009759, F31NR014957] Funding Source: NIH RePORTER	This work was supported by NIH-NINR (1F31NR014957-01 and T32NR009759), as well as grants from the following foundations and professional societies: The Pittsburgh Foundation, Sigma Theta Tau International Eta Chapter, and the International Society for Nurses in Genetics, and the American Association of Neuroscience Nursing/Neuroscience Nursing Foundation. In addition to these granting agencies, the authors would like to thank Marilyn K. Farmer for her continued editorial support.	Anderson G, 2015, WORLDV EVID-BASED NU, V12, P165, DOI 10.1111/wvn.12096; Bennetts P, 2014, EXP PHYSIOL, V99, P1007, DOI 10.1113/expphysiol.2014.078600; Bhattacharya D, 2015, DEV BIOL, V408, P196, DOI 10.1016/j.ydbio.2015.11.003; Blaumanis O R, 1990, Adv Neurol, V52, P385; Blix A, 2014, CLIN J ONCOL NURS, V18, P437, DOI 10.1188/14.CJON.437-441; Bomont P, 2000, NAT GENET, V26, P370, DOI 10.1038/81701; Bond EF, 1998, RES NURS HEALTH, V21, P221, DOI 10.1002/(SICI)1098-240X(199806)21:3<221::AID-NUR5>3.0.CO;2-J; Briones T L, 2000, Biol Res Nurs, V1, P299, DOI 10.1177/109980040000100406; Callaway E, 2016, NATURE, V532, P289, DOI 10.1038/532289a; Citton V, 2009, PEDIATR NEUROL, V41, P146, DOI 10.1016/j.pediatrneurol.2009.02.021; Dorr RT, 2001, ANTI-CANCER DRUG, V12, P213, DOI 10.1097/00001813-200103000-00007; Dorsey SG, 2006, NEURON, V51, P21, DOI 10.1016/j.neuron.2006.06.009; Dorsey SG, 2009, BIOL RES NURS, V11, P7, DOI 10.1177/1099800409332726; Foundation for Biomedical Research, 2006, THANKS AN RES THEYLL; Frazier S K, 2001, Biol Res Nurs, V2, P167, DOI 10.1177/109980040100200302; Funk JL, 2013, MICROCIRCULATION, V20, P544, DOI 10.1111/micc.12054; Funk JL, 2003, AM J PHYSIOL-REG I, V284, pR1021, DOI 10.1152/ajpregu.00436.2002; Goodyear-Bruch CA, 2008, BIOL RES NURS, V9, P293, DOI 10.1177/1099800408314573; Hampton T, 2016, JAMA-J AM MED ASSOC, V315, P546, DOI 10.1001/jama.2015.19150; Holden J E, 2000, Biol Res Nurs, V1, P165, DOI 10.1177/109980040000100302; Holden JE, 2001, BRAIN RES, V911, P27, DOI 10.1016/S0006-8993(01)02567-7; Holtzclaw Barbara J, 2002, Crit Care Nurs Q, V24, P30; KASPER CE, 1993, RES NURS HEALTH, V16, P265, DOI 10.1002/nur.4770160405; Kasper CE, 2013, ANNU REV NURS RES-SE, V31, P1, DOI 10.1891/0739-6686.31.1; Kuhlenbaumer G, 2002, NEUROLOGY, V58, P1273, DOI 10.1212/WNL.58.8.1273; Lan S-Y, 2016, PEDIAT NEONATOLOGY; Landis CA, 1997, RES NURS HEALTH, V20, P259, DOI 10.1002/(SICI)1098-240X(199706)20:3<259::AID-NUR8>3.3.CO;2-7; Leach V, 2016, INT J NURS PRACT, V22, P307, DOI 10.1111/ijn.12431; Ledford H, 2016, NATURE, V531, P156, DOI 10.1038/531156a; LePage David F., 2006, V129, P41; LI HS, 1994, ORL J OTO-RHINO-LARY, V56, P61, DOI 10.1159/000276611; Lira FS, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-74; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Low BE, 2016, METHODS MOL BIOL, V1438, P115, DOI 10.1007/978-1-4939-3661-8_7; Mashimo T, 2009, CURR PHARM BIOTECHNO, V10, P214, DOI 10.2174/138920109787315105; Matthews KA, 2005, NAT REV GENET, V6, P179, DOI 10.1038/nrg1554; McCarthy DO, 2000, RES NURS HEALTH, V23, P222, DOI 10.1002/1098-240X(200006)23:3<222::AID-NUR6>3.3.CO;2-V; McClearn GE, 1961, J COMP PHYSL PSYCHOL; Melo JA, 1996, NAT GENET, V13, P147, DOI 10.1038/ng0696-147; Morris ZS, 2011, J ROY SOC MED, V104, P510, DOI 10.1258/jrsm.2011.110180; National Research Council, 2010, GUIDE CARE USE LAB A; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Page GG, 2004, NURS OUTLOOK, V52, P102, DOI 10.1016/j.outlook.2003.10.011; Page GG, 2001, PAIN, V90, P191, DOI 10.1016/S0304-3959(00)00403-6; RENNELS ML, 1985, BRAIN RES, V326, P47, DOI 10.1016/0006-8993(85)91383-6; Ritter L, 2008, MICROCIRCULATION, V15, P297, DOI 10.1080/10739680701713840; Ritter L, 2008, NURS SCI QUART, V21, P41, DOI 10.1177/08943184080210010703; Ritter L, 2011, MICROCIRCULATION, V18, P552, DOI 10.1111/j.1549-8719.2011.00115.x; Rodgers B, 2004, NURS OUTLOOK, V52, P164, DOI 10.1016/j.outlook.2004.06.004; Rowsey PJ, 2015, WESTERN J NURS RES, V37, P1515, DOI 10.1177/0193945915578815; Rowsey PJ, 2009, BIOL RES NURS, V10, P374, DOI 10.1177/1099800408329409; Rowsey PJ, 2006, ARCH TOXICOL, V80, P81, DOI 10.1007/s00204-005-0036-2; Rowsey PJ, 2003, ENVIRON RES, V92, P27, DOI 10.1016/S0013-9351(02)00096-8; Rowsey PJ, 2000, AUTON NEUROSCI-BASIC, V85, P148, DOI 10.1016/S1566-0702(00)00234-4; ROWSEY PJ, 1993, AM J PHYSIOL, V265, pR1121, DOI 10.1152/ajpregu.1993.265.5.R1121; Rowsey PJ, 1997, TOXICOLOGY, V121, P215, DOI 10.1016/S0300-483X(97)00068-1; Ruehl ML, 2002, NEUROL RES, V24, P226, DOI 10.1179/016164102101199738; Sadler GR, 1999, J PROF NURS, V15, P106, DOI 10.1016/S8755-7223(99)80081-7; Schumacher AM, 2010, J PERIANESTH NURS, V25, P212, DOI 10.1016/j.jopan.2010.06.001; Schutte DL, 2006, BIOL RES NURS, V8, P67, DOI 10.1177/1099800406289909; Seibert DC, 2014, NURSE PRACTITIONER, V39, P28; Seibert Diane C, 2014, Nurse Pract, V39, P18, DOI 10.1097/01.NPR.0000453641.13662.03; Smith SA, 2012, ILAR J, V53, P208, DOI 10.1093/ilar.53.2.208; Stanley K L, 1997, Semin Oncol Nurs, V13, P3, DOI 10.1016/S0749-2081(97)80043-5; Statler KD, 2006, BRAIN RES, V1076, P216, DOI 10.1016/j.brainres.2005.12.106; Statler KD, 2000, J NEUROTRAUM, V17, P1179, DOI 10.1089/neu.2000.17.1179; The Jackson Laboratory, 2013, STRAIN NAM C57BL 6J; Tkacs NC, 2006, BIOL RES NURS, V8, P78, DOI 10.1177/1099800406289717; Tkacs NC, 1999, BRAIN RES BULL, V48, P223, DOI 10.1016/S0361-9230(98)00167-1; Tkacs NC, 1997, J COMP NEUROL, V379, P592, DOI 10.1002/(SICI)1096-9861(19970324)379:4<592::AID-CNE9>3.0.CO;2-Y; Tkacs NC, 2000, DIABETES, V49, P820, DOI 10.2337/diabetes.49.5.820; Turner C, 1997, Clin Oncol (R Coll Radiol), V9, P54, DOI 10.1016/S0936-6555(97)80063-5; Umberger R, 2013, NURS CLIN N AM, V48, P499, DOI 10.1016/j.cnur.2013.08.006; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Wagner JL, 2014, ALCOHOL, V48, P99, DOI 10.1016/j.alcohol.2013.12.001; Watson AJ, 2015, AM J PHYSIOL-REG I, V308, pR199, DOI 10.1152/ajpregu.00422.2014; Weizmann Institute of Sciences, 2015, ZECH CEID SYNDR; Williams JK, 2016, NURS OUTLOOK, V64, P225, DOI 10.1016/j.outlook.2015.12.006; Witek-Janusek L, 2004, NURS OUTLOOK, V52, P108, DOI 10.1016/j.outlook.2003.10.012; WITEKJANUSEK L, 1986, AM J PHYSIOL, V251, pE178, DOI 10.1152/ajpendo.1986.251.2.E178; WITEKJANUSEK L, 1991, CIRC SHOCK, V33, P200; WITEKJANUSEK L, 1988, AM J PHYSIOL, V255, pE525, DOI 10.1152/ajpendo.1988.255.4.E525; YELICH MR, 1994, SHOCK, V2, P438, DOI 10.1097/00024382-199412000-00009; Zheng HP, 2016, CEREBROVASC DIS, V42, P155, DOI 10.1159/000445170	84	1	1	1	13	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0897-1897	1532-8201		APPL NURS RES	Appl. Nurs. Res.	NOV	2016	32						247	256		10.1016/j.apnr.2016.07.016			10	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	EC3WF	WOS:000388057100043	27969037	Green Accepted			2022-02-06	
J	Ruedrich, ED; Chikkannaiah, M; Kumar, G				Ruedrich, Elizabeth Day; Chikkannaiah, Mahesh; Kumar, Gogi			Wallenberg's lateral medullary syndrome in an adolescent	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							VERTEBRAL ARTERY-OCCLUSION; INFARCTION	Concussion and sports-related injuries are common in children. Given the heightened awareness about concussion in recent years, there has been an increase in the diagnosis of concussion in children presenting to the emergency department with head injuries. Often, little consideration is given to other etiologies of neurologic symptoms such as stroke. This may be due to the fact that stroke is uncommon in children when compared to adults. However, there are several case reports of arterial dissection and stroke in the pediatric age group resulting from trivial trauma. We present a case of an adolescent who presented with brainstem stroke with lateral medullary syndrome after a minor injury. Arterial dissection and stroke should be suspected in all children who present with new onset neurologic symptoms after sports-related injuries.	[Ruedrich, Elizabeth Day] Wright State Univ, Boonshoft Sch Med, Dayton, OH 45435 USA; [Chikkannaiah, Mahesh; Kumar, Gogi] Wright State Univ, Dayton, OH 45435 USA; [Chikkannaiah, Mahesh; Kumar, Gogi] Dayton Childrens Hosp, Dayton, OH 45404 USA		Chikkannaiah, M (corresponding author), Wright State Univ, Dayton, OH 45435 USA.; Chikkannaiah, M (corresponding author), Dayton Childrens Hosp, Dayton, OH 45404 USA.	Chikkannaiahm@childrensdayton.org		Oddo, Elizabeth/0000-0001-5527-308X			FRUMKIN LR, 1990, NEUROLOGY, V40, P611, DOI 10.1212/WNL.40.4.611; Kim JS, 1997, NEUROLOGY, V49, P1557, DOI 10.1212/WNL.49.6.1557; Kim JS, 2003, BRAIN, V126, P1864, DOI 10.1093/brain/awg169; KLEIN RA, 1976, JAMA-J AM MED ASSOC, V235, P940; OKAWARA S, 1974, STROKE, V5, P640, DOI 10.1161/01.STR.5.5.640; Toelle SP, 1997, LANCET, V350, P1516, DOI 10.1016/S0140-6736(97)09415-4	6	1	1	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	NOV	2016	34	11							2254.e1	10.1016/j.ajem.2016.05.022			2	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	EE3SD	WOS:000389517200060	27246963				2022-02-06	
J	Vanga, SR; Korlakunta, H; Duthuluru, S; Bommana, S; Narotam, P; Ryschon, K; Mohiuddin, SM; Porter, C; Dawn, B; Lakkireddy, D				Vanga, Subba Reddy; Korlakunta, Hema; Duthuluru, Sowjanya; Bommana, Sudharani; Narotam, Pradeep; Ryschon, Kay; Mohiuddin, Syed M.; Porter, Charles; Dawn, Buddhadeb; Lakkireddy, Dhanunjaya			Partial Brain Tissue Oxygen Levels Predict Arrhythmia and Prognosis in Patients With Brain Injury	AMERICAN JOURNAL OF THERAPEUTICS			English	Article						cardiac arrhythmia; intracranial pressure; partial brain tissue oxygen	SUDDEN CARDIAC DEATH; PAROXYSMAL ATRIAL-FIBRILLATION; SUBARACHNOID HEMORRHAGE; ELECTROCARDIOGRAPHIC ABNORMALITIES; SYMPATHETIC ACTIVITY; ACUTE STROKE; CATECHOLAMINES; VARIABILITY; MECHANISMS; ISCHEMIA	The objective of this study was to examine the clinical determinants of incidence and prognosis of arrhythmias in the setting of acute brain injury. Acute brain injury is known to cause electrocardiographic abnormalities and cardiac arrhythmias. The relation between partial brain tissue oxygen (PBTO) and intracranial pressure (ICP) with arrhythmia incidence and prognosis remains unknown. Consecutive patients with acute brain injury and intracranial bleed admitted to the neurosurgical intensive care unit were enrolled in the study. Baseline characteristics [demographics, medical history, etiology of brain injury, Glasgow Coma Scale (GCS) score, blood pressure, and respiratory rate] were documented. Patient's telemetry recordings were reviewed for daily mean heart rates and arrhythmias. If arrhythmia was noted, PBTO levels at the beginning of arrhythmia, ICP, brain tissue temperature, and outcomes were recorded. A total of 106 subjects (53% men, age 39 +/- 18 years, 65 traumatic and 41 nontraumatic brain injuries) were studied. Overall, 62% of subjects developed a total of 241 arrhythmia episodes. Ventricular arrhythmias were associated with significantly higher daily mean heart rates, low PBTO levels, and low GCS scores, whereas atrial arrhythmias were associated with lower daily mean heart rates, normal PBTO levels, and higher GCS and ICP. Three or more episodes of arrhythmia predicted worse outcomes, including mortality (P = 0.001). In patients with acute brain injury, poor PBTO levels are associated with higher incidence of ventricular tachyarrhythmias. In contrast, atrial tachyarrhythmias occur in patients with normal PBTO levels and higher ICP. Incidence of ventricular arrhythmia in those with poor PBTO is associated with increased mortality.	[Vanga, Subba Reddy; Bommana, Sudharani; Ryschon, Kay; Porter, Charles; Dawn, Buddhadeb; Lakkireddy, Dhanunjaya] Univ Kansas, Med Ctr & Hosp, Div Cardiovasc Dis, Kansas City, KS USA; [Vanga, Subba Reddy; Bommana, Sudharani; Ryschon, Kay; Porter, Charles; Dawn, Buddhadeb; Lakkireddy, Dhanunjaya] Univ Kansas, Med Ctr & Hosp, Cardiovasc Res Inst, Kansas City, KS USA; [Korlakunta, Hema] Texas Hlth, Cardiovasc Consultants PC, Denton, TX USA; [Duthuluru, Sowjanya] Univ Kansas, Med Ctr, Dept Pulm & Crit Care Med, Kansas City, KS 66103 USA; [Narotam, Pradeep] Union Hosp Neurosci, Terre Haute, IN USA; [Mohiuddin, Syed M.] Creighton Univ, Med Ctr, Omaha, NE USA		Lakkireddy, D (corresponding author), Univ Kansas, Hosp & Med Ctr, Mid Amer Cardiol, Med,Bloch Heart Rhythm Ctr, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.; Lakkireddy, D (corresponding author), Univ Kansas, Hosp & Med Ctr, Mid Amer Cardiol, Ctr Excellence Atrial Fibrillat,Bloch Heart Rhyth, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.; Lakkireddy, D (corresponding author), Univ Kansas, Hosp & Med Ctr, Mid Amer Cardiol, EP Res KU Cardiovasc Res Inst,Bloch Heart Rhythm, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	dlakkireddy@mac.md					ANDREOLI A, 1987, STROKE, V18, P558, DOI 10.1161/01.STR.18.3.558; Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; BREUER HWM, 1993, BRIT HEART J, V70, P144; BURCH GE, 1954, CIRCULATION, V9, P719, DOI 10.1161/01.CIR.9.5.719; BYER E, 1947, AM HEART J, V33, P796, DOI 10.1016/0002-8703(47)90025-2; Cao JM, 2000, CIRC RES, V86, P816, DOI 10.1161/01.RES.86.7.816; Chen PS, 2001, CARDIOVASC RES, V50, P409, DOI 10.1016/S0008-6363(00)00308-4; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; Coumel P, 1996, J CARDIOVASC ELECTR, V7, P999, DOI 10.1111/j.1540-8167.1996.tb00474.x; CRUICKSHANK JM, 1974, BRIT HEART J, V36, P697; Dick TE, 2004, AM J PHYSIOL-REG I, V286, pR1121, DOI 10.1152/ajpregu.00485.2003; Dings J, 1998, NEUROSURGERY, V43, P1082, DOI 10.1097/00006123-199811000-00045; DIPASQUALE G, 1987, AM J CARDIOL, V59, P596, DOI 10.1016/0002-9149(87)91176-3; ELVAN A, 1995, CIRCULATION, V91, P2235, DOI 10.1161/01.CIR.91.8.2235; GOLDSTEIN DS, 1979, STROKE, V10, P253, DOI 10.1161/01.STR.10.3.253; GRAD A, 1991, STROKE, V22, P746, DOI 10.1161/01.STR.22.6.746; GUYENET PG, 1986, BRAIN RES, V364, P301, DOI 10.1016/0006-8993(86)90843-7; Herweg B, 1998, AM J CARDIOL, V82, P869, DOI 10.1016/S0002-9149(98)00494-9; Kawahara E, 2003, CIRC J, V67, P753; Khechinashvili G, 2002, CEREBROVASC DIS, V14, P67, DOI 10.1159/000064733; KOCSIS B, 1991, J APPL PHYSIOL, V70, P2181, DOI 10.1152/jappl.1991.70.5.2181; Kothavale A, 2006, NEUROCRIT CARE, V4, P199, DOI 10.1385/NCC:4:3:199; Lavy S, 1973, STROKE, V4, P751, DOI 10.1161/01.STR.5.6.775; LEVY MN, 1969, J APPL PHYSIOL, V27, P465, DOI 10.1152/jappl.1969.27.4.465; Liu LL, 1997, AM J PHYSIOL-HEART C, V273, pH805, DOI 10.1152/ajpheart.1997.273.2.H805; Macmillan CSA, 2002, INTENS CARE MED, V28, P1012, DOI 10.1007/s00134-002-1382-7; Manning GW, 1937, CAN MED ASSOC J, V37, P314; SHUSTER S, 1960, BRIT HEART J, V22, P316; Verrier RL, 2004, CURR OPIN CARDIOL, V19, P2, DOI 10.1097/00001573-200401000-00003; Wan WH, 2008, J CLIN NEUROSCI, V15, P223, DOI 10.1016/j.jocn.2007.05.025; Yesil M, 1999, ANGIOLOGY, V50, P729, DOI 10.1177/000331979905000906; Zhou SM, 2001, J CARDIOVASC ELECTR, V12, P1068, DOI 10.1046/j.1540-8167.2001.01068.x	32	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1075-2765	1536-3686		AM J THER	Am. J. Ther.	NOV-DEC	2016	23	6					E1781	E1787		10.1097/MJT.0b013e31822831b3			7	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	ED2ST	WOS:000388699800070	27219536				2022-02-06	
J	Wong, CG; Rapport, LJ; Meachen, SJ; Hanks, RA; Lumley, MA				Wong, Christina G.; Rapport, Lisa J.; Meachen, Sarah-Jane; Hanks, Robin A.; Lumley, Mark A.			Behavioral Inhibition and Activation Systems in Traumatic Brain Injury	REHABILITATION PSYCHOLOGY			English	Article						traumatic brain injury; personality; behavioral inhibition system/behavioral activation system (BIS/BAS)	LARGE-SAMPLE; BIS-BAS; PSYCHOMETRIC PROPERTIES; COGNITIVE APPRAISAL; IMPAIRED AWARENESS; SELF-AWARENESS; PERSONALITY; REHABILITATION; BIS/BAS; IMPULSIVITY	Purpose/Objective: Personality has been linked to cognitive appraisal and health outcomes; however, research specific to traumatic brain injury (TBI) has been sparse. Gray's theory of behavioral inhibition system and behavioral activation system (BIS/BAS) offers a neurobiologic view of personality that may be especially relevant to neurobehavioral change associated with TBI. The present study examined theoretical and psychometric issues of using the BIS/BAS scale among adults with TBI as well as BIS/BAS personality correlates of TBI. Research Method/Design: Eighty-one adults with complicated-mild to severe TBI and 76 of their significant others (SOs) participated. Measures included the BIS/BAS scale, Positive and Negative Affect Schedule, and Awareness Questionnaire. Results: Among adults with TBI, BIS/BAS internal consistency reliabilities were similar to those found in normative samples of adults without TBI. The TBI group endorsed significantly higher BAS than did the SO group, and injury severity was positively correlated to BAS. The SO group showed expected patterns of correlation between personality and affect; positive affect was associated with BAS, and negative affect with BIS. In contrast, in the TBI group, BAS was positively correlated to both positive and negative affect. Impaired awareness of abilities moderated the intensity of relationships between BIS/BAS and affect. Conclusions/Implications: TBI was associated with relatively intensified BAS (approach behavior) but not BIS (avoidance behavior). The observed pattern is consistent with the neurobiology of TBI-related personality change and with theory regarding the independence of the BIS and BAS systems. The BIS/BAS scale shows promise as a personality measure in TBI.	[Wong, Christina G.; Rapport, Lisa J.; Meachen, Sarah-Jane; Lumley, Mark A.] Wayne State Univ, Dept Psychol, 5057 Woodward Ave, Detroit, MI 48202 USA; [Hanks, Robin A.] Wayne State Univ, Dept Phys Med & Rehabil, Detroit, MI 48202 USA		Rapport, LJ (corresponding author), Wayne State Univ, Dept Psychol, 5057 Woodward Ave, Detroit, MI 48202 USA.	rapport@wayne.edu		Rapport, Lisa/0000-0001-8014-9523	Del Harder Research Fund	This study was supported by a grant from the Del Harder Research Fund. Preliminary results of this study were presented at the 42nd annual conference of the International Neuropsychological Society, Seattle, Washington (February 2014).	*AM PSYCH ASS, 2002, AM PSYCHOL, V57, P1060, DOI DOI 10.1037/0003-066X.57.12.1060; Amodio DM, 2008, PSYCHOPHYSIOLOGY, V45, P11, DOI 10.1111/j.1469-8986.2007.00609.x; Arango-Lasprilla JC, 2010, J HEAD TRAUMA REHAB, V25, P128, DOI 10.1097/HTR.0b013e3181d36ca3; Ashton MC, 2005, J PERS DISORD, V19, P303, DOI 10.1521/pedi.2005.19.3.303; Braddock KH, 2011, J PERS, V79, P793, DOI 10.1111/j.1467-6494.2011.00699.x; Brenner SL, 2005, PSYCHOPHYSIOLOGY, V42, P108, DOI 10.1111/j.1469-8986.2005.00261.x; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Campbell-Sills L, 2004, PSYCHOL ASSESSMENT, V16, P244, DOI 10.1037/1040-3590.16.3.244; Carver C. L, 2007, BIS BAS SCALES; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cohen J., 2013, STAT POWER ANAL BEHA; DeLongis A, 2005, J PERS, V73, P1633, DOI 10.1111/j.1467-6494.2005.00361.x; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Erdle S, 2010, PERS INDIV DIFFER, V48, P762, DOI 10.1016/j.paid.2010.01.025; ERGH TC, 2002, THE JOURNAL OF HEAD, V17, P155, DOI DOI 10.1097/00001199-200204000-00006; FOLKMAN S, 1986, J PERS SOC PSYCHOL, V50, P992, DOI 10.1037/0022-3514.50.5.992; Franken IHA, 2005, J PSYCHOPATHOL BEHAV, V27, P25, DOI 10.1007/s10862-005-3262-2; Gable SL, 2000, J PERS SOC PSYCHOL, V78, P1135, DOI 10.1037//0022-3514.78.6.1135; Gray J, 1972, BIOL BASES INDIVIDUA, P182, DOI DOI 10.1016/B978-0-12-515350-8.50017-X; GRAY JA, 1990, COGNITION EMOTION, V4, P269, DOI 10.1080/02699939008410799; Gray JA, 1981, MODEL PERSONALITY, P246, DOI DOI 10.1007/978-3-642-67783-0_8; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; Griffen JA, 2011, CLIN NEUROPSYCHOL, V25, P1158, DOI 10.1080/13854046.2011.609841; Gunthert KC, 1999, J PERS SOC PSYCHOL, V77, P1087, DOI 10.1037/0022-3514.77.5.1087; Heponiemi T, 2004, PSYCHOPHYSIOLOGY, V41, P37, DOI 10.1111/1469-8986.00118; HERRICK S, 1994, J CLIN PSYCHOL MED S, V1, P269, DOI 10.1007/BF01989628; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Johnson SL, 2003, J PSYCHOPATHOL BEHAV, V25, P25, DOI 10.1023/A:1022247919288; JOHNSTONE B, 1995, BRAIN INJURY, V9, P377, DOI 10.3109/02699059509005777; Jorm AF, 1999, PERS INDIV DIFFER, V26, P49; Juengst SB, 2014, REHABIL PSYCHOL, V59, P242, DOI 10.1037/a0036294; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kennis M, 2013, NEUROSCI BIOBEHAV R, V37, P73, DOI 10.1016/j.neubiorev.2012.10.012; Kervick RB, 2005, BRAIN INJURY, V19, P881, DOI 10.1080/02699050400025273; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; Krpan KM, 2007, J CLIN EXP NEUROPSYC, V29, P36, DOI 10.1080/13803390500376816; Krpan KM, 2011, J INT NEUROPSYCH SOC, V17, P248, DOI 10.1017/S1355617710001499; KURTZ JE, 1998, THE JOURNAL OF HEAD, V13, P1, DOI DOI 10.1097/00001199-199806000-00002; LANGLOIS JA, 2005, THE JOURNAL OF HEAD, V20, P229, DOI DOI 10.1097/00001199-200505000-00006; Langlois JA., 2004, TRAUMATIC BRAIN INJU; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Li YD, 2014, BEHAV BRAIN RES, V274, P400, DOI 10.1016/j.bbr.2014.08.041; MAX JE, 2015, THE JOURNAL OF NEURO, V27, P272, DOI DOI 10.1176/APPI.NEUR0PSYCH.15030073; MCCRAE RR, 1987, J PERS SOC PSYCHOL, V52, P81, DOI 10.1037/0022-3514.52.1.81; McKay C, 2011, TOP STROKE REHABIL, V18, P549, DOI 10.1310/tsr1805-549; Morean ME, 2014, PSYCHOL ASSESSMENT, V26, P1003, DOI 10.1037/pas0000003; Ownsworth T, 2006, REHABIL PSYCHOL, V51, P50, DOI 10.1037/0090-5550.51.1.50; Ownsworth T, 2006, CLIN PSYCHOL REV, V26, P783, DOI 10.1016/j.cpr.2006.05.003; Paradee CV, 2008, REHABIL PSYCHOL, V53, P46, DOI 10.1037/0090-5550.53.1.46; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Poythress NG, 2008, PERS INDIV DIFFER, V45, P732, DOI 10.1016/j.paid.2008.07.021; Prigatano G. P., 1991, AWARENESS DEFICIT BR; Prigatano GP, 2005, ACT NEUR S, V93, P39; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Quay HC, 1997, J ABNORM CHILD PSYCH, V25, P7, DOI 10.1023/A:1025799122529; Quilty LC, 2004, PERS INDIV DIFFER, V37, P429, DOI 10.1016/j.paid.2003.09.014; Rapport LJ, 2008, ARCH PHYS MED REHAB, V89, P922, DOI 10.1016/j.apmr.2008.01.009; Rapport LJ, 1998, ARCH PHYS MED REHAB, V79, P629, DOI 10.1016/S0003-9993(98)90035-1; Rath JF, 2011, REHABIL PSYCHOL, V56, P320, DOI 10.1037/a0025817; Rothbart MK, 2000, J PERS SOC PSYCHOL, V78, P122, DOI 10.1037/0022-3514.78.1.122; Rush BK, 2006, REHABIL PSYCHOL, V51, P257, DOI 10.1037/0090-5550.51.3.257; Ryan KA, 2009, J CLIN EXP NEUROPSYC, V31, P126, DOI 10.1080/13803390802119922; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Sherer M, 1998, NEUROREHABILITATION, V10, P25, DOI 10.3233/NRE-1998-10104; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Smits DJM, 2006, EUR J PERSONALITY, V20, P255, DOI 10.1002/per.583; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Suls J, 1996, J PERS, V64, P711, DOI 10.1111/j.1467-6494.1996.tb00942.x; Tate RL, 2003, NEUROPSYCHOL REHABIL, V13, P43, DOI 10.1080/09602010244000372; TEASDALE G, 1974, LANCET, V2, P81; Trudel TM, 1998, REHABIL PSYCHOL, V43, P267, DOI 10.1037/0090-5550.43.4.267; Turiano NA, 2012, J GERONTOL B-PSYCHOL, V67, P4, DOI 10.1093/geronb/gbr072; Warriner EM, 2003, J CLIN EXP NEUROPSYC, V25, P904, DOI 10.1076/jcen.25.7.904.16494; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; WechslerD, 2001, WECHSLER TEST ADULT; Westen D, 1996, J RES PERS, V30, P400, DOI 10.1006/jrpe.1996.0028	78	1	1	1	10	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2016	61	4					397	407		10.1037/rep0000109			11	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	EC3BK	WOS:000387999200006	27831731				2022-02-06	
J	Law-ye, B; Hangard, C; Felter, A; Safa, D; Denormandie, P; Genet, F; Carlier, RY				Law-ye, Bruno; Hangard, Chloe; Felter, Adrien; Safa, Dominique; Denormandie, Philippe; Genet, Francois; Carlier, Robert-Yves			Pre-surgical CT-assessment of neurogenic myositis ossificans of the hip and risk factors of recurrence: a series of 101 consecutive patients	BMC MUSCULOSKELETAL DISORDERS			English	Article						Osteoma; Neurogenic myositis ossificans; Paraplegia; Spinal cord injury; Brain trauma	HETEROTOPIC BONE-FORMATION; TRAUMATIC BRAIN-INJURY	Background: Neurogenic Myositis Ossificans (NMO) is a rare disabling pathology characterized by peri-articular heterotopic ossifications following severe peripheral or central nervous system injuries. It results in ankylosis and vessels or nerves compressions. Our study aimed to describe the pre-operative findings of patients with NMO of the hip using biphasic computerized tomography (CT). Methods: Between 2006 and 2012, we retrospectively analyzed 101 consecutive patients with hip NMO. We analyzed all CTs and surgical reports following a standardized grid depicting the osteoma and its relations with joint capsule, vessels and nerves and bone mineralization. We studied surgical complications and recurrence during follow-up. Chi2-test and Fischer's test were performed to compare qualitative values with respectively normal and non-normal distribution. Quantitative values were analyzed with a one factor analysis of variance (ANOVA) test. Agreement between pre-surgical CT and surgical observations was evaluated with Cohen's kappa test. Results: Correlation between pre-operative CT and surgical findings was excellent regarding relationships with vessels (0,82) and was good concerning relationships with sciatic nerves (0.62) and with joint capsule (0.68). Close contact or disruption of joint capsule (p = 0.005), joint space narrowing (p = 0.007) and bone demineralization (p < 0.001) were correlated with NMO recurrence. Conclusions: Biphasic enhanced-CT allows pre-operative assessment of NMO with good correlation to surgical observations and helps prevent surgical complications.	[Law-ye, Bruno] Hop La Pitie Salpetriere, APHP, Dept Neuroradiol, Paris, France; [Law-ye, Bruno] Sorbonne Univ, Pierre & Marie Curie Fac Med, Paris, France; [Hangard, Chloe; Felter, Adrien; Safa, Dominique; Carlier, Robert-Yves] Hop Raymond Poincare, APHP, Neuromusculoskeletal Pole, Dept Radiol, F-92380 Garches, France; [Hangard, Chloe; Felter, Adrien; Genet, Francois; Carlier, Robert-Yves] Versailles Univ, Paris Saclay UMR 1179, End Icap, St Quentin En Yveline, France; [Denormandie, Philippe] Hop Raymond Poincare, APHP, Dept Orthoped Surg, Neuroorthoped Unit,Neuromusculoskeletal Pole, F-92380 Garches, France; [Genet, Francois] Hop Raymond Poincare, APHP, Rehabil Dept & Pole, F-92380 Garches, France; [Carlier, Robert-Yves] Hop Raymond Poincare, CIC 1429, F-92380 Garches, France		Carlier, RY (corresponding author), Hop Raymond Poincare, APHP, Neuromusculoskeletal Pole, Dept Radiol, F-92380 Garches, France.; Carlier, RY (corresponding author), Versailles Univ, Paris Saclay UMR 1179, End Icap, St Quentin En Yveline, France.; Carlier, RY (corresponding author), Hop Raymond Poincare, CIC 1429, F-92380 Garches, France.	robert.carlier@aphp.fr					AHRENGART L, 1988, CLIN ORTHOP RELAT R, V229, P265; Baird Evan O, 2009, J Orthop Surg Res, V4, P12, DOI 10.1186/1749-799X-4-12; Carlier RY, 2005, J BONE JOINT SURG BR, V87B, P301, DOI 10.1302/0301-620X.87B3.14737; CASSARPULLICINO VN, 1993, PARAPLEGIA, V31, P40, DOI 10.1038/sc.1993.7; Chalidis B, 2007, J NEUROTRAUM, V24, P1675, DOI 10.1089/neu.2007.0342; Ebinger T, 2000, J TRAUMA, V48, P1058, DOI 10.1097/00005373-200006000-00010; Genet F, 2012, J HEAD TRAUMA REHAB, V27, P443, DOI 10.1097/HTR.0b013e31822b54ba; Genet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016632; LAL S, 1989, ARCH PHYS MED REHAB, V70, P387; MAJOR P, 1980, RADIOLOGY, V136, P797, DOI 10.1148/radiology.136.3.6773108; Pape HC, 2004, J BONE JOINT SURG BR, V86B, P783, DOI 10.1302/0301-620X.86B6.15356; SCHAEFFER MA, 1995, ARCH PHYS MED REHAB, V76, P284, DOI 10.1016/S0003-9993(95)80617-2; Shehab D, 2002, J NUCL MED, V43, P346; SINGER BR, 1993, BRIT J HOSP MED, V49, P247; Weber EWG, 2003, EUR J ANAESTH, V20, P963, DOI 10.1097/00003643-200312000-00005; Zagarella A, 2013, INSIGHTS IMAGING, V4, P595, DOI 10.1007/s13244-013-0265-5	16	1	1	0	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2474			BMC MUSCULOSKEL DIS	BMC Musculoskelet. Disord.	OCT 18	2016	17								433	10.1186/s12891-016-1294-2			8	Orthopedics; Rheumatology	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Rheumatology	EM0TQ	WOS:000395031000007	27756329	gold, Green Published			2022-02-06	
J	Calabria, KE				Calabria, Kathryn E.			Battlefield Acupuncture Effect on Chronic Sequelae of Severe Traumatic Brain Injury	MEDICAL ACUPUNCTURE			English	Article						Auricular Acupuncture (AA); Battlefield Acupuncture (BFA); Severe Traumatic Brain Injury (TBI); Chronic Cognitive Sequelae		Background: Since 2001, Battlefield Acupuncture (BFA), an auricular acupuncture protocol, has been used to treat members of the U.S. Military who have acute and chronic pain conditions. One of the many pain issues treated is the pain associated with traumatic brain injury (TBI), which may manifest anywhere in the body. Case: A 65-year old man with a 6-year history of severe TBI was treated with BFA for back pain after signing an informed consent form. Results: This patient experienced resolution of his back pain, an unexpected recovery from most of the incurred cognitive sequelae, as well as from a severe emotional injury incurred in his childhood. Conclusions: In this case, BFA appeared to be a successful treatment of the chronic sequelae of mild and severe TBI and was a possible alternative to using multiple medications to treat this condition.	[Calabria, Kathryn E.] Maximum Potential Hlth Med PC, 2797 Montauk Highway, Brookhaven, NY 11719 USA		Calabria, KE (corresponding author), Maximum Potential Hlth Med PC, 2797 Montauk Highway, Brookhaven, NY 11719 USA.	kecalabria84@gmail.com					King HC, 2013, MIL MED, V178, P867, DOI 10.7205/MILMED-D-13-00075; Kobeissy F., 2015, BRAIN NEUROTRAUMA MO; Niemtzow RC, 2007, MED ACUPUNCT, V19, P225, DOI 10.1089/acu.2007.0603; Pock AR, 2011, MED ACUPUNCT, V23, P205, DOI 10.1089/acu.2011.0835; Wong V., 2011, COCHRANE DB SYST REV, V5	5	1	1	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1933-6586	1933-6594		MED ACUPUNCT	Med. Acupunct.	OCT	2016	28	5					278	282		10.1089/acu.2016.1200			5	Integrative & Complementary Medicine	Emerging Sources Citation Index (ESCI)	Integrative & Complementary Medicine	EB7ML	WOS:000387571600019					2022-02-06	
J	Christensen, MA; Cooper, CM				Christensen, Michael A.; Cooper, Caleb M.			Developing Guidelines for the Reversal of Anticoagulant and Antithrombotic Agents in the Setting of Intracranial Hemorrhage	JOURNAL OF NEUROSCIENCE NURSING			English	Article						anticoagulant; antiplatelet; antithrombotic; intracranial hemorrhage; traumatic brain injury	PROTHROMBIN COMPLEX CONCENTRATE; INTRACEREBRAL HEMORRHAGE; DABIGATRAN; MANAGEMENT; WARFARIN	Background: The use of anticoagulants and antithrombotic agents in the population is increasing as the population ages with a concomitant rise in chronic diseases such as atrial fibrillation. The incidence of intracranial hemorrhage (ICH) with these agents is small but clinically significant. The purpose of this article is to illustrate how a single institution developed anticoagulation-associated ICH treatment guidelines. Methodology: A literature review of the topic was performed using the PubMed and Cochrane Evidence-Based Medicine review databases using keywords including antithrombotic agents, antiplatelet agents, traumatic brain injury, and intracranial hemorrhage. The results of the search were reviewed, and relevant English-language manuscripts were retained. The pharmacology of each agent was reviewed. Results: Anticoagulants increase the risk and severity of ICH; the association is not as clear with the use of antithrombotic agents. Each agent's pharmacology and development is discussed, and reversal strategies are reviewed. Whereas some agents may be reversed medically, others are dialyzable, and a few agents have no effective reversal mechanism currently available. Conclusion: ICH, either primary or traumatic, that is complicated by these agents must be rapidly recognized and appropriately treated. Use of a common, simple clinical practice guideline will assist clinicians in intervening rapidly for this patient group.	[Christensen, Michael A.; Cooper, Caleb M.] Sutter East Bay Neurosci Inst, Castro Valley, CA 94546 USA		Christensen, MA (corresponding author), Sutter East Bay Neurosci Inst, Castro Valley, CA 94546 USA.	npneuro@gmail.com					Cervera A, 2012, J NEUROL, V259, P212, DOI 10.1007/s00415-011-6153-3; Chang DN, 2013, AM J KIDNEY DIS, V61, P487, DOI 10.1053/j.ajkd.2012.08.047; Connolly SJ, 2011, NEW ENGL J MED, V364, P806, DOI 10.1056/NEJMoa1007432; Dentali F, 2011, THROMB HAEMOSTASIS, V106, P429, DOI 10.1160/TH11-01-0052; Eikelboom JW, 2013, NEW ENGL J MED, V369, P1206, DOI 10.1056/NEJMoa1300615; Fawole A, 2013, CLEV CLIN J MED, V80, P443, DOI 10.3949/ccjm.80a.13025; James RF, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2013.2.FOCUS1328; Lauer A, 2013, LANCET NEUROL, V12, P394, DOI 10.1016/S1474-4422(13)70049-8; Le Roux P, 2014, J NEUROSURG, V121, P1, DOI 10.3171/2014.8.paradigm; Naidech AM, 2012, NEUROCRIT CARE, V16, P82, DOI 10.1007/s12028-011-9619-3; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Solbeck S, 2014, INT J CARDIOL, V176, P794, DOI 10.1016/j.ijcard.2014.07.084; Solbeck S, 2014, SCAND J CLIN LAB INV, V74, P591, DOI 10.3109/00365513.2014.921930; SUTCLIFFE P, 2013, HEALTH TECHNOL ASSES, V17, P1; Topol EJ, 2011, NAT MED, V17, P40, DOI 10.1038/nm0111-40; U.S. Food and Drug Administration, 2015, ID; Voils SA, 2012, THROMB RES, V130, P833, DOI 10.1016/j.thromres.2012.10.001; Watanabe M, 2012, NEUROCRIT CARE, V16, P203, DOI 10.1007/s12028-011-9591-y; Zhou W, 2011, STROKE, V42, P3594, DOI 10.1161/STROKEAHA.111.624650	19	1	1	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0888-0395	1945-2810		J NEUROSCI NURS	J. Neurosci. Nurs.	OCT	2016	48	5					256	259		10.1097/JNN.0000000000000210			4	Clinical Neurology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Nursing	DX4BT	WOS:000384324600006	27579959				2022-02-06	
J	Ditz, C; Klaus, S; Bahlmann, L; Onken, N; Keck, A; Gliemroth, J				Ditz, Claudia; Klaus, Stephan; Bahlmann, Ludger; Onken, Nils; Keck, Alexander; Gliemroth, Jan			Microdialysis as a Part of Invasive Cerebral Monitoring During Porcine Septic Shock	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						microdialysis; cerebral monitoring; metabolism; septic shock	TRAUMATIC BRAIN-INJURY; INTRACEREBRAL MICRODIALYSIS; EXPERIMENTAL PERITONITIS; SUBARACHNOID HEMORRHAGE; METABOLIC-DISORDERS; ENERGY-METABOLISM; ENDOTOXIN-SHOCK; BLOOD-FLOW; SEPSIS; LACTATE	Background: Metabolic changes in critically ill patients with endotoxin-induced septic shock are measured primarily by techniques that afford organ-specific metabolic monitoring based on interstitial fluid samples. The present study was designed to evaluate the role of cerebral microdialysis (MD) as a part of invasive neuromonitoring during endotoxemia in a porcine model. Materials and Methods: Continuous endotoxin infusion was administered to 7 female pigs and, in addition to hemodynamic monitoring and blood chemistry, interstitial lactate, pyruvate, glucose and glycerol concentrations in muscle, liver, and cerebral tissue were measured via in vivo MD for an observation period of 180 minutes. Results: The cerebral concentrations of lactate and glycerol showed no significant increases, whereas the hepatic and muscular levels rose dramatically under endotoxemia. However, the lactate/pyruvate ratio and especially the lactate/glucose ratio showed a profound and significant increase in brain tissue as well. Cerebral perfusion pressure decreased from 77 to 50 mm Hg without reaching pathologic values. Conclusions: Although our results confirm the special protection of the brain during endotoxemia compared with other organs, early metabolic changes become evident by increasing lactate/ pyruvate ratio and lactate/glucose ratio. MD appears to be a suitable additional technique in invasive neuromonitoring for obtaining early information about metabolic deterioration in the brain during septic shock.	[Ditz, Claudia; Gliemroth, Jan] Univ Lubeck, Dept Neurosurg, Ratzeburger Allee 160, D-23538 Lubeck, Germany; [Klaus, Stephan] Herz Jesu Krankenhaus Hiltrup GmbH, Dept Anesthesiol, Munster, Germany; [Bahlmann, Ludger] Sankt Ansgar Krankenhaus, Dept Anesthesiol, Hoxter, Germany; [Onken, Nils] Klinikum Bremen Mitte, Dept Pediat, Bremen, Germany; [Keck, Alexander] Klinikum Osnabruck, Dept Obstet & Gynecol, Osnabruck, Germany		Gliemroth, J (corresponding author), Univ Lubeck, Dept Neurosurg, Ratzeburger Allee 160, D-23538 Lubeck, Germany.	jan.gliemroth@t-online.de					AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; Abrahamsson P, 2005, J PHARMACEUT BIOMED, V39, P730, DOI 10.1016/j.jpba.2005.04.036; Adam N, 2013, EXPERT REV ANTI-INFE, V11, P211, DOI [10.1586/eri.12.159, 10.1586/ERI.12.159]; Alston TA, 1999, CRIT CARE MED, V27, P690, DOI 10.1097/00003246-199904000-00013; Astiz ME, 1998, LANCET, V351, P1501, DOI 10.1016/S0140-6736(98)01134-9; Bahlmann Ludger, 2002, J Clin Monit Comput, V17, P309, DOI 10.1023/A:1021284608837; Bardt TF, 1998, ACTA NEUROCHIR, V140, P357, DOI 10.1007/s007010050109; Bellomo R, 2002, CRIT CARE, V6, P322; Bellomo R, 1996, CHEST, V110, P198, DOI 10.1378/chest.110.1.198; Chew MS, 2008, ACTA ANAESTH SCAND, V52, P959, DOI 10.1111/j.1399-6576.2008.01603.x; Choi IY, 2001, J CEREBR BLOOD F MET, V21, P653, DOI 10.1097/00004647-200106000-00003; Dusick JR, 2007, J CEREBR BLOOD F MET, V27, P1593, DOI 10.1038/sj.jcbfm.9600458; Ebersoldt M, 2007, INTENS CARE MED, V33, P941, DOI 10.1007/s00134-007-0622-2; Eggers V, 2003, ANAESTHESIST, V52, P294, DOI 10.1007/s00101-003-0496-9; Gardenfors A, 2002, ACTA NEUROCHIR, V144, P601, DOI 10.1007/s00701-002-0954-1; Goodman JC, 1999, CRIT CARE MED, V27, P1965, DOI 10.1097/00003246-199909000-00041; HARIRI RJ, 1993, SURG GYNECOL OBSTET, V176, P155; Hillered L, 1998, J NEUROL NEUROSUR PS, V64, P486, DOI 10.1136/jnnp.64.4.486; Hutchinson PJA, 2002, ACT NEUR S, V81, P359; Johnston Andrew J, 2002, Curr Opin Crit Care, V8, P121, DOI 10.1097/00075198-200204000-00006; Klaus S, 2003, INTENS CARE MED, V29, P634, DOI 10.1007/s00134-002-1602-1; Klaus S, 2002, LANGENBECK ARCH SURG, V387, P276, DOI 10.1007/s00423-002-0320-z; Kopterides P, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2012.08.003; Kopterides P, 2011, INTENS CARE MED, V37, P1756, DOI 10.1007/s00134-011-2336-8; KORF J, 1990, INT J BIOCHEM, V22, P1371, DOI 10.1016/0020-711X(90)90225-R; Landolt H, 1996, ACT NEUR S, V67, P31; Larach DB, 2011, NEUROCRIT CARE, V15, P609, DOI 10.1007/s12028-011-9517-8; Levy B, 2006, CURR OPIN CRIT CARE, V12, P315, DOI 10.1097/01.ccx.0000235208.77450.15; Lundy DJ, 2011, CRIT CARE NURS CLIN, V23, P67, DOI 10.1016/j.ccell.2010.12.004; Matta BF, 1996, BRIT J ANAESTH, V76, P790, DOI 10.1093/bja/76.6.790; Mendelowitsch A, 2001, METHODS, V23, P73, DOI 10.1006/meth.2000.1107; Nielsen TH, 2013, ACTA ANAESTH SCAND, V57, P793, DOI 10.1111/aas.12092; Nikitas N, 2013, MINERVA ANESTESIOL, V79, P1229; Nordstrom CH, 2010, CHILD NERV SYST, V26, P465, DOI 10.1007/s00381-009-1035-z; Ohashi Hitoshi, 2011, Journal of Smooth Muscle Research, V47, P37; Oldner A, 1999, CRIT CARE MED, V27, P790, DOI 10.1097/00003246-199904000-00037; Oldner A, 1996, SHOCK, V6, P188, DOI 10.1097/00024382-199609010-00006; Papadopoulos MC, 2000, CRIT CARE MED, V28, P3019, DOI 10.1097/00003246-200008000-00057; Peerdeman SM, 2002, J NEUROL, V249, P676, DOI 10.1007/s00415-002-0689-1; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Persson L, 1996, J NEUROSURG, V84, P606, DOI 10.3171/jns.1996.84.4.0606; Pytel P, 2009, CURR OPIN NEUROL, V22, P283, DOI 10.1097/WCO.0b013e32832b3101; RASMUSSEN I, 1994, SHOCK, V1, P60, DOI 10.1097/00024382-199401000-00011; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Rosdahl H, 1998, AM J PHYSIOL-ENDOC M, V274, pE936, DOI 10.1152/ajpendo.1998.274.5.E936; Sarrafzadeh A, 2004, J NEUROSURG, V100, P400, DOI 10.3171/jns.2004.100.3.0400; Sarrafzadeh A, 2010, NEUROCRIT CARE, V13, P339, DOI 10.1007/s12028-010-9432-4; Smith SM, 1998, J CRIT CARE, V13, P104, DOI 10.1016/S0883-9441(98)90013-2; SPRUNG CL, 1990, CRIT CARE MED, V18, P801, DOI 10.1097/00003246-199008000-00001; Stuart RM, 2010, NEUROCRIT CARE, V12, P188, DOI 10.1007/s12028-010-9330-9; Swindle MM, 2013, J INVEST SURG, V26, P63, DOI 10.3109/08941939.2012.693149; Taccone FS, 2014, CRIT CARE MED, V42, pE114, DOI 10.1097/CCM.0b013e3182a641b8; Terborg C, 2001, INTENS CARE MED, V27, P1231, DOI 10.1007/s001340101005; Tsuneyoshi I, 2001, CRIT CARE MED, V29, P487, DOI 10.1097/00003246-200103000-00004; UNGERSTEDT U, 1991, J INTERN MED, V230, P365, DOI 10.1111/j.1365-2796.1991.tb00459.x; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa P, 2012, CRIT CARE MED, V40, P1923, DOI 10.1097/CCM.0b013e31824e0fcc; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; YOUNG GB, 1990, CLIN INVEST MED, V13, P297	59	1	1	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	OCT	2016	28	4					323	330		10.1097/ANA.0000000000000220			8	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	DY6JI	WOS:000385211800008	26418071				2022-02-06	
J	Faure, CE; Fitzpatrick, JM				Faure, Caroline E.; Fitzpatrick, John M.			Professional Action Sport Athletes' Experiences with and Attitudes Toward Concussion: A Phenomenological Study	QUALITATIVE REPORT			English	Article						Concussion; Action Sports; Freestyle BMX; Freestyle Motocross; Big Air; Mega Ramp; X Games	QUALITATIVE RESEARCH; KNOWLEDGE; HEALTH	This study examined the lived experiences and subsequent attitudes of freestyle BMX and motocross athletes relative to suffering concussions. Eleven professional athletes were interviewed using a semi-structured protocol. All cited a significant personal history with concussion and those personal accounts, along with their observations of others who experienced similar head injuries, shaped the athletes' attitudes towards concussion. Both intrinsic and extrinsic factors contributed to each athlete's acceptance of concussion risk inherent in their respective sport. Generally, athletes accepted concussion risk as part of their sport, but were largely unfamiliar with what concussion was and what long-term effects could result from a history of concussion. Additionally, athletes knew of no concussion protocols or guidelines in their sport and cited an overall lack of organized medical care accessible to them on an ongoing basis, as is the case with mainstream sports.	[Faure, Caroline E.; Fitzpatrick, John M.] Idaho State Univ, Dept Sport Sci & Phys Educ, Pocatello, ID 83209 USA		Faure, CE (corresponding author), Idaho State Univ, Dept Sport Sci & Phys Educ, Pocatello, ID 83209 USA.	faurcaro@isu.edu					[Anonymous], 2015, NY TIMES; Belson K, 2015, NY TIMES; Biddle SJH, 2001, J SPORT SCI, V19, P777, DOI 10.1080/026404101317015438; Branch J., 2013, NY TIMES; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Didehbani N, 2013, ARCH CLIN NEUROPSYCH, V28, P418, DOI 10.1093/arclin/act028; DOOB LW, 1947, PSYCHOL REV, V54, P135, DOI 10.1037/h0058371; Gibbs G., 2007, ANAL QUALITATIVE DAT, DOI 10.4135/9781849208574; Higgins M., 2016, OUTSIDE         0217; Hogg M, 2005, SOCIAL PSYCHOL; Jennum P, 2013, SPINE, V38, P449, DOI 10.1097/BRS.0b013e3182819203; Jung C. G., 1971, COLLECTED WORKS CG J, V6; King NS, 2003, BRIT J PSYCHIAT, V183, P276, DOI 10.1192/bjp.183.4.276; Klonoff P. S., 2010, PSYCHOTHERAPY BRAIN; Knoxville J., 2010, 30 30 BIRTH BIG AIR; KREFTING L, 1991, AM J OCCUP THER, V45, P214, DOI 10.5014/ajot.45.3.214; LaPiere RT, 1934, SOC FORCES, V13, P230, DOI 10.2307/2570339; Lincoln Yvonna S., 1985, NATURALISTIC INQUIRY; Ma R, 2012, J BONE JOINT SURG AM, V94A, P1618, DOI 10.2106/JBJS.K.01127; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McGrath B., 2014, NEW YORKER, V90; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Murray IR, 2015, CLIN J SPORT MED, V25, P75, DOI 10.1097/JSM.0000000000000134; Nicholls D, 2009, INT J THER REHABIL, V16, P638, DOI 10.12968/ijtr.2009.16.12.45433; Onwuegbuzie AJ, 2007, QUAL REP, V12, P238; Patton M. Q., 2002, QUALITATIVE RES EVAL; Pickert K, 2009, TIME; Provvidenza C, 2013, BRIT J SPORT MED, V47, P332, DOI 10.1136/bjsports-2012-092099; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Roenigk A., 2016, ESPN MAGAZINE   0524; Saldana J, 2015, CODING MANUAL QUALIT; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Sharma VK, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967114564358; Smith J.A., 2003, QUALITATIVE PSYCHOL, P51; Tesch R., 1990, QUALITATIVE RES ANAL; Wedcliffe T, 2001, S Afr J Commun Disord, V48, P77; Whiteside Kelly, 2014, US TODAY	38	1	1	2	3	NOVA SOUTHEASTERN UNIV	FORT LAUDERDALE-DAVIE	3301 COLLEGE AVE, FORT LAUDERDALE-DAVIE, FL 33314 USA	2160-3715			QUAL REP	Qual. Rep.	OCT	2016	21	10					1836	1854					19	Social Sciences, Interdisciplinary	Emerging Sources Citation Index (ESCI)	Social Sciences - Other Topics	EG9KZ	WOS:000391378900006					2022-02-06	
J	Garcia, M; Poza, J; Bachiller, A; Santamarta, D; Hornero, R				Garcia, Maria; Poza, Jesus; Bachiller, Alejandro; Santamarta, David; Hornero, Roberto			Effect of infusion tests on the dynamical properties of intracranial pressure in hydrocephalus	COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE			English	Article						Hydrocephalus; Infusion test; Intracranial pressure; Wavelet entropy; Wavelet turbulence	CEREBROSPINAL COMPENSATORY RESERVE; FLUID OUTFLOW RESISTANCE; TRAUMATIC BRAIN-INJURY; ADULT HYDROCEPHALUS; VASCULAR COMPLIANCE; COMPLEXITY; ENTROPY; WAVES; PULSE; HYPERTENSION	Background and objective: Hydrocephalus comprises a number of conditions characterised by clinical symptoms, dilated ventricles and anomalous cerebrospinal fluid (CSF) dynamics. Infusion tests (ITs) are usually performed to study CSF circulation and in the preoperatory evaluation of patients with hydrocephalus. The study of intracranial pressure (ICP) signals recorded during ITs could be useful to gain insight into the underlying pathophysiology of this condition and to further support treatment decisions. In this study, two wavelet parameters, wavelet turbulence (WT) and wavelet entropy (WE), were analysed in order to characterise the variability, irregularity and similarity in spectral content of ICP signals in hydrocephalus. Methods: One hundred and twelve ICP signals were analysed using WT and WE. These parameters were calculated in two frequency bands: B-1 (0.15-0.3 Hz) and B-2 (0.67-2.5 Hz). Each signal was divided into four artefact-free epochs corresponding to the basal, early infusion, plateau and recovery phases of the IT. We calculated the mean and standard deviation of WT and WE and analysed whether these parameters revealed differences between epochs of the IT. Results: Statistically significant differences (p < 1.70 . 10(-3), Bonferroni-corrected Wilcoxon signed-rank tests) in pairwise comparisons between phases of ITs were found using the mean and standard deviation of WT and WE. These differences were mainly found in B-2. Conclusions: Wavelet parameters like WT and WE revealed changes in the signal time-scale representation during ITs. Statistically significant differences were mainly found in B2, associated with ICP pulse waves, and included a higher degree of similarity in the spectral content, together with a lower irregularity and variability in the plateau phase with respect to the basal phase. (C) 2016 Elsevier Ireland Ltd. All rights reserved.	[Garcia, Maria; Poza, Jesus; Bachiller, Alejandro; Hornero, Roberto] Univ Valladolid, ETS Ingn Telecomunicac, Dept TSCIT, Biomed Engn Grp, Valladolid, Spain; [Poza, Jesus; Hornero, Roberto] Univ Valladolid, IMUVA, Inst Invest Matemat, Valladolid, Spain; [Poza, Jesus] Univ Salamanca, INCYL, Salamanca, Spain; [Santamarta, David] Hosp Univ Leon, Serv Neurocirugia, Leon, Spain		Garcia, M (corresponding author), Univ Valladolid, ETS Ingn Telecomunicac, Dept TSCIT, Biomed Engn Grp GIB, Paseo Belen 15, E-47011 Valladolid, Spain.	maria.garcia@tel.uva.es	Hornero, Roberto/M-5313-2019; Bachiller, Alejandro/H-8520-2019; Garcia, Maria/F-3347-2011; Poza, Jesus/B-4509-2008; Bachiller, Alejandro/Q-7661-2018	Hornero, Roberto/0000-0001-9915-2570; Bachiller, Alejandro/0000-0001-6507-1027; Garcia, Maria/0000-0002-4037-0351; Poza, Jesus/0000-0001-8577-9559; Bachiller, Alejandro/0000-0001-6507-1027	Ministerio de Economia y CompetitividadSpanish Government [TEC2014-53196-R]; FEDEREuropean Commission; Consejeria de Educacion de la Junta de Castilla y Leon [VA059U13]; PIF-UVA grant from the University of Valladolid	This study was supported by the project TEC2014-53196-R from "Ministerio de Economia y Competitividad" and FEDER and the project VA059U13 from the "Consejeria de Educacion de la Junta de Castilla y Leon". A. Bachiller was in receipt of a PIF-UVA grant from the University of Valladolid.	Aboy M, 2005, ACT NEUR S, V95, P307; Addison P.S., 2015, IEEE REV BIOMED ENG, V8, P78, DOI DOI 10.1109/RBME.2015.2436978; Agren-Wilsson A, 2005, J NEUROL NEUROSUR PS, V76, P1088, DOI 10.1136/jnnp.2004.042838; Bachiller A, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/1/016007; Barbosa PRB, 2006, INT J CARDIOL, V107, P307, DOI 10.1016/j.ijcard.2005.03.073; Bateman GA, 2000, AM J NEURORADIOL, V21, P1574; Bateman GA, 2008, NEURORADIOLOGY, V50, P491, DOI 10.1007/s00234-008-0374-x; Bergsneider M, 2008, NEUROSURGERY, V62, P643, DOI [10.1227/01.neu.0000316269.82467.f7, 10.1227/01.NEU.0000296954.22901.C6]; Chari A, 2014, J NEUROSURG, V120, P697, DOI 10.3171/2013.11.JNS121895; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Czosnyka M, 2004, PHYSIOL MEAS, V25, pR51, DOI 10.1088/0967-3334/25/5/R01; Egnor M, 2002, PEDIATR NEUROSURG, V36, P281, DOI 10.1159/000063533; Eide PK, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-11; Eklund A, 2007, MED BIOL ENG COMPUT, V45, P719, DOI 10.1007/s11517-007-0199-5; Elixmann IM, 2014, IEEE T BIO-MED ENG, V61, P2379, DOI 10.1109/TBME.2014.2308927; Garcia M, 2013, IEEE ENG MED BIO, P2543, DOI 10.1109/EMBC.2013.6610058; Garcia M, 2013, MED ENG PHYS, V35, P1490, DOI 10.1016/j.medengphy.2013.04.002; Haubrich C, 2007, STROKE, V38, P2677, DOI 10.1161/STROKEAHA.107.485847; Haubrich C, 2015, MED ENG PHYS, V37, P175, DOI 10.1016/j.medengphy.2014.11.009; Heissler Hans E, 2012, Acta Neurochir Suppl, V114, P93, DOI 10.1007/978-3-7091-0956-4_16; Holm S, 2008, MED ENG PHYS, V30, P164, DOI 10.1016/j.medengphy.2007.03.003; Hornero R, 2005, IEEE T BIO-MED ENG, V52, P1671, DOI 10.1109/TBME.2005.855722; Hornero R, 2007, MED BIOL ENG COMPUT, V45, P617, DOI 10.1007/s11517-007-0194-x; Hu XA, 2006, MED ENG PHYS, V28, P304, DOI 10.1016/j.medengphy.2005.07.006; Hu X, 2009, IEEE T BIO-MED ENG, V56, P696, DOI 10.1109/TBME.2008.2008636; Jobson J.D., 1991, APPL MULTIVARIATE DA; Kasprowicz M, 2010, J NEUROSCI METH, V190, P310, DOI 10.1016/j.jneumeth.2010.05.015; Kim DJ, 2009, NEUROSURGERY, V64, P494, DOI 10.1227/01.NEU.0000338434.59141.89; Latka M, 2007, PHYSIOL MEAS, V28, P465, DOI 10.1088/0967-3334/28/5/002; LEMAIRE JJ, 1994, COMPUT METH PROG BIO, V42, P1, DOI 10.1016/0169-2607(94)90133-3; Lenfeldt N, 2008, BRAIN, V131, P2904, DOI 10.1093/brain/awn232; Lu CW, 2012, BRAIN, V135, P2399, DOI 10.1093/brain/aws155; Mallat S., 2008, TOUR SIGNAL PROCESSI; Misgeld Berno J. E., 2015, IFAC - Papers Online, V48, P183, DOI 10.1016/j.ifacol.2015.10.136; Momjian S, 2004, BRIT J NEUROSURG, V18, P56, DOI 10.1080/02688690410001660481; Poza J, 2007, MED ENG PHYS, V29, P1073, DOI 10.1016/j.medengphy.2006.11.006; Poza J, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/2/026010; Rioul O, 1991, IEEE SIGNAL PROC MAG, V8, P14, DOI 10.1109/79.91217; Roach BJ, 2008, SCHIZOPHRENIA BULL, V34, P907, DOI 10.1093/schbul/sbn093; Santamarta D, 2012, ACTA NEUROCHIR, V154, P1595, DOI 10.1007/s00701-012-1441-y; Santamarta D, 2010, CHILD NERV SYST, V26, P1683, DOI 10.1007/s00381-010-1244-5; Schmidt EA, 2005, ACTA NEUROCHIR SUPPL, V95, P253; Serulle Y, 2014, J NEUROL, V261, P1994, DOI 10.1007/s00415-014-7454-0; Sleigh JW, 2004, PHYSIOL MEAS, V25, P921, DOI 10.1088/0967-3334/25/4/011; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Turalska M, 2008, ACTA NEUROCHIR SUPPL, V102, P43, DOI 10.1007/978-3-211-85578-2_9; Wagshul ME, 2009, J NEUROSURG-PEDIATR, V3, P354, DOI 10.3171/2009.1.PEDS08109; Weerakkody RA, 2011, ACTA NEUROL SCAND, V124, P85, DOI 10.1111/j.1600-0404.2010.01467.x; Xu P, 2013, COMPUT BIOL MED, V43, P425, DOI 10.1016/j.compbiomed.2013.01.022	49	1	1	0	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0169-2607	1872-7565		COMPUT METH PROG BIO	Comput. Meth. Programs Biomed.	OCT	2016	134						225	235		10.1016/j.cmpb.2016.06.007			11	Computer Science, Interdisciplinary Applications; Computer Science, Theory & Methods; Engineering, Biomedical; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Medical Informatics	DT7DJ	WOS:000381647000020	27480746	Green Submitted			2022-02-06	
J	Hifumi, T; Kuroda, Y; Kawakita, K; Yamashita, S; Oda, Y; Dohi, K; Maekawa, T				Hifumi, Toru; Kuroda, Yasuhiro; Kawakita, Kenya; Yamashita, Susumu; Oda, Yasutaka; Dohi, Kenji; Maekawa, Tsuyoshi		Brain Hypothermia Study Grp Japan	Plasma Potassium Concentration on Admission Correlates with Neurologic Outcome in Traumatic Brain Injury Patients Treated with Targeted Temperature Management: A Post Hoc Analysis of a Multicenter Randomized Controlled Trial	WORLD NEUROSURGERY			English	Article						Heterogeneous pathophysiology; Multicenter randomized controlled trial; Potassium; Traumatic brain injury; Therapeutic hypothermia	MILD THERAPEUTIC HYPOTHERMIA; FEVER CONTROL; HYPOKALEMIA; CARE	BACKGROUND: Recent studies have focused on the association between plasma electrolytes, particularly potassium level and neurologic outcomes in patients with traumatic brain injury (TBI). We hypothesized that potassium level on admission is an indicator for initiation of targeted temperature management in patients with severe TBI. METHODS: We re-evaluated the Brain Hypothermia Study data based on the potassium levels on admission (i.e., hypokalemia [< 3.5 mEq/L] or normokalemia [3.5-5 mEq/L]) and compared these values and Glasgow Outcome Scale scores at 6 months by per protocol analysis. Consequently, 135 patients were enrolled. Finally, groups 50 and 23 patients with hypokalemia and 34 and 23 patients with normokalemia were allocated to mild therapeutic hypothermia (MTH) and fever control groups, respectively. Baseline characteristics, complication rates, and favorable neurologic outcome rates were compared between the two groups. RESULTS: In the normokalemia patients, fever control management was associated with a significant increase in favorable neurologic outcome compared with those in the MTH group (68.2% vs. 35.3%; P = 0.03). The complication rate was significantly higher in the MTH group than in the fever control group for patients with normokalemia (23.4% vs. 0%; P = 0.03). Conversely, hypokalemia patients in the MTH group revealed relatively better favorable neurologic outcomes compared with those in the fever control group (52.0% vs. 39.1%; P = 0.33). CONCLUSIONS: The initial potassium level may be an indicator in determining appropriate targeted temperature management for patients with TBI. Fever control may be considered instead of MTH for normokalemia patients with TBI on admission.	[Hifumi, Toru; Kuroda, Yasuhiro; Kawakita, Kenya] Kagawa Univ Hosp, Dept Emergency Disaster & Crit Care Med, Kita, Kagawa, Japan; [Yamashita, Susumu] Tokuyama Cent Hosp, Dept Emergency Med, Yamaguchi, Japan; [Oda, Yasutaka] Yamaguchi Univ, Sch Med, Adv Med Emergency & Crit Care Ctr, Yamaguchi, Japan; [Dohi, Kenji] Jikei Univ, Sch Med, Dept Emergency Med, Tokyo, Japan; [Maekawa, Tsuyoshi] Yamaguchi Prefectural Grand Med Ctr, Yamaguchi, Japan		Hifumi, T (corresponding author), Kagawa Univ Hosp, Dept Emergency Disaster & Crit Care Med, Kita, Kagawa, Japan.	hifumitoru@gmail.com		dohi, kenji/0000-0002-4451-0382	Japanese Ministry of Health, Labour and WelfareMinistry of Health, Labour and Welfare, Japan [H-14-shinkin-005, H-15-shinkin-001, H-16-shinkin-001]; Japanese Human Science Association	This study was supported by research project grants from the Japanese Ministry of Health, Labour and Welfare (H-14-shinkin-005, H-15-shinkin-001, and H-16-shinkin-001) and by the Japanese Human Science Association, 2002-2004.	Beal AL, 2002, SHOCK, V18, P107, DOI 10.1097/00024382-200208000-00002; Bosarge PL, 2015, J TRAUMA ACUTE CARE, V79, P289, DOI 10.1097/TA.0000000000000716; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Fox JL, 2010, CAN J EMERG MED, V12, P355; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; Hifumi T, 2016, J NEUROTRAUM, V33, P1047, DOI 10.1089/neu.2015.4033; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Kawada T, 2007, J APPL PHYSIOL, V102, P622, DOI 10.1152/japplphysiol.00622.2006; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Maekawa T, 2015, J NEUROTRAUM, V32, P422, DOI 10.1089/neu.2013.3197; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Ookuma T, 2015, J INTENSIVE CARE, V3, DOI 10.1186/s40560-015-0103-6; Polderman KH, 2008, INTENS CARE MED, V34, P1738, DOI 10.1007/s00134-008-1132-6; Polderman KH, 2009, CRIT CARE MED, V37, P1101, DOI 10.1097/CCM.0b013e3181962ad5; POMERANZ S, 1989, ACTA NEUROCHIR, V97, P62, DOI 10.1007/BF01577741; Shiozaki T, 2001, J NEUROSURG, V94, P50, DOI 10.3171/jns.2001.94.1.0050; Suehiro E, 2015, J NEUROTRAUM, V32, P353, DOI 10.1089/neu.2014.3584; The Japan Society of Neurotraumatology, 2001, GUID MAN SEV HEAD IN; Wu X, 2015, INJURY, V46, P35, DOI 10.1016/j.injury.2014.08.002	20	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	OCT	2016	94						437	441		10.1016/j.wneu.2016.07.040			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EF5EJ	WOS:000390353200057	27450973				2022-02-06	
J	Korogod, SM; Demianenko, LE				Korogod, S. M.; Demianenko, L. E.			Temperature Deactivation of the Depolarizing TRP Current as a Mechanism of Hypothermia-Related Inhibition of Neuronal Activity: a Model Study	NEUROPHYSIOLOGY			English	Article						computer models; TRP channels; granule neuron of the hippocampus; excitability; temperature sensitivity; therapeutic hypothermia	TRAUMATIC BRAIN-INJURY; THERAPEUTIC HYPOTHERMIA; MODULATION; CHANNELS; CALCIUM	Therapeutic neuroprotective hypothermia is becoming increasingly used to suppress abnormally high neuronal activity in the brain occurring under conditions of ischemic and traumatic injuries, refractory epilepsy, etc. This makes especially topical examination of the factors determining the temperature dependence of the intensity of neuronal excitation. In this respect, of interest are thermosensitive TRP-type channels conducting depolarization currents and found in central neurons. We explored such channels and their functional role using computer modeling. These channels were present in the membrane of a simulated dentate gyrus granule cell of the hippocampus. The chanels can be in two states, open and closed, and the probabilities of these states are temperature-dependent. The model adequately reproduced the key feature of the prototype, namely voltage-dependent activation of TRP channels shifted toward depolarization with a decrease in the temperature. At identical potentials, the level of such activation was reduced, i.e., a deactivation phenomenon was observed. The decrease of temperature from 37 degrees C (normothermia) to 20 degrees C (focal deep hypothermia) was accompanied by a significant decrease in the frequency of action potentials generated by the simulated neuron in response to tonic synaptic excitation of the same intensity. This hypothermic inhibition was most pronounced within the temperature range where temperature-dependent deactivation of TRP channels developed. This effect was much less manifested in the case where TRP channels were " turned off," which mimicked their genetic knockout. Such results obtained on a rather simplified model reveal new aspects of the neuroprotective effect of hypothermia, which deserves further in-depth studies.	[Korogod, S. M.] Natl Acad Sci Ukraine, Int Ctr Mol Physiol, Dnipropetrovsk Div, Dnipro, Ukraine; [Demianenko, L. E.] Minist Publ Hlth Ukraine, Dnipropetrovsk Med Acad, Dnipro, Ukraine		Korogod, SM (corresponding author), Natl Acad Sci Ukraine, Int Ctr Mol Physiol, Dnipropetrovsk Div, Dnipro, Ukraine.; Demianenko, LE (corresponding author), Minist Publ Hlth Ukraine, Dnipropetrovsk Med Acad, Dnipro, Ukraine.	dnipro@biph.kiev.ua; liliya.mailss@gmail.com	Korogod, Sergiy M/G-6675-2013	Demianenko, Liliia/0000-0001-6252-3040			ABBOTT LF, 1991, NETWORK-COMP NEURAL, V2, P245, DOI 10.1088/0954-898X/2/3/002; Aradi I, 1999, J COMPUT NEUROSCI, V6, P215, DOI 10.1023/A:1008801821784; Bregy A, 2012, EXP NEUROL, V233, P821, DOI 10.1016/j.expneurol.2011.12.008; Carnevale N. T., 2006, NEURON BOOK; Chavez AE, 2014, J NEUROSCI, V34, P16621, DOI 10.1523/JNEUROSCI.3635-14.2014; COLLINS CA, 1982, Q J EXP PHYSIOL CMS, V67, P41, DOI 10.1113/expphysiol.1982.sp002623; Dietrich WD, 2016, BRAIN RES, V1640, P94, DOI 10.1016/j.brainres.2015.12.034; Dietrich WD, 2011, NEUROTHERAPEUTICS, V8, P229, DOI 10.1007/s13311-011-0035-3; Drury PP, 2010, SEMIN FETAL NEONAT M, V15, P287, DOI 10.1016/j.siny.2010.05.005; Fujii M, 2012, EPILEPSIA, V53, P485, DOI 10.1111/j.1528-1167.2011.03388.x; Hartwig C., 2014, NEUROSCI LETT, P1; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hofmann T, 2003, CURR BIOL, V13, P1153, DOI 10.1016/S0960-9822(03)00431-7; Kim YS, 2013, J NEUROPHYSIOL, V109, P1174, DOI 10.1152/jn.01168.2011; Lei YT, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00267; Liu D, 2003, P NATL ACAD SCI USA, V100, P15160, DOI 10.1073/pnas.2334159100; Luscombe M, 2006, BJA EDUC, V6, P23, DOI 10.1093/ceaccp/mki064; Menigoz A, 2016, PFLUG ARCH EUR J PHY, V468, P593, DOI 10.1007/s00424-015-1764-7; Motamedi GK, 2013, EPILEPSIA, V54, P959, DOI 10.1111/epi.12144; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Polderman KH, 2009, CRIT CARE MED, V37, P1101, DOI 10.1097/CCM.0b013e3181962ad5; Prawitt D, 2003, P NATL ACAD SCI USA, V100, P15166, DOI 10.1073/pnas.2334624100; Rothman SM, 2009, NEUROTHERAPEUTICS, V6, P251, DOI 10.1016/j.nurt.2008.12.002; Shankaran S, 2012, CURR TREAT OPTION NE, V14, P608, DOI [10.1007/s11940-012-0200-y, 10.1097/MOP.0000000000000199]; Shibasaki K, 2007, J NEUROSCI, V27, P1566, DOI 10.1523/JNEUROSCI.4284-06.2007; Silveira RC, 2015, J PEDIAT-BRAZIL, V91, pS78, DOI 10.1016/j.jped.2015.07.004; Talavera K, 2005, NATURE, V438, P1022, DOI 10.1038/nature04248; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Voets T, 2012, REV PHYSIOL BIOCH P, V162, P91, DOI 10.1007/112_2011_5; Wilson M, 2016, CRIT CARE NURS CLIN, V28, P125, DOI 10.1016/j.cnc.2015.10.006; Yarishkin O, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0080-z; Yokobori S, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0137-4; YUEN GLF, 1991, NEUROSCIENCE, V41, P411, DOI 10.1016/0306-4522(91)90337-N; Zhang Z, 2007, J NEUROSCI, V27, P5777, DOI 10.1523/JNEUROSCI.4973-06.2007	34	1	1	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-2977	1573-9007		NEUROPHYSIOLOGY+	Neurophysiology	OCT	2016	48	5					324	331		10.1007/s11062-017-9605-2			8	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	EQ6MS	WOS:000398196700001					2022-02-06	
J	Kristofersson, GK; Beckers, T; Krueger, R				Kristofersson, Gisli K.; Beckers, Tom; Krueger, Rick			Perceptions of an Adapted Mindfulness Program for Persons Experiencing Substance Use Disorders and Traumatic Brain Injury	JOURNAL OF ADDICTIONS NURSING			English	Article						mindfulness; substance use disorders; traumatic brain injury	MAJOR DEPRESSIVE DISORDER; QUALITY-OF-LIFE; STRESS REDUCTION; METAANALYSIS; BENEFITS; STUDENTS; OUTCOMES; ABUSE; TBI	Background: Of the 1.4 million Americans who sustain traumatic brain injuries (TBIs) each year up to half experience substance use disorders (SUDs). This often leads to various issues such as increased rates of mental health problems and delay or lack of return to full employment. Aims: The purpose of this program evaluation was to describe Vinland National Center's (Vinland's) client and staff perceptions of a 4-week mindfulness-based intervention adapted from the original mindfulness-based stress reduction program for persons experiencing SUDs and TBIs. It focused on the possible relevance and applicability of mindfulness practice for this population. Method: Four focus groups were conducted based on Krueger's methods in conducting focus groups: two with Vinland staff members and two focus groups with residents. Results: The analysis of staff focus groups revealed general staff satisfactions with the intervention. A general consensus was that the mindfulness intervention fitted well with the needs of Vinland's clients and their current program. Client feedback further revealed general satisfaction with the mindfulness curriculum. No adverse effects were noted related to the mindfulness intervention. Conclusions: The results of this program evaluation suggest that implementing a mindfulness-based intervention for persons experiencing SUDs/TBIs warrants further investigation.	[Kristofersson, Gisli K.] Univ Akureyri, Sch Hlth Sci, Solborg 5 Nordurslod, IS-600 Akureyri, Iceland; [Kristofersson, Gisli K.] Univ Minnesota, Ctr Spiritual & Healing, Minneapolis, MN USA; [Kristofersson, Gisli K.] Univ Minnesota, Sch Nursing, Minneapolis, MN 55455 USA; [Beckers, Tom; Krueger, Rick] Vinland Natl Ctr, Loretto, MN USA		Kristofersson, GK (corresponding author), Univ Akureyri, Sch Hlth Sci, Solborg 5 Nordurslod, IS-600 Akureyri, Iceland.	gislik@unak.is		Kristofersson, Gisli/0000-0002-5102-4569	Trust for the Meditation Process, a charitable foundation encouraging meditation and contemplative prayer	This project was made possible by a grant from the Trust for the Meditation Process, a charitable foundation encouraging meditation and contemplative prayer (http://www.trustformeditation.org).	Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Azulay J, 2013, J HEAD TRAUMA REHAB, V28, P323, DOI 10.1097/HTR.0b013e318250ebda; Bedard Michel, 2012, Adv Mind Body Med, V26, P14; Bjork JM, 2009, J NEUROTRAUM, V26, P1077, DOI [10.1089/neu.2008.0849, 10.1089/neu.2008-0849]; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; CARNEY J, 1994, PEDIATR ANN, V23, P47, DOI 10.3928/0090-4481-19940101-10; Chiesa A, 2010, PSYCHOL MED, V40, P1239, DOI 10.1017/S0033291709991747; Chiesa A, 2014, SUBST USE MISUSE, V49, P492, DOI 10.3109/10826084.2013.770027; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P29; Cox WM, 2003, J ADDICT DIS, V22, P93, DOI 10.1300/J069v22n01_07; Ehlhardt LA, 2008, NEUROPSYCHOL REHABIL, V18, P300, DOI 10.1080/09602010701733190; Glang A, 2008, J HEAD TRAUMA REHAB, V23, P243, DOI 10.1097/01.HTR.0000327256.46504.9f; Goyal M, 2014, JAMA INTERN MED, V174, P357, DOI 10.1001/jamainternmed.2013.13018; Graham DP, 2008, ANN NY ACAD SCI, V1141, P148, DOI 10.1196/annals.1441.029; Grossman P, 2004, J PSYCHOSOM RES, V57, P35, DOI 10.1016/S0022-3999(03)00573-7; Guilfoyle MR, 2010, J NEUROTRAUM, V27, P2173, DOI 10.1089/neu.2010.1353; Hofmann SG, 2010, J CONSULT CLIN PSYCH, V78, P169, DOI 10.1037/a0018555; Hux K, 2010, BRAIN INJURY, V24, P13, DOI 10.3109/02699050903446823; Jacobsson LJ, 2010, BRAIN INJURY, V24, P1075, DOI 10.3109/02699052.2010.494590; Johansson B, 2012, BRAIN INJURY, V26, P1621, DOI 10.3109/02699052.2012.700082; Johansson B, 2015, MINDFULNESS, V6, P227, DOI 10.1007/s12671-013-0249-z; Kabat-Zinn, 1994, WHEREVER YOU GO THER; Kabat-Zinn J, 1990, STRESS REDUCTION CLI; Krueger RA, 2001, SOCIAL ANAL SELECTED, P4; Lattimore P, 2011, APPETITE, V56, P241, DOI 10.1016/j.appet.2010.12.007; Lovasik D, 2001, Crit Care Nurs Q, V23, P24; MacLennan DL, 2008, NEUROREHABILITATION, V23, P521; Mateer CA, 2006, NEUROREHABILITATION, V21, P315; McCown D, 2010, TEACHING MINDFULNESS: A PRACTICAL GUIDE FOR CLINICIANS AND EDUCATORS, P1, DOI 10.1007/978-0-387-09484-7; McMillan T., 2002, NEUROPSYCHOLOGICAL R, V12; Micozzi Marc S., 2006, FUNDAMENTALS COMPLEM; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; Shapiro SL, 2009, J CLIN PSYCHOL, V65, P555, DOI 10.1002/jclp.20602; Thaxton L, 2002, J HEAD TRAUMA REHAB, V17, P335, DOI 10.1097/00001199-200208000-00007; Thombs BD, 2010, JAMA-J AM MED ASSOC, V304, P857, DOI 10.1001/jama.2010.1170; Winbush NY, 2007, EXPLORE-NY, V3, P585, DOI 10.1016/j.explore.2007.08.003; Ylvisaker M, 2001, J HEAD TRAUMA REHAB, V16, P76, DOI 10.1097/00001199-200102000-00009	38	1	1	1	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1088-4602	1548-7148		J ADDICT NURS	J. Addict. Nurs.	OCT-DEC	2016	27	4					247	253		10.1097/JAN.0000000000000144			7	Substance Abuse; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse; Nursing	EF0TZ	WOS:000390040300006	27922476				2022-02-06	
J	Kumar, R; Htwe, O; Baharudin, A; Ariffin, MH; Rhani, SA; Ibrahim, K; Rustam, A; Gan, R				Kumar, Ramesh; Htwe, Ohnmar; Baharudin, Azmi; Ariffin, Mohammad Hisam; Rhani, Shaharuddin Abdul; Ibrahim, Kamalnizat; Rustam, Aishah; Gan, Robert			Spinal Cord Injury-Assessing Tolerability and Use of Combined Rehabilitation and NeuroAiD (SATURN Study): Protocol of An Exploratory Study In Assessing the Safety and Efficacy of NeuroAiD Amongst People Who Sustain Severe Spinal Cord Injury	JMIR RESEARCH PROTOCOLS			English	Article						spinal cord injury; NeuroAiD; MLC601; MLC901; safety; recovery; efficacy	TRADITIONAL CHINESE MEDICINE; TRAUMATIC BRAIN-INJURY; STROKE RECOVERY; CLINICAL-TRIALS; ICCP PANEL; DOUBLE-BLIND; MLC601 NEUROAID(R); CHIMES; GUIDELINES; CONDUCT	Background: Spinal cord injury (SCI) is a devastating condition with limited therapeutic options despite decades of research. Current treatment options include use of steroids, surgery, and rehabilitation. Nevertheless, many patients with SCI remain disabled. MLC601 (NeuroAiD), a combination of natural products, has been shown to be safe and to aid neurological recovery after brain injuries and may have a potential role in improving recovery after SCI. Objective: The aim of this study is to evaluate the safety and efficacy of NeuroAiD amongst people who sustain SCI in the study setting. Methods: Spinal Cord Injury-Assessing Tolerability and Use of Combined Rehabilitation and NeuroAiD (SATURN) is a prospective cohort study of patients with moderately severe to severe SCI, defined as American Spinal Injury Association (ASIA) Impairment Scale (AIS) A and B. These patients will be treated with open-label NeuroAiD for 6 months in addition to standard care and followed for 24 months. Anonymized data will be prospectively collected at baseline and months 1, 3, 6, 12, 18, and 24 and will include information on demographics; main diagnostics; and neurological and functional state assessed by the Spinal Cord Independence Measure, ASIA-International Standard for Neurological Classification Spinal Cord Injury, and Short Form (SF-8) Health Survey. In addition, NeuroAiD treatment, compliance, concomitant therapies, and side effects, if any, will be collected. Investigators will use a secured online system for data entry. The study is approved by the ethics committee of Hospital University Kebangsaan Malaysia. Results: The coprimary endpoints are safety, AIS grade, and improvement in ASIA motor score at 6 months. Secondary endpoints are AIS grade, ASIA motor scores and sensory scores, Spinal Cord Independence Measure (SCIM), SF-8 Health Survey, and compliance at other time points. Conclusions: SATURN investigates the promising role of NeuroAiD in SCI especially given its excellent safety profile. We described here the protocol and online data collection tool we will use for this prospective cohort study. The selection of moderately severe to severe SCI provides an opportunity to investigate the role of NeuroAiD in addition to standard rehabilitation in patients with poor prognosis. The results will provide important information on the feasibility of conducting larger controlled trials to improve long-term outcome of patients with SCI.	[Kumar, Ramesh] Univ Kebangsaan Malaysia, Med Ctr, Fac Med, Dept Neurosurg, Jalan Yaacob Latif, Kuala Lumpur, Malaysia; [Htwe, Ohnmar; Baharudin, Azmi; Ariffin, Mohammad Hisam; Rhani, Shaharuddin Abdul; Ibrahim, Kamalnizat] Univ Kebangsaan Malaysia, Med Ctr, Fac Med, Dept Orthopaed & Traumatol, Kuala Lumpur, Malaysia; [Rustam, Aishah; Gan, Robert] Moleac, Med Affairs, Biopolis Way, Singapore, Singapore		Kumar, R (corresponding author), Univ Kebangsaan Malaysia, Med Ctr, Fac Med, Dept Neurosurg, Jalan Yaacob Latif, Kuala Lumpur, Malaysia.	rameshkumar71@hotmail.com		Rustam, Aishah/0000-0002-2356-690X; Gan, Robert/0000-0003-0317-0374; HTWE, OHNMAR/0000-0001-6303-9859; KUMAR, RAMESH/0000-0002-4979-9031	Moleac Singapore Pte Ltd, Singapore	This study is supported in part by Moleac Singapore Pte Ltd, 11 Biopolis Way #09-08 Helios, Singapore 138667. RK has received support for clinical trials and presentations at scientific meetings from Moleac Singapore. AR and RG are employees of Moleac Singapore. Other than support for this study, the other authors have no other competing interests to declare.	Chankrachang S, 2015, J STROKE CEREBROVASC, V24, P823, DOI 10.1016/j.jstrokecerebrovasdis.2014.11.017; Chen C, 2009, STROKE, V40, P859, DOI 10.1161/STROKEAHA.108.531616; Chen CLH, 2013, STROKE, V44, P3580, DOI 10.1161/STROKEAHA.113.003226; Chen CLH, 2013, STROKE, V44, P2093, DOI 10.1161/STROKEAHA.113.002055; Chen CLH, 2013, CEREBROVASC DIS, V35, P23, DOI 10.1159/000346234; Fawcett JW, 2007, SPINAL CORD, V45, P190, DOI 10.1038/sj.sc.3102007; Gan R, 2008, CEREBROVASC DIS, V25, P450, DOI 10.1159/000126919; Ghandehari K, 2011, NEURAL REGEN RES, V6, P418, DOI 10.3969/j.issn.1673-5374.2011.06.003; Harandi AA, 2011, STROKE RES TREAT, V2011, DOI 10.4061/2011/721613; Heurteaux C, 2013, CEREBROVASC DIS, V35, P1, DOI 10.1159/000346228; Heurteaux C, 2010, NEUROPHARMACOLOGY, V58, P987, DOI 10.1016/j.neuropharm.2010.01.001; Kaishibayev N, 2012, WORLD STROK C BRAS B; Kong KH, 2009, CEREBROVASC DIS, V28, P514, DOI 10.1159/000247001; Kumar R, 2015, AS AUSTR C NEUR SURG; Kumar R, 2014, INT C NEUR EP KUAL L; Lammertse D, 2007, SPINAL CORD, V45, P232, DOI 10.1038/sj.sc.3102010; Lee BB, 2014, SPINAL CORD, V52, P110, DOI 10.1038/sc.2012.158; Maati HMO, 2012, NEUROPHARMACOLOGY, V63, P692, DOI 10.1016/j.neuropharm.2012.05.035; Navarro JC, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/506387; Navarro JC, 2014, INT J STROKE, V9, P102, DOI 10.1111/ijs.12324; Navarro JC, 2013, INT J STROKE, V8, P491, DOI 10.1111/ijs.12044; Quintard H, 2014, NEUROSCIENCE, V277, P72, DOI 10.1016/j.neuroscience.2014.06.047; Quintard H, 2011, NEUROPHARMACOLOGY, V61, P622, DOI 10.1016/j.neuropharm.2011.05.003; Shahripour RB, 2014, CHIN J INTEGR MED, V20, P812, DOI 10.1007/s11655-014-1687-8; Shahripour RB, 2011, EUR J INTERN MED, V22, P509, DOI 10.1016/j.ejim.2011.01.002; Siddiqui FJ, 2013, CEREBROVASC DIS, V35, P8, DOI 10.1159/000346231; Silva NA, 2014, PROG NEUROBIOL, V114, P25, DOI 10.1016/j.pneurobio.2013.11.002; Siow CHC, 2008, EUR NEUROL, V60, P264, DOI 10.1159/000155220; Steeves JD, 2007, SPINAL CORD, V45, P206, DOI 10.1038/sj.sc.3102008; Tsai MC, 2015, J NEUROIMMUNE PHARM, V10, P45, DOI 10.1007/s11481-014-9570-0; Tuszynski MH, 2007, SPINAL CORD, V45, P222, DOI 10.1038/sj.sc.3102009; Venketasubramanian N, 2009, INT J STROKE, V4, P54, DOI 10.1111/j.1747-4949.2009.00237.x; Venketasubramanian N, 2015, CEREBROVASC DIS, V39, P309, DOI 10.1159/000382082; World Health Organization, NEUROAID US WHO UMC; Yeo T.T., 2010, INT J STROKE S2, V5, P308, DOI [10.1111/j.1747-4949.2010.00480.x, DOI 10.1111/J.1747-4949.2010.00480.X]; Young SHY, 2010, CEREBROVASC DIS, V30, P1, DOI 10.1159/000313398	36	1	1	0	3	JMIR PUBLICATIONS, INC	TORONTO	59 WINNERS CIRCLE, TORONTO, ON M4L 3Y7, CANADA	1929-0748			JMIR RES PROTOC	JMIR RES. Protoc.	OCT-DEC	2016	5	4							e230	10.2196/resprot.6275			9	Health Care Sciences & Services; Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	EG4VR	WOS:000391042300043	27919862	Green Submitted, Green Published, gold			2022-02-06	
J	Oliveira, DMD; Pereira, CU; Freitas, ZMD				Oliveira, Debora Moura da P.; Pereira, Carlos Umberto; Freitas, Zaira Moura da P.			Prognosis of Patients With Traumatic Brain Injury After Implementation of a Nurse Assessment Protocol	JOURNAL OF NEUROSCIENCE NURSING			English	Article						brain trauma; morbidity; mortality; prognosis; protocols	GLASGOW COMA SCALE; MORTALITY; PREDICTION; AGE	Background: The prognosis of a patient with traumatic brain injury (TBI) depends on the severity of the injury, the patient's level of consciousness upon admission, and differences in treatment protocols. Aim: The aim of this study was to analyze the prognosis of TBI victims after implementation of a nurse assessment protocol. Method: This is a blind, nonrandomized clinical study carried out at a public emergency hospital in the state of Sergipe, Brazil. Results: The study involved 480 patients with an average (SD) age of 35.7 (+/- 16.6) years. Most of the patients were male (p = .02). In the preprotocol and postprotocol groups, motorcycle accidents (p = .023) were more frequent, with a 10.2% death rate. The clinical conditions associated with TBI and the tomographic findings were not affected in either the preprotocol or postprotocol groups (p = .07). There was a significant reduction (p = .05) in death rate from 12.6% to 7.3% and a decrease in the percentage of discharge with aftereffects from 32.8% to 22.8%. Factors independently associated with mortality were as follows: approximately 2.5 times more likely to not apply the protocol associated with an increased chance of death, followed by a 23 times higher risk of TBI severity, and age, with an odds ratio of 1.04. Conclusions: Implementing the protocol, there was a reduction of death rate of patients with severe TBI and aftereffects in patients with moderate TBI. The severity of TBI was the main independent predictive determinant of mortality, followed by nonuse of protocol and age.	[Oliveira, Debora Moura da P.; Freitas, Zaira Moura da P.] Univ Fed Sergipe, Hlth Sci, Aracaju, Brazil; [Pereira, Carlos Umberto] Univ Fed Sergipe, Dept Med, Aracaju, Brazil		Oliveira, DMD (corresponding author), Univ Fed Sergipe, Hlth Sci, Aracaju, Brazil.	debora_aju@yahoo.com.br					Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Anness E., 2009, AM NURSE TODAY; Aylin P, 2010, QUAL SAF HEALTH CARE, V19, P213, DOI 10.1136/qshc.2008.028639; Settervall CHC, 2011, REV LAT-AM ENFERM, V19, P1337, DOI 10.1590/S0104-11692011000600009; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; Ercegovic Z., 2011, ACTA MED SALINIANA, V40, P52; Ghanem H. M., 2012, J AM SCI, V8, P686; Graves JM, 2013, J SAFETY RES, V45, P133, DOI 10.1016/j.jsr.2012.11.001; Harrison-Felix C, 2012, J HEAD TRAUMA REHAB, V27, pE45, DOI 10.1097/HTR.0b013e31827340ba; Hoffmann M, 2012, BRIT J SURG, V99, P122, DOI 10.1002/bjs.7707; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Katsnelson M, 2012, NEUROSURGERY, V70, P1095, DOI 10.1227/NEU.0b013e318240c1ed; Ley EJ, 2013, J TRAUMA ACUTE CARE, V75, P682, DOI 10.1097/TA.0b013e31829d024f; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Pearson WS, 2012, PREHOSP EMERG CARE, V16, P323, DOI 10.3109/10903127.2012.682701; Rehn M, 2012, BRIT J SURG, V99, P199, DOI 10.1002/bjs.7794; Schneider EB, 2012, J SURG RES, V177, P295, DOI 10.1016/j.jss.2012.06.022; Schonberger M, 2009, J NEUROTRAUM, V26, P2157, DOI 10.1089/neu.2009.0939; Timmons SD, 2011, J TRAUMA, V71, P1172, DOI 10.1097/TA.0b013e31822b0f4b	20	1	1	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0888-0395	1945-2810		J NEUROSCI NURS	J. Neurosci. Nurs.	OCT	2016	48	5					278	284		10.1097/JNN.0000000000000219			7	Clinical Neurology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Nursing	DX4BT	WOS:000384324600011	27579964				2022-02-06	
J	Palacios, CRF; Haugen, EN; Thompson, AM; Rasmussen, RW; Goracke, N; Goyal, P				Palacios, Carlos R. Franco; Haugen, Eric N.; Thompson, Amanda M.; Rasmussen, Richard W.; Goracke, Nathan; Goyal, Pankaj			Clinical outcomes with a systolic blood pressure lower than 120mmHg in older patients with high disease burden	RENAL FAILURE			English	Article						Hypertension; chronic kidney disease; elderly; cardiovascular disease; outcomes	RENAL-FUNCTION; HYPERTENSION; MORTALITY; ADULTS; AGE	Background: The target blood pressure in older patients is controversial. Recent studies provided clinical evidence supporting a target systolic blood pressure <120mmHg in patients >50 years at high risk of cardiovascular events.Methods: Retrospective study of 380 consecutive patients 60 years with stages 1-5 pre-dialysis chronic kidney disease seen between January 2013 and November 2015. The outcomes of a systolic blood pressure <120mmHg in older patients with chronic kidney disease and multiple comorbidities were analyzed.Results: Sixty-eight patients had a systolic blood pressure<120mmHg, 312 patients had a systolic blood pressure120mmHg. Forty-three patients died during the follow up (11.3%). Patients with a systolic blood pressure <120mmHg had a higher risk of death: 21 (30.9%) vs 22 (7%).Primary cause of death: Cardiovascular: 11 (25.6%), infectious 9 (20.9%), cancer 5 (11.6%), renal failure 6 (13.9%), COPD/pulmonary fibrosis 2 (4.6%), end stage liver disease 3 (6.9%), traumatic brain injury 1 (2.3%), gastrointestinal hemorrhage 4 (9.3%), complications of diabetes 1 (2.3%), unknown 1 (2.3%). After adjusting for confounding factors, a systolic blood pressure <120mmHg remained associated with increased mortality. There was a trend to more cardiovascular outcomes in those with a lower blood pressure.Conclusions: A systolic blood pressure below 120mmHg in older patients with high disease burden was associated with adverse outcomes. Individualization of blood pressure therapy to each specific patient is warranted.	[Palacios, Carlos R. Franco; Haugen, Eric N.; Rasmussen, Richard W.] Rice Mem Hosp, Dept Nephrol, Affiliated Community Med Ctr, Willmar, MN USA; [Thompson, Amanda M.; Goracke, Nathan] Rice Mem Hosp, Dept Pharm, Willmar, MN USA; [Goyal, Pankaj] Rice Mem Hosp, Hosp Med Dept, Affiliated Community Med Ctr, Willmar, MN USA		Palacios, CRF (corresponding author), Rice Mem Hosp, Affiliated Community Med Ctr, 101 Willmar Ave SW, Willmar, MN 56201 USA.	drcarlosfranco@yahoo.com					Bakris GL, 2000, AM J KIDNEY DIS, V36, P646, DOI 10.1053/ajkd.2000.16225; Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Dolan E, 2005, HYPERTENSION, V46, P156, DOI 10.1161/01.HYP.0000170138.56903.7a; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Kovesdy CP, 2013, ANN INTERN MED, V159, P233, DOI 10.7326/0003-4819-159-4-201308200-00004; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; MADHAVAN S, 1994, HYPERTENSION, V23, P395, DOI 10.1161/01.HYP.23.3.395; O'Hare AM, 2007, J AM SOC NEPHROL, V18, P2758, DOI 10.1681/ASN.2007040422; Palacios CRF, 2015, RENAL FAILURE, V37, P961, DOI 10.3109/0886022X.2015.1044399; Palombo C, 2016, VASC PHARMACOL, V77, P1, DOI 10.1016/j.vph.2015.11.083; Sim JJ, 2014, J AM COLL CARDIOL, V64, P588, DOI 10.1016/j.jacc.2014.04.065; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Tinetti ME, 2014, JAMA INTERN MED, V174, P588, DOI 10.1001/jamainternmed.2013.14764; Weber MA, 2014, J HYPERTENS, V32, P3, DOI [10.1111/jch.12237, 10.1097/HJH.0000000000000065]; Weiss JW, 2015, CLIN J AM SOC NEPHRO, V10, P1553, DOI 10.2215/CJN.11391114	16	1	1	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0886-022X	1525-6049		RENAL FAILURE	Ren. Fail.	OCT	2016	38	9					1364	1369		10.1080/0886022X.2016.1227924			6	Urology & Nephrology	Science Citation Index Expanded (SCI-EXPANDED)	Urology & Nephrology	ED5ZJ	WOS:000388932600008	27607547	gold			2022-02-06	
J	Qalab, A; Asad, R; Hakeem, M; Ahmed, M; Anwar, H; Darbar, A				Qalab, Abbas; Asad, Rayaan; Hakeem, Mahnaz; Ahmed, Maria; Anwar, Haque; Darbar, Aneela			Paediatric External Ventricular Drains: Experience from a tertiary care hospital of a Developing Country	JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION			English	Article						EVD; Paediatric; Hydrocephalus; Infections; Complications		The aim of the study was to describe indications and complications of external ventricular drain (EVD) placement in children aged between 1 month and 16 years. This retrospective chart review was conducted at the Aga Khan University Hospital, Karachi, and comprised all children who underwent EVD placement from January 2007 to December 2014. Of the 177 patients identified, 117(66%) were males 60(34%) were girls. The overall mean age was 5.4 +/- 5.2 years. The median Glasgow Coma Scale score on presentation and discharge was 13 (interquartile range [IQR]: 7) and 15 (IQR: 4), respectively. Major diagnosis included intracranial tumour 60(34%), bacterial meningitis 34(19%), tuberculous meningitis 33(18.6%), and haemorrhage 23(13%). Clinical indications for EVD insertion were acute hydrocephalus secondary to infection 64(36.2%), tumour 54(30.5%), and haemorrhage 23(13%) ventriculoperitoneal shunt malfunction or infection 25(14.1%) and traumatic brain injury 11(6.2%). Complications were observed in 47(26%) patients including infections 25(14.1%), malfunction 11(6.2%), haemorrhage 6(3.4%), misplacement 3(1.7%) and obstruction 2(1.1%). Staphylococcus was the main organism isolated. Moreover, 25(14%) patients expired. Acute hydrocephalus was the major indication and EVD infection was the major complication.	[Qalab, Abbas; Hakeem, Mahnaz; Ahmed, Maria] Aga Khan Univ, Dept Pediat & Child Hlth, Karachi, Pakistan; [Asad, Rayaan; Darbar, Aneela] Aga Khan Univ, Karachi, Pakistan; [Anwar, Haque] Aga Khan Univ, Dept Surg, Sect Neurosurg, Karachi, Pakistan		Qalab, A (corresponding author), Aga Khan Univ, Dept Pediat & Child Hlth, Karachi, Pakistan.	qalab.abbas@aku.edu					Arif SH, 2012, JK PRACT, V17, P27; Bratton SL, 2007, J NEUROTRAUMA S1, V24, pS45, DOI DOI 10.1089/NEU.2007.9989; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; FRIEDMAN WA, 1980, J NEUROSURG, V53, P662, DOI 10.3171/jns.1980.53.5.0662; Hill M, 2012, J NEUROSCI NURS, V44, P188, DOI 10.1097/JNN.0b013e3182527672; Kubilay Z, 2013, J NEUROSURG, V118, P514, DOI 10.3171/2012.11.JNS121336; Kulkarni AV, 2009, PEDIATR CRIT CARE ME, V10, P412, DOI 10.1097/PCC.0b013e3181a32f75; Ngo QN, 2009, PEDIATR CRIT CARE ME, V10, P346, DOI 10.1097/PCC.0b013e3181a320cd; Rafiq Mirza Faisal Ahmed, 2011, J Ayub Med Coll Abbottabad, V23, P118; Walker CT, 2012, PEDIATR NEUROSURG, V48, P342, DOI 10.1159/000353608	10	1	2	0	0	PAKISTAN MEDICAL ASSOC	KARACHI	PMA HOUSE, AGA KHAN III RD, KARACHI, 00000, PAKISTAN	0030-9982			J PAK MED ASSOC	J. Pak. Med. Assoc.	OCT	2016	66	10		3			S72	S74					3	Medicine, General & Internal; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Research & Experimental Medicine	VI2UF	WOS:000467475900023	27895360				2022-02-06	
J	Ujjan, B; Waqas, M; Khan, MB; Bakhshi, SK; Bari, ME				Ujjan, Badar; Waqas, Muhammad; Khan, Muhammad Babar; Bakhshi, Saqib Kamran; Bari, Muhammad Ehsan			Paediatric traumatic brain injury: Presentation, prognostic indicators and Outcome analysis from a tertiary care center in a developing country	JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION			English	Article						Traumatic brain injury; Paediatrics; Prognostic factors; Outcomes; Developing country		Traumatic brain injury (TBI) is the leading cause of morbidity and mortality in children worldwide. This study was conducted to report the presentation, management, outcomes and prognostic indicators in a large series of patients from a tertiary care centre in a developing country. It is a review of prospectively collected data of paediatric patients with TBI admitted at our centre between July 2010 and December 2013. A total of 291 patients with a mean age of 7.2 +/- 5.0 years were dichotomised into survivors and non-survivors, and variables were compared between the two groups. The mean post-resuscitation Glasgow coma scale (GCS) score was 11.6 +/- 3.9, mean Marshall Score was 2.26 +/- 0.95 and the mean revised trauma score at presentation was 10.58 +/- 1.7. Younger age, lower GCS score after resuscitation, lower revised trauma score, absent cisterns on imaging, associated subarachnoid haemorrhage (SAH) and intraventricular haemorrhage (IVH) and a lower Marshall score were associated with higher mortality.	[Ujjan, Badar; Waqas, Muhammad; Khan, Muhammad Babar; Bakhshi, Saqib Kamran; Bari, Muhammad Ehsan] Aga Khan Univ Hosp, Sect Neurosurg, Dept Surg, Karachi, Pakistan		Bari, ME (corresponding author), Aga Khan Univ Hosp, Sect Neurosurg, Dept Surg, Karachi, Pakistan.	ehsan.bari@aku.edu	Khan, Muhammad Babar/T-9016-2019				Alexiou George A, 2011, J Emerg Trauma Shock, V4, P403, DOI 10.4103/0974-2700.83872; American College of Surgeons, 2004, ADV TRAUM LIF SUPP A; Atabaki SM, 2007, PEDIATR REV, V28, P215, DOI 10.1542/pir.28-6-215; Dawodu ST, TRAUMATIC BRAIN INJU; Dinh MM, 2013, INJURY, V44, P606, DOI 10.1016/j.injury.2012.01.011; Ezenkwele U A, 2001, Inj Prev, V7, P245, DOI 10.1136/ip.7.3.245; Jennett B, 1998, ARCH DIS CHILD, V78, P403, DOI 10.1136/adc.78.5.403; Quayle KS, 2014, NEW ENGL J MED, V371, P1945, DOI 10.1056/NEJMc1407902; Sharma M, 1994, Indian Pediatr, V31, P733; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tonks James, 2011, Clin Child Psychol Psychiatry, V16, P185, DOI 10.1177/1359104511403583	11	1	1	0	0	PAKISTAN MEDICAL ASSOC	KARACHI	PMA HOUSE, AGA KHAN III RD, KARACHI, 00000, PAKISTAN	0030-9982			J PAK MED ASSOC	J. Pak. Med. Assoc.	OCT	2016	66	10		3			S65	S67					3	Medicine, General & Internal; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Research & Experimental Medicine	VI2UF	WOS:000467475900021	27895358				2022-02-06	
J	Yoshizawa, J; Namiki, J; Nishida, Y; Kaneko, Y; Hori, S				Yoshizawa, Joe; Namiki, Jun; Nishida, Yusho; Kaneko, Yasushi; Hori, Shingo			Vitamin K, fresh frozen plasma, and platelet transfusion used to arrest progression of intracranial hemorrhage after traumatic brain injury in a patient taking anticoagulant and antiplatelet agents	ACUTE MEDICINE & SURGERY			English	Article						Anticoagulant; fresh frozen plasma transfusion; platelet transfusion; traumatic brain injury; vitamin K	INTRACEREBRAL HEMORRHAGE; WARFARIN; REVERSAL; CONCENTRATE; ENLARGEMENT; MORTALITY; OUTCOMES; IMPACT	Case: An 89-year-old man fell from stairs and sustained head trauma. He was taking warfarin and aspirin. Upon arrival at our hospital, his Glasgow Coma Scale score was 14. Initial head computed tomography showed small acute subdural hematoma. We immediately administered vitamin K and ordered fresh-frozen plasma. Repeat computed tomography 3 and 6 h after trauma revealed the acute subdural hematoma had increased to 14 and 20 mm, respectively, and there were several new intracranial hemorrhages. Fresh-frozen plasma and platelet transfusion were initiated. Outcome: Follow-up computed tomography revealed no further progression of intracranial hemorrhages, and the patient's consciousness did not deteriorate further. Conclusion: Appropriate administration of vitamin K, fresh-frozen plasma, and platelets successfully arrested progression of traumatic intracranial hemorrhages in this patient taking anticoagulant/antiplatelet agents and may have averted brain surgery.	[Yoshizawa, Joe; Namiki, Jun; Nishida, Yusho; Kaneko, Yasushi; Hori, Shingo] Keio Univ, Dept Emergency & Crit Care Med, Sch Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan		Namiki, J (corresponding author), Keio Univ, Dept Emergency & Crit Care Med, Sch Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	namikijun@a8.keio.jp					Campbell PG, 2010, WORLD NEUROSURG, V74, P279, DOI 10.1016/j.wneu.2010.05.030; Coimbra R, 2005, J TRAUMA, V59, P374, DOI 10.1097/01.ta.000174728.46883.a4; Ferraris VA, 2012, J TRAUMA ACUTE CARE, V73, P492, DOI 10.1097/TA.0b013e31825b85f1; Hackam DG, 2005, CIRCULATION, V111, P2250, DOI 10.1161/01.CIR.0000163548.38396.E7; Inui TS, 2014, J TRAUMA ACUTE CARE, V76, P642, DOI 10.1097/TA.0000000000000138; Ivascu FA, 2005, J TRAUMA, V59, P1131, DOI 10.1097/01.ta.0000189067.16368.83; Ivascu FA, 2006, J TRAUMA, V61, P318, DOI 10.1097/01.ta.0000223944.25922.91; Kuwashiro T, 2011, CEREBROVASC DIS, V31, P170, DOI 10.1159/000321766; Makris M, 1997, THROMB HAEMOSTASIS, V77, P477; McMillian WD, 2009, J TRAUMA, V66, P942, DOI 10.1097/TA.0b013e3181978e7b; Namiki J, 2014, INC SEM CLIN MAN HEA, P36; Peck KA, 2014, J TRAUMA ACUTE CARE, V76, P431, DOI 10.1097/TA.0000000000000107; Siracuse JJ, 2010, SURGERY, V148, P724, DOI 10.1016/j.surg.2010.07.014; Yasaka M, 2003, THROMB HAEMOSTASIS, V89, P278; Yokota H, 2014, JPN J NEUROSURG, V23, P942	15	1	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2052-8817			ACUTE MED SURG	Acute Med. Surg.	OCT	2016	3	4					392	396		10.1002/ams2.200			5	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	EC5YE	WOS:000388212400021	29123820	Green Published			2022-02-06	
J	Safaeian, R; Hassani, V; Faiz, HR				Safaeian, Reza; Hassani, Valiollah; Faiz, Hamid Reza			Anesthesia for Traumatic Diaphragmatic Hernia Associated with Corneal Laceration	AMERICAN JOURNAL OF CASE REPORTS			English	Article						Anesthesia; Corneal Diseases; Hernia; Diaphragmatic	RUPTURE; DIAGNOSIS	Objective: Rare co-existance of disease or pathology Background: Diaphragmatic rupture can be seen in up to 5% of car accidents, and 80%-100% of diaphragmatic hernias are associated with other vital organ injuries. Brain, pelvis, long bones, liver, spleen, and aorta are some other organs that can be severely damaged and need different anesthetic managements. Case Report: A 37-year-old male victim of a head-on collision who was suffering diaphragmatic rupture and corneal laceration was prepared for an emergency operation 11 hours after the car accident. Gastric decompression, preoxygenation, rapid sequence induction with succinylcholine, immediate use of non-depolarizing muscle relaxant, and mechanical ventilation with low tidal volume after intubation were used in anesthetic management of the patient. Conclusions: Because of the high prevalence of coexisting pathologies with traumatic diaphragmatic hernia, anesthetic management must be tailored to the associated pathologies.	[Safaeian, Reza; Hassani, Valiollah; Faiz, Hamid Reza] Iran Univ Med Sci, Dept Anesthesiol, Rasoul Akram Med Complex, Tehran, Iran		Faiz, HR (corresponding author), Iran Univ Med Sci, Dept Anesthesiol, Rasoul Akram Med Complex, Tehran, Iran.	hrfaiz@hotmail.com	faiz, seyed hamid reza/P-2089-2018	faiz, seyed hamid reza/0000-0001-7925-0878; Hassani, Valiollah/0000-0003-1964-6779			Al Skaini M S, 2013, Ann R Coll Surg Engl, V95, pe27, DOI 10.1308/003588413X13511609955337; Alpard SK, 2002, THORACIC TRAUMA CRIT, P479; Drummond JC, 2009, MILLERS ANESTHESIA, P2049; Estes JM, 2006, OBSTET GYNECOL, V107, P530, DOI 10.1097/01.AOG.0000187952.21896.4a; Gwely Noureldin Noaman, 2010, Asian Cardiovasc Thorac Ann, V18, P240, DOI 10.1177/0218492310368740; Hwang Sang-Won, 2011, Korean J Thorac Cardiovasc Surg, V44, P348, DOI 10.5090/kjtcs.2011.44.5.348; Karmy-Jones R, 2002, AM SURGEON, V68, P167; Karmy-Jones R, 2004, CURR PROB SURG, V41, P223, DOI 10.1016/j.cpsurg.2003.12.004; Launey Y, 2007, ANESTH ANALG, V104, P224, DOI 10.1213/01.ane.0000249800.53662.8b; Lee WJ, 2009, BMJ CASE REP, V2009; LIBONATI MM, 1985, ANESTHESIOLOGY, V62, P637, DOI 10.1097/00000542-198505000-00017; LOBB TR, 1974, CAN ANAESTH SOC J, V21, P173, DOI 10.1007/BF03013110; LOEHNING RW, 1965, ARCH SURG-CHICAGO, V90, P109; MEYERS BF, 1993, ANN SURG, V218, P783, DOI 10.1097/00000658-199312000-00013; Pekmezci S, 2007, ULUS TRAVMA ACIL CER, V13, P36; Williams DJ, 2003, BRIT J ANAESTH, V90, P96, DOI 10.1093/bja/aeg007; Yee LL, 1995, TXB MILITARY MED S 4, V1, P455; Yoshidome K, 1992, Nihon Kyobu Geka Gakkai Zasshi, V40, P560; Zisis C, 2006, ANN THORAC SURG, V82, pE1, DOI 10.1016/j.athoracsur.2006.03.079	19	1	1	0	6	INT SCIENTIFIC LITERATURE, INC	SMITHTOWN	361 FOREST LANE, SMITHTOWN, NY 11787 USA	1941-5923			AM J CASE REP	Am. J. Case Rep.	SEP 6	2016	17						646	649		10.12659/AJCR.897908			4	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	EO5EE	WOS:000396715100001	27595907	Green Published			2022-02-06	
J	AbdAllah, NB; Zeitoun, AE; Fattah, MGEA				AbdAllah, Nouran B.; Zeitoun, Alaa El-Din; Fattah, Mostafa Gamal El-Deen Abdel			Adherence to standard admission and discharge criteria and its association with outcome of pediatric intensive care unit cases in Al-Ahrar Hospital Zagazig	EGYPTIAN PEDIATRIC ASSOCIATION GAZETTE			English	Article						Critical care unit; American Academy of Pediatrics; Pediatric index of mortality; Mortality rate; Standard criteria	SCORING SYSTEM; MORTALITY-2 PIM2; INDEX; RISK; PREDICTION; VALIDATION; PRISM; COST	Background: The effective use of pediatric intensive care unit (PICU) beds is an important issue as they are expensive and have limited resources. Adherence to well-defined admission and discharge criteria for PICU cases will be very helpful for better PICU bed utilization. Aim of the study: The aim of the present study is to evaluate of criteria of admission and discharge of all admitted and discharged patients to the PICU in Al-Ahrar Hospital, Zagazig, Egypt, in comparison to the standard criteria of admission and discharge of the American Academy of Pediatrics (AAP). Methods: This study included 125 children admitted to the PICU with different diagnoses during a six month period from July 2013 to December 2013. The recorded data of the recruited patients include demographic data, cause of referral, criteria of admission, physical examination, provisional diagnoses at admission, diagnostic studies, definite diagnoses, outcome and criteria of discharge. Pediatric index of mortality second version (PIM-2) was calculated from the collected information within one hour period from the time of admission to the PICU. Results: The admission of male children to PICU was slightly higher than females (51.2% versus 48.8%). Incompatible admission represented 18.4% of all admitted cases. Complicated gastroenteritis was the most frequent final diagnosis in our PICU (16.8%). This was followed by pneumonia (15.2%), traumatic brain injury (12%), status epilepticus (8.8%), sepsis (6.4%) and meningitis (4.8%). Overall mortality rate was 14.4% (18 out of 125). The highest mortality rate was in traumatic cases (33.3%), followed by multiple organ dysfunction syndrome (MODS) in sepsis cases (22.2%) and neurological cases (22.2%). Incompatible discharge represented 4.8% of all discharged cases. Average LOS and mean PIM-2 were significantly higher in non-survivors group than in survivors group (18.3 days and 34.1% versus 5.4 days and 2.1%, respectively). These two factors were also the only significant predictors of outcome. The optimal cutoff value of PIM-2 to predict mortality rate in the studied patients was >5% with high sensitivity and specificity (100% and 95.3%, respectively). Conclusion: PICU facilities at Al-Ahrar Hospital, Zagazig are insufficient to meet the demand. An admission score based on the PIM-2 score could assist in the selection of patients for these limited PICU facilities. (C) 2016 The Egyptian Pediatric Association. Production and hosting by Elsevier B.V.	[AbdAllah, Nouran B.; Zeitoun, Alaa El-Din] Suez Canal Univ, Fac Med, Dept Pediat, Ismailia, Egypt; [Fattah, Mostafa Gamal El-Deen Abdel] Al Ahrar Hosp, Dept Pediat, El Zagazig, Egypt		AbdAllah, NB (corresponding author), Suez Canal Univ, Fac Med, Dept Pediat, Ismailia, Egypt.	nouranboym2@hotmail.com					Ahmad OB, 2000, B WORLD HEALTH ORGAN, V78, P1175; Arnon SS, 2011, NELSON TXB PEDIAT, P993; Ballot DE, 1995, S AFR MED J, V85, P1221; Brady AR, 2006, PEDIATRICS, V117, pE733, DOI 10.1542/peds.2005-1853; Briassoulis G, 2004, QJM-INT J MED, V97, P507, DOI 10.1093/qjmed/hch087; Cooper LM, 2004, CRIT CARE MED, V32, P2247, DOI 10.1097/01.CCM.0000146301.47334.BD; degli Atti MLC, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-100; El Halal MGD, 2012, INDIAN J CRIT CARE M, V16, P81, DOI 10.4103/0972-5229.99114; Edwina-Winiarti, 2012, PAEDIAT INDONES, V52, P165; Eghbalkhah A, 2006, IRAN J PEDIATR, V16, P399; El-Nawawy A, 2003, J TROP PEDIATRICS, V49, P109, DOI 10.1093/tropej/49.2.109; Embu Henry Y, 2011, Afr J Paediatr Surg, V8, P57, DOI 10.4103/0189-6725.78670; Eulmesekian PG, 2007, PEDIATR CRIT CARE ME, V8, P54, DOI 10.1097/01.pcc.0000256619.78382.93; Gandhi J, 2013, INDIAN J CRIT CARE M, V17, P288, DOI 10.4103/0972-5229.120320; Humayun IK, 2006, PROF MED J, V13, P358; Imamura T, 2012, INTENS CARE MED, V38, P649, DOI 10.1007/s00134-011-2460-5; Jeena PM, 1999, INTENS CARE MED, V25, P88, DOI 10.1007/s001340050792; Kapil Dinesh, 1993, Indian Journal of Pediatrics, V60, P5, DOI 10.1007/BF02860496; Khajeh A, 2013, IRAN J PEDIATR, V23, P546; Khilnani Praveen, 2004, Indian Journal of Pediatrics, V71, P587, DOI 10.1007/BF02724117; Marcin JP, 2001, CRIT CARE MED, V29, P652, DOI 10.1097/00003246-200103000-00035; Martha Vanessa Feller, 2005, J. Pediatr. (Rio J.), V81, P259, DOI 10.1590/S0021-75572005000400014; McHugh G J, 1999, Crit Care Resusc, V1, P234; Mestrovic J, 2005, EUR J PEDIATR, V164, P783, DOI 10.1007/s00431-005-1755-3; Moerer O, 2007, CRIT CARE, V11, DOI 10.1186/cc5952; Netto Antonio Lima, 2014, Rev Bras Ter Intensiva, V26, P44; Peeters B, 2010, INTENS CARE MED, V36, P1923, DOI 10.1007/s00134-010-2020-4; Piva Jefferson Pedro, 2005, Paediatr Respir Rev, V6, P160, DOI 10.1016/j.prrv.2005.06.001; Pronovost P, 2009, AM SOC INT MED, V4, P199; Qureshi Ahmad Usaid, 2007, J Ayub Med Coll Abbottabad, V19, P49; Rahman S, 2002, ARCH DIS CHILD-FETAL, V87, P4; Garcia PCR, 2007, PEDIATR CRIT CARE ME, V8, P77, DOI 10.1097/01.pcc.0000256687.90460.4d; Rosenberg DI, 2004, PEDIATRICS, V114, P1114, DOI 10.1542/peds.2004-1599; Rozenfeld RA, 2011, NELSON TXB PEDIAT, P1504; Salamati P, 2012, IRAN J PEDIATR, V22, P481; Slater Anthony, 2004, Pediatr Crit Care Med, V5, P447, DOI 10.1097/01.PCC.0000138557.31831.65; Straney L, 2013, PEDIATR CRIT CARE ME, V14, P673, DOI 10.1097/PCC.0b013e31829760cf; Thukral A, 2006, PEDIATR CRIT CARE ME, V7, P356, DOI 10.1097/01.PCC.0000227105.20897.89; Visser IHE, 2013, INTENS CARE MED, V39, P942, DOI 10.1007/s00134-013-2857-4; Wolfler A, 2007, INTENS CARE MED, V33, P1407, DOI 10.1007/s00134-007-0694-z	40	1	1	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1110-6638	2090-9942		EGYPT PEDIATR ASSO	EGYPT. PEDIATR. ASSOC. GAZ.	SEP	2016	64	3					111	119		10.1016/j.epag.2016.08.002			9	Pediatrics	Emerging Sources Citation Index (ESCI)	Pediatrics	EE0FT	WOS:000389250300003		gold			2022-02-06	
J	Arai, N; Nakamura, A; Tabuse, M; Miyazaki, H				Arai, Nobuhiko; Nakamura, Akiyoshi; Tabuse, Masanao; Miyazaki, Hiromichi			Delayed Acute Subdural Hematoma Associated With Percutaneous Coronary Intervention	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Cardiac pulmonary arrest; delayed acute subdural hematoma; mild traumatic brain injury; percutaneous coronary intervention	EPIDURAL HEMATOMA	Background:Delayed acute subdural hematoma (DASH) is a subdural hematoma which is detected later. An initial computed tomography (CT) does not reveal any intracranial hemorrhage at all. Few patients of DASH after mild traumatic brain injury associated with percutaneous coronary intervention (PCI) have been published.Patient Presentation:A 63-year-old woman presented with cardiac pulmonary arrest due to acute myocardial infarction and lethal arrhythmia. She had hit her head on the road. The initial CT did not reveal any hemorrhage in the intra-cranium. She fully recovered after PCI. However, 1 hour after PCI, she lost consciousness and immediate CT showed acute subdural hematoma and subarachnoid hemorrhage. The period from losing consciousness to brain herniation presenting as anisocoria was very shortonly 30 minutes in our patient. Although emergent evacuation of hematoma and external decompression were performed, the patient died 1 day after the operation.Conclusion:The authors encountered a patient of DASH after PCI that resulted in death. Clinicians should be aware that subdural hemorrhage can occur after PCI if no hemorrhage is noted in the initial head CT, and the operation should be performed as soon as possible when the consciousness level decreases.	[Arai, Nobuhiko; Nakamura, Akiyoshi; Tabuse, Masanao; Miyazaki, Hiromichi] Hiratsuka City Hosp, Dept Neurosurg, Hiratsuka, Kanagawa, Japan		Arai, N (corresponding author), Hiratsuka City Hosp, Hiratsuka, Kanagawa, Japan.	dobu@i.softbank.jp		Arai, Nobuhiko/0000-0003-4434-7551			ASHKENAZI E, 1990, J TRAUMA, V30, P613, DOI 10.1097/00005373-199005000-00015; CASSIN BJ, 1983, J FORENSIC SCI, V28, P1013; Cohen T, 1995, TRAUMA, P689; DIAZ FG, 1979, J NEUROSURG, V50, P217, DOI 10.3171/jns.1979.50.2.0217; DOHERTY DL, 1988, ARCH PHYS MED REHAB, V69, P542; DOMENICUCCI M, 1995, NEUROSURG REV, V18, P109, DOI 10.1007/BF00417668; EVANS JP, 1946, J NEUROSURG, V3, P101, DOI 10.3171/jns.1946.3.2.0101; Itshayek E, 2006, NEUROSURGERY, V58, P851, DOI 10.1227/01.NEU.0000209653.B2936.96; Koumtchev Y, 1994, Folia Med (Plovdiv), V36, P59; Kranus J, 1989, MILD HEAD INJURY, P8; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Wakoto M, 2008, J TRAUMA, V65, P461	13	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	SEP	2016	27	6					E514	E516		10.1097/SCS.0000000000002825			3	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	DX3KD	WOS:000384271100002	27526240	Green Published			2022-02-06	
J	Dezman, ZDW; Hu, E; Hu, PF; Yang, SM; Stansbury, LG; Cooke, R; Fang, R; Miller, C; Mackenzie, CF				Dezman, Zachary D. W.; Hu, Eric; Hu, Peter F.; Yang, Shiming; Stansbury, Lynn G.; Cooke, Rhonda; Fang, Raymond; Miller, Catriona; Mackenzie, Colin F.			COMPUTER MODELLING USING PREHOSPITAL VITALS PREDICTS TRANSFUSION AND MORTALITY	PREHOSPITAL EMERGENCY CARE			English	Article						transfusion; vital signs; mortality; prehospital care	TRAUMATIC BRAIN-INJURY; INTRACRANIAL HYPERTENSION; LIFESAVING INTERVENTIONS; EARLY COAGULOPATHY; DECISION-MAKING; SHOCK INDEX; PLATELETS; PRESSURE; JUDGMENT; PLASMA	Objective: Test computer-assisted modeling techniques using prehospital vital signs of injured patients to predict emergency transfusion requirements, number of intensive care days, and mortality, compared to vital signs alone. Methods: This single-center retrospective analysis of 17,988 trauma patients used vital signs data collected between 2006 and 2012 to predict which patients would receive transfusion, require 3 or more days of intensive care, or die. Standard transmitted prehospital vital signs (heart rate, blood pressure, shock index, and respiratory rate) were used to create a regression model (PH-VS) that was internally validated and evaluated using area under the receiver operating curve (AUROC). Transfusion records were matched with blood bank records. Documentation of death and duration of intensive care were obtained from the trauma registry. Results: During the course of their hospital stay, 720 of the 17,988 patients in the study population died (4%), 2,266 (12.6%) required at least a 3-day stay in the intensive care unit (ICU), 1,171 (6.5%) required transfusions, and 210 (1.2%) received massive transfusions. The PH-VS model significantly outperformed any individual vital sign across all outcomes (average AUROC = 0.82), The PH-VS model correctly predicted that 512 of 777 (65.9%) and 580 of 931 (62.3%) patients in the study population would receive transfusions within the first 2 and 6hours of admission, respectively. Conclusions: The predictive ability of individual vital signs to predict outcomes is significantly enhanced with the model. This could support prehospital triage by enhancing decision makers' ability to match critically injured patients with appropriate resources with minimal delays.	[Dezman, Zachary D. W.] Univ Maryland, Sch Med, Emergency Med, 110 Paca,6th Floor, Baltimore, MD 21201 USA; [Hu, Eric; Hu, Peter F.; Yang, Shiming; Stansbury, Lynn G.; Fang, Raymond; Mackenzie, Colin F.] Univ Maryland, Sch Med, RA Cowley Shock Trauma Ctr, Shock Trauma Anesthesia Organized Res Ctr STAR OR, Baltimore, MD 21201 USA; [Cooke, Rhonda] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA		Dezman, ZDW (corresponding author), Univ Maryland, Sch Med, Emergency Med, 110 Paca,6th Floor, Baltimore, MD 21201 USA.	zachary.dezman@gmail.com	Yang, Shiming/I-3695-2015	Yang, Shiming/0000-0003-0338-4268; /0000-0001-6405-724X	USAF [FA8650-11-2-6D01, FA8650-13-2-6D11]	This research was funded in part by the following grants: USAF: (FA8650-11-2-6D01) Continuing non-invasive monitoring and the development of predictive triage indices for outcomes following trauma (ONPOINT1) and FA8650-13-2-6D11 Predicting Casualty Blood Product Needs using Prehospital Vital Signs (ONPOINT2).	Anazodo AN, 2015, INJURY, V46, P791, DOI 10.1016/j.injury.2014.10.063; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Bruijns SR, 2013, J TRAUMA ACUTE CARE, V74, P1432, DOI 10.1097/TA.0b013e31829246c7; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Camazine MN, 2015, J TRAUMA ACUTE CARE, V78, pS48, DOI 10.1097/TA.0000000000000641; Centers for Disease Control and Prevention, FAST STATS; Committee on Trauma and Committee on Shock Division of Medical Sciences National Academy of Sciences and National Research Council, 1966, ACC DEATH DIS NEGL D; Cooke R, 2015, E COMMUNICATION 0521; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; FAWCETT T, 2003, HP INVEN, V6, P27; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hess JR, 2015, TRANSFUSION, V55, P1362, DOI 10.1111/trf.13118; Hu Peter, 2014, Air Med J, V33, P27, DOI 10.1016/j.amj.2013.09.003; Hu Peter F, 2008, AMIA Annu Symp Proc, P980; Johnson K., 2013, APPL PREDICTIVE MODE, P61, DOI [10.1007/978-1-4614-6849-3_4, DOI 10.1007/978-1-4614-6849-3_4]; Jones CMC, 2016, PREHOSP EMERG CARE, V20, P6, DOI 10.3109/10903127.2015.1025157; Kahraman S, 2011, J TRAUMA, V70, P547, DOI 10.1097/TA.0b013e31820c768a; Kahraman S, 2010, J TRAUMA, V69, P110, DOI 10.1097/TA.0b013e3181c99853; King RW, 1996, ACAD EMERG MED, V3, P1041, DOI 10.1111/j.1553-2712.1996.tb03351.x; LUSTED LB, 1971, NEW ENGL J MED, V284, P416, DOI 10.1056/NEJM197102252840805; Mackenzie CF, 2015, SHOCK, V43, P238, DOI 10.1097/SHK.0000000000000288; Mackenzie CF, 2014, J TRAUMA ACUTE CARE, V76, P1379, DOI 10.1097/TA.0000000000000235; Mackenzie Colin F, 2008, AMIA Annu Symp Proc, P318; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; Nathens AB, 2008, REGIONAL TRAUMA SYST; Newgard CD, 2014, PREHOSP EMERG CARE, V18, P461, DOI 10.3109/10903127.2014.912707; Niles SE, 2008, J TRAUMA, V64, P1459, DOI 10.1097/TA.0b013e318174e8bc; Shackelford SA, 2014, J TRAUMA ACUTE CARE, V77, pS222, DOI 10.1097/TA.0000000000000198; Stein DM, 2011, J TRAUMA, V71, P364, DOI 10.1097/TA.0b013e31822820da; Willenbring BD, 2016, PREHOSP EMERG CARE, V20, P1, DOI 10.3109/10903127.2015.1056896; Woodford MR, 2012, J TRAUMA ACUTE CARE, V72, P1006, DOI 10.1097/TA.0b013e318241c059; World Health Organization, DIS INJ COUNTR EST B; Zink KA, 2009, AM J SURG, V197, P565, DOI 10.1016/j.amjsurg.2008.12.014	34	1	1	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1090-3127	1545-0066		PREHOSP EMERG CARE	Prehosp. Emerg. Care	SEP-OCT	2016	20	5					609	614		10.3109/10903127.2016.1142624			6	Emergency Medicine; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Public, Environmental & Occupational Health	DW8OI	WOS:000383915000009	26985695				2022-02-06	
J	Filley, CM				Filley, Christopher M.			White Matter Dementia: Origin, Development, Progress, and Prospects	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; RISK-FACTOR; MEDITERRANEAN DIET; METABOLIC SYNDROME; SERUM-CHOLESTEROL; PROCESSING SPEED; GRAY-MATTER; PLASTICITY; MICROSTRUCTURE	The term white matter dementia (WMD) was introduced in 1988 to highlight the role of white matter in the development of dementia. As the concept has been refined with new insights into the structure and function of normal and abnormal white matter, research has expanded to consider normal cognition, network connectivity, novel treatment ideas, and the etiopath-ogenesis of neurodegenerative dementia. Emerging data are also identifying new opportunities for dementia prevention by avoidance of acquired vascular and traumatic white matter insults. The idea of WMD promises to continue as a useful construct informing the study of dementia and the understanding of brain-behavior relationships.	[Filley, Christopher M.] Univ Colorado, Sch Med, Behav Neurol Sect, Aurora, CO 80045 USA; [Filley, Christopher M.] Denver Vet Affairs Med Ctr, Denver, CO 80220 USA		Filley, CM (corresponding author), Univ Colorado, Sch Med, Behav Neurol Sect, Aurora, CO 80045 USA.; Filley, CM (corresponding author), Denver Vet Affairs Med Ctr, Denver, CO 80220 USA.	christopher.filley@ucdenver.edu					Acosta CMR, 2013, CNS NEUROL DISORD-DR, V12, P1242; ALBERT ML, 1974, J NEUROL NEUROSUR PS, V37, P121, DOI 10.1136/jnnp.37.2.121; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Alix JJP, 2011, NEUROLOGY, V76, P397, DOI 10.1212/WNL.0b013e3182088273; Ambrosius WT, 2014, CLIN TRIALS, V11, P532, DOI 10.1177/1740774514537404; Anstey KJ, 2009, AM J GERIAT PSYCHIAT, V17, P542, DOI 10.1097/JGP.0b013e3181a2fd07; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Bartzokis G, 2007, BIOL PSYCHIAT, V62, P294, DOI 10.1016/j.biopsych.2006.08.020; Bartzokis G, 2012, NEUROPHARMACOLOGY, V62, P2137, DOI 10.1016/j.neuropharm.2012.01.015; Bartzokis G, 2011, NEUROBIOL AGING, V32, P1341, DOI 10.1016/j.neurobiolaging.2009.08.007; Bartzokis G, 2010, NEUROBIOL AGING, V31, P1554, DOI 10.1016/j.neurobiolaging.2008.08.015; Ben-Hur T, 2008, ANN NY ACAD SCI, V1142, P218, DOI 10.1196/annals.1444.014; Biessels GJ, 2014, DIABETES, V63, P2244, DOI 10.2337/db14-0348; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Brickman AM, 2012, NEUROBIOL AGING, V33, P1699, DOI 10.1016/j.neurobiolaging.2011.06.001; Butters Meryl A, 2008, Dialogues Clin Neurosci, V10, P345; Calza L, 2010, J MOL ENDOCRINOL, V44, P13, DOI 10.1677/JME-09-0067; Carvalho C, 2016, J NEURAL TRANSM, V123, P107, DOI 10.1007/s00702-015-1367-7; Cheng CY, 2013, J GERIATR PSYCH NEUR, V26, P158, DOI 10.1177/0891988713493503; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; de Bruijn RFAG, 2013, EUR J EPIDEMIOL, V28, P277, DOI 10.1007/s10654-013-9773-3; Debette S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3666; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; DELAMONTE SM, 1989, ANN NEUROL, V25, P450, DOI 10.1002/ana.410250506; Durazzo TC, 2010, INT J ENV RES PUB HE, V7, P3760, DOI 10.3390/ijerph7103760; Ettle B., 2015, MOL NEUROBIOL; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Fields RD, 2015, NAT REV NEUROSCI, V16, P756, DOI 10.1038/nrn4023; Fields RD, 2011, NEUROSCIENTIST, V17, P185, DOI 10.1177/1073858410383696; Filley Christopher M, 2015, Neurol Clin Pract, V5, P193, DOI 10.1212/CPJ.0000000000000108; Filley CM, 2015, NEUROLOGY, V84, P2146, DOI 10.1212/WNL.0000000000001612; Filley CM, 2009, COGN BEHAV NEUROL, V22, P38, DOI 10.1097/WNN.0b013e318190d174; Filley CM, 2004, J NEUROPATH EXP NEUR, V63, P1; Filley CM, 2001, NEW ENGL J MED, V345, P425, DOI 10.1056/NEJM200108093450606; FILLEY CM, 1990, NEUROLOGY, V40, P532, DOI 10.1212/WNL.40.3_Part_1.532; FILLEY CM, 1989, ARCH NEUROL-CHICAGO, V46, P157, DOI 10.1001/archneur.1989.00520380061013; Filley CM, 2012, BEHAV NEUROLOGY WHIT, V2nd; Filley CM, 1988, NEUROPSY NEUROPSY BE, V1, P239; Forette F, 2002, ARCH INTERN MED, V162, P2046, DOI 10.1001/archinte.162.18.2046; Fratiglioni L, 2007, J ALZHEIMERS DIS, V12, P11; Fung TT, 2001, AM J CLIN NUTR, V73, P61; Gabrieli JDE, 1997, NEUROPSYCHOLOGY, V11, P272, DOI 10.1037/0894-4105.11.2.272; Gardener H, 2012, ARCH NEUROL-CHICAGO, V69, P251, DOI 10.1001/archneurol.2011.548; Geldmacher DS, 1996, NEW ENGL J MED, V335, P330, DOI 10.1056/NEJM199608013350507; GESCHWIN.N, 1965, BRAIN, V88, P585, DOI 10.1093/brain/88.3.585; Gold BT, 2012, BBA-MOL BASIS DIS, V1822, P416, DOI 10.1016/j.bbadis.2011.07.009; Greco CM, 2006, BRAIN, V129, P243, DOI 10.1093/brain/awh683; Grigsby J, 2014, J NEURODEV DISORD, V6, DOI 10.1186/1866-1955-6-28; Henderson JM, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00015; HORMES JT, 1986, NEUROLOGY, V36, P698, DOI 10.1212/WNL.36.5.698; Jagust W, 2005, ARCH NEUROL-CHICAGO, V62, P1545, DOI 10.1001/archneur.62.10.1545; Johansson BB, 2011, ACTA NEUROL SCAND, V123, P147, DOI 10.1111/j.1600-0404.2010.01417.x; Kim H, 2013, SLEEP, V36, P709, DOI 10.5665/sleep.2632; Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556; Kou ZF, 2014, GLIA, V62, P1831, DOI 10.1002/glia.22690; Kozora E, 2011, J INT NEUROPSYCH SOC, V17, P385, DOI 10.1017/S1355617711000191; Kremer D, 2015, MULT SCLER J, V21, P541, DOI 10.1177/1352458514566419; Kullmann S, 2016, NEUROIMAGE, V125, P36, DOI 10.1016/j.neuroimage.2015.10.006; Kutzelnigg A, 2005, BRAIN, V128, P2705, DOI 10.1093/brain/awh641; Lafosse JM, 2007, J CLIN EXP NEUROPSYC, V29, P142, DOI 10.1080/13803390600582438; Larson EB, 2013, NEW ENGL J MED, V369, P2275, DOI 10.1056/NEJMp1311405; Lee JH, 2011, NEUROLOGY, V77, P18, DOI 10.1212/WNL.0b013e318221acee; Leehey MA, 2009, J INVEST MED, V57, P830, DOI 10.2310/JIM.0b013e3181af59c4; Sosa-Ortiz AL, 2012, ARCH MED RES, V43, P600, DOI 10.1016/j.arcmed.2012.11.003; Lundgaard I, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001743; Mackey AP, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00032; McHugh PR, 1975, PSYCHIAT SYNDROMES H, V1; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; MENDEZ MF, 2000, J NEUROPSYCHIATRY CL, V12, P133; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; Murray ME, 2010, ARCH NEUROL-CHICAGO, V67, P1379, DOI 10.1001/archneurol.2010.280; Nieuwenhuys R, 2013, BRAIN STRUCT FUNCT, V218, P303, DOI 10.1007/s00429-012-0460-z; PARKER WD, 1994, NEUROLOGY, V44, P1090, DOI 10.1212/WNL.44.6.1090; Parvizi J, 2009, TRENDS COGN SCI, V13, P354, DOI 10.1016/j.tics.2009.04.008; Rao SM, 1996, BRAIN COGNITION, V31, P250, DOI 10.1006/brcg.1996.0044; Reitz C, 2011, NAT REV NEUROL, V7, P137, DOI [10.1038/nrneurol.2011.2, 10.1101/cshperspect.a006239]; Ropper A.H., 2014, ADAMS VICTORS PRINCI, V10th ed.; ROSENBERG NL, 1988, ANN NEUROL, V23, P611, DOI 10.1002/ana.410230614; Roth G, 2005, TRENDS COGN SCI, V9, P250, DOI 10.1016/j.tics.2005.03.005; Rushton JP, 2009, INT J NEUROSCI, V119, P691, DOI 10.1080/00207450802325843; Sankar T, 2015, BRAIN STIMUL, V8, P645, DOI 10.1016/j.brs.2014.11.020; Scarmeas N, 2006, ANN NEUROL, V59, P912, DOI 10.1002/ana.20854; Schlaug G, 2009, ANN NY ACAD SCI, V1169, P385, DOI 10.1111/j.1749-6632.2009.04587.x; Schmahmann J.D., 2006, FIBER PATHWAYS BRAIN; Schmahmann JD, 2008, ANN NY ACAD SCI, V1142, P266, DOI 10.1196/annals.1444.017; Schneider JA, 2007, NEUROLOGY, V69, P2197, DOI 10.1212/01.wnl.0000271090.28148.24; Segura B, 2009, NEUROLOGY, V73, P438, DOI 10.1212/WNL.0b013e3181b163cd; Segura B, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-64; Sepulcre J, 2008, NEUROIMAGE, V42, P1237, DOI 10.1016/j.neuroimage.2008.05.038; Sexton CE, 2016, NEUROIMAGE, V131, P81, DOI 10.1016/j.neuroimage.2015.09.071; Solomon A, 2009, DEMENT GERIATR COGN, V28, P75, DOI 10.1159/000231980; Spira AP, 2013, JAMA NEUROL, V70, P1537, DOI 10.1001/jamaneurol.2013.4258; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Steele CJ, 2013, J NEUROSCI, V33, P1282, DOI 10.1523/JNEUROSCI.3578-12.2013; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Takeuchi H, 2010, J NEUROSCI, V30, P3297, DOI 10.1523/JNEUROSCI.4611-09.2010; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Turken AU, 2008, NEUROIMAGE, V42, P1032, DOI 10.1016/j.neuroimage.2008.03.057; Van Essen DC, 2012, NEUROIMAGE, V62, P1299, DOI 10.1016/j.neuroimage.2012.01.032; Vu NQ, 2013, CURR OPIN NEUROL, V26, P656, DOI 10.1097/WCO.0000000000000028; Wenning GK, 2008, ANN NEUROL, V64, P239, DOI 10.1002/ana.21465; Williams VJ, 2013, HUM BRAIN MAPP, V34, P1826, DOI 10.1002/hbm.22030; Wortzel HS, 2013, BEHAV SCI LAW, V31, P721, DOI 10.1002/bsl.2079; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Zhang K, 2000, P NATL ACAD SCI USA, V97, P5621, DOI 10.1073/pnas.090504197; Zhang RL, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00201; Zheng X, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00229; Zimmerman ME, 2012, CURR NEUROL NEUROSCI, V12, P537, DOI 10.1007/s11910-012-0298-z	110	1	1	0	5	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	FAL	2016	28	4					262	272		10.1176/appi.neuropsych.16010003			11	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	EA3NO	WOS:000386510100002	27255854	Bronze			2022-02-06	
J	Forbes, JA; Laughlin, I; Newberry, S; Ryhn, M; Pasley, J; Newberry, T				Forbes, Jonathan A.; Laughlin, Ian; Newberry, Shane; Ryhn, Michael; Pasley, Jason; Newberry, Travis			Stratification of risk to the surgical team in removal of small arms ammunition implanted in the craniofacial region: case report	JOURNAL OF NEUROSURGERY			English	Article						small arms ammunition; unexploded ordnance; UXO; implanted projectile; traumatic brain injury	BULLETS	In cases of penetrating injury with implantation of small arms ammunition, it can often be difficult to tell the difference between simple ballistics and ballistics associated with unexploded ordnances (UXOs). In the operative environment, where highly flammable substances are often close to the surgical site, detonation of UXOs could have catastrophic consequences for both the patient and surgical team. There is a paucity of information in the literature regarding how to evaluate whether an implanted munition contains explosive material. This report describes a patient who presented during Operation Enduring Freedom with an implanted munition suspicious for a UXO and the subsequent workup organized by Explosive Ordnance Disposal (EOD) Company prior to surgical removal. Clinical risk factors for UXOs include assassination attempts and/or wartime settings. Specific radiological features suggestive of a UXO include projectile size greater than 7.62-mm caliber, alterations in density of the tip, as well as radiological evidence of a hollowed-out core. If an implanted UXO is suspected, risks to the surgical and anesthesia teams can be minimized by notifying the nearest military installation with EOD capabilities and following clinical practice guidelines set forth by the Joint Theater Trauma System.	[Forbes, Jonathan A.] David Grant Med Ctr, Dept Neurol Surg, 32 Parkside Dr, Davis, CA 95616 USA; [Laughlin, Ian] US 47th OD CO EOD, Killeen, TX USA; [Newberry, Shane] San Antonio Mil Med Ctr, Dept Radiol, San Antonio, TX USA; [Ryhn, Michael] Tripler Med Ctr, Dept Oral Maxillofacial Surg, Honolulu, HI USA; [Pasley, Jason] Univ Maryland, Dept Surg, CSTARS Baltimore RA Cowley Shock Trauma, Baltimore, MD 21201 USA; [Newberry, Travis] San Antonio Mil Med Ctr, Dept Otolaryngol, San Antonio, TX USA		Forbes, JA (corresponding author), David Grant Med Ctr, Dept Neurol Surg, 32 Parkside Dr, Davis, CA 95616 USA.	jonathan.a.forbes@gmail.com					Altman LK., 1982, NEW YORK TIMES; Fedoroff B.T., 1975, ENCY EXPLOSIVES RELA, V7; Hagan C, 2010, MIL DOCS PLUCK LIV S; Jandial R, 2008, NEUROSURGERY, V62, P472, DOI 10.1227/01.neu.0000316015.05550.7a; KNIGHT B, 1982, BRIT MED J, V284, P768, DOI 10.1136/bmj.284.6318.768; Knight M, 2014, WTKR NEWS       1016; Schlager D, 1996, ANN EMERG MED, V28, P183, DOI 10.1016/S0196-0644(96)70060-4; Spitz WU, 1993, MEDICOLEGAL INVESTIG, P311; Swan K G, 1985, Surg Annu, V17, P163; Swift B, 2004, J CLIN PATHOL, V57, P108, DOI 10.1136/jcp.57.1.108	10	1	1	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	SEP	2016	125	3					661	666		10.3171/2015.6.JNS15779			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DT8YS	WOS:000381782300017	26832604	Bronze			2022-02-06	
J	Javed, G; Waqas, M; Qadeer, M; Bari, E; Murtaza, G				Javed, Gohar; Waqas, Muhammad; Qadeer, Mohsin; Bari, Ehsan; Murtaza, Ghulam			Use of Levetiracetam in Prophylaxis of Early Post-Traumatic Seizures	TURKISH NEUROSURGERY			English	Article						Early post-traumatic seizure; Levetiracetam; Phenytoin; Head injury; Prophylaxis	TRAUMATIC BRAIN-INJURY; INTRAVENOUS-INFUSION; PHENYTOIN; PHARMACOKINETICS; PLACEBO	AIM: Traumatic brain injury is one of the leading causes of mortality and morbidity worldwide. The role of prophylactic anti-epileptic drugs has been established. Phenytoin used traditionally for this purpose carries a burden of adverse reactions and cumbersome need of monitoring and maintaining levels in serum. Therefore, as the evidence on levetiracetam, emerged part of neurosurgery section started using this drug for seizure prophylaxis after early loading with phenytoin. So we decided to assess the use of enteral levetiracetam in prophylaxis of early post-traumatic seizures. MATERIAL and METHODS: This was a retrospective cohort study done at the department of neurosurgery of Aga Khan University in Karachi from July 2010 to March 2011. Charts of patients who were started on levetiracetam enterally were reviewed and followed for occurrence of clinical seizures within one week of trauma. The results were then compared to the group of patients treated prophylactically with phenytoin alone over the same time period. RESULTS: The study included 50 patients in each group. Both groups were comparable in terms of demographics and baseline characteristics. However, 2 patients in each group suffered from clinical seizures with a non-significant p value. CONCLUSION: Enteral levetiracetam after initial phenytoin loading is a viable option in the armamentarium of anti-epileptic drugs. Further larger prospective studies are required to improve the evidence.	[Javed, Gohar; Waqas, Muhammad; Qadeer, Mohsin; Bari, Ehsan; Murtaza, Ghulam] Aga Khan Univ Hosp, Dept Surg, Sect Neurosurg, Karachi, Pakistan		Qadeer, M (corresponding author), Aga Khan Univ Hosp, Dept Surg, Sect Neurosurg, Karachi, Pakistan.	mohsin.qadeer@gmail.com					Anderson GD, 2000, ANN PHARMACOTHER, V34, P697; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Carnes MB, 2011, AM J VET RES, V72, P1247, DOI 10.2460/ajvr.72.9.1247; GABL M, 1986, Zentralblatt fuer Neurochirurgie, V47, P339; GUERRA IC, 1986, J ALLERGY CLIN IMMUN, V77, P603, DOI 10.1016/0091-6749(86)90353-2; Haltiner A M, 1996, J Int Neuropsychol Soc, V2, P494; Jones KE, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E3; Patel NC, 2006, SEIZURE-EUR J EPILEP, V15, P137, DOI 10.1016/j.seizure.2005.12.003; Patsalos PN, 2004, CLIN PHARMACOKINET, V43, P707, DOI 10.2165/00003088-200443110-00002; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Ramael S, 2006, CLIN THER, V28, P734, DOI 10.1016/j.clinthera.2006.05.004; Ramael S, 2006, EPILEPSIA, V47, P1128, DOI 10.1111/j.1528-1167.2006.00586.x; RAPP RP, 1983, NEUROSURGERY, V13, P272, DOI 10.1227/00006123-198309000-00010; Schierhout G, 2012, COCHRANE DB SYST REV, V6; Szaflarski JP, 2010, NEUROCRIT CARE, V12, P165, DOI 10.1007/s12028-009-9304-y; Temkin N R, 1991, Neurosurg Clin N Am, V2, P425; Temkin NR, 2001, EPILEPSIA, V42, P515, DOI 10.1046/j.1528-1157.2001.28900.x; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; World Health Organization, 2002, WORLD REPORT ROAD TR; YABLON SA, 1993, ARCH PHYS MED REHAB, V74, P983	22	1	1	0	1	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.	SEP	2016	26	5					732	735		10.5137/1019-5149.JTN.8245-13.1			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DY7VY	WOS:000385338600013	27337228	Bronze			2022-02-06	
J	Mrazik, M; Naidu, D; Manning, DE; Brooks, BL				Mrazik, Martin; Naidu, Dhiren; Manning, David E.; Brooks, Brian L.			Does Game Participation Impact Cognition and Symptoms in Elite Football Players?	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						sport concussion; cognitive functioning; brain injury	CONCUSSION	Objective:To measure neurocognitive functioning in college and professional football players after game participation.Study Design:Retrospective, cross-sectional cohort design.Participants:Ninety-four male university and professional football players.Intervention:All participants completed Immediate Postconcussion Assessment and Cognitive Testing (ImPACT) testing at baseline, and either at postconcussion (group 1) or postgame (group 2) participation.Main Outcome Measures:Results from the 5 ImPACT composite scores (Verbal Memory, Visual Memory, Visual Motor Speed, Reaction Time and Impulse Control) and Total Symptom Score.Results:Repeated-measures analysis of variance demonstrated a significant main effect for time (improvements) in 3 of 5 domains for the postconcussion group, but no improvements in the postgame group. The postconcussion group presented with significantly improved results on 4 of 5 ImPACT domains compared with the postgame group at the follow-up time interval.Conclusions:Participation in a football game with potential cumulative head contacts did not yield increased symptoms or cognitive impairment. However, the absence of improvement in cognitive functioning in noninjured football players, which was found in those players who were returned to play after an injury, may suggest that there is a measureable impact as a result of playing football.	[Mrazik, Martin; Naidu, Dhiren; Manning, David E.] Univ Alberta, Dept Educ Psychol, Edmonton, AB, Canada; [Brooks, Brian L.] Alberta Childrens Prov Gen Hosp, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Cumming Sch Med, Dept Paediat, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Cumming Sch Med, Dept Clin Neurosci, Calgary, AB, Canada; [Brooks, Brian L.] Alberta Childrens Hosp Res Inst Child & Maternal, Calgary, AB, Canada		Mrazik, M (corresponding author), Univ Alberta, 6-135 Educ Bldg North, Edmonton, AB T6G 2G5, Canada.	mrazik@ualberta.ca			Health Pointe Education Fund	Health Pointe Education Fund provided financial support for this project.	Broglio SP, 2012, ANN BIOMED ENG, V40, P37, DOI 10.1007/s10439-011-0396-0; Delaney JS, 2004, CLIN J SPORT MED, V14, P80, DOI 10.1097/00042752-200403000-00005; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Miller JR, 2007, AM J SPORT MED, V35, P1284, DOI 10.1177/0363546507300261; Mulligan I, 2012, J ORTHOP SPORT PHYS, V42, P625, DOI 10.2519/jospt.2012.3798; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e; Talavage TM, 2013, J NEUROTRAUM, V45, P737	10	1	1	0	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	SEP	2016	26	5					432	434		10.1097/JSM.0000000000000269			3	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	DW8LH	WOS:000383906800017	26580473				2022-02-06	
J	Sadeghisani, M; Karimi, MT; Kamali, M				Sadeghisani, Meissam; Karimi, Mohammad Taghi; Kamali, Mostafa			Nonlinear analysis of postural sway in subjects with below knee amputation during opened and closed eye conditions	JOURNAL OF ORTHOPAEDICS			English	Article						Balance; Below knee amputee; SACH foot; Single axis foot; Force plate	TRANS-TIBIAL AMPUTEES; LOWER-LIMB AMPUTATION; APPROXIMATE ENTROPY; CEREBRAL CONCUSSION; MULTIPLE-SCLEROSIS; STANDING BALANCE; YOUNG-ADULTS; BODY SWAY; STABILITY; PERFORMANCE	Objective: The aim of this study was to compare the structure of postural sway in healthy people and amputees with SACH foot (solid ankle cushion heel) and single axis foot during standing. Methods: Twenty healthy, 10 amputees with single axis foot, and 10 amputees with SACH foot participated in this study. The structure of postural sway of the subjects was evaluated using approximate entropy (ApEn). Results: People with SACH foot prosthesis exhibit increased regularity in postural sway compared to healthy people and people with single axis foot. Conclusion: Amputees who used single axis prosthesis achieved appropriate adaptation to their prosthesis device. (C) 2016 Prof. PK Surendran Memorial Education Foundation. Published by Elsevier, a division of Reed Elsevier India, Pvt. Ltd. All rights reserved.	[Sadeghisani, Meissam] Shahid Beheshti Univ Med Sci, Rehabil Fac, Phys Therapy Dept, Tehran, Iran; [Karimi, Mohammad Taghi; Kamali, Mostafa] Isfahan Univ Med Sci, Rehabil Fac, Musculoskeletal Res Ctr, Esfahan, Iran		Karimi, MT (corresponding author), Isfahan Univ Med Sci, Rehabil Fac, Musculoskeletal Res Ctr, Esfahan, Iran.	Sadeghi.m@sbmu.ac.ir; karimi@rehab.mui.ac.ir		Sadeghisani, Meissam/0000-0003-2730-0209	Shahid Beheshti University of Medical Sciences; Isfahan University of Medical Sciences	We thank Shahid Beheshti and Isfahan Universities of Medical Sciences that supported our research.	Blaszczyk JW, 2001, ACTA NEUROBIOL EXP, V61, P105; Bohne WHO, 1987, ATLAS AMPUTATION SUR; Buckley JG, 2002, AM J PHYS MED REHAB, V81, P13, DOI 10.1097/00002060-200201000-00004; Cavanaugh JT, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-42; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; CYBULSKI GR, 1986, ARCH PHYS MED REHAB, V67, P103, DOI 10.1016/0003-9993(86)90113-9; DAY BL, 1993, J PHYSIOL-LONDON, V469, P479, DOI 10.1113/jphysiol.1993.sp019824; Deffeyes JE, 2011, INFANT BEHAV DEV, V34, P81, DOI 10.1016/j.infbeh.2010.10.001; Dillon MP, 2014, PROSTHET ORTHOT INT, V38, P122, DOI 10.1177/0309364613490441; EDWARDS AS, 1946, J EXP PSYCHOL, V36, P526, DOI 10.1037/h0059909; FERNIE GR, 1978, J BONE JOINT SURG AM, V60, P895, DOI 10.2106/00004623-197860070-00003; Gaerlan MG, 2012, J AM ACAD NURSE PRAC, V24, P375, DOI 10.1111/j.1745-7599.2012.00699.x; Hendershot BD, 2013, GAIT POSTURE, V38, P438, DOI 10.1016/j.gaitpost.2013.01.008; HERMODSSON Y, 1994, PROSTHET ORTHOT INT, V18, P150; Huisinga JM, 2012, NEUROSCI LETT, V524, P124, DOI 10.1016/j.neulet.2012.07.020; ISAKOV E, 1994, CLIN BIOMECH, V9, P258, DOI 10.1016/0268-0033(94)90008-6; Jacobson GP., 1993, HDB BALANCE FUNCTION; Kavounoudias A, 2005, ARCH PHYS MED REHAB, V86, P633, DOI 10.1016/j.apmr.2004.10.030; Lenka P., 2010, J MED SCI, V3, P50; Mayer A, 2011, BODY AWARENESS STAND; Mohieldin A. H. A., 2010, Macedonian Journal of Medical Sciences, V3, P138, DOI 10.3889/MJMS.1857-5773.2010.0095; MURRAY MP, 1975, J BONE JOINT SURG AM, VA 57, P510, DOI 10.2106/00004623-197557040-00012; Negahban H, 2013, NEUROSCI LETT, V553, P126, DOI 10.1016/j.neulet.2013.08.024; PINCUS S, 1995, CHAOS, V5, P110, DOI 10.1063/1.166092; Pincus S, 1997, P NATL ACAD SCI USA, V94, P3513, DOI 10.1073/pnas.94.8.3513; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Quai TM, 2005, CLIN REHABIL, V19, P668, DOI 10.1191/0269215505cr857oa; Rigoldi C, 2013, RES DEV DISABIL, V34, P840, DOI 10.1016/j.ridd.2012.11.007; Rougier PR, 2009, AM J PHYS MED REHAB, V88, P896, DOI 10.1097/PHM.0b013e3181b331af; Unwin N, 2000, BRIT J SURG, V87, P328, DOI 10.1046/j.1365-2168.2000.01344.x; Viton JM, 2000, PROSTHET ORTHOT INT, V24, P108, DOI 10.1080/03093640008726533; VITTAS D, 1986, PROSTHET ORTHOT INT, V10, P139; Zahedi M S, 1986, J Rehabil Res Dev, V23, P2	34	1	1	0	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0972-978X			J ORTHOP	J. Orthop.	SEP	2016	13	3					152	156		10.1016/j.jor.2016.03.009			5	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	DY9FB	WOS:000385438000008	27408487	Green Published			2022-02-06	
J	Schirmer, C				Schirmer, Cynthia			Correlation of lesions in the corpus callosum and course of impact in linear head injuries	ROMANIAN JOURNAL OF LEGAL MEDICINE			English	Article						blunt head injury; corpus callosum injuries; diffuse axonal injury; subependymal hemorrhage; inner cerebral trauma	DIFFUSE VASCULAR INJURY; COMPUTED-TOMOGRAPHY; AXONAL INJURY; BRAIN; TRAUMA; MECHANISM; DAMAGE	This is a retrospective investigation of both forensic autopsy and neuropathological examination findings of 107 blunt head injuries of adults and children collected from 1980 to 2005, from the Forensic Institute of Berlin (until 2004 from the Free University of Berlin). Macroscopic lesions in central structures, defined as being the ventricular system and close-by grey matter, were found in 68 cases which are connected with macroscopic corpus callosum (CC) lesions. This is 63.6% of the 107 cases with central brain lesions. Because of the high involvement of the CC in traumatic brain injuries, this structure plays a central part in investigating traumatic intracranial pathology. The object of the study is the localization of lesions in the CC in correlation with a linear force to the head, excluding diffuse intracerebral trauma findings. For this analysis 25 cases were eligible. In every case lesions were found in a linear direction in the CC. In those cases the lesions of the CC can help to reconstruct the accident.	[Schirmer, Cynthia] Charite Univ Med Berlin, Inst Legal Med & Forens Sci, Berlin, Germany; [Schirmer, Cynthia] Vivantes Hosp Friedrichshain, Dept Urol, Berlin, Germany		Schirmer, C (corresponding author), Charite Univ Med Berlin, Inst Legal Med & Forens Sci, Berlin, Germany.; Schirmer, C (corresponding author), Vivantes Hosp Friedrichshain, Dept Urol, Berlin, Germany.	cynthiamaria.schirmer@vivantes.de					ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; BESENSKI N, 1992, NEURORADIOLOGY, V34, P126, DOI 10.1007/BF00588158; Bratzke H, 1988, Beitr Gerichtl Med, V46, P289; Davceva N, 2010, ROM J LEG MED, V18, P115, DOI 10.4323/rjlm.2010.115; Friese SA, 2000, NEURORADIOLOGY, V42, P795, DOI 10.1007/s002340000430; Gennarelli T, 1996, NEUROSURGERY, V2, P2611; GENTRY LR, 1988, AM J NEURORADIOL, V9, P1129; GRCEVIC N, 1988, SCAND J REHABIL MED, P25; Grcevic N, 1982, JUGOSL ACAD SCI, V402, P265; KOMATSU S, 1979, NEUROSURGERY, V5, P32, DOI 10.1227/00006123-197907010-00005; Kuroda N, 2009, LEG MED, V11, P180; Kuroda N, 2010, ROM J LEG MED, V18, P103, DOI 10.4323/rjlm.2010.103; LINDENBERG R, 1955, AM J PATHOL, V31, P297; Makino Y, 2004, J NEUROTRAUM, V21, P585, DOI 10.1089/089771504774129919; Maxeiner H, 2011, RECHTSMEDIZIN, V21, P197, DOI 10.1007/s00194-011-0753-1; Maxeiner H., 2009, Legal Medicine, V11, P278, DOI 10.1016/j.legalmed.2009.08.005; McKenzie KJ, 1996, ACTA NEUROPATHOL, V92, P608, DOI 10.1007/s004010050568; MIYAKAWA K, 1992, Nippon Acta Radiologica, V52, P949; Pittella JEH, 2003, J FORENSIC SCI, V48, P626; SCHACHT L, 1965, ARCH PSYCHIAT NERVEN, V207, P416, DOI 10.1007/BF00361232; Schewe G, 1969, Beitr Gerichtl Med, V25, P243; SELLIER K, 1963, Hefte Unfallheilkd, V76, P1; SHIGEMORI M, 1986, ACTA NEUROCHIR, V81, P36, DOI 10.1007/BF01456262; Shiramizu H, 2008, NEUROL MED-CHIR, V48, P1, DOI 10.2176/nmc.48.1; STRICH SJ, 1961, LANCET, V2, P443; Uber Krauland W., 1950, DTSCH Z NERVENHEILK, V163, P265; WILBERGER JE, 1990, NEUROSURGERY, V27, P208, DOI 10.1227/00006123-199008000-00006; Zarkovic K, 1991, Neurol Croat, V40, P129; [No title captured]	30	1	1	0	1	ROMANIAN LEGAL MED SOC	BUCHAREST	SOS VITAN-BIRZESTI 9, BUCHAREST, 75669, ROMANIA	1221-8618			ROM J LEG MED	Rom. J. Leg. Med.	SEP	2016	24	3					180	189		10.4323/rjlm.2016.180			10	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	EB5PP	WOS:000387428800006					2022-02-06	
J	Schweitzer, J; James, C; Jenkins, W; Reiff, MI; Stein, MT				Schweitzer, Jason; James, Christine; Jenkins, Willough; Reiff, Michael I.; Stein, Martin T.			Acute Agitation and Self-Injury in a 5-Year Old with Autism	JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS			English	Article						self-injury; autism		CASE: A 5-year-old nonverbal child with autism spectrum disorder (ASD) was admitted to inpatient pediatrics with new onset agitation and self-injurious behavior. His parents described him as a pleasant child without previous episodes of self-injury. Four days before admission, the parents noted new irritability followed by 2 days of self-injury to the face without clear precipitant. His hitting intensified with closed fist to face, and he required parental physical restraint to prevent further injury. Car rides and ibuprofen provided only temporary relief. He consumed minimal liquid and ate no solid food for 2 days. The parents denied any changes to the environment or routine and denied recent travel, sick contacts, fevers, cough, otalgia, vomiting, diarrhea, and constipation. The patient had been diagnosed with ASD at age 18 months old but had no other significant medical history. On examination, the child was alert but distressed and restless, wearing padded mitts as his parents attempted to calm him by pushing him in a stroller. He had multiple areas of severe bruising and facial swelling in the right periorbital area, cheek, and jaw. The rest of the physical examination was unremarkable. Laboratory results included a leukocytosis with left shift, a normal metabolic panel, and an elevated creatine kinase. Other investigations included a normal lumber puncture, chest radiograph, head and face computerized tomography without contrast, and brain magnetic resonance imaging. A dentist consultant examined him and noted an erupting molar but no decay or abscesses. A psychiatric evaluation was requested as there was no clear medical source for the patient's distress.	[Schweitzer, Jason; James, Christine; Jenkins, Willough] Univ Calif San Diego, Rady Childrens Hosp, Child & Adolescent Psychiat, San Diego, CA 92103 USA; [Reiff, Michael I.] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Stein, Martin T.] Univ Calif San Diego, Div Child Dev & Community Hlth, San Diego, CA 92103 USA		Schweitzer, J (corresponding author), Univ Calif San Diego, Rady Childrens Hosp, Child & Adolescent Psychiat, San Diego, CA 92103 USA.						American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU; BERWICK DM, 1982, ARCH DIS CHILD, V57, P347, DOI 10.1136/adc.57.5.347; Buie T, 2010, PEDIATRICS, V125, pS1, DOI 10.1542/peds.2009-1878C	3	1	1	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0196-206X	1536-7312		J DEV BEHAV PEDIATR	J. Dev. Behav. Pediatr.	SEP	2016	37	7					592	594		10.1097/DBP.0000000000000324			3	Behavioral Sciences; Psychology, Developmental; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Psychology; Pediatrics	DW1OM	WOS:000383412500010	27355884				2022-02-06	
J	Turner, TH; Renfroe, JB; Morella, K; Marriott, BP				Turner, Travis H.; Renfroe, Jenna B.; Morella, Kristen; Marriott, Bernadette P.		BRAVO Working Grp	Evaluating cognitive effort in a randomized controlled trial	INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH			English	Article						clinical trials; malingering; effort; neurocognition; suicide	PREDICTS SUICIDAL-BEHAVIOR; TRAUMATIC BRAIN-INJURY; PERFORMANCE TEST-II	Many randomized controlled trials (RCTs) of neuropsychiatric conditions involve cognitive outcome measures; however, validity of cognitive data relies on adequate effort during testing, and such screening is seldom performed. Given well-established rates of 10 to 30% poor effort in clinical settings, this is not a trivial concern. This preliminary study evaluated effort during cognitive testing in an RCT of omega-3 supplementation to reduce suicidality in a high-risk psychiatric population. An interim analysis of sustained attentions measures from the Connors Performance Test (CPT-2) at baseline for the first 60 participants was conducted. Previously validated cut points to detect insufficient effort on the CPT-2 were applied. At baseline, 12% (7) were identified as giving poor effort. Follow-up analyses indicated less psychiatric distress and suicidality among those who gave poor effort. Results suggest comparable likelihood of a poor effort on cognitive testing in clinical and RCT participation. Reduced psychiatric distress in the poor effort group raises concern regarding interpretation of other measures. The importance of screening cognitive data for effort in RCTs is highlighted. Future studies will examine effort at follow-up visits, and explore relationships to attrition, adherence, and response to treatment. Copyright (c) 2016 John Wiley & Sons, Ltd.	[Turner, Travis H.] Ralph H Johnson VAMC, Mental Hlth Serv, Charleston, SC USA; [Turner, Travis H.; Marriott, Bernadette P.] Dept Psychiat & Behav Sci, Charleston, SC USA; [Turner, Travis H.; Renfroe, Jenna B.] Med Univ South Carolina, Dept Neurol Neurosci, Movement Disorders Program, Charleston, SC USA; [Morella, Kristen] Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC USA; [Marriott, Bernadette P.] Med Univ South Carolina, Div Gastroenterol & Hepatol, Nutr Sect, Dept Med, Charleston, SC USA		Turner, TH (corresponding author), VAMC MH 116, RHJ, 109 Bee St, Charleston, SC 29401 USA.	turnertr@musc.edu			Department of Defense (DoD)United States Department of Defense [W81XWH-13-2-0015]; US Army Medical Research and Materiel Command (USAMRMC)U.S. Army Medical Research & Materiel Command (USAMRMC); Congressionally Directed Medical Research Programs (CDMRP) through the US Army Medical Research Acquisition Authority (USAMRAA); intramural program of the National Institute on Alcohol Abuse and Alcoholism	The BRAVO study is sponsored by award # W81XWH-13-2-0015 from the Department of Defense (DoD), US Army Medical Research and Materiel Command (USAMRMC), Congressionally Directed Medical Research Programs (CDMRP) through the US Army Medical Research Acquisition Authority (USAMRAA). The intramural program of the National Institute on Alcohol Abuse and Alcoholism also provides support for this study. The BRAVO study team wishes to acknowledge the excellent support of Samantha Wise in all aspects of the study.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Cha CB, 2010, J ABNORM PSYCHOL, V119, P616, DOI 10.1037/a0019710; Conners, 2004, CONNERS CONTINUOUS P; Lange RT, 2013, PSYCHOL ASSESSMENT, V25, P339, DOI 10.1037/a0030915; Larrabee GJ, 2009, CLIN NEUROPSYCHOL, V23, P841, DOI 10.1080/13854040902796735; LORR M, 1982, J PERS ASSESS, V46, P432, DOI 10.1207/s15327752jpa4604_16; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Nock MK, 2010, PSYCHOL SCI, V21, P511, DOI 10.1177/0956797610364762; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P380, DOI 10.1080/13803390903066881; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Tombaugh T.N., 1996, TOMM TEST MEMORY MAL; vansHout M. S. E., 2008, PSYCHOTHER PSYCHOSOM, V77, P289; Warrington E, 1984, RECOGNITION MEMORY T, V1	14	1	1	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1049-8931	1557-0657		INT J METH PSYCH RES	Int. J. Methods Psychiatr. Res.	SEP	2016	25	3					199	204		10.1002/mpr.1505			6	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	DW6HE	WOS:000383750200005	27074873	Green Published			2022-02-06	
J	Wang, KKW; Yang, ZH; Chiu, A; Lin, F; Rubenstein, R				Wang, Kevin K. W.; Yang, Zhihui; Chiu, Allen; Lin, Fan; Rubenstein, Richard			Examining the Neural and Astroglial Protective Effects of Cellular Prion Protein Expression and Cell Death Protease Inhibition in Mouse Cerebrocortical Mixed Cultures	MOLECULAR NEUROBIOLOGY			English	Article						Cellular prion protein; Calpain; Caspase; Necrosis; Apoptosis; Cytotoxin; Cytoprotection; Proteases; Biomarkers	TRAUMATIC BRAIN-INJURY; HIPPOCAMPAL-NEURONS; IN-VITRO; CALPAIN; RAT; BIOMARKERS; DAMAGE; NEURODEGENERATION; NEUROPROTECTION; PROTEOLYSIS	Overexpression of cellular prion protein, PrPC, has cytoprotective effects against neuronal injuries. Inhibition of cell death-associated proteases such as necrosis-linked calpain and apoptosis-linked caspase are also neuroprotective. Here, we systematically studied how PrPC expression levels and cell death protease inhibition affect cytotoxic challenges to both neuronal and glial cells in mouse cerebrocortical mixed cultures (CCM). Primary CCM derived from three mouse lines expressing no (PrPC knockout mice (PrPKO)), normal (wild-type (wt)), or high (tga20) levels of PrPC were subjected to necrotic challenge (calcium ionophore A23187) and apoptotic challenge (staurosporine (STS)). CCM which originated from tga20 mice provided the most robust neuron-astroglia protective effects against necrotic and early apoptotic cell death (lactate dehydrogenase (LDH) release) at 6 h but subsequently lost its cytoprotective effects. In contrast, PrPKO-derived cultures displayed elevated A23187- and STS-induced cell death at 24 h. Calpain inhibitor SNJ-1945 protected against A23187 challenge at 6 h in CCM from all three mouse lines but protected only against A23187 and STS treatments by 24 h in the PrPKO line. In parallel, caspase inhibitor Z-D-DCB protected against pro-apoptotic STS challenge at 6 and 24 h. Furthermore, we also examined alpha II-spectrin breakdown products (primarily from neurons) and glial fibrillary acidic protein (GFAP) breakdown products (from astroglia) as cytoskeletal proteolytic biomarkers. Overall, it appeared that both neurons and astroglial cells were less vulnerable to proteolytic attack during A23187 and STS challenges in tga20-derived cultures but more vulnerable in PrPKO-derived cultures. In addition, calpain and caspase inhibitors provide further protection against respective protease attacks on these neuronal and glial cytoskeletal proteins in CCM regardless of mouse-line origin. Lastly, some synergistic cytoprotective effects between PrPC expression and addition of cell death-linked protease inhibitors were also observed.	[Wang, Kevin K. W.; Yang, Zhihui; Lin, Fan] Univ Florida, McKnight Brain Inst, Program Neurotrauma Neuroprote & Biomarkers Res, Dept Psychiat, 1149 South Newell Dr, Gainesville, FL 32611 USA; [Wang, Kevin K. W.; Yang, Zhihui; Lin, Fan] Univ Florida, McKnight Brain Inst, Program Neurotrauma Neuroprote & Biomarkers Res, Dept Neurosci, 1149 South Newell Dr, Gainesville, FL 32611 USA; [Wang, Kevin K. W.; Yang, Zhihui; Lin, Fan] Univ Florida, McKnight Brain Inst, Program Neurotrauma Neuroprote & Biomarkers Res, Dept Physiol Sci, 1149 South Newell Dr, Gainesville, FL 32611 USA; [Chiu, Allen; Rubenstein, Richard] Suny Downstate Med Ctr, Dept Neurol, Lab Neurodegenerat Dis & CNS Biomarker Discovery, 450 Clarkson Ave,Box 1213, Brooklyn, NY 11203 USA; [Chiu, Allen; Rubenstein, Richard] Suny Downstate Med Ctr, Dept Physiol Pharmacol, Lab Neurodegenerat Dis & CNS Biomarker Discovery, 450 Clarkson Ave,Box 1213, Brooklyn, NY 11203 USA		Wang, KKW (corresponding author), Univ Florida, McKnight Brain Inst, Program Neurotrauma Neuroprote & Biomarkers Res, Dept Psychiat, 1149 South Newell Dr, Gainesville, FL 32611 USA.; Wang, KKW (corresponding author), Univ Florida, McKnight Brain Inst, Program Neurotrauma Neuroprote & Biomarkers Res, Dept Neurosci, 1149 South Newell Dr, Gainesville, FL 32611 USA.; Wang, KKW (corresponding author), Univ Florida, McKnight Brain Inst, Program Neurotrauma Neuroprote & Biomarkers Res, Dept Physiol Sci, 1149 South Newell Dr, Gainesville, FL 32611 USA.; Rubenstein, R (corresponding author), Suny Downstate Med Ctr, Dept Neurol, Lab Neurodegenerat Dis & CNS Biomarker Discovery, 450 Clarkson Ave,Box 1213, Brooklyn, NY 11203 USA.; Rubenstein, R (corresponding author), Suny Downstate Med Ctr, Dept Physiol Pharmacol, Lab Neurodegenerat Dis & CNS Biomarker Discovery, 450 Clarkson Ave,Box 1213, Brooklyn, NY 11203 USA.	kawangwang17@gmail.com; richard.rubenstein@downstate.edu		Wang, Kevin/0000-0002-9343-6473	SUNY Downstate Medical Center; University of Florida Department of Psychiatry; McKnight Brain Institute faculty development funds; US Department of Defense (DoD)United States Department of Defense; DoDUnited States Department of Defense; Office of the Assistant Secretary of Defense for Health Affairs through the US Army Medical Research and Materiel Command [W81XWH-11-2-0069]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS049175, R21NS085455, R44NS048685] Funding Source: NIH RePORTER	This work was supported, in part, by the SUNY Downstate Medical Center, the University of Florida Department of Psychiatry and McKnight Brain Institute faculty development funds (KKW), and an award from the US Department of Defense (DoD) (RR). For the DoD funding, (1) the US Army Medical Research Acquisition Activity, Fort Detrick, MD 21702-5014 is the awarding and administrating acquisition office. (2) This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the US Army Medical Research and Materiel Command under award # W81XWH-11-2-0069. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the DoD. And (3) in conducting research using animals, the investigators adhere to the laws of the USA and regulations of the Department of Agriculture.	ALOISI F, 1988, J NEUROSCI RES, V21, P188, DOI 10.1002/jnr.490210211; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; Brown DR, 1997, EXP NEUROL, V146, P104, DOI 10.1006/exnr.1997.6505; Caughey B, 2001, ADV VIRUS RES, V56, P277, DOI 10.1016/S0065-3527(01)56031-5; Chen SZ, 2003, MOL CELL NEUROSCI, V22, P227, DOI 10.1016/S1044-7431(02)00014-3; Coulpier M, 2006, NEUROSCIENCE, V141, P1827, DOI 10.1016/j.neuroscience.2006.05.037; Deveraux QL, 1999, IAP FAMILY PROTEINS; DOD-DVBIC, 2014, DVBIC WORLDW TBI 200; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Guingab-Cagmat JD, 2012, ELECTROPHORESIS, V33, P3786, DOI 10.1002/elps.201200326; Hoshino S, 2003, ACT NEUR S, V86, P297; Kanaani J, 2005, J NEUROCHEM, V95, P1373, DOI 10.1111/j.1471-4159.2005.03469.x; Kim BH, 2004, MOL BRAIN RES, V124, P40, DOI 10.1016/j.molbrainres.2004.02.005; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; Krebs B, 2007, J NEUROCHEM, V100, P358, DOI 10.1111/j.1471-4159.2006.04256.x; Lapchak PA, 2011, TRANSL STROKE RES, V2, P1, DOI 10.1007/s12975-010-0057-x; Larner SF, 2008, HDB NEUROCHEMISTRY, P249; Liu J, 2008, SCI SIGNAL, V1, DOI [10.1126/stke.114re1, 10.1126/scisignal.123tr3]; Liu MC, 2006, BIOCHEM J, V394, P715, DOI 10.1042/BJ20050905; Lopes MH, 2005, J NEUROSCI, V25, P11330, DOI 10.1523/JNEUROSCI.2313-05.2005; LYNCH G, 1987, BRAIN RES BULL, V18, P809, DOI 10.1016/0361-9230(87)90220-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mitteregger G, 2007, BRAIN PATHOL, V17, P174, DOI 10.1111/j.1750-3639.2007.00061.x; Nath R, 1998, J NEUROCHEM, V71, P186; Nicotera P, 1999, TRENDS PHARMACOL SCI, V20, P46, DOI 10.1016/S0165-6147(99)01304-8; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Paitel E, 2004, J BIOL CHEM, V279, P612, DOI 10.1074/jbc.M310453200; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Park SY, 2007, NEUROSCIENCE, V144, P119, DOI 10.1016/j.neuroscience.2006.09.012; Prusiner SB, 1998, BRAIN PATHOL, V8, P499; Ray SK, 2006, NEUROSCIENCE, V139, P577, DOI 10.1016/j.neuroscience.2005.12.057; Sales N, 1998, EUR J NEUROSCI, V10, P2464, DOI 10.1046/j.1460-9568.1998.00258.x; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Siman R, 2005, J CEREBR BLOOD F MET, V25, P1433, DOI 10.1038/sj.jcbfm.9600138; Takano E, 1997, Tanpakushitsu Kakusan Koso, V42, P2181; Villa PG, 1998, J CELL SCI, V111, P713; Wang Kevin K W, 2012, Front Neurol, V3, P147, DOI 10.3389/fneur.2012.00147; Wang KK, 2013, SPIE DEFENSE SECURIT; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; WANG KKW, 1994, TRENDS PHARMACOL SCI, V15, P412, DOI 10.1016/0165-6147(94)90090-6; Wang YB, 2013, J NEUROSCI, V33, P18880, DOI 10.1523/JNEUROSCI.3293-13.2013; White AR, 2003, NATURE, V422, P80, DOI 10.1038/nature01457; Williams SK, 2011, AM J PATHOL, V178, P2823, DOI 10.1016/j.ajpath.2011.02.046; Yang ZH, 2014, J CEREBR BLOOD F MET, V34, P1444, DOI 10.1038/jcbfm.2014.105; Zhang ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092698; Zhang ZQ, 2009, APOPTOSIS, V14, P1289, DOI 10.1007/s10495-009-0405-z; Zoltewicz JS, 2013, J NEUROTRAUM, V30, P1161, DOI 10.1089/neu.2012.2762	47	1	1	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	SEP	2016	53	7					4821	4832		10.1007/s12035-015-9407-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DS3JI	WOS:000380678600044	26337296	Green Accepted			2022-02-06	
J	Xie, DJ; Xie, JX; Wan, YF; Qi, XC; Yang, SX				Xie, Dajiang; Xie, Jixi; Wan, Yingfeng; Qi, Xuchen; Yang, Shuxu			The Comparison Between Surgical Procedure and Conservative Treatment in the Management of Traumatic Subdural Effusion	TURKISH NEUROSURGERY			English	Article						Traumatic subdural effusion; Conservative treatment; Surgical procedure	HYGROMA; PATHOGENESIS	AIM: Traumatic subdural effusion (TSE) occurs following traumatic brain injury and may be treated by either conservative methods or surgical procedure commonly according to the patients' clinical information. We aimed to compare the effective rate of effusion removal and the standardized morbidity ratio of poor prognosis of the two different treatments, and to discuss the future treatment methods possible. MATERIAL and METHODS: We reviewed the clinical records of patients who were divided into two groups according to the treatment choices in our center, and the effective rate of effusion removal and the standardized morbidity ratio of poor prognosis were compared. RESULTS: Eighty patients were identified, and divided into two groups: conservative treatment and surgical procedure group. The mean CRASH-CT predicted risk of mortality in two weeks and unfavorable outcome at six months was higher in the surgical procedure group compared with the conservative treatment group. Effective rate of effusion removal was observed in 57.1 % of conservative treatment group versus 88.5% of surgical procedure group (p=0.002). The standardized morbidity ratio of poor prognosis (observed/expected poor prognosis) was 0.56 (95 % CI: 0.32-0.80) for the conservative treatment group versus 0.25 (95 % CI: 18 0.08-0.42) for the surgical procedure group. CONCLUSION: Conservative treatment and surgical procedure are used for the management of traumatic subdural effusion, and the former is used more commonly to treat the mildly affected patients than the latter one, but a surgical procedure may be more effective for the patients in poor clinical condition. Adequate evidence is required to clear the indications.	[Xie, Dajiang; Xie, Jixi; Wan, Yingfeng; Qi, Xuchen; Yang, Shuxu] Zhejiang Univ, Coll Med Sci, Sir Run Run Shaw Hosp, Dept Neurosurg, Hangzhou, Zhejiang, Peoples R China		Yang, SX (corresponding author), Zhejiang Univ, Coll Med Sci, Sir Run Run Shaw Hosp, Dept Neurosurg, Hangzhou, Zhejiang, Peoples R China.	yangshuxu@2980.com			Natural Science Foundation of Zhejiang Province of ChinaNatural Science Foundation of Zhejiang Province [Y13H160006]	This work was supported by Natural Science Foundation of Zhejiang Province of China (Y13H160006).	Borzone M, 1983, J Neurosurg Sci, V27, P161; Caldarelli M, 2002, ACTA NEUROCHIR, V144, P581, DOI 10.1007/s00701-002-0947-0; Herold TJS, 2004, J EMERG MED, V27, P361, DOI 10.1016/j.jemermed.2004.03.018; JACCARD E, 1983, NEUROCHIRURGIE, V29, P333; John JN, 1981, NEUROSURGERY, V9, P621; Kumar R, 2008, CHILD NERV SYST, V24, P1391, DOI 10.1007/s00381-008-0645-1; Lee KS, 2000, J KOREAN MED SCI, V15, P560, DOI 10.3346/jkms.2000.15.5.560; Lee KS, 1998, BRAIN INJURY, V12, P595, DOI 10.1080/026990598122359; LITOFSKY NS, 1992, NEUROSURGERY, V31, P445, DOI 10.1227/00006123-199209000-00009; Liu YG, 2009, INJURY, V40, P968, DOI 10.1016/j.injury.2009.01.006; MASUZAWA T, 1984, NEURORADIOLOGY, V26, P245, DOI 10.1007/BF00342423; Murata Keiji, 1993, Neurologia Medico-Chirurgica, V33, P691, DOI 10.2176/nmc.33.691; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Sonmez OF, 2013, CLIN NEUROL NEUROSUR, V115, P160, DOI 10.1016/j.clineuro.2012.04.023; TODOROW S, 1981, NEUROCHIRURGIA, V24, P131; Tsuang FY, 2012, J NEUROSURG, V116, P558, DOI 10.3171/2011.10.JNS11711; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Zanini MA, 2008, J TRAUMA, V64, P705, DOI 10.1097/TA.0b013e3180485cfc; Zanini MA, 2007, ARQ NEURO-PSIQUIAT, V65, P68, DOI 10.1590/S0004-282X2007000100015	19	1	2	0	0	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.	SEP	2016	26	5					725	731		10.5137/1019-5149.JTN.11826-14.1			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DY7VY	WOS:000385338600012	27337229	Bronze			2022-02-06	
J	Agarwal, V; Phadke, RV; Singh, V				Agarwal, Vivek; Phadke, R. V.; Singh, Vivek			Posttraumatic Internal Carotid Artery Pseudoaneurysm: Endovascular Management by Stent-Graft Placement	INDIAN JOURNAL OF NEUROTRAUMA			English	Article						intracavernous internal carotid artery; stent graft; epistaxis; pseudoaneurysm	COVERED STENT; ANEURYSMS	Intracavernous internal carotid artery (ICA) pseudoaneurysms are extremely rare among isolated sphenoid fractures. We report a case of a 28-year-old man who suffered from neurotrauma due to a fall of the ceiling fan over the head and subsequently developed headache with recurrent episodes of profuse epistaxis for the next 10 days. Magnetic resonance angiography revealed a large pseudoaneurysm involving intracavernous ICA. The patient underwent emergent digital subtraction angiography and a covered stent graft was used to reconstruct the ICA. Patient was discharged 5 days later completely asymptomatic and was called up for follow-up after 3 months. This case report highlights the importance of high index of suspicion of vascular injury and emergent endovascular treatment to prevent mortality in base of skull fractures.	[Agarwal, Vivek; Phadke, R. V.; Singh, Vivek] Sanjay Gandhi Postgrad Inst Med Sci, Dept Radiol, Lucknow, Uttar Pradesh, India		Agarwal, V (corresponding author), Sanjay Gandhi Postgrad Inst Med Sci, Dept Radiol, Lucknow, Uttar Pradesh, India.	vivekagarwal0004@gmail.com					BARR HWK, 1971, BRAIN, V94, P607, DOI 10.1093/brain/94.4.607; Eckert B, 1998, AM J NEURORADIOL, V19, P577; Fiorella D, 2006, NEUROSURGERY, V59, P291, DOI 10.1227/01.NEU.0000223650.11954.6C; Maras D, 2006, CARDIOVASC INTER RAD, V29, P958, DOI 10.1007/s00270-005-0367-7; Saatci I, 2004, AM J NEURORADIOL, V25, P1742; WANG AN, 1986, SURG NEUROL, V25, P77, DOI 10.1016/0090-3019(86)90120-5; Zhuang Q, 2007, J NEUROSURG, V106, P512, DOI 10.3171/jns.2007.106.3.512	7	1	1	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0973-0508	2213-3739		INDIAN J NEUROTRAUM	Indian J. Neurotrauma	AUG	2016	13	2					116	119		10.1055/s-0036-1586739			4	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	DX9BO	WOS:000384688500011					2022-02-06	
J	Clark, JF; Caudell-Stamper, DN; Dailey, SW; Divine, JG				Clark, Joseph F.; Caudell-Stamper, Danielle N.; Dailey, Stephen W.; Divine, Jon G.			Can a transient exertion-related carotid (TERC) murmur heard during a symptom-limited exercise test be used as a means for managing sports concussion?	MEDICAL HYPOTHESES			English	Article							NEUROGENESIS; BRAIN	We hypothesize that a transient exertion-related carotid (TERC) murmur flow murmur similar in nature to a "bruit" heard best at the carotid artery during exercise in healthy individuals can be used as a means for assessing post-concussion injury exertion tolerance. Typically there are no arterial sounds heard at the carotid artery in healthy individuals. Bruit, heard at rest, is an indicator of cardiovascular disease. Listening for a flow murmur or bruit-like sounds during exercise may indicate brain blood flow autoregulation and that this audible change in brain blood flow autoregulation could be used to assess exercise tolerance. We present very preliminary evidence supporting our hypothesis in that a transient exertion-related carotid (TERC) murmur is heard at a HR (HR) of approximately 150 beats per minute (bpm) in healthy individuals and 120 bpm in concussion patients. Future prospective clinical studies to validate this hypothesis and these methods may aid clinicians who manage concussion patients by using this method to help guide exertion protocols. (C) 2016 Published by Elsevier Ltd.	[Clark, Joseph F.] Univ Cincinnati, Coll Med, Dept Neurol, Cincinnati, OH 45267 USA; [Clark, Joseph F.] Univ Cincinnati, Coll Med, Dept Rehabil Med, Cincinnati, OH 45267 USA; [Caudell-Stamper, Danielle N.] Univ Cincinnati, Coll Med, Div Intervent Pulmonol, Dept Pulm Crit Care & Sleep Med, Cincinnati, OH 45267 USA; [Dailey, Stephen W.; Divine, Jon G.] Univ Cincinnati, Coll Med, Dept Orthopaed Surg, Div Sports Med, Cincinnati, OH 45267 USA		Clark, JF (corresponding author), Univ Cincinnati, Cincinnati, OH 45267 USA.	joseph.clark@uc.edu					Bickley L, 2013, BATES GUIDE PHYS EXA; Bixenmann B, 2014, INT J PHYS MED REHAB, V2; Curlik DM, 2013, NEUROPHARMACOLOGY, V64, P506, DOI 10.1016/j.neuropharm.2012.07.027; Hall JE, 2011, GUYTON HALL TXB MED; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Jacotte-Simancas A, 2015, J NEUROTRAUM, V32, P739, DOI 10.1089/neu.2014.3502; Kim BK, 2014, J EXERC REHABIL, V10, P2, DOI 10.12965/jer.140086; Kozlowski KF, 2013, J ATHL TRAINING, V48, P627, DOI 10.4085/1062-6050-48.5.02; Laennec RTH, 1819, AUSCULTATION MEDIATE; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; McCance KL, 2010, PATHOPHYSIOLOGY BIOL; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Schneiders AG, 2008, BRIT J SPORT MED, V42, P1011, DOI 10.1136/bjsm.2007.041665; Smiri JD, 2015, J APPL PHYSIOL, V2015	15	1	1	0	3	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	AUG	2016	93						11	15		10.1016/j.mehy.2016.05.003			5	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	DR7KG	WOS:000380077900004	27372849				2022-02-06	
J	Galal, S				Galal, Sherif			External fixation of paediatric subtrochanteric fractures using calcar rather than neck pins	STRATEGIES IN TRAUMA AND LIMB RECONSTRUCTION			English	Article						External fixator; Paediatric; Subtrochanteric; Fracture	FEMORAL-SHAFT FRACTURES; FEMUR FRACTURES; PLATE FIXATION; SPICA CAST; CHILDREN; TRACTION	Subtrochanteric femoral fractures in children are uncommon and have received limited attention in the literature. Its treatment is controversial, and different options are available: traction, spica casting, internal fixation and external fixation. The aim of this study is to present our results with external fixation of subtrochanteric femoral fractures in children using Ilizarov frame. Between January 2012 and January 2014, 14 patients with closed subtrochanteric femoral fractures were treated in Cairo University School of Medicine Teaching Hospital. The average age at the time of injury was 6.4 years (range 3.8-11.5 years). Pathological fractures and fractures associated with neuromuscular diseases were excluded from this study. Two patients were multiply injured with abdominal injuries (as ruptured spleen). In all cases, a low profile Ilizarov frame was inserted using two half pins inserted proximally from greater to lesser trochanters parallel to the hip joint orientation line (line between tip of greater trochanter and femoral head centre) and secured to an arch, and another three half pins were inserted distally perpendicular to the femoral shaft and secured to an arch that was connected by three rods to the proximal arch. No post-operative spica was used. Average follow-up was 18 months (range 12-36 months). All fractures united with anatomical alignment within an average of 8 weeks (range 6-12 weeks). There were no deep infections and no significant limb length discrepancies. At the latest follow-up, no patient had any restriction of activities. External fixation with a low profile Ilizarov frame appears as a good treatment option for subtrochanteric femoral fractures in children.	[Galal, Sherif] Cairo Univ, Kasr Al Ainy Sch Med, Fac Med, Dept Orthopaed Surg & Traumatol, Cairo 11559, Egypt		Galal, S (corresponding author), Cairo Univ, Kasr Al Ainy Sch Med, Fac Med, Dept Orthopaed Surg & Traumatol, Cairo 11559, Egypt.	Sherif.Galal@kasralainy.edu.eg	Hassan, Sherif G./AAK-1188-2020	Hassan, Sherif G./0000-0002-2120-0621			ARONSON DD, 1987, J BONE JOINT SURG AM, V69A, P1435; Blasier RD, 1997, J PEDIATR ORTHOPED, V17, P342, DOI 10.1097/00004694-199705000-00014; DELEE JC, 1981, J BONE JOINT SURG AM, V63, P773, DOI 10.2106/00004623-198163050-00012; Ferguson J, 2000, J PEDIATR ORTHOPED, V20, P189, DOI 10.1097/00004694-200003000-00011; Flynn JM, 2001, J PEDIATR ORTHOPED, V21, P4, DOI 10.1097/01241398-200101000-00003; Fyodorov I, 1999, J PEDIATR ORTHOPED, V19, P578, DOI 10.1097/00004694-199909000-00004; HUGHES BF, 1995, J PEDIATR ORTHOPED, V15, P457, DOI 10.1097/01241398-199507000-00009; IRELAND DCR, 1975, CLIN ORTHOP RELAT R, P157; Kasser JR, 2006, ROCKWOOD WILKINS FRA, V3, P894; KREGOR PJ, 1993, J BONE JOINT SURG AM, V75A, P1774, DOI 10.2106/00004623-199312000-00006; MARTINEZ AG, 1991, J PEDIATR ORTHOPED, V11, P712, DOI 10.1097/01241398-199111000-00002; Miner T, 2000, J PEDIATR ORTHOPED, V20, P405, DOI 10.1097/00004694-200005000-00027; REEVES RB, 1990, J PEDIATR ORTHOPED, V10, P592, DOI 10.1097/01241398-199009000-00004; WARD WT, 1992, J PEDIATR ORTHOPED, V12, P626	14	1	1	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1828-8928	1828-8936		STRATEG TRAUMA LIMB	Strateg. Trauma Limb Reconstr.	AUG	2016	11	2					99	104		10.1007/s11751-016-0252-8			6	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	EB2HB	WOS:000387177400003	27072558	gold, Green Published			2022-02-06	
J	Hawley, L; Gerber, D; Pretz, C; Morey, C; Whiteneck, G				Hawley, Lenore; Gerber, Donald; Pretz, Christopher; Morey, Clare; Whiteneck, Gale			Initial Validation of Personal Self-Advocacy Measures for Individuals With Acquired Brain Injury	REHABILITATION PSYCHOLOGY			English	Article						consumer advocacy; brain injury; chronic; traumatic brain injury; outcome assessment; self-efficacy	EFFICACY; COMMUNITY; FAMILIES; STUDENTS; PROGRAM; SATISFACTION; OUTCOMES; SUPPORT; SCALE	Purpose/Objective: The purpose of this study was to evaluate the psychometric properties of 2 novel measures assessing personal advocacy, self-efficacy and personal advocacy activities in individuals with acquired brain injury (ABI). Design: This was an instrument development study using (a) expert panel review with a content validity index, (b) consumer survey, and (c) Rasch analysis. Participants were adults (N = 162) with ABI recruited through a community survey. Main Outcome Measure: Participants completed the Self-Advocacy Scale (SAS) and the Personal Advocacy Activity Scale (PAAS). Results: Using Rasch analysis to inform instrument development, after modification on the basis of item response theory analysis, the SAS, a measure of advocacy self-efficacy, was found to be unidimensional with an eigenvalue of 1.6, exhibited monotonicity, and had an item reliability of 0.97. Similarly, the PAAS, a measure of advocacy activity, was found to exhibit monotonicity, is unidimensional (eigenvalue of 1.7) and had an item reliability of 0.97. Both measures demonstrated concurrent validity, because they were significantly correlated with other established measures of related constructs and with each other. A separation reliability of 0.97 (real not model) for both the SAS and PAAS suggests that items will likely hold their relative positions in a similar sample. Conclusions: This study supported the PAAS and the SAS as reliable and valid measures of personal advocacy activity and associated self-efficacy in individuals post-ABI. Impact and Implications Although individuals with acquired brain injury (ABI) have an increased need for personal self-advocacy to obtain necessary services and resources, there are no specific measures of personal advocacy self-efficacy and behaviors post-ABI. This study provides initial validation of two novel measures assessing personal advocacy self-efficacy and personal advocacy behaviors for individuals with ABI. Rehabilitation clinicians should consider using these measures when planning interventions designed to empower individuals with ABI as self-advocates.	[Hawley, Lenore; Gerber, Donald; Pretz, Christopher; Morey, Clare; Whiteneck, Gale] Craig Hosp, Res Dept, Englewood, CO 80113 USA		Hawley, L (corresponding author), Craig Hosp, 3425 South Clarkson St, Englewood, CO 80113 USA.	lhawley@craighospital.org			Craig Hospital Foundation	The authors would like to thank the Craig Hospital Foundation for funding this research.	BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bandura A., 2006, SELF EFFICACY BELIEF, P307, DOI DOI 10.1017/CBO9781107415324.004; Berzins D., 2009, SELF ADVOCACY PLANNI; Bond T. G., 2007, APPL RASCH MODEL FUN, V2; Boone W, 2014, RASCH ANAL HUMAN SCI; Cakar F.S., 2012, INT ED STUDIES, V5, P123, DOI DOI 10.5539/IES.V5N6P123; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; CORRIGAN J, 1999, TRAUM BRAIN INJ 21 C; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; Curtin RB, 2008, ADV CHRONIC KIDNEY D, V15, P191, DOI 10.1053/j.ackd.2008.01.006; Dawson J., SELF ADVOCACY VALUAB; Degeneffe CE, 2011, REHABIL PSYCHOL, V56, P243, DOI 10.1037/a0024465; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Engelhard G, 2013, INVARIANT MEASUREMENT: USING RASCH MODELS IN THE SOCIAL, BEHAVIORAL, AND HEALTH SCIENCES, P1; Fiedler CR, 2007, FOCUS EXCEPT CHILD, V39, P1; Foster AM, 2012, DISABIL REHABIL, V34, P1855, DOI 10.3109/09638288.2012.670028; Glang A, 2007, J HEAD TRAUMA REHAB, V22, P198, DOI 10.1097/01.HTR.0000271121.42523.3a; Hawley L. A., 2008, SAIL SELF ADVOCACY I; Hibbard MR, 2002, J HEAD TRAUMA REHAB, V17, P112, DOI 10.1097/00001199-200204000-00004; Judge TA, 1998, HUM PERFORM, V11, P167, DOI 10.1207/s15327043hup1102&3_4; Kincaid J. P., 1975, 875 NAV AIR STAT; Kissel H., 2006, AM ED RES ASS ANN C; Linacre JM., 2013, WINSTEPS RASCH MEASU; Luszczynska A, 2005, J PSYCHOL, V139, P439, DOI 10.3200/JRLP.139.5.439-457; Malec JF, 2010, DISABIL REHABIL, V32, P33, DOI 10.3109/09638280902980936; Man D, 1999, BRAIN INJURY, V13, P433, DOI 10.1080/026990599121485; Man DWK, 2006, BRAIN INJURY, V20, P959, DOI 10.1080/02699050600909789; Man DWK, 1998, BRAIN INJURY, V12, P245, DOI 10.1080/026990598122728; Masel B, 2009, CONCEPTUALIZING BRAI; Merchant D. J., 1997, J VOCATIONAL REHABIL, V8, P223, DOI DOI 10.1016/S1052-2263(97)00005-6; National Mental Health Consumer's Self-Help Clearinghouse, TEACH GUID FREED SEL; Palmer C, 2000, J REHABIL, V66, P38; Pew Research Center, 2015, INT SURV; PHILLIPS P, 1990, J LEARN DISABIL, V23, P466, DOI 10.1177/002221949002300803; POWERS LE, 1995, J REHABIL, V61, P33; Raiche G., 2005, RASCH MEASUREMENT T, V19, P1012, DOI DOI 10.1016/B978-012471352-9/50004-3; Rasch G., 1960, PROBABILISTIC MODELS; Roberts EL, 2016, J DISABIL POLICY STU, V26, P209, DOI 10.1177/1044207314540213; Roessler R., 1998, J POSTSECONDARY ED D, V13, P132; Rotondi AJ, 2005, J HEAD TRAUMA REHAB, V20, P173, DOI 10.1097/00001199-200503000-00005; Rubio DM, 2003, SOC WORK RES, V27, P94, DOI 10.1093/swr/27.2.94; Schwarzer R., 1995, MEASURES HLTH PSYCHO, P35, DOI DOI 10.1037/T00393-000; Schwarzer R., GEN SELF EFFICACY SC; Sokol K, 1999, 127 ANN M AM PUBL HL; SurveyMonkey, FREE ONL SURV SOFTW; Szymanski CM, 2006, ADV SPEC EDUC, V17, P155, DOI 10.1016/S0270-4013(06)17010-5; Test DW, 2005, REM SPEC EDUC, V26, P43, DOI 10.1177/07419325050260010601; Wehmeyer M, 1997, EXCEPT CHILDREN, V63, P245, DOI 10.1177/001440299706300207; Zimmerman MA, 1998, REHABIL PSYCHOL, V43, P3, DOI 10.1037/0090-5550.43.1.3	50	1	1	1	9	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	AUG	2016	61	3					308	316		10.1037/rep0000093			9	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	DV9HR	WOS:000383251900010	27177213				2022-02-06	
J	Rubin, G; Orbach, H; Rinott, M; Rozen, N				Rubin, Guy; Orbach, Hagay; Rinott, Micha; Rozen, Nimrod			Complex Dorsal Metacarpophalangeal Dislocation: Long-Term Follow-Up	JOURNAL OF HAND SURGERY-AMERICAN VOLUME			English	Article						Adolescent; adult; child; complications; dislocations; metacarpophalangeal joint	INDEX FINGER; PATHOLOGICAL ANATOMY; JOINT	Purpose To describe the long-term follow-up results of complex dorsal metacarpophalangeal joint dislocation (MPJD). We hypothesize that there would be no long-term functional deficit in most patients, even with the presence of one of the familiar complications. Methods We describe 5 patients with a median follow-up of 13 (range, 7-36) years and review the literature focusing on follow-up and complications. Results All patients reported full function of the hand. Compared with the contralateral finger, a mild loss of MPJ flexion was noted in 2 patients. Grip strength was reduced in 2 patients. The mean QuickDASH score was 4.5 (range, 0-20.5). Two patients with osteochondral metacarpal head fractures treated with screw fixation demonstrated secondary osteoarthritis changes on x-ray. The literature indicates that complications in patients with complex dorsal MPJD are related to failure of diagnosis, multiple attempts at closed reduction, concomitant osteochondral fracture, traumatic open reduction, or prolonged immobilization, and may result in joint stiffness, early degenerative arthritis, or osteonecrosis of the metacarpal head, pain, premature epiphysis closure, and metacarpal shortening. Conclusions The findings from this study suggest that complex dorsal MPJD treated on the day of injury with dorsal or volar open reduction techniques can eventually result in a satisfactory outcome, even with one of the complications mentioned. Copyright (C) 2016 by the American Society for Surgery of the Hand. All rights reserved.	[Rubin, Guy; Orbach, Hagay; Rinott, Micha; Rozen, Nimrod] Emek Med Ctr, Dept Orthoped, Afula, Israel; [Rubin, Guy] Technion, Fac Med, Haifa, Israel		Rubin, G (corresponding author), Haemek Med Ctr, Dept Orthopaed, Afula, Israel.	guytalr@bezeqint.net	Rubin, Guy/AAN-8891-2020	Rubin, Guy/0000-0002-1032-7280; Orbach, Hagay/0000-0001-8350-0614			ANDERSEN JA, 1987, J HAND SURG-BRIT EUR, V12B, P264, DOI 10.1016/0266-7681(87)90029-5; BALDWIN LW, 1967, J BONE JOINT SURG AM, VA 49, P1587, DOI 10.2106/00004623-196749080-00010; BARRY K, 1988, J HAND SURG-BRIT EUR, V13B, P466, DOI 10.1016/0266-7681(88)90182-9; BECTON JL, 1975, J BONE JOINT SURG AM, V57, P698, DOI 10.2106/00004623-197557050-00024; BOHART PG, 1982, CLIN ORTHOP RELAT R, P208; Dinh P, 2009, J AM ACAD ORTHOP SUR, V17, P318, DOI 10.5435/00124635-200905000-00006; GILSANZ V, 1977, AM J ROENTGENOL, V129, P737, DOI 10.2214/ajr.129.4.737; GREEN DP, 1973, J BONE JOINT SURG AM, VA 55, P1480, DOI 10.2106/00004623-197355070-00015; HUNT JC, 1967, J BONE JOINT SURG AM, VA 49, P1572, DOI 10.2106/00004623-196749080-00008; Imbriglia J E, 1979, J Hand Surg Am, V4, P72; KAPLAN EB, 1957, J BONE JOINT SURG AM, V39, P1081, DOI 10.2106/00004623-195739050-00008; LIGHT TR, 1988, J PEDIATR ORTHOPED, V8, P300, DOI 10.1097/01241398-198805000-00009; McLaughlin H L, 1965, J Trauma, V5, P683, DOI 10.1097/00005373-196511000-00001; MURPHY AF, 1967, J BONE JOINT SURG AM, VA 49, P1579, DOI 10.2106/00004623-196749080-00009	14	1	1	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0363-5023	1531-6564		J HAND SURG-AM	J. Hand Surg.-Am. Vol.	AUG	2016	41	8					E229	E233		10.1016/j.jhsa.2016.05.010			5	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	DW0MO	WOS:000383334700001	27311864				2022-02-06	
J	Shanavas, C; Basheer, N; Alapatt, JP; Kuruvilla, R				Shanavas, C.; Basheer, Noufal; Alapatt, Jacob P.; Kuruvilla, Rojan			A Prospective Study on Hyponatremia in Traumatic Brain Injury	INDIAN JOURNAL OF NEUROTRAUMA			English	Article						hyponatremia; head injury; cerebral salt wasting	CHILDREN; SIADH	Background Hyponatremia is the commonest electrolyte imbalance in traumatic brain injury (TBI) with a reported incidence of 15 to 20%. Methodology A prospective observational analytical study was conducted from January 2015 to December 2015. Mild and moderate TBI patients aged between 13 and 65 years, with no comorbid conditions were included in the study. Patients were monitored for hyponatremia, and etiology was found out using standard investigation protocol. Results A total of 153 patients were included in the study. Incidence of hyponatremia was 21.6% (33/153). Cerebral salt wasting syndrome was more common than syndrome of inappropriate secretion of antidiuretic hormone. Incidence was higher in patients with low Glasgow coma scale score (p = 0.001) and in patients with parenchymal contusions (p = 0.008). Incidence correlated well with Marshal computed tomography (CT) score (p = 0.013). No significant difference of incidence was noted in relation to age or gender. Patients with hyponatremia had significantly prolonged intensive care unit (p < 0.001) and hospital stay (p < 0.001). Outcome at discharge was worse in patients with hyponatremia (p = 0.002), whereas both groups had similar outcome at 3-month follow-up (p = 0.087). Conclusions Hyponatremia is a very common electrolyte imbalance in patients of TBI. Marshal CT grading and initial Glasgow coma scale score correlate well with the incidence of hyponatremia. More aggressive sodium monitoring may be required in parenchymal contusions in view of increased chance of development of hyponatremia. Hyponatremia adversely affect the immediate outcome in TBI, while long term outcome is usually unaffected.	[Shanavas, C.; Kuruvilla, Rojan] Med Sci Hosp, Aster Malabar Inst, Dept Gen Surg, Calicut, Kerala, India; [Basheer, Noufal; Alapatt, Jacob P.] Med Sci Hosp, Dept Neurosurg, Aster Malabar Inst, Calicut, Kerala, India		Basheer, N (corresponding author), Med Sci Hosp, Aster Malabar Inst, Govindapuram PO, Calicut 673016, Kerala, India.	basheer.noufal@gmail.com	Cholakkal, Shanavas/AAH-4135-2021	Cholakkal, Shanavas/0000-0002-2345-1029			Adrogue HJ, 2000, NEW ENGL J MED, V342, P1581, DOI 10.1056/NEJM200005253422107; Alimohamadi Maysam, 2016, Asian J Neurosurg, V11, P29, DOI 10.4103/1793-5482.154978; ARIEFF AI, 1992, BRIT MED J, V304, P1218, DOI 10.1136/bmj.304.6836.1218; Bayan Pankaj, 2013, Int J Crit Illn Inj Sci, V3, P8, DOI 10.4103/2229-5151.109409; Betjes M G, 2000, Ned Tijdschr Geneeskd, V144, P553; Betjes Michiel G.H., 2002, Eur J Intern Med, V13, P9, DOI 10.1016/S0953-6205(01)00192-3; Bussmann C, 2001, CHILD NERV SYST, V17, P58; DOCZI T, 1982, NEUROSURGERY, V10, P685, DOI 10.1227/00006123-198206010-00001; Ganveer Gunjan B, 2005, Indian J Med Sci, V59, P9; LAURENO R, 1983, ANN NEUROL, V13, P232, DOI 10.1002/ana.410130303; Leonard J, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0180-5; Lohani S, 2011, WORLD NEUROSURG, V76, P355, DOI 10.1016/j.wneu.2011.03.042; Meng XF, 2016, J NEUROSURG ANESTH, V28, P21, DOI 10.1097/ANA.0000000000000192; Momi Jasminder, 2010, Perm J, V14, P62; Moro N, 2007, SURG NEUROL, V68, P387, DOI 10.1016/j.surneu.2006.11.052; Paiva WS, 2011, THER CLIN RISK MANAG, V7, P345, DOI 10.2147/TCRM.S17692; Sherlock M, 2006, CLIN ENDOCRINOL, V64, P250, DOI 10.1111/j.1365-2265.2006.02432.x; Singh S, 2002, CRIT CARE MED, V30, P2575, DOI 10.1097/00003246-200211000-00028; Sorkhi H, 2013, IRAN J CHILD NEUROL, V7, P34; Spasovski G, 2014, NEPHROL DIAL TRANSPL, V29, P1, DOI 10.1093/ndt/gfu040; Yumoto T, 2015, ACTA MED OKAYAMA, V69, P213	21	1	1	0	2	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0973-0508	2213-3739		INDIAN J NEUROTRAUM	Indian J. Neurotrauma	AUG	2016	13	2					94	100		10.1055/s-0036-1592186			7	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	DX9BO	WOS:000384688500007					2022-02-06	
J	Sprouse, RA; Harris, GD; Sprouse, GDE; Humerick, M; Miller, RT				Sprouse, Ryan A.; Harris, George D.; Sprouse, Gretchen D. E.; Humerick, Madison; Miller, Ryan T.			Sport-related concussion: How best to help young athletes	JOURNAL OF FAMILY PRACTICE			English	Article							TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; FAMILY PHYSICIANS; SOCCER PLAY; FOOTBALL; YOUTH; MANAGEMENT; STATEMENT; RECOVERY; RISK		[Sprouse, Ryan A.; Harris, George D.; Sprouse, Gretchen D. E.; Humerick, Madison; Miller, Ryan T.] West Virginia Univ, Sch Med, Eastern Div, Harpers Ferry, WV 25425 USA		Sprouse, RA (corresponding author), West Virginia Univ, Sch Med, Eastern Div, Harpers Ferry, WV 25425 USA.	rsprouse@wvumedicine.org					Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Baker A, 2015, ACCIDENT ANAL PREV, V79, P50, DOI 10.1016/j.aap.2015.03.014; Black AM, 2016, BRIT J SPORT MED, V50, P55, DOI 10.1136/bjsports-2015-095103; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Buckley TA, 2015, J HEAD TRAUMA REHAB; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; COUNCIL SPORTS MED FITNESS, 2015, PEDIATRICS, V136, pE1419, DOI 10.1542/peds.2015-3282; DeMatteo C, 2015, CLIN PEDIATR, V54, P152, DOI 10.1177/0009922814558256; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Haran FJ, 2013, INT J SPORTS MED, V34, P350, DOI 10.1055/s-0032-1304647; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Jordan SE, 1996, AM J SPORT MED, V24, P205, DOI 10.1177/036354659602400216; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3; Kontos AP, 2013, J PEDIATR-US, V163, P717, DOI 10.1016/j.jpeds.2013.04.011; Kontos AP, 2011, BRAIN INJURY, V25, P1234, DOI 10.3109/02699052.2011.608209; Lancaster M, 2016, AM AC NEUR 2016 SPOR; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lebrun CM, 2013, BRIT J SPORT MED, V47, P54, DOI 10.1136/bjsports-2012-091480; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Maerlender A, 2015, DEV NEUROPSYCHOL, V40, P273, DOI 10.1080/87565641.2015.1067706; Mannix R, 2014, ANN CLIN TRANSL NEUR, V1, P433, DOI 10.1002/acn3.70; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Poole VN, 2015, DEV NEUROPSYCHOL, V40, P12, DOI 10.1080/87565641.2014.984810; Putukian M, 2015, CLIN J SPORT MED, V25, P36, DOI 10.1097/JSM.0000000000000102; Randolph C, 2005, J ATHL TRAINING, V40, P139; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Savica R, 2012, MAYO CLIN PROC, V87, P335, DOI 10.1016/j.mayocp.2011.12.016; Shrier I, 2012, CLIN J SPORT MED, V22, P211, DOI 10.1097/JSM.0b013e31824cc5f9; Stephens R, 2005, CHILD NEUROPSYCHOL, V11, P513, DOI 10.1080/092970490959629; Stephens R, 2010, J NEUROPSYCH CLIN N, V22, P295, DOI 10.1176/appi.neuropsych.22.3.295; Stoller J, 2014, CAN FAM PHYSICIAN, V60, P548; Straume-Naesheim TM, 2005, BRIT J SPORT MED, V39, pI70, DOI 10.1136/bjsm.2005.019646; Terwilliger VK, 2016, J NEUROTRAUM, V33, P761, DOI 10.1089/neu.2015.4082; Witol AD, 2003, ARCH CLIN NEUROPSYCH, V18, P397, DOI 10.1016/S0887-6177(02)00151-8; Yorke AM, PHYS THER; Zemek R, 2014, PAED CHILD HEALT-CAN, V19, P474, DOI 10.1093/pch/19.9.475	43	1	1	0	12	DOWDEN HEALTH MEDIA	MONTVALE	110 SUMMIT AVE, MONTVALE, NJ 07645-1712 USA	0094-3509			J FAM PRACTICE	J. Fam. Pract.	AUG	2016	65	8					538	546					8	Primary Health Care; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DY9VN	WOS:000385483300007	27660837				2022-02-06	
J	Stam, D				Stam, Daniel			Acute Treatment of an Atypical Benign Paroxysmal Positional Vertigo Variant Postsevere Traumatic Brain Injury	JOURNAL OF ACUTE CARE PHYSICAL THERAPY			English	Article							LATERAL CANALOLITHIASIS; LEAN TEST; DIZZINESS; BPPV; BOW	Background and Purpose: The differential diagnosis and treatment of peripheral vestibular disorders in persons with traumatic brain injury presents a complex set of challenges. In the acute rehabilitation setting, orthopedic and medical restrictions, agitation, and/or the inability of the patient to verbalize current symptoms present barriers to many traditional means of assessment and intervention. The purpose of this article is to present a case report of 2 patients successfully treated in the acute inpatient rehabilitation setting postsevere traumatic brain injury with an atypical variant of horizontal canal benign paroxysmal positional vertigo in which both examination and intervention modifications were required in a novel context when applied to this patient population. Case Description: Two patients were consulted to have a vestibular rehabilitation examination performed given interdisciplinary reports of nystagmus and in 1 case significant emesis associated with bed mobility. Both patients presented as Rancho Los Amigos classification 3 to 4, were nonverbal, and presented with multiple comorbidities. Intervention: Both patients were treated for apogeotropic horizontal canal benign paroxysmal positional vertigo using a sequence of bedside canalith repositioning maneuvers safely and efficiently accommodating the clinical brain injury presentation. Outcomes: Both patients demonstrated complete remission of horizontal nystagmus and remission of associated emesis in the 1 case allowing for increased interdisciplinary rehabilitation participation. Discussion: This case report illustrates how application of recent scientific and clinical evidence may be applied within the early acute brain injury population. Vestibular rehabilitation may be an important component to acute neurological rehabilitation posttraumatic brain injury, even when the patient cannot actively verbalize symptoms. In these cases, the clinician must then use a collaborative approach as well as a clinical decision-making model on the basis of an understanding of the neurological underpinning of eye movements and nystagmus.	[Stam, Daniel] Mayo Clin Minnesota, Rochester, MN 55905 USA		Stam, D (corresponding author), Mayo Clin Minnesota, Rochester, MN 55905 USA.	destam@alumni.nmu.edu					Appiani GC, 2005, OTOL NEUROTOL, V26, P257, DOI 10.1097/00129492-200503000-00022; Bhattacharyya N, 2008, OTOLARYNG HEAD NECK, V139, pS47, DOI 10.1016/j.otohns.2008.08.022; Califano L, 2013, ACTA OTORHINOLARYNGO, V33, P254; Califano L, 2008, ACTA OTORHINOLARYNGO, V28, P287; Casani AP, 2011, AUDIOL NEURO-OTOL, V16, P175, DOI 10.1159/000317113; Choung YH, 2006, LARYNGOSCOPE, V116, P1776, DOI 10.1097/01.mlg.0000231291.44818.be; Fife TD, 2013, SEMIN NEUROL, V33, P238, DOI 10.1055/s-0033-1354599; Hagen C., 1972, LEVELS COGNITIVE FUN; Hain T., 2015, LATERAL CANAL BPPV; Herdman SJ, 2007, VESTIBULAR REHABILIT; Katsarkas A, 1999, ACTA OTO-LARYNGOL, V119, P745, DOI 10.1080/00016489950180360; Kerrigan MA, 2013, PM&R, V5, P778, DOI 10.1016/j.pmrj.2013.05.010; Lee JB, 2010, LARYNGOSCOPE, V120, P2339, DOI 10.1002/lary.21117; Leigh RJ, 2006, NEUROLOGY EYE MOVEME; Libonati GA, 2012, INT J OTORHINOLARYNG, V4, P25; Liu HJ, 2012, ACTA OTO-LARYNGOL, V132, P803, DOI 10.3109/00016489.2012.657359; Motin M, 2005, BRAIN INJURY, V19, P693, DOI 10.1080/02699050400013600; Oghalai JS, 2000, OTOLARYNG HEAD NECK, V122, P630, DOI 10.1016/S0194-5998(00)70187-2; Tomanovic T, 2013, ACTA OTO-LARYNGOL, V133, P796, DOI 10.3109/00016489.2013.777472; Zasler ND, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P1	20	1	1	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2158-8686	2159-0524		J ACUTE CARE PHYS TH	J. ACUTE CARE PHYS. THER.	AUG	2016	7	3					101	112		10.1097/JAT.0000000000000035			12	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	DW5PG	WOS:000383697800004					2022-02-06	
J	Wang, SB; Reeves, B; Sparkenbaugh, EM; Russell, J; Soltys, Z; Zhang, H; Faber, JE; Key, NS; Kirchhofer, D; Granger, DN; Mackman, N; Pawlinski, R				Wang, Shaobin; Reeves, Brandi; Sparkenbaugh, Erica M.; Russell, Janice; Soltys, Zbigniew; Zhang, Hua; Faber, James E.; Key, Nigel S.; Kirchhofer, Daniel; Granger, D. Neil; Mackman, Nigel; Pawlinski, Rafal			Protective and detrimental effects of neuroectodermal cell-derived tissue factor in mouse models of stroke	JCI INSIGHT			English	Article							ACUTE ISCHEMIC-STROKE; PLASMINOGEN-ACTIVATOR; ANTICOAGULANT-THERAPY; THROMBIN ACTIVITY; NEURONAL DAMAGE; NERVOUS-SYSTEM; FACTOR PATHWAY; HEART; HEMOSTASIS; PROTHROMBIN	Within the CNS, a dysregulated hemostatic response contributes to both hemorrhagic and ischemic strokes. Tissue factor (TF), the primary initiator of the extrinsic coagulation cascade, plays an essential role in hemostasis and also contributes to thrombosis. Using both genetic and pharmacologic approaches, we characterized the contribution of neuroectodermal (NE) cell TF to the pathophysiology of stroke. We used mice with various levels of TF expression and found that astrocyte TF activity reduced to similar to 5% of WT levels was still sufficient to maintain hemostasis after hemorrhagic stroke but was also low enough to attenuate inflammation, reduce damage to the blood-brain barrier, and improve outcomes following ischemic stroke. Pharmacologic inhibition of TF during the reperfusion phase of ischemic stroke attenuated neuronal damage, improved behavioral deficit, and prevented mortality of mice. Our data demonstrate that NE cell TF limits bleeding complications associated with the transition from ischemic to hemorrhagic stroke and also contributes to the reperfusion injury after ischemic stroke. The high level of TF expression in the CNS is likely the result of selective pressure to limit intracerebral hemorrhage (ICH) after traumatic brain injury but, in the modern era, poses the additional risk of increased ischemia-reperfusion injury after ischemic stroke.	[Wang, Shaobin; Sparkenbaugh, Erica M.; Zhang, Hua; Faber, James E.; Key, Nigel S.; Mackman, Nigel; Pawlinski, Rafal] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC USA; [Reeves, Brandi; Key, Nigel S.; Mackman, Nigel; Pawlinski, Rafal] Univ N Carolina, Dept Med, Div Hematol & Oncol, Chapel Hill, NC USA; [Russell, Janice; Granger, D. Neil] Louisiana State Univ, Hlth Sci Ctr, Dept Mol & Cellular Physiol, Shreveport, LA 71105 USA; [Soltys, Zbigniew] Jagiellonian Univ, Inst Zool, Dept Neuroanat, Krakow, Poland; [Zhang, Hua; Faber, James E.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC USA; [Kirchhofer, Daniel] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA		Pawlinski, R (corresponding author), Dept Med, Div Hematol Oncol, 1043 Genet Med Bldg,120 Mason Farm Rd, Chapel Hill, NC 27599 USA.	rafal_pawlinski@med.unc.edu	PAwlinski, Rafal/AAD-6090-2022; Reeves, Brandi/AAM-5324-2021; Soltys, Zbigniew/F-7603-2015	Soltys, Zbigniew/0000-0003-0656-8505			Adams MJ, 2006, BLOOD COAGUL FIBRIN, V17, P527, DOI 10.1097/01.mbc.0000245294.41774.06; Barber PA, 2001, NEUROLOGY, V56, P1015, DOI 10.1212/WNL.56.8.1015; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Bhatia R, 2010, STROKE, V41, P2254, DOI 10.1161/STROKEAHA.110.592535; Boulaftali Y, 2013, J CLIN INVEST, V123, P908, DOI 10.1172/JCI65154; Bushi D, 2013, J MOL NEUROSCI, V51, P844, DOI 10.1007/s12031-013-0072-y; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Carmeliet P, 1996, NATURE, V383, P73, DOI 10.1038/383073a0; Chen B, 2012, J NEUROSCI, V32, P7622, DOI 10.1523/JNEUROSCI.0369-12.2012; Cheng T, 2003, NAT MED, V9, P338, DOI 10.1038/nm826; Chiang T, 2011, JOVE-J VIS EXP, DOI 10.3791/2761; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; del Zoppo GJ, 2009, STROKE, V40, P2945, DOI 10.1161/STROKEAHA.109.192535; DRAKE TA, 1989, AM J PATHOL, V134, P1087; EDDLESTON M, 1993, J CLIN INVEST, V92, P349, DOI 10.1172/JCI116573; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Hacke Werner, 2008, N Engl J Med, V359, P1317, DOI 10.1056/NEJMoa0804656; Hamill CE, 2009, EXP NEUROL, V217, P136, DOI 10.1016/j.expneurol.2009.01.023; Hankey GJ, 2012, NAT REV NEUROL, V8, P319, DOI 10.1038/nrneurol.2012.77; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Junge CE, 2003, P NATL ACAD SCI USA, V100, P13019, DOI 10.1073/pnas.2235594100; Jurk K, 2004, THROMB HAEMOSTASIS, V91, P334, DOI 10.1160/TH03-01-0044; Kacem K, 1998, GLIA, V23, P1; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Loubele STBG, 2010, THROMB HAEMOSTASIS, V104, P136, DOI 10.1160/TH09-08-0582; Lyden P, 2013, CURR PHARM DESIGN, V19, P7479; Mackman N, 2008, NATURE, V451, P914, DOI 10.1038/nature06797; Mackman N, 2012, J CLIN INVEST, V122, P2331, DOI 10.1172/JCI60229; Mackman N, 2009, ANESTH ANALG, V108, P1447, DOI 10.1213/ane.0b013e31819bceb1; Manly DA, 2011, ANNU REV PHYSIOL, V73, P515, DOI 10.1146/annurev-physiol-042210-121137; Mao YY, 2010, J CEREBR BLOOD F MET, V30, P1044, DOI 10.1038/jcbfm.2009.283; Mosnier LO, 2014, THROMB HAEMOSTASIS, V112, P883, DOI 10.1160/TH14-05-0448; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Mullins ES, 2009, BLOOD, V113, P696, DOI 10.1182/blood-2008-07-169003; Nagai M, 2010, NEUROSURGERY, V66, P560, DOI 10.1227/01.NEU.0000365745.49583.FD; Owens AP, 2012, THROMB RES, V129, pS30, DOI 10.1016/j.thromres.2012.02.026; Parry GCN, 1998, J CLIN INVEST, V101, P560, DOI 10.1172/JCI814; Pawlinski R, 2007, J THROMB HAEMOST, V5, P1693, DOI 10.1111/j.1538-7836.2007.02649.x; Pawlinski R, 2002, P NATL ACAD SCI USA, V99, P15333, DOI 10.1073/pnas.242501899; Pawlinski R, 2010, BLOOD, V116, P806, DOI 10.1182/blood-2009-12-259267; Pedersen B, 2005, BLOOD, V105, P2777, DOI 10.1182/blood-2004-09-3724; Prabhakaran S, 2015, JAMA-J AM MED ASSOC, V313, P1451, DOI 10.1001/jama.2015.3058; Rajput PS, 2014, NEUROSCIENCE, V281, P229, DOI 10.1016/j.neuroscience.2014.09.038; Riek-Burchardt M, 2002, NEUROSCI LETT, V329, P181, DOI 10.1016/S0304-3940(02)00645-6; Rosen ED, 1997, NATURE, V390, P290, DOI 10.1038/36862; Sandercock PAG, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000024.pub4; Saver JL, 2012, LANCET, V380, P1241, DOI 10.1016/S0140-6736(12)61384-1; Stein ES, 2015, SCI REP-UK, V5, DOI 10.1038/srep07912; Taubman MB, 1997, THROMB HAEMOSTASIS, V78, P200; THOMAS WS, 1993, STROKE, V24, P847, DOI 10.1161/01.STR.24.6.847; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Wang SL, 2010, CIRC RES, V107, P558, DOI 10.1161/CIRCRESAHA.110.224634; Wang YZ, 2013, J NANOMATER, V2013, DOI 10.1155/2013/169405; Wardlaw JM, 2012, LANCET, V379, P2364, DOI 10.1016/S0140-6736(12)60738-7; Williams Julie C, 2012, Front Biosci (Elite Ed), V4, P358; Yepes M, 2003, J CLIN INVEST, V112, P1533, DOI 10.1172/JCI200319212	59	1	1	1	4	AMER SOC CLINICAL INVESTIGATION INC	ANN ARBOR	2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA		2379-3708		JCI INSIGHT	JCI Insight	JUL 21	2016	1	11							e86663	10.1172/jci.insight.86663			13	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	EB1MH	WOS:000387115900004		gold, Green Accepted, Green Published			2022-02-06	
J	Cole, T; Underhill, A; Kennedy, S				Cole, Tanya; Underhill, Ann; Kennedy, Sue			Adherence behavior in an acute pediatric hand trauma population: A pilot study of parental report of adherence levels and influencing factors	JOURNAL OF HAND THERAPY			English	Article						Adherence; Pediatric; Hand injury; Plaster wear; Sport	GENDER-DIFFERENCES; CHILDREN; FRACTURES; PLAY; ADOLESCENTS; CONCUSSION; SPLINTS; RETURN; BRAIN	Introduction: Descriptive and cross-sectional study. Purpose of the Study: The hand is a common site of injury in children; however, little is known regarding adherence to hand trauma management in this population. Purpose: This pilot study aimed to describe adherence to plaster slab immobilization, advice regarding return to sport, appointment attendance, and the factors influencing nonadherence. Method: Forty-seven parents of children with hand trauma completed an online questionnaire reporting their child's adherence to the initial medical management. Results: Parents reported that 34% (16 of 47) of children were adherent to all aspects of management. Nonadherence with plaster slab immobilization was reported by 38% (18 of 47), and 45% (21 of 47) reported nonadherence with advice regarding return to sport. Hygiene, discomfort, and restriction were the most common reasons for plaster removal. Belief that sport would not cause harm and social factors influenced return to sport against medical advice. Conclusion: Nonadherence behavior is commonly reported in children with acute hand trauma. Crown Copyright (C) 2016 Published by Elsevier Inc. on behalf of Hanley & Belfus, an imprint of Elsevier Inc. All rights reserved.	[Cole, Tanya] Royal Childrens Hosp, Parkville, Vic, Australia; [Cole, Tanya; Underhill, Ann; Kennedy, Sue] Univ Derby, Derby, England; [Cole, Tanya] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic, Australia		Cole, T (corresponding author), The Alfred, Alfred Hlth, Occupat Therapy Dept, Box 315, Prahran, Vic 3181, Australia.	t.cole@alfred.org.au					Australian commission on Safety and Quality in Health Care, 2014, HLTH LIT TAK ACT IMP; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Bowling A, 2009, RES METHODS HLTH; Brewer BW, 1998, J APPL SPORT PSYCHOL, V10, P70, DOI 10.1080/10413209808406378; Bugni VM, 2012, J PEDIAT-BRAZIL, V88, P483, DOI [10.2223/JPED.2227, 10.1590/S0021-75572012000600007]; Burkhart PV, 2002, CHRONIC ILLNESS IN CHILDREN: AN EVIDENCE-BASED APPROACH, P199; Callinan NJ, 1996, AM J OCCUP THER, V50, P347, DOI 10.5014/ajot.50.5.347; Chung KC, 2001, J HAND SURG-AM, V26A, P908, DOI 10.1053/jhsu.2001.26322; Feehan L, 2011, REHABILITATION HAND; Feehan LM, 2006, J HAND SURG-AM, V31A, P1068, DOI 10.1016/j.jhsa.2006.06.006; Groth G N, 1994, J Hand Ther, V7, P21; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Helfenstein A, 2006, SPINE, V31, P339, DOI 10.1097/01.brs.0000197412.70050.0d; Hillier LM, 1998, J PEDIATR PSYCHOL, V23, P229, DOI 10.1093/jpepsy/23.4.229; Hollis SJ, 2012, BRIT J SPORT MED, V46, P735, DOI 10.1136/bjsm.2011.085332; Jolles BM, 2005, J CLIN EPIDEMIOL, V58, P791, DOI 10.1016/j.jclinepi.2005.01.012; Kaskutas V, 2013, J HAND THER, V26, P22, DOI 10.1016/j.jht.2012.08.004; Kozin SH, 2010, ROCKWOOD WILKINS FRA; Larson RW, 1999, PSYCHOL BULL, V125, P701, DOI 10.1037/0033-2909.125.6.701; Law M, 2002, AM J OCCUP THER, V56, P640, DOI 10.5014/ajot.56.6.640; LAW M, 1993, DEV MED CHILD NEUROL, V35, P983, DOI 10.1111/j.1469-8749.1993.tb11580.x; Lyngcoln Anthony, 2005, J Hand Ther, V18, P2, DOI 10.1197/j.jht.2004.10.008; McQuillan R, 2006, PUBLIC HEALTH, V120, P732, DOI 10.1016/j.puhe.2006.02.011; Norman, 2003, HLTH MEASUREMENT SCA; O'Brien L, 2008, BRAIN INJURY, V22, P411, DOI 10.1080/02699050802008067; O'Brien L, 2010, HAND THER, V15, P3, DOI 10.1258/ht.2009.009025; O'Brien L, 2012, J HAND THER, V25, P247, DOI 10.1016/j.jht.2012.03.006; O'Brien L, 2010, J HAND THER, V23, P249, DOI 10.1016/j.jht.2010.01.002; Oppenheim A.N., 1992, QUESTIONNAIRE DESIGN; Paternostro-Sluga T, 2003, AM J PHYS MED REHAB, V82, P86, DOI 10.1097/00002060-200302000-00002; Pesata V, 1999, J Pediatr Health Care, V13, P178, DOI 10.1016/S0891-5245(99)90037-8; Pettengill K, 2011, REHABILITATION HAND; Ramirez N, 2011, J PEDIATR ORTHOPED, V31, P710, DOI 10.1097/BPO.0b013e318221eaa1; Rapoff M, 2010, ADHERENCE PEDIAT MED; Rapoff MA, 2006, BEST PRACT RES CL RH, V20, P301, DOI 10.1016/j.berh.2005.11.002; RETTIG AC, 1989, AM J SPORT MED, V17, P567, DOI 10.1177/036354658901700420; Sabate E, 2003, ADHERENCE LONG TERM; Sandford F, 2008, J HAND THER, V21, P44, DOI 10.1197/j.jht.2007.07.004; Schroder N, 2002, BR J OCCUP THER, V65, P75; SLUIJS EM, 1993, PHYS THER, V73, P786, DOI 10.1093/ptj/73.11.786; *STAT CAN, 2001, NAT LONG SURV CHILDR; Teoh KH, 2010, INT J ORTHOP TRAUMA, V14, P82, DOI 10.1016/j.joon.2009.10.003; Valencia J, 2005, CLIN ORTHOP RELAT R, P77, DOI 10.1097/01.blo.0000155376.88317.b7; Williams S, 2000, INT J THER REHAB, V7, P34; Yard EE, 2009, BRAIN INJURY, V23, P888, DOI 10.1080/02699050903283171	45	1	1	0	5	HANLEY & BELFUS-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0894-1130	1545-004X		J HAND THER	J. Hand Ther.	JUL-SEP	2016	29	3					299	306		10.1016/j.jht.2016.02.005			8	Orthopedics; Rehabilitation; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Rehabilitation; Surgery	DT8CR	WOS:000381717200009	27496984				2022-02-06	
J	Hussain, FS; Hussain, NS				Hussain, Fadilah S.; Hussain, Namath S.			A Unique Case of Intracranial Mucormycosis Following an Assault	CUREUS			English	Article						traumatic brain injury (tbi); mucormycosis		Intracranial mucormycosis is a very unusual presentation of an infection after a depressed skull fracture due to an assault. Only sporadic cases have been reported in the literature previously. A 30-year-old male with a traumatic brain injury following an assault, status-post debridement and elevation of a depressed skull fracture, was discharged home several weeks postoperatively. A CT scan of the head with contrast was obtained due to mental status changes and revealed an enhancing ring-shaped lesion in the right frontal lobe consistent with a brain abscess. The patient was taken to the operating room for image-guided excisional biopsy of the lesion, with pathology revealing mucormycosis.	[Hussain, Fadilah S.] Wayne State Univ, Sch Med, Radiol, Detroit, MI 48202 USA; [Hussain, Namath S.] Loma Linda Univ, Med Ctr, Dept Neurosurg, Loma Linda, CA 92350 USA		Hussain, NS (corresponding author), Loma Linda Univ, Med Ctr, Dept Neurosurg, Loma Linda, CA 92350 USA.	namath.hussain@gmail.com					Deja M, 2006, MED MYCOL, V44, P683, DOI 10.1080/13693780600803888; El Deeb Y, 2005, ANN SAUDI MED, V25, P343, DOI 10.5144/0256-4947.2005.343; Keijzer A, 2006, HAEMATOLOGICA, V91, P139; Melsom S M, 2000, Australas Radiol, V44, P104, DOI 10.1046/j.1440-1673.2000.00751.x; Munir N, 2007, J LARYNGOL OTOL, V121, P192, DOI 10.1017/S0022215106003409; Park SK, 2006, ACTA OTO-LARYNGOL, V126, P1339, DOI 10.1080/00016480500316852; Schutz P, 2006, J ORAL MAXIL SURG, V64, P1795, DOI 10.1016/j.joms.2006.05.010; Sridhara SR, 2005, J OTOLARYNGOL, V34, P402; Szalai G, 2006, ANN NY ACAD SCI, V1084, P520, DOI 10.1196/annals.1372.010; Tiong WHC, 2006, J PLAST RECONSTR AES, V59, P1367, DOI 10.1016/j.bjps.2006.03.053	10	1	1	0	0	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	JUL	2016	8	7							e696	10.7759/cureus.696			10	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	VH6EI	WOS:000453614100032	27672528	Green Published, Green Submitted, gold			2022-02-06	
J	Imran, A; Qureshi, AA; Tariq, A				Imran, Ahmad; Qureshi, Abid Ali; Tariq, Amna			Role of Computed Tomography in Pediatric Traumatic Brain Injury and its Correlation with Glasgow Coma Scale at Presentation	ANNALS OF KING EDWARD MEDICAL UNIVERSITY LAHORE PAKISTAN			English	Article						Computed tomography; head injury; GCS	HEAD-INJURY; CHILDHOOD; CANCER; SCANS; RISK	The study was aimed at documenting the relationship between Glasgow coma score with imaging findings on computed tomography in children with traumatic brain injury. Un-necessary radiation exposure can be detrimental in pediatric age group and can lead to an increased risk of radiation induced malignancies. Patients and Methods: This retrospective study was conducted in Department of Radiology Lahore from 15.8.11 to 15.11.11. It included 48 children who presented in emergency department with history of fall or trauma to head. These patients underwent computed tomography using standard imaging protocols. All the data was analyzed by using SPSS version 17. Results: A total of 48 patients from 6 months to 15 years of age with history of fall or trauma to head who underwent CT scan were included in study. 20 (42%) patients revealed normal study. Extra/intra axial bleed is noted in 11 (23%), evidence of cerebral edema was noted in 4 (8%) patients. 9 (19%) patients had fracture of skull bones and cephalhematoma was noted among 4 (8%) patients. Imaging findings were seen in majority of the patients with GCS less than 13/15. Conclusion: Neuroimaging can serve as a useful guide regarding management of traumatic brain injury however un-necessary radiation exposure is detrimental in pediatric age group. A correlation between GCS and decision regarding imaging can serve as an effective approach to decrease rates of neuroimaging after pediatric head trauma.	[Imran, Ahmad; Tariq, Amna] Children Hosp, Dept Radiol, Lahore, Pakistan; [Qureshi, Abid Ali] Children Hosp, Radiol, Lahore, Pakistan		Imran, A (corresponding author), Children Hosp, Dept Radiol, Lahore, Pakistan.	ahmedimran9@gmail.com					Alexiou George A, 2011, J Emerg Trauma Shock, V4, P403, DOI 10.4103/0974-2700.83872; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Gulsen I, 2014, EMERG MED INT, V2014, DOI 10.1155/2014/248967; ICRP, 1991, ICRP PUBL, V60; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; Klassen TP, 2000, ACAD EMERG MED, V7, P739, DOI 10.1111/j.1553-2712.2000.tb02260.x; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Kuppermann N, 2008, PEDIATR RADIOL, V38, pS670, DOI 10.1007/s00247-008-0996-5; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Miller Erik C., 1997, Journal of Emergency Medicine, V15, P453, DOI 10.1016/S0736-4679(97)00071-1; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; TEPAS JJ, 1990, J PEDIATR SURG, V25, P92, DOI 10.1016/S0022-3468(05)80170-8; Thukral Brij Bhushan, 2015, Indian J Radiol Imaging, V25, P359, DOI 10.4103/0971-3026.169466	15	1	1	0	0	RESEARCH & MEDICAL EDUCATION CENTRE	LAHORE	KING EDWARD MEDICAL COLLEGE, NILA GUMBAD, LAHORE, 00000, PAKISTAN	2079-7192	2079-0694		ANN KING EDWARD MED	Ann. King Edward Med. Univ. Lahore Pak.	JUL-SEP	2016	22	3					232	236					5	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	FC0FQ	WOS:000406514500014					2022-02-06	
J	Zheng, LSX; Keegan, JP; Rosenthal, D; Talley, W; Hunter, CA				Zheng, Lisa Xi; Keegan, John P.; Rosenthal, David; Talley, William; Hunter, Celeste A.			Examining the Attributions of Discrimination toward People with Mental Illness among Chinese College Students	AUSTRALIAN JOURNAL OF REHABILITATION COUNSELLING			English	Article						mental illness; schizophrenia; attribution model; discrimination; stigma	CULTURE; STIGMA; SCHIZOPHRENIA; HEALTH; DISORDERS; EMOTION	The purpose of this study was to test the usefulness of the attribution model (Corrigan, Markowitz, Watson, Rowan & Kubiak, 2003; Weiner, 1995) in a Chinese cultural context to explain Chinese college students' perceptions of discrimination toward people withmental illness. A total of 293 college students (male = 142; female = 151; age from 18 to 22) completed an Attribution Questionnaire (AQ) after reading vignettes, consisting of a male who either used illicit drugs or had a traumatic brain injury. Data were analysed using a hierarchical regression to determine the amount of variance accounted for in discriminatory behaviours by the attribution model. The results showed, when controlling for all other factors, that controllability and the three emotions (pity, anger, and fear) were found to be significant predictors of discrimination. The relationship between controllability, responsibility, and discrimination was not consistent with the attribution model since responsibility did not mediate the controllability of cause. These results provide support for the idea that disability attributions are culturally influenced.	[Zheng, Lisa Xi; Talley, William] Univ Maryland Eastern Shore, Dept Rehabil, Princess Anne, MD 21853 USA; [Keegan, John P.] CUNY, Hunter Coll, Dept Educ Fdn & Counseling Programs, New York, NY 10021 USA; [Rosenthal, David; Hunter, Celeste A.] Univ Wisconsin, Dept Rehabil Psychol & Special Educ, Madison, WI USA		Zheng, LSX (corresponding author), Univ Maryland Eastern Shore, Dept Rehabil, Princess Anne, MD 21853 USA.	lzheng@umes.edu					Bedford O, 2003, J THEOR SOC BEHAV, V33, P127, DOI 10.1111/1468-5914.00210; Brown SA, 2008, PSYCHIATR REHABIL J, V32, P89, DOI 10.2975/32.2.2008.89.94; Corrigan P, 2003, J HEALTH SOC BEHAV, V44, P162, DOI 10.2307/1519806; Corrigan P, 2004, AM PSYCHOL, V59, P614, DOI 10.1037/0003-066X.59.7.614; Corrigan PW, 1999, J NERV MENT DIS, V187, P378, DOI 10.1097/00005053-199906000-00008; Heider F., 1958, PSYCHOL INTERPERSONA; Hopper K, 2000, SCHIZOPHRENIA BULL, V26, P835, DOI 10.1093/oxfordjournals.schbul.a033498; KARASAWA K, 1991, J APPL SOC PSYCHOL, V21, P482, DOI 10.1111/j.1559-1816.1991.tb00532.x; Kulhara P, 2001, PSYCHIAT CLIN N AM, V24, P449, DOI 10.1016/S0193-953X(05)70240-9; Lin YN, 2002, AM J PSYCHOTHER, V56, P46, DOI 10.1176/appi.psychotherapy.2002.56.1.46; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; MILLER JG, 1984, J PERS SOC PSYCHOL, V46, P961; Monahan J, 2003, HEALTH AFFAIR, V22, P28, DOI 10.1377/hlthaff.22.5.28; PEARSON V, 1993, J FAM THER, V15, P163, DOI 10.1111/j.1467-6427.1993.00752.x; Phillips MR, 2002, BRIT J PSYCHIAT, V181, P488, DOI 10.1192/bjp.181.6.488; ROSS L, 1977, ADV EXPT SOCIAL PSYC, P173; TSANG WHH, 2000, PSYCHIATR REHABIL J, V4, P1; WEINER B, 1988, J PERS SOC PSYCHOL, V55, P738, DOI 10.1037/0022-3514.55.5.738; Weiner B., 1995, JUDGMENTS RESPONSIBI; Xiang YT, 2012, LANCET, V380, P1715, DOI 10.1016/S0140-6736(11)60893-3; Zheng X.S., 2011, THESIS	21	1	1	4	9	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1323-8922	1838-6059		AUST J REHABIL COUNS	Aust. J. Rehabil. Couns.	JUL	2016	22	1					40	50		10.1017/jrc.2016.3			11	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	DU3RI	WOS:000382129500004					2022-02-06	
J	Hayashi, T; Ago, K; Nakamae, T; Higo, E; Ogata, M				Hayashi, Takahito; Ago, Kazutoshi; Nakamae, Takuma; Higo, Eri; Ogata, Mamoru			Interleukin (IL)-8 immunoreactivity of injured axons and surrounding oligodendrocytes in traumatic head injury	FORENSIC SCIENCE INTERNATIONAL			English	Article						Traumatic axonal injury; Beta-amyloid precursor protein (A beta PP); Interleukin (IL)-8; Remyelination; Immunohistochemistry; Postmortem diagnosis	AMYLOID PRECURSOR PROTEIN; BRAIN-INJURY; BETA-APP; DAMAGE; IMMUNOHISTOCHEMISTRY; CHEMOTAXIS; DIAGNOSIS; MARKER; ADULTS	Interleukin (IL)-8 has been suggested to be a positive regulator of myelination in the central nervous system, in addition to its principal role as a chemokine for neutrophils. Immunostaining for beta-amyloid precursor protein (A beta PP) is an effective tool for detecting traumatic axonal injury, although AbPP immunoreactivity can also indicate axonal injury due to hypoxic causes. In this study, we examined IL-8 and A beta PP immunoreactivity in sections of corpus callosum obtained from deceased patients with blunt head injury and from equivalent control tissue. A beta PP immunoreactivity was detected in injured axons, such as axonal bulbs and varicose axons, in 24 of 44 head injury cases. These A beta PP immunoreactive cases had survived for more than 3 h. The A beta PP immunostaining pattern can be classified into two types: traumatic (Pattern 1) and non-traumatic (Pattern 2) axonal injuries, which we described previously [Hayashi et al. Int. J. Legal Med. 129 (2015) 1085-1090]. Three of 44 control cases also showed A beta PP immunoreactive injured axons as Pattern 2. In contrast, IL-8 immunoreactivity was detected in 7 A beta PP immunoreactive and in 2 non-A beta PP immunoreactive head injury cases, but was not detected in any of the 44 control cases, including the 3 A beta PP immunoreactive control cases. The IL-8 immunoreactive cases had survived from 3 to 24 days, whereas those cases who survived less than 3 days (n = 29) and who survived 90 days (n = 1) were not IL-8 immunoreactive. Moreover, IL-8 was detected as Pattern 1 axons only. In addition, double immunofluorescence analysis showed that IL-8 is expressed by oligodendrocytes surrounding injured axons. In conclusion, our results suggest that immunohistochemical detection of IL-8 may be useful as a complementary diagnostic marker of traumatic axonal injury. (C) 2016 Elsevier Ireland Ltd. All rights reserved.	[Hayashi, Takahito; Ago, Kazutoshi; Nakamae, Takuma; Higo, Eri; Ogata, Mamoru] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Legal Med, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan		Hayashi, T; Ogata, M (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Legal Med, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	takahito@m2.kufm.kagoshima-u.ac.jp; ogatam@m.kufm.kagoshima-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [19590677, 22790599]	This study was supported financially by Grants-in-Aid for Scientific Research (C) (grant No. 19590677 to M. Ogata) and for Young Scientists (B) (grant No. 22790599 to T. Hayashi) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Ferreira LCB, 2014, BRAIN INJURY, V28, P1311, DOI 10.3109/02699052.2014.916818; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; Darbinyan A, 2013, J NEUROSCI RES, V91, P116, DOI 10.1002/jnr.23135; Davceva N, 2012, J FORENSIC LEG MED, V19, P413, DOI 10.1016/j.jflm.2012.04.011; Geddes JF, 2000, NEUROPATH APPL NEURO, V26, P105, DOI 10.1046/j.1365-2990.2000.026002105.x; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; Goodman JC, 2008, ACTA NEUROCHIR SUPPL, V102, P437, DOI 10.1007/978-3-211-85578-2_85; Graham DI, 2004, FORENSIC SCI INT, V146, P89, DOI 10.1016/S0379-0738(03)00274-3; Harrington D, 2000, J Clin Forensic Med, V7, P19, DOI 10.1054/jcfm.2000.0359; Hayashi T, 2015, INT J LEGAL MED, V129, P1085, DOI 10.1007/s00414-015-1245-8; Hayashi T, 2010, FORENSIC SCI INT, V202, P17, DOI 10.1016/j.forsciint.2010.04.014; Hayashi Takahito, 2009, Leg Med (Tokyo), V11 Suppl 1, pS171, DOI 10.1016/j.legalmed.2009.01.076; Hortobagyi T, 2007, NEUROPATH APPL NEURO, V33, P226, DOI 10.1111/j.1365-2990.2006.00794.x; Kadi L, 2006, J NEUROIMMUNOL, V174, P133, DOI 10.1016/j.jneuroim.2006.01.011; Kaur B, 1999, J CLIN PATHOL, V52, P203, DOI 10.1136/jcp.52.3.203; Kelland EE, 2011, GLIA, V59, P1864, DOI 10.1002/glia.21230; Kushi H, 2003, ACTA NEUROCHIR SUPPL, V86, P347; MAXWELL WL, 1993, ACTA NEUROPATHOL, V86, P136, DOI 10.1007/BF00334880; McKenzie KJ, 1996, ACTA NEUROPATHOL, V92, P608, DOI 10.1007/s004010050568; Mukaida N, 2000, INT J HEMATOL, V72, P391; Oehmichen M, 1999, INT J LEGAL MED, V112, P261, DOI 10.1007/s004140050246; Oehmichen M, 1998, FORENSIC SCI INT, V95, P67, DOI 10.1016/S0379-0738(98)00075-9; Oehmichen Manfred, 2003, Leg Med (Tokyo), V5, P190, DOI 10.1016/S1344-6223(03)00077-4; Ogata M, 1999, INT J LEGAL MED, V113, P19, DOI 10.1007/s004140050273; Ogata Mamoru, 2007, Legal Medicine, V9, P105, DOI 10.1016/j.legalmed.2006.11.013; Omari KM, 2005, BRAIN, V128, P1003, DOI 10.1093/brain/awh479; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V88, P433; Sohrevardi SM, 2013, TURK NEUROSURG, V23, P151, DOI 10.5137/1019-5149.JTN.5858-12.2; Yang XF, 2011, MED HYPOTHESES, V77, P60, DOI 10.1016/j.mehy.2011.03.023	31	1	3	0	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0379-0738	1872-6283		FORENSIC SCI INT	Forensic Sci.Int.	JUN	2016	263						48	54		10.1016/j.forsciint.2016.03.055			7	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	DL9EP	WOS:000375944700009	27065055				2022-02-06	
J	Jalil, MFA; Russell, J; Delatycki, M; Gonzalvo, A				Jalil, Muhammad Fahmi Abdul; Russell, Jeremy; Delatycki, Martin; Gonzalvo, Augusto			Congenital biparietal foramina presenting with multiple concussions	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Potocki-Shaffer syndrome; Biparietal foramina; Cranioplasty; Concussion	GENE-DELETION SYNDROME; MANAGEMENT	We report a man with biparietal foramina secondary to Potocki-Shaffer syndrome. This is due to incomplete ossification of parietal bones secondary to haploinsuffiency of ALX4 gene. He presented with multiple episodes of concussion following minimal head trauma. Cranioplasty was performed to close the skull defects with the aim of preventing further concussion and permanent traumatic brain injury. Crown Copyright (C) 2016 Published by Elsevier B.V. All rights reserved.	[Jalil, Muhammad Fahmi Abdul; Russell, Jeremy; Gonzalvo, Augusto] Austin Hosp, Dept Neurosurg, 145 Studley Rd, Heidelberg, Vic 3084, Australia; [Delatycki, Martin] Austin Hosp, Clin Genet Serv, 145 Studley Rd, Heidelberg, Vic 3084, Australia		Jalil, MFA (corresponding author), Austin Hosp, Dept Neurosurg, 145 Studley Rd, Heidelberg, Vic 3084, Australia.	fahmi.abduljalil@gmail.com	Russell, Jeremy/K-1988-2019	Russell, Jeremy/0000-0003-3692-120X			Kortesis B, 2003, J CRANIOFAC SURG, V14, P538, DOI 10.1097/00001665-200307000-00028; Potocki L, 1996, AM J MED GENET, V62, P319, DOI 10.1002/(SICI)1096-8628(19960329)62:3<319::AID-AJMG22>3.0.CO;2-M; Swarr DT, 2010, AM J MED GENET A, V152A, P565, DOI 10.1002/ajmg.a.33245; Winkler PA, 2000, J NEUROSURG, V93, P53, DOI 10.3171/jns.2000.93.1.0053; Wu YQ, 2000, AM J HUM GENET, V67, P1327	5	1	1	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	JUN	2016	145						6	7		10.1016/j.clineuro.2016.03.013			2	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DP0KZ	WOS:000378180000002	27058439				2022-02-06	
J	Ji, XR; Zhang, YL; Zhang, LH; Chen, H; Peng, Y; Tang, PF				Ji, Xinran; Zhang, Yiling; Zhang, Lihai; Chen, Hua; Peng, Ye; Tang, Peifu			Inhibition of p21-Activated Kinase 1 by IPA-3 Promotes Locomotor Recovery After Spinal Cord Injury in Mice	SPINE			English	Article						blood-spinal cord barrier; inflammatory cytokines; IPA-3; neurological functions; PAK1; spinal cord injury; water content	ACTIVATED PROTEIN-KINASE; TRAUMATIC BRAIN-INJURY; MIDDLE CEREBRAL-ARTERY; MATRIX METALLOPROTEINASES; SECONDARY INJURY; GENE-EXPRESSION; FOCAL ISCHEMIA; RAT-BRAIN; INVASION; PAK1	Study Design.Ninety-six male adult CD-1 mice were randomly divided into sham, spinal cord injury (SCI)+vehicle, and SCI+IPA-3 groups. Expression of matrix metalloproteinase (MMP)-2 and MMP-9, production of tumor necrosis factors (TNF)- and interleukin (IL)-1, tissue edema, blood-spinal cord barrier penetrability, neural cell apoptosis, and neurological function recovery were measured.Objective.The aim of the study was to evaluate the effect of specific inhibition of p21-activated kinase 1 (PAK1) by IPA-3 on SCI and the underlying mechanisms thereof.Summary of Background Data.SCI is a devastating clinical condition that may result in long-lasting and deteriorating functional deficits. The major goal of SCI treatment is to limit the development of secondary injury. IPA-3, a PAK1 inhibitor, exhibited neuroprotection against secondary damage after traumatic brain injury and subarachnoid hemorrhage (SAH).Methods.MMP-2, MMP-9, and cleaved caspase-3 expression were assessed by Western blot. Inflammatory cytokines TNF- and IL-1 were detected by enzyme-linked immunosorbent assay (ELISA). The blood-spinal cord barrier disruption was measured by water content and Evans blue extravasation of the spinal cord. Neuronal apoptosis was evaluated by Nissl staining and Terminal-deoxynucleoitidyl Transferase Mediated Nick End Labeling (TUNEL) assay. The locomotor behavior of hind limb was evaluated by Basso Mouse Scale (BMS) at 1, 3, 7, 14, and 28 days post-injury.Results.Compared with SCI+vehicle mice, IPA-3 treatment showed decreased p-PAK1, MMP-2, MMP-9, cleaved caspase-3, TNF-, and IL-1 expression. Moreover, inhibition of PAK1 by IPA-3 reduced spinal cord water content and Evans blue extravasation, increased neuronal survival, and reduced TUNEL-positive cells at 24 hours after SCI. Furthermore, IPA-3 improved spinal cord functional recovery 7 days after SCI.Conclusion.Inhibition of PAK1 by IPA-3 promoted recovery of neurological function, possibly by downregulating the expression of MMP-2, MMP-9, TNF-, and IL-1. Our data suggest that PAK1 may be a potential therapeutic target in patients with SCI.Level of Evidence: 1	[Ji, Xinran; Zhang, Yiling; Zhang, Lihai; Chen, Hua; Peng, Ye; Tang, Peifu] Peoples Liberat Army, Gen Hosp, Hosp 301, Dept Orthopaed Surg, 28 Fuxing Rd, Beijing 100000, Peoples R China		Ji, XR; Tang, PF (corresponding author), Peoples Liberat Army, Gen Hosp, Hosp 301, Dept Orthopaed Surg, 28 Fuxing Rd, Beijing 100000, Peoples R China.	tangpf301@163.com; tangpf301@163.com	chen, hua/AAD-7881-2022	Tang, Peifu/0000-0003-4279-1704; chen, hua/0000-0002-4410-6742	China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2014M562548, 2015T81100]; Chinese National Natural Science FoundationNational Natural Science Foundation of China (NSFC) [81520108017]	This study was supported by China Postdoctoral Science Foundation funded project (No. 2014M562548; No. 2015T81100), and this project was supported by Chinese National Natural Science Foundation (No. 81520108017)	Allen EA, 2012, NEURON, V74, P603, DOI 10.1016/j.neuron.2012.05.001; Basak C, 2005, J BIOL CHEM, V280, P4279, DOI 10.1074/jbc.M412820200; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Bray N, 2014, NAT REV DRUG DISCOV, V13, DOI 10.1038/nrd4284; Cao Y, 2010, BRAIN RES, V1357, P115, DOI 10.1016/j.brainres.2010.07.108; Esposito E, 2008, J PINEAL RES, V45, P149, DOI 10.1111/j.1600-079X.2008.00569.x; Figley SA, 2014, J NEUROTRAUM, V31, P541, DOI 10.1089/neu.2013.3034; Frost JA, 2000, J BIOL CHEM, V275, P19693, DOI 10.1074/jbc.M909860199; Fu D, 2012, RHEUMATOLOGY, V51, P1170, DOI 10.1093/rheumatology/kes031; Gaudet AD, 2014, EXP NEUROL, V258, P24, DOI 10.1016/j.expneurol.2013.11.020; Hasturk A, 2009, TURK NEUROSURG, V19, P353; Hu AM, 2015, SPINAL CORD, V53, P98, DOI 10.1038/sc.2014.209; Jazayeri SB, 2014, EUR SPINE J; Ji XR, 2014, BRAIN RES, V1585, P13, DOI 10.1016/j.brainres.2014.08.026; Justicia C, 2003, J CEREBR BLOOD F MET, V23, P1430, DOI 10.1097/01.WCB.0000090680.07515.C8; Kesanakurti D, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.182; Lee EJ, 2014, J IMMUNOL, V193, P2384, DOI 10.4049/jimmunol.1303240; Li C, 2014, NEURAL REGEN RES, V9, P2205, DOI 10.4103/1673-5374.147954; Li XQ, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0069-7; Liu M, 2015, J SPINAL CORD MED, V38, P745, DOI 10.1179/2045772314Y.0000000224; Lu W, 2013, NEOPLASMA, V60, P493, DOI 10.4149/neo_2013_064; Mitsios N, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-93; Nikolic M, 2008, MOL NEUROBIOL, V37, P187, DOI 10.1007/s12035-008-8032-1; Oyinbo CA, 2011, ACTA NEUROBIOL EXP, V71, P281; Rao VLR, 2003, J NEUROSCI RES, V71, P208, DOI 10.1002/jnr.10486; Repici M, 2012, NEUROBIOL DIS, V46, P710, DOI 10.1016/j.nbd.2012.03.014; Rider L, 2013, MOL ENDOCRINOL, V27, P1048, DOI 10.1210/me.2012-1322; Romanic AM, 1998, STROKE, V29, P1020, DOI 10.1161/01.STR.29.5.1020; Rosenberg GA, 2001, BRAIN RES, V893, P104, DOI 10.1016/S0006-8993(00)03294-7; Singh A, 2014, CLIN EPIDEMIOL, V6, P309, DOI 10.2147/CLEP.S68889; Siu MKY, 2010, AM J PATHOL, V176, P3015, DOI 10.2353/ajpath.2010.091263; Tep C, 2013, J NEUROSCI, V33, P397, DOI 10.1523/JNEUROSCI.0399-12.2013; Winkler EA, 2012, J CEREBR BLOOD F MET, V32, P1841, DOI 10.1038/jcbfm.2012.113; Yan JH, 2013, STROKE, V44, P1410, DOI 10.1161/STROKEAHA.113.678474; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Yi KW, 2015, FERTIL STERIL, V103, P1089, DOI 10.1016/j.fertnstert.2014.12.124; Yu DS, 2014, J NEUROL SCI, V346, P51, DOI 10.1016/j.jns.2014.07.056; Zegers M, 2008, INT REV CEL MOL BIO, V267, P253, DOI 10.1016/S1937-6448(08)00606-0; Zhang C, 2014, J HUAZHONG U SCI-MED, V34, P554, DOI 10.1007/s11596-014-1314-0; Zhang HQ, 2010, NEUROSCIENTIST, V16, P156, DOI 10.1177/1073858409355830; ZHANG SJ, 1995, J BIOL CHEM, V270, P23934, DOI 10.1074/jbc.270.41.23934; Zhang T, 2012, CARDIOVASC RES, V93, P471, DOI 10.1093/cvr/cvr346; Zhou L, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-15; Zhou Y, 2014, CELL MOL NEUROBIOL, V34, P1151, DOI 10.1007/s10571-014-0090-5	44	1	1	1	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0362-2436	1528-1159		SPINE	SPINE	JUN	2016	41	11					919	925		10.1097/BRS.0000000000001491			7	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	DN2RA	WOS:000376909500013	26863260				2022-02-06	
J	Kuramatsu, JB; Huttner, HB; Schwab, S				Kuramatsu, J. B.; Huttner, H. B.; Schwab, S.			Specialized neurological neurosurgical intensive care medicine	NERVENARZT			German	Article						Neurocritical care; Multimodal neuromonitoring; Middle cerebral artery infarction; malignant; Intracerebral hemorrhage; Subarachnoid hemorrhage	TRAUMATIC BRAIN-INJURY; MIDDLE-CEREBRAL-ARTERY; ACUTE ISCHEMIC-STROKE; NEUROCRITICAL CARE; SUBARACHNOID HEMORRHAGE; INTRAVENTRICULAR HEMORRHAGE; INTRACEREBRAL HEMORRHAGE; PLASMINOGEN-ACTIVATOR; INTRACRANIAL-PRESSURE; COST-EFFECTIVENESS	In Germany dedicated neurological-neurosurgical critical care (NCC) is the fastest growing specialty and one of the five big disciplines integrated within the German critical care society (Deutsche Interdisziplinare Vereinigung fur Intensiv- und Notfallmedizin; DIVI). High-quality investigations based on resilient evidence have underlined the need for technical advances, timely optimization of therapeutic procedures, and multidisciplinary team-work to treat those critically ill patients. This evolution has repeatedly raised questions, whether NCC-units should be run independently or better be incorporated within multidisciplinary critical care units, whether treatment variations exist that impact clinical outcome, and whether nowadays NCC-units can operate cost-efficiently? Stroke is the most frequent disease entity treated on NCC-units, one of the most common causes of death in Germany leading to a great socio-economic burden due to long-term disabled patients. The main aim of NCC employs surveillance of structural and functional integrity of the central nervous system as well as the avoidance of secondary brain damage. However, clinical evaluation of these severely injured commonly sedated and mechanically ventilated patients is challenging and highlights the importance of neuromonitoring to detect secondary damaging mechanisms. This multimodal strategy not only requires medical expertise but also enforces the need for specialized teams consisting of qualified nurses, technical assistants and medical therapists. The present article reviews most recent data and tries to answer the aforementioned questions.	[Kuramatsu, J. B.; Huttner, H. B.; Schwab, S.] Univ Erlangen Nurnberg, Neurol Klin, Schwabachanlage 6, D-91054 Erlangen, Germany		Kuramatsu, JB (corresponding author), Univ Erlangen Nurnberg, Neurol Klin, Schwabachanlage 6, D-91054 Erlangen, Germany.	Joji.Kuramatsu@uk-erlangen.de					Bardach NS, 2004, CIRCULATION, V109, P2207, DOI 10.1161/01.CIR.0000126433.12527.E6; Boudreau DM, 2014, STROKE, V45, P3032, DOI 10.1161/STROKEAHA.114.005852; Budohoski KP, 2013, NAT REV NEUROL, V9, P152, DOI 10.1038/nrneurol.2013.11; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Damian MS, 2013, INTENS CARE MED, V39, P1405, DOI 10.1007/s00134-013-2960-6; Dey M, 2015, NEUROSURGERY, V76, P291, DOI 10.1227/NEU.0000000000000624; Diringer MN, 2001, CRIT CARE MED, V29, P635, DOI 10.1097/00003246-200103000-00031; Du B, 2015, INTENS CARE MED, V41, P1841, DOI 10.1007/s00134-015-3954-3; English SW, 2013, NEUROCRIT CARE, V18, P131, DOI 10.1007/s12028-012-9748-3; Gooch RA, 2014, JAMA-J AM MED ASSOC, V311, P567, DOI 10.1001/jama.2013.283800; Hacke W, 1996, ARCH NEUROL-CHICAGO, V53, P309, DOI 10.1001/archneur.1996.00550040037012; Hemphill JC, 2011, NAT REV NEUROL, V7, P451, DOI 10.1038/nrneurol.2011.101; Juttler E, 2014, NEW ENGL J MED, V370, P1091, DOI 10.1056/NEJMoa1311367; Khan NR, 2014, STROKE, V45, P2662, DOI 10.1161/STROKEAHA.114.005990; Kowoll CM, 2014, NEUROCRIT CARE, V20, P176, DOI 10.1007/s12028-013-9893-3; Kramer AH, 2014, CURR OPIN CRIT CARE, V20, P174, DOI 10.1097/MCC.0000000000000076; Kurtz P, 2011, NEUROCRIT CARE, V15, P477, DOI 10.1007/s12028-011-9539-2; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; Le Roux P, 2014, CURR OPIN CRIT CARE, V20, P141, DOI 10.1097/MCC.0000000000000078; Li YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080599; Macdonald RL, 2014, NAT REV NEUROL, V10, P44, DOI 10.1038/nrneurol.2013.246; Pandey AS, 2015, NEUROSURGERY, V77, P462, DOI 10.1227/NEU.0000000000000850; Pineda JA, 2013, LANCET NEUROL, V12, P45, DOI 10.1016/S1474-4422(12)70269-7; Rincon F, 2007, CURR OPIN CRIT CARE, V13, P115, DOI 10.1097/MCC.0b013e32808255c6; ROPPER AH, 1992, ANN NEUROL, V32, P564, DOI 10.1002/ana.410320413; Staykov D, 2009, STROKE, V40, P3275, DOI 10.1161/STROKEAHA.109.551945; Svendsen ML, 2012, STROKE, V43, P3041, DOI 10.1161/STROKEAHA.111.645184; Torbey MT, 2015, NEUROCRIT CARE, V22, P146, DOI 10.1007/s12028-014-0085-6; Tung CE, 2011, STROKE, V42, P2257, DOI 10.1161/STROKEAHA.111.615682; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Wijdicks EFM, 2011, MAYO CLIN PROC, V86, P903, DOI 10.4065/mcp.2010.0815	31	1	1	0	12	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0028-2804	1433-0407		NERVENARZT	Nervenarzt	JUN	2016	87	6					583	+		10.1007/s00115-016-0129-6			7	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	DN9PX	WOS:000377413000002	27206707				2022-02-06	
J	Levert, MJ; Lefebvre, H; Gelinas, I; McKerall, M; Roy, O; Proulx, M				Levert, Marie-Josee; Lefebvre, Helene; Gelinas, Isabelle; McKerall, Michelle; Roy, Odette; Proulx, Michelle			Experience in the use of public places by aged persons with TBI in the presence of a citizen guide: pilot project	CANADIAN JOURNAL ON AGING-REVUE CANADIENNE DU VIEILLISSEMENT			French	Article						Elderly; Brain injury; Social integration; Public places; Accompanying; Age-Friendly cities (VADA)	TRAUMATIC BRAIN-INJURY; OLDER-ADULTS; COMMUNITY INTEGRATION; NEIGHBORHOOD; PEOPLE; REHABILITATION; CONTEXT	This pilot project aims to test and see the relevance of the direct observation method to collect data on the barriers and facilitators to attending public places by seniors with TBI. The study is based on the conceptual framework VADA WHO which focuses on the development of friendly built and technological environments for seniors. Three elderly people participated in the study, recruited from an ongoing project, The Citizen Intervention in Community Living (APIC), in the presence of their personalized attendant. The study shows the feasibility of the method in terms of its acceptability and resources mobilized. It shows its relevance to access additional data that would have been difficult to obtain using others methods (e.g., semi-structured interview), such as the identification of the strategies used by the participants to address the obstacles encountered (avoidance, travel planning, use of physical and preventative support of the personalized attendant).	[Levert, Marie-Josee; Lefebvre, Helene; Roy, Odette] Univ Montreal, Fac Sci Infirmieres, Quebec City, PQ, Canada; [Levert, Marie-Josee; Gelinas, Isabelle; McKerall, Michelle] Ctr Rech Interdisciplinaire Readaptat Montreal Me, CP 6128,Succ Ctr Ville, Montreal, PQ H3C 3J7, Canada; [Levert, Marie-Josee; Gelinas, Isabelle; Proulx, Michelle] Grp Interdisciplinaire Rech Resilience & Readapta, CP 6128,Succ Ctr Ville, Montreal, PQ H3C 3J7, Canada; [Gelinas, Isabelle] McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ, Canada; [McKerall, Michelle] Univ Montreal, Dept Psychol, Quebec City, PQ, Canada; [Roy, Odette] Ctr Hosp Maisonneuve Rosemont, Montreal, PQ, Canada		Levert, MJ (corresponding author), Ctr Rech Interdisciplinaire Readaptat Montreal Me, CP 6128,Succ Ctr Ville, Montreal, PQ H3C 3J7, Canada.; Levert, MJ (corresponding author), Grp Interdisciplinaire Rech Resilience & Readapta, CP 6128,Succ Ctr Ville, Montreal, PQ H3C 3J7, Canada.; Levert, MJ (corresponding author), Univ Montreal, Fac Sci Infirmieres, CP 6128,Succ Ctr Ville, Montreal, PQ H3C 3J7, Canada.	mj.levert@umontreal.ca					Alsnih R., 2003, MOBILITY ACCESSIBILI; Andonian L, 2011, BRIT J OCCUP THER, V74, P2, DOI 10.4276/030802211X12947686093486; Arrif T, 2011, PRAT PSYCHOL, V17, P5, DOI 10.1016/j.prps.2009.12.003; Bourque D., 2005, EC SOLIDARITES, V36, P13; Bruce DG, 2002, J AM GERIATR SOC, V50, P84, DOI 10.1046/j.1532-5415.2002.50012.x; BRUCHONSCHWEITZ.M, 2002, PSYCHOL SANTE MODELE; Buffel T, 2012, CRIT SOC POLICY, V32, P597, DOI 10.1177/0261018311430457; Burns V., 2012, J AGING RES, DOI [10.1155/2012/148287.AMBIGUOUS, DOI 10.1155/2012/148287.AMBIGUOUS]; Caldwell Kay, 2005, Nurse Res, V13, P42; Casey Dympna, 2006, Nurse Res, V13, P75; Centers for Disease Control and Prevention National Center for Injury Prevention and Control, 2006, WEB BAS INJ STAT QUE; Clarke P, 2008, AM J EPIDEMIOL, V168, P506, DOI 10.1093/aje/kwn185; Dahan-Oliel N., 2008, CRITICAL REV PHYS RE, V20, P159, DOI DOI 10.1615/CRITREVPHYSREHABILMED.V20.I2.40; DENZIN NK, 1997, INTERPRETATIVE ETHNO; Deslauriers J. P., 1991, RECHERCHE QUALITATIV; Faul M, 2010, TRAUMATIC BRAIN INJU; Flanagan SR, 2006, CLIN GERIATR MED, V22, P449, DOI 10.1016/j.cger.2005.12.011; Freund A., 2003, REV QUEBECOISE PSYCH, V24, P27; Hardaker N., 2011, PRAGMATIC EVIDENCE B; Holleran RS, 2015, CRIT CARE NURS Q, V38, P298, DOI 10.1097/CNQ.0000000000000075; Institut national de sante publique du Quebec (INSPQ), 2011, TROUSS DIAGN SEC LIN; Jaccoud Mylene, 1997, RECHERCHE QUALITATIV, P211; Kim H, 2010, AM J OCCUP THER, V64, P709, DOI 10.5014/ajot.2010.09188; Krishnasamy C, 2011, HONG KONG J OCCUP TH, V21, P80, DOI 10.1016/j.hkjot.2011.12.002; Lamontagne ME, 2009, BRAIN INJURY, V23, P693, DOI 10.1080/02699050902970760; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; Lefebvre H, 2014, ALTER, V8, P183, DOI 10.1016/j.alter.2014.03.005; Lefebvre H, 2013, RECH SOINS INFIRM, P107, DOI 10.3917/rsi.115.0107; Levert M. -J., 2012, PRESERVER AUTONOMIE; Levin T, 2007, TOP STROKE REHABIL, V14, P72, DOI 10.1310/tsr1401-72; McCabe P, 2007, BRAIN INJURY, V21, P231, DOI 10.1080/02699050701201631; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; McColl MA, 2007, BRAIN IMPAIR, V8, P238, DOI DOI 10.1375/BRIM.8.3.238; Michael YL, 2006, HEALTH PLACE, V12, P734, DOI 10.1016/j.healthplace.2005.08.002; Mulhall A, 2003, J ADV NURS, V41, P306, DOI 10.1046/j.1365-2648.2003.02514.x; Nagel CL, 2008, AM J EPIDEMIOL, V168, P461, DOI 10.1093/aje/kwn158; Novek S, 2014, AGEING SOC, V34, P1052, DOI 10.1017/S0144686X1200150X; Organisation mondiale de la sante (OMS), 2007, GUID MOND VILL AM AI; Paille P., 2012, ANAL QUALITATIVE SCI, V3; Pires A., 1997, RECHERCHE QUALITATIV, P113; PUNCH M, 1994, HDB QUALITATIVE RES; Raymond E., 2008, PARTICIPATION SOCIAL; Schaefer-McDaniel N, 2010, SOC SCI MED, V71, P651, DOI 10.1016/j.socscimed.2010.03.060; Sendroy-Terrill M, 2010, ARCH PHYS MED REHAB, V91, P489, DOI 10.1016/j.apmr.2009.11.011; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; VANDERMAREN JM, 1995, METHODES RECHERCHE E; Whiteneck G. G., 2004, J HEAD TRAUMA REHAB, V25, P320; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; Yi A, 2013, NEUROREHABILITATION, V32, P267, DOI 10.3233/NRE-130843; Zygun DA, 2005, CAN J NEUROL SCI, V32, P87, DOI 10.1017/S0317167100016930	50	1	1	1	10	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	0714-9808	1710-1107		CAN J AGING	Can. J. Aging-Rev. Can. Vieil.	JUN	2016	35	2					229	241		10.1017/S0714980816000180			13	Gerontology	Social Science Citation Index (SSCI)	Geriatrics & Gerontology	DO7OS	WOS:000377972500007	27223579				2022-02-06	
J	Ouellet, J; Boisvert, L; Fischer, L				Ouellet, Jerome; Boisvert, Leslie; Fischer, Lisa			Patients presenting to an outpatient sport medicine clinic with concussion Retrospective observational analysis	CANADIAN FAMILY PHYSICIAN			English	Article							STATES HIGH-SCHOOL; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; EPIDEMIOLOGY; HEAD; FOOTBALL; INJURY; VISITS; ZURICH	Objective To describe the characteristics of patients who presented to outpatient sport and exercise medicine clinics with concussion. Design Retrospective chart review of electronic medical records. Setting Three specialized sport and exercise medicine clinics in London, Ont. Participants A total of 283 patients presenting with concussion. Main outcome measures Data collected included demographic variables (age and sex), sport participation at the time of injury, previous medical history (including history of concussion), Post-Concussion Symptom Scale (PCSS) scores, and return-to-play (RTP) variables (delay and outcome). Results The mean age of patients presenting for care was 17.6 years; 70.9% of patients were younger than 18 years of age (considered pediatric patients); 58.8% of patients were male; and 31.7% of patients had a previous history of concussion. The main sports associated with injury were hockey (40.0%), soccer (12.6%), and football (11.7%). Return to play was granted to 50.9% of patients before the 3-week mark and 80.2% of patients before 8 weeks. Total PCSS scores (maximum score was 132) and neck scores (part of the PCSS, maximum score was 6) were significantly higher in adults compared with pediatric patients (36.2 vs 27.6, P =.02, and 1.8 vs 1.2, P =.02, respectively). A significant difference was seen in RTP, with pediatric patients returning earlier than adults did (P =.04). This difference was not seen when comparing males with females (P =.07). Longer duration of follow-up did not influence RTP outcomes. Previous history of concussion was associated with restriction from contact or collision sports (P <.001). Conclusion Given the age and sex variability found in this study, as well as in previous published reports, it is important to manage each patient individually using current best available practice strategies to optimize long-term outcomes.	[Ouellet, Jerome] Ctr Med Sport Laval, Chomedey, PQ, Canada; [Boisvert, Leslie] Univ Western Ontario, Dept Family Med, Schulich Sch Med & Dent, London, ON, Canada; [Fischer, Lisa] Schulich Sch Med & Dent, Dept Family Med, London, ON, Canada; [Fischer, Lisa] Fowler Kennedy Sport Med Clin, Primary Care Sport Med, London, ON, Canada		Ouellet, J (corresponding author), Ctr Med Sport Laval, Chomedey, PQ, Canada.	jeromeouellet@hotmail.com	Fischer, Lisa K/H-3999-2015	Fischer, Lisa K/0000-0001-5992-0176			Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Canadian Heritage, 2013, SPORT PARTICIPATION; Cantu RC, 2010, PM&R, V2, P1088, DOI 10.1016/j.pmrj.2010.07.483; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Clarke KS, 1998, CLIN SPORT MED, V17, P83, DOI 10.1016/S0278-5919(05)70063-6; Concannon LG, 2014, CURR SPORT MED REP, V13, P365, DOI 10.1249/JSR.0000000000000098; Concannon LG, 2014, SPORTS HEALTH, V6, P396, DOI 10.1177/1941738114530958; Congress of Neurological Surgeons, 1966, CLIN NEUROSURG, VIn: Vol 12, P386; Coronado V, 2012, EPIDEMIOLOG IN PRESS; Covassin T, 2003, J ATHL TRAINING, V38, P238; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Finkelstein E., 2006, INCIDENCE EC BURDEN; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gordon KE, 2006, PEDIATR NEUROL, V34, P376, DOI 10.1016/j.pediatrneurol.2005.09.007; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Hynes LM, 2006, BRAIN INJURY, V20, P179, DOI 10.1080/02699050500443707; Kelly KD, 2001, CLIN J SPORT MED, V11, P77, DOI 10.1097/00042752-200104000-00003; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Mannix R, 2013, NEUROSURGERY, V73, P129, DOI 10.1227/01.neu.0000429846.14579.41; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Purcell LK, 2012, PAED CHILD HEALT-CAN, V17, P36; Statistics Canada, 2015, INJ CAN INS CAN COMM; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832	34	1	1	0	4	COLL FAMILY PHYSICIANS CANADA	MISSISSAUGA	2630 SKYMARK AVE, MISSISSAUGA, ONTARIO L4W 5A4, CANADA	0008-350X	1715-5258		CAN FAM PHYSICIAN	Can. Fam. Phys.	JUN	2016	62	6					E340	E345					6	Primary Health Care; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP2QQ	WOS:000378335100013					2022-02-06	
J	Rabelo, NN; Rabelo, NN; Machado, FS; Joaquim, MAS; Dias, LAA; Pereira, CU				Rabelo, Nicollas Nunes; Rabelo, Neiffer Nunes; Machado, Fabio Santana; Stavale Joaquim, Marcos Augusto; Araujo Dias Junior, Luiz Antonio; Pereira, Carlos Umberto			Critical Analysis of Sedation and Analgesia in Severe Head Trauma	BRAZILIAN NEUROSURGERY-ARQUIVOS BRASILEIROS DE NEUROCIRURGIA			English	Article						brain injury; intracranial hypertension; sedation; analgesia	INTENSIVE-CARE-UNIT; MECHANICALLY VENTILATED PATIENTS; CEREBRAL PERFUSION-PRESSURE; CONFUSION ASSESSMENT METHOD; END-EXPIRATORY PRESSURE; ISCHEMIC BRAIN-DAMAGE; CLINICAL-PRACTICE GUIDELINES; RESTING ENERGY-EXPENDITURE; INTRACRANIAL-PRESSURE; ILL PATIENTS	Introduction Head injury is a direct determinant of morbidity, disability, and mortality in the young population. Sedatives and analgesics are commonly used in patients with brain injury to retrieve an ICP, CMRO2, and CBF, preserving the cerebral regulation system and self-avoiding hypotension. Objective The objective of this paper is to review on this topic, linking the main drugs, side effects, costs, anxiolytic properties, anticonvulsants, and correlating them with complacency and brain metabolism. Methods We perform a literature review using PubMed database, MEDLINE, EMBASE, Science Direct, The Cochrane Database, Google Scholar, and Clinical trials. We selected papers from the period between 1958 and 2014, which totaled 254 papers. Of these, we selected 129 papers based on keywords, inclusion, and exclusion criteria. Evidence Review The volume of the brain decreases due to dislocation of the CBV out of the skull. The main sedatives and analgesics are propofol, midazolam, etomidate, ketamine, barbiturates, dexedetomedina, morphine, fentanyl, alfentanil, sulfenatil, and remifentanil. We hereby discuss the algorithm for a fast intubation sequence and the algorithm for intracranial hypertension treatment regarding the systematic sedation therapy. A range of sedatives and analgesic agents are available for sedation. Each class has its own positive and negative effects on neurotrauma patients. Conclusions The correct analysis of sedation and analgesia in neurotrauma, rapid sequence intubation, and management of medications in intracranial hypertension can lead to an ideal management of brain injury.	[Rabelo, Nicollas Nunes] Santa Casa Hosp, Dept Neurosurg, Ribeirao Preto, SP, Brazil; [Rabelo, Neiffer Nunes] Fac Atenas, Paracatu, MG, Brazil; [Machado, Fabio Santana] Univ Sao Paulo, Hosp Sirio Libanes, Dept Pathol, Neurointensivism, Sao Paulo, SP, Brazil; [Stavale Joaquim, Marcos Augusto] Univ Sao Paulo, Hosp Sirio Libanes, Dept Neurosurg, Neurooncol & Neurointensivism, Sao Paulo, SP, Brazil; [Araujo Dias Junior, Luiz Antonio] Santa Casa Hosp, Dept Neurosurg, Ribeirao Preto, SP, Brazil; [Pereira, Carlos Umberto] FBHC, Dept Neurosurg, Aracaju, Sergipe, Brazil; [Rabelo, Nicollas Nunes; Pereira, Carlos Umberto] Neurosurg Serv, Aracaju, Sergipe, Brazil		Rabelo, NN (corresponding author), Av Antonio Diederichsen 190,Ap 193, BR-14020250 Ribeirao Preto, SP, Brazil.	nicollasrabelo@hotmail.com	RABELO, NICOLLAS/V-9824-2018	RABELO, NICOLLAS/0000-0001-5238-8658			Albanese J, 1997, ANESTHESIOLOGY, V87, P1328, DOI 10.1097/00000542-199712000-00011; Albanese J, 2004, ANN FR ANESTH, V23, P528, DOI 10.1016/j.annfar.2004.01.010; ALBANESE J, 1993, ANESTHESIOLOGY, V79, P493, DOI 10.1097/00000542-199309000-00012; Albanese J, 1999, CRIT CARE MED, V27, P407, DOI 10.1097/00003246-199902000-00050; Albert PS, 1999, STAT MED, V18, P1707, DOI 10.1002/(SICI)1097-0258(19990715)18:13<1707::AID-SIM138>3.0.CO;2-H; Arias-Rivera S, 2008, ENFERM INTENSIV, V19, P71, DOI 10.1016/S1130-2399(08)72747-0; Arias-Rivera S, 2008, CRIT CARE MED, V36, P2054, DOI 10.1097/CCM.0b013e31817bfd60; Augustes R, 2011, ANAESTH INTENS CARE, V39, P401, DOI 10.1177/0310057X1103900310; Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; Barton Richard G., 1997, Journal of Burn Care and Rehabilitation, V18, P461, DOI 10.1097/00004630-199709000-00019; Bayat A, 2003, BRIT J PLAST SURG, V56, P272, DOI 10.1016/S0007-1226(03)00110-3; Blamoun J, 2009, AM J INFECT CONTROL, V37, P172, DOI 10.1016/j.ajic.2008.05.010; Bourgoin A, 2005, CRIT CARE MED, V33, P1109, DOI 10.1097/01.CCM.0000162491.26292.98; Bourgoin A, 2003, CRIT CARE MED, V31, P711, DOI 10.1097/01.CCM.0000044505.24727.16; BRADFIELD RB, 1971, AM J CLIN NUTR, V24, P1148; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS77; Brook AD, 1999, CRIT CARE MED, V27, P2609, DOI 10.1097/00003246-199912000-00001; Brosh A, 2007, J ANIM SCI, V85, P1213, DOI 10.2527/jas.2006-298; Brucia J, 1996, HEART LUNG, V25, P295, DOI 10.1016/S0147-9563(96)80065-3; Bruder N, 1998, CRIT CARE MED, V26, P568, DOI 10.1097/00003246-199803000-00033; BRUDER N, 1994, CRIT CARE MED, V22, P1114, DOI 10.1097/00003246-199407000-00011; Bucknall TK, 2008, CRIT CARE MED, V36, P1444, DOI 10.1097/CCM.0b013e318168f82d; CLIFTON GL, 1986, J NEUROSURG, V64, P895, DOI 10.3171/jns.1986.64.6.0895; CLIFTON GL, 1983, J NEUROSURG, V59, P447, DOI 10.3171/jns.1983.59.3.0447; DAMASK MC, 1982, ANESTHESIOLOGY, V57, P213, DOI 10.1097/00000542-198209000-00011; Dasta JF, 2009, CRIT CARE CLIN, V25, P571, DOI 10.1016/j.ccc.2009.03.002; de Nadal M, 2000, ANESTHESIOLOGY, V92, P11, DOI 10.1097/00000542-200001000-00008; de Wit M, 2008, CRIT CARE, V12, DOI 10.1186/cc6908; Delvaux B, 2005, ANESTHESIOLOGY, V102, P1281, DOI 10.1097/00000542-200506000-00030; Dimopoulou I, 2005, INTENS CARE MED, V31, P1020, DOI 10.1007/s00134-005-2689-y; Dimopoulou I, 2004, INTENS CARE MED, V30, P1051, DOI 10.1007/s00134-004-2257-x; Eckstein M, 2000, J TRAUMA, V48, P643, DOI 10.1097/00005373-200004000-00010; Egerod I, 2006, INTENS CARE MED, V32, P60, DOI 10.1007/s00134-005-2856-1; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Elliott R, 2006, INTENS CARE MED, V32, P1506, DOI 10.1007/s00134-006-0309-0; Ely EW, 2003, JAMA-J AM MED ASSOC, V289, P2983, DOI 10.1001/jama.289.22.2983; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; Ely EW, 2001, CRIT CARE MED, V29, P1370, DOI 10.1097/00003246-200107000-00012; Epstein CD, 2000, CRIT CARE MED, V28, P1363, DOI 10.1097/00003246-200005000-00017; FEIBEL JH, 1977, JAMA-J AM MED ASSOC, V238, P1374, DOI 10.1001/jama.238.13.1374; Frankenfield David, 2006, Nutr Clin Pract, V21, P430, DOI 10.1177/0115426506021005430; GANDEVIA B, 1964, Med J Aust, V2, P320; Gelinas C, 2007, CLIN J PAIN, V23, P497, DOI 10.1097/ajp.0b013e31806a23fb; Georgiadis D, 2001, STROKE, V32, P2088, DOI 10.1161/hs0901.095406; Giner M, 1996, NUTRITION, V12, P23, DOI 10.1016/0899-9007(95)00015-1; Girard TD, 2008, LANCET, V371, P126, DOI 10.1016/S0140-6736(08)60105-1; GRAHAM DI, 1971, LANCET, V1, P265; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; Guenther U, 2010, J CRIT CARE, V25, P144, DOI 10.1016/j.jcrc.2009.08.005; Gueorguieva R, 2004, ARCH GEN PSYCHIAT, V61, P310, DOI 10.1001/archpsyc.61.3.310; Hedeker D., 2006, LONGITUDINAL DATA AN; Hooper MH, 2009, CRIT CARE CLIN, V25, P515, DOI 10.1016/j.ccc.2009.04.002; Horn Ed, 2004, Gastrointest Endosc Clin N Am, V14, P247, DOI 10.1016/j.giec.2004.01.001; HSIANG JK, 1994, CRIT CARE MED, V22, P1471, DOI 10.1097/00003246-199409000-00019; Huynh T, 2002, J TRAUMA, V53, P488, DOI 10.1097/00005373-200209000-00016; Jacobi J, 2002, CRIT CARE MED, V30, P119, DOI 10.1097/00003246-200201000-00020; JENSEN MP, 1989, CLIN J PAIN, V5, P153, DOI 10.1097/00002508-198906000-00005; Kanouff AJ, 2008, CRIT CARE NURS Q, V31, P302, DOI 10.1097/01.CNQ.0000336815.81676.88; Kelly DF, 1999, J NEUROSURG, V90, P1042, DOI 10.3171/jns.1999.90.6.1042; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kollef MH, 1998, CHEST, V114, P541, DOI 10.1378/chest.114.2.541; Krakau K, 2006, BRAIN INJURY, V20, P345, DOI 10.1080/02699050500487571; Kress JP, 2007, CRIT CARE MED, V35, P365, DOI 10.1097/01.CCM.0000254334.46406.B3; Kress JP, 2006, CRIT CARE MED, V34, P2541, DOI 10.1097/01.CCM.0000239117.39890.E3; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Kress JP, 2003, AM J RESP CRIT CARE, V168, P1457, DOI 10.1164/rccm.200303-455OC; Lauer KK, 1997, CAN J ANAESTH, V44, P929, DOI 10.1007/BF03011963; Lemson J, 2008, INTENS CARE MED, V34, P2268, DOI 10.1007/s00134-008-1252-z; Leone M, 2004, ANESTH ANALG, V99, P1193, DOI 10.1213/01.ANE.0000132546.79769.91; Little R. J., 2019, STAT ANAL MISSING DA, V793; Livingstone MBE, 1997, BRIT J NUTR, V78, P869, DOI 10.1079/BJN19970205; Lutz A, 2011, ANASTH INTENSIV NOTF, V46, P568, DOI 10.1055/s-0031-1286607; MACIVER IN, 1958, LANCET, V1, P390; MANTHOUS CA, 1995, AM J RESP CRIT CARE, V151, P210, DOI 10.1164/ajrccm.151.1.7812556; Marik PE, 1996, CHEST, V109, P1038, DOI 10.1378/chest.109.4.1038; Marshall J, 2008, CRIT CARE MED, V36, P427, DOI 10.1097/01.CCM.0000300275.63811.B3; Martin Jorg, 2010, Ger Med Sci, V8, pDoc02, DOI 10.3205/000091; Mattia C, 2006, MINERVA ANESTESIOL, V72, P769; Mautes AEM, 2001, ACTA NEUROCHIR, V143, P51, DOI 10.1007/s007010170138; McCall M, 2003, JPEN-PARENTER ENTER, V27, P27, DOI 10.1177/014860710302700127; McGuire G, 1997, CRIT CARE MED, V25, P1059, DOI 10.1097/00003246-199706000-00025; McKnight P. E., 2007, MISSING DATA GENTLE; Mehta S, 2008, CRIT CARE MED, V36, P2092, DOI 10.1097/CCM.0b013e31817bff85; Michaels AJ, 2004, CRIT CARE CLIN, V20, P83, DOI 10.1016/S0749-0704(03)00099-X; Moore F, 2002, J TRAUMA, V53, P492; Murray JA, 2000, J TRAUMA, V49, P1065, DOI 10.1097/00005373-200012000-00015; Nasraway SA, 2002, CRIT CARE MED, V30, P117, DOI 10.1097/00003246-200201000-00019; Nolan JP, 2005, RESUSCITATION, V67, pS39, DOI 10.1016/j.resuscitation.2005.10.009; O'Connor M, 2009, J CLIN NURS, V18, P1239, DOI 10.1111/j.1365-2702.2008.02513.x; OLSSON T, 1990, J INTERN MED, V228, P287, DOI 10.1111/j.1365-2796.1990.tb00233.x; PAPAZIAN L, 1993, BRIT J ANAESTH, V71, P267, DOI 10.1093/bja/71.2.267; Payen JF, 2007, ANESTHESIOLOGY, V106, P687, DOI 10.1097/01.anes.0000264747.09017.da; Payen JF, 2001, CRIT CARE MED, V29, P2258, DOI 10.1097/00003246-200112000-00004; PAYNE PR, 1971, AM J CLIN NUTR, V24, P1164; Peberdy MA, 2010, CIRCULATION, V122, pS768, DOI 10.1161/CIRCULATIONAHA.110.971002; Pepe JL, 1999, J HEAD TRAUMA REHAB, V14, P462, DOI 10.1097/00001199-199910000-00007; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Puntillo K A, 2001, Am J Crit Care, V10, P238; RAURICH JM, 1994, JPEN-PARENTER ENTER, V18, P521, DOI 10.1177/0148607194018006521; Rhoney DH, 2001, NEUROL RES, V23, P237, DOI 10.1179/016164101101198398; Roberts R, 2012, CRIT CARE MED, V40, P406, DOI 10.1097/CCM.0b013e31822f0af5; Robinson BRH, 2008, J TRAUMA, V65, P517, DOI 10.1097/TA.0b013e318181b8f6; SAKABE T, 2001, ANESTHESIA NEUROSURG, P129; Sanchez-Izquierdo-Riera JA, 1998, ANESTH ANALG, V86, P1219, DOI 10.1097/00000539-199806000-00016; Savard JF, 2008, CRIT CARE MED, V36, P1175, DOI 10.1097/CCM.0b013e3181691502; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Schweickert WD, 2004, CRIT CARE MED, V32, P1272, DOI 10.1097/01.CCM.0000127263.54807.79; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Sessler CN, 2008, CHEST, V133, P552, DOI 10.1378/chest.07-2026; Sessler CN, 2009, CRIT CARE CLIN, V25, P489, DOI 10.1016/j.ccc.2009.03.001; Shehabi Y, 2011, ANAESTH INTENS CARE, V39, P339, DOI 10.1177/0310057X1103900302; Singer J, 2003, APPL LONGITUDINAL DA APPL LONGITUDINAL DA, DOI [10.1093/acprof:oso/ 9780195152968.003.0001, DOI 10.1093/ACPROF:OSO/9780195152968.003.0001]; Sloane C, 2000, J EMERG MED, V19, P259, DOI 10.1016/S0736-4679(00)00235-3; Strom T, 2010, LANCET, V375, P475, DOI 10.1016/S0140-6736(09)62072-9; SUNDERLAND PM, 1992, NEUROSURGERY, V31, P246, DOI 10.1227/00006123-199208000-00009; Tanios MA, 2009, J CRIT CARE, V24, P66, DOI 10.1016/j.jcrc.2008.03.037; Terao Y, 2003, CRIT CARE MED, V31, P830, DOI 10.1097/01.CCM.0000054868.93459.E1; TerMinassian A, 1997, ANESTH ANALG, V84, P127; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P539; Tobar E, 2010, MED INTENSIVA, V34, P4, DOI 10.1016/j.medin.2009.04.003; TODD MM, 1992, ANESTHESIOLOGY, V76, P161; Vanderbilt University, 2002, MET EV CONF UCI CAM; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; WARD JD, 1985, J NEUROSURG, V62, P383, DOI 10.3171/jns.1985.62.3.0383; Weisbrodt L, 2011, AM J CRIT CARE, V20, pE90, DOI 10.4037/ajcc2011415; Wilson RF, 1998, J HEAD TRAUMA REHAB, V13, P11, DOI 10.1097/00001199-199802000-00005; Youngquist P, 2007, JT COMM J QUAL PATIE, V33, P219, DOI 10.1016/S1553-7250(07)33026-2	128	1	1	1	8	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0103-5355	2359-5922		BRAZ NEUROSURG	Braz. Neurosurg.	JUN	2016	35	2					135	147		10.1055/s-0036-1582447			13	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	EI4NC	WOS:000392469500005		gold			2022-02-06	
J	Stahl, JB; Hoecherl, EF; Durner, J; Nagel, D; Wolf, K; Holdenrieder, S				Stahl, Juliane Barbara; Hoecherl, Eduard F.; Durner, Juergen; Nagel, Dorothea; Wolf, Konrad; Holdenrieder, Stefan			HMGB1, nucleosomes and sRAGE as new prognostic serum markers after multiple trauma	LABORATORIUMSMEDIZIN-JOURNAL OF LABORATORY MEDICINE			English	Article						HMGB1; nucleosomes; prognosis; serum biomarkers; sRAGE; trauma	IMMUNOGENIC CELL-DEATH; PREANALYTICAL EVALUATION; RAGE; RECEPTOR; DNA; BIOMARKERS; RELEASE	Background: The prognostic relevance of blood markers in multiple trauma is still a matter of controversial debate. Besides clinical scores new biomarkers indicating the disease severity and the prognosis during the first hours of therapy are highly needed to improve individual patient management. Methods: In prospectively collected sera of 164 patients, among them 115 with multiple trauma, the values of circulating nucleosomes, high-mobility-group-box protein 1 (HMGB1) and soluble receptor of advanced glycation end products (sRAGE) were determined at time of admission to the resuscitation room. Disease severity and clinical status were quantified by injury severity score (ISS) and Glasgow Coma Scale (GCS). As controls, 24 patients with femoral neck fractures and 25 patients with ankle fractures (AFs) were included. Results: Patients with severe multiple trauma (SMT) showed significantly higher HMGB1 and sRAGE levels than patients with moderate trauma and single fractures. Interestingly, HMGB1 and nucleosomes (R=0.56; p<0.01) as well as HMGB1 and sRAGE (R=0.44; p<0.01) correlated significantly with each other. In multiple trauma patients, high HMGB1 and sRAGE levels were significantly associated with more severe trauma according ISS (both p<0.01) and more severe traumatic brain injury (TBI) (GCS <= 8; both p<0.01). Thirteen of the multiple injured patients died during the first week after trauma. Non-surviving patients showed significantly higher values of HMGB1, nucleosomes, and sRAGE than survivors (p<0.01; p=0.01; p=0.02). Best prediction of first-week mortality was obtained in receiver operating characteristic (ROC) curves for HMGB1 that yielded an area under the curve (AUC) of 90.6%. Conclusions: HMGB1, nucleosomes and sRAGE are valuable biomarkers indicating trauma severity and prognosis of trauma patients.	[Holdenrieder, Stefan] Univ Hosp Bonn, Inst Clin Chem & Clin Pharmacol, Sigmund Freud Str 15, D-53127 Bonn, Germany; [Stahl, Juliane Barbara; Nagel, Dorothea] Univ Hosp Munich, Inst Lab Med, Munich, Germany; [Hoecherl, Eduard F.; Wolf, Konrad] Hosp Munich Schwabing, Dept Trauma Surg, Munich, Germany; [Durner, Juergen] Lab Dr Staber & Partners, Nurnberg, Germany		Holdenrieder, S (corresponding author), Univ Hosp Bonn, Inst Clin Chem & Clin Pharmacol, Sigmund Freud Str 15, D-53127 Bonn, Germany.	Stefan.Holdenrieder@uni-bonn.de					Abraham E, 2009, CRIT CARE, V13, DOI 10.1186/cc8141; Beiter T, 2011, CLIN CHEM, V57, P633, DOI 10.1373/clinchem.2010.158030; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; Bopp C, 2008, J SURG RES, V147, P79, DOI 10.1016/j.jss.2007.07.014; Chawda MN, 2004, INJURY, V35, P347, DOI 10.1016/S0020-1383(03)00140-2; Cohen MJ, 2009, CRIT CARE, V13, DOI 10.1186/cc8152; Dewar D, 2009, INJURY, V40, P912, DOI 10.1016/j.injury.2009.05.024; Fahmueller YN, 2013, INT J CANCER, V132, P2349, DOI 10.1002/ijc.27894; Geiger S, 2007, J NEUROL, V254, P617, DOI 10.1007/s00415-006-0407-5; Gennarelli T, 1990, ABBREVIATED INJURY S; Geroldi D, 2006, CURR MED CHEM, V13, P1971, DOI 10.2174/092986706777585013; GOODWIN GH, 1973, EUR J BIOCHEM, V38, P14, DOI 10.1111/j.1432-1033.1973.tb03026.x; Heron Melonie, 2011, Natl Vital Stat Rep, V59, P1; Holdenrieder S, 2001, CLIN CHEM LAB MED, V39, P596, DOI 10.1515/CCLM.2001.095; Holdenrieder S, 2009, CRIT REV CL LAB SCI, V46, P1, DOI [10.1080/10408360802485875, 10.1080/10408360802485875 ]; Keel M, 2005, INJURY, V36, P691, DOI 10.1016/j.injury.2004.12.037; Khorasanizadeh S, 2004, CELL, V116, P259, DOI 10.1016/S0092-8674(04)00044-3; Kohles N, 2012, TUMOR BIOL, V33, P33, DOI 10.1007/s13277-011-0237-7; Lehner J, 2012, ANTICANCER RES, V32, P2059; Lo YMD, 2000, CLIN CHEM, V46, P319; Margraf S, 2008, SHOCK, V30, P352, DOI 10.1097/SHK.0b013e31816a6bb1; Martins GA, 2000, ANN NY ACAD SCI, V906, P134; Muhammad S, 2008, J NEUROSCI, V28, P12023, DOI 10.1523/JNEUROSCI.2435-08.2008; Peltz ED, 2009, SHOCK, V32, P17, DOI 10.1097/SHK.0b013e3181997173; Probst C, 2009, INJURY, V40, P77, DOI 10.1016/j.injury.2008.10.004; Rouhiainen A, 2004, BLOOD, V104, P1174, DOI 10.1182/blood-2003-10-3536; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Stoetzer OJ, 2012, EXPERT OPIN BIOL TH, V12, pS217, DOI 10.1517/14712598.2012.689280; Weber U, 2005, ORTHOPADE, V34, P821, DOI 10.1007/s00132-005-0841-6; Wittwer C, 2012, ANTICANCER RES, V32, P2075; Yamagishi Sho-ichi, 2010, Front Biosci (Elite Ed), V2, P1184; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100; Zuercher M, 2009, BRAIN INJURY, V23, P371, DOI 10.1080/02699050902926267	34	1	1	0	5	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0342-3026	1439-0477		LABORATORIUMSMEDIZIN	LaboratoriumsMedizin	JUN	2016	40	3					165	173		10.1515/labmed-2016-0004			9	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	DO1VY	WOS:000377569100002					2022-02-06	
J	Wood, DP; Wiederhold, BK; Wiederhold, MD; Spira, JA				Wood, Dennis Patrick; Wiederhold, Brenda K.; Wiederhold, Mark D.; Spira, James A.			Virtual Reality Therapy for the Treatment of Combat-Related Posttraumatic Stress Disorder: A Case Report 10 Years Post Combat Deployment	ANNUAL REVIEW OF CYBERTHERAPY AND TELEMEDICINE			English	Article						Virtual Reality Graded Exposure Therapy (VR-GET); Veterans Administration (VA); Department of Defense (DOD); Posttraumatic Stress Disorder (PTSD); mild Traumatic Brain Injury; Sentinel Events	EXPOSURE THERAPY	Important challenges confronting DOD/military and the Department of Veterans Affairs medical care are that of maintaining or increasing the quality of care and increasing the effectiveness of treatments for warriors diagnosed with Posttraumatic Stress Disorder (PTSD) secondary to their combat deployments to Iraq and/or Afghanistan. Virtual Reality Graded Exposure Therapy with Arousal Control (VR-GET) has demonstrated a positive treatment effectiveness resulting in significant reductions of PTSD symptom severity. In this report, we describe the outcome of VR-GET, for the treatment of combat-related PTSD, in a warrior who experienced no treatment for his PTSD for the 10 years following his return from combat duty.	[Wood, Dennis Patrick; Wiederhold, Brenda K.; Wiederhold, Mark D.] Virtual Real Med Ctr, San Diego, CA 92121 USA; [Spira, James A.] Univ Hawaii, Sch Med, Dept Psychiat, Honolulu, HI 96822 USA		Wood, DP (corresponding author), Virtual Real Med Ctr, San Diego, CA 92121 USA.	dpwcapt@aol.com	Wiederhold, Brenda K/Z-1993-2019	Wiederhold, Brenda K/0000-0002-3320-0303			American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Arthur D.C., 2007, ACHIEVABLE VISION RE; Forsten R, 2005, PSYCHIAT QUART, V76, P343, DOI 10.1007/s11126-005-4968-9; Hepner K.A., 2016, QUALITY CARE PTSD DE; Hoge C. W., 2013, FEDERAL PRACTITIONER, V30, p3S; Howard LMD, 2008, MIL MED, V173, P339, DOI 10.7205/MILMED.173.4.339; Kok BC, 2012, J NERV MENT DIS, V200, P444, DOI 10.1097/NMD.0b013e3182532312; McLay RN, 2011, CYBERPSYCH BEH SOC N, V14, P223, DOI 10.1089/cyber.2011.0003; Ritchie EC, 2004, PSYCHIAT CLIN N AM, V27, P459, DOI 10.1016/j.psc.2004.03.005; Roy M. J., 2016, STUDIES HLTH TECHNOL, V219, P123; Tanielian T, 2008, RAND CORPORATION MON; Wood D. P., MED MEETS VIRT REAL, P696; Wood DP, 2007, CYBERPSYCHOL BEHAV, V10, P309, DOI 10.1089/cpb.2006.9951; Wood DP, 2009, MIL MED, V174, P1215, DOI 10.7205/MILMED-D-03-4408	14	1	1	0	12	INTERACTIVE MEDIA INST	SAN DIEGO	9565 WAPLES ST, STE 200, SAN DIEGO, CA 92121 USA	1554-8716	2352-927X		ANN REV CYBERTHERAPY	Ann. Rev. CyberTherapy Telemed.	SUM	2016	14						161	166					6	Computer Science, Cybernetics	Emerging Sources Citation Index (ESCI)	Computer Science	EJ8DA	WOS:000393453500026					2022-02-06	
J	Bjorkdahl, A; Esbjornsson, E; Ljungqvist, J; Skoglund, T; Sunnerhagen, KS				Bjorkdahl, Ann; Esbjornsson, Eva; Ljungqvist, Johan; Skoglund, Thomas; Sunnerhagen, Katharina Stibrant			Decline in cognitive function due to diffuse axonal injury does not necessarily imply a corresponding decline in ability to perform activities	DISABILITY AND REHABILITATION			English	Article						Cognitive reserve; compensatory strategies; ICF; rehabilitation; traumatic brain injury	TRAUMATIC BRAIN-INJURY; NEUROLOGICAL-INSTITUTE SCREEN; OCCUPATIONAL PERFORMANCE; MODERATE; POPULATION; VALIDATION; PREDICTION; INTEGRITY; OUTCOMES; IMPACT	Purpose: The study explored the direction of change (decline vs. improvement) after diffuse axonal injury (DAI) in the domains of the ICF: body structure, body function, and activity. Methods: Thirteen patients with DAI were assessed by using diffusion tensor imaging (DTI) to measure body structure, the Barrow Neurological Institute Screen for Higher Cerebral Functions (BNIS) to measure body function, and the Assessment of Motor and Process Skills (AMPS) to measure activity. The DTI, BNIS, and AMPS were applied at the acute phase (A1), and at 6 and 12 months post-injury (A2 and A3). Visual and statistical analyses were conducted to explore time-dependent changes in the ICF domains. Results: Improvements were observed for most patients in all ICF domains from injury until six months. Thereafter, the results diverged, with half of the subjects showing a decline in DTI and BNIS scores between A2-A3, and all but one of the patients exhibiting identical or better A2-A3 AMPS process skill scores. Conclusions: From 6 to 12 months post-injury, some patients underwent an ongoing degenerative process, causing a decline in cognitive function. The same decline was not observed in the activity measure, which might be explained by the use of compensatory strategies.Implications for rehabilitationIn rehabilitation it is essential to be aware that in some cases with TBI, an ongoing degenerative process in the white matter can be expected, causing an adverse late effect on cognitive function.The cognitive decline, caused by DAI, does not necessarily mean a concurrent decrease in activity performance, possibly explained by the use of compensatory strategies. This suggests that, after the post-acute phase, rehabilitation offering strategy training may be beneficial to enhance every-day functioning.Strategy use requires awareness, which imply the need to assess level of awareness in order to guide rehabilitation.	[Bjorkdahl, Ann] Ersta Skondal Univ Coll, Gothenburg, Sweden; [Bjorkdahl, Ann; Esbjornsson, Eva; Ljungqvist, Johan; Skoglund, Thomas; Sunnerhagen, Katharina Stibrant] Gothenburg Univ, Sahlgrenska Acad, Inst Neurosci & Physiol, Gothenburg, Sweden		Bjorkdahl, A (corresponding author), Ersta Skondal Hgsk, Campus Bracke,POB 210 62, S-41669 Gothenburg, Sweden.	ann.bjorkdahl@esh.se	Bjorkdahl, Ann/ABD-6197-2021; Sunnerhagen, Katharina Stibrant/AAE-2405-2020	Bjorkdahl, Ann/0000-0002-2194-6773; Sunnerhagen, Katharina Stibrant/0000-0002-5940-4400			Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Denvall V, 2002, J REHABIL MED, V34, P153, DOI 10.1080/16501970213231; Devitt R, 2006, DISABIL REHABIL, V28, P547, DOI 10.1080/00222930500219258; Esbjornsson E, 2013, J REHABIL MED, V45, P771, DOI 10.2340/16501977-1170; Esbjornsson E, 2013, BRAIN INJURY, V27, P521, DOI 10.3109/02699052.2012.743179; FISHER AG, 1993, AM J OCCUP THER, V47, P319, DOI 10.5014/ajot.47.4.319; FISHER AG, 2003, DEV STANDARDIZATION, V1; Ham TE, 2012, CURR OPIN NEUROL, V25, P662, DOI 10.1097/WCO.0b013e328359488f; Hofgren C, 2007, J REHABIL MED, V39, P547, DOI 10.2340/16501977-0085; Irimia A, 2012, NEUROIMAGE-CLIN, V1, P1, DOI 10.1016/j.nicl.2012.08.002; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Larsson J, 2010, SCAND J PUBLIC HEALT, V38, P541, DOI 10.1177/1403494810371143; Ljungqvist J, 2011, BRAIN INJURY, V25, P370, DOI 10.3109/02699052.2011.558038; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Moen KG, 2012, J NEUROL NEUROSUR PS, V83, P1193, DOI 10.1136/jnnp-2012-302644; Ng K, 2008, ARCH PHYS MED REHAB, V89, pS35, DOI 10.1016/j.apmr.2008.07.006; Prigatano GP, 1991, BNI Q, V2, P9; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Spitz G, 2013, BRAIN TOPOGR, V26, P648, DOI 10.1007/s10548-013-0283-0; Stern Y, 2003, J CLIN EXP NEUROPSYC, V25, P589, DOI 10.1076/jcen.25.5.589.14571; Toglia JP, 2012, CAN J OCCUP THER, V79, P225, DOI 10.2182/cjot.2012.79.4.4; Topiwala Anya, 2012, Am J Neurodegener Dis, V1, P152; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Westwood P., 2006, TEACHING LEARNING DI, V2nd; World Health Organization, 2007, INT CLASS FUNCT DIS	29	1	1	0	12	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	MAY 7	2016	38	10					1006	1015		10.3109/09638288.2015.1076073			10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	DG1HE	WOS:000371815900010	26497159				2022-02-06	
J	Gefvert, B				Gefvert, Barbara			Photobiomodulation and the brain: Traumatic brain injury and beyond	LASER FOCUS WORLD			English	Article							THERAPY; LIGHT	Can lasers help the brain repair itself? After years of research and application to a host of biomedical conditions, photobiomodulation (low-level light therapy) is being tested in clinical trials for treatment of traumatic brain injury (TBI), among other neurological and psychiatric conditions.									Anders JJ, 2015, PHOTOMED LASER SURG, V33, P183, DOI 10.1089/pho.2015.9848; Ando T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026212; Hashmi JT, 2010, PM&R, V2, pS292, DOI 10.1016/j.pmrj.2010.10.013; Karu T, 2013, PHOTOMED LASER SURG, V31, P189, DOI 10.1089/pho.2013.3510; Naeser MA, 2015, PHOTOMED LASER SURG, V33, P443, DOI 10.1089/pho.2015.3986; Naeser MA, 2010, PROC SPIE, V7552, DOI 10.1117/12.842510; Santana-Blank L, 2016, PHOTOMED LASER SURG, V34, P93, DOI 10.1089/pho.2015.4015; Sharma SK, 2011, LASER SURG MED, V43, P851, DOI 10.1002/lsm.21100; Wu Q., 2010, P SOC PHOTO-OPT INS, V7552, DOI 10.1117/2.1200906.1669	9	1	1	0	4	PENNWELL PUBL CO	NASHUA	98 SPIT BROOK RD, NASHUA, NH 03062-2801 USA	1043-8092			LASER FOCUS WORLD	Laser Focus World	MAY	2016	52	5					31	35					5	Optics	Science Citation Index Expanded (SCI-EXPANDED)	Optics	DL9OA	WOS:000375971400012					2022-02-06	
J	Hazarika, R; Ahmed, S; Parua, S; Kundu, R				Hazarika, Rajib; Ahmed, Shameem; Parua, Samit; Kundu, Rupak			An Indigenous Intracranial Pressure Monitoring System: A Devise for Succour	INTERNATIONAL JOURNAL OF SCIENTIFIC STUDY			English	Article						Head injury; Indigenous intracranial pressure monitor; Intracranial pressure	INTRA-CRANICAL PRESSURE; SEVERE HEAD-INJURY; HYPERTENSION; SCREW	Introduction: Intracranial pressure (ICP) monitoring system is an important tool in managing traumatic brain injury (TBI) patients. However, in developing countries like India, intraparenchymal ICP monitoring systems are not feasible and intraventricular monitoring is not preferred due to high infection rates as well as difficulty in placement in the absence of ventriculomegaly. We tried to evaluate the feasibility and utility of indigenous, low-cost subdural ICP monitor in TBI patients. Materials and Methods: This prospective observational study over 12-month of the period included patients aged 18 years or more with a Glasgow coma score (GCS) of less than 12 following a head injury, who were admitted within 12 h of the injury. ICP was measured in these patients when there was no definitive operable finding on computed tomography head. Patients having ventriculomegaly and/or coagulopathy were excluded. Soft sterile silicon (6 FG) was placed subdurally after making a small burr hole and connected to a central venous pressure manometer, sterile saline used as coupling agent. The total cost of consumables was around INR 1125. Based on serial ICP recording (up to 72 h), patients were grouped as high ICP (> 20 cm H2O) Group H (N = 12) and normal ICP (< 20 cm H2O) Group N (N = 7). The outcome was assessed at 6 months with GCS. Results: A total of 19 patients were analyzed, 14 (74%) were severe head injured (GCS - 3-8) and 5 (26%) patients sustained a moderate head injury (GCS - 9-12); all were male with a mean age of 34 years. 14 (73.6%) patients had high ICP, all of whom were subsequently operated. Median GCS was 5 (range 4 - 6) at 6 months follow-up in the operated Group H and median GCS of 6 (range 4 - 7) in the non-operated Group N. Conclusions: Our indigenous and cheap subdural ICP monitoring system is feasible, easy to use and may be an attractive alternative in resource-constrained setting.	[Hazarika, Rajib; Parua, Samit; Kundu, Rupak] Gauhati Med Coll & Hosp, Dept Anaesthesiol & Crit Care, Gauhati, Assam, India; [Ahmed, Shameem] Gauhati Med Coll & Hosp, Dept Neurosurg, Gauhati, Assam, India		Ahmed, S (corresponding author), Gauhati Med Coll & Hosp, Dept Neurosurg, Gauhati, Assam, India.	shameemahmed@gmail.com					Bailey BM, 2011, J TRAUMA, V72, P263; CHAMBERS IR, 1990, NEUROSURGERY, V26, P421, DOI 10.1227/00006123-199003000-00007; CRUTCHFIELD JS, 1990, J NEUROSURG, V72, P482, DOI 10.3171/jns.1990.72.3.0482; GALBRAITH S, 1981, J NEUROSURG, V55, P75, DOI 10.3171/jns.1981.55.1.0075; GUILLAUME J, 1951, REV NEUROL, V84, P131; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; NORTH B, 1986, NEUROSURGERY, V18, P730, DOI 10.1227/00006123-198606000-00009; OSTRUP RC, 1987, J NEUROSURG, V67, P206, DOI 10.3171/jns.1987.67.2.0206; Stocchetti N, 2007, J NEUROTRAUM, V24, P1339, DOI 10.1089/neu.2007.0300; VENES J, 1980, CHILD BRAIN, V7, P236; VRIES JK, 1973, J NEUROSURG, V39, P416, DOI 10.3171/jns.1973.39.3.0416; WINN HR, 1977, SURG NEUROL, V8, P41	14	1	1	0	0	INT JOURNAL SCIENTIFIC STUDY-IJSS	MAHARASHTRA	9-2, SATYALOK BUILDING, GADITAL, HADAPSAR, PUNE, MAHARASHTRA, 411028, INDIA	2321-6379	2321-595X		INT J SCI STUDY	Int. J. Sci. Study	MAY	2016	4	2					30	33		10.17354/ijss/2016/246			4	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	FF2TN	WOS:000408749800006					2022-02-06	
J	Konigs, M; van Heurn, LWE; Vermeulen, RJ; Goslings, JC; Luitse, JSK; Poll-The, BT; Beelen, A; van der Wees, M; Kemps, RJJK; Catsman-Berrevoets, CE; Luman, M; Oosterlaan, J				Konigs, M.; van Heurn, L. W. E.; Vermeulen, R. J.; Goslings, J. C.; Luitse, J. S. K.; Poll-The, B. T.; Beelen, A.; van der Wees, M.; Kemps, R. J. J. K.; Catsman-Berrevoets, C. E.; Luman, M.; Oosterlaan, J.			Feedback learning and behavior problems after pediatric traumatic brain injury	PSYCHOLOGICAL MEDICINE			English	Article						Behavioral functioning; feedback learning; generalization of learning; pediatrics; traumatic brain injury	PSYCHIATRIC-DISORDERS; CHILDREN; TBI; ADOLESCENTS; PERFORMANCE; RECOVERY; OUTCOMES	Background. Feedback learning is essential for behavioral development. We investigated feedback learning in relation to behavior problems after pediatric traumatic brain injury (TBI). Method. Children aged 6-13 years diagnosed with TBI (n = 112; 1.7 years post-injury) were compared with children with traumatic control (TC) injury (n = 52). TBI severity was defined as mild TBI without risk factors for complicated TBI (mild(RF-) TBI, n = 24), mild TBI with >= 1 risk factor for complicated TBI (mild(RF+) TBI, n = 51) and moderate/severe TBI (n = 37). The Probabilistic Learning Test was used to measure feedback learning, assessing the effects of inconsistent feedback on learning and generalization of learning from the learning context to novel contexts. The relation between feedback learning and behavioral functioning rated by parents and teachers was explored. Results. No evidence was found for an effect of TBI on learning from inconsistent feedback, while the moderate/severe TBI group showed impaired generalization of learning from the learning context to novel contexts (p = 0.03, d =-0.51). Furthermore, the mild(RF+) TBI and moderate/severe TBI groups had higher parent and teacher ratings of internalizing problems (p's <= 0.04, d's >= 0.47) than the TC group, while the moderate/severe TBI group also had higher parent ratings of externalizing problems (p = 0.006, d = 0.58). Importantly, poorer generalization of learning predicted higher parent ratings of externalizing problems in children with TBI (p = 0.03, beta =-0.21) and had diagnostic utility for the identification of children with TBI and clinically significant externalizing behavior problems (area under the curve = 0.77, p = 0.001). Conclusions. Moderate/severe pediatric TBI has a negative impact on generalization of learning, which may contribute to post-injury externalizing problems.	[Konigs, M.; Luman, M.; Oosterlaan, J.] Vrije Univ Amsterdam, Dept Clin Neuropsychol, Boechorststr 1, NL-1081 BT Amsterdam, Netherlands; [van Heurn, L. W. E.] Emma Childrens Hosp, Acad Med Ctr, Pediat Surg Ctr Amsterdam, Amsterdam, Netherlands; [van Heurn, L. W. E.] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; [Vermeulen, R. J.] Vrije Univ Amsterdam, Med Ctr, Dept Pediat Neurol, Amsterdam, Netherlands; [Goslings, J. C.] Univ Amsterdam, Acad Med Ctr, Trauma Unit, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Luitse, J. S. K.] Univ Amsterdam, Acad Med Ctr, Dept Emergency Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Poll-The, B. T.] Emma Childrens Hosp, Acad Med Ctr, Dept Pediat Neurol, Amsterdam, Netherlands; [Beelen, A.] Univ Amsterdam, Acad Med Ctr, Dept Rehabil, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Beelen, A.] Merem Rehabil Ctr De Trappenberg, Huizen, Netherlands; [van der Wees, M.] Libra Rehabil Ctr Blixembosch, Eindhoven, Netherlands; [Kemps, R. J. J. K.] Libra Rehabil Ctr Leijpark, Tilburg, Netherlands; [Catsman-Berrevoets, C. E.] Erasmus MC, Dept Pediat Neurol, Rotterdam, Netherlands; [Luman, M.] Vrije Univ Amsterdam, Dept Methods, Amsterdam, Netherlands; [Oosterlaan, J.] Emma Childrens Hosp, Acad Med Ctr, Amsterdam, Netherlands		Konigs, M (corresponding author), Vrije Univ Amsterdam, Dept Clin Neuropsychol, Boechorststr 1, NL-1081 BT Amsterdam, Netherlands.	m.konigs@vu.nl		Luman, Marjolein/0000-0002-1539-2831; Vermeulen, R. Jeroen/0000-0002-3503-3625; Poll-The, Bwee Tien/0000-0002-8118-5419	Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Scientific Research (NWO) [022.003.010]	This work was supported by the Netherlands Organization for Scientific Research (NWO), grant number 022.003.010.	American College of Surgeons Committee on Trauma, 2004, ADV TRAUM LIF SUPP P, V7; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bongers IL, 2008, PSYCHOL MED, V38, P989, DOI 10.1017/S0033291707002309; Breslau J, 2009, PEDIATRICS, V123, P1472, DOI 10.1542/peds.2008-1406; Broidy LM, 2003, DEV PSYCHOL, V39, P222, DOI 10.1037/0012-1649.39.2.222; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Donders J, 2004, CLIN NEUROPSYCHOL, V18, P521, DOI 10.1080/11385404049052411; Doya K, 2008, NAT NEUROSCI, V11, P410, DOI 10.1038/nn2077; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Field A., 2017, DISCOVERING STAT USI, V5th; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Gershman SJ, 2015, TOP COGN SCI, V7, P391, DOI 10.1111/tops.12138; Glascher J, 2010, NEURON, V66, P585, DOI 10.1016/j.neuron.2010.04.016; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Hammerer D, 2012, DEV PSYCHOL, V48, P862, DOI 10.1037/a0027342; Kaufman AS, 1996, J CLIN CHILD PSYCHOL, V25, P97, DOI 10.1207/s15374424jccp2501_11; Kizilbash A, 1999, CHILD NEUROPSYCHOL, V5, P224, DOI 10.1076/0929-7049(199912)05:04;1-R;FT224; Larson MJ, 2007, J INT NEUROPSYCH SOC, V13, P615, DOI 10.1017/S1355617707070762; Levin H S, 1997, J Int Neuropsychol Soc, V3, P598; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Maia TV, 2011, NAT NEUROSCI, V14, P154, DOI 10.1038/nn.2723; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; Max JE, 2012, J AM ACAD CHILD PSY, V51, P1208, DOI 10.1016/j.jaac.2012.08.026; Roberts RM, 2014, DEV NEUROPSYCHOL, V39, P600, DOI 10.1080/87565641.2014.973958; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Schmidt AT, 2012, INT J DEV NEUROSCI, V30, P225, DOI 10.1016/j.ijdevneu.2011.11.003; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Slawik H, 2009, J NEUROTRAUM, V26, P1891, DOI 10.1089/neu.2009.0942; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; SPSS Inc, 2013, IBM SPSS STAT WIND V; Statistics Netherlands, 2006, STAND OND 2006; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; STOKES TF, 1977, J APPL BEHAV ANAL, V10, P349, DOI 10.1901/jaba.1977.10-349; Tabachnick BG., 2012, USING MULTIVARIATE S; Tamminen J, 2015, COGNITIVE PSYCHOL, V79, P1, DOI 10.1016/j.cogpsych.2015.03.003; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; van den Bos W, 2012, CEREB CORTEX, V22, P1247, DOI 10.1093/cercor/bhr198; Van der Ende J, 2013, HANDLEIDING ASEBA VR; Van Duijvenvoorde ACK, 2013, BIOL PSYCHOL, V93, P175, DOI 10.1016/j.biopsycho.2013.01.006; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Yeates KO., 2006, EXCEPTIONALITY, V14, P141, DOI DOI 10.1207/S15327035EX1403_	44	1	1	4	17	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0033-2917	1469-8978		PSYCHOL MED	Psychol. Med.	MAY	2016	46	7					1473	1484		10.1017/S0033291716000106			12	Psychology, Clinical; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Psychiatry	DJ4IN	WOS:000374168700012	26951460				2022-02-06	
J	Rus, D; Chereches, RM; Peek-Asa, C; Marton-Vasarhely, EO; Oprescu, F; Brinzaniuc, A; Mocean, F				Rus, Diana; Chereches, Razvan Mircea; Peek-Asa, Corinne; Marton-Vasarhely, Emanuela Oana; Oprescu, Florin; Brinzaniuc, Alexandra; Mocean, Floarea			Paediatric head injuries treated in a children's emergency department from Cluj-Napoca, Romania	INTERNATIONAL JOURNAL OF INJURY CONTROL AND SAFETY PROMOTION			English	Article						surveillance; children; advanced care; injury database; head injury	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; UNINTENTIONAL INJURIES; RISK-FACTORS; ADOLESCENTS; PATTERNS; ADULTS	The aim of the study was to describe paediatric head injuries and identify factors that led to advanced care. Incident cases of head injuries that sought care from December 2008 to October 2010 at Children's Emergency Hospital Cluj-Napoca were evaluated. The main outcome was transfer or admission to advanced care. From a total of 3053 children treated for an injury, 1541 (50.4%) presented with head injury. A total of 960 (62.3%) of the children with a head injury required advanced care treatment. Young children were more likely to suffer a head injury than older children, but a higher proportion of older children required advanced care (70.3%). Children who suffered a head injury as a consequence of road traffic were almost five times more likely to require advanced care (OR: 4.97; 3.09-8.06) than being released. Our results suggest that data on injuries provide evidence-based information on the nature of injuries children are prone to, and what activity, type, and mechanism of injury impact Romanian children.	[Rus, Diana; Mocean, Floarea] Univ Med & Pharm Iuliu Hatieganu, Dept Hlth Management & Publ Hlth, Cluj Napoca, Romania; [Chereches, Razvan Mircea; Marton-Vasarhely, Emanuela Oana; Brinzaniuc, Alexandra] Univ Babes Bolyai, Ctr Hlth Policy & Publ Hlth, R-3400 Cluj Napoca, Romania; [Peek-Asa, Corinne] Univ Iowa, Dept Occupat & Environm Hlth, Iowa City, IA USA; [Oprescu, Florin] Univ Sunshine Coast, Sch Hlth & Environm Hlth, Brisbane, Qld, Australia		Chereches, RM (corresponding author), Univ Babes Bolyai, Ctr Hlth Policy & Publ Hlth, R-3400 Cluj Napoca, Romania.	razvan.chereches@publichealth.ro	Oprescu, Florin/C-4908-2011	Oprescu, Florin/0000-0003-1342-3566	PHASE Grant [2006123]; Austrian Road Safety Board (KfV), Department Home, Leisure Sport [IDB3]; NIH-Fogarty International Trauma Training Program at the University of Iowa [5D43TW007261]; FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [D43TW007261] Funding Source: NIH RePORTER	The research study used data collected as part of the IDB Pilot Project-Romania, financed through the PHASE Grant Agreement No. 2006123 having as project leader SafeStrat: EuroSafe and the Work Package leader IDB3: Austrian Road Safety Board (KfV), Department Home, Leisure & Sport. Partial funding was also provided by the NIH-Fogarty International Trauma Training Program at the University of Iowa (5D43TW007261). The authors gratefully acknowledge all members of the IDB for their work on the project overall and for the contributions of project documentation used in this manuscript.	Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; Alexandrescu R, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-226; Baeur R., 2009, INJURIES EUROPEAN UN; Bahloul Mabrouk, 2011, J Emerg Trauma Shock, V4, P29, DOI 10.4103/0974-2700.76831; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Dinesh S., 2008, EUROPEAN REPORT CHIL; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Gaines BA, 2005, CLIN PEDIATR EMERG M, V6, P4, DOI 10.1016/j.cpem.2004.12.003; Horneman G, 2005, INT J REHABIL RES, V28, P245, DOI 10.1097/00004356-200509000-00007; Hu CF, 2013, PEDIATR NEONATOL, V54, P73, DOI 10.1016/j.pedneo.2012.12.011; Institute of Consumer Safety, 2005, INJ DAT IDB COD MAN, P13; Khambalia A, 2006, INJURY PREV, V12, P378, DOI 10.1136/ip.2006.012161; Kisser R, 2009, INT J INJ CONTROL SA, V16, P103, DOI 10.1080/17457300902885769; MACNAB AJ, 1995, CAN FAM PHYSICIAN, V41, P1545; McCarthy ML, 2006, ARCH PEDIAT ADOL MED, V160, P252, DOI 10.1001/archpedi.160.3.252; McKinlay A, 2010, INJURY PREV, V16, P31, DOI 10.1136/ip.2009.022483; Mihic J, 2011, ACTA CLIN CROAT, V50, P539; Niedzwecki CM, 2008, J HEAD TRAUMA REHAB, V23, P209, DOI 10.1097/01.HTR.0000327253.61751.29; Oprescu F, 2008, EUR J EMERG MED, V15, P268, DOI 10.1097/MEJ.0b013e3283026219; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Pennington N, 2010, J SCH NURS, V26, P26, DOI 10.1177/1059840509341881; Pinto PS, 2012, J NEUROIMAGING, V22, pe18, DOI 10.1111/j.1552-6569.2011.00690.x; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Redmond Carrie, 2006, Nutr Clin Pract, V21, P450, DOI 10.1177/0115426506021005450; Sleet DA, 2010, ANNU REV PUBL HEALTH, V31, P195, DOI 10.1146/annurev.publhealth.012809.103616; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; Taylor HG, 2008, J INT NEUROPSYCH SOC, V14, P734, DOI 10.1017/S1355617708081150; Theurer WM, 2013, AM FAM PHYSICIAN, V87, P502; Wanda L., 2003, CLIN PEDIAT EMERGENC, V4, P112, DOI [10.1016/S1522-8401(03)00018-1, DOI 10.1016/S1522-8401(03)00018-1]; Wasserberg J, 2002, BMJ-BRIT MED J, V325, P454, DOI 10.1136/bmj.325.7362.454; Winston, 1998, CHILD MALTREATMENT, V3, P116, DOI [DOI 10.1177/1077559598003002006, 10.1177/1077559598003002006]	31	1	1	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1745-7300	1745-7319		INT J INJ CONTROL SA	Int. J. Inj. Control Saf. Promot.	APR 2	2016	23	2					206	213		10.1080/17457300.2013.872671			8	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	DI9LJ	WOS:000373823900011	24479864	Green Accepted			2022-02-06	
J	Farook, AK; Ilangovan, G; Ravi, R; Farook, AS; Magudeeswaran, PK				Farook, Abdul Khader; Ilangovan, Gurubharath; Ravi, Rajesh; Farook, Abubacker Sulaiman; Magudeeswaran, Praveen Kumar			Role of Multiplanar Reconstruction Imaging and Three-dimensional Computed Tomography Imaging in Diagnosing Cranial and Facial Fractures	INTERNATIONAL JOURNAL OF SCIENTIFIC STUDY			English	Article						Cranial; Fractures; Reconstruction	AXIAL HELICAL CT; SPIRAL CT; RADIATION; EXPOSURE	Introduction: Skull fractures can occur in road traffic accidents, assaults, sports, and any other injuries. Fractures to the skull can occur in any region of the skull. The role of plain radiographs in assessing facial traumas has declined over the years. The use of multiplanar reconstruction (MPR) and three-dimensional (3D) recon images of multiple detector computed tomography (MDCT) in the musculoskeletal system is of tremendous advantage in traumatic injuries when the results of plain radiography fail to answer the doubts of the surgeons regarding satisfactory alignment of complex fractures. Objective: To assess the accuracy of MDCT with MPR and 3D reconstruction sequences in imaging cranial and facial fractures. Materials and Methods: A total of 100 patients fulfilling the criteria were included in the study, the average age taken was from 22 to 44 with appropriate brain and facial protocols with bone and soft tissue reconstruction. Inclusion criteria: Traumatic cranial and facial fractures. Exclusion criteria: Pregnant and lactating women. Nontraumatic. Results: The results of the present study revealed that compared to the four types of fractures, simple undisplaced was found to be the most frequently occurring one, wherein MPR technique was found to be more detective for fractures compared to MRP and 3D, MPR, axial and 3D, MPR and axial. Conclusions: Thus, this study has high lightened the usefulness of MPR technique as an imaging tool in enabling accurate localization of free bone fragments and assessing the degree of their displacement, thus helping reduce recurrent exposures.	[Farook, Abdul Khader] Shri Sathya Sai Med Coll & Res Inst, Dept Orthopaed, Kanchipuram, Tamil Nadu, India; [Ilangovan, Gurubharath] Shri Sathya Sai Med Coll & Res Inst, Dept Radiol & Imaging Sci, Kanchipuram, Tamil Nadu, India; [Ravi, Rajesh; Farook, Abubacker Sulaiman; Magudeeswaran, Praveen Kumar] Chettinad Hosp & Res Inst, Dept Radiol & Imaging Sci, Kanchipuram, Tamil Nadu, India		Farook, AS (corresponding author), Chettinad Hosp & Res Inst, Dept Radiol & Imaging Sci, Kanchipuram, Tamil Nadu, India.	fasulaiman@hotmail.com					Abrahams JJ, 2001, RADIOLOGY, V219, P334, DOI 10.1148/radiology.219.2.r01ma33334; Anderson M, 2009, FDN ATHLETIC TRAININ, P192; Bernhardt TM, 1998, BRIT J RADIOL, V71, P846, DOI 10.1259/bjr.71.848.9828797; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; DALY BD, 1990, CLIN RADIOL, V41, P272, DOI 10.1016/S0009-9260(05)81664-2; Downing A, 2003, EMERG MED J, V20, P434, DOI 10.1136/emj.20.5.434; ELLIS E, 1985, ORAL SURG ORAL MED O, V59, P120, DOI 10.1016/0030-4220(85)90002-7; Fazel R, 2009, NEW ENGL J MED, V361, P849, DOI 10.1056/NEJMoa0901249; FISHMAN EK, 1993, RADIOGRAPHICS, V13, P463, DOI 10.1148/radiographics.13.2.8460231; FISHMAN EK, 1993, SKELETAL RADIOL, V22, P253; Greene J., 2010, HIGH SCH BASEBALL PL; HAUG RH, 1990, J ORAL MAXIL SURG, V48, P926, DOI 10.1016/0278-2391(90)90004-L; Hoeffner EG, 2001, BRIT J RADIOL, V74, P323, DOI 10.1259/bjr.74.880.740323; Kalra MK, 2005, CURR PROBL DIAGN RAD, V34, P171, DOI 10.1067/j.cpradiol.2005.06.002; M?hlum, 2004, CLIN GUIDE SPORTS IN; Olszycki M, 2004, POL J RADIOL, V69, P94; Pogorzelska-Stronczak B, 2002, PRZEGL LEK, V59, P4; Pretorius ES, 1999, RADIOGRAPHICS, V19, P1143, DOI 10.1148/radiographics.19.5.g99se061143; Rizzo S, 2006, AM J ROENTGENOL, V186, P673, DOI 10.2214/AJR.04.1513; Rozylo-Kalinowska I, 2000, Ann Univ Mariae Curie Sklodowska Med, V55, P309; Rozylo-Kalinowska Ingrid, 2002, Ann Univ Mariae Curie Sklodowska Med, V57, P549; SANDEROV B, 1988, ANN EMERG MED, V17, P973, DOI 10.1016/S0196-0644(88)80681-4; TURVEY TA, 1977, J ORAL SURG, V35, P887; WIESENBAUGH JM, 1970, J ORAL SURG, V28, P204	24	1	1	1	1	INT JOURNAL SCIENTIFIC STUDY-IJSS	MAHARASHTRA	9-2, SATYALOK BUILDING, GADITAL, HADAPSAR, PUNE, MAHARASHTRA, 411028, INDIA	2321-6379	2321-595X		INT J SCI STUDY	Int. J. Sci. Study	APR	2016	4	1					237	241		10.17354/ijss/2016/224			5	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	FF2TG	WOS:000408749100048					2022-02-06	
J	Khan, SA; Waqas, M; Ujjan, BU; Salim, A; Javed, G; Ahmed, SI; Surani, M; Khan, M				Khan, Saad Akhtar; Waqas, Muhammad; Ujjan, Badar Uddin; Salim, Adnan; Javed, Gohar; Ahmed, Syed Ijlal; Surani, Malikah; Khan, Marium			Providing Care Beyond the Hospital: Perspective of a Tertiary Care Hospital from a Developing Country	WORLD NEUROSURGERY			English	Article						Disability; Neurosurgery; Nursing; Rehabilitation	NURSING-HOME PLACEMENT; FAMILY-MEMBER; COST; BRAIN	BACKGROUND: Neurorehabilitation is an important aspect of continuing care for neurosurgical patients with functional disability. In developing countries, where formal home nursing frequently is unavailable, ensuring care after discharge is a difficult task. Training attendants to provide nursing care is an alternate option. In this study, we compared the outcomes of patients nursed by family members versus those looked after by a professional nurse. METHODS: This was a retrospective observational study conducted at the Aga Khan University Hospital Karachi. The study consisted of 2 groups. Group 1 (consisting of patients cared for by a professional nurse) included 94 patients and group 2 (patients cared for by family members) included 102. All these patients had activity of daily living score of >= 3. Glasgow Outcomes Scale score, time to decannulation, development/worsening of bedsores, and mortality were recorded and compared between the groups at follow-up. RESULTS: The study included 196 patients. Traumatic brain injury was the most common diagnosis. Nursing requirements were similar between the 2 groups and included tracheostomy care, percutaneous endoscopic gastrostomy tube care, peripherally inserted central catheter line care, care of patients with no bone flap, and log-rolling. The outcomes of the 2 groups were comparable and included bedsore development/worsening of grade, Glasgow Outcomes Scale score at follow-up, time to decannulation, and 30-day mortality. CONCLUSIONS: There was no statistically significant difference in outcomes of patients nursed by family members compared with the patients looked after by professional nurses.	[Khan, Saad Akhtar; Waqas, Muhammad; Ujjan, Badar Uddin; Javed, Gohar; Ahmed, Syed Ijlal; Surani, Malikah; Khan, Marium] Aga Khan Univ Hosp, Dept Surg, Sect Neurosurg, Karachi, Pakistan; [Salim, Adnan] Dow Univ Hlth Sci, Dow Med Coll, Karachi, Pakistan		Khan, M (corresponding author), Aga Khan Univ Hosp, Dept Surg, Sect Neurosurg, Karachi, Pakistan.	marium.khan@aku.edu	Ahmed, Syed Ijlal/K-3736-2019; Salim, Adnan/AAO-9806-2020; Waqas, Muhammad/A-5673-2013	Salim, Adnan/0000-0003-4185-673X; Khan, Saad Akhtar/0000-0002-2545-4020; Waqas, Muhammad/0000-0003-4500-7954			Andlin-Sobocki P, 2005, EUR J NEUROL, V12, P1, DOI 10.1111/j.1468-1331.2005.01202.x; Chiu L, 2001, J ADV NURS, V33, P380, DOI 10.1046/j.1365-2648.2001.01703.x; Chiu L, 1999, J ADV NURS, V29, P1005, DOI 10.1046/j.1365-2648.1999.00969.x; CLARFIELD AM, 1983, CAN MED ASSOC J, V129, P1181; Garity J, 2006, J GERONTOL NURS, V32, P39, DOI 10.3928/00989134-20060601-07; JACOBS P, 1989, PUBLIC HEALTH REP, V104, P158; Lane Paula, 2003, Res Theory Nurs Pract, V17, P137; Martire LM, 2004, HEALTH PSYCHOL, V23, P599, DOI 10.1037/0278-6133.23.6.599; MCCORKLE R, 1989, CANCER, V64, P1375, DOI 10.1002/1097-0142(19890915)64:6<1375::AID-CNCR2820640634>3.0.CO;2-6; MITCHELL JB, 1978, MED CARE, V16, P439, DOI 10.1097/00005650-197806000-00001; Mukand JA, 2001, AM J PHYS MED REHAB, V80, P346, DOI 10.1097/00002060-200105000-00005; NIELSEN M, 1972, AM J PUBLIC HEALTH N, V62, P1094, DOI 10.2105/AJPH.62.8.1094; Penrod J, 2012, WESTERN J NURS RES, V34, P174, DOI 10.1177/0193945911400920; Pitsenberger D Jeanne, 2006, AAOHN J, V54, P181; Sorrell Jeanne M, 2007, J Psychosoc Nurs Ment Health Serv, V45, P17, DOI 10.3928/02793695-20071101-05; Stajduhar KI, 2003, J PALLIATIVE CARE, V19, P27, DOI 10.1177/082585970301900106; Stevenson J P, 1990, J Neurosci Nurs, V22, P179; Stommel M, 1993, CANCER, V71, P1876; Strahan GW, 1997, ADV VITAL HLTH STAT; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Wolff JL, 2005, J AM GERIATR SOC, V53, P851, DOI 10.1111/j.1532-5415.2005.53262.x; Wolinsky F D, 1988, Annu Rev Gerontol Geriatr, V8, P71; Wu SC, 1995, CHINESE J PUBLIC HLT, V14, P369	23	1	1	1	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	APR	2016	88						370	373		10.1016/j.wneu.2015.12.086			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	DK1CI	WOS:000374649700052	26752090	Green Published			2022-02-06	
J	Kumar, V; Singh, AK; Bhaikhel, KS				Kumar, Vikul; Singh, Atul Kumar; Bhaikhel, Kulwant Singh			Penetrating injury of orbital roof and brain sparing the eye ball in a pediatric patient: A rare occurrence	JOURNAL OF PEDIATRIC NEUROSCIENCES			English	Article						Duroplasty; orbit injury; pediatric trauma; penetrating injury	FRACTURES; MANAGEMENT; AGE; TRAUMA; FLOOR	Blowout fractures are a common occurrence in traumatic brain injury patients. In pediatric age group, orbital floor fracture is a common occurrence. We report a case of 2-year-old male admitted to trauma center, with penetrating injury to the left eye by the clutch of motorbike which fell on the child. Noncontrast computed tomography scan revealed fracture of the roof of left orbit with left frontal contusion sparing the left eyeball. There was also the continuous leak of brain matter from the left eye which suggested tear of dura mater. Urgent left frontal craniotomy was done with the evacuation of contusion, reconstruction of orbital roof, and duroplasty under general anesthesia.	[Kumar, Vikul; Bhaikhel, Kulwant Singh] Banaras Hindu Univ, Inst Med Sci, Dept Neurosurg, Varanasi, Uttar Pradesh, India; [Singh, Atul Kumar] Banaras Hindu Univ, Inst Med Sci, Dept Anaesthesiol, Varanasi, Uttar Pradesh, India		Kumar, V (corresponding author), Flat 406,Ganpati Apartment, Varanasi 221005, Uttar Pradesh, India.	vikul44@rediffmail.com					Bansagi ZC, 2000, OPHTHALMOLOGY, V107, P829, DOI 10.1016/S0161-6420(00)00015-4; Davis DP, 2010, J TRAUMA, V69, P294, DOI 10.1097/TA.0b013e3181dc6c7f; DEMAN K, 1991, INT J ORAL MAX SURG, V20, P330, DOI 10.1016/S0901-5027(05)80260-7; Kim JW, 2012, ARCH PLAST SURG-APS, V39, P31, DOI 10.5999/aps.2012.39.1.31; KOLTAI PJ, 1995, ARCH OTOLARYNGOL, V121, P1375; Liesemer K, 2011, J NEUROTRAUM, V28, P755, DOI 10.1089/neu.2010.1518; MCGRAW BL, 1990, ARCH OTOLARYNGOL, V116, P41; PIOTROWSKI WP, 1995, J CRANIO MAXILL SURG, V23, P6, DOI 10.1016/S1010-5182(05)80247-1; Sires BS, 1998, ARCH OPHTHALMOL-CHIC, V116, P955; Wu CT, 2010, ANESTH ANALG, V110, P903, DOI 10.1213/ANE.0b013e3181cb3f8b	10	1	1	0	0	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	1817-1745	1998-3948		J PEDIATR NEUROSCI	J. Pediatr. Neurosci.	APR-JUN	2016	11	2					134	136		10.4103/1817-1745.187642			3	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	EF1VW	WOS:000390114100012	27606024	Green Published			2022-02-06	
J	Lundberg, GD; Metzner, D				Lundberg, George D.; Metzner, David			How to Rescue American Football	CUREUS			English	Article						football; brain damage; chronic traumatic encephalopathy; concussions; punch-drunk; helmets; safety rules; contact sports; tau protein; prevention		Blows to the head damage the brain. American football is a contact/collision sport that produces many injuries, including to the brain. Football has many supporters who cite important redeeming characteristics of the activity. Public attention to the hazards of children and adults playing football has heightend recently due to many new scientific discoveries, not least of which is the frequency with which players are seriously harmed and do not recover. It is now incumbent on all interested parties to invent and implement far better safety practices, equipment, rules, and processes or the sport must cease to exist in its current form. This paper presents several safety proposals for consideration and study.	[Lundberg, George D.] CollabRx, San Francisco, CA 94104 USA; [Lundberg, George D.] Stanford Univ, Sch Med, Stanford, CA 94305 USA		Lundberg, GD (corresponding author), CollabRx, San Francisco, CA 94104 USA.; Lundberg, GD (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.	gdlundberg@gmail.com					Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; LAMPERT PW, 1984, JAMA-J AM MED ASSOC, V251, P2676, DOI 10.1001/jama.251.20.2676; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358	4	1	1	0	1	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	APR	2016	8	4							e592	10.7759/cureus.592			4	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	VH6EA	WOS:000453611400042	27284499	gold, Green Published			2022-02-06	
J	Parida, S; Varadharajan, R; Bidkar, PU; Mishra, SK; Balachander, H; Badhe, AS; Kundra, P				Parida, Satyen; Varadharajan, Ramesh; Bidkar, Prasanna Udupi; Mishra, Sandeep Kumar; Balachander, Hemavathi; Badhe, Ashok Shankar; Kundra, Pankaj			A survey of a population of anaesthesiologists from South India regarding practices for rapid sequence intubation in patients with head injury	INDIAN JOURNAL OF ANAESTHESIA			English	Article						Anaesthesiologists; cricoid pressure; endotracheal intubation; head injury; rapid sequence intubation	CRICOID PRESSURE; INDUCTION	Background and Aims: Evidence and utility of the individual steps of the rapid sequence induction and tracheal intubation protocols have been debated, especially in the setting of traumatic brain injury. The purpose of this survey was to determine preferences in the current approach to rapid sequence intubation (RSI) in head injury patients among a population of anaesthesiologists from South India. Methods: A questionnaire was E-mailed to all the members of the Indian Society of Anaesthesiologists' South Zone Chapter to ascertain their preferences, experience and comfort level with regard to their use of rapid sequence intubation techniques in adult patients with head injury. Participants were requested to indicate their practices for RSI technique for a head-injured patient upon arrival at the Emergency Medical Services department of their hospital. Results: The total response rate was 56.9% (530/932). Of the total respondents, 35% of the clinicians used cricoid pressure routinely, most respondents (68%) stated that they pre-oxygenate the patients for about 3 min prior to RSI, thiopentone (61%) and propofol (34%) were commonly used prior to intubation. Rocuronium was the muscle relaxant of choice for RSI among the majority (44%), compared to succinylcholine (39%). Statistical analyses were performed after the initial entry onto a spreadsheet. Data were summarised descriptively using frequency distribution. Conclusion: In a rapid sequence intubation situation, the practice differed significantly among anaesthesiologists. Owing to disagreements and paucity of evidence-based data regarding the standards of RSI, it is apparent that RSI practice still has considerable variability in clinical practice.	[Parida, Satyen; Varadharajan, Ramesh; Bidkar, Prasanna Udupi; Mishra, Sandeep Kumar; Balachander, Hemavathi; Badhe, Ashok Shankar; Kundra, Pankaj] JIPMER, Dept Anaesthesiol & Crit Care, Pondicherry, India		Parida, S (corresponding author), Qr D 2 18,JIPMER Campus, Pondicherry 605006, India.	jipmersatyen@gmail.com	Bidkar, Prasanna/AAQ-4198-2021; Parida, Satyen/S-9184-2019	Bidkar, Prasanna/0000-0002-4497-6772; Parida, Satyen/0000-0003-4752-3653			Brown JPR, 2009, ANAESTHESIA, V64, P784, DOI 10.1111/j.1365-2044.2009.05972.x; Gobindram A, 2008, ANAESTHESIA, V63, P1258, DOI 10.1111/j.1365-2044.2008.05717.x; Jung JY, 2015, KOREAN J ANESTHESIOL, V68, P213, DOI 10.4097/kjae.2015.68.3.213; Khan RM, 2011, INDIAN J ANAESTH, V55, P463, DOI 10.4103/0019-5049.89870; Koerber JP, 2009, ANAESTHESIA, V64, P54, DOI 10.1111/j.1365-2044.2008.05681.x; Perry JJ, 2008, COCHRANE DB SYST REV, V2; Rice MJ, 2010, MINERVA ANESTESIOL, V76, P304; Rice MJ, 2009, ANESTH ANALG, V109, P1546, DOI 10.1213/ane.0b013e3181b05404; STEPT WJ, 1970, ANESTH ANAL CURR RES, V49, P633; Sultan P, 2008, BRIT J HOSP MED, V69, P177, DOI 10.12968/hmed.2008.69.3.28763; Wong DT, 2014, CAN J ANESTH, V61, P717, DOI 10.1007/s12630-014-0183-0	11	1	1	0	0	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	0019-5049	0976-2817		INDIAN J ANAESTH	Indian J. Anaesth.	APR	2016	60	4					258	263		10.4103/0019-5049.179463			6	Anesthesiology	Emerging Sources Citation Index (ESCI)	Anesthesiology	DJ0WR	WOS:000373925600006	27141109	Green Published, gold			2022-02-06	
J	Rao, MG; Singh, D; Khandelwal, N; Sharma, SK				Rao, Murali Gundu; Singh, Dalbir; Khandelwal, Niranjan; Sharma, Suresh Kumar			Dating of Early Subdural Haematoma: A Correlative Clinico-Radiological Study	JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH			English	Article						Attenuation coefficient; Computed tomography; Post-traumatic interval; Subdural haemorrhage; Volume	COMPUTED-TOMOGRAPHY; MRI; CT; AUTOPSY; TRIAL; MSCT; AGE	Introduction: Determination of post-traumatic interval remains one of the foremost important goals of any forensic investigation related to human crimes. The estimation of time since injury in cases of subdural haemorrhage has been studied only by a few investigators on the histological and radiological front. Aim: The purpose of this study was to determine the post-traumatic interval of Subdural Haemorrhage (SDH) based on Hounsfield Unit measurements (HU) on Computed Tomography (CT) in surviving victims of head injury. Materials and Methods: The study included a total of 100 cases of closed head injury with subdural haemorrhage. The Post-traumatic Time Interval (PTI) varied from 0.5 hours to a maximum of 249 hours, with a mean of 54.2 hours. Results: Statistically significant results were obtained between the HU measurements of the SDH and the post-traumatic intervals and were found to be statistically significant. A rough attempt was made to determine the effect of haematoma volume on attenuation and was found out to be statistically insignificant. Conclusion: The density of the subdural haematoma decreases with increase in the post-traumatic interval that concurs with the limited number of studies being conducted in the past. We concluded that further sorting of cases could be done according to its age with additional research and uniformity in the methodology.	[Rao, Murali Gundu; Singh, Dalbir] Post Grad Inst Med Educ & Res, Dept Forens Med, Res Block B, Chandigarh 160012, India; [Khandelwal, Niranjan] Post Grad Inst Med Educ & Res, Dept Radiodiag & Imaging, Chandigarh, India; [Sharma, Suresh Kumar] Panjab Univ, Dept Stat, Chandigarh, India		Singh, D (corresponding author), Post Grad Inst Med Educ & Res, Dept Forens Med, Res Block B, Chandigarh 160012, India.	drdalbirsingh@hotmail.com					Anon J, 2008, J MAGN RESON IMAGING, V28, P823, DOI 10.1002/jmri.21495; [Anonymous], 2015, ATT COEFF; [Anonymous], 2015, OVERVIEW HEAD INJURI; [Anonymous], 2015, IMAGING SUBDURAL HAE; BERGSTROM M, 1977, J COMPUT ASSIST TOMO, V1, P449, DOI 10.1097/00004728-197710000-00011; BRANT WE, 2007, FUNDAMENTALS DIAGNOS; Gary LH, 2012, J AM OSTEOPATH COLL, V1, P23; Gebel JM, 1998, STROKE, V29, P1799, DOI 10.1161/01.STR.29.9.1799; Hillewig E, 2007, RESUSCITATION, V72, P149, DOI 10.1016/j.resuscitation.2006.06.023; Horn EM, 2006, SURG NEUROL, V65, P150, DOI 10.1016/j.surneu.2005.05.030; Lee Kyeong-Seok, 1997, Journal of Korean Medical Science, V12, P353; Leestma JE, 2014, FORENSIC NEUROPATHOL; Marion DW, 2006, NEUROSURGERY, V58, P655; MCCULLOUGH EC, 1983, AM J ROENTGENOL, V141, P135, DOI 10.2214/ajr.141.1.135; MORI K, 1991, MRI CENTRAL NERVOUS; MOSTROM U, 1988, J COMPUT ASSIST TOMO, V12, P474, DOI 10.1097/00004728-198805010-00023; Muzii V F, 2005, J Neurosurg Sci, V49, P41; Oehmichen M, 2006, FORENSIC NEUROPATHOL, P123; Postema FAM, 2014, EMERG RADIOL, V21, P349, DOI 10.1007/s10140-014-1196-2; Ruder TD, 2012, FORENSIC SCI INT, V220, P219, DOI 10.1016/j.forsciint.2012.03.004; Santarius T, 2009, LANCET, V374, P1067, DOI 10.1016/S0140-6736(09)61115-6; SCOTTI G, 1977, J NEUROSURG, V47, P311, DOI 10.3171/jns.1977.47.3.0311; Sieswerda-Hoogendoorn T, 2014, EUR J RADIOL, V83, P1257, DOI 10.1016/j.ejrad.2014.03.015; Strandberg Soren, 2010, BMC Med Imaging, V10, P18, DOI 10.1186/1471-2342-10-18; Vezina G, 2009, PEDIATR RADIOL, V39, P586, DOI 10.1007/s00247-009-1212-y; Walter Till, 2009, Leg Med (Tokyo), V11 Suppl 1, pS56, DOI 10.1016/j.legalmed.2009.01.112; Yen K, 2007, FORENSIC SCI INT, V173, P21, DOI 10.1016/j.forsciint.2007.01.027	27	1	1	0	0	PREMCHAND SHANTIDEVI RESEARCH FOUNDATION	DELHI	71 JAIN COLONY, VEER NAGAR, DELHI, 110 007, INDIA	2249-782X	0973-709X		J CLIN DIAGN RES	J. Clin. Diagn. Res.	APR	2016	10	4					HO1	HO5		10.7860/JCDR/2016/17207.7644			5	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	EQ1RZ	WOS:000397848600049	27190831	Green Published, gold			2022-02-06	
J	Rasmus, A; Manko, G; Miotk-Mrozowska, M; Hajdukiewicz, A; Kizewska, A				Rasmus, Anna; Manko, Grzegorz; Miotk-Mrozowska, Magdalena; Hajdukiewicz, Anna; Kizewska, Anna			THE QUALITY OF LIFE OF CHILDREN AFTER MILD AND MODERATE TRAUMATIC BRAIN INJURY	ACTA NEUROPSYCHOLOGICA			English	Article						TBI; mood; support; KIDSCREEN-27		Background: The aim of the study was to evaluate the quality of life of children after mild and moderate traumatic brain injury (TBI) and an analysis of the specific assessment of individual areas of functioning in these children's perception. This subject is important both in terms of the further education of the children but also in terms of their adapting to life after brain injury. Material/Methods: We tested 20 children after traumatic brain injury treated at the Neurotherpeutic Centre in Bydgoszcz in the period of 2014-2015. Nine of these children had experienced mild brain injury and eleven moderate brain injury, and had returned to school education. An analysis of the documentation (interviews and medical records) as well as the Scale for Quality of Life KIDSCREEN-27 was used in the examination of the children. Results: We found that the quality of life of children after mild to moderate traumatic brain injury is significantly reduced in the areas of assessment of physical functioning, general mood and school life. The quality of life of the examined children did not differ from the normative group in the area of family functioning and the assessment of received support and peer relations. Conclusions: The results substantiated the validity of including within research children after mild and moderate traumatic brain injury through the assisting of specialist interactions in three key environments.	[Rasmus, Anna] Kazimierz Wielki Univ, Dept Gen Psychol & Hlth Psychol, Jana Karola Chodkiewicza 30, PL-85064 Bydgoszcz, Poland; [Manko, Grzegorz] Jagiellonian Univ, Inst Physiotherapy, Fac Allied Hlth Sci, Dept Ergon & Exert Physiol,Coll Med, Krakow, Poland; [Miotk-Mrozowska, Magdalena] Kazimierz Wielki Univ, Inst Psychol, Bydgoszcz, Poland; [Hajdukiewicz, Anna] Old Polish Univ, Kielce, Poland; [Kizewska, Anna] Univ Clin Ctr, Gdansk, Poland		Rasmus, A (corresponding author), Kazimierz Wielki Univ, Dept Gen Psychol & Hlth Psychol, Jana Karola Chodkiewicza 30, PL-85064 Bydgoszcz, Poland.	ania.rasmus@gmail.com		Rasmus, Anna/0000-0001-5125-3081; Miotk-Mrozowska, Magdalena/0000-0002-4093-7290			Brzezinska A., 2005, PSYCHOL PORTRETY CZL; Brzezinska A, 2015, PSYCHOL ROZWOJU CZLO; Bulinski L., 2009, FIZJOTERAPIA POLSKA, V4, P340; Camfield L., 2004, CHALLENGES QUALITY L, V24, P45; Dabrowska A., 2010, STRES RODZICOW DZIEC; Dabrowska A, 2007, PSYCHIATR POL, V41, P189; DIETRICH AM, 1993, ANN EMERG MED, V22, P1535, DOI 10.1016/S0196-0644(05)81254-5; Gawlowicz K, 2012, HYGEIA PUBLIC HLTH, V47, P145; Gawlowicz K., 2010, THESIS; Kaja B.M., 2010, PSYCHOL WSPOMAGANIA; Kowalik S., 2007, JAKOSC ZYCIA ZWIAZAN, P147; Kubicz A., 2008, PRZEGLAD MEDYCZNY UN, V2, P170; Kwissa Z., 2006, PSYCHOL JAKOSCI ZYCI, V5, P119; Master CL, 2012, PEDIATR ANN, V41, pE174, DOI 10.3928/00904481-20120827-08; Michalska A., 2012, NEUROLOGIA DZIECIECA, V21, P39; Michalska A., RAPORT BADAN DOTYCZA; Michalska A., 2012, NEUROLOGIA DZIECIECA, V21, P35; Oles P., 2002, JAK SWIATA MNIEJ WID, P37; Oles P., 2005, PSYCHOL JAKOSCI ZYCI, P219; Pachalska M., 2008, REHABILITACJA NEUROP; Pachalska M., 2007, NEUROPSYCHOLOGIA KLI, V2; Pachalska M, 2015, ACTA NEUROPSYCHOL, V13, P105, DOI 10.5604/17307503.1162511; Paszkiewicz-Mes E., 2015, PIELEGNIARSTWO 21 WI, V50, P50; Prigatano GP, 2009, REHABILITACJA NEUROP; Przybyszewski B, 2008, PEDIAT POL, V83, P54, DOI [10.1016/S0031-3939(08)70290-7, DOI 10.1016/S0031-3939(08)70290-7]; Topor E., 2010, NEUROLOGIA DZIECIECA, V19, P61; Twardowski A., 2003, SZKOLA SPOLECZNOSCI, P192; Twardowski A, 2014, WCZESNE WSPOMAGANIE	28	1	1	0	3	MEDSPORTPRESS PUBLISHING HOUSE	WARSAW	UL MARYMONCKA 34 SKR 23, WARSAW, 01813, POLAND	1730-7503	2084-4298		ACTA NEUROPSYCHOL	Acta Neuropsychol.	APR-JUN	2016	14	2					141	154		10.5604/17307503.1213002			14	Psychology	Emerging Sources Citation Index (ESCI)	Psychology	EA4EQ	WOS:000386562900004					2022-02-06	
J	Ruedl, G; Pocecco, E; Raas, C; Blauth, M; Brucker, PU; Burtscher, M; Kopp, M				Ruedl, Gerhard; Pocecco, Elena; Raas, Christoph; Blauth, Michael; Brucker, Peter U.; Burtscher, Martin; Kopp, Martin			Influence of adult role modeling on child/adolescent helmet use in recreational sledging: an observational study	WIENER KLINISCHE WOCHENSCHRIFT			English	Article						Sledging; Sledding; Tobogganing; Injury prevention; Ski helmet; Role modeling	AUSTRIAN SKI SLOPES; SLEDDING-RELATED INJURIES; TRAUMATIC-BRAIN-INJURY; TOBOGGANING INJURIES; SNOW SPORTS; CHILDREN; ATTITUDES; EDUCATION	Background During recreational sledging (tobogganing), the head represents the most frequent injured body region with approximately one-third of all sledging injuries among children and adolescents. Whether children are wearing a helmet or not might be influenced on parental encouragement and role modeling of helmet use. Therefore, the aim of this study was to evaluate the impact of adult helmet use on child/adolescent helmet use in recreational sledging. Methods More than 500 adults sitting together with another adult or child/adolescent on a two-seater sledge were interviewed during two winter seasons at the bottom of six sledging tracks on demographics, mean frequency of sledging per season, self-estimated skill level, risk-taking behavior, and the use of a helmet. Results Total helmet use of all observed persons was 41.0 %. Helmet use among interviewed adults significantly increased with increasing age up to 45 years, frequency of sledging, and skill level, respectively. Helmet use of interviewed adults was 46.5 % if a child/adolescent was sitting on the same sledge and 29.8 % (odds ratios (OR): 2.1, 95 % confidence intervals (CI): 1.4-2.9, p < 0.001) when sledging together with another adult. Helmet use was 71.3 % among children/adolescents and 26.7 % among adults (OR: 6.8, 95 % CI: 4.6-10.1, p < 0.001) sitting on the same sledge as the interviewed person, respectively. Conclusion Adults were wearing more often a helmet during recreational sledging when sitting together with a child/adolescent on the sledge. However, helmet use during sledging is clearly below 50 %. Thus, more intense educational campaigns on helmet use are urgently needed for tobogganists.	[Ruedl, Gerhard; Pocecco, Elena; Burtscher, Martin; Kopp, Martin] Univ Innsbruck, Dept Sport Sci, Furstenweg 185, A-6020 Innsbruck, Austria; [Raas, Christoph; Blauth, Michael] Med Univ Innsbruck, Dept Trauma Surg & Sports Med, A-6020 Innsbruck, Austria; [Brucker, Peter U.] Tech Univ Munich, Klinikum Rechts Isar, Dept Orthopaed Sports Med, D-80290 Munich, Germany		Ruedl, G (corresponding author), Univ Innsbruck, Dept Sport Sci, Furstenweg 185, A-6020 Innsbruck, Austria.	gerhard.ruedl@uibk.ac.at	Kopp, Martin/K-1369-2017; Burtscher, Martin/M-7015-2019	Kopp, Martin/0000-0002-3011-387X; Burtscher, Martin/0000-0002-5232-3632			Bfu-Erhebung BFU, 2013, TRAG SCHUTZ BEIM ROD; Bianchi G, 2012, SICHERHEITSANALYSE S; Burtscher M, 2013, PAED CHILD HEALT-CAN, V18, P471, DOI 10.1093/pch/18.9.471; Cimpello LB, 2009, J TRAUMA, V66, pS23, DOI 10.1097/TA.0b013e318160f856; Corra Stefano, 2007, J Trauma Manag Outcomes, V1, P5, DOI 10.1186/1752-2897-1-5; Cundy TP, 2010, J TRAUMA, V69, P1486, DOI 10.1097/TA.0b013e3181fee31c; Heim D, 2014, INJURY, V45, P338, DOI 10.1016/j.injury.2012.08.027; Herman R, 2015, PEDIATR SURG INT, V31, P237, DOI 10.1007/s00383-014-3639-y; Howell CA, 2010, PEDIATRICS, V126, P517, DOI 10.1542/peds.2009-1499; Juang D, 2010, J TRAUMA, V69, pS206, DOI 10.1097/TA.0b013e3181f1e81f; Jung CS, 2011, ACTA NEUROCHIR, V153, P101, DOI 10.1007/s00701-010-0704-8; KIM PCW, 1995, J PEDIATR SURG, V30, P1135, DOI 10.1016/0022-3468(95)90005-5; Lerner RM, 1998, ANNU REV PSYCHOL, V49, P413, DOI 10.1146/annurev.psych.49.1.413; Mauritz W, 2014, WIEN KLIN WOCHENSCHR, V126, P42, DOI 10.1007/s00508-013-0456-6; Ortega HW, 2005, PEDIATR EMERG CARE, V21, P839, DOI 10.1097/01.pec.0000190233.27857.6a; Philippe M, 2014, SPORTVERLETZ SPORTSC, V28, P188, DOI 10.1055/s-0034-1366874; Pornbacher H, 2012, ASTAT INFO, V64, P1; Provance AJ, 2012, CLIN J SPORT MED, V22, P240, DOI 10.1097/JSM.0b013e3182410335; Robertson DW, 2014, ACCIDENT ANAL PREV, V70, P314, DOI 10.1016/j.aap.2014.04.011; Ruedl G, 2014, SPORTVERLETZ SPORTSC, V28, P183, DOI 10.1055/s-0034-1385244; Ruedl G, 2010, SPORTVERLETZ SPORTSC, V24, P27, DOI 10.1055/s-0028-1110011; Ruedl G, 2013, WILD ENVIRON MED, V24, P118, DOI 10.1016/j.wem.2012.11.021; Ruedl G, 2012, BRIT J SPORT MED, V46, P1091, DOI 10.1136/bjsports-2012-091374; Ruedl G, 2011, J TRAUMA, V71, P1085, DOI 10.1097/TA.0b013e31821e7e91; Rughani AI, 2011, J NEUROSURG-PEDIATR, V7, P268, DOI 10.3171/2010.12.PEDS10415; Russell K, 2010, CAN MED ASSOC J, V182, P333, DOI 10.1503/cmaj.091080; Selig HF, 2011, WIEN KLIN WOCHENSCHR, V123, P552, DOI 10.1007/s00508-011-0006-z; Shorter NA, 1999, AM J EMERG MED, V17, P32, DOI 10.1016/S0735-6757(99)90010-4; Skarbek-Borowska S, 2006, ACAD EMERG MED, V13, P181, DOI 10.1111/j.1553-2712.2006.tb01669.x	29	1	1	0	5	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0043-5325	1613-7671		WIEN KLIN WOCHENSCHR	Wien. Klin. Wochen.	APR	2016	128	7-8					266	270		10.1007/s00508-015-0862-z			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM8JG	WOS:000376607700007	26438101				2022-02-06	
J	Verma, PK; Sinha, VD; Srivastava, T				Verma, Pawan Kumar; Sinha, V. D.; Srivastava, Trilochan			An Unusual Posttraumatic Pseudoaneurysm of Intracranial Segment (V4) of the Vertebral Artery	INDIAN JOURNAL OF NEUROTRAUMA			English	Article						pseudoaneurysms; vertebral artery; intracranial; extracranial; endovascular	MANAGEMENT; INJURY	Traumatic pseudoaneurysm of the vertebral artery is an uncommon and one of the most difficult lesions to treat. Posttraumatic vertebral artery pseudoaneurysm is located mostly extracranially, and its intracranial occurrence is exceedingly rare. We report a case of an 18-year-old man who underwent successful treatment of posttraumatic intracranial pseudoaneurysm of V4 segment of the vertebral artery by endovascular embolization. The patient who sustained trauma in a road accident presented with the complaints of headache, giddiness, and vomiting for the last 13 days. On admission, he was conscious but drowsy with no focal neurologic deficit. CT scan of the brain was suggestive of no significant intracranial abnormality. As the patient had headache, vomiting, and drowsiness, the CT was unable to explain his clinical picture, so CT angiography was performed to exclude vascular abnormality. CT angiography of the brain was suggestive of left vertebral artery aneurysm arising from V4 segment of the left vertebral artery. DSA showed a large pseudoaneurysm arising from left V4 segment of the vertebral artery near origin of PICA. Because of its difficult location, surgical treatment is less preferable as compared with endovascular treatment. The patient underwent endovascular coiling of pseudoaneurysm. Postcoiling DSA showed complete occlusion of pseudoaneurysm. The patient had uneventful postoperative period and showed good recovery.	[Verma, Pawan Kumar; Sinha, V. D.] SMS Med Coll & Hosp, Dept Neurosurg, JLN Marg,Gangawal Pk, Jaipur 302004, Rajasthan, India; [Srivastava, Trilochan] SMS Med Coll & Hosp, Dept Neurol, Jaipur, Rajasthan, India		Verma, PK (corresponding author), SMS Med Coll & Hosp, Dept Neurosurg, JLN Marg,Gangawal Pk, Jaipur 302004, Rajasthan, India.	dr.pawankverma@gmail.com					Anxionnat R, 2003, NEUROSURGERY, V53, P289, DOI 10.1227/01.NEU.0000073417.01297.93; JEFFERY P, 1995, EUR J VASC ENDOVASC, V10, P391, DOI 10.1016/S1078-5884(05)80158-3; KATIRJI MB, 1985, ARCH NEUROL-CHICAGO, V42, P242, DOI 10.1001/archneur.1985.04060030060010; Lee JW, 2007, YONSEI MED J, V48, P425, DOI 10.3349/ymj.2007.48.3.425; MacKay CI, 2003, NEUROSURGERY, V53, P754, DOI 10.1227/01.NEU.0000080065.49651.48; Matas R, 1893, Ann Surg, V18, P477; Molnar RG, 1998, SURG CLIN N AM, V78, P901, DOI 10.1016/S0039-6109(05)70357-1; REID JDS, 1988, J TRAUMA, V28, P1007, DOI 10.1097/00005373-198807000-00016; Shimizu J, 1992, Rinsho Shinkeigaku, V32, P430	9	1	1	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0973-0508	2213-3739		INDIAN J NEUROTRAUM	Indian J. Neurotrauma	APR	2016	13	1					55	58		10.1055/s-0036-1583261			4	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	DX9BG	WOS:000384687400012					2022-02-06	
J	Wilfong, L; Edwards, NE; Yehle, KS; Ross, K				Wilfong, Leah; Edwards, Nancy E.; Yehle, Karen S.; Ross, Karla			Frontotemporal Dementia: Identification and Management	JNP-JOURNAL FOR NURSE PRACTITIONERS			English	Article						advanced practice nurse; dementia diagnosis; frontotemporal dementia; management	LOBAR DEGENERATION; DISEASE; EPIDEMIOLOGY; DIAGNOSIS	Dementia is a disease primarily affecting older adults in their ability to carry out daily activities. Frontotemporal dementia (FTD), a leading cause of early-onset dementia, can present in the fourth and fifth decade by progressive changes in personality, affect, and behavior. The atypical presentation of FTD may resemble a midlife crisis, depression, schizophrenia, or a traumatic brain injury among its causes. The etiology of FTD is unknown, although genetic links have been suggested, thus treatment focuses on behavioral and symptom management. Early diagnosis of FTD is needed to better support the emotional and financial burdens of family and caregivers.	[Wilfong, Leah; Edwards, Nancy E.; Yehle, Karen S.; Ross, Karla] Purdue Univ, Sch Nursing, W Lafayette, IN 47907 USA		Edwards, NE (corresponding author), Purdue Univ, Sch Nursing, W Lafayette, IN 47907 USA.	edwardsn@purdue.edu		Edwards, Nancy/0000-0002-3477-8094			Ahlskog JE, 2011, MAYO CLIN PROC, V86, P876, DOI 10.4065/mcp.2011.0252; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Association for Frontotemporal Degeneration, 2011, FAST FACTS FRONT DEG; Bird T, 2003, ANN NEUROL, V54, pS29, DOI 10.1002/ana.10572; Borson S, 2000, INT J GERIATR PSYCH, V15, P1021, DOI 10.1002/1099-1166(200011)15:11<1021::AID-GPS234>3.0.CO;2-6; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Goldman JS, 2005, NEUROLOGY, V65, P1817, DOI 10.1212/01.wnl.0000187068.92184.63; Gorno-Tempini ML, 2011, NEUROLOGY, V76, P1006, DOI 10.1212/WNL.0b013e31821103e6; Knopman DS, 2011, J MOL NEUROSCI, V45, P330, DOI 10.1007/s12031-011-9538-y; Mathias JL, 2010, J CLIN EXP NEUROPSYC, V32, P682, DOI 10.1080/13803390903427414; Merrilees J, 2010, CLIN NURSE SPEC, V24, P245, DOI 10.1097/NUR.0b013e3181ecdc32; Mesulam MM, 2001, ANN NEUROL, V49, P425, DOI 10.1002/ana.91; Nardell M, 2014, AM J ALZHEIMERS DIS, V29, P123, DOI 10.1177/1533317513507375; Onyike CU, 2013, INT REV PSYCHIATR, V25, P130, DOI 10.3109/09540261.2013.776523; Portugal MD, 2011, REV BRAS PSIQUIATR, V33, P81, DOI 10.1590/S1516-44462011000100016; Rademakers R, 2012, NAT REV NEUROL, V8, P423, DOI 10.1038/nrneurol.2012.117; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Seltman RE, 2012, CNS DRUGS, V26, P841, DOI 10.2165/11640070-000000000-00000; Snowden JS, 2011, BRAIN, V134, P2478, DOI 10.1093/brain/awr189	19	1	1	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1555-4155	1878-058X		JNP-J NURSE PRACT	JNP-J. Nurse Pract.	APR	2016	12	4					277	282		10.1016/j.nurpra.2015.08.006			6	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	DH5PI	WOS:000372843200023		Bronze			2022-02-06	
J	Yuan, XS; Bian, XX; Wei, WF; Tang, Y; Bao, Q				Yuan, Xuesong; Bian, Xiaoxing; Wei, Wenfeng; Tang, Yin; Bao, Qing			Effect of recombinant human erythropoietin expressions of apoptosis genes in rats following traumatic brain injury	TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH			English	Article						Recombinant human erythropoietin; NF-kappa B; Traumatic brain injury; Apoptosis; Neuronal damage; Fas/Fasl expression	MODEL; INFLAMMATION; RESPONSES	Purpose: To explore the effect of recombinant human erythropoietin (r-HuEPO) on apoptosis in rats after traumatic brain injury. Methods: A total of 48 traumatic brain-injured Sprague Dawley (SD) rats were obtained by improved Feeney's traumatic brain injury model, and were randomly divided into four groups: normal saline-treated rats (control) and rats treated with r-HuEPO at doses of 1000 U/kg, 3000 U/kg and 5000 U/kg. Brain tissues were collected on the 7th day after trauma surgery. Apoptotic cells, and NF-kappa B (NF-kappa B)-, c-myc-, and Fas/Fasl-positive cells were identified in brain tissues by immunohistochemical assay. Results: After treatment with r-HuEPO (3000 and 5000 U/kg), expression of NF-kappa B and Fas/Fasl were significantly decreased (p < 0.05) compared to control rats, especially at the 5000 U/kg dose (p < 0.01). However, for c-myc, no significant difference was observed between r-HuEPO treatment and control groups (p > 0.05). Compared to the 1000 U/kg r-HuEPO group, Fas/Fasl expression levels were significantly lower in the 3000 and 5000 U/kg r-HuEPO groups (p < 0.05). Additionally, expression of NF-kappa B and Fasl in the 5000 U/kg r-HuEPO group was significantly lower than that in the 3000 U/kg r-HuEPO group (p < 0.05). Moreover, the number of apoptotic cells in the r-HuEPO group (5000 U/kg) was significantly lower than in the control group (p < 0.05). Conclusion: Thus, r-HuEPO may be beneficial for treating traumatic brain injury via inhibition of NF-kappa B and Fas/Fasl expressions.	[Yuan, Xuesong; Bian, Xiaoxing; Wei, Wenfeng; Bao, Qing] Jiangsu Univ, Affiliated Wujin Hosp, Dept Neurosurg, Changzhou 213002, Jiangsu, Peoples R China; [Tang, Yin] Jiangsu Univ, Affiliated Wujin Hosp, Dept Pathol, Changzhou 213002, Jiangsu, Peoples R China		Yuan, XS (corresponding author), Jiangsu Univ, Affiliated Wujin Hosp, Dept Neurosurg, Changzhou 213002, Jiangsu, Peoples R China.	yuan_cedar@sina.com					Angeloni C, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/370312; Bolkvadze T, 2015, EPILEPSY BEHAV, V51, P19, DOI 10.1016/j.yebeh.2015.06.037; Chatagner A, 2010, ARCH PEDIATRIE, V17, pS78, DOI 10.1016/S0929-693X(10)70905-2; Chen G, 2007, NEUROSCI LETT, V425, P177, DOI 10.1016/j.neulet.2007.08.022; Cho YK, 2012, BIOCHEM BIOPH RES CO, V417, P753, DOI 10.1016/j.bbrc.2011.12.029; Erbayraktar S, 2003, P NATL ACAD SCI USA, V100, P6741, DOI 10.1073/pnas.1031753100; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Gaither JB, 2015, J EMERG MED, V49, P375, DOI 10.1016/j.jemermed.2015.01.038; Gao WW, 2015, BRAIN RES, V1622, P230, DOI 10.1016/j.brainres.2015.04.035; Hu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050764; Keller M, 2006, NEUROBIOL DIS, V24, P357, DOI 10.1016/j.nbd.2006.07.007; Li YG, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0283-y; Lu Y, 2012, NEUROCHEM INT, V61, P649, DOI 10.1016/j.neuint.2012.07.005; Niu FN, 2012, BRAIN BEHAV IMMUN, V26, P61, DOI 10.1016/j.bbi.2011.07.235; Ponce Lucido L, 2013, Pathophysiology, V20, P31, DOI 10.1016/j.pathophys.2012.02.005; Xu F, 2012, EXP THER MED, V4, P977, DOI 10.3892/etm.2012.723; Yu WR, 2011, BRAIN, V134, P1277, DOI 10.1093/brain/awr054	17	1	1	0	3	PHARMACOTHERAPY GROUP	BENIN CITY	UNIV BENIN, FACULTY PHARMACY, BENIN CITY, 00000, NIGERIA	1596-5996			TROP J PHARM RES	Trop. J. Pharm. Res.	APR	2016	15	4					695	699		10.4314/tjpr.v15i4.4			5	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	DN0LP	WOS:000376755700004		gold, Green Submitted, Green Published			2022-02-06	
J	Diduch, BK; Hudson, K; Resch, JE; Shen, F; Broshek, DK; Brady, W; Cole, SL; Courson, R; Castens, T; Shimer, A; Miller, MD				Diduch, B. Kent; Hudson, Korin; Resch, Jacob E.; Shen, Francis; Broshek, Donna K.; Brady, William; Cole, Steven L.; Courson, Ron; Castens, Titus; Shimer, Adam; Miller, Mark D.			TREATMENT OF HEAD AND NECK INJURIES IN THE HELMETED ATHLETE	JBJS REVIEWS			English	Article							ASSOCIATION POSITION STATEMENT; KING-DEVICK TEST; SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; CERVICAL-SPINE MOTION; HIGH-SCHOOL; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; FOOTBALL PLAYERS; EMERGENCY PREPAREDNESS	Sport-related concussion treatment includes three major phases: initial evaluation at the time of the injury, treatment while the patient is symptomatic, and evaluation of the readiness for a gradual return to participation. Each concussion evaluation should include similar elements: assessment of symptoms, assessment of cognitive ability, assessment of coordination (of the eyes, upper extremities, and lower extremities), and assessment for additional injuries. The spine-boarding recommendations from the American College of Emergency Physicians, National Association of EMS Physicians, and National Athletic Trainers' Association have changed. These recommendations include both decreased use of spinal immobilization and removal of the helmet and shoulder pads prior to securing the athlete to the board when sufficient numbers of trained providers are present. Preseason training and pregame meetings or "medical time outs" should become standard practice for the sidelines medical team (including the athletic trainer, team physician, emergency response personnel, and possibly others).	[Diduch, B. Kent] James Madison Univ, Dept Hlth Sci, Harrisonburg, VA 22807 USA; [Hudson, Korin] MedStar Georgetown Univ Hosp, Dept Emergency Med, Washington, DC USA; [Hudson, Korin] Washington Hosp Ctr, Washington, DC 20010 USA; [Resch, Jacob E.] Univ Virginia, Sch Med, Dept Kinesiol, Charlottesville, VA 22908 USA; [Shen, Francis] Univ Virginia, Sch Med, Spine Div, Spine Ctr,Dept Orthopaed Surg, Charlottesville, VA 22908 USA; [Broshek, Donna K.] Univ Virginia, Sch Med, Dept Psychiat & Neurobehav Sci, Charlottesville, VA 22908 USA; [Brady, William] Univ Virginia, Sch Med, Dept Emergency Med, Charlottesville, VA 22908 USA; [Shimer, Adam] Univ Virginia, Dept Orthopaed Surg, Orthoped Inpatient Unit, Charlottesville, VA USA; [Miller, Mark D.] Univ Virginia, Div Sports Med, Charlottesville, VA USA; [Cole, Steven L.] Coll William & Mary, Williamsburg, VA USA; [Courson, Ron] Univ Georgia, Athens, GA 30602 USA; [Castens, Titus] Albemarle Cty Fire Rescue, Charlottesville, VA USA		Diduch, BK (corresponding author), James Madison Univ, Dept Hlth Sci, Harrisonburg, VA 22807 USA.	diduchbk@jmu.edu	Broshek, Donna/ABA-4208-2021	Broshek, Donna/0000-0002-7175-7815			American College of Emergency Physicians, 2015, EMS MAN PAT POT SPIN; Andersen JC, 2002, J ATHL TRAINING, V37, P99; Assenmacher B, 2013, OPER TECHN SPORT MED, V21, P152, DOI 10.1053/j.otsm.2013.10.008; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Banerjee R, 2004, AM J SPORT MED, V32, P1077, DOI 10.1177/0363546504265605; Bledsoe EB, 2009, INTERMEDIATE EMERGEN; Boden BP, 2013, AM J SPORT MED, V41, P1108, DOI 10.1177/0363546513478572; Boutis K, 2015, J PEDIAT, V166; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Campbell J, 2012, INT TRAUM LIF SUPP E; Cantu RC, 2013, CURR SPORT MED REP, V12, P14, DOI 10.1249/JSR.0b013e31827dc1fb; Chloe MC, 2015, SEMIN NEUROL, V35, P2; Cournoyer J, 2014, J ATHL TRAINING, V49, P654, DOI 10.4085/1062-6050-49.3.34; Courson R, 2014, J ATHL TRAINING, V49, P128, DOI 10.4085/1062-6050-49.1.06; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Dahl MC, 2009, J APPL BIOMECH, V25, P119, DOI 10.1123/jab.25.2.119; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Daniels JM, 2005, PHYSICIAN SPORTSMED, V33, P9, DOI 10.3810/psm.2005.12.269; Davis GA, 2009, BRIT J SPORT MED, V43, pI36, DOI 10.1136/bjsm.2009.058123; Del Rossi G, 2011, RESUSCITATION, V82, P908, DOI 10.1016/j.resuscitation.2011.02.022; Drezner JA, 2007, J ATHL TRAINING, V42, P143; Duenas M, 2014, SURG NEUROL INT, V5, P91, DOI DOI 10.4103/2152-7806.134364; Eckner JT, 2010, CURR SPORT MED REP, V9, P8, DOI 10.1249/JSR.0b013e3181caa778; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Fitch R Warne, 2011, J Surg Orthop Adv, V20, P83; Fung M, 2006, BRAIN INJURY, V20, P889, DOI 10.1080/02699050600831934; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Gammons M, 2014, CURR REV MUSCULOSKE, V7, P342, DOI 10.1007/s12178-014-9245-8; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Guskiewicz K. M., 2011, CLIN SPORTS MED, V30, pix; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Jacobson B, 2014, J ATHL TRAINING, V49, P42, DOI 10.4085/1062-6050-48.6.11; Jones K, 2010, J FAM PRACTICE, V59, P159; Kanwar R, 2015, EMERG MED CLIN N AM, V33, P241, DOI 10.1016/j.emc.2014.12.002; King D, 2015, J NEUROL SCI, V357, P75, DOI 10.1016/j.jns.2015.06.069; Kleiner DM, 2003, CLIN J SPORT MED, V13, P59, DOI 10.1097/00042752-200301000-00014; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Leong Danielle F, 2015, J Optom, V8, P131, DOI 10.1016/j.optom.2014.12.005; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lyttle MD, 2012, EMERG MED J, V29, P785, DOI 10.1136/emermed-2011-200225; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Marinides Z, 2014, NEUROCLIN PRACT; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2001, CLIN J SPORT MED, V11, P176, DOI 10.1097/00042752-200107000-00008; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; McLeod TCV, 2015, BRAIN INJURY, V29, P175, DOI 10.3109/02699052.2014.965206; McLeod TCV, 2012, J ATHL TRAINING, V47, P221; Meehan WP, 2015, PEDIATRICS, V135, P362, DOI 10.1542/peds.2014-3665; Michaleff ZA, 2012, CAN MED ASSOC J, V184, pE867, DOI 10.1503/cmaj.120675; Natl Assoc EMS Phys Amer Coll Surg, 2013, PREHOSP EMERG CARE, V17, P392, DOI 10.3109/10903127.2013.773115; Naunheim RS, 2008, J HEAD TRAUMA REHAB, V23, P116, DOI 10.1097/01.HTR.0000314530.30401.70; Olympia RP, 2013, PHYSICIAN SPORTSMED, V41, P15, DOI 10.3810/psm.2013.05.2008; Papa L, 2012, ACAD EMERG MED, V19, P2, DOI 10.1111/j.1553-2712.2011.01247.x; Peery CA, 2007, PREHOSP EMERG CARE, V11, P293, DOI 10.1080/10903120701348172; Piland SG, 2006, MED SCI SPORT EXER, V38, P27, DOI 10.1249/01.mss.0000183186.98212.d5; Piland SG, 2003, J ATHL TRAINING, V38, P104; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Potter B., 2006, ATHLETIC THERAPY TOD, V11, P46; Potter BW, 2009, ATHLET THER TODAY, V14, P29, DOI 10.1123/att.14.6.29; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Resch JE, 2015, J CHILD NEUROL, V30, P1686, DOI 10.1177/0883073815574335; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Seidman DH, 2015, J NEUROL SCI, V356, P97, DOI 10.1016/j.jns.2015.06.021; Shrier I, 2015, PREHOSP EMERG CARE, V19, P116, DOI 10.3109/10903127.2014.936634; Silverberg ND, 2014, BRAIN INJURY, V28, P1590, DOI 10.3109/02699052.2014.943287; Swartz EE, 2009, J ATHL TRAINING, V44, P306, DOI 10.4085/1062-6050-44.3.306; Thomas M, 2011, PEDIATRICS, V128, pE1, DOI 10.1542/peds.2010-2743; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Waninger KN, 2014, CLIN J SPORT MED, V24, P280, DOI 10.1097/JSM.0000000000000022; Wilkins SA, 2014, J NEUROSURG-PEDIATR, V13, P82, DOI 10.3171/2013.10.PEDS13241; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8; Yuh Esther L, 2014, Neurosurgery, V75 Suppl 4, pS50, DOI 10.1227/NEU.0000000000000491; Zuckerbraun NS, 2014, PEDIATRICS, V133, P635, DOI 10.1542/peds.2013-2600	86	1	1	0	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2329-9185			JBJS REV	JBJS Rev.	MAR 29	2016	4	3							e2	10.2106/JBJS.RVW.15.00077			12	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	DU8FV	WOS:000382449600002	27500432				2022-02-06	
J	Sha, SJ; Khazenzon, AM; Ghosh, PM; Rankin, KP; Pribadi, M; Coppola, G; Geschwind, DH; Rabinovici, GD; Miller, BL; Lee, SE				Sha, Sharon J.; Khazenzon, Anna M.; Ghosh, Pia M.; Rankin, Katherine P.; Pribadi, Mochtar; Coppola, Giovanni; Geschwind, Daniel H.; Rabinovici, Gil D.; Miller, Bruce L.; Lee, Suzee E.			Early-onset Alzheimer's disease versus frontotemporal dementia: resolution with genetic diagnoses?	NEUROCASE			English	Article						Frontotemporal dementia; Alzheimer's disease	HEXANUCLEOTIDE REPEAT EXPANSION; AMYOTROPHIC-LATERAL-SCLEROSIS; TRAUMATIC BRAIN-INJURY; BEHAVIORAL VARIANT; C9ORF72 MUTATIONS; TEMPORAL-LOBE; HEAD TRAUMA; ATROPHY; TAU; DEGENERATION	We report a diagnostically challenging case of a 64-year-old man with a history of remote head trauma who developed mild behavioral changes and dyscalculia. He was diagnosed with clinical Alzheimer's disease (AD), with additional features consistent with behavioral variant frontotemporal dementia. Structural magnetic resonance imaging revealed atrophy in bilateral frontal and parietal cortices and hippocampi on visual inspection and left frontal pole and bilateral anterior temporal encephalomalacia, suspected to be due to head trauma. Consistent with the diagnosis of Alzheimer's pathology, positron emission tomography (PET) with Pittsburgh compound B suggested the presence of beta-amyloid. Fluorodeoxyglucose PET demonstrated hypometabolism in bilateral frontal and temporoparietal cortices. Voxel-based morphometry showed atrophy predominant in ventral frontal regions (bilateral orbitofrontal cortex, pregenual anterior cingulate/medial superior frontal gyrus), bilateral mid cingulate, bilateral lateral temporal cortex, and posterior insula. Bilateral caudate, thalamus, hippocampi, and cerebellum were prominently atrophied. Unexpectedly, a pathologic hexanucleotide repeat expansion in C9ORF72 was identified in this patient. This report underscores the clinical variability in C9ORF72 expansion carriers and the need to consider mixed pathologies, particularly when imaging studies are inconsistent with a single syndrome or pathology.	[Sha, Sharon J.] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Khazenzon, Anna M.; Ghosh, Pia M.; Rankin, Katherine P.; Rabinovici, Gil D.; Miller, Bruce L.; Lee, Suzee E.] Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA USA; [Ghosh, Pia M.; Rabinovici, Gil D.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Pribadi, Mochtar; Coppola, Giovanni; Geschwind, Daniel H.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Dept Psychiat, Los Angeles, CA 90024 USA; [Pribadi, Mochtar; Coppola, Giovanni; Geschwind, Daniel H.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Dept Neurol, Los Angeles, CA 90024 USA; [Rabinovici, Gil D.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Dept Radiol, Berkeley, CA 94720 USA		Lee, SE (corresponding author), Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA USA.	suzeelee@memory.ucsf.edu	Rabinovici, Gil/AAA-2495-2020; Lee, Suzee/AAG-2393-2019		National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01 AG029577, P50 AG023501, P01 AG019724, K23 AG039414]; John Douglas French Alzheimer's Foundation; Tau Consortium; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [RF1AG029577, R01AG029577, P01AG019724, K23AG039414, T32AG023481, P50AG023501] Funding Source: NIH RePORTER	Dr. Rankin is supported by the National Institute on Aging under Grant R01 AG029577. Dr. Coppola is supported by the John Douglas French Alzheimer's Foundation and the Tau Consortium. Dr. Miller is supported by the National Institute on Aging under Grant P50 AG023501; under grant P01 AG019724. Dr. Geschwind is also supported by P01 AG019724, Miller, PI and the Tau Consortium. Dr. Lee is supported by the National Institute on Aging under grant K23 AG039414.	Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Boccardi M, 2005, NEUROBIOL AGING, V26, P37, DOI 10.1016/j.neurobiolaging.2004.02.019; Boeve BF, 2012, BRAIN, V135, P765, DOI 10.1093/brain/aws004; Broe M, 2003, NEUROLOGY, V60, P1005, DOI 10.1212/01.WNL.0000052685.09194.39; Cato MA, 2004, J INT NEUROPSYCH SOC, V10, P453, DOI 10.1017/S1355617704103123; Coleman RE, 2007, PET CLIN, V2, P25, DOI 10.1016/j.cpet.2007.09.003; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Harms M, 2013, JAMA NEUROL, V70, P736, DOI 10.1001/2013.jamaneurol.537; Hong YT, 2014, JAMA NEUROL, V71, P23, DOI 10.1001/jamaneurol.2013.4847; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Irwin DJ, 2013, J NEUROL NEUROSUR PS, V84, P163, DOI 10.1136/jnnp-2012-303507; JOBST KA, 1992, J NEUROL NEUROSUR PS, V55, P190, DOI 10.1136/jnnp.55.3.190; Laforce R, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt93; Lee SE, 2014, BRAIN, V137, P3047, DOI 10.1093/brain/awu248; Lippert-Gruner M, 2006, BRAIN INJURY, V20, P569, DOI 10.1080/02699050600664467; Mahoney CJ, 2012, BRAIN, V135, P736, DOI 10.1093/brain/awr361; Majounie E, 2012, NEW ENGL J MED, V366, P283, DOI 10.1056/NEJMc1113592; Mielke MM, 2014, NEUROLOGY, V82, P70, DOI 10.1212/01.wnl.0000438229.56094.54; Minoshima S, 1997, ANN NEUROL, V42, P85, DOI 10.1002/ana.410420114; Murray ME, 2011, ACTA NEUROPATHOL, V122, P673, DOI 10.1007/s00401-011-0907-y; Narvid J, 2009, NEUROCASE, V15, P190, DOI 10.1080/13554790802632967; Perry RJ, 2006, DEMENT GERIATR COGN, V22, P278, DOI 10.1159/000095128; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Rosen HJ, 2002, NEUROLOGY, V58, P198, DOI 10.1212/WNL.58.2.198; Seeley WW, 2008, ARCH NEUROL-CHICAGO, V65, P249, DOI 10.1001/archneurol.2007.38; Seeley WW, 2005, NEUROLOGY, V64, P1384, DOI 10.1212/01.WNL.0000158425.46019.5C; Sha SJ, 2012, NEUROLOGY, V79, P1002, DOI 10.1212/WNL.0b013e318268452e; Simon-Sanchez J, 2012, BRAIN, V135, P723, DOI 10.1093/brain/awr353; Snowden JS, 2012, BRAIN, V135, P693, DOI 10.1093/brain/awr355; Sturm VE, 2013, P NATL ACAD SCI USA, V110, P9944, DOI 10.1073/pnas.1301119110; Wallon D, 2012, J ALZHEIMERS DIS, V32, P19, DOI 10.3233/JAD-2012-120877; Whitwell JL, 2012, LANCET NEUROL, V11, P868, DOI 10.1016/S1474-4422(12)70200-4; Whitwell JL, 2012, BRAIN, V135, P794, DOI 10.1093/brain/aws001	37	1	1	2	24	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1355-4794	1465-3656		NEUROCASE	Neurocase	MAR 3	2016	22	2					161	167		10.1080/13554794.2015.1080283			7	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	DD2RR	WOS:000369770400005	26304661	Green Accepted			2022-02-06	
J	Chen, CB; Lin, CC; Chen, JC; Kuo, CW; Weng, YM				Chen, Chen-Bin; Lin, Chi-Chun; Chen, Jih-Chang; Kuo, Chan-Wei; Weng, Yi-Ming			Commotio cordis during prolonged cardiac ventricular repolarization due to exercise-induced hypokalemia: A case report	JOURNAL OF ACUTE MEDICINE			English	Article						cardiac arrhythmia; cardiac concussion; commotio cordis; sudden cardiac death; ventricular fibrillation	SUDDEN-DEATH; IMPACT; ARREST; BLOWS; TIME; RISK	Background: Commotio cordis is ventricular fibrillation after a direct precordial blow without mechanical damage to organs. Early recognition and prompt cardiopulmonary resuscitation with defibrillation save lives. According to previous reports, the major determinants of commotio cordis include location and timing of the blow. Other risk factors are young age, a thin and undeveloped chest cage, and a small hard spherical projectile. The pathophysiology of commotion cordis remains uncertain, such as individual susceptibility to prolonged repolarization and long QT. Case report: A 32-year-old man suddenly collapsed after a direct blow to the anterior chest from an elbow during a basketball game. A bystander called an ambulance and activated the emergency medical service immediately. Dispatch assisted the bystander with cardiopulmonary resuscitation via telephone. An automated external defibrillator was applied when emergency medical technicians arrived, which showed ventricular fibrillation. The patient regained a pulse after the first electrical shock and five-cycle-chest compression. Further examinations revealed a long QT on electrocardiogram and hypokalemia. The QT interval was within normal limits without any ventricular arrhythmia after the potassium level had been normalized. Conclusion: This case reminds physicians of the risk of commotio cordis associated with exercise-induced hypokalemia. An electrocardiogram should be checked for QT prolongation immediately after return of spontaneous circulation in patients of sudden cardiac arrest. Supplying adequate potassium for hypokalemia related QT prolongation should be considered as treatment and primary prevention in such case. Copyright (C) 2016, Taiwan Society of Emergency Medicine. Published by Elsevier Taiwan LLC.	Chang Gung Mem Hosp, Dept Emergency Med, Linkou, Taiwan; Chang Gung Univ, Coll Med, Linkou, Taiwan		Weng, YM (corresponding author), Chang Gung Mem Hosp, Dept Emergency Med, 5 Fushing St, Taoyuan, Taiwan.	yiming33@adm.cgmh.org.tw					Bazett HC, 1920, HEART-J STUD CIRC, V7, P353; Berdowski J, 2009, CIRCULATION, V119, P2096, DOI 10.1161/CIRCULATIONAHA.108.768325; El-Sherif N, 2011, CARDIOL J, V18, P233; KNOCHEL JP, 1972, J CLIN INVEST, V51, P242, DOI 10.1172/JCI106809; Link MS, 2008, PEDIATRICS, V122, P437, DOI 10.1542/peds.2007-2054; Link MS, 2002, PEDIATRICS, V109, P873, DOI 10.1542/peds.109.5.873; Link MS, 1999, CIRCULATION, V100, P413, DOI 10.1161/01.CIR.100.4.413; Link MS, 1998, NEW ENGL J MED, V338, P1805, DOI 10.1056/NEJM199806183382504; Maron BJ, 2013, HEART RHYTHM, V10, P219, DOI 10.1016/j.hrthm.2012.10.034; Maron BJ, 2010, NEW ENGL J MED, V362, P917, DOI 10.1056/NEJMra0910111; Maron BJ, 2009, PEDIATRICS, V124, P966, DOI 10.1542/peds.2009-0167; MARON BJ, 1995, NEW ENGL J MED, V333, P337, DOI 10.1056/NEJM199508103330602; Maruyama M, 2014, HEART RHYTHM, V11, P697, DOI 10.1016/j.hrthm.2013.12.032; NORDREHAUG JE, 1985, CIRCULATION, V71, P645, DOI 10.1161/01.CIR.71.4.645	14	1	1	1	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2211-5587	2211-5595		J ACUTE MED		MAR	2016	6	1								10.1016/j.jacme.2016.03.001			4	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	DU0NX	WOS:000381902900004		hybrid			2022-02-06	
J	Kim, DH; Chung, YN; Park, YS; Min, KS; Lee, MS; Kim, YG				Kim, Dong Ho; Chung, You Nam; Park, Young Seok; Min, Kyung Soo; Lee, Mou Seop; Kim, Young Gyu			Epidemiologic Impact of Rapid Industrialization on Head Injury Based on Traffic Accident Statistics in Korea	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						Epidemiology; Head injury; Industrialization	TRAUMATIC BRAIN-INJURY; TRENDS; TAIWAN	Objective : The aim of the present study is to estimate the incidence trend of head injury and the mortality based on traffic accident statistics and to investigate the impacts of rapid industrialization and economic growth on epidemiology of head injury in Korea over the period 1970-2012 including both pre-industrialized and post-industrialized stages. Methods : We collected data of head injury estimated from traffic accident statistics and seven hospital based reports to see incidence trends between 1970 and 2012. We also investigated the population structure and Gross National Income (GNI) per capita of Korea over the same period. The age specific data were investigated from 1992 to 2012. Results : The incidence of head injury gradually rose in the 1970s and the 1980s but stabilized until the 1990s with transient rise and then started to decline slowly in the 2000s. The mortality grew until 1991 but gradually declined ever since. However, the old age groups showed rather slight increase in both rates. The degree of decrease in the mortality has been more rapid than the incidence on head injury. Conclusion : In Korea during the low income stage, rapid industrialization cause considerable increase in the mortality and the incidence of head injury. During the high income stage, the incidence of head injury gradually declined and the mortality dropped more rapidly than the incidence due to preventive measures and satisfactory medical care. Nevertheless, the old age groups revealed rather slight increase in both rates owing to the large population structure and the declining birth rate.	[Kim, Dong Ho; Park, Young Seok; Min, Kyung Soo; Lee, Mou Seop; Kim, Young Gyu] Chungbuk Natl Univ Hosp, Dept Neurosurg, 77 1Sunhwan Ro, Cheongju 28644, South Korea; [Chung, You Nam] Jeju Natl Univ Hosp, Dept Neurosurg, Jeju, South Korea		Kim, DH (corresponding author), Chungbuk Natl Univ Hosp, Dept Neurosurg, 77 1Sunhwan Ro, Cheongju 28644, South Korea.	dhkim@chungbuk.ac.kr			Chungbuk National University	This work was supported by the research grant of the Chungbuk National University in 2012.	Andersson EH, 2003, ACTA NEUROL SCAND, V107, P256, DOI 10.1034/j.1600-0404.2003.00112.x; BACHULIS BL, 1988, AM J SURG, V155, P708, DOI 10.1016/S0002-9610(88)80151-X; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; CHIU WT, 1995, J CLIN NEUROSCI, V2, P210, DOI 10.1016/S0967-5868(95)80004-2; Chiu WT, 2000, AM J PUBLIC HEALTH, V90, P793, DOI 10.2105/AJPH.90.5.793; Cho MK, 1972, J KOREAN NEUROSURG S, V1, P79; FINELLI FC, 1989, J TRAUMA, V29, P541, DOI 10.1097/00005373-198905000-00001; Frankowski R F, 1986, Adv Psychosom Med, V16, P153; HERNESNIEMI J, 1979, ACTA NEUROCHIR, V49, P67, DOI 10.1007/BF01809175; Ivan K, 1970, E BOOK MACROECONOMIC; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; Jun YH, 1986, J KOREAN NEUROSURG S, V15, P395; Kim DH, 2013, KOREAN J NEUROTRAUMA, V9, P31; Kim WH, 1989, J KOREAN NEUROSURG S, V18, P290; Lee BW, 1985, J KOREAN NEUROSURG S, V14, P153; Lee KS, 2001, J KOREAN MED SCI, V16, P342, DOI 10.3346/jkms.2001.16.3.342; Lee SC, 1977, J KOREAN NEUROSURG S, V6, P435; Lee SK, 2012, KOREAN J NEUROTRAUMA, V8, P1; Moon SB, 1977, J KOREAN NEUROSURG S, V6, P379; PENNINGS JL, 1993, ARCH SURG-CHICAGO, V128, P787; PENNINGS JL, 1993, ARCH SURG-CHICAGO, V128, P793; Perez K, 2012, ACCIDENT ANAL PREV, V46, P37, DOI 10.1016/j.aap.2011.12.004; Rhee HJ, 1972, J KOREAN NEUROSURG S, V1, P67; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Tokutomi T, 2008, J NEUROTRAUM, V25, P1407, DOI 10.1089/neu.2008.0577; Yang Bong-Min, 2003, Inj Control Saf Promot, V10, P89, DOI 10.1076/icsp.10.1.89.14120	26	1	1	0	2	KOREAN NEUROSURGICAL SOC	SEOUL	#402 POSCO # OFFICE BUILDING 151 SUNHWA-DONG, JUNG-GU, SEOUL, 100-130, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	MAR	2016	59	2					149	153		10.3340/jkns.2016.59.2.149			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DG7VL	WOS:000372291700010	26962421	gold, Green Submitted, Green Published			2022-02-06	
J	Li, M; Zhang, Y; Wu, KS; Hu, YH				Li, Min; Zhang, Ying; Wu, Kang-Song; Hu, Ying-Hong			Assessment of the effect of continuous sedation with mechanical ventilation on adrenal insufficiency in patients with traumatic brain injury	JOURNAL OF INVESTIGATIVE MEDICINE			English	Article							ACUTE-PHASE; DYSFUNCTION; SECONDARY; ADULTS	The aim of this study was to assess the effect of continuous propofol sedation plus prolonged mechanical ventilation on adrenal insufficiency (AI) in patients with traumatic brain injury (TBI). Eighty-five adult patients diagnosed with moderate TBI (Glasgow Coma Scale (GCS) score 9-13) from October 2011 to October 2012 were included in this prospective study. The patients comprised three groups: no mechanical ventilation and sedation (n=27), mechanical ventilation alone (n=24) and mechanical ventilation plus sedation (n=34). The low-dose short Synacthen test was performed at 8: 00 on the first, third, and fifth days after TBI. Logistic regression analysis was performed to identify factors affecting the use of mechanical ventilation and sedation, and the incidence of AI. On the fifth day after injury, the mean baseline cortisol and simulated cortisol levels were significantly lower in the mechanical ventilation plus sedation group compared with the other two groups. Multivariate regression analysis showed that the Acute Physiology and Chronic Health Evaluation (APACHE) score was independently associated with treatment with mechanical ventilation and sedation compared to mechanical ventilation alone. Furthermore, hypoxemia on admission and shock were associated with the development of AI. The findings showed that sedation is associated with an increased incidence of AI. Patients with TBI who are treated with continuous sedation should be monitored for AI carefully.	[Li, Min; Zhang, Ying; Wu, Kang-Song; Hu, Ying-Hong] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Neurointens Care Unit, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China		Hu, YH (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Neurointens Care Unit, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China.	2504188@zju.edu.cn					Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Arlt W, 2003, LANCET, V361, P1881, DOI 10.1016/S0140-6736(03)13492-7; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; Dekkers OM, 2011, EUR J ENDOCRINOL, V164, P83, DOI 10.1530/EJE-10-0621; Dimopoulou I, 2005, INTENS CARE MED, V31, P1020, DOI 10.1007/s00134-005-2689-y; Dimopoulou L, 2004, CRIT CARE MED, V32, P404, DOI 10.1097/01.CCM.0000108885.37811.CA; Dupuis C, 2010, INTENS CARE MED, V36, P1906, DOI 10.1007/s00134-010-2012-4; Ely EW, 2003, JAMA-J AM MED ASSOC, V289, P2983, DOI 10.1001/jama.289.22.2983; Fakhry SM, 2006, J TRAUMA, V60, P997, DOI 10.1097/01.ta.0000217285.94057.5e; Grap MJ, 2012, AM J CRIT CARE, V21, pE53, DOI 10.4037/ajcc2012301; Kazlauskaite R, 2008, J CLIN ENDOCR METAB, V93, P4245, DOI 10.1210/jc.2008-0710; Kleindienst A, 2009, J NEUROTRAUM, V26, P1435, DOI 10.1089/neu.2008.0601; Klose M, 2007, CLIN ENDOCRINOL, V67, P598, DOI 10.1111/j.1365-2265.2007.02931.x; Kollef MH, 1998, CHEST, V114, P541, DOI 10.1378/chest.114.2.541; LEDINGHAM IM, 1983, LANCET, V1, P1270; Lindgren C, 2013, ACTA ANAESTH SCAND, V57, P452, DOI 10.1111/aas.12014; Mistraletti G, 2005, CURR OPIN CRIT CARE, V11, P312, DOI 10.1097/01.ccx.0000166397.50517.1f; Morel J, 2011, BRIT J ANAESTH, V107, P503, DOI 10.1093/bja/aer169; Nelson BJ, 2000, CRIT CARE MED, V28, P3626, DOI 10.1097/00003246-200011000-00013; Roberts DJ, 2011, CRIT CARE MED, V39, P2743, DOI 10.1097/CCM.0b013e318228236f; Schricker T, 1999, ANESTHESIOLOGY, V90, P1636, DOI 10.1097/00000542-199906000-00020; Skoglund K, 2012, CRIT CARE MED, V40, P216, DOI 10.1097/CCM.0b013e31822d7dbd; Sweeney DA, 2010, CRIT CARE MED, V38, P553, DOI 10.1097/CCM.0b013e3181cb0a25; Vadeboncoeur TF, 2006, J EMERG MED, V30, P131, DOI 10.1016/j.jemermed.2005.04.019	26	1	1	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1081-5589	1708-8267		J INVEST MED	J. Invest. Med.	MAR	2016	64	3					752	758		10.1136/jim-2015-000012			7	Medicine, General & Internal; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Research & Experimental Medicine	DG6GE	WOS:000372180700004	26912007				2022-02-06	
J	Matthew, BJ; Gedzior, JS				Matthew, Binoj J.; Gedzior, Joanna S.			A Disabled Army Veteran with Severe Traumatic Brain Injury and Chronic Suicidal Ideation	PSYCHIATRIC ANNALS			English	Article							POSTTRAUMATIC-STRESS-DISORDER; CLOSED-HEAD INJURY; PSEUDOMEMORIES; MEMORIES		[Matthew, Binoj J.] Univ Calif San Francisco, Fresno Med Educ Program, Psychiat, Fresno, CA 93730 USA; [Gedzior, Joanna S.] VA Cent California Hlth Care Syst, Dept Psychiat, Menlo Pk, CA USA		Matthew, BJ (corresponding author), Univ Calif San Francisco, Fresno Med Educ Program, 645 E Champlain Dr,131, Fresno, CA 93730 USA.	binojmatthew@gmail.com					American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Braakman MH, 2009, ACTA PSYCHIAT SCAND, V119, P15, DOI 10.1111/j.1600-0447.2008.01252.x; Bryant RA, 1996, J TRAUMA STRESS, V9, P621; Bryant RA, 1998, APPL COGNITIVE PSYCH, V12, P81, DOI 10.1002/(SICI)1099-0720(199802)12:1<81::AID-ACP507>3.0.CO;2-8; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Centers for Disease Control, 2016, INJ PREV CONTR TRAUM; CHARNEY DS, 1993, ARCH GEN PSYCHIAT, V50, P294; Department of Veterans Affairs, 2016, TRAUMATIC BRAIN INJU; Department of Veterans Affairs and Department of Defense, 2010, VA DOD CLIN PRACT GU; Gilbertson MW, 2002, NAT NEUROSCI, V5, P1242, DOI 10.1038/nn958; Grond M, 2000, STROKE, V31, P133, DOI 10.1161/01.STR.31.1.133; Harvey AG, 2001, J TRAUMA STRESS, V14, P277, DOI 10.1023/A:1011108816888; McMillan TM, 1996, BRAIN INJURY, V10, P749, DOI 10.1080/026990596124016; MCMILLAN TM, 1991, BRIT J PSYCHIAT, V159, P431, DOI 10.1192/bjp.159.3.431; Molloy C, 2011, SCHIZOPHRENIA BULL, V37, P1104, DOI 10.1093/schbul/sbr091; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; Ravindran LN, 2009, BRAIN RES, V1293, P24, DOI 10.1016/j.brainres.2009.03.037; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; Tan LW, 2013, NEURAL REGEN RES, V8, P2405, DOI 10.3969/j.issn.1673-5374.2013.26.001	20	1	1	0	1	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0048-5713	1938-2456		PSYCHIAT ANN	Psychiatr. Ann.	MAR	2016	46	3					157	160		10.3928/00485713-20160209-01			4	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	DK8YG	WOS:000375215200003					2022-02-06	
J	Montanaro, CJ				Montanaro, Christopher J.			Airway pressure release ventilation in a patient with refractory intracranial hypertension	JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS			English	Article						mechanical ventilation; airway pressure release; intracranial hypertension; refractory; traumatic brain injury; alveolar recruitment	INDUCED LUNG INJURY; CEREBRAL VASODILATATION; MECHANICAL VENTILATION	Patients with refractory intracranial hypertension often require short-term mechanical ventilation because they cannot protect their airway. Airway pressure release ventilation (APRV) is less commonly used than other modes because it is thought to increase intracranial pressure. However, this case study describes how APRV improved alveolar recruitment and functional residual capacity in a patient with refractory intracranial hypertension secondary to severe traumatic brain injury.	[Montanaro, Christopher J.] Univ Rochester, Strong Mem Hosp, Neuromed ICU, Rochester, NY 14642 USA		Montanaro, CJ (corresponding author), Univ Rochester, Strong Mem Hosp, Neuromed ICU, Rochester, NY 14642 USA.						Albert SP, 2009, J APPL PHYSIOL, V106, P757, DOI 10.1152/japplphysiol.90735.2008; BRATTON SL, 2007, J NEUROTRAUMA S1, V24, pS87; Frawley P M, 2001, AACN Clin Issues, V12, P234, DOI 10.1097/00044067-200105000-00007; Gupta AK, 1997, ANESTH ANALG, V85, P817, DOI 10.1097/00000539-199710000-00018; Habashi Nader, 2004, Curr Opin Crit Care, V10, P549, DOI 10.1097/01.ccx.0000145473.01597.13; Habashi Nader M, 2005, Crit Care Med, V33, pS228, DOI 10.1097/01.CCM.0000155920.11893.37; KOGURE K, 1970, J APPL PHYSIOL, V29, P223, DOI 10.1152/jappl.1970.29.2.223; Marik PE, 2012, NEUROCRIT CARE, V17, P219, DOI 10.1007/s12028-012-9739-4; Nyquist P, 2008, NEUROCRIT CARE, V9, P400, DOI 10.1007/s12028-008-9130-7; PEARCE WJ, 1995, PHARMACOL THERAPEUT, V65, P75, DOI 10.1016/0163-7258(94)00058-B; Putensen C, 2001, AM J RESP CRIT CARE, V164, P43, DOI 10.1164/ajrccm.164.1.2001078; Roy SK, 2013, SHOCK, V40, P210, DOI 10.1097/SHK.0b013e31829efb06; Stevens RD, 2008, NEUROL CLIN, V26, P543, DOI 10.1016/j.ncl.2008.03.014; Wrigge H, 2005, CRIT CARE, V9, pR780, DOI 10.1186/cc3908; Wrigge H, 2003, ANESTHESIOLOGY, V99, P376, DOI 10.1097/00000542-200308000-00019	15	1	1	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1547-1896	0893-7400		JAAPA-J AM ACAD PHYS	JAAPA-J. Am. Acad. Physician Assist.	MAR	2016	29	3					38	40		10.1097/01.JAA.0000476211.89195.c6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DO3PJ	WOS:000377693200011	26914779				2022-02-06	
J	Nakamura, Y; Uchiyama, M; Hara, S; Mizunuma, M; Nakano, T; Ishikura, H; Hoshino, K; Kawano, Y; Takata, T				Nakamura, Yoshihiko; Uchiyama, Masanobu; Hara, Shuuji; Mizunuma, Mariko; Nakano, Takafumi; Ishikura, Hiroyasu; Hoshino, Kota; Kawano, Yasumasa; Takata, Tohru			Therapeutic Dose Monitoring for Linezolid in a Patient with MRSA Pneumonia with Bacteremia in Diabetes Insipidus	INFECTIOUS DISEASES AND THERAPY			English	Article						Area under the plasma drug concentration-time curve/minimum inhibitory concentration; Bacteremia; Blood concentration; Diabetes insipidus; Linezolid; Methicillin-resistant Staphylococcus aureus; Pneumonia	CRITICALLY-ILL PATIENTS; PHARMACOKINETICS; PHARMACODYNAMICS; PROGRAM; PLASMA	Few studies have investigated the effect of increased creatinine clearance (CrCl) on linezolid (LZD) concentration. Herein, we report the pharmacokinetic/pharmacodynamic (PK/PD) profile of LZD used in the management of methicillin-resistant Staphylococcus aureus (MRSA) pneumonia with concomitant bacteremia in a patient with high CrCl caused by diabetes insipidus (DI). A 19-year-old man was admitted to the intensive care unit following a traumatic brain injury. After admission, he underwent a craniotomy for the severe brain injury. However, he developed DI after the operation. Despite treatment with vasopressin, his urine output reached 5-6 L/day as a result of the DI, and his CrCl increased to 180-278 mL/min. We were required to administer 6-7 L of fluid a day to compensate for the high urinary fluid output. On day 55, MRSA pneumonia with sepsis was suspected and, consequently, LZD was administrated intravenously (600 mg every 12 h). He was treated with LZD for 14 days. The patient has since successfully recovered from MRSA pneumonia with concomitant bacteremia, and was transferred to the general ward on day 82. Blood LZD levels from days 60-68, which were measured after the patient's transfer to the general ward, showed that the trough levels were lower than the threshold level of detection. The blood 24-h area under the plasma LZD concentration-time curve (AUC)(24)/minimum inhibitory concentration (MIC) was 69.3. In spite of the low level of LZD AUC(24)/MIC caused by the high CrCl with DI, MRSA pneumonia with concomitant bacteremia was successfully treated with LZD.	[Nakamura, Yoshihiko; Mizunuma, Mariko; Ishikura, Hiroyasu; Hoshino, Kota; Kawano, Yasumasa] Fukuoka Univ, Dept Emergency & Crit Care Med, Fac Med, Fukuoka, Japan; [Uchiyama, Masanobu; Nakano, Takafumi] Fukuoka Univ Hosp, Dept Pharm, Fukuoka, Japan; [Hara, Shuuji] Fukuoka Univ, Fac Pharmaceut Sci, Fukuoka, Japan; [Takata, Tohru] Fukuoka Univ, Sch Med, Dept Oncol Hematol & Infect Dis, Fukuoka, Japan; [Takata, Tohru] Fukuoka Univ Hosp, Dept Infect Control, Fukuoka, Japan		Nakamura, Y (corresponding author), Fukuoka Univ, Dept Emergency & Crit Care Med, Fac Med, Fukuoka, Japan.	pdmxy827@yahoo.co.jp					Ager Sally, 2012, Infect Drug Resist, V5, P87, DOI 10.2147/IDR.S25890; Andes D, 2002, ANTIMICROB AGENTS CH, V46, P3484, DOI 10.1128/AAC.46.11.3484-3489.2002; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Conte JE, 2002, ANTIMICROB AGENTS CH, V46, P1475, DOI 10.1128/AAC.46.5.1475-1480.2002; Cox H, 2012, INT J TUBERC LUNG D, V16, P447, DOI 10.5588/ijtld.11.0451; Hara S, 2015, BIOMED CHROMATOGR, V29, P1428, DOI 10.1002/bmc.3441; MacGowan AP, 2003, J ANTIMICROB CHEMOTH, V51, P17, DOI 10.1093/jac/dkg248; Onda H, 2001, INT J ANTIMICROB AG, V18, P263, DOI 10.1016/S0924-8579(01)00374-0; Rayner CR, 2003, CLIN PHARMACOKINET, V42, P1411, DOI 10.2165/00003088-200342150-00007; Rybak Michael, 2009, Am J Health Syst Pharm, V66, P82, DOI 10.2146/ajhp080434; Sisson TL, 2002, EUR J CLIN PHARMACOL, V57, P793, DOI 10.1007/s00228-001-0380-y; Slatter JG, 2001, DRUG METAB DISPOS, V29, P1136; Stalker DJ, 2003, CLIN PHARMACOKINET, V42, P1129, DOI 10.2165/00003088-200342130-00004; Wunderink RG, 2012, CLIN INFECT DIS, V54, P621, DOI 10.1093/cid/cir895; Yagi T, 2013, INT J ANTIMICROB AG, V42, P329, DOI 10.1016/j.ijantimicag.2013.06.015; YAMAOKA K, 1981, J PHARMACOBIO-DYNAM, V4, P879, DOI 10.1248/bpb1978.4.879; Zoller M, 2014, CRIT CARE, V18, DOI 10.1186/cc13984	17	1	1	0	1	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	2193-8229	2193-6382		INFECT DIS THER	Infect. Dis. Ther.	MAR	2016	5	1					81	87		10.1007/s40121-015-0100-z			7	Infectious Diseases	Emerging Sources Citation Index (ESCI)	Infectious Diseases	EL0LQ	WOS:000394314300008	26686501	Green Published, gold			2022-02-06	
J	Wilson, M; Della Penna, A				Wilson, Marie; Della Penna, Amy			Targeted Temperature Modulation in the Neuroscience Patient	CRITICAL CARE NURSING CLINICS OF NORTH AMERICA			English	Article						Targeted temperature management; Induced hypothermia; Normothermia; Shivering	TRAUMATIC BRAIN-INJURY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; AMERICAN-HEART-ASSOCIATION; THERAPEUTIC HYPOTHERMIA; BODY-TEMPERATURE; ISCHEMIC-STROKE; CARDIAC-ARREST; FEVER; MANAGEMENT; NORMOTHERMIA	There are many approaches to and opportunities for implementing temperature modulation in critically ill patients, but barriers also exist. Conceptually, the process of cooling is rather straightforward; however, targeted temperature management is anything but simplistic. The need for a collaborative approach (physicians champions, nursing support, respiratory therapists, pharmacists, laboratory personnel, and supply chain representatives) to address definitions of normothermia and fever, patient inclusion/exclusion criteria for therapy based on underlying neurorelated pathologies, determination of methods of induction/maintenance, monitoring required, education planning, and strategies to minimize potential complications are warranted.	[Wilson, Marie; Della Penna, Amy] Thomas Jefferson Univ Hosp, Neurosci Intens Care Unit, 111 South 11th St,Gibbon Bldg,Room 9300, Philadelphia, PA 19107 USA		Wilson, M (corresponding author), Thomas Jefferson Univ Hosp, Neurosci Intens Care Unit, 111 South 11th St,Gibbon Bldg,Room 9300, Philadelphia, PA 19107 USA.	Marie.Wilson@jefferson.edu					Agostoe DV, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00047; Alyagari V, 2007, J NEUROL SCI, V261, P39, DOI 10.1016/j.jns.2007.04.030; American Heart Association, HEART STROK STAT; Avery KR, 2015, CRIT CARE NURSE, V35, P29, DOI 10.4037/ccn2015937; Badiatia N, 2009, CURR OPIN CRIT CARE, V15, P79, DOI 10.1097/MCC.0b013e32832922e9; Badjatia N, 2007, NEUROCRIT CARE, V6, P186, DOI 10.1007/s12028-007-0011-2; Badjatia N, 2009, CRIT CARE MED, V37, P1893, DOI 10.1097/CCM.0b013e31819fffd3; Badjatia N, 2008, STROKE, V39, P3242, DOI 10.1161/STROKEAHA.108.523654; Beniga JG, 2014, NURS CLIN N AM, V49, P399, DOI 10.1016/j.cnur.2014.05.013; Bratton SL, 2007, J NEUROTRAUMA S1, V24, pS21; Bukur M, 2012, J SURG RES, V175, P24, DOI 10.1016/j.jss.2011.07.003; Choi HA, 2011, NEUROCRIT CARE, V14, P389, DOI 10.1007/s12028-010-9474-7; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Clifton Guy L, 2004, Curr Opin Crit Care, V10, P116, DOI 10.1097/00075198-200404000-00007; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Diringer MN, 2011, NEUROCRIT CARE, V15, P211, DOI 10.1007/s12028-011-9605-9; Doufas AG, 2003, STROKE, V34, P1218, DOI 10.1161/01.STR.0000068787.76670.A4; Faridar A, 2011, FRONT NEUROL, V2, P1; Fernandez A, 2007, NEUROLOGY, V68, P1013, DOI 10.1212/01.wnl.0000258543.45879.f5; Green Deborah M, 2013, J Intensive Care Med, V28, P341, DOI 10.1177/0885066611434100; Greer DM, 2008, STROKE, V39, P3029, DOI 10.1161/STROKEAHA.108.521583; Guly H, 2011, RESUSCITATION, V82, P122, DOI 10.1016/j.resuscitation.2010.09.465; Harris OA, 2002, ARCH NEUROL-CHICAGO, V59, P1077, DOI 10.1001/archneur.59.7.1077; Karaszewski B, 2013, J CEREBR BLOOD F MET, V33, P1083, DOI 10.1038/jcbfm.2013.52; Kasner SE, 2002, STROKE, V33, P130, DOI 10.1161/hs0102.101477; Kramer LW, 2010, DIMENS CRIT CARE NUR, V29, P20, DOI 10.1097/DCC.0b013e3181be4a74; Kupchik NL, 2009, CRIT CARE MED, V37, pS279, DOI 10.1097/CCM.0b013e3181aa61c5; Lavinio A, 2007, BRIT J ANAESTH, V99, P237, DOI 10.1093/bja/aem118; Laws C., 2010, JEFFERSON HOSP NEURO, V5, P22; Li J, 2012, J NEUROTRAUM, V29, P96, DOI 10.1089/neu.2011.1753; Linares G, 2009, CRIT CARE MED, V37, pS243, DOI 10.1097/CCM.0b013e3181aa5de1; Liu-DeRyke X, 2008, PHARM MANAGEMENT THE; Madden LK, 2015, J NEUROSCI NURS, V47, P190, DOI 10.1097/JNN.0000000000000142; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Mcilvoy L, 2012, AANN CLIN PRACT GUID, P1; Mcilvoy L, 2012, AACN ADV CRIT CARE, V23, P204, DOI 10.1097/NCI.0b013e31824db1c6; Ng L, 2014, CRIT CARE CLIN, V30, P557, DOI 10.1016/j.ccc.2014.03.002; Oddo M, 2009, STROKE, V40, P1913, DOI 10.1161/STROKEAHA.108.534115; Peberdy MA, 2010, CIRCULATION, V122, pS768, DOI 10.1161/CIRCULATIONAHA.110.971002; Perman SM, 2014, CHEST, V145, P386, DOI 10.1378/chest.12-3025; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Rockett H, 2015, J NEUROSCI NURS, V47, P66, DOI 10.1097/JNN.0000000000000118; Sacho RH, 2010, J NEUROTRAUM, V27, P2157, DOI 10.1089/neu.2010.1384; Sadaka F, 2012, BRAIN INJURY, V26, P899, DOI 10.3109/02699052.2012.661120; SAFAR P, 1964, J Iowa Med Soc, V54, P629; Summers D, 2009, STROKE, V40, P2911, DOI 10.1161/STROKEAHA.109.192362; Thompson HJ, 2015, STROKE, V46, pE98, DOI 10.1161/STROKEAHA.115.008188; Thompson Hilaire J, 2010, J Trauma Nurs, V17, P173, DOI 10.1097/JTN.0b013e3181ff272e; Thompson HJ, 2003, J NEUROL NEUROSUR PS, V74, P614, DOI 10.1136/jnnp.74.5.614; Tokutomi T, 2009, J TRAUMA, V66, P166, DOI 10.1097/TA.0b013e318157dbec; Zhao QJ, 2011, J CRIT CARE, V26, P311, DOI 10.1016/j.jcrc.2010.08.014; Zweifler RM, 2004, STROKE, V35, P2331, DOI 10.1161/01.STR.0000141161.63181.f1	53	1	3	0	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0899-5885	1558-3481		CRIT CARE NURS CLIN	Crit. Care Nurs. Clin. N. Am.	MAR	2016	28	1					125	+		10.1016/j.cnc.2015.10.006			14	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	DD1TR	WOS:000369705200012	26873765				2022-02-06	
J	Yaylaci, S; Dallar, Y; Sayar, Y; Tasar, MA; Tiras, U; Tekin, D; Unlu, A; Ulukol, B; Beyaztas, FY; Butun, C; Ozum, U; Buken, B; Kandemir, F; Gokoglu, A; Kondolot, M; Menku, A; Patiroglu, T; Tunc, A; Yagmur, F; Yikilmaz, A; Akar, T; Beyazova, U; Degirmenci, B; Iseri, E; Sahin, F; Isir, AB; Bilen, AG; Oral, R; Gazioglu, N; Balci, Y; Eryuruk, M; Karagoz, F				Yaylaci, Serpil; Dallar, Yildiz; Sayar, Yavuz; Tasar, Medine Aysin; Tiras, Ulku; Tekin, Deniz; Unlu, Agahan; Ulukol, Betul; Beyaztas, Fatma Yucel; Butun, Celal; Ozum, Unal; Buken, Bora; Kandemir, Ferhan; Gokoglu, Ahmet; Kondolot, Meda; Menku, Ahmet; Patiroglu, Turkan; Tunc, Aydin; Yagmur, Fatih; Yikilmaz, Ali; Akar, Taner; Beyazova, Ufuk; Degirmenci, Bulent; Iseri, Elvan; Sahin, Figen; Isir, Aysun Baransel; Bilen, Ayse Gul; Oral, Resmiye; Gazioglu, Nurperi; Balci, Yasemin; Eryuruk, Mesut; Karagoz, Feyza			Abusive Head Trauma in Turkey and Impact of Multidisciplinary Team Establishment Efforts on Case Finding and Management: Preliminary Findings	EURASIAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Abusive head trauma; multidisciplinary team; diagnostic workup	SHAKEN BABY SYNDROME; YOUNG-CHILDREN; RETINAL HEMORRHAGES; PHYSICAL ABUSE; BRAIN-INJURY; INFANTS	Aim: Abusive head trauma (AHT) is the most common cause of death as the result of child abuse. A task force is planned to provide training on AHT to professionals in different disciplines on clinical presentation, diagnostic workup, and organization of multidisciplinary evaluation at the hospital and community levels. This study reports on the preliminary findings of the pre-intervention phase of a larger study. Materials and Methods: This is a descriptive, retrospective study exploring the rates of documentation of relevant data in charts, including risk factors for abuse, family demographics, completeness of diagnostic workup, and case finding. Results: Overall, 345 cases were found in hospital databases that were eligible for the retrospective study from 10 participating hospitals. In total, 305 cases (88.4%) were younger than 2 years of age. The most common documented risk factors were low parental education level in 82 families (23.8%), more than three children under 7 years of age in 76 families (22.0%), and bad child temper in 16 families (4.6%), among others. The rate of complete diagnostic workup in hospitals with a multidisciplinary team (MDT) (25.7%) was statistically significantly higher than in hospitals without an MDT (2.9%) (p=0.001). Etiology was identified as inflicted in 78 cases (22.6%), possibly inflicted in 24 (7.0%), undetermined in 79 (22.9%), and accidental in 164 (47.5%) by the researchers, compared to only three cases (0.8%) diagnosed as inflicted by the treating physicians (p<0.0001). In two of the three cases, the perpetrator was convicted; in one, the prosecutor closed the case without a trial on the basis of "no confession" despite the death of the child and medical evidence. Conclusion: Clinicians' knowledge of the diagnosis of AHT should be increased to improve case finding, which will allow determination of more accurate incidence/prevalence. This can be accomplished via the establishment of an MDT in teaching hospitals as well as staff training on how to recognize suspicious cases, how to utilize MDT services, and how to report and manage cases on a community level multidisciplinary basis.	[Yaylaci, Serpil] Acibadem Univ, Dept Emergency, Istanbul, Turkey; [Dallar, Yildiz; Sayar, Yavuz; Tasar, Medine Aysin; Tiras, Ulku] Ankara Hosp, Dept Pediat, Minist Hlth, Ankara, Turkey; [Tekin, Deniz; Ulukol, Betul] Ankara Univ, Dept Pediat, Sch Med, Ankara, Turkey; [Unlu, Agahan] Ankara Univ, Sch Med, Dept Neurosurg, Ankara, Turkey; [Beyaztas, Fatma Yucel; Butun, Celal] Cumhuriyet Univ, Dept Forens Med, Sch Med, Sivas, Turkey; [Ozum, Unal] Cumhuriyet Univ, Sch Med, Dept Neurosurg, Sivas, Turkey; [Buken, Bora; Kandemir, Ferhan] Duzce Univ, Sch Med, Dept Forens Med, Bolu, Turkey; [Gokoglu, Ahmet; Kondolot, Meda; Patiroglu, Turkan; Tunc, Aydin] Erciyes Univ, Sch Med, Dept Pediat, Kayseri, Turkey; [Menku, Ahmet] Erciyes Univ, Sch Med, Dept Neurosurg, Kayseri, Turkey; [Yagmur, Fatih] Erciyes Univ, Sch Med, Dept Forens Med, Kayseri, Turkey; [Yikilmaz, Ali] Erciyes Univ, Sch Med, Dept Radiol, Kayseri, Turkey; [Akar, Taner; Degirmenci, Bulent] Gazi Univ, Sch Med, Dept Forens Sci, Ankara, Turkey; [Beyazova, Ufuk; Sahin, Figen] Gazi Univ, Sch Med, Dept Pediat, Ankara, Turkey; [Iseri, Elvan] Gazi Univ, Sch Med, Dept Psychiat, Ankara, Turkey; [Isir, Aysun Baransel; Bilen, Ayse Gul] Gaziantep Univ, Dept Forens Med, Gaziantep, Turkey; [Isir, Aysun Baransel; Bilen, Ayse Gul] Childrens Hosp, Gaziantep, Turkey; [Oral, Resmiye] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Gazioglu, Nurperi] Istanbul Univ, Istanbul Sch Med, Dept Neurosurg, Istanbul, Turkey; [Balci, Yasemin; Eryuruk, Mesut] Osmangazi Univ, Sch Med, Dept Forens Med, Eskisehir, Turkey; [Karagoz, Feyza] Vakif Gureba Hosp, Dept Neurosurg, Istanbul, Turkey		Yaylaci, S (corresponding author), Acibadem Univ, Dept Emergency, Istanbul, Turkey.	serpilyaylaci@hotmail.com	KONDOLOT, MEDA/A-5973-2018; ISIR, AYSUN BARANSEL/AAH-1205-2020; Gazioglu, Nurperi/AAJ-3648-2021; tekin, deniz/AAM-8858-2020; YAYLACI, serpil/W-9408-2018; Ozum, Unal/ABE-5136-2021; GUZEY, FEYZA KARAGOZ/A-6908-2018	KONDOLOT, MEDA/0000-0002-1168-3228; Gazioglu, Nurperi/0000-0001-7785-8628; tekin, deniz/0000-0001-9654-3664; Ozum, Unal/0000-0003-2065-2033; GUZEY, FEYZA KARAGOZ/0000-0002-4260-9821; BARANSEL ISIR, AYSUN/0000-0002-0550-3470			Agirtan CA, 2009, CHILD ABUSE NEGLECT, V33, P247, DOI 10.1016/j.chiabu.2008.12.008; Barr RG, 2012, P NATL ACAD SCI USA, V109, P17294, DOI 10.1073/pnas.1121267109; BEYAZTAS FY, 2006, MIDDLE E J FAMILY ME, V4, P21; Brown J, 1998, CHILD ABUSE NEGLECT, V22, P1065, DOI 10.1016/S0145-2134(98)00087-8; Caylan ND, 2013, ULUS TRAVMA ACIL CER, V19, P261, DOI 10.5505/tjtes.2013.01460; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Forbes BJ, 2010, J AAPOS, V14, P267, DOI 10.1016/j.jaapos.2010.03.002; Gilbert R, 2009, LANCET, V373, P167, DOI 10.1016/S0140-6736(08)61707-9; Gumbs GR, 2013, PEDIATRICS, V132, P668, DOI 10.1542/peds.2013-0168; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Karakus A, 2015, EURASIAN J EMERG MED, V14, P201, DOI 10.5152/jaem.2013.022; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Koc F, 2012, TURK KLIN TIP BILIM, V32, P1781, DOI 10.5336/medsci.2011-25176; Levin AV, 2010, PEDIATRICS, V126, P961, DOI 10.1542/peds.2010-1220; Morad Y, 2003, J PEDIATR-US, V142, P431, DOI 10.1067/mpd.2003.161; Oral R, 2001, CHILD ABUSE NEGLECT, V25, P279, DOI 10.1016/S0145-2134(00)00241-6; Oral R, 2008, PEDIATR EMERG CARE, V24, P816, DOI 10.1097/PEC.0b013e31818e9f5d; Palusci, 2001, SHAKEN BABY SYNDROME, V5, P19; Pinheiro P.S., 2006, WORLD REPORT VIOLENC; Piteau SJ, 2012, PEDIATRICS, V130, P315, DOI 10.1542/peds.2011-1545; Runyan DK, 2010, PEDIATRICS, V126, pE701, DOI 10.1542/peds.2008-2374; Sieswerda-Hoogendoorn T, 2013, ACTA PAEDIATR, V102, pE497, DOI 10.1111/apa.12377; World Health Organisation, 2002, WORLD REPORT VIOLENC; Yagmur F, 2010, ADLI TIP DERGISI, V24, P42; Yalcin S. Songul, 2011, Cocuk Sagligi ve Hastaliklari Dergisi, V54, P227	26	1	2	1	12	AVES	SISLI	BUYUKDERE CAD 105-9, MECIDIYEKOY, SISLI, ISTANBUL 34394, TURKEY	2149-5807	2149-6048		EURASIAN J EMERG MED	Eurasian J. Emerg. Med.	MAR	2016	15	1					24	29		10.5152/eajem.2016.52386			6	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	DV4CU	WOS:000382873200006		gold, Green Published			2022-02-06	
J	Lopez, WOC; Azevedo, AR; Cury, RG; Alencar, F; Neville, IS; Reis, PR; Navarro, J; Monaco, B; da Silva, FEF; Teixeira, MJ; Fonoff, ET				Contreras Lopez, William Omar; Azevedo, Angelo R.; Cury, Rubens G.; Alencar, Francisco; Neville, Iuri S.; Reis, Paul R.; Navarro, Jessie; Monaco, Bernardo; Fernandes da Silva, Fabio E.; Teixeira, Manoel J.; Fonoff, Erich T.			Caudal Zona Incerta/VOP Radiofrequency Lesioning Guided by Combined Stereotactic MRI and Microelectrode Recording for Posttraumatic Midbrain Resting-Kinetic Tremor	WORLD NEUROSURGERY			English	Article						Ablative radiofrequency surgery; Deep brain stimulation; Diffuse axonal injury; Forel's fields; Microelectrode recording; Traumatic brain injury; Tremor; Zona incerta	DEEP BRAIN-STIMULATION; POSTERIOR SUBTHALAMIC AREA; PARKINSONS-DISEASE; HOLMES TREMOR; NUCLEUS	OBJECTIVE: Reporting the outcome of two patients who underwent unilateral ablative stereotactic surgery to treat pharmacologic resistant posttraumatic tremor (PTT). METHODS: We present two patients (31 and 47 years old) with refractory PTT severely affecting their quality of life. Under stereotactic guidance, refined by T2-weighted magnetic resonance imaging and double-channel multi-unit microelectrode recording (MER), three sequential radiofrequency lesions were performed in the caudal zona incerta (cZi) up to the base of thalamus (VOP). Effects of cZi/VOP lesion were prospectively rated with a tremor rating scale. RESULTS: Both patients demonstrated intraoperative tremor suppression with sustained results up to 18 months follow-up, with improvement of 92% and 84%, respectively, on the tremor rating scale. Tremor improvement was associated with enhancement functionality and quality of life for the patients. The patients returned to their work after the procedure. No adverse effects were observed up to the last follow-up. CONCLUSION: Radiofrequency lesion of the cZi/VOP target was effective for posttraumatic tremor in both cases. The use of T2-weighted images and MER was found helpful in increasing the precision and safety of the procedure, because it leads the RF probe by relying on neighbor structures based on thalamus and subthalamic nucleus.	[Contreras Lopez, William Omar; Azevedo, Angelo R.; Cury, Rubens G.; Alencar, Francisco; Neville, Iuri S.; Reis, Paul R.; Navarro, Jessie; Monaco, Bernardo; Fernandes da Silva, Fabio E.; Teixeira, Manoel J.; Fonoff, Erich T.] Univ Sao Paulo, Sch Med, Hosp Clin, Div Funct Neurosurg,Inst Psychiat, BR-05508 Sao Paulo, Brazil		Fonoff, ET (corresponding author), Univ Sao Paulo, Sch Med, Hosp Clin, Div Funct Neurosurg,Inst Psychiat, BR-05508 Sao Paulo, Brazil.	erich.fonoff@gmail.com	Monaco, Bernardo/H-8275-2016; Cury, Rubens/J-7210-2015; Neville, Iuri/AAI-2852-2021; Neville, Iuri S/P-5360-2014; Fonoff, Erich Talamoni/E-4327-2012; de Azevedo, Angelo Rafael Cunha/AAM-4947-2020	Monaco, Bernardo/0000-0002-2475-9228; Cury, Rubens/0000-0001-6305-3327; Neville, Iuri/0000-0002-8561-9069; Neville, Iuri S/0000-0002-8561-9069; Fonoff, Erich Talamoni/0000-0001-7831-9941; de Azevedo, Angelo Rafael Cunha/0000-0002-3302-6464			Bejjani BP, 2000, J NEUROSURG, V92, P615, DOI 10.3171/jns.2000.92.4.0615; Bhidayasiri R, 2012, HOLMES MOVEMENT DISO, P56; Blomstedt P, 2009, ACTA NEUROCHIR, V151, P31, DOI 10.1007/s00701-008-0163-7; Blomstedt P, 2012, PARKINSONISM RELAT D, V18, P1062, DOI 10.1016/j.parkreldis.2012.05.024; Ghilardi MGD, 2015, NEUROLOGY, V84, P1904, DOI 10.1212/WNL.0000000000001553; Martinez JAE, 2015, NEUROSURG REV, V38, P753, DOI 10.1007/s10143-015-0636-0; Fonoff ET, 2011, PARKINSONISM RELAT D, V17, P649, DOI 10.1016/j.parkreldis.2011.05.005; Foote KD, 2006, NEUROSURGERY, V58, P280, DOI 10.1227/01.NEU.0000192692.95455.FD; Fytagoridis A, 2013, CLIN NEUROL NEUROSUR, V115, P65, DOI 10.1016/j.clineuro.2012.04.015; Fytagoridis A, 2012, J NEUROL NEUROSUR PS, V83, P258, DOI 10.1136/jnnp-2011-300765; Grabska N, 2014, NEUROL NEUROCHIR POL, V48, P292, DOI 10.1016/j.pjnns.2014.06.002; Hagglund P, 2015, J VOICE; Hamani C, 2004, BRAIN, V127, P4, DOI 10.1093/brain/awh029; HARMON R L, 1991, Brain Injury, V5, P213, DOI 10.3109/02699059109008092; Jimenez F, 2000, ARCH MED RES, V31, P270, DOI 10.1016/S0188-4409(00)00066-7; KRAUSS JK, 1994, J NEUROSURG, V80, P810, DOI 10.3171/jns.1994.80.5.0810; Kudo M, 2001, MOVEMENT DISORD, V16, P170, DOI 10.1002/1531-8257(200101)16:1<170::AID-MDS1033>3.0.CO;2-P; LEHMAN RM, 1972, CONFIN NEUROL, V34, P200; Menendez DFS, 2014, TREMOR OTHER HYPERK, V4, DOI 10.7916/D8PG1PXT; Mitrofanis J, 2005, NEUROSCIENCE, V130, P1, DOI 10.1016/j.neuroscience.2004.08.017; MUNDINGER F, 1965, CONFIN NEUROL, V26, P222; MUNDINGER F, 1970, CONFIN NEUROL, V32, P71; MUNDINGER F, 1965, DEUT MED WOCHENSCHR, V90, P2002, DOI 10.1055/s-0028-1113463; Ohye C, 2000, STEREOT FUNCT NEUROS, V75, P54, DOI 10.1159/000048384; Plaha P, 2008, J NEUROL NEUROSUR PS, V79, P504, DOI 10.1136/jnnp.2006.112334; SAMIE MR, 1990, NEUROLOGY, V40, P62, DOI 10.1212/WNL.40.1.62; SPIEGEL E A, 1962, Trans Am Neurol Assoc, V87, P240; SPIEGEL EA, 1963, J NEUROSURG, V20, P871, DOI 10.3171/jns.1963.20.10.0871; Zrinzo L, 2013, MOVEMENT DISORD, V28, P254, DOI 10.1002/mds.25302	29	1	1	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	FEB	2016	86						316	320		10.1016/J.WNEU.2015.09.031			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DD0QU	WOS:000369625300065	26416091				2022-02-06	
J	Engelhard, K				Engelhard, K.			Neuroanesthesia	ANAESTHESIST			German	Article						Craniotomy; Intracranial pressure; Brain edema; Sitting position; Awake craniotomy	RANDOMIZED CONTROLLED-TRIALS; TRAUMATIC BRAIN-INJURY; VENOUS AIR-EMBOLISM; INTRACRANIAL-PRESSURE; CRANIOTOMY; POSITION; SURGERY; METAANALYSIS; MANNITOL; MANAGEMENT	Anesthesiological challenges during craniotomy result from the anatomically related low compensatory capacity of the intracranial space in response to increased volume and the low ischemic tolerance of brain tissue. The anesthetic agents used should therefore not increase the intracranial volume and improve the ischemic tolerance. An acute life-threatening increase of intracranial pressure can be temporarily treated by hyperventilation until measures, such as osmotherapy and infusion of intravenous anesthetics become effective. During an operation the homeostatic parameters including blood volume, blood pressure, partial pressure of carbon dioxide and oxygen in blood, plasma glucose concentration and core body temperature have to be closely monitored and kept normal (6 Ns). Optimal implementation of anesthesia necessitates a detailed knowledge of the surgical approach and potential complications. Postoperatively, patients should be extubated as soon as possible to closely monitor cognitive function so that potential deterioration can be detected.	[Engelhard, K.] Univ Med Mainz, Klin Anasthesiol, Langenbeckstr 1, D-55131 Mainz, Germany		Engelhard, K (corresponding author), Univ Med Mainz, Klin Anasthesiol, Langenbeckstr 1, D-55131 Mainz, Germany.	engelhak@uni-mainz.de					Chui J, 2014, CAN J ANESTH, V61, P347, DOI 10.1007/s12630-014-0118-9; Devereaux PJ, 2014, NEW ENGL J MED, V370, P1494, DOI 10.1056/NEJMoa1401105; Dostal P, 2015, J NEUROSURG ANESTH, V27, P51, DOI 10.1097/ANA.0000000000000091; Feigl GC, 2014, WORLD NEUROSURG, V81, P159, DOI 10.1016/j.wneu.2013.01.003; Fritz G, 2008, ANASTH INTENSIVMED, V49, P5; Ghoneim AA, 2015, J NEUROSURG ANESTH, V27, P1, DOI 10.1097/ANA.0000000000000058; Gracia I, 2014, CURR OPIN ANESTHESIO, V27, P474, DOI 10.1097/ACO.0000000000000104; Jameson Leslie C, 2012, Anesthesiol Clin, V30, P311, DOI 10.1016/j.anclin.2012.05.005; Jian M, 2014, BRIT J ANAESTH, V113, P832, DOI 10.1093/bja/aeu185; Klein KU, 2010, J NEUROSURG ANESTH, V22, P269, DOI 10.1097/ANA.0b013e3181dcb5b8; Lee SH, 2015, ACTA NEUROCHIR, V157, P1879, DOI 10.1007/s00701-015-2581-7; MacDonald DB, 2013, CLIN NEUROPHYSIOL, V124, P2291, DOI 10.1016/j.clinph.2013.07.025; Pasternak JJ, 2015, J NEUROSURG ANESTH, V27, P87, DOI 10.1097/ANA.0000000000000167; Peng K, 2014, J CLIN NEUROSCI, V21, P1951, DOI 10.1016/j.jocn.2014.02.023; Rickard AC, 2014, EMERG MED J, V31, P679, DOI 10.1136/emermed-2013-202679; Scheller C, 2014, J NEUROL SURG PART A, V75, P2, DOI 10.1055/s-0033-1345686; Schlundt J, 2012, CAN J ANESTH, V59, P478, DOI 10.1007/s12630-012-9680-1; Schramm P, 2013, J NEUROSURG ANESTH, V25, P162, DOI 10.1097/ANA.0b013e31827c2f46; Seemann M, 2015, ANAESTHESIST, V64, P128, DOI 10.1007/s00101-014-2396-6; Smith TR, 2014, J NEURO-ONCOL, V120, P347, DOI 10.1007/s11060-014-1557-4; Sorani MD, 2008, J NEUROTRAUM, V25, P291, DOI 10.1089/neu.2007.0411	21	1	1	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0003-2417	1432-055X		ANAESTHESIST	Anaesthesist	FEB	2016	65	2					151	160		10.1007/s00101-015-0121-8			10	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	DG6BC	WOS:000372166200011	26696267				2022-02-06	
J	Guzman, J; Aktan, N				Guzman, Jill; Aktan, Nadine			Comparison of the Wii Balance Board and the BESS tool measuring postural stability in collegiate athletes	APPLIED NURSING RESEARCH			English	Article						Concussion; Postural stability; Balance Error Scoring System, BESS; Wii Balance Board	SPORT-RELATED CONCUSSION; HIGH-SCHOOL; RELIABILITY; STATEMENT; SYMPTOMS	Concussions are a major health concern for athletes given the potential for these injuries in a wide range of sport activities. The leading concern for clinicians is that athletes are at risk for devastating consequences if they are not evaluated properly and cleared too early to return to play or competition. The evaluation of postural stability has been identified as an important aspect to the comprehensive management of such injuries. Clinicians are in need of a portable tool they can use in various settings to aid in decision making and health care delivery for concussed athletes. The Nintendo Wii Balance Board (Nintendo of America Inc., Redmond, Washington) is a portable, cost-effective tool that has the potential to aid in the evaluation of postural stability in concussed individuals. The purpose of this study was to evaluate the Wii Balance Board as an objective, user-friendly, cost effective, valid alternative tool for the measurement of postural stability in college athletes. This study questioned whether the Wii Balance Board, when compared to the Balance Error Scoring System (BESS), is an objective tool that can be used as an acceptable measurement of postural stability in college athletes. (C) 2015 Elsevier Inc. All rights reserved.	[Guzman, Jill; Aktan, Nadine] William Paterson Univ, 300 Pompton Rd, Wayne, NJ 07470 USA		Guzman, J (corresponding author), William Paterson Univ, 300 Pompton Rd, Wayne, NJ 07470 USA.	guzmanj21@wpunj.edu		Guzman, Jill /0000-0001-6496-1351			Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Bey T, 2009, WEST J EMERG MED, V10, P6; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Broglio SP, 2009, J ATHL TRAINING, V44, P497, DOI 10.4085/1062-6050-44.5.497; Butler DP, 2010, INJURY, V41, P883, DOI 10.1016/j.injury.2010.03.024; Clark RA, 2010, GAIT POSTURE, V31, P307, DOI 10.1016/j.gaitpost.2009.11.012; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; US Centers for Disease Control and Prevention, 2007, MMWR-MORBID MORTAL W, V56, P733; Wikstrom EA, 2012, J ATHL TRAINING, V47, P306, DOI 10.4085/1062-6050-47.3.16	14	1	1	0	11	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0897-1897	1532-8201		APPL NURS RES	Appl. Nurs. Res.	FEB	2016	29						1	4		10.1016/j.apnr.2015.04.008			4	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	DE8JH	WOS:000370881800001	26856479				2022-02-06	
J	Koay, CG; Yeh, PH; Ollinger, JM; Irfanoglu, MO; Pierpaoli, C; Basser, PJ; Oakes, TR; Riedy, G				Koay, Cheng Guan; Yeh, Ping-Hong; Ollinger, John M.; Irfanoglu, M. Okan; Pierpaoli, Carlo; Basser, Peter J.; Oakes, Terrence R.; Riedy, Gerard			Tract Orientation and Angular Dispersion Deviation Indicator (TOADDI): A framework for single-subject analysis in diffusion tensor imaging	NEUROIMAGE			English	Article						Elliptical cone of uncertainty; DTI; FDR; FNR; Exact Wilcoxon-Mann-Whitney p-value computation	FALSE DISCOVERY RATE; PHYSIOLOGICAL NOISE; FIBER ORIENTATION; ROBUST ESTIMATION; MR; UNCERTAINTY; BRAIN; FIELD; PROPAGATION; TRACKING	The purpose of this work is to develop a framework for single-subject analysis of diffusion tensor imaging (DTI) data. This framework is termed Tract Orientation and Angular Dispersion Deviation Indicator (TOADDI) because it is capable of testing whether an individual tract as represented by the major eigenvector of the diffusion tensor and its corresponding angular dispersion are significantly different from a group of tracts on a voxel-by-voxel basis. This work develops two complementary statistical tests based on the elliptical cone of uncertainty, which is a model of uncertainty or dispersion of the major eigenvector of the diffusion tensor. The orientation deviation test examines whether the major eigenvector from a single subject is within the average elliptical cone of uncertainty formed by a collection of elliptical cones of uncertainty. The shape deviation test is based on the two-tailed Wilcoxon-Mann-Whitney two-sample test between the normalized shape measures (area and circumference) of the elliptical cones of uncertainty of the single subject against a group of controls. The False Discovery Rate (FDR) and False Non-discovery Rate (FNR) were incorporated in the orientation deviation test. The shape deviation test uses FDR only. TOADDI was found to be numerically accurate and statistically effective. Clinical data from two Traumatic Brain Injury (TBI) patients and one non-TBI subject were tested against the data obtained from a group of 45 non-TBI controls to illustrate the application of the proposed framework in single-subject analysis. The frontal portion of the superior longitudinal fasciculus seemed to be implicated in both tests (orientation and shape) as significantly different from that of the control group. The TBI patients and the single non-TBI subject were well separated under the shape deviation test at the chosen FDR level of 0.0005. TOADDI is a simple but novel geometrically based statistical framework for analyzing DTI data. TOADDI may be found useful in single-subject, graph-theoretic and group analyses of DTI data or DTI-based tractography techniques. Published by Elsevier Inc.	[Koay, Cheng Guan; Yeh, Ping-Hong; Ollinger, John M.; Oakes, Terrence R.; Riedy, Gerard] Natl Intrepid Ctr Excellence NICoE, Bethesda, MD USA; [Yeh, Ping-Hong; Irfanoglu, M. Okan] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA; [Koay, Cheng Guan; Irfanoglu, M. Okan; Pierpaoli, Carlo; Basser, Peter J.] NICHD, Sect Tissue Biophys & Biomimet, NIH, Bethesda, MD USA; [Koay, Cheng Guan] NorthTide Grp LLC, Dulles, VA USA; [Riedy, Gerard] Natl Capital Neuroimaging Consortium, Bethesda, MD USA		Koay, CG (corresponding author), Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA.	guankoac@mail.nih.gov	Koay, Cheng Guan/AAH-8017-2020; Pierpaoli, Carlo/E-1672-2011	Koay, Cheng Guan/0000-0002-4343-8040; Pierpaoli, Carlo/0000-0001-8558-4428	Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	C.G. Koay dedicates this work to the memory of Madam Oh Soo See. The authors would like to thank Drs Connie Duncan and Louis French for sharing TBI patients' imaging data. The authors would also like to thank Ms. Elyssa Sham for coordinating the recruitment of patients and volunteers, Mr. John A. Morissette for acquiring the clinical data, Mr. Justin S. Senseney for managing the clinical data. Appendix E contains an abridged and concise version of the first part of the author's unpublished lecture note prepared for the occasion of the Mathematics/Computer Science Annual Alumni Lecture at Berea College on November 9, 2012. The current implementation of the proposed framework was built upon the HI-SPEED software packets of which C.G. Koay is the principal developer. HI-SPEED software packets are available for research use at URL:http://sites.google.com/site/hispeedpackets/. P.J. Basser and C. Pierpaoli are supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development. The Mathematica (R) implementation of the two versions of the Wilcoxon-Mann-Whitney U tests, one with tied ranks and the other one without tied ranks, will be available as online supplementary materials on the publisher website.	Anderson AW, 2001, MAGNET RESON MED, V46, P1174, DOI 10.1002/mrm.1315; Anderson AW, 2005, MAGN RESON MED, V54, P1194, DOI 10.1002/mrm.20667; Andersson JLR, 2008, NEUROIMAGE, V42, P1340, DOI 10.1016/j.neuroimage.2008.05.053; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Barbieri S, 2011, NEUROIMAGE, V55, P532, DOI 10.1016/j.neuroimage.2010.12.069; Basser P.J., 1997, P INT SOC MAGN RESON; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Basser PJ, 2003, IEEE T MED IMAGING, V22, P785, DOI 10.1109/TMI.2003.815059; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 2002, MAGN RESON MED, V47, P392, DOI 10.1002/mrm.10052; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Bellman R., 1970, INTRO MATRIX ANAL; Beltrachini L, 2013, MAGN RESON IMAGING, V31, P1372, DOI 10.1016/j.mri.2013.04.009; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Caruyer Emmanuel, 2013, Magn Reson Med, V69, P1534, DOI 10.1002/mrm.24736; Chang LC, 2005, MAGN RESON MED, V53, P1088, DOI 10.1002/mrm.20426; Chang LC, 2007, MAGN RESON MED, V57, P141, DOI 10.1002/mrm.21111; Chang LC, 2012, MAGN RESON MED, V68, P1654, DOI 10.1002/mrm.24173; Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422; Cook PA, 2007, J MAGN RESON IMAGING, V25, P1051, DOI 10.1002/jmri.20905; Coxeter HSM, 1989, INTRO GEOMETRY; Deriche R, 2009, MED IMAGE ANAL, V13, P564, DOI 10.1016/j.media.2009.05.008; Descoteaux M, 2007, MAGN RESON MED, V58, P497, DOI 10.1002/mrm.21277; Descoteaux M, 2011, MED IMAGE ANAL, V15, P603, DOI 10.1016/j.media.2010.07.001; Dubois J, 2006, MAGN RESON MATER PHY, V19, P134, DOI 10.1007/s10334-006-0036-0; Euler L, 1776, NOVI COMMENTARII ACA, P189; Genovese C, 2002, J ROY STAT SOC B, V64, P499, DOI 10.1111/1467-9868.00347; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; HARDING EF, 1984, J R STAT SOC C-APPL, V33, P1; HENKELMAN RM, 1985, MED PHYS, V12, P232, DOI 10.1118/1.595711; Hirsch M.W., 1974, DIFFERENTIAL EQUATIO; Hutchinson EB, 2012, J NEUROSCI METH, V206, P40, DOI 10.1016/j.jneumeth.2012.02.004; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jeong H.K., 2005, P INT SOC MAGN RESON; Jeong HK, 2008, MAGN RESON MED, V60, P1408, DOI 10.1002/mrm.21734; Jezzard P, 1999, HUM BRAIN MAPP, V8, P80, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<80::AID-HBM2>3.0.CO;2-C; Jian B, 2007, NEUROIMAGE, V37, P164, DOI 10.1016/j.neuroimage.2007.03.074; Jones DK, 2005, MAGNET RESON MED, V53, P1143, DOI 10.1002/mrm.20466; Jones DK, 2004, MAGN RESON MED, V52, P979, DOI 10.1002/mrm.20283; Jones DK, 2003, MAGN RESON MED, V49, P7, DOI 10.1002/mrm.10331; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Koay C.G., 2009, HIGHLY SPECIFIC EDGI; Koay CG, 2006, J MAGN RESON, V179, P317, DOI 10.1016/j.jmr.2006.01.016; Koay CG, 2008, IEEE T MED IMAGING, V27, P834, DOI 10.1109/TMI.2008.915663; Koay CG, 2007, IEEE T MED IMAGING, V26, P1017, DOI 10.1109/TMI.2007.897415; Koay CG, 2006, J MAGN RESON, V182, P115, DOI 10.1016/j.jmr.2006.06.020; Koay CG, 2014, MAGN RESON MED, V71, P723, DOI 10.1002/mrm.24715; Koay CG, 2013, CONCEPT MAGN RESON A, V42, P116, DOI [10.1002/cmr.a.21269, 10.1002/cmr.21269]; Koay CG, 2012, MED PHYS, V39, P2499, DOI 10.1118/1.3700166; Koay CG, 2011, MED PHYS, V38, P4795, DOI 10.1118/1.3615163; Koay CG, 2009, MECH MATER, V41, P951, DOI 10.1016/j.mechmat.2008.12.006; Koay CG, 2009, J MAGN RESON, V199, P94, DOI 10.1016/j.jmr.2009.03.005; Koay CG, 2009, J MAGN RESON, V197, P108, DOI 10.1016/j.jmr.2008.11.015; Lazar M, 2005, NEUROIMAGE, V24, P524, DOI 10.1016/j.neuroimage.2004.08.050; Lazar M, 2005, MAGN RESON MED, V54, P860, DOI 10.1002/mrm.20653; Lazar M, 2003, NEUROIMAGE, V20, P1140, DOI 10.1016/S1053-8119(03)00277-5; Lehmann E.L., 2006, NONPARAMETRICS STAT; Liu CL, 2004, MAGN RESON MED, V51, P924, DOI 10.1002/mrm.20071; Mangin JF, 2002, MED IMAGE ANAL, V6, P191, DOI 10.1016/S1361-8415(02)00079-8; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Maximov II, 2011, J MAGN RESON, V213, P136, DOI 10.1016/j.jmr.2011.09.035; Moakher M, 2006, J ELASTICITY, V82, P273, DOI 10.1007/s10659-005-9035-z; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Nagarajan N, 2009, COMPUTATION STAT, V24, P605, DOI 10.1007/s00180-009-0148-x; Oguz I, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00004; Ozarslan E, 2003, MAGN RESON MED, V50, P955, DOI 10.1002/mrm.10596; Pajevic S, 2002, J MAGN RESON, V154, P85, DOI 10.1006/jmre.2001.2452; Parker GJM, 2003, J MAGN RESON IMAGING, V18, P242, DOI 10.1002/jmri.10350; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Pinheiro JC, 1996, STAT COMPUT, V6, P289, DOI 10.1007/BF00140873; Polders DL, 2011, J MAGN RESON IMAGING, V33, P1456, DOI 10.1002/jmri.22554; Poonawalla AH, 2004, J MAGN RESON IMAGING, V19, P489, DOI 10.1002/jmri.20020; Poupon C, 2001, MED IMAGE ANAL, V5, P1, DOI 10.1016/S1361-8415(00)00030-X; Poupon C, 2000, NEUROIMAGE, V12, P184, DOI 10.1006/nimg.2000.0607; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sachs L., 1984, APPL STAT HDB TECHNI; Schwarz CG, 2014, NEUROIMAGE, V94, P65, DOI 10.1016/j.neuroimage.2014.03.026; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; STEJSKAL EO, 1965, J CHEM PHYS, V43, P3597, DOI 10.1063/1.1696526; Veraart J, 2013, MAGN RESON MED, V70, P972, DOI 10.1002/mrm.24529; Walker L, 2011, NEUROIMAGE, V54, P1168, DOI 10.1016/j.neuroimage.2010.08.048; Wang ZZ, 2004, IEEE T MED IMAGING, V23, P930, DOI 10.1109/TMI.2004.831218; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Wu YC, 2004, MAGN RESON MED, V52, P1146, DOI 10.1002/mrm.20254; Yekutieli D, 1999, J STAT PLAN INFER, V82, P171, DOI 10.1016/S0378-3758(99)00041-5; Zhang H, 2006, MED IMAGE ANAL, V10, P764, DOI 10.1016/j.media.2006.06.004; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072	90	1	1	1	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	FEB 1	2016	126						151	163		10.1016/j.neuroimage.2015.11.046			13	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	DC5VX	WOS:000369289800014	26638985	Green Accepted, Green Submitted			2022-02-06	
J	Luse, TM; Slosek, J; Rennix, C				Luse, Tina M.; Slosek, Jean; Rennix, Christopher			Comparison of Select Health Outcomes by Deployment Health Assessment Completion	MILITARY MEDICINE			English	Article							COMBAT; AFGHANISTAN; SERVICES; BARRIERS; DUTY; CARE; IRAQ	The Department of Defense (DoD) requires service members to complete regular health assessments for identification of deployment-related physical/behavioral issues and environmental/occupational exposures. Compliance among active duty Department of the Navy personnel varies; however, and the impact of incomplete assessments on generalizability of results is unclear. This study examines the differences between Navy and Marine Corps service members who completed both the Post-Deployment Health Assessment and Post-Deployment Health Reassessment (n = 9,452) as compared to service members who never attempted either form (n = 5,603) in fiscal year 2010. Deployment rosters, assessments, and clinical data were analyzed to determine certified assessment completion rates and incidence of certain health conditions in these populations. Only 38.9% of applicable personnel met the completion and certification criteria for the required assessments. Service members who did not complete the forms were distinctly different demographically and at increased risk for psychotropic drug use, post-traumatic stress disorder diagnosis, and traumatic brain injury diagnosis following deployment. The prevailing assumption that the risk of adverse health effects on operational forces can be estimated using the population that completed the required assessments is incorrect, and the true operational impact and medical burden of these conditions may be underestimated.	[Luse, Tina M.; Slosek, Jean; Rennix, Christopher] Navy & Marine Corps Public Hlth Ctr, EpiData Ctr Dept, 620 John Paul Jones Circle,Suite 100, Portsmouth, VA 23708 USA		Luse, TM (corresponding author), Navy & Marine Corps Public Hlth Ctr, EpiData Ctr Dept, 620 John Paul Jones Circle,Suite 100, Portsmouth, VA 23708 USA.		Rennix, Christopher/AAF-3942-2021				Armed Forces Health Surveillance Center (AFHSC), 2011, SECT 13 NEUR TRAUM B; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Kim PY, 2010, PSYCHIAT SERV, V61, P582, DOI 10.1176/ps.2010.61.6.582; Warner CH, 2011, ARCH GEN PSYCHIAT, V68, P1065, DOI 10.1001/archgenpsychiatry.2011.112	5	1	1	0	0	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075	1930-613X		MIL MED	Milit. Med.	FEB	2016	181	2					123	128		10.7205/MILMED-D-15-00019			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI3ND	WOS:000373404500013	26837080	Bronze			2022-02-06	
J	Marsden, SP; Boddy, IJS; Strachan, RD; Chambers, IR				Marsden, S. P.; Boddy, I. J. S.; Strachan, R. D.; Chambers, I. R.			In-house development of a dedicated data acquisition and monitoring system for intracranial pressure, patient posture and patient symptoms in a regional neurosciences centre	PHYSIOLOGICAL MEASUREMENT			English	Article						intracranial pressure; patient monitoring; instrumentation; medical devices	TRAUMATIC BRAIN-INJURY; CEREBRAL PERFUSION-PRESSURE; HYPERTENSION; MANAGEMENT	Management of traumatic brain injury and cerebrospinal fluid (CSF) flow disorders can be aided by measurement and monitoring of intracranial pressure (ICP). In addition to pressure measurement, knowledge of patient symptoms and posture during monitoring are also valuable, particularly in the management of CSF flow disorders. ICP monitoring systems have been developed in this centre to meet clinical needs in the absence of commercially available solutions. An early system (mark I) was developed and the technical challenges in its design are described, along with limitations to this system that motivated the development of a new mark II system. The mark II system is then described.	[Marsden, S. P.; Boddy, I. J. S.; Chambers, I. R.] South Tees Hosp NHS Fdn Trust, James Cook Univ Hosp, Dept Med Phys, Middlesbrough TS4 3BW, Cleveland, England; [Strachan, R. D.] South Tees Hosp NHS Fdn Trust, James Cook Univ Hosp, Dept Neurosurg, Middlesbrough TS4 3BW, Cleveland, England		Boddy, IJS (corresponding author), South Tees Hosp NHS Fdn Trust, James Cook Univ Hosp, Dept Med Phys, Middlesbrough TS4 3BW, Cleveland, England.	ian.boddy@stees.nhs.uk	Strachan, Roger/AAT-8295-2020				Andresen M, 2015, ACTA NEUROCHIR, V157, P109, DOI 10.1007/s00701-014-2250-2; Baral B, 2007, PAK J MED SCI, V23, P798; Biousse V, 2012, J NEUROL NEUROSUR PS, V83, P488, DOI 10.1136/jnnp-2011-302029; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Ducros A, 2015, LANCET NEUROL, V14, P655, DOI 10.1016/S1474-4422(15)00015-0; Eide PK, 2010, NEUROSURGERY, V66, P80, DOI 10.1227/01.NEU.0000363408.69856.B8; Fan Jun-Yu, 2004, J Neurosci Nurs, V36, P278; Farahmand D, 2015, J NEUROL NEUROSUR PS, V86, P222, DOI 10.1136/jnnp-2014-307873; FELDMAN Z, 1992, J NEUROSURG, V76, P207, DOI 10.3171/jns.1992.76.2.0207; Graff-Radford SB, 2014, HEADACHE, V54, P394, DOI 10.1111/head.12283; Guiza F, 2013, CRIT CARE MED, V41, P554, DOI 10.1097/CCM.0b013e3182742d0a; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Lam MF, 2011, J CLIN NEUROSCI, V18, P988, DOI 10.1016/j.jocn.2010.11.024; LEE ST, 1989, HEART LUNG, V18, P411; Mokri B, 2013, HEADACHE, V53, P1034, DOI 10.1111/head.12149; Ng I, 2004, NEUROSURGERY, V54, P593, DOI 10.1227/01.NEU.0000108639.16783.39; Poca MA, 2006, NEUROSURGERY, V58, P899, DOI 10.1227/01.NEU.0000209915.16235.6D; Signorini DF, 1997, CRIT CARE MED, V25, P2048, DOI 10.1097/00003246-199712000-00024; Smith M, 2008, ANESTH ANALG, V106, P240, DOI 10.1213/01.ane.0000297296.52006.8e; Warden KF, 2011, J NEURO-OPHTHALMOL, V31, P202, DOI 10.1097/WNO.0b013e3182183c8d; Weerakkody RA, 2011, ACTA NEUROL SCAND, V124, P85, DOI 10.1111/j.1600-0404.2010.01467.x; Winkelman C, 2000, Am J Crit Care, V9, P373	24	1	1	0	2	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0967-3334	1361-6579		PHYSIOL MEAS	Physiol. Meas.	FEB	2016	37	2					N1	N10		10.1088/0967-3334/37/2/N1			10	Biophysics; Engineering, Biomedical; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering; Physiology	DC6WC	WOS:000369359300009	26767623				2022-02-06	
J	Tesson, SA; Nogajski, RR; Macey, JA; Paget, SP				Tesson, Stephanie A.; Nogajski, Rebecca R.; Macey, Julie-Anne; Paget, Simon P.			Reliability of the Abbreviated Westmead Post-traumatic Amnesia Scale in children: Impact of age on test results	EMERGENCY MEDICINE AUSTRALASIA			English	Article						Abbreviated Westmead Post-traumatic Amnesia Scale; concussion; mild traumatic brain injury; paediatric; post-traumatic amnesia	SPORT-RELATED CONCUSSION; GLASGOW COMA SCALE; VALIDATION; DURATION; MEMORY	ObjectiveThis study aimed to determine the reliability of the Abbreviated Westmead Post-traumatic Amnesia Scale (A-WPTAS) in children by examining the impact of age on A-WPTAS performance. MethodsParticipants were typically developing patients with minor illnesses or injuries and/or accompanying siblings aged 5-10years, attending a children's hospital ED. Exclusion criteria included: (i) a recent traumatic brain injury; (ii) developmental disability; (iii) recent drug administration judged to impact cognition; and/or (iv) non-English speaking background. The A-WPTAS was administered on two occasions separated by approximately 60min. Logistic regression was used to determine the odds of passing based on age. ResultsA total of 125 children completed the A-WPTAS assessments. A-WPTAS pass rates were 36% for 5yearolds, 68% for 6yearolds, and exceeded 90% for 7-10year olds. Compared with 9yearolds, 5yearolds had significantly lower odds of passing (P=0.003), a trend that persisted for 6yearolds (P=0.052). Among 5 and 6yearolds, failure was predominantly due to difficulty with temporo-spatial orientation items. ConclusionsThe A-WPTAS is reliable for use in children aged 7years and older, while its use in children aged 6years and under results in an unsatisfactory high false positive rate, limiting its clinical utility. The adult-level performance of children aged 7years onwards provides strong support for using the tool in the early management of these children with mild traumatic brain injury in Australian EDs.	[Tesson, Stephanie A.; Paget, Simon P.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Nogajski, Rebecca R.] Childrens Hosp Westmead, Emergency Dept, Westmead, NSW 2145, Australia; [Macey, Julie-Anne; Paget, Simon P.] Childrens Hosp Westmead, Kids Rehab, Sydney, NSW, Australia		Paget, SP (corresponding author), Childrens Hosp Westmead, Kids Rehab, Hawkesbury Rd & Hainsworth St, Westmead, NSW 2145, Australia.	simon.paget@health.nsw.gov.au	Meijer, Anna/K-5118-2016	Paget, Simon/0000-0001-6605-3330; Tesson, Stephanie/0000-0002-9650-0696	Sydney Medical School, the University of Sydney	The authors thank the parents and children who generously dedicated their time to participating in this research. We also acknowledge the assistance of Ms Jessica Wiese (Occupational Therapist) for training in administering the tool and Dr Liz Barnes at the Children's Hospital Westmead for her statistical support. This research was funded by a grant from Sydney Medical School, the University of Sydney.	Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Briggs R, 2015, DEV MED CHILD NEUROL, V57, P618, DOI 10.1111/dmcn.12674; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Emergency Care Institute, 2015, A WPTAS STAT FORM EX; FRIEDMAN WJ, 1991, CHILD DEV, V62, P139, DOI 10.2307/1130710; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; MAROSSZEKY NEV, 1993, CLIN NEUROPSYCHOL, V7, P85, DOI 10.1080/13854049308401890; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; Meares S, 2015, ARCH PHYS MED REHAB, V96, P956, DOI 10.1016/j.apmr.2014.12.014; Meares S, 2011, BRAIN INJURY, V25, P1198, DOI 10.3109/02699052.2011.608213; NSW Department of Health, 2015, PD2011024 NSW DEP HL; Ponsford J, 1995, J HEAD TRAUMA REHAB, V10, P87; Rocca A., 2001, THESIS MACQUARIE U S; Rocca A, 2008, BRAIN IMPAIR, V9, P14, DOI 10.1375/brim.9.1.14; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; RUIJS MBM, 1992, DEV MED CHILD NEUROL, V34, P885; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; WALKER P, 1994, INT J BEHAV DEV, P73	21	1	1	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-6731	1742-6723		EMERG MED AUSTRALAS	Emerg. Med. Australas.	FEB	2016	28	1					73	77		10.1111/1742-6723.12502			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	DD9SN	WOS:000370266000011	26558740				2022-02-06	
J	Elbuken, G; Tanriverdi, F; Karaca, Z; Eser, B; Hasdiraz, L; Unluhizarci, K; Gokoglu, A; Cetin, A; Selcuklu, A; Kelestimur, F				Elbuken, Gulsah; Tanriverdi, Fatih; Karaca, Zuleyha; Eser, Bulent; Hasdiraz, Leyla; Unluhizarci, Kursad; Gokoglu, Abdulkerim; Cetin, Aysun; Selcuklu, Ahmet; Kelestimur, Fahrettin			Evaluation of peripheral blood CD34+ cell count in the acute phase of traumatic brain injury and chest trauma	BRAIN INJURY			English	Article						CD 34; Hematopoeitic stem cell; healthy group; cortisol; chest trauma; traumatic brain injury	ENDOTHELIAL PROGENITOR CELLS; STEM-CELLS; NEOVASCULARIZATION; MOBILIZATION; HYPOPITUITARISM; THERAPY	Aim: To determine the impact of traumatic brain injury (TBI) and chest trauma (CT) on the number of peripheral blood (PB) stem cells in affected patients in comparison to normal controls. Additionally, the aim was to determine the relationship between CD34+ cell counts and TBI-induced hypothalamus-pituitary-adrenal axis dysfunction in the acute phase of trauma. Patients and method: Thirty patients with TBI, 12 patients with CT and 53 healthy subjects were included in the study. Results: CD34+ cell counts within the first 24-48 hours of TBI were found to be lower than those obtained on the 7(th) day of TBI and those in the healthy controls. CD34+ cell counts obtained on the 2(nd) day of CT were lower than those in the healthy group, but did not differ from those measured on the 7(th) day of CT. There was no correlation between CD34+ cell counts and serum total cortisol (STC) levels on the 2(nd) and 7(th) days in the TBI or CT groups. Conclusion: An increase in CD34+ cell counts as observed on the 7(th) day in both TBI and CT groups suggested that CD34 changes were not specific to TBI. Moreover, this study showed for the first time that CD34 response was not affected by changes in cortisol levels induced by TBI and severity of TBI.	[Elbuken, Gulsah; Tanriverdi, Fatih; Karaca, Zuleyha; Unluhizarci, Kursad; Kelestimur, Fahrettin] Erciyes Univ, Sch Med, Dept Endocrinol & Metab, TR-38039 Kayseri, Turkey; [Eser, Bulent] Erciyes Univ, Sch Med, Dept Hematol, TR-38039 Kayseri, Turkey; [Hasdiraz, Leyla] Erciyes Univ, Sch Med, Dept Chest Surg, TR-38039 Kayseri, Turkey; [Gokoglu, Abdulkerim; Selcuklu, Ahmet] Erciyes Univ, Sch Med, Dept Neurosurg, TR-38039 Kayseri, Turkey; [Cetin, Aysun] Erciyes Univ, Sch Med, Dept Biochem, TR-38039 Kayseri, Turkey		Kelestimur, F (corresponding author), Erciyes Univ, Sch Med, Dept Endocrinol & Metab, TR-38039 Kayseri, Turkey.	fktimur@erciyes.edu.tr	kelestimur, f/ABE-9873-2021; Karaca, Zuleyha/ABB-7891-2021; Elbuken, Gulsah/ABD-5689-2020	Elbuken, Gulsah/0000-0002-0920-6895	Erciyes University Council of Scientific InvestigationsErciyes University [TSA-10-2905]	This study was supported by the Erciyes University Council of Scientific Investigations (Project code: TSA-10-2905). The authors reports no conflicts of interest. The authors alone are responsible for the content and writing of the paper.	Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Bensinger W, 2009, BONE MARROW TRANSPL, V43, P181, DOI 10.1038/bmt.2008.410; Bodera P, 2014, PHARMACOL REP, V66, P288, DOI 10.1016/j.pharep.2013.12.003; CIVIN CI, 1990, PROG CLIN BIOL RES, V333, P387; Cooper Mark Stuart, 2007, J Intensive Care Med, V22, P348, DOI 10.1177/0885066607307832; Gertz MA, 2010, BRIT J HAEMATOL, V150, P647, DOI 10.1111/j.1365-2141.2010.08313.x; Guo XB, 2009, J NEUROTRAUM, V26, P1337, DOI [10.1089/neu.2008.0733, 10.1089/neu.2008-0733]; Hannon MJ, 2013, J CLIN ENDOCR METAB, V98, P3229, DOI 10.1210/jc.2013-1555; Heike T, 2002, BBA-MOL CELL RES, V1592, P313, DOI 10.1016/S0167-4889(02)00324-5; Jin XL, 2014, MICROCIRCULATION, V21, P696, DOI 10.1111/micc.12150; Kawamoto A, 2006, CIRCULATION, V114, P2163, DOI 10.1161/CIRCULATIONAHA.106.644518; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Li ZY, 2012, J NEUROTRAUM, V29, P343, DOI 10.1089/neu.2011.1807; Liu L, 2007, J NEUROTRAUM, V24, P936, DOI 10.1089/neu.2006.0250; Liu L, 2011, CRIT CARE MED, V39, P1760, DOI 10.1097/CCM.0b013e3182186cee; Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898; Paczkowska E, 2009, STROKE, V40, P1237, DOI 10.1161/STROKEAHA.108.535062; Schneider HJ, 2011, J NEUROTRAUM, V28, P1693, DOI 10.1089/neu.2011.1887; Schuster MD, 2004, AM J PHYSIOL-HEART C, V287, pH525, DOI 10.1152/ajpheart.00058.2004; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Tanriverdi F, 2007, BRAIN INJURY, V21, P433, DOI 10.1080/02699050701311083; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; TEASDALE G, 1974, LANCET, V2, P81; Wang L, 2014, TRANSLATIONAL S 0803; Wei HJ, 2011, NEUROSCI LETT, V498, P114, DOI 10.1016/j.neulet.2011.04.061; Xue S, 2010, NEUROSCI LETT, V473, P186, DOI 10.1016/j.neulet.2010.02.035	26	1	1	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 28	2016	30	2					179	183		10.3109/02699052.2015.1090015			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DF3MM	WOS:000371248400008	26649467				2022-02-06	
S	Al-Ali, H; Lemmon, VP; Bixby, JL		Kobeissy, F; Dixon, CE; Hayes, RL; Mondello, S		Al-Ali, Hassan; Lemmon, Vance P.; Bixby, John L.			Phenotypic Screening of Small-Molecule Inhibitors: Implications for Therapeutic Discovery and Drug Target Development in Traumatic Brain Injury	INJURY MODELS OF THE CENTRAL NERVOUS SYSTEM: METHODS AND PROTOCOLS	Methods in Molecular Biology		English	Article; Book Chapter						High-content screening; Primary neurons; Cell-based assay; Axon regeneration; CNS injury; Kinase inhibitor; Drug discovery	CHONDROITIN SULFATE PROTEOGLYCANS; MYELIN-ASSOCIATED INHIBITORS; SPINAL-CORD-INJURY; AXONAL REGENERATION; KINASE INHIBITORS; NEURITE OUTGROWTH; CORTICAL-NEURONS; RHO-KINASE; GROWTH; CNS	The inability of central nervous system (CNS) neurons to regenerate damaged axons and dendrites following traumatic brain injury (TBI) creates a substantial obstacle for functional recovery. Apoptotic cell death, deposition of scar tissue, and growth-repressive molecules produced by glia further complicate the problem and make it challenging for re-growing axons to extend across injury sites. To date, there are no approved drugs for the treatment of TBI, accentuating the need for relevant leads. Cell-based and organotypic bioassays can better mimic outcomes within the native CNS microenvironment than target-based screening methods and thus should speed the discovery of therapeutic agents that induce axon or dendrite regeneration. Additionally, when used to screen focused chemical libraries such as small-molecule protein kinase inhibitors, these assays can help elucidate molecular mechanisms involved in neurite outgrowth and regeneration as well as identify novel drug targets. Here, we describe a phenotypic cellular (high content) screening assay that utilizes brain-derived primary neurons for screening small-molecule chemical libraries.	[Al-Ali, Hassan; Lemmon, Vance P.; Bixby, John L.] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Lemmon, Vance P.; Bixby, John L.] Univ Miami, Miller Sch Med, Ctr Computat Sci, Miami, FL 33136 USA; [Lemmon, Vance P.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA; [Bixby, John L.] Univ Miami, Miller Sch Med, Mol & Cellular Pharmacol, Miami, FL 33136 USA		Al-Ali, H (corresponding author), Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA.		Lemmon, Vance/A-7410-2010	Lemmon, Vance/0000-0003-3550-7576; Al-Ali, Hassan/0000-0002-8899-3443	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD057632] Funding Source: NIH RePORTER		Al-Ali H., 2013, ASSAY GUID MAN; Al-Ali H, 2015, ACS CHEM BIOL, V10, P1939, DOI 10.1021/acschembio.5b00289; Al-Ali H, 2013, ACS CHEM BIOL, V8, P1027, DOI 10.1021/cb300584e; Bermel C, 2009, MOL CELL NEUROSCI, V42, P427, DOI 10.1016/j.mcn.2009.09.005; Blackmore MG, 2011, MOL CELL, V44, P43; Blackmore MG, 2010, MOL CELL NEUROSCI, V44, P43, DOI 10.1016/j.mcn.2010.02.002; Buchser WJ, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.52; Cafferty WBJ, 2008, TRENDS NEUROSCI, V31, P215, DOI 10.1016/j.tins.2008.02.004; Centers for Disease Control and Prevention, 2013, INJ PREV CONTR TRAUM; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Don ASA, 2012, DRUG DISCOV TODAY, V17, P861, DOI 10.1016/j.drudis.2012.04.010; Duffy P, 2009, J NEUROSCI, V29, P15266, DOI 10.1523/JNEUROSCI.4650-09.2009; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Frantz S, 2005, NATURE, V437, P942, DOI 10.1038/437942a; Giuliano KA, 1997, J BIOMOL SCREEN, V2, P249, DOI 10.1177/108705719700200410; Itoh T, 2007, NEUROL RES, V29, P734, DOI 10.1179/016164107X208086; Klebl BM, 2005, EXPERT OPIN THER TAR, V9, P975, DOI 10.1517/14728222.9.5.975; Lee JK, 2012, EXP NEUROL, V235, P33, DOI 10.1016/j.expneurol.2011.05.001; Lee JK, 2010, J NEUROSCI, V30, P10899, DOI 10.1523/JNEUROSCI.2269-10.2010; Lerch JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030417; Lingor P, 2007, J NEUROCHEM, V103, P181, DOI 10.1111/j.1471-4159.2007.04756.x; Loh SHY, 2008, CELL DEATH DIFFER, V15, P283, DOI 10.1038/sj.cdd.4402258; Lu Q, 2009, CURR MED CHEM, V16, P1355, DOI 10.2174/092986709787846569; Meberg PJ, 2003, METHOD CELL BIOL, V71, P111, DOI 10.1016/S0091-679X(03)01007-0; Monnier PP, 2003, MOL CELL NEUROSCI, V22, P319, DOI 10.1016/S1044-7431(02)00035-0; Mueller BK, 2005, NAT REV DRUG DISCOV, V4, P387, DOI 10.1038/nrd1719; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Pettus LH, 2008, CURR TOP MED CHEM, V8, P1452, DOI 10.2174/156802608786264245; Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310; Shields LBE, 2008, SURG NEUROL, V69, P568, DOI 10.1016/j.surneu.2008.02.009; Sivasankaran R, 2004, NAT NEUROSCI, V7, P261, DOI 10.1038/nn1193; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; Wang HJ, 2011, NEUROREPORT, V22, P733, DOI 10.1097/WNR.0b013e32834a58e8; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Welsbie DS, 2013, P NATL ACAD SCI USA, V110, P4045, DOI 10.1073/pnas.1211284110; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	37	1	2	1	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	1064-3745		978-1-4939-3816-2; 978-1-4939-3814-8	METHODS MOL BIOL	Methods Mol. Biol.		2016	1462						677	688		10.1007/978-1-4939-3816-2_37	10.1007/978-1-4939-3816-2		12	Biochemical Research Methods; Biochemistry & Molecular Biology; Neurosciences	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology; Neurosciences & Neurology	BH1UG	WOS:000398551500039	27604745				2022-02-06	
J	Basar, HM; Seluk, S; Aydin, N				Basar, Hatice Melek; Seluk, Semiha; Aydin, Nazan			Secondary Psychotic Mania Following Traumatic Brain Injury: A Case Report	JOURNAL OF MOOD DISORDERS			English	Article						bipolar disorder; traumatic brain injury; secondary mania; head trauma	MULTIPLE-SCLEROSIS; BIPOLAR DISORDER; COMORBIDITY	Secondary manic or hypomanic states are associated with several conditions. Common post - traumatic brain injury psychiatric comorbidities include affective, behavioral and cognitive disorders. While bipolar disorder is not as common as other mood disorders or anxiety disorders after traumatic brain injury, it is nevertheless a potential psychiatric complication of traumatic brain injury. In this article we present a case that has been reported psychiatric conditions changing after a traumatic brain injury. We recommend taking attention to those possible causes of changed psychiatric conditions after traumatic brain injury, and the association between comorbid diseases and the diagnostic difficulties.	[Basar, Hatice Melek] Buyukcekmece State Hosp, Dept Psychiat, Istanbul, Turkey; [Seluk, Semiha; Aydin, Nazan] Bakirkoy Res & Training Hosp, Psychiat Neurol & Neurosurg, Istanbul, Turkey		Basar, HM (corresponding author), Bakirkoy Res & Training Hosp, Psychiat Neurol & Neurosurg, Istanbul, Turkey.	hmelekbasar@hotmail.com	AYDIN, Nazan/Y-1869-2019	AYDIN, Nazan/0000-0003-3232-7713			Altinbas K, 2007, TURKIYE KLIN DAHILI, V3, P30; Bolu A, 2012, B CLIN PSYCHOPHAR S1, V22, pS104; Bozikas VP, 2003, PROG NEURO-PSYCHOPH, V27, P835, DOI 10.1016/S0278-5846(03)00116-7; Casanova MF, 1996, J NEUROPSYCH CLIN N, V8, P206; Chwastiak LA, 2007, PSYCHIAT CLIN N AM, V30, P803, DOI 10.1016/j.psc.2007.07.003; Deb S, 1999, AM J PSYCHIAT, V156, P374; Dilbaz N, 2014, BIPOLAR DEPRESYON TE, V7, P56; Handel SF, AFFECTIVE DISORDER P, V48, P67; HEILA H, 1995, J AM ACAD CHILD PSY, V34, P1591, DOI 10.1097/00004583-199512000-00009; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; JORGE RE, 1993, AM J PSYCHIAT, V150, P916; Keskin N, 2013, CUKUROVA MED J, V38, P832; ORAL ET, 1994, DUSUNEN ADAM, V7, P30; Rao V, 2002, PSYCHIAT CLIN N AM, V25, P43, DOI 10.1016/S0193-953X(03)00052-2; de Cerqueira ACR, 2010, REV BRAS PSIQUIATR, V32, P454, DOI 10.1590/S1516-44462010000400021; SCHIFFER RB, 1986, AM J PSYCHIAT, V143, P94; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; Sidhom Y, 2014, BEHAV NEUROL, V4, P1; Ybarra MI, 2007, ARQ NEURO-PSIQUIAT, V65, P1177, DOI 10.1590/S0004-282X2007000700016	19	1	1	0	2	YERKURE TANITIM & YAYINCILIK HIZMETLERI A S	ISTANB	CUMHURYET CAD 48-3B, HARBIYE, ISTANB, 34367, TURKEY	2146-1473	2146-2380		J MOOD DISORD	J. Mood Disord.		2016	6	2					79	81		10.5455/jmood.20150622013455			3	Psychiatry	Emerging Sources Citation Index (ESCI)	Psychiatry	EC2LC	WOS:000387949200006					2022-02-06	
J	Bergman, TJ; Saporito, RC; Hope, T				Bergman, Taylor J.; Saporito, Rachael C.; Hope, Thomas			Bilateral Superior Cerebellar Artery Embolic Occlusion with a Fetal-Type Posterior Cerebral Artery Providing Collateral Circulation	CASE REPORTS IN NEUROLOGY			English	Article						Superior cerebellar artery; Embolic occlusion; Fetal-type posterior cerebral artery; Collateral circulation; Cardioembolic stroke		Bilateral infarction of the superior cerebellar arteries with sparing of the rest of the posterior circulation, particularly the posterior cerebral arteries, is an uncommon finding in neurological practice. Most commonly, the deficits of the superior cerebellar arteries and posterior cerebral arteries occur together due to the close proximity of their origins at the top of the basilar artery. A patient was transferred to the neurological intensive care unit with a history of recent-onset falls from standing, profound hypertension, dizziness, and headaches. The neurological exam revealed cerebellar signs, including dysmetria of the right upper extremity and a decreased level of consciousness. Computed tomography of the head and neck revealed decreased attenuation throughout most of the cerebellar hemispheres suggestive of ischemic injury with sparing of the rest of the brain. Further investigation with a computed tomography angiogram revealed a fetal-type posterior cerebral artery on the right side that was providing collateral circulation to the posterior brain. Due to this embryological anomaly, the patient was spared significant morbidity and mortality that would have likely occurred had the circulation been more typical of an adult male. (C) 2016 The Author(s) Published by S. Karger AG, Basel	[Bergman, Taylor J.; Saporito, Rachael C.; Hope, Thomas] Mercer Univ, Sch Med, Dept Internal Med, Div Neurol, Macon, GA 31207 USA		Bergman, TJ (corresponding author), Med Ctr Cent Georgia, West Tower Box 30,777 Hemlock St, Macon, GA 31217 USA.	bergman_tj@med.mercer.edu					Arboix A, 2012, CURR CARDIOL REV, V8, P54, DOI 10.2174/157340312801215791; CAPLAN LR, 1980, NEUROLOGY, V30, P72, DOI 10.1212/WNL.30.1.72; Devuyst G, 2002, ARCH NEUROL-CHICAGO, V59, P567, DOI 10.1001/archneur.59.4.567; FERBERT A, 1990, STROKE, V21, P1135, DOI 10.1161/01.STR.21.8.1135; Kathuria S, 2011, SEMIN ULTRASOUND CT, V32, P242, DOI 10.1053/j.sult.2011.02.002; Terao S, 1996, STROKE, V27, P1679, DOI 10.1161/01.STR.27.9.1679; van Raamt AF, 2006, CEREBROVASC DIS, V22, P217, DOI 10.1159/000094007	7	1	2	1	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1662-680X			CASE REP NEUROL	Case Rep. Neurol.		2016	8	3					258	263		10.1159/000452942			6	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	EG4FU	WOS:000390999900012	28203181	Green Published, gold			2022-02-06	
J	Bogle, JM; Barrs, D; Wester, M; Davis, L; Cevette, MJ				Bogle, Jamie M.; Barrs, David; Wester, Matthew; Davis, Laurie; Cevette, Michael J.			Labyrinthine concussion following gunshot injury: A case report	INTERNATIONAL JOURNAL OF AUDIOLOGY			English	Article						Medical audiology; vestibular; anatomy and physiology; electrophysiology	HEARING-LOSS; HEAD TRAUMA; DIZZINESS	Objective: Labyrinthine concussion due to a postauricular gunshot wound has not been well reported. Design: Retrospective chart review. Study sample: We describe an otherwise healthy 22-year-old male who received a gunshot wound to the left mastoid and subsequently reported hearing loss and rotational vertigo. Results: Audiometric testing demonstrated significant inverted scoop shaped sensorineural hearing loss. Vestibular diagnostic testing indicated a significant uncompensated left peripheral vestibulopathy. Imaging demonstrated no structural changes to the middle ear or labyrinth, suggesting that the auditory and vestibular losses noted on diagnostic examination were likely due to labyrinthine concussion. Conclusions: Labyrinthine concussion may lead to reduced vestibular reflex pathway following gunshot wounds to the temporal bone. Clinical presentation is likely to vary significantly among cases.	[Bogle, Jamie M.; Barrs, David; Cevette, Michael J.] Mayo Clin Arizona, Dept Otolaryngol, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA; [Wester, Matthew; Davis, Laurie] Mayo Clin Arizona, Dept Audiol, Scottsdale, AZ USA		Bogle, JM (corresponding author), Mayo Clin Arizona, Dept Otolaryngol, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA.	bogle.jamie@mayo.edu					Akin FW, 2011, OTOLARYNG CLIN N AM, V44, P323, DOI 10.1016/j.otc.2011.01.005; Bergemalm PO, 2003, ACTA OTO-LARYNGOL, V123, P836, DOI 10.1080/00016480310002474; Brunner H, 1940, LARYNGOSCOPE, V50, P921; BYRNES DP, 1974, BRIT J SURG, V61, P169, DOI 10.1002/bjs.1800610302; Canalis R. F., 1999, EAR COMPREHENSIVE OT; DUNCAN NO, 1986, OTOLARYNG HEAD NECK, V94, P47, DOI 10.1177/019459988609400109; Fitzgerald DC, 1996, J TRAUMA, V40, P488, DOI 10.1097/00005373-199603000-00034; GROS JC, 1967, SOUTHERN MED J, V60, P705, DOI 10.1097/00007611-196707000-00006; Guyot JP, 2001, ANN OTO RHINOL LARYN, V110, P562, DOI 10.1177/000348940111000611; Motin M, 2005, BRAIN INJURY, V19, P693, DOI 10.1080/02699050400013600	10	1	1	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1499-2027	1708-8186		INT J AUDIOL	Int. J. Audiol.		2016	55	7					425	428		10.3109/14992027.2016.1166398			4	Audiology & Speech-Language Pathology; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Otorhinolaryngology	DN3XE	WOS:000376996700006	27092730				2022-02-06	
J	Brickham, D; Kim, JH; Gonzalez, R; Rosenthal, D				Brickham, Dana; Kim, Jeong Han; Gonzalez, Rene; Rosenthal, David			Vocational outcomes of people with alcohol abuse/dependence who received state vocational rehabilitation services	JOURNAL OF VOCATIONAL REHABILITATION			English	Article						Vocational rehabilitation; alcohol abuse; substance abuse; RSA 911; employment outcomes; CHAID	TRAUMATIC BRAIN-INJURY; EMPLOYMENT OUTCOMES; DISABILITIES; INDIVIDUALS; CLIENTS; EDUCATION	BACKGROUND: Vocational rehabilitation for people with alcohol abuse/dependence can help individuals access and maintain employment, and further enhance physical and psychological health and well-being. OBJECTIVE: To examine demographic and rehabilitation service patterns affecting employment outcomes of consumers with alcohol abuse/dependence in state vocational rehabilitation agencies. METHODS: The sample included 7,798 persons (74% men and 26% women) with alcohol abuse/dependence who were closed either as rehabilitated or not rehabilitated by their state-run vocational rehabilitation agencies in the fiscal year 2009. Mean age of participants was 40.1 years (SD = 10.2). The dependent variable was employment outcome. The predictor variables include a set of demographic variables and vocational rehabilitation service variables. RESULTS: The chi-squared automatic interaction detector (CHAID) analysis indicated that counseling and guidance services significantly enhanced competitive employment outcomes. The study also revealed the underutilization of job related services for assistance in finding employment, gaining employment, and retaining employment (e.g., job search assistance, job placement, and on-the-job supports). Also, an underutilization of training type services such as on-the-job training, miscellaneous training, occupational/vocational, and college or university training were revealed in serving consumers with alcohol abuse/dependence. CONCLUSIONS: The data mining approach (i.e., CHAID analysis) provided detailed information and insight about interactions among demographic variables, rehabilitation service patterns, and competitive employment rates ranging from a low of 41% to a high of 76%, and these differences can be explained by rehabilitation service patterns.	[Brickham, Dana] Western Washington Univ, Grad Program Rehabil Counseling, Bellingham, WA 98225 USA; [Kim, Jeong Han] Virginia Commonwealth Univ, Dept Rehabil Counseling, Richmond, VA USA; [Gonzalez, Rene] Univ Texas Rio Grande Valley, Sch Rehabil Serv & Counseling, Edinburg, TX USA; [Rosenthal, David] Univ Wisconsin, Dept Rehabil Psychol & Special Educ, Madison, WI 53706 USA		Brickham, D (corresponding author), Western Washington Univ, Grad Program Rehabil Counseling, Bellingham, WA 98225 USA.	Dana.Brickham@wwu.edu					[Anonymous], 2011, VR PROGRAM POLICY MA; Bakken S. K, 2005, DISS ABSTR INT, V66, P4472; Batiste LC, 2005, ACCOMMODATION COMPLI; Bolton BF, 2000, REHABIL COUNS BULL, V44, P10, DOI 10.1177/003435520004400103; Bounds TA, 2003, NEUROREHABILITATION, V18, P189; BRITTEN ND, 1984, J REHABIL, V50, P47; Bureau of Labor Statistics, 2010, DAT EMPL STAT PEOPL; Cardoso E., 2009, UNDERSTANDING PSYCHO, P399; Catalano D, 2006, NEUROREHABILITATION, V21, P279; Chan F, 2006, DISABIL REHABIL, V28, P257, DOI 10.1080/09638280500158307; Chronister J., 2008, J TEACHING ADDICTION, V7, P31; Crisp R, 2005, J REHABIL, V71, P30; Cardoso EDS, 2007, J HEAD TRAUMA REHAB, V22, P85, DOI 10.1097/01.HTR.0000265096.44683.6b; Dowdy CA, 1996, J LEARN DISABIL, V29, P137, DOI 10.1177/002221949602900203; Dutta A, 2008, J OCCUP REHABIL, V18, P326, DOI 10.1007/s10926-008-9154-z; Glenn M. K., 2011, SUBSTANCE USE DISORD; Glenn M. K., 2008, J REHABILITATION COU, V39, P37; Gonzalez R, 2011, J VOCAT REHABIL, V34, P163, DOI 10.3233/JVR-2011-0544; Hayward B. J., 2003, LONGITUDINAL STUDY V; Hitchen S R, 2001, Am Indian Alsk Native Ment Health Res, V10, P85; Hollar D., 2008, J APPL REHABILITATIO, V39, P25; Janikowski T., 2005, CASE MANAGEMENT REHA, P248; Keferl J., 2008, J APPL REHABILITATIO, V39, P3; Kosciulek J. F., 2004, REHABILITATION ED, V18, P139; Leahy MJ, 2003, REHABIL COUNS BULL, V46, P66, DOI 10.1177/00343552030460020101; Marini I, 2008, J VOCAT REHABIL, V28, P1; Martin FH, 2010, REHABIL COUNS BULL, V54, P26, DOI 10.1177/0034355209360420; McAweeney M., 2008, J APPL REHABILITATIO, V39, P12; McAweeney M., 2008, J APPL REHABILITATIO, V39, P30; Ong L. Z., 2008, REHABILITATION ED, V21, P179; PLATT JJ, 1995, PSYCHOL BULL, V117, P416, DOI 10.1037/0033-2909.117.3.416; Rehabilitation Services Administration, 2004, RSA911; Rosenthal DA, 2005, J REHABIL, V71, P36; Rosenthal DA, 2007, INT J SOC PSYCHIATR, V53, P357, DOI 10.1177/0020764006074555; SCHOTTENFELD RS, 1992, J SUBST ABUSE TREAT, V9, P3, DOI 10.1016/0740-5472(92)90003-7; Smart J. F., 2007, J APPL REHABILITATIO, V38, P3; SPSS, 2002, ANSWERTREE 3 1 US GU; Walls RT, 2009, J REHABIL, V75, P35; WEST SL, 1999, J APPL REHABILITATIO, V0030, P00033, DOI DOI 10.1891/0047-2220.3; Wilson K. B., 2001, J APPL REHABILITATIO, V32, P24; Wilson KB, 2000, REHABIL COUNS BULL, V43, P97, DOI 10.1177/003435520004300205	41	1	1	0	1	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1052-2263	1878-6316		J VOCAT REHABIL	J. Vocat. Rehabil.		2016	45	3					267	279		10.3233/JVR-160828			13	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	ED3EY	WOS:000388733400004					2022-02-06	
J	Briggs, R; Birse, J; Tate, R; Brookes, N; Epps, A; Lah, S				Briggs, Rachel; Birse, Jason; Tate, Robyn; Brookes, Naomi; Epps, Adrienne; Lah, Suncica			Natural sequence of recovery from child post-traumatic amnesia: A retrospective cohort study	CHILD NEUROPSYCHOLOGY			English	Article						Traumatic brain injuries; Amnesia; Pediatric; Rehabilitation	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; GALVESTON ORIENTATION; PRACTICAL SCALE; MEMORY; SEVERITY; PTA; CONSCIOUSNESS; MULTICENTER; DURATION	The aim of this study was to determine the sequence of skills recovery during post-traumaticamnesia (PTA) in children with moderate to severe traumatic brain injuries (TBIs). Setting: Fifty children aged 8 to 15 years consecutively admitted to a children's hospital with TBI and PTA>24 were tested in a retrospective cohort study where the main measure was the Westmead PTA Scale (WPTAS). The group analyses show that orientation to time took longer to recover than orientation to person and place, but not memory, while the individual analyses revealed that when orientation to time was grouped with memory, 94% of children recovered orientation to person and place before orientation to time and memory (examiner and pictures). Correlation coefficients between age and the number of days taken to recover skills were not found to be significant. It was established that, in terms of the natural sequence of skills recovery in children aged 8 to 15 years followingmoderate to severe TBI, recovery of orientation to time is more closely aligned tomemory than to orientation to person and place. It was also established that WPTAS items are developmentally appropriate for children aged 8 to 15 years who have sustained TBI. These findings are clinically important because monitoring recovery from PTA both impacts the rehabilitation offered to individuals during acute care and aids discharge planning.	[Briggs, Rachel; Lah, Suncica] Univ Sydney, Sch Psychol, Sydney, NSW 2008, Australia; [Briggs, Rachel; Lah, Suncica] Australian Res Council, Ctr Excellence Cognit & Its Disorders, Sydney, NSW, Australia; [Birse, Jason; Brookes, Naomi; Epps, Adrienne] Sydney Childrens Hosp, Brain Injury Rehabil Program, Randwick, NSW, Australia; [Tate, Robyn] NHMRC Ctr Res Excellence Traumat Brain Injury Reh, Sydney, NSW, Australia; [Tate, Robyn] Univ Sydney, Rehabil Studies Unit, Northern Clin Sch, Sydney Med Sch, Sydney, NSW, Australia		Lah, S (corresponding author), Univ Sydney, Sch Psychol, Sydney, NSW 2008, Australia.	sunnyl@psych.usyd.edu.au		Lah, Suncica/0000-0003-2282-4812	University of SydneyUniversity of Sydney [2012-02364]	Suncica Lah was in part supported by The University of Sydney Thompson Fellowship [grant number 2012-02364].	Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson V., 2011, NEUROPSYCHOLOGY, V124, P1064; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; ARTIOLAIFORTUNY L, 1980, J NEUROL NEUROSUR PS, V43, P377, DOI 10.1136/jnnp.43.5.377; Briggs R, 2015, DEV MED CHILD NEUROL, V57, P618, DOI 10.1111/dmcn.12674; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Calvert S, 2008, DEV MED CHILD NEUROL, V50, P426, DOI 10.1111/j.1469-8749.2008.02061.x; CORRIGAN JD, 1985, ARCH PHYS MED REHAB, V66, P626; de Haan M, 2006, TRENDS NEUROSCI, V29, P374, DOI 10.1016/j.tins.2006.05.008; EWINGCOBBS L, 1990, NEUROSURGERY, V27, P683, DOI 10.1227/00006123-199011000-00003; FORRESTER G, 1994, BRAIN INJURY, V8, P175, DOI 10.3109/02699059409150969; GEFFEN G, 1994, AUST OCCUP THER J, V41, P31, DOI DOI 10.1111/J.1440-1630.1994.TB01809.X; GEFFEN GM, 1991, NEUROREPORT, V2, P105, DOI 10.1097/00001756-199102000-00010; GRIFFITH R, 1970, ABILITIES YOUNG CHIL; GRONWALL D, 1980, Journal of Clinical Neuropsychology, V2, P51, DOI 10.1080/01688638008403780; HIGH WM, 1990, J CLIN EXP NEUROPSYC, V12, P703, DOI 10.1080/01688639008401013; Kosch Y, 2010, BRAIN INJURY, V24, P479, DOI 10.3109/02699051003610417; Leach K, 2006, BRAIN INJURY, V20, P1241, DOI 10.1080/02699050601049874; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; MAROSSZEKY NEV, 1993, CLIN NEUROPSYCHOL, V7, P85, DOI 10.1080/13854049308401890; McFarland K, 2001, CLIN NEUROPSYCHOL, V15, P59, DOI 10.1076/clin.15.1.59.1916; Novack TA, 2000, J HEAD TRAUMA REHAB, V15, P957, DOI 10.1097/00001199-200006000-00008; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; Sandhaug M, 2010, BRAIN INJURY, V24, P740, DOI 10.3109/02699051003652849; SANEDA D L, 1992, Brain Injury, V6, P167, DOI 10.3109/02699059209029655; Segal S, 2001, INTENS CARE MED, V27, P236, DOI 10.1007/s001340000717; Shores E A, 1995, Appl Neuropsychol, V2, P167; SHORES EA, 1989, J NEUROL NEUROSUR PS, V52, P126, DOI 10.1136/jnnp.52.1.126-a; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Snow P, 2013, TRAUMATIC BRAIN INJU, P34; Tate RL, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.074989; Tate RL, 2001, J HEAD TRAUMA REHAB, V16, P525, DOI 10.1097/00001199-200112000-00002; Tate RL, 2000, J NEUROL NEUROSUR PS, V68, P178, DOI 10.1136/jnnp.68.2.178; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; TEASDALE G, 1974, LANCET, V2, P81; Wheeler MA, 1997, PSYCHOL BULL, V121, P331, DOI 10.1037/0033-2909.121.3.331	37	1	1	0	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.		2016	22	6					666	678		10.1080/09297049.2015.1038988			13	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	DV0BO	WOS:000382582900003	26069988				2022-02-06	
J	Paiva, ALC; de Aguiar, GB; Ferraz, VR; Araujo, JLV; Toita, MH; Veiga, JCE				Campos Paiva, Aline Lariessy; de Aguiar, Guilherme Brasileiro; Ferraz, Vinicius Riccieri; Vitorino Araujo, Joao Luiz; Toita, Milton Hikaro; Esteves Veiga, Jose Carlos			Retroclival Pneumocephalus Associated with Bilateral Abducens Palsy in a Child	PEDIATRIC NEUROSURGERY			English	Article						Traumatic brain injury; Posterior fossa; Clivus; Abducens nerve; Traumatic pneumocephalus	NERVE PALSY	Traumatic brain injury (TBI) is less common in children than in adults. Posterior fossa lesions are even more uncommon, but, when present, are usually epidural hematomas. These lesions, even when small, may have a bad outcome because of the possibility of compression of the important structures that the infratentorial compartment contains, such as the brainstem and cranial nerves, and the constriction of the fourth ventricle, causing acute hydrocephalus. Although unusual, posterior fossa lesions are increasingly being diagnosed because of the better quality of and easier access to cranial tomography. In this paper, we report a case of a 12-year-old male patient who had suffered a TBI and presented with several pneumocephali, one of them in the retroclival region, causing a mass effect and then compression of the sixth cranial nerve which is the most susceptible to these injuries. We discuss these traumatic posterior fossa lesions, with an emphasis on retroclival pneumocephalus, not yet described in the literature in association with bilateral abducens palsy. In addition, we discuss associated lesions and the trauma mechanism. (C) 2016 S. Karger AG, Basel	[Campos Paiva, Aline Lariessy; de Aguiar, Guilherme Brasileiro; Ferraz, Vinicius Riccieri; Vitorino Araujo, Joao Luiz; Toita, Milton Hikaro; Esteves Veiga, Jose Carlos] Fac Ciencias Med Santa Casa Sao Paulo, Dept Surg, Neurosurg Div, St Cesario Motta Jr,112 Vila Buarque, BR-01221900 Sao Paulo, SP, Brazil		de Aguiar, GB (corresponding author), Fac Ciencias Med Santa Casa Sao Paulo, Dept Surg, Neurosurg Div, St Cesario Motta Jr,112 Vila Buarque, BR-01221900 Sao Paulo, SP, Brazil.	guilhermebraguiar@yahoo.com.br	de Aguiar, Guilherme Brasileiro/AAQ-6955-2020; Veiga, Jose/AAV-1687-2020				Alharthy Nesrin, 2015, J Emerg Trauma Shock, V8, P88, DOI 10.4103/0974-2700.155504; Bonilha L, 2002, ARQ NEURO-PSIQUIAT, V60, P636, DOI 10.1590/S0004-282X2002000400023; Calisaneller T, 2006, CHILD NERV SYST, V22, P726, DOI 10.1007/s00381-005-0036-9; Chen JG, 2015, ACTA NEUROCHIR, V157, P1493, DOI 10.1007/s00701-015-2516-3; Holmes J M, 1998, J AAPOS, V2, P265, DOI 10.1016/S1091-8531(98)90081-7; Iaconetta G, 2007, NEUROSURGERY, V61, P7, DOI 10.1227/01.NEU.0000280037.32286.F2; Kwon TH, 2008, NEUROL MED-CHIR, V48, P347, DOI 10.2176/nmc.48.347; OTSUKA S-I, 1990, Neurologia Medico-Chirurgica, V30, P24, DOI 10.2176/nmc.30.24; Ozveren MF, 2002, NEUROSURGERY, V50, P829, DOI 10.1097/00006123-200204000-00027; Selcuk F, 2013, AM J CASE REP, V14, P230, DOI 10.12659/AJCR.889065; Souza RB, 2011, PEDIATR NEUROSURG, V47, P288; Takagi H, 1976, No Shinkei Geka, V4, P963; Tubbs RS, 2010, NEUROSURGERY, V67, P404, DOI 10.1227/01.NEU.0000372085.70895.E7	13	1	1	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291	1423-0305		PEDIATR NEUROSURG	Pediatr. Neurosurg.		2016	51	5					269	272		10.1159/000445905			4	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	DS9NM	WOS:000381110100009	27193585				2022-02-06	
J	Cheng, ZH; Lin, T; Chen, WS; Wu, WG; Yan, SG				Cheng, Zhaohui; Lin, Tiao; Chen, Weishan; Wu, Weigang; Yan, Shigui			The effect of erythropoietin in the treatment of acute spinal cord injury	INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE			English	Article						Acute spinal cord injury; erythropoietin; neurological function	TRAUMATIC BRAIN-INJURY; RANDOMIZED CONTROLLED-TRIAL; NEUROPROTECTION; RATS; METHYLPREDNISOLONE; RECOVERY; EFFICACY; THERAPY; REPAIR	Objectives: The aim of this study was to evaluate the recovery of motor and sensory function in patients with acute spinal cord injury (ASCI) after recombinant human erythropoietin (EPO) treatment. The safety and efficacy of EPO for ASCI was discussed as well. Methods: The clinical data of 60 ASCI cases were analyzed in a retrospective manner, in which EPO-treated therapy group (n=30) and the EPO-untreated group (n=30) were included. The neurological function of each patient at admission, twelve and twenty- fourth months were reviewed. The adverse events were recorded as well. Results: All of the 60 patients were followed up for 2 similar to 3 years (average 2.4 years) after treatment. The follow-up of both groups showed that the patients in the therapy group had a better improvement in the AIS and ASIA motor score and more sensation of touch than the control group (P<0.05). No statistically significant difference regarding the red blood cell count and hemoglobin (Hb) concentration between therapy group and control group was found (P>0.05). Conclusion: EPO is a safe and effective drug for treating ASCI. Early application of EPO can promote the recovery of the motor and sensory function in patients with ASCI.	[Cheng, Zhaohui; Chen, Weishan; Wu, Weigang; Yan, Shigui] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Orthopaed Surg, Hangzhou 310009, Zhejiang, Peoples R China; [Cheng, Zhaohui] Huangyan Hosp, Wenzhou Med Coll, Dept Orthopaed Surg, Taizhou 318020, Zhejiang, Peoples R China; [Lin, Tiao] Sun Yat Sen Univ, Affiliated Hosp 1, Musculoskeletal Oncol Ctr, Guangzhou 510080, Guangdong, Peoples R China		Yan, SG (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Orthopaed Surg, Hangzhou 310009, Zhejiang, Peoples R China.	zrjwsj@zju.edu.cn			Huangyan Science and Technology Bureau (Science and Technology Project) [2010060]	At the point of finishing this paper, I'd like to express my sincere thanks to all the patients who were involved in this study. This project was supported by Huangyan Science and Technology Bureau (Science and Technology Project 2010060 to Cheng).	Alibai Ehsanali, 2014, Acta Med Iran, V52, P275; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; Brines M CA, 2006, NOVEL THERAPEUTIC OP, P147; Cerri G, 2012, NEUROSCIENCE, V219, P290, DOI 10.1016/j.neuroscience.2012.05.041; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; Fehlings MG, 2016, SPINAL CORD, V54, P8, DOI 10.1038/sc.2015.95; Freitag MT, 2015, J NEUROIMAGING, V25, P582, DOI 10.1111/jon.12202; Gelain F, 2011, ACS NANO, V5, P227, DOI 10.1021/nn102461w; Gorio A, 2002, P NATL ACAD SCI USA, V99, P9450, DOI 10.1073/pnas.142287899; Grasso G, 2007, DRUG NEWS PERSPECT, V20, P315, DOI 10.1358/dnp.2007.20.5.1120219; [郭新庆 GUO Xinqing], 2007, [中国康复医学杂志, Chinese Journal of Rehabilitation Medicine], V22, P503; Guo Xinqing ZQ, 2006, CHINESE J CLIN REHAB, V10; Hawryluk GWJ, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E14; Hayes KC, 2000, ARCH PHYS MED REHAB, V81, P644, DOI 10.1053/mr.2000.3873.; Hu Y, 2009, CHIN J EXP SURG, V1, P26; Hugenholtz H, 2003, CAN MED ASSOC J, V168, P1145; Jin W, 2014, J TRAUMA ACUTE CARE, V76, P1228, DOI 10.1097/TA.0000000000000211; King VR, 2007, EUR J NEUROSCI, V26, P90, DOI 10.1111/j.1460-9568.2007.05635.x; Kontogeorgakos VA, 2009, ARCH ORTHOP TRAUM SU, V129, P189, DOI 10.1007/s00402-008-0594-x; Kwon BK, 2005, SPINE, V30, pS3, DOI 10.1097/01.brs.0000175186.17923.87; Kwon BK, 2011, J NEUROTRAUM, V28, P1545, DOI 10.1089/neu.2009.1149; Marca L, 2006, AM J PHYS MED REHABI, V85, P310; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Pannu R, 2005, J NEUROSCI RES, V79, P340, DOI 10.1002/jnr.20345; Peng WJ, 2014, J NEUROSURG, V121, P653, DOI 10.3171/2014.6.JNS132577; Pickelsimer E, 2010, J SPINAL CORD MED, V33, P221, DOI 10.1080/10790268.2010.11689699; Pimentel L, 2010, EMERG MED CLIN N AM, V28, P719, DOI 10.1016/j.emc.2010.07.003; Pointillart V, 2000, SPINAL CORD, V38, P71, DOI 10.1038/sj.sc.3100962; Pollard ME, 2003, SPINE, V28, P33, DOI 10.1097/00007632-200301010-00009; Rangarajan V, 2014, PEDIATR NEUROL, V51, P481, DOI 10.1016/j.pediatrneurol.2014.06.008; Savitsky Eric, 1997, Journal of Emergency Medicine, V15, P49, DOI 10.1016/S0736-4679(96)00258-2; Schwab ME, 2002, SCIENCE, V295, P1029, DOI 10.1126/science.1067840; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; Wang JG ZQ, 2005, CHINESE J CLIN REHAB, V9; [王金光 Wang Jinguang], 2003, [中国脊柱脊髓杂志, Chinese Journal of Spine and Spinal Cord], V13, P674; Wong BR, 1997, J BIOL CHEM, V272, P25190, DOI 10.1074/jbc.272.40.25190; Zheng QX WY, 2005, CHIN J REHABIL THEOR, V11; Zhu L, 2009, BRAIN RES, V1289, P96, DOI 10.1016/j.brainres.2009.07.015	38	1	1	0	2	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	1940-5901			INT J CLIN EXP MED	Int. J. Clin. Exp. Med.		2016	9	11					22267	22274					8	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	EG7UD	WOS:000391260800211					2022-02-06	
S	Clausen, F		Janowski, M		Clausen, Fredrik			Animal Models of Traumatic Brain Injury	EXPERIMENTAL NEUROSURGERY IN ANIMAL MODELS	Neuromethods		English	Article; Book Chapter						Traumatic brain injury; Mice; Rats; Controlled cortical impact; Fluid percussion injury; Weight drop injury; Stereotaxy	CONTROLLED CORTICAL IMPACT; FLUID-PERCUSSION MODEL; INTRACRANIAL-PRESSURE; RATS; CRANIECTOMY; MOUSE	Animal models of traumatic brain injury (TBI) have been the core of the research on the molecular, cellular, and functional effects of the disease. To be able to simulate the heterogeneous aspects of TBI several models have been designed. This chapter aims to describe the three most commonly used experimental models of TBI in rodents.	[Clausen, Fredrik] Uppsala Univ, Dept Neurosci, Sect Neurosurg, Uppsala, Sweden		Clausen, F (corresponding author), Uppsala Univ, Dept Neurosci, Sect Neurosurg, Uppsala, Sweden.						Carbonnel WS, 1999, ACTA NEUROPATHOL, V98, P396, DOI 10.1007/s004010051100; Clausen F, 2005, ACTA NEUROCHIR, V147, P775, DOI 10.1007/s00701-005-0550-2; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Floyd CL, 2002, J NEUROTRAUM, V19, P303, DOI 10.1089/089771502753594873; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Frey LC, 2009, J NEUROSCI METH, V177, P267, DOI 10.1016/j.jneumeth.2008.10.022; Goren S, 2001, J NEUROSURG ANESTH, V13, P113, DOI 10.1097/00008506-200104000-00008; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Stalhammar D, 1987, Brain Inj, V1, P73, DOI 10.3109/02699058709034448; Uematsu M, 2009, NEUROREPORT, V20, P219, DOI 10.1097/WNR.0b013e328302ee46; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	15	1	1	0	2	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES	0893-2336		978-1-4939-3730-1; 978-1-4939-3728-8	NEUROMETHODS	Neuromethods		2016	116						1	12		10.1007/978-1-4939-3730-1_1	10.1007/978-1-4939-3730-1		12	Clinical Neurology; Surgery	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Surgery	BG4LP	WOS:000388975500003					2022-02-06	
S	Davidsson, J; Risling, M		Kobeissy, F; Dixon, CE; Hayes, RL; Mondello, S		Davidsson, Johan; Risling, Marten			Experimental Models for Neurotrauma Research	INJURY MODELS OF THE CENTRAL NERVOUS SYSTEM: METHODS AND PROTOCOLS	Methods in Molecular Biology		English	Article; Book Chapter						Traumatic brain injury (TBI); Diffuse axonal injury (DAI); Mechanisms; Blast trauma; White matter	TRAUMATIC BRAIN-INJURY; DIFFUSE AXONAL INJURY; VENTRAL FUNICULUS LESION; CLOSED-HEAD INJURY; ADULT-RAT BRAIN; SPINAL-CORD; ROOT AVULSION; IMPULSE NOISE; ROTATIONAL ACCELERATION; INTRAMEDULLARY AXOTOMY	Physical trauma in the central nervous system (CNS) is usually the result of a number of forces in different directions and dimensions. A large number of experimental models have been developed to improve the possibilities to understand the outcome of CNS trauma. In this chapter, we will describe the need for a variety of experimental models for research on traumatic brain injury (TBI) and spinal cord injury (SCI). Models can serve different needs, such as: to test new treatments for injuries, to reveal thresholds for injuries, to provide a better understanding of injury mechanisms, or to test tools and methods for translation between experiments and clinical data. In this chapter, we will discuss on the validation of models and translation between experimental and clinical studies.	[Davidsson, Johan] Chalmers, Dept Appl Mech, Vehicle Safety Div, Gothenburg, Sweden; [Risling, Marten] Karolinska Inst, Expt Traumatol, Dept Neurosci, Stockholm, Sweden		Davidsson, J (corresponding author), Chalmers, Dept Appl Mech, Vehicle Safety Div, Gothenburg, Sweden.		Davidsson, Johan/A-3229-2016	Davidsson, Johan/0000-0002-1717-1514			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Agoston DV, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00129; Agoston Denes V, 2012, Front Neurol, V3, P3, DOI 10.3389/fneur.2012.00003; Andersson RWG, 2000, STUDY BIOMECHANICS A; Antona-Makoshi J, 2013, P 2013 INT IRCOBI C; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; CAREY ME, 1989, J NEUROSURG, V71, P754, DOI 10.3171/jns.1989.71.5.0754; CARLSTEDT T, 1986, ACTA PHYSIOL SCAND, V128, P645, DOI 10.1111/j.1748-1716.1986.tb08024.x; CARLSTEDT T, 1995, LANCET, V346, P1323, DOI 10.1016/S0140-6736(95)92342-X; Carlstedt T, 2009, NAT REV NEUROL, V5, P571, DOI 10.1038/nrneurol.2009.137; CELANDER H, 1955, ACTA PHYSIOL SCAND, V33, P6, DOI 10.1111/j.1748-1716.1955.tb01188.x; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; Chew DJ, 2011, NEUROPATH APPL NEURO, V37, P613, DOI 10.1111/j.1365-2990.2011.01176.x; Chew DJ, 2013, J NEUROTRAUM, V30, P160, DOI 10.1089/neu.2012.2481; CLEMEDSON C.-J., 1957, ACTA PATHOL ET MICROBIOL SCAND, V40, P89; Clemedson C. J., 1949, ACTA PHYSL SCAND S61, V18, P7; CLEMEDSON CARL-JOHAN, 1955, JOUR AVIATION MED, V26, P373; CLEMEDSON CJ, 1956, ACTA PHYSIOL SCAND, V37, P202; CLEMEDSON CJ, 1956, NATURE, V177, P380, DOI 10.1038/177380a0; CLEMEDSON CJ, 1958, AM J PHYSIOL, V194, P601, DOI 10.1152/ajplegacy.1958.194.3.601; CROCKARD HA, 1977, J NEUROSURG, V46, P776, DOI 10.3171/jns.1977.46.6.0776; CULLHEIM S, 1989, NEUROSCIENCE, V29, P725, DOI 10.1016/0306-4522(89)90144-9; Davidsson J, 2011, FRONTIERS NEUROTRAUM, V2, P1; Davidsson J, 2009, INT IRCOBI C BIOM IN; Davidsson J, 2008, APROSYS2008 EU; Davidsson J., 2013, P JSAE ANN C YOK JAP; Deckner M, 2000, EXP NEUROL, V166, P350, DOI 10.1006/exnr.2000.7543; DeFelipe J, 1928, HIST NEUROSCIENCE, V5; Ellingson Benjamin M., 2005, V41, P86; Fijalkowski RJ, 2007, J NEUROTRAUM, V24, P1387, DOI 10.1089/neu.2007.0268; FINNIE JW, 1993, J COMP PATHOL, V108, P93, DOI 10.1016/S0021-9975(08)80231-9; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Frisen J, 1998, J NEUROSCI, V18, P5714; FRISEN J, 1992, P NATL ACAD SCI USA, V89, P11282, DOI 10.1073/pnas.89.23.11282; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gutierrez E, 2001, J NEUROTRAUM, V18, P247, DOI 10.1089/08977150151070874; Holbourn AHS, 1943, LANCET, V2, P438; Jacobo A-M, 2014, INT J AUTOMOTIVE ENG, V5, P31; Kamnaksh A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04809; Kirkegaard M, 2006, NEUROSCIENCE, V142, P425, DOI 10.1016/j.neuroscience.2006.06.037; Kleiven Svein, 2013, Front Bioeng Biotechnol, V1, P15; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; LINDA H, 1992, J COMP NEUROL, V318, P188, DOI 10.1002/cne.903180205; LINDA H, 1985, BRAIN RES, V358, P329, DOI 10.1016/0006-8993(85)90978-3; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Lu J, 2012, J NEUROTRAUM, V29, P1434, DOI 10.1089/neu.2010.1591; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Melvin J, 1993, ACCIDENTAL INJURY BI; Murai N, 2008, J NEUROTRAUM, V25, P72, DOI 10.1089/neu.2007.0346; ONO K, 1980, P 24 STAPP CAR CRASH, P101; Plantman S, 2012, J NEUROTRAUM, V29, P1219, DOI 10.1089/neu.2011.2182; POVLISHOCK JT, 1995, BRAIN PATHOL, V5, P415, DOI 10.1111/j.1750-3639.1995.tb00620.x; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; RICHARDSON PM, 1980, NATURE, V284, P264, DOI 10.1038/284264a0; Richmond D. R., 1967, 1854 DASA FISS PROD, P1; RISLING M, 1993, BRAIN RES BULL, V30, P405, DOI 10.1016/0361-9230(93)90272-D; RISLING M, 1983, BRAIN RES, V280, P15, DOI 10.1016/0006-8993(83)91169-1; RISLING M, 1989, BRAIN RES, V494, P13, DOI 10.1016/0006-8993(89)90138-8; RISLING M, 1992, J NEUROCYTOL, V21, P79, DOI 10.1007/BF01189007; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Risling M., 2012, FRONT NEUROL, P1; Risling M, 2004, 7 INT NEUR S; Risling Marten, 2011, Front Neurol, V1, P159, DOI 10.3389/fneur.2010.00159; ROSS DT, 1994, EXP NEUROL, V126, P291, DOI 10.1006/exnr.1994.1067; Rostami E, 2014, BRAIN RES, V1542, P195, DOI 10.1016/j.brainres.2013.10.047; Rostami E, 2013, J NEUROTRAUM, V30, P1954, DOI 10.1089/neu.2012.2583; Rostami Elham, 2012, Front Neurol, V3, P115, DOI 10.3389/fneur.2012.00115; Rostami E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027389; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Runnerstam M, 2001, J NEUROTRAUM, V18, P259, DOI 10.1089/08977150151070892; SALAZAR AM, 1995, NEUROSURG CLIN N AM, V6, P715; Saljo A, 2002, J NEUROTRAUM, V19, P985, DOI 10.1089/089771502320317131; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Saljo Annette, 2001, Pathophysiology, V8, P105, DOI 10.1016/S0928-4680(01)00067-0; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; STRICH SJ, 1961, LANCET, V2, P443; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Tan YH, 1998, J ORAL MAXIL SURG, V56, P345, DOI 10.1016/S0278-2391(98)90113-6; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; Viano DC, BRAIN INJURY BIOMECH; White C S, 1965, CEX Rep Civ Eff Exerc, P1; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; WISMANS J., 2000, INJURY BIOMECHANICS; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	91	1	1	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	1064-3745		978-1-4939-3816-2; 978-1-4939-3814-8	METHODS MOL BIOL	Methods Mol. Biol.		2016	1462						267	288		10.1007/978-1-4939-3816-2_16	10.1007/978-1-4939-3816-2		22	Biochemical Research Methods; Biochemistry & Molecular Biology; Neurosciences	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology; Neurosciences & Neurology	BH1UG	WOS:000398551500018	27604724				2022-02-06	
J	Degeneffe, CE				Degeneffe, Charles Edmund			A Clarion Call for Social Work Attention: Brothers and Sisters of Persons With Acquired Brain Injury in the United States	JOURNAL OF SOCIAL WORK IN DISABILITY & REHABILITATION			English	Article						Acquired brain injury; disability; family; family caregiving; long-term care; pediatric; siblings; traumatic brain injury	QUALITY-OF-LIFE; ADULT SIBLINGS; PERSPECTIVES; PREDICTORS; DEPRESSION; PROGRAM	This article presents a clarion call for increased social work attention to the needs of siblings of persons with acquired brain injury (ABI) in the United States. The article overviews how siblings are psychosocially affected, how they provide care to the injured brothers and sisters, and how they personally develop as a result of their experiences. The article highlights the fact that social workers and other professionals often overlook the needs of siblings of persons with ABI and makes an appeal for social workers to advance clinical practice and research to benefit this often neglected population.	[Degeneffe, Charles Edmund] San Diego State Univ, Dept Adm Rehabil & Postsecondary Educ, Rehabil Counseling Program, 5500 Campanile Dr,EBA 227a, San Diego, CA 92182 USA		Degeneffe, CE (corresponding author), San Diego State Univ, Dept Adm Rehabil & Postsecondary Educ, Rehabil Counseling Program, 5500 Campanile Dr,EBA 227a, San Diego, CA 92182 USA.	cdegenef@mail.sdsu.edu					Berger E, 1999, RESTOR NEUROL NEUROS, V14, P93; Bishop M, 2006, AUST J REHABIL COUNS, V12, P73, DOI 10.1375/jrc.12.2.73; Bodley-Scott SEM, 2015, BRAIN IMPAIR, V16, P205, DOI 10.1017/BrImp.2015.22; Boss P., 1999, AMBIGUOUS LOSS LEARN; Brain Injury Association of America, 2015, WELC ACBIS; Bursnall S., 2003, THESIS; Bursnall S, 2013, HLTH HEALING TRAUMAT, P101; Centers for Disease Control and Prevention, 2015, TRAUMATIC BRAIN INJU; Centers for Disease Control and Prevention, 2016, TBI GET FACTS; Cicirelli V. G., 1991, FAMILIES INTERGENERA, P291; Council on Social Work Education, 2012, ED POL ACCR STAND; Degeneffe C.E., 2014, MILITARY DEPLOYMENT, P293; Degeneffe C.E., 2008, J APPL REHABIL COUS, V39, P42; Degeneffe CE, 2006, REHABIL COUNS BULL, V49, P130, DOI 10.1177/00343552060490030101; Degeneffe CE, 2001, HEALTH SOC WORK, V26, P257, DOI 10.1093/hsw/26.4.257; Degeneffe CE, 2009, AUST J REHABIL COUNS, V15, P12, DOI 10.1375/jrc.15.1.12; Degeneffe CE, 2008, J REHABIL, V74, P10; Degeneffe CE, 2015, J REHABIL, V81, P5; Degeneffe CE, 2015, SOC WORK, V60, P19, DOI 10.1093/sw/swu047; Degeneffe CE, 2010, J REHABIL, V76, P27; Degeneffe CE, 2010, BRAIN INJURY, V24, P1416, DOI 10.3109/02699052.2010.514317; Degeneffe CE, 2008, REHABIL COUNS BULL, V51, P240, DOI 10.1177/0034355207311319; Doka KJ., 2002, DISENFRANCHISED GRIE; Faul M, 2010, TRAUMATIC BRAIN INJU; Gan C, 2006, BRAIN INJURY, V20, P587, DOI 10.1080/02699050600743725; Gill D. J., 2000, REHABILITATION NURSI, V25, P48, DOI [10.1002/j.2048-7940.2000.tb01862.x, DOI 10.1002/J.2048-7940.2000.TB01862.X]; JACOBS HE, 1989, NEUROPSYCHOLOGICAL T, P297; Knox L., 2015, NEUROPSYCHOL REHABIL, V26, P1; Knox L, 2015, BRAIN INJURY, V29, P745, DOI 10.3109/02699052.2015.1004753; Kosciulek JF, 1996, J REHABIL, V62, P49; Lewinsohn PM, 1997, PSYCHOL AGING, V12, P277, DOI 10.1037/0882-7974.12.2.277; McIntyre M, 2013, HLTH HEALING TRAUMAT, P57; Medlar T, 1998, SEX DISABIL, V16, P11, DOI 10.1023/A:1023067630449; National Association of Social Workers, 2016, PACE BUILD POL POW S; Orsillo SM, 1993, J HEAD TRAUMA REHAB, V8, DOI [10.1097/00001199-199303000-00010, DOI 10.1097/00001199-199303000-00010]; PRIGATANO GP, 1995, J HEAD TRAUMA REHAB, V10, P87; Raj SP, 2015, J HEAD TRAUMA REHAB, V30, P347, DOI 10.1097/HTR.0000000000000052; Rehabilitation Research and Training Center on Community Integration of Persons with Traumatic Brain Injury, 2014, 3 REH RES TRAIN CTR; Roger VL, 2012, CIRCULATION, V125, P188, DOI 10.1161/CIR.0b013e3182456d46; Sambuco M, 2008, BRAIN INJURY, V22, P7, DOI 10.1080/02699050701822022; Sambuco M, 2012, J HEAD TRAUMA REHAB, V27, P413, DOI 10.1097/HTR.0b013e3182274162; SELTZER GB, 1991, FAM RELAT, V40, P310, DOI 10.2307/585017; Swift EE, 2003, J DEV BEHAV PEDIATR, V24, P24, DOI 10.1097/00004703-200302000-00007; Tucker M, 2013, AUST J REHABIL COUNS, V19, P135, DOI 10.1017/jrc.2013.16; Willer B., 1990, CANADIAN J REHABILIT, V3, P167; Williams J., 1990, J HEAD TRAUMA REHAB, V5, P9, DOI [https://doi.org/10.1097/00001199-199003000-00004, DOI 10.1097/00001199-199003000-00004]	46	1	1	0	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1536-710X	1536-7118		J SOC WORK DISABIL R	J. Soc. Work Disabil. Rehabil.		2016	15	3-4					332	350		10.1080/1536710X.2016.1220881			19	Social Work	Emerging Sources Citation Index (ESCI)	Social Work	EB4NM	WOS:000387348600009	27618343				2022-02-06	
J	Del Castillo-Calcaneo, JD; Bravo-Angel, U; Mendez-Olan, R; Rodriguez-Valencia, F; Valdes-Garcia, J; Garcia-Gonzalez, U; Broc-Haro, GG				Del Castillo-Calcaneo, Juan D.; Bravo-Angel, Ulises; Mendez-Olan, Raul; Rodriguez-Valencia, Francisco; Valdes-Garcia, Javier; Garcia-Gonzalez, Ulises; Broc-Haro, Guy G.			Traumatic brain injury with a machete penetrating the dura and brain: Case report from southeast Mexico	INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS			English	Article						Machete; Traumatic brain injury; Decompressive craniectomy; Case report		INTRODUCTION: Traumatic Brain Injury (TBI) is a major cause of death and disability in our society, we present the first case report of non-missile penetrating (NMP) cranial trauma with a machete in Mexico, and our objective by presenting this case is to prove the usefulness of recently proposed algorithms in the treatment of NMP PRESENTATION OF CASE: We present the case of a 47 year old woman who received a machete hit to the right side of her head during an assault., she arrived fully conscious to the emergency department (ED), computed tomography was performed and based on the findings of this study and in accordance to recently proposed algorithms for managing NMP cranial trauma a craniotomy was performed, at follow-up the patient presented wtih minor neurological disability in the form of left hemiparesis. DISCUSSION: Non-missile penetrating (NMP) lesions are defined as having an impact velocity of less than 100 m/s, causing injury by laceration and maceration, An algorithm for treating NMP cranial trauma has been recently published in the Journal World Neurosurgery by De Holanda et al., in this case we followed the algorithm in order to provide best care available for our patient with good results. CONCLUSION: The use of current algorithms for managing NMP cranial trauma has proved to be very useful when applied on this particular case. GCS on admission is an important prognostic factor in NMP cranial trauma. (C) 2016 The Author( s). Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd.	[Del Castillo-Calcaneo, Juan D.; Garcia-Gonzalez, Ulises; Broc-Haro, Guy G.] Univ Nacl Autonoma Mexico, Neurosurg, Mexico City, DF, Mexico; [Del Castillo-Calcaneo, Juan D.; Garcia-Gonzalez, Ulises] Mexican Oil Co Pemex, High Specialty Hosp, Neurosurg Dept, Mexico City, DF, Mexico; [Bravo-Angel, Ulises; Mendez-Olan, Raul] Mexican Oil Co Pemex, Reg Hosp, Neurosurg Dept, Villahermosa, Tabasco, Mexico; [Rodriguez-Valencia, Francisco; Garcia-Gonzalez, Ulises; Broc-Haro, Guy G.] Amer British Cowdray Hosp, Neurosurg Dept, Mexico City, DF, Mexico; [Valdes-Garcia, Javier; Broc-Haro, Guy G.] Lopez Mateos Reg Hosp, Social Secur Inst State Workers ISSSTE, Neurosurg Dept, Mexico City, DF, Mexico; [Bravo-Angel, Ulises] Med Specialty Ctr Julian A Manzur Ocana, Social Secur Inst Tabasco ISSET, Neurosurg Dept, Villahermosa, Tabasco, Mexico		Del Castillo-Calcaneo, JD (corresponding author), Mexican Oil Co, High Specialty Hosp, Ave Perifer Sur 4091,4th Floor, Cdmx 14140, Mexico.	dr.calcaneo@gmail.com	Del Castillo-Calcaneo, Juan D/H-7811-2019	Del Castillo-Calcaneo, Juan D/0000-0002-7941-4104; Garcia Gonzalez, Ulises/0000-0002-6661-5409			Adoga Adeyi A, 2014, J Emerg Trauma Shock, V7, P77, DOI 10.4103/0974-2700.130875; [Anonymous], 2008, ASP CLIN EP TRAUM CR; Chibbaro S, 2006, ACTA NEUROCHIR, V148, P937, DOI 10.1007/s00701-006-0794-5; Crandon IW, 2011, INT J INJ CONTROL SA, V18, P293, DOI 10.1080/17457300.2011.569890; de Holanda L.F., 2016, WORLD NEUROSURG; Enicker B, 2014, INJURY, V45, P1355, DOI 10.1016/j.injury.2014.04.036; Gagnier JJ, 2014, J CLIN EPIDEMIOL, V67, P46, DOI 10.1016/j.jclinepi.2013.08.003; Martin Gus, 2011, SAGE ENCY TERRORISM, P490	8	1	1	0	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2210-2612			INT J SURG CASE REP	Int. J. Surg. Case Rep.		2016	23						169	172		10.1016/j.ijscr.2016.04.037			4	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	DO8BB	WOS:000378005900044	27156252	gold, Green Published			2022-02-06	
J	Ducis, K; Thakrar, R; Tranmer, B				Ducis, Katrina; Thakrar, Raj; Tranmer, Bruce			Ventriculostomies without dressings: Low infection rates but room for quality improvement	TRAUMA-ENGLAND			English	Article						Ventriculostomy; EVD; neurocritical care; traumatic brain injury; stroke; infection	EXTERNAL VENTRICULAR DRAINAGE; PROPHYLACTIC ANTIBIOTICS; INTRACRANIAL-PRESSURE; SURGICAL INTRODUCTION; CATHETERS; EFFICACY; RISK; COMPLICATIONS; EXPERIENCE; MANAGEMENT	Objective Ventriculostomies are common procedures for patients with severe neurologic insults including trauma, aneurysmal rupture, tumor, infection or following an operation. Infection secondary to a ventriculostomy, meningitis or ventriculitis, carries a high morbidity and mortality. Insertion practices and maintenance of these interventions was evaluated. Methods A retrospective review was completed of patients receiving ventriculostomies at a single institution from October 2007 through September 2013. Basic patient demographics, methods of insertion and presence of infection were collected and analyzed. Results The mean of age of patients receiving ventriculostomies was 49 years of age and the most common indications for insertion were trauma, infection and nontraumatic intracranial hemorrhage (aneurysmal subarachnoid hemorrhage (SAH), hemorrhagic stroke, arteriovenous malformation (AVM)). External ventricular drains (EVDs) were inserted after minimal hair removal at the time of procedure, tunneling following procedure and securement of EVDs with suture at exit of skin and remainder of drain stapled to scalp without additional dressing applied. The infection rate using this practice was 5.1%. Conclusion Ventriculostomies with minimal hair removal and no dressing have equivalent infection rates with the most recent published national average.	[Ducis, Katrina; Thakrar, Raj; Tranmer, Bruce] Univ Vermont, Med Ctr, Burlington, VT 05401 USA		Ducis, K (corresponding author), Univ Vermont, Med Ctr, Fletcher 5,111 Colchester Ave, Burlington, VT 05401 USA.	katrina.ducis@uvmhealth.org					Abla AA, 2011, NEUROSURGERY, V68, P437, DOI 10.1227/NEU.0b013e3182039a14; Alleyne CH, 2000, NEUROSURGERY, V47, P1124, DOI 10.1097/00006123-200011000-00020; Arabi Y, 2005, AM J INFECT CONTROL, V33, P137, DOI 10.1016/j.ajic.2004.11.008; Babu MA, 2012, NEUROCRIT CARE, V16, P194, DOI 10.1007/s12028-011-9647-z; CLARK WC, 1989, NEUROSURGERY, V25, P20; Cui ZW, 2015, AM J INFECT CONTROL, V43, pE23, DOI 10.1016/j.ajic.2015.03.015; Cummings R, 1992, J Neurosci Nurs, V24, P84; Dey M, 2012, CURR NEUROL NEUROSCI, V12, P24, DOI 10.1007/s11910-011-0231-x; Fichtner J, 2010, J NEUROSURG, V112, P840, DOI 10.3171/2009.8.JNS091297; Flint AC, 2013, NEUROSURGERY, V72, P993, DOI 10.1227/NEU.0b013e31828e8dfd; Ghajar J, 1995, New Horiz, V3, P395; Gigante P, 2010, BRIT J NEUROSURG, V24, P625, DOI 10.3109/02688697.2010.505989; Gozal YM, 2014, NEUROCRIT CARE, V21, P147, DOI 10.1007/s12028-013-9936-9; Gutierrez-Gonzalez R, 2010, J INFECTION, V61, P9, DOI 10.1016/j.jinf.2010.03.030; Hill M, 2012, J NEUROSCI NURS, V44, P188, DOI 10.1097/JNN.0b013e3182527672; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Kitchen WJ, 2011, BRIT J NEUROSURG, V25, P632, DOI 10.3109/02688697.2011.578770; Kubilay Z, 2013, J NEUROSURG, V118, P514, DOI 10.3171/2012.11.JNS121336; Li LM, 2010, ANESTH ANALG, V111, P736, DOI 10.1213/ANE.0b013e3181e75cd1; Lopez-Alvarez B, 2009, ACTA NEUROCHIR, V151, P1465, DOI 10.1007/s00701-009-0382-6; Lozier AP, 2002, NEUROSURGERY, V51, P170, DOI 10.1097/00006123-200207000-00024; Lyke KE, 2001, CLIN INFECT DIS, V33, P2028, DOI 10.1086/324492; MAYHALL CG, 1984, NEW ENGL J MED, V310, P553, DOI 10.1056/NEJM198403013100903; McCarthy PJ, 2010, NEUROCRIT CARE, V12, P220, DOI 10.1007/s12028-009-9284-y; Munch Tina Norgaard, 2008, Ugeskr Laeger, V170, P131; Muttaiyah S, 2010, J CLIN NEUROSCI, V17, P296, DOI 10.1016/j.jocn.2009.06.016; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; Ngo QN, 2009, PEDIATR CRIT CARE ME, V10, P346, DOI 10.1097/PCC.0b013e3181a320cd; Ratilal B, 2011, ADV TECH STAND NEURO, V36, P139, DOI 10.1007/978-3-7091-0179-7_6; Ratilal B, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.Cd005365.pub2; Ratilal B, 2008, J NEUROS-PEDIATR, V1, P48, DOI 10.3171/PED-08/01/048; Razmkon A, 2009, ACTA NEUROCHIR, V151, P985, DOI 10.1007/s00701-009-0292-7; Rivero-Garvia M, 2011, ACTA NEUROCHIR, V153, P647, DOI 10.1007/s00701-010-0905-1; Soleman J, 2012, ACTA NEUROCHIR, V154, P161, DOI 10.1007/s00701-011-1156-5; Sonabend AM, 2011, NEUROSURGERY, V68, P996, DOI 10.1227/NEU.0b013e3182096d84; Speck V, 2011, NEUROCRIT CARE, V14, P208, DOI 10.1007/s12028-010-9459-6; Tamburrini G, 2008, ACTA NEUROCHIR, V150, P1049, DOI 10.1007/s00701-008-0022-6; Wang X, 2013, CRIT CARE, V17, DOI 10.1186/cc12608; Zhong J, 2003, NEUROL RES, V25, P339, DOI 10.1179/016164103101201661; Zingale A, 1999, J Neurosurg Sci, V43, P125; 2000, J NEUROTRAUMA, V17, P497	41	1	1	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1460-4086	1477-0350		TRAUMA	Trauma	JAN	2016	18	1					40	45		10.1177/1460408615613099			6	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	CZ9VT	WOS:000367445900006					2022-02-06	
J	Durak, MA; Aydogan, MS; Gurbuz, S				Durak, M. A.; Aydogan, M. S.; Gurbuz, S.			The effects of iron deficiency on blood transfusion requirements in traumatic brain injury	BIOMEDICAL RESEARCH-INDIA			English	Article						Iron deficiency; Blood transfusion; Traumatic brain injury	RANDOMIZED CONTROLLED-TRIAL; CRITICALLY-ILL PATIENTS; CEREBRAL OXYGENATION; CELL TRANSFUSION; CLINICAL-TRIAL; MULTICENTER; RECIPIENTS; ANEMIA; CARE; ICU	Introduction: Traumatic brain injury (TBI) is the leading cause of preventable death in trauma patients. TBI often need blood transfusion, iron deficiency (ID) is known as the first cause of anemia worldwide, but no known predictors of transfusion requirements are available at intensive care unit (ICU). The aims of this study were to investigate ID relationship with blood transfusion requirements in TBI patients at ICU. Methods: One hundred forty-two patients with severe TBI, as defined by Glasgow Coma Scale (GCS) scores < 8 with an expected ICU length of stay >= 48 hours were admitted to the general ICU were enrolled in the prospective observational study between April 1, 2013, and December 31, 2015. Patients were divided into 2 groups according to their baseline iron status: iron-deficient (ID) and non-ID (normal iron profile) cohorts. Demographic features, laboratory values, blood transfusions, and length of ICU stay were recorded. Results: A total of 134 patients were included in this analysis. The mean Glasgow coma score at baseline was 6 +/- 5 and Injury Severity Score (ISS) 18.5 +/- 4.5. ID with TBI patients, which was diagnosed in 65 patients (48.5%), compared with non-ID patients, with higher ISS but no difference in admission GCS score or APACHE II scores. ID was associated with a greater use of blood transfusions (5 and 2 U/patient, respectively; p=.0001). The median length of ICU stay after TBI was longer among the ID versus the non-ID group (25 and 17 days per patient, respectively; p=.0001). Conclusion: We found that ID was highly prevalent at ICU admission patients with TBI and that it was associated with higher blood transfusion requirements. Therefore, ID may be a prognostic factor for the blood transfusion requirements in TBI at ICU.	[Durak, M. A.] Inonu Univ, Fac Med, Dept Neurosurg, Malatya, Turkey; [Aydogan, M. S.] Inonu Univ, Fac Med, Dept Anesthesiol & Reanimat, Malatya, Turkey; [Gurbuz, S.] Inonu Univ, Fac Med, Dept Emergency Med, Malatya, Turkey		Aydogan, MS (corresponding author), Inonu Univ, Sch Med, Dept Anesthesiol & Reanimat, Anesthesiol & Reanimat, Malatya, Turkey.		aydogan, mustafa said/AAA-2828-2021; Gurbuz, Sukru/ABI-3276-2020; durak, mehmet akif/ABI-1169-2020	aydogan, mustafa said/0000-0002-7106-1156; Gurbuz, Sukru/0000-0003-2616-0304; durak, mehmet akif/0000-0003-0827-2708			Aydogan MS, 2013, TRANSPL P, V45, P2277, DOI 10.1016/j.transproceed.2012.11.001; Aydogan MS, 2013, TRANSPL P, V45, P978, DOI 10.1016/j.transproceed.2013.02.057; Bratton SL, 2007, J NEUROTRAUMA S1, V24, P555, DOI DOI 10.1089/NEU.2007.9988; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; CORWIN HL, 1995, CHEST, V108, P767, DOI 10.1378/chest.108.3.767; Corwin HL, 2004, CRIT CARE MED, V32, P39, DOI 10.1097/01.CCM.0000104112.34142.79; Hajjar LA, 2010, JAMA-J AM MED ASSOC, V304, P1559, DOI 10.1001/jama.2010.1446; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Ichai C, 2013, INTENS CARE MED, V39, P1413, DOI 10.1007/s00134-013-2978-9; Lasocki S, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0542-9; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Retter A, 2013, BRIT J HAEMATOL, V160, P445, DOI 10.1111/bjh.12143; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sekhon MS, 2012, CRIT CARE, V16, DOI 10.1186/cc11431; Shander A, 2010, TRANSFUSION, V50, P753, DOI 10.1111/j.1537-2995.2009.02518.x; Smith MJ, 2005, CRIT CARE MED, V33, P1104, DOI 10.1097/01.CCM.0000162685.60609.49; Tango HK, 2009, J TRAUMA, V66, P720, DOI 10.1097/TA.0b013e3181719b35; Zygun DA, 2009, CRIT CARE MED, V37, P1074, DOI 10.1097/CCM.0b013e318194ad22	20	1	1	0	3	SCIENTIFIC PUBLISHERS INDIA	ALIGARH	87-GREATER AZAD ENCLAVE, P O QUARSI, ALIGARH, 00000, INDIA	0970-938X	0976-1683		BIOMED RES-INDIA	Biomed. Res.-India		2016	27	3					849	853					5	Engineering, Biomedical; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Research & Experimental Medicine	EC9HT	WOS:000388456100046					2022-02-06	
J	Elliott, RJS; Batiste, O; Hitto, I; Walker, B; Leary, LD				Elliott, Ross-Jordon S.; Batiste, Oliver; Hitto, Imran; Walker, Bridget; Leary, Linda D.			Pediatric sport-related concussion education: Effectiveness and long-term retention of the head safety in youth sports (HSYS) program for youth athletes aged 11-16	COGENT EDUCATION			English	Article						youth athletes; concussion education; long term retention		Objective: The goals of this study are to evaluate the effectiveness of the curriculum for youth athletes and determine long-term retention in those who have previously participated. Design: Prospective cohort study. Setting: Middle schools. Participants: 887 male and female sixth-through eighth-grade Physical Education students, ranging from ages 11 to 16 entered and 858 students finished the HSYS Program. Subjects (n = 29) were excluded if they did not complete their pre-workshop or post-workshop test. Interventions: The program is designed to be a 35-45 min workshop. Main Outcome Measures: Tests were administered before and after workshop participation to evaluate knowledge of concussion and response to head injury. Results: The aggregated pre-workshop and post-workshop mean test scores for participants from all five middle schools were 68 +/- 2% and 85 +/- 3%, respectively, which demonstrated significant improvement in test scores after participation in the HSYS Program (paired t-test, p < 0.0001). Analyzed individually, each school (MS1-5) demonstrated significant improvement between pre-and post-workshop mean test scores (paired t-test, p < 0.0001). On evaluation of long-term retention of the HSYS Program, students (n = 78) from MS3 who had previously participated in the program scored 7% higher than those students (n = 145) who had no prior exposure (unpaired t-test, p < 0.05). Conclusion: HSYS Program is a multifactorial curriculum that effectively educates students and provides long-term retention about concussion and head safety. The program engages youth athletes in understanding the significance of head safety and creates an opportunity to initiate this discussion and influence athletic behavior to improve head safety.	[Elliott, Ross-Jordon S.; Batiste, Oliver; Hitto, Imran; Walker, Bridget; Leary, Linda D.] Med Arts & Res Ctr MARC, Dept Neurol, San Antonio, TX 78229 USA		Elliott, RJS (corresponding author), Med Arts & Res Ctr MARC, Dept Neurol, San Antonio, TX 78229 USA.	ELLIOTTR@livemail.uthscsa.edu		Elliott, Ross-Jordon/0000-0002-5416-0128	Baptist Health Foundation of San Antonio; BBVA Compass BankBBVA Foundation	The authors would like to thank Melanie Stone, MPH, Med, Ruth Berggren, M.D., and the Center for Medical Humanities & Ethics at UTHSCSA for providing us with the opportunity to conduct this research by funding our CSL Midi-grant and Mini-grant through sponsorship from the Baptist Health Foundation of San Antonio and from BBVA Compass Bank, respectively.	American Association of Neurological Surgeons, 2014, PAT INF SPORTS REL H; [Anonymous], 2015, VIRGINIA BOARD ED GU; Bagley AF, 2012, CLIN J SPORT MED, V22, P385, DOI 10.1097/JSM.0b013e3182639bb4; Centers for Disease Control and Prevention (CDC), 2011, INJ PREV CONTR TRAUM; Edwards JC, 2014, J LAW MED ETHICS, V42, P128, DOI 10.1111/jlme.12126; Gerhardstein D. B., 2007, SCI NURSING, V24, P1; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Marshall Cameron M, 2012, J Can Chiropr Assoc, V56, P299; McAllister-Deitrick J, 2014, ATHL TRAIN SPORTS HL, V6, P280, DOI DOI 10.3928/01484834-20141112-03; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Paasche-Orlow MK, 2007, AM J HEALTH BEHAV, V31, pS19; Parker EM, 2015, J HEAD TRAUMA REHAB, V30, P198, DOI 10.1097/HTR.0000000000000097; Schatz P, 2011, CLIN NEUROPSYCHOL, V25, P1042, DOI 10.1080/13854046.2011.556669; Williamson Richard W, 2014, Neurosurgery, V75 Suppl 4, pS131, DOI 10.1227/NEU.0000000000000482; World Health Organization (WHO), 1998, WHOHPR981	18	1	1	0	4	TAYLOR & FRANCIS AS	OSLO	KARL JOHANS GATE 5, NO-0154 OSLO, NORWAY	2331-186X			COGENT EDUC	Cogent Educ.		2016	3								UNSP 1256141	10.1080/2331186X.2016.1256141			11	Education & Educational Research	Emerging Sources Citation Index (ESCI)	Education & Educational Research	EF1WJ	WOS:000390115500001		gold			2022-02-06	
B	Fina, BA; Lichner, TK; Foa, EB; Peterson, AL		Martin, CR; Preedy, VR; Patel, VB		Fina, Brooke A.; Lichner, Tracey K.; Foa, Edna B.; Peterson, Alan L.			Case Study of Prolonged Exposure Therapy for Comorbid Combat-Related Post-Traumatic Stress Disorder and Traumatic Brain Injury	COMPREHENSIVE GUIDE TO POST-TRAUMATIC STRESS DISORDERS, VOLS 1 AND 2			English	Article; Book Chapter							PTSD; VETERANS; MILITARY; CARE	This case report reviews the successful implementation of prolonged exposure therapy with an active duty service member with combat-related PTSD and a co-occurring history of mild traumatic brain injury. Very few modifications were made to the treatment protocol to accommodate the patient's postconcussive symptoms. Posttreatment assessments indicated the absence of a PTSD diagnosis at posttreatment through the 6-month follow-up and then the return of a PTSD diagnosis at the 1-year follow-up. This case report demonstrates the potential complexities of treating comorbid PTSD and traumatic brain injury.	[Fina, Brooke A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, Sch Med, San Antonio, TX 78229 USA; [Lichner, Tracey K.; Foa, Edna B.] Univ Penn, Ctr Treatment & Study Anxiety, Perelman Sch Med, Philadelphia, PA 19104 USA; [Peterson, Alan L.] Univ Texas Hlth Sci Ctr San Antonio, Div Behav Med, STRONG STAR PTSD Res Consortium, Dept Psychiat,Sch Med, San Antonio, TX 78229 USA; [Peterson, Alan L.] South Texas Vet Hlth Care Syst, San Antonio, TX USA; [Peterson, Alan L.] Univ Texas San Antonio, Dept Psychol, San Antonio, TX USA		Fina, BA (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, Sch Med, San Antonio, TX 78229 USA.	fina@uthsesa.edu; lichner@mail.med.upenn.edu; foa@mail.med.upenn.edu; petersona3@uthscsa.edu					American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Beck A., 1996, MANUAL BDI 2; Cahill SP, 2006, J TRAUMA STRESS, V19, P597, DOI 10.1002/jts.20173; Chard KM, COMPREHENSIVE GUIDE; Cigrang J.A., 2005, PRAGMATIC CASE STUD, V1, P1, DOI [10.14713/pcsp.v1i2.857, DOI 10.14713/PCSP.V1I2.857]; Cigrang JA, 2011, PSYCHOL SERV, V8, P104, DOI 10.1037/a0022740; Foa E.B., 1993, AM PSYCHIAT PRESS RE, V12, P273; Foa E.B., 2007, PROLONGED EXPOSURE T; Foa EB, 2000, J TRAUMA STRESS, V13, P181, DOI 10.1023/A:1007781909213; Foa EB, 1999, J CONSULT CLIN PSYCH, V67, P194, DOI 10.1037/0022-006X.67.2.194; Foa EB, 2005, J CONSULT CLIN PSYCH, V73, P953, DOI 10.1037/0022-006X.73.5.953; FOA EB, 1993, J TRAUMA STRESS, V6, P459, DOI 10.1002/jts.2490060405; FOA EB, 1986, PSYCHOL BULL, V99, P20, DOI 10.1037/0033-2909.99.1.20; Foa EB, 1998, TREATING TRAUMA RAPE; Glynn SM, 1999, J CONSULT CLIN PSYCH, V67, P243, DOI 10.1037/0022-006X.67.2.243; Gray MJ, 2004, ASSESSMENT, V11, P330, DOI 10.1177/1073191104269954; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; KEANE TM, 1989, BEHAV THER, V20, P245, DOI 10.1016/S0005-7894(89)80072-3; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; McLay RN, 2010, CYBERPSYCH BEH SOC N, V13, P37, DOI 10.1089/cyber.2009.0346; Moring JC, COMPREHENSIVE GUIDE; Nacasch N, 2011, J CLIN PSYCHIAT, V72, P1174, DOI 10.4088/JCP.09m05682blu; Rauch SAM, 2009, J TRAUMA STRESS, V22, P60, DOI 10.1002/jts.20380; Resick PA, 2002, J CONSULT CLIN PSYCH, V70, P867, DOI 10.1037//0022-006X.70.4.867; Rothbaum BO, 2005, J TRAUMA STRESS, V18, P607, DOI 10.1002/jts.20069; Schnurr PP, 2007, JAMA-J AM MED ASSOC, V297, P820, DOI 10.1001/jama.297.8.820; Sripada RK, 2013, J TRAUMA STRESS, V26, P369, DOI 10.1002/jts.21813; Tuerk PW, 2011, J ANXIETY DISORD, V25, P397, DOI 10.1016/j.janxdis.2010.11.002; Weathers F, 1993, 10 ANN M INT SOC TRA; Wolf GK, 2012, J HEAD TRAUMA REHAB, V27, P26, DOI 10.1097/HTR.0b013e31823cd01f	30	1	1	0	1	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND			978-3-319-08359-9; 978-3-319-08358-2				2016							2237	2247		10.1007/978-3-319-08359-9_116	10.1007/978-3-319-08359-9		11	Psychiatry; Psychology	Book Citation Index – Science (BKCI-S)	Psychiatry; Psychology	BP6WJ	WOS:000560802800127					2022-02-06	
J	Ge, JH; Chen, L; Xiang, Z				Ge, Jianhua; Chen, Long; Xiang, Zhou			Application of loop plating technique in fractures of ulna coronoid process	INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE			English	Article						Coronoid process fractures; dislocation; loop plating technique; internal fixation; ligament repairing	RADIAL HEAD; ELBOW; DISLOCATIONS; STABILITY; MANAGEMENT; INJURY	Objective: Although ulna coronoid process fracture is uncommon, it is a complex injury and its treatment remains difficult. This study assessed the clinical efficacy of loop plating technique, a potential method to treat ulna coronoid process fracture. Materials and Methods: Seven cases of ulna coronoid process fractures treated with loop plating technique from October 2012 to May 2015 were analyzed retrospectively. Patients' age ranged from 18-55 years (mean age 36 years). All cases were closed fractures. X-ray and 3D computed tomography were applied to all patients before surgery. After anteromedial incision, a homemade loop plate was fixed after satisfactory reduction of fractures. Lateral collateral ligament injuries were repaired and reconstructed in 4 cases and medial collateral ligament injury was repaired in 1 case during surgery because of elbow instability. Functional evaluation data were collected and analyzed statistically. Results: No patients suffered from delayed incision healing, redisplacement, fixation failure, or elbow joint instability. At last follow-up, mean Broberg and Morrey score was 94.1, Mayo Elbow Performance Index was 92.1, Ewald scoring system was 88.6 and Disabilities of the Arm, Shoulder and Hand score was 5.4. During follow-up, only 1 patient had elbow heterotopic ossification (grade I-II). Conclusion: Application of loop plating technique might be a valid method for treatment of ulna coronoid process fractures, including various fracture styles, especially for comminuted fractures, but excluding simple coronion fractures of ulna coronoid process.	[Ge, Jianhua; Chen, Long; Xiang, Zhou] Sichuan Univ, West China Hosp, Dept Orthoped, 37 Guoxue Xiang, Chengdu 610041, Peoples R China; [Chen, Long] Guizhou Prov Peoples Hosp, Dept Orthoped, Guiyang, Guizhou, Peoples R China		Xiang, Z (corresponding author), Sichuan Univ, West China Hosp, Dept Orthoped, 37 Guoxue Xiang, Chengdu 610041, Peoples R China.	xiangzhou5@hot-mail.com		Chen, Long/0000-0002-7347-3074			Adams JE, 2009, J BONE JOINT SURG BR, V91B, P632, DOI [10.1302/0301-620X.91B5.21755, 10.1302/0301-620X.91B5]; Adams JE, 2012, J SHOULDER ELB SURG, V21, P782, DOI 10.1016/j.jse.2012.01.008; Butler DP, 2011, J SHOULDER ELB SURG, V20, pE1, DOI 10.1016/j.jse.2010.08.018; Chen HW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124821; Closkey RF, 2000, J BONE JOINT SURG AM, V82A, P1749, DOI 10.2106/00004623-200012000-00009; Egol KA, 2007, BULL HOSP JT DIS, V65, P263; Garrigues GE, 2011, J BONE JOINT SURG AM, V93A, P1873, DOI 10.2106/JBJS.I.01673; Gray AB, 2013, J HAND SURG-AM, V38A, P1753, DOI 10.1016/j.jhsa.2013.05.004; Han Soo-Hong, 2013, Eur J Orthop Surg Traumatol, V23, P395, DOI 10.1007/s00590-012-1007-y; Hull JR, 2005, J SHOULDER ELB SURG, V14, P441, DOI 10.1016/j.jse.2004.11.005; Jeon IH, 2005, J TRAUMA, V59, P416, DOI 10.1097/01.ta.0000174734.23193.e0; Kalicke T, 2007, ARCH ORTHOP TRAUM SU, V127, P925, DOI 10.1007/s00402-007-0424-6; Kiene J, 2013, Open Orthop J, V7, P86, DOI 10.2174/1874325001307010086; Manidakis N, 2012, INJURY, V43, P989, DOI 10.1016/j.injury.2011.08.030; Nalbantoglu U, 2008, ACTA ORTHOP TRAUMATO, V42, P112; O'Driscoll Shawn W, 2003, Instr Course Lect, V52, P113; Park SM, 2015, J SHOULDER ELB SURG, V24, P74, DOI 10.1016/j.jse.2014.07.010; Ranganathan K, 2015, J BONE JOINT SURG AM, V97A, P1101, DOI 10.2106/JBJS.N.01056; REGAN W, 1989, J BONE JOINT SURG AM, V71A, P1348, DOI 10.2106/00004623-198971090-00011; Reichel LM, 2013, J SHOULDER ELB SURG, V22, P323, DOI 10.1016/j.jse.2012.10.038; Ring D, 2012, J HAND SURG-AM, V37A, P570, DOI 10.1016/j.jhsa.2011.12.016; Shukla DR, 2015, J SHOULDER ELB SURG, V24, P333, DOI 10.1016/j.jse.2014.11.037; Steinmann SP, 2008, J AM ACAD ORTHOP SUR, V16, P519; van Riet RP, 2005, J SHOULDER ELB SURG, V14, P519, DOI 10.1016/j.jse.2004.11.007; Wang Xin, 2013, Eur J Orthop Surg Traumatol, V23, P251, DOI 10.1007/s00590-012-0990-3; Wang YZ, 2009, BIOFABRICATION, V1, DOI 10.1088/1758-5082/1/1/015001; Wells J, 2008, CLIN MED RES, V6, P40, DOI 10.3121/cmr.2008.753; Zeiders GJ, 2008, J BONE JOINT SURG AM, V90A, P75, DOI 10.2106/JBJS.H.00893; Zhao HR, 2013, CLIN BIOMECH, V28, P626, DOI 10.1016/j.clinbiomech.2013.05.004	29	1	1	0	2	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	1940-5901			INT J CLIN EXP MED	Int. J. Clin. Exp. Med.		2016	9	11					21252	21260					9	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	EG7UD	WOS:000391260800081					2022-02-06	
J	Grujicic, M; Ramaswami, S; Snipes, JS; Yavari, R; Dudt, P				Grujicic, M.; Ramaswami, S.; Snipes, J. S.; Yavari, R.; Dudt, P.			Experimental and computational investigations of the potential improvement in helmet blast-protection through the use of a polyurea-based external coating	MULTIDISCIPLINE MODELING IN MATERIALS AND STRUCTURES			English	Article						Polyurea; Traumatic brain injury; Advanced Combat Helmet; Helmet Augmentation	TRAUMATIC BRAIN-INJURY; MATERIAL-MODEL; CAPABILITY	Purpose - The design of the Advanced Combat Helmet (ACH) currently in use was optimized by its designers in order to attain maximum protection against ballistic impacts (fragments, shrapnel, etc.) and hard-surface/head collisions. Since traumatic brain injury experienced by a significant fraction of the soldiers returning from the recent conflicts is associated with their exposure to blast, the ACH should be redesigned in order to provide the necessary level of protection against blast loads. The paper aims to discuss this issue. Design/methodology/approach - In the present work, an augmentation of the ACH for improved blast protection is considered. This augmentation includes the use of a polyurea (a nano-segregated elastomeric copolymer) based ACH external coating. To demonstrate the efficacy of this approach, blast experiments are carried out on instrumented head-mannequins (without protection, protected using a standard ACH, and protected using an ACH augmented by a polyurea explosive-resistant coating (ERC)). These experimental efforts are complemented with the appropriate combined Eulerian/Lagrangian transient non-linear dynamics computational fluid/solid interaction finite-element analysis. Findings - The results obtained clearly demonstrated that the use of an ERC on an ACH affects (generally in a beneficial way) head-mannequin dynamic loading and kinematic response as quantified by the intracranial pressure, impulse, acceleration and jolt. Originality/value - To the authors' knowledge, the present work is the first reported combined experimental/computational study of the blast-protection efficacy and the mild traumatic brain-injury mitigation potential of polyurea when used as an external coating on a helmet.	[Grujicic, M.; Ramaswami, S.; Snipes, J. S.; Yavari, R.] Clemson Univ, Dept Mech Engn, Clemson, SC 29634 USA; [Dudt, P.] Naval Surface Warfare Ctr, Carderock Div, Survivabil & Weap Effects, West Bethesda, MD USA		Grujicic, M (corresponding author), Clemson Univ, Dept Mech Engn, Clemson, SC 29634 USA.	gmica@clemson.edu			Office of Naval Research (ONR)Office of Naval Research [N00014-14-1-0286]	The material presented in this paper is based on work supported by the Office of Naval Research (ONR) research contract entitled "Reactive-Moiety Functionalization of Polyurea for Increased Shock-Mitigation Performance," Contract Number N00014-14-1-0286. The authors would like to express their appreciation to Dr Roshdy Barsoum, ONR, program sponsor, for many helpful discussions, guidance and continuing interest.	Ackland K, 2011, EXPT NUMERICAL INVES; Altair Engineering Inc, 2010, HYP HYPERWORKS 10 0; [Anonymous], 2014, ABAQUS VERS 6 14 US; Bogoslovov RB, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2745212; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Christou GA, 2010, THESIS; Ganpule S, 2013, BIOMECH MODEL MECHAN, V12, P511, DOI 10.1007/s10237-012-0421-8; Goel R, 2011, THESIS; Greer AD, 2006, THESIS; Grujicic A, 2012, J MATER ENG PERFORM, V21, P1562, DOI 10.1007/s11665-011-0065-3; Grujicic A., 2013, REV BIOINFORMATICS B, V2, P45; Grujicic M, 2013, MULTIDISCIP MODEL MA, V9, P214, DOI 10.1108/MMMS-04-2013-0029; Grujicic M, 2012, MULTIDISCIP MODEL MA, V8, P213, DOI 10.1108/15736101211251220; Grujicic M, 2012, MULTIDISCIP MODEL MA, V8, P524, DOI 10.1108/15736101211281632; Grujicic M, 2013, P I MECH ENG L-J MAT, V227, P124, DOI 10.1177/1464420712470356; Grujicic M, 2011, J MATER ENG PERFORM, V20, P877, DOI 10.1007/s11665-010-9724-z; Grujicic M, 2011, MAT SCI ENG A-STRUCT, V528, P3799, DOI 10.1016/j.msea.2011.01.081; Grujicic M, 2010, MAT SCI ENG A-STRUCT, V527, P7741, DOI 10.1016/j.msea.2010.08.042; Grujicic M, 2010, MATER DESIGN, V31, P4050, DOI 10.1016/j.matdes.2010.05.002; Grujicic M, 2014, AIMS MATER SCI, V1, P15, DOI 10.3934/matersci.2014.1.15; Grujicic M, 2013, MULTIDISCIP MODEL MA, V9, P548, DOI 10.1108/MMMS-10-2012-0014; Grujicic M, 2014, J MATER ENG PERFORM, V23, P357, DOI 10.1007/s11665-013-0769-7; Grujicic M, 2011, J MATER SCI, V46, P1767, DOI 10.1007/s10853-010-4998-y; Hirsch AE, 1966, HEAD INJURY C P, P37; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Hyde D., 1988, USERS GUIDE FORMICRO; Ivancevic VG, 2009, COGN NEURODYNAMICS, V3, P281, DOI 10.1007/s11571-008-9070-0; Jazi MS, 2014, COMPUT METHOD BIOMEC, V17, P1368, DOI 10.1080/10255842.2012.748755; Littlestone A, 2010, NSWCCD66TR201036; Lockhart P, 2011, J TRAUMA, V70, pE29, DOI 10.1097/TA.0b013e3181de3f4b; Mediavilla Varas Jesus, 2011, Front Neurol, V2, P58, DOI 10.3389/fneur.2011.00058; Moss W.C., 2009, J ACOUST SOC AM, V125, P2650; Nyein MK, 2013, THESIS; Roberts JC, 2012, J BIOMECH, V45, P2899, DOI 10.1016/j.jbiomech.2012.07.027; Sharma S, 2011, OH STAT U INJ BIOM S; Shridharani Jay K, 2012, Front Neurol, V3, P70, DOI 10.3389/fneur.2012.00070; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006; Zhu F, 2012, BIOMECH MODEL MECHAN, V11, P341, DOI 10.1007/s10237-011-0314-2	40	1	3	0	11	EMERALD GROUP PUBLISHING LTD	BINGLEY	HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND	1573-6105	1573-6113		MULTIDISCIP MODEL MA	Multidiscip. Model. Mater. Struct.		2016	12	1					33	72		10.1108/MMMS-02-2015-0009			40	Materials Science, Multidisciplinary; Mechanics	Emerging Sources Citation Index (ESCI)	Materials Science; Mechanics	FB6OD	WOS:000406261400002					2022-02-06	
S	Gunderson, CH; Daroff, RB		Tatu, L; Bogousslavsky, J		Gunderson, Carl H.; Daroff, Robert B.			Neurology in the Vietnam War	WAR NEUROLOGY	Frontiers of Neurology and Neuroscience		English	Article; Book Chapter							PENETRATING HEAD-INJURY; CEREBRAL MALARIA; VETERANS; SEIZURES; EPILEPSY	Between December 1965 and December 1971, the United States maintained armed forces in Vietnam never less than 180,000 men and women in support of the war. At one time, this commitment exceeded half a million soldiers, sailors, and airmen from both the United States and its allies. Such forces required an extensive medical presence, including 19 neurologists. All but two of the neurologists had been drafted for a 2-year tour of duty after deferment for residency training. They were assigned to Vietnam for one of those 2 years in two Army Medical Units and one Air Force facility providing neurological care for American and allied forces, as well as many civilians. Their practice included exposure to unfamiliar disorders including cerebral malaria, Japanese B encephalitis, sleep deprivation seizures, and toxic encephalitis caused by injection or inhalation of C-4 explosive. They and neurologists at facilities in the United States published studies on all of these entities both during and after the war. These publications spawned the Defense and Veterans Head Injury Study, which was conceived during the Korean War and continues today as the Defense and Veterans Head Injury Center. It initially focused on post-traumatic epilepsy and later on all effects of brain injury. The Agent Orange controversy arose after the war; during the war, it was not perceived as a threat by medical personnel. Although soldiers in previous wars had developed serious psychological impairments, post-traumatic stress disorder was formally recognized in the servicemen returning from Vietnam. (C) 2016 S. Karger AG, Basel	[Gunderson, Carl H.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Bethesda, MD 20814 USA; [Daroff, Robert B.] Case Western Reserve Univ, Sch Med, Dept Neurol, Cleveland, OH 44106 USA		Gunderson, CH (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Neurol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	carl.gunderson@usuhs.edu					Barrett O, 1982, INTERNAL MED VIETNAM, VII, P295; BLOCKER WW, 1968, AM J PSYCHIAT, V125, P192, DOI 10.1176/ajp.125.2.192; BLOUNT RE, 1969, ANN INTERN MED, V70, P142, DOI 10.7326/0003-4819-70-1-142; CAVENESS WF, 1979, J NEUROSURG, V50, P545, DOI 10.3171/jns.1979.50.5.0545; Caveness WF, 1969, COMBAT HEAD INJURY P; Committee to Review the Health Effects in Vietnam Veterans of Exposure to Herbicides (Ninth Biennial Update), 2014, VETERANS AGENT ORANG; DAROFF RB, 1967, J AMER MED ASSOC, V202, P679; Daroff RB, 1999, J NEUROL SCI, V170, P131, DOI 10.1016/S0022-510X(99)00224-5; Daroff RB, 2001, J NEUROL NEUROSUR PS, V70, P817; GRAFMAN J, 1988, BRAIN, V111, P169, DOI 10.1093/brain/111.1.169; GRAFMAN J, 1986, J NEUROSCI, V6, P301; GUNDERSO.CH, 1973, NEUROLOGY, V23, P678, DOI 10.1212/WNL.23.7.678; Gunderson CH, 2004, MIL MED, V169, P768, DOI 10.7205/MILMED.169.10.768; Gunderson CH, 2002, ARCH NEUROL-CHICAGO, V59, P141, DOI 10.1001/archneur.59.1.141; Hodgins-Vermaas R, 2002, BMJ-BRIT MED J, V324, P321; Hyams KC, 1996, ANN INTERN MED, V125, P398, DOI 10.7326/0003-4819-125-5-199609010-00007; KASTL AJ, 1968, J NERV MENT DIS, V147, P553, DOI 10.1097/00005053-196812000-00004; KETEL WB, 1972, NEUROLOGY, V22, P871; KETEL WB, 1971, AM J MED SCI, V261, P271, DOI 10.1097/00000441-197105000-00006; LINCOLN AF, 1952, JAMA-J AM MED ASSOC, V150, P268, DOI 10.1001/jama.1952.03680040010003; Lind M, 2002, VIETNAM NECESSARY WA; Salazar A, 1987, ADV EPILEPTOL, P267; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Summers Harry G., 1985, VIETNAM WAR ALMANAC; Varney NR, 1997, J NERV MENT DIS, V185, P695, DOI 10.1097/00005053-199711000-00008; WARRELL DA, 1982, NEW ENGL J MED, V306, P313, DOI 10.1056/NEJM198202113060601	26	1	1	0	2	KARGER	BASEL	POSTFACH, CH-4009 BASEL, SWITZERLAND	1660-4431		978-3-318-05606-8; 978-3-318-05605-1	FRONT NEUROL NEUROSC	Front. Neurol. Neurosci.		2016	38						201	213		10.1159/000442657	10.1159/isbn.978-3-318-05606-8		13	History & Philosophy Of Science; Clinical Neurology; Neurosciences	Book Citation Index – Science (BKCI-S)	History & Philosophy of Science; Neurosciences & Neurology	BG1RX	WOS:000387056900018	27035455				2022-02-06	
J	Harris, JE; Mays, J; Ratcliff, G; Chase, S; Vemich, L; Colantonio, A				Harris, J. E.; Mays, J.; Ratcliff, G.; Chase, S.; Vemich, L.; Colantonio, A.			Level of agreement of occupational titles between persons with traumatic brain injury and their informants	WORK-A JOURNAL OF PREVENTION ASSESSMENT & REHABILITATION			English	Article						Traumatic brain injury; return to work; rehabilitation; validity; reliability	MODERATE; RETURN; WORK; TIME; INDIVIDUALS; EMPLOYMENT; AWARENESS; MEMORY; MODEL	BACKGROUND: Returning to work is one of the most important goals cited by individuals with traumatic brain injury (TBI). However, they may have difficulty evoking past work history. The ability to recall work history is integral to the rehabilitation process of return to work. OBJECTIVE: The aim of this study was to determine 1) the level of agreement on the reporting of occupations and 2) if agreement is affected when specific occupational details are required in recall between adults with traumatic brain injury and their informants. METHODS: This is a retrospective cohort study of 259 individuals, with moderate to severe traumatic brain injury, and their selected informants (e.g. spouse, parent). Interviews were conducted separately for the individual and respective informant to gather information on type of occupation at time of injury and at time of interview. Reported occupations were coded using a standard classification system. Level of agreement was analyzed by interclass correlation coefficients and percent agreement, and the significance of bias was calculated. RESULTS: Participants were a mean age of 44.5 at time of study with 40% employed compared to 77% at time of injury. Agreement between participants and their informants for occupational title was high for both time periods though more so at the time of injury compared to current status. Level of agreement for specificity was moderate to high however, decreased as need for specificity of detail increased. CONCLUSION: While participant-informant responses appear to be reliable for occupational classification, when detailed information is required corroborating information is likely needed.	[Harris, J. E.] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada; [Mays, J.] Bloorview MacMillan Childrens Ctr, Toronto, ON, Canada; [Ratcliff, G.] HealthSouth Harrnarville Rehabil Ctr, Pittsburgh, PA USA; [Chase, S.] Working Order, Pittsburgh, PA USA; [Vemich, L.] Univ Toronto, Dept Publ Hlth Sci, Toronto, ON, Canada; [Colantonio, A.] Toronto Rehabil Inst, Toronto, ON, Canada; [Colantonio, A.] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada		Colantonio, A (corresponding author), Toronto Rehabil Inst, Gender Work & Hlth, 160 500 Univ Ave, Toronto, ON M5G 1V7, Canada.	angela.colantonio@utoronto.ca	Harris, Jocelyn Ellen/ABE-7420-2021	Harris, Jocelyn Ellen/0000-0002-3293-1833; Colantonio, Angela/0000-0003-2094-4765	NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS34740-2]; NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [F33 AG05856-OIAI]; Washington County Head Injury Foundation; Saunderson Family Chair at the Toronto Rehabilitation Institute; Canadian Institutes of Health Research Chair in Gender, Work and HealthCanadian Institutes of Health Research (CIHR) [494372]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS034740] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [F33AG005856] Funding Source: NIH RePORTER	We thank Beverly Wilson for assistance with coding, Tamara Arenovich for statistical consultation, Judy Kirk for providing working papers from Florida State University, Center for the Study of Population, Rhonda Sussman, Sandra Sokoloff and Aldith Dawson for administrative support. Sources of funding: This project was supported by the NINDS (NS34740-2), NIA (F33 AG05856-OIAI) and the Washington County Head Injury Foundation. Dr. Colantonio was supported by the Saunderson Family Chair at the Toronto Rehabilitation Institute and a Canadian Institutes of Health Research Chair in Gender, Work and Health (grant #494372).	Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Boake C, 2005, NEUROSURGERY, V56, P994, DOI 10.1227/01.NEU.0000158319.38230.C3; Boake C, 2001, ARCH PHYS MED REHAB, V82, P761, DOI 10.1053/apmr.2001.23753; Bootes Kylie, 2002, Work, V19, P255; Bryson-Campbell M, 2013, WORK, V44, P57, DOI [10.3233/WOR-2012-1561, 10.3233/WOR-2012-01561]; Buchanan KM, 2000, NEUROSURGERY, V46, P831, DOI 10.1097/00006123-200004000-00012; CAVALLO M M, 1992, Brain Injury, V6, P327, DOI 10.3109/02699059209034947; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Colantonio A, 2001, ARCH PHYS MED REHAB, V82, P1495; Cusick CP, 2000, J HEAD TRAUMA REHAB, V15, P739, DOI 10.1097/00001199-200002000-00012; Dodson MB, 2010, WORK, V36, P449, DOI 10.3233/WOR-2010-1044; Everitt BS., 1994, STAT METHODS MED INV; Flashman LA, 2002, NEUROREHABILITATION, V17, P285; Grauwmeijer E, 2012, ARCH PHYS MED REHAB, V93, P993, DOI 10.1016/j.apmr.2012.01.018; Henneberger PK, 1996, OCCUP MED, V11, P393; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Lanham RA, 2000, J HEAD TRAUMA REHAB, V15, P1123, DOI 10.1097/00001199-200010000-00006; Magaziner J, 1996, AM J EPIDEMIOL, V143, P283; Mioni G, 2012, J INT NEUROPSYCH SOC, V18, P697, DOI 10.1017/S1355617712000306; Morton N, 2010, J INT NEUROPSYCH SOC, V16, P1089, DOI 10.1017/S1355617710000925; Nalder E, 2012, BRAIN INJURY, V26, P1381, DOI 10.3109/02699052.2012.676225; Ocampo S, 1997, OCCUP THER INT, V161; Ownsworth T, 2006, NEUROPSYCHOL REHABIL, V16, P415, DOI 10.1080/09602010500505641; Ownsworth T, 2010, WORK, V36, P381, DOI 10.3233/WOR-2010-1041; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Saltychev M, 2013, BRAIN INJ; Schmitter-Edgecombe M, 2008, J CLIN EXP NEUROPSYC, V30, P212, DOI 10.1080/13803390701363803; Soeker MS, 2012, WORK, V43, P313, DOI 10.3233/WOR-2012-1412; Terrie EW, 1990, 94118 FLOR STAT U CT; U.S. Bureau of Labor Statistics, STAND OCC CLASS; van der Naalt J, 2001, J CLIN EXP NEUROPSYC, V23, P837, DOI 10.1076/jcen.23.6.837.1018; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335	32	1	1	0	5	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1051-9815	1875-9270		WORK	Work		2016	53	3					561	567		10.3233/WOR-152223			7	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	DI0TG	WOS:000373209500011	26835851				2022-02-06	
J	Hrabovsky, D; Jancalek, R; Riha, I; Chrastina, J				Hrabovsky, D.; Jancalek, R.; Riha, I.; Chrastina, J.			Complications of Cranioplasty after Decompressive Craniectomy	CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE			Czech	Article						cranioplasty; decompressive craniectomy; brain ischaemia; craniocerebral injury; hydrocephalus; neurosurgical complication	TRAUMATIC BRAIN-INJURY; CLINICAL ARTICLE; HEMICRANIECTOMY; HYDROCEPHALUS; MULTICENTER; IMPROVEMENT; INFARCTION; OUTCOMES; DEFECT	Aim: Reported incidence of cranioplasty complications after decompressive craniectomy may exceed 30%. The aim of the study was to analyse the incidence, causes and treatment options for neurosurgical complications of cranioplasty after decompressive craniectomy for expansive supratentorial ischaemic stroke and craniocerebral injury and to analyse the reasons for not performing cranioplasty in a subgroup of patients after decompressive craniectomy. Patients and methods: During a retrospective study (2006-2014) cranioplasty was performed in 25 of 35 patients after decompressive craniectomy for expansive supratentorial ischaemia (71.4%) and in 33 of 68 (48.5%) patients after decompressive craniectomy for posttraumatic intracranial hypertension. Results: Death was the most frequent reason for not performing cranioplasty after decompressive craniectomy. The frequency of early cranioplasties (< 10 weeks after decompressive craniectomy) was 20% in patients with ischaemic stroke and 61.3% in head-injured patients. The incidence of neurosurgical complications was 12% in patients after expansive brain ischaemia (cranioplasty explantation rate 8%). The incidence of cranioplasty complications in patients after craniocerebral injury was 9.1% (cranioplasty explantation rate 3%). Subdural collections and hydrocephalus were observed in 9.1% and 6% of patients after craniocerebral injury before cranioplasty, resp. Hydrocephalus requiring neurosurgical treatment was found in 6% of patients after craniocerebral injury and 4% of patients with brain ischaemia during the postcranioplasty period. Conclusions: Although the incidence of cranioplasty complications after decompressive craniectomy is lower than that reported in literature, it exceeds the rates expected for elective surgeries. Subdural collections and hydrocephalus cannot be unequivocally considered a complication of cranioplasty, because they are frequently observed before cranioplasty and may be caused by the disease requiring decompressive craniectomy.	[Hrabovsky, D.; Jancalek, R.; Riha, I.; Chrastina, J.] Sv Anny Brne, Neurochirurg Klin LF MU FN, Pekarska 53, Brno 65691, Czech Republic; [Jancalek, R.] Sv Anny Brne, FN, ICRC Mezinarodni Ctr Klin Vyzkumu, Brno 65691, Czech Republic; [Riha, I.; Chrastina, J.] MU, CEITEC Stredoevropsky Technol Inst, Brno, Czech Republic		Chrastina, J (corresponding author), Sv Anny Brne, Neurochirurg Klin LF MU FN, Pekarska 53, Brno 65691, Czech Republic.	jan.chrastina@fnusa.cz	Jancalek, Radim/AAP-9193-2020	Jancalek, Radim/0000-0001-6834-6567			Bender A, 2013, BRAIN INJURY, V27, P1073, DOI 10.3109/02699052.2013.794972; Buchvald P, 2009, CESK SLOV NEUROL N, V72, P169; Chibbaro S, 2013, REV NEUROL-FRANCE, V169, P240, DOI 10.1016/j.neurol.2012.06.016; Coulter IC, 2014, ACTA NEUROCHIR, V156, P1361, DOI 10.1007/s00701-014-2081-1; El Ghoul W, 2015, BRIT J NEUROSURG, V29, P64, DOI 10.3109/02688697.2014.957157; Esquenazi Y, 2015, CLIN NEUROL NEUROSUR, V128, P117, DOI 10.1016/j.clineuro.2014.11.015; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Heo J, 2014, J NEUROSURG, V121, P313, DOI 10.3171/2014.2.JNS131480; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Homolkova H, 2012, CESK SLOV NEUROL N, V75, P617; Jelcic N, 2013, BRAIN INJURY, V27, P1723, DOI 10.3109/02699052.2013.844857; Juran V, 2009, CESK SLOV NEUROL N, V72, P439; Kammersgaard LP, 2013, NEUROREHABILITATION, V33, P473, DOI 10.3233/NRE-130980; Mak CHK, 2013, VASC HEALTH RISK MAN, V9, P353, DOI 10.2147/VHRM.S34046; Movassaghi K, 2006, PLAST RECONSTR SURG, V117, P202, DOI 10.1097/01.prs.0000187152.48402.17; Mracek J, 2010, Rozhl Chir, V89, P109; Mracek J, 2015, ACTA NEUROCHIR, V157, P501, DOI 10.1007/s00701-014-2333-0; Nalbach SV, 2012, J CLIN NEUROSCI, V19, P1222, DOI 10.1016/j.jocn.2012.01.016; Oh CH, 2008, J KOREAN NEUROSURG S, V44, P211, DOI 10.3340/jkns.2008.44.4.211; Paredes I, 2015, NEUROCIRUGIA, V26, P115, DOI 10.1016/j.neucir.2014.10.001; Perez-Bovet J, 2012, ACTA NEUROCHIR, V154, P1717, DOI 10.1007/s00701-012-1323-3; Piedra MP, 2013, J NEUROSURG, V118, P109, DOI 10.3171/2012.10.JNS121037; RISH BL, 1979, NEUROSURGERY, V4, P381, DOI 10.1227/00006123-197905000-00002; Salunke P, 2015, J NEUROSURG, V122, P602, DOI 10.3171/2014.10.JNS14780; Sarov M, 2010, STROKE, V41, P560, DOI 10.1161/STROKEAHA.109.568543; Stephens FL, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1026; Tsang ACO, 2015, J CLIN NEUROSCI, V22, P834, DOI 10.1016/j.jocn.2014.11.021; Wiggins A, 2013, NEUROSURGERY, V72, P248, DOI 10.1227/NEU.0b013e31827b98f3; Yadla S, 2011, NEUROSURGERY, V68, P1124, DOI 10.1227/NEU.0b013e31820a5470; Zanaty M, 2015, J NEUROSURG, V123, P182, DOI 10.3171/2014.9.JNS14405	30	1	1	0	8	CZECH MEDICAL SOC	PRAGUE 2	SOKOLSKA 31, PRAGUE 2 120 26, CZECH REPUBLIC	1210-7859	1802-4041		CESK SLOV NEUROL N	Cesk. Slov. Neurol. Neurochir.		2016	79	1					77	81					5	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DC8KF	WOS:000369467600012					2022-02-06	
J	Joshi, SP; Challawar, NS; Agrawal, PV; Gajjar, AS				Joshi, Satyen Praful; Challawar, Nikhil Subhash; Agrawal, Parth Vinod; Gajjar, Arpit S.			Dyspnea in a case of shoulder dislocation - to beware of this rare life-threatening symptom	SICOT-J			English	Article						Shoulder dislocation; Dyspnea; Intra-thoracic migration of head of humerus	HUMERAL HEAD	Shoulder dislocation is a common injury in orthopedic practice. In an acute presentation, closed reduction of the shoulder joint leads to an uneventful recovery. However, in the developing world neglected shoulder dislocation and treatments from quacks are not uncommon. Improper treatment and neglect can rarely become life threatening. We present one such case, emphasizing the need to investigate the symptom of dyspnea in a patient with history of shoulder dislocation.	[Joshi, Satyen Praful; Challawar, Nikhil Subhash; Agrawal, Parth Vinod; Gajjar, Arpit S.] Dr Vasantrao Pawar Med Coll & Res Ctr, Nasik 422003, Maharashtra, India		Agrawal, PV (corresponding author), Dr Vasantrao Pawar Med Coll & Res Ctr, Nasik 422003, Maharashtra, India.	parth_agrawal018@yahoo.co.in					Abellan Juan F, 2010, J Orthop Surg (Hong Kong), V18, P254; Chen JM, 2015, ULUS TRAVMA ACIL CER, V21, P149, DOI 10.5505/tjtes.2015.72566; Tsai YM, 2014, ANN THORAC CARDIOVAS, V20, P592, DOI 10.5761/atcs.cr.12.02194	3	1	1	0	1	EDP SCIENCES S A	LES ULIS CEDEX A	17, AVE DU HOGGAR, PA COURTABOEUF, BP 112, F-91944 LES ULIS CEDEX A, FRANCE	2426-8887			SICOT-J	SICOT-J		2016	2								30	10.1051/sicotj/2016022			2	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	FB0WA	WOS:000405864400030	27658507	Green Published, gold, Green Submitted			2022-02-06	
J	Kearns, WD; Fozard, JL; Ray, RD; Scott, S; Jasiewicz, JM; Craighead, JD; Pagano, CV				Kearns, William D.; Fozard, James L.; Ray, Roger D.; Scott, Steven; Jasiewicz, Jan M.; Craighead, Jeffrey D.; Pagano, Craig V.			Movement Path Tortuosity Predicts Compliance With Therapeutic Behavioral Prompts in Patients With Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						location aware technology; memory prompting and spatial disorientation; movement path tortuosity; traumatic brain injury	PAGING SYSTEM; MEMORY; PEOPLE; TRIAL; ADULTS	Objective: Rehabilitation of patients with traumatic brain injury typically includes therapeutic prompts for keeping appointments and adhering to medication regimens. Level of cognitive impairment may significantly affect a traumatic brain injury victim's ability to benefit from text-based prompting. We tested the hypothesis that spatial disorientation as measured by movement path tortuosity during ambulation would be associated with poorer compliance with automated prompts by veterans actively being treated for traumatic brain injury. Setting: Clinical polytrauma center. Participants: Ten (1 female) veteran patients mean age = 35.4 (SD = 12.4) years. Design: Small group correlational study without random assignment. Main Measures: Fractal Dimension, a measure of movement path tortuosity derived from a GPS logging device used to record casual outdoor ambulation at the start of the study. Compliance with smart home machine-generated therapeutic prompts received during rehabilitation at the James A. Haley Veterans Administration Hospital Polytrauma Transitional Rehabilitation Program. A patient was compliant with a prompt if they transited from where the prompt was presented to the prescribed destination (both within the Polytrauma Transitional Rehabilitation Program) within 30 minutes. Noncompliance was failure to appear at the destination within the allotted time. Results: Fractal dimension was significantly inversely related to overall prompt compliance (r = -0.603, n = 10, P = .032; 1-tailed). Conclusions: The findings support the hypothesis that increased spatial disorientation adversely impacts compliance with automated prompts throughout therapy. The results are consistent with previous studies linking elevated path tortuosity to cognitive impairment and increased risk for falls in assisted living facility residents.	[Kearns, William D.] Univ S Florida, Coll Behav & Community Sci, Dept Rehabil & Mental Hlth Counseling, 13301 N Bruce B Downs Blvd,MHC 1601, Tampa, FL 33612 USA; [Fozard, James L.] Univ S Florida, Coll Behav & Community Sci, Sch Aging Studies, Tampa, FL 33612 USA; [Ray, Roger D.] Rollins Coll, Dept Psychol, Winter Pk, FL 32789 USA; [Scott, Steven; Pagano, Craig V.] US Dept Vet Affairs, James A Haley Vet Adm Hosp, Phys Med & Rehabil Serv, Tampa, FL USA; [Jasiewicz, Jan M.; Craighead, Jeffrey D.] US Dept Vet Affairs, James A Haley Vet Adm Hosp, Ctr Innovat Disabil & Rehabil Res CINDRR, Tampa, FL USA		Kearns, WD (corresponding author), Univ S Florida, Coll Behav & Community Sci, Dept Rehabil & Mental Hlth Counseling, 13301 N Bruce B Downs Blvd,MHC 1601, Tampa, FL 33612 USA.	Kearns@usf.edu	Kearns, William D/F-9810-2015	Kearns, William D/0000-0002-0241-814X	US Department of DefenseUnited States Department of Defense [W81XWH-11-1-0634]	This research was supported by the US Department of Defense under award number W81XWH-11-1-0634 to Dr Paul Sanberg "Battlefield-Related Injury Translational Research, Post-Traumatic Disease, and Disability Veterans Injury Translational Research, Post-Traumatic Disease, and Disability Veterans Re-Integration."	Bowen Mary Elizabeth, 2010, Gerontechnology, V9, P464, DOI 10.4017/gt.2010.09.04.005.00; Evans JJ, 2003, J INT NEUROPSYCH SOC, V9, P925, DOI 10.1017/S1355617703960127; Fish J, 2008, J NEUROL NEUROSUR PS, V79, P930, DOI 10.1136/jnnp.2007.125203; Goldstein CM, 2014, J TELEMED TELECARE, V20, P293, DOI 10.1177/1357633X14541039; Jamieson M, 2014, NEUROPSYCHOL REHABIL, V24, P419, DOI 10.1080/09602011.2013.825632; Jasiewicz J, 2011, J REHABIL RES DEV, V48, pVII, DOI 10.1682/JRRD.2011.07.0129; Jeffery KJ, 2013, BEHAV BRAIN SCI, V36, P523, DOI 10.1017/S0140525X12002476; Kearns WD, 2009, J NUTR HLTH AGING S1, V13, P54; Kearns WD, 2011, VHA RTLS TRACK OUR F; Kearns WD, 2008, TELEMED E HLTH, V14, P611; Kearns WD, 2015, J HEAD TRAUMA REHAB, V30, pE8, DOI 10.1097/HTR.0000000000000021; Kearns WD, 2012, J AM MED DIR ASSOC, V13, DOI 10.1016/j.jamda.2012.06.010; Lemoncello R, 2011, NEUROPSYCHOL REHABIL, V21, P825, DOI 10.1080/09602011.2011.618661; Malec JF, 2004, ARCH PHYS MED REHAB, V85, P1989, DOI 10.1016/j.apmr.2004.01.032; Moffat SD, 2009, NEUROPSYCHOL REV, V19, P478, DOI 10.1007/s11065-009-9120-3; Nams V, FRACTAL PROGRAM ESTI; Nams VO, 2006, ANIM BEHAV, V72, P1197, DOI 10.1016/j.anbehav.2006.04.005; NAMS VO, 1989, CAN J ZOOL, V67, P254, DOI 10.1139/z89-036; Nams VO, 2005, OECOLOGIA, V143, P179, DOI 10.1007/s00442-004-1804-z; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; US Centers for Disease Control, 2014, INJ PREV CONTR TRAUM; Wilson BA, 2005, BRAIN INJURY, V19, P891, DOI 10.1080/02699050400002363; Wilson BA, 1997, J NEUROL NEUROSUR PS, V63, P113, DOI 10.1136/jnnp.63.1.113	23	1	1	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2016	31	1					E20	E27		10.1097/HTR.0000000000000126			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DK9CN	WOS:000375228000003	25931182				2022-02-06	
J	Lee, S; Lee, JA; Choi, H				Lee, Sol; Lee, Jung Ah; Choi, Hyun			Driving Trail Making Test part B: a variant of the TMT-B	JOURNAL OF PHYSICAL THERAPY SCIENCE			English	Article						Trail Making Test B; Driving simulator; Driving assessment	TRAUMATIC BRAIN-INJURY; OLDER DRIVERS; ELDERLY DRIVERS; PERFORMANCE; SIMULATOR; POPULATION; VALIDITY; STROKE; METAANALYSIS; RELIABILITY	[Purpose] The Trail Making Test part B (TMT-B) is used in evaluating driving abilities and includes testing for the executive function. A driving simulator version of this test (DTMT-B) was developed to measure drivers' executive abilities in three-dimensional space. The purpose of the present study was to assess the validity of the DTMT-B for driving assessment. [Subjects] Thirty stroke patients and 65 healthy subjects were recruited. [Methods] Participants performed the TMT-B and DTMT-B. The DTMT-B was run on a driving simulator in which the individual performed a task on virtual roads connecting the lettered and numbered TMT-B points by simulated driving instead of connecting them with lines as in the paper or computerized TMT-B. Intra-class correlation coefficients (ICCs) were used to assess validities. Significant correlations were found between the TMT-B and DTMT-B. [Results] Participants performed the TMT-B and DTMT-B. Intra-class correlation coefficients (ICCs) were used to assess validities. Significant correlations were found between the TMT-B and DTMT-B. [Conclusion] The results suggest that the DTMT-B may be useful as part of driver screening assessment using a driving simulator for stroke patients and that it may also be used to assess the executive functions for healthy people.	[Lee, Sol] Korea Natl Rehabil Res Inst, Dept Rehabil Standard & Policy, Seoul, South Korea; [Lee, Jung Ah; Choi, Hyun] Korea Natl Rehabil Res Inst, Dept Clin Res Rehabil, Seoul 142884, South Korea		Lee, JA (corresponding author), Korea Natl Rehabil Res Inst, Dept Clin Res Rehabil, Seoul 142884, South Korea.	leejungah@korea.kr			Korea National Rehabilitation Research Institute [12-B-01]	This research was supported by a grant (12-B-01) by Korea National Rehabilitation Research Institute.	Akinwuntan AE, 2005, NEUROLOGY, V65, P843, DOI 10.1212/01.wnl.0000171749.71919.fa; Betz ME, 2009, TRAFFIC INJ PREV, V10, P415, DOI 10.1080/15389580903132819; Classen S, 2008, TRAFFIC INJ PREV, V9, P456, DOI 10.1080/15389580802260026; Crundall D, 2010, ACCIDENT ANAL PREV, V42, P2117, DOI 10.1016/j.aap.2010.07.001; De Raedt R, 2000, J AM GERIATR SOC, V48, P1664, DOI 10.1111/j.1532-5415.2000.tb03880.x; Devlin A, 2012, ACCIDENT ANAL PREV, V49, P300, DOI 10.1016/j.aap.2012.02.022; Devos H, 2011, NEUROLOGY, V76, P747, DOI 10.1212/WNL.0b013e31820d6300; Freund B, 2005, ACCIDENT ANAL PREV, V37, P613, DOI 10.1016/j.aap.2005.03.002; Gamache PL, 2011, BRAIN INJURY, V25, P416, DOI 10.3109/02699052.2011.558039; Han C, 2008, ARCH GERONTOL GERIAT, V47, P302, DOI 10.1016/j.archger.2007.08.012; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Hault-Dubrulle A, 2011, ACCIDENT ANAL PREV, V43, P66, DOI 10.1016/j.aap.2010.07.012; Horberry T, 2010, APPL ERGON, V41, P796, DOI 10.1016/j.apergo.2010.01.006; Horimoto Y, 2011, J PHYS THER SCI, V23, P221, DOI 10.1589/jpts.23.221; Ivancic K, 2000, ERGONOMICS, V43, P1966, DOI 10.1080/00140130050201427; Kay LG, 2012, AUST OCCUP THER J, V59, P89, DOI 10.1111/j.1440-1630.2011.00989.x; Lee HC, 2003, J SAFETY RES, V34, P453, DOI 10.1016/j.jsr.2003.09.007; Lengenfelder J, 2002, J HEAD TRAUMA REHAB, V17, P26, DOI 10.1097/00001199-200202000-00005; Lundberg C, 1998, ACCIDENT ANAL PREV, V30, P371, DOI 10.1016/S0001-4575(97)00111-5; Mathias JL, 2009, INT PSYCHOGERIATR, V21, P637, DOI 10.1017/S1041610209009119; Messinis L, 2011, ARCH CLIN NEUROPSYCH, V26, P322, DOI 10.1093/arclin/acr027; Park SW, 2011, PM&R, V3, P198, DOI 10.1016/j.pmrj.2010.12.008; Ricker, 1994, Assessment, V1, P47, DOI 10.1177/1073191194001001007; Roenker DL, 2003, HUM FACTORS, V45, P218, DOI 10.1518/hfes.45.2.218.27241; Sackley CM, 2005, CLIN REHABIL, V19, P746, DOI 10.1191/0269215505cr863oa; Sanchez-Cubillo I, 2009, J INT NEUROPSYCH SOC, V15, P438, DOI 10.1017/S1355617709090626; Seo EH, 2006, INT J GERIATR PSYCH, V21, P844, DOI 10.1002/gps.1570; Shin HK, 2012, J PHYS THER SCI, V24, P567, DOI 10.1589/jpts.24.567; Stutts JC, 1998, ACCIDENT ANAL PREV, V30, P337, DOI 10.1016/S0001-4575(97)00108-5; Takasaki H, 2013, ACCIDENT ANAL PREV, V60, P5, DOI 10.1016/j.aap.2013.07.033; Vazzana R, 2010, J AM GERIATR SOC, V58, P719, DOI 10.1111/j.1532-5415.2010.02780.x; Wang TY, 2012, ARCH CLIN NEUROPSYCH, V27, P781, DOI 10.1093/arclin/acs073; Yoo I, 2015, J PHYS THER SCI, V27, P1823, DOI 10.1589/jpts.27.1823	33	1	1	3	6	SOC PHYSICAL THERAPY SCIENCE	TOKYO	C/O PUBLICATION CENTER, 1-24-12 SUGAMO, TOSHIMA-KU, TOKYO, 170-0002, JAPAN	0915-5287	2187-5626		J PHYS THER SCI	J. Phys. Ther. Sci.	JAN	2016	28	1					148	153		10.1589/jpts.28.148			6	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	DF3IP	WOS:000371237800029	26957747	gold, Green Published			2022-02-06	
J	Li, XP; Guan, JW; Hou, W; Cheng, ST; Jiang, Z; Wang, YH; Liu, YY; Wang, ZR				Li, Xuepei; Guan, Junwen; Hou, Wang; Cheng, Shuting; Jiang, Zhou; Wang, Yuhui; Liu, Yangyou; Wang, Zhengrong			The circadian intracranial pressure would be a prognostic factor in traumatic brain injury?	BIOLOGICAL RHYTHM RESEARCH			English	Article						Circadian rhythm; intracranial pressure; traumatic brain injury; prognosis	SLEEP DISORDERS; HEAD-INJURY; RHYTHMS; CANCER; SCALE; ATTENDANTS; IMPACT; LIGHT; COMA	Traumatic brain injury (TBI) generally influences circadian rhythms and has been implicated changes in circadian rhythm. Whether TBI-induced changes in circadian rhythm may affect the prognosis or recovery from TBI remains to be investigated. Sixty-two patients with TBI were continuously monitored for intracranial pressure (ICP) during the first 24 hours after the implantation of ICP monitor. The data from each patient were analyzed using the least squares fit of a 24-h cosine function by single cosinor method. Parameters of circadian A (Amplitude)/M (MESOR) were used to evaluate the circadian rhythm of the patients. Student's t-test and Pearson's chi-squared test were utilized to analyze the differences between good prognosis group and poor prognosis. A linear regression analysis was then applied to calculate the correlation between circadian A/M of ICP and Glasgow Coma Scale (GCS) before discharge, the Extended Glasgow Outcome Scale (GOS-E), the dosage of mannitol, and time spent in the intensive care unit (ICU), respectively. The results demonstrated that circadian A/M of patients' ICP exhibited a positive correlation with GCS scores taken before discharge, GOS-E scores, and was negatively correlated with the amount of mannitol, and time spent in the ICU. We conclude that changes in the ICP circadian rhythm in TBI patients could reflect an internal signal of brain damage and, therefore, may be useful to predict a patient's prognosis and recovery from TBI.	[Li, Xuepei; Hou, Wang; Cheng, Shuting; Jiang, Zhou; Wang, Yuhui; Liu, Yangyou; Wang, Zhengrong] Sichuan Univ, China Hlth Minist, Key Lab Chronobiol, Chengdu, Peoples R China; [Guan, Junwen] Sichuan Univ, West China Hosp, Nurosurg Dept, Chengdu, Peoples R China		Wang, ZR (corresponding author), Sichuan Univ, China Hlth Minist, Key Lab Chronobiol, Chengdu, Peoples R China.	wangzhengrong@126.com	Jiang, Zhou/AAN-2519-2020		National Nature Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31371180, 31500935]; China Medical Board [88-486]; Key Technology Research and Development Program of Science and Technology of Sichuan Province [2014SZ0193]; Science Research Project of Sichuan Health Department [130049]	This work was supported by the National Nature Science Foundation of China under [grant number 31371180], [grant number 31500935]; China Medical Board under [grant number 88-486]; the Key Technology Research and Development Program of Science and Technology of Sichuan Province under [grant number 2014SZ0193]; and Science Research Project of Sichuan Health Department under [grant number 130049].	Bechtold DA, 2010, TRENDS PHARMACOL SCI, V31, P191, DOI 10.1016/j.tips.2010.01.002; Boone DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046204; Bullock RM, 2000, J NEUROTRAUM, V17, P449; CLIFTON GL, 1992, NEUROSURGERY, V31, P975, DOI 10.1227/00006123-199211000-00028; CORNELISSEN G, 1990, AM J CARDIOL, V66, P863, DOI 10.1016/0002-9149(90)90369-C; Cornelissen G, 2014, THEOR BIOL MED MODEL, V11, DOI 10.1186/1742-4682-11-16; Coronado G, 2011, MMWR-MORBID MORTAL W, V60, P1; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Duclos C, 2014, NEUROREHAB NEURAL RE, V28, P472, DOI 10.1177/1545968313517756; Dunn LT, 2002, J NEUROL NEUROSUR PS, V73, pI23; Faden AI, 1996, JAMA-J AM MED ASSOC, V276, P569, DOI 10.1001/jama.276.7.569; Gardani M, 2015, ARCH PHYS MED REHAB, V96, P1691, DOI 10.1016/j.apmr.2015.05.006; Guan JW, 2009, BRAIN RES, V1258, P78, DOI 10.1016/j.brainres.2008.11.106; HALBERG F, 1969, ANNU REV PHYSIOL, V31, P675, DOI 10.1146/annurev.ph.31.030169.003331; Hansen J, 2001, JNCI-J NATL CANCER I, V93, P1513, DOI 10.1093/jnci/93.20.1513; Howlader G, 2006, J INSECT PHYSIOL, V52, P779, DOI 10.1016/j.jinsphys.2006.05.001; Ivan V, 2009, BRAIN INJURY, V10, P45; Jacque JM, 2002, NATURE, V418, P435, DOI 10.1038/nature00896; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; JOHNSTONE AJ, 1993, BRAIN INJURY, V7, P501, DOI 10.3109/02699059309008177; Lack LC, 1996, J SLEEP RES, V5, P211, DOI 10.1111/j.1365-2869.1996.00211.x; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Le Roux P, 2014, CURR OPIN CRIT CARE, V20, P141, DOI 10.1097/MCC.0000000000000078; Mazzoccoli G, 2012, J BIOL REG HOMEOS AG, V26, P265; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; Meerlo P, 2009, SLEEP MED REV, V13, P187, DOI 10.1016/j.smrv.2008.07.004; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Paul T, 2007, CHRONOBIOL INT, V24, P45, DOI 10.1080/07420520601142569; Portaluppi F, 2010, CHRONOBIOL INT, V27, P1652, DOI 10.3109/07420528.2010.510788; PUKKALA E, 1995, BRIT MED J, V311, P649, DOI 10.1136/bmj.311.7006.649; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Reynolds P, 2002, CANCER CAUSE CONTROL, V13, P317, DOI 10.1023/A:1015284014563; Sabir M, 2015, BRAIN BEHAV IMMUN, V47, P118, DOI 10.1016/j.bbi.2014.12.023; Shigenobu S, 1982, BRAIN RES, V247, P154; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255; TEASDALE G, 1974, LANCET, V2, P81; Terman M, 1995, J BIOL RHYTHM, V10, P135, DOI 10.1177/074873049501000206; Wang T, 2014, HIV MED, V15, P565, DOI 10.1111/hiv.12154; Zisapel N, 2001, CNS DRUGS, V15, P311, DOI 10.2165/00023210-200115040-00005	39	1	1	0	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0929-1016	1744-4179		BIOL RHYTHM RES	Biol. Rhythm Res.		2016	47	6					823	832		10.1080/09291016.2016.1197515			10	Biology; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics; Physiology	DV5JE	WOS:000382962400002					2022-02-06	
J	LoBuono, DL; Taetzsch, AG; Lofgren, IE; Xu, FR; Delmonico, MJ; Mahler, L				LoBuono, Dara L.; Taetzsch, Amy G.; Lofgren, Ingrid E.; Xu, Furong; Delmonico, Matthew J.; Mahler, Leslie			Cognitive status and cardio-metabolic risk of patients with acquired brain injury and Parkinson's disease	DISABILITY AND HEALTH JOURNAL			English	Article						Parkinson's disease; Stroke; Traumatic brain injury	UNITED-STATES; STROKE; REHABILITATION; DISABILITY; MORTALITY; SURVIVAL; OBESITY; LIFE	Background: Parkinson's disease (PD) and acquired brain injury (ABI) share common symptoms. People with PD and ABI risk nutritional decline at diagnosis, but little is known about their long-term health a year or more after diagnosis. Objective: This cross-sectional study describes cognitive and dietary characteristics of people living with PD or ABI 12 months or more post diagnosis to identify cardio-metabolic risk factors. Methods: Twelve community-dwelling participants (8 PD, 4 ABI) received interdisciplinary evaluations. Cognitive-linguistic status was assessed using the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). Nutritional and cardiometabolic statuses were measured using the dietary screening tool (DST), anthropometrics, biochemical, and clinical measures. Descriptive statistics, independent t-tests and correlations were used to analyze the data. Results: Mean BMI (n = 12) was 26.8 +/- 3.0 kg/m(2) and the majority of participants were overweight. Participants with PD had significantly higher total RBANS scores than participants with ABI (87.1 +/- 14.6 vs. 66.0 +/- 12.6, p = 0.034, d = 2.455). DST scores indicated 58% (N = 7) at possible nutrition risk and 25% (N 5 3) were at nutrition risk. A positive correlation was found between general activity level and DST scores (r = 0.697, p = 0.012). Multiple risk factors for development of cardiovascular disease (CVD) were present in all participants. Conclusion: These findings confirmed the presence of cognitive and dietary deficits in our participant group and support the need for an interdisciplinary team approach to improve health and prevent the development of symptoms for these populations a year or more after diagnosis. (C) 2016 Elsevier Inc. All rights reserved.	[Mahler, Leslie] Univ Rhode Isl, Dept Communicat Disorders, Kingston, RI 02281 USA; [LoBuono, Dara L.; Taetzsch, Amy G.; Lofgren, Ingrid E.] Univ Rhode Isl, Dept Nutr & Food Sci, Kingston, RI 02881 USA; [Xu, Furong; Delmonico, Matthew J.] Univ Rhode Isl, Dept Kinesiol, Kingston, RI 02881 USA		Mahler, L (corresponding author), Univ Rhode Isl, Dept Communicat Disorders, Independence Sq 1, Kingston, RI 02281 USA.	lmahler@uri.edu					Aiello M, 2015, APPETITE, V84, P204, DOI 10.1016/j.appet.2014.10.011; Bailey RL, 2009, AM J CLIN NUTR, V90, P177, DOI 10.3945/ajcn.2008.27268; Barichella M, 2009, MOVEMENT DISORD, V24, P1881, DOI 10.1002/mds.22705; Breed ST, 2004, ARCH PHYS MED REHAB, V85, pS61, DOI 10.1016/j.apmr.2003.08.115; Cassani E, 2013, NUTRITION, V29, P1331, DOI 10.1016/j.nut.2013.04.013; Centers for Disease Control and Prevention, 2012, CHOLESTEROL; Cereda E, 2013, NUTR METAB CARDIOVAS, V23, P264, DOI 10.1016/j.numecd.2011.04.004; Chen YH, 2011, STROKE, V42, P2733, DOI 10.1161/STROKEAHA.111.620112; Cilia R., 2014, J NEUROL NEUROSURG P; Cohen J., 2013, STAT POWER ANAL BEHA; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Doehner W, 2013, EUR HEART J, V34, P268, DOI 10.1093/eurheartj/ehs340; Driver S, 2012, BRAIN INJURY, V26, P1482, DOI 10.3109/02699052.2012.694568; Fall PA, 2003, MOVEMENT DISORD, V18, P1312, DOI 10.1002/mds.10537; Faul M, 2010, TRAUMATIC BRAIN INJU; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Krakau K, 2007, NUTRITION, V23, P308, DOI 10.1016/j.nut.2007.01.010; Laditka JN, 2014, DISABIL HEALTH J, V7, P472, DOI 10.1016/j.dhjo.2014.06.005; Leroi I, 2012, J GERIATR PSYCH NEUR, V25, P208, DOI 10.1177/0891988712464823; Lotfus, 2009, NEUROTRAUMA CRITICAL, P3; Murphy MP, 2012, NEUROREHABILITATION, V31, P85, DOI 10.3233/NRE-2012-0777; Prodam F, 2013, GROWTH HORM IGF RES, V23, P109, DOI 10.1016/j.ghir.2013.04.001; Randolph C., 1998, REPEATABLE BATTERY A; Scherbakov N, 2011, STROKE, V42, P3646, DOI 10.1161/STROKEAHA.111.619163; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	25	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1936-6574	1876-7583		DISABIL HEALTH J	Disabil. Health J.	JAN	2016	9	1					134	139		10.1016/j.dhjo.2015.06.001			6	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health; Rehabilitation	CY7AQ	WOS:000366560600018	26162808				2022-02-06	
J	Lu, C				Lu, Chuan			Reversal of Oxidative Stress in Neural Cells by an Injectable Curcumin/Thermosensitive Hydrogel	CURRENT DRUG DELIVERY			English	Article						Curcumin hydrogel; in vitro release; oxidative stress	TRAUMATIC BRAIN-INJURY; ANTIOXIDANT THERAPIES; LIPID-PEROXIDATION; CANCER-THERAPY; DRUG-DELIVERY; IN-VITRO; CURCUMIN; FORMULATION; MICELLES; CHEMOTHERAPY	Curcumin as an antioxidative agent which has been widely used medicinally in India and China. However, rapid metabolism coupled with the instability of curcumin under physiological conditions has greatly limited its applications in vivo. In the present study, a thermosensitive hydrogel with high payload of curcumin was developed by using a co-precipitation method, and its reversion of oxidative stress in Neuro-2a cells was investigated. With an increase in drug loading capacity, the solgel transition temperature of the thermosensitive hydrogel decreased accordingly. The stability of curcumin in phosphate-buffered saline (PBS; pH= 7.4) was greatly improved by encapsulation in the thermosensitive hydrogel, as indicated by an in vitro degradation test. An in vitro release study showed that the encapsulated curcumin was rapidly released from the hydrogel within 6 h. A curcumin/F-127 aqueous solution under the threshold concentration of 4 mu g/mL was non-toxic against Neuro-2a cells after 24-h incubation. A MitoSOX assay indicated that the developed curcumin formulation could attenuate the oxidative damage induced by H2O2 as compared to that of the H2O2 group. All these results suggested that the developed curcumin/thermosensitive hydrogel might have great potential application in the reversion of oxidative stress after traumatic brain injury.	[Lu, Chuan] Wenzhou Cent Hosp, Dept Neurosurg, 32 Dajian Xiang, Wenzhou 325027, Peoples R China		Lu, C (corresponding author), Wenzhou Cent Hosp, Dept Neurosurg, 32 Dajian Xiang, Wenzhou 325027, Peoples R China.	luchuanwz@163.com			Zhejiang Medicines Health Science and Technology Program [2014ZHB005]	This work was supported by Zhejiang Medicines Health Science and Technology Program (2014ZHB005).	Casalino E, 1996, INT J BIOCHEM CELL B, V28, P137, DOI 10.1016/1357-2725(95)00131-X; Catala A, 2007, CURR MOL MED, V7, P638, DOI 10.2174/156652407782564444; Chiappetta DA, 2007, EUR J PHARM BIOPHARM, V66, P303, DOI 10.1016/j.ejpb.2007.03.022; Clond MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061819; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Darvesh AS, 2012, CURR PHARM BIOTECHNO, V13, P218; Drisko JA, 2003, GYNECOL ONCOL, V88, P434, DOI 10.1016/S0090-8258(02)00067-7; Fernandez-Gajardo R, 2014, CNS DRUGS, V28, P229, DOI 10.1007/s40263-013-0138-y; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Jomova K, 2011, CURR PHARM DESIGN, V17, P3460, DOI 10.2174/138161211798072463; Jung HH, 2010, J CONTROL RELEASE, V147, P84, DOI 10.1016/j.jconrel.2010.06.020; Kim SY, 2000, J CONTROL RELEASE, V65, P345, DOI 10.1016/S0168-3659(99)00207-2; Li XY, 2014, J BIOMED NANOTECHNOL, V10, P1458, DOI 10.1166/jbn.2014.1840; Li XY, 2013, INT J PHARMACEUT, V448, P96, DOI 10.1016/j.ijpharm.2013.03.024; Lu XY, 2014, J SURG RES, V188, P206, DOI 10.1016/j.jss.2013.11.1106; Mohanty C, 2010, BIOMATERIALS, V31, P6597, DOI 10.1016/j.biomaterials.2010.04.062; Mohanty C, 2010, NANOMEDICINE-UK, V5, P433, DOI 10.2217/NNM.10.9; Moss RW, 2006, INTEGR CANCER THER, V5, P63, DOI 10.1177/1534735405285882; Murphy MP, 2014, FREE RADICAL BIO MED, V66, P20, DOI 10.1016/j.freeradbiomed.2013.04.010; Rejinold NS, 2011, J BIOMED NANOTECHNOL, V7, P521, DOI 10.1166/jbn.2011.1320; Riganello F, 2008, J PSYCHOPHYSIOL, V22, P166, DOI 10.1027/0269-8803.22.4.166; Sahebkar A, 2013, BIOFACTORS, V39, P197, DOI 10.1002/biof.1062; Sindhu RK, 2004, CLIN EXP HYPERTENS, V26, P43, DOI 10.1081/CEH-120027330; Slemmer JE, 2008, CURR MED CHEM, V15, P404, DOI 10.2174/092986708783497337; Smith RAJ, 2011, DISCOV MED, V11, P106; Tsai YM, 2011, INT J PHARMACEUT, V416, P331, DOI 10.1016/j.ijpharm.2011.06.030; Yallapu MM, 2012, DRUG DISCOV TODAY, V17, P71, DOI 10.1016/j.drudis.2011.09.009; Zheng XL, 2010, DRUG DELIV, V17, P138, DOI 10.3109/10717541003604874; Zhu HT, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-59	29	1	1	1	15	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1567-2018	1875-5704		CURR DRUG DELIV	Curr. Drug Deliv.		2016	13	5					682	687		10.2174/1567201813666151109102532			6	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	DY0PZ	WOS:000384800000005	26549040				2022-02-06	
J	Marzban, C; Gu, WX; Mourad, PD				Marzban, Caren; Gu, Wenxiao; Mourad, Pierre D.			Mixture Models for Estimating Maximum Blood Flow Velocity	JOURNAL OF ULTRASOUND IN MEDICINE			English	Article						blood flow; brain; head injury; noninvasive; transcranial Doppler ultrasound	FINITE MIXTURE; DOPPLER	Objectives-A gaussian mixture model (GMM) was recently developed for estimating the probability density function of blood flow velocity measured with transcranial Doppler ultrasound data. In turn, the quantiles of the probability density function allow one to construct estimators of the "maximum" blood flow velocity. However, GMMs assume gaussianity, a feature that is not omnipresent in observed data. The objective of this work was to develop mixture models that do not invoke the gaussian assumption. Methods-Here, GMMs were extended to a skewed GMM and a nongaussian kernel mixture model. All models were developed on data from 59 patients with closed head injuries from multiple hospitals in the United States, with ages ranging from 13 to 81 years and Glasgow Coma Scale scores ranging from 3 to 11. The models were assessed in terms of the log likelihood (a goodness-of-fit measure) and via visual comparison with the underlying spectrograms. Results-Among the models examined, the skewed GMM showed a significantly (P < .05) higher log likelihood for 56 of the 59 patients and produced maximum flow velocity estimates consistent with the observed spectrograms for all patients. Kernel mixture models are generally less "robust" in that their quality is inconsistent across patients. Conclusions-Among the models examined, it was found that the skewed GMM provided a better model of the data both in terms of the quality of the fit and in terms of visual comparison of the underlying spectrogram and the estimated maximum blood flow velocity. Nongaussian mixture models have potential for even higher-quality assessment of blood flow, but further development is called for.	[Marzban, Caren; Mourad, Pierre D.] Univ Washington, Appl Phys Lab, Seattle, WA 98195 USA; [Marzban, Caren; Gu, Wenxiao] Univ Washington, Dept Stat, Seattle, WA 98195 USA; [Mourad, Pierre D.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Mourad, Pierre D.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA		Marzban, C (corresponding author), Univ Washington, Dept Stat, Box 354322, Seattle, WA 98195 USA.	marzban@stat.washington.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R43NS46824-01A1]; National Space Biomedical Research Institute [SMS00701-2009-513]; PhysioSonics Inc.; PhysioSonics	We thank Paul R. Illian and David Morison for contributions made during an early phase of this project. This work received support from the National Institutes of Health (grant R43NS46824-01A1), National Space Biomedical Research Institute (grant SMS00701-2009-513), and PhysioSonics Inc. Dr Mourad has a financial interest in PhysioSonics.	AASLID R, 1984, J NEUROSURG, V60, P32, DOI 10.3171/jns.1984.60.1.0032; AASLID R, 1984, J NEUROSURG, V60, P37, DOI 10.3171/jns.1984.60.1.0037; AASLID R, 1986, NEURORADIOLOGY, V28, P11, DOI 10.1007/BF00341759; Aaslid Rune, 2002, Eur J Ultrasound, V16, P3, DOI 10.1016/S0929-8266(02)00045-9; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Babikian VL., 1999, TRANSCRANIAL DOPPLER; Basso RM, 2010, COMPUT STAT DATA AN, V54, P2926, DOI 10.1016/j.csda.2009.09.031; Benaglia T, 2011, NONPARAMETRIC STATISTICS AND MIXTURE MODELS: A FESTSCHRIFT IN HONOR OF THOMAS P HETTMANSPERGER, P15; Benaglia T, 2009, J STAT SOFTW, V32, P1; Benaglia T, 2009, J COMPUT GRAPH STAT, V18, P505, DOI 10.1198/jcgs.2009.07175; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Dinov I.D, 2008, EXPECTATION MAXIMIZA; Fernando KL, 2004, IEEE T BIO-MED ENG, V51, P2085, DOI 10.1109/TBME.2004.826647; Guler I, 2002, COMPUT BIOL MED, V32, P445, DOI 10.1016/S0010-4825(02)00036-7; Hastie T., 2008, RANDOM FORESTS, DOI DOI 10.1007/978-0-387-84858-7_15; Marzban C, 2013, J ULTRAS MED, V32, P1913, DOI 10.7863/ultra.32.11.1913; Marzban C, 2013, J NEUROSURG ANESTH, V25, P25, DOI 10.1097/ANA.0b013e318263c295; McLachlan GJ., 2000, WILEY SER PROB STAT, DOI 10.1002/0471721182; Moraes R., 1995, J VASCULAR INVEST, V1, P126; Ostlund N, 2004, IEEE T BIO-MED ENG, V51, P1541, DOI 10.1109/TBME.2004.827930; Pereira M, 2010, BIOMEDICAL DIAGNOSTI, P263; Prates MO, 2013, J STAT SOFTW, V54, P1; R Development Core Team, 2011, R LANG ENV STAT COMP; Rubin JM, 1997, RADIOLOGY, V205, P757, DOI 10.1148/radiology.205.3.9393532; Ryan T. P., 2009, MODERN REGRESSION ME; Silverman B.W, 1986, DENSITY ESTIMATION; Sloan M, 1999, TRANSCRANIAL DOPPLER, P109; Tegeler CH, 1999, TRANSCRANIAL DOPPLER, P3; Tsivgoulis G, 2009, CURR NEUROL NEUROSCI, V9, P46, DOI 10.1007/s11910-009-0008-7	29	1	1	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0278-4297	1550-9613		J ULTRAS MED	J. Ultrasound Med.	JAN	2016	35	1					93	101		10.7863/ultra.14.05069			9	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	CZ6RN	WOS:000367228500012	26643758				2022-02-06	
J	McGillivray, K				McGillivray, Kiera			Application of the Intersystem Approach for Combat Veterans Experiencing Sexual Problems Related to Trauma and Injuries of War	JOURNAL OF FAMILY PSYCHOTHERAPY			English	Article						Combat veterans; limb amputation; post-traumatic stress disorder; sexual functioning; traumatic brain injury	DYSFUNCTION; IMPACT	The purpose of this article is to explore how the Intersystem Approach can be applied to combat veterans experiencing sexual problems related to post-traumatic stress disorder, traumatic brain injury, and severe wounds. Thousands of combat veterans have returned home with injuries and traumatic memories that are influencing their overall functioning. The information presented looks at 5 different domains combat veterans might experience problems within, including individual/medical, individual/psychological, dyadic, intergenerational, and society/culture. Assessment ideas and treatment considerations are described in detail within the domains, conveying to therapists the importance of the issue. Following the descriptions of problems combat veterans might face overseas and returning home is a case example. The presenting problems, theoretical framework, and treatment approach are thoroughly explained in order to see how the application of the Intersystem Approach can be used with combat veterans experiencing invisible and physical injuries.	[McGillivray, Kiera] Univ Nevada, Dept Marriage & Family Therapy, 4505 Maryland Pkwy,Box 453045, Las Vegas, NV 89154 USA		McGillivray, K (corresponding author), Univ Nevada, Dept Marriage & Family Therapy, 4505 Maryland Pkwy,Box 453045, Las Vegas, NV 89154 USA.	mcgillivray.kiera@gmail.com					Ace K. J., 2007, SEX HEALTH, P301; Aloni A, 1999, BRAIN INJURY, V13, P89, DOI 10.1080/026990599121755; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th; Bagalman E., 2013, R40941 CRS; Blount T, 2015, COGN BEHAV PRACT, V22, P458, DOI 10.1016/j.cbpra.2014.05.001; Carter JK., 2012, J REHABIL RES DEV, V49, P1443, DOI DOI 10.1682/JRRD.2011.12.0228; Chevret M, 2004, J SEX MARITAL THER, V30, P157, DOI 10.1080/00926230490262366; Clayton AH, 2013, CURR PSYCHIATRY REV, V9, P293, DOI 10.2174/15734005113096660007; Corona G, 2004, INT J IMPOT RES, V16, P275, DOI 10.1038/sj.ijir.3901158; Corona G, 2009, J SEX MED, V6, P1259, DOI 10.1111/j.1743-6109.2009.01248.x; Cosgrove DJ, 2002, UROLOGY, V60, P881, DOI 10.1016/S0090-4295(02)01899-X; Dean R, 2012, EVALUATION TREATMENT; Fischer H., 2014, RS22452 CRS; Foley S, 2015, SYSTEMIC SEX THERAPY, 2ND EDITION, P107; Gambescia N, 2015, SYSTEMIC SEX THERAPY, 2ND EDITION, P72; Gawande A, 2004, NEW ENGL J MED, V351, P2471, DOI 10.1056/NEJMp048317; Geertzen JHB, 2009, DISABIL REHABIL, V31, P522, DOI 10.1080/09638280802240589; Hall K, 2015, SYSTEMIC SEX THERAPY, 2ND EDITION, P55; Hirsch KA, 2009, MIL MED, V174, P520, DOI 10.7205/MILMED-D-03-3508; Jeszior J. R., 2012, EVALUATION TREATMENT; Kooijman CM, 2000, PAIN, V87, P33, DOI 10.1016/S0304-3959(00)00264-5; Letourneau EJ, 1997, J TRAUMA STRESS, V10, P125, DOI 10.1002/jts.2490100112; Lipsith J, 2003, SEX RELATSH THER, V18, P447; Martinez-Pineiro L, 2010, EUR UROL, V57, P791, DOI 10.1016/j.eururo.2010.01.013; Matyja A. M., 2014, THESIS; McCabe M.P., 2005, INT J STRESS MANAGE, V12, P379, DOI [10.1037/1072-5245.12.4.379, DOI 10.1037/1072-5245.12.4.379]; McCabe MP, 2015, SYSTEMIC SEX THERAPY, 2ND EDITION, P171; Mills B., 2001, SEX RELATSH THER, V16, P299, DOI [10.1080/14681990120064531, DOI 10.1080/14681990120064531]; Oberst M T, 1985, Top Clin Nurs, V7, P46; Robins N, 2012, THESIS; Sakaluk JK, 2014, J SEX RES, V51, P516, DOI 10.1080/00224499.2012.745473; Sautter FJ, 2009, J MARITAL FAM THER, V35, P343, DOI 10.1111/j.1752-0606.2009.00125.x; Solomon Z, 2008, J FAM PSYCHOL, V22, P659, DOI 10.1037/a0013596; Solursh Lionel P, 2011, Int J Adolesc Med Health, V7, P119, DOI 10.1515/IJAMH.1994.7.2.119; Trudeau-Hern S, 2012, CONTEMP FAM THER, V34, P534, DOI 10.1007/s10591-012-9211-9; Weeks GR, 2015, SYSTEMIC SEX THERAPY, 2ND EDITION, P125; WILLIAMSON GM, 1996, THE JOURNAL OF SEX R, V33, P221, DOI DOI 10.1080/00224499609551838; WILSON PG, 1983, VASCULAR SURG, V17, P165, DOI 10.1177/153857448301700306; WINCZE JP, 2001, SEXUAL DYSFUNCTION G	39	1	1	0	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0897-5353	1540-4080		J FAM PSYCHOTHER	J. Fam. Psychother.		2016	27	4					243	259		10.1080/08975353.2016.1235431			17	Psychology, Clinical	Emerging Sources Citation Index (ESCI)	Psychology	EC3ES	WOS:000388009100002					2022-02-06	
J	McGilloway, E; Mitchell, J; Dharm-Datta, S; Roberts, A; Tilley, H; Etherington, J				McGilloway, Emer; Mitchell, James; Dharm-Datta, Shreshth; Roberts, Andrew; Tilley, Haydn; Etherington, John			The Mayo Portland Adaptability Inventory-4 outcome measure is superior to UK FIM plus FAM in a British military population	BRAIN INJURY			English	Article						Traumatic brain injury; outcome; rehabilitation; head injury; assessment; quality of life	TRAUMATIC BRAIN-INJURY; ASSESSMENT MEASURE FIM+FAM; REHABILITATION; RELIABILITY; RATINGS; SAMPLE; SCALE	Objective: The aim of this study was to identify the most appropriate rehabilitation outcome measure for use in a young adult population with acquired brain injury.Methods: A 2-year prospective study of patients admitted to a UK military neuro-rehabilitation unit with acquired brain injury to compare the appropriateness of the Functional Independence Measure/Functional Assessment Measure (FIM+FAM) vs the Mayo-Portland Adaptability Inventory Version 4 (MPAI-4) in assessing outcomes. Patients were assessed at admission, discharge and at 4-month follow-up using FIM+FAM and MPAI-4.Results: The FIM+FAM total motor score showed a marked ceiling affect, 42% of patients scored the maximum on admission rising to 80% at discharge. The MPAI-4 did not show significant ceiling effects. The other sub-scales of FIM+FAM and MPAI-4 were generally comparable, no more than 17% achieved ceiling at follow-up.Conclusions: This is the first comparative study of FIM+FAM and MPAI-4 in a young adult military population following acquired brain injury. All patients showed improvements in both outcome measures following intensive inpatient rehabilitation. However, the MPAI-4 did not show ceiling effects in motor scores. This measure was, therefore, found to be more appropriate in the cohort.	[McGilloway, Emer; Mitchell, James; Dharm-Datta, Shreshth; Roberts, Andrew; Tilley, Haydn; Etherington, John] Def Med Rehabil Ctr DMRC Headley Court, Epsom KT18 6JW, Surrey, England		Mitchell, J (corresponding author), Def Med Rehabil Ctr DMRC Headley Court, Epsom KT18 6JW, Surrey, England.	dmrc-neuroconsultant@mod.uk					Bohac DL, 1997, BRAIN INJURY, V11, P469, DOI 10.1080/713802185; Dharm-Datta Shreshth, 2015, J Trauma Acute Care Surg, V79, pS197, DOI 10.1097/TA.0000000000000721; Hall K. M., 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199308020-00008; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; Hawley CA, 1999, J NEUROL NEUROSUR PS, V67, P749, DOI 10.1136/jnnp.67.6.749; Hobart JC, 2001, NEUROLOGY, V57, P639, DOI 10.1212/WNL.57.4.639; Kean J, 2013, ARCH PHYS MED REHAB, V94, P2417, DOI 10.1016/j.apmr.2013.08.006; Kean J, 2011, J NEUROTRAUM, V28, P745, DOI 10.1089/neu.2010.1573; Law J, 2009, DISABIL REHABIL, V31, P825, DOI 10.1080/09638280802355049; Lezak M.D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI DOI 10.1097/00001199-198703000-00009; Linn R T, 1999, J Outcome Meas, V3, P339; MAHONEY F I, 1965, Md State Med J, V14, P61; Malec J. F., 1994, J HEAD TRAUMA REHAB, V9, P1, DOI [10. 1097/ 00001199- 199412000- 00003, DOI 10.1097/00001199-199412000-00003]; Malec JF, 2004, BRAIN INJURY, V18, P563, DOI 10.1080/02699050310001646134; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Malec JF, 2000, J HEAD TRAUMA REHAB, V15, P670, DOI 10.1097/00001199-200002000-00006; McCulloch K, 2015, J HEAD TRAUMA REHAB, V30, P38, DOI 10.1097/HTR.0000000000000041; McPherson KM, 1996, DISABIL REHABIL, V18, P341, DOI 10.3109/09638289609165892; Nathan D, 2012, BRAIN INJURY MED, P1; Olivier E, 2016, J ROY ARMY MED CORPS, V162, P125, DOI 10.1136/jramc-2015-000410; Skinner A, 2006, CLIN REHABIL, V20, P609, DOI 10.1191/0269215506cr981oa; The Mayo-Portland Adaptability Inventory, MAYO PORTL AD INV; Turner-Stokes L, 1999, CLIN REHABIL, V13, P277, DOI 10.1191/026921599676896799; Turner-Stokes L, 1999, NEUROPSYCHOL REHABIL, V9, P329, DOI 10.1080/096020199389419; Turner-Stokes L., UK FIM FAM VERSION 2; Turner-Stokes L, 2012, DISABIL REHABIL, V34, P1900, DOI 10.3109/09638288.2012.670042; Turner-Stokes L, 2009, J REHABIL MED, V41, P528, DOI 10.2340/16501977-0383; Zasler N, 2009, BRAIN INJURY MED, P1	28	1	1	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	10					1208	1212		10.1080/02699052.2016.1188215			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DX4BR	WOS:000384324300006	27467810				2022-02-06	
J	Miliuniene, L; Radzeviciene, L; Vuranok, TT				Miliuniene, Lina; Radzeviciene, Liuda; Vuranok, Turan Tolga			STRESS IN COMMUNICATION IN FAMILIES TAKING CARE ABOUT PERSONS AFTER COMA AWAKENING	SOCIAL WELFARE INTERDISCIPLINARY APPROACH			English	Article						Parents; stress; communication skills; coma awakenings	TRAUMATIC BRAIN-INJURY	The article presents the results of the pilot research, which reveals the communication in a family taking care of their adult children after awakening from coma. The research is sponsored by Erasmus+ project "Links United for Coma Awakenings through Sport" No. 557075-EPP-1-2014-1-IT-SPO-SCP. Analysing the results of family communication and coping with stress qualitative research was applied. The results show that family members taking care about their adult children awakening after coma experience a different level of stress. Communication peculiarities reflect the lack of communication skills. The ways to cope with stress in the communication process are individual and based on self-realization and meeting of emotional needs of the family.	[Miliuniene, Lina; Radzeviciene, Liuda] Siauliai Univ, Shiauliai, Lithuania; [Vuranok, Turan Tolga] Univ Marmara, Istanbul, Turkey		Miliuniene, L (corresponding author), Siauliai Univ, Shiauliai, Lithuania.		Radzeviciene, Liuda/AAD-1033-2019	Radzeviciene, Liuda/0000-0001-8468-3176			Anderson M. I., 2009, J BRAIN INJURY, V16, P743; Calvete E, 2012, BRAIN INJURY, V26, P834, DOI 10.3109/02699052.2012.655363; Cobb N., 2013, IMPORTANCE GOODWILL; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; DeBaillie AM, 2014, EFFECTS TRAUMATIC BR; Foster AM, 2012, DISABIL REHABIL, V34, P1855, DOI 10.3109/09638288.2012.670028; Fyrberg A, 2013, J INTERACT RES COM D, V4, P157, DOI 10.1558/jircd.v4i2.157; Kolakowsky-Hayner Miner K., 2011, J HEAD TRAUMA REHAB, V16, P374; KOSCIULEK JF, 1994, REHABIL PSYCHOL, V39, P215, DOI 10.1037/h0080325; Lequerica A., 2010, COGNITIVE PROBLEMS T; Lietuvos sveikatos statistika, 2012, LIET SVEIK STAT; McDonald S., 2013, SOCIAL COMMUNICATION; Ponsford J., 2009, BRAIN INJURY, V8, P453; Ponsford J., 2012, TRAUMATIC BRAIN INJU, V2nd Edition; Smith M., 2016, IMPROVING MENTAL EMO; Sutton, 2002, HLTH BEHAV PSYCHOSOC; Tsaousides T, 2009, REHABIL PSYCHOL, V54, P299, DOI 10.1037/a0016807; Verhaeghe S., 2005, STRESS COPING FAMILI, DOI [10.1111/j.1365-2702.2005.01126.x, DOI 10.1111/J.1365-2702.2005.01126.X]; Wilson Ch. M., 2005, DISCUSSION PAPER SER, V1619	19	1	1	0	1	SIAULIAI UNIV & OPEN INT UNIV HUMAN DEV UKRAINE	VILNUS	VILNIAUS G 88, VILNUS, 76285, LITHUANIA	2029-7424	2424-3876		SOC WELF INTERDISCIP	Soc. Welf. Interdiscip. Approach		2016	6	2					198	207		10.21277/sw.v2i6.269			10	Social Work	Emerging Sources Citation Index (ESCI)	Social Work	EG8JP	WOS:000391303300017		gold			2022-02-06	
J	Mo, YM; Chandramouli, A; Kong, N				Mo, Yuming; Chandramouli, Ashwin; Kong, Nan			A simulation study on the US rehabilitation service process for patients with modest-to-severe traumatic brain injury	INTERNATIONAL JOURNAL OF PRODUCTION RESEARCH			English	Article						care transition; process modelling; simulation; stochastic models; traumatic brain injury	LENGTH-OF-STAY; DISCRETE-EVENT SIMULATION; SEVERE HEAD-INJURY; HEALTH-CARE; READMISSION RATES; OCCUPANCY	Traumatic brain injury (TBI) is a devastating injury with severe consequences. In this paper, we conduct a simulation study on the commonly implemented care delivery process for TBI rehabilitation in the US, which covers three care categories: inpatient acute, outpatient sub-acute and general residential care. Our investigation is focused on assessing how coverage duration of publicly funded rehabilitation impacts two key system outcomes: sub-acute rehabilitation readmission and total rehabilitation spending. We develop prediction models on the above two outcomes for patients of different conditions. We introduce the notions of forceful transition and medical necessity adjustment, and embed the notions in a state-transition simulation model. Our simulation results suggest that to minimise the care spending, the duration of publicly insured outpatient sub-acute rehab be set smaller than what is currently implemented but not to the point where coverage should be completely removed. Our sensitivity analysis justifies the robustness of our results under variations on model parameters.	[Mo, Yuming; Chandramouli, Ashwin] Purdue Univ, Sch Ind Engn, W Lafayette, IN 47907 USA; [Kong, Nan] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA		Kong, N (corresponding author), Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.	nkong@purdue.edu					CDC, 2010, ALL DAT SOURC MAINT; CDC, 2006, TRAUMATIC BRAIN INJU; *CDC, 2007, NAT CTR INJ PREV CON; Centers for Disease Control and Prevention (CDC), 2016, NAT CTR INJ PREV CON; Chan L, 2001, ARCH PHYS MED REHAB, V82, P1151, DOI 10.1053/apmr.2001.24892; Chaussalet TJ, 2006, METHOD INFORM MED, V45, P492; COPE DN, 1982, ARCH PHYS MED REHAB, V63, P433; Crawford EA, 2014, MED DECIS MAKING, V34, P231, DOI 10.1177/0272989X13503500; Eapen Z, 2012, J AM COLL CARDIOL, V59, pE1029, DOI 10.1016/S0735-1097(12)61030-4; el-Darzi E, 1998, Health Care Manag Sci, V1, P143; Faddy M, 2009, VALUE HEALTH, V12, P309, DOI 10.1111/j.1524-4733.2008.00421.x; Faddy MJ, 2005, METHOD INFORM MED, V44, P369, DOI 10.1055/s-0038-1633979; Faul M, 2010, TRAUMATIC BRAIN INJU; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Feldman Z., 1996, NEUROTRAUMA, P43; Finkelstein E.A., 2006, INCIDENCE EC BURDEN, DOI [10.1093/acprof:oso/9780195179484.001.0001, DOI 10.1093/ACPROF:OSO/9780195179484.001.0001]; Forster AJ, 2003, ACAD EMERG MED, V10, P127, DOI 10.1197/aemj.10.2.127; Frayne SM, 2011, J GEN INTERN MED, V26, P33, DOI 10.1007/s11606-010-1497-4; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Green LV, 2008, OPER RES, V56, P1526, DOI 10.1287/opre.1080.0575; Gunal MM, 2010, J SIMUL, V4, P42, DOI 10.1057/jos.2009.25; Harper PR, 2002, J OPER RES SOC, V53, P11, DOI 10.1057/palgrave/jors/2601278; Heggestad T, 2002, HEALTH SERV RES, V37, P647, DOI 10.1111/1475-6773.00042; Helm J. E., 2015, PRODUCTION OPERATION, V25, P233; Helm JE, 2011, PROD OPER MANAG, V20, P359, DOI 10.1111/j.1937-5956.2011.01231.x; Jacobson SH, 2006, INT SER OPER RES MAN, V91, P211, DOI 10.1007/978-0-387-33636-7_8; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; JOHNSTON MV, 1994, ARCH PHYS MED REHAB, V75, pSC2; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Koizumi Naoru, 2005, Health Care Manag Sci, V8, P49, DOI 10.1007/s10729-005-5216-3; Kucukyazici B, 2007, OPERATIONAL RESEARCH FOR HEALTH POLICY: MAKING BETTER DECISIONS, P253; Lee DKK, 2009, OPER RES, V57, P852, DOI 10.1287/opre.1080.0666; Leyland AH, 1995, IMA J MATH APPL MED, V12, P175; Lin F., 2012, COMMUNITY BASED OPER, V167, P297; Lin HC, 2006, SCHIZOPHR RES, V83, P211, DOI 10.1016/j.schres.2006.01.012; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; Mamelak AN, 1996, J TRAUMA, V41, P91, DOI 10.1097/00005373-199607000-00014; Masini BD, 2011, J TRAUMA, V71, pS98, DOI 10.1097/TA.0b013e3182218fbc; Murtaugh CM, 2002, MED CARE, V40, P227; NHTSA, 2009, MOT HELM US HEAD FAC; Oh H, 2009, CRIT CARE NURSE, V29, P12, DOI 10.4037/ccn2009279; Patrick J, 2011, PROD OPER MANAG, V20, P347, DOI 10.1111/j.1937-5956.2011.01229.x; Peek-Asa C, 2011, ACCIDENT ANAL PREV, V43, P595, DOI 10.1016/j.aap.2010.07.019; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Shi P., 2015, MANAGE SCI, V62, P1, DOI DOI 10.1287/MNSC.2014.2112; SPETTELL CM, 1991, ARCH PHYS MED REHAB, V72, P320; Taylor GJ, 2000, J ROY STAT SOC A STA, V163, P39, DOI 10.1111/1467-985X.00155; VA, 2010, TRAUMATIC BRAIN INJU; Van Baalen B, 2003, DISABIL REHABIL, V25, P9, DOI 10.1080/713813430; Wright J, 2000, J HEAD TRAUMA REHAB, V15, P734, DOI 10.1097/00001199-200002000-00011; Zasler ND, 1997, ARCH PHYS MED REHAB, V78, pS12, DOI 10.1016/S0003-9993(97)90150-7; Zhang Y, 2012, OPER RES, V60, P249, DOI 10.1287/opre.1110.1026	52	1	1	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0020-7543	1366-588X		INT J PROD RES	Int. J. Prod. Res.		2016	54	18					5594	5606		10.1080/00207543.2016.1178863			13	Engineering, Industrial; Engineering, Manufacturing; Operations Research & Management Science	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Engineering; Operations Research & Management Science	DS8VJ	WOS:000381060800015					2022-02-06	
J	Moore, CL; Wang, NN				Moore, Corey L.; Wang, Ningning			A national benchmark investigation of return-to-work outcome rates between African American, Native American or Alaskan Native, Latino, Asian American or Pacific Islander, and Non-Latino White veterans served by state vocational rehabilitation agencies: Application of bootstrap data expansion	JOURNAL OF VOCATIONAL REHABILITATION			English	Article						Veterans of color; return-to-work outcomes and probabilities; bootstrap data expansion approaches	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; INTERNAL VALIDATION; REGRESSION; MODELS	BACKGROUND: Research examining the provision of effective state vocational rehabilitation agency (SVRA) sponsored services is pertinent to improving successful return-to-work outcomes among veterans of color (i.e., African Americans, Native Americans or Alaska Natives, Latinos, and Asian Americans or Pacific Islanders versus non-Latino Whites). To date, however, scant attention has been paid to examining these target groups' outcome patterns. OBJECTIVE: This study employed a stratified bootstrap data expansion approach to assess the relationship between race/ethnicity, gender, level of educational attainment at closure and return-to-work among veterans with a signed individualized plan for employment (IPE). METHODS: National fiscal year (FY) 2013 Rehabilitation Services Administration (RSA)-911 case records (N = 11,603) were extracted and re-sampled across multiple trials using bootstrap procedures to increase logistic regression model accuracy. RESULTS: The findings indicated that African American and female veterans were statistically significantly less likely to return-to-work compared to non-Latino White and female veterans, respectively. Return-to-work probabilities were 'poorest' for African American veterans followed by Native Americans or Alaska Natives, Asian Americans or Pacific Islanders, Latinos, and then non-Latino Whites. CONCLUSIONS: These findings warrant new service (e.g., greater SVRA and U.S. Department of Veterans Affairs' (VA) co-service provision) and policy initiatives.	[Moore, Corey L.; Wang, Ningning] Langston Univ, Rehabil Res & Training Ctr LU RRTC Res & Capac Bl, Oklahoma City, OK USA		Moore, CL (corresponding author), Delta Sigma Theta Soror Inc, Washington, DC 20009 USA.; Moore, CL (corresponding author), Langston Univ, Rehabil Res & Training Ctr RRTC Res & Capac Bldg, 4205 N Lincoln Blvd, Oklahoma City, OK 73105 USA.	clmoore@langston.edu					Agresti Alan., 2013, CATEGORICAL DATA ANA, V3rd ed; Ainspan N. D., 2011, US NAVAL I P, V137, P44; Alston R, 2014, MED CARE, V52, pS17, DOI 10.1097/MLR.0000000000000105; [Anonymous], 2013, MIN VET 2011; Atkins B. J., 2011, IMPROVING VOCATIONAL, P71; Bleeker SE, 2003, J CLIN EPIDEMIOL, V56, P826, DOI 10.1016/S0895-4356(03)00207-5; Chatterjee S., 2013, REGRESSION ANAL EXAM; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Dupret G, 2001, EUR J OPER RES, V134, P141, DOI 10.1016/S0377-2217(00)00244-7; Duwe G, 2012, SEX ABUSE-J RES TR, V24, P350, DOI 10.1177/1079063211429470; Efron B, 1997, J AM STAT ASSOC, V92, P548, DOI 10.2307/2965703; Efron B., 1994, INTRO BOOTSTRAP; Feist-Price S., 2011, IMPROVING VOCATIONAL, P26; Frain MP, 2010, J REHABIL, V76, P13; Gelman A., 2014, BAYESIAN DATA ANAL, V2; Grossman PD, 2009, J POSTSECOND EDUC DI, V22, P4; Gude JA, 2009, WILDLIFE BIOL, V15, P352, DOI 10.2981/08-057; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Harris-Haywood S, 2014, MED CARE, V52, pE7, DOI 10.1097/MLR.0b013e31824df149; He HB, 2009, IEEE T KNOWL DATA EN, V21, P1263, DOI 10.1109/TKDE.2008.239; Henderson AR, 2005, CLIN CHIM ACTA, V359, P1, DOI 10.1016/j.cccn.2005.04.002; Hosmer D. W., 2004, APPL LOGISTIC REGRES; Koch, 2012, CATEGORICAL DATA ANA; Kromrey JD, 1996, J EXP EDUC, V64, P240, DOI 10.1080/00220973.1996.9943806; Lewis AN, 2007, J VOCAT REHABIL, V26, P89; Madaus JW, 2009, J POSTSECOND EDUC DI, V22, P10; Moore C. L., 2011, BARRIERS VR SERVICE; Moore CL, 2016, REHABIL COUNS BULL, V59, P158, DOI 10.1177/0034355215579917; Moran S, 2013, J REHABIL, V79, P34; National Alliance on Mental Illness, 2014, VET CULT DIV POP; Pedhazur E. J., 1982, MULTIPLE REGRESSION; SAS Institute, 2012, SAS STAT 12 1 US GUI; SAS Institute, 2014, BAS SAS 9 4 PROC GUI; Sheehan C. M., 2012, DUTY HONOR COUNTRY D; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Taylor JMG, 2008, CLIN CANCER RES, V14, P5977, DOI 10.1158/1078-0432.CCR-07-4534; Tennant J, 2012, MON LABOR REV, V135, P3; Tervalon M, 1998, J HEALTH CARE POOR U, V9, P117; Thirty-eight Institute on Rehabilitaion Issues, 2015, ASS NOTH MON 38 I RE; Twamley EW, 2014, J REHABIL RES DEV, V51, P59, DOI 10.1682/JRRD.2013.01.0020; Twamley EW, 2013, J REHABIL RES DEV, V50, P663, DOI 10.1682/JRRD.2012.08.0137; Wolf L. A., 2008, MORBILITY MORTALITY; Ye F., 2010, CANC BIOST WORKSH; Zhu WM, 1997, RES Q EXERCISE SPORT, V68, P44, DOI 10.1080/02701367.1997.10608865	44	1	1	0	2	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1052-2263	1878-6316		J VOCAT REHABIL	J. Vocat. Rehabil.		2016	45	2					133	147		10.3233/JVR-160818			15	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	EB7NR	WOS:000387575300003					2022-02-06	
B	Moring, JC; Blankenship, AE; Williams, JM; Molino, A; Peterson, AL		Martin, CR; Preedy, VR; Patel, VB		Moring, John C.; Blankenship, Abby E.; Williams, Jacob M.; Molino, Alma; Peterson, Alan L.			PTSD and Mild Traumatic Brain Injury in Iraq and Afghanistan War	COMPREHENSIVE GUIDE TO POST-TRAUMATIC STRESS DISORDERS, VOLS 1 AND 2			English	Article; Book Chapter							POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH PROBLEMS; PERSISTENT POSTCONCUSSIVE SYMPTOMS; SERVICE MEMBERS; DEPLOYMENT; OUTCOMES; REHABILITATION; ASSOCIATION; TIME; CARE	For more than a decade, several million US and other coalition military forces have been deployed to support the military conflicts in and around Iraq and Afghanistan. Post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI) are two of the signature injuries sustained by deployed military personnel. This chapter reviews the symptomatology, epidemiology, etiology, assessment, and diagnosis of PTSD and mild TBI in Iraq and Afghanistan war veterans. The chapter also reviews the prevention and treatment of PTSD and mild TBI in these populations.	[Moring, John C.; Peterson, Alan L.] Univ Texas Hlth Sci Ctr San Antonio, Div Behav Med, STRONG STAR PTSD Res Consortium, Dept Psychiat,Sch Med, San Antonio, TX 78229 USA; [Blankenship, Abby E.; Williams, Jacob M.; Molino, Alma] Univ Texas Hlth Sci Ctr San Antonio, Div Behav Med, STRONG STAR PTSD Res Consortium, Dept Psychiat,Sch Med,Ft Hood Site, Fort Hood, TX 78229 USA; [Peterson, Alan L.] South Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA; [Peterson, Alan L.] Univ Texas San Antonio, Dept Psychol, San Antonio, TX 78249 USA		Peterson, AL (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Div Behav Med, STRONG STAR PTSD Res Consortium, Dept Psychiat,Sch Med, San Antonio, TX 78229 USA.; Peterson, AL (corresponding author), South Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA.; Peterson, AL (corresponding author), Univ Texas San Antonio, Dept Psychol, San Antonio, TX 78249 USA.	MoringJ@uthscsa.edu; Blankenshipa@UTHSCSA.edu; williamsj10@uthscsa.edu; molino@uthscsa.edu; petersona3@uthscsa.edu					Adler AB, 2009, MIL MED, V174, P21, DOI 10.7205/MILMED-D-00-2208; Armed Forces Health Surveillance Center, 2014, DOD WORLDW NUMB TBI; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Browne T, 2007, BRIT J PSYCHIAT, V190, P484, DOI 10.1192/bjp.bp.106.030544; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Bryant RA, 2003, AM J PSYCHIAT, V160, P585, DOI 10.1176/appi.ajp.160.3.585; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Champion HR, 2009, J TRAUMA, V66, P1468, DOI 10.1097/TA.0b013e3181a27e7f; Chard KM, 2011, J TRAUMA STRESS, V24, P347, DOI 10.1002/jts.20644; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Cornum R, 2011, AM PSYCHOL, V66, P4, DOI 10.1037/a0021420; Department of Defense, 2012, NAT DEF AUTH ACT FIS; Department of Veterans Affairs and Department of Defense, 2009, VA DOD CLIN PRACT GU; French LM, 2008, J CLIN PSYCHOL, V64, P1004, DOI 10.1002/jclp.20514; Gawande A, 2004, NEW ENGL J MED, V351, P2471, DOI 10.1056/NEJMp048317; Gaylord KM, 2008, J TRAUMA, V64, pS200, DOI 10.1097/TA.0b013e318160ba42; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Institute of Medicine, 2014, LONG TERM EFF BLAST, V9; Institute of Medicine Committee on Treatment of Posttraumatic Stress Disorder Board on Population Health and Public Health Practice, 2008, TREATM POSTTR STRESS; International Security Assistance Force, 2014, TROOP CONTR NAT; Joseph S, 1999, J TRAUMA STRESS, V12, P437, DOI 10.1023/A:1024762919372; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kessler RC, 2008, ANNU REV PUBL HEALTH, V29, P115, DOI 10.1146/annurev.publhealth.29.020907.090847; Marx BP, 2009, ARCH GEN PSYCHIAT, V66, P996, DOI 10.1001/archgenpsychiatry.2009.109; McAllister TW, 2002, NEUROREHABILITATION, V17, P265; Mclay RN, 2008, AM J PSYCHIAT, V165, P775, DOI 10.1176/appi.ajp.2008.07121960; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; Murray CK, 2005, MIL MED, V170, P516, DOI 10.7205/MILMED.170.6.516; National Institute for Clinical Excellence, 2005, POST TRAUM STRESS DI; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; Peterson AL, 2011, J CLIN PSYCHOL MED S, V18, P164, DOI 10.1007/s10880-011-9238-3; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Ramchand R, 2008, INVISIBLE WOUNDS WAR; Resick PA, 2002, J CONSULT CLIN PSYCH, V70, P867, DOI 10.1037//0022-006X.70.4.867; Resick PA, 2012, J CONSULT CLIN PSYCH, V80, P201, DOI 10.1037/a0026602; Richardson LK, 2010, AUST NZ J PSYCHIAT, V44, P4, DOI 10.3109/00048670903393597; Ryan PB, 2011, BRAIN INJURY, V25, P1019, DOI 10.3109/02699052.2011.597044; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Stein NR, 2012, BEHAV MODIF, V36, P787, DOI 10.1177/0145445512446945; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Weathers F.W., 2013, PTSD CHECKLIST DSM5; Weathers F.W., 1993, ANN CONV INT SOC TRA	48	1	1	0	0	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND			978-3-319-08359-9; 978-3-319-08358-2				2016							489	503		10.1007/978-3-319-08359-9_69	10.1007/978-3-319-08359-9		15	Psychiatry; Psychology	Book Citation Index – Science (BKCI-S)	Psychiatry; Psychology	BP6WJ	WOS:000560802800030					2022-02-06	
J	Mracek, J				Mracek, Jan			Indications for Decompressive Craniectomy	CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE			Czech	Article						decompressive craniectomy; indications; traumatic brain injury; malignant infarction; subarachnoidal hemorrhage; intracerebral hemorrhage; cerebral venous thrombosis	MIDDLE-CEREBRAL-ARTERY; TRAUMATIC BRAIN-INJURY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; MINIMALLY-INVASIVE SURGERY; HEALTH-CARE PROFESSIONALS; SUPRATENTORIAL INTRACEREBRAL HEMORRHAGE; REFRACTORY INTRACRANIAL HYPERTENSION; INITIAL CONSERVATIVE TREATMENT; DURAL SINUS THROMBOSIS; ACUTE ISCHEMIC-STROKE	The fundamental idea behind decompressive craniectomy (DC) is a surgical solution to the conflict of an increasing intracranial content within the fixed-volume intracranial cavity. The expanding intracranial content is caused by brain edema caused by a variety of pathologies. In spite of DC renaissance over the recent years and some evidence of its effectiveness, its use is not yet generally accepted. Traumatic brain injury is by far the most frequent indication for DC. However, the evidence of its effectiveness is limited. Data on the role of secondary decompression in patients with refractory intracranial hypertension after conservative treatment failure are expected to be released soon. Bifrontal early DC is not superior to medical management in patients with diffuse traumatic injury. Primary decompression in patients with acute subdural haematoma has been investigated in a randomized trial. The most conclusive evidence is in patients with malignant middle cerebral artery infarction. In spite of this, the surgery is still underutilized and the frequency of its use does not correspond with the incidence of malignant infarction. When decompression is performed within 48 hours of stroke onset in patients younger than 60 years, it reduces mortality and improves functional outcome. DC is also a lifesaving procedure in patients over 60 years of age for whom it improves chances of survival without total dependency. Decompression should be considered in patients with cerebral venous thrombosis that causes intractable intracranial hypertension. Furthermore, patients with bilateral mydriasis can also profit from the procedure. DC with or without hematoma evacuation might reduce mortality in patients with large supratentorial intracerebral hemorrhage who are in coma or have refractory intracranial hypertension. Even though the DC can be effective in selected subgroups of patients with subarachnoid hemorrhage, current guidelines, do not specify the role of decompression in these patients.	[Mracek, Jan] LF UK, Neurochirurg klin, Alej Svobody 80, Plzen 30460, Czech Republic; [Mracek, Jan] FN Plzen, Alej Svobody 80, Plzen 30460, Czech Republic		Mracek, J (corresponding author), LF UK, Neurochirurg klin, Alej Svobody 80, Plzen 30460, Czech Republic.; Mracek, J (corresponding author), FN Plzen, Alej Svobody 80, Plzen 30460, Czech Republic.	mracek@fnplzen.cz					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Aaron S, 2013, J NEUROL NEUROSUR PS, V84, P995, DOI 10.1136/jnnp-2012-303356; Agrawal D, 2005, EUR J CLIN MICROBIOL, V24, P772, DOI 10.1007/s10096-005-0017-7; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Albrecht GL, 1999, SOC SCI MED, V48, P977, DOI 10.1016/S0277-9536(98)00411-0; Poca MA, 2010, J NEUROSURG, V112, P648, DOI 10.3171/2009.7.JNS081677; Appelboom G, 2013, WORLD NEUROSURG, V80, pE153, DOI 10.1016/j.wneu.2011.05.013; Asgari S, 2008, ZBL NEUROCHIR, V69, P22, DOI 10.1055/s-2007-992136; Ausman J I, 1976, Surg Neurol, V6, P97; Babinski J., 1910, REV NEUROL, V21, P27; Babinski J., 1901, REV NEUROL, V9, P266; Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; BAILES JE, 1990, J NEUROSURG, V72, P559, DOI 10.3171/jns.1990.72.4.0559; Balami JS, 2012, LANCET NEUROL, V11, P101, DOI 10.1016/S1474-4422(11)70264-2; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Bar M, 2010, J NEUROSURG, V113, P897, DOI 10.3171/2009.10.JNS09888; Barbati G, 2003, Minerva Anestesiol, V69, P919; Berrouschot J, 1998, INTENS CARE MED, V24, P620, DOI 10.1007/s001340050625; Bor-Seng-Shu E, 2013, NEUROSURG REV, V36, P361, DOI 10.1007/s10143-013-0453-2; Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Buschmann U, 2007, ACTA NEUROCHIR, V149, P59, DOI 10.1007/s00701-006-1069-x; Canhao P, 2005, J NEUROSURG, V36, P1720, DOI DOI 10.3171/20126.JNS11102; Chambers IR, 2001, J NEUROSURG, V94, P412, DOI 10.3171/jns.2001.94.3.0412; Chambers IR, 2001, BRIT J NEUROSURG, V15, P140; Cho DY, 2006, SURG NEUROL, V65, P547, DOI 10.1016/j.surneu.2005.09.032; Cho DY, 1995, PEDIATR NEUROSURG, V23, P192, DOI 10.1159/000120958; Clark DJ, 2013, ACTA NEUROCHIR, V155, P1329, DOI 10.1007/s00701-013-1748-3; Compagnone C, 2005, NEUROSURGERY, V57, P1183; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Cooper DJ, 2011, MED J AUSTRALIA, V194, P437, DOI 10.5694/j.1326-5377.2011.tb03053.x; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Coutinho JM, 2009, STROKE, V40, P2233, DOI 10.1161/STROKEAHA.108.543421; Cruz-Flores S, 2012, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858; Cushing H, 1908, ANN SURG, V47, P641, DOI 10.1097/00000658-190805000-00001; Cushing H, 1905, SURG GYNECOL OBSTET, V1, P297; D'Ambrosio AL, 2005, NEUROSURGERY, V56, P12, DOI 10.1227/01.NEU.0000144820.38439.63; DELASHAW JB, 1990, STROKE, V21, P874, DOI 10.1161/01.STR.21.6.874; Deshaies EM, 2012, AM J NEURORADIOL, V33, P1411, DOI 10.3174/ajnr.A2971; DIERSSEN G, 1983, ACTA NEUROCHIR, V69, P53, DOI 10.1007/BF02055853; Diringer MN, 2011, NEUROCRIT CARE, V15, P211, DOI 10.1007/s12028-011-9605-9; Dombrowski KE, 2011, BRIT J NEUROSURG, V25, P249, DOI 10.3109/02688697.2010.544784; Dorfer C, 2010, WORLD NEUROSURG, V74, P465, DOI 10.1016/j.wneu.2010.08.001; Farahvar A, 2011, J NEUROSURG, V114, P1471, DOI 10.3171/2010.11.JNS101116; Ferro JM, 2004, STROKE, V35, P664, DOI 10.1161/01.STR.0000117571.76197.26; Ferro JM, 2011, STROKE, V42, P2825, DOI 10.1161/STROKEAHA.111.615393; Ferro JM, 2010, CEREBROVASC DIS, V29, P440, DOI 10.1159/000289347; Figaji AA, 2003, CHILD NERV SYST, V19, P666, DOI 10.1007/s00381-003-0804-3; Fischer U, 2011, J NEUROL NEUROSUR PS, V82, P885, DOI 10.1136/jnnp.2009.198648; Frank JI, 2014, STROKE, V45, P781, DOI 10.1161/STROKEAHA.113.003200; FRANK JI, 1995, NEUROLOGY, V45, P1286, DOI 10.1212/WNL.45.7.1286; Fukuhara T, 1998, NEUROL MED-CHIR, V38, P710, DOI 10.2176/nmc.38.710; Fung C, 2012, STROKE, V43, P3207, DOI 10.1161/STROKEAHA.112.666537; GAAB MR, 1990, ACT NEUR S, V51, P326; Granget E, 2012, CHILD NERV SYST, V28, P1121, DOI 10.1007/s00381-012-1733-9; Guresir E, 2012, NEUROSURGERY, V70, P881, DOI 10.1227/NEU.0b013e318237a6a6; Guresir E, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0954; Guerra WKW, 1999, INTENS CARE MED, V25, P1327; Gupta R, 2004, STROKE, V35, P539, DOI 10.1161/01.STR.0000109772.64650.18; Gurdjian ES, 1964, CAS LEK CES, V12, P56; Gurdjian ES, 1970, OPERATIVE NEUROSURGE; Hacke W, 1996, ARCH NEUROL-CHICAGO, V53, P309, DOI 10.1001/archneur.1996.00550040037012; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Hayes SB, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2013.2.FOCUS12422; Hejazi N, 2002, EUR J PEDIATR, V161, P99, DOI 10.1007/s00431-001-0864-x; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Heuer GG, 2004, J NEUROSURG, V101, P408, DOI 10.3171/jns.2004.101.3.0408; Heuts SG, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2013.2.FOCUS1326; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Honeybul S, 2011, J NEUROTRAUM, V28, P2199, DOI 10.1089/neu.2011.1907; Honeybul S, 2010, J NEUROTRAUM, V27, P1225, DOI 10.1089/neu.2010.1316; Horsley V, 1906, BRIT MED J, V1906, P411; Hutchinson P, 2011, NAT REV NEUROL, V38, P541, DOI DOI 10.1038/NRNEUROL.2013.106; Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Juttler E, 2014, NEW ENGL J MED, V370, P1091, DOI 10.1056/NEJMoa1311367; Juran V, 2009, CESK SLOV NEUROL N, V72, P439; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; Kastrau F, 2005, STROKE, V36, P825, DOI 10.1161/01.STR.0000157595.93115.70; Kazui S, 1996, STROKE, V27, P1783, DOI 10.1161/01.STR.27.10.1783; Keller E, 2005, ACTA NEUROCHIR SUPPL, V94, P177; KERR FWL, 1968, MAYO CLIN PROC, V43, P852; Kim KT, 2009, ACTA NEUROCHIR, V151, P21, DOI 10.1007/s00701-008-0164-6; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kocher T., 1901, HIRNERSCHUTTERUNG HI, V3, P262; Krayenbuhl H A, 1966, Clin Neurosurg, V14, P1; Kunze E, 1998, ACT NEUR S, V71, P16; Ma L, 2010, J STROKE CEREBROVASC, V19, P294, DOI 10.1016/j.jstrokecerebrovasdis.2009.07.002; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Maira G, 2002, NEUROL RES, V24, P54, DOI 10.1179/016164102101199549; Marion DW, 2006, NEUROSURGERY, V58, P655; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Masdeu JC, 2006, EUR J NEUROL, V13, P1271, DOI 10.1111/j.1468-1331.2006.01507.x; McKenzie KG, 1936, ARCH NEURO PSYCHIATR, V36, P542, DOI 10.1001/archneurpsyc.1936.02260090095005; Mendelow AD, 2013, LANCET, V382, P397, DOI 10.1016/S0140-6736(13)60986-1; Mendelow AD, 2005, LANCET, V365, P387; Morgan T, 2008, ACTA NEUROCHIR SUPPL, V105, P147; Mork J, 2014, CESK SLOV NEUROL N, V77, P765; Mould WA, 2013, STROKE, V44, P627, DOI 10.1161/STROKEAHA.111.000411; MOULIN DE, 1985, STROKE, V16, P282, DOI 10.1161/01.STR.16.2.282; Mracek J, 2007, Rozhl Chir, V86, P217; Mracek Z, 1978, Cesk Neurol Neurochir, V41, P390; Mracek Z, 1977, Rozhl Chir, V56, P597; MRACEK Z, 1981, Z KINDERCHIR, V34, P207; Mracek Z., 1983, PLZEN LEK SBORN S, V46, P47; Mracek Z., 1996, PLZEN LEK SBORN S, V70, P147; Mracek Z, 2000, PLZEN LEK SBORN S, V74, P195; Muench E, 2007, CRIT CARE MED, V35, P1844, DOI 10.1097/01.CCM.0000275392.08410.DD; Murthy JMK, 2005, NEUROCRIT CARE, V2, P258, DOI 10.1385/NCC:2:3:258; Mussack T, 2005, J TRAUMA, V58, P1061, DOI 10.1097/01.TA.0000171989.63817.8c; Nagel A, 2009, J NEUROSURG, V111, P94, DOI 10.3171/2009.1.JNS08587; Navratil L, 2007, CESK SLOV NEUROL N, V70, P294; Neugebauer H, 2014, NEUROCRIT CARE, V21, P27, DOI 10.1007/s12028-014-9956-0; Neugebauer H, 2013, INT J STROKE, V8, P383, DOI 10.1111/ijs.12086; Neugebauer H, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-115; Nguyen Ha Son, 2011, Childs Nerv Syst, V27, P657, DOI 10.1007/s00381-010-1285-9; Nirula R, 2014, J TRAUMA ACUTE CARE, V76, P944, DOI 10.1097/TA.0000000000000194; Otani N, 2008, CEREBROVASC DIS, V26, P612, DOI 10.1159/000165115; PARIKH RM, 1990, ARCH NEUROL-CHICAGO, V47, P785, DOI 10.1001/archneur.1990.00530070083014; Perez-Bovet J, 2012, ACTA NEUROCHIR, V154, P1717, DOI 10.1007/s00701-012-1323-3; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Priban V, 2010, ROZL CHIR, V89, P536; Rahme R, 2012, J NEUROSURG, V117, P749, DOI 10.3171/2012.6.JNS111140; Ramnarayan R, 2009, J STROKE CEREBROVASC, V18, P1, DOI 10.1016/j.jstrokecerebrovasdis.2008.09.001; RANSOHOFF J, 1971, J NEUROSURG, V34, P70, DOI 10.3171/jns.1971.34.1.0070; Raza E, 2014, J STROKE CEREBROVASC, V23, pE13, DOI 10.1016/j.jstrokecerebrovasdis.2013.07.045; RENNICK G, 1993, BRIT MED J, V306, P953, DOI 10.1136/bmj.306.6883.953; Rinkel GJ, 2004, COCHRANE DB SYST REV, V4; Rodriguez-Luna D, 2011, NEUROLOGY, V77, P1599, DOI 10.1212/WNL.0b013e3182343387; Ruf B, 2003, CRIT CARE, V7, pR133, DOI 10.1186/cc2361; Rutigliano D, 2006, J PEDIATR SURG, V41, P83, DOI 10.1016/j.jpedsurg.2005.10.010; Sahuquillo J, 2006, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD003983-PUB2; Sahuquillo J, 2013, CURR OPIN CRIT CARE, V19, P101, DOI 10.1097/MCC.0b013e32835eba1a; Saposnik G, 2011, STROKE, V42, P1158, DOI 10.1161/STR.0b013e31820a8364; SCARCELLA G, 1956, J NEUROSURG, V13, P366; Schirmer CM, 2007, STROKE, V38, P987, DOI 10.1161/01.STR.0000257962.58269.e2; Schuss P, 2013, J NEUROL, V260, P2149, DOI 10.1007/s00415-013-6950-y; Shimamura N, 2011, ACTA NEUROCHIR SUPPL, V111, P415, DOI 10.1007/978-3-7091-0693-8_71; Skoglund TS, 2006, J NEUROTRAUM, V23, P1502, DOI 10.1089/neu.2006.23.1502; Smith ER, 2002, NEUROSURGERY, V51, P117, DOI 10.1097/00006123-200207000-00018; Soukiasian HJ, 2002, AM SURGEON, V68, P1066; Spiller WG, 1906, J AMER MED ASSOC, V47, P679; Spiller WG, 1906, JAMA-J AM MED ASSOC, P849; Spiller WG, 1906, JAMA-J AM MED ASSOC, P923; Spiller WG, 1906, JAMA-J AM MED ASSOC, P744; Stefini R, 1999, NEUROSURGERY, V45, P626, DOI 10.1097/00006123-199909000-00038; Steiner T, 2006, CEREBROVASC DIS, V22, P294, DOI 10.1159/000094831; Stevens RD, 2009, INTENS CARE MED, V35, P1556, DOI 10.1007/s00134-009-1533-1; Stuart RM, 2011, NEUROCRIT CARE, V15, P146, DOI 10.1007/s12028-009-9264-2; Takeuchi Satoru, 2013, Acta Neurochir Suppl, V118, P277, DOI 10.1007/978-3-7091-1434-6_53; Takeuchi S, 2012, CLIN NEUROL NEUROSUR, V114, P1312, DOI 10.1016/j.clineuro.2012.03.044; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Theaudin M, 2010, STROKE, V41, P727, DOI 10.1161/STROKEAHA.109.572909; Timmons SD, 2011, NEW ENGL J MED, V365, P373, DOI 10.1056/NEJMc1106421; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; TROJANOWSKI T, 1984, ACTA NEUROCHIR, V72, P79, DOI 10.1007/BF01406816; Uozumi Y, 2014, CEREBROVASC DIS, V37, P109, DOI 10.1159/000356979; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; van der Worp HB, 2010, J CEREBR BLOOD F MET, V30, P1079, DOI 10.1038/jcbfm.2010.44; Vlcek E, 1971, NEUROSURGICAL DIS PR; von Sarnowski B, 2012, CLIN NEUROL NEUROSUR, V114, P627, DOI 10.1016/j.clineuro.2011.12.026; Wada Y, 2002, NEUROL MED-CHIR, V42, P414, DOI 10.2176/nmc.42.414; Weber J, 2004, ZBL NEUROCHIR, V65, P135, DOI 10.1055/s-2004-816239; Weber J, 2013, ACTA NEUROCHIR, V155, P651, DOI 10.1007/s00701-013-1627-y; Whitfield PC, 2001, BRIT J NEUROSURG, V15, P500, DOI 10.1080/02688690120105110; Wijdicks EFM, 2014, STROKE, V45, P1222, DOI 10.1161/01.str.0000441965.15164.d6; Winter CD, 2005, J CLIN NEUROSCI, V12, P619, DOI 10.1016/j.jocn.2005.02.002; Wirtz C R, 1997, Neurosurg Focus, V2, pE3; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Xi GH, 2004, NEUROCRIT CARE, V1, P5, DOI 10.1385/NCC:1:1:5; Zazulia AR, 1999, STROKE, V30, P1167, DOI 10.1161/01.STR.30.6.1167; Zeng L, 2007, EUR J NEUROL, V14, pE27, DOI 10.1111/j.1468-1331.2006.01560.x; Zhou XY, 2012, STROKE, V43, P2923, DOI 10.1161/STROKEAHA.112.667535; Zuurbier SM, 2012, J NEUROL, V259, P1099, DOI 10.1007/s00415-011-6307-3	178	1	1	0	9	CZECH MEDICAL SOC	PRAGUE 2	SOKOLSKA 31, PRAGUE 2 120 26, CZECH REPUBLIC	1210-7859	1802-4041		CESK SLOV NEUROL N	Cesk. Slov. Neurol. Neurochir.		2016	79	1					7	20					14	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DC8KF	WOS:000369467600002					2022-02-06	
J	Nekkanti, S; Shaik, R; Mondem, S; Meruva, N; Elumalai, G				Nekkanti, Sirisha; Shaik, Rahul; Mondem, Srinivas; Meruva, Nandini; Elumalai, Gunathevan			Effect of Right Median Nerve Stimulation on Level of Consciousness in Traumatic Brain Injury Subjects	ASIAN JOURNAL OF PHARMACEUTICAL RESEARCH AND HEALTH CARE			English	Article						Right Median Nerve Stimulation; Traumatic Brain Injury; Unconsciousness	ELECTRICAL-STIMULATION; VEGETATIVE STATE; COMA; INTERVENTIONS; DISORDERS; AGITATION	Background: The median nerve serves a peripheral gateway to the central nervous system. Median nerve stimulation is positively associated with regaining the level of consciousness in patients with traumatic brain injury, but the level of evidence is still a research question. So the purpose of the study is to find out the effectiveness of right median nerve stimulation on the level of consciousness and the relation between them in subjects with traumatic brain injury. Methodology: Twenty subjects with traumatic brain injury of axonal type were selected for study and randomized into two groups. Experimental group received right median nerve stimulation along with medications where as control group received medications only one month, 30minutes a day. Glasgow coma scale is used to assess the changes in conscious levels. Result: The results have revealed that there is a significant improvement noted in experimental group when compared to control group. Comparison of Glasgow coma scale scores between experimental and control groups after one month showed significant difference with a P value of 0.0261. Conclusion: Right median nerve stimulation is strongly associated with improvement of consciousness in patients with traumatic brain injury.	[Nekkanti, Sirisha; Shaik, Rahul; Meruva, Nandini] SIMS Coll Physiotherapy, Guntur 522001, Andhra Prades, India; [Mondem, Srinivas; Elumalai, Gunathevan] UPSI, Fac Sports Sci & Coaching, Perak, Malaysia		Nekkanti, S (corresponding author), SIMS Coll Physiotherapy, Guntur 522001, Andhra Prades, India.		Elumalai, Gunathevan/E-6966-2016				Agrawal Amit, 2012, Int J Crit Illn Inj Sci, V2, P167, DOI 10.4103/2229-5151.100915; Arumugam G, 2013, INT J PHYSIOTHERAPY, V1, P83; Board Editorial, 2015, ENDOCRINOLOGY, V156, p2C; Bradt J., 2010, COCHRANE DATABASE SY; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cooper EB, 2005, NEUROPSYCHOL REHABIL, V15, P389, DOI 10.1080/09602010443000317; Cooper JB, 1999, BRAIN INJURY, V13, P261, DOI 10.1080/026990599121638; Gill PS, 2012, INT J GEN MED, V5, P923, DOI 10.2147/IJGM.S37110; Gultekin R, 2016, INJURY, V47, P516, DOI 10.1016/j.injury.2015.10.011; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; Hayashi N., 1997, SOC TREAT COMA, V6, P133; Iranmanesh F, 2009, INDIAN J PEDIATR, V76, P929, DOI 10.1007/s12098-009-0143-9; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Liu CY, 2008, NEUROSURGERY, V63, pN12, DOI 10.1227/01.NEU.0000339457.01711.3B; Liu JT, 2003, ACTA NEUROCHIR SUPPL, V87, P11; Lnu M., 2012, INT J HEAD NECK SURG, V3, P137; Lombard LA, 2005, AM J PHYS MED REHAB, V84, P797, DOI 10.1097/01.phm.0000179438.22235.08; Lombardi F, 2002, CLIN REHABIL, V16, P464, DOI 10.1191/0269215502cr519oa; Madder H, 2012, J MED ETHICS, V38, P662, DOI 10.1136/medethics-2012-100869; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Moriya T, 2000, SOC TREAT COMA, V9, P159; Oyedele EA, 2015, INT J PUBLIC HLTH RE, V3, P127; Peri CV, 2001, BRAIN INJURY, V15, P903, DOI 10.1080/02699050110065709; Sharma V, 2015, INDIAN J NEUROTRAUM, V12, P144, DOI 10.1055/s-0035-1569473; Sung HC, 2006, INT J GERIATR PSYCH, V21, P999, DOI 10.1002/gps.1585; Tadrisi SD, 2012, IRAN J CRIT CARE NUR, V5, P95; Tolle P, 2003, AXON, V25; Uysal H, 2010, J NEUROL SCI-TURK, V27, P28	28	1	1	0	5	SARASEERUHA PUBL	VISAKHAPATANAM	202, B-BLOCK, VUDA APTS, SEETHAMMADHARA, VISAKHAPATANAM, 530022, INDIA	2250-1444	2250-1460		ASIAN J PHARM RES HE	Asian J. Pharm. Res. Health Care		2016	8	3					67	71		10.18311/ajprhc/2016/751			5	Pharmacology & Pharmacy	Emerging Sources Citation Index (ESCI)	Pharmacology & Pharmacy	DQ2HZ	WOS:000379024700001		Green Published, Bronze			2022-02-06	
S	Oertel, J; Tschan, CA; Keiner, D		Janowski, M		Oertel, Joachim; Tschan, Christoph A.; Keiner, Doerther			Animal Models for Experimental Neurosurgery of Peripheral and Cranial Nerves	EXPERIMENTAL NEUROSURGERY IN ANIMAL MODELS	Neuromethods		English	Article; Book Chapter						Waterjet dissection; Cranial nerve; Sciatic nerve; Surgical technique; Animal model; Nerve regeneration; Traumatic injury	WATER-JET DISSECTION; SCHWANNOMAS ACOUSTIC NEUROMAS; RAT SCIATIC-NERVE; FACIAL-NERVE; VESTIBULAR SCHWANNOMAS; LIVER RESECTION; RENAL SURGERY; IN-VIVO; BRAIN; REGENERATION	Common experimental models for investigation of cranial and peripheral nerve function after trauma include sciatic nerve crush injuries and direct cutting of cochlear or facial nerves. Partial nerve transection, spinal nerve ligation, and chronic constriction injury are applied in neuropathic pain studies. Although these models are well established due to their potential to create reliable and reproducible results, an experimental setup for studying incomplete nerve lesions which resemble the intraoperative surgical condition was missing for years. In neurosurgery, manipulation of peripheral or cranial nerves-such as in surgical procedures in the cerebellar-pontine angle or at the skull base-may lead to severe functional loss despite morphologically intact nerves. In the past years, different therapeutic agents for regeneration of the functional recovery have been investigated intensely. The authors' group has developed animal models to investigate the therapeutic potential of various substances in incomplete nerve injuries. In these models, the severity of the nerve lesion with distinct functional loss and recovery depends on the preset jet pressures.	[Oertel, Joachim; Keiner, Doerther] Univ Klinikum Saarlandes Homburg Saar, Neurochirurg Klin, Homburg, Germany; [Tschan, Christoph A.] Neurochirurg Klin, Ludmillenstift Meppenr, Germany		Oertel, J (corresponding author), Univ Klinikum Saarlandes Homburg Saar, Neurochirurg Klin, Homburg, Germany.		Keiner, Doerthe/AAK-1195-2020; Oertel, Joachim/AAO-5012-2021	Keiner, Doerthe/0000-0003-2975-7704; 			Baer H U, 1993, HPB Surg, V6, P189, DOI 10.1155/1993/82362; BAIN JR, 1989, PLAST RECONSTR SURG, V83, P129, DOI 10.1097/00006534-198901000-00024; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Brunelli G, 2005, P NATL ACAD SCI USA, V102, P8752, DOI 10.1073/pnas.0500530102; Costa Heloisa Juliana Zabeu Rossi, 2006, Rev. Bras. Otorrinolaringol., V72, P786, DOI 10.1590/S0034-72992006000600009; Dinh P, 2009, MICROSURG, V29, P644, DOI 10.1002/micr.20685; Dodla MC, 2008, BIOMATERIALS, V29, P33, DOI 10.1016/j.biomaterials.2007.08.045; Gordon E, 1998, J REFRACT SURG, V14, P338; HATA Y, 1994, J PEDIATR SURG, V29, P648, DOI 10.1016/0022-3468(94)90732-3; Huang JH, 2009, TISSUE ENG PT A, V15, P1677, DOI 10.1089/ten.tea.2008.0294; Hubert J, 1996, UROL RES, V24, P355, DOI 10.1007/BF00389793; Isaacson B, 2003, OTOL NEUROTOL, V24, P812, DOI 10.1097/00129492-200309000-00020; Kalender AM, 2009, J BRACHIAL PLEX PERI, V4, DOI 10.1186/1749-7221-4-6; Keiner D, 2010, NEUROSURGERY, V67, DOI 10.1227/NEU.0b013e3181f743bb; KOBAYASHI M, 1995, ACTA RADIOL, V36, P453; Koka R, 2001, EXP NEUROL, V168, P192, DOI 10.1006/exnr.2000.7600; Lindenlaub T, 2004, METH MOLEC MED, P47; Lipshitz I, 1996, J REFRACT SURG, V12, P184; Ma MY, 2000, J NEUROCYTOL, V29, P249, DOI 10.1023/A:1026519720352; Magill CK, 2007, EXP NEUROL, V207, P64, DOI 10.1016/j.expneurol.2007.05.028; Martins RS, 2005, ARQ NEURO-PSIQUIAT, V63, P601, DOI 10.1590/S0004-282X2005000400009; Moinzadeh A, 2005, J UROLOGY, V174, P317, DOI 10.1097/01.ju.0000161587.95033.c9; Oertel J, 2004, MINIM INVAS NEUROSUR, V47, P154, DOI 10.1055/s-2004-818512; Oertel J, 2004, ACTA NEUROCHIR, V146, P713, DOI 10.1007/s00701-004-0265-9; Oertel J, 2004, J NEUROSURG, V100, P498, DOI 10.3171/jns.2004.100.3.0498; Oertel J, 2003, NEUROSURG REV, V26, P168, DOI 10.1007/s10143-002-0244-7; Oertel J, 2003, EUR J SURG ONCOL, V29, P407, DOI 10.1053/ejso.2002.1428; Oertel J, 2003, NEUROSURGERY, V52, P153, DOI 10.1097/00006123-200301000-00020; Oertel Joachim, 2005, Neurosurgery, V56, P142, DOI 10.1227/01.NEU.0000144316.87764.13; Pan HC, 2009, NEUROCHEM RES, V34, P518, DOI 10.1007/s11064-008-9815-5; PAPACHRISTOU DN, 1982, BRIT J SURG, V69, P93, DOI 10.1002/bjs.1800690212; Penchev RD, 1999, J UROLOGY, V162, P772, DOI 10.1097/00005392-199909010-00040; Piek J, 1998, J NEUROSURG, V89, P861, DOI 10.3171/jns.1998.89.5.0861; Piek J, 2002, J NEUROSURG, V96, P690, DOI 10.3171/jns.2002.96.4.0690; Rau HG, 2008, HPB, V10, P275, DOI 10.1080/13651820802167706; Rau HG, 2001, CHIRURG, V72, P105, DOI 10.1007/s001040051277; Samii M, 1997, NEUROSURGERY, V40, P696, DOI 10.1097/00006123-199704000-00007; Samii M, 1997, NEUROSURGERY, V40, P684, DOI 10.1097/00006123-199704000-00006; Samii M, 2006, J NEUROSURG, V105, P527, DOI 10.3171/jns.2006.105.4.527; SCHMALBRUCH H, 1986, ANAT REC, V215, P71, DOI 10.1002/ar.1092150111; Sekiya T, 2001, BRAIN RES, V905, P152, DOI 10.1016/S0006-8993(01)02523-9; Seol HJ, 2006, NEUROL MED-CHIR, V46, P176, DOI 10.2176/nmc.46.176; Shekarriz H, 2003, SURGERY, V133, P635, DOI 10.1067/msy.2003.155; Siegert R, 1998, EUR ARCH OTO-RHINO-L, V255, P325, DOI 10.1007/s004050050070; Tschan CA, 2009, ACTA NEUROCHIR, V151, P1473, DOI 10.1007/s00701-009-0333-2; Tschan C, 2009, J NEUROSURG, V110, P656, DOI 10.3171/2008.5.17561; Tschan CA, 2010, NEUROSURGERY, V67, DOI 10.1227/NEU.0b013e3181f9b0c8; Tschan CA, 2010, BRIT J NEUROSURG, V24, P641, DOI 10.3109/02688697.2010.495170; Yan JG, 2010, MICROSURG, V30, P138, DOI 10.1002/micr.20709	49	1	1	0	0	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES	0893-2336	1940-6045	978-1-4939-3730-1; 978-1-4939-3728-8	NEUROMETHODS	Neuromethods		2016	116						151	163		10.1007/978-1-4939-3730-1_12	10.1007/978-1-4939-3730-1		13	Clinical Neurology; Surgery	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Surgery	BG4LP	WOS:000388975500014					2022-02-06	
J	Okonogi, H; Harada, M; Sato, H; Tokoro, K; Nakayama, I; Tsuboi, N; Miyazaki, Y; Kawamura, T; Ogura, M; Yokoo, T				Okonogi, Hideo; Harada, Mikio; Sato, Hironobu; Tokoro, Kazuhiko; Nakayama, Issei; Tsuboi, Nobuo; Miyazaki, Yoichi; Kawamura, Tetsuya; Ogura, Makoto; Yokoo, Takashi			Fluctuation in Serum Sodium Levels Related to Ipragliflozin Administration in a Patient with Diabetic Nephropathy and Sequela of Traumatic Brain Injury	INTERNAL MEDICINE			English	Article						SGLT2 inhibitor; electrolyte free-water clearance; CSWS; SIADH; DPP-4 inhibitor	MELLITUS; CANAGLIFLOZIN	A 46-year-old diabetic man underwent the removal of a hematoma caused by traumatic brain injury. After surgery, severe hyponatremia occurred. The subsequent administration of NaCl and fludrocortisone improved his laboratory findings. The patient was transferred to our hospital, and his insulin therapy was replaced by teneligliptin. One week later, ipragliflozin treatment was initiated and induced an immediate increase in the serum sodium levels. NaCl and fludrocortisone were therefore discontinued. However, hyponatremia recurred after ipragliflozin withdrawal due to a urinary tract infection. NaCl and fludrocortisone were initiated again, and the laboratory data improved. We herein report a case of serum sodium fluctuation related to ipragliflozin administration.	[Okonogi, Hideo; Tsuboi, Nobuo; Miyazaki, Yoichi; Kawamura, Tetsuya; Ogura, Makoto; Yokoo, Takashi] Jikei Univ, Div Nephrol & Hypertens, Dept Internal Med, Sch Med, Tokyo, Japan; [Okonogi, Hideo; Harada, Mikio; Nakayama, Issei] Kanagawa Rehabil Hosp, Dept Internal Med, Atsugi, Kanagawa, Japan; [Sato, Hironobu; Tokoro, Kazuhiko] Kanagawa Rehabil Hosp, Dept Neurosurg, Atsugi, Kanagawa, Japan		Okonogi, H (corresponding author), Jikei Univ, Div Nephrol & Hypertens, Dept Internal Med, Sch Med, Tokyo, Japan.; Okonogi, H (corresponding author), Kanagawa Rehabil Hosp, Dept Internal Med, Atsugi, Kanagawa, Japan.	hokonogi@s3.dion.ne.jp					Bodonyi-Kovacs G, 2008, CLIN EXP NEPHROL, V12, P74, DOI 10.1007/s10157-007-0021-6; Cherney DZI, 2014, CIRCULATION, V129, P587, DOI 10.1161/CIRCULATIONAHA.113.005081; Kirkman MA, 2013, NEUROCRIT CARE, V18, P406, DOI 10.1007/s12028-012-9805-y; Kurtz I, 2005, KIDNEY INT, V68, P1982, DOI 10.1111/j.1523-1755.2005.00652.x; Lu DC, 2008, SURG NEUROL, V69, P226, DOI 10.1016/j.surneu.2007.02.051; Nauck MA, 2014, DRUG DES DEV THER, V8, P1335, DOI 10.2147/DDDT.S50773; Plosker GL, 2014, DRUGS, V74, P807, DOI 10.1007/s40265-014-0225-5; Sha S, 2014, DIABETES OBES METAB, V16, P1087, DOI 10.1111/dom.12322; Takahara M, 2015, ENDOCR J, V62, P77, DOI 10.1507/endocrj.EJ14-0335; Vasilakou D, 2013, ANN INTERN MED, V159, P262, DOI 10.7326/0003-4819-159-4-201308200-00007; Yale JF, 2014, DIABETES OBES METAB, V16, P1016, DOI 10.1111/dom.12348	11	1	1	0	1	JAPAN SOC INTERNAL MEDICINE	TOKYO	34-3 3-CHOME HONGO BUNKYO-KU, TOKYO, 113, JAPAN	0918-2918	1349-7235		INTERNAL MED	Intern. Med.		2016	55	14					1887	1891		10.2169/internalmedicine.55.5482			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS5DN	WOS:000380801100011	27432098	gold			2022-02-06	
J	Poland, KM; McKay, MP; Zonfrillo, MR; Barth, TH; Kaminski, R				Poland, Kristin M.; McKay, Mary Pat; Zonfrillo, Mark R.; Barth, Thomas H.; Kaminski, Ronald			Changes in baseline concussion assessment scores following a school bus crash	TRAFFIC INJURY PREVENTION			English	Article						Concussion; cognitive testing; crash; school bus; athlete; transportation	IMPACT	Objective: The objective of this article is to present concussion assessment data for 30 male athletes prior to and after being involved in a large school bus crash. The athletes on the bus, all male and aged 14-18years, were participants in their school's concussion management program that included baseline and postinjury testing using Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT).Methods: This case study described changes in concussion assessment scores for 30 male athletes following a primarily frontal school bus crash. Data from the school's concussion management program, including baseline test data and postinjury assessment data, were reviewed. Athletes who required multiple postinjury assessments by the program were identified as having had significant cognitive changes as a result of the bus crash.Results: Twenty-nine of 30 athletes were injured. One had lumbar compression fractures; others had various lacerations, abrasions, contusions, sprains, and nasal fractures. ImPACT data (postcrash) were available for all 30 athletes and 28 had available precrash baseline data. A total of 16 athletes (53.3%) had significant cognitive changes indicated by changes in their concussion assessment scores, some of which took months to improve.Conclusion: This case study highlights a unique opportunity to evaluate concussion assessment data from 30 male athletes involved in a high-speed school bus crash. Further, these data provide additional insight into assessing the effectiveness of current school bus occupant protection systems.	[Poland, Kristin M.; McKay, Mary Pat] Natl Transportat Safety Board, Off Res & Engn, 490 Enfant Plaza East, Washington, DC 20594 USA; [Zonfrillo, Mark R.] Brown Univ, Hasbro Childrens Hosp, Providence, RI 02912 USA; [Zonfrillo, Mark R.] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [Barth, Thomas H.; Kaminski, Ronald] Natl Transportat Safety Board, Off Highway Safety, Denver, CO USA		Poland, KM (corresponding author), Natl Transportat Safety Board, Off Res & Engn, 490 Enfant Plaza East, Washington, DC 20594 USA.	kristin.poland@ntsb.gov	Zonfrillo, Mark R./H-9403-2017	Zonfrillo, Mark R./0000-0002-0610-9563			Barlow KM, 2016, J CHILD NEUROL, V31, P57, DOI 10.1177/0883073814543305; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; ImPACT, 2016, IMPACT TEST; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; National Transportation Safety Board, 1999, SIR9904 NAT TRANSP S; National Transportation Safety Board, 2015, HAB1501 NAT TRANSP S; National Transportation Safety Board, 2015, SIR1502 NAT TRANSP S; National Transportation Safety Board, 2013, HAR1301 NAT TRANSP S; National Transportation Safety Board. Centerville, 2014, HWY14MH006 NAT TRANS; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Zonfrillo MR, 2015, ACAD EMERG MED, V22, P872, DOI 10.1111/acem.12696	13	1	1	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-9588	1538-957X		TRAFFIC INJ PREV	Traffic Inj. Prev.		2016	17			1	SI		6	10		10.1080/15389588.2016.1194518			5	Public, Environmental & Occupational Health; Transportation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Transportation	DW8ID	WOS:000383897600003	27586095	Green Submitted			2022-02-06	
S	Postolache, TT; Manalai, P; Brenner, LA; Brundin, L		Kaschka, WP; Rujescu, D		Postolache, Teodor T.; Manalai, Partam; Brenner, Lisa A.; Brundin, Lena			Inflammation and Suicidal Behavior	BIOLOGICAL ASPECTS OF SUICIDAL BEHAVIOR	Advances in Biological Psychiatry		English	Article; Book Chapter							TOXOPLASMA-GONDII INFECTION; SYSTEMIC-LUPUS-ERYTHEMATOSUS; ACUTE PSYCHOLOGICAL STRESS; ARYL-HYDROCARBON RECEPTOR; DEFENSIVE RAGE BEHAVIOR; PERIAQUEDUCTAL GRAY PAG; NECROSIS-FACTOR-ALPHA; T-CELL PROLIFERATION; VITAMIN-D; INDOLEAMINE 2,3-DIOXYGENASE	Clinical and epidemiological data accumulated over the past decade strongly suggest that inflammation, certain upstream triggers of the immune system and downstream molecular mediators of inflammation, may contribute to the pathophysiology of suicidal behavior. Upstream factors include autoimmune factors, infections, traumatic brain injury, and stress. Downstream factors potentially mediating the effects of inflammation include molecules of the kynurenine pathway, which are known to modulate neuroinflammation and glutamate neurotransmission. The following could contribute to an important rejuvenation of our suicide prevention arsenal: (1) targeting immune dysregulation in patients with a history of suicidal behavior; (2) preventive factors involving upstream activators such as chronic latent infections or allergens and, (3) interrupting downstream pathophysiological pathways of inflammation. Additionally, the focus on individual triggers and diatheses will increase the precision of our treatment interventions in suicide prevention. Finally, it might be possible to increase the accuracy of suicide risk estimation by adding analysis of inflammatory biomarkers to our clinical information and neuropsychological testing. Discovering novel agents that target inflammation may also rejuvenate our therapeutic interval in suicide prevention. (c) 2016 S. Karger AG, Basel	[Postolache, Teodor T.] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA; [Postolache, Teodor T.] Mental Illness Res Educ & Clin Ctr MIRECC, Vet Integrated Serv Network VISN 5, Baltimore, MD 21201 USA; [Postolache, Teodor T.] Rocky Mt Mental Illness Res Educ & Clin Ctr MIREC, Denver, CO 80220 USA; [Manalai, Partam] Howard Univ, Dept Psychiat, Washington, DC 20059 USA; [Brenner, Lisa A.] Univ Colorado, Dept Psychiat, Anschutz Med Campus, Aurora, CO USA; [Brenner, Lisa A.] Univ Colorado, Dept Phys Med & Rehabil, Anschutz Med Campus, Aurora, CO USA; [Brenner, Lisa A.] Univ Colorado, Dept Neurol, Anschutz Med Campus, Aurora, CO USA; [Brundin, Lena] Michigan State Univ, Coll Human Med, Div Psychiat & Behav Med, Grand Rapids, MI USA; [Brundin, Lena] Van Andel Res Inst, Grand Rapids, MI USA		Postolache, TT (corresponding author), Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA.; Postolache, TT (corresponding author), Mental Illness Res Educ & Clin Ctr MIRECC, Vet Integrated Serv Network VISN 5, Baltimore, MD 21201 USA.; Postolache, TT (corresponding author), Rocky Mt Mental Illness Res Educ & Clin Ctr MIREC, Denver, CO 80220 USA.		Brenner, Lisa A./AAG-2442-2019	Postolache, Teodor/0000-0001-6056-4244			Afonso C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032489; Ajioka I, 2007, CELL, V131, P378, DOI 10.1016/j.cell.2007.09.036; Altemus M, 2001, J INVEST DERMATOL, V117, P309, DOI 10.1046/j.1523-1747.2001.01373.x; Alvarado-Esquivel C, 2013, J NERV MENT DIS, V201, P948, DOI 10.1097/NMD.0000000000000037; Arling TA, 2009, J NERV MENT DIS, V197, P905, DOI 10.1097/NMD.0b013e3181c29a23; ASBERG M, 1976, ARCH GEN PSYCHIAT, V33, P1193; Bach H, 2012, NEUROBIOLOGICAL BASI; Bauer TM, 2005, TRANSPL INT, V18, P95, DOI 10.1111/j.1432-2277.2004.00031.x; Bay-Richter C, 2015, BRAIN BEHAV IMMUN, V43, P110, DOI 10.1016/j.bbi.2014.07.012; Beattie MS, 2010, EUR J NEUROSCI, V32, P290, DOI 10.1111/j.1460-9568.2010.07343.x; Benros ME, 2013, JAMA PSYCHIAT, V70, P812, DOI 10.1001/jamapsychiatry.2013.1111; Bertolote Jose Manoel, 2002, World Psychiatry, V1, P181; Bezemer G, 2012, NEUROPSYCHOBIOLOGY, V65, P126, DOI 10.1159/000330585; Bhatt S, 2006, BEHAV BRAIN RES, V167, P251, DOI 10.1016/j.bbr.2005.09.011; Bhatt S, 2008, BRAIN BEHAV IMMUN, V22, P224, DOI 10.1016/j.bbi.2007.07.011; Black C, 2015, BIOL PSYCHIAT, V78, P28, DOI 10.1016/j.biopsych.2014.10.014; Borsini A, 2015, TRENDS NEUROSCI, V38, P145, DOI 10.1016/j.tins.2014.12.006; Bower JE, 2007, BRAIN BEHAV IMMUN, V21, P251, DOI 10.1016/j.bbi.2006.08.001; Bronnum-Hansen H, 2005, J NEUROL NEUROSUR PS, V76, P1457, DOI 10.1136/jnnp.2004.056747; Cannell JJ, 2006, EPIDEMIOL INFECT, V134, P1129, DOI 10.1017/S0950268806007175; Carroll JE, 2011, BRAIN BEHAV IMMUN, V25, P232, DOI 10.1016/j.bbi.2010.09.024; CHEW KSY, 1995, SOC SCI MED, V40, P223, DOI 10.1016/0277-9536(94)E0070-9; Christodoulou C, 2012, ACTA PSYCHIAT SCAND, V125, P127, DOI 10.1111/j.1600-0447.2011.01750.x; Chwastiak L, 2002, AM J PSYCHIAT, V159, P1862, DOI 10.1176/appi.ajp.159.11.1862; Coccaro EF, J CLIN PSYCHIAT; Cook TB, 2015, J PSYCHIATR RES, V60, P87, DOI 10.1016/j.jpsychires.2014.09.019; Correale J, 2009, BRAIN, V132, P1146, DOI 10.1093/brain/awp033; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Dargel AA, 2015, J CLIN PSYCHIAT, V76, P142, DOI 10.4088/JCP.14r09007; Daubener W, 1999, ADV EXP MED BIOL, V467, P517; DeCarvalho LP, 1996, NEUROCHEM INT, V28, P445; DiazGranados N, 2010, J CLIN PSYCHIAT, V71, P1605, DOI 10.4088/JCP.09m05327blu; Dieperink E, 2004, GEN HOSP PSYCHIAT, V26, P237, DOI 10.1016/j.genhosppsych.2004.01.003; Dubey JP, 2008, INT J PARASITOL, V38, P1257, DOI 10.1016/j.ijpara.2008.03.007; Edinger AL, 2002, P NATL ACAD SCI USA, V99, P1107, DOI 10.1073/pnas.042707999; Erhardt S, 2013, NEUROPSYCHOPHARMACOL, V38, P743, DOI 10.1038/npp.2012.248; Erhardt S, 2009, CNS DRUGS, V23, P91, DOI 10.2165/00023210-200923020-00001; ERICSSON A, 1995, J COMP NEUROL, V361, P681, DOI 10.1002/cne.903610410; Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016/j.jchemneu.2004.08.006; Falcone T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011089; Fallarino F, 2006, J IMMUNOL, V176, P6752, DOI 10.4049/jimmunol.176.11.6752; Fang Beverly J, 2010, Front Biosci (Schol Ed), V2, P30; Fazel S, 2014, JAMA PSYCHIAT, V71, P326, DOI 10.1001/jamapsychiatry.2013.3935; Fekadu A, 2010, FOLIA PARASIT, V57, P105, DOI 10.14411/fp.2010.013; Fernandes de Abreu D A, 2009, Psychoneuroendocrinology, V34 Suppl 1, pS265, DOI 10.1016/j.psyneuen.2009.05.023; Flegr J, 2000, BIOL PSYCHOL, V53, P57, DOI 10.1016/S0301-0511(00)00034-X; Fragoso YD, 2010, CLIN NEUROPHARMACOL, V33, P312, DOI 10.1097/WNF.0b013e3181f8d513; Fredrikson S, 2003, NEUROEPIDEMIOLOGY, V22, P146, DOI 10.1159/000068746; Frumento G, 2002, J EXP MED, V196, P459, DOI 10.1084/jem.20020121; Gabbay V, 2009, J CHILD ADOL PSYCHOP, V19, P423, DOI 10.1089/cap.2008.0140; Garcia-Oscos F, 2012, BIOL PSYCHIAT, V71, P574, DOI 10.1016/j.biopsych.2011.11.018; Gaskell EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004801; Gonzalez LE, 2007, BEHAV BRAIN RES, V177, P70, DOI 10.1016/j.bbr.2006.11.012; Goodwin RD, 2012, CURR PSYCHIAT REP, V14, P30, DOI 10.1007/s11920-011-0243-x; Gorman S, 2007, J IMMUNOL, V179, P6273, DOI 10.4049/jimmunol.179.9.6273; GRANT IH, 1990, AIDS, V4, P519, DOI 10.1097/00002030-199006000-00004; Groer M, 2010, J OCCUP ENVIRON MED, V52, P595, DOI 10.1097/JOM.0b013e3181e129da; Grudet C, 2014, PSYCHONEUROENDOCRINO, V50, P210, DOI 10.1016/j.psyneuen.2014.08.016; Guillemin GJ, 2012, FEBS J, V279, P1355, DOI 10.1111/j.1742-4658.2012.08493.x; Hannestad J, 2013, BRAIN BEHAV IMMUN, V33, P131, DOI 10.1016/j.bbi.2013.06.010; Harris EC, 1997, BRIT J PSYCHIAT, V170, P205, DOI 10.1192/bjp.170.3.205; Hassanain M, 2003, NEUROSCIENCE, V120, P227, DOI 10.1016/S0306-4522(03)00264-1; Havlicek J, 2001, PARASITOLOGY, V122, P515, DOI 10.1017/S0031182001007624; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; HAY J, 1984, ANN TROP MED PARASIT, V78, P611, DOI 10.1080/00034983.1984.11811872; Heesen C, 2002, BRAIN BEHAV IMMUN, V16, P282, DOI 10.1006/brbi.2001.0628; Herber DL, 2006, GLIA, V53, P382, DOI 10.1002/glia.20272; Hewison M, 2010, ENDOCRIN METAB CLIN, V39, P365, DOI 10.1016/j.ecl.2010.02.010; Hinze-Selch D, 2010, FOLIA PARASIT, V57, P129, DOI 10.14411/fp.2010.016; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Izawa S, 2013, BIOL PSYCHOL, V94, P249, DOI 10.1016/j.biopsycho.2013.06.006; Janelidze S, 2011, BRAIN BEHAV IMMUN, V25, P335, DOI 10.1016/j.bbi.2010.10.010; JANSSEN HLA, 1994, J HEPATOL, V21, P241, DOI 10.1016/S0168-8278(05)80402-7; Juengst SB, 2014, BRAIN BEHAV IMMUN, V41, P134, DOI 10.1016/j.bbi.2014.05.020; Kawasaki Y, 2008, J NEUROSCI, V28, P5189, DOI 10.1523/JNEUROSCI.3338-07.2008; Kiank C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011825; Kim C, 2010, AM J PSYCHIAT, V167, P1100, DOI 10.1176/appi.ajp.2010.09050706; Kim YK, 2008, PROG NEURO-PSYCHOPH, V32, P356, DOI 10.1016/j.pnpbp.2007.08.041; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Kocazeybek B, 2009, FORENSIC SCI INT, V187, P103, DOI 10.1016/j.forsciint.2009.03.007; Krug EG, 2002, LANCET, V360, P1083, DOI 10.1016/S0140-6736(02)11133-0; Lauvsnes MB, 2012, J NEUROL, V259, P622, DOI 10.1007/s00415-011-6232-5; Le-Niculescu H, 2013, MOL PSYCHIATR, V18, P1249, DOI 10.1038/mp.2013.95; Lehnardt S, 2010, GLIA, V58, P253, DOI 10.1002/glia.20928; LEKLEM JE, 1971, AM J CLIN NUTR, V24, P659; LEMIRE JM, 1984, J CLIN INVEST, V74, P657, DOI 10.1172/JCI111465; Linderholm KR, 2012, SCHIZOPHRENIA BULL, V38, P426, DOI 10.1093/schbul/sbq086; Lindova J, 2010, FOLIA PARASIT, V57, P136, DOI 10.14411/fp.2010.017; Lindqvist D, 2009, BIOL PSYCHIAT, V66, P287, DOI 10.1016/j.biopsych.2009.01.030; Ling VJ, 2011, J NERV MENT DIS, V199, P440, DOI 10.1097/NMD.0b013e318221416e; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Lotrich FE, 2010, CLIN NEUROPHARMACOL, V33, P191, DOI 10.1097/WNF.0b013e3181de8966; Ludvigsson JF, 2011, DIGEST LIVER DIS, V43, P616, DOI 10.1016/j.dld.2011.02.009; Mackay GM, 2006, EUR J NEUROL, V13, P30, DOI 10.1111/j.1468-1331.2006.01220.x; MAES M, 1993, ACTA PSYCHIAT SCAND, V88, P156, DOI 10.1111/j.1600-0447.1993.tb03431.x; Maes M, 2011, NEUROENDOCRINOL LETT, V32, P7; Mahrnood A.A., 2013, J BAGHDAD COLL DENT, V24, P72; Malkesman O, 2009, TRENDS PHARMACOL SCI, V30, P165, DOI 10.1016/j.tips.2009.01.004; Manalai P, 2012, BIPOLAR DISORD, V14, P90, DOI 10.1111/j.1399-5618.2012.00983.x; Mann JJ, 2009, BIOL PSYCHIAT, V65, P556, DOI 10.1016/j.biopsych.2008.11.021; Mann JJ, 2003, NAT REV NEUROSCI, V4, P819, DOI 10.1038/nrn1220; Mastrolonardo M, 2007, ARCH MED RES, V38, P206, DOI 10.1016/j.arcmed.2006.09.009; Meers S, 2010, CLIN INFECT DIS, V50, P1127, DOI 10.1086/651266; Mellor AL, 2003, J IMMUNOL, V171, P1652, DOI 10.4049/jimmunol.171.4.1652; Meszaros ZS, 2012, J CLIN PSYCHIAT, V73, P993, DOI [10.4088/JCP.11m07043, 10.4088/JCP.11r07425]; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Miller AH, 2013, NEUROPSYCHOPHARMACOL, V38, P1607, DOI 10.1038/npp.2013.140; Miura H, 2008, STRESS, V11, P160, DOI 10.1080/10253890701685908; Mizrahi R, 2012, J CEREBR BLOOD F MET, V32, P968, DOI 10.1038/jcbfm.2012.46; Modabbernia A, 2013, BIOL PSYCHIAT, V74, P15, DOI 10.1016/j.biopsych.2013.01.007; Monnerie H, 2003, J NEUROSCI RES, V74, P688, DOI 10.1002/jnr.10797; Moretti S, 2014, J CLIN ENDOCR METAB, V99, pE832, DOI 10.1210/jc.2013-3351; Munkholm K, 2013, J AFFECT DISORDERS, V144, P16, DOI 10.1016/j.jad.2012.06.010; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; Myint AM, 2007, J AFFECT DISORDERS, V98, P143, DOI 10.1016/j.jad.2006.07.013; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; NASSBERGER L, 1993, ACTA PSYCHIAT SCAND, V88, P48, DOI 10.1111/j.1600-0447.1993.tb03412.x; Nguyen NT, 2010, P NATL ACAD SCI USA, V107, P19961, DOI 10.1073/pnas.1014465107; Notarangelo FM, 2014, SCHIZOPHR RES, V152, P261, DOI 10.1016/j.schres.2013.11.011; O'Donovan A, 2013, DEPRESS ANXIETY, V30, P307, DOI 10.1002/da.22087; Okusaga O, 2013, WORLD J BIOL PSYCHIA, V14, P509, DOI 10.3109/15622975.2012.747699; Okusaga O, 2011, SCHIZOPHR RES, V133, P150, DOI 10.1016/j.schres.2011.08.006; Okusaga O, 2011, J AFFECT DISORDERS, V130, P220, DOI 10.1016/j.jad.2010.09.029; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Owen DR, 2012, J CEREBR BLOOD F MET, V32, P1, DOI 10.1038/jcbfm.2011.147; Pandey GN, 2012, J PSYCHIATR RES, V46, P57, DOI 10.1016/j.jpsychires.2011.08.006; Pappas G, 2009, INT J PARASITOL, V39, P1385, DOI 10.1016/j.ijpara.2009.04.003; Patel A, 2010, BRAIN BEHAV IMMUN, V24, P1276, DOI 10.1016/j.bbi.2010.05.005; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Pearce BD, 2012, BIOL PSYCHIAT, V72, P290, DOI 10.1016/j.biopsych.2012.01.003; Pedersen MG, 2012, ARCH GEN PSYCHIAT, V69, P1123, DOI 10.1001/archgenpsychiatry.2012.668; Petridou E, 2002, EPIDEMIOLOGY, V13, P106, DOI 10.1097/00001648-200201000-00017; Postolache TT, 2010, J AFFECT DISORDERS, V121, P88, DOI 10.1016/j.jad.2009.05.015; Postolache Teodor T, 2008, Curr Treat Options Neurol, V10, P363, DOI 10.1007/s11940-008-0039-4; Postolache TT, 2005, MOL PSYCHIATR, V10, P232, DOI 10.1038/sj.mp.4001620; Prendergast GC, 2014, CANCER IMMUNOL IMMUN, V63, P721, DOI 10.1007/s00262-014-1549-4; Price RB, 2009, BIOL PSYCHIAT, V66, P522, DOI 10.1016/j.biopsych.2009.04.029; Qin P, 2011, ALLERGY, V66, P658, DOI 10.1111/j.1398-9995.2010.02523.x; Qin P, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002462; Raison CL, 2010, MOL PSYCHIATR, V15, P393, DOI 10.1038/mp.2009.116; Raison CL, 2009, BIOL PSYCHIAT, V65, P296, DOI 10.1016/j.biopsych.2008.08.010; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; Raison CL, 2005, J CLIN PSYCHIAT, V66, P41, DOI 10.4088/JCP.v66n0106; Reichenberg A, 2001, ARCH GEN PSYCHIAT, V58, P445, DOI 10.1001/archpsyc.58.5.445; Rodgers KM, 2009, BRAIN, V132, P2478, DOI 10.1093/brain/awp177; Rohleder N, 2003, PSYCHONEUROENDOCRINO, V28, P261, DOI 10.1016/S0306-4530(02)00019-7; Roy A, 2009, J PSYCHIATR PRACT, V15, P282, DOI 10.1097/01.pra.0000358314.88931.b5; Rupprecht R, 2010, NAT REV DRUG DISCOV, V9, P971, DOI 10.1038/nrd3295; SALTER M, 1985, BIOCHEM J, V229, P499, DOI 10.1042/bj2290499; Samojlowicz D, 2013, PRZEGL EPIDEMIOL, V67, P115; Samojlowicz Dorota, 2013, Przegl Epidemiol, V67, P29; Savitz J, 2015, PSYCHONEUROENDOCRINO, V52, P200, DOI 10.1016/j.psyneuen.2014.11.015; Savitz J, 2015, NEUROPSYCHOPHARMACOL, V40, P463, DOI 10.1038/npp.2014.194; Schele E, 2012, J NEUROENDOCRINOL, V24, P930, DOI 10.1111/j.1365-2826.2012.02286.x; SCHOBITZ B, 1993, EUR J NEUROSCI, V5, P1426, DOI 10.1111/j.1460-9568.1993.tb00210.x; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; Schwieler L, 2015, J PSYCHIATR NEUROSCI, V40, P126, DOI 10.1503/jpn.140126; Serafini G, 2013, EUR NEUROPSYCHOPHARM, V23, P1672, DOI 10.1016/j.euroneuro.2013.06.002; Setiawan E, 2015, JAMA PSYCHIAT, V72, P268, DOI 10.1001/jamapsychiatry.2014.2427; Slavish DC, 2015, BRAIN BEHAV IMMUN, V44, P253, DOI 10.1016/j.bbi.2014.08.008; Soldati, 2007, TOXOPLASMA MOL CELLU, P111; Steiner J, 2008, J PSYCHIATR RES, V42, P151, DOI 10.1016/j.jpsychires.2006.10.013; Steiner J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-94; Steptoe A, 2007, BRAIN BEHAV IMMUN, V21, P901, DOI 10.1016/j.bbi.2007.03.011; STONE TW, 1993, PHARMACOL REV, V45, P309; Suarez EC, 2006, BRAIN BEHAV IMMUN, V20, P331, DOI 10.1016/j.bbi.2005.09.005; Sublette ME, 2011, BRAIN BEHAV IMMUN, V25, P1272, DOI 10.1016/j.bbi.2011.05.002; Szodoray P, 2008, SCAND J IMMUNOL, V68, P261, DOI 10.1111/j.1365-3083.2008.02127.x; Tangpricha V, 2002, AM J MED, V112, P659, DOI 10.1016/S0002-9343(02)01091-4; Tariq Muhammad M, 2011, Int J Adolesc Med Health, V23, P157; Tonelli LH, 2008, ACTA PSYCHIAT SCAND, V117, P198, DOI 10.1111/j.1600-0447.2007.01128.x; Tonelli LH, 2008, NEUROPSYCHOPHARMACOL, V33, P1038, DOI 10.1038/sj.npp.1301488; Tonelli Leonardo H, 2008, Int J Child Health Hum Dev, V1, P305; Tonelli LH, 2009, BRAIN BEHAV IMMUN, V23, P784, DOI 10.1016/j.bbi.2009.02.017; Tonelli LH, 2005, NEUROL RES, V27, P679, DOI 10.1179/016164105X49463; Tonelli LH, 2005, FRONT BIOSCI, V10, P675, DOI 10.2741/1562; Torrey EF, 2012, SCHIZOPHRENIA BULL, V38, P642, DOI 10.1093/schbul/sbs043; Town T, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-24; Umhau JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051543; Urata Y, 2014, AM J REPROD IMMUNOL, V72, P496, DOI 10.1111/aji.12282; van Heeringen K, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00824; Vogelzangs N, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.27; Vyas A, 2007, P NATL ACAD SCI USA, V104, P6442, DOI 10.1073/pnas.0608310104; Westling S, 2011, ACTA PSYCHIAT SCAND, V124, P301, DOI 10.1111/j.1600-0447.2011.01734.x; Wium-Andersen MK, 2013, JAMA PSYCHIAT, V70, P176, DOI 10.1001/2013.jamapsychiatry.102; Woo JM, 2012, ACTA PSYCHIAT SCAND, V125, P168, DOI 10.1111/j.1600-0447.2011.01813.x; Woo JM, 2012, INT J ENV RES PUB HE, V9, P531, DOI 10.3390/ijerph9020531; Woo JM, 2011, J CLIN PSYCHIAT, V72, P1423, DOI 10.4088/JCP.10m06765; Yagmur F, 2010, FORENSIC SCI INT, V199, P15, DOI 10.1016/j.forsciint.2010.02.020; Yip PSF, 2000, BRIT J PSYCHIAT, V177, P366, DOI 10.1192/bjp.177.4.366; Zhang YF, 2012, J CLIN PSYCHIAT, V73, P1069, DOI 10.4088/JCP.11m07532; Zunszain PA, 2012, NEUROPSYCHOPHARMACOL, V37, P939, DOI 10.1038/npp.2011.277	192	1	1	0	3	KARGER	BASEL	POSTFACH, CH-4009 BASEL, SWITZERLAND	0378-7354	1662-2774	978-3-318-05584-9; 978-3-318-05583-2	ADV BIOL PSYCH-KARG	Adv.Biol.Psychiatry		2016	30						123	144		10.1159/000434746			22	Behavioral Sciences; Clinical Neurology; Psychiatry	Book Citation Index – Science (BKCI-S)	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	BL8XP	WOS:000457097900012					2022-02-06	
S	Rajan, TS; Cuzzocrea, S; Bruschetta, D; Quartarone, A		Kobeissy, F; Dixon, CE; Hayes, RL; Mondello, S		Rajan, Thangavelu Soundara; Cuzzocrea, Salvatore; Bruschetta, Daniele; Quartarone, Angelo			Repetitive Transcranial Magnetic Stimulation as a Novel Therapy in Animal Models of Traumatic Brain Injury	INJURY MODELS OF THE CENTRAL NERVOUS SYSTEM: METHODS AND PROTOCOLS	Methods in Molecular Biology		English	Article; Book Chapter						rTMS; TBI; Neuroprotection; Rodent brain injury models	CENTRAL-NERVOUS-SYSTEM; HUMAN MOTOR CORTEX; C-FOS; HIGH-FREQUENCY; RATS; EXCITABILITY; EXPRESSION; INCREASES; NEUROPLASTICITY; PLASTICITY	Traumatic brain injury (TBI) in humans causes a broad range of structural damage and functional deficits due to both primary and secondary injury mechanisms. Over the past three decades, animal models have been established to replicate the diverse changes of human TBI, to study the underlying pathophysiology and to develop new therapeutic strategies. However, drugs that were identified as neuroprotective in animal brain injury models were not successful in clinical trials phase II or phase III. Repetitive transcranial magnetic stimulation (rTMS) is a powerful noninvasive approach to excite cortical neurons in humans and animals, widely applied for therapeutic purpose in patients with brain diseases. In addition, recent animal studies showed rTMS as a strong neuroprotective tool. In this chapter, we discuss the rationale and mechanisms related to rTMS as well as therapeutic applications and putative molecular mechanisms. Furthermore, relevant biochemical studies and neuroprotective effect in animal models and possible application of rTMS as a novel treatment for rodent brain injury models are discussed.	[Rajan, Thangavelu Soundara; Quartarone, Angelo] Univ Messina, Policlin Univ, Dept Neurosci, Messina, Italy; [Rajan, Thangavelu Soundara; Quartarone, Angelo] IRCCS Ctr Neurolesi Bonino Pulejo, Messina, Italy; [Cuzzocrea, Salvatore] Univ Messina, Dept Biol & Environm Sci, Messina, Italy; [Cuzzocrea, Salvatore] Univ Manchester, Manchester Biomed Res Ctr, Manchester, Lancs, England; [Bruschetta, Daniele] Univ Messina, Dept Biomed Sci & Morphol & Funct Images, Messina, Italy; [Quartarone, Angelo] NYU, Sch Med, Dept Physiol & Pharmacol, New York, NY USA		Rajan, TS (corresponding author), Univ Messina, Policlin Univ, Dept Neurosci, Messina, Italy.; Rajan, TS (corresponding author), IRCCS Ctr Neurolesi Bonino Pulejo, Messina, Italy.		Rajan, Thangavelu Soundara/J-9840-2016	Rajan, Thangavelu Soundara/0000-0001-8728-6176; Cuzzocrea, Salvatore/0000-0001-6131-3690			Arias-Carrion Oscar, 2008, Int Arch Med, V1, P2, DOI 10.1186/1755-7682-1-2; Aydin-Abidin S, 2008, EXP BRAIN RES, V188, P249, DOI 10.1007/s00221-008-1356-2; Baek K, 2012, NEUROSCIENCE, V200, P159, DOI 10.1016/j.neuroscience.2011.09.050; Cooke SF, 2006, BRAIN, V129, P1659, DOI 10.1093/brain/awl082; Demirtas-Tatlidede A, 2012, J HEAD TRAUMA REHAB, V27, P274, DOI 10.1097/HTR.0b013e318217df55; Edwards MJ, 2008, LANCET NEUROL, V7, P827, DOI 10.1016/S1474-4422(08)70190-X; Erhardt A, 2004, NEUROPSYCHOPHARMACOL, V29, P2074, DOI 10.1038/sj.npp.1300493; Esser SK, 2006, BRAIN RES BULL, V69, P86, DOI 10.1016/j.brainresbull.2005.11.003; Feng SF, 2012, BEHAV BRAIN RES, V232, P245, DOI 10.1016/j.bbr.2012.04.019; Flanagan Steven R, 2008, Neuropsychiatr Dis Treat, V4, P877; Fujiki M, 2003, J NEUROSURG, V99, P1063, DOI 10.3171/jns.2003.99.6.1063; Gao F, 2010, EUR J NUCL MED MOL I, V37, P954, DOI 10.1007/s00259-009-1342-3; Gersner R, 2011, J NEUROSCI, V31, P7521, DOI 10.1523/JNEUROSCI.6751-10.2011; Hallett M, 2000, NATURE, V406, P147, DOI 10.1038/35018000; Hausmann A, 2000, MOL BRAIN RES, V76, P355, DOI 10.1016/S0169-328X(00)00024-3; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Ikeda T, 2013, BIOCHEM BIOPH RES CO, V436, P121, DOI 10.1016/j.bbrc.2013.03.017; Kammer T, 2001, CLIN NEUROPHYSIOL, V112, P250, DOI 10.1016/S1388-2457(00)00513-7; Keck ME, 2000, J PSYCHIAT RES, V34, P265, DOI 10.1016/S0022-3956(00)00028-5; Kim JY, 2013, J KOREAN MED SCI, V28, P295, DOI 10.3346/jkms.2013.28.2.295; Kobayashi M, 2003, LANCET NEUROL, V2, P145, DOI 10.1016/S1474-4422(03)00321-1; Kole MHP, 1999, BRAIN RES, V826, P309, DOI 10.1016/S0006-8993(99)01257-3; Kuwabara S, 2002, MUSCLE NERVE, V25, P176, DOI 10.1002/mus.10030.abs; Muller MB, 2000, NEUROPSYCHOPHARMACOL, V23, P205, DOI 10.1016/S0893-133X(00)00099-3; Okada K, 2002, BRAIN RES, V957, P37, DOI 10.1016/S0006-8993(02)03582-5; Pape TLB, 2006, J HEAD TRAUMA REHAB, V21, P437, DOI 10.1097/00001199-200609000-00063; Post A, 2001, J PSYCHIATR RES, V35, P193, DOI 10.1016/S0022-3956(01)00023-1; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Stefan K, 2002, J PHYSIOL-LONDON, V543, P699, DOI 10.1113/jphysiol.2002.023317; Tan T, 2013, BRAIN RES, V1520, P23, DOI 10.1016/j.brainres.2013.04.053; Thielscher A, 2004, CLIN NEUROPHYSIOL, V115, P1697, DOI 10.1016/j.clinph.2004.02.019; Ueyama E, 2011, PSYCHIAT CLIN NEUROS, V65, P77, DOI 10.1111/j.1440-1819.2010.02170.x; Villamar MF, 2012, NEUROMODULATION, V15, P326, DOI 10.1111/j.1525-1403.2012.00474.x; Wang F, 2010, J MOL NEUROSCI, V41, P145, DOI 10.1007/s12031-009-9311-7; Wang HY, 2011, J NEUROSCI, V31, P11044, DOI 10.1523/JNEUROSCI.2125-11.2011; Yoon KJ, 2011, EXP BRAIN RES, V214, P549, DOI 10.1007/s00221-011-2853-2; Yue L, 2009, BRAIN RES, V1260, P94, DOI 10.1016/j.brainres.2009.01.009; Zhang XQ, 2007, J HUAZHONG U SCI-MED, V27, P415, DOI 10.1007/s11596-007-0416-3	38	1	1	1	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	1064-3745	1940-6029	978-1-4939-3816-2; 978-1-4939-3814-8	METHODS MOL BIOL	Methods Mol. Biol.		2016	1462						433	443		10.1007/978-1-4939-3816-2_24	10.1007/978-1-4939-3816-2		11	Biochemical Research Methods; Biochemistry & Molecular Biology; Neurosciences	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology; Neurosciences & Neurology	BH1UG	WOS:000398551500026	27604732				2022-02-06	
J	Rawool, VW				Rawool, Vishakha Waman			Emerging technologies with potential for objectively evaluating speech recognition skills	INTERNATIONAL JOURNAL OF AUDIOLOGY			English	Article; Proceedings Paper	40th Annual Meeting of the National-Hearing-Conservation-Association (NHCA) on Celebrating Hearing Loss Prevention	2015	New Orleans, LA	Natl Hearing Conservat Assoc, Natl Inst Occupat Safety & Hlth, Council Accrediat Occupat Hearing Conservat, Safe Sound, ETYMOTIC, Workplace Integra		Speech processing; speech recognition scores; neural networks; stimulus reconstruction; neuroaudioethics; neurosecurity; electroencephalography; magnetoencephalography; auditory evoked potentials; auditory evoked fields	BRAIN-WAVE RECOGNITION; STEM RESPONSE; NOISE; PERFORMANCE; INTERFACE; TIME; SOFT	Work-related exposure to noise and other ototoxins can cause damage to the cochlea, synapses between the inner hair cells, the auditory nerve fibers, and higher auditory pathways, leading to difficulties in recognizing speech. Procedures designed to determine speech recognition scores (SRS) in an objective manner can be helpful in disability compensation cases where the worker claims to have poor speech perception due to exposure to noise or ototoxins. Such measures can also be helpful in determining SRS in individuals who cannot provide reliable responses to speech stimuli, including patients with Alzheimer's disease, traumatic brain injuries, and infants with and without hearing loss. Cost-effective neural monitoring hardware and software is being rapidly refined due to the high demand for neurogaming (games involving the use of brain-computer interfaces), health, and other applications. More specifically, two related advances in neuro-technology include relative ease in recording neural activity and availability of sophisticated analysing techniques. These techniques are reviewed in the current article and their applications for developing objective SRS procedures are proposed. Issues related to neuroaudioethics (ethics related to collection of neural data evoked by auditory stimuli including speech) and neurosecurity (preservation of a person's neural mechanisms and free will) are also discussed.	[Rawool, Vishakha Waman] W Virginia Univ, Dept Commun Sci & Disorders, Morgantown, WV 26508 USA		Rawool, VW (corresponding author), W Virginia Univ, Dept Commun Sci & Disorders, Morgantown, WV 26508 USA.	VWRawool@mail.wvu.edu		Rawool, Vishakha/0000-0003-4675-9357			Anderson S, 2013, J SPEECH LANG HEAR R, V56, P31, DOI 10.1044/1092-4388(2012/12-0043); Bankowski E., 2011, TARDEC21952 ARM TANK; Bramhall N, 2015, J AM ACAD AUDIOL, V26, P509, DOI 10.3766/jaaa.14100; Chan AM, 2011, NEUROIMAGE, V54, P3028, DOI 10.1016/j.neuroimage.2010.10.073; Chang EF, 2010, NAT NEUROSCI, V13, P1428, DOI 10.1038/nn.2641; Chi Yu M., 2013, Foundations of Augmented Cognition. 7th International Conference, AC 2013. Held as Part of HCI International 2013. Proceedings, P649, DOI 10.1007/978-3-642-39454-6_69; Chi YM, 2012, IEEE T NEUR SYS REH, V20, P228, DOI 10.1109/TNSRE.2011.2174652; CHIZECK H., 2014, US Patent App., Patent No. [14/174,818, 14174818, 14/174, 818]; Correia JM, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00071; Defense Advanced Research Projects Agency (DARPA), 2009, DEP DEF FISC YEAR 20; Denning T, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.4.FOCUS0985; Fan JA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4266; Farahany NA, 2012, STANFORD LAW REV, V64, P351; Frank M., 2013, 13126052 ARXIV; Fuente A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-39; Fujihira H, 2015, CLIN NEUROPHYSIOL, V126, P96, DOI 10.1016/j.clinph.2014.05.001; Gallun FJ, 2012, J REHABIL RES DEV, V49, P1005, DOI 10.1682/JRRD.2012.03.0038; Guenther FH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008218; Guimaraes MP, 2007, IEEE T BIO-MED ENG, V54, P436, DOI 10.1109/TBME.2006.888824; Gurgel RK, 2012, OTOLARYNG HEAD NECK, V147, P803, DOI 10.1177/0194599812458401; Jeong JW, 2015, NEURON, V86, P175, DOI 10.1016/j.neuron.2014.12.035; Jeong JW, 2014, ADV HEALTHC MATER, V3, P642, DOI 10.1002/adhm.201300334; Johnson Ann-Christin, 2006, Noise Health, V8, P45; Kameda K, 2015, JPN J APPL PHYS, V54, DOI 10.7567/JJAP.54.026601; Kim DH, 2011, SCIENCE, V333, P838, DOI 10.1126/science.1206157; Kitching J, 2008, 2008 IEEE INTERNATIONAL FREQUENCY CONTROL SYMPOSIUM, VOLS 1 AND 2, P789, DOI 10.1109/FREQ.2008.4623107; KOHONEN T, 1988, COMPUTER, V21, P11, DOI 10.1109/2.28; Kohonen T, 2006, NEURAL NETWORKS, V19, P723, DOI 10.1016/j.neunet.2006.05.001; Koskinen M, 2013, HUM BRAIN MAPP, V34, P1477, DOI 10.1002/hbm.22004; Kujawa SG, 2015, HEARING RES, V330, P191, DOI 10.1016/j.heares.2015.02.009; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Le Prell CG, 2015, OXID STRESS APPL BAS, P163, DOI 10.1007/978-3-319-13473-4_9; Levy BR, 2014, PSYCHOL SCI, V25, P2127, DOI 10.1177/0956797614551970; Luo H, 2007, NEURON, V54, P1001, DOI 10.1016/j.neuron.2007.06.004; Macrae J. H., 1991, 124 DEP COMM SERV HL; Malech R. G., 1976, U. S. Patent, Patent No. [3,951,134, 3951134]; Mardirossian A., 2000, U. S. Patent, Patent No. [6,011,991, 6011991]; Martin Stephanie, 2014, Front Neuroeng, V7, P14, DOI 10.3389/fneng.2014.00014; Mesgarani N, 2014, SCIENCE, V343, P1006, DOI 10.1126/science.1245994; Morata TC, 2012, SPRINGER HANDB AUDIT, V40, P223, DOI 10.1007/978-1-4419-9523-0_11; Norton JJS, 2015, P NATL ACAD SCI USA, V112, P3920, DOI 10.1073/pnas.1424875112; Pasley BN, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001251; Power A. J., 2013, NEUROSCIENCE 2013; Rawool V. W., 2015, AUDIOL TODAY, V27, P22; Rawool V. W., 2012, HEARING CONSERVATION, P242; Rawool V. W., 2016, AUDITORY PROCESSING, P429; RAWOOL VW, 1989, SCAND AUDIOL, V18, P113, DOI 10.3109/01050398909070731; Sander TH, 2012, BIOMED OPT EXPRESS, V3, P981, DOI 10.1364/BOE.3.000981; Shah VK, 2013, PHYS MED BIOL, V58, P8153, DOI 10.1088/0031-9155/58/22/8153; Shapiro B., 2014, BRAIN EAGER WIRELESS; Soman S, 2015, PROCEDIA COMPUT SCI, V46, P292, DOI 10.1016/j.procs.2015.02.023; Song, 2012, 21 USENIX SEC S USEN, P143; Suppes P, 1997, P NATL ACAD SCI USA, V94, P14965, DOI 10.1073/pnas.94.26.14965; Suppes P, 1998, P NATL ACAD SCI USA, V95, P15861, DOI 10.1073/pnas.95.26.15861; Suppes P, 1999, P NATL ACAD SCI USA, V96, P12953, DOI 10.1073/pnas.96.22.12953; Suppes P, 2009, NEURAL COMPUT, V21, P3228, DOI 10.1162/neco.2009.04-08-764; von Luhmann A, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00617; Wardlaw JM, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5190; Weinberg I. N., 2015, U. S. Patent, Patent No. [2015/0238110, 20150238110]; Wickenden A. E., 2009, ARLTR4807; Wu QZ, 2011, HUM BRAIN MAPP, V32, P1290, DOI 10.1002/hbm.21108; Yang M, 2015, INTERNATIONAL TECHNICAL CONFERENCE AND EXHIBITION ON PACKAGING AND INTEGRATION OF ELECTRONIC AND PHOTONIC MICROSYSTEMS, 2015, VOL 3	62	1	1	0	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1499-2027	1708-8186		INT J AUDIOL	Int. J. Audiol.		2016	55			1	SI		S41	S50		10.3109/14992027.2015.1128570			10	Audiology & Speech-Language Pathology; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Audiology & Speech-Language Pathology; Otorhinolaryngology	DM9XW	WOS:000376720000006	26807789				2022-02-06	
S	Roussas, A; Martinez, BI; Addington, CP; Stabenfeldt, SE		WilsonRawls, J; Kusumi, K		Roussas, Adam; Martinez, Briana I.; Addington, Caroline P.; Stabenfeldt, Sarah E.			Regenerative Strategies for the Central Nervous System	INNOVATIONS IN MOLECULAR MECHANISMS AND TISSUE ENGINEERING	Stem Cell Biology and Regenerative Medicine		English	Article; Book Chapter							SPINAL-CORD-INJURY; NEURAL STEM-CELLS; NECROSIS-FACTOR-ALPHA; FIBROBLAST-GROWTH-FACTOR; TRAUMATIC BRAIN-INJURY; OLFACTORY-ENSHEATHING GLIA; CHONDROITIN SULFATE PROTEOGLYCANS; FOCAL CEREBRAL-ISCHEMIA; GLUTAMATE-INDUCED EXCITOTOXICITY; OLIGODENDROCYTE PRECURSOR CELLS		[Roussas, Adam; Martinez, Briana I.; Addington, Caroline P.; Stabenfeldt, Sarah E.] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85287 USA		Stabenfeldt, SE (corresponding author), Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85287 USA.	aroussas@asu.edu; bimarti1@asu.edu; caroline.addington@asu.edu; sarah.stabenfeldt@asu.edu		Addington, Caroline/0000-0003-4534-8222			Abrams MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038760; Addington CP, 2015, BIOMARK INSIGHTS, V10, P43, DOI [10.4137/BMI.S20062, 10.4137/BMIMI.S20062]; Adeeb N, 2014, BRAIN BEHAV, V4, P105, DOI 10.1002/brb3.207; Afshari FT, 2010, J NEUROSCI, V30, P4246, DOI 10.1523/JNEUROSCI.3351-09.2010; Anderson JM, 2012, ADV DRUG DELIVER REV, V64, P72, DOI 10.1016/j.addr.2012.09.004; Anderson L, 2007, NEUROBIOL DIS, V27, P133, DOI 10.1016/j.nbd.2007.03.015; [Anonymous], 2015, SPIN CORD INJ SCI FA; ARAUJO DM, 1992, J NEUROSCI, V12, P1668; Argaw AT, 2012, J CLIN INVEST, V122, P2454, DOI 10.1172/JCI60842; Arvidsson L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027393; Arvin KL, 2002, ANN NEUROL, V52, P54, DOI 10.1002/ana.10242; Ashton RS, 2007, BIOMATERIALS, V28, P5518, DOI 10.1016/j.biomaterials.2007.08.038; Atkins CM, 2012, J NEUROSCI RES, V90, P1861, DOI 10.1002/jnr.23069; Atkins CM, 2013, NEUROSCI LETT, V532, P1, DOI 10.1016/j.neulet.2012.10.019; Aurand ER, 2012, NEUROSCI RES, V72, P199, DOI 10.1016/j.neures.2011.12.005; Azim K, 2012, GLIA, V60, P1977, DOI 10.1002/glia.22413; Balgude AP, 2001, BIOMATERIALS, V22, P1077, DOI 10.1016/S0142-9612(00)00350-1; Bamber NI, 2001, EUR J NEUROSCI, V13, P257, DOI 10.1046/j.1460-9568.2001.01387.x; Banerjee A, 2009, BIOMATERIALS, V30, P4695, DOI 10.1016/j.biomaterials.2009.05.050; Bansal R, 2003, DEV NEUROSCI-BASEL, V25, P83, DOI 10.1159/000072258; Barnabe-Heider F, 2010, CELL STEM CELL, V7, P470, DOI 10.1016/j.stem.2010.07.014; Barritt AW, 2006, J NEUROSCI, V26, P10856, DOI 10.1523/JNEUROSCI.2980-06.2006; Bartus K, 2014, J NEUROSCI, V34, P4822, DOI 10.1523/JNEUROSCI.4369-13.2014; Basu A, 2002, J NEUROSCI, V22, P6071; Beaumont E, 2009, NEUROSCIENCE, V163, P985, DOI 10.1016/j.neuroscience.2009.07.039; Ben-David U, 2011, NAT REV CANCER, V11, P268, DOI 10.1038/nrc3034; Benoit JP, 2000, J CONTROL RELEASE, V65, P285, DOI 10.1016/S0168-3659(99)00250-3; Bergles DE, 1997, NEURON, V19, P1297, DOI 10.1016/S0896-6273(00)80420-1; Bhatheja K, 2006, INT J BIOCHEM CELL B, V38, P1995, DOI 10.1016/j.biocel.2006.05.007; Blesch A, 2002, BRAIN RES BULL, V57, P833, DOI 10.1016/S0361-9230(01)00774-2; Blesch A, 2007, J NEUROSCI, V27, P10535, DOI 10.1523/JNEUROSCI.1903-07.2007; Blits B, 2005, RESTOR NEUROL NEUROS, V23, P313; Blitts B, 2003, NEUROSCIENCE, V118, P271, DOI 10.1016/S0306-4522(02)00970-3; Bonner JF, 2010, J NEUROSCI RES, V88, P1182, DOI 10.1002/jnr.22288; Borisoff JF, 2003, MOL CELL NEUROSCI, V22, P405, DOI 10.1016/S1044-7431(02)00032-5; Boros C, 2008, BRAIN RES, V1209, P105, DOI 10.1016/j.brainres.2008.02.029; Bovolenta R, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-81; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; Bradbury EJ, 1998, EUR J NEUROSCI, V10, P3058, DOI 10.1046/j.1460-9568.1998.00307.x; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Bradbury EJ, 2011, BRAIN RES BULL, V84, P306, DOI 10.1016/j.brainresbull.2010.06.015; BROGI E, 1994, CIRCULATION, V90, P649, DOI 10.1161/01.CIR.90.2.649; Bruce AJ, 1996, NAT MED, V2, P788, DOI 10.1038/nm0796-788; Burdick JA, 2006, BIOMATERIALS, V27, P452, DOI 10.1016/j.biomaterials.2005.06.034; Busch SA, 2010, J NEUROSCI, V30, P255, DOI 10.1523/JNEUROSCI.3705-09.2010; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Butt AM, 2005, J NEUROIMMUNOL, V166, P75, DOI 10.1016/j.jneuroim.2005.05.015; Buttini M, 1997, BRIT J PHARMACOL, V122, P1483, DOI 10.1038/sj.bjp.0701502; Bydon M, 2014, WORLD NEUROSURG, V82, P848, DOI 10.1016/j.wneu.2013.02.062; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Cafferty WBJ, 2007, J NEUROSCI, V27, P2176, DOI 10.1523/JNEUROSCI.5176-06.2007; Caldeira J, 2015, MICROENVIRONMENT INS; Cao QL, 2010, J NEUROSCI, V30, P2989, DOI 10.1523/JNEUROSCI.3174-09.2010; Cao XD, 1999, BIOMATERIALS, V20, P329, DOI 10.1016/S0142-9612(98)00172-0; CARONI P, 1988, NEURON, V1, P85, DOI 10.1016/0896-6273(88)90212-7; Cavazzin C, 2006, GLIA, V53, P167, DOI 10.1002/glia.20256; Cerqueira SR, 2013, SMALL, V9, P738, DOI 10.1002/smll.201201888; Chan CCM, 2005, EXP NEUROL, V196, P352, DOI 10.1016/j.expneurol.2005.08.011; Chen AQ, 1996, EXP NEUROL, V138, P261, DOI 10.1006/exnr.1996.0065; Chen G, 2010, CHINESE MED J-PEKING, V123, P2424, DOI 10.3760/cma.j.issn.0366-6999.2010.17.025; Chen LX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115997; Chen MH, 2013, INT J CLIN EXP PATHO, V6, P2312; Chen XR, 2014, BRAIN RES, V1543, P324, DOI 10.1016/j.brainres.2013.12.002; Cheng CH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138705; Chew SY, 2005, BIOMACROMOLECULES, V6, P2017, DOI 10.1021/bm0501149; Chi LY, 2008, NEUROSCI LETT, V438, P174, DOI 10.1016/j.neulet.2008.04.043; Ching S, 2005, BRAIN BEHAV IMMUN, V19, P127, DOI 10.1016/j.bbi.2004.06.001; Cho SR, 2009, CELL TRANSPLANT, V18, P1359, DOI 10.3727/096368909X475329; Choy DKS, 2013, TISSUE ENG PT A, V19, P2382, DOI [10.1089/ten.TEA.2012.0733, 10.1089/ten.tea.2012.0733]; Christopherson GT, 2009, BIOMATERIALS, V30, P556, DOI 10.1016/j.biomaterials.2008.10.004; Chu K, 2005, NEUROSCI RES, V53, P384, DOI 10.1016/j.neures.2005.08.010; Cobbs CS, 1998, NEUROSCI LETT, V249, P79, DOI 10.1016/S0304-3940(98)00377-2; Corey JM, 2007, J BIOMED MATER RES A, V83A, P636, DOI 10.1002/jbm.a.31285; Cregg JM, 2014, EXP NEUROL, V253, P197, DOI 10.1016/j.expneurol.2013.12.024; Crompton KE, 2007, BIOMATERIALS, V28, P441, DOI 10.1016/j.biomaterials.2006.08.044; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Cui M, 2011, GLIA, V59, P641, DOI 10.1002/glia.21134; Cui WG, 2008, INT J PHARMACEUT, V361, P47, DOI 10.1016/j.ijpharm.2008.05.005; Cui WG, 2006, BIOMACROMOLECULES, V7, P1623, DOI 10.1021/bm060057z; Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2; Curinga GM, 2007, J NEUROCHEM, V102, P275, DOI 10.1111/j.1471-4159.2007.04530.x; Dadsetan M, 2009, BIOMATERIALS, V30, P3874, DOI 10.1016/j.biomaterials.2009.04.018; Dasari Venkata Ramesh, 2014, World J Stem Cells, V6, P120, DOI 10.4252/wjsc.v6.i2.120; De Laporte L, 2011, J BIOMED MATER RES A, V98A, P372, DOI 10.1002/jbm.a.33112; Dergham P, 2002, J NEUROSCI, V22, P6570; Dillon GP, 1998, J BIOMAT SCI-POLYM E, V9, P1049, DOI 10.1163/156856298X00325; Dinomais M, 2009, J REHABIL MED, V41, P286, DOI 10.2340/16501977-0329; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Donnelly EM, 2010, J GENE MED, V12, P863, DOI 10.1002/jgm.1509; Ebert AD, 2008, EXP NEUROL, V209, P213, DOI 10.1016/j.expneurol.2007.09.022; Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103; EMERICH DF, 1994, J COMP NEUROL, V349, P148, DOI 10.1002/cne.903490110; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Erceg S, 2010, STEM CELLS, V28, P1541, DOI 10.1002/stem.489; Esposito E, 2011, TRENDS PHARMACOL SCI, V32, P107, DOI 10.1016/j.tips.2010.11.009; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Felice B, 2014, MAT SCI ENG C-MATER, V41, P178, DOI 10.1016/j.msec.2014.04.049; Folkersma H, 2008, ACTA NEUROCHIR, V150, P1277, DOI 10.1007/s00701-008-0151-y; Fouad K, 2005, J NEUROSCI, V25, P1169, DOI 10.1523/JNEUROSCI.3562-04.2005; Fouad K, 2004, EUR J NEUROSCI, V20, P2479, DOI 10.1111/j.1460-9568.2004.03716.x; Fraley SI, 2010, NAT CELL BIOL, V12, P598, DOI 10.1038/ncb2062; Franssen EHP, 2007, BRAIN RES REV, V56, P236, DOI 10.1016/j.brainresrev.2007.07.013; Freund P, 2006, NAT MED, V12, P790, DOI 10.1038/nm1436; Friedman WJ, 2005, MOL NEUROBIOL, V32, P133, DOI 10.1385/MN:32:2:133; Gabay C, 2010, NAT REV RHEUMATOL, V6, P232, DOI 10.1038/nrrheum.2010.4; Gao L, 2010, ACTA NEUROL SCAND, V122, P41, DOI 10.1111/j.1600-0404.2009.01253.x; Garbossa D, 2012, NEUROSURG REV, V35, P293, DOI 10.1007/s10143-012-0385-2; Gelain F, 2007, MACROMOL BIOSCI, V7, P544, DOI 10.1002/mabi.200700033; Gennai S, 2015, BRIT J ANAESTH, V115, P203, DOI 10.1093/bja/aev229; George A, 2000, PAIN, V88, P267, DOI 10.1016/S0304-3959(00)00333-X; Ghirnikar RS, 2000, J NEUROSCI RES, V59, P63, DOI 10.1002/(SICI)1097-4547(20000101)59:1<63::AID-JNR8>3.3.CO;2-N; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Ghirnikar RS, 1998, NEUROSCI LETT, V247, P21, DOI 10.1016/S0304-3940(98)00268-7; Goddard DR, 2002, J ANAT, V200, P57, DOI 10.1046/j.0021-8782.2001.00002.x; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Guest JD, 2005, EXP NEUROL, V192, P384, DOI 10.1016/j.expneurol.2004.11.033; Gunn JW, 2005, J BIOMED MATER RES A, V72A, P91, DOI 10.1002/jbm.a.30203; Guo J, 2007, NANOMED-NANOTECHNOL, V3, P311, DOI 10.1016/j.nano.2007.09.003; Guo JS, 2009, NANOMED-NANOTECHNOL, V5, P345, DOI 10.1016/j.nano.2008.12.001; Hagen EM, 2010, J NEUROL NEUROSUR PS, V81, P368, DOI 10.1136/jnnp.2009.178798; Harris NG, 2010, J NEUROTRAUM, V27, P1971, DOI 10.1089/neu.2010.1470; Hashimoto M, 2002, J BIOL CHEM, V277, P32985, DOI 10.1074/jbc.M202803200; Hatinen S, 2008, RESTOR NEUROL NEUROS, V26, P493; He CL, 2009, J BIOMED MATER RES A, V89A, P80, DOI 10.1002/jbm.a.32004; Hedley ML, 1998, NAT MED, V4, P365, DOI 10.1038/nm0398-365; Heese K, 1998, J NEUROCHEM, V70, P699; Hermann GE, 2001, NEUROBIOL DIS, V8, P590, DOI 10.1006/nbdi.2001.0414; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Hicks RR, 1999, EXP NEUROL, V160, P469, DOI 10.1006/exnr.1999.7216; Hicks RR, 1997, MOL BRAIN RES, V48, P401, DOI 10.1016/S0169-328X(97)00158-7; Homsi S, 2009, BRAIN RES, V1291, P122, DOI 10.1016/j.brainres.2009.07.031; Horn KP, 2008, J NEUROSCI, V28, P9330, DOI 10.1523/JNEUROSCI.2488-08.2008; Hou SP, 2012, J NEUROSCI, V32, P13206, DOI 10.1523/JNEUROSCI.5041-11.2012; Hu W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004151; Hu XL, 2014, J CONTROL RELEASE, V185, P12, DOI 10.1016/j.jconrel.2014.04.018; Huang YC, 2011, CARBOHYD POLYM, V84, P788, DOI 10.1016/j.carbpol.2010.03.034; Hyakkoku K, 2009, NEUROSCIENCE, V159, P760, DOI 10.1016/j.neuroscience.2008.12.043; Hyatt AJT, 2010, J CONTROL RELEASE, V147, P24, DOI 10.1016/j.jconrel.2010.06.026; HYMAN C, 1991, NATURE, V350, P230, DOI 10.1038/350230a0; Hynes SR, 2009, J BIOMED MATER RES A, V89A, P499, DOI 10.1002/jbm.a.31987; Hyun J, 2013, STEM CELL TRANSL MED, V2, P690, DOI 10.5966/sctm.2013-0035; Iannotti CA, 2011, EXP NEUROL, V230, P3, DOI 10.1016/j.expneurol.2010.03.010; Ide C, 2010, BRAIN RES, V1332, P32, DOI 10.1016/j.brainres.2010.03.043; Ignatious F, 2002, US Patent Appl, Patent No. [10/181,640, 10181640]; Jain NK, 2013, EXPERT OPIN DRUG DEL, V10, P353, DOI 10.1517/17425247.2013.751370; Jakovcevski I, 2007, J NEUROSCI, V27, P7222, DOI 10.1523/JNEUROSCI.0739-07.2007; Jha RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065974; Jiang T, 2015, PROG POLYM SCI, V46, P1, DOI 10.1016/j.progpolymsci.2014.12.001; Jiang Y, 2011, NEUROSCIENCE, V172, P398, DOI 10.1016/j.neuroscience.2010.10.054; Jing Z, 2003, J CONTROL RELEASE, V92, P227, DOI 10.1016/S0168-3659(03)00372-9; Johnson PJ, 2010, SOFT MATTER, V6, P5127, DOI 10.1039/c0sm00173b; Johnson-Farley NN, 2007, BRAIN RES, V1154, P40, DOI 10.1016/j.brainres.2007.04.026; Jones LL, 2003, EXP NEUROL, V182, P399, DOI 10.1016/S0014-4886(03)00087-6; Jones M, 2000, J BIOL CHEM, V275, P7964, DOI 10.1074/jbc.275.11.7964; Kabu S, 2015, J CONTROL RELEASE, V219, P141, DOI 10.1016/j.jconrel.2015.08.060; Kamada T, 2011, NEUROPATHOLOGY, V31, P48, DOI 10.1111/j.1440-1789.2010.01130.x; Kang SK, 2003, DEV BRAIN RES, V145, P141, DOI 10.1016/S0165-3806(03)00224-4; Karussis D, 2008, J NEUROL SCI, V265, P131, DOI 10.1016/j.jns.2007.05.005; Kasai M, 2014, J NEUROTRAUM, V31, P1584, DOI 10.1089/neu.2009.1108; Kaya D, 2005, J CEREBR BLOOD F MET, V25, P1111, DOI 10.1038/sj.jcbfm.9600109; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kelso ML, 2011, NEUROSCI LETT, V488, P60, DOI 10.1016/j.neulet.2010.11.003; Kenawy ER, 2002, J CONTROL RELEASE, V81, P57, DOI 10.1016/S0168-3659(02)00041-X; Khasnavis S, 2012, J BIOL CHEM, V287, P29529, DOI 10.1074/jbc.M111.338012; Kim D, 2001, NEUROREHAB NEURAL RE, V15, P141, DOI 10.1177/154596830101500207; Kim H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021744; Kim HM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004987; Kim S, 2006, BRAIN RES, V1123, P27, DOI 10.1016/j.brainres.2006.09.044; Kim YT, 2009, BIOMATERIALS, V30, P2582, DOI 10.1016/j.biomaterials.2008.12.077; Klusman I, 1997, BRAIN RES, V762, P173, DOI 10.1016/S0006-8993(97)00381-8; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; Koda M, 2002, J NEUROTRAUM, V19, P777, DOI 10.1089/08977150260139147; Kolar MK, 2014, STEM CELLS DEV, V23, P1659, DOI 10.1089/scd.2013.0416; Koopmans GC, 2009, EXP NEUROL, V216, P490, DOI 10.1016/j.expneurol.2009.01.005; Koutsoudaki PN, 2016, GLIA, V64, P763, DOI 10.1002/glia.22959; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; KRUPINSKI J, 1994, STROKE, V25, P1794, DOI 10.1161/01.STR.25.9.1794; Kubinova S, 2010, MINIM INVASIV THER, V19, P144, DOI 10.3109/13645706.2010.481398; Kubow Kristopher E, 2011, Nat Cell Biol, V13, P3, DOI 10.1038/ncb0111-3; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Kundu AK, 2009, TISSUE ENG PT A, V15, P273, DOI 10.1089/ten.tea.2008.0055; Kusano K, 2010, BIOCHEM BIOPH RES CO, V393, P812, DOI 10.1016/j.bbrc.2010.02.088; Lampe KJ, 2013, ACTA BIOMATER, V9, P5590, DOI 10.1016/j.actbio.2012.10.033; Lampe KJ, 2010, J BIOMED MATER RES A, V94A, P1162, DOI 10.1002/jbm.a.32787; LANGER R, 1990, SCIENCE, V249, P1527, DOI 10.1126/science.2218494; Langlois JA, 2006, TRAUMATIC BRAIN INJU; LAPCHAK PA, 1993, NEUROSCIENCE, V54, P445, DOI 10.1016/0306-4522(93)90265-H; Leach JB, 2007, J NEURAL ENG, V4, P26, DOI 10.1088/1741-2560/4/2/003; Lee H, 2010, P NATL ACAD SCI USA, V107, P3340, DOI 10.1073/pnas.0905437106; Lee JK, 2004, J NEUROSCI, V24, P6209, DOI 10.1523/JNEUROSCI.1643-04.2004; Lee JM, 2013, BIOMED RES INT, V2013, DOI [10.1155/2013/782041, 10.1155/2013/758731]; Lee KD, 2009, J NEUROTRAUM, V26, P2335, DOI 10.1089/neu.2008.0840; Lee MR, 2010, BIOMATERIALS, V31, P4360, DOI 10.1016/j.biomaterials.2010.02.012; Lee SM, 2003, J NEUROTRAUM, V20, P1017, DOI 10.1089/089771503770195867; Lee TT, 1999, J NEUROTRAUM, V16, P347, DOI 10.1089/neu.1999.16.347; Lee YB, 2000, EXP NEUROL, V166, P190, DOI 10.1006/exnr.2000.7494; Lenzlinger PM, 2005, NEUROSCIENCE, V134, P1047, DOI 10.1016/j.neuroscience.2005.04.048; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Leu S, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-63; Li Y, 1997, SCIENCE, V277, P2000, DOI 10.1126/science.277.5334.2000; Li Yu, 2014, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V28, P1006; Liberto CM, 2004, J NEUROCHEM, V89, P1092, DOI 10.1111/j.1471-4159.2004.02420.x; Liebscher T, 2005, ANN NEUROL, V58, P706, DOI 10.1002/ana.20627; Lim SH, 2009, ADV DRUG DELIVER REV, V61, P1084, DOI 10.1016/j.addr.2009.07.011; Lin R, 2008, J NEUROCHEM, V104, P400, DOI 10.1111/j.1471-4159.2007.05066.x; Lin SY, 2000, J MICROENCAPSUL, V17, P577; Liu JF, 2011, TISSUE ENG PT A, V17, P2343, DOI [10.1089/ten.TEA.2011.0034, 10.1089/ten.tea.2011.0034]; Liu XJ, 2015, INT J CLIN EXP PATHO, V8, P3811; Liu Y, 1999, J NEUROSCI, V19, P4370; Liu Y, 2010, NEUROBIOL DIS, V37, P384, DOI 10.1016/j.nbd.2009.10.018; Liu YF, 2013, STAT INTERFACE, V6, P1; Llado J, 2004, MOL CELL NEUROSCI, V27, P322, DOI 10.1016/j.mcn.2004.07.010; Lu KW, 2002, J NEUROTRAUM, V19, P1081, DOI 10.1089/089771502760341983; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; Luttichau HR, 2000, J EXP MED, V191, P171, DOI 10.1084/jem.191.1.171; Lutton C, 2012, J NEUROTRAUM, V29, P957, DOI 10.1089/neu.2010.1423; Lynn DG, 2000, J STRUCT BIOL, V130, P153, DOI 10.1006/jsbi.2000.4287; Ma HY, 2012, NEUROCHEM RES, V37, P69, DOI 10.1007/s11064-011-0584-1; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Madigan NN, 2009, RESP PHYSIOL NEUROBI, V169, P183, DOI 10.1016/j.resp.2009.08.015; Mahairaki V, 2011, TISSUE ENG PT A, V17, P855, DOI [10.1089/ten.tea.2010.0377, 10.1089/ten.TEA.2010.0377]; Mahmood A, 2004, NEUROSURGERY, P55; Mantovani A, 2006, NAT REV IMMUNOL, V6, P907, DOI 10.1038/nri1964; Matsusue Y, 1995, CLIN ORTHOP RELAT R, P317; MATTSON MP, 1995, J NEUROSCI RES, V42, P357, DOI 10.1002/jnr.490420310; McKenzie JL, 2004, BIOMATERIALS, V25, P1309, DOI 10.1016/j.biomaterials.2003.08.006; McKeon RJ, 1999, J NEUROSCI, V19, P10778, DOI 10.1523/JNEUROSCI.19-24-10778.1999; MCKEON RJ, 1995, EXP NEUROL, V136, P32, DOI 10.1006/exnr.1995.1081; McKerracher L, 2006, J NEUROTRAUM, V23, P309, DOI 10.1089/neu.2006.23.309; Mehrabi S, 2013, BASIC CLIN NEUROSCI, V4, P172; Mejia ROS, 2001, NEUROSURGERY, V48, P1393, DOI 10.1097/00006123-200106000-00051; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; Meng XT, 2011, EXP NEUROL, V227, P210, DOI 10.1016/j.expneurol.2010.11.002; Mergenthaler P, 2004, METAB BRAIN DIS, V19, P151, DOI 10.1023/B:MEBR.0000043966.46964.e6; Monnier PP, 2003, MOL CELL NEUROSCI, V22, P319, DOI 10.1016/S1044-7431(02)00035-0; Morshead CM, 1998, DEVELOPMENT, V125, P2251; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Nakaguchi K, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/915160; Nakajima H, 2007, J NEUROTRAUM, V24, P703, DOI 10.1089/neu.2006.0004; Nakajima H, 2010, SPINE, V35, P497, DOI 10.1097/BRS.0b013e3181b8e89b; Nemati S, 2014, CELL J, V16, P117; Neri M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010145; NeuralStem Inc, 2014, HUM SPIN CORD DER NE; Nie L, 2015, COLLOID SURFACE B, V125, P51, DOI 10.1016/j.colsurfb.2014.11.010; Niece KL, 2003, J AM CHEM SOC, V125, P7146, DOI 10.1021/ja028215r; Ninomiya M, 2006, NEUROSCI LETT, V403, P63, DOI 10.1016/j.neulet.2006.04.039; Nishio T, 2009, J NEUROL, V256, pS306, DOI 10.1007/s00415-009-5244-x; Nistor GI, 2005, GLIA, V49, P385, DOI 10.1002/glia.20127; Nori S, 2011, P NATL ACAD SCI USA, V108, P16825, DOI 10.1073/pnas.1108077108; Novikova LN, 2000, J COMP NEUROL, V428, P671, DOI 10.1002/1096-9861(20001225)428:4<671::AID-CNE7>3.0.CO;2-H; O'Collins VE, 2006, ANN NEUROL, V59, P467, DOI 10.1002/ana.20741; Oh JS, 2011, CELL TRANSPLANT, V20, P837, DOI 10.3727/096368910X539083; Oh JS, 2012, NEUROREPORT, P23; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Okazaki T, 2008, NEUROSCI LETT, V430, P109, DOI 10.1016/j.neulet.2007.10.046; Olson HE, 2009, TISSUE ENG PT A, V15, P1797, DOI 10.1089/ten.tea.2008.0364; Ong WY, 1999, NEUROSCIENCE, V92, P83, DOI 10.1016/S0306-4522(98)00751-9; Osaka M, 2010, BRAIN RES, V1343, P226, DOI 10.1016/j.brainres.2010.05.011; Paniagua RT, 2006, J CLIN INVEST, V116, P2633, DOI 10.1172/JCI28546; Pannu R, 2007, J NEUROCHEM, V101, P182, DOI 10.1111/j.1471-4159.2006.04354.x; Panyam J, 2003, ADV DRUG DELIVER REV, V55, P329, DOI 10.1016/S0169-409X(02)00228-4; Papa S, 2016, BIOMATERIALS, V75, P13, DOI 10.1016/j.biomaterials.2015.10.015; Pardridge WM, 2002, ADV EXP MED BIOL, V513, P397; Parr AM, 2008, NEUROSCIENCE, V155, P760, DOI 10.1016/j.neuroscience.2008.05.042; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Pearse DD, 2007, GLIA, V55, P976, DOI 10.1002/glia.20490; Pedersen MO, 2009, HISTOL HISTOPATHOL, V24, P573, DOI 10.14670/HH-24.573; Pego AP, 2012, J CELL MOL MED, V16, P2564, DOI 10.1111/j.1582-4934.2012.01603.x; Perale G, 2011, ACS CHEM NEUROSCI, V2, P336, DOI 10.1021/cn200030w; Pfeifer K, 2006, REGEN MED, V1, P255, DOI 10.2217/17460751.1.2.255; Pineau I, 2010, BRAIN BEHAV IMMUN, V24, P540, DOI 10.1016/j.bbi.2009.11.007; Pinzon A, 2001, J NEUROSCI RES, V64, P533, DOI 10.1002/jnr.1105; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Prang P, 2006, BIOMATERIALS, V27, P3560, DOI 10.1016/j.biomaterials.2006.01.053; Qi MB, 2008, EUR J PHARM BIOPHARM, V70, P445, DOI 10.1016/j.ejpb.2008.05.003; Quertainmont R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039500; Ra JC, 2011, STEM CELLS DEV, V20, P1297, DOI 10.1089/scd.2010.0466; Rabchevsky AG, 2000, EXP NEUROL, V164, P280, DOI 10.1006/exnr.2000.7399; Raisman G, 2007, NAT REV NEUROSCI, V8, P312, DOI 10.1038/nrn2099; Ramon-Cueto A, 1998, J NEUROSCI, V18, P3803; Read TA, 1999, INT J DEV NEUROSCI, V17, P653, DOI 10.1016/S0736-5748(99)00052-0; Reches M, 2002, J BIOL CHEM, V277, P35475, DOI 10.1074/jbc.M206039200; Recknor JB, 2006, BIOMATERIALS, V27, P4098, DOI 10.1016/j.biomaterials.2006.03.029; Reid AJ, 2011, NEUROSCIENCE, V199, P515, DOI 10.1016/j.neuroscience.2011.09.064; Reilly JF, 1998, GLIA, V22, P202, DOI 10.1002/(SICI)1098-1136(199802)22:2<202::AID-GLIA11>3.0.CO;2-1; Rethelyi M, 2008, NEUROSCI LETT, V445, P153, DOI 10.1016/j.neulet.2008.08.070; Ribeiro A, 2012, TISSUE ENG PT A, V18, P93, DOI 10.1089/ten.tea.2011.0221; Rooney GE, 2008, SPINE, V33, pE914, DOI 10.1097/BRS.0b013e318186b2b1; Rossi F, 2012, J FUNCT BIOMATER, V3, P199, DOI 10.3390/jfb3010199; Rottlaender A, 2011, IMMUNOLOGY, V133, P370, DOI 10.1111/j.1365-2567.2011.03450.x; Ruffini F, 2001, GENE THER, V8, P1207, DOI 10.1038/sj.gt.3301523; Ryan PL, 2001, P NATL ACAD SCI USA, V98, P4323, DOI 10.1073/pnas.071615398; Sabelstrom H, 2013, SCIENCE, V342, P637, DOI 10.1126/science.1242576; Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217; Sasaki M, 2009, J NEUROSCI, V29, P14932, DOI 10.1523/JNEUROSCI.2769-09.2009; Sasaki T, 2007, STROKE, V38, P1597, DOI 10.1161/STROKEAHA.106.476754; Sato Y, 2008, REPROD SCI, V15, P613, DOI 10.1177/1933719108317299; Schaal SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043634; Schabitz WR, 2000, STROKE, V31, P2212, DOI 10.1161/01.STR.31.9.2212; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Schnell E, 2007, BIOMATERIALS, V28, P3012, DOI 10.1016/j.biomaterials.2007.03.009; SCHNELL L, 1994, NATURE, V367, P170, DOI 10.1038/367170a0; Schwab ME, 2002, SCIENCE, V295, P1029, DOI 10.1126/science.1067840; Sebastian J, 2003, MOL CELL BIOL NEUROP, V513, P87, DOI DOI 10.1007/978-1-4615-0123-7_3; Sekiya I, 2002, STEM CELLS, V20, P530, DOI 10.1634/stemcells.20-6-530; Shamash S, 2002, J NEUROSCI, V22, P3052, DOI 10.1523/JNEUROSCI.22-08-03052.2002; Sharma HS, 2006, ACTA NEUROCHIR SUPPL, V96, P329; Sharma HS, 2007, ANN NY ACAD SCI, V1122, P95, DOI 10.1196/annals.1403.007; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Shi WX, 2012, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2012-141; Shields LBE, 2008, SURG NEUROL, V69, P568, DOI 10.1016/j.surneu.2008.02.009; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; Shohami E, 1996, J CEREBR BLOOD F MET, V16, P378, DOI 10.1097/00004647-199605000-00004; Shtilerman MD, 2002, BIOCHEMISTRY-US, V41, P3855, DOI 10.1021/bi0120906; Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783; Silva NA, 2014, PROG NEUROBIOL, V114, P25, DOI 10.1016/j.pneurobio.2013.11.002; Skaper Stephen D, 2012, Methods Mol Biol, V846, P1, DOI 10.1007/978-1-61779-536-7_1; Slovinska L, 2015, ACTA NEUROBIOL EXP, V75, P107; Smith ED, 2014, J BIOL CHEM, V289, P20615, DOI 10.1074/jbc.M114.568659; Soderblom C, 2013, J NEUROSCI, V33, P13882, DOI 10.1523/JNEUROSCI.2524-13.2013; Straley KS, 2010, J NEUROTRAUM, V27, P1, DOI 10.1089/neu.2009.0948; Su EJ, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00385; Sun ZC, 2003, ADV MATER, V15, P1929, DOI 10.1002/adma.200305136; Sung JK, 2003, BRAIN RES, V959, P29, DOI 10.1016/S0006-8993(02)03717-4; Sykova E, 2006, CELL MOL NEUROBIOL, V26, P1113, DOI 10.1007/s10571-006-9007-2; Tabata Y, 2009, J R SOC INTERFACE, V6, pS311, DOI 10.1098/rsif.2008.0448.focus; Takami T, 2002, J NEUROSCI, V22, P6670; Tang XF, 2003, J NEUROSCI RES, V71, P427, DOI 10.1002/jnr.10523; TASDEMIROGLU E, 1995, SPINE, V20, P1704, DOI 10.1097/00007632-199508000-00011; Tator CH, 1998, NEUROSURGERY, V42, P696, DOI 10.1097/00006123-199804000-00007; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Taylor L, 2006, J NEUROSCI, V26, P9713, DOI 10.1523/JNEUROSCI.0734-06.2006; Teekamp N, 2015, EXPERT OPIN DRUG DEL, V12, P1311, DOI 10.1517/17425247.2015.1003807; Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899; Thau-Zuchman O, 2012, J MOL NEUROSCI, V47, P166, DOI 10.1007/s12031-012-9706-8; Thomas TW, 2000, MED BIOL ENG COMPUT, V38, P360, DOI 10.1007/BF02347059; Timmer M, 2007, J NEUROSCI, V27, P459, DOI 10.1523/JNEUROSCI.4493-06.2007; Titomanlio L, 2011, ANN NEUROL, V70, P698, DOI 10.1002/ana.22518; Tobias CA, 2005, J NEUROTRAUM, V22, P138, DOI 10.1089/neu.2005.22.138; Tobias CA, 2003, EXP NEUROL, V184, P97, DOI 10.1016/S0014-4886(03)00394-7; Tolosa L, 2008, J NEUROCHEM, V105, P1080, DOI 10.1111/j.1471-4159.2007.05206.x; Tong LQ, 2008, NEUROBIOL AGING, V29, P1380, DOI 10.1016/j.neurobiolaging.2007.02.027; Tong LQ, 2012, J NEUROSCI, V32, P17714, DOI 10.1523/JNEUROSCI.1253-12.2012; Tovar-y-Romo LB, 2010, J NEUROCHEM, V115, P1090, DOI 10.1111/j.1471-4159.2010.06766.x; Trounson A, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-52; Tsai EC, 2006, BIOMATERIALS, V27, P519, DOI 10.1016/j.biomaterials.2005.07.025; Tsai MC, 2008, MOL CELL PROTEOMICS, V7, P1668, DOI 10.1074/mcp.M800076-MCP200; Tse JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015978; Tsukamoto A, 2013, STEM CELL RES THER, V4, DOI [10.1186/scrt313, 10.1186/1757-6512-4-102]; Tuszynski MH, 2003, EXP NEUROL, V181, P47, DOI 10.1016/S0014-4886(02)00055-9; Tysseling VM, 2010, J NEUROSCI RES, V88, P3161, DOI 10.1002/jnr.22472; Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008; Uchida K, 2008, J NEUROSCI RES, V86, P1789, DOI 10.1002/jnr.21627; van Bruggen N, 1999, J CLIN INVEST, V104, P1613, DOI 10.1172/JCI8218; Van Den Bosch L, 2004, NEUROBIOL DIS, V17, P21, DOI 10.1016/j.nbd.2004.06.004; van Velthoven CTJ, 2010, J NEUROSCI, V30, P9603, DOI 10.1523/JNEUROSCI.1835-10.2010; Varghese M, 2010, ARCH ITAL BIOL, V148, P85; VARON S, 1979, NEUROCHEM RES, V4, P155, DOI 10.1007/BF00964141; Volpato FZ, 2013, BIOMATERIALS, V34, P4945, DOI 10.1016/j.biomaterials.2013.03.057; Wang HY, 2015, BIOCHEM BIOPH RES CO, V464, P453, DOI 10.1016/j.bbrc.2015.06.146; Wang JA, 2015, MAT SCI ENG C-MATER, V46, P140, DOI 10.1016/j.msec.2014.10.019; Wang JX, 2012, J BIOMED MATER RES A, V100A, P632, DOI 10.1002/jbm.a.33291; Wang LS, 2010, BIOMATERIALS, V31, P1148, DOI 10.1016/j.biomaterials.2009.10.042; Wang YX, 2012, BRAIN RES, V1448, P137, DOI 10.1016/j.brainres.2012.02.007; Wang YC, 2008, BIOMATERIALS, V29, P4546, DOI 10.1016/j.biomaterials.2008.07.050; Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013; Webber DJ, 2009, AM J PATHOL, V175, P2332, DOI 10.2353/ajpath.2009.090051; Wells JEA, 2003, BRAIN, V126, P1628, DOI 10.1093/brain/awg178; Whitaker CM, 2008, NEUROSCI LETT, V438, P200, DOI 10.1016/j.neulet.2008.03.087; Wiessner C, 2003, J CEREBR BLOOD F MET, V23, P154, DOI 10.1097/01.WCB.0000040400.30600.AF; Wilems TS, 2015, ACTA BIOMATER, V28, P23, DOI 10.1016/j.actbio.2015.09.018; Wilkins A, 2003, J NEUROSCI, V23, P4967, DOI 10.1523/jneurosci.23-12-04967.2003; Windrem MS, 2004, NAT MED, V10, P93, DOI 10.1038/nm974; Windrem MS, 2002, J NEUROSCI RES, V69, P966, DOI 10.1002/jnr.10397; Woerly S, 1999, TISSUE ENG, V5, P467, DOI 10.1089/ten.1999.5.467; Wright LS, 2006, EXP CELL RES, V312, P2107, DOI 10.1016/j.yexcr.2006.03.012; Wu MC, 2015, CELL BIOCHEM BIOPHYS, V71, P1, DOI 10.1007/s12013-014-0174-3; Xia L, 2013, CHINESE MED J-PEKING, V126, P909, DOI 10.3760/cma.j.issn.0366-6999.20120476; Xie JW, 2009, BIOMATERIALS, V30, P354, DOI 10.1016/j.biomaterials.2008.09.046; Xing XB, 2008, OPT EXPRESS, V16, P10815, DOI 10.1364/OE.16.010815; Xiong Y, 2012, INT J NANOMED, V7, P1977, DOI 10.2147/IJN.S30706; Xu HY, 2010, J NEUROSCI RES, V88, P3598, DOI 10.1002/jnr.22501; Xu XM, 1999, EUR J NEUROSCI, V11, P1723, DOI 10.1046/j.1460-9568.1999.00591.x; XU XM, 1995, J COMP NEUROL, V351, P145, DOI 10.1002/cne.903510113; XU XM, 1995, EXP NEUROL, V134, P261, DOI 10.1006/exnr.1995.1056; Yan YF, 2014, NEURAL REGEN RES, V9, P798, DOI 10.4103/1673-5374.131596; Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051; Yang H, 2016, MOL NEUROBIOL, V53, P2826, DOI 10.1007/s12035-015-9157-7; Yang J- P, 2009, J INVESTIG SURG; Yang JP, 2008, NEUROSCI LETT, V434, P212, DOI 10.1016/j.neulet.2008.01.078; Yang Y, 2008, J BIOMED MATER RES A, V86A, P374, DOI 10.1002/jbm.a.31595; Yang Y, 2008, EUR J PHARM BIOPHARM, V69, P106, DOI 10.1016/j.ejpb.2007.10.016; Yarnall A., 2012, MEDICINE, V40, P529, DOI DOI 10.1016/J.MPMED.2012.07.008; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Yoshikawa M, 1999, MULT SCLER J, V5, P126, DOI 10.1191/135245899678847194; Young TH, 2008, BIOMATERIALS, V29, P3521, DOI 10.1016/j.biomaterials.2008.05.013; Young TH, 2009, BIOMATERIALS, V30, P5031, DOI 10.1016/j.biomaterials.2009.05.065; Yuan ZM, 2014, BIOMATER SCI-UK, V2, P502, DOI 10.1039/c3bm60198f; Yune TY, 2003, J NEUROTRAUM, V20, P207, DOI 10.1089/08977150360547116; Zaminy A, 2013, ARCH IRAN MED, V16, P533, DOI 013169/AIM.0011; Zhan Y, 2015, J NEUROSCI RES, V93, P94, DOI 10.1002/jnr.23475; Zhang S, 2009, CHIN J TRAUMATOL, V12, P195, DOI 10.3760/cma.j.issn.1008-1275.2009.04.001; Zhang Y, 2006, BRAIN RES, V1111, P227, DOI 10.1016/j.brainres.2006.07.005; Zhao RR, 2011, J NEUROSCI METH, V201, P228, DOI 10.1016/j.jneumeth.2011.08.003; Zhou LJ, 2003, J NEUROSCI, V23, P1424, DOI 10.1523/JNEUROSCI.23-04-01424.2003; Zhou ZL, 2013, CYTOTHERAPY, V15, P434, DOI 10.1016/j.jcyt.2012.11.015; Zhu J, 2001, CNS DRUG REV, V7, P387; Zhu W, 2005, NEUROSURGERY, V57, P325, DOI 10.1227/01.NEU.0000166682.50272.BC; Zou JY, 2005, BRAIN RES, V1034, P11, DOI 10.1016/j.brainres.2004.11.014	411	1	1	2	5	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	2196-8985	2196-8993	978-3-319-44996-8; 978-3-319-44994-4	STEM CELLS BIOL REG	Stem Cell Biol. Regen. Med.		2016							121	173		10.1007/978-3-319-44996-8_7	10.1007/978-3-319-44996-8		53	Cell & Tissue Engineering; Cell Biology; Developmental Biology	Book Citation Index – Science (BKCI-S)	Cell Biology; Developmental Biology	BI9QB	WOS:000416351300008					2022-02-06	
J	Schnitzler, S; Kopitz, J; Plaschke, K				Schnitzler, Sebastian; Kopitz, Juergen; Plaschke, Konstanze			Increased hippocampal CD38 and systemic inflammation after partial hepatectomy does not induce impairment of spatial cognition	NEUROLOGICAL RESEARCH			English	Article						CD38; cognition; inflammation; sevoflurane anaesthesia; surgery	CYCLIC ADP-RIBOSE; TRAUMATIC BRAIN-INJURY; INDUCED CELL-DEATH; CEREBRAL HYPERPERFUSION; NITRIC-OXIDE; AGED RATS; SEVOFLURANE; SURGERY; NEUROINFLAMMATION; DYSFUNCTION	Objective: The role of inflammation in cognitive alterations in a post-operative setting is still not fully understood. Surgical interventions can cause systemic inflammations which eventually can induce neuroinflammation. However, the main causes of functional changes after surgery are still elusive. In this study, we investigated the role of CD38, a TNF alpha-inducible NADH(+) cyclase and hydrolase. We assume that CD38 overexpression impairs mitochondrial ATP synthesis. Within the hippocampus, the resulting cellular death could lead to cognitive impairment. Methods: Seventy-nine Wistar-HAN rats were subjected for three hours either to partial hepatectomy under sevoflurane anaesthesia ('surgery'), sevoflurane anaesthesia alone ('anaesthesia') or control. Rats were randomly selected to determine levels of CD38, TNF alpha, IL-6, and ATP, for GFAP immunohistochemistry and for Morris Water Maze testing. Results: Plasma TNF alpha and IL-6 levels were significantly higher in the surgery group in the immediate postoperative phase. GFAP expression and hippocampal CD38 concentration were significantly elevated 24 h after the intervention in the surgery group as compared to anaesthesia alone and controls. ATP levels did not differ significantly between the three groups. No treatment differences in spatial cognition parameters were found. Conclusions: Surgery in the form of partial hepatectomy activated the peripheral immune system and induced hippocampal glial activation and a CD38 increase. These changes, however, were not associated with rats' cognitive impairment >= 24 h after surgery.	[Schnitzler, Sebastian; Plaschke, Konstanze] Heidelberg Univ, Fac Med, Dept Anaesthesiol, Neuenheimer Feld 110, D-69120 Heidelberg, Germany; [Kopitz, Juergen] Heidelberg Univ, Fac Med, Dept Pathol, Heidelberg, Germany		Plaschke, K (corresponding author), Heidelberg Univ, Fac Med, Dept Anaesthesiol, Neuenheimer Feld 110, D-69120 Heidelberg, Germany.	konstanze.plaschke@med.uni-heidelberg.de					Adamczyk S, 2010, BRIT J ANAESTH, V104, P191, DOI 10.1093/bja/aep365; BAIGRIE RJ, 1992, BRIT J SURG, V79, P757, DOI 10.1002/bjs.1800790813; Banerjee S, 2008, J NEUROIMMUNE PHARM, V3, P154, DOI 10.1007/s11481-008-9105-7; Bendel S, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/1471-2253-15-2; Braidy N, 2014, BIOGERONTOLOGY, V15, P177, DOI 10.1007/s10522-013-9489-5; Bruzzone S, 2004, J NEUROCHEM, V89, P264, DOI 10.1111/j.1471-4159.2003.02326.x; Cao XZ, 2010, PROG NEURO-PSYCHOPH, V34, P1426, DOI 10.1016/j.pnpbp.2010.07.027; Cerejeira J, 2010, ACTA NEUROPATHOL, V119, P737, DOI 10.1007/s00401-010-0674-1; Choe CU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019046; Cibelli M, 2010, ANN NEUROL, V68, P360, DOI 10.1002/ana.22082; Elena G, 2003, LAB ANIM-UK, V37, P193, DOI 10.1258/002367703766453038; Garrity-Park M, 2012, INFLAMM BOWEL DIS, V18, P275, DOI 10.1002/ibd.21681; Haseneder R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064732; Hovens IB, 2014, BRAIN BEHAV IMMUN, V38, P202, DOI 10.1016/j.bbi.2014.02.002; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; Hu N, 2014, BRAIN RES, V1551, P13, DOI 10.1016/j.brainres.2014.01.015; Ibrahim RM, 2015, INT J DEV NEUROSCI, V45, P11, DOI 10.1016/j.ijdevneu.2015.04.351; Iqbal J, 2007, AM J PHYSIOL-RENAL, V292, pF1283, DOI 10.1152/ajprenal.00381.2006; Iqbal J, 2006, AM J PHYSIOL-RENAL, V291, pF557, DOI 10.1152/ajprenal.00066.2006; John GR, 2003, NEUROSCIENTIST, V9, P10, DOI 10.1177/1073858402239587; Kim S, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0195-5; Kristian T, 2011, J NEUROSCI RES, V89, P1946, DOI 10.1002/jnr.22626; Lai ZM, 2016, BRAIN RES, V1630, P25, DOI 10.1016/j.brainres.2015.10.050; Levy A, 2009, J NEUROTRAUM, V26, P1521, DOI 10.1089/neu.2008.0746; Liu JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134217; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma YX, 2012, BIOCHEM BIOPH RES CO, V418, P714, DOI 10.1016/j.bbrc.2012.01.084; Madrahimov N, 2006, ANN SURG, V244, P89, DOI 10.1097/01.sla.0000218093.12408.0f; Mamik MK, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-145; Marana E, 2013, MINERVA ANESTESIOL, V79, P7; Mayo L, 2007, CELL DEATH DIFFER, V14, P183, DOI 10.1038/sj.cdd.4401989; Mayo L, 2008, J IMMUNOL, V181, P92, DOI 10.4049/jimmunol.181.1.92; MIZUGUCHI M, 1995, BRAIN RES, V697, P235, DOI 10.1016/0006-8993(95)00885-T; Nanba T, 2012, CEREBROVASC DIS, V34, P358, DOI 10.1159/000343505; Partida-Sanchez S, 2004, J IMMUNOL, V172, P1896, DOI 10.4049/jimmunol.172.3.1896; Peng QY, 2016, J SURG RES, V201, P480, DOI 10.1016/j.jss.2015.11.029; Plaschke K, 1999, BRAIN RES, V830, P320, DOI 10.1016/S0006-8993(99)01427-4; Pollock JM, 2009, AM J NEURORADIOL, V30, P378, DOI 10.3174/ajnr.A1316; Reyes-Harde M, 1999, J NEUROPHYSIOL, V82, P1569, DOI 10.1152/jn.1999.82.3.1569; Reyes-Harde M, 1999, P NATL ACAD SCI USA, V96, P4061, DOI 10.1073/pnas.96.7.4061; Riess ML, 2002, AM J PHYSIOL-HEART C, V283, pH53, DOI 10.1152/ajpheart.01057.2001; Rosczyk HA, 2008, EXP GERONTOL, V43, P840, DOI 10.1016/j.exger.2008.06.004; Tan HY, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-93; Terrando N, 2011, ANN NEUROL, V70, P986, DOI 10.1002/ana.22664; Terrando N, 2010, P NATL ACAD SCI USA, V107, P20518, DOI 10.1073/pnas.1014557107; Verderio C, 2001, J NEUROCHEM, V78, P646, DOI 10.1046/j.1471-4159.2001.00455.x; Wan YJ, 2007, ANESTHESIOLOGY, V106, P436, DOI 10.1097/00000542-200703000-00007; Wang W, 2016, ANESTH ANALG, V123, P93, DOI 10.1213/ANE.0000000000001238; Warner KJ, 2007, J TRAUMA, V62, P1330, DOI 10.1097/TA.0b013e31804a8032; Wen Xiao-Hong, 2004, Hepatobiliary Pancreat Dis Int, V3, P38; Wuppen K, 2010, J NEURAL TRANSM, V117, P1055, DOI 10.1007/s00702-010-0441-4; Zhang DX, 2015, INT J CLIN EXP MED, V8, P20853; Zhang Y, 2015, GENE, V569, P60, DOI 10.1016/j.gene.2015.05.026	53	1	1	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.		2016	38	11					973	980		10.1080/01616412.2016.1242452			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EA1CQ	WOS:000386330500005	27724820				2022-02-06	
J	Sousa, LM; De Andrade, AF; Belon, AR; Soares, MS; Amorim, RL; Otochi, JP; Teixeira, MJ; Paiva, WS				Sousa, Leonardo M., Jr.; de Andrade, Almir F.; Belon, Alessandro R.; Soares, Matheus S.; Amorim, Robson Luis; Otochi, Jose Pinhata; Teixeira, Manoel J.; Paiva, Wellingson S.			Evaluation of the Maintained Effect of 3% Hypertonic Saline Solution in an Animal Model of Intracranial Hypertension	MEDICAL SCIENCE MONITOR BASIC RESEARCH			English	Article						Intracranial Hypertension; Intracranial Pressure Saline Solution, Hypertonic	HEALTH-CARE PROFESSIONALS; TRAUMATIC BRAIN-INJURY; OSMOTHERAPY; GUIDELINES; MANAGEMENT; HEMORRHAGE; INFUSION	Background: Current clinical treatment methods for refractory intracranial hypertension include elevation of the decubitus, ventilation adjustment, and use of hypertonic solutions such as hypertonic saline and mannitol solutions. Previous studies have shown that hypertonic solutions are particularly effective. Although several concentrations of saline solution have been proposed, a 3% solution is the most widely used. The aim of this study was to evaluate the maintained efficacy of a 3% hypertonic saline solution in an experimental model of intracranial hypertension. Material/Methods: A porcine model of reversible intracranial hypertension was created by inserting a balloon catheter into the brain parenchyma, which was inflated and deflated to simulate intracranial hypertension and its surgical correction. The experiment included 3 groups of animals (A, B, and C) with different balloon inflation volumes. In group B, balloons were inflated 2 times to simulate reexpansion. A 20 mL/kg bolus of 3% saline solution was infused using a pump 90 minutes after the start of balloon inflation, and the effects of intracranial pressure were evaluated 60 minutes after infusion. Results: No increases outside of the normal range were observed in mean serum sodium concentrations (p=0.09). In addition, we identified no differences within each group in serum sodium levels measured during hypertonic saline infusion (p=0.21). No significant reductions in intracranial pressure were observed in any of the 3 groups. Conclusions: Bolus infusion of 3% hypertonic saline solution with the aid of a pump does not significantly reduce intracranial pressure in an animal model of intracranial hypertension.	[Sousa, Leonardo M., Jr.; de Andrade, Almir F.; Amorim, Robson Luis; Paiva, Wellingson S.] Univ Sao Paulo, Sch Med, Div Neurosurg, Sao Paulo, SP, Brazil; [Sousa, Leonardo M., Jr.; de Andrade, Almir F.; Belon, Alessandro R.; Soares, Matheus S.; Otochi, Jose Pinhata; Teixeira, Manoel J.; Paiva, Wellingson S.] Univ Sao Paulo, Sch Med, LIM 26 Expt Surg Lab, Sao Paulo, SP, Brazil; [Paiva, Wellingson S.] Samaritano Hosp, Clin Res Ctr, Sao Paulo, SP, Brazil		Paiva, WS (corresponding author), Univ Sao Paulo, Sch Med, Div Neurosurg, Sao Paulo, SP, Brazil.; Paiva, WS (corresponding author), Univ Sao Paulo, Sch Med, LIM 26 Expt Surg Lab, Sao Paulo, SP, Brazil.; Paiva, WS (corresponding author), Samaritano Hosp, Clin Res Ctr, Sao Paulo, SP, Brazil.	wellingsonpaiva@yahoo.com.br	Paiva, Wellingson S/G-5517-2013; Amorim, Robson/AAK-1368-2021	Paiva, Wellingson S/0000-0002-5165-7040; Amorim, Robson/0000-0003-2391-7519	Sao Paulo Research FoundationFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/01160-1]	The study was conducted with the aid of the Sao Paulo Research Foundation, process number 2013/01160-1	Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Bhardwaj A, 2007, CURR NEUROL NEUROSCI, V7, P513, DOI 10.1007/s11910-007-0079-2; Bhardwaj Anish, 2004, Curr Opin Crit Care, V10, P126, DOI 10.1097/00075198-200404000-00009; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS14, DOI 10.1089/neu.2007.9994; Hauer EM, 2011, CRIT CARE MED, V39, P1766, DOI 10.1097/CCM.0b013e318218a390; Hays AN, 2011, NEUROCRIT CARE, V14, P222, DOI 10.1007/s12028-010-9477-4; Helmy A, 2007, BRIT J ANAESTH, V99, P32, DOI 10.1093/bja/aem139; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Koenig MA, 2008, NEUROLOGY, V70, P1023, DOI 10.1212/01.wnl.0000304042.05557.60; Li YQ, 2015, MED SCI MONITOR, V21, P1752, DOI 10.12659/MSM.892924; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Mortimer Diane Schretzman, 2006, J Neurosci Nurs, V38, P142; Nau R, 2000, CLIN PHARMACOKINET, V38, P23, DOI 10.2165/00003088-200038010-00002; Nelson CG, 2016, AM J CASE REP, V17, DOI 10.12659/AJCR.897116; Qureshi AI, 1999, NEUROLOGY, V52, P266, DOI 10.1212/WNL.52.2.266; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; Thongrong C, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2013.02.027; Tyagi R, 2007, NEUROSURG REV, V30, P277, DOI 10.1007/s10143-007-0091-7; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; Wakai A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001049.pub5; White H, 2006, ANESTH ANALG, V102, P1836, DOI 10.1213/01.ane.0000217208.51017.56; Zornow MH, 1996, J NEUROSURG ANESTH, V8, P175, DOI 10.1097/00008506-199604000-00021	22	1	1	0	6	INT SCIENTIFIC INFORMATION, INC	MELVILLE	150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA	2325-4416	2325-4394		MED SCI MONIT BASIC	Med. Sci. Monit. Basic Res.		2016	22						123	127		10.12659/MSMBR.899661			5	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	ER9PH	WOS:000399158100019	27777397	Green Published			2022-02-06	
J	St Pierre, ME; Parente, R				St Pierre, Maria E.; Parente, Rick			Efficacy of legal judgments for defendants with traumatic brain injury	NEUROREHABILITATION			English	Article						Traumatic brain injury; jury; attribution theory; verdict; forensic psychology; perception; decision making	FORENSIC PSYCHIATRY; CRIMINAL BEHAVIOR; MISCONCEPTIONS; POPULATION; AGGRESSION; PREVALENCE; VIOLENCE	BACKGROUND: Literature has compared the frequency of aggressive behaviors of the TBI population and the non-TBI population, suggesting that the TBI population is predisposed to aggressive tendencies because the injury enables impulsivity, loss of self-control, and the inability to modify behaviors. These behavior changes have consequently, been found to lead to criminal involvement. In fact, the majority of the prison population has sustained at least one TBI in their lifetime compared to the prevalence of brain injuries in the general population. However, there is little research investigating the perceptions of criminality and guilt of these individuals. METHODS: Two experiments were conducted that investigated the perceptions of morality, level of guilt, and appropriate sentencing of crimes committed by defendants with different severities of TBI (i.e., mild, severe, and no TBI). Participants were asked to read scenarios about crimes being committed by the defendant. Experiment 1 used a 1-between (crime), 1-within (TBI) mixed design ANOVA testing three dependent variables (morality, guilt, and sentencing). Using a more in vivo jury approach, Experiment 2 used a 3 (TBI) x2 (crime) independent groups factorial design testing the three dependent measures. RESULTS: Overall, defendants with TBI were found less guilty of their crime, perceived as behaving morally to the crime, and receiving a milder punishment relative to the no-TBI defendants. CONCLUSIONS: In the courtroom, the defense attorney should educate the judge and/or the jury on the effects brain injuries have on the cognition, behavior, and emotions of an individual. Thus, this education will ensure the best verdict is being reached.	[St Pierre, Maria E.; Parente, Rick] Towson Univ, Towson, MD USA		St Pierre, ME (corresponding author), Towson Univ, Dept Psychol, 8000 York Rd, Towson, MD 21252 USA.	mstpie1@students.towson.edu	Parente, Frederick/W-2570-2019	Parente, Frederick/0000-0002-2784-3433			Barnfield TV, 1998, BRAIN INJURY, V12, P455, DOI 10.1080/026990598122421; Brower MC, 2001, J NEUROL NEUROSUR PS, V71, P720, DOI 10.1136/jnnp.71.6.720; Carnes NC, 2015, PERS SOC PSYCHOL B, V41, P351, DOI 10.1177/0146167214566187; Chapman RCG, 2010, BRAIN INJURY, V24, P797, DOI 10.3109/02699051003709607; Colantonio A, 2007, BRAIN INJURY, V21, P1353, DOI 10.1080/02699050701785054; Daftary-Kapur T, 2010, LEGAL CRIMINOL PSYCH, V15, P133, DOI 10.1348/135532509X465624; Dyer KFW, 2006, BRAIN INJURY, V20, P1163, DOI 10.1080/02699050601049312; Elwork Amiram, 1977, LAW HUMAN BEHAV, V1, P163; Freedman D, 2000, SOC SCI MED, V50, P1757, DOI 10.1016/S0277-9536(99)00417-7; Haegerich TM, 2013, PSYCHOL PUBLIC POL L, V19, P81, DOI 10.1037/a0027808; Hux K, 2006, BRAIN INJURY, V20, P547, DOI 10.1080/02699050600676784; Hux K, 2013, SUPPORT LEARN, V28, P109, DOI 10.1111/1467-9604.12028; Mavis I, 2013, BRAIN INJURY, V27, P587, DOI 10.3109/02699052.2013.772236; Palijan TZ, 2010, PSYCHIAT DANUB, V22, P253; Perkes I, 2011, BRAIN INJURY, V25, P131, DOI 10.3109/02699052.2010.536193; Ramchand R, 2009, J QUANT CRIMINOL, V25, P129, DOI 10.1007/s10940-008-9061-7; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Sarapatta M, 1998, BRAIN INJURY, V12, P821, DOI 10.1080/026990598122061; Slaughter B, 2003, BRAIN INJURY, V17, P731, DOI 10.1080/0269905031000088649; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Turkstra L, 2003, BRAIN INJURY, V17, P39, DOI 10.1080/0269905021000010122; Wortzel HS, 2013, J AM ACAD PSYCHIATRY, V41, P274; Yuhasz JE, 2013, J CORRECT HEALTH CAR, V19, P135, DOI 10.1177/1078345812474644	23	1	1	0	8	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2016	39	1					125	134		10.3233/NRE-161344			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DS9QD	WOS:000381117400012	27341367				2022-02-06	
J	Su, JG; Quan, K; Fan, K; Zhang, JY; Liu, JF; Hua, W; Mao, Y				Su, Jianguang; Quan, Kai; Fan, Kun; Zhang, Jiaying; Liu, Jingfang; Hua, Wei; Mao, Ying			High omega-3/omega-6 ratio diet could alleviate blood-brain barrier dysfunction in rat model with traumatic brain injury	INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE			English	Article						Omega-3 fatty acids; traumatic brain injury; blood-brain barrier; tight junction proteins; 4-hydroxy-2-nonenal	OMEGA-3-FATTY-ACID SUPPLEMENTATION; 4-HYDROXYNONENAL 4-HNE; DOCOSAHEXAENOIC ACID; AXONAL INJURY; PERMEABILITY; MITOCHONDRIA; PROTEINS; MFSD2A	Objectives: Polyunsaturated fatty acids (PUFAs) have functional activity in many aspects, including brain trauma. Diets with different ratios of omega-3/omega-6 were applied to investigate the protective effect on delayed blood brain barrier (BBB) dysfunction after traumatic brain injury (TBI) in rat models. Methods: Moderate TBI was mimicked by Feeney's weight-dropping rat models. The effects of PUFA, with different omega-3/omega-6 ratios (1:1, 1:5, and 1:30) on BBB disruption, were examined by Evans blue (EB) dye varying from different time (day 3, 5, 7) after TBI. The corresponding change of 4-HNE and tight junction proteins were analyzed by immunofluorescence staining and western blotting technology. In the meantime, D-penicillamine (4-HNE inhibitor) was administrated to verify the role of 4-HNE in this event. Cognitive function was evaluated by Morris water maze test. Results: Delayed BBB disruption was observed in the injured brains. High omega-3/omega-6 ratios diet significantly reduced EB extravagation and 4-HNE level, and also enhanced the expression of tight junction proteins (ZO-1 and occludin). Inhibiting 4-HNE by administrating D-penicillamine could exert protective effects as well. In addition, high omega-3/omega-6 ratios diet could also promote the recovery of cognitive function after TBI. Conclusions: High omega-3/omega-6 ratio diet could alleviate delayed BBB dysfunction, which was associated with reduction of 4-HNE and enhancement of tight junction proteins. Besides, 1:1 might be a more suitable dietary omega-3/omega-6 ratio for TBI patient.	[Su, Jianguang; Fan, Kun; Zhang, Jiaying; Liu, Jingfang] Fudan Univ, Huashan Hosp, Dept Clin Nutr, 12 Middle Wulumuqi Rd, Shanghai 200040, Peoples R China; [Quan, Kai; Hua, Wei; Mao, Ying] Fudan Univ, Huashan Hosp, Dept Neurosurg, 12 Middle Wulumuqi Rd, Shanghai 200040, Peoples R China; [Fan, Kun] Fudan Univ, Inst Biomed Sci, Shanghai, Peoples R China; [Mao, Ying] Fudan Univ, Inst Brain Sci, State Key Lab Med Neurobiol, Shanghai, Peoples R China; [Mao, Ying] Fudan Univ, Collaborat Innovat Ctr Brain Sci, Shanghai, Peoples R China		Liu, JF (corresponding author), Fudan Univ, Huashan Hosp, Dept Clin Nutr, 12 Middle Wulumuqi Rd, Shanghai 200040, Peoples R China.; Hua, W (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurosurg, 12 Middle Wulumuqi Rd, Shanghai 200040, Peoples R China.	ljfhuashan@hotmail.com; doctor.huawei@gmail.com	Quan, Kai/AAZ-6374-2020	Mao, Ying/0000-0001-8055-115X	Huashan Hospital, Fudan University [2013QD04]	This work was funded by the Scientific Research project supported by Huashan Hospital, Fudan University (2013QD04). The authors' contributions were as follow: S.J. and Q.K. developed the TBI animal models, performed EB dye and immunofluorescence staining, and drafted the manuscript. F.K. did western blot. H.W. and M.Y. guided the experiments and revised the manuscript. Z.J. participated in the statistical analysis, and L.J. was involved in the study design. We would like to thank Professor Yang Guoyuan and the staff from Med-X Research Institute of Shanghai Jiaotong University for their collaborative support. We also thank Wang Xiaowen and Nelson Nellie for proofreading the manuscript.	Andringa KK, 2014, REDOX BIOL, V2, P1038, DOI 10.1016/j.redox.2014.09.006; Bailes JE, 2010, J NEUROTRAUM, V27, P1617, DOI 10.1089/neu.2009.1239; Barrett EC, 2014, ADV NUTR, V5, P268, DOI 10.3945/an.113.005280; Baskaya MK, 2000, J NEUROSURG, V92, P448, DOI 10.3171/jns.2000.92.3.0448; Bays HE, 2007, AM J CARDIOL, V99, p35C, DOI 10.1016/j.amjcard.2006.11.020; Ben-Zvi A, 2014, NATURE, V509, P507, DOI 10.1038/nature13324; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Draper E, 2011, J NUTR BIOCHEM, V22, P784, DOI 10.1016/j.jnutbio.2010.06.009; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Janssen CIF, 2014, PROG LIPID RES, V53, P1, DOI 10.1016/j.plipres.2013.10.002; Lewis M, 2013, AM J EMERG MED, V31, DOI 10.1016/j.ajem.2012.05.014; Lim SN, 2013, NEUROBIOL DIS, V51, P104, DOI 10.1016/j.nbd.2012.10.021; Lin Y, 2012, LAB INVEST, V92, P1623, DOI 10.1038/labinvest.2012.118; Mertsch K, 2001, NEUROSCI LETT, V314, P135, DOI 10.1016/S0304-3940(01)02299-6; Mills JD, 2011, J NEUROSURG, V114, P77, DOI 10.3171/2010.5.JNS08914; Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241; Russell KL, 2014, PROSTAG LEUKOTR ESS, V90, P5, DOI 10.1016/j.plefa.2013.11.003; Simopoulos AP, 2000, POULTRY SCI, V79, P961, DOI 10.1093/ps/79.7.961; Simopoulos AP, 2011, MOL NEUROBIOL, V44, P203, DOI 10.1007/s12035-010-8162-0; Usatyuk PV, 2006, J BIOL CHEM, V281, P35554, DOI 10.1074/jbc.M607305200; Wellhauser L, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-60; Zhang MJ, 2014, J NEUROSCI, V34, P1903, DOI 10.1523/JNEUROSCI.4043-13.2014; Zhong HQ, 2015, REDOX BIOL, V4, P193, DOI 10.1016/j.redox.2014.12.011	25	1	1	1	6	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	1940-5901			INT J CLIN EXP MED	Int. J. Clin. Exp. Med.		2016	9	11					21270	+					11	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	EG7UD	WOS:000391260800083					2022-02-06	
J	Sun, CQ; He, W; Xu, XY; Yuhui, JY; Wang, GS; Zhang, JN				Sun, Changqing; He, Wei; Xu, Xiangying; Yuhui, Jieyan; Wang, Guangshun; Zhang, Jianning			Serum level of IL-1 beta and IL-18 in patients with traumatic brain injury and their effects on cognitive impairment	INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY			English	Article						Traumatic brain injury; cognitive impairment; IL-1 beta; IL-18	MINI-MENTAL STATE; ALZHEIMERS-DISEASE; BLOOD-CELLS; MICE; INTERLEUKIN-1-BETA; INVOLVEMENT; RECEPTOR; MODERATE	Objective: The purpose of this study was to evaluate the changes of cognitive function for patients undergoing traumatic brain injury (TBI) and its association with interleukin (IL)-1 beta and IL-18 concentration within 6 months post-injury. Methods: 102 patients with TBI were recruited in test group, while 56 persons undergoing orthopedic operation and 50 healthy volunteers were divided into control group. Cognitive function and IL-1 beta and IL-18 concentration in control group was assessed at the beginning of the study (T0). For the test group, the endpoint indexes were evaluated at 7 days (T0), 3 months (T1) and 6 months (T2) post-injury. We compared the changes of cognitive function and its association with interleukin concentration with time going in test group. Results: Patients in test group exhibited poor cognitive status and increased IL-1 beta and IL-18 level (18.39 +/- 4.21, 99.73 +/- 13.49 pg/mL, respectively), compared with those in the control group (7.62 +/- 1.81, 54.78 +/- 6.26 pg/mL, respectively). The cognitive impairment occurrence and interleukin level were significantly associated with injury intensity (P<0.05 for all). Moreover, cognitive function of patients with TBI was improved with time going. And the improvement was significantly associated with down-regulated IL-1 beta and IL-18 level (P<0.05 for all). Conclusion: cognitive impairment occurrence is significantly correlated with GCS score and IL-1 beta and IL-18 level. Additionally, with time going cognitive function is improved and interleukin may be involved in.	[Sun, Changqing] Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin Baodi Peoples Hosp, Tianjin, Peoples R China; [He, Wei] Tianjin Med Univ, Baodi Clin Hosp, Dept Ophthalmol, Tianjin Baodi Peoples Hosp, Tianjin, Peoples R China; [Xu, Xiangying] Tianjin Med Univ, Baodi Clin Hosp, Dept Respirat, Tianjin Baodi Peoples Hosp, Tianjin, Peoples R China; [Wang, Guangshun] Tianjin Med Univ, Baodi Clin Hosp, Dept Oncol, Tianjin Baodi Peoples Hosp, Tianjin 301800, Peoples R China; [Yuhui, Jieyan; Zhang, Jianning] Tianjin Med Univ, Tianjin Neurol Inst, Gen Hosp, Dept Neurosurg, Tianjin 300052, Peoples R China		Wang, GS (corresponding author), Tianjin Med Univ, Baodi Clin Hosp, Dept Oncol, Tianjin Baodi Peoples Hosp, Tianjin 301800, Peoples R China.; Zhang, JN (corresponding author), Tianjin Med Univ, Tianjin Neurol Inst, Gen Hosp, Dept Neurosurg, Tianjin 300052, Peoples R China.	guangs-hunhan@163.com; jianningshun@sina.com					ANTHONY JC, 1982, PSYCHOL MED, V12, P397, DOI 10.1017/S0033291700046730; Bossu P, 2008, BRAIN BEHAV IMMUN, V22, P487, DOI 10.1016/j.bbi.2007.10.001; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Briones TL, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-57; Ciaramella A, 2014, NEUROIMMUNOMODULAT, V21, P8, DOI 10.1159/000354764; Clausen F, 2011, EUR J NEUROSCI, V34, P110, DOI 10.1111/j.1460-9568.2011.07723.x; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Dursun E, 2015, J NEUROIMMUNOL, V283, P50, DOI 10.1016/j.jneuroim.2015.04.014; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gorska-Ciebiada M., 2015, METAB BRAIN DIS; Gu YL, 2014, NEUROSCI LETT, V570, P86, DOI 10.1016/j.neulet.2014.04.004; Han D, 2015, INT J CLIN EXP MED, V8, P10696; Khuman J, 2011, J CEREBR BLOOD F MET, V31, P778, DOI 10.1038/jcbfm.2010.172; Kokiko-Cochran O., 2015, J NEUROTRAUMA; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mina F, 2014, MOL NEUROBIOL, V49, P1069, DOI 10.1007/s12035-013-8581-9; Mondello S, 2012, BRAIN INJURY, V26, P1629, DOI 10.3109/02699052.2012.700083; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Salani F, 2013, CYTOKINE, V61, P360, DOI 10.1016/j.cyto.2012.11.001; Saleem M, 2015, J ALZHEIMERS DIS, V47, P669, DOI 10.3233/JAD-150042; Skandsen T, 2010, ARCH PHYS MED REHAB, V91, P1904, DOI 10.1016/j.apmr.2010.08.021; Walker PA, 2009, J TRAUMA, V67, pS120, DOI 10.1097/TA.0b013e3181ad323a; Yousefzadeh-Chabok S, 2015, ARCH TRAUMA RES, V4, DOI 10.5812/atr.18357; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	25	1	1	0	12	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	1936-2625			INT J CLIN EXP PATHO	Int. J. Clin. Exp. Pathol.		2016	9	2					1975	1981					7	Oncology; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Pathology	DG1EU	WOS:000371809200171					2022-02-06	
J	Tseng, JG; Huang, BW; Ou, YW; Yen, KT; Wu, YT				Tseng, Jung-Ge; Huang, Bo-Wun; Ou, Yi-Wen; Yen, Ke-Tien; Wu, Yi-Te			Dynamic analysis of the human brain with complex cerebral sulci	BIOENGINEERED			English	Article						complex cerebral sulci; dynamic characteristics; head; human brain tissue; normal mode analysis	FINITE-ELEMENT-ANALYSIS	The brain is one of the most vulnerable organs inside the human body. Head accidents often appear in daily life and are easy to cause different level of brain damage inside the skull. Once the brain suffered intense locomotive impact, external injuries, falls, or other accidents, it will result in different degrees of concussion. This study employs finite element analysis to compare the dynamic characteristics between the geometric models of an assumed simple brain tissue and a brain tissue with complex cerebral sulci. It is aimed to understand the free vibration of the internal brain tissue and then to protect the brain from injury caused by external influences. Reverse engineering method is used for a Classic 5-Part Brain (C18) model produced by 3B Scientific Corporation. 3D optical scanner is employed to scan the human brain structure model with complex cerebral sulci and imported into 3D graphics software to construct a solid brain model to simulate the real complex brain tissue. Obtaining the normal mode analysis by inputting the material properties of the true human brain into finite element analysis software, and then to compare the simplified and the complex of brain models.	[Tseng, Jung-Ge; Yen, Ke-Tien] Cheng Shiu Univ, Dept Leisure & Sports Management, Kaohsiung, Taiwan; [Huang, Bo-Wun; Ou, Yi-Wen; Wu, Yi-Te] Cheng Shiu Univ, Dept Mech Engn, Kaohsiung, Taiwan		Huang, BW (corresponding author), Cheng Shiu Univ, Dept Mech Engn, Kaohsiung, Taiwan.	huangbw@gcloud.csu.edu.tw			National Science Foundation, Taiwan, R.O.C.National Science Foundation (NSF) [NSC99-2632-E-230-001-MY3]	This research was financially supported by the National Science Foundation, Taiwan, R.O.C. NSC99-2632-E-230-001-MY3.	El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; Ho J, 2009, J BIOMECH, V42, P2074, DOI 10.1016/j.jbiomech.2009.06.051; Huang BW, 2009, LIFE SCI J, V6, P15; Huang HM, 2000, MED BIOL ENG COMPUT, V38, P253, DOI 10.1007/BF02347044; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; Lin M-X, 1991, THESIS; Post A, 2012, J BIOMECH, V45, P679, DOI 10.1016/j.jbiomech.2011.12.005; Rashid B, 2012, J MECH BEHAV BIOMED, V10, P23, DOI 10.1016/j.jmbbm.2012.01.022; Wei Cai, 2011, THESIS; Xu S., 1991, NEW PRACTICAL ANATOM; Zhu XS, 1990, THESIS	11	1	2	1	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	2165-5979	2165-5987		BIOENGINEERED	Bioengineered		2016	7	4			SI		219	225		10.1080/21655979.2016.1197591			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DT6GJ	WOS:000381581400002	27459595	Green Published, gold			2022-02-06	
J	Wang, X; Song, ZG; Huang, DX; Gao, H; Wang, Q; Wang, ZP				Wang, X.; Song, Z. G.; Huang, D. X.; Gao, H.; Wang, Q.; Wang, Z. P.			A single nucleotide polymorphism in GABA(A) receptor isoforms is potentially responsible for isoflurane sensitivity in mice	GENETICS AND MOLECULAR RESEARCH			English	Article						GABA(A) receptors; Isoflurane sensitivity; Median effective dose; Mice; SNP	TRAUMATIC BRAIN-INJURY; BETA-3 SUBUNIT; A RECEPTOR; ANESTHESIA; PHARMACOLOGY; PATHWAYS; VOLATILE; SUBTYPES	GABA(A) receptors are chloride channels in the brain that are activated by binding with gamma-aminobutyric acid (GABA). The cDNA sequences of GABA(A) receptor subunits from two strains of mice with different sensitivities to isoflurane were compared to identify nucleotide mutations. Included 80 mice from two strains with different sensitivities to isoflurane on C57BL/6 background. Forty mice were from an isoflurane-sensitive strain (S group) and 40 mice were from a resistant strain (R group). RNA was extracted from brains of the mice, and cDNA were reverse transcribed using AMV reverse transcriptase. The amplified products were processed, sequenced, and analyzed for differences between the two strains. Chi-square analysis was performed to compare differences in nucleotide mutation frequencies between the two strains. No differences were identified in the alpha 1-6, beta(2), beta(3), or gamma 1-3 nucleotide sequences and no single nucleotide polymorphisms were found in the comparison with the GenBank sequence for the GABA(A) receptor subunit. A single nucleotide polymorphism (SNP) at the nucleotide position 462 (C/G) in the beta(1) sequence was found. This SNP was observed in 5 mice from the sensitive strain and in 36 mice from the resistant strain. The Fischer exact test (P < 0.01) was used to compare two strains of mice for SNP in the cDNA sequence of the beta(1) subunit. Additional studies are required to understand whether the GABA(A) receptor is a specific target of inhaled anesthetic action or whether the identified SNP affects the action of the volatile anesthetic.	[Wang, X.; Song, Z. G.; Huang, D. X.; Gao, H.; Wang, Q.; Wang, Z. P.] Nanjing Med Univ, Wuxi Peoples Hosp, Dept Anesthesiol, Wuxi, Peoples R China		Wang, Q (corresponding author), Nanjing Med Univ, Wuxi Peoples Hosp, Dept Anesthesiol, Wuxi, Peoples R China.	wangqianlive@126.com			National Natural Science Funds for Young Scholar [81100814]	Research supported by the National Natural Science Funds for Young Scholar (#81100814).	Barnard EA, 1998, PHARMACOL REV, V50, P291; Belelli D, 1999, TRENDS PHARMACOL SCI, V20, P496, DOI 10.1016/S0165-6147(99)01405-4; Belelli D, 2009, J NEUROSCI, V29, P12757, DOI 10.1523/JNEUROSCI.3340-09.2009; Blarre T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108458; Chen SY, 2007, J CEREBR BLOOD F MET, V27, P939, DOI 10.1038/sj.jcbfm.9600393; Chiara DC, 2013, J BIOL CHEM, V288, P19343, DOI 10.1074/jbc.M113.479725; CONCAS A, 1992, ADV BIOCHEM PSYCHOPH, V47, P349; Davies M, 2003, J PSYCHIATR NEUROSCI, V28, P263; Fukazawa K, 2014, J AM SOC NEPHROL, V25, P884, DOI 10.1681/ASN.2013111215; Hu BR, 2004, J CEREBR BLOOD F MET, V24, P934, DOI 10.1097/01.WCB.0000125888.56462.A1; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; LI WH, 1991, GENETICS, V129, P513; Liu NK, 2006, ANN NEUROL, V59, P606, DOI 10.1002/ana.20798; Maclver MB, 2014, ANESTH ANALG, V119, P558, DOI 10.1213/ANE.0000000000000321; McKernan RM, 2000, NAT NEUROSCI, V3, P587, DOI 10.1038/75761; Nelson LE, 2002, NAT NEUROSCI, V5, P979, DOI 10.1038/nn913; Quinlan JJ, 1998, ANESTHESIOLOGY, V88, P775, DOI 10.1097/00000542-199803000-00030; Rau V, 2011, ANESTH ANALG, V113, P500, DOI 10.1213/ANE.0b013e3182273aff; Reynolds DS, 2003, J NEUROSCI, V23, P8608; Rudolph U, 1999, NATURE, V401, P796, DOI 10.1038/44579; Sekine S, 2006, NEUROCHEM RES, V31, P439, DOI 10.1007/s11064-005-9024-4; VIRMANI MA, 1990, ENDOCRINOLOGY, V126, P2499, DOI 10.1210/endo-126-5-2499; Wang QA, 2010, CHINESE MED J-PEKING, V123, P1315, DOI 10.3760/cma.j.issn.0366-6999.2010.10.017; Wang Q, 2009, J AM ASSOC LAB ANIM, V48, P714; Yanovsky Y, 2012, PFLUG ARCH EUR J PHY, V463, P187, DOI 10.1007/s00424-011-0988-4; Zaker Sayed Rasoul, 2014, Adv Biomed Res, V3, P70, DOI 10.4103/2277-9175.125856; Zhou JX, 2006, ANESTH ANALG, V102, P129, DOI 10.1213/01.ane.0000189612.24147.07	27	1	1	0	3	FUNPEC-EDITORA	RIBEIRAO PRETO	RUA FLORIANO PEIXOTO 2444, ALTO DA BOA VISTA, RIBEIRAO PRETO, SP 00000, BRAZIL	1676-5680			GENET MOL RES	Genet. Mol. Res.		2016	15	2							15027340	10.4238/gmr.15027340			10	Biochemistry & Molecular Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Genetics & Heredity	DY1UH	WOS:000384879400059	27323147	Bronze			2022-02-06	
J	Wang, ZM; Law, JH; King, NKK; Rajeswaran, DK; Soh, S; Rao, JP; Ng, WH; Chua, KSG				Wang, Zhe Min; Law, Jia Hao; King, Nicolas Kon Kam; Rajeswaran, Deshan Kumar; Soh, Samantha; Rao, Jai Prashanth; Ng, Wai Hoe; Chua, Karen Sui Geok			Treatment of severe, disabling spasticity with continuous intrathecal baclofen therapy following acquired brain injury: the experience of a tertiary institution in Singapore	SINGAPORE MEDICAL JOURNAL			English	Article						dystonia; hypertonia; intrathecal baclofen pump; spasticity; traumatic brain injury	CEREBRAL-PALSY; INTRACTABLE SPASTICITY; HYPERTONIA; EFFICACY; INFUSION; CHILDREN; ADULTS	INTRODUCTION Intrathecal baclofen (ITB) therapy is a proven, effective treatment for disabling cortical spasticity. We describe the first local series of five patients with acquired brain injury (ABI) who received ITB and were followed up for 63.8 months. METHODS A retrospective review of medical and rehabilitation records of patients who received ITB therapy was carried out. Data studied included baseline demographic and injury variables, implantation data, spasticity and function, ITB dosage over time and complications. RESULTS From 2006 to 2010, a total of five patients received ITB therapy via implanted pumps about 39.4 months after ABI. Four out of five patients experienced significant reductions in their lower limb spasticity scores and improvements in global function and dependency. One patient had minor adverse events associated with baclofen-related sedation. The mean ITB dose at one year was 182.7 +/- 65.6 mcg/day. CONCLUSION Our preliminary study showed encouraging long-term outcomes and safety for ITB therapy after ABI-related intractable spasticity. Individual ITB responses over time were variable, with gender differences. The outcomes experienced by our centre were comparable to those in the general ABI population, supporting the efficacy of ITB therapy for chronic disabling spasticity.	[Wang, Zhe Min; Law, Jia Hao] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117595, Singapore; [King, Nicolas Kon Kam; Soh, Samantha; Rao, Jai Prashanth; Ng, Wai Hoe] Natl Neurosci Inst, Dept Neurosurg, Singapore, Singapore; [Rajeswaran, Deshan Kumar; Chua, Karen Sui Geok] Tan Tock Seng Hosp, Dept Rehabil Med, Singapore 569766, Singapore		Chua, KSG (corresponding author), Tan Tock Seng Hosp, Dept Rehabil Med, 17 Ang Mo Kio Ave 9, Singapore 569766, Singapore.	Karen_Chua@ttsh.com.sg		Kon Kam King, Nicolas/0000-0002-6009-4411			ALBRIGHT AL, 1991, JAMA-J AM MED ASSOC, V265, P1418, DOI 10.1001/jama.265.11.1418; Albright AL, 2003, J NEUROSURG, V98, P291, DOI 10.3171/jns.2003.98.2.0291; ALBRIGHT AL, 1993, JAMA-J AM MED ASSOC, V270, P2475, DOI 10.1001/jama.270.20.2475; Avellino AM, 2000, NEUROMODULATION, V3, P75, DOI 10.1046/j.1525-1403.2000.00075.x; Bensmail D, 2009, NEUROREHAB NEURAL RE, V23, P546, DOI 10.1177/1545968308328724; COFFEY RJ, 1993, J NEUROSURG, V78, P226, DOI 10.3171/jns.1993.78.2.0226; Cuny E, 2001, BRAIN INJURY, V15, P917, DOI 10.1080/02699050110065277; Francisco G E, 2001, Top Stroke Rehabil, V8, P36; Francisco GE, 2005, BRAIN INJURY, V19, P359, DOI 10.1080/02699050400003999; Gianino JM, 1996, INTRATHECAL DRUG THE; Gilmartin R, 2000, J CHILD NEUROL, V15, P71, DOI 10.1177/088307380001500201; Grabb PA, 1999, NEUROSURGERY, V45, P833, DOI 10.1097/00006123-199910000-00020; Gregson JM, 1999, ARCH PHYS MED REHAB, V80, P1013, DOI 10.1016/S0003-9993(99)90053-9; Haranhalli N, 2011, CHILD NERV SYST, V27, P421, DOI 10.1007/s00381-010-1277-9; Hoarau X, 2012, BRAIN INJURY, V26, P927, DOI 10.3109/02699052.2012.661913; Johnson RL, 1998, SPINAL CORD, V36, P45, DOI 10.1038/sj.sc.3100494; Kolaski K, 2008, J PEDIATR REHAB MED, V1, P3; Margetis K, 2014, NEUROMODULATION, V17, P699, DOI 10.1111/ner.12147; Mathur SN, 2014, PM&R, V6, P506, DOI 10.1016/j.pmrj.2013.12.005; Mayer NH, 1991, NEUROREHAB NEURAL RE, V5, pS1; Medical Advisory Secretariat, 2005, Ont Health Technol Assess Ser, V5, P1; Meythaler JM, 1997, J NEUROSURG, V87, P415, DOI 10.3171/jns.1997.87.3.0415; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P155, DOI 10.1053/apmr.2001.19246; Meythaler JM, 2001, STROKE, V32, P2099, DOI 10.1161/hs0901.095682; Murphy NA, 2002, ARCH PHYS MED REHAB, V83, P1721, DOI 10.1053/apmr.2002.36068; NANCE P, 1995, CAN J NEUROL SCI, V22, P22, DOI 10.1017/S0317167100040452; PENN RD, 1989, NEW ENGL J MED, V320, P1517, DOI 10.1056/NEJM198906083202303; Posteraro F, 2013, BRAIN INJURY, V27, P1671, DOI 10.3109/02699052.2013.828852; Taira T, 2006, ACTA NEUROCHIR SUPPL, V99, P61, DOI 10.1007/978-3-211-35205-2_12; Walter M, 2014, DEV NEUROREHABIL, V17, P368, DOI 10.3109/17518423.2013.827256	30	1	1	0	1	SINGAPORE MEDICAL ASSOC	SINGAPORE	2985 JALAN BUKIT MERAH, #02-2C, SMF BUILDING, SINGAPORE, SINGAPORE	0037-5675			SINGAP MED J	Singap. Med. J.	JAN	2016	57	1					8	12					5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB3RU	WOS:000368429800003	26831310	Green Published, Bronze			2022-02-06	
J	Wu, JG; Li, H; Wang, DS; Xu, DS; Wang, W				Wu, Jianguo; Li, Hong; Wang, Desheng; Xu, Desheng; Wang, Wei			Intravenous adipose-derived stem cells transplantation ameliorates memory impairment in moderate traumatic brain injury rats via the phosphorylation of extracellular signal-regulated kinase 1/2	INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE			English	Article						Adipose-derived stem cells; traumatic brain injury; ERK1/2; CREB; BDNF	LONG-TERM POTENTIATION; STROMAL CELLS; INTRACEREBRAL TRANSPLANTATION; SYNAPTIC PLASTICITY; FUNCTIONAL RECOVERY; OBJECT RECOGNITION; CEREBRAL-ISCHEMIA; PROTEIN-KINASE; SPINAL-CORD; ADAS CELLS	Preliminary studies showed transplantation of adipose-derived stem cells (ADSCs) could actually ameliorate memory impairment in TBI and the mechanisms involved are still to be elucidated. The effect of ADSCs transplantation on memory impairment of rats after TBI were accessed by the Morris water maze (MWM) and the novel object recognition testing (NOR). ADSCs-transplanted rats showed more curiosity versus vehicle-treated control group in NOR. In MWM test, rats in vehicle-treated group required significantly longer time to found the hidden platform than those that were spent by rats in sham and ADSCs transplantation groups. Rats in ADSCs transplantation group had significantly longer latencies to cross the location of the previously hidden platform than rats in vehicle-treated group during the probe trial, and rats in these two groups show significant difference in the number of platform crossing. And expression levels of phosphorylated cAMP response element binding protein (pCREB) and phosphorylated ERK (pERK) in the hippocampus were increased indicated by western blot and immunohistochemical. In conclusion, intravenous ADSCs transplantation could efficiently ameliorate memory impairment in TBI rats. Meanwhile, the learning-associated ERK and CREB activity were predominantly enhanced in the hippocampus.	[Wu, Jianguo; Li, Hong; Wang, Desheng; Xu, Desheng; Wang, Wei] Tianjin Med Univ, Hosp 2, 23 Pingjiang Rd, Tianjin 300211, Peoples R China		Wu, JG (corresponding author), Tianjin Med Univ, Hosp 2, 23 Pingjiang Rd, Tianjin 300211, Peoples R China.	wood2008cn@sina.com			Tianjin Bureau of Health [2012KZ088]	This research was supported by the Tianjin Bureau of Health (2012KZ088).	Banko JL, 2005, J NEUROSCI, V25, P9581, DOI 10.1523/JNEUROSCI.2423-05.2005; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; BRANDEIS R, 1989, INT J NEUROSCI, V48, P29, DOI 10.3109/00207458909002151; Chopp M, 2008, J NEUROL SCI, V265, P97, DOI 10.1016/j.jns.2007.06.013; Chwang WB, 2007, J NEUROSCI, V27, P12732, DOI 10.1523/JNEUROSCI.2522-07.2007; Coyne TM, 2006, STEM CELLS, V24, P2483, DOI 10.1634/stemcells.2006-0174; English JD, 1996, J BIOL CHEM, V271, P24329, DOI 10.1074/jbc.271.40.24329; English JD, J BIOL; Ennaceur A, 2010, BEHAV BRAIN RES, V215, P244, DOI 10.1016/j.bbr.2009.12.036; Estes BT, 2010, NAT PROTOC, V5, P1294, DOI 10.1038/nprot.2010.81; Gimble JM, 2003, CURR TOP DEV BIOL, V58, P137, DOI 10.1016/S0070-2153(03)58005-X; Hunt DPJ, 2008, CELL TRANSPLANT, V17, P865, DOI 10.3727/096368908786516738; Kang SK, 2003, EXP NEUROL, V183, P355, DOI 10.1016/S0014-4886(03)00089-X; KLANN E, 1991, J BIOL CHEM, V266, P24253; Koshizuka S, 2004, J NEUROPATH EXP NEUR, V63, P64, DOI 10.1093/jnen/63.1.64; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li DH, 2012, INT J MOL MED, V29, P848, DOI 10.3892/ijmm.2012.909; Longhi L, 2005, TRANSPL IMMUNOL, V15, P143, DOI 10.1016/j.trim.2005.09.003; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Mahmood A, 2002, J NEUROTRAUM, V19, P1609, DOI 10.1089/089771502762300265; Mccoy MK, 2008, EXP NEUROL, V210, P14, DOI 10.1016/j.expneurol.2007.10.011; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nagai T, 2006, NEUROREPORT, V17, P1453, DOI 10.1097/01.wnr.0000233095.74913.88; Ohtaki H, 2008, P NATL ACAD SCI USA, V105, P14638, DOI 10.1073/pnas.0803670105; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Pati S, 2011, STEM CELLS DEV, V20, P89, DOI 10.1089/scd.2010.0013; Peng S, 2010, INT J MOL SCI, V11, P222, DOI 10.3390/ijms11010222; Planat-Benard V, 2004, CIRC RES, V94, P223, DOI 10.1161/01.RES.0000109792.43271.47; Prockop DJ, 2007, CLIN PHARMACOL THER, V82, P241, DOI 10.1038/sj.clpt.6100313; Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Thiels E, 2001, REV NEUROSCIENCE, V12, P327; Uccelli A, 2010, CURR OPIN IMMUNOL, V22, P768, DOI 10.1016/j.coi.2010.10.012; Yamamoto T, 1988, J NEUROTRAUM, V5, P69, DOI 10.1089/neu.1988.5.69; Zietlow R, 2008, CELL TISSUE RES, V331, P301, DOI 10.1007/s00441-007-0488-1; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	40	1	1	0	2	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	1940-5901			INT J CLIN EXP MED	Int. J. Clin. Exp. Med.		2016	9	7					12649	12658					10	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	EA2MT	WOS:000386428400024					2022-02-06	
J	Yong, WWD; Kua, PHJ; Soon, SS; Pek, PPM; Ong, MEH				Yong, Wei Wei Dayna; Kua, Phek Hui Jade; Soon, Swee Sung; Pek, Pin Pin Maeve; Ong, Marcus Eng Hock			DARE Train-the-Trainer Pedagogy Development Using 2-Round Delphi Methodology	BIOMED RESEARCH INTERNATIONAL			English	Article							HOSPITAL CARDIAC ARRESTS; CARDIOPULMONARY-RESUSCITATION; AGONAL RESPIRATIONS; DISPATCHER; SURVIVAL	The Dispatcher-Assisted first REsponder programme aims to equip the public with skills to perform hands-only cardiopulmonary resuscitation (CPR) and to use an automated external defibrillator (AED). By familiarising them with instructions given by a medical dispatcher during an out-of-hospital cardiac arrest call, they will be prepared and empowered to react in an emergency. We aim to formalise curriculum and standardise the way information is conveyed to the participants. A panel of 20 experts were chosen. Using Delphi methodology, selected issues were classified into open-ended and close-ended questions. Consensus for an item was established at a 70% agreement rate within the panel. Questions that had 60%-69% agreement were edited and sent to the panel for another round of voting. After 2 rounds of voting, 70 consensus statements were agreed upon. These covered the following: focus of CPR; qualities and qualifications of trainers; recognition of agonal breathing; head-tilt-chin lift; landmark for chest compression; performance of CPR when injuries are present; trainers' involvement in training lay people; modesty of female patients during CPR; AED usage; content of trainer's manual; addressing of questions and answers; updates-dissemination to trainers and attendance of refresher courses. Recommendations for pedagogy for trainers of dispatcher-assisted CPR programmes were developed.	[Yong, Wei Wei Dayna] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore; [Kua, Phek Hui Jade] KK Womens & Childrens Hosp, Dept Emergency Med, Singapore, Singapore; [Soon, Swee Sung] Natl Univ Singapore, Dept Pharm, Singapore, Singapore; [Pek, Pin Pin Maeve; Ong, Marcus Eng Hock] Singapore Gen Hosp, Dept Emergency Med, Singapore, Singapore		Yong, WWD (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore.	daynayong6@gmail.com		Ong, Marcus/0000-0001-7874-7612	Temasek Cares	The authors report a grant from Temasek Cares, during the conduct of the study. The authors declare that there are no competing interests regarding the publication of this paper.	Bang A, 2003, RESUSCITATION, V56, P25, DOI 10.1016/S0300-9572(02)00278-2; Bobrow BJ, 2012, CURR OPIN CRIT CARE, V18, P228, DOI 10.1097/MCC.0b013e328351736b; BOUILLON B, 1994, ANAESTHESIST, V43, P786, DOI 10.1007/s001010050124; CLARK JJ, 1992, ANN EMERG MED, V21, P1464, DOI 10.1016/S0196-0644(05)80062-9; CULLEY LL, 1991, ANN EMERG MED, V20, P362, DOI 10.1016/S0196-0644(05)81655-5; Fernandez-Llamazares CM, 2013, PHARMACOL RES, V68, P31, DOI 10.1016/j.phrs.2012.11.001; Hsu C., 2007, PRACTICAL ASSESSMENT, V12, P1, DOI DOI 10.1016/S0169-2070(99)00018-7; Huisstede BMA, 2007, OCCUP ENVIRON MED, V64, P313, DOI 10.1136/oem.2005.023861; Lai H, 2015, RESUSCITATION, V89, P155, DOI 10.1016/j.resuscitation.2015.01.034; Marteau, 1998, HEALTH TECHNOL ASSES, V2, pI, DOI DOI 10.3310/hta2030; Ong MEH, 2015, RESUSCITATION, V96, P100, DOI 10.1016/j.resuscitation.2015.07.026; Orfaly RA, 2005, J PUBLIC HEALTH MAN, pS123; Rea TD, 2005, CURR OPIN CRIT CARE, V11, P188, DOI 10.1097/01.ccx.0000162095.08148.64; Sans S, 1997, EUR HEART J, V18, P1231; Valenzuela TD, 1997, CIRCULATION, V96, P3308; Verhagen AP, 1998, J CLIN EPIDEMIOL, V51, P1235, DOI 10.1016/S0895-4356(98)00131-0	16	1	1	0	3	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2016	2016								5460964	10.1155/2016/5460964			9	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Research & Experimental Medicine	DV7DR	WOS:000383096800001	27660757	gold, Green Published, Green Submitted			2022-02-06	
J	Zhang, JC; Dai, KR				Zhang, Jincheng; Dai, Kerong			Anti-neuron apoptosis of Resina Draconis water extracts on rats with traumatic brain injury	BIOMEDICAL RESEARCH-INDIA			English	Article						Traumatic brain injury; Resina draconis; Anti-neuron apoptosis; MDA	PERMEABILITY; CELLS	Objectives: This study was to observe the effects of Resina Draconis water extracts (RDWE) on traumatic nerve cell apoptosis, oxidative damage and inflammatory reaction of brain in rats. Methods: 100 healthy Wistar male rats were selected and randomly divided into sham operation group, brain injury group, Resina Draconis water extract 40 or 80 mg/kg group, 25 rats each group. Making traumatic brain injury animal model by improved Feeney's free falling body injury device. The rats were given 1ml of 0.9% sodium chloride and different doses of Resina Draconis (40 and 80 mg kg(-1)) by intraperitoneal injections for 5 days. Then killed for blood, taken out the whole brain tissue at 2 h, 6 h, 24 h, 1 d, 3 d and 5 d after traumatic brain injury. Serum superoxide dismutase activity (SOD), concentration of MDA (MDA), interleukin 1 beta, tumor necrosis factor alpha (TNF-alpha) and IL-6 (IL-6) concentration were detected. Brain tissue apoptosis of neural cells were detected by in situ terminal transferase labeling technique, and then statistical analysis. Results: There were no statistically significant differences (p>0.05) that the rat neuronal apoptosis quantity. The SOD activities and the levels of MDA, IL-1, TNF-alpha and IL-6 of Resina Draconis (80 mg kg-1) group was significantly decreased (p<0.05) compared with the brain injury group at the five times, but shows no statistically significant differences (p>0.05) in 2 h and 6 h after traumatic brain injury. Conclusions: It is possible to reduce the free radicals and inflammatory responses in vivo, which could inhibit the apoptosis of nerve cells after traumatic brain injury.	[Zhang, Jincheng] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Dept Orthopaed, Sch Med, Shanghai 200030, Peoples R China; [Dai, Kerong] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Dept Orthopaed, Sch Med,Shanghai Key Lab Orthopaed Implant, Shanghai 200030, Peoples R China; [Dai, Kerong] Shanghai Jiao Tong Univ, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai 200030, Peoples R China; [Dai, Kerong] Chinese Acad Sci, Shanghai Inst Biol Sci, Beijing 100864, Peoples R China		Dai, KR (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Inst Hlth Sci, Key Lab Stem Cell Biol, 639 Zhizaoju Rd, Shanghai 200011, Peoples R China.; Dai, KR (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, 639 Zhizaoju Rd, Shanghai 200011, Peoples R China.	zjc850420@163.com; krdai@163.com			Chinese Academy of SciencesChinese Academy of Sciences [XDA01030502]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81190133]	This work was supported by grant from the Chinese Academy of Sciences (No. XDA01030502) and a grant from the National Natural Science Foundation of China (No. 81190133)	Dash PK, 2016, J NEUROSCI, V36, P2809, DOI 10.1523/JNEUROSCI.3197-15.2016; Deryugina A. V., 2015, Eksperimental'naya i Klinicheskaya Farmakologiya, V78, P14; Feng Y, 2016, INT J MOL MED; Heo SK, 2010, FOOD CHEM TOXICOL, V48, P1129, DOI 10.1016/j.fct.2009.06.043; Kim H, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/459301; Meng XE, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15016933; Meng XE, 2016, MED SCI MONITOR, V22, P284, DOI 10.12659/MSM.894148; Orhan N, 2016, BRAIN RES, V1631, P113, DOI 10.1016/j.brainres.2015.11.038; Ren WY, 2013, NEURAL REGEN RES, V8, P2703, DOI 10.3969/j.issn.1673-5374.2013.29.002; Shu LF, 2016, NEUROSCI LETT, V611, P74, DOI 10.1016/j.neulet.2015.11.012; Tian R, 2016, BRAIN RES; Tsai WJ, 1998, EUR J PHARMACOL, V346, P103, DOI 10.1016/S0014-2999(98)00011-9; Wang B, 2016, NEUROSCIENCE, V316, P296, DOI 10.1016/j.neuroscience.2015.12.046	13	1	1	0	3	ALLIED ACAD	LONDON	40 BLOOMSBURY WAY, LOWER GROUND FLR, LONDON, WC1A 2SE, ENGLAND	0970-938X	0976-1683		BIOMED RES-INDIA	Biomed. Res.-India		2016	27	4					1240	1244					5	Engineering, Biomedical; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Research & Experimental Medicine	EJ8NG	WOS:000393482000047					2022-02-06	
J	Zhou, LX; Yu, JL; Sun, LC; Han, YW; Wang, GM				Zhou, Lixiang; Yu, Jinlu; Sun, Lichao; Han, Yanwu; Wang, Guangming			Overdrainage after ventriculoperitoneal shunting in a patient with a wide depressed skull bone defect: The effect of atmospheric pressure gradient	INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS			English	Article						Atmospheric pressure; Cranioplasty; Decompressive craniectomy; Hydrocephalus; Overdrainage; Ventriculoperitoneal shunt	BRAIN; HYDROCEPHALUS; CRANIECTOMY	INTRODUCTION: In patients with traumatic brain injury, an effective approach for managing refractory intracranial hypertension is wide decompressive craniectomy. Postoperative hydrocephalus is a frequent complication requiring cerebrospinal fluid (CSF) diversion. PRESENTATION OF CASE: A 50-year-old male who underwent decompressive craniectomy after traumatic brain injury. He developed hydrocephalus postoperatively, and accordingly we placed a ventriculoperitoneal shunt. However, an imbalance between the intra- and extra-cranial atmospheric pressures led to overdrainage, and he suffered cognitive disorders and extremity weakness. He remained supine for 5 days to avoid the effect of gravity on CSF diversion. After 20 days, we performed a cranioplasty using a titanium plate. The postoperative course was uneventful, and the patient achieved satisfactory recovery. DISCCUSION: The gravitational effect and the atmospheric pressure gradient effect are two factors associated in the ventriculoperitoneal (VP) shunt treatment of hydrocephalus for the patient who had decompressive craniectomy. These effects can be eliminated by supine bed rest and cranioplasty. CONCLUSION: We herein emphasize the efficacy of VP shunt, supine bed rest and cranioplasty in treating hydrocephalus patients who have undergone craniectomy. A flexible application of these procedures to change the gravitational effect and the atmospheric pressure gradient effect should promote a favorable outcome. 2016 The Authors. Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd.	[Zhou, Lixiang; Yu, Jinlu; Han, Yanwu; Wang, Guangming] Jilin Univ, Hosp 1, Dept Neurosurg, 71 Xinmin Ave, Changchun 130021, Peoples R China; [Sun, Lichao] Jilin Univ, Hosp 1, Dept Emergency, Changchun 130021, Peoples R China		Wang, GM (corresponding author), Jilin Univ, Hosp 1, Dept Neurosurg, 71 Xinmin Ave, Changchun 130021, Peoples R China.	it.isgmwang@163.com					Agha RA, 2016, INT J SURG, V34, P180, DOI 10.1016/j.ijsu.2016.08.014; Freimann FB, 2012, J NEUROSURG, V117, P1197, DOI 10.3171/2012.8.JNS1233; Jung Young Taek, 2015, KOREAN J NEUROTRAUMA, V11; Kelley GR, 2004, NEUROLOGY, V62, P157, DOI 10.1212/WNL.62.1.157; Meier U, 2013, NEUROSURGERY, V73, P1054, DOI 10.1227/NEU.0000000000000155; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Pachatouridis D, 2014, TURK NEUROSURG, V24, P855, DOI 10.5137/1019-5149.JTN.8871-13.1; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Schaller B, 2003, BRAIN RES, V982, P31, DOI 10.1016/S0006-8993(03)02900-7; Wee HY, 2014, INT MED CASE REP J, V7, P67, DOI 10.2147/IMCRJ.S59410; Yang X.F., ACTA NEUROCHIR WIEN, V150	11	1	1	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2210-2612			INT J SURG CASE REP	Int. J. Surg. Case Rep.		2016	29						11	15		10.1016/j.ijscr.2016.10.012			5	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	EF0MY	WOS:000390020900004	27810603	Green Published, gold			2022-02-06	
J	Zhu, YJ; Jin, W; Liu, H; Peng, DQ; Ding, ZY; Tang, ZX; Zhu, LL; Yu, YX				Zhu, Yongjian; Jin, Wen; Liu, Hui; Peng, Deqing; Ding, Zheyuan; Tang, Zhuxiao; Zhu, Liangliang; Yu, Yunxian			Effects of electromagnetic fields from mobile phones on depression and anxiety after titanium mesh cranioplasty among patients with traumatic brain injury	BRAIN INJURY			English	Article						Anxiety; cranioplasty; depression; electromagnetic; mobile phone; traumatic brain injury	RAT-BRAIN; PSYCHIATRIC-DISORDERS; FREQUENCY; VIBRATION; EXPOSURE; RISK; GABA; GSM	Objective: To explore the effects of radiofrequency-electromagnetic fields (RF-EMFs) from mobile phones on depression and anxiety after titanium mesh cranioplasty among patients with traumatic brain injury (TBI). Methods: Two hundred and twenty patients with TBI and titanium mesh cranioplasty who were hospitalized from 2008-2012 were recruited in this study. From November-December 2012, the relevant information was surveyed including socio-demographic characteristics, lifestyle variables, injury-related information, RF-EMF exposure of mobile phone, Self-rating Depression Scale (SDS) and Self-rating Anxiety Scale (SAS). Associations of RF-EMFs exposure after titanium mesh cranioplasty with SAS and SDS were respectively estimated by multivariable linear regression models. Results: The patients with long durations of mobile phone use (beta = -6.6, p = 0.002), long individual call duration (beta = -5.3, p = 0.012), more daily calls (beta = -3.6, p = 0.027), invariably answer call immediately (beta = -3.9, p = 0.022) and high comprehensive exposure level (beta = -4.8, p = 0.003) had a lower score of depression compared with those without a mobile phone. Moreover, an ipsilateral and contralateral answering phone enhanced the protective effect on depression. Individuals with a long duration of mobile phone use had a lower score of anxiety (beta = -4.2, p = 0.008), while those with a bilateral answering phone had higher anxiety (beta = 3.9, p = 0.012) in comparison to those without a mobile phone. Conclusion: RF-EMFs after cranioplasty were significantly associated with the lower risk of depression and anxiety status among patients with TBI. Chronic and frequent RF-EMFs exposure may improve psychiatric disorders among patients with TBI.	[Zhu, Yongjian; Peng, Deqing; Tang, Zhuxiao; Zhu, Liangliang] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurosurg, Hangzhou, Zhejiang, Peoples R China; [Jin, Wen; Liu, Hui; Ding, Zheyuan; Yu, Yunxian] Zhejiang Univ, Dept Epidemiol & Hlth Stat, Sch Med, Sch Publ Hlth, Hangzhou 310003, Zhejiang, Peoples R China; [Jin, Wen; Liu, Hui; Tang, Zhuxiao; Yu, Yunxian] Zhejiang Univ, Chron Dis Res Inst, Sch Publ Hlth, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China		Yu, YX (corresponding author), Zhejiang Univ, Sch Med, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, 866 Yu Hang Tang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	yunxianyu@zju.edu.cn	yongjian, zhu/AAR-5445-2021		National Basic Research Program of China (973 Program)National Basic Research Program of China [2011CB503706]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81172624]	The authors report no conflicts of interest concerning the materials or methods used in this study or the findings specified in this paper. The study was funded by grants from the National Basic Research Program of China (973 Program) (Grant No. 2011CB503706) and the National Natural Science Foundation of China (Grant No. 81172624).	Ahlbom A, 2009, EPIDEMIOLOGY, V20, P639, DOI 10.1097/EDE.0b013e3181b0927d; Anacker C, 2011, PSYCHONEUROENDOCRINO, V36, P415, DOI 10.1016/j.psyneuen.2010.03.007; ARIIZUMI M, 1983, EUR J APPL PHYSIOL O, V52, P15, DOI 10.1007/BF00429019; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Booij L, 2003, MOL PSYCHIATR, V8, P951, DOI 10.1038/sj.mp.4001423; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Cao Z, 2000, Wei Sheng Yan Jiu, V29, P28; Ezz HSA, 2013, EUR REV MED PHARMACO, V17, P1782; Gould KR, 2011, J HEAD TRAUMA REHAB, V26, P79, DOI 10.1097/HTR.0b013e3182036799; Hart T, 2012, ARCH PHYS MED REHAB, V93, P1343, DOI 10.1016/j.apmr.2012.03.036; Hepworth SJ, 2006, BMJ-BRIT MED J, V332, P883, DOI 10.1136/bmj.38720.687975.55; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; Hindmarch I, 2002, EUR PSYCHIAT, V17, p294S; Hyland GJ, 2000, LANCET, V356, P1833, DOI 10.1016/S0140-6736(00)03243-8; INABA R, 1992, EUR J APPL PHYSIOL O, V65, P124, DOI 10.1007/BF00705068; Janecka IP, 2000, ARCH OTOLARYNGOL, V126, P396, DOI 10.1001/archotol.126.3.396; Kleinlogel H, 2008, BIOELECTROMAGNETICS, V29, P488, DOI 10.1002/bem.20418; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Lydiard RB, 2003, J CLIN PSYCHIAT, V64, P21; Mann K, 1998, NEUROENDOCRINOLOGY, V67, P139, DOI 10.1159/000054308; Mausset-Bonnefont AL, 2004, NEUROBIOL DIS, V17, P445, DOI 10.1016/j.nbd.2004.07.004; Owens MJ, 2004, J CLIN PSYCHIAT, V65, P5; SAFAROV MI, 1991, FIZIOL ZH SSSR, V37, P3; Sigurdardottir S, 2013, J REHABIL MED, V45, P808, DOI 10.2340/16501977-1156; Wang Qiang, 2005, Wei Sheng Yan Jiu, V34, P546; Whelan-Goodinson R, 2010, J HEAD TRAUMA REHAB, V25, P320, DOI 10.1097/HTR.0b013e3181c8f8e7; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa	27	1	1	0	9	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	1					66	73		10.3109/02699052.2015.1089594			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DJ8YT	WOS:000374501200009	26595678				2022-02-06	
